PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhou, YG; Madej, MG; Guan, L; Nie, YL; Kaback, HR				Zhou, Yonggang; Madej, M. Gregor; Guan, Lan; Nie, Yiling; Kaback, H. Ronald			An Early Event in the Transport Mechanism of LacY Protein INTERACTION BETWEEN HELICES V AND I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL CROSS-LINKING; SITE-DIRECTED ALKYLATION; INDUCED CONFORMATIONAL-CHANGES; POLYTOPIC MEMBRANE-PROTEINS; LACTOSE PERMEASE; ESCHERICHIA-COLI; SCANNING MUTAGENESIS; PERIPLASMIC PATHWAY; ALTERNATING ACCESS; SUGAR	Helix V in LacY, which abuts and crosses helix I in the N-terminal helix bundle of LacY, contains Arg(144) and Trp(151), two residues that play direct roles in sugar recognition and binding, as well as Cys(154), which is important for conformational flexibility. In this study, paired Cys replacement mutants in helices V and I were strategically constructed with tandem factor Xa protease cleavage sites in the loop between the two helices to test cross-linking. None of the mutants form disulfides spontaneously; however, three mutants (Pro(28) -> Cys/Cys(154), Pro(28) -> Cys/Val(158) -> Cys, and Phe(29) -> Cys/Val(158) -> Cys) exhibit crosslinking after treatment with copper/1,10-phenanthroline (Cu/Ph) or 1,1-methanediyl bismethanethiosulfonate ((MTS)(2)-1), 3-4 angstrom), and cross-linking is quantitative in the presence of ligand. Remarkably, with one mutant, complete cross-linking with (MTS) 2-1 has no effect on lactose transport, whereas quantitative disulfide cross-linking catalyzed by Cu/Ph markedly inhibits transport activity. The findings are consistant with a number of previous conclusions suggesting that sugar binding to LacY causes a localized scissors-like movement between helices V and I near the point where the two helices cross in the middle of the membrane. This ligand-induced movement may act to initiate the global conformational change resulting from sugar binding.	[Zhou, Yonggang; Madej, M. Gregor; Guan, Lan; Nie, Yiling; Kaback, H. Ronald] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Kaback, H. Ronald] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Kaback, H. Ronald] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kaback, HR (corresponding author), Univ Calif Los Angeles, Dept Physiol, Macdonald Res Bldg,Rm 6-720,675 Charles E Young D, Los Angeles, CA 90095 USA.	rkaback@mednet.ucla.edu		Madej, M. Gregor/0000-0001-9181-6387	National Institutes of Health [DK51131, DK069463, GM073210, GM074929]; National Science Foundation [0450970]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK069463, R01DK051131, R56DK051131, R01DK069463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074929, P50GM073210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK51131, DK069463, GM073210, and GM074929 and National Science Foundation Grant 0450970 (to H. R. K.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; CARRASCO N, 1984, P NATL ACAD SCI-BIOL, V81, P4672, DOI 10.1073/pnas.81.15.4672; Chervitz SA, 1996, P NATL ACAD SCI USA, V93, P2545, DOI 10.1073/pnas.93.6.2545; CONSLER TG, 1991, BIOCHEMISTRY-US, V30, P1291, DOI 10.1021/bi00219a019; COSSON P, 1992, SCIENCE, V258, P659, DOI 10.1126/science.1329208; COSTELLO MJ, 1987, J BIOL CHEM, V262, P17072; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Ermolova N, 2006, BIOCHEMISTRY-US, V45, P4182, DOI 10.1021/bi052631h; Ermolova N, 2003, P NATL ACAD SCI USA, V100, P10187, DOI 10.1073/pnas.1434239100; Ermolova NV, 2005, BIOCHEMISTRY-US, V44, P7669, DOI 10.1021/bi0502801; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; Garcia-Celma JJ, 2009, P NATL ACAD SCI USA, V106, P7373, DOI 10.1073/pnas.0902471106; Guan L, 2003, BIOCHEMISTRY-US, V42, P1377, DOI 10.1021/bi027152m; Guan L, 2002, P NATL ACAD SCI USA, V99, P3475, DOI 10.1073/pnas.052703699; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Jiang XX, 2011, BIOCHEMISTRY-US, V50, P1634, DOI 10.1021/bi101988s; JUNG K, 1995, BIOCHEMISTRY-US, V34, P1030, DOI 10.1021/bi00003a038; Kaback H R, 1974, Methods Enzymol, V31, P698; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Kaback HR, 2011, J MEMBRANE BIOL, V239, P85, DOI 10.1007/s00232-010-9327-5; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; KONINGS WN, 1971, J BIOL CHEM, V246, P5857; le Coutre J, 1998, P NATL ACAD SCI USA, V95, P6114, DOI 10.1073/pnas.95.11.6114; LeCoutre J, 1997, P NATL ACAD SCI USA, V94, P10167, DOI 10.1073/pnas.94.19.10167; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; Majumdar DS, 2007, P NATL ACAD SCI USA, V104, P12640, DOI 10.1073/pnas.0700969104; MENICK DR, 1985, BIOCHEM BIOPH RES CO, V132, P162, DOI 10.1016/0006-291X(85)91002-2; Mirza O, 2006, EMBO J, V25, P1177, DOI 10.1038/sj.emboj.7601028; Nie W, 2008, J MOL BIOL, V379, P695, DOI 10.1016/j.jmb.2008.04.015; Nie Y, 2007, J MOL BIOL, V374, P356, DOI 10.1016/j.jmb.2007.09.006; Nie YL, 2006, J BIOL CHEM, V281, P35779, DOI 10.1074/jbc.M607232200; Nie YL, 2010, P NATL ACAD SCI USA, V107, P9903, DOI 10.1073/pnas.1004515107; Nie Y, 2009, BIOCHEMISTRY-US, V48, P738, DOI 10.1021/bi801976r; OVERATH P, 1987, P NATL ACAD SCI USA, V84, P5535, DOI 10.1073/pnas.84.16.5535; Patzlaff JS, 1998, BIOCHEMISTRY-US, V37, P15363, DOI 10.1021/bi981142x; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; Sahin-Toth M, 2001, BIOCHEMISTRY-US, V40, P13015, DOI 10.1021/bi011233l; SAHINTOTH M, 1994, P NATL ACAD SCI USA, V91, P5421, DOI 10.1073/pnas.91.12.5421; SAHINTOTH M, 1995, BIOCHEMISTRY-US, V34, P1107, DOI 10.1021/bi00004a001; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Sayeed WMH, 2009, BBA-BIOMEMBRANES, V1788, P1108, DOI 10.1016/j.bbamem.2009.01.010; SHORT SA, 1975, J BIOL CHEM, V250, P4291; Smirnova IN, 2003, BIOCHEMISTRY-US, V42, P3025, DOI 10.1021/bi027329c; Smirnova I, 2007, P NATL ACAD SCI USA, V104, P16504, DOI 10.1073/pnas.0708258104; Smirnova I, 2009, P NATL ACAD SCI USA, V106, P21561, DOI 10.1073/pnas.0911434106; SMITH SO, 1995, P NATL ACAD SCI USA, V92, P488, DOI 10.1073/pnas.92.2.488; Sorgen PL, 2002, P NATL ACAD SCI USA, V99, P14037, DOI 10.1073/pnas.182552199; Sun JZ, 1997, BIOCHEMISTRY-US, V36, P11959, DOI 10.1021/bi971172k; VANIWAARDEN PR, 1993, BIOCHEMISTRY-US, V32, P5419, DOI 10.1021/bi00071a017; Vazquez-Ibar JL, 2003, P NATL ACAD SCI USA, V100, P12706, DOI 10.1073/pnas.1835645100; Weinglass AB, 2001, BIOCHEMISTRY-US, V40, P769, DOI 10.1021/bi002171m; Wolin CD, 2000, BIOCHEMISTRY-US, V39, P6130, DOI 10.1021/bi0001269; Wu JH, 1996, P NATL ACAD SCI USA, V93, P14498, DOI 10.1073/pnas.93.25.14498; Wu JH, 1997, J MOL BIOL, V270, P285, DOI 10.1006/jmbi.1997.1099; Wu JH, 1998, J MOL BIOL, V282, P959, DOI 10.1006/jmbi.1998.2065; Wu JH, 1998, BIOCHEMISTRY-US, V37, P15785, DOI 10.1021/bi981501o; Wu JH, 1999, BIOCHEMISTRY-US, V38, P2320, DOI 10.1021/bi982288z; Wu JH, 1999, BIOCHEMISTRY-US, V38, P1715, DOI 10.1021/bi982342b; Zhou YG, 2005, J BIOL CHEM, V280, P20316, DOI 10.1074/jbc.M412937200; Zhou YG, 2008, P NATL ACAD SCI USA, V105, P3774, DOI 10.1073/pnas.0800825105; Zhou YG, 2009, J MOL BIOL, V394, P219, DOI 10.1016/j.jmb.2009.09.043	64	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30415	30422		10.1074/jbc.M111.268433	http://dx.doi.org/10.1074/jbc.M111.268433			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730060	Green Published, hybrid			2022-12-25	WOS:000294283600020
J	Xue, Y; Lee, SW; Wang, YC; Ha, Y				Xue, Yi; Lee, Sangwon; Wang, Yongcheng; Ha, Ya			Crystal Structure of the E2 Domain of Amyloid Precursor Protein-like Protein 1 in Complex with Sucrose Octasulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; HEPARIN-BINDING; CORTICAL-NEURONS; BETA-SECRETASE; MICE LACKING; APP; SULFATE; SURFACE; GENE; IDENTIFICATION	Missense mutations in the amyloid precursor protein (APP) gene can cause familial Alzheimer disease. It is thought that APP and APP-like proteins (APLPs) may play a role in adhesion and signal transduction because their ectodomains interact with components of the extracellular matrix. Heparin binding induces dimerization of APP and APLPs. To help explain how these proteins interact with heparin, we have determined the crystal structure of the E2 domain of APLP1 in complex with sucrose octasulfate (SOS). A total of three SOS molecules are bound to the E2 dimer. Two SOSs are bound inside a narrow intersubdomain groove, and the third SOS is bound near the two-fold axis of the protein. Mutational analyses show that most residues interacting with SOS also contribute to heparin binding, although in varying degrees; a deep pocket, defined by His-376, Lys-422, and Arg-429, and an interfacial site between Lys-314 and its symmetry mate are most important in the binding of the negatively charged polysaccharide. Comparison with a lower resolution APP structure shows that all key heparin binding residues are conserved and identically positioned, suggesting that APLP1 and APP may bind heparin similarly. In transfected HEK-293 cells, mutating residues responsible for heparin binding causes little change in the proteolysis of APP by the secretases. However, mutating a pair of conserved basic residues (equivalent to Arg-414 and Arg-415 of APLP1) immediately adjacent to the heparin binding site affects both the maturation and the processing of APP.	[Xue, Yi; Lee, Sangwon; Wang, Yongcheng; Ha, Ya] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Ha, Y (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	ya.ha@yale.edu		Lee, Sangwon/0000-0002-9441-6546	National Institutes of Health [GM077547]; United States Department of Energy; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM077547 (to Y. H.).; We thank S. Bian, D. Calderwood, and C. Chen for advice on mammalian cell culture. We also thank A. Heroux, H. Robinson, and A. Soares at NSLS X25 and X29 for assistance during x-ray diffraction data collection. Financial support for the beamlines comes principally from the United States Department of Energy and from the National Institutes of Health.	Bergamaschini L, 2004, J NEUROSCI, V24, P4181, DOI 10.1523/JNEUROSCI.0550-04.2004; Dahms SO, 2010, P NATL ACAD SCI USA, V107, P5381, DOI 10.1073/pnas.0911326107; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gralle M, 2006, J MOL BIOL, V357, P493, DOI 10.1016/j.jmb.2005.12.053; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; HAASS C, 1994, J BIOL CHEM, V269, P17741; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heber S, 2000, J NEUROSCI, V20, P7951; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Hoopes JT, 2010, J BIOL CHEM, V285, P2165, DOI 10.1074/jbc.M109.018432; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KISILEVSKY R, 1995, NAT MED, V1, P143, DOI 10.1038/nm0295-143; Klaver D, 2010, NEURODEGENER DIS, V7, P187, DOI 10.1159/000295661; Lee S, 2011, BIOCHEMISTRY-US, V50, P5453, DOI 10.1021/bi101846x; Leveugle B, 1998, J NEUROCHEM, V70, P736; Leveugle B, 1997, NEUROCHEM INT, V30, P543, DOI 10.1016/S0197-0186(96)00103-9; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Mok SS, 1997, FEBS LETT, V415, P303, DOI 10.1016/S0014-5793(97)01146-0; NINOMIYA H, 1993, J CELL BIOL, V121, P879, DOI 10.1083/jcb.121.4.879; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parkash V, 2008, J BIOL CHEM, V283, P35164, DOI 10.1074/jbc.M802543200; Quast T, 2003, FASEB J, V17, P1739, DOI 10.1096/fj.02-1059fje; READ RJ, 1998, ACTA CRYSTALLOGR D, V54, P905; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; Scholefield Z, 2003, J CELL BIOL, V163, P97, DOI 10.1083/jcb.200303059; SCHUBERT D, 1989, P NATL ACAD SCI USA, V86, P2066, DOI 10.1073/pnas.86.6.2066; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Storey E, 1996, BRAIN RES, V735, P217, DOI 10.1016/0006-8993(96)00608-7; van Horssen J, 2003, LANCET NEUROL, V2, P482, DOI 10.1016/S1474-4422(03)00484-8; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Yamazaki T, 1997, J NEUROSCI, V17, P1004; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	41	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29748	29757		10.1074/jbc.M111.219659	http://dx.doi.org/10.1074/jbc.M111.219659			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21715329	Green Published, hybrid			2022-12-25	WOS:000294046600034
J	Reese, ML; Boothroyd, JC				Reese, Michael L.; Boothroyd, John C.			A Conserved Non-canonical Motif in the Pseudoactive Site of the ROP5 Pseudokinase Domain Mediates Its Effect on Toxoplasma Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; FAMILY; FEATURES; REVEALS; GONDII; PARASITE; BINDING; ROLES; FOLD	The ROP5 family is a closely related set of polymorphic pseudokinases that are critical to the ability of Toxoplasma to cause disease. Polymorphisms in ROP5 also make it a major determinant of strain-specific differences in virulence. ROP5 possesses all of the major kinase motifs required for catalysis except for a substitution at the catalytic Asp. We show that this substitution in the catalytic loop of ROP5 is part of a motif conserved in other pseudokinases of both Toxoplasma and human origin, and that this motif is required for the full activity in vivo of ROP5. This suggests evolutionary selection at this site for a biochemical function, rather than simple drift away from catalysis. We present the crystal structures of a virulent isoform of ROP5 both in its ATP-bound and -unbound states and have demonstrated that despite maintaining the canonical ATP-binding motifs, ROP5 binds ATP in a distorted conformation mediated by unusual magnesium coordination sites that would not be predicted from the primary sequence. In addition, we have mapped the polymorphisms spread throughout the primary sequence of ROP5 to two major surfaces, including the activation segment of ROP5. This suggests that the pseudoactive site of this class of pseudokinases may have evolved to use the canonical ATP-binding motifs for non-catalytic signaling through allostery.	[Reese, Michael L.; Boothroyd, John C.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Stanford University	Boothroyd, JC (corresponding author), Fairchild Bldg,Rm D305,299 Campus Dr, Stanford, CA 94305 USA.	john.boothroyd@stanford.edu		Reese, Michael/0000-0001-9401-9594; Boothroyd, John C./0000-0001-9719-745X	National Institutes of Health [AI73756]; American Cancer Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI73756.; Supported, in part, by a postdoctoral fellowship from the American Cancer Society.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Behnke MS, 2011, P NATL ACAD SCI USA, V108, P9631, DOI 10.1073/pnas.1015338108; Bellon S, 1999, STRUCTURE, V7, P1057, DOI 10.1016/S0969-2126(99)80173-7; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Bradley PJ, 2007, CURR OPIN MICROBIOL, V10, P582, DOI 10.1016/j.mib.2007.09.013; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DONALD RGK, 1995, P NATL ACAD SCI USA, V92, P5749, DOI 10.1073/pnas.92.12.5749; El Hajj H, 2007, CELL MICROBIOL, V9, P54, DOI 10.1111/j.1462-5822.2006.00767.x; El Hajj H, 2006, PROTEOMICS, V6, P5773, DOI 10.1002/pmic.200600187; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Golebiowski A, 2005, BIOORG MED CHEM LETT, V15, P2285, DOI 10.1016/j.bmcl.2005.03.007; Turjanski AG, 2009, J AM CHEM SOC, V131, P6141, DOI 10.1021/ja8071995; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Henkelman G, 2005, P NATL ACAD SCI USA, V102, P15347, DOI 10.1073/pnas.0506425102; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Khavrutskii IV, 2009, BIOCHEMISTRY-US, V48, P11532, DOI 10.1021/bi901475g; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Labesse G, 2009, STRUCTURE, V17, P139, DOI 10.1016/j.str.2008.11.005; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min XS, 2004, STRUCTURE, V12, P1303, DOI 10.1016/j.str.2004.04.014; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Ong YC, 2010, J BIOL CHEM, V285, P28731, DOI 10.1074/jbc.M110.112359; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Peixoto L, 2010, CELL HOST MICROBE, V8, P208, DOI 10.1016/j.chom.2010.07.004; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Qiu W, 2009, EMBO J, V28, P969, DOI 10.1038/emboj.2009.24; Reese ML, 2011, P NATL ACAD SCI USA, V108, P9625, DOI 10.1073/pnas.1015980108; Reese ML, 2009, TRAFFIC, V10, P1458, DOI 10.1111/j.1600-0854.2009.00958.x; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Valiev M, 2003, J AM CHEM SOC, V125, P9926, DOI 10.1021/ja029618u; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126	47	63	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29366	29375		10.1074/jbc.M111.253435	http://dx.doi.org/10.1074/jbc.M111.253435			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21708941	Green Published, hybrid			2022-12-25	WOS:000293837000071
J	Tanioka, T; Tamura, Y; Fukaya, M; Shinozaki, S; Mao, J; Kim, M; Shimizu, N; Kitamura, T; Kaneki, M				Tanioka, Toshihiro; Tamura, Yoshiaki; Fukaya, Makiko; Shinozaki, Shohei; Mao, Ji; Kim, Minhye; Shimizu, Nobuyuki; Kitamura, Tadahiro; Kaneki, Masao			Inducible Nitric-oxide Synthase and Nitric Oxide Donor Decrease Insulin Receptor Substrate-2 Protein Expression by Promoting Proteasome-dependent Degradation in Pancreatic beta-Cells INVOLVEMENT OF GLYCOGEN SYNTHASE KINASE-3 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONOBESE DIABETIC MICE; HIGH-FAT DIET; GLUCOSE-HOMEOSTASIS; HUMAN ISLETS; NOD MICE; KINASE-B; MASS; INHIBITOR; IRS-2; INOS	Insulin receptor substrate-2 (IRS-2) plays a critical role in the survival and function of pancreatic beta-cells. Gene disruption of IRS-2 results in failure of the beta-cell compensatory mechanism and diabetes. Nonetheless, the regulation of IRS-2 protein expression in beta-cells remains largely unknown. Inducible nitricoxide synthase (iNOS), a major mediator of inflammation, has been implicated in beta-cell damage in type 1 and type 2 diabetes. The effects of iNOS on IRS-2 expression have not yet been investigated in beta-cells. Here, we show that iNOS and NO donor decreased IRS-2 protein expression in INS-1/832 insulinoma cells and mouse islets, whereas IRS-2 mRNA levels were not altered. Interleukin-1 beta (IL-1 beta), alone or in combination with interferon-gamma(IFN-gamma), reduced IRS-2 protein expression in an iNOS-dependent manner without altering IRS-2 mRNA levels. Proteasome inhibitors, MG132 and lactacystin, blocked the NO donor-induced reduction in IRS-2 protein expression. Treatment with NO donor led to activation of glycogen synthase kinase-3 beta (GSK-3 beta) and c-Jun N-terminal kinase (JNK/SAPK) in beta-cells. Inhibition of GSK-3 beta by pharmacological inhibitors or siRNA-mediated knockdown significantly prevented NO donor-induced reduction in IRS-2 expression in beta-cells. In contrast, a JNK inhibitor, SP600125, did not effectively block reduced IRS-2 expression in NO donor-treated beta-cells. These data indicate that iNOS-derived NO reduces IRS-2 expression by promoting protein degradation, at least in part, through a GSK-3 beta-dependent mechanism. Our findings suggest that iNOS-mediated decreased IRS-2 expresssion may contribute to the progression and/or exacerbation of beta-cell failure in diabetes.	[Tanioka, Toshihiro; Tamura, Yoshiaki; Fukaya, Makiko; Shinozaki, Shohei; Mao, Ji; Kim, Minhye; Shimizu, Nobuyuki; Kaneki, Masao] Harvard Univ, Shriners Hosp Children, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med,Med Sch, Charlestown, MA 02129 USA; [Kitamura, Tadahiro] Gunma Univ, Inst Mol & Cellular Regulat, Metab Signal Res Ctr, Gunma 3718512, Japan	Harvard University; Massachusetts General Hospital; Gunma University	Kaneki, M (corresponding author), 149 13th St,Rm 6604, Charlestown, MA 02129 USA.	mkaneki@helix.mgh.harvard.edu	Shinozaki, Shohei/AAT-3018-2021		National Institutes of Health [R01DK05827, P30NS045776, 5 u42 RR006042]; American Diabetes Association [7-08-RA-77]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR006042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045776] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23590474] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK05827 (to M. K.) and P30NS045776 (to the Microscopy and Image Analysis Core of Massachusetts General Hospital). This work was also supported by American Diabetes Association Grant 7-08-RA-77 (to M. K.).; We are grateful to Dr. C. B. Newgard for providing INS-1/832 cells. We acknowledge use of human islets provided by the National Disease Research Interchange, with support from National Institutes of Health Grant 5 u42 RR006042.	Andersson AK, 2005, MOL CELL ENDOCRINOL, V240, P50, DOI 10.1016/j.mce.2005.06.001; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Baylis SA, 1999, MOL HUM REPROD, V5, P277, DOI 10.1093/molehr/5.3.277; Bellenger J, 2011, DIABETES, V60, P1090, DOI 10.2337/db10-0901; Brandhorst D, 2001, TRANSPLANTATION, V71, P179, DOI 10.1097/00007890-200101270-00002; Briaud I, 2005, J BIOL CHEM, V280, P2282, DOI 10.1074/jbc.M412179200; Cantley J, 2007, DIABETOLOGIA, V50, P1248, DOI 10.1007/s00125-007-0637-9; Chen YT, 2009, TRANSPL P, V41, P1786, DOI 10.1016/j.transproceed.2008.10.093; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P8992, DOI 10.1073/pnas.90.19.8992; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; CORBETT JA, 1995, J EXP MED, V181, P559, DOI 10.1084/jem.181.2.559; Flodstrom M, 1999, DIABETES, V48, P706, DOI 10.2337/diabetes.48.4.706; Granata R, 2008, DIABETES, V57, P967, DOI 10.2337/db07-1104; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kato Y, 2003, DIABETOLOGIA, V46, P1228, DOI 10.1007/s00125-003-1173-x; Kitamura T, 2001, MOL CELL BIOL, V21, P5624, DOI 10.1128/MCB.21.16.5624-5630.2001; KLEEMANN R, 1993, FEBS LETT, V328, P9, DOI 10.1016/0014-5793(93)80954-S; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Lingohr MK, 2006, J BIOL CHEM, V281, P15884, DOI 10.1074/jbc.M600356200; Liu Y, 2010, DIABETOLOGIA, V53, P2600, DOI 10.1007/s00125-010-1882-x; Liu Z, 2008, DIABETOLOGIA, V51, P623, DOI 10.1007/s00125-007-0914-7; McCabe C, 2007, BIOCHEM BIOPH RES CO, V357, P75, DOI 10.1016/j.bbrc.2007.03.115; Montolio M, 2007, J ENDOCRINOL, V192, P169, DOI 10.1677/joe.1.06968; Norquay LD, 2009, ENDOCRINOLOGY, V150, P4531, DOI 10.1210/en.2009-0395; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Papaccio G, 2000, J CELL BIOCHEM, V77, P82, DOI 10.1002/(SICI)1097-4644(20000401)77:1<82::AID-JCB9>3.3.CO;2-M; Park SM, 2007, J APPL PHYSIOL, V103, P1764, DOI 10.1152/japplphysiol.00434.2007; Pfleger C, 2008, DIABETES, V57, P929, DOI 10.2337/db07-1697; Rabinovitch A, 1996, ENDOCRINOLOGY, V137, P2093, DOI 10.1210/en.137.5.2093; Reddy S, 1999, HISTOCHEM J, V31, P303, DOI 10.1023/A:1003765918017; Reddy S, 2001, HISTOCHEM J, V33, P317, DOI 10.1023/A:1012422821187; Rydgren T, 2002, EUR J ENDOCRINOL, V147, P543, DOI 10.1530/eje.0.1470543; Salehi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002165; Sekiya M, 2009, CELL METAB, V10, P219, DOI 10.1016/j.cmet.2009.08.004; Shimabukuro M, 1997, J CLIN INVEST, V100, P290, DOI 10.1172/JCI119534; Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017; Storling J, 2005, DIABETOLOGIA, V48, P2039, DOI 10.1007/s00125-005-1912-2; Takamura T, 1998, J BIOL CHEM, V273, P2493, DOI 10.1074/jbc.273.5.2493; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Tanabe K, 2008, PLOS BIOL, V6, P307, DOI 10.1371/journal.pbio.0060037; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Thomas HE, 2004, DIABETES, V53, P113, DOI 10.2337/diabetes.53.1.113; Thomas HE, 2002, DIABETES, V51, P311, DOI 10.2337/diabetes.51.2.311; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yasuda H, 2009, DIABETES RES CLIN PR, V83, P200, DOI 10.1016/j.diabres.2008.11.029; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Zumsteg U, 2000, DIABETES, V49, P39, DOI 10.2337/diabetes.49.1.39	55	22	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29388	29396		10.1074/jbc.M110.192732	http://dx.doi.org/10.1074/jbc.M110.192732			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21700708	Green Published, hybrid			2022-12-25	WOS:000293837000073
J	Raida, MK; Nylen, J; Holten-Andersen, L; Buchmann, K				Raida, Martin K.; Nylen, Jorgen; Holten-Andersen, Lars; Buchmann, Kurt			Association between Plasma Antibody Response and Protection in Rainbow Trout Oncorhynchus mykiss Immersion Vaccinated against Yersinia ruckeri	PLOS ONE			English	Article							SALMO-GAIRDNERI RICHARDSON; VIBRIO-ANGUILLARUM; BACTERINS; IMMUNIZATION; IMMUNITY; WALBAUM; INFECTIONS; EFFICACY; DISEASE; FISH	A key hallmark of the vertebrate adaptive immune system is the generation of antigen-specific antibodies from B cells. Fish are the most primitive gnathostomes (jawed vertebrates) possessing an adaptive immune system. Vaccination of rainbow trout against enteric redmouth disease (ERM) by immersion in Yersinia ruckeri bacterin confers a high degree of protection to the fish. The immune mechanisms responsible for protection may comprise both cellular and humoral elements but the role of specific immunoglobulins in this system has been questioned and not previously described. The present study demonstrates significant increase in plasma antibody titers following immersion vaccination and significantly reduced mortality during Y. ruckeri challenge. Rainbow trout were immersion-vaccinated, using either a commercial ERM vaccine (AquaVac (TM) ERM vet) or an experimental Y. ruckeri bacterin. Half of the trout vaccinated with AquaVac (TM) ERM vet received an oral booster (AquaVac (TM) ERM Oral vet). Sub-groups of the fish from each group were subsequently exposed to 1x10(9) CFU Y. ruckeri/ml either eight or twenty-six weeks post vaccination (wpv). All vaccinated groups showed 0% mortality when challenged, which was highly significant compared to the non-vaccinated controls (40 and 28% mortality eight and twenty-six weeks post vaccination (wpv), respectively) (P < 0.0001). Plasma samples from all groups of vaccinated fish were taken 0, 4, 8, 12, 16 and 26 wpv. and Y. ruckeri specific IgM antibody levels were measured with ELISA. A significant increase in titers was recorded in vaccinated fish, which also showed a reduced bacteremia during challenge. In vitro plasma studies showed a significantly increased bactericidal effect of fresh plasma from vaccinated fish indicating that plasma proteins may play a role in protection of vaccinated rainbow trout.	[Raida, Martin K.; Holten-Andersen, Lars; Buchmann, Kurt] Univ Copenhagen, Dept Vet Dis Biol, Fac Life Sci, Frederiksberg, Denmark; [Nylen, Jorgen] Intervet Schering Plough Anim Hlth, Ballerup, Denmark	University of Copenhagen; Merck & Company; Schering Plough Corporation	Raida, MK (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Fac Life Sci, Frederiksberg, Denmark.	mkr@life.ku.dk		Buchmann, Kurt/0000-0002-2747-237X	Danish Agency for Science Technology and Innovation [274-07-0354]	Danish Agency for Science Technology and Innovation	This work was supported by the Danish Agency for Science Technology and Innovation Grant 274-07-0354. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEND DF, 1983, J FISH DIS, V6, P337, DOI 10.1111/j.1365-2761.1983.tb00085.x; ANDERSON DP, 1985, AM ZOOL, V25, P75; CIPRIANO RC, 1987, J WILDLIFE DIS, V23, P545, DOI 10.7589/0090-3558-23.4.545; COSSARINIDUNIER M, 1986, J FISH DIS, V9, P27, DOI 10.1111/j.1365-2761.1986.tb00976.x; Fernandez L, 2007, VET MICROBIOL, V125, P1, DOI 10.1016/j.vetmic.2007.06.013; Fouz B, 2006, J FISH DIS, V29, P339, DOI 10.1111/j.1365-2761.2006.00723.x; HORNE MT, 1999, FISH DIS DISORDERS, V3, P455; HUNTER VA, 1980, J FISH DIS, V3, P467, DOI 10.1111/j.1365-2761.1980.tb00433.x; JOHNSON KA, 1983, J FISH DIS, V6, P331, DOI 10.1111/j.1365-2761.1983.tb00084.x; JOHNSON KA, 1982, J FISH DIS, V5, P207, DOI 10.1111/j.1365-2761.1982.tb00475.x; JOHNSON KA, 1983, J FISH DIS, V6, P473, DOI 10.1111/j.1365-2761.1983.tb00101.x; Larsen JL, 1997, DEV BIOLOGICALS, V90, P391; OLESEN NJ, 1991, J APPL ICHTHYOL, V7, P36, DOI 10.1111/j.1439-0426.1991.tb00592.x; Raida MK, 2008, VACCINE, V26, P1050, DOI 10.1016/j.vaccine.2007.12.029; Raida MK, 2008, FISH SHELLFISH IMMUN, V25, P533, DOI 10.1016/j.fsi.2008.07.008; Raida MK, 2009, DEV COMP IMMUNOL, V33, P35, DOI 10.1016/j.dci.2008.07.001; Ryckaert J, 2010, FISH SHELLFISH IMMUN, V29, P648, DOI 10.1016/j.fsi.2010.06.009; Stevenson RMW, 1997, DEV BIOLOGICALS, V90, P117; TATNER MF, 1987, AQUACULTURE, V62, P173, DOI 10.1016/0044-8486(87)90164-5; Tobback E, 2007, J FISH DIS, V30, P257, DOI 10.1111/j.1365-2761.2007.00816.x; Tobback E, 2009, DIS AQUAT ORGAN, V84, P219, DOI 10.3354/dao02057; TORROBA M, 1993, HISTOL HISTOPATHOL, V8, P363	22	51	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e18832	10.1371/journal.pone.0018832	http://dx.doi.org/10.1371/journal.pone.0018832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731605	Green Published, Green Submitted, gold			2022-12-25	WOS:000292036900001
J	Willett, CS				Willett, Christopher S.			Complex Deleterious Interactions Associated with Malic Enzyme May Contribute to Reproductive Isolation in the Copepod Tigriopus californicus	PLOS ONE			English	Article							DOBZHANSKY-MULLER INCOMPATIBILITIES; ELECTRON-TRANSPORT SYSTEM; CYTOCHROME-C GENOTYPES; HYBRID STERILITY; POPULATION DIFFERENTIATION; DROSOPHILA-MELANOGASTER; OUTBREEDING DEPRESSION; EPISTATIC INTERACTIONS; GENE CAUSES; EVOLUTION	Dobzhansky-Muller incompatibilities can result from the interactions of more than a single pair of interacting genes and there are several different models of how such complex interactions can be structured. Previous empirical work has identified complex conspecific epistasis as a form of complex interaction that has contributed to postzygotic reproductive isolation between taxa, but other forms of complexity are also possible. Here, I probe the genetic basis of reproductive isolation in crosses of the intertidal copepod Tigriopus californicus by looking at the impact of markers in genes encoding metabolic enzymes in F-2 hybrids. The region of the genome associated with the locus ME2 is shown to have strong, repeatable impacts on the fitness of hybrids in crosses and epistatic interactions with another chromosomal region marked by the GOT2 locus in one set of crosses. In a cross between one of these populations and a third population, these two regions do not appear to interact despite the continuation of a large effect of the ME2 region itself in both crosses. The combined results suggest that the ME2 chromosomal region is involved in incompatibilities with several unique partners. If these deleterious interactions all stem from the same factor in this region, that would suggest a different form of complexity from complex conspecific epistasis, namely, multiple independent deleterious interactions stemming from the same factor. Confirmation of this idea will require more fine-scale mapping of the interactions of the ME2 region of the genome.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Willett, CS (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	willett4@email.unc.edu	Willett, Christopher/F-9443-2011	Willett, Christopher/0000-0002-9094-9265	National Science Foundation [DEB-0516139, DEB-0821003]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grants DEB-0516139 and DEB-0821003 to CSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbash DA, 2000, GENETICS, V154, P1747; Bordenstein SR, 2001, J EVOLUTION BIOL, V14, P490, DOI 10.1046/j.1420-9101.2001.00289.x; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Burton RS, 1998, EVOLUTION, V52, P734, DOI 10.1111/j.1558-5646.1998.tb03698.x; BURTON RS, 1987, EVOLUTION, V41, P504, DOI 10.1111/j.1558-5646.1987.tb05821.x; Burton RS, 1997, EVOLUTION, V51, P993, DOI 10.1111/j.1558-5646.1997.tb03681.x; BURTON RS, 1985, MAR BIOL, V86, P247, DOI 10.1007/BF00397511; CABOT EL, 1994, GENETICS, V137, P175; Chang AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015377; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Coyne JA, 1998, GENETICS, V150, P1091; Coyne JA, 2004, SPECIATION, V37; Davis AW, 1996, GENETICS, V143, P1287; DAVIS AW, 1994, GENETICS, V137, P191; Demuth JP, 2007, EVOLUTION, V61, P494, DOI 10.1111/j.1558-5646.2007.00048.x; DILL MM, 1984, BIOCHEM GENET, V22, P339, DOI 10.1007/BF00484232; Edmands S, 1999, EVOLUTION, V53, P1757, DOI 10.1111/j.1558-5646.1999.tb04560.x; Edmands S, 2004, J EXP MAR BIOL ECOL, V303, P183, DOI 10.1016/j.jembe.2003.11.012; Edmands S, 2001, MOL ECOL, V10, P1743, DOI 10.1046/j.0962-1083.2001.01306.x; Edmands S, 2009, EVOLUTION, V63, P2184, DOI 10.1111/j.1558-5646.2009.00689.x; Fay JC, 2000, GENETICS, V155, P1405; FU YX, 1993, GENETICS, V133, P693; GANZ HH, 1995, MAR BIOL, V123, P821, DOI 10.1007/BF00349126; HALDANE JBS, 1964, J GENET, V59, P29, DOI 10.1007/BF02984134; Harrison JS, 2006, J EVOLUTION BIOL, V19, P2040, DOI 10.1111/j.1420-9101.2006.01145.x; Hoelzel A.R., 1992, P159; Johnson NA, 2010, TRENDS GENET, V26, P317, DOI 10.1016/j.tig.2010.04.005; Kondrashov AS, 2003, EVOLUTION, V57, P151; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maside XR, 1998, GENETICS, V150, P745; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Moyle LC, 2009, GENETICS, V181, P347, DOI 10.1534/genetics.108.095679; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; ORR HA, 1995, GENETICS, V139, P1805; Orr HA, 2001, GENETICS, V158, P1089; Palmer CA, 2000, MAR BIOL, V136, P693, DOI 10.1007/s002270050729; PEREZ DE, 1995, GENETICS, V140, P201; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; TAJIMA F, 1989, GENETICS, V123, P585; Tang SW, 2009, SCIENCE, V323, P779, DOI 10.1126/science.1169123; Wade MJ, 1999, EVOLUTION, V53, P855, DOI [10.2307/2640725, 10.1111/j.1558-5646.1999.tb05379.x]; Welch JJ, 2004, EVOLUTION, V58, P1145; Willett CS, 2007, J EVOLUTION BIOL, V20, P1196, DOI 10.1111/j.1420-9101.2006.01281.x; Willett CS, 2008, GENETICA, V133, P129, DOI 10.1007/s10709-007-9191-0; Willett CS, 2008, J HERED, V99, P56, DOI 10.1093/jhered/esm088; Willett CS, 2006, GENETICS, V173, P1465, DOI 10.1534/genetics.105.051011; Willett CS, 2011, GENETICA, V139, P575, DOI 10.1007/s10709-010-9525-1; Willett CS, 2010, EVOLUTION, V64, P2521, DOI 10.1111/j.1558-5646.2010.01008.x; Willett CS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-139; Willett CS, 2004, MOL BIOL EVOL, V21, P443, DOI 10.1093/molbev/msh031; Willett CS, 2003, EVOLUTION, V57, P2286; Willett CS, 2001, EVOLUTION, V55, P1592; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	54	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21177	10.1371/journal.pone.0021177	http://dx.doi.org/10.1371/journal.pone.0021177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731664	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700043
J	Lopes-dos-Santos, V; Conde-Ocazionez, S; Nicolelis, MAL; Ribeiro, ST; Tort, ABL				Lopes-dos-Santos, Vitor; Conde-Ocazionez, Sergio; Nicolelis, Miguel A. L.; Ribeiro, Sidarta T.; Tort, Adriano B. L.			Neuronal Assembly Detection and Cell Membership Specification by Principal Component Analysis	PLOS ONE			English	Article							ENSEMBLE ACTIVITY; SURROGATE-DATA; CORTICAL ACTIVITY; FIRING PATTERNS; SINGLE NEURONS; NETWORK; CORTEX; NONLINEARITY; HIPPOCAMPUS; SYNCHRONIZATION	In 1949, Donald Hebb postulated that assemblies of synchronously activated neurons are the elementary units of information processing in the brain. Despite being one of the most influential theories in neuroscience, Hebb's cell assembly hypothesis only started to become testable in the past two decades due to technological advances. However, while the technology for the simultaneous recording of large neuronal populations undergoes fast development, there is still a paucity of analytical methods that can properly detect and track the activity of cell assemblies. Here we describe a principal component-based method that is able to (1) identify all cell assemblies present in the neuronal population investigated, (2) determine the number of neurons involved in ensemble activity, (3) specify the precise identity of the neurons pertaining to each cell assembly, and (4) unravel the time course of the individual activity of multiple assemblies. Application of the method to multielectrode recordings of awake and behaving rats revealed that assemblies detected in the cerebral cortex and hippocampus typically contain overlapping neurons. The results indicate that the PCA method presented here is able to properly detect, track and specify neuronal assemblies, irrespective of overlapping membership.	[Lopes-dos-Santos, Vitor; Conde-Ocazionez, Sergio; Ribeiro, Sidarta T.; Tort, Adriano B. L.] Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil; [Lopes-dos-Santos, Vitor; Conde-Ocazionez, Sergio; Nicolelis, Miguel A. L.; Ribeiro, Sidarta T.; Tort, Adriano B. L.] Edmond & Lily Safra Int Inst Neurosci Natal, Natal, RN, Brazil; [Nicolelis, Miguel A. L.] Duke Univ, Ctr Neuroengn, Durham, NC USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Neurobiol, Durham, NC USA	Universidade Federal do Rio Grande do Norte; Duke University; Duke University	Lopes-dos-Santos, V (corresponding author), Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil.	vtlsantos@gmail.com; tort@neuro.ufrn.br	Tort, Adriano/A-9945-2009; Lopes-dos-Santos, Vítor/C-3541-2014; Ribeiro, Sidarta/C-5794-2016	Tort, Adriano/0000-0002-9877-7816; Lopes-dos-Santos, Vitor/0000-0002-1858-0125; Ribeiro, Sidarta/0000-0001-9325-9545; Conde-Ocazionez, Sergio/0000-0002-8290-5502	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Associacao Alberto Santos Dumont para Apoio a Pesquisa	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Associacao Alberto Santos Dumont para Apoio a Pesquisa	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and Associacao Alberto Santos Dumont para Apoio a Pesquisa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1988, J NEUROPHYSIOL, V60, P909, DOI 10.1152/jn.1988.60.3.909; Abeles M, 2001, J NEUROSCI METH, V107, P141, DOI 10.1016/S0165-0270(01)00364-8; Abeles M, 1991, CORTICONICS NEURAL C; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; BERGER D, 2010, COMPUTATIONAL INTELL, DOI DOI 10.1155/2010/439648).HINDAWI; Berger D, 2007, NEUROCOMPUTING, V70, P2112, DOI 10.1016/j.neucom.2006.10.141; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bowers JS, 2009, PSYCHOL REV, V116, P220, DOI 10.1037/a0014462; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Carmena Jose M, 2003, PLoS Biol, V1, pE42; Chapin JK, 1999, J NEUROSCI METH, V94, P121, DOI 10.1016/S0165-0270(99)00130-2; Freiwald W A, 2001, Prog Brain Res, V130, P111; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Grun S, 2009, J NEUROPHYSIOL, V101, P1126, DOI 10.1152/jn.00093.2008; Grun S, 2002, NEURAL COMPUT, V14, P43, DOI 10.1162/089976602753284455; Harris KD, 2005, NAT REV NEUROSCI, V6, P399, DOI 10.1038/nrn1669; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hebb Donald O., 1949, ORG BEHAV; Humphries MD, 2011, J NEUROSCI, V31, P2321, DOI 10.1523/JNEUROSCI.2853-10.2011; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; KELEMEN E, 2010, PLOS BIOL, V8; Khoa TQD, 2008, J PHYSIOL SCI, V58, P47, DOI 10.2170/physiolsci.RP012707; Koch C, 1996, CEREB CORTEX, V6, P93, DOI 10.1093/cercor/6.2.93; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Leger JF, 2005, J NEUROPHYSIOL, V93, P281, DOI 10.1152/jn.00067.2003; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Louis S, 2010, NEURAL NETWORKS, V23, P705, DOI 10.1016/j.neunet.2010.05.004; Maldonado P, 2008, J NEUROPHYSIOL, V100, P1523, DOI 10.1152/jn.00076.2008; Marcenko V. A., 1967, MATH USSR SB, V1, P457, DOI [10.1070/SM1967v001n04ABEH001994, DOI 10.1070/SM1967V001N04ABEH001994]; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Mokeichev A, 2007, NEURON, V53, P413, DOI 10.1016/j.neuron.2007.01.017; Nicolelis MAL, 1997, NEURON, V19, P219, DOI 10.1016/S0896-6273(00)80932-0; Nicolelis MAL, 1998, NAT NEUROSCI, V1, P621, DOI 10.1038/2855; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; Nicolelis MAL, 1999, J NEUROSCI METH, V94, P3; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Perc M, 2008, BIOPHYS CHEM, V132, P33, DOI 10.1016/j.bpc.2007.10.002; Peyrache A, 2010, J COMPUT NEUROSCI, V29, P309, DOI 10.1007/s10827-009-0154-6; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Pipa G, 2008, J COMPUT NEUROSCI, V25, P64, DOI 10.1007/s10827-007-0065-3; Plerou V, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066126; Pradhan N, 1996, PHYS REV E, V53, P2684, DOI 10.1103/PhysRevE.53.2684; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; Quiroga RQ, 2008, TRENDS COGN SCI, V12, P87, DOI 10.1016/j.tics.2007.12.003; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; Ribeiro S, 2007, FRONT NEUROSCI-SWITZ, V1, P43, DOI 10.3389/neuro.01.1.1.003.2007; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schreiber T, 1999, PHYS REP, V308, P2, DOI 10.1016/S0370-1573(98)00035-0; Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635; Shmiel T, 2006, J NEUROPHYSIOL, V96, P2645, DOI 10.1152/jn.00798.2005; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Staude B, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00016; Staude B, 2010, J COMPUT NEUROSCI, V29, P327, DOI 10.1007/s10827-009-0195-x; Stevenson IH, 2011, NAT NEUROSCI, V14, P139, DOI 10.1038/nn.2731; Tetko IV, 2001, J NEUROSCI METH, V105, P1, DOI 10.1016/S0165-0270(00)00336-8; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; TRACY CA, 1994, COMMUN MATH PHYS, V159, P151, DOI 10.1007/BF02100489; Volman V, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043013; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; Wang QY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026206; Waydo S, 2006, J NEUROSCI, V26, P10232, DOI 10.1523/JNEUROSCI.2101-06.2006; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	75	57	58	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20996	10.1371/journal.pone.0020996	http://dx.doi.org/10.1371/journal.pone.0020996			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698248	gold, Green Published			2022-12-25	WOS:000291730000037
J	Nityananda, V; Bee, MA				Nityananda, Vivek; Bee, Mark A.			Finding Your Mate at a Cocktail Party: Frequency Separation Promotes Auditory Stream Segregation of Concurrent Voices in Multi-Species Frog Choruses	PLOS ONE			English	Article							HYLA-VERSICOLOR; TONE SEQUENCES; SONGBIRD FOREBRAIN; GREY TREEFROGS; PERCEPTUAL ORGANIZATION; BEHAVIORAL MEASURES; SCENE ANALYSIS; CALL DURATION; RECOGNITION; PREFERENCES	Vocal communication in crowded social environments is a difficult problem for both humans and nonhuman animals. Yet many important social behaviors require listeners to detect, recognize, and discriminate among signals in a complex acoustic milieu comprising the overlapping signals of multiple individuals, often of multiple species. Humans exploit a relatively small number of acoustic cues to segregate overlapping voices (as well as other mixtures of concurrent sounds, like polyphonic music). By comparison, we know little about how nonhuman animals are adapted to solve similar communication problems. One important cue enabling source segregation in human speech communication is that of frequency separation between concurrent voices: differences in frequency promote perceptual segregation of overlapping voices into separate "auditory streams" that can be followed through time. In this study, we show that frequency separation (Delta F) also enables frogs to segregate concurrent vocalizations, such as those routinely encountered in mixed-species breeding choruses. We presented female gray treefrogs (Hyla chrysoscelis) with a pulsed target signal (simulating an attractive conspecific call) in the presence of a continuous stream of distractor pulses (simulating an overlapping, unattractive heterospecific call). When the Delta F between target and distractor was small (e.g., <= 3 semitones), females exhibited low levels of responsiveness, indicating a failure to recognize the target as an attractive signal when the distractor had a similar frequency. Subjects became increasingly more responsive to the target, as indicated by shorter latencies for phonotaxis, as the Delta F between target and distractor increased (e.g., Delta F = 6-12 semitones). These results support the conclusion that gray treefrogs, like humans, can exploit frequency separation as a perceptual cue to segregate concurrent voices in noisy social environments. The ability of these frogs to segregate concurrent voices based on frequency separation may involve ancient hearing mechanisms for source segregation shared with humans and other vertebrates.	[Nityananda, Vivek; Bee, Mark A.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Nityananda, V (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	mbee@umn.edu	Bee, Mark A/A-9410-2013	Bee, Mark A/0000-0002-6770-9730; Nityananda, Vivek/0000-0002-2878-2425	NIDCD [DC009582]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009582] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIDCD DC009582 (http://www.nidcd.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder TB, 1998, NAT NEUROSCI, V1, P519, DOI 10.1038/2237; ASSMANN PF, 1999, P 14 INT C PHON SCI, P179; Bee MA, 2005, BRAIN BEHAV EVOLUT, V66, P197, DOI 10.1159/000087854; Bee MA, 2004, J NEUROPHYSIOL, V92, P1088, DOI 10.1152/jn.00884.2003; Bee MA, 2008, ANIM BEHAV, V76, P845, DOI 10.1016/j.anbehav.2008.01.029; Bee MA, 2008, J COMP PSYCHOL, V122, P235, DOI 10.1037/0735-7036.122.3.235; Bee MA, 2008, ANIM BEHAV, V75, P1781, DOI 10.1016/j.anbehav.2007.10.032; Bee MA, 2010, J COMP PHYSIOL A, V196, P543, DOI 10.1007/s00359-010-0542-4; Bee MA, 2010, ETHOLOGY, V116, P564, DOI 10.1111/j.1439-0310.2010.01773.x; Bee MA, 2009, J ACOUST SOC AM, V126, P2788, DOI 10.1121/1.3224707; Bird J., 1998, PSYCHOPHYSICAL PHYSL, P263; Bregman A.S., 1990, AUDITORY SCENE ANAL; BROKX JPL, 1982, J PHONETICS, V10, P23, DOI 10.1016/S0095-4470(19)30909-X; Bush SL, 2002, ANIM BEHAV, V63, P7, DOI 10.1006/anbe.2001.1880; Capranica RR, 1983, ADV VERTEBRATE NEURO, P701, DOI DOI 10.1007/978-1-4684-4412-4_36; Carlyon RP, 2004, TRENDS COGN SCI, V8, P465, DOI 10.1016/j.tics.2004.08.008; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; Darwin CJ, 1997, TRENDS COGN SCI, V1, P327, DOI 10.1016/S1364-6613(97)01097-8; Edwards CJ, 2002, NAT NEUROSCI, V5, P934, DOI 10.1038/nn916; Elliott L., 2009, FROGS TOADS N AM COM; Endepols H, 2003, BEHAV BRAIN RES, V145, P63, DOI 10.1016/S0166-4328(03)00098-6; Fay Richard R., 2008, V29, P307; Fay RR, 2000, HEARING RES, V149, P1, DOI 10.1016/S0378-5955(00)00168-4; Fay RR, 1998, HEARING RES, V120, P69, DOI 10.1016/S0378-5955(98)00058-6; Fishman YI, 2004, J ACOUST SOC AM, V116, P1656, DOI 10.1121/1.1778903; Fishman YI, 2001, HEARING RES, V151, P167, DOI 10.1016/S0378-5955(00)00224-0; Gerhardt HC, 2005, ANIM BEHAV, V70, P39, DOI 10.1016/j.anbehav.2004.09.021; Gerhardt HC, 2000, BEHAV ECOL, V11, P663, DOI 10.1093/beheco/11.6.663; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; HILLERY CM, 1984, COPEIA, P844; HILLERY CM, 1982, J COMP PHYSIOL, V146, P435, DOI 10.1007/BF00609440; HILLERY CM, 1984, HEARING RES, V14, P129, DOI 10.1016/0378-5955(84)90012-1; Howard RD, 1998, ANIM BEHAV, V55, P1165, DOI 10.1006/anbe.1997.0683; Hulse SH, 2002, ADV STUD BEHAV, V31, P163, DOI 10.1016/S0065-3454(02)80008-0; Izumi A, 2002, COGNITION, V82, pB113, DOI 10.1016/S0010-0277(01)00161-5; Larson KA, 2004, COPEIA, P676; Ma L, 2010, J COMP PSYCHOL, V124, P317, DOI 10.1037/a0018273; MacDougall-Shackleton SA, 1998, J ACOUST SOC AM, V103, P3581, DOI 10.1121/1.423063; Marshall VT, 2006, ANIM BEHAV, V72, P449, DOI 10.1016/j.anbehav.2006.02.001; McDermott JH, 2009, CURR BIOL, V19, pR1024, DOI 10.1016/j.cub.2009.09.005; MEGELA AL, 1983, J COMP PHYSIOL, V151, P423, DOI 10.1007/BF00605458; Micheyl C, 2005, NEURON, V48, P139, DOI 10.1016/j.neuron.2005.08.039; Moore BCJ, 2002, ACTA ACUST UNITED AC, V88, P320; NARINS PM, 1995, SCI AM, V273, P78, DOI 10.1038/scientificamerican0895-78; Narins PM, 2007, HEARING SOUND COMMUN; Popper AN, 1997, BRAIN BEHAV EVOLUT, V50, P213; Pressnitzer D, 2008, CURR BIOL, V18, P1124, DOI 10.1016/j.cub.2008.06.053; PTACEK MB, 1994, EVOLUTION, V48, P898, DOI 10.1111/j.1558-5646.1994.tb01370.x; Schul J, 2002, P ROY SOC B-BIOL SCI, V269, P1847, DOI 10.1098/rspb.2002.2092; Schwartz JJ, 2001, BEHAV ECOL SOCIOBIOL, V49, P443, DOI 10.1007/s002650100317; Shamma SA, 2010, CURR OPIN NEUROBIOL, V20, P361, DOI 10.1016/j.conb.2010.03.009; Swanson EM, 2007, CAN J ZOOL, V85, P921, DOI 10.1139/Z07-074; Yost W. A., 2008, AUDITORY PERCEPTION; Zakon H.H., 1988, P125	55	33	33	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21191	10.1371/journal.pone.0021191	http://dx.doi.org/10.1371/journal.pone.0021191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778TS	21698268	Green Published, gold			2022-12-25	WOS:000291730000059
J	Ye, L; Mayberry, R; Lo, CY; Britt, KL; Stanley, EG; Elefanty, AG; Gargett, CE				Ye, Louie; Mayberry, Robyn; Lo, Camden Y.; Britt, Kara L.; Stanley, Edouard G.; Elefanty, Andrew G.; Gargett, Caroline E.			Generation of Human Female Reproductive Tract Epithelium from Human Embryonic Stem Cells	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; HUMAN ENDOMETRIUM; DIRECTED DIFFERENTIATION; PROGESTERONE-RECEPTOR; MULLERIAN DUCT; GROWTH-FACTOR; IN-VITRO; EXPRESSION; MOUSE; MICE	Background: Recent studies have identified stem/progenitor cells in human and mouse uterine epithelium, which are postulated to be responsible for tissue regeneration and proliferative disorders of human endometrium. These progenitor cells are thought to be derived from Mullerian duct (MD), the primordial female reproductive tract (FRT). Methodology/Principal Findings: We have developed a model of human reproductive tract development in which inductive neonatal mouse uterine mesenchyme (nMUM) is recombined with green fluorescent protein (GFP)-tagged human embryonic stem cells (hESCs); GFP-hESC (ENVY). We demonstrate for the first time that hESCs can be differentiated into cells with a human FRT epithelial cell phenotype. hESC derived FRT epithelial cells emerged from cultures containing MIXL1(+) mesendodermal precursors, paralleling events occurring during normal organogenesis. Following transplantation, nMUM treated embryoid bodies (EBs) generated epithelial structures with a typical MD phenotype that expressed the MD markers PAX2, HOXA10. Functionally, the hESCs derived FRT epithelium responded to exogenous estrogen by proliferating and secreting uterine-specific glycodelin A (GdA). Conclusions/Significance: These data show nMUM can induce differentiation of hESC to form the FRT epithelium. This may provide a model to study early developmental events of the human FRT.	[Ye, Louie; Gargett, Caroline E.] Monash Univ, Ritchie Ctr, Monash Inst Med Res, Melbourne, Vic 3004, Australia; [Ye, Louie; Gargett, Caroline E.] Monash Univ, Dept Obstet & Gynecol, Melbourne, Vic 3004, Australia; [Mayberry, Robyn; Stanley, Edouard G.; Elefanty, Andrew G.] Monash Univ, Monash Immunol & Stem Cell Labs, Melbourne, Vic 3004, Australia	Monash University; Monash University; Monash University	Ye, L (corresponding author), Monash Univ, Ritchie Ctr, Monash Inst Med Res, Melbourne, Vic 3004, Australia.	caroline.gargett@monash.edu	Stanley, Ed G/A-2985-2013; Britt, Kara/B-2437-2013; Elefanty, Andrew G/A-6066-2008; Britt, Kara/A-5568-2009; Gargett, Caroline E/Q-7911-2019; Gargett, Caroline Eve/I-4895-2019	Stanley, Ed G/0000-0002-6389-3665; Britt, Kara/0000-0001-6069-7856; Gargett, Caroline E/0000-0002-3590-2077; Elefanty, Andrew/0000-0001-6448-8314; Lo, Camden/0000-0002-6215-2363				Barberini F, 2007, ARCH HISTOL CYTOL, V70, P21, DOI 10.1679/aohc.70.21; Batchelder CA, 2009, DIFFERENTIATION, V78, P45, DOI 10.1016/j.diff.2009.05.001; BIGSBY RM, 1986, AM J PHYSIOL, V251, pE630, DOI 10.1152/ajpendo.1986.251.5.E630; BISCHOF P, 1993, EUR J OBSTET GYN R B, V49, P93, DOI 10.1016/0028-2243(93)90131-U; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; Couse JF, 2001, ANN NY ACAD SCI, V948, P1; Cunha G R, 1987, Prog Clin Biol Res, V239, P273; CUNHA GR, 1976, J EXP ZOOL, V196, P361, DOI 10.1002/jez.1401960310; Daftary GS, 2007, FERTIL STERIL, V87, P367, DOI 10.1016/j.fertnstert.2006.06.041; Dai W, 2007, J MOL CELL CARDIOL, V43, P504, DOI 10.1016/j.yjmcc.2007.07.001; Funayama N, 1999, DEVELOPMENT, V126, P4129; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gargett CE, 2007, HUM REPROD UPDATE, V13, P87, DOI 10.1093/humupd/dml045; Gargett CE, 2008, MOL CELL ENDOCRINOL, V288, P22, DOI 10.1016/j.mce.2008.02.026; GARGETT CE, 2009, BIOL REPROD; Hatzistavrou T, 2009, NAT METHODS, V6, P659, DOI [10.1038/nmeth.1364, 10.1038/NMETH.1364]; Hu JB, 2004, BIOL REPROD, V70, P1870, DOI 10.1095/biolreprod.103.026336; HUBBARD SA, REPRODUCTION, V140, P23; KAITUULINO TJ, ENDOCRINOLOGY, V151, P3386; Kishi Y, 2008, CELL TRANSPLANT, V17, P1095, DOI 10.3727/096368908786991560; Klattig J, 2007, SEX DEV, V1, P271, DOI 10.1159/000108929; Kobayashi A, 2003, NAT REV GENET, V4, P969, DOI 10.1038/nrg1225; Kurita T, 2005, DIFFERENTIATION, V73, P313, DOI 10.1111/j.1432-0436.2005.00033.x; Kurita T, 2000, BIOL REPROD, V62, P821, DOI 10.1095/biolreprod62.4.831; Kurita T, 2001, DEV BIOL, V240, P194, DOI 10.1006/dbio.2001.0458; LAIRD SM, 1995, HUM REPROD, V10, P1346, DOI 10.1093/HUMREP/10.6.1346; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; MASUDA H, PLOS ONE, V5; Mazal PR, 2005, MODERN PATHOL, V18, P535, DOI 10.1038/modpathol.3800320; Merjava S, 2009, EXP EYE RES, V89, P426, DOI 10.1016/j.exer.2009.04.009; MOSER FG, 1975, J CELL BIOL, V66, P676, DOI 10.1083/jcb.66.3.676; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Ng ES, 2008, NAT PROTOC, V3, P768, DOI 10.1038/nprot.2008.42; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Nicholas CR, 2009, HUM MOL GENET, V18, P4376, DOI 10.1093/hmg/ddp393; Okada A, 2004, J MOL ENDOCRINOL, V32, P615, DOI 10.1677/jme.0.0320615; Okada Akinobu, 2005, Journal of Toxicological Sciences, V30, P75, DOI 10.2131/jts.30.75; Oottamasathien S, 2007, DEV BIOL, V304, P556, DOI 10.1016/j.ydbio.2007.01.010; Orvis GD, 2007, DEV BIOL, V306, P493, DOI 10.1016/j.ydbio.2007.03.027; Pick M, 2007, STEM CELLS, V25, P2206, DOI 10.1634/stemcells.2006-0713; Przyborski SA, 2005, STEM CELLS, V23, P1242, DOI 10.1634/stemcells.2005-0014; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Seppala M, 2002, ENDOCR REV, V23, P401, DOI 10.1210/er.2001-0026; Simon L, 2009, STEM CELLS, V27, P1666, DOI 10.1002/stem.93; Stoikos CJ, 2008, HUM REPROD, V23, P1447, DOI 10.1093/humrep/den110; Takeyama J, 2001, J CLIN ENDOCR METAB, V86, P2258, DOI 10.1210/jc.86.5.2258; Taylor RA, 2006, NAT METHODS, V3, P179, DOI 10.1038/nmeth855; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; Tong GX, 2007, MODERN PATHOL, V20, P856, DOI 10.1038/modpathol.3800827; Torres M, 1995, DEVELOPMENT, V121, P4057; Tulac S, 2003, J CLIN ENDOCR METAB, V88, P3860, DOI 10.1210/jc.2003-030494; WANG T, 1989, ARCH GYNECOL OBSTET, V246, P169, DOI 10.1007/BF00934078; Wang Y, 2008, DIFFERENTIATION, V76, P1081, DOI 10.1111/j.1432-0436.2008.00295.x; Wei QX, 2009, FERTIL STERIL, V91, P1686, DOI 10.1016/j.fertnstert.2008.02.121; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353; ZABAGLO L, J CLIN PATHOL, V63, P800; Zhang Y, 2007, AM J RESP CELL MOL, V36, P515, DOI 10.1165/rcmb.2006-0475RC	58	32	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21136	10.1371/journal.pone.0021136	http://dx.doi.org/10.1371/journal.pone.0021136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698266	gold, Green Published			2022-12-25	WOS:000291730000055
J	Acunzo, M; Visone, R; Romano, G; Veronese, A; Lovat, F; Palmieri, D; Bottoni, A; Garofalo, M; Gasparini, P; Condorelli, G; Chiariello, M; Croce, CM				Acunzo, M.; Visone, R.; Romano, G.; Veronese, A.; Lovat, F.; Palmieri, D.; Bottoni, A.; Garofalo, M.; Gasparini, P.; Condorelli, G.; Chiariello, M.; Croce, C. M.			miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222	ONCOGENE			English	Article						MET; miR-130a; NSCLC; TRAIL	CELL LUNG-CANCER; SIGNALING PATHWAY; OVARIAN-CANCER; RESISTANCE; APOPTOSIS	Non-small cell lung cancer (NSCLC) accounts for similar to 80% of all lung cancers. Although some advances in lung cancer therapy have been made, patient survival is still quite poor. Two microRNAs, miR-221 and miR-222, upregulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TNF-related apoptosis-inducing ligand (TRAIL) resistance in NSCLC cell lines, through the downregulation of p27(kip1), PTEN and TIMP3. Here, we further investigated this pathway and showed that miR-130a, expressed at low level in lung cancer cell lines, by targeting MET was able to reduce TRAIL resistance in NSCLC cells through the c-Jun-mediated downregulation of miR-221 and miR-222. Moreover, we found that miR-130a reduced migratory capacity of NSCLC. A better understanding of MET-miR-221 and 222 axis regulation in drug resistance is the key in developing new strategies in NSCLC therapy. Oncogene (2012) 31, 634-642; doi:10.1038/onc.2011.260; published online 27 June 2011	[Acunzo, M.; Visone, R.; Veronese, A.; Lovat, F.; Palmieri, D.; Bottoni, A.; Garofalo, M.; Gasparini, P.; Croce, C. M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Romano, G.] Fdn IRCCS SDN, Naples, Italy; [Palmieri, D.; Condorelli, G.] Univ Naples Federico II, Fac Biotechnol Sci, Consiglio Nazl Ric, Dept Cellular & Mol Biol & Pathol,Ist Endocrinol, Naples, Italy; [Chiariello, M.] Consiglio Nazl Ric IFC CNR, ITT, Siena, Italy; [Chiariello, M.] Consiglio Nazl Ric IFC CNR, Ist Fisiol Clin, Siena, Italy	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Croce, CM (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	carlo.croce@osumc.edu	visone, rosa/K-7910-2016; Chiariello, Mario/O-3642-2014; Young, Richard A/F-6495-2012; Condorelli, Gerolama/AAC-3472-2022; Acunzo, Mario/ABE-1739-2020; Gasparini, Pierluigi/ABA-2811-2021; Veronese, Angelo/I-4292-2019	Chiariello, Mario/0000-0001-8434-5177; Young, Richard A/0000-0001-8855-8647; Condorelli, Gerolama/0000-0003-0177-8829; Gasparini, Pierluigi/0000-0001-8311-8845; Veronese, Angelo/0000-0002-1451-1392; Palmieri, Dario/0000-0002-0797-4268; Acunzo, Mario/0000-0002-3942-9061; VISONE, Rosa/0000-0002-4993-0220	NCI; Associazione Italiana Ricerca sul Cancro, AIRC; NATIONAL CANCER INSTITUTE [P01CA129242, U01CA152758] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Associazione Italiana Ricerca sul Cancro, AIRC(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the NCI grants to (CMC) and Associazione Italiana Ricerca sul Cancro, AIRC grant to GC. We thank Veronica Balatti, Giampiero di Leva, Claudia Piovan, Hansjuerg Alder and Paolo Fadda for the helpful discussions about this manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; Cecchi F, 2010, EUR J CANCER, V46, P1260, DOI 10.1016/j.ejca.2010.02.028; Cimmino A, 2006, P NATL ACAD SCI USA, V103, P2464, DOI 10.1073/pnas.0510793103; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Fan S, 2004, MOL CELL BIOL, V21, P4968; Gao W, 2010, BIOMED PHARMACOTHER, V64, P399, DOI 10.1016/j.biopha.2010.01.018; Garofalo M, 2008, ONCOGENE, V27, P3845, DOI 10.1038/onc.2008.6; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Incoronato M, 2010, CANCER RES, V70, P3638, DOI 10.1158/0008-5472.CAN-09-3341; Mariani SM, 1997, J CELL BIOL, V137, P221, DOI 10.1083/jcb.137.1.221; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Ramalingam S, 1998, J CLIN ONCOL, V16, P651, DOI 10.1200/JCO.1998.16.2.651; Schaefer U, 2007, FRONT BIOSCI, V12, P3813, DOI 10.2741/2354; Segarra J, 2006, J BIOL CHEM, V281, P4771, DOI 10.1074/jbc.M508298200; Socinski MA, 2007, CHEST, V132, p277S, DOI 10.1378/chest.07-1381; Song H, 2006, NEUROSCI RES, V56, P29, DOI 10.1016/j.neures.2006.04.019; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Tulasne D, 2008, CELL DEATH DIFFER, V15, P427, DOI 10.1038/sj.cdd.4402229; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488	24	160	174	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	5					634	642		10.1038/onc.2011.260	http://dx.doi.org/10.1038/onc.2011.260			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MS	21706050	Green Accepted			2022-12-25	WOS:000300221800009
J	Niu, X; Zhang, T; Liao, L; Zhou, L; Lindner, DJ; Zhou, M; Rini, B; Yan, Q; Yang, H				Niu, X.; Zhang, T.; Liao, L.; Zhou, L.; Lindner, D. J.; Zhou, M.; Rini, B.; Yan, Q.; Yang, H.			The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C	ONCOGENE			English	Article						von Hippel-Lindau; hypoxia-inducible factor; JARID1C/KDM5C/SMCX; trimethyl H3K4; gene expression	HYPOXIA-INDUCIBLE-FACTOR; RENAL-CELL CARCINOMA; HIF-ALPHA; INHIBITION; STABILIZATION; INACTIVATION; METHYLATION; ACTIVATION; COMPONENT; REVEALS	In clear-cell renal cell carcinoma (ccRCC), inactivation of the tumor suppressor von Hippel-Lindau (VHL) occurs in the majority of the tumors and is causal for the pathogenesis of ccRCC. Recently, a large-scale genomic sequencing study of ccRCC tumors revealed that enzymes that regulate histone H3 lysine 4 trimethylation (H3K4Me3), such as JARID1C/KDM5C/SMCX and MLL2, were mutated in ccRCC tumors, suggesting that H3K4Me3 might have an important role in regulating gene expression and tumorigenesis. In this study we report that in VHL-deficient ccRCC cells, the overall H3K4Me3 levels were significantly lower than that of VHL+/+ counterparts. Furthermore, this was hypoxia-inducible factor (HIF) dependent, as depletion of HIF subunits by small hairpin RNA in VHL-deficient ccRCC cells restored H3K4Me3 levels. In addition, we demonstrated that only loss of JARID1C, not JARID1A or JARID1B, abolished the difference of H3K4Me3 levels between VHL-/- and VHL+/+ cells, and JARID1C displayed HIF-dependent expression pattern. JARID1C in VHL-/- cells was responsible for the suppression of HIF-responsive genes insulin-like growth factor-binding protein 3 (IGFBP3), DNAJC12, COL6A1, growth and differentiation factor 15 (GDF15) and density-enhanced phosphatase 1. Consistent with these findings, the H3K4Me3 levels at the promoters of IGFBP3, DNAJC12, COL6A1 and GDF15 were lower in VHL-/- cells than in VHL+/+ cells, and the differences disappeared after JARID1C depletion. Although HIF2 alpha is an oncogene in ccRCC, some of its targets might have tumor suppressive activity. Consistent with this, knockdown of JARID1C in 786-O VHL-/- ccRCC cells significantly enhanced tumor growth in a xenograft model, suggesting that JARID1C is tumor suppressive and its mutations are tumor promoting in ccRCC. Thus, VHL inactivation decreases H3K4Me3 levels through JARID1C, which alters gene expression and suppresses tumor growth. Oncogene (2012) 31, 776-786; doi:10.1038/onc.2011.266; published online 4 July 2011	[Niu, X.; Zhang, T.; Liao, L.; Zhou, L.; Yang, H.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Lindner, D. J.; Rini, B.] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44195 USA; [Zhou, M.] Cleveland Clin, Dept Pathol, Cleveland, OH 44195 USA; [Yan, Q.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Yale University	Yang, H (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Canc Biol, NB-40,9500 Euclid Ave, Cleveland, OH 44195 USA.	yangh2@ccf.org	Zhou, Liang/F-7201-2014; Lindner, Daniel/ABB-5440-2020; Zhou, Liang/N-8220-2013; Yan, Qin/E-8893-2012	Yan, Qin/0000-0003-4077-453X	American Cancer Society; Cleveland Clinic; V scholar Award; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Cleveland Clinic; V scholar Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The 786-O and RCC4 cell lines were kind gifts from Dr William Kaelin Jr. This work was supported by American Cancer Society Pilot Award (to HY) and the seed fund from Cleveland Clinic to HY. QY is a Breast Cancer Alliance Young Investigator who was also supported by V scholar Award. We thank Dr Donal Luse for his critical reading of the manuscript.	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BERRIOS M, 1985, P NATL ACAD SCI USA, V82, P4142, DOI 10.1073/pnas.82.12.4142; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Isaacs JS, 2004, J BIOL CHEM, V279, P16128, DOI 10.1074/jbc.M313342200; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Li N, 2008, P NATL ACAD SCI USA, V105, P17055, DOI 10.1073/pnas.0807765105; Linehan WM, 2004, CLIN CANCER RES, V10, p6282S, DOI 10.1158/1078-0432.CCR-050013; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Mikhaylova O, 2008, MOL CELL BIOL, V28, P2701, DOI 10.1128/MCB.01231-07; Nakamura E, 2006, AM J PATHOL, V168, P574, DOI 10.2353/ajpath.2006.050867; Negrotto S, 2011, CANCER RES, V71, P1431, DOI 10.1158/0008-5472.CAN-10-2422; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Rini BI, 2005, BJU INT, V96, P286, DOI 10.1111/j.1464-410X.2005.05616.x; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Schraml P, 2009, MODERN PATHOL, V22, P31, DOI 10.1038/modpathol.2008.132; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Semenza GL, 1997, KIDNEY INT, V51, P553, DOI 10.1038/ki.1997.77; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Thoma CR, 2009, NAT CELL BIOL, V11, P994, DOI 10.1038/ncb1912; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhou X, 2010, CANCER RES, V70, P4214, DOI 10.1158/0008-5472.CAN-09-2942; Zimmer M, 2004, MOL CANCER RES, V2, P89	46	106	108	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	6					776	786		10.1038/onc.2011.266	http://dx.doi.org/10.1038/onc.2011.266			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MU	21725364	Green Accepted			2022-12-25	WOS:000300222100010
J	Jia, JJ; Yao, W; Guan, M; Dai, WW; Shahnazari, M; Kar, R; Bonewald, L; Jiang, JX; Lane, NE				Jia, Junjing; Yao, Wei; Guan, Min; Dai, Weiwei; Shahnazari, Mohammad; Kar, Rekha; Bonewald, Lynda; Jiang, Jean X.; Lane, Nancy E.			Glucocorticoid dose determines osteocyte cell fate	FASEB JOURNAL			English	Article						osteoporosis; apoptosis; autophagy; antioxidant; MLO-Y4 cell; LC3	INDUCED BONE LOSS; PARATHYROID-HORMONE TREATMENT; CONTROLLED CLINICAL-TRIAL; ERECT BIPEDAL STANCE; OXIDATIVE STRESS; INDUCED OSTEOPOROSIS; INDUCED AUTOPHAGY; MULTIFUNCTIONAL CELLS; CANCELLOUS BONE; TREATED MICE	In response to cellular insult, several pathways can be activated, including necrosis, apoptosis, and autophagy. Because glucocorticoids (GCs) have been shown to induce both osteocyte apoptosis and autophagy, we sought to determine whether osteocyte cell fate in the presence of GCs was dose dependent by performing in vivo and in vitro studies. Male Swiss-Webster mice were treated with slow-release prednisolone pellets at 1.4, 2.8, and 5.6 mg/kg/d for 28 d. An osteocyte cell line, MLO-Y4 cells, was treated with various doses of dexamethasone. We found that GC treatments dose dependently decreased activation of antioxidant-, autophagy-, and antiapoptosis-focused RT-PCR gene pathways in mouse cortical bone. The activation of antioxidant genes was correlated with autophagy gene expression after the GC treatments. The presence of osteocyte autophagy, as detected by immunostaining for LC3, increased similar to 50% at the distal femur cortical bone region but not at trabecular bone region at the 1.4 and 2.8 mg/kg/d GC dose levels. The number of apoptotic osteocytes was increased at the cortical bone region by similar to 40% initially observed at the 2.8 mg/kg/d dose level. In addition, the presence of the osteocyte autophagy was associated with an increased protein level of cathepsin K in vitro after the GC treatments. In summary, we found that GC treatment dose-dependently decreased antioxidant gene expression, with lower GC doses activating autophagy, whereas a higher dose increased apoptosis. These data suggest that autophagy may provide a mechanism for osteocytes to survive the stress after GC exposure and provide further insight into how GCs alter bone cell fate.-Jia, J., Yao, W., Guan, M., Dai, W., Shahnazari, M., Kar, R., Bonewald, L., Jiang, J. X., Lane, N. E. Glucocorticoid dose determines osteocyte cell fate. FASEB J. 25, 3366-3376 (2011). www.fasebj.org	[Jia, Junjing; Yao, Wei; Guan, Min; Dai, Weiwei; Shahnazari, Mohammad; Lane, Nancy E.] Univ Calif Davis, Med Ctr, Dept Med, Sacramento, CA 95817 USA; [Kar, Rekha; Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Bonewald, Lynda] Univ Missouri, Sch Dent, Dept Oral Biol, Kansas City, MO USA	University of California System; University of California Davis; University of Texas System; University of Texas Health San Antonio; University of Missouri System; University of Missouri Kansas City	Lane, NE (corresponding author), Univ Calif Davis, Med Ctr, Dept Med, 4800 2nd Ave,Suite 2600, Sacramento, CA 95817 USA.	nelane@ucdavis.edu	Bonewald, Lynda/Q-3638-2019; Yao, Wei/O-8187-2019; Shahnazari, Mohammad Reza/AAU-8573-2020; yao, wei/GVS-3913-2022	Yao, Wei/0000-0002-1198-1161; Shahnazari, Mohammad Reza/0000-0001-8647-5426; yao, wei/0000-0002-1198-1161; Jiang, Jean/0000-0002-2185-5716; Guan, Min/0000-0003-3851-8553	U.S. National Institutes of Health [1K12-HD05195801, R01-AR043052-07, K24-AR048841, 5R21-AR57515-2, P01-AR46798]; National Institute of Child Health and Human Development; Office of Research on Women's Health; Office of Dietary Supplements; National Institute of Aging; Welch Foundation [AQ-1507]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043052, K24AR048841, R21AR057515, P01AR046798] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Welch Foundation(The Welch Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Dr. Frank Chuang (Center for Biophotonics and Science Technology, University of California at Davis Medical Center) for generously providing GFP-tagged LC3 expression vector and photographing the cells. This work was funded by U.S. National Institutes of Health grants 1K12-HD05195801 (cofunded by the National Institute of Child Health and Human Development, the Office of Research on Women's Health, the Office of Dietary Supplements, and the National Institute of Aging), R01-AR043052-07, K24-AR048841, 5R21-AR57515-2, and P01-AR46798 (to L. F.B. and J.X.J), and Welch Foundation grant AQ-1507 (to J.X.J.).	Adcock Ian M, 2005, Proc Am Thorac Soc, V2, P313, DOI 10.1513/pats.200504-035SR; Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Almeida M, 2010, MOL ENDOCRINOL, V24, P2030, DOI 10.1210/me.2010-0189; Almeida M, 2010, J BONE MINER RES, V25, P769, DOI 10.1359/jbmr.091017; Bardeguez AD, 1997, AM J OBSTET GYNECOL, V176, P158, DOI 10.1016/S0002-9378(97)80029-4; BELANGER LF, 1969, CALC TISS RES, V4, P1, DOI 10.1007/BF02279101; BOASS A, 1981, ENDOCRINOLOGY, V109, P505, DOI 10.1210/endo-109-2-505; Bonapace L, 2010, J CLIN INVEST, V120, P1310, DOI 10.1172/JCI39987; Bonewald L., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P331; Bonewald LF, 2007, ANN NY ACAD SCI, V1116, P281, DOI 10.1196/annals.1402.018; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Carbonare LD, 2001, J BONE MINER RES, V16, P97, DOI 10.1359/jbmr.2001.16.1.97; Chen JL, 2009, AUTOPHAGY, V5, P244, DOI 10.4161/auto.5.2.7549; Chiodini I, 1998, J CLIN ENDOCR METAB, V83, P1863, DOI 10.1210/jc.83.6.1863; Edinger AL, 2009, BIOCHEM SOC T, V37, P253, DOI 10.1042/BST0370253; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Evans BJ, 2006, BLOOD, V107, P3593, DOI 10.1182/blood-2005-09-3695; Feng JQ, 2009, CURR OPIN NEPHROL HY, V18, P285, DOI 10.1097/MNH.0b013e32832c224f; Ferioli ME, 1999, BIOCHEM PHARMACOL, V58, P1907, DOI 10.1016/S0006-2952(99)00280-4; Fukumoto S, 2009, MOL CELL ENDOCRINOL, V310, P63, DOI 10.1016/j.mce.2008.08.031; Fukumoto S, 2009, TRENDS ENDOCRIN MET, V20, P230, DOI 10.1016/j.tem.2009.02.001; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; HARMAN D, 1988, MOL CELL BIOCHEM, V84, P155, DOI 10.1007/BF00421050; HARMAN D, 1992, ANN NY ACAD SCI, V673, P126, DOI 10.1111/j.1749-6632.1992.tb27444.x; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; JEE WSS, 1991, ANAT RECORD, V230, P332, DOI 10.1002/ar.1092300306; JEE WSS, 1990, ANAT REC, V227, P418, DOI 10.1002/ar.1092270405; Jilka RL, 2007, J BONE MINER RES, V22, P1492, DOI 10.1359/JBMR.070518; Jilka RL, 2010, AGING CELL, V9, P851, DOI 10.1111/j.1474-9726.2010.00616.x; Kalajzic I, 2004, BONE, V35, P74, DOI 10.1016/j.bone.2004.03.006; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; KE HZ, 1993, BONE, V14, P481, DOI 10.1016/8756-3282(93)90183-B; Komatsu F, 2007, J GERONTOL A-BIOL, V62, P459, DOI 10.1093/gerona/62.4.459; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Laane E, 2009, CELL DEATH DIFFER, V16, P1018, DOI 10.1038/cdd.2009.46; Lane NE, 2000, J BONE MINER RES, V15, P944, DOI 10.1359/jbmr.2000.15.5.944; Lane NE, 1998, J CLIN INVEST, V102, P1627, DOI 10.1172/JCI3914; Lane NE, 2006, J BONE MINER RES, V21, P466, DOI 10.1359/JBMR.051103; Lane NE, 2005, J BONE MINER RES, V20, P58, DOI 10.1359/JBMR.041017; Lee CW, 2006, WORLD J SURG, V30, P2217, DOI 10.1007/s00268-006-0143-0; Lester DR, 1996, CLIN ORTHOP RELAT R, P271; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Martinet W, 2009, CLIN SCI, V116, P697, DOI 10.1042/CS20080508; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Muthusami S, 2005, CLIN CHIM ACTA, V360, P81, DOI 10.1016/j.cccn.2005.04.014; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; Ogasawara M, 1999, ENDOCR J, V46, P99, DOI 10.1507/endocrj.46.99; Ong SLH, 2008, CLIN EXP PHARMACOL P, V35, P477, DOI 10.1111/j.1440-1681.2008.04900.x; Orzechowski A, 2002, J VET MED A, V49, P256, DOI 10.1046/j.1439-0442.2002.00443.x; Planey SL, 2003, CANCER RES, V63, P172; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Qing H, 2009, INT J ORAL SCI, V1, P59, DOI 10.4248/ijos.09019; RASMUSSEN P, 1977, CALC TISS RES, V23, P95, DOI 10.1007/BF02012772; Rowe PSN, 2006, BONE, V39, P773, DOI 10.1016/j.bone.2006.04.012; Saag KG, 2007, NEW ENGL J MED, V357, P2028, DOI 10.1056/NEJMoa071408; Saag Kenneth G, 2002, Curr Rheumatol Rep, V4, P218, DOI 10.1007/s11926-002-0068-z; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Srinivas V, 2009, CELL CYCLE, V8, P391, DOI 10.4161/cc.8.3.7545; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Teti A, 2009, BONE, V44, P11, DOI 10.1016/j.bone.2008.09.017; Todde V, 2009, BBA-MOL BASIS DIS, V1792, P3, DOI 10.1016/j.bbadis.2008.10.016; Tsuchihara K, 2009, CANCER LETT, V278, P130, DOI 10.1016/j.canlet.2008.09.040; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Van Staa TP, 2003, ARTHRITIS RHEUM, V48, P3224, DOI 10.1002/art.11283; Walther FJ, 1998, J APPL PHYSIOL, V85, P273, DOI 10.1152/jappl.1998.85.1.273; Weinstein R S, 2001, Rev Endocr Metab Disord, V2, P65, DOI 10.1023/A:1010007108155; Weinstein RS, 2007, NAT CLIN PRACT ENDOC, V3, P86, DOI 10.1038/ncpendmet0372; Weinstein RS, 2002, J CLIN INVEST, V109, P1041, DOI 10.1172/JCI200214538; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Xia XC, 2010, J BONE MINER RES, V25, P2479, DOI 10.1002/jbmr.160; Yao W, 2000, BONE, V27, P667, DOI 10.1016/S8756-3282(00)00377-X; Yao W, 2000, J BONE MINER RES, V15, P1158, DOI 10.1359/jbmr.2000.15.6.1158; Yao W, 2008, ARTHRITIS RHEUM, V58, P3485, DOI 10.1002/art.23954; Yao W, 2008, ARTHRITIS RHEUM, V58, P1674, DOI 10.1002/art.23454; Yao W, 2007, BONE, V41, P804, DOI 10.1016/j.bone.2007.06.021; Yao W, 2010, J BONE MINER RES, V25, P190, DOI 10.1359/jbmr.090719	79	109	126	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3366	3376		10.1096/fj.11-182519	http://dx.doi.org/10.1096/fj.11-182519			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21705669	Green Published			2022-12-25	WOS:000295356400009
J	Gallo, LI; Lagadari, M; Piwien-Pilipuk, G; Galigniana, MD				Gallo, Luciana I.; Lagadari, Mariana; Piwien-Pilipuk, Graciela; Galigniana, Mario D.			The 90-kDa Heat-shock Protein (Hsp90)-binding Immunophilin FKBP51 Is a Mitochondrial Protein That Translocates to the Nucleus to Protect Cells against Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYLPROLYL ISOMERASE DOMAIN; GLUCOCORTICOID-RECEPTOR; HSP90-BINDING IMMUNOPHILINS; TETRATRICOPEPTIDE REPEATS; MINERALOCORTICOID RECEPTOR; CYTOPLASMIC DYNEIN; IN-VIVO; HSP90; COMPLEXES; CHAPERONES	Confocal microscopy images revealed that the tetratricopeptide repeat motif (TPR) domain immunophilin FKBP51 shows colocalization with the specific mitochondrial marker MitoTracker. Signal specificity was tested with different antibodies and by FKBP51 knockdown. This unexpected subcellular localization of FKBP51 was confirmed by colocalization studies with other mitochondrial proteins, biochemical fractionation, and electron microscopy imaging. Interestingly, FKBP51 forms complexes in mitochondria with the glucocorticoid receptor and the Hsp90/Hsp70-based chaperone heterocomplex. Although Hsp90 inhibitors favor FKBP51 translocation from mitochondria to the nucleus in a reversible manner, TPR domain-deficient mutants of FKBP51 are constitutively nuclear and fully excluded from mitochondria, suggesting that a functional TPR domain is required for its mitochondrial localization. FKBP51 overexpression protects cells against oxidative stress, whereas FKBP51 knockdown makes them more sensitive to injury. In summary, this is the first demonstration that FKBP51 is a major mitochondrial factor that undergoes nuclear-mitochondrial shuttling, an observation that may be related to antiapoptotic mechanisms triggered during the stress response.	[Gallo, Luciana I.; Lagadari, Mariana; Piwien-Pilipuk, Graciela; Galigniana, Mario D.] Consejo Nacl Invest Cient & Tecn, IBYME, Inst Biol & Med Expt, RA-1428 Buenos Aires, DF, Argentina; [Galigniana, Mario D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires	Galigniana, MD (corresponding author), Consejo Nacl Invest Cient & Tecn, IBYME, Inst Biol & Med Expt, Vuelta Obligado 2490, RA-1428 Buenos Aires, DF, Argentina.	mgali@qb.fcen.uba	Lagadari, Mariana/ABE-2248-2021; Gallo, Luciana I/S-4451-2019	Lagadari, Mariana/0000-0002-9355-1439; Gallo, Luciana I./0000-0001-7050-0121; GALIGNIANA, MARIO/0000-0002-9130-8574	Guggenheim Foundation; Universidad de Buenos Aires; Agencia Nacional de Promocion Cientifica y Tecnologica ProyectoS de Investigacion Cientifica y Tecnologica (ANPCyT PICT) [2010-1170]; National Institutes of Health [R03TW008143-01A1]; ANPCyT [PICT 2007-00640]; FOGARTY INTERNATIONAL CENTER [R03TW008143] Funding Source: NIH RePORTER	Guggenheim Foundation; Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica ProyectoS de Investigacion Cientifica y Tecnologica (ANPCyT PICT)(ANPCyT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ANPCyT(ANPCyT); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by grants from the Guggenheim Foundation, Universidad de Buenos Aires (UBACyT Program), and Agencia Nacional de Promocion Cientifica y Tecnologica ProyectoS de Investigacion Cientifica y Tecnologica (ANPCyT PICT) 2010-1170 (to M. D. G.) and by National Institutes of Health Fogarty International Research Collaboration Award (FIRCA) Award R03TW008143-01A1 and ANPCyT PICT 2007-00640 (to G. P. P.).	Aviezer-Hagai K, 2007, PLANT MOL BIOL, V63, P237, DOI 10.1007/s11103-006-9085-z; Barik S, 2006, CELL MOL LIFE SCI, V63, P2889, DOI 10.1007/s00018-006-6215-3; Carrello A, 1999, J BIOL CHEM, V274, P2682, DOI 10.1074/jbc.274.5.2682; Cheung-Flynn J, 2005, MOL ENDOCRINOL, V19, P1654, DOI 10.1210/me.2005-0071; Colo GP, 2008, ONCOGENE, V27, P2430, DOI 10.1038/sj.onc.1210900; Cox M.B., 2006, NETWORKING CHAPERONE, P13; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; DeFranco DB, 2002, MOL ENDOCRINOL, V16, P1449, DOI 10.1210/me.16.7.1449; DEMONACOS C, 1993, J STEROID BIOCHEM, V46, P401, DOI 10.1016/0960-0760(93)90231-K; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; EVANSSTORMS RB, 1995, J STEROID BIOCHEM, V53, P1, DOI 10.1016/0960-0760(95)00034-W; Fan ACY, 2006, J BIOL CHEM, V281, P33313, DOI 10.1074/jbc.M605250200; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Galigniana MD, 2010, NUCLEUS-PHILA, V1, P299, DOI 10.4161/nucl.1.4.11743; Galigniana MD, 2010, MOL CELL BIOL, V30, P1285, DOI 10.1128/MCB.01190-09; Galigniana MD, 2004, J BIOL CHEM, V279, P55754, DOI 10.1074/jbc.M406259200; Galigniana MD, 2004, J BIOL CHEM, V279, P22483, DOI 10.1074/jbc.M402223200; Galigniana MD, 2004, MOL BRAIN RES, V123, P27, DOI 10.1016/j.molbrainres.2003.12.015; Galigniana MD, 2001, J BIOL CHEM, V276, P14884, DOI 10.1074/jbc.M010809200; Galigniana MD, 1999, J BIOL CHEM, V274, P16222, DOI 10.1074/jbc.274.23.16222; Galigniana MD, 1998, BIOCHEM J, V333, P555, DOI 10.1042/bj3330555; Gallo LI, 2007, BIOCHEMISTRY-US, V46, P14044, DOI 10.1021/bi701372c; Giordano A, 2006, AM J PHYSIOL-HEART C, V290, pH2459, DOI 10.1152/ajpheart.00750.2005; Gkika D, 2006, AM J PHYSIOL-RENAL, V290, pF1253, DOI 10.1152/ajprenal.00298.2005; Gottlieb E, 2002, P NATL ACAD SCI USA, V99, P12801, DOI 10.1073/pnas.202477599; Harrell JM, 2004, J BIOL CHEM, V279, P54647, DOI 10.1074/jbc.M406863200; Herr I, 2007, APOPTOSIS, V12, P271, DOI 10.1007/s10495-006-0624-5; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; King FW, 2001, EMBO J, V20, P6297, DOI 10.1093/emboj/20.22.6297; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Liu FH, 1999, J BIOL CHEM, V274, P34425, DOI 10.1074/jbc.274.48.34425; Mukhopadhyay A, 2002, ARCH BIOCHEM BIOPHYS, V400, P97, DOI 10.1006/abbi.2002.2777; Nur-E-Kamal A, 2004, J BIOL CHEM, V279, P24911, DOI 10.1074/jbc.C400051200; Periyasamy S, 2007, ENDOCRINOLOGY, V148, P4716, DOI 10.1210/en.2007-0145; Pirkl F, 2001, J MOL BIOL, V308, P795, DOI 10.1006/jmbi.2001.4595; Poyton RO, 2009, TRENDS ENDOCRIN MET, V20, P332, DOI 10.1016/j.tem.2009.04.001; Pratt WB, 2004, CELL SIGNAL, V16, P857, DOI 10.1016/j.cellsig.2004.02.004; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Psarra AMG, 2009, BBA-BIOENERGETICS, V1787, P431, DOI 10.1016/j.bbabio.2008.11.011; Quinta HR, 2010, J NEUROCHEM, V115, P716, DOI 10.1111/j.1471-4159.2010.06970.x; Ratajczak T, 2003, CURR TOP MED CHEM, V3, P1348, DOI 10.2174/1568026033451934; Ratajczak T, 1996, J BIOL CHEM, V271, P2961, DOI 10.1074/jbc.271.6.2961; Riggs DL, 2003, EMBO J, V22, P1158, DOI 10.1093/emboj/cdg108; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schlegel T, 2007, MOL BIOL EVOL, V24, P2763, DOI 10.1093/molbev/msm211; Schmidt U, 2003, J BIOL CHEM, V278, P4926, DOI 10.1074/jbc.M212000200; Silverstein AM, 1999, J BIOL CHEM, V274, P36980, DOI 10.1074/jbc.274.52.36980; Sinars CR, 2003, P NATL ACAD SCI USA, V100, P868, DOI 10.1073/pnas.0231020100; Sinkins WG, 2004, J BIOL CHEM, V279, P34521, DOI 10.1074/jbc.M401156200; SIVILS JC, 2011, TOP PHARM IN PRESS, V11; Tago K, 2004, MOL CELL ENDOCRINOL, V213, P131, DOI 10.1016/j.mce.2003.10.057; Thomas M, 2004, J BIOL CHEM, V279, P8389, DOI 10.1074/jbc.M311761200; Warrier M, 2010, ENDOCRINOLOGY, V151, P3225, DOI 10.1210/en.2009-1158; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Wu BL, 2004, P NATL ACAD SCI USA, V101, P8348, DOI 10.1073/pnas.0305969101; Zhao WH, 2006, VIROLOGY, V353, P283, DOI 10.1016/j.virol.2006.04.042	58	73	78	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30152	30160		10.1074/jbc.M111.256610	http://dx.doi.org/10.1074/jbc.M111.256610			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21730050	Green Published, hybrid			2022-12-25	WOS:000294046600072
J	Ida-Eto, M; Ohgami, N; Iida, M; Yajima, I; Kumasaka, MY; Takaiwa, K; Kimitsuki, T; Sone, M; Nakashima, T; Tsuzuki, T; Komune, S; Yanagisawa, M; Kato, M				Ida-Eto, Michiru; Ohgami, Nobutaka; Iida, Machiko; Yajima, Ichiro; Kumasaka, Mayuko Y.; Takaiwa, Kazutaka; Kimitsuki, Takashi; Sone, Michihiko; Nakashima, Tsutomu; Tsuzuki, Toyonori; Komune, Shizuo; Yanagisawa, Masashi; Kato, Masashi			Partial Requirement of Endothelin Receptor B in Spiral Ganglion Neurons for Postnatal Development of Hearing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WAARDENBURG-HIRSCHSPRUNG-DISEASE; PRIMARY AUDITORY NEURONS; ENTERIC NERVOUS-SYSTEM; STRIA VASCULARIS; MOUSE MODEL; COAT COLOR; INNER-EAR; MICE; GENE; MUTATION	Impairments of endothelin receptor B (Ednrb/EDNRB) cause the development of Waardenburg-Shah syndrome with congenital hearing loss, hypopigmentation, and megacolon disease in mice and humans. Hearing loss in WaardenburgShah syndrome has been thought to be caused by an Ednrbmediated congenital defect of melanocytes in the stria vascularis (SV) of inner ears. Here we show that Ednrb expressed in spiral ganglion neurons (SGNs) in inner ears is required for postnatal development of hearing in mice. Ednrb protein was expressed in SGNs from WT mice on postnatal day 19 (P19), whereas it was undetectable in SGNs from WT mice on P3. Correspondingly, Ednrb homozygously deleted mice (Ednrb(-/-) mice) with congenital hearing loss showed degeneration of SGNs on P19 but not on P3. The congenital hearing loss involving neurodegeneration of SGNs as well as megacolon disease in Ednrb(-/-) mice were markedly improved by introducing an Ednrb transgene under control of the dopamine beta-hydroxylase promoter (Ednrb(-/-); DBH-Ednrb mice) on P19. Neither defects of melanocytes nor hypopigmentation in the SV and skin in Ednrb(-/-) mice was rescued in the Ednrb(-/-); DBH-Ednrb mice. Thus, the results of this study indicate a novel role of Ednrb expressed in SGNs distinct from that in melanocytes in the SV contributing partially to postnatal hearing development.	[Ida-Eto, Michiru; Ohgami, Nobutaka; Iida, Machiko; Yajima, Ichiro; Kumasaka, Mayuko Y.; Kato, Masashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Unit Environm Hlth Sci, Aichi 4878501, Japan; [Takaiwa, Kazutaka; Kimitsuki, Takashi; Komune, Shizuo] Kyushu Univ, Grad Sch Med, Dept Otorhinolaryngol, Fukuoka 8128582, Japan; [Sone, Michihiko; Nakashima, Tsutomu] Nagoya Univ, Grad Sch Med, Dept Otorhinolaryngol, Nagoya, Aichi 4668550, Japan; [Tsuzuki, Toyonori] Nagoya Daini Red Cross Hosp, Dept Pathol, Nagoya, Aichi 4668650, Japan; [Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Chubu University; Kyushu University; Nagoya University; Japanese Red Cross Nagoya Daini Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kato, M (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Unit Environm Hlth Sci, 50 Bldg,1200 Matsumoto, Aichi 4878501, Japan.	katomasa@isc.chubu.ac.jp	Ohgami, Nobutaka/I-4572-2014; Tsuzuki, Toyonori/GRJ-7409-2022; KATO, Masashi/I-7250-2014; YAJIMA, Ichiro/I-7467-2014; Nakashima, Tsutomu/B-8259-2012; Ida-Eto, Michiru/J-9615-2019	Tsuzuki, Toyonori/0000-0002-4855-4366; Nakashima, Tsutomu/0000-0003-3930-9120; Ida-Eto, Michiru/0000-0002-2469-4006	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [19390168, 20406003, 18790738, 20791232]; Chubu University [S0801055]; Lydia O'Leary Memorial Foundation; Japan Society for the Promotion of Science; Tokyo Biochemical Research Foundation; Adaptable and Seamless Technology Transfer Program through Target-driven RD; Japan Science and Technology Agency; Research Foundation, Institute of Science and Technology Research in Chubu University; Chubu University; Grants-in-Aid for Scientific Research [23791891] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Chubu University; Lydia O'Leary Memorial Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokyo Biochemical Research Foundation; Adaptable and Seamless Technology Transfer Program through Target-driven RD; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Research Foundation, Institute of Science and Technology Research in Chubu University; Chubu University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research (B) 19390168 and 20406003 (to M. K.), Grants-in-aid for Young Scientists (B) 18790738 (to N. O.) and 20791232 (to M. I.-E.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Center of Excellence Project (Health Science Hills) for Private Universities from MEXT and Chubu University Grant S0801055 (to N. O. and M. K.), Lydia O'Leary Memorial Foundation (to M. K.), Asia and Africa Science Platform Program from the Japan Society for the Promotion of Science (to M. K.), a research grant from the Tokyo Biochemical Research Foundation (to M. K.), Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency (to N. O.), Research Foundation from the Institute of Science and Technology Research in Chubu University (to M. K.), and Chubu University Grants A, B, and C (to N. O. and M. K.).	Bagnato A, 2005, ENDOCR-RELAT CANCER, V12, P761, DOI 10.1677/erc.1.01077; Brown SDM, 2008, NAT REV GENET, V9, P277, DOI 10.1038/nrg2309; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; Gariepy CE, 1996, P NATL ACAD SCI USA, V93, P867, DOI 10.1073/pnas.93.2.867; Gariepy CE, 1998, J CLIN INVEST, V102, P1092, DOI 10.1172/JCI3702; Graham CE, 2011, J NEUROSCI, V31, P1267, DOI 10.1523/JNEUROSCI.4545-10.2011; Gurtler N, 2002, OTOLARYNG CLIN N AM, V35, P891, DOI 10.1016/S0030-6665(02)00053-1; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Hubbs AF, 2007, AM J PATHOL, V170, P2068, DOI 10.2353/ajpath.2007.060898; KAPUR RP, 1992, DEVELOPMENT, V116, P167; KAPUR RP, 1991, NEURON, V7, P717, DOI 10.1016/0896-6273(91)90275-5; Knipper M, 2006, J PHYSIOL-LONDON, V576, P73, DOI 10.1113/jphysiol.2006.116889; Laghmani K, 2001, J CLIN INVEST, V107, P1563, DOI 10.1172/JCI11234; Lang HN, 2006, J NEUROSCI, V26, P3541, DOI 10.1523/JNEUROSCI.2488-05.2006; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Matsushima Y, 2002, MAMM GENOME, V13, P30, DOI 10.1007/s00335-001-3038-2; Moller A, 1985, AUDITORY BRAINSTEM R, P13; Nin F, 2008, P NATL ACAD SCI USA, V105, P1751, DOI 10.1073/pnas.0711463105; OHGAMI N, 2011, NEUROBIOL A IN PRESS; Ohgami N, 2010, P NATL ACAD SCI USA, V107, P13051, DOI 10.1073/pnas.1004520107; Pardono E, 2003, AM J MED GENET A, V117A, P223, DOI 10.1002/ajmg.a.10193; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SALT AN, 1987, LARYNGOSCOPE, V97, P984; SEWELL WF, 1984, J PHYSIOL-LONDON, V347, P685, DOI 10.1113/jphysiol.1984.sp015090; SHIMADA A, 1992, J NEUROPATH EXP NEUR, V51, P440, DOI 10.1097/00005072-199207000-00006; Stanchina L, 2006, DEV BIOL, V295, P232, DOI 10.1016/j.ydbio.2006.03.031; STEEL KP, 1989, DEVELOPMENT, V107, P453; STEEL KP, 1992, DEVELOPMENT, V115, P1111; STOCKARD JJ, 1977, NEUROLOGY, V27, P316, DOI 10.1212/WNL.27.4.316; Trigueiros-Cunha N, 2003, EUR J NEUROSCI, V18, P2653, DOI 10.1046/j.1460-9568.2003.02989.x; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	33	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29621	29626		10.1074/jbc.M111.236802	http://dx.doi.org/10.1074/jbc.M111.236802			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21715336	Green Published, hybrid			2022-12-25	WOS:000294046600020
J	Jascur, T; Fotedar, R; Greene, S; Hotchkiss, E; Boland, CR				Jascur, Thomas; Fotedar, Rati; Greene, Serena; Hotchkiss, Erin; Boland, C. Richard			N-Methyl-N '-nitro-N-nitrosoguanidine (MNNG) Triggers MSH2 and Cdt2 Protein-dependent Degradation of the Cell Cycle and Mismatch Repair (MMR) Inhibitor Protein p21(Waf1/Cip1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-ETA; HUMAN TUMOR-CELLS; NUCLEAR ANTIGEN; UV-IRRADIATION; MUTS-ALPHA; MICROSATELLITE INSTABILITY; REPLICATIVE DNA; IN-VIVO; PCNA; P21	p21(Waf1/Cip1) protein levels respond to DNA damage; p21 is induced after ionizing radiation, but degraded after UV. p21 degradation after UV is necessary for optimal DNA repair, presumably because p21 inhibits nucleotide excision repair by blocking proliferating cell nuclear antigen (PCNA). Because p21 also inhibits DNA mismatch repair (MMR), we investigated how p21 levels respond to DNA alkylation by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), which triggers the MMR system. We show that MNNG caused rapid degradation of p21, and this involved the ubiquitin ligase Cdt2 and the proteasome. p21 degradation further required MSH2 but not MLH1. p21 mutants that cannot bind PCNA or cannot be ubiquitinated were resistant to MNNG. MNNG induced the formation of PCNA complexes with MSH6 and Cdt2. Finally, when p21 degradation was blocked, MNNG treatment resulted in reduced recruitment of MMR proteins to chromatin. This study describes a novel pathway that removes p21 to allow cells to efficiently activate the MMR system.	[Jascur, Thomas; Greene, Serena; Hotchkiss, Erin; Boland, C. Richard] Baylor Univ, Med Ctr, Baylor Res Inst, Dallas, TX 75246 USA; [Jascur, Thomas; Greene, Serena; Hotchkiss, Erin; Boland, C. Richard] Baylor Univ, Med Ctr, Sammons Canc Ctr, Dallas, TX 75246 USA; [Fotedar, Rati] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center; Sanford Burnham Prebys Medical Discovery Institute	Jascur, T (corresponding author), Baylor Univ, Med Ctr, Baylor Res Inst, Dallas, TX 75246 USA.	thomasja@baylorhealth.edu			National Institutes of Health [R01 CA72851]; Baylor Research Institute; NATIONAL CANCER INSTITUTE [R01CA072851] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA72851 (to C. R. B.). This work was also supported by funds from the Baylor Research Institute.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Berardini M, 2000, J BIOL CHEM, V275, P27851; Blagosklonny MV, 1996, BIOCHEM BIOPH RES CO, V227, P564, DOI 10.1006/bbrc.1996.1546; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Carethers JM, 1996, J CLIN INVEST, V98, P199, DOI 10.1172/JCI118767; Christmann M, 2000, J BIOL CHEM, V275, P36256, DOI 10.1074/jbc.M005377200; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; Guo SL, 2004, J BIOL CHEM, V279, P16912, DOI 10.1074/jbc.M313213200; HARPER JW, 1993, CELL, V75, P805; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hidaka M, 2005, NUCLEIC ACIDS RES, V33, P5703, DOI 10.1093/nar/gki878; Hong Z, 2008, J CELL SCI, V121, P3146, DOI 10.1242/jcs.026393; Ishii T, 2010, J BIOL CHEM, V285, P41993, DOI 10.1074/jbc.M110.161661; Iyer RR, 2008, J BIOL CHEM, V283, P13310, DOI 10.1074/jbc.M800606200; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; KOI M, 1994, CANCER RES, V54, P4308; Kreklau EL, 1999, J PHARMACOL EXP THER, V291, P1269; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lau PJ, 2002, MOL CELL BIOL, V22, P6669, DOI 10.1128/MCB.22.19.6669-6680.2002; Masih PJ, 2008, NUCLEIC ACIDS RES, V36, P67, DOI 10.1093/nar/gkm943; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; PAGANO M, 1994, GENE DEV, V8, P1627, DOI 10.1101/gad.8.14.1627; Schroering AG, 2008, DNA REPAIR, V7, P951, DOI 10.1016/j.dnarep.2008.03.023; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Soria G, 2006, ONCOGENE, V25, P2829, DOI 10.1038/sj.onc.1209315; Stuart SA, 2009, J BIOL CHEM, V284, P15061, DOI 10.1074/jbc.M808810200; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; TOSCHI L, 1988, J CELL BIOL, V107, P1623, DOI 10.1083/jcb.107.5.1623; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Umar A, 1997, CANCER RES, V57, P3949; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Wang Q, 2001, ONCOGENE, V20, P4640, DOI 10.1038/sj.onc.1204625; Wang Y, 2000, GENE DEV, V14, P927; WARBRICK E, 1995, CURR BIOL, V5, P275, DOI 10.1016/S0960-9822(95)00058-3; Wilson TM, 2005, J EXP MED, V201, P637, DOI 10.1084/jem.20042066; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023	46	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29531	29539		10.1074/jbc.M111.221341	http://dx.doi.org/10.1074/jbc.M111.221341			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21725088	hybrid, Green Published			2022-12-25	WOS:000294046600010
J	Chauleau, M; Mora, L; Serba, J; de Zamaroczy, M				Chauleau, Mathieu; Mora, Liliana; Serba, Justyna; de Zamaroczy, Miklos			FtsH-dependent Processing of RNase Colicins D and E3 Means That Only the Cytotoxic Domains Are Imported into the Cytoplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEASE; ESCHERICHIA-COLI; IMMUNITY PROTEIN; CRYSTAL-STRUCTURE; LEADER PEPTIDASE; NUCLEOTIDE-SEQUENCE; SIGNAL PEPTIDASE; RECEPTOR-BINDING; CHOLERA-TOXIN; OMPT PROTEASE	It has long been suggested that the import of nuclease colicins requires protein processing; however it had never been formally demonstrated. Here we show that two RNase colicins, E3 and D, which appropriate two different translocation machineries to cross the outer membrane (BtuB/Tol and FepA/TonB, respectively), undergo a processing step inside the cell that is essential to their killing action. We have detected the presence of the C-terminal catalytic domains of these colicins in the cytoplasm of target bacteria. The same processed forms were identified in both colicin-sensitive cells and in cells immune to colicin because of the expression of the cognate immunity protein. We demonstrate that the inner membrane protease FtsH is necessary for the processing of colicins D and E3 during their import. We also show that the signal peptidase LepB interacts directly with the central domain of colicin D in vitro and that it is a specific but not a catalytic requirement for in vivo processing of colicin D. The interaction of colicin D with LepB may ensure a stable association with the inner membrane that in turn allows the colicin recognition by FtsH. We have also shown that the outer membrane protease OmpT is responsible for alternative and distinct endoproteolytic cleavages of colicins D and E3 in vitro, presumably reflecting its known role in the bacterial defense against antimicrobial peptides. Even though the OmpT-catalyzed in vitro cleavage also liberates the catalytic domain from colicins D and E3, it is not involved in the processing of nuclease colicins during their import into the cytoplasm.	[Chauleau, Mathieu; Mora, Liliana; Serba, Justyna; de Zamaroczy, Miklos] Inst Biol Physicochim, CNRS, UPR 9073, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS)	de Zamaroczy, M (corresponding author), 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	zamaroczy@ibpc.fr			Centre National de la Recherche Scientifique [UPR 9073]; Ecole Doctorale GGC (Genes, Genomes, Cellules), Universite Paris	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Ecole Doctorale GGC (Genes, Genomes, Cellules), Universite Paris	This work was supported by the Centre National de la Recherche Scientifique (UPR 9073) and by a studentship from the Ecole Doctorale GGC (Genes, Genomes, Cellules), Universite Paris 11 ( to M. C.).	AKIYAMA Y, 1990, BIOCHEM BIOPH RES CO, V167, P711, DOI 10.1016/0006-291X(90)92083-C; AKIYAMA Y, 1995, J BIOL CHEM, V270, P23485, DOI 10.1074/jbc.270.40.23485; Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; Ayuso-Tejedor S, 2010, J STRUCT BIOL, V171, P117, DOI 10.1016/j.jsb.2010.05.001; BENEDETTI H, 1991, J MOL BIOL, V217, P429, DOI 10.1016/0022-2836(91)90747-T; Betton JM, 1996, J BIOL CHEM, V271, P8046, DOI 10.1074/jbc.271.14.8046; Bieniossek C, 2009, P NATL ACAD SCI USA, V106, P21579, DOI 10.1073/pnas.0910708106; BOWMAN CM, 1971, P NATL ACAD SCI USA, V68, P964, DOI 10.1073/pnas.68.5.964; BRAUN V, 1994, ARCH MICROBIOL, V161, P199, DOI 10.1007/s002030050042; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; DALBEY RE, 1985, J BIOL CHEM, V260, P5925; Dalbey RE, 1997, PROTEIN SCI, V6, P1129, DOI 10.1002/pro.5560060601; de Zamaroczy M, 2002, BIOCHIMIE, V84, P423, DOI 10.1016/S0300-9084(02)01426-8; de Zamaroczy M, 2001, MOL CELL, V8, P159, DOI 10.1016/S1097-2765(01)00276-3; de Zamaroczy M, 2011, PROKARYOTIC ANTIMICROBIAL PEPTIDES: FROM GENES TO APPLICATIONS, P255, DOI 10.1007/978-1-4419-7692-5_14; Dubuisson JF, 2005, MICROBIOL-SGM, V151, P3337, DOI 10.1099/mic.0.28237-0; Duche D, 2006, J BACTERIOL, V188, P8593, DOI 10.1128/JB.00941-06; Duche D, 2009, J BIOCHEM, V145, P95, DOI 10.1093/jb/mvn149; ELISH ME, 1988, J GEN MICROBIOL, V134, P1355; FREY J, 1986, J BACTERIOL, V166, P15, DOI 10.1128/jb.166.1.15-19.1986; Graille M, 2004, EMBO J, V23, P1474, DOI 10.1038/sj.emboj.7600162; GRODBERG J, 1988, J BACTERIOL, V170, P1245, DOI 10.1128/jb.170.3.1245-1253.1988; GRODBERG J, 1988, NUCLEIC ACIDS RES, V16, P1209, DOI 10.1093/nar/16.3.1209; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; Higgs PI, 2002, MOL MICROBIOL, V44, P271, DOI 10.1046/j.1365-2958.2002.02880.x; Hilsenbeck JL, 2004, MOL MICROBIOL, V51, P711, DOI 10.1111/j.1365-2958.2003.03884.x; Housden NG, 2005, P NATL ACAD SCI USA, V102, P13849, DOI 10.1073/pnas.0503567102; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Kramer RA, 2000, FEBS LETT, V468, P220, DOI 10.1016/S0014-5793(00)01231-X; Kramer RA, 2002, EUR J BIOCHEM, V269, P1746, DOI 10.1046/j.1432-1327.2002.02820.x; Kramer RA, 2001, FEBS LETT, V505, P426, DOI 10.1016/S0014-5793(01)02863-0; Kramer RA, 2000, EUR J BIOCHEM, V267, P885, DOI 10.1046/j.1432-1327.2000.01073.x; KRONE WJA, 1986, J BACTERIOL, V166, P260, DOI 10.1128/jb.166.1.260-268.1986; Kurisu G, 2003, NAT STRUCT BIOL, V10, P948, DOI 10.1038/nsb997; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Liao CC, 2001, BIOCHEM BIOPH RES CO, V284, P556, DOI 10.1006/bbrc.2001.5016; MASAKI H, 1985, J MOL BIOL, V182, P217, DOI 10.1016/0022-2836(85)90340-7; Masi M, 2007, J BACTERIOL, V189, P2667, DOI 10.1128/JB.01448-06; Mora L, 2005, J BACTERIOL, V187, P2693, DOI 10.1128/JB.187.8.2693-2697.2005; Mora L, 2008, J BIOL CHEM, V283, P4993, DOI 10.1074/jbc.M706846200; Mosbahi K, 2006, PROTEIN SCI, V15, P620, DOI 10.1110/ps.051890306; Mosbahi K, 2004, J BIOL CHEM, V279, P22145, DOI 10.1074/jbc.M400402200; Mosbahi K, 2002, NAT STRUCT BIOL, V9, P476, DOI 10.1038/nsb797; Narberhaus F, 2009, RES MICROBIOL, V160, P652, DOI 10.1016/j.resmic.2009.08.011; Okuno T, 2006, GENES CELLS, V11, P261, DOI 10.1111/j.1365-2443.2006.00940.x; Paetzel M, 1997, J BIOL CHEM, V272, P9994; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Paquelin A, 2001, MOL MICROBIOL, V42, P995, DOI 10.1046/j.1365-2958.2001.02628.x; Qiagen, 2003, QIA EXPR HDB HIGH LE; ROOS U, 1989, MOL MICROBIOL, V3, P891, DOI 10.1111/j.1365-2958.1989.tb00238.x; Sharma O, 2007, J BIOL CHEM, V282, P23163, DOI 10.1074/jbc.M703004200; Sharma O, 2007, J BACTERIOL, V189, P363, DOI 10.1128/JB.01344-06; Shi ZH, 2005, J BIOL CHEM, V280, P24663, DOI 10.1074/jbc.M501216200; Soelaiman S, 2001, MOL CELL, V8, P1053, DOI 10.1016/S1097-2765(01)00396-3; Striebel F, 2009, CURR OPIN STRUC BIOL, V19, P209, DOI 10.1016/j.sbi.2009.02.006; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Stumpe S, 1998, J BACTERIOL, V180, P4002, DOI 10.1128/JB.180.15.4002-4006.1998; SUGIMURA K, 1988, J BACTERIOL, V170, P5625, DOI 10.1128/jb.170.12.5625-5632.1988; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; Tatsuta T, 1998, MOL MICROBIOL, V30, P583, DOI 10.1046/j.1365-2958.1998.01091.x; Tomita K, 2000, P NATL ACAD SCI USA, V97, P8278, DOI 10.1073/pnas.140213797; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; TSCHANTZ WR, 1993, J BIOL CHEM, V268, P27349; van Roosmalen ML, 2001, MICROBIOL-UK, V147, P909, DOI 10.1099/00221287-147-4-909; Vandeputte-Rutten L, 2001, EMBO J, V20, P5033, DOI 10.1093/emboj/20.18.5033; Vankemmelbeke M, 2009, J BIOL CHEM, V284, P18932, DOI 10.1074/jbc.M806149200; Walker D, 2007, J BIOL CHEM, V282, P31389, DOI 10.1074/jbc.M705883200; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Zhang Y, 2008, J BACTERIOL, V190, P4342, DOI 10.1128/JB.00047-08	70	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29397	29407		10.1074/jbc.M111.242354	http://dx.doi.org/10.1074/jbc.M111.242354			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21700705	hybrid, Green Published			2022-12-25	WOS:000293837000074
J	Popiolek, M; Ross, JF; Charych, E; Chanda, P; Gundelfinger, ED; Moss, SJ; Brandon, NJ; Pausch, MH				Popiolek, Michael; Ross, John F.; Charych, Erik; Chanda, Pranab; Gundelfinger, Eckart D.; Moss, Stephen J.; Brandon, Nicholas J.; Pausch, Mark H.			D-Amino Acid Oxidase Activity Is Inhibited by an Interaction with Bassoon Protein at the Presynaptic Active Zone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-ASPARTATE RECEPTORS; D-SERINE LEVELS; IMMUNOCYTOCHEMICAL LOCALIZATION; POSTSYNAPTIC DENSITIES; RAT CEREBELLUM; HIGH-AFFINITY; MUTANT MICE; SCHIZOPHRENIA; BRAIN; PEROXISOMES	Schizophrenia is a highly heritable neuropsychiatric disorder affecting similar to 1% of the world's population. Linkage and association studies have identified multiple candidate schizophrenia susceptibility genes whose functions converge on the glutamatergic neurotransmitter system. One such susceptibility gene encoding D-amino acid oxidase (DAO), an enzyme that metabolizes the NMDA receptor (NMDAR) co-agonist D-serine, has the potential to modulate NMDAR function in the context of schizophrenia. To further investigate its cellular regulation, we sought to identify DAO-interacting proteins that participate in its functional regulation in rat cerebellum, where DAO expression is especially high. Immunoprecipitation with DAO-specific antibodies and subsequent mass spectrometric analysis of co-precipitated proteins yielded 24 putative DAO-interacting proteins. The most robust interactions occurred with known components of the presynaptic active zone, such as bassoon (BSN) and piccolo (PCLO). The interaction of DAO with BSN was confirmed through co-immunoprecipitation assays using DAO- and BSN-specific antibodies. Moreover, DAO and BSN colocalized with one another in cultured cerebellar granule cells and in synaptic junction membrane protein fractions derived from rat cerebellum. The functional consequences of this interaction were studied through enzyme assay experiments, where DAO enzymatic activity was significantly inhibited as a result of its interaction with BSN. Taking these results together, we hypothesize that synaptic D-serine concentrations may be under tight regulation by a BSN-DAO complex. We therefore predict that this mechanism plays a role in the modulation of glutamatergic signaling through NMDARs. It also furthers our understanding of the biology underlying this potential therapeutic entry point for schizophrenia and other psychiatric disorders.	[Popiolek, Michael; Charych, Erik; Chanda, Pranab; Brandon, Nicholas J.; Pausch, Mark H.] Pfizer Global Res & Dev, Neurosci Res Unit, Groton, CT 06340 USA; [Ross, John F.] Aileron Therapeut, Cambridge, MA USA; [Gundelfinger, Eckart D.] Leibniz Inst Neurobiol, Magdenburg, Germany; [Pausch, Mark H.] Merck, West Point, PA 19486 USA; [Moss, Stephen J.] Tufts Univ, Boston, MA 02111 USA	Pfizer; Leibniz Institut fur Neurobiologie (LIN); Tufts University	Brandon, NJ (corresponding author), Pfizer Global Res & Dev, Neurosci Res Unit, Groton, CT 06340 USA.	nick.brandon@pfizer.com		Brandon, Nicholas/0000-0002-3917-0096	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051195, R01NS081986] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS051195, R01 NS081986] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Almond SL, 2006, MOL CELL NEUROSCI, V32, P324, DOI 10.1016/j.mcn.2006.05.003; Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Andersen JD, 2004, NEUROPSYCHOPHARMACOL, V29, P1080, DOI 10.1038/sj.npp.1300394; ARNOLD G, 1979, J HISTOCHEM CYTOCHEM, V27, P735, DOI 10.1177/27.3.39097; Bendikov I, 2007, SCHIZOPHR RES, V90, P41, DOI 10.1016/j.schres.2006.10.010; Bortolotto ZA, 1998, NEUROPHARMACOLOGY, V37, P535, DOI 10.1016/S0028-3908(98)00058-6; Burnet PWJ, 2008, MOL PSYCHIATR, V13, P658, DOI 10.1038/mp.2008.47; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chin LS, 2000, J BIOL CHEM, V275, P1191, DOI 10.1074/jbc.275.2.1191; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Corvin A, 2007, AM J MED GENET B, V144B, P949, DOI 10.1002/ajmg.b.30452; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Cristiano L, 2001, J NEUROCYTOL, V30, P671, DOI 10.1023/A:1016525716209; DANIELLO A, 1993, COMP BIOCHEM PHYS B, V105, P731, DOI 10.1016/0305-0491(93)90113-J; DEDUVE C, 1966, PHYSIOL REV, V46, P323, DOI 10.1152/physrev.1966.46.2.323; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Fukasawa Y, 2000, J BIOL CHEM, V275, P9690, DOI 10.1074/jbc.275.13.9690; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Ghiglieri V, 2009, EUR J NEUROSCI, V29, P1979, DOI 10.1111/j.1460-9568.2009.06733.x; Hamase K, 2005, BIOL PHARM BULL, V28, P1578, DOI 10.1248/bpb.28.1578; Hashimoto A, 2005, BRAIN RES, V1033, P210, DOI 10.1016/j.brainres.2004.11.031; Hashimoto K, 2003, ARCH GEN PSYCHIAT, V60, P572, DOI 10.1001/archpsyc.60.6.572; Hashimoto K, 2009, BIOL PSYCHIAT, V65, P1103, DOI 10.1016/j.biopsych.2009.01.002; Helboe L, 2003, EUR J NEUROSCI, V18, P2227, DOI 10.1046/j.1460-9568.2003.02966.x; HORIIKE K, 1994, BRAIN RES, V652, P297, DOI 10.1016/0006-8993(94)90240-2; HORIIKE K, 1987, BRAIN RES BULL, V19, P587, DOI 10.1016/0361-9230(87)90076-1; Kapoor R, 2006, BRAIN RES, V1106, P205, DOI 10.1016/j.brainres.2006.05.082; Kartvelishvily E, 2006, J BIOL CHEM, V281, P14151, DOI 10.1074/jbc.M512927200; KONNO R, 1983, GENETICS, V103, P277; Korostishevsky M, 2006, AM J MED GENET B, V141B, P91, DOI 10.1002/ajmg.b.30212; Labrie V, 2010, GENES BRAIN BEHAV, V9, P11, DOI 10.1111/j.1601-183X.2009.00529.x; LEIGHTON F, 1968, J CELL BIOL, V37, P482, DOI 10.1083/jcb.37.2.482; Li Y, 2006, J BIOL CHEM, V281, P2506, DOI 10.1074/jbc.M508165200; Liu XM, 2004, NEUROSCI LETT, V369, P228, DOI 10.1016/j.neulet.2004.07.078; Madeira C, 2008, SCHIZOPHR RES, V101, P76, DOI 10.1016/j.schres.2008.02.002; Maekawa M, 2005, NEUROSCI RES, V53, P34, DOI 10.1016/j.neures.2005.05.008; Marino MJ, 2008, J MED CHEM, V51, P1077, DOI 10.1021/jm701094q; Matsuo H, 2004, NEUROSCI LETT, V358, P123, DOI 10.1016/j.neulet.2004.01.014; Moreno S, 1999, J NEUROCYTOL, V28, P169, DOI 10.1023/A:1007064504007; Nakauchi J, 2000, NEUROSCI LETT, V287, P231, DOI 10.1016/S0304-3940(00)01169-1; NEIMS AH, 1966, J NEUROCHEM, V13, P163, DOI 10.1111/j.1471-4159.1966.tb07508.x; Ono K, 2009, J NEURAL TRANSM, V116, P1335, DOI 10.1007/s00702-009-0289-7; Owald D, 2009, CURR OPIN NEUROBIOL, V19, P311, DOI 10.1016/j.conb.2009.03.003; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Rosenberg D, 2010, FASEB J, V24, P2951, DOI 10.1096/fj.09-147967; Rutter AR, 2007, EUR J NEUROSCI, V25, P1757, DOI 10.1111/j.1460-9568.2007.05446.x; Sacchi S, 2008, J BIOL CHEM, V283, P22244, DOI 10.1074/jbc.M709153200; Sakata K, 1999, BIOCHEMISTRY-US, V38, P10099, DOI 10.1021/bi990246k; SASAKI M, 1992, BIOCHIM BIOPHYS ACTA, V1139, P315, DOI 10.1016/0925-4439(92)90107-X; Schumacher J, 2004, MOL PSYCHIATR, V9, P203, DOI 10.1038/sj.mp.4001421; Shao ZJ, 2009, J NEUROSCI RES, V87, P2520, DOI 10.1002/jnr.22086; Shi JJ, 2008, SCHIZOPHR RES, V98, P89, DOI 10.1016/j.schres.2007.10.004; Smith SM, 2009, J PHARMACOL EXP THER, V328, P921, DOI 10.1124/jpet.108.147884; TANII Y, 1994, J PHARMACOL EXP THER, V269, P1040; USUDA N, 1986, J HISTOCHEM CYTOCHEM, V34, P1709, DOI 10.1177/34.12.2878022; Vilella E, 2008, J PSYCHIATR RES, V42, P278, DOI 10.1016/j.jpsychires.2007.02.005; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang LZ, 2003, ACTA PHARMACOL SIN, V24, P965; Wang XW, 2009, J NEUROSCI, V29, P12584, DOI 10.1523/JNEUROSCI.1255-09.2009; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Weidenhofer J, 2006, MOL CELL NEUROSCI, V31, P243, DOI 10.1016/j.mcn.2005.09.013; Weidenhofer J, 2008, J PSYCHIATR RES, V43, P282, DOI 10.1016/j.jpsychires.2008.04.001; WEIMAR WR, 1977, J NEUROCHEM, V29, P649, DOI 10.1111/j.1471-4159.1977.tb07782.x; Wirgenes KV, 2009, NEUROPSYCHOBIOLOGY, V60, P31, DOI 10.1159/000235799; Wolosker Herman, 2006, Sci STKE, V2006, ppe41, DOI 10.1126/stke.3562006pe41; Wyneken U, 2001, NEUROSCIENCE, V102, P65, DOI 10.1016/S0306-4522(00)00469-3; Yamada K, 2005, BIOL PSYCHIAT, V57, P1493, DOI 10.1016/j.biopsych.2005.03.018	71	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28867	28875		10.1074/jbc.M111.262063	http://dx.doi.org/10.1074/jbc.M111.262063			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21700703	Green Published, hybrid			2022-12-25	WOS:000293837000024
J	Sugiura, N; Setoyama, Y; Chiba, M; Kimata, K; Watanabe, H				Sugiura, Nobuo; Setoyama, Yuka; Chiba, Mie; Kimata, Koji; Watanabe, Hideto			Baculovirus Envelope Protein ODV-E66 Is a Novel Chondroitinase with Distinct Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; MOLECULAR-CLONING; CATALYTIC MACHINERY; STRUCTURAL-ANALYSIS; HEPARAN-SULFATE; ACTIVE-SITE; TOUT-VELU; IN-VIVO; ABC-I; POLYMERASE	Chondroitin sulfate is a linear polysaccharide of alternating D-glucuronic acid and N-acetyl-D-galactosamine residues with sulfate groups at various positions of the sugars. It interacts with and regulates cytokine and growth factor signal transduction, thus influencing development, organ morphogenesis, inflammation, and infection. We found chondroitinase activity in medium conditioned by baculovirus-infected insect cells and identified a novel chondroitinase. Sequence analysis revealed that the enzyme was a truncated form of occlusion-derived virus envelope protein 66 (ODV-E66) of Autographa californica nucleopolyhedrovirus. The enzyme was a novel chondroitin lyase with distinct substrate specificity. The enzyme was active over a wide range of pH (pH 4-9) and temperature (30-60 degrees C) and was unaffected by divalent metal ions. The ODV-E66 truncated protein digested chondroitin most efficiently followed by chondroitin 6-sulfate. It degraded hyaluronan to a minimal extent but did not degrade dermatan sulfate, heparin, and N-acetylheparosan. Further analysis using chemo-enzymatically synthesized substrates revealed that the enzyme specifically acted on glucuronate residues in non-sulfated and chondroitin 6-sulfate structures but not in chondroitin 4-sulfate structures. These results suggest that this chondroitinase is useful for detailed structural and compositional analysis of chondroitin sulfate, preparation of specific chondroitin oligosaccharides, and study of baculovirus infection mechanism.	[Sugiura, Nobuo; Setoyama, Yuka; Chiba, Mie; Watanabe, Hideto] Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan	Aichi Medical University	Sugiura, N (corresponding author), Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan.	nsugiura@aichi-med-u.ac.jp		Watanabe, Hideto/0000-0001-5291-0696	New Energy and Industrial Technology Development Organization (NEDO); Seikagaku Corporation; Grants-in-Aid for Scientific Research [23570176] Funding Source: KAKEN	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Seikagaku Corporation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the New Energy and Industrial Technology Development Organization (NEDO) and by special research funding from Seikagaku Corporation.	Baker JR, 1997, BIOCHEM J, V327, P65, DOI 10.1042/bj3270065; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Braunagel SC, 2004, P NATL ACAD SCI USA, V101, P8372, DOI 10.1073/pnas.0402727101; Dinglasan RR, 2007, P NATL ACAD SCI USA, V104, P15882, DOI 10.1073/pnas.0706340104; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Fukuta M, 1998, BBA-GENE STRUCT EXPR, V1399, P57, DOI 10.1016/S0167-4781(98)00089-X; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Hamai A, 1997, J BIOL CHEM, V272, P9123; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; HIYAMA K, 1975, J BIOL CHEM, V250, P1824; HONG T, 1994, VIROLOGY, V204, P210, DOI 10.1006/viro.1994.1525; Hong T, 1997, P NATL ACAD SCI USA, V94, P4050, DOI 10.1073/pnas.94.8.4050; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; KATO F, 1990, CLIN ORTHOP RELAT R, P301; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; MICHELACCI YM, 1975, BIOCHEM J, V151, P121, DOI 10.1042/bj1510121; Ninomiya T, 2002, J BIOL CHEM, V277, P21567, DOI 10.1074/jbc.M201719200; OHYA T, 1970, BIOCHIM BIOPHYS ACTA, V198, P607, DOI 10.1016/0005-2744(70)90139-7; Osawa T, 2009, BIOCHEM BIOPH RES CO, V378, P10, DOI 10.1016/j.bbrc.2008.08.121; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pinto DO, 2004, GLYCOBIOLOGY, V14, P529, DOI 10.1093/glycob/cwh070; Prabhakar V, 2005, BIOCHEM J, V386, P103, DOI 10.1042/BJ20041222; Prabhakar V, 2006, BIOCHEMISTRY-US, V45, P11130, DOI 10.1021/bi0605484; Prabhakar V, 2009, J BIOL CHEM, V284, P974, DOI 10.1074/jbc.M806630200; Rohrmann G.F., 2019, BACULOVIRUS MOL BIOL; Shaya D, 2008, GLYCOBIOLOGY, V18, P270, DOI 10.1093/glycob/cwn002; Sinnis P, 2007, J BIOL CHEM, V282, P25376, DOI 10.1074/jbc.M704698200; Sobhany M, 2008, J BIOL CHEM, V283, P32328, DOI 10.1074/jbc.M804332200; Sugiura N, 2008, GLYCOCONJUGATE J, V25, P521, DOI 10.1007/s10719-008-9105-0; Sugiura N, 2007, ANAL BIOCHEM, V365, P62, DOI 10.1016/j.ab.2007.02.023; Takeo S, 2004, J BIOL CHEM, V279, P18920, DOI 10.1074/jbc.M314293200; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Toyoda H, 2000, J BIOL CHEM, V275, P21856, DOI 10.1074/jbc.M003540200; TOYODA H, 1988, ANAL SCI, V4, P381, DOI 10.2116/analsci.4.381; Vigdorovich V, 2007, J VIROL, V81, P3124, DOI 10.1128/JVI.02177-06; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; Yamauchi S, 2000, J BIOL CHEM, V275, P8975, DOI 10.1074/jbc.275.12.8975	37	31	34	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29026	29034		10.1074/jbc.M111.251157	http://dx.doi.org/10.1074/jbc.M111.251157			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21715327	Green Published, hybrid			2022-12-25	WOS:000293837000039
J	Ke, L; Meijering, RAM; Hoogstra-Berends, F; Mackovicova, K; Vos, MJ; Van Gelder, IC; Henning, RH; Kampinga, HH; Brundel, BJJM				Ke, Lei; Meijering, Roelien A. M.; Hoogstra-Berends, Femke; Mackovicova, Katarina; Vos, Michel J.; Van Gelder, Isabelle C.; Henning, Robert H.; Kampinga, Harm H.; Brundel, Bianca J. J. M.			HSPB1, HSPB6, HSPB7 and HSPB8 Protect against RhoA GTPase-Induced Remodeling in Tachypaced Atrial Myocytes	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ALPHA-B-CRYSTALLIN; PHOSPHORYLATION; ACTIN; CYTOSKELETON; STRESS; HSP25; OVEREXPRESSION; LOCALIZATION; DYSFUNCTION	Background: We previously demonstrated the small heat shock protein, HSPB1, to prevent tachycardia remodeling in in vitro and in vivo models for Atrial Fibrillation (AF). To gain insight into its mechanism of action, we examined the protective effect of all 10 members of the HSPB family on tachycardia remodeling. Furthermore, modulating effects of HSPB on RhoA GTPase activity and F-actin stress fiber formation were examined, as this pathway was found of prime importance in tachycardia remodeling events and the initiation of AF. Methods and Results: Tachypacing (4 Hz) of HL-1 atrial myocytes significantly and progressively reduced the amplitude of Ca2+ transients (CaT). In addition to HSPB1, also overexpression of HSPB6, HSPB7 and HSPB8 protected against tachypacinginduced CaT reduction. The protective effect was independent of HSPB1. Moreover, tachypacing induced RhoA GTPase activity and caused F-actin stress fiber formation. The ROCK inhibitor Y27632 significantly prevented tachypacing-induced Factin formation and CaT reductions, showing that RhoA activation is required for remodeling. Although all protective HSPB members prevented the formation of F-actin stress fibers, their mode of action differs. Whilst HSPB1, HSPB6 and HSPB7 acted via direct prevention of F-actin formation, HSPB8-protection was mediated via inhibition of RhoA GTPase activity. Conclusion: Overexpression of HSPB1, as well as HSPB6, HSPB7 and HSPB8 independently protect against tachycardia remodeling by attenuation of the RhoA GTPase pathway at different levels. The cardioprotective role for multiple HSPB members indicate a possible therapeutic benefit of compounds able to boost the expression of single or multiple members of the HSPB family.	[Ke, Lei; Vos, Michel J.; Kampinga, Harm H.] Univ Groningen, Dept Radiat & Stress Cell Biol, Univ Inst Drug Explorat GUIDE, Univ Med Ctr Groningen, Groningen, Netherlands; [Meijering, Roelien A. M.; Hoogstra-Berends, Femke; Mackovicova, Katarina; Henning, Robert H.; Brundel, Bianca J. J. M.] Univ Groningen, Dept Clin Pharmacol, GUIDE, Univ Med Ctr Groningen, Groningen, Netherlands; [Hoogstra-Berends, Femke] Nyken BV, Groningen, Netherlands; [Van Gelder, Isabelle C.] Univ Groningen, Dept Cardiol, GUIDE, Univ Med Ctr Groningen, Utrecht, Netherlands; [Van Gelder, Isabelle C.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands	University of Groningen; University of Groningen; University of Groningen; Interuniversity Cardiology Institute of the Netherlands; Utrecht University	Ke, L (corresponding author), Univ Groningen, Dept Radiat & Stress Cell Biol, Univ Inst Drug Explorat GUIDE, Univ Med Ctr Groningen, Groningen, Netherlands.	B.J.J.M.Brundel@med.umcg.nl	Henning, Robert H/AAY-5222-2020	Vos, Michel/0000-0001-9379-2219; Kampinga, Harm/0000-0002-8966-8466; Henning, Robert/0000-0002-5135-4621	Dutch Organization for Scientific Research (NWO) [916.46.043]; Dutch Heart Foundation [2007B217]; EFRO; Ubbo Emmius Bursaal grant [800403]	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Heart Foundation(Netherlands Heart Foundation); EFRO; Ubbo Emmius Bursaal grant	This study was supported by the Dutch Organization for Scientific Research (NWO program grant 916.46.043), Dutch Heart Foundation (2007B217), EFRO grant (Operationeel Programma Noord-Nederland 2007-2013 (OP-EFRO), Drug delivery en targeting cluster) and Ubbo Emmius Bursaal grant (UMCG Number 800403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Femke Hoogstra-Berends, a technician employed by Nyken BV, helped with execution of experiments. The funder Nyken BV played a role in this study as an employer of Femke Hoogstra-Berends.	Adam O, 2007, J AM COLL CARDIOL, V50, P359, DOI 10.1016/j.jacc.2007.03.041; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Brundel BJJM, 2006, CIRC RES, V99, P1394, DOI 10.1161/01.RES.0000252323.83137.fe; Brundel BJJM, 2006, J MOL CELL CARDIOL, V41, P555, DOI 10.1016/j.yjmcc.2006.06.068; Brundel BJJM, 2004, CARDIOVASC RES, V62, P521, DOI 10.1016/j.cardiores.2004.02.007; Bryantsev AL, 2002, CELL STRESS CHAPERON, V7, P146, DOI 10.1379/1466-1268(2002)007<0146:DPAAOH>2.0.CO;2; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Carra S, 2010, J BIOL CHEM, V285, P37811, DOI 10.1074/jbc.M110.127498; Carra S, 2009, J BIOL CHEM, V284, P5523, DOI 10.1074/jbc.M807440200; Dobrev D, 2010, LANCET, V375, P1212, DOI 10.1016/S0140-6736(10)60096-7; Fan GC, 2004, CIRC RES, V94, P1474, DOI 10.1161/01.RES.0000129179.66631.00; FAN GC, 2010, J MOL CELL IN PRESS; Golenhofen N, 2004, HISTOCHEM CELL BIOL, V122, P415, DOI 10.1007/s00418-004-0711-z; Hoch B, 1996, MOL CELL BIOCHEM, V161, P231, DOI 10.1007/BF00240054; Janmey PA, 1998, PHYSIOL REV, V78, P763, DOI 10.1152/physrev.1998.78.3.763; Johnson BD, 2005, P NATL ACAD SCI USA, V102, P4191, DOI 10.1073/pnas.0409695102; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Kerfant BG, 2001, CIRC RES, V88, pE59, DOI 10.1161/hh0701.090462; Krief S, 1999, J BIOL CHEM, V274, P36592, DOI 10.1074/jbc.274.51.36592; Landry J, 1995, BIOCHEM CELL BIOL, V73, P703, DOI 10.1139/o95-078; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Leach RN, 2005, CELL CALCIUM, V38, P515, DOI 10.1016/j.ceca.2005.07.006; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Ogata T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Reil JC, 2010, CARDIOVASC RES, V87, P485, DOI 10.1093/cvr/cvq079; Sah VP, 1999, J CLIN INVEST, V103, P1627, DOI 10.1172/JCI6842; Sanbe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005351; Simon S, 2007, J BIOL CHEM, V282, P34276, DOI 10.1074/jbc.M703267200; Sui XZ, 2009, CIRC RES, V104, P887, DOI 10.1161/CIRCRESAHA.108.192328; Sun XK, 2004, J BIOL CHEM, V279, P2394, DOI 10.1074/jbc.M311324200; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Vos MJ, 2011, AUTOPHAGY, V7, P101, DOI 10.4161/auto.7.1.13935; Vos MJ, 2010, HUM MOL GENET, V19, P4677, DOI 10.1093/hmg/ddq398; VOS MJ, 2009, THESIS; VOS MJ, 2010, AUTOPHAGY, V7, P1	38	65	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e20395	10.1371/journal.pone.0020395	http://dx.doi.org/10.1371/journal.pone.0020395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731611	Green Published, gold, Green Submitted			2022-12-25	WOS:000292036900003
J	Rigden, DJ; Woodhead, DD; Wong, PWH; Galperin, MY				Rigden, Daniel J.; Woodhead, Duncan D.; Wong, Prudence W. H.; Galperin, Michael Y.			New Structural and Functional Contexts of the Dx[DN]xDG Linear Motif: Insights into Evolution of Calcium-Binding Proteins	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ACTIN-ASSOCIATED PROTEIN; BIEDL-SYNDROME PROTEINS; CRYSTAL-STRUCTURE; EF-HAND; PHOSPHOLIPASE-D; SITES; RECOGNITION; SUBTILISIN; DOMAIN	Binding of calcium ions (Ca2+) to proteins can have profound effects on their structure and function. Common roles of calcium binding include structure stabilization and regulation of activity. It is known that diverse families - EF-hands being one of at least twelve - use a Dx[DN]xDG linear motif to bind calcium in near-identical fashion. Here, four novel structural contexts for the motif are described. Existing experimental data for one of them, a thermophilic archaeal subtilisin, demonstrate for the first time a role for Dx[DN]xDG-bound calcium in protein folding. An integrin-like embedding of the motif in the blade of a beta-propeller fold - here named the calcium blade - is discovered in structures of bacterial and fungal proteins. Furthermore, sensitive database searches suggest a common origin for the calcium blade in b-propeller structures of different sizes and a pan-kingdom distribution of these proteins. Factors favouring the multiple convergent evolution of the motif appear to include its general Asp-richness, the regular spacing of the Asp residues and the fact that change of Asp into Gly and vice versa can occur though a single nucleotide change. Among the known structural contexts for the Dx[DN] xDG motif, only the calcium blade and the EF-hand are currently found intracellularly in large numbers, perhaps because the higher extracellular concentration of Ca2+ allows for easier fixing of newly evolved motifs that have acquired useful functions. The analysis presented here will inform ongoing efforts toward prediction of similar calcium-binding motifs from sequence information alone.	[Rigden, Daniel J.; Woodhead, Duncan D.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Wong, Prudence W. H.] Univ Liverpool, Dept Comp Sci, Liverpool, Merseyside, England; [Galperin, Michael Y.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	University of Liverpool; University of Liverpool; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Rigden, DJ (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	drigden@liv.ac.uk	Galperin, Michael Y./B-5859-2013	Galperin, Michael Y./0000-0002-2265-5572; Rigden, Daniel/0000-0002-7565-8937; Wong, Prudence W.H./0000-0001-7935-7245	Biotechnology and Biological Sciences Research Council; National Institutes of Health at the National Library of Medicine	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health at the National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Biotechnology and Biological Sciences Research Council studentship (DDW); National Institutes of Health Intramural Research Program at the National Library of Medicine (MYG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adany R, 2003, CELL MOL LIFE SCI, V60, P1049, DOI 10.1007/s00018-003-2178-9; Alba MM, 1999, J MOL EVOL, V49, P789, DOI 10.1007/PL00006601; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; BEARER EL, 1992, J NEUROSCI, V12, P750; Bearer EL, 2000, ANN HUM GENET, V64, P189, DOI 10.1046/j.1469-1809.2000.6430189.x; Bearer EL, 1999, EUR J CELL BIOL, V78, P117, DOI 10.1016/S0171-9335(99)80013-2; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; Brakoulias A, 2004, PROTEINS, V56, P250, DOI 10.1002/prot.20123; Bronner F, 2001, ScientificWorldJournal, V1, P919; Caines MEC, 2008, J BIOL CHEM, V283, P31279, DOI 10.1074/jbc.C800150200; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; CARAFOLI E, CALCIUM CELLULAR REG; Chaudhuri I, 2008, PROTEINS, V71, P795, DOI 10.1002/prot.21764; Cioci G, 2006, J MOL BIOL, V357, P1575, DOI 10.1016/j.jmb.2006.01.066; Dragani B, 1999, ARCH BIOCHEM BIOPHYS, V368, P211, DOI 10.1006/abbi.1999.1312; Dutta A, 2010, STRUCTURE, V18, P1140, DOI 10.1016/j.str.2010.06.013; Eddy Sean R, 2009, Genome Inform, V23, P205; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fiscella M, 2003, NAT BIOTECHNOL, V21, P302, DOI 10.1038/nbt797; Gahmberg CG, 2009, BBA-GEN SUBJECTS, V1790, P431, DOI 10.1016/j.bbagen.2009.03.007; GANGOLA P, 1987, J BIOL CHEM, V262, P12570; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hoskins BE, 2003, HUM MUTAT, V22, P151, DOI 10.1002/humu.10241; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kawasaki H, 1998, BIOMETALS, V11, P277, DOI 10.1023/A:1009282307967; Kleywegt GJ, 1999, J MOL BIOL, V285, P1887, DOI 10.1006/jmbi.1998.2393; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; KRETSINGER RH, 1976, ANNU REV BIOCHEM, V45, P239, DOI 10.1146/annurev.bi.45.070176.001323; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kurakata Y, 2008, J MOL BIOL, V381, P116, DOI 10.1016/j.jmb.2008.05.061; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li JY, 1999, ARCH BIOCHEM BIOPHYS, V361, P142, DOI 10.1006/abbi.1998.0969; LI JY, 1994, J BIOL CHEM, V269, P28963; Li N, 2010, MOL MICROBIOL, V76, P861, DOI 10.1111/j.1365-2958.2010.07123.x; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; MCPHALEN CA, 1991, ADV PROTEIN CHEM, V42, P77; Mykytyn K, 2004, TRENDS MOL MED, V10, P106, DOI 10.1016/j.molmed.2004.01.003; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Nitz M, 2004, ANGEW CHEM INT EDIT, V43, P3682, DOI 10.1002/anie.200460028; Ochiai A, 2007, J BIOL CHEM, V282, P37134, DOI 10.1074/jbc.M704663200; Orans J, 2010, P NATL ACAD SCI USA, V107, P1065, DOI 10.1073/pnas.0911616107; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Pidcock E, 2001, J BIOL INORG CHEM, V6, P479, DOI 10.1007/s007750100214; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Redruello B, 2010, GENE, V456, P1, DOI 10.1016/j.gene.2010.02.003; Richard GF, 2000, EMBO REP, V1, P122, DOI 10.1093/embo-reports/kvd031; Rigden DJ, 2004, J MOL BIOL, V343, P971, DOI 10.1016/j.jmb.2004.08.077; Rigden DJ, 2003, TRENDS MICROBIOL, V11, P295, DOI 10.1016/S0966-842X(03)00153-7; Rigden DJ, 2003, FEMS MICROBIOL LETT, V221, P103, DOI 10.1016/S0378-1097(03)00160-5; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Shah AS, 2008, P NATL ACAD SCI USA, V105, P3380, DOI 10.1073/pnas.0712327105; Shinde U, 1996, ADV EXP MED BIOL, V379, P147; Smith R J, 1995, Adv Microb Physiol, V37, P83, DOI 10.1016/S0065-2911(08)60144-7; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Suzuki R, 2009, J BIOCHEM, V146, P389, DOI 10.1093/jb/mvp086; Takeuchi Y, 2009, BIOCHEMISTRY-US, V48, P10637, DOI 10.1021/bi901334b; Tanaka SI, 2007, J MOL BIOL, V372, P1055, DOI 10.1016/j.jmb.2007.07.027; Tanaka SI, 2007, J BIOL CHEM, V282, P8246, DOI 10.1074/jbc.M610137200; Torrance JW, 2008, PROTEINS, V71, P813, DOI 10.1002/prot.21741; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wells RD, 1996, J BIOL CHEM, V271, P2875, DOI 10.1074/jbc.271.6.2875; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Yadid I, 2010, P NATL ACAD SCI USA, V107, P7287, DOI 10.1073/pnas.0912616107; Ye YM, 2003, PROTEIN ENG, V16, P429, DOI 10.1093/protein/gzg051; Ye YM, 2001, PROTEIN ENG, V14, P1001, DOI 10.1093/protein/14.12.1001; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414	92	42	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21507	10.1371/journal.pone.0021507	http://dx.doi.org/10.1371/journal.pone.0021507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720552	gold, Green Submitted, Green Published			2022-12-25	WOS:000292036900046
J	Takagi, T; Ishii, K; Shibata, S; Yasuda, A; Sato, M; Nagoshi, N; Saito, H; Okano, HJ; Toyama, Y; Okano, H; Nakamura, M				Takagi, Takehiko; Ishii, Ken; Shibata, Shinsuke; Yasuda, Akimasa; Sato, Momoka; Nagoshi, Narihito; Saito, Harukazu; Okano, Hirotaka J.; Toyama, Yoshiaki; Okano, Hideyuki; Nakamura, Masaya			Schwann-Spheres Derived from Injured Peripheral Nerves in Adult Mice - Their In Vitro Characterization and Therapeutic Potential	PLOS ONE			English	Article							SPINAL-CORD-INJURY; PLURIPOTENT STEM-CELLS; FUNCTIONAL RECOVERY; LOCOMOTOR RECOVERY; PROGENITOR CELLS; NERVOUS-SYSTEM; AXONAL GROWTH; SELF-RENEWAL; GLIAL-CELLS; TRANSPLANTATION	Multipotent somatic stem cells have been identified in various adult tissues. However, the stem/progenitor cells of the peripheral nerves have been isolated only from fetal tissues. Here, we isolated Schwann-cell precursors/immature Schwann cells from the injured peripheral nerves of adult mice using a floating culture technique that we call "Schwann-spheres." The Schwann-spheres were derived from de-differentiated mature Schwann cells harvested 24 hours to 6 weeks after peripheral nerve injury. They had extensive self-renewal and differentiation capabilities. They strongly expressed the immature-Schwann- cell marker p75, and differentiated only into the Schwann-cell lineage. The spheres showed enhanced myelin formation and neurite growth compared to mature Schwann cells in vitro. Mature Schwann cells have been considered a promising candidate for cell-transplantation therapies to repair the damaged nervous system, whereas these "Schwann-spheres" would provide a more potential autologous cell source for such transplantation.	[Takagi, Takehiko; Ishii, Ken; Yasuda, Akimasa; Sato, Momoka; Toyama, Yoshiaki; Nakamura, Masaya] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Takagi, Takehiko; Shibata, Shinsuke; Yasuda, Akimasa; Sato, Momoka; Okano, Hirotaka J.; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Sato, Momoka] Keio Univ, Ctr Integrated Med Res, Tokyo, Japan; [Nagoshi, Narihito; Saito, Harukazu] Natl Hosp Org, Murayama Med Ctr, Dept Orthopaed Surg, Tokyo, Japan	Keio University; Keio University; Keio University	Takagi, T (corresponding author), Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan.	hidokano@sc.itc.keio.ac.jp; masa@sc.itc.keio.ac.jp	Shibata, Shinsuke/AAM-6620-2020; Nakamura, Masaya/K-4111-2013; Okano, Hideyuki/I-7584-2019; Toyama, Yoshiaki/K-5743-2013	ISHII, KEN/0000-0003-0094-7918; Okano, Hirotaka James/0000-0003-4611-7098	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Science and Technology Corporation (JST); General Insurance Association of Japan; Keio University; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)); General Insurance Association of Japan; Keio University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Leading Project for Realization of Regenerative Medicine from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, from the Japan Science and Technology Corporation (JST), and from the General Insurance Association of Japan. This work was also supported by a Keio University grant-in-aid for the encouragement of young medical scientists, by grants-in-aid for scientific research from MEXT, Japan, by a grant-in-aid for research fellowship for young scientists from the Japan Society for the Promotion of Science, and by a grant-in-aid from the Global COE Program of MEXT, Japan to Keio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUAYO AJ, 1981, J EXP BIOL, V95, P231; Agudo M, 2008, GLIA, V56, P1263, DOI 10.1002/glia.20695; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073/pnas.0508440102; Amoh Y, 2008, CELL CYCLE, V7, P1865, DOI 10.4161/cc.7.12.6056; Amoh Y, 2009, J CELL BIOCHEM, V107, P1016, DOI 10.1002/jcb.22204; Biernaskie J, 2007, J NEUROSCI, V27, P9545, DOI 10.1523/JNEUROSCI.1930-07.2007; Casella CTB, 1996, GLIA, V17, P327, DOI 10.1002/(SICI)1098-1136(199608)17:4<327::AID-GLIA7>3.0.CO;2-W; Chau CH, 2004, FASEB J, V18, P194, DOI 10.1096/fj.03-0196fje; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Fortun J, 2009, NEUROSCI LETT, V456, P124, DOI 10.1016/j.neulet.2008.08.092; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Golden KL, 2007, EXP NEUROL, V207, P203, DOI 10.1016/j.expneurol.2007.06.023; Grimpe B, 2005, MOL CELL NEUROSCI, V28, P18, DOI 10.1016/j.mcn.2004.06.010; Haastert K, 2007, NAT PROTOC, V2, P99, DOI 10.1038/nprot.2006.486; Hill CE, 2006, GLIA, V53, P338, DOI 10.1002/glia.20287; Hisahara S, 2000, EMBO J, V19, P341, DOI 10.1093/emboj/19.3.341; Hood B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E4; Hoshikawa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003464; Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436; Iwashita Y, 2000, EXP NEUROL, V164, P292, DOI 10.1006/exnr.2000.7440; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jones LL, 2001, J PHYSIOL-LONDON, V533, P83, DOI 10.1111/j.1469-7793.2001.0083b.x; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kohyama J, 2008, P NATL ACAD SCI USA, V105, P18012, DOI 10.1073/pnas.0808417105; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Kulbatski I, 2008, PROG HISTOCHEM CYTO, V43, P123, DOI 10.1016/j.proghi.2008.04.001; Kumagai G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007706; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Liu F, 2011, CELL CYCLE, V10, P830, DOI 10.4161/cc.10.5.14969; McKenzie IA, 2006, J NEUROSCI, V26, P6651, DOI 10.1523/JNEUROSCI.1007-06.2006; Mirsky R, 2002, J PHYSIOL-PARIS, V96, P17, DOI 10.1016/S0928-4257(01)00076-6; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Molteni R, 2004, P NATL ACAD SCI USA, V101, P8473, DOI 10.1073/pnas.0401443101; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Nakamura M, 2005, J NEUROSCI RES, V81, P457, DOI 10.1002/jnr.20580; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Plant GW, 2001, MOL CELL NEUROSCI, V17, P471, DOI 10.1006/mcne.2000.0948; Stolt CC, 2004, DEVELOPMENT, V131, P2349, DOI 10.1242/dev.01114; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takami T, 2002, J NEUROSCI, V22, P6670; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Vukojevic K, 2010, GENE EXPR PATTERNS, V10, P144, DOI 10.1016/j.gep.2009.12.001; Weidner N, 1999, J COMP NEUROL, V413, P495, DOI 10.1002/(SICI)1096-9861(19991101)413:4<495::AID-CNE1>3.0.CO;2-Z; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; WIDERA D, 2011, STEM CELLS IN PRESS; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156	54	8	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21497	10.1371/journal.pone.0021497	http://dx.doi.org/10.1371/journal.pone.0021497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720551	Green Published, Green Submitted, gold			2022-12-25	WOS:000292036900044
J	Lilliebridge, RA; Tong, SYC; Giffard, PM; Holt, DC				Lilliebridge, Rachael A.; Tong, Steven Y. C.; Giffard, Philip M.; Holt, Deborah C.			The Utility of High-Resolution Melting Analysis of SNP Nucleated PCR Amplicons-An MLST Based Staphylococcus aureus Typing Scheme	PLOS ONE			English	Article							METHICILLIN-RESISTANT; CLONAL COMPLEX; SMALL SET; BACTERIAL; DNA; IDENTIFICATION; ASSIGNMENT	High resolution melting (HRM) analysis is gaining prominence as a method for discriminating DNA sequence variants. Its advantage is that it is performed in a real-time PCR device, and the PCR amplification and HRM analysis are closed tube, and effectively single step. We have developed an HRM-based method for Staphylococcus aureus genotyping. Eight single nucleotide polymorphisms (SNPs) were derived from the S. aureus multi-locus sequence typing (MLST) database on the basis of maximized Simpson's Index of Diversity. Only G <-> A, G <-> T, C <-> A, C <-> T SNPs were considered for inclusion, to facilitate allele discrimination by HRM. In silico experiments revealed that DNA fragments incorporating the SNPs give much higher resolving power than randomly selected fragments. It was shown that the predicted optimum fragment size for HRM analysis was 200 bp, and that other SNPs within the fragments contribute to the resolving power. Six DNA fragments ranging from 83 bp to 219 bp, incorporating the resolution optimized SNPs were designed. HRM analysis of these fragments using 94 diverse S. aureus isolates of known sequence type or clonal complex (CC) revealed that sequence variants are resolved largely in accordance with G+C content. A combination of experimental results and in silico prediction indicates that HRM analysis resolves S. aureus into 268 "melt types" (MelTs), and provides a Simpson's Index of Diversity of 0.978 with respect to MLST. There is a high concordance between HRM analysis and the MLST defined CCs. We have generated a Microsoft Excel key which facilitates data interpretation and translation between MelT and MLST data. The potential of this approach for genotyping other bacterial pathogens was investigated using a computerized approach to estimate the densities of SNPs with unlinked allelic states. The MLST databases for all species tested contained abundant unlinked SNPs, thus suggesting that high resolving power is not dependent upon large numbers of SNPs.	[Lilliebridge, Rachael A.; Tong, Steven Y. C.; Giffard, Philip M.; Holt, Deborah C.] Charles Darwin Univ, Menzies Sch Hlth Res, Trop & Emerging Infect Dis Div, Darwin, NT 0909, Australia	Charles Darwin University; Menzies School of Health Research	Lilliebridge, RA (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Trop & Emerging Infect Dis Div, Darwin, NT 0909, Australia.	deborah.holt@menzies.edu.au	Holt, Deborah/A-8002-2012; Giffard, Philip/N-2293-2013; Tong, Steven/N-2353-2013	Tong, Steven/0000-0002-1368-8356; Holt, Deborah/0000-0003-4951-1891; Giffard, Phil/0000-0002-3030-9127	Australian National Health and Medical Research Council [508829]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	SYCT is supported by an Australian National Health and Medical Research Council Postdoctoral Training Fellowship (508829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Coombs GW, 2010, ANTIMICROB AGENTS CH, V54, P1914, DOI 10.1128/AAC.01287-09; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Hall TA, 2009, J CLIN MICROBIOL, V47, P1733, DOI 10.1128/JCM.02175-08; Honsa E, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-140; Huygens F, 2006, J CLIN MICROBIOL, V44, P3712, DOI 10.1128/JCM.00843-06; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Ng JWS, 2009, J CLIN MICROBIOL, V47, P2295, DOI 10.1128/JCM.00122-09; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Price EP, 2006, J MED MICROBIOL, V55, P1061, DOI 10.1099/jmm.0.46460-0; Price EP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-278; Richardson LJ, 2011, CLIN MICROBIOL INFEC, V17, P1426, DOI 10.1111/j.1469-0691.2010.03433.x; Robertson GA, 2004, J MED MICROBIOL, V53, P35, DOI 10.1099/jmm.0.05365-0; SCHILDKRAUT C, 1965, BIOPOLYMERS, V3, P195, DOI 10.1002/bip.360030207; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Stephens AJ, 2006, J MED MICROBIOL, V55, P43, DOI 10.1099/jmm.0.46157-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tong SYC, 2009, CLIN MICROBIOL INFEC, V15, P1126, DOI 10.1111/j.1469-0691.2009.02732.x; Tong SYC, 2010, J INFECT DIS, V202, P760, DOI 10.1086/655396; Tong SYC, 2009, J INFECT DIS, V199, P1461, DOI 10.1086/598218	23	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e19749	10.1371/journal.pone.0019749	http://dx.doi.org/10.1371/journal.pone.0019749			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731606	Green Published, gold			2022-12-25	WOS:000292033700003
J	Thalappilly, S; Feng, XL; Pastyryeva, S; Suzuki, K; Muruve, D; Larocque, D; Richard, S; Truss, M; von Deimling, A; Riabowol, K; Tallen, G				Thalappilly, Subhash; Feng, Xiaolan; Pastyryeva, Svitlana; Suzuki, Keiko; Muruve, Daniel; Larocque, Daniel; Richard, Stephane; Truss, Matthias; von Deimling, Andreas; Riabowol, Karl; Tallen, Gesche			The p53 Tumor Suppressor Is Stabilized by Inhibitor of Growth 1 (ING1) by Blocking Polyubiquitination	PLOS ONE			English	Article							PHD FINGER; CELL-PROLIFERATION; PLANT HOMEODOMAIN; PROTEIN-DEGRADATION; DNA-DAMAGE; BINDING; EXPRESSION; P33(ING1); APOPTOSIS; UBIQUITINATION	The INhibitor of Growth tumor suppressors (ING1-ING5) affect aging, apoptosis, DNA repair and tumorigenesis. Plant homeodomains (PHD) of ING proteins bind histones in a methylation-sensitive manner to regulate chromatin structure. ING1 and ING2 contain a polybasic region (PBR) adjacent to their PHDs that binds stress-inducible phosphatidylinositol monophosphate (PtIn-MP) signaling lipids to activate these INGs. ING1 induces apoptosis independently of p53 but other studies suggest proapoptotic interdependence of ING1 and p53 leaving their functional relationship unclear. Here we identify a novel ubiquitin-binding domain (UBD) that overlaps with the PBR of ING1 and shows similarity to previously described UBDs involved in DNA damage responses. The ING1 UBD binds ubiquitin with high affinity (K-d similar to 100 nM) and ubiquitin competes with PtIn-MPs for ING1 binding. ING1 expression stabilized wild-type, but not mutant p53 in an MDM2-independent manner and knockdown of endogenous ING1 depressed p53 levels in a transcription-independent manner. ING1 stabilized unmodified and six multimonoubiquitinated forms of wild-type p53 that were also seen upon DNA damage, but not p53 mutants lacking the six known sites of ubiquitination. We also find that ING1 physically interacts with herpesvirus-associated ubiquitin-specific protease (HAUSP), a p53 and MDM2 deubiquitinase (DUB), and knockdown of HAUSP blocks the ability of ING1 to stabilize p53. These data link lipid stress signaling to ubiquitin-mediated proteasomal degradation through the PBR/UBD of ING1 and further indicate that ING1 stabilizes p53 by inhibiting polyubiquitination of multimonoubiquitinated forms via interaction with and colocalization of the HAUSP-deubiquitinase with p53.	[Thalappilly, Subhash; Feng, Xiaolan; Pastyryeva, Svitlana; Suzuki, Keiko; Riabowol, Karl] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Thalappilly, Subhash; Feng, Xiaolan; Pastyryeva, Svitlana; Suzuki, Keiko; Riabowol, Karl] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Muruve, Daniel] Univ Calgary, Dept Med, Calgary, AB, Canada; [Larocque, Daniel] GlaxoSmithKline Biol N Amer, Chron Disorders DAP, Preclin Res Team Neurodegenerat Dis, Laval, PQ, Canada; [Richard, Stephane] McGill Univ, Dept Med & Oncol, Lady Davis Inst, Montreal, PQ, Canada; [Truss, Matthias] Charite, Dept Pediat, Mol Biol Lab, D-13353 Berlin, Germany; [von Deimling, Andreas] Heidelberg Univ, Inst Pathol, Dept Neuropathol, D-6900 Heidelberg, Germany; [von Deimling, Andreas] Clin Cooperat Unit Neuropathol, Heidelberg, Germany; [Tallen, Gesche] Charite, Dept Pediat Oncol Haematol, D-13353 Berlin, Germany	University of Calgary; University of Calgary; University of Calgary; GlaxoSmithKline; Lady Davis Institute; McGill University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Thalappilly, S (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	gesche.tallen@charite.de	von Deimling, Andreas/F-7774-2013; Feng, Xiaolan/J-9997-2019	von Deimling, Andreas/0000-0002-5863-540X; Feng, Xiaolan/0000-0002-7333-8198; Thalappilly, Subhash/0000-0003-1766-3057	Canadian Institutes for Health Research (CIHR); German Federal Ministry for Research and Education (BMBF) [NGFN KR-S01T06, 01GS04363]; Kind Philipp-Leukamie-Stiftung and Charite-Universitatsmedizin Berlin	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); German Federal Ministry for Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Kind Philipp-Leukamie-Stiftung and Charite-Universitatsmedizin Berlin	D.L. was supported by a Canadian Institutes for Health Research (CIHR) studentship and X.F. held AHFMR and CIHR studentships. K.R. is an AHFMR Scientist. This work was supported by grants to K.R. from the CIHR, to A.v.D. and M.T. from the German Federal Ministry for Research and Education (BMBF) (NGFN KR-S01T06, 01GS04363), and to G.T. from the Kind Philipp-Leukamie-Stiftung and Charite-Universitatsmedizin Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2003, CELL CYCLE, V2, P123, DOI 10.4161/cc.2.2.335; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Champagne KS, 2008, PROTEINS, V72, P1371, DOI 10.1002/prot.22140; Cheung KJJ, 2000, BRIT J CANCER, V83, P1468, DOI 10.1054/bjoc.2000.1464; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Coles AH, 2008, CANCER RES, V68, P8705, DOI 10.1158/0008-5472.CAN-08-0923; Coles AH, 2007, CANCER RES, V67, P2054, DOI 10.1158/0008-5472.CAN-06-3558; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Fang S, 2003, SEMIN CANCER BIOL, V13, P5, DOI 10.1016/S1044-579X(02)00095-0; FRIEDMAN PN, 1993, P NATL ACAD SCI USA, V90, P3319, DOI 10.1073/pnas.90.8.3319; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; Garkavtsev I, 1998, NATURE, V391, P295, DOI 10.1038/34675; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gong W, 2006, MOL CELL BIOL, V26, P2947, DOI 10.1128/MCB.26.8.2947-2954.2006; Gordon PMK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-426; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Han XJ, 2008, NAT CELL BIOL, V10, P1333, DOI 10.1038/ncb1792; He GHY, 2005, MOL BIOL EVOL, V22, P104, DOI 10.1093/molbev/msh256; Helbing CC, 1997, CANCER RES, V57, P1255; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Jones DR, 2006, MOL CELL, V23, P685, DOI 10.1016/j.molcel.2006.07.014; Kaadige MR, 2006, J BIOL CHEM, V281, P28831, DOI 10.1074/jbc.M605624200; Kataoka H, 2003, CANCER RES, V63, P5785; Kuo WHW, 2007, EXP CELL RES, V313, P1628, DOI 10.1016/j.yexcr.2007.02.010; Leung KM, 2002, CANCER RES, V62, P4890; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Luo JJ, 2009, GENETICS, V181, P473, DOI 10.1534/genetics.107.080515; Marchenko ND, 2007, CELL CYCLE, V6, P1718, DOI 10.4161/cc.6.14.4503; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Nencioni A, 2007, LEUKEMIA, V21, P30, DOI 10.1038/sj.leu.2404444; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Russell MW, 2008, BIOCHEM BIOPH RES CO, V374, P490, DOI 10.1016/j.bbrc.2008.07.076; Scott M, 2001, J CELL SCI, V114, P3455; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Soliman MA, 2008, AGING CELL, V7, P783, DOI 10.1111/j.1474-9726.2008.00427.x; SUZUKI K, 2011, HYBRIDOMA IN PRESS; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vieyra D, 2002, CANCER RES, V62, P4445; Vieyra D, 2002, J BIOL CHEM, V277, P29832, DOI 10.1074/jbc.M200197200; Yang YL, 2009, CANCER SCI, V100, P24, DOI 10.1111/j.1349-7006.2008.01013.x; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Ythier D, 2008, INT J CANCER, V123, P1483, DOI 10.1002/ijc.23790	51	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21065	10.1371/journal.pone.0021065	http://dx.doi.org/10.1371/journal.pone.0021065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731648	Green Submitted, gold, Green Published			2022-12-25	WOS:000292033700033
J	Dye, C; Trunz, BB; Lonnroth, K; Roglic, G; Williams, BG				Dye, Christopher; Trunz, Bernadette Bourdin; Loennroth, Knut; Roglic, Gojka; Williams, Brian G.			Nutrition, Diabetes and Tuberculosis in the Epidemiological Transition	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; PREVALENCE; INDIA; URBAN; KOREA; RISK; MELLITUS; CRITERIA; BURDEN; TRENDS	Background: Diabetes prevalence and body mass index reflect the nutritional profile of populations but have opposing effects on tuberculosis risk. Interactions between diabetes and BMI could help or hinder TB control in growing, aging, urbanizing populations. Methods and Findings: We compiled data describing temporal changes in BMI, diabetes prevalence and population age structure in rural and urban areas for men and women in countries with high (India) and low (Rep. Korea) TB burdens. Using published data on the risks of TB associated with these factors, we calculated expected changes in TB incidence between 1998 and 2008. In India, TB incidence cases would have increased (28% from 1.7 m to 2.1 m) faster than population size (22%) because of adverse effects of aging, urbanization, changing BMI and rising diabetes prevalence, generating an increase in TB incidence per capita of 5.5% in 10 years. In India, general nutritional improvements were offset by a fall in BMI among the majority of men who live in rural areas. The growing prevalence of diabetes in India increased the annual number of TB cases in people with diabetes by 46% between 1998 and 2008. In Korea, by contrast, the number of TB cases increased more slowly (6.1% from 40,200 to 42,800) than population size (14%) because of positive effects of urbanization, increasing BMI and falling diabetes prevalence. Consequently, TB incidence per capita fell by 7.8% in 10 years. Rapid population aging was the most significant adverse effect in Korea. Conclusions: Nutritional and demographic changes had stronger adverse effects on TB in high-incidence India than in lower-incidence Korea. The unfavourable effects in both countries can be overcome by early drug treatment but, if left unchecked, could lead to an accelerating rise in TB incidence. The prevention and management of risk factors for TB would reinforce TB control by chemotherapy.	[Dye, Christopher; Loennroth, Knut] World Hlth Org, Stop TB Dept, Geneva, Switzerland; [Trunz, Bernadette Bourdin] Petit Lancy, Geneva, Switzerland; [Williams, Brian G.] SACEMA, Stellenbosch, South Africa	World Health Organization	Dye, C (corresponding author), World Hlth Org, Stop TB Dept, Geneva, Switzerland.	dyec@who.int	Dye, Christopher/AIC-4659-2022; Lönnroth, Knut/L-2339-2014; Lonnroth, Knut/H-5470-2017	Lönnroth, Knut/0000-0001-5054-8240; Lonnroth, Knut/0000-0001-6944-0256; Dye, Christopher/0000-0002-2957-1793; Williams, Brian/0000-0002-3174-4876; Roglic, Gojka/0000-0003-0872-0689	World Health Organization	World Health Organization(World Health Organization)	The work was funded by the World Health Organization, and done as part of the routine work of the authors who are WHO staff (except BBT, who was a consultant to the WHO at the time of the study). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, GLOB TUB CONTR; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P116; Choi YJ, 2009, DIABETES CARE, V32, P2016, DOI 10.2337/dc08-2228; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dowdy DW, 2009, B WORLD HEALTH ORGAN, V87, P296, DOI 10.2471/BLT.08.054510; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; GOLDHABERFIEBER.JD, 2011, INT J EPIDEMIOLOGY; Hong YP, 1998, INT J TUBERC LUNG D, V2, P27; IIPS & ORC Macro, 2000, NATL FAMILY HLTH SUR; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Khan M., 2006, DUAL BURDEN OVERWEIG; Kim SJ, 1995, TUBERCLE LUNG DIS, V76, P529, DOI 10.1016/0962-8479(95)90529-4; Kim WY, 2008, ASIA PAC J CLIN NUTR, V17, P47; Kim Y, 2004, OBES RES, V12, P445, DOI 10.1038/oby.2004.50; Lee HY, 2010, J KOREAN MED SCI, V25, P1777, DOI 10.3346/jkms.2010.25.12.1777; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Mohan V, 2006, DIABETOLOGIA, V49, P1175, DOI 10.1007/s00125-006-0219-2; Mohan V, 2008, DIABETES RES CLIN PR, V80, P159, DOI 10.1016/j.diabres.2007.11.018; Nyamdorj R, 2008, OBESITY, V16, P1622, DOI 10.1038/oby.2008.73; Ramachandran A, 2001, DIABETOLOGIA, V44, P1094, DOI 10.1007/s001250100627; Ruslami R, 2010, TROP MED INT HEALTH, V15, P1289, DOI 10.1111/j.1365-3156.2010.02625.x; Sadikot SM, 2004, DIABETES RES CLIN PR, V66, P293, DOI 10.1016/j.diabres.2004.04.007; Sadikot SM, 2004, DIABETES RES CLIN PR, V66, P301, DOI 10.1016/j.diabres.2004.04.008; Stevenson CR, 2007, CHRONIC ILLN, V3, P228, DOI 10.1177/1742395307081502; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Styblo K, 1991, EPIDEMIOLOGY TUBERCU; Tuei Vivian C, 2010, Diabetes Metab Res Rev, V26, P433, DOI 10.1002/dmrr.1106; *UN DOEASA POP DIV, 2009, WORLD PROSP 2008 REV; *UN DOEASA POP DIV, 2010, WORLD URB PROSP 2009; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P943, DOI 10.1017/S0950268807008552; *WHO, 2009, GLOB TUB CONTR SHORT; WHO, 2010, GLOB TUB CONTR 2010	37	62	69	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21161	10.1371/journal.pone.0021161	http://dx.doi.org/10.1371/journal.pone.0021161			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712992	Green Published, gold			2022-12-25	WOS:000291985100014
J	Tan, SJ; Rudd, JA; Yew, DT				Tan, Sijie; Rudd, John A.; Yew, David T.			Gene Expression Changes in GABA(A) Receptors and Cognition Following Chronic Ketamine Administration in Mice	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; RECENT TRENDS; RAT-BRAIN; MEMORY; SUBUNITS; ALPHA-5; POTENTIATION; HIPPOCAMPUS; ANESTHETICS; NEURONS	Ketamine is a well-known anesthetic agent and a drug of abuse. Despite its widespread use and abuse, little is known about its long-term effects on the central nervous system. The present study was designed to evaluate the effect of long-term (1- and 3-month) ketamine administration on learning and memory and associated gene expression levels in the brain. The Morris water maze was used to assess spatial memory and gene expression changes were assayed using Affymetrix Genechips; a focus on the expression of GABA(A) receptors that mediate a tonic inhibition in the brain, was confirmed by quantitative real-time PCR and western blot. Compared with saline controls, there was a decline in learning and memory performance in the ketamine-treated mice. Genechip results showed that 110 genes were up-regulated and 136 genes were down-regulated. An ontology analysis revealed the most significant effects of ketamine were on GABAA receptors. In particular, there was a significant up-regulation of both mRNA and protein levels of the alpha 5 subunit (Gabra5) of the GABAA receptors in the prefrontal cortex. In conclusion, chronic exposure to ketamine impairs working memory in mice, which may be explained at least partly by up-regulation of Gabra5 subunits in the prefrontal cortex.	[Tan, Sijie; Yew, David T.] Chinese Univ Hong Kong, Fac Med, Brain Res Ctr, Shatin, Hong Kong, Peoples R China; [Rudd, John A.] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Yew, DT (corresponding author), Chinese Univ Hong Kong, Fac Med, Brain Res Ctr, Shatin, Hong Kong, Peoples R China.	david-yew@cuhk.edu.hk	Tan, Sijie/W-6260-2019; Rudd, John A./R-6603-2018; McAlonan, Grainne/G-1541-2011	Rudd, John A./0000-0002-8316-0792; tan, Sijie/0000-0002-8389-7372; McAlonan, Grainne/0000-0002-4466-2343	Beat Drugs Fund Association, Hong Kong Government [080048, 100052]	Beat Drugs Fund Association, Hong Kong Government	This work was supported by the Beat Drugs Fund Association, Hong Kong Government, Grant Numbers: 080048 and 100052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bergman S A, 1999, Anesth Prog, V46, P10; Chambers MS, 2003, J MED CHEM, V46, P2227, DOI 10.1021/jm020582q; Chapouthier Georges, 2002, Current Topics in Medicinal Chemistry, V2, P841, DOI 10.2174/1568026023393552; Collinson N, 2002, J NEUROSCI, V22, P5572; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Curran HV, 2000, ADDICTION, V95, P575, DOI 10.1046/j.1360-0443.2000.9545759.x; Degenhardt L, 2005, SUBST USE MISUSE, V40, P1241, DOI 10.1081/JA-200066777; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fang YX, 2006, ACTA PHARMACOL SIN, V27, P140, DOI 10.1111/j.1745-7254.2006.00270.x; Hijazi Y, 2002, DRUG METAB DISPOS, V30, P853, DOI 10.1124/dmd.30.7.853; Hirota K, 1999, J Anesth, V13, P107, DOI 10.1007/s005400050035; Honey GD, 2005, CEREB CORTEX, V15, P749, DOI 10.1093/cercor/bhh176; Ibla JC, 2009, CURR DRUG SAF, V4, P11, DOI 10.2174/157488609787354495; Irifune M, 2000, ANESTH ANALG, V91, P230, DOI 10.1097/00000539-200007000-00043; JONES EG, 1993, CEREB CORTEX, V3, P361, DOI 10.1093/cercor/3.5.361-a; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; Li F, 2009, NEW ENGL J MED, V361, P302, DOI 10.1056/NEJMcibr0902052; Li Q, 2007, NEUROCHEM INT, V50, P848, DOI 10.1016/j.neuint.2007.02.005; LIN LH, 1992, J PHARMACOL EXP THER, V263, P569; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mak YT, 2010, MICROSC RES TECHNIQ, V73, P195, DOI 10.1002/jemt.20774; Martin LJ, 2010, J NEUROSCI, V30, P5269, DOI 10.1523/JNEUROSCI.4209-09.2010; Maxwell JC, 2005, SUBST USE MISUSE, V40, P1203, DOI 10.1081/JA-200066736; MHATRE MC, 1992, MOL BRAIN RES, V14, P71, DOI 10.1016/0169-328X(92)90012-Z; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mizoguchi Y, 2003, J BIOL CHEM, V278, P44097, DOI 10.1074/jbc.M305872200; Mizukami K, 1997, EXP NEUROL, V147, P333, DOI 10.1006/exnr.1997.6591; Morgan CJA, 2010, ADDICTION, V105, P121, DOI 10.1111/j.1360-0443.2009.02761.x; Morgan CJA, 2004, NEUROPSYCHOPHARMACOL, V29, P208, DOI 10.1038/sj.npp.1300342; Narita M, 2001, ADDICT BIOL, V6, P373, DOI 10.1080/13556210020077091; OLIVERIO ALBERTO, 1966, LIFE SCI, V5, P1317, DOI 10.1016/0024-3205(66)90033-6; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Perry JL, 2011, BRAIN RES REV, V65, P124, DOI 10.1016/j.brainresrev.2010.09.001; Ricaurte GA, 2005, LANCET, V365, P2137, DOI 10.1016/S0140-6736(05)66737-2; Ricci V, 2011, PSYCHOPHARMACOLOGY, V215, P143, DOI 10.1007/s00213-010-2121-3; Rissman RA, 2003, NEUROSCIENCE, V120, P695, DOI 10.1016/S0306-4522(03)00030-7; Rissman RA, 2007, J NEUROCHEM, V103, P1285, DOI 10.1111/j.1471-4159.2007.04832.x; Rowland LM, 2005, NEUROPSYCHOPHARMACOL, V30, P633, DOI 10.1038/sj.npp.1300642; SCHOLFIELD CN, 1980, PFLUG ARCH EUR J PHY, V383, P249, DOI 10.1007/BF00587527; Shi Q, 2010, NEUROSCIENCE, V166, P852, DOI 10.1016/j.neuroscience.2010.01.007; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Watanabe M, 2002, INT REV CYTOL, V213, P1; WISDEN W, 1992, J NEUROSCI, V12, P1040; Wolff K, 2006, CNS DRUGS, V20, P199, DOI 10.2165/00023210-200620030-00003; Wu Y, 2005, NEUROCHEM INT, V46, P565, DOI 10.1016/j.neuint.2005.01.002; Xu Q, 2007, CLIN EXP PHARMACOL P, V34, P499, DOI 10.1111/j.1440-1681.2007.04601.x; Yeung LY, 2010, TOXICOL LETT, V193, P189, DOI 10.1016/j.toxlet.2010.01.008; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029	50	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21328	10.1371/journal.pone.0021328	http://dx.doi.org/10.1371/journal.pone.0021328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712993	gold, Green Submitted, Green Published			2022-12-25	WOS:000291985100030
J	Kitchen, CMR; Yeghiazarian, L; Hoh, R; McCune, JM; Sinclair, E; Martin, JN; Deeks, SG				Kitchen, Christina M. R.; Yeghiazarian, Lilit; Hoh, Rebecca; McCune, Joseph M.; Sinclair, Elizabeth; Martin, Jeffrey N.; Deeks, Steven G.			Immune Activation, Cd4+T Cell Counts, and Viremia Exhibit Oscillatory Patterns over Time in Patients with Highly Resistant HIV Infection	PLOS ONE			English	Article							T-LYMPHOCYTE ACTIVATION; MULTIPLE IMPUTATION; VIROLOGICAL FAILURE; ANTIRETROVIRAL THERAPY; PREDICTIVE-VALUE; SIV INFECTION; EL-NINO; DYNAMICS; RNA; INDIVIDUALS	The rates of immunologic and clinical progression are lower in patients with drug-resistant HIV compared to wild-type HIV. This difference is not fully explained by viral load. It has been argued that reductions in T cell activation and/or viral fitness might result in preserved target cells and an altered relationship between the level of viremia and the rate of CD4+ T cell loss. We tested this hypothesis over time in a cohort of patients with highly resistant HIV. Fifty-four antiretroviral-treated patients with multi-drug resistant HIV and detectable plasma HIV RNA were followed longitudinally. CD4+ T cell counts and HIV RNA levels were measured every 4 weeks and T cell activation (CD38/HLA-DR) was measured every 16 weeks. We found that the levels of CD4+ T cell activation over time were a strong independent predictor of CD4+ T cell counts while CD8+ T cell activation was more strongly associated with viremia. Using spectral analysis, we found strong evidence for oscillatory (or cyclic) behavior in CD4+ T cell counts, HIV RNA levels, and T cell activation. Each of the cell populations exhibited an oscillatory behavior with similar frequencies. Collectively, these data suggest that there may be a mechanistic link between T cell activation, CD4+ T cell counts, and viremia and lends support for the hypothesis of altered predator-prey dynamics as a possible explanation of the stability of CD4+ T cell counts in the presence of sustained multi-drug resistant viremia.	[Kitchen, Christina M. R.; Yeghiazarian, Lilit] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90024 USA; [Yeghiazarian, Lilit] Univ Cincinnati, Sch Energy Biol & Med Engn, Environm Engn Program, Cincinnati, OH USA; [Hoh, Rebecca; Deeks, Steven G.] Univ Calif San Francisco, Dept Med, HIV AIDS Program, San Francisco, CA USA; [McCune, Joseph M.; Sinclair, Elizabeth] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA USA; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California Los Angeles; University System of Ohio; University of Cincinnati; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kitchen, CMR (corresponding author), Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90024 USA.	cr@ucla.edu	Ramirez, Christina/AAT-5088-2021	Ramirez, Christina/0000-0002-8435-0416	University of California Los Angeles Center for AIDS Research (CMRK); National Institutes of Health [AI055273, AI44595, AI069994, DPI OD00329]; University of California San Francisco (UCSF) CFAR [P30 MH59037]; UCSF Clinical and Translational Research Institute Clinical Research Center [UL1 RR024131]; Center for AIDS Prevention Studies [P30 MH62246]; Burroughs Wellcome Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044595, K24AI069994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH059037, P30MH062246] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000329] Funding Source: NIH RePORTER	University of California Los Angeles Center for AIDS Research (CMRK); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco (UCSF) CFAR; UCSF Clinical and Translational Research Institute Clinical Research Center; Center for AIDS Prevention Studies; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the University of California Los Angeles Center for AIDS Research (CMRK) AIDS Training Grant (LY), the National Institutes of Health (AI055273, AI44595, AI069994), University of California San Francisco (UCSF) CFAR (P30 MH59037); the UCSF Clinical and Translational Research Institute Clinical Research Center (UL1 RR024131); and the Center for AIDS Prevention Studies (P30 MH62246). JMM is a recipient of the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research and the NIH Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research, through grant number DPI OD00329. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, INFECT DIS HUMANS DY; BEAL SL, 1982, CRIT REV BIOMED ENG, V8, P195; Bloomfield P., 2000, FOURIER ANAL TIME SE, P261; Bonhoeffer S, 1997, J VIROL, V71, P3275, DOI 10.1128/JVI.71.4.3275-3278.1997; Bouma MJ, 1996, TROP MED INT HEALTH, V1, P86, DOI 10.1046/j.1365-3156.1996.d01-7.x; Broersen PMT, 2004, AUTOMATICA, V40, P1495, DOI 10.1016/j.automatica.2004.04.011; Catalfamo M, 2008, P NATL ACAD SCI USA, V105, P19851, DOI 10.1073/pnas.0810032105; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Deeks SG, 2000, J INFECT DIS, V181, P946, DOI 10.1086/315334; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Grossman Z, 1998, P NATL ACAD SCI USA, V95, P6314, DOI 10.1073/pnas.95.11.6314; Hales S, 1999, ENVIRON HEALTH PERSP, V107, P99, DOI 10.2307/3434364; Havlir DV, 1998, NEW ENGL J MED, V339, P1261, DOI 10.1056/NEJM199810293391801; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hopke PK, 2001, BIOMETRICS, V57, P22, DOI 10.1111/j.0006-341X.2001.00022.x; Hunt PW, 2006, AIDS, V20, P691, DOI 10.1097/01.aids.0000216369.30948.18; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; LEE H, 2011, ASTROPHYSIC IN PRESS; Lindblade KA, 1999, T ROY SOC TROP MED H, V93, P480, DOI 10.1016/S0035-9203(99)90344-9; Liu Z, 1998, J ACQ IMMUN DEF SYND, V18, P332, DOI 10.1097/00042560-199808010-00004; Mellors JW, 2007, JAMA-J AM MED ASSOC, V297, P2349, DOI 10.1001/jama.297.21.2349; Nowak MA, 1996, SCIENCE, V272, P74, DOI 10.1126/science.272.5258.74; Penn ML, 2001, AIDS RES HUM RETROV, V17, P517, DOI 10.1089/08892220151126580; PERELSON AS, 1993, MATH BIOSCI, V114, P81, DOI 10.1016/0025-5564(93)90043-A; Petersen ML, 2008, AIDS, V22, P2097, DOI 10.1097/QAD.0b013e32830f97e2; Phillips AN, 1997, J MED VIROL, V53, P261, DOI 10.1002/(SICI)1096-9071(199711)53:3<261::AID-JMV14>3.0.CO;2-K; PRESS WH, NUMERICAL RECIPES C; Reuman DC, 2006, P NATL ACAD SCI USA, V103, P18860, DOI 10.1073/pnas.0608571103; Robbins GK, 2009, CLIN INFECT DIS, V48, P350, DOI 10.1086/595888; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Silvestri G, 2007, J CLIN INVEST, V117, P3148, DOI 10.1172/JCI33034; Spouge JL, 1996, MATH BIOSCI, V138, P1, DOI 10.1016/S0025-5564(96)00064-8; Spratt M, 2010, AM J EPIDEMIOL, V172, P478, DOI 10.1093/aje/kwq137; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tesselaar K, 2003, NAT IMMUNOL, V4, P49, DOI 10.1038/ni869; Vaidya NK, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001012; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944	46	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21190	10.1371/journal.pone.0021190	http://dx.doi.org/10.1371/journal.pone.0021190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701594	Green Published, Green Submitted, gold			2022-12-25	WOS:000291983800030
J	Gupta, RK; Chhibber, S; Harjai, K				Gupta, Ravi Kumar; Chhibber, Sanjay; Harjai, Kusum			Acyl Homoserine Lactones from Culture Supernatants of Pseudomonas aeruginosa Accelerate Host Immunomodulation	PLOS ONE			English	Article							MOLECULE N-(3-OXODODECANOYL)-L-HOMOSERINE LACTONE; SENSING SIGNAL MOLECULES; IN-VIVO; QUORUM; INDUCTION; INFECTION; RESPONSES; ANALOGS; VITRO	The virulence of Pseudomonas aeruginosa is multifactorial and under the control of quorum sensing signals, such as acyl homoserine lactones (AHLs). The importance of these molecules in the establishment of infection has been previously reported. These molecules either improve the virulence potential of P. aeruginosa or modulate the host immune response. To establish the immune modulating potential of quorum sensing signal molecules, previous studies have only used synthetic AHLs. However, there can be differences in the biological properties of synthetic and natural AHLs. The use of naturally extracted AHLs from the culture supernatant of P. aeruginosa is likely to simulate natural conditions more than the use of synthetic AHLs. Therefore, in the present study, the immune modulating potential of synthetic and naturally extracted AHLs was compared using a thymidine uptake assay, immunophenotyping and sandwich ELISA in order to assess mouse T-cell proliferation and production of Th1 and Th2 cytokines. Natural AHLs were able to suppress T-cell proliferation, even at low concentrations, compared to synthetic AHLs. The majority of cells undergoing proliferation were CD4+, as revealed by immunophenotyping. The inhibition of T-cells was stronger with natural AHLs compared to synthetic AHLs. Moreover, the natural AHLs were also able to shift immune responses away from host protective Th1 responses to pathogen protective Th2 responses.	[Gupta, Ravi Kumar; Chhibber, Sanjay; Harjai, Kusum] Panjab Univ, Dept Microbiol, Chandigarh 160014, India	Panjab University	Gupta, RK (corresponding author), Panjab Univ, Dept Microbiol, Bio Med Sci Block, Chandigarh 160014, India.	kusum_harjai@hotmail.com			Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The study was funded by the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boontham P, 2008, CLIN SCI, V115, P343, DOI 10.1042/CS20080018; CHHABRA SR, 1993, J ANTIBIOT, V46, P441, DOI 10.7164/antibiotics.46.441; Chhabra SR, 2003, J MED CHEM, V46, P97, DOI 10.1021/jm020909n; Hooi DSW, 2004, INFECT IMMUN, V72, P6463, DOI 10.1128/IAI.72.11.6463-6470.2004; Lithgow JK, 2000, MOL MICROBIOL, V37, P81, DOI 10.1046/j.1365-2958.2000.01960.x; McGrath S, 2004, FEMS MICROBIOL LETT, V230, P27, DOI 10.1016/S0378-1097(03)00849-8; Moser C, 2002, CLIN EXP IMMUNOL, V127, P206, DOI 10.1046/j.1365-2249.2002.01731.x; Pomini AM, 2005, J AGR FOOD CHEM, V53, P6262, DOI 10.1021/jf050586e; Pomini AM, 2008, J NAT PROD, V71, P1032, DOI 10.1021/np800127b; Pomini AM, 2006, J CHEM ECOL, V32, P1769, DOI 10.1007/s10886-006-9108-x; Ritchie AJ, 2005, INFECT IMMUN, V73, P1648, DOI 10.1128/IAI.73.3.1648-1655.2005; Ritchie AJ, 2003, INFECT IMMUN, V71, P4421, DOI 10.1128/IAI.71.8.4421-4431.2003; Rumbaugh KP, 2004, J SURG RES, V116, P137, DOI 10.1016/j.jss.2003.08.009; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; Smith RS, 2002, J BACTERIOL, V184, P1132, DOI 10.1128/jb.184.4.1132-1139.2002; Smith RS, 2001, J IMMUNOL, V167, P366, DOI 10.4049/jimmunol.167.1.366; STEVENSON MM, 1995, CLIN EXP IMMUNOL, V99, P98, DOI 10.1111/j.1365-2249.1995.tb03478.x; Telford G, 1998, INFECT IMMUN, V66, P36, DOI 10.1128/IAI.66.1.36-42.1998; Wagner VE, 2007, ANAL BIOANAL CHEM, V387, P469, DOI 10.1007/s00216-006-0964-6; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039	20	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20860	10.1371/journal.pone.0020860	http://dx.doi.org/10.1371/journal.pone.0020860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698201	Green Submitted, gold, Green Published			2022-12-25	WOS:000291734100026
J	Shimamura, M; Huang, Y; Hidaka, H				Shimamura, Michio; Huang, Ying; Hidaka, Hiroshi			Modulation of Immunoglobulin Production by Invariant V alpha 19-J alpha 33 TCR-Bearing Cells	PLOS ONE			English	Article							ALPHA-MANNOSYL CERAMIDE; V-ALPHA-19 NKT CELL; T-CELLS; IMMUNE-RESPONSES; GENES; LIVER; MICE; IL-4	We have previously shown that invariant V alpha 19-J alpha 33 TCR+ (V alpha 19i T) cells suppress the disease progress in some models for organ specific autoimmune diseases and type IV allergy that deteriorate along with decline to excess in Th1- or Th17-immunity. In this study, we examined the effects of over-generation of V alpha 19i T cells on the Th2-controlled immunoglobulin isotype production in the models for type I allergy. IgE production by invariant V alpha 19-J alpha 33 TCR transgenic (Tg) mice was suppressed compared with that by non-Tg controls following administration with goat anti-mouse IgD antiserum or OVA, while IgG2a production was not influenced by the introduction of the transgene into the recipients. IgE production by wild type mice was similarly reduced when they were subjected to adoptive transfer with invariant V alpha 19-J alpha 33 TCR Tg(+) but not Tg(-) cells prior to immunization. Furthermore, the suppression of IgE production by these recipients was enhanced when they were previously administered with a V alpha 19i T cell activator, one of the modified alpha-mannosyl ceramides. In summary, it is suggested that V alpha 19i T cells have potential to participate in the homeostasis of immunity and that they suppress disease progression resulting from not only Th1- but also Th2-immunity excess.	[Shimamura, Michio] Univ Tsukuba, Tsukuba Res Ctr Interdisciplinary Mat Sci, Tsukuba, Ibaraki, Japan; [Shimamura, Michio] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki, Japan; [Shimamura, Michio; Huang, Ying; Hidaka, Hiroshi] Mitsubishi Kagaku Inst Life Sci, Dev Immunol Unit, Tokyo, Japan; [Shimamura, Michio] Fdn Adv Int Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; Mitsubishi Kagaku Institute of Life Sciences (MITILS)	Shimamura, M (corresponding author), Univ Tsukuba, Tsukuba Res Ctr Interdisciplinary Mat Sci, Tsukuba, Ibaraki, Japan.	michio@chem.tsukuba.ac.jp			Ministry of Health, Welfare and Labor of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [20570146]	Ministry of Health, Welfare and Labor of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Health, Welfare and Labor of Japan and a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 20570146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Bendelac A, 1996, J EXP MED, V184, P1285, DOI 10.1084/jem.184.4.1285; Croxford JL, 2006, NAT IMMUNOL, V7, P987, DOI 10.1038/ni1370; Cui JQ, 1999, J EXP MED, V190, P783, DOI 10.1084/jem.190.6.783; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; HASHIMOTO K, 1995, SCIENCE, V269, P693, DOI 10.1126/science.7624800; Kawachi I, 2006, J IMMUNOL, V176, P1618, DOI 10.4049/jimmunol.176.3.1618; LEBOURHIS L, 2010, NAT IMMUNOL, V13, P200; Lehuen A, 1998, J EXP MED, V188, P1831, DOI 10.1084/jem.188.10.1831; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Okamoto N, 2005, CHEM BIOL, V12, P677, DOI 10.1016/j.chembiol.2005.04.014; Oki S, 2004, J CLIN INVEST, V113, P1631, DOI 10.1172/JCI200420862; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Shimamura M, 1997, J IMMUNOL, V158, P3682; Shimamura M, 2002, FEBS LETT, V516, P97, DOI 10.1016/S0014-5793(02)02509-7; Shimamura M, 2007, EUR J IMMUNOL, V37, P1836, DOI 10.1002/eji.200636689; Shimamura M, 2007, FEBS J, V274, P2921, DOI 10.1111/j.1742-4658.2007.05826.x; Shimamura M, 2006, EUR J MED CHEM, V41, P569, DOI 10.1016/j.ejmech.2005.11.013; Shimamura M, 2011, IMMUNOBIOLOGY, V216, P374, DOI 10.1016/j.imbio.2010.08.003; Shimamura M, 2009, INT IMMUNOL, V21, P179, DOI 10.1093/intimm/dxn136; Shimamura M, 2008, IMMUNOL LETT, V121, P38, DOI 10.1016/j.imlet.2008.08.002; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Zhang Y, 1997, AM J RESP CRIT CARE, V155, P661, DOI 10.1164/ajrccm.155.2.9032210	27	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20915	10.1371/journal.pone.0020915	http://dx.doi.org/10.1371/journal.pone.0020915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698203	Green Published, gold, Green Submitted			2022-12-25	WOS:000291734100031
J	Ye, X; Liu, Z; Hemida, MG; Yang, DC				Ye, Xin; Liu, Zhen; Hemida, Maged Gomaa; Yang, Decheng			Targeted Delivery of Mutant Tolerant Anti-Coxsackievirus Artificial MicroRNAs Using Folate Conjugated Bacteriophage Phi29 pRNA	PLOS ONE			English	Article							DNA-PACKAGING MOTOR; RNA INTERFERENCE; MUTATION-RATES; B3 REPLICATION; IN-VITRO; SIRNA; INHIBITION; EXPRESSION; CELLS; GENE	Background: Myocarditis is the major heart disease in infants and young adults. It is very commonly caused by coxsackievirus B3 (CVB3) infection; however, no specific treatment or vaccine is available at present. RNA interference (RNAi)-based anti-viral therapy has shown potential to inhibit viral replication, but this strategy faces two major challenges; viral mutational escape from drug suppression and targeted delivery of the reagents to specific cell populations. Methodology/Principal Findings: In this study, we designed artificial microRNAs (AmiRs) targeting the 3'untranslated region (3'UTR) of CVB3 genome with mismatches to the central region of their targeting sites. Antiviral evaluation showed that AmiR-1 and AmiR-2 reduced CVB3 (Kandolf and CG strains) replication approximately 100-fold in both HeLa cells and HL-1 cardiomyoctes. To achieve specific delivery, we linked AmiRs to the folate-conjugated bacterial phage packaging RNA (pRNA) and delivered the complexes into HeLa cells, a folate receptor positive cancer cells widely used as an in vitro model for CVB3 infection, via folate-mediated specific internalization. We found that our designed pRNA-AmiRs conjugates were tolerable to target mutations and have great potential to suppress viral mutational escape with little effect on triggering interferon induction. Conclusion/Significance: This study provides important clues for designing AmiRs targeting the 3'UTR of viral genome. It also proves the feasibility of specific deliver of AmiRs using conjugated pRNA vehicles. These small AmiRs combined with pRNA-folate conjugates could form a promising system for antiviral drug development.	[Ye, Xin; Liu, Zhen; Hemida, Maged Gomaa; Yang, Decheng] Univ British Columbia, St Pauls Hosp, Dept Pathol & Lab Med, Inst Heart & Lung Hlth, Vancouver, BC V5Z 1M9, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan	Ye, X (corresponding author), Univ British Columbia, St Pauls Hosp, Dept Pathol & Lab Med, Inst Heart & Lung Hlth, Vancouver, BC V5Z 1M9, Canada.	decheng.yang@hli.ubc.ca	Hemida, Maged/L-9888-2016	Hemida, Maged/0000-0002-5986-7237	Heart and Stroke Foundation of British Columbia and Yukon [G-07-YA-2806]; University of British Columbia; CIHR-IMPACT	Heart and Stroke Foundation of British Columbia and Yukon; University of British Columbia; CIHR-IMPACT(Canadian Institutes of Health Research (CIHR))	This work was supported by the Heart and Stroke Foundation of British Columbia and Yukon (G-07-YA-2806) to DY (http://www.heartandstroke.bc.ca); a Graduate Fellowship was provided by University of British Columbia to XY (http://grad.ubc.ca); and MGH is a recipient of the CIHR-IMPACT postdoctoral training fellowship (http://impacttraining.icapture.ubc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELMAWLA S, MOL THER; Ahn J, 2005, J VIROL, V79, P8620, DOI 10.1128/JVI.79.13.8620-8624.2005; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CP, 2000, J BIOL CHEM, V275, P17510, DOI 10.1074/jbc.M909662199; Chen CP, 1999, RNA, V5, P805, DOI 10.1017/S1355838299990350; Chen Jie-bin, 2006, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V22, P306; Chen Y, 2008, PHARM RES-DORDR, V25, P72, DOI 10.1007/s11095-007-9504-0; Cheung P, 2007, CELL MICROBIOL, V9, P1705, DOI 10.1111/j.1462-5822.2007.00904.x; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Crotty S, 2002, MICROBES INFECT, V4, P1301, DOI 10.1016/S1286-4579(02)00008-4; DARLIX JL, 1983, NUCLEIC ACIDS RES, V11, P5953, DOI 10.1093/nar/11.17.5953; De Guire V, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq354; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; DRORY Y, 1991, AM J CARDIOL, V68, P1388, DOI 10.1016/0002-9149(91)90251-F; Dunn JJ, 2000, J VIROL, V74, P4787, DOI 10.1128/JVI.74.10.4787-4794.2000; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Fechner H, 2008, J MOL MED, V86, P987, DOI 10.1007/s00109-008-0363-x; Ge Q, 2004, VIRUS RES, V102, P37, DOI 10.1016/j.virusres.2004.01.013; Gitlin L, 2005, J VIROL, V79, P1027, DOI 10.1128/JVI.79.2.1027-1035.2005; Gitlin L, 2002, NATURE, V418, P430, DOI 10.1038/nature00873; GUO P, NAT NANOTECHNOL, V5, P833; Guo PX, 2005, METH MOL B, V300, P285; GUO PX, 1987, SCIENCE, V236, P690, DOI 10.1126/science.3107124; Guo PX, 1998, MOL CELL, V2, P149, DOI 10.1016/S1097-2765(00)80124-0; Guo PX, 2002, PROG NUCLEIC ACID RE, V72, P415, DOI 10.1016/S0079-6603(02)72076-X; Guo S, 2006, GENE THER, V13, P814, DOI 10.1038/sj.gt.3302716; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Huang H, 2009, NUCLEIC ACIDS RES, V37, P7560, DOI 10.1093/nar/gkp835; Huber SA, 1999, ADV VIRUS RES, V51, P35; Israsena N, 2009, ANTIVIR RES, V84, P76, DOI 10.1016/j.antiviral.2009.07.012; Kapadia SB, 2003, P NATL ACAD SCI USA, V100, P2014, DOI 10.1073/pnas.252783999; KELLEY M, 2010, MICRORNA SCAFFOLDS N; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Khaled A, 2005, NANO LETT, V5, P1797, DOI 10.1021/nl051264s; Kim YJ, 2008, VIRUS GENES, V36, P141, DOI 10.1007/s11262-007-0192-y; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee HS, 2007, J GEN VIROL, V88, P2003, DOI 10.1099/vir.0.82633-0; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li L, 2009, MOL BIOSYST, V5, P1361, DOI 10.1039/b903428e; Liu YP, 2009, NUCLEIC ACIDS RES, V37, P6194, DOI 10.1093/nar/gkp644; Long Dang, 2008, Pac Symp Biocomput, P64; Ma Z, 2005, BIOCHEM BIOPH RES CO, V330, P755, DOI 10.1016/j.bbrc.2005.03.041; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Marques JT, 2005, NAT BIOTECHNOL, V23, P1399, DOI 10.1038/nbt1161; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Melchers WJG, 1997, J VIROL, V71, P686, DOI 10.1128/JVI.71.1.686-696.1997; Merl S, 2005, CIRCULATION, V111, P1583, DOI 10.1161/01.CIR.0000160360.02040.AB; Merl S, 2007, OLIGONUCLEOTIDES, V17, P44, DOI 10.1089/oli.2007.0057; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Parker N, 2005, ANAL BIOCHEM, V338, P284, DOI 10.1016/j.ab.2004.12.026; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Schubert S, 2005, J MOL BIOL, V346, P457, DOI 10.1016/j.jmb.2004.11.074; Shu D, 2003, J NANOSCI NANOTECHNO, V3, P295, DOI 10.1166/jnn.2003.160; SHU Y, METHODS; Son J, 2008, BIOCHEM BIOPH RES CO, V374, P214, DOI 10.1016/j.bbrc.2008.06.125; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Tan FL, 2004, CELL RES, V14, P460, DOI 10.1038/sj.cr.7290248; Tang GL, 2005, TRENDS BIOCHEM SCI, V30, P106, DOI 10.1016/j.tibs.2004.12.007; TARAPORE P, 2010, MOL THER; Tran T, 2005, CANCER RES, V65, P4431, DOI 10.1158/0008-5472.CAN-04-2890; Tsuda N, 2006, CLIN CANCER RES, V12, P6557, DOI 10.1158/1078-0432.CCR-06-0588; Wang AK, 2001, ANTIMICROB AGENTS CH, V45, P1043, DOI 10.1128/AAC.45.4.1043-1052.2001; WEITMAN SD, 1992, CANCER RES, V52, P3396; Xia W, 2009, BLOOD, V113, P438, DOI 10.1182/blood-2008-04-150789; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Ye Xin, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P206; Yuan J, 2005, J VIROL, V79, P2151, DOI 10.1128/JVI.79.4.2151-2159.2005; Yuan J, 2004, LAB INVEST, V84, P703, DOI 10.1038/labinvest.3700083; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhang CL, 1995, RNA, V1, P1041; Zhang HFM, 2009, ANTIVIR RES, V83, P307, DOI 10.1016/j.antiviral.2009.07.005	78	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21215	10.1371/journal.pone.0021215	http://dx.doi.org/10.1371/journal.pone.0021215			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698212	Green Published, gold, Green Submitted			2022-12-25	WOS:000291730000063
J	Dou, L; Zheng, D; Li, J; Li, Y; Gao, L; Wang, L; Yu, L				Dou, L.; Zheng, D.; Li, J.; Li, Y.; Gao, L.; Wang, L.; Yu, L.			Methylation-mediated repression of microRNA-143 enhances MLL-AF4 oncogene expression	ONCOGENE			English	Article						miR-143; MLL-AF4; methylation; leukemia	ACUTE MYELOID-LEUKEMIA; COLORECTAL-CANCER; MIR-143; PROGNOSIS; AND-145; GENE; TUMORIGENESIS; TRANSCRIPTION; DIAGNOSIS; PROFILES	Fusion proteins containing the amino terminus of mixed lineage leukemia (MLL) are common in acute lymphoblastic leukemia (ALL) due to translocations. The MLL-AF4 fusion protein is generated by the translocation t(4;11)(q21;q23), and t(4;11)-positive ALL patients (MLL-AF4 ALL), have a notoriously poorer prognosis compared with patients with other MLL-associated leukemias. The detailed role of this fusion protein in leukemogenesis is not well understood. MicroRNAs (miRNAs) targeting the AF4 3' untranslated regions may modulate MLL-AF4 fusion protein levels, raising the question of whether regulation of these miRNAs are involved in the progression of MLL-AF4 ALL. In this study, we show that miR-143 was identified as a regulator of MLL-AF4 expression in MLL-AF4 ALL samples. Restoration of miR-143 in MLL-AF4-positive RS4;11 and MV4-11 cells induced apoptosis, negatively contributing to leukemia cell growth by reducing MLL-AF4 fusion protein levels. Furthermore, miR-143 was epigenetically repressed by promoter hypermethylation in MLL-AF4-positive primary blasts and cell lines, but not in normal bone marrow cells and MLL-AF4-negative primary blasts, which was directly associated with expression of the MLL-AF4 oncogene. This is the first study to show that miR-143 functions as a tumor suppressor in MLL-AF4 B-cell ALL. These data reveal the therapeutic promise of upregulating miR-143 expression for MLL-AF4 B-cell ALL. Oncogene (2012) 31, 507-517; doi: 10.1038/onc.2011.248; published online 27 June 2011	[Dou, L.; Li, J.; Li, Y.; Gao, L.; Wang, L.; Yu, L.] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing 100853, Peoples R China; [Zheng, D.] Chinese PLA 309th Hosp, Dept Hepatobiliary Surg, Organ Transplant Ctr, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Yu, L (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Fuxing Rd 28th, Beijing 100853, Peoples R China.	daughter126@126.com; chunhuiliyu@yahoo.com		Yu, Li/0000-0001-6872-2665	National Natural Science Foundation of China [30800482, 30971297, 90919044]; Medical Capital Development Fund [2007-2040]; Beijing Natural Science Foundation of China [7102147]; National 973 Project of China [2005CB522400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Capital Development Fund; Beijing Natural Science Foundation of China(Beijing Natural Science Foundation); National 973 Project of China(National Basic Research Program of China)	We are grateful to Professor Xiaofei Zheng for miRNA-expressing plasmids. We thank Wei Wang, Yi Ding, Yuanyuan Xu, Nan Wang, Chengwang Xu, Meng Li, Xufeng Luo, Huiyuan Kang, Xinrong Wang and Xiaoning Gao for excellent technical assistance. This work was supported by the National Natural Science Foundation of China (Nos. 30800482, 30971297 and 90919044), Medical Capital Development Fund (2007-2040), the Beijing Natural Science Foundation of China (No. 7102147) and the National 973 Project of China (No. 2005CB522400).	Akao Y, 2010, CANCER GENE THER, V17, P398, DOI 10.1038/cgt.2009.88; Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Akao Y, 2009, LEUKEMIA RES, V33, P1530, DOI 10.1016/j.leukres.2009.04.019; Bittner S, 2010, ANN NEUROL, V68, P58, DOI 10.1002/ana.22010; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Erfurth FE, 2008, P NATL ACAD SCI USA, V105, P7517, DOI 10.1073/pnas.0800090105; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020; Gao W, 2010, BIOMED PHARMACOTHER, V64, P399, DOI 10.1016/j.biopha.2010.01.018; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Glas M, 2010, ANN NEUROL, V68, P264, DOI 10.1002/ana.22036; Langevin SM, 2011, CANCER-AM CANCER SOC, V117, P1454, DOI 10.1002/cncr.25689; Lin TC, 2011, LEUKEMIA, V25, P32, DOI 10.1038/leu.2010.222; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Lowenberg B, 2008, NEW ENGL J MED, V358, P1960, DOI 10.1056/NEJMe0802379; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Luty AA, 2010, ANN NEUROL, V68, P639, DOI 10.1002/ana.22274; Metzler M, 2006, ONCOGENE, V25, P3093, DOI 10.1038/sj.onc.1209636; Meyer B, 2011, NUCLEIC ACIDS RES, V39, P1526, DOI 10.1093/nar/gkq931; RONCHI AE, 1995, J BIOL CHEM, V270, P21934, DOI 10.1074/jbc.270.37.21934; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Thomas M, 2005, BLOOD, V106, P3559, DOI 10.1182/blood-2005-03-1283; Walker BA, 2011, BLOOD, V117, P553, DOI 10.1182/blood-2010-04-279539; Wang CJ, 2009, DIS MARKERS, V26, P27, DOI [10.3233/DMA-2009-0601, 10.1155/2009/921907]; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu L, 2005, NAT GENET, V37, P265, DOI 10.1038/ng1521	32	44	54	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2012	31	4					507	517		10.1038/onc.2011.248	http://dx.doi.org/10.1038/onc.2011.248			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891LU	21706045				2022-12-25	WOS:000300219300009
J	Choi, UB; Xiao, SF; Wollmuth, LP; Bowen, ME				Choi, Ucheor B.; Xiao, Shifeng; Wollmuth, Lonnie P.; Bowen, Mark E.			Effect of Src Kinase Phosphorylation on Disordered C-terminal Domain of N-Methyl-D-aspartic Acid (NMDA) Receptor Subunit GluN2B Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NR2 SUBUNITS; TRAFFICKING; ZINC; PALMITOYLATION; HIPPOCAMPAL; CHARGE	NMDA receptors are ligand-gated ion channels with a regulatory intracellular C-terminal domain (CTD). In GluN2B, the CTD is the largest domain in the protein but is intrinsically disordered. The GluN2B subunit is the major tyrosine-phosphorylated protein in synapses. Src kinase phosphorylates the GluN2B CTD, but it is unknown how this affects channel activity. In disordered proteins, phosphorylation can tip the balance between order and disorder. Transitions can occur in both directions, so it is not currently possible to predict the effects of phosphorylation. We used single molecule fluorescence to characterize the effects of Src phosphorylation on GluN2B. Scanning fluorescent labeling sites throughout the domain showed no positional dependence of the energy transfer. Instead, efficiency only scaled with the separation between labeling sites suggestive of a relatively featureless conformational energy landscape. Src phosphorylation led to a general expansion of the polypeptide, which would result in greater exposure of known protein-binding sites and increase the physical separation between contiguous sites. Phosphorylation makes the CTD more like a random coil leaving open the question of how Src exerts its effects on the NMDA receptor.	[Choi, Ucheor B.; Bowen, Mark E.] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Xiao, Shifeng] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Wollmuth, Lonnie P.] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bowen, ME (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, BST 5-121, Stony Brook, NY 11794 USA.	mark.bowen@sunysb.edu		Wollmuth, Lonnie/0000-0002-8179-1259; Bowen, Mark/0000-0002-9525-6986	National Institutes of Health [MH081923, MH066892]; National Research Service Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081923, R01MH066892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants MH081923 (to M. E. B.) and MH066892 (to L. P. W.). This work was also supported by a National Research Service Award (to U. B. C.).	Ascher P, 1998, NAT NEUROSCI, V1, P173, DOI 10.1038/619; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Choi UB, 2011, STRUCTURE, V19, P566, DOI 10.1016/j.str.2011.01.011; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Garza AMS, 2010, MOL CELL BIOL, V30, P220, DOI 10.1128/MCB.00552-09; Groc L, 2009, NEUROSCIENCE, V158, P4, DOI 10.1016/j.neuroscience.2008.05.029; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Mao AH, 2010, P NATL ACAD SCI USA, V107, P8183, DOI 10.1073/pnas.0911107107; Marsh JA, 2010, BIOPHYS J, V98, P2383, DOI 10.1016/j.bpj.2010.02.006; McCann JJ, 2011, STRUCTURE, V19, P810, DOI 10.1016/j.str.2011.02.017; McCann JJ, 2010, BIOPHYS J, V99, P961, DOI 10.1016/j.bpj.2010.04.063; Mittag T, 2010, STRUCTURE, V18, P494, DOI 10.1016/j.str.2010.01.020; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; Muller-Spath S, 2010, P NATL ACAD SCI USA, V107, P14609, DOI 10.1073/pnas.1001743107; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Ryan TJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-6; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Sass LE, 2010, BIOCHEMISTRY-US, V49, P3174, DOI 10.1021/bi901871u; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Xiong ZG, 1999, J NEUROSCI, V19; Yu XM, 1999, P NATL ACAD SCI USA, V96, P7697, DOI 10.1073/pnas.96.14.7697; Zheng F, 1998, NAT NEUROSCI, V1, P185, DOI 10.1038/634; Zhou HX, 2010, BIOPHYS J, V98, pL15, DOI 10.1016/j.bpj.2009.11.029	38	36	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29904	29912		10.1074/jbc.M111.258897	http://dx.doi.org/10.1074/jbc.M111.258897			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21712388	Green Published, hybrid			2022-12-25	WOS:000294046600049
J	Evans, SF; Irmady, K; Ostrow, K; Kim, T; Nykjaer, A; Saftig, P; Blobel, C; Hempstead, BL				Evans, Sarah Felice; Irmady, Krithi; Ostrow, Katya; Kim, Taeho; Nykjaer, Anders; Saftig, Paul; Blobel, Carl; Hempstead, Barbara L.			Neuronal Brain-derived Neurotrophic Factor Is Synthesized in Excess, with Levels Regulated by Sortilin-mediated Trafficking and Lysosomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; AMYLOID PRECURSOR PROTEIN; ACTIVITY-DEPENDENT SECRETION; BDNF MESSENGER-RNA; CONVERTING-ENZYME; GROWTH-FACTOR; FACTOR-RECEPTOR; CELL-DEATH; VAL66MET POLYMORPHISM; ALZHEIMERS-DISEASE	Brain-derived neurotrophic factor (BDNF) regulates neuronal differentiation, synaptic plasticity, and morphology, and modest changes in BDNF levels results in complex behavioral phenotypes. BDNF levels and intracellular localization in neurons are regulated by multiple mechanisms, including use of distinct promoters, mRNA and protein transport, and regulated cleavage of proBDNF to mature BDNF. Sortilin is an intracellular chaperone that binds to the prodomain of BDNF to traffic it to the regulated secretory pathway. However, sortilin binds to numerous ligands and plays a major role in mannose 6-phosphate receptor-independent transport of lysosomal hydrolases utilizing motifs in the intracellular domain that mediate trafficking from the Golgi and late endosomes. Sortilin is modified by ectodomain shedding, although the biological implications of this are not known. Here we demonstrate that ADAM10 is the preferred protease to cleave sortilin in the extracellular stalk region, to release the ligand binding sortilin ectodomain from the transmembrane and cytoplasmic domains. We identify sortilin shedding at the cell surface and in an intracellular compartment. Both sortilin and BDNF are trafficked to and degraded by the lysosome in neurons, and this is dependent upon the sortilin cytoplasmic tail. Indeed, expression of the sortilin ectodomain, which corresponds to the domain released after shedding, impairs lysosomal targeting and degradation of BDNF. These findings characterize the regulation of sortilin shedding and identify a novel mechanism by which sortilin ectodomain shedding acts as a regulatory switch for delivery of BDNF to the secretory pathway or to the lysosome, thus modulating the bioavailability of endogenous BDNF.	[Irmady, Krithi; Ostrow, Katya; Hempstead, Barbara L.] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10065 USA; [Evans, Sarah Felice; Hempstead, Barbara L.] Cornell Univ, Grad Program Neurosci, New York, NY 10065 USA; [Kim, Taeho] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Nykjaer, Anders] Univ Aarhus, Dept Med Biochem, MIND Ctr, DK-8000 Aarhus, Denmark; [Saftig, Paul] Univ Kiel, Inst Biochem, D-2300 Kiel, York, Germany; [Blobel, Carl] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA	Cornell University; Cornell University; Stanford University; Aarhus University; University of Kiel	Hempstead, BL (corresponding author), Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10065 USA.	blhempst@med.cornell.edu	Saftig, Paul/A-7966-2010; Evans, Sarah/AAI-1228-2021	Nykjaer, Anders/0000-0001-6422-6736; Irmady, Krithi/0000-0003-2034-1809	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030687, R01NS064114] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS064114, R01 NS030687] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Akaneya Y, 1997, J NEUROSCI, V17, P6707; Althoff K, 2001, BIOCHEM J, V353, P663, DOI 10.1042/0264-6021:3530663; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Bernstein HG, 2003, J NEUROCYTOL, V32, P153, DOI 10.1023/B:NEUR.0000005600.61844.a6; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Boutilier J, 2008, J BIOL CHEM, V283, P12709, DOI 10.1074/jbc.M710018200; BRAKEBUSCH C, 1994, J BIOL CHEM, V269, P32488; Canuel M, 2008, BIOCHEM BIOPH RES CO, V373, P292, DOI 10.1016/j.bbrc.2008.06.021; Canuel M, 2008, BIOCHEM BIOPH RES CO, V366, P724, DOI 10.1016/j.bbrc.2007.12.015; Canuel M, 2009, HISTOL HISTOPATHOL, V24, P481, DOI 10.14670/HH-24.481; Carter AR, 2002, J NEUROSCI, V22, P1316, DOI 10.1523/JNEUROSCI.22-04-01316.2002; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Chiaruttini C, 2009, P NATL ACAD SCI USA, V106, P16481, DOI 10.1073/pnas.0902833106; Colciaghi F, 2002, MOL MED, V8, P67, DOI 10.1007/BF03402076; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Ehlers MRW, 1996, BIOCHEMISTRY-US, V35, P9549, DOI 10.1021/bi9602425; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; Gatta L, 2009, J NEURAL TRANSM, V116, P79, DOI 10.1007/s00702-008-0147-z; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hermans-Borgmeyer I, 1999, MOL BRAIN RES, V65, P216, DOI 10.1016/S0169-328X(99)00022-4; Hermey G, 2006, BIOCHEM J, V395, P285, DOI 10.1042/BJ20051364; Hinkle CL, 2004, J BIOL CHEM, V279, P24179, DOI 10.1074/jbc.M312141200; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Karkkainen I, 2000, MOL CELL NEUROSCI, V15, P547, DOI 10.1006/mcne.2000.0848; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kieseier BC, 2003, GLIA, V42, P398, DOI 10.1002/glia.10226; Kim T, 2009, EMBO J, V28, P1612, DOI 10.1038/emboj.2009.118; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lefrancois S, 2003, EMBO J, V22, P6430, DOI 10.1093/emboj/cdg629; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; Lou H, 2005, NEURON, V45, P245, DOI 10.1016/j.neuron.2004.12.037; Marcinkiewicz M, 2000, J NEUROCHEM, V75, P2133, DOI 10.1046/j.1471-4159.2000.0752133.x; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Nakamura K, 2007, CELL DEATH DIFFER, V14, P1552, DOI 10.1038/sj.cdd.4402173; Navarro V, 2002, BIOCHEM BIOPH RES CO, V298, P760, DOI 10.1016/S0006-291X(02)02564-0; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nyborg AC, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-3; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Rybakowski JK, 2008, PHARMACOGENOMICS, V9, P1589, DOI 10.2217/14622416.9.11.1589; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sarret P, 2003, J COMP NEUROL, V461, P483, DOI 10.1002/cne.10708; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Solomon KA, 1997, J IMMUNOL, V159, P4524; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Westergaard UB, 2004, J BIOL CHEM, V279, P50221, DOI 10.1074/jbc.M408873200; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001	71	80	83	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29556	29567		10.1074/jbc.M111.219675	http://dx.doi.org/10.1074/jbc.M111.219675			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21730062	Green Published, hybrid			2022-12-25	WOS:000294046600013
J	Geraghty, P; Dabo, AJ; D'Armiento, J				Geraghty, Patrick; Dabo, Abdoulaye J.; D'Armiento, Jeanine			TLR4 Protein Contributes to Cigarette Smoke-induced Matrix Metalloproteinase-1 (MMP-1) Expression in Chronic Obstructive Pulmonary Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; NEUTRAL SPHINGOMYELINASE 2; GENE-EXPRESSION; DIFFERENTIAL REGULATION; LUNG INFLAMMATION; HUMAN MONOCYTES; KAPPA-B; EMPHYSEMA; KINASE; ACTIVATION	Cigarette smoke is the major risk factor associated with the development of chronic obstructive pulmonary disease and alters expression of proteolytic enzymes that contribute to disease pathology. Previously, we reported that smoke exposure leads to the induction of matrix metalloproteinase-1 (MMP-1) through the activation of ERK1/2, which is critical to the development of emphysema. To date, the upstream signaling pathway by which cigarette smoke induces MMP-1 expression has been undefined. This study demonstrates that cigarette smoke mediates MMP-1 expression via activation of the TLR4 signaling cascade. In vitro cell culture studies demonstrated that cigarette smoke-induced MMP-1 was regulated by TLR4 via MyD88/IRAK1. Blockade of TLR4 or inhibition of IRAK1 prevented cigarette smoke induction of MMP-1. Mice exposed to acute levels of cigarette smoke exhibited increased TLR4 expression. To further confirm the in vivo relevance of this signaling pathway, rabbits exposed to acute cigarette smoke were found to have elevated TLR4 signaling and subsequent MMP-1 expression. Additionally, lungs from smokers exhibited elevated TLR4 and MMP-1 levels. Therefore, our data indicate that TLR4 signaling, through MyD88 and IRAK1, plays a predominant role in MMP-1 induction by cigarette smoke. The identification of the TLR4 pathway as a regulator of smoke-induced protease production presents a series of novel targets for future therapy in chronic obstructive pulmonary disease.	[D'Armiento, Jeanine] Columbia Univ, Coll Phys & Surg, Dept Med, Med Ctr, New York, NY 10032 USA	Columbia University	D'Armiento, J (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, Med Ctr, 630 W 168th St, New York, NY 10032 USA.	jmd12@columbia.edu		Geraghty, Patrick/0000-0003-1647-5505	National Institutes of Health [R01 HL086936, T32 HL007343]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007343, R01HL086936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL086936 (to J.D.) and Training Grant T32 HL007343 (to P.G.).	Ahmad R, 2007, CELL SIGNAL, V19, P2549, DOI 10.1016/j.cellsig.2007.08.013; Brenneisen P, 1997, FREE RADICAL BIO MED, V22, P515, DOI 10.1016/S0891-5849(96)00404-2; Chang ZL, 2010, INFLAMM RES, V59, P791, DOI 10.1007/s00011-010-0208-2; Coste I, 2010, J CLIN INVEST, V120, P3663, DOI 10.1172/JCI42771; Couillin I, 2009, J IMMUNOL, V183, P8195, DOI 10.4049/jimmunol.0803154; Cuschieri J, 2006, J LEUKOCYTE BIOL, V80, P407, DOI 10.1189/jlb.1105622; DARMIENTO J, 1992, CELL, V71, P955, DOI 10.1016/0092-8674(92)90391-O; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Dunne A, 2010, J BIOL CHEM, V285, P18276, DOI 10.1074/jbc.M109.098137; Filosto S, 2010, J BIOL CHEM, V285, P10213, DOI 10.1074/jbc.M109.069963; Fischer H, 2007, CELL MICROBIOL, V9, P1239, DOI 10.1111/j.1462-5822.2006.00867.x; Foronjy R, 2001, RESPIR RES, V2, P348, DOI 10.1186/rr85; Foronjy RF, 2003, AM J PHYSIOL-LUNG C, V284, pL727, DOI 10.1152/ajplung.00349.2002; Frantz S, 2001, J BIOL CHEM, V276, P5197, DOI 10.1074/jbc.M009160200; Friedland JS, 2002, MATRIX BIOL, V21, P103, DOI 10.1016/S0945-053X(01)00175-5; Geraghty P, 2007, J IMMUNOL, V178, P5871, DOI 10.4049/jimmunol.178.9.5871; Greene CM, 2008, EXPERT OPIN THER TAR, V12, P1481, DOI [10.1517/14728220802515293, 10.1517/14728220802515293 ]; Hasday JD, 1999, CHEST, V115, P829, DOI 10.1378/chest.115.3.829; Ho HH, 2008, J IMMUNOL, V181, P5089, DOI 10.4049/jimmunol.181.7.5089; Huang X, 2009, J IMMUNOL, V182, P5810, DOI 10.4049/jimmunol.0804073; Imai K, 2001, AM J RESP CRIT CARE, V163, P786, DOI 10.1164/ajrccm.163.3.2001073; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Koch S, 2009, J MOL MED, V87, P261, DOI 10.1007/s00109-008-0420-5; Lai WC, 2003, J IMMUNOL, V170, P6244, DOI 10.4049/jimmunol.170.12.6244; LAURENT P, 1983, CHEST, V83, pS63, DOI 10.1378/chest.83.5.63S; Levy M, 2009, AM J PHYSIOL-LUNG C, V297, pL125, DOI 10.1152/ajplung.00031.2009; MacRedmond RE, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-84; Maes T, 2006, INT ARCH ALLERGY IMM, V141, P354, DOI 10.1159/000095462; McColgan P, 2009, INT J CANCER, V125, P1473, DOI 10.1002/ijc.24441; McGettrick AF, 2010, SUBCELL BIOCHEM, V53, P153, DOI 10.1007/978-90-481-9078-2_7; Mercer BA, 2004, J BIOL CHEM, V279, P17690, DOI 10.1074/jbc.M313842200; Mercer Becky, 2006, Proc Am Thorac Soc, V3, P477, DOI 10.1513/pats.200603-041MS; Mercer BA, 2009, AM J RESP CELL MOL, V40, P4, DOI 10.1165/rcmb.2007-0310OC; Monaco C, 2009, CIRCULATION, V120, P2462, DOI 10.1161/CIRCULATIONAHA.109.851881; O'Neill LAJ, 2005, NAT MED, V11, P1161, DOI 10.1038/nm1105-1161; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Pardo A, 2005, INT J BIOCHEM CELL B, V37, P283, DOI 10.1016/j.biocel.2004.06.017; Pauly JL, 2010, IMMUNOL RES, V46, P127, DOI 10.1007/s12026-009-8117-6; Petrache I, 2008, AM J PHYSIOL-LUNG C, V295, pL44, DOI 10.1152/ajplung.00448.2007; Reunanen N, 1998, J BIOL CHEM, V273, P5137, DOI 10.1074/jbc.273.9.5137; Ritter Mirko, 2005, J Inflamm (Lond), V2, P16, DOI 10.1186/1476-9255-2-16; Sarir H, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-12; SHAH SA, J THORAC CARDIOVASC, V139, P984; SHAH SA, J THORAC CARDIOVASC, V139, P990; Shiomi T, 2003, EXP LUNG RES, V29, P1, DOI 10.1080/01902140303761; Speletas M, 2009, CLIN DEV IMMUNOL, DOI 10.1155/2009/260286; Su SL, 2005, OSTEOARTHR CARTILAGE, V13, P879, DOI 10.1016/j.joca.2005.04.017; Sundararaj KP, 2008, J LEUKOCYTE BIOL, V84, P1120, DOI 10.1189/jlb.0108064; Togbe D, 2006, LAB INVEST, V86, P1126, DOI 10.1038/labinvest.3700473; Trujillo G, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001510; Walters MJ, 2005, MOL PHARMACOL, V68, P1343, DOI 10.1124/mol.105.012591; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139	57	60	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30211	30218		10.1074/jbc.M111.238824	http://dx.doi.org/10.1074/jbc.M111.238824			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21730072	Green Published, hybrid			2022-12-25	WOS:000294046600078
J	Wojtala, RL; Tavares, IA; Morton, PE; Valderrama, F; Thomas, NSB; Morris, JDH				Wojtala, Rachael L.; Tavares, Ignatius A.; Morton, Penny E.; Valderrama, Ferran; Thomas, N. Shaun B.; Morris, Jonathan D. H.			Prostate-derived Sterile 20-like Kinases (PSKs/TAOKs) Are Activated in Mitosis and Contribute to Mitotic Cell Rounding and Spindle Positioning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; STE20-LIKE KINASE; PROTEIN-KINASE; MICROTUBULE ORGANIZATION; P21-ACTIVATED KINASES; PHOSPHORYLATION; ACTIN; SLK; GROWTH; TAO1	Prostate-derived sterile 20-like kinases (PSKs) 1-alpha, 1-beta, and 2 are members of the germinal-center kinase-like sterile 20 family of kinases. Previous work has shown that PSK 1-alpha binds and stabilizes microtubules whereas PSK2 destabilizes microtubules. Here, we have investigated the activation and autophosphorylation of endogenous PSKs and show that their catalytic activity increases as cells accumulate in G(2)/M and declines as cells exit mitosis. PSKs are stimulated in synchronous HeLa cells as they progress through mitosis, and these proteins are activated catalytically during each stage of mitosis. During prophase and metaphase activated PSKs are located in the cytoplasm and at the spindle poles, and during telophase and cytokinesis stimulated PSKs are present in trans-Golgi compartments. In addition, small interferingRNA(siRNA) knockdown of PSK1-alpha/beta or PSK2 expression inhibits mitotic cell rounding as well as spindle positioning and centralization. These results show that PSK catalytic activity increases during mitosis and suggest that these proteins can contribute functionally to mitotic cell rounding and spindle centralization during cell division.	[Wojtala, Rachael L.; Tavares, Ignatius A.; Morton, Penny E.; Morris, Jonathan D. H.] Kings Coll London, Canc Div, London SE1 1UL, England; [Valderrama, Ferran] St George Hosp, Div Biomed Sci, London SW17 0RE, England; [Thomas, N. Shaun B.] Kings Coll London, Canc Div, Rayne Inst, London SE5 9NU, England	University of London; King's College London; St Georges University London; University of London; King's College London	Morris, JDH (corresponding author), Kings Coll London, Canc Div, New Hunts House,Guys Campus, London SE1 1UL, England.	jonathan.morris@kcl.ac.uk		Morris, Jonathan/0000-0002-3211-1798	Association for International Cancer Research (St. Andrews, Scotland); King's Medical Research Trust; Biotechnology and Biological Sciences Research Council United Kingdom [29/C14086]; Laura Price; Leukemia and Lymphoma Research	Association for International Cancer Research (St. Andrews, Scotland); King's Medical Research Trust; Biotechnology and Biological Sciences Research Council United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Laura Price; Leukemia and Lymphoma Research	This work was supported by the Association for International Cancer Research (St. Andrews, Scotland), King's Medical Research Trust, the Biotechnology and Biological Sciences Research Council United Kingdom Grant 29/C14086, and by a donation from Laura Price.; Supported by Leukemia and Lymphoma Research.	Agromayor M, 2009, MOL BIOL CELL, V20, P1374, DOI 10.1091/mbc.E08-05-0474; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Akhmanova A, 2010, J CELL SCI, V123, P3415, DOI 10.1242/jcs.062414; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Banerjee M, 2002, CURR BIOL, V12, P1233, DOI 10.1016/S0960-9822(02)00956-9; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bompard G, 2010, J CELL BIOL, V190, P807, DOI 10.1083/jcb.200912056; Burakov AV, 2008, MOL BIOL CELL, V19, P1952, DOI 10.1091/mbc.E06-12-1156; Cau J, 2001, J CELL BIOL, V155, P1029, DOI 10.1083/jcb.200104123; Chen Z, 1999, J BIOL CHEM, V274, P28803, DOI 10.1074/jbc.274.40.28803; Choi JH, 2002, EMBO REP, V3, P988, DOI 10.1093/embo-reports/kvf197; Dallol A, 2009, CURR BIOL, V19, P1227, DOI 10.1016/j.cub.2009.05.064; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Ellinger-Ziegelbauer H, 2000, GENES CELLS, V5, P491, DOI 10.1046/j.1365-2443.2000.00337.x; Eswaran J, 2008, TRENDS BIOCHEM SCI, V33, P394, DOI 10.1016/j.tibs.2008.06.002; Grill SW, 2005, DEV CELL, V8, P461, DOI 10.1016/j.devcel.2005.03.014; Heng YW, 2010, INT J BIOCHEM CELL B, V42, P1622, DOI 10.1016/j.biocel.2010.04.007; Hergovich A, 2009, CURR BIOL, V19, P1692, DOI 10.1016/j.cub.2009.09.020; Hubner NC, 2010, CHROMOSOMA, V119, P149, DOI 10.1007/s00412-009-0244-2; Hutchison M, 1998, J BIOL CHEM, V273, P28625, DOI 10.1074/jbc.273.44.28625; Johne C, 2008, MOL BIOL CELL, V19, P1391, DOI 10.1091/mbc.E07-07-0730; Johnson TM, 2008, BIOCHEMISTRY-US, V47, P3688, DOI 10.1021/bi702134c; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Liu T, 2010, J CELL SCI, V123, P2708, DOI 10.1242/jcs.068726; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Maroto B, 2008, ONCOGENE, V27, P4900, DOI 10.1038/onc.2008.131; Matenia D, 2005, MOL BIOL CELL, V16, P4410, DOI 10.1091/mbc.E05-01-0081; Mitsopoulos C, 2003, J BIOL CHEM, V278, P18085, DOI 10.1074/jbc.M213064200; Mitsushima M, 2009, MOL CELL BIOL, V29, P2816, DOI 10.1128/MCB.01713-08; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Moore TM, 2000, J BIOL CHEM, V275, P4311, DOI 10.1074/jbc.275.6.4311; O'Reilly PG, 2005, J BIOL CHEM, V280, P42383, DOI 10.1074/jbc.M510763200; Pearson CG, 2004, NAT REV MOL CELL BIO, V5, P481, DOI 10.1038/nrm1402; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Raman M, 2007, EMBO J, V26, P2005, DOI 10.1038/sj.emboj.7601668; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Tassi E, 1999, J BIOL CHEM, V274, P33287, DOI 10.1074/jbc.274.47.33287; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Thiel DA, 2002, CURR BIOL, V12, P1227, DOI 10.1016/S0960-9822(02)00931-4; Timm T, 2006, NEURODEGENER DIS, V3, P207, DOI 10.1159/000095258; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Timm T, 2008, J BIOL CHEM, V283, P18873, DOI 10.1074/jbc.M706596200; Tsutsumi T, 2008, ARCH BIOCHEM BIOPHYS, V477, P267, DOI 10.1016/j.abb.2008.07.013; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200; Wagner S, 2002, J BIOL CHEM, V277, P37685, DOI 10.1074/jbc.M205899200; Westhorpe FG, 2010, CHROMOSOMA, V119, P371, DOI 10.1007/s00412-010-0261-1; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wittmann T, 2005, J CELL BIOL, V169, P929, DOI 10.1083/jcb.200412114; Wuhr M, 2009, CELL CYCLE, V8, P1115; Yustein JT, 2003, ONCOGENE, V22, P6129, DOI 10.1038/sj.onc.1206605; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035; Zhou TJ, 2004, STRUCTURE, V12, P1891, DOI 10.1016/j.str.2004.07.021; Zihni C, 2006, J BIOL CHEM, V281, P7317, DOI 10.1074/jbc.M513769200; Zihni C, 2007, J BIOL CHEM, V282, P6484, DOI 10.1074/jbc.M608336200; Zimniak T, 2009, J CELL BIOL, V186, P379, DOI 10.1083/jcb.200901036	58	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30161	30170		10.1074/jbc.M111.228320	http://dx.doi.org/10.1074/jbc.M111.228320			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21705329	Green Published, hybrid			2022-12-25	WOS:000294046600073
J	Fernandez, N; Gottardo, FL; Alonso, MN; Monczor, F; Shayo, C; Davio, C				Fernandez, Natalia; Gottardo, Federico L.; Alonso, Maria N.; Monczor, Federico; Shayo, Carina; Davio, Carlos			Roles of Phosphorylation-dependent and -independent Mechanisms in the Regulation of Histamine H2 Receptor by G Protein-coupled Receptor Kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; ADENYLYL-CYCLASE; BETA-ARRESTINS; RGS PROTEINS; DESENSITIZATION; INTERNALIZATION; CELLS; INVOLVEMENT; RECEPTOR-KINASE-2; INHIBITION	It is widely assumed that G protein-coupled receptor kinase 2 (GRK2)-mediated specific inhibition of G protein-coupled receptors (GPCRs) response involves GRK-mediated receptor phosphorylation followed by beta-arrestin binding and subsequent uncoupling from the heterotrimeric G protein. It has recently become evident that GRK2-mediated GPCRs regulation also involves phosphorylation-independent mechanisms. In the present study we investigated whether the histamine H2 receptor (H2R), a G alpha(s)-coupled GPCR known to be desensitized by GRK2, needs to be phosphorylated for its desensitization and/or internalization and resensitization. For this purpose we evaluated the effect of the phosphorylating-deficient GRK2K220R mutant on H2R signaling in U937, COS7, and HEK293T cells. We found that although this mutant functioned as dominant negative concerning receptor internalization and resensitization, it desensitized H2R signaling in the same degree as the GRK2 wild type. To identify the domains responsible for the kinase-independent receptor desensitization, we co-transfected the receptor with constructions encoding the GRK2 RGS-homology domain (RH) and the RH or the kinase domain fused to the pleckstrin-homology domain. Results demonstrated that the RH domain of GRK2 was sufficient to desensitize the H2R. Moreover, disruption of RGS functions by the use of GRK2D110A/K220R double mutant, although coimmunoprecipitating with the H2R, reversed GRK2K220R-mediated H2R desensitization. Overall, these results indicate that GRK2 induces desensitization of H2R through a phosphorylation-independent and RGS-dependent mechanism and extends the GRK2 RH domain-mediated regulation of GPCRs beyond G alpha(q)-coupled receptors. On the other hand, GRK2 kinase activity proved to be necessary for receptor internalization and the resulting resensitization.	[Fernandez, Natalia; Gottardo, Federico L.; Monczor, Federico; Davio, Carlos] Univ Buenos Aires, Fac Farm & Bioquim, Lab Farmacol Receptores, Catedra Quim Med, RA-1113 Buenos Aires, DF, Argentina; [Alonso, Maria N.; Shayo, Carina] Inst Biol & Med Expt, Lab Farmacol & Patol Mol, RA-1426 Buenos Aires, DF, Argentina; [Fernandez, Natalia; Alonso, Maria N.; Monczor, Federico; Shayo, Carina; Davio, Carlos] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Fernandez, N (corresponding author), Junin 956, RA-1113 Buenos Aires, DF, Argentina.	natycfernandez@gmail.com			Universidad de Buenos Aires [UBACyT B050, B808]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 38318]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas [CONICET-PIP 6110]	Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas	This work was supported by Universidad de Buenos Aires Grants UBACyT B050 and B808, Agencia Nacional de Promocion Cientifica y Tecnologica Grant PICT 38318, and Consejo Nacional de Investigaciones Cientificas y Tecnologicas Grant CONICET-PIP 6110. This work was also supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas fellowships (to M. N. A.).	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Barlic J, 1999, J BIOL CHEM, V274, P16287, DOI 10.1074/jbc.274.23.16287; Chatterjee TK, 1997, J BIOL CHEM, V272, P15481, DOI 10.1074/jbc.272.24.15481; Chen ZG, 2004, MOL PHARMACOL, V66, P377; Day PW, 2004, METHOD ENZYMOL, V390, P295; Dhami GK, 2004, J BIOL CHEM, V279, P16614, DOI 10.1074/jbc.M314090200; Dhami GK, 2002, J BIOL CHEM, V277, P25266, DOI 10.1074/jbc.M203593200; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; Diviani D, 1996, J BIOL CHEM, V271, P5049; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; Fernandez N, 2002, MOL PHARMACOL, V62, P1506, DOI 10.1124/mol.62.6.1506; Fernandez N, 2008, MOL PHARMACOL, V74, P1109, DOI 10.1124/mol.108.045336; Freedman NJ, 1997, J BIOL CHEM, V272, P17734, DOI 10.1074/jbc.272.28.17734; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; Horie K, 2000, J BIOL CHEM, V275, P29433, DOI 10.1074/jbc.M003413200; Jean-Baptiste G, 2006, CELL MOL LIFE SCI, V63, P1969, DOI 10.1007/s00018-006-6066-y; KONG GH, 1994, J BIOL CHEM, V269, P13084; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lazari MDM, 1999, MOL ENDOCRINOL, V13, P866, DOI 10.1210/me.13.6.866; Legnazzi BL, 2000, BIOCHEM PHARMACOL, V60, P159, DOI 10.1016/S0006-2952(00)00295-1; Lodowski DT, 2005, BIOCHEMISTRY-US, V44, P6958, DOI 10.1021/bi050119q; Luttrell LM, 2002, J CELL SCI, V115, P455; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; Oppermann M, 1996, J BIOL CHEM, V271, P13266, DOI 10.1074/jbc.271.22.13266; PEI G, 1995, MOL PHARMACOL, V48, P173; Reiter E, 2001, BIOCHEM BIOPH RES CO, V282, P71, DOI 10.1006/bbrc.2001.4534; Riddle EL, 2005, CIRC RES, V96, P401, DOI 10.1161/01.RES.0000158287.49872.4e; Roy AA, 2006, CELL SIGNAL, V18, P336, DOI 10.1016/j.cellsig.2005.05.004; Sachs G, 2002, BEST PRACT RES CL GA, V16, P835, DOI 10.1053/bega.2002.0338; Sallese M, 2000, MOL PHARMACOL, V57, P826, DOI 10.1124/mol.57.4.826; Shayo C, 2004, BIOCHEM BIOPH RES CO, V314, P798, DOI 10.1016/j.bbrc.2003.12.166; Shayo C, 2001, MOL PHARMACOL, V60, P1049, DOI 10.1124/mol.60.5.1049; Spitaler MM, 2002, CLIN EXP PHARMACOL P, V29, P711, DOI 10.1046/j.1440-1681.2002.03704.x; Sterne-Marr R, 2004, METHOD ENZYMOL, V390, P310; Tiruppathi C, 2000, P NATL ACAD SCI USA, V97, P7440, DOI 10.1073/pnas.97.13.7440	36	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28697	28706		10.1074/jbc.M111.269613	http://dx.doi.org/10.1074/jbc.M111.269613			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705320	hybrid, Green Published			2022-12-25	WOS:000293837000007
J	Arora, S; Bhardwaj, A; Srivastava, SK; Singh, S; McClellan, S; Wang, B; Singh, AP				Arora, Sumit; Bhardwaj, Arun; Srivastava, Sanjeev K.; Singh, Seema; McClellan, Steven; Wang, Bin; Singh, Ajay P.			Honokiol Arrests Cell Cycle, Induces Apoptosis, and Potentiates the Cytotoxic Effect of Gemcitabine in Human Pancreatic Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; DOWN-REGULATION; CHEMOTHERAPY; INHIBITION; ACTIVATION; INDUCTION; PATHWAYS; ANGIOGENESIS; MODULATION; RESISTANCE	Survival rates for patients with pancreatic cancer are extremely poor due to its asymptomatic progression to advanced and metastatic stage for which current therapies remain largely ineffective. Therefore, novel therapeutic agents and treatment approaches are desired to improve the clinical outcome. In this study, we determined the effects of honokiol, a biologically active constituent of oriental medicinal herb Magnolia officinalis/grandiflora, on two pancreatic cancer cell lines, MiaPaCa and Panc1, alone and in combination with the standard chemotherapeutic drug, gemcitabine. Honokiol exerted growth inhibitory effects on both the pancreatic cancer cell lines by causing cell cycle arrest at G(1) phase and induction of apoptosis. At the molecular level, honokiol markedly decreased the expression of cyclins (D1 and E) and cyclin-dependent kinases (Cdk2 and Cdk4), and caused an increase in Cdk inhibitors, p21 and p27. Furthermore, honokiol treatment led to augmentation of Bax/Bcl-2 and Bax/Bcl-xL ratios to favor apoptosis in pancreatic cancer cells. These changes were accompanied by enhanced cytoplasmic accumulation of NF-kappa B with a concomitant decrease in nuclear fraction and reduced transcriptional activity of NF-kappa B responsive promoter. This was associated with decreased phosphorylation of inhibitor of kappa B alpha (IkB-alpha) causing its stabilization and thus increased cellular levels. Importantly, honokiol also potentiated the cytotoxic effects of gemcitabine, in part, by restricting the gemcitabine-induced nuclear accumulation of NF-kappa B in the treated pancreatic cancer cell lines. Altogether, these findings demonstrate, for the first time, the growth inhibitory effects of honokiol in pancreatic cancer and indicate its potential usefulness as a novel natural agent in prevention and therapy.	[Arora, Sumit; Bhardwaj, Arun; Srivastava, Sanjeev K.; Singh, Seema; McClellan, Steven; Singh, Ajay P.] Univ S Alabama, Dept Oncol Sci, Mitchell Canc Inst, Mobile, AL 36688 USA; [Wang, Bin] Univ S Alabama, Dept Math & Stat, Coll Arts & Sci, Mobile, AL 36688 USA; [Singh, Ajay P.] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL USA	University of South Alabama; University of South Alabama; University of South Alabama	Arora, S (corresponding author), Univ S Alabama, Dept Oncol Sci, Mitchell Canc Inst, Mobile, AL 36688 USA.	asingh@usouthal.edu	Singh, Ajay/AAF-4414-2020	Singh, Ajay/0000-0003-3492-6330; Wang, Bin/0000-0002-3689-6932	National Institutes of Health/National Cancer Institute (NIH/NCI) [CA137513]; USAMCI; NATIONAL CANCER INSTITUTE [R03CA137513] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); USAMCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant support from National Institutes of Health/National Cancer Institute (NIH/NCI) (CA137513) and USAMCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Call JA, 2008, LANCET ONCOL, V9, P1002, DOI 10.1016/S1470-2045(08)70209-2; Cappella P, 2001, INT J CANCER, V93, P401, DOI 10.1002/ijc.1351.abs; Chen CY, 2007, EUR J PHARMACOL, V574, P94, DOI 10.1016/j.ejphar.2007.07.028; Chen F, 2004, WORLD J GASTROENTERO, V10, P3459; Chen YJ, 2010, CANCER LETT, V291, P20, DOI 10.1016/j.canlet.2009.08.032; Chilampalli S, 2010, ANTICANCER RES, V30, P777; Dahlman JM, 2009, J CELL BIOCHEM, V106, P42, DOI 10.1002/jcb.21976; DHAYAT S, 2011, INT J CANC, V10; Fong WF, 2005, INT J BIOCHEM CELL B, V37, P427, DOI 10.1016/j.biocel.2004.05.021; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Giovannetti E, 2010, CANCER RES, V70, P4528, DOI 10.1158/0008-5472.CAN-09-4467; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HUANG P, 1995, CANCER CHEMOTH PHARM, V36, P181, DOI 10.1007/BF00685844; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kamat AM, 2007, MOL CANCER THER, V6, P1022, DOI 10.1158/1535-7163.MCT-06-0545; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lee SY, 2008, EUR J PHARMACOL, V582, P17, DOI 10.1016/j.ejphar.2007.12.027; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li ZY, 2008, EUR J OBSTET GYN R B, V140, P95, DOI 10.1016/j.ejogrb.2008.02.023; Liptay S, 2003, INT J CANCER, V105, P735, DOI 10.1002/ijc.11081; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Park EJ, 2009, CANCER LETT, V277, P133, DOI 10.1016/j.canlet.2008.11.029; Perkins ND, 2000, TRENDS BIOCHEM SCI, V25, P434, DOI 10.1016/S0968-0004(00)01617-0; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; Singh S, 2010, BRIT J CANCER, V103, P1671, DOI 10.1038/sj.bjc.6605968; Srivastava SK, 2004, CARCINOGENESIS, V25, P1701, DOI 10.1093/carcin/bgh179; Uwagawa T, 2009, ANTICANCER RES, V29, P3173; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Wharry CE, 2009, CANCER BIOL THER, V8, P1567, DOI 10.4161/cbt.8.16.8961; Wong HH, 2009, NAT REV GASTRO HEPAT, V6, P412, DOI 10.1038/nrgastro.2009.89; Yang SE, 2002, BIOCHEM PHARMACOL, V63, P1641, DOI 10.1016/S0006-2952(02)00894-8; Yokoi K, 2004, CLIN CANCER RES, V10, P2299, DOI 10.1158/1078-0432.CCR-03-0488	40	108	111	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21573	10.1371/journal.pone.0021573	http://dx.doi.org/10.1371/journal.pone.0021573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720559	Green Published, gold, Green Submitted			2022-12-25	WOS:000292036900055
J	Wells, S; Nornes, S; Lardelli, M				Wells, Simon; Nornes, Svanhild; Lardelli, Michael			Transgenic Zebrafish Recapitulating tbx16 Gene Early Developmental Expression	PLOS ONE			English	Article							FLUORESCENT PROTEIN EXPRESSION; SPINAL NEURONS; PROMOTER; VERTEBRATES; EVOLUTION; MUTATION; ELEMENTS; EMBRYOS; MARKS	We describe the creation of a transgenic zebrafish expressing GFP driven by a 7.5 kb promoter region of the tbx16 gene. This promoter segment is sufficient to recapitulate early embryonic expression of endogenous tbx16 in the presomitic mesoderm, the polster and, subsequently, in the hatching gland. Expression of GFP in the transgenic lines later in development diverges to some extent from endogenous tbx16 expression with the serendipitous result that one line expresses GFP specifically in commissural primary ascending (CoPA) interneurons of the developing spinal cord. Using this line we demonstrate that the gene mafba (valentino) is expressed in CoPA interneurons.	[Wells, Simon; Nornes, Svanhild; Lardelli, Michael] Univ Adelaide, Dept Mol Biosci, Special Res Ctr Mol Genet Dev, Adelaide, SA, Australia	University of Adelaide	Wells, S (corresponding author), Univ Adelaide, Dept Mol Biosci, Special Res Ctr Mol Genet Dev, Adelaide, SA, Australia.	simon.wells@adelaide.edu.au		Lardelli, Michael/0000-0002-4289-444X	Australian Research Council via its Special Research Centre for the Molecular Genetics of Development [S00001531]	Australian Research Council via its Special Research Centre for the Molecular Genetics of Development(Australian Research Council)	This work was supported by funds from the Australian Research Council via its Special Research Centre for the Molecular Genetics of Development (S00001531). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN JY, 2010, FISH PHYSIOL BIOCHEM, P5; Ellingsen S, 2005, DEVELOPMENT, V132, P3799, DOI 10.1242/dev.01951; Gong ZY, 2002, DEV DYNAM, V223, P204, DOI 10.1002/dvdy.10051; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Higashijima S, 2004, J NEUROSCI, V24, P5827, DOI 10.1523/JNEUROSCI.5342-03.2004; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; Jowett T., 1997, TISSUE IN SITU HYBRI; Ju BS, 2003, DEV DYNAM, V227, P14, DOI 10.1002/dvdy.10273; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; KIMMEL CB, 1989, NATURE, V337, P358, DOI 10.1038/337358a0; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kimura Y, 2006, J NEUROSCI, V26, P5684, DOI 10.1523/JNEUROSCI.4993-05.2006; KUWADA JY, 1990, J COMP NEUROL, V302, P617, DOI 10.1002/cne.903020316; Mione M, 2008, DEV NEUROSCI-BASEL, V30, P65, DOI 10.1159/000109853; MOLVEN A, 1990, DEVELOPMENT, V109, P279; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Roberts A, 2000, BRAIN RES BULL, V53, P585, DOI 10.1016/S0361-9230(00)00392-0; Ruvinsky I, 1998, DEV GENES EVOL, V208, P94, DOI 10.1007/s004270050158; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Tamme Richard, 2002, BMC Dev Biol, V2, P9, DOI 10.1186/1471-213X-2-9; WELLS S, 2010, EXP CELL RES, P1; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yeo SY, 2007, DEV BIOL, V301, P555, DOI 10.1016/j.ydbio.2006.10.020	23	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21559	10.1371/journal.pone.0021559	http://dx.doi.org/10.1371/journal.pone.0021559			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720556	Green Published, gold, Green Submitted			2022-12-25	WOS:000292036900052
J	Bish, LT; Yarchoan, M; Sleeper, MM; Gazzara, JA; Morine, KJ; Acosta, P; Barton, ER; Sweeney, HL				Bish, Lawrence T.; Yarchoan, Mark; Sleeper, Meg M.; Gazzara, Jeffrey A.; Morine, Kevin J.; Acosta, Pedro; Barton, Elisabeth R.; Sweeney, H. Lee			Chronic Losartan Administration Reduces Mortality and Preserves Cardiac but Not Skeletal Muscle Function in Dystrophic Mice	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MDX-MICE; HEART-FAILURE; TGF-BETA; HYPERTROPHIC CARDIOMYOPATHY; FIBROSIS; TGF-BETA-1; MODEL	Duchenne muscular dystrophy (DMD) is a degenerative disorder affecting skeletal and cardiac muscle for which there is no effective therapy. Angiotension receptor blockade (ARB) has excellent therapeutic potential in DMD based on recent data demonstrating attenuation of skeletal muscle disease progression during 6-9 months of therapy in the mdx mouse model of DMD. Since cardiac-related death is major cause of mortality in DMD, it is important to evaluate the effect of any novel treatment on the heart. Therefore, we evaluated the long-term impact of ARB on both the skeletal muscle and cardiac phenotype of the mdx mouse. Mdx mice received either losartan (0.6 g/L) (n = 8) or standard drinking water (n = 9) for two years, after which echocardiography was performed to assess cardiac function. Skeletal muscle weight, morphology, and function were assessed. Fibrosis was evaluated in the diaphragm and heart by Trichrome stain and by determination of tissue hydroxyproline content. By the study endpoint, 88% of treated mice were alive compared to only 44% of untreated (p = 0.05). No difference in skeletal muscle morphology, function, or fibrosis was noted in losartan-treated animals. Cardiac function was significantly preserved with losartan treatment, with a trend towards reduction in cardiac fibrosis. We saw no impact on the skeletal muscle disease progression, suggesting that other pathways that trigger fibrosis dominate over angiotensin II in skeletal muscle long term, unlike the situation in the heart. Our study suggests that ARB may be an important prophylactic treatment for DMD-associated cardiomyopathy, but will not impact skeletal muscle disease.	[Bish, Lawrence T.; Yarchoan, Mark; Gazzara, Jeffrey A.; Morine, Kevin J.; Acosta, Pedro; Sweeney, H. Lee] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Sleeper, Meg M.] Univ Penn, Vet Hosp, Dept Clin Studies, Div Cardiol, Philadelphia, PA 19104 USA; [Barton, Elisabeth R.] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Barton, Elisabeth R.] Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Bish, LT (corresponding author), Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA.	bish@mail.med.upenn.edu	Sweeney, H Lee/F-1862-2010	Yarchoan, Mark/0000-0003-4401-0748	National Institutes of Health [P01-HL059407, U54-AR052646, T32-HL-007748]; Parent Project Muscular Dystrophy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007748, P01HL059407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parent Project Muscular Dystrophy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (P01-HL059407 to HLS, U54-AR052646 to HLS, T32-HL-007748 to LTB) and the Parent Project Muscular Dystrophy to HLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton ER, 2006, AM J PHYSIOL-CELL PH, V290, pC411, DOI 10.1152/ajpcell.00192.2005; Baxter P, 2006, DEV MED CHILD NEUROL, V48, P163, DOI 10.1017/S0012162206000351; Bostick B, 2009, MOL THER, V17, P253, DOI 10.1038/mt.2008.264; Campistol JM, 1999, KIDNEY INT, V56, P714, DOI 10.1046/j.1523-1755.1999.00597.x; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Colussi C, 2010, CARDIOVASC RES, V87, P73, DOI 10.1093/cvr/cvq035; Dupont E, 2001, CIRCULATION, V103, P842, DOI 10.1161/01.CIR.103.6.842; Esmatjes E, 2001, NEPHROL DIAL TRANSPL, V16, P90, DOI 10.1093/ndt/16.suppl_1.90; Ferreira JCB, 2011, LIFE SCI, V88, P578, DOI 10.1016/j.lfs.2011.01.009; Gregorevic P, 2008, MOL THER, V16, P657, DOI 10.1038/mt.2008.28; Gunther S, 2010, N-S ARCH PHARMACOL, V382, P265, DOI 10.1007/s00210-010-0544-3; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Kaye DM, 2008, ANNU REV MED, V59, P13, DOI 10.1146/annurev.med.59.052407.103237; Kuehn BM, 2007, JAMA-J AM MED ASSOC, V298, P1385, DOI 10.1001/jama.298.12.1385; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lim DS, 2001, CIRCULATION, V103, P789, DOI 10.1161/01.CIR.103.6.789; Mouisel E, 2010, MUSCLE NERVE, V41, P809, DOI 10.1002/mus.21624; Nowak KJ, 2004, EMBO REP, V5, P872, DOI 10.1038/sj.embor.7400221; Passerini L, 2002, NEUROMUSCULAR DISORD, V12, P828, DOI 10.1016/S0960-8966(02)00071-8; PICKERING JG, 1990, CIRCULATION, V81, P949, DOI 10.1161/01.CIR.81.3.949; Silcocks PB, 1997, HEART, V78, P237, DOI 10.1136/hrt.78.3.237; Spurney CF, 2011, J CARDIOVASC PHARM T, V16, P87, DOI 10.1177/1074248410381757; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Van Erp C, 2010, MUSCLE NERVE, V42, P504, DOI 10.1002/mus.21716; Vinge LE, 2008, CIRC RES, V102, P1458, DOI 10.1161/CIRCRESAHA.108.173195; Wagner KR, 2008, NEUROTHERAPEUTICS, V5, P583, DOI 10.1016/j.nurt.2008.08.013	26	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20856	10.1371/journal.pone.0020856	http://dx.doi.org/10.1371/journal.pone.0020856			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731628	Green Published, gold			2022-12-25	WOS:000292033700017
J	Kromrey, S; Bart, E; Hegde, J				Kromrey, Sarah; Bart, Evgeniy; Hegde, Jay			What the 'Moonwalk' Illusion Reveals about the Perception of Relative Depth from Motion	PLOS ONE			English	Article							DYNAMIC OCCLUSION; STIMULI; ORDER	When one visual object moves behind another, the object farther from the viewer is progressively occluded and/or disoccluded by the nearer object. For nearly half a century, this dynamic occlusion cue has beenthought to be sufficient by itself for determining the relative depth of the two objects. This view is consistent with the self-evident geometric fact that the surface undergoing dynamic occlusion is always farther from the viewer than the occluding surface. Here we use a contextual manipulation of a previously known motion illusion, which we refer to as the 'Moonwalk' illusion, to demonstrate that the visual system cannot determine relative depth from dynamic occlusion alone. Indeed, in the Moonwalk illusion, human observers perceive a relative depth contrary to the dynamic occlusion cue. However, the perception of the expected relative depth is restored by contextual manipulations unrelated to dynamic occlusion. On the other hand, we show that an Ideal Observer can determine using dynamic occlusion alone in the same Moonwalk stimuli, indicating that the dynamic occlusion cue is, in principle, sufficient for determining relative depth. Our results indicate that in order to correctly perceive relative depth from dynamic occlusion, the human brain, unlike the Ideal Observer, needs additionalsegmentation information that delineate the occluder from the occluded object. Thus, neural mechanisms of object segmentation must, in addition to motion mechanisms that extract information about relative depth, play a crucial role in the perception of relative depth from motion.	[Kromrey, Sarah; Hegde, Jay] Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA; [Kromrey, Sarah; Hegde, Jay] Georgia Hlth Sci Univ, Vis Discovery Inst, Augusta, GA USA; [Bart, Evgeniy] Xerox Corp, Palo Alto Res Ctr, Palo Alto, CA 94304 USA; [Hegde, Jay] Georgia Hlth Sci Univ, Dept Ophthalmol, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Xerox; University System of Georgia; Augusta University	Kromrey, S (corresponding author), Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA.	jhegde@mcg.edu			Brain and Behavior Discovery Institute; Vision Discovery Institute of the Georgia Health Sciences University	Brain and Behavior Discovery Institute; Vision Discovery Institute of the Georgia Health Sciences University	This study was supported in part by the Brain and Behavior Discovery Institute and by the Vision Discovery Institute of the Georgia Health Sciences University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ALBRIGHT TD, 1992, SCIENCE, V255, P1141, DOI 10.1126/science.1546317; ANDERSEN GJ, 1989, PERCEPT PSYCHOPHYS, V46, P49, DOI 10.3758/BF03208073; ANSTIS SM, 1989, P 2 RET RES FDN C, P247; Baker CL, 2001, PROG BRAIN RES, V134, P171; Beck C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003807; BRUNO N, 1990, PERCEPT PSYCHOPHYS, V48, P331, DOI 10.3758/BF03206684; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; CHUBB C, 1988, J OPT SOC AM A, V5, P1986, DOI 10.1364/JOSAA.5.001986; CRATON LG, 1990, PERCEPT PSYCHOPHYS, V47, P169, DOI 10.3758/BF03205981; FLEET DJ, 1994, VISION RES, V34, P3057, DOI 10.1016/0042-6989(94)90278-X; FLEET DJ, 2005, MATH MODELS COMPUTER, P1; FLEET DJ, 2002, EXPLORING ARTIFICIAL, P139; GIBSON JJ, 1969, PERCEPT PSYCHOPHYS, V5, P113, DOI 10.3758/BF03210533; Hegde J, 2004, J VISION, V4, P838, DOI 10.1167/4.10.1; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Howard I. P., 2002, SEEING DEPTH, V2; KAPLAN GA, 1969, PERCEPT PSYCHOPHYS, V6, P193, DOI 10.3758/BF03207015; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; MICHOTTE A, 1964, STUDIA PSYCHOLOGIA; MUTCH KM, 1988, NATURAL COMPUTATION, P44; NIYOGI SA, 1995, DETECTING KINETIC OC, P1044; ONO H, 1988, PERCEPTION, V17, P255, DOI 10.1068/p170255; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; RAMACHANDRAN VS, 1990, PERCEPTION, V19, P611, DOI 10.1068/p190611; ROYDEN CS, 1988, PERCEPTION, V17, P289, DOI 10.1068/p170289; THOMPSON WB, 1985, IEEE T PATTERN ANAL, V7, P374, DOI 10.1109/TPAMI.1985.4767677; Vaina LM, 2003, PROG BRAIN RES, V144, P197, DOI 10.1016/S0079-6123(03)14401-4; YONAS A, 1987, PERCEPT PSYCHOPHYS, V41, P53, DOI 10.3758/BF03208213	29	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20951	10.1371/journal.pone.0020951	http://dx.doi.org/10.1371/journal.pone.0020951			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782TF	21731635	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700022
J	Calvi, CL; Podowski, M; D'Alessio, FR; Metzger, SL; Misono, K; Poonyagariyagorn, H; Lopez-Mercado, A; Ku, T; Lauer, T; Cheadle, C; Talbot, CC; Jie, CF; McGrath-Morrow, S; King, LS; Walston, J; Neptune, ER				Calvi, Carla L.; Podowski, Megan; D'Alessio, Franco R.; Metzger, Shana L.; Misono, Kaori; Poonyagariyagorn, Hataya; Lopez-Mercado, Armando; Ku, Therese; Lauer, Thomas; Cheadle, Christopher; Talbot, C. Conover, Jr.; Jie, Chunfa; McGrath-Morrow, Sharon; King, Landon S.; Walston, Jeremy; Neptune, Enid R.			Critical Transition in Tissue Homeostasis Accompanies Murine Lung Senescence	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OXIDATIVE STRESS; B-CELL; MATRIX METALLOPROTEINASE-1; AUTOIMMUNITY; OLD; IMMUNOSENESCENCE; INFLAMMATION; EMPHYSEMA; C57BL/6J	Background: Respiratory dysfunction is a major contributor to morbidity and mortality in aged populations. The susceptibility to pulmonary insults is attributed to "low pulmonary reserve'', ostensibly reflecting a combination of age-related musculoskeletal, immunologic and intrinsic pulmonary dysfunction. Methods/Principal Findings: Using a murine model of the aging lung, senescent DBA/2 mice, we correlated a longitudinal survey of airspace size and injury measures with a transcriptome from the aging lung at 2, 4, 8, 12, 16 and 20 months of age. Morphometric analysis demonstrated a nonlinear pattern of airspace caliber enlargement with a critical transition occurring between 8 and 12 months of age marked by an initial increase in oxidative stress, cell death and elastase activation which is soon followed by inflammatory cell infiltration, immune complex deposition and the onset of airspace enlargement. The temporally correlative transcriptome showed exuberant induction of immunoglobulin genes coincident with airspace enlargement. Immunohistochemistry, ELISA analysis and flow cytometry demonstrated increased immunoglobulin deposition in the lung associated with a contemporaneous increase in activated B-cells expressing high levels of TLR4 (toll receptor 4) and CD86 and macrophages during midlife. These midlife changes culminate in progressive airspace enlargement during late life stages. Conclusion/Significance: Our findings establish that a tissue-specific aging program is evident during a presenescent interval which involves early oxidative stress, cell death and elastase activation, followed by B lymphocyte and macrophage expansion/activation. This sequence heralds the progression to overt airspace enlargement in the aged lung. These signature events, during middle age, indicate that early stages of the aging immune system may have important correlates in the maintenance of tissue morphology. We further show that time-course analyses of aging models, when informed by structural surveys, can reveal nonintuitive signatures of organ-specific aging pathology.	[Calvi, Carla L.; Podowski, Megan; D'Alessio, Franco R.; Metzger, Shana L.; Misono, Kaori; Poonyagariyagorn, Hataya; Lopez-Mercado, Armando; Ku, Therese; King, Landon S.; Neptune, Enid R.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21218 USA; [Cheadle, Christopher] Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD USA; [Talbot, C. Conover, Jr.; Jie, Chunfa] Johns Hopkins Univ, Sch Med, JHMI Microarray Core, Baltimore, MD USA; [Walston, Jeremy] Johns Hopkins Univ, Sch Med, Div Geriatr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Calvi, CL (corresponding author), Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21218 USA.	eneptune@jhmi.edu	Ku, Therese/Q-4857-2019	Ku, Therese/0000-0002-8353-4985	National Institutes of Health [RO1-HL085312]; National Institute on Aging (NIA) through the Johns Hopkins Older Americans Independence Center (OAIC) [P30 AG021334]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging (NIA) through the Johns Hopkins Older Americans Independence Center (OAIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the National Institutes of Health (grants RO1-HL085312 to E.R.N.). This work has also been supported by the National Institute on Aging (NIA) through the Johns Hopkins Older Americans Independence Center (OAIC), P30 AG021334 (to E.R.N. and J.D.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boren E, 2004, AUTOIMMUN REV, V3, P401, DOI 10.1016/j.autrev.2004.03.004; Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; Dasgupta J, 2010, J CELL PHYSIOL, V225, P52, DOI 10.1002/jcp.22193; Dorshkind K, 2009, NAT REV IMMUNOL, V9, P57, DOI 10.1038/nri2471; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Gibson KL, 2009, AGING CELL, V8, P18, DOI 10.1111/j.1474-9726.2008.00443.x; Guerrettaz LM, 2008, P NATL ACAD SCI USA, V105, P11898, DOI 10.1073/pnas.0805498105; Hasler P, 2005, CELL IMMUNOL, V233, P102, DOI 10.1016/j.cellimm.2005.04.012; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Huang KW, 2007, J APPL PHYSIOL, V102, P1632, DOI 10.1152/japplphysiol.00833.2006; Huang KW, 2007, J APPL PHYSIOL, V102, P200, DOI 10.1152/japplphysiol.00400.2006; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Larbi A, 2008, ADV EXP MED BIOL, V640, P312, DOI 10.1007/978-0-387-09789-3_21; Listi F, 2006, ANN NY ACAD SCI, V1089, P487, DOI 10.1196/annals.1386.013; McElhaney JE, 2009, CURR OPIN IMMUNOL, V21, P418, DOI 10.1016/j.coi.2009.05.023; Misra V, 2007, PHYSIOL GENOMICS, V31, P429, DOI 10.1152/physiolgenomics.00060.2007; Pawelec G, 1999, MECH AGEING DEV, V108, P1; Podowski M, 2009, AM J PATHOL, V175, P84, DOI 10.2353/ajpath.2009.080870; RICHARDS D W, 1956, Bull N Y Acad Med, V32, P407; Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC; Speziali E, 2009, CELL IMMUNOL, V256, P1, DOI 10.1016/j.cellimm.2009.01.010; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; VERBEKEN EK, 1992, CHEST, V101, P793, DOI 10.1378/chest.101.3.793; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201	30	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e20712	10.1371/journal.pone.0020712	http://dx.doi.org/10.1371/journal.pone.0020712			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713037	Green Published, Green Submitted, gold			2022-12-25	WOS:000291985100004
J	Jiang, Q; Ho, YY; Hao, L; Berrios, CN; Chakravarti, A				Jiang, Qian; Ho, Yen-Yi; Hao, Li; Berrios, Courtney Nichols; Chakravarti, Aravinda			Copy Number Variants in Candidate Genes Are Genetic Modifiers of Hirschsprung Disease	PLOS ONE			English	Article							DEPENDENT PROBE AMPLIFICATION; STRUCTURAL VARIATION; RET ENHANCER; HUMAN GENOME; COMMON; EXPRESSION; CHROMOSOME-10; MALFORMATIONS; DUPLICATIONS; ASSOCIATION	Hirschsprung disease (HSCR) is a neurocristopathy characterized by absence of intramural ganglion cells along variable lengths of the gastrointestinal tract. The HSCR phenotype is highly variable with respect to gender, length of aganglionosis, familiality and the presence of additional anomalies. By molecular genetic analysis, a minimum of 11 neuro-developmental genes (RET, GDNF, NRTN, SOX10, EDNRB, EDN3, ECE1, ZFHX1B, PHOX2B, KIAA1279, TCF4) are known to harbor rare, high-penetrance mutations that confer a large risk to the bearer. In addition, two other genes (RET, NRG1) harbor common, low-penetrance polymorphisms that contribute only partially to risk and can act as genetic modifiers. To broaden this search, we examined whether a set of 67 proven and candidate HSCR genes harbored additional modifier alleles. In this pilot study, we utilized a custom-designed array CGH with similar to 33,000 test probes at an average resolution of similar to 185 bp to detect gene-sized or smaller copy number variants (CNVs) within these 67 genes in 18 heterogeneous HSCR patients. Using stringent criteria, we identified CNVs at three loci (MAPK10, ZFHX1B, SOX2) that are novel, involve regulatory and coding sequences of neuro-developmental genes, and show association with HSCR in combination with other congenital anomalies. Additional CNVs are observed under relaxed criteria. Our research suggests a role for CNVs in HSCR and, importantly, emphasizes the role of variation in regulatory sequences. A much larger study will be necessary both for replication and for identifying the full spectrum of small CNV effects.	[Jiang, Qian; Ho, Yen-Yi; Hao, Li; Berrios, Courtney Nichols; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA	Johns Hopkins University	Jiang, Q (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.	aravinda@jhmi.edu	Jiang, Qian/ABG-8183-2020	Jiang, Qian/0000-0001-6023-2290; Berrios, Courtney/0000-0001-5170-070X	U.S. National Institutes of Health [R37 HD28088]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD028088] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the U.S. National Institutes of Health for funding (R37 HD28088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Arnold S, 2009, HUM MUTAT, V30, P771, DOI 10.1002/humu.20944; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Brewer C, 1999, AM J HUM GENET, V64, P1702, DOI 10.1086/302410; Brewer C, 1998, AM J HUM GENET, V63, P1153, DOI 10.1086/302041; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Chaignat E, 2011, GENOME RES, V21, P106, DOI 10.1101/gr.112748.110; CHAKRAVARTI A, 2001, METABOLIC MOL BASES, P6231; CLEVELAND WS, 1981, AM STAT, V35, P54, DOI 10.2307/2683591; Cox JJ, 2011, NEW ENGL J MED, V364, P91, DOI 10.1056/NEJMc1010311; Dathe K, 2009, AM J HUM GENET, V84, P483, DOI 10.1016/j.ajhg.2009.03.001; de Pontual L, 2007, HUM MUTAT, V28, P790, DOI 10.1002/humu.20517; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Fanciulli M, 2010, CLIN GENET, V77, P201, DOI 10.1111/j.1399-0004.2009.01342.x; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Haldane JBS, 1941, J GENET, V41, P149, DOI 10.1007/BF02983018; Heanue TA, 2006, P NATL ACAD SCI USA, V103, P6919, DOI 10.1073/pnas.0602152103; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Huber W, 2002, BIOINFORMATICS, V18, pS96; Kurth I, 2009, NAT GENET, V41, P862, DOI 10.1038/ng0809-862; Lower KM, 2009, P NATL ACAD SCI USA, V106, P21771, DOI 10.1073/pnas.0909331106; LYONNET S, 1993, NAT GENET, V4, P346, DOI 10.1038/ng0893-346; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matsuzaki H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r125; Neidhart S, 2001, FEBS LETT, V508, P259, DOI 10.1016/S0014-5793(01)03090-3; Nunez-Torres R, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-119; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Serra A, 2009, ANN HUM GENET, V73, P147, DOI 10.1111/j.1469-1809.2008.00503.x; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Thomas DJ, 2007, NUCLEIC ACIDS RES, V35, pD663, DOI 10.1093/nar/gkl1017; Wakamatsu N, 2001, NAT GENET, V27, P369, DOI 10.1038/86860	41	48	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21219	10.1371/journal.pone.0021219	http://dx.doi.org/10.1371/journal.pone.0021219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712996	Green Submitted, gold, Green Published			2022-12-25	WOS:000291985100017
J	Leventhal, JS; Alsauskas, Z; Snyder, A; Gong, PF; Wang, B; D'Agati, V; Ross, MJ				Leventhal, Jeremy S.; Alsauskas, Zygimantas; Snyder, Alexandra; Gong, Pengfei; Wang, Bin; D'Agati, Vivette; Ross, Michael J.			Renal HIV Expression Is Unaffected by Serum LPS Levels in an HIV Transgenic Mouse Model of LPS Induced Kidney Injury	PLOS ONE			English	Article							FACTOR-KAPPA-B; TUBULAR EPITHELIAL-CELLS; HOSPITALIZED-PATIENTS; INFECTED PATIENTS; GENE-EXPRESSION; VIRAL LOAD; FAILURE; ACTIVATION; NEPHROPATHY; TAT	Acute kidney injury (AKI) is associated with increased rates of mortality. For unknown reasons, HIV infected individuals have a higher risk of AKI than uninfected persons. We tested our hypothesis that increased circulating LPS increases renal expression of HIV and that HIV transgenic (Tg26) mice have increased susceptibility to AKI. Tg26 mice harbor an HIV transgene encoding all HIV genes except gag and pol, and develop a phenotype analogous to HIVAN. Mice were used at 4-6 weeks of age before the onset of gross renal disease. Mice were injected i.p. with LPS or sterile saline. Renal function, tubular injury, cytokine expression, and HIV transcription were evaluated in Tg26 and wild type (WT) mice. LPS injection induced a median 60.1-fold increase in HIV expression in spleen but no change in kidney. There was no significant difference in renal function, cytokine expression, or tubular injury scores at baseline or 24 hours after LPS injection. HIV transcription was also analyzed in vitro using a human renal tubular epithelial cell (RTEC) line. HIV transcription increased minimally in human RTEC, by 1.47 fold, 48 hours after LPS exposure. We conclude that Tg26 mice do not increase HIV expression or have increased susceptibility to LPS induced AKI. The increased risk of AKI in HIV infected patients is not mediated via increased renal expression of HIV in the setting of sepsis. Moreover, renal regulation of HIV transcription is different to that in the spleen.	[Leventhal, Jeremy S.; Gong, Pengfei; Wang, Bin; Ross, Michael J.] Mt Sinai Sch Med, Dept Med, Div Nephrol, New York, NY 10029 USA; [Leventhal, Jeremy S.] James J Peters Bronx VA Med Ctr, Div Nephrol, Bronx, NY USA; [Alsauskas, Zygimantas] Univ Louisville, Div Nephrol, Louisville, KY 40292 USA; [D'Agati, Vivette] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of Louisville; Columbia University	Leventhal, JS (corresponding author), Mt Sinai Sch Med, Dept Med, Div Nephrol, New York, NY 10029 USA.	jeremy.leventhal@mssm.edu			National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK078510]; National Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078510] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases grant R01 DK078510 (to PI MR) and by a National Kidney Foundation Fellowship Grant (to JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2005, J NEUROIMMUNOL, V160, P219, DOI 10.1016/j.jneuroim.2004.11.009; Ayyavoo V, 1997, NAT MED, V3, P1117, DOI 10.1038/nm1097-1117; Banda NK, 2006, J IMMUNOL, V177, P1904, DOI 10.4049/jimmunol.177.3.1904; Bieniasz PD, 2000, J VIROL, V74, P9868, DOI 10.1128/JVI.74.21.9868-9877.2000; Bruggeman LA, 1997, J CLIN INVEST, V100, P84, DOI 10.1172/JCI119525; Bruggeman LA, 2001, KIDNEY INT, V59, P2174, DOI 10.1046/j.1523-1755.2001.0590062174.x; Buchacz K, 2004, AIDS, V18, P2075, DOI 10.1097/00002030-200410210-00012; Chen DM, 2003, AM J TRANSPLANT, V3, P1216, DOI 10.1046/j.1600-6143.2003.00207.x; Chowdhury P, 2006, CLIN EXP IMMUNOL, V145, P346, DOI 10.1111/j.1365-2249.2006.03116.x; Cunningham PN, 2002, J IMMUNOL, V168, P5817, DOI 10.4049/jimmunol.168.11.5817; DICKIE P, 1991, VIROLOGY, V185, P109, DOI 10.1016/0042-6822(91)90759-5; Equils O, 2001, J IMMUNOL, V166, P2342, DOI 10.4049/jimmunol.166.4.2342; Franceschini N, 2005, KIDNEY INT, V67, P1526, DOI 10.1111/j.1523-1755.2005.00232.x; GRIFFIN GE, 1989, NATURE, V339, P70, DOI 10.1038/339070a0; Husain M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019642.55998.69; Kofoed K, 2006, SEX TRANSM DIS, V33, P143, DOI 10.1097/01.olq.0000187262.56820.c0; KOPP JB, 1992, P NATL ACAD SCI USA, V89, P1577, DOI 10.1073/pnas.89.5.1577; Liu XY, 2006, J INFECT DIS, V194, P751, DOI 10.1086/506360; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinka S, 2006, AM J PHYSIOL-RENAL, V290, pF657, DOI 10.1152/ajprenal.00208.2005; MERZOUKI A, 1994, J VIROL METHODS, V50, P115, DOI 10.1016/0166-0934(94)90168-6; Muthumani K, 2000, J LEUKOCYTE BIOL, V68, P366; Nordone SK, 2007, AIDS RES HUM RETROV, V23, P1387, DOI 10.1089/aid.2007.0033; Nowroozalizadeh S, 2010, J INFECT DIS, V201, P1150, DOI 10.1086/651430; Pu H, 2003, MOL CELL NEUROSCI, V24, P224, DOI 10.1016/S1044-7431(03)00171-4; Qi W, 2007, NEPHROLOGY, V12, P155, DOI 10.1111/j.1440-1797.2007.00779.x; Ray PE, 1998, KIDNEY INT, V53, P1217, DOI 10.1046/j.1523-1755.1998.00900.x; Remoli AL, 2006, BIOCHEM J, V396, P371, DOI 10.1042/BJ20051570; Roe J, 2008, CLIN INFECT DIS, V47, P242, DOI 10.1086/589296; Ross MJ, 2006, J AM SOC NEPHROL, V17, P996, DOI 10.1681/ASN.2005070692; Ross MJ, 2006, JAIDS-J ACQ IMM DEF, V42, P1, DOI 10.1097/01.qai.0000218353.60099.4f; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Snyder A, 2009, CURR HIV RES, V7, P129, DOI 10.2174/157016209787581526; Tanaka J, 2000, AIDS, V14, P1299, DOI 10.1097/00002030-200007070-00001; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; Viedt C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015609.31253.7F; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Wu XY, 2007, AM J PHYSIOL-RENAL, V293, pF1262, DOI 10.1152/ajprenal.00445.2006; Wyatt CM, 2006, AIDS, V20, P561, DOI 10.1097/01.aids.0000210610.52836.07; Zhang N, 2003, AM J TRANSPLANT, V3, P1230, DOI 10.1046/j.1600-6143.2003.00215.x	42	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20688	10.1371/journal.pone.0020688	http://dx.doi.org/10.1371/journal.pone.0020688			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698182	Green Published, gold, Green Submitted			2022-12-25	WOS:000291734100014
J	Cinnamon, J; Schuurman, N; Hameed, SM				Cinnamon, Jonathan; Schuurman, Nadine; Hameed, S. Morad			Pedestrian Injury and Human Behaviour: Observing Road-Rule Violations at High-Incident Intersections	PLOS ONE			English	Article							SIGNALIZED INTERSECTIONS; DRIVER BEHAVIOR; SAFETY; CRASHES; PREVENTION; COLLISIONS; PATTERNS	Background: Human behaviour is an obvious, yet under-studied factor in pedestrian injury. Behavioural interventions that address rule violations by pedestrians and motorists could potentially reduce the frequency of pedestrian injury. In this study, a method was developed to examine road-rule non-compliance by pedestrians and motorists. The purpose of the study was to examine the potential association between violations made by pedestrians and motorists at signalized intersections, and collisions between pedestrians and motor-vehicles. The underlying hypothesis is that high-incident pedestrian intersections are likely to vary with respect to their aetiology, and thus are likely to require individualized interventions - based on the type and rate of pedestrian and motorist violation. Methods: High-incident pedestrian injury intersections in Vancouver, Canada were identified using geographic information systems. Road-rule violations by pedestrians and motorists were documented at each incident hotspot by a team of observers at several different time periods during the day. Results: Approximately 9,000 pedestrians and 18,000 vehicles were observed in total. In total for all observed intersections, over 2000 (21%) pedestrians committed one of the observed pedestrian road-crossing violations, while approximately 1000 (5.9%) drivers committed one of the observed motorist violations. Great variability in road-rule violations was observed between intersections, and also within intersections at different observation periods. Conclusions: Both motorists and pedestrians were frequently observed committing road-rule violations at signalized intersections, suggesting a potential human behavioural contribution to pedestrian injury at the study sites. These results suggest that each intersection may have unique mechanisms that contribute to pedestrian injury, and may require targeted behavioural interventions. The method described in this study provides the basis for understanding the relationship between violations and pedestrian injury risk at urban intersections. Findings could be applied to targeted prevention campaigns designed to reduce the number of pedestrian injuries at signalized intersections.	[Cinnamon, Jonathan; Schuurman, Nadine] Simon Fraser Univ, Dept Geog, Burnaby, BC V5A 1S6, Canada; [Hameed, S. Morad] Vancouver Gen Hosp, Trauma Serv, Vancouver, BC, Canada	Simon Fraser University; University of British Columbia	Cinnamon, J (corresponding author), Simon Fraser Univ, Dept Geog, Burnaby, BC V5A 1S6, Canada.	jca80@sfu.ca	Cinnamon, Jonathan/ABB-8331-2021	Cinnamon, Jonathan/0000-0001-7383-6886	SSHRC; Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health Research (MSFHR)	SSHRC(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	A Mathematics of Information Technology and Computing Science (MITACS) Accelerate internship held by JC provided funding for this project, which was carried out in conjunction with Trauma Services at Vancouver General Hospital (VGH). Additional research support for JC was provided by a SSHRC doctoral scholarship. NS is supported by career awards from the Canadian Institutes of Health Research (CIHR) and Michael Smith Foundation for Health Research (MSFHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghamdi AS, 2002, ACCIDENT ANAL PREV, V34, P205, DOI 10.1016/S0001-4575(01)00015-X; Anderson RWG, 1997, ACCIDENT ANAL PREV, V29, P667, DOI 10.1016/S0001-4575(97)00036-5; Boyce TE, 2000, ENVIRON BEHAV, V32, P502, DOI 10.1177/00139160021972630; Chakravarthy B, 2007, ANN EMERG MED, V50, pS99, DOI 10.1016/j.annemergmed.2007.06.378; Clifton KJ, 2007, ACCIDENT ANAL PREV, V39, P708, DOI 10.1016/j.aap.2006.11.003; Cusimano M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008669; de Lavalette BC, 2009, SAFETY SCI, V47, P1248, DOI 10.1016/j.ssci.2009.03.016; Duperrex O, 2002, BRIT MED J, V324, P1129, DOI 10.1136/bmj.324.7346.1129; ESRI, 2006, ARCGIS 9 2; Geyer J., 2005, CONTINUING DEBATE SA; Guo F, 2010, ACCIDENT ANAL PREV, V42, P84, DOI 10.1016/j.aap.2009.07.005; HARBLUK JL, 2002, IMPACT COGNITIVE DIS, P1; Harre N, 2004, TRANSPORT RES F-TRAF, V7, P167, DOI 10.1016/j.trf.2004.07.002; HARWOOD DW, 2008, PEDESTRIAN SAFETY PR, DOI DOI 10.1016/J.AAP.2005.03.019; Hatfield J, 2007, ACCIDENT ANAL PREV, V39, P833, DOI 10.1016/j.aap.2006.12.005; HEINONEN JA, 2007, PEDESTRIAN INJURIES; Holland CA, 2009, HEALTH EDUC RES, V24, P674, DOI 10.1093/her/cyp003; Jacobsen PL, 2003, INJURY PREV, V9, P205, DOI 10.1136/ip.9.3.205rep; Kim K, 2008, ACCIDENT ANAL PREV, V40, P894, DOI 10.1016/j.aap.2007.10.004; Kim K, 2008, ACCIDENT ANAL PREV, V40, P2043, DOI 10.1016/j.aap.2008.08.021; King MJ, 2009, ACCIDENT ANAL PREV, V41, P485, DOI 10.1016/j.aap.2009.01.008; LaScala EA, 2000, ACCIDENT ANAL PREV, V32, P651, DOI 10.1016/S0001-4575(99)00100-1; Leden L, 2002, ACCIDENT ANAL PREV, V34, P457, DOI 10.1016/S0001-4575(01)00043-4; Lee C, 2005, ACCIDENT ANAL PREV, V37, P775, DOI 10.1016/j.aap.2005.03.019; Li Y, 2010, ACCIDENT ANAL PREV, V42, P1156, DOI 10.1016/j.aap.2010.01.004; Lyons RA, 2006, INJURY PREV, V12, P312, DOI 10.1136/ip.2006.011916; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Nasar J.L., 2003, TRANSPORT RES F-TRAF, V6, P175, DOI [DOI 10.1016/J.TRF.2004.07.002, DOI 10.1016/S1369-8478(03)00024-X]; Nasar J, 2008, ACCIDENT ANAL PREV, V40, P69, DOI 10.1016/j.aap.2007.04.005; National Highway Traffic Safety Administration, 2010, TRAFF SAF FACTS 2009; Nilsen P, 2004, INJURY PREV, V10, P268, DOI 10.1136/ip.2004.005744; Nilsen Per, 2007, Int J Inj Contr Saf Promot, V14, P241, DOI 10.1080/17457300701736726; Papaioannou P, 2007, ACCIDENT ANAL PREV, V39, P147, DOI 10.1016/j.aap.2006.06.014; Preusser DF, 2002, ACCIDENT ANAL PREV, V34, P703, DOI 10.1016/S0001-4575(01)00070-7; Pulugurtha SS, 2011, ACCIDENT ANAL PREV, V43, P439, DOI 10.1016/j.aap.2010.09.014; Retting RA, 2001, ACCIDENT ANAL PREV, V33, P723, DOI 10.1016/S0001-4575(00)00086-5; Rosen E, 2009, ACCIDENT ANAL PREV, V41, P536, DOI 10.1016/j.aap.2009.02.002; RUSSWURM L, 2010, WERE ALL PEDESTRIAN, DOI DOI 10.1016/J.JSR.2007.01.008; RUSSWURM L, 2010, VANCOUVER AREA NETWO; Schuurman N, 2008, CAN J SURG, V51, P389; Schuurman N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-233; Sciortino S, 2005, ACCIDENT ANAL PREV, V37, P1102, DOI 10.1016/j.aap.2005.06.010; Stevenson M, 2006, INJURY PREV, V12, P1, DOI 10.1136/ip.2005.010413; STEVENSON MR, 1995, INT J EPIDEMIOL, V24, P957, DOI 10.1093/ije/24.5.957; Stutts J. C., 1996, TRANSPORT RES REC, V1538, P68, DOI [DOI 10.1177/0361198196153800109, 10.1177/0361198196153800109]; *TRANSP CAN, 2004, CAN MOT VEH COLL STA; *TRANSP CAN, 2008, QUICK LOOK INT CRASH; Transport Canada, 2008, QUICK LOOK SPEED CRA; Transport Canada, 2010, CAN MOT VEH COLL STA; Ulfarsson GF, 2010, ACCIDENT ANAL PREV, V42, P1805, DOI 10.1016/j.aap.2010.05.001; Wier M, 2009, ACCIDENT ANAL PREV, V41, P137, DOI 10.1016/j.aap.2008.10.001; Winston FK, 2010, INJURY PREV, V16, P107, DOI 10.1136/ip.2009.021972; World Health Organization, 2009, GLOB STAT REP ROAD S; Yang CYD, 2007, J SAFETY RES, V38, P311, DOI 10.1016/j.jsr.2007.01.008; Young K., 2003, DRIVER DISTRACTION R, P1	55	47	47	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21063	10.1371/journal.pone.0021063	http://dx.doi.org/10.1371/journal.pone.0021063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778TS	21698258	Green Published, gold, Green Submitted			2022-12-25	WOS:000291730000047
J	Spassov, DS; Wong, CH; Harris, G; McDonough, S; Phojanakong, P; Wang, D; Hann, B; Bazarov, AV; Yaswen, P; Khanafshar, E; Moasser, MM				Spassov, D. S.; Wong, C. H.; Harris, G.; McDonough, S.; Phojanakong, P.; Wang, D.; Hann, B.; Bazarov, A. V.; Yaswen, P.; Khanafshar, E.; Moasser, M. M.			A tumor-suppressing function in the epithelial adhesion protein Trask	ONCOGENE			English	Article						Trask; CDCP1; SIMA135; 3p21.3; metastasis	DOMAIN-CONTAINING PROTEIN-1; CUB-DOMAIN; SUBSTRATE TRASK; LUNG METASTASIS; FAK INHIBITOR; CANCER-CELLS; KINASE; EXPRESSION; CDCP1; ADENOCARCINOMA	Trask/CDCP1 is a transmembrane glycoprotein widely expressed in epithelial tissues whose functions are just beginning to be understood, but include a role as an anti-adhesive effector of Src kinases. Early studies looking at RNA transcript levels seemed to suggest overexpression in some cancers, but immunostaining studies are now providing more accurate analyses of its expression. In an immuno-histochemical survey of human cancer specimens, we find that Trask expression is retained, reduced or sometimes lost in some tumors compared with their normal epithelial tissue counterparts. A survey of human cancer cell lines also show a similar wide variation in the expression of Trask, including some cell types with the loss of Trask expression, and additional cell types that have lost the physiological detachment-induced phosphorylation of Trask. Three experimental models were established to interrogate the role of Trask in tumor progression, including two gain-of-function models with tet-inducible expression of Trask in tumor cells lacking Trask expression, and one loss-of-function model to suppress Trask expression in tumor cells with abundant Trask expression. The induction of Trask expression and phosphorylation in MCF-7 cells and in 3T3v-src cells was associated with a reduction in tumor metastases while the shRNA-induced knockdown of Trask in L3.6pl cancer cells was associated with increased tumor metastases. The results from these three models are consistent with a tumor-suppressing role for Trask. These data identify Trask as one of several potential candidates for functionally relevant tumor suppressors on the 3p21.3 region of the genome frequently lost in human cancers. Oncogene (2012) 31, 419-431; doi: 10.1038/onc.2011.246; published online 27 June 2011	[Spassov, D. S.; Wong, C. H.; Harris, G.; McDonough, S.; Moasser, M. M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Spassov, D. S.; Wong, C. H.; Phojanakong, P.; Wang, D.; Hann, B.; Moasser, M. M.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Bazarov, A. V.; Yaswen, P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Khanafshar, E.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Moasser, MM (corresponding author), Univ Calif San Francisco, Dept Med, UCSF Box 1387,2340 Sutter St,Rm N-144, San Francisco, CA 94143 USA.	mmoasser@medicine.ucsf.edu	Spassov, Danislav S/GQA-4368-2022	Spassov, Danislav S/0000-0002-6680-877X	National Institutes of Health [CA113952]; Susan G Komen for the Cure; California Breast Cancer Research Program Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [R01CA113952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G Komen for the Cure(Susan G. Komen Breast Cancer Foundation); California Breast Cancer Research Program Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Institutes of Health CA113952 (MMM). DS is funded by a Susan G Komen for the Cure Postdoctoral Fellowship. CHW is funded by a California Breast Cancer Research Program Postdoctoral Fellowship. We wish to thank Michael McManus and the UCSF Sandler Lentiviral RNAi core facility. We acknowledge the use of core facilities of the UCSF Helen Diller Family Comprehensive Cancer Center, including the Preclinical Therapeutics Core, the immunohistochemistry core and the mouse pathology core.	Abdel-Ghany M, 2002, J BIOL CHEM, V277, P34391, DOI 10.1074/jbc.M205307200; Awakura Y, 2008, J CANCER RES CLIN, V134, P1363, DOI 10.1007/s00432-008-0412-4; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Brakebusch C, 2002, J CLIN INVEST, V109, P999, DOI 10.1172/JCI200215468; Brown TA, 2004, J BIOL CHEM, V279, P14772, DOI 10.1074/jbc.M309678200; Chen JS, 2010, CLIN EXP METASTAS, V27, P71, DOI 10.1007/s10585-010-9306-3; Conze T, 2003, ANN NY ACAD SCI, V996, P222, DOI 10.1111/j.1749-6632.2003.tb03249.x; Felding-Habermann B, 2003, CLIN EXP METASTAS, V20, P203, DOI 10.1023/A:1022983000355; Hanada M, 2005, CLIN EXP METASTAS, V22, P485, DOI 10.1007/s10585-005-3733-6; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Ikeda JI, 2006, J PATHOL, V210, P75, DOI 10.1002/path.2026; Ikeda JI, 2009, CANCER SCI, V100, P429, DOI 10.1111/j.1349-7006.2008.01066.x; Ji Lin, 2005, Future Oncol, V1, P79, DOI 10.1517/14796694.1.1.79; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Mamat S, 2010, ONCOL REP, V23, P1221, DOI 10.3892/or_00000753; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Perry SE, 2007, FEBS LETT, V581, P1137, DOI 10.1016/j.febslet.2007.02.025; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Provenzano PP, 2008, AM J PATHOL, V173, P1551, DOI 10.2353/ajpath.2008.080308; Ramsay AG, 2007, CANCER METAST REV, V26, P567, DOI 10.1007/s10555-007-9078-7; Rathinam R, 2010, CANCER METAST REV, V29, P223, DOI 10.1007/s10555-010-9211-x; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Siva AC, 2008, CANCER RES, V68, P3759, DOI 10.1158/0008-5472.CAN-07-1657; Spassov DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019154; Spassov DS, 2011, MOL CELL BIOL, V31, P766, DOI 10.1128/MCB.00841-10; Spassov DS, 2009, AM J PATHOL, V174, P1756, DOI 10.2353/ajpath.2009.080890; Spiegelberg BD, 2007, CURR OPIN GENET DEV, V17, P40, DOI 10.1016/j.gde.2006.12.002; Srinivasan Divya Mani, 2005, Curr Opin Investig Drugs, V6, P1246; Sun HH, 2010, CANCER BIOL THER, V10, P38, DOI 10.4161/cbt.10.1.11993; Tang J, 2008, CELL MOL LIFE SCI, V65, P2933, DOI 10.1007/s00018-008-8315-8; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Trimmer C, 2010, CANCER RES, V70, P7489, DOI 10.1158/0008-5472.CAN-10-0900; Uekita T, 2008, AM J PATHOL, V172, P1729, DOI 10.2353/ajpath.2008.070981; van Nimwegen MJ, 2005, CANCER RES, V65, P4698, DOI 10.1158/0008-5472.CAN-04-4126; Walsh C, 2010, CANCER BIOL THER, V9, P778, DOI 10.4161/cbt.9.10.11433; Wistuba II, 2000, CANCER RES, V60, P1949; Wong CH, 2009, CLIN CANCER RES, V15, P2311, DOI 10.1158/1078-0432.CCR-08-2533	41	11	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2012	31	4					419	431		10.1038/onc.2011.246	http://dx.doi.org/10.1038/onc.2011.246			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891LU	21706059	Green Submitted, Green Accepted			2022-12-25	WOS:000300219300002
J	Fujishiro, T; Shoji, O; Nagano, S; Sugimoto, H; Shiro, Y; Watanabe, Y				Fujishiro, Takashi; Shoji, Osami; Nagano, Shingo; Sugimoto, Hiroshi; Shiro, Yoshitsugu; Watanabe, Yoshihito			Crystal Structure of H2O2-dependent Cytochrome P450(SP alpha) with Its Bound Fatty Acid Substrate INSIGHT INTO THE REGIOSELECTIVE HYDROXYLATION OF FATTY ACIDS AT THE alpha POSITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC RESONANCE; SITE-DIRECTED MUTAGENESIS; HYDROGEN-PEROXIDE; THERMOPHILIC CYTOCHROME-P450; MACROMOLECULAR STRUCTURES; SULFOLOBUS-SOLFATARICUS; CATALYTIC MECHANISM; ANGSTROM RESOLUTION; BACILLUS-SUBTILIS; OPEN CONFORMATION	Cytochrome P450(SP alpha) (CYP152B1) isolated from Sphingomonas paucimobilis is the first P450 to be classified as a H2O2-dependent P450. P450(SP alpha) hydroxylates fatty acids with high alpha-regioselectivity. Herein we report the crystal structure of P450(SP alpha) with palmitic acid as a substrate at a resolution of 1.65 angstrom. The structure revealed that the C-alpha of the bound palmitic acid in one of the alternative conformations is 4.5 angstrom from the heme iron. This conformation explains the highly selective alpha-hydroxylation of fatty acid observed in P450(SP alpha). Mutations at the active site and the F-G loop of P450(SP alpha) did not impair its regioselectivity. The crystal structures of mutants (L78F and F288G) revealed that the location of the bound palmitic acid was essentially the same as that in the WT, although amino acids at the active site were replaced with the corresponding amino acids of cytochrome P450(BS alpha) (CYP152A1), which shows beta-regioselectivity. This implies that the high regioselectivity of P450(SP alpha) is caused by the orientation of the hydrophobic channel, which is more perpendicular to the heme plane than that of P450(BS alpha)	[Watanabe, Yoshihito] Nagoya Univ, Res Ctr Mat Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Fujishiro, Takashi; Shoji, Osami] Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Nagano, Shingo] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808550, Japan; [Sugimoto, Hiroshi; Shiro, Yoshitsugu] RIKEN SPring 8 Ctr Harima Inst, Sayo, Hyogo 6795148, Japan	Nagoya University; Nagoya University; Tottori University; RIKEN	Watanabe, Y (corresponding author), Nagoya Univ, Res Ctr Mat Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	yoshi@nucc.cc.nagoya-u.ac.jp	Fujishiro, Takashi/F-4804-2013; Sugimoto, Hiroshi/K-4041-2017; Sugimoto, Hiroshi/AAR-5442-2021; Shiro, Yoshitsugu Y/J-3757-2014	Fujishiro, Takashi/0000-0001-7967-8380; Sugimoto, Hiroshi/0000-0002-3140-8362; Shiro, Yoshitsugu Y/0000-0003-0695-8327; Shoji, Osami/0000-0003-3522-0065	Ministry of Education, Culture, Sports, Science, and Technology (Japan) [19105044, 22105012, 21685018]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [21245041] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research (S) 19105044 (to Y. W.), Grant-in-Aid for Scientific Research on Innovative Areas 22105012 (to Y. S.), and Grant-in-Aid for Young Scientists (A) 21685018 (to O. S.) from the Ministry of Education, Culture, Sports, Science, and Technology (Japan).; Supported by Japan Society for the Promotion of Science Research Fellowships for Young Scientists.	Allen EE, 2000, J BACTERIOL, V182, P1264, DOI 10.1128/JB.182.5.1264-1271.2000; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; HASEMANN CA, 1994, J MOL BIOL, V236, P1169, DOI 10.1016/0022-2836(94)90019-1; HOLLENBERG PF, 1980, J BIOL CHEM, V255, P4801; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; Lee DS, 2003, J BIOL CHEM, V278, P9761, DOI 10.1074/jbc.M211575200; Lee YT, 2010, BIOCHEMISTRY-US, V49, P3412, DOI 10.1021/bi100183g; Leys D, 2003, J BIOL CHEM, V278, P5141, DOI 10.1074/jbc.M209928200; Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140; LI HY, 1995, J AM CHEM SOC, V117, P6297, DOI 10.1021/ja00128a019; LIPSCOMB JD, 1980, BIOCHEMISTRY-US, V19, P3590, DOI 10.1021/bi00556a027; Makino M, 2007, P NATL ACAD SCI USA, V104, P11591, DOI 10.1073/pnas.0702946104; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; Matsui T, 1999, J AM CHEM SOC, V121, P9952, DOI 10.1021/ja9914846; Matsunaga I, 1996, FEBS LETT, V386, P252, DOI 10.1016/0014-5793(96)00451-6; Matsunaga I, 2000, LIPIDS, V35, P365, DOI 10.1007/s11745-000-533-y; MATSUNAGA I, 1994, BIOCHEM BIOPH RES CO, V201, P1554, DOI 10.1006/bbrc.1994.1881; Matsunaga I, 2001, ARCH BIOCHEM BIOPHYS, V394, P45, DOI 10.1006/abbi.2001.2512; McLean KJ, 2009, J BIOL CHEM, V284, P35524, DOI 10.1074/jbc.M109.032706; MILES JS, 1992, BIOCHEM J, V288, P503, DOI 10.1042/bj2880503; Modi S, 1996, NAT STRUCT BIOL, V3, P414, DOI 10.1038/nsb0596-414; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Nagano S, 2004, J BIOL CHEM, V279, P42844, DOI 10.1074/jbc.M404217200; Oku Y, 2004, J INORG BIOCHEM, V98, P1194, DOI 10.1016/j.jinorgbio.2004.05.002; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Ozaki S, 1997, J AM CHEM SOC, V119, P6666, DOI 10.1021/ja970453c; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Park SY, 2002, J INORG BIOCHEM, V91, P491, DOI 10.1016/S0162-0134(02)00446-4; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; POULOS TL, 1980, J BIOL CHEM, V255, P8199; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; POULOS TL, 1985, J BIOL CHEM, V260, P6122; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shoji O, 2007, ANGEW CHEM INT EDIT, V46, P3656, DOI 10.1002/anie.200700068; Shoji O, 2010, J BIOL INORG CHEM, V15, P1331, DOI 10.1007/s00775-010-0692-4; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; Sundaramoorthy M, 1998, CHEM BIOL, V5, P461, DOI 10.1016/S1074-5521(98)90003-5; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WANG JM, 1990, BIOCHEMISTRY-US, V29, P7160, DOI 10.1021/bi00483a003; Wester MR, 2004, J BIOL CHEM, V279, P35630, DOI 10.1074/jbc.M405427200; Williams PA, 2003, NATURE, V424, P464, DOI 10.1038/nature01862; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yano JK, 2000, J BIOL CHEM, V275, P31086, DOI 10.1074/jbc.M004281200; Yano JK, 2005, NAT STRUCT MOL BIOL, V12, P822, DOI 10.1038/nsmb971; Yano JK, 2003, J BIOL CHEM, V278, P608, DOI 10.1074/jbc.M206568200; [No title captured]	65	83	84	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29941	29950		10.1074/jbc.M111.245225	http://dx.doi.org/10.1074/jbc.M111.245225			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21719702	Green Published, hybrid			2022-12-25	WOS:000294046600053
J	Ognibene, M; Vanni, C; Segalerba, D; Mancini, P; Merello, E; Torrisi, MR; Bosco, MC; Varesio, L; Eva, A				Ognibene, Marzia; Vanni, Cristina; Segalerba, Daniela; Mancini, Patrizia; Merello, Elisa; Torrisi, Maria Rosaria; Bosco, Maria Carla; Varesio, Luigi; Eva, Alessandra			The Tumor Suppressor Hamartin Enhances Dbl Protein Transforming Activity through Interaction with Ezrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; EZRIN/RADIXIN/MOESIN ERM PROTEINS; T-CELL-ACTIVATION; RHO-KINASE; SIGNALING PATHWAY; EPITHELIAL-CELLS; IN-VIVO; PHOSPHORYLATION; ADHESION; BINDING	The Rho guanine nucleotide exchange factor (GEF) Dbl binds to the N-terminal region of ezrin, a member of the ERM (ezrin, radixin, moesin) proteins known to function as linkers between the plasma membrane and the actin cytoskeleton. Here we have characterized the interaction between ezrin and Dbl. We show that binding of Dbl with ezrin involves positively charged amino acids within the region of the pleckstrin homology (PH) domain comprised between beta 1 and beta 2 sheets. In addition, we show that Dbl forms a complex with the tuberous sclerosis-1 (TSC-1) gene product hamartin and with ezrin. We demonstrate that hamartin and ezrin are both required for activation of Dbl. In fact, the knock-down of ezrin and hamartin, as well as the expression of a mutant hamartin, unable to bind ezrin, inhibit Dbl transforming and exchange activity. These results suggest that Dbl is regulated by hamartin through association with ezrin.	[Ognibene, Marzia; Vanni, Cristina; Segalerba, Daniela; Bosco, Maria Carla; Varesio, Luigi; Eva, Alessandra] Ist Giannina Gaslini, Mol Biol Lab, I-16147 Genoa, Italy; [Mancini, Patrizia; Torrisi, Maria Rosaria] Univ Roma La Sapienza, Dipartimento Med Chim & Mol, I-00161 Rome, Italy; [Merello, Elisa] Ist Giannina Gaslini, Lab Neurochirurg, I-16147 Genoa, Italy; [Torrisi, Maria Rosaria] Azienda Osped St Andrea, I-00189 Rome, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; Sapienza University Rome; University of Genoa; IRCCS Istituto Giannina Gaslini; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Eva, A (corresponding author), Ist Giannina Gaslini, Mol Biol Lab, Largo Gaslini 5, I-16147 Genoa, Italy.	alessandraeva@ospedale-gaslini.ge.it	Segalerba, Daniela/AAB-2023-2020; Eva, Alessandra/J-8268-2016; Ognibene, Marzia/AAA-7275-2020; varesio, luigi/J-8261-2016; Bosco, Maria Carla/J-7928-2016	Segalerba, Daniela/0000-0002-3232-5497; Eva, Alessandra/0000-0003-2949-078X; Ognibene, Marzia/0000-0003-3698-9319; varesio, luigi/0000-0001-5659-2218; Bosco, Maria Carla/0000-0003-1857-7193; mancini, patrizia/0000-0003-0556-2056	Italian Association for Cancer Researc; Compagnia di S. Paolo; Ministero della Salute; MIUR	Italian Association for Cancer Researc(Fondazione AIRC per la ricerca sul cancro); Compagnia di S. Paolo(Compagnia di San Paolo); Ministero della Salute(Ministry of Health, Italy); MIUR(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the Italian Association for Cancer Research, from the Compagnia di S. Paolo, from the Ministero della Salute, and from MIUR.	Abe R, 1999, J BIOL CHEM, V274, P30410, DOI 10.1074/jbc.274.43.30410; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Batchelor CL, 2007, CELL CYCLE, V6, P353, DOI 10.4161/cc.6.3.3819; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; D'Angelo R, 2007, MOL BIOL CELL, V18, P4780, DOI 10.1091/mbc.E06-12-1144; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hayashi K, 1999, J CELL SCI, V112, P1149; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Ilani T, 2007, J CELL BIOL, V179, P733, DOI 10.1083/jcb.200707199; Kourlas PJ, 2000, P NATL ACAD SCI USA, V97, P2145, DOI 10.1073/pnas.040569197; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Lasserre R, 2010, EMBO J, V29, P2301, DOI 10.1038/emboj.2010.127; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Mao JH, 1998, J BIOL CHEM, V273, P27118, DOI 10.1074/jbc.273.42.27118; Matsui T, 1999, CURR BIOL, V9, P1259, DOI 10.1016/S0960-9822(99)80508-9; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; McMullen ME, 2005, J BIOL CHEM, V280, P20995, DOI 10.1074/jbc.M407060200; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Naba A, 2008, EMBO J, V27, P38, DOI 10.1038/sj.emboj.7601943; Nakamura F, 1999, MOL BIOL CELL, V10, P2669, DOI 10.1091/mbc.10.8.2669; Nakamura F, 1996, BIOCHEM BIOPH RES CO, V226, P650, DOI 10.1006/bbrc.1996.1410; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Perez OD, 2002, IMMUNITY, V16, P51, DOI 10.1016/S1074-7613(02)00266-2; Poullet P, 2001, J BIOL CHEM, V276, P37686, DOI 10.1074/jbc.M106175200; Pujuguet P, 2003, MOL BIOL CELL, V14, P2181, DOI 10.1091/mbc.E02-07-0410; Quang CT, 2000, EMBO J, V19, P4565, DOI 10.1093/emboj/19.17.4565; Ruppelt A, 2007, J IMMUNOL, V179, P5159, DOI 10.4049/jimmunol.179.8.5159; Russo C, 2001, J BIOL CHEM, V276, P19524, DOI 10.1074/jbc.M009742200; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Stanasila L, 2006, J BIOL CHEM, V281, P4354, DOI 10.1074/jbc.M511989200; Takahashi K, 1998, ONCOGENE, V16, P3279, DOI 10.1038/sj.onc.1201874; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; Urzainqui A, 2002, IMMUNITY, V17, P401, DOI 10.1016/S1074-7613(02)00420-X; Vanni C, 2002, J BIOL CHEM, V277, P19745, DOI 10.1074/jbc.M111025200; Vanni C, 2004, ONCOGENE, V23, P4098, DOI 10.1038/sj.onc.1207509; Vanni C, 2007, CELL CYCLE, V6, P2058, DOI 10.4161/cc.6.16.4574; Vanni C, 2006, CELL CYCLE, V5, P2657, DOI 10.4161/cc.5.22.3445; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Weernink PAO, 2000, J BIOL CHEM, V275, P10168, DOI 10.1074/jbc.275.14.10168	48	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29973	29983		10.1074/jbc.M111.270785	http://dx.doi.org/10.1074/jbc.M111.270785			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21712385	hybrid, Green Published			2022-12-25	WOS:000294046600056
J	Cerda, O; Trimmer, JS				Cerda, Oscar; Trimmer, James S.			Activity-dependent Phosphorylation of Neuronal Kv2.1 Potassium Channels by CDK5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNEL; RAT-BRAIN; PROTEIN PHOSPHATASE-1; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; NMDA RECEPTOR; EXCITABILITY; MODULATION; STATE; P35	Dynamic modulation of ion channel expression, localization, and/or function drives plasticity in intrinsic neuronal excitability. Voltage-gated Kv2.1 potassium channels are constitutively maintained in a highly phosphorylated state in neurons. Increased neuronal activity triggers rapid calcineurin-dependent dephosphorylation, loss of channel clustering, and hyperpolarizing shifts in voltage-dependent activation that homeostatically suppress neuronal excitability. These changes are reversible, such that rephosphorylation occurs after removal of excitatory stimuli. Here, we show that cyclin-dependent kinase 5 (CDK5), a Pro-directed Ser/Thr protein kinase, directly phosphorylates Kv2.1, and determines the constitutive level of Kv2.1 phosphorylation, the rapid increase in Kv2.1 phosphorylation upon acute blockade of neuronal activity, and the recovery of Kv2.1 phosphorylation after stimulus-induced dephosphorylation. We also demonstrate that although the phosphorylation state of Kv2.1 is also shaped by the activity of the PP1 protein phosphatase, the regulation of Kv2.1 phosphorylation by CDK5 is not mediated through the previously described regulation of PP1 activity by CDK5. Together, these studies support a novel role for CDK5 in regulating Kv2.1 channels through direct phosphorylation.	[Cerda, Oscar; Trimmer, James S.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Trimmer, James S.] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Trimmer, JS (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, 196 Briggs Hall,1 Shields Ave, Davis, CA 95616 USA.	jtrimmer@ucdavis.edu	Cerda, Oscar/N-3895-2018	Cerda, Oscar/0000-0003-2873-5722	National Institutes of Health [NS42225]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS42225 (to J. S. T.).	Baranauskas G, 1999, J NEUROSCI, V19, P6394; Berendt FJ, 2010, J PROTEOME RES, V9, P1976, DOI 10.1021/pr901171q; Buraei Z, 2007, NEUROPHARMACOLOGY, V52, P883, DOI 10.1016/j.neuropharm.2006.10.006; Cai XH, 1997, NEUROSCI RES, V28, P355, DOI 10.1016/S0168-0102(97)00063-1; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Dodson PD, 2004, TRENDS NEUROSCI, V27, P210, DOI 10.1016/j.tins.2004.02.012; Guan D, 2007, J PHYSIOL-LONDON, V581, P941, DOI 10.1113/jphysiol.2007.128454; Hammond RS, 2008, J NEUROSCI, V28, P7513, DOI 10.1523/JNEUROSCI.1951-08.2008; Hisanaga S, 2003, NEUROSIGNALS, V12, P221, DOI 10.1159/000074624; Hosokawa T, 2006, J NEUROSCI RES, V84, P747, DOI 10.1002/jnr.20975; Ito T, 2010, NEUROBIOL DIS, V38, P85, DOI 10.1016/j.nbd.2010.01.002; Jessberger S, 2009, TRENDS NEUROSCI, V32, P575, DOI 10.1016/j.tins.2009.07.002; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Johnston J, 2010, J PHYSIOL-LONDON, V588, P3187, DOI 10.1113/jphysiol.2010.191973; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Kress GJ, 2009, NEUROSCIENCE, V158, P211, DOI 10.1016/j.neuroscience.2008.03.021; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li T, 2007, J BIOL CHEM, V282, P6619, DOI 10.1074/jbc.M606347200; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Misonou H, 2005, J NEUROSCI, V25, P11184, DOI 10.1523/JNEUROSCI.3370-05.2005; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Misonou H, 2008, J NEUROSCI, V28, P8529, DOI 10.1523/JNEUROSCI.1417-08.2008; Misonou H, 2006, J NEUROSCI, V26, P13505, DOI 10.1523/JNEUROSCI.3970-06.2006; Mulholland PJ, 2008, J NEUROSCI, V28, P8801, DOI 10.1523/JNEUROSCI.2405-08.2008; Mulholland PJ, 2009, ALCOHOL, V43, P45, DOI 10.1016/j.alcohol.2008.10.001; Munton RP, 2004, FEBS LETT, V567, P121, DOI 10.1016/j.febslet.2004.03.121; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Murakoshi H, 1997, MOL PHARMACOL, V52, P821, DOI 10.1124/mol.52.5.821; Nataraj K, 2010, NEURON, V68, P750, DOI 10.1016/j.neuron.2010.09.033; Nishi A, 2002, J NEUROCHEM, V81, P832, DOI 10.1046/j.1471-4159.2002.00876.x; Park Kang-Sik, 2007, Channels (Austin), V1, P59; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Schuman EM, 2003, PHILOS T ROY SOC B, V358, P749, DOI 10.1098/rstb.2002.1256; Shah MM, 2010, TRENDS NEUROSCI, V33, P307, DOI 10.1016/j.tins.2010.03.002; Song P, 2005, NAT NEUROSCI, V8, P1335, DOI 10.1038/nn1533; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; Vacher H, 2011, J CELL BIOL, V192, P813, DOI 10.1083/jcb.201007113; Wei FY, 2005, J NEUROCHEM, V93, P502, DOI 10.1111/j.1471-4159.2005.03058.x; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214	42	45	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28738	28748		10.1074/jbc.M111.251942	http://dx.doi.org/10.1074/jbc.M111.251942			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21712386	Green Published, hybrid			2022-12-25	WOS:000293837000012
J	Gopalakrishna, KN; Doddapuneni, K; Boyd, KK; Masuho, I; Martemyanov, KA; Artemyev, NO				Gopalakrishna, Kota N.; Doddapuneni, Krishnarao; Boyd, Kimberly K.; Masuho, Ikuo; Martemyanov, Kirill A.; Artemyev, Nikolai O.			Interaction of Transducin with Uncoordinated 119 Protein (UNC119) IMPLICATIONS FOR THE MODEL OF TRANSDUCIN TRAFFICKING IN ROD PHOTORECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-DEPENDENT REDISTRIBUTION; HETEROTRIMERIC G-PROTEIN; PRENYL-BINDING PROTEIN; CGMP PHOSPHODIESTERASE; ALPHA-SUBUNIT; GAMMA-SUBUNIT; DRIVEN TRANSLOCATION; RETINAL DEGENERATION; LIPID MODIFICATIONS; GTP-BINDING	The key visual G protein, transducin undergoes bi-directional translocations between the outer segment (OS) and inner compartments of rod photoreceptors in a light-dependent manner thereby contributing to adaptation and neuroprotection of rods. A mammalian uncoordinated 119 protein (UNC119), also known as Retina Gene 4 protein (RG4), has been recently implicated in transducin transport to the OS in the dark through its interaction with the N-acylated GTP-bound transducin-alpha subunit (G alpha(t1)). Here, we demonstrate that the interaction of human UNC119 (HRG4) with transducin is dependent on the N-acylation, but does not require the GTP-bound form of G alpha(t1). The lipid specificity of UNC119 is unique: UNC119 bound the myristoylated N terminus of G alpha(t1) with much higher affinity than a prenylated substrate, whereas the homologous prenyl-binding protein PrBP/delta did not interact with the myristoylated peptide. UNC119 was capable of interacting with G alpha(t1) GDP as well as with heterotrimeric transducin (G(t)). This interaction of UNC119 with G(t) led to displacement of G beta(1)gamma(1) from the heterotrimer. Furthermore, UNC119 facilitated solubilization of G(t) from dark-adapted rod OS membranes. Consistent with these observations, UNC119 inhibited rhodopsin-dependent activation of G(t), but had no effect on the GTP-hydrolysis by G alpha(t1). A model for the role of UNC119 in the IS -> OS translocation of G(t) is proposed based on the UNC119 ability to dissociate G(t) subunits from each other and the membrane. We also found that UNC119 inhibited activation of G(o) by D2 dopamine receptor in cultured cells. Thus, UNC119 may play conserved inhibitory role in regulation of GPCR-G protein signaling in non-visual tissues.	[Gopalakrishna, Kota N.; Doddapuneni, Krishnarao; Boyd, Kimberly K.; Artemyev, Nikolai O.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Artemyev, Nikolai O.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Masuho, Ikuo; Martemyanov, Kirill A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA	University of Iowa; University of Iowa; Scripps Research Institute	Artemyev, NO (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA.	nikolai-artemyev@uiowa.edu	Masuho, Ikuo/J-6115-2014	Artemyev, Nikolai/0000-0002-5266-6854	National Institutes of Health [EY-12682, DAO21743, DAO26405, EYO18135]; NATIONAL EYE INSTITUTE [R01EY018139, R01EY012682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY-12682 (to N. O. A.), DAO21743, DAO26405, and EYO18135 (to K. A. M.).	Artemyev NO, 2008, MOL NEUROBIOL, V37, P44, DOI 10.1007/s12035-008-8015-2; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; BIGAY J, 1994, BIOCHEMISTRY-US, V33, P14081, DOI 10.1021/bi00251a017; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; Fain GL, 2006, BIOESSAYS, V28, P344, DOI 10.1002/bies.20382; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; FUKADA Y, 1990, NATURE, V346, P658, DOI 10.1038/346658a0; GILLESPIE PG, 1989, J BIOL CHEM, V264, P12187; Goc A, 2008, BIOCHEMISTRY-US, V47, P12409, DOI 10.1021/bi8015444; Grayson C, 2002, HUM MOL GENET, V11, P3065, DOI 10.1093/hmg/11.24.3065; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Higashide T, 1996, J BIOL CHEM, V271, P1797, DOI 10.1074/jbc.271.3.1797; Higashide T, 1998, INVEST OPHTH VIS SCI, V39, P690; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Ishiba Y, 2007, EXP EYE RES, V84, P473, DOI 10.1016/j.exer.2006.10.016; Karan S, 2008, VISION RES, V48, P442, DOI 10.1016/j.visres.2007.08.020; Karim Z, 2010, CELL SIGNAL, V22, P128, DOI 10.1016/j.cellsig.2009.09.022; Kerov V, 2005, J BIOL CHEM, V280, P41069, DOI 10.1074/jbc.M508849200; Kerov V, 2011, MOL CELL NEUROSCI, V46, P340, DOI 10.1016/j.mcn.2010.10.006; Kobayashi A, 2000, INVEST OPHTH VIS SCI, V41, P3268; Kobayashi A, 2003, FEBS LETT, V534, P26, DOI 10.1016/S0014-5793(02)03766-3; LAI RK, 1990, P NATL ACAD SCI USA, V87, P7673, DOI 10.1073/pnas.87.19.7673; Lambert NA, 2010, P NATL ACAD SCI USA, V107, P7066, DOI 10.1073/pnas.0912934107; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lobanova ES, 2008, J NEUROSCI, V28, P3510, DOI 10.1523/JNEUROSCI.0338-08.2008; Lobanova ES, 2007, J NEUROSCI, V27, P1151, DOI 10.1523/JNEUROSCI.5010-06.2007; Lobanova ES, 2010, J NEUROSCI, V30, P6815, DOI 10.1523/JNEUROSCI.0613-10.2010; MADURO M, 1995, GENETICS, V141, P977; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; MUMBY SM, 1994, METHOD ENZYMOL, V237, P254; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; NEUBERT TA, 1992, J BIOL CHEM, V267, P18274; Norton AW, 2005, J BIOL CHEM, V280, P1248, DOI 10.1074/jbc.M410475200; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; Posokhova E, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000570; RAMDAS L, 1991, BIOCHEMISTRY-US, V30, P11637, DOI 10.1021/bi00114a005; Rosenzweig DH, 2007, J NEUROSCI, V27, P5484, DOI 10.1523/JNEUROSCI.1421-07.2007; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Slepak VZ, 2008, IUBMB LIFE, V60, P2, DOI 10.1002/iub.7; Sokolov M, 2004, J BIOL CHEM, V279, P19149, DOI 10.1074/jbc.M311058200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; SOKOLOV M, 2011, ARVO ANN M; Song H, 2007, J BIOL CHEM, V282, P23613, DOI 10.1074/jbc.M701974200; Swanson DA, 1998, INVEST OPHTH VIS SCI, V39, P2085; Veltel S, 2008, FEBS LETT, V582, P2501, DOI 10.1016/j.febslet.2008.05.053; Wang Q, 2008, J BIOL CHEM, V283, P30015, DOI 10.1074/jbc.M803953200; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013; YAMANAKA G, 1985, BIOCHEMISTRY-US, V24, P8094, DOI 10.1021/bi00348a039; YAMAZAKI A, 1988, METHOD ENZYMOL, V159, P702; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104; Zhang HB, 2004, J BIOL CHEM, V279, P407, DOI 10.1074/jbc.M306559200; Zhang HB, 2003, MOL VIS, V9, P231; Zhang HB, 2011, NAT NEUROSCI, V14, P874, DOI 10.1038/nn.2835	55	33	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28954	28962		10.1074/jbc.M111.268821	http://dx.doi.org/10.1074/jbc.M111.268821			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21712387	Green Published, hybrid			2022-12-25	WOS:000293837000032
J	Lee, B; Park, I; Jin, S; Choi, H; Kwon, JT; Kim, J; Jeong, J; Cho, BN; Eddy, EM; Cho, C				Lee, Boyeon; Park, Inju; Jin, Sora; Choi, Heejin; Kwon, Jun Tae; Kim, Jihye; Jeong, Juri; Cho, Byung-Nam; Eddy, Edward M.; Cho, Chunghee			Impaired Spermatogenesis and Fertility in Mice Carrying a Mutation in the Spink2 Gene Expressed Predominantly in Testes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE INHIBITOR; PANCREATIC ACINAR-CELLS; TRYPSIN-INHIBITOR; MATRIX METALLOPROTEINASES; NETHERTON-SYNDROME; MOLECULAR-CLONING; AMINO-ACID; HUSI-II; KAZAL; APOPTOSIS	Spermatogenesis is a complex process involving an intrinsic genetic program composed of germ cell-specific and -predominant genes. In this study, we investigated the mouse Spink2 (serine protease inhibitor Kazal-type 2) gene, which belongs to the SPINK family of proteins characterized by the presence of a Kazal-type serine protease inhibitor-pancreatic secretory trypsin inhibitor domain. We showed that recombinant mouse SPINK2 has trypsin-inhibitory activity. Distribution analyses revealed that Spink2 is transcribed strongly in the testis and weakly in the epididymis, but is not detected in other mouse tissues. Expression of Spink2 is specific to germ cells in the testis and is first evident at the pachytene spermatocyte stage. Immunoblot analyses demonstrated that SPINK2 protein is present in male germ cells at all developmental stages, including in testicular spermatogenic cells, testicular sperm, and mature sperm. To elucidate the functional role of SPINK2 in vivo, we generated mutant mice with diminished levels of SPINK2 using a gene trap mutagenesis approach. Mutant male mice exhibit significantly impaired fertility; further phenotypic analyses revealed that testicular integrity is disrupted, resulting in a reduction in sperm number. Moreover, we found that testes from mutant mice exhibit abnormal spermatogenesis and germ cell apoptosis accompanied by elevated serine protease activity. Our studies thus provide the first demonstration that SPINK2 is required for maintaining normal spermatogenesis and potentially regulates serine protease-mediated apoptosis in male germ cells.	[Lee, Boyeon; Park, Inju; Jin, Sora; Choi, Heejin; Kwon, Jun Tae; Kim, Jihye; Jeong, Juri; Cho, Chunghee] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea; [Cho, Byung-Nam] Catholic Univ Korea, Dept Sci, Puchon 420743, South Korea; [Eddy, Edward M.] NIEHS, Gamete Biol Sect, Lab Reprod & Dev Toxicol, NIH, Res Triangle Pk, NC 27709 USA	Gwangju Institute of Science & Technology (GIST); Catholic University of Korea; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cho, C (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea.	choch@gist.ac.kr		Park, Inju/0000-0002-8850-5032	Korea Science and Engineering Foundation [2010-0028776]; Korea Research Foundation [KRF-2008-313-C00736]; Gwangju Institute of Science and Technology Systems Biology Infrastructure Establishment; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070076] Funding Source: NIH RePORTER	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korea Research Foundation(National Research Foundation of Korea); Gwangju Institute of Science and Technology Systems Biology Infrastructure Establishment; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Korea Science and Engineering Foundation Grant 2010-0028776, a Korea Research Foundation Grant KRF-2008-313-C00736, and a Gwangju Institute of Science and Technology Systems Biology Infrastructure Establishment Grant.	Araki M, 2009, CURR PHARM BIOTECHNO, V10, P221, DOI 10.2174/138920109787315006; Bird P I, 1998, Results Probl Cell Differ, V24, P63; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Eddy EM, 1995, REPROD FERT DEVELOP, V7, P695, DOI 10.1071/RD9950695; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Eddy EM, 1998, SEMIN CELL DEV BIOL, V9, P451, DOI 10.1006/scdb.1998.0201; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Egger L, 2003, CELL DEATH DIFFER, V10, P1188, DOI 10.1038/sj.cdd.4401288; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; FINK E, 1990, FEBS LETT, V270, P222, DOI 10.1016/0014-5793(90)81273-Q; Gong BD, 1999, CELL GROWTH DIFFER, V10, P491; Hooper NM, 2002, PROTEASES BIOL MED; Jalkanen J, 2006, BIOCHEM BIOPH RES CO, V349, P245, DOI 10.1016/j.bbrc.2006.08.023; KAZAL LA, 1948, J AM CHEM SOC, V70, P3034, DOI 10.1021/ja01189a060; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Krane SM, 2003, ARTHRITIS RES THER, V5, P2, DOI 10.1186/ar600; Krause R, 1998, DIFFERENTIATION, V63, P285, DOI 10.1046/j.1432-0436.1998.6350285.x; Lamontagne J, 2010, J VIROL, V84, P907, DOI 10.1128/JVI.01249-09; LEYTUS SP, 1983, BIOCHEM J, V215, P253, DOI 10.1042/bj2150253; Lin MH, 2008, REPRODUCTION, V136, P559, DOI 10.1530/REP-07-0375; Lu XY, 2008, APOPTOSIS, V13, P483, DOI 10.1007/s10495-008-0193-x; Luttun A, 2000, Curr Atheroscler Rep, V2, P407, DOI 10.1007/s11883-000-0079-z; Marchbank T, 1998, DIGESTION, V59, P167, DOI 10.1159/000007485; MORITZ A, 1991, FEBS LETT, V278, P127, DOI 10.1016/0014-5793(91)80099-O; Oh J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-314; Ohmuraya M, 2005, GASTROENTEROLOGY, V129, P696, DOI 10.1053/j.gastro.2005.05.057; Ohmuraya M, 2006, PANCREAS, V33, P104, DOI 10.1097/01.mpa.0000226889.86322.9b; PHELPS BM, 1990, J CELL BIOL, V111, P1839, DOI 10.1083/jcb.111.5.1839; Raghunath M, 2004, J INVEST DERMATOL, V123, P474, DOI 10.1111/j.0022-202X.2004.23220.x; Rawlings ND, 2010, BIOCHIMIE, V92, P1463, DOI 10.1016/j.biochi.2010.04.013; Rockett JC, 2004, MUTAT RES-FUND MOL M, V549, P225, DOI 10.1016/j.mrfmmm.2003.11.017; RUGGIERO V, 1987, CELL IMMUNOL, V107, P317, DOI 10.1016/0008-8749(87)90240-1; Shaha C, 2010, PHILOS T R SOC B, V365, P1501, DOI 10.1098/rstb.2009.0124; Thiemmara V, 2002, CELL DEATH DIFFER, V9, P1343, DOI 10.1038/sj.cdd.4401098; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Yang T, 2004, GENE DEV, V18, P2354, DOI 10.1101/gad.1232104	36	39	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29108	29117		10.1074/jbc.M111.244905	http://dx.doi.org/10.1074/jbc.M111.244905			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705336	Green Published, hybrid			2022-12-25	WOS:000293837000047
J	Lin, JF; Tritschler, D; Song, KK; Barber, CF; Cobb, JS; Porter, ME; Nicastro, D				Lin, Jianfeng; Tritschler, Douglas; Song, Kangkang; Barber, Cynthia F.; Cobb, Jennifer S.; Porter, Mary E.; Nicastro, Daniela			Building Blocks of the Nexin-Dynein Regulatory Complex in Chlamydomonas Flagella	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER ARM DYNEINS; INTERMEDIATE CHAIN; GENE-EXPRESSION; RADIAL SPOKES; I1 DYNEIN; BENDING PATTERNS; CILIARY MOTILITY; PROTEIN; PHOSPHORYLATION; SUBUNIT	The directional flow generated by motile cilia and flagella is critical for many processes, including human development and organ function. Normal beating requires the control and coordination of thousands of dynein motors, and the nexin-dynein regulatory complex (N-DRC) has been identified as an important regulatory node for orchestrating dynein activity. The nexin link appears to be critical for the transformation of dynein-driven, linear microtubule sliding to flagellar bending, yet the molecular composition and mechanism of the N-DRC remain largely unknown. Here, we used proteomics with special attention to protein phosphorylation to analyze the composition of the N-DRC and to determine which subunits may be important for signal transduction. Two-dimensional electrophoresis and MALDI-TOF mass spectrometry of WT and mutant flagellar axonemes from Chlamydomonas identified 12 N-DRC-associated proteins, including all seven previously observed N-DRC components. Sequence and PCR analyses identified the mutation responsible for the phenotype of the sup-pf-4 strain, and biochemical comparison with a radial spoke mutant revealed two components that may link the N-DRC and the radial spokes. Phosphoproteomics revealed eight proteins with phosphorylated isoforms for which the isoform patterns changed with the genotype as well as two components that may play pivotal roles in N-DRC function through their phosphorylation status. These data were assembled into a model of the N-DRC that explains aspects of its regulatory function.	[Lin, Jianfeng; Song, Kangkang; Barber, Cynthia F.; Nicastro, Daniela] Brandeis Univ, Dept Biol, Rosenstiel Ctr, Waltham, MA 02454 USA; [Tritschler, Douglas; Porter, Mary E.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Cobb, Jennifer S.] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA	Brandeis University; University of Minnesota System; University of Minnesota Twin Cities; Brandeis University	Nicastro, D (corresponding author), Brandeis Univ, Dept Biol, Rosenstiel Ctr, MS029,415 South St, Waltham, MA 02454 USA.	nicastro@brandeis.edu		Lin, Jianfeng/0000-0003-1215-0906; Lin, Jianfeng/0000-0001-5732-1209; Nicastro, Daniela/0000-0002-0122-7173	National Institutes of Health [GM083122, GM55667]; Pew Scholars award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055667, R01GM083122, R37GM055667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM083122 (to D. N.) and GM55667 (to M. E. P.). This work was also supported by a Pew Scholars award (to D. N.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Bekker JM, 2007, CELL MOTIL CYTOSKEL, V64, P461, DOI 10.1002/cm.20196; Boesger J, 2009, EUKARYOT CELL, V8, P922, DOI 10.1128/EC.00067-09; Bower R, 2009, MOL BIOL CELL, V20, P3055, DOI 10.1091/mbc.E09-04-0277; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; BROKAW CJ, 1985, CELL MOTIL CYTOSKEL, V5, P195, DOI 10.1002/cm.970050303; BROKAW CJ, 1987, CELL MOTIL CYTOSKEL, V8, P68, DOI 10.1002/cm.970080110; Chamberlain KL, 2008, GENETICS, V179, P7, DOI 10.1534/genetics.107.082149; Colantonio JR, 2009, NATURE, V457, P205, DOI 10.1038/nature07520; Dymek EE, 2007, J CELL BIOL, V179, P515, DOI 10.1083/jcb.200703107; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gaillard AR, 2001, J CELL BIOL, V153, P443, DOI 10.1083/jcb.153.2.443; GARDNER LC, 1994, J CELL BIOL, V127, P1311, DOI 10.1083/jcb.127.5.1311; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Habermacher G, 1997, J CELL BIOL, V136, P167, DOI 10.1083/jcb.136.1.167; Habermacher G, 1996, J CELL SCI, V109, P1899; Hendrickson TW, 2004, MOL BIOL CELL, V15, P5431, DOI 10.1091/mbc.E04-08-0694; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Hozumi A, 2008, CELL MOTIL CYTOSKEL, V65, P249, DOI 10.1002/cm.20258; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; Juneja R, 1998, J ANDROL, V19, P183; Kabututu ZP, 2010, J CELL SCI, V123, P3587, DOI 10.1242/jcs.073817; King SJ, 1997, J CELL BIOL, V136, P177, DOI 10.1083/jcb.136.1.177; Lin JF, 2007, INT J CANCER, V121, P2596, DOI 10.1002/ijc.23016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; MASTRONARDE DN, 1992, J CELL BIOL, V118, P1145, DOI 10.1083/jcb.118.5.1145; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Moseley JL, 2006, EUKARYOT CELL, V5, P26, DOI 10.1128/EC.5.1.26-44.2006; Myster SH, 1997, MOL BIOL CELL, V8, P607, DOI 10.1091/mbc.8.4.607; Nematollahi G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-321; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Pan JM, 2005, DEV CELL, V9, P431, DOI 10.1016/j.devcel.2005.07.010; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Perrone CA, 1998, MOL BIOL CELL, V9, P3351, DOI 10.1091/mbc.9.12.3351; PIPERNO G, 1994, J CELL BIOL, V125, P1109, DOI 10.1083/jcb.125.5.1109; PIPERNO G, 1992, J CELL BIOL, V118, P1455, DOI 10.1083/jcb.118.6.1455; PIPERNO G, 1981, J CELL BIOL, V88, P73, DOI 10.1083/jcb.88.1.73; Porter ME, 2000, J CELL BIOL, V151, pF37, DOI 10.1083/jcb.151.5.F37; Raggiaschi R, 2006, PROTEOMICS, V6, P748, DOI 10.1002/pmic.200500064; Ralston KS, 2006, PLOS PATHOG, V2, P873, DOI 10.1371/journal.ppat.0020101; Rupp G, 2003, J CELL BIOL, V162, P47, DOI 10.1083/jcb.200303019; Rupp G, 1996, J CELL BIOL, V135, P1853, DOI 10.1083/jcb.135.6.1853; SANAGUSTIN JT, 1994, CELL MOTIL CYTOSKEL, V27, P206, DOI 10.1002/cm.970270303; SATIR P, 1968, J CELL BIOL, V39, P77, DOI 10.1083/jcb.39.1.77; SCHLOSS JA, 1990, MOL GEN GENET, V221, P443, DOI 10.1007/BF00259410; Smith EF, 2004, CELL MOTIL CYTOSKEL, V57, P8, DOI 10.1002/cm.10155; Smith EF, 2002, CELL MOTIL CYTOSKEL, V52, P33, DOI 10.1002/cm.10031; SUMMERS KE, 1971, P NATL ACAD SCI USA, V68, P3092, DOI 10.1073/pnas.68.12.3092; Tuxhorn J, 1998, CELL MOTIL CYTOSKEL, V40, P133, DOI 10.1016/j.semcdb.2008.07.005; WARGO MJ, 2005, TEST, V118, P4655; WEEKS DP, 1979, DEV BIOL, V69, P400, DOI 10.1016/0012-1606(79)90300-2; Wirschell M, 2007, CELL MOTIL CYTOSKEL, V64, P569, DOI 10.1002/cm.20211; Wirschell M, 2009, MOL BIOL CELL, V20, P3044, DOI 10.1091/mbc.E09-04-0276; WITMAN GB, 1972, J CELL BIOL, V54, P507, DOI 10.1083/jcb.54.3.507; Yamagata A, 2002, PROTEOMICS, V2, P1267, DOI 10.1002/1615-9861(200209)2:9<1267::AID-PROT1267>3.0.CO;2-R; Yanagisawa H, 2004, MOL BIOL CELL, V15, P2105, DOI 10.1091/mbc.E03-11-0854; Yang PF, 2000, J BIOL CHEM, V275, P18905, DOI 10.1074/jbc.M002134200; Yang PF, 1998, MOL BIOL CELL, V9, P3335, DOI 10.1091/mbc.9.12.3335; Yang Y, 2011, MOL BIOL CELL, V22, P976, DOI 10.1091/mbc.E10-04-0331; Zheng Y, 2006, INT J MOL MED, V18, P1119	64	66	67	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29175	29191		10.1074/jbc.M111.241760	http://dx.doi.org/10.1074/jbc.M111.241760			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21700706	Green Published, hybrid			2022-12-25	WOS:000293837000054
J	Luo, KT; Yuan, J; Lou, ZK				Luo, Kuntian; Yuan, Jian; Lou, Zhenkun			Oligomerization of MDC1 Protein Is Important for Proper DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; ATM-DEPENDENT PHOSPHORYLATION; S-PHASE CHECKPOINT; CHROMATIN; MEDIATOR; DOMAIN; SITES; BRCA1; NBS1; AUTOPHOSPHORYLATION	Mediator of DNA damage checkpoint 1 (MDC1) plays an important role in the DNA damage response (DDR). MDC1 functions as a mediator protein and binds multiple proteins involved in different aspects of the DDR. However, little is know about the organization of MDC1 complexes. Here we show that ataxia telangiectasia, mutated (ATM) phosphorylates MDC1 at Thr-98 following DNA damage, which promotes its oligomerization. Oligomerization of MDC1 is important for the accumulation of MDC1 complex at the sites of DNA damage. Mutation of Thr-98 (T98A) would abolish its oligomerization and result in a defect in DNA damage checkpoint activation and increased sensitivity to irradiation. Taken together, these results suggest that the oligomerization of MDC1 plays an important role in DDR and help understand the formation of proteins complexes at the sites of DNA damage.	[Luo, Kuntian; Yuan, Jian] Tongji Univ, Sch Med, Key Lab Arrhythmias, Minist Educ, Shanghai 200120, Peoples R China; [Luo, Kuntian; Yuan, Jian] Tongji Univ, Sch Med, Inst Med Genet, East Hosp, Shanghai 200120, Peoples R China; [Luo, Kuntian; Yuan, Jian; Lou, Zhenkun] Mayo Clin, Div Oncol Res, Rochester, MN 55902 USA	Tongji University; Tongji University; Mayo Clinic	Luo, KT (corresponding author), Tongji Univ, Sch Med, Key Lab Arrhythmias, Minist Educ, Shanghai 200120, Peoples R China.	luo.kuntian@gmail.com; Lou.Zhenkun@mayo.edu		Yuan, Jian/0000-0002-2801-8849	National Institutes of Health [CA130996]; National Natural Science Foundation of China; "973" Program Fund of China [2007CB512100, 2011CB504006]; Ministry of Education of China; Kendall-Mayo; NATIONAL CANCER INSTITUTE [R01CA130996, R01CA148940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973" Program Fund of China(National Basic Research Program of China); Ministry of Education of China(Ministry of Education, China); Kendall-Mayo; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA130996. This work was also supported by the Young Scientists Fund of the National Natural Science Foundation of China, the "973" Program Fund of China (Grants 2007CB512100 and 2011CB504006), and the Program Fund for Innovative Research Teams of the Ministry of Education of China.; Recipients of a Kendall-Mayo Fellowship in biochemistry.	Ball HL, 2005, J BIOL CHEM, V280, P31390, DOI 10.1074/jbc.M504961200; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Coster G, 2010, NUCLEUS-PHILA, V1, P166, DOI 10.4161/nucl.1.2.11176; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Gatei M, 2000, CANCER RES, V60, P3299; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Inoue K, 2008, BIOCHEM BIOPH RES CO, V371, P829, DOI 10.1016/j.bbrc.2008.04.155; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lou ZK, 2004, J BIOL CHEM, V279, P46359, DOI 10.1074/jbc.C400375200; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Luo KT, 2009, NAT CELL BIOL, V11, P204, DOI 10.1038/ncb1828; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Nakanishi M, 2007, J BIOL CHEM, V282, P22993, DOI 10.1074/jbc.M611412200; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; So SR, 2009, J CELL BIOL, V187, P977, DOI 10.1083/jcb.200906064; Soulier J, 1999, CURR BIOL, V9, P551, DOI 10.1016/S0960-9822(99)80242-5; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stuck M, 2004, DNA REPAIR, V3, P953, DOI 10.1016/j.dnarep.2004.03.007; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Townsend K, 2009, J BIOL CHEM, V284, P33939, DOI 10.1074/jbc.M109.009191; Usui T, 2009, MOL CELL, V33, P147, DOI 10.1016/j.molcel.2008.12.022; Wu LM, 2008, P NATL ACAD SCI USA, V105, P11200, DOI 10.1073/pnas.0802885105; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Zhang JR, 2005, NAT STRUCT MOL BIOL, V12, P902, DOI 10.1038/nsmb991; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083	36	17	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28192	28199		10.1074/jbc.M111.258087	http://dx.doi.org/10.1074/jbc.M111.258087			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21705321	Green Published, hybrid			2022-12-25	WOS:000293557800037
J	Noinaj, N; Bhasin, SK; Song, ES; Scoggin, KE; Juliano, MA; Juliano, L; Hersh, LB; Rodgers, DW				Noinaj, Nicholas; Bhasin, Sonia K.; Song, Eun Suk; Scoggin, Kirsten E.; Juliano, Maria A.; Juliano, Luiz; Hersh, Louis B.; Rodgers, David W.			Identification of the Allosteric Regulatory Site of Insulysin	PLOS ONE			English	Article							INSULIN-DEGRADING ENZYME; AMYLOID-BETA-PEPTIDE; ALZHEIMERS-DISEASE; PROTEIN; IDE; ATP; SOFTWARE; BINDING; GENE; RECOGNITION	Background: Insulin degrading enzyme (IDE) is responsible for the metabolism of insulin and plays a role in clearance of the Ab peptide associated with Alzheimer's disease. Unlike most proteolytic enzymes, IDE, which consists of four structurally related domains and exists primarily as a dimer, exhibits allosteric kinetics, being activated by both small substrate peptides and polyphosphates such as ATP. Principal Findings: The crystal structure of a catalytically compromised mutant of IDE has electron density for peptide ligands bound at the active site in domain 1 and a distal site in domain 2. Mutating residues in the distal site eliminates allosteric kinetics and activation by a small peptide, as well as greatly reducing activation by ATP, demonstrating that this site plays a key role in allostery. Comparison of the peptide bound IDE structure (using a low activity E111F IDE mutant) with unliganded wild type IDE shows a change in the interface between two halves of the clamshell-like molecule, which may enhance enzyme activity by altering the equilibrium between closed and open conformations. In addition, changes in the dimer interface suggest a basis for communication between subunits. Conclusions/Significance: Our findings indicate that a region remote from the active site mediates allosteric activation of insulysin by peptides. Activation may involve a small conformational change that weakens the interface between two halves of the enzyme.	[Noinaj, Nicholas; Bhasin, Sonia K.; Song, Eun Suk; Scoggin, Kirsten E.; Hersh, Louis B.; Rodgers, David W.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Noinaj, Nicholas; Bhasin, Sonia K.; Song, Eun Suk; Scoggin, Kirsten E.; Hersh, Louis B.; Rodgers, David W.] Univ Kentucky, Struct Biol Ctr, Lexington, KY USA; [Juliano, Maria A.; Juliano, Luiz] Univ Fed Sao Paulo, Dept Biophys, Escola Paulista Med, Sao Paulo, Brazil	University of Kentucky; University of Kentucky; Universidade Federal de Sao Paulo (UNIFESP)	Noinaj, N (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	david.rodgers@uky.edu	Juliano, Luiz/D-7204-2012; Complexos, INCT Fluidos/H-9172-2013	Juliano, Luiz/0000-0002-5589-2822; Scoggin, Kirsten/0000-0003-1348-641X	United States Public Health Services [NS38041, DA02243, DA016176, P20 RR20171, T32 DA016176]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS038041, R01NS038041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA016176, R01DA002243] Funding Source: NIH RePORTER	United States Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by United States Public Health Services grants NS38041, DA02243, DA016176, and P20 RR20171. N.N. was supported by a United States Public Health Services training grant (T32 DA016176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Authier F, 1996, CLIN INVEST MED, V19, P149; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrett AJ, 2003, HDB PROTEOLYTIC ENZY; BAUMEISTER H, 1993, FEBS LETT, V317, P250, DOI 10.1016/0014-5793(93)81286-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Camberos MC, 2001, EXP BIOL MED, V226, P334, DOI 10.1177/153537020122600411; Chalkley RJ, 2005, MOL CELL PROTEOMICS, V4, P1194, DOI 10.1074/mcp.D500002-MCP200; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; GOMISRUTH FX, 1994, J BIOL CHEM, V269, P17111; Guo Q, 2010, J MOL BIOL, V395, P430, DOI 10.1016/j.jmb.2009.10.072; Gutfreund H., 1995, KINETICS LIFE SCI RE; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; Hersh LB, 2003, CURR PHARM DESIGN, V9, P449, DOI 10.2174/1381612033391676; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; Karamohamed S, 2003, DIABETES, V52, P1562, DOI 10.2337/diabetes.52.6.1562; Kim M, 2007, J BIOL CHEM, V282, P7825, DOI 10.1074/jbc.M609168200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Manolopoulou M, 2009, J BIOL CHEM, V284, P14177, DOI 10.1074/jbc.M900068200; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogino T, 2004, J VIROL, V78, P11766, DOI 10.1128/JVI.78.21.11766-11777.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Safavi A, 1996, BIOCHEMISTRY-US, V35, P14318, DOI 10.1021/bi960582q; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Song ES, 2005, J MOL NEUROSCI, V25, P201, DOI 10.1385/JMN:25:3:201; Song ES, 2004, J BIOL CHEM, V279, P54216, DOI 10.1074/jbc.M411177200; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Song ES, 2001, J BIOL CHEM, V276, P1152, DOI 10.1074/jbc.M008702200; Song ES, 2005, J BIOL CHEM, V280, P17701, DOI 10.1074/jbc.M501896200; Song ES, 2006, BIOCHEMISTRY-US, V45, P15085, DOI 10.1021/bi061298u; Song ES, 2011, J BIOL CHEM, V286, P13852, DOI 10.1074/jbc.M110.191668; Song ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009719; Vepsalainen S, 2009, J NEUROL NEUROSUR PS, V80, P1268, DOI 10.1136/jnnp.2008.160002; Vepsalainen S, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.048470; Yao HB, 2006, ARCH BIOCHEM BIOPHYS, V451, P175, DOI 10.1016/j.abb.2006.04.011; Zuo XM, 2009, BRAIN RES, V1249, P1, DOI 10.1016/j.brainres.2008.10.034	51	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e20864	10.1371/journal.pone.0020864	http://dx.doi.org/10.1371/journal.pone.0020864			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731629	gold, Green Published, Green Submitted			2022-12-25	WOS:000292036900008
J	Xie, ZG; Bi, CL; Cheong, LL; Liu, SC; Huang, GF; Zhou, JB; Yu, Q; Chen, CS; Chng, WJ				Xie, Zhigang; Bi, Chonglei; Cheong, Lip Lee; Liu, Shaw Cheng; Huang, Gaofeng; Zhou, Jianbiao; Yu, Qiang; Chen, Chien-Shing; Chng, Wee Joo			Determinants of Sensitivity to DZNep Induced Apoptosis in Multiple Myeloma Cells	PLOS ONE			English	Article							BCL-2 FAMILY PROTEINS; PROSTATE-CANCER; HISTONE METHYLTRANSFERASE; CD44 EXPRESSION; CARCINOMA-CELLS; INHIBITOR; 5-LIPOXYGENASE; GENE; ABT-737; LEUKEMIA	The 3-Deazaneplanocin A (DZNep), one of S-adenosylhomocysteine (AdoHcy) hydrolase inhibitors, has shown antitumor activities in a broad range of solid tumors and acute myeloid leukemia. Here, we examined its effects on multiple myeloma (MM) cells and found that, at 500 nM, it potently inhibited growth and induced apoptosis in 2 of 8 MM cell lines. RNA from un-treated and DZNep treated cells was profiled by Affymetrix HG-U133 Plus 2.0 microarray and genes with a significant change in gene expression were determined by significance analysis of microarray (SAM) testing. ALOX5 was the most down-regulated gene (5.8-fold) in sensitive cells and was expressed at low level in resistant cells. The results were corroborated by quantitative RT-PCR. Western-blot analysis indicated ALOX5 was highly expressed only in sensitive cell line H929 and greatly decreased upon DZNep treatment. Ectopic expression of ALOX5 reduced sensitivity to DZNep in H929 cells. Furthermore, down- regulation of ALOX5 by RNA interference could also induce apoptosis in H929. Gene expression analysis on MM patient dataset indicated ALOX5 expression was significantly higher in MM patients compared to normal plasma cells. We also found that Bcl-2 was overexpressed in DZNep insensitive cells, and cotreatment with DZNep and ABT-737, a Bcl-2 family inhibitor, synergistically inhibited growth and induced apoptosis of DZNep insensitive MM cells. Taken together, this study shows one of mechanisms of the DZNep efficacy on MM correlates with its ability to down- regulate the ALOX5 levels. In addition, DZNep insensitivity might be associated with overexpression of Bcl-2, and the combination of ABT-737 and DZNep could synergistically induced apoptosis. These results suggest that DZNep may be exploited therapeutically for a subset of MM.	[Xie, Zhigang; Bi, Chonglei; Liu, Shaw Cheng; Zhou, Jianbiao; Chng, Wee Joo] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Cheong, Lip Lee; Chen, Chien-Shing; Chng, Wee Joo] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore; [Huang, Gaofeng; Chng, Wee Joo] Natl Univ Hlth Syst, Dept Haematol & Oncol, Singapore, Singapore; [Yu, Qiang] Genome Inst Singapore, Singapore, Singapore; [Chen, Chien-Shing] Loma Linda Univ, Sch Med, Div Hematol & Oncol, Loma Linda, CA USA	National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Loma Linda University	Xie, ZG (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore.	mdccwj@nus.edu.sg	Xie, Zhigang/AAF-6102-2019; Bi, Chonglei/D-2158-2011	Xie, Zhigang/0000-0003-2974-1825; Bi, Chonglei/0000-0002-9597-3985; Yu, Qiang/0000-0003-2132-8278	National Medical Research Council of Singapore [NMRC/CG/NCIS/2010]	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This project is funded by the National Medical Research Council of Singapore (http://www.nmrc.gov.sg/) grant NMRC/CG/NCIS/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belfiore MC, 2007, CANCER LETT, V254, P236, DOI 10.1016/j.canlet.2007.03.010; Bergsagel PL, 2005, J CLIN ONCOL, V23, P6333, DOI 10.1200/JCO.2005.05.021; Bergsagel PL, 1996, P NATL ACAD SCI USA, V93, P13931, DOI 10.1073/pnas.93.24.13931; Bray M, 2000, ANTIVIR RES, V45, P135, DOI 10.1016/S0166-3542(00)00066-8; Chang H, 2004, BRIT J HAEMATOL, V125, P64, DOI 10.1111/j.1365-2141.2004.04867.x; Chauhan D, 2007, ONCOGENE, V26, P2374, DOI 10.1038/sj.onc.1210028; Chen YY, 2009, NAT GENET, V41, P783, DOI 10.1038/ng.389; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; DECLERCQ E, 1989, ANTIMICROB AGENTS CH, V33, P1291, DOI 10.1128/AAC.33.8.1291; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Feinman R, 1999, BLOOD, V93, P3044; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Ghosh J, 1998, P NATL ACAD SCI USA, V95, P13182, DOI 10.1073/pnas.95.22.13182; Ghosh J, 2003, BIOCHEM BIOPH RES CO, V307, P342, DOI 10.1016/S0006-291X(03)01201-4; GLAZER RI, 1986, BIOCHEM BIOPH RES CO, V135, P688, DOI 10.1016/0006-291X(86)90048-3; GLAZER RI, 1986, BIOCHEM PHARMACOL, V35, P4523, DOI 10.1016/0006-2952(86)90774-4; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Keats JJ, 2003, BLOOD, V101, P1520, DOI 10.1182/blood-2002-06-1675; Keats JJ, 2006, LEUKEMIA LYMPHOMA, V47, P2289, DOI 10.1080/10428190600822128; Kho PS, 2004, J BIOL CHEM, V279, P21183, DOI 10.1074/jbc.M311912200; Kirsch DG, 1999, J BIOL CHEM, V274, P21155, DOI 10.1074/jbc.274.30.21155; Kline MP, 2007, LEUKEMIA, V21, P1549, DOI 10.1038/sj.leu.2404719; Marango J, 2008, BLOOD, V111, P3145, DOI 10.1182/blood-2007-06-092122; Mason KD, 2009, LEUKEMIA, V23, P2034, DOI 10.1038/leu.2009.151; MAYERS DL, 1995, P NATL ACAD SCI USA, V92, P215, DOI 10.1073/pnas.92.1.215; Melstrom LG, 2008, CLIN CANCER RES, V14, P6525, DOI 10.1158/1078-0432.CCR-07-4631; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ozvaran MK, 2004, MOL CANCER THER, V3, P545; Pandit B, 2010, PROSTATE, V70, P825, DOI 10.1002/pros.21116; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peters-Golden M, 1998, AM J RESP CRIT CARE, V157, pS227, DOI 10.1164/ajrccm.157.6.mar4; Puthier D, 1999, BRIT J HAEMATOL, V107, P392, DOI 10.1046/j.1365-2141.1999.01705.x; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; SANGFELT O, 1995, INT J CANCER, V63, P190, DOI 10.1002/ijc.2910630207; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tu YP, 1996, BLOOD, V88, P1805, DOI 10.1182/blood.V88.5.1805.bloodjournal8851805; Xie ZG, 2008, CANCER CHEMOTH PHARM, V62, P949, DOI 10.1007/s00280-008-0684-z; Zhou GX, 2007, BBA-GEN SUBJECTS, V1770, P1021, DOI 10.1016/j.bbagen.2007.03.002; Zhou J, 2008, LEUKEMIA, V22, P138, DOI 10.1038/sj.leu.2404960	44	28	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21583	10.1371/journal.pone.0021583	http://dx.doi.org/10.1371/journal.pone.0021583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720561	Green Published, Green Submitted, gold			2022-12-25	WOS:000292036900057
J	Zajdowicz, SLW; Jones-Carson, J; Vazquez-Torres, A; Jobling, MG; Gill, RE; Holmes, RK				Zajdowicz, Sheryl L. W.; Jones-Carson, Jessica; Vazquez-Torres, Andres; Jobling, Michael G.; Gill, Ronald E.; Holmes, Randall K.			Alanine Racemase Mutants of Burkholderia pseudomallei and Burkholderia mallei and Use of Alanine Racemase as a Non-Antibiotic-Based Selectable Marker	PLOS ONE			English	Article							THYMIDYLATE SYNTHASE GENE; COMPLETE GENOME SEQUENCE; FREE D-SERINE; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; MOLECULAR CHARACTERIZATION; ENZYME-PURIFICATION; LACTOCOCCUS-LACTIS; BACILLUS-SUBTILIS	Burkholderia pseudomallei and Burkholderia mallei are category B select agents and must be studied under BSL3 containment in the United States. They are typically resistant to multiple antibiotics, and the antibiotics used to treat B. pseudomallei or B. mallei infections may not be used as selective agents with the corresponding Burkholderia species. Here, we investigated alanine racemase deficient mutants of B. pseudomallei and B. mallei for development of non-antibiotic-based genetic selection methods and for attenuation of virulence. The genome of B. pseudomallei K96243 has two annotated alanine racemase genes (bpsl2179 and bpss0711), and B. mallei ATCC 23344 has one (bma1575). Each of these genes encodes a functional enzyme that can complement the alanine racemase deficiency of Escherichia coli strain ALA1. Herein, we show that B. pseudomallei with in-frame deletions in both bpsl2179 and bpss0711, or B. mallei with an in-frame deletion in bma1575, requires exogenous D-alanine for growth. Introduction of bpsl2179 on a multicopy plasmid into alanine racemase deficient variants of either Burkholderia species eliminated the requirement for D-alanine. During log phase growth without D-alanine, the viable counts of alanine racemase deficient mutants of B. pseudomallei and B. mallei decreased within 2 hours by about 1000-fold and 10-fold, respectively, and no viable bacteria were present at 24 hours. We constructed several genetic tools with bpsl2179 as a selectable genetic marker, and we used them without any antibiotic selection to construct an in-frame Delta flgK mutant in the alanine racemase deficient variant of B. pseudomallei K96243. In murine peritoneal macrophages, wild type B. mallei ATCC 23344 was killed much more rapidly than wild type B. pseudomallei K96243. In addition, the alanine racemase deficient mutant of B. pseudomallei K96243 exhibited attenuation versus its isogenic parental strain with respect to growth and survival in murine peritoneal macrophages.	[Zajdowicz, Sheryl L. W.; Jones-Carson, Jessica; Vazquez-Torres, Andres; Jobling, Michael G.; Gill, Ronald E.; Holmes, Randall K.] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO 80011 USA; [Zajdowicz, Sheryl L. W.] Metropolitan State Coll, Dept Biol, Denver, CO 80204 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Zajdowicz, SLW (corresponding author), Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO 80011 USA.	randall.holmes@ucdenver.edu	Jobling, Michael G/AAJ-3814-2021	Jobling, Michael/0000-0001-7689-3093	NIH/NIAID [R21 AI074606, U54 AI065357, G-7819]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357, R21AI074606] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH/NIAID grant R21 AI074606 (to RKH) and NIH/NIAID grant U54 AI065357 subaward #G-7819 (to AVT). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ausubel F. M., 2002, SHORT PROTOCOLS MOL; Bron PA, 2002, APPL ENVIRON MICROB, V68, P5663, DOI 10.1128/AEM.68.11.5663-5670.2002; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Choi KH, 2008, APPL ENVIRON MICROB, V74, P1064, DOI 10.1128/AEM.02430-07; Choi KH, 2006, NAT PROTOC, V1, P162, DOI 10.1038/nprot.2006.25; Dance DAB, 2000, ACTA TROP, V74, P159, DOI 10.1016/S0001-706X(99)00066-2; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; FERRARI E, 1985, BIO-TECHNOL, V3, P1003, DOI 10.1038/nbt1185-1003; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Fischer W., 1990, HDB LIPID RES, P123; GALAN JE, 1990, GENE, V94, P29, DOI 10.1016/0378-1119(90)90464-3; Gilad Jacob, 2007, Recent Pat Antiinfect Drug Discov, V2, P233, DOI 10.2174/157489107782497335; Hamad MA, 2009, GENE, V430, P123, DOI 10.1016/j.gene.2008.10.011; Hamase K, 1997, BBA-GEN SUBJECTS, V1334, P214, DOI 10.1016/S0304-4165(96)00095-5; Hamase K, 1999, AMINO ACIDS, V17, P277, DOI 10.1007/BF01366926; Handfield M, 1998, BIOTECHNIQUES, V24, P261, DOI 10.2144/98242st02; HASHIMOTO A, 1993, NEUROSCI LETT, V152, P33, DOI 10.1016/0304-3940(93)90476-2; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Hols P, 1997, J BACTERIOL, V179, P3804, DOI 10.1128/jb.179.11.3804-3807.1997; INAGAKI K, 1986, BIOCHEMISTRY-US, V25, P3268, DOI 10.1021/bi00359a028; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Kim HS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-174; Leelarasmee Amorn, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P410; Lenz LL, 2008, CLIN VACCINE IMMUNOL, V15, P1414, DOI 10.1128/CVI.00208-08; Limmathurotsakul D, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000327; McCollister BD, 2005, J EXP MED, V202, P625, DOI 10.1084/jem.20050246; Milligan DL, 2007, J BACTERIOL, V189, P8381, DOI 10.1128/JB.01201-07; NAGATA Y, 1992, BIOCHIM BIOPHYS ACTA, V1115, P208, DOI 10.1016/0304-4165(92)90055-Y; NAGATA Y, 1992, EXPERIENTIA, V48, P986, DOI 10.1007/BF01919147; Neubauer H, 2005, J VET MED B, V52, P201, DOI 10.1111/j.1439-0450.2005.00855.x; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Oikawa T, 2006, J BIOTECHNOL, V125, P503, DOI 10.1016/j.jbiotec.2006.04.002; PRESTON RA, 1984, J GEN MICROBIOL, V130, P3123; Propst KL, 2010, INFECT IMMUN, V78, P3136, DOI 10.1128/IAI.01313-09; Reitzer L.J., 1996, ESCHERICHIA COLI SAL, P391; ROSS P, 1990, APPL ENVIRON MICROB, V56, P2156, DOI 10.1128/AEM.56.7.2156-2163.1990; ROSS P, 1990, APPL ENVIRON MICROB, V56, P2164, DOI 10.1128/AEM.56.7.2164-2169.1990; ROSSO G, 1969, BIOCHEM BIOPH RES CO, V34, P134, DOI 10.1016/0006-291X(69)90539-7; RUHLAND GJ, 1987, SYST APPL MICROBIOL, V9, P40, DOI 10.1016/S0723-2020(87)80054-1; Stevens JM, 2005, J BACTERIOL, V187, P7857, DOI 10.1128/JB.187.22.7857-7862.2005; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Strych U, 2002, J BACTERIOL, V184, P4321, DOI 10.1128/JB.184.15.4321-4325.2002; Strych U, 2001, FEMS MICROBIOL LETT, V196, P93, DOI 10.1016/S0378-1097(01)00045-3; Strych U, 2000, CURR MICROBIOL, V41, P290, DOI 10.1007/s002840010136; Strych U, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-40; Tauch A, 2002, J BIOTECHNOL, V99, P79, DOI 10.1016/S0168-1656(02)00159-1; Thompson RJ, 1998, INFECT IMMUN, V66, P3552, DOI 10.1128/IAI.66.8.3552-3561.1998; Thongdee M, 2008, APPL ENVIRON MICROB, V74, P2985, DOI 10.1128/AEM.00030-08; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Verch T, 2004, INFECT IMMUN, V72, P6418, DOI 10.1128/IAI.72.11.6418-6425.2004; Waag DM., 2004, BIOL WEAPONS DEFENSE, P209; WALSH CT, 1989, J BIOL CHEM, V264, P2393; WASSERMAN SA, 1983, J BACTERIOL, V153, P1439, DOI 10.1128/JB.153.3.1439-1450.1983; WASSERMAN SA, 1984, BIOCHEMISTRY-US, V23, P5182, DOI 10.1021/bi00317a015; Whitlock GC, 2007, FEMS MICROBIOL LETT, V277, P115, DOI 10.1111/j.1574-6968.2007.00949.x; WIJSMAN HJW, 1972, GENET RES, V20, P269, DOI 10.1017/S001667230001380X; WILD J, 1985, MOL GEN GENET, V198, P315, DOI 10.1007/BF00383013; YABUUCHI E, 1992, MICROBIOL IMMUNOL, V36, P1251, DOI 10.1111/j.1348-0421.1992.tb02129.x; YONAHA K, 1975, J FERMENT TECHNOL, V53, P579	62	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21523	10.1371/journal.pone.0021523	http://dx.doi.org/10.1371/journal.pone.0021523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720554	Green Submitted, gold, Green Published			2022-12-25	WOS:000292036900048
J	Parikh, RY; Ramanathan, R; Coloe, PJ; Bhargava, SK; Patole, MS; Shouche, YS; Bansal, V				Parikh, Rasesh Y.; Ramanathan, Rajesh; Coloe, Peter J.; Bhargava, Suresh K.; Patole, Milind S.; Shouche, Yogesh S.; Bansal, Vipul			Genus-Wide Physicochemical Evidence of Extracellular Crystalline Silver Nanoparticles Biosynthesis by Morganella spp.	PLOS ONE			English	Article							FUNGUS FUSARIUM-OXYSPORUM; BIOLOGICAL SYNTHESIS; GOLD NANOPARTICLES; SILICA; PROVIDENCIA; RESISTANCE; PROTEUS; OXIDE; SAND; AG	This study was performed to determine whether extracellular silver nanoparticles (AgNPs) production is a genus-wide phenotype associated with all the members of genus Morganella, or only Morganella morganii RP-42 isolate is able to synthesize extracellular Ag nanoparticles. To undertake this study, all the available Morganella isolates were exposed to Ag+ ions, and the obtained nanoproducts were thoroughly analyzed using physico-chemical characterization tools such as transmission electron microscopy (TEM), UV-visible spectrophotometry (UV-vis), and X-ray diffraction (XRD) analysis. It was identified that extracellular biosynthesis of crystalline silver nanoparticles is a unique biochemical character of all the members of genus Morganella, which was found independent of environmental changes. Significantly, the inability of other closely related members of the family Enterobacteriaceae towards AgNPs synthesis strongly suggests that AgNPs synthesis in the presence of Ag+ ions is a phenotypic character that is uniquely associated with genus Morganella.	[Parikh, Rasesh Y.; Patole, Milind S.; Shouche, Yogesh S.] Natl Ctr Cell Sci, Pune, Maharashtra, India; [Ramanathan, Rajesh; Coloe, Peter J.; Bhargava, Suresh K.; Bansal, Vipul] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Royal Melbourne Institute of Technology (RMIT)	Shouche, YS (corresponding author), Natl Ctr Cell Sci, Pune Univ Campus, Pune, Maharashtra, India.	yogesh@nccs.res.in; vipul.bansal@rmit.edu.au	Ramanathan, Rajesh/H-1617-2011; Bhargava, Suresh K./AAQ-2675-2020; Bhargava, Suresh K./C-5783-2011; Bansal, Vipul/B-2485-2008	Bhargava, Suresh K./0000-0002-3127-8166; Bhargava, Suresh K./0000-0002-3127-8166; Bansal, Vipul/0000-0002-3354-4317; Ramanathan, Rajesh/0000-0002-8500-9148	Australian Research Council (ARC); APD [DP0988099]; Department of Education, Employment and Workplace Relations (DEEWR), Commonwealth of Australia	Australian Research Council (ARC)(Australian Research Council); APD; Department of Education, Employment and Workplace Relations (DEEWR), Commonwealth of Australia(Australian Government)	This work was supported in part by the Australian Research Council (ARC) Discovery grant and an APD Fellowship to V. B. (DP0988099), and an Endeavour Research Award to R.Y.P. from the Department of Education, Employment and Workplace Relations (DEEWR), Commonwealth of Australia to pursue this work at RMIT University, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2003, LANGMUIR, V19, P3550, DOI 10.1021/la026772l; Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1; Bansal V, 2005, J MATER CHEM, V15, P2583, DOI 10.1039/b503008k; Bansal V, 2005, ADV MATER, V17, P889, DOI 10.1002/adma.200401176; Bansal V, 2004, J MATER CHEM, V14, P3303, DOI 10.1039/b407904c; Bansal V, 2006, J AM CHEM SOC, V128, P11958, DOI 10.1021/ja063011m; Bansal V, 2007, LANGMUIR, V23, P4993, DOI 10.1021/la062535x; Bansal V, 2006, J AM CHEM SOC, V128, P14059, DOI 10.1021/ja062113+; Bansal V, 2011, AUST J CHEM, V64, P279, DOI 10.1071/CH10343; Bansal V, 2010, CRYSTENGCOMM, V12, P4280, DOI 10.1039/c0ce00215a; Bansal V, 2009, ELECTROCHEM COMMUN, V11, P1639, DOI 10.1016/j.elecom.2009.06.018; Bharde A, 2006, SMALL, V2, P135, DOI 10.1002/smll.200500180; Bharde AA, 2008, LANGMUIR, V24, P5787, DOI 10.1021/la704019p; BRENNER DJ, 1978, INT J SYST BACTERIOL, V28, P269, DOI 10.1099/00207713-28-2-269; Egger S, 2009, APPL ENVIRON MICROB, V75, P2973, DOI 10.1128/AEM.01658-08; Emborg J, 2006, INT J SYST EVOL MICR, V56, P2473, DOI 10.1099/ijs.0.64357-0; Fulton M, 1943, J BACTERIOL, V46, P79, DOI 10.1128/JB.46.1.79-82.1943; Galeano B, 2003, APPL ENVIRON MICROB, V69, P4329, DOI 10.1128/AEM.69.7.4329-4331.2003; Gupta A, 1999, NAT MED, V5, P183, DOI 10.1038/5545; JENSEN KT, 1992, INT J SYST BACTERIOL, V42, P613; KLAUS JT, 2001, TRENDS BIOTECHNOL, V19, P15; Klaus T, 1999, P NATL ACAD SCI USA, V96, P13611, DOI 10.1073/pnas.96.24.13611; Nangia Y, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-39; Niemeyer C.M., 2005, NANOBIOTECHNOLOGY CO; O'Hara CM, 2000, CLIN MICROBIOL REV, V13, P534, DOI 10.1128/CMR.13.4.534-546.2000; Parikh RY, 2008, CHEMBIOCHEM, V9, P1415, DOI 10.1002/cbic.200700592; Pearson A, 2010, CHEM COMMUN, V46, P731, DOI 10.1039/b918866e; Ramanathan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017707; Ramanathan R, 2011, LANGMUIR, V27, P714, DOI 10.1021/la1036162; Schultz S, 2000, P NATL ACAD SCI USA, V97, P996, DOI 10.1073/pnas.97.3.996; Selvakannan PR, 2004, LANGMUIR, V20, P7825, DOI 10.1021/la049258j; Shankar SS, 2004, NAT MATER, V3, P482, DOI 10.1038/nmat1152; Song JY, 2010, BIOPROC BIOSYST ENG, V33, P159, DOI 10.1007/s00449-009-0373-2; Song JY, 2009, BIOPROC BIOSYST ENG, V32, P79, DOI 10.1007/s00449-008-0224-6; Sweeney RY, 2004, CHEM BIOL, V11, P1553, DOI 10.1016/j.chembiol.2004.08.022; Thakkar KN, 2010, NANOMED-NANOTECHNOL, V6, P257, DOI 10.1016/j.nano.2009.07.002; Yang HL, 2009, WATER RES, V43, P3777, DOI 10.1016/j.watres.2009.06.002	37	47	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21401	10.1371/journal.pone.0021401	http://dx.doi.org/10.1371/journal.pone.0021401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713008	gold, Green Submitted, Green Published			2022-12-25	WOS:000291985100039
J	Ankeny, RF; Thourani, VH; Weiss, D; Vega, JD; Taylor, WR; Nerem, RM; Jo, H				Ankeny, Randall F.; Thourani, Vinod H.; Weiss, Daiana; Vega, J. David; Taylor, W. Robert; Nerem, Robert M.; Jo, Hanjoong			Preferential Activation of SMAD1/5/8 on the Fibrosa Endothelium in Calcified Human Aortic Valves - Association with Low BMP Antagonists and SMAD6	PLOS ONE			English	Article							BONE MORPHOGENIC PROTEIN-4; SPEMANN ORGANIZER; CAROTID BIFURCATION; EARLY LESION; STENOSIS; CELLS; FLOW; ATHEROSCLEROSIS; CALCIFICATION; NOGGIN	Background: Aortic valve (AV) calcification preferentially occurs on the fibrosa side while the ventricularis side remains relatively unaffected. Here, we tested the hypothesis that side-dependent activation of bone morphogenic protein (BMP) pathway in the endothelium of the ventricularis and fibrosa is associated with human AV calcification. Methods and Results: Human calcified AVs obtained from AV replacement surgeries and non-calcified AVs from heart transplantations were used for immunohistochemical studies. We found SMAD-1/5/8 phosphorylation (a canonical BMP pathway) was higher in the calcified fibrosa than the non-calcified fibrosa while SMAD-2/3 phosphorylation (a canonical TGF beta pathway) did not show any difference. Interestingly, we found that BMP-2/4/6 expression was significantly higher on the ventricularis endothelium compared to the fibrosa in both calcified and non-calcified AV cusps; however, BMP antagonists (crossvienless-2/BMPER and noggin) expression was significantly higher on the ventricularis endothelium compared to the fibrosa in both disease states. Moreover, significant expression of inhibitory SMAD-6 expression was found only in the non-calcified ventricularis endothelium. Conclusions: SMAD-1/5/8 is preferentially activated in the calcified fibrosa endothelium of human AVs and it correlates with low expression of BMP antagonists and inhibitory SMAD6. These results suggest a dominant role of BMP antagonists in the side-dependent calcification of human AVs.	[Ankeny, Randall F.; Taylor, W. Robert; Jo, Hanjoong] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Thourani, Vinod H.; Vega, J. David] Emory Univ, Div Cardiothorac Surg, Atlanta, GA 30322 USA; [Weiss, Daiana; Taylor, W. Robert; Jo, Hanjoong] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA; [Nerem, Robert M.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Jo, Hanjoong] Ewha Womans Univ, Dept Bioinspired Sci, Seoul, South Korea	University System of Georgia; Georgia Institute of Technology; Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; Ewha Womans University	Ankeny, RF (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	hjo@bme.gatech.edu	Jo, Hanjoong/L-6216-2019; thourani, vinod/AAP-5968-2020	Jo, Hanjoong/0000-0003-1833-372X; 	National Institutes of Health [HL75209, HL87012, HL80711, PO1 HL05800, PO1 HL075209]; WCU [R31-2008-000-10010-0]; American Heart Association [0715417B]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070531, R01HL087012, P01HL075209, U01HL080711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WCU; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funding from National Institutes of Health grants HL75209, HL87012, and HL80711, and WCU Program (R31-2008-000-10010-0) (HJ), as well as an American Heart Association pre-doctoral fellowship 0715417B (RFA). Imaging studies were performed in part through the use of the Emory Internal Medicine Imaging Core, (supported by NIH grants PO1 HL05800 and PO1 HL075209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW LC, 2004, J ORTHOPAED RES, V22, P1188; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; BUTCHER JT, 2005, ARTERIOSCLER THROMB; Chang K, 2007, CIRCULATION, V116, P1258, DOI 10.1161/CIRCULATIONAHA.106.683227; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; Guerraty MA, 2010, ARTERIOSCL THROM VAS, V30, P225, DOI 10.1161/ATVBAHA.109.198549; HEMMATIBRIVANLOU A, 1994, CELL, V77, P283, DOI 10.1016/0092-8674(94)90320-4; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Hsu SY, 2005, INT J CLIN PRACT, V59, P72, DOI 10.1111/j.1368-5031.2004.00219.x; Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6; Jian B, 2001, AM J PATHOL, V159, P321, DOI 10.1016/S0002-9440(10)61698-7; Koos R, 2009, THROMB HAEMOSTASIS, V101, P706, DOI 10.1160/TH08-09-0611; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Miriyala S, 2006, CIRCULATION, V113, P2818, DOI 10.1161/CIRCULATIONAHA.106.611822; Miyazono K, 1999, BONE, V25, P91, DOI 10.1016/S8756-3282(99)00113-1; Mohler ER, 2000, LANCET, V356, P524, DOI 10.1016/S0140-6736(00)02572-1; Mohler ER, 2004, AM J CARDIOL, V94, P1396, DOI 10.1016/j.amjcard.2004.08.013; MOHLER ER, 1991, CLIN CARDIOL, V14, P995, DOI 10.1002/clc.4960141210; Mohler ER, 2001, CIRCULATION, V103, P1522, DOI 10.1161/01.cir.103.11.1522; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; OBrien KD, 1996, ARTERIOSCL THROM VAS, V16, P523, DOI 10.1161/01.ATV.16.4.523; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Otto CM, 1999, NEW ENGL J MED, V341, P142, DOI 10.1056/NEJM199907153410302; Parolari A, 2009, EUR J CARDIO-THORAC, V35, P493, DOI 10.1016/j.ejcts.2008.11.033; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Rajamannan NM, 2003, CIRCULATION, V107, P2181, DOI 10.1161/01.CIR.0000070591.21548.69; Sacks MS, 2007, PHILOS T R SOC B, V362, P1369, DOI 10.1098/rstb.2007.2122; Simmons CA, 2005, CIRC RES, V96, P792, DOI 10.1161/01.RES.0000161998.92009.64; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Sorescu GP, 2004, CIRC RES, V95, P773, DOI 10.1161/01.RES.0000145728.22878.45; Sorescu GP, 2003, J BIOL CHEM, V278, P31128, DOI 10.1074/jbc.M300703200; Sucosky P, 2009, ARTERIOSCL THROM VAS, V29, P254, DOI 10.1161/ATVBAHA.108.176347; Sudo S, 2004, J BIOL CHEM, V279, P23134, DOI 10.1074/jbc.M402376200; Thourani VH, 2008, ANN THORAC SURG, V86, P1458, DOI 10.1016/j.athoracsur.2008.06.036; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314; Weiss RM, 2006, CIRCULATION, V114, P2065, DOI 10.1161/CIRCULATIONAHA.106.634139; Yetkin E, 2009, INT J CARDIOL, V135, P4, DOI 10.1016/j.ijcard.2009.03.108; ZARINS CK, 1983, CIRC RES, V53, P502, DOI 10.1161/01.RES.53.4.502; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	41	54	59	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20969	10.1371/journal.pone.0020969	http://dx.doi.org/10.1371/journal.pone.0020969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698246	Green Published, gold, Green Submitted			2022-12-25	WOS:000291730000033
J	Colzato, LS; Ruiz, MJ; van den Wildenberg, WPM; Hommel, B				Colzato, Lorenza S.; Ruiz, Manuel J.; van den Wildenberg, Wery P. M.; Hommel, Bernhard			Khat Use Is Associated with Impaired Working Memory and Cognitive Flexibility	PLOS ONE			English	Article							CATHA-EDULIS; INDIVIDUAL-DIFFERENCES; EXECUTIVE FUNCTIONS; PREFRONTAL CORTEX; DOPAMINE; ECSTASY; TASK; INTELLIGENCE; INVOLVEMENT; PERCEPTION	Rationale: Khat consumption has increased during the last decades in Eastern Africa and has become a global phenomenon spreading to ethnic communities in the rest of the world, such as The Netherlands, United Kingdom, Canada, and the United States. Very little is known, however, about the relation between khat use and cognitive control functions in khat users. Objective: We studied whether khat use is associated with changes in working memory (WM) and cognitive flexibility, two central cognitive control functions. Methods: Khat users and khat-free controls were matched in terms of sex, ethnicity, age, alcohol and cannabis consumption, and IQ (Raven's progressive matrices). Groups were tested on cognitive flexibility, as measured by a Global-Local task, and on WM using an N-back task. Result: Khat users performed significantly worse than controls on tasks tapping into cognitive flexibility as well as monitoring of information in WM. Conclusions: The present findings suggest that khat use impairs both cognitive flexibility and the updating of information in WM. The inability to monitor information in WM and to adjust behavior rapidly and flexibly may have repercussions for daily life activities.	[Colzato, Lorenza S.; Ruiz, Manuel J.; Hommel, Bernhard] Leiden Univ, Inst Psychol Res, Leiden, Netherlands; [Colzato, Lorenza S.; Ruiz, Manuel J.; Hommel, Bernhard] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [van den Wildenberg, Wery P. M.] Univ Amsterdam, Dept Psychol, Amsterdam Ctr Study Adapt Control Brain & Behav A, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam	Colzato, LS (corresponding author), Leiden Univ, Inst Psychol Res, Leiden, Netherlands.	colzato@fsw.leidenuniv.nl	Hommel, Bernhard/F-8173-2010; Colzato, Lorenza S/H-6296-2013; Ruiz, Manuel J./M-7894-2014	Hommel, Bernhard/0000-0003-4731-5125; Ruiz, Manuel J./0000-0002-1286-6624; Ruiz, Manuel J/0000-0002-2926-702X; Colzato, Lorenza/0000-0003-1735-1280	NWO (Netherlands Organisation for Scientific Research)	NWO (Netherlands Organisation for Scientific Research)(Netherlands Organization for Scientific Research (NWO))	The research of LSC, WVDW and BH is supported by NWO (Netherlands Organisation for Scientific Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PL, 2005, PSYCHOL BULL, V131, P30, DOI 10.1037/0033-2909.131.1.30; Al-Habori Molham, 2005, Expert Opin Drug Saf, V4, P1145, DOI 10.1517/14740338.4.6.1145; Baicy K, 2007, ADDICTION, V102, P5, DOI 10.1111/j.1360-0443.2006.01777.x; Balint EE, 2009, WIEN KLIN WOCHENSCHR, V121, P604, DOI 10.1007/s00508-009-1259-7; Banjaw MY, 2005, BEHAV BRAIN RES, V156, P181, DOI 10.1016/j.bbr.2004.05.020; Beckerleg S, 2008, SUBST USE MISUSE, V43, P749, DOI 10.1080/10826080701739057; Berman S, 2008, ANN NY ACAD SCI, V1141, P195, DOI 10.1196/annals.1441.031; Braver TS, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P713; BRENNEISEN R, 1990, BRIT J CLIN PHARMACO, V30, P825, DOI 10.1111/j.1365-2125.1990.tb05447.x; Carrier N, 2008, SUBST USE MISUSE, V43, P803, DOI 10.1080/10826080701739016; Chappell JS, 2010, FORENSIC SCI INT, V195, P108, DOI 10.1016/j.forsciint.2009.12.002; Colzato LS, 2010, NEUROSCIENCE, V170, P782, DOI 10.1016/j.neuroscience.2010.07.050; Colzato LS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001143; Colzato LS, 2006, PSYCHON B REV, V13, P1043, DOI 10.3758/BF03213923; Colzato LS, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00219; Colzato LS, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00008; Colzato LS, 2010, NEUROPSYCHOLOGIA, V48, P2764, DOI 10.1016/j.neuropsychologia.2010.04.023; Colzato LS, 2009, PSYCHOPHARMACOLOGY, V207, P225, DOI 10.1007/s00213-009-1650-0; Colzato LS, 2004, NEUROSCI LETT, V360, P103, DOI 10.1016/j.neulet.2004.01.054; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Cools R, 2008, J NEUROSCI, V28, P1208, DOI 10.1523/JNEUROSCI.4475-07.2008; Cox G, 2003, ADV PSYCHIAT TREAT, V9, P456, DOI [10.1192/apt.9.6.456, DOI 10.1192/APT.9.6.456]; Daumann J, 2004, BIOL PSYCHIAT, V56, P349, DOI 10.1016/j.biopsych.2004.06.011; Daumann J, 2003, NEUROREPORT, V14, P1983, DOI 10.1097/00001756-200310270-00021; Feyissa AM, 2008, PROG NEURO-PSYCHOPH, V32, P1147, DOI 10.1016/j.pnpbp.2007.12.033; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Hartman M, 2005, PSYCHOL AGING, V20, P645, DOI 10.1037/0882-7974.20.4.645; Hassan N. A. G. M., 2007, Eastern Mediterranean Health Journal, V13, P706; Hoffman R, 2010, J ETHNOPHARMACOL, V132, P554, DOI 10.1016/j.jep.2010.05.033; Kalix P, 1996, PHARM WORLD SCI, V18, P69, DOI 10.1007/BF00579708; KALIX P, 1985, PHARMACOL REV, V37, P149; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Kray J, 2002, BRAIN COGNITION, V49, P363, DOI 10.1006/brcg.2001.1505; KRIKORIAN AD, 1984, J ETHNOPHARMACOL, V12, P115, DOI 10.1016/0378-8741(84)90047-3; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Monsell S., 1996, UNSOLVED MYSTERIES M, P93; Moustafa AA, 2008, NEUROPSYCHOLOGIA, V46, P3144, DOI 10.1016/j.neuropsychologia.2008.07.011; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Nordahl TE, 2003, J NEUROPSYCH CLIN N, V15, P317, DOI 10.1176/appi.neuropsych.15.3.317; Odenwald M, 2007, SUCHT, V53, P9, DOI DOI 10.1024/2007.01.03; PANTELIS C, 1989, PSYCHOL MED, V19, P657, DOI 10.1017/S0033291700024259; Patel NB, 2000, E AFR MED J, V77, P329; Pennings EJM, 2008, REGUL TOXICOL PHARM, V52, P199, DOI 10.1016/j.yrtph.2008.08.005; Raven JohnC., 1988, ADV PROGRESSIVE MATR; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Siessmeier T, 2006, EUR J NEUROSCI, V24, P305, DOI 10.1111/j.1460-9568.2006.04903.x; *UNODC, WORLD DRUG REP 2010; van der Plas EAA, 2009, J CLIN EXP NEUROPSYC, V31, P706, DOI 10.1080/13803390802484797; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; von Geusau NA, 2004, PSYCHOPHARMACOLOGY, V175, P331, DOI 10.1007/s00213-004-1832-8; WAGNER GC, 1982, DRUG ALCOHOL DEPEN, V9, P279, DOI 10.1016/0376-8716(82)90067-9; ZELGER JL, 1981, NEUROPHARMACOLOGY, V20, P839, DOI 10.1016/0028-3908(81)90076-9	54	55	55	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20602	10.1371/journal.pone.0020602	http://dx.doi.org/10.1371/journal.pone.0020602			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778TS	21698275	Green Published, Green Submitted, gold			2022-12-25	WOS:000291730000016
J	Floegel, A; Drogan, D; Wang-Sattler, R; Prehn, C; Illig, T; Adamski, J; Joost, HG; Boeing, H; Pischon, T				Floegel, Anna; Drogan, Dagmar; Wang-Sattler, Rui; Prehn, Cornelia; Illig, Thomas; Adamski, Jerzy; Joost, Hans-Georg; Boeing, Heiner; Pischon, Tobias			Reliability of Serum Metabolite Concentrations over a 4-Month Period Using a Targeted Metabolomic Approach	PLOS ONE			English	Article							EPIC-GERMANY; PLASMA; BIOMARKERS; STABILITY; WOMEN; REPRODUCIBILITY; DISEASES; 1-YEAR	Metabolomics is a promising tool for discovery of novel biomarkers of chronic disease risk in prospective epidemiologic studies. We investigated the between- and within-person variation of the concentrations of 163 serum metabolites over a period of 4 months to evaluate the metabolite reliability expressed by the intraclass-correlation coefficient (ICC: the ratio of between-person variance and total variance). The analyses were performed with the BIOCRATES AbsoluteIDQ (TM) targeted metabolomics technology, including acylcarnitines, amino acids, glycerophospholipids, sphingolipids and hexose in 100 healthy individuals from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study who had provided two fasting blood samples 4 months apart. Overall, serum reliability of metabolites over a 4-month period was good. The median ICC of the 163 metabolites was 0.57. The highest ICC was observed for hydroxysphingomyelin C14:1 (ICC = 0.85) and the lowest was found for acylcarnitine C3:1 (ICC = 0). Reliability was high for hexose (ICC = 0.76), sphingolipids (median ICC = 0.66; range: 0.24-0.85), amino acids (median ICC = 0.58; range: 0.41-0.72) and glycerophospholipids (median ICC = 0.58; range: 0.03-0.81). Among acylcarnitines, reliability of short and medium chain saturated compounds was good to excellent (ICC range: 0.50-0.81). Serum reliability was lower for most hydroxyacylcarnitines and monounsaturated acylcarnitines (ICC range: 0.11-0.45 and 0.00-0.63, respectively). For most of the metabolites a single measurement may be sufficient for risk assessment in epidemiologic studies with healthy subjects.	[Floegel, Anna; Drogan, Dagmar; Boeing, Heiner; Pischon, Tobias] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Wang-Sattler, Rui; Illig, Thomas] German Res Ctr Environm Hlth, Inst Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Prehn, Cornelia; Adamski, Jerzy] German Res Ctr Environm Hlth, Inst Expt Genet, Helmholtz Zentrum Munchen, Genome Anal Ctr, Neuherberg, Germany; [Joost, Hans-Georg] German Inst Human Nutr Potsdam Rehbrucke, Dept Pharmacol, Nuthetal, Germany; [Pischon, Tobias] Max Delbruck Ctr Mol Med MDC, Mol Epidemiol Grp, Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Floegel, A (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany.	anna.floegel@dife.de	Floegel, Anna/F-4854-2013; Joost, Hans-Georg/J-4462-2013; Pischon, Tobias/HGE-8577-2022; Wang-Sattler, Rui/B-5354-2014	Joost, Hans-Georg/0000-0002-5860-606X; Pischon, Tobias/0000-0003-1568-767X; Wang-Sattler, Rui/0000-0002-8794-8229; Adamski, Jerzy/0000-0001-9259-0199; Prehn, Cornelia/0000-0002-1274-4715; Floegel, Anna/0000-0001-9806-4288	Federal Ministry of Education and Research, Germany (Bundesministerium fur Bildung und Forschung, Forderkennzeichen) [01GI0922]	Federal Ministry of Education and Research, Germany (Bundesministerium fur Bildung und Forschung, Forderkennzeichen)(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the Federal Ministry of Education and Research, Germany (Bundesministerium fur Bildung und Forschung, Forderkennzeichen 01GI0922). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Bergmann MM, 1999, ANN NUTR METAB, V43, P225, DOI 10.1159/000012789; Boeing H, 1999, ANN NUTR METAB, V43, P205, DOI 10.1159/000012787; Boeing H, 1999, ANN NUTR METAB, V43, P195, DOI 10.1159/000012786; BOULAT O, 1993, EUR J CLIN CHEM CLIN, V31, P585; Crews B, 2009, ANAL CHEM, V81, P8538, DOI 10.1021/ac9014947; Fleiss J., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923.ch1, DOI 10.1002/9781118032923.CH1, DOI 10.1002/9781118032923]; Gowda GAN, 2008, EXPERT REV MOL DIAGN, V8, P617, DOI 10.1586/14737159.8.5.617; HARTUNG J, 1981, ANN STAT, V9, P278, DOI 10.1214/aos/1176345394; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Kaplan RC, 2007, CANCER EPIDEM BIOMAR, V16, P1291, DOI 10.1158/1055-9965.EPI-06-1089; Koeberl DD, 2003, PEDIATR RES, V54, P219, DOI 10.1203/01.PDR.0000074972.36356.89; Kotsopoulos J, 2010, CANCER EPIDEM BIOMAR, V19, P938, DOI 10.1158/1055-9965.EPI-09-1318; Lewis GD, 2008, J AM COLL CARDIOL, V52, P117, DOI 10.1016/j.jacc.2008.03.043; Lin D, 2009, CAN J CARDIOL, V25, p9A, DOI 10.1016/S0828-282X(09)71048-7; McBride KL, 2007, MOL GENET METAB, V90, P217, DOI 10.1016/j.ymgme.2006.08.010; MIHALIK SJ, 2010, OBESITY SILVER SPRIN; Oresic M, 2009, NUTR METAB CARDIOVAS, V19, P816, DOI 10.1016/j.numecd.2009.04.018; Pavoine C, 2009, CARDIOVASC RES, V82, P175, DOI 10.1093/cvr/cvp030; Pischon T, 2003, CLIN CHEM, V49, P650, DOI 10.1373/49.4.650; Romisch-Margl W, 2011, METABOLOMICS; ROSNER B, 2006, FUNDAMENTALS BIOSTAT, P606; Rosner B, 2006, FUNDAMENTALS BIOSTAT, P613; Soares JC, 1999, PSYCHIAT RES, V86, P107, DOI 10.1016/S0165-1781(99)00028-1; Strnadova KA, 2007, CLIN CHEM, V53, P717, DOI 10.1373/clinchem.2006.076679; Vinayavekhin N, 2010, ACS CHEM BIOL, V5, P91, DOI 10.1021/cb900271r; Wang-Sattler R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003863; Weikert C, 2007, CLIN CHEM LAB MED, V45, P899, DOI 10.1515/CCLM.2007.148; Weinberger Klaus M, 2008, Ther Umsch, V65, P487, DOI 10.1024/0040-5930.65.9.487; Zelena E, 2009, ANAL CHEM, V81, P1357, DOI 10.1021/ac8019366; Zhang P, 1997, J BIOL CHEM, V272, P9609; Zhao XJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE384, DOI 10.1152/ajpendo.90748.2008; Zivkovic AM, 2009, METABOLOMICS, V5, P507, DOI 10.1007/s11306-009-0174-2	33	100	102	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21103	10.1371/journal.pone.0021103	http://dx.doi.org/10.1371/journal.pone.0021103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698256	Green Accepted, gold, Green Published			2022-12-25	WOS:000291730000053
J	Luo, YC; Robinson, S; Fujita, J; Siconolfi, L; Magidson, J; Edwards, CK; Wassmann, K; Storm, K; Norris, DA; Bankaitis-Davis, D; Robinson, WA; Fujita, M				Luo, Yuchun; Robinson, Steven; Fujita, Junichi; Siconolfi, Lisa; Magidson, Jay; Edwards, Carl K.; Wassmann, Karl; Storm, Kathleen; Norris, David A.; Bankaitis-Davis, Danute; Robinson, William A.; Fujita, Mayumi			Transcriptome Profiling of Whole Blood Cells Identifies PLEK2 and C1QB in Human Melanoma	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MULTIPLE-SCLEROSIS PATIENTS; GENE-EXPRESSION SIGNATURES; PERIPHERAL-BLOOD; MONONUCLEAR-CELLS; CUTANEOUS MELANOMA; MALIGNANT-MELANOMA; CANCER; REVEALS; INFLAMMATION	Background: Developing analytical methodologies to identify biomarkers in easily accessible body fluids is highly valuable for the early diagnosis and management of cancer patients. Peripheral whole blood is a "nucleic acid-rich" and "inflammatory cell-rich" information reservoir and represents systemic processes altered by the presence of cancer cells. Methodology/Principal Findings: We conducted transcriptome profiling of whole blood cells from melanoma patients. To overcome challenges associated with blood-based transcriptome analysis, we used a PAXgene (TM) tube and NuGEN Ovation (TM) globin reduction system. The combined use of these systems in microarray resulted in the identification of 78 unique genes differentially expressed in the blood of melanoma patients. Of these, 68 genes were further analyzed by quantitative reverse transcriptase PCR using blood samples from 45 newly diagnosed melanoma patients (stage I to IV) and 50 healthy control individuals. Thirty-nine genes were verified to be differentially expressed in blood samples from melanoma patients. A stepwise logit analysis selected eighteen 2-gene signatures that distinguish melanoma from healthy controls. Of these, a 2-gene signature consisting of PLEK2 and C1QB led to the best result that correctly classified 93.3% melanoma patients and 90% healthy controls. Both genes were upregulated in blood samples of melanoma patients from all stages. Further analysis using blood fractionation showed that CD45- and CD45(+) populations were responsible for the altered expression levels of PLEK2 and C1QB, respectively. Conclusions/Significance: The current study provides the first analysis of whole blood-based transcriptome biomarkers for malignant melanoma. The expression of PLEK2, the strongest gene to classify melanoma patients, in CD45(-) subsets illustrates the importance of analyzing whole blood cells for biomarker studies. The study suggests that transcriptome profiling of blood cells could be used for both early detection of melanoma and monitoring of patients for residual disease.	[Luo, Yuchun; Fujita, Junichi; Edwards, Carl K.; Norris, David A.; Fujita, Mayumi] Univ Colorado Denver, Dept Dermatol, Aurora, CO USA; [Robinson, Steven; Robinson, William A.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Siconolfi, Lisa; Wassmann, Karl; Storm, Kathleen; Bankaitis-Davis, Danute] Source MDx, Boulder, CO USA; [Magidson, Jay] Stat Innovat, Belmont, MA USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Luo, YC (corresponding author), Univ Colorado Denver, Dept Dermatol, Aurora, CO USA.	mayumi.fujita@ucdenver.edu	Luo, Yuchun/B-8683-2014	Robinson, William/0000-0003-1875-9691	National Institutes of Health [CA125833]; Wendy Will Case Cancer Fund; Skin Cancer Foundation; Tadamitu Cancer Research Fund; Moore Family Foundation; NATIONAL CANCER INSTITUTE [R03CA125833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wendy Will Case Cancer Fund; Skin Cancer Foundation; Tadamitu Cancer Research Fund; Moore Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health grants CA125833 (to M. F.), Wendy Will Case Cancer Fund grant (to M.F.), Skin Cancer Foundation (to M.F.), Tadamitu Cancer Research Fund (to M. F.) and Moore Family Foundation (to W.A.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aaroe Jorgen, 2010, Breast Cancer Res, V12, pR7, DOI 10.1186/bcr2472; Abe M, 2003, CARCINOGENESIS, V24, P861, DOI 10.1093/carcin/bgg030; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Batliwalla FM, 2005, GENES IMMUN, V6, P388, DOI 10.1038/sj.gene.6364209; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bomprezzi R, 2003, HUM MOL GENET, V12, P2191, DOI 10.1093/hmg/ddg221; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Brentani RR, 2005, CRIT REV ONCOL HEMAT, V54, P95, DOI 10.1016/j.critrevonc.2004.12.006; Burczynski ME, 2005, CLIN CANCER RES, V11, P1181; Byrnes KR, 2006, GLIA, V53, P420, DOI 10.1002/glia.20295; Carr KM, 2003, ONCOGENE, V22, P3076, DOI 10.1038/sj.onc.1206448; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Coca S, 1997, CANCER-AM CANCER SOC, V79, P2320, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Wit NJW, 2005, BRIT J CANCER, V92, P2249, DOI 10.1038/sj.bjc.6602612; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Grant EP, 2002, ARTHRITIS RHEUM-US, V46, P874, DOI 10.1002/art.10014; Han M, 2008, CLIN CANCER RES, V14, P455, DOI 10.1158/1078-0432.CCR-07-1801; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Heller RA, 1997, P NATL ACAD SCI USA, V94, P2150, DOI 10.1073/pnas.94.6.2150; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hu MH, 1999, J BIOL CHEM, V274, P21515, DOI 10.1074/jbc.274.31.21515; Jaeger J, 2007, CLIN CANCER RES, V13, P806, DOI 10.1158/1078-0432.CCR-06-1820; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johansson M, 2008, IMMUNOL REV, V222, P145, DOI 10.1111/j.1600-065X.2008.00600.x; Keezer SM, 2003, CANCER RES, V63, P6405; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Koyanagi K, 2005, J CLIN ONCOL, V23, P8057, DOI 10.1200/JCO.2005.02.0958; Koyanagi K, 2010, CLIN CANCER RES, V16, P2402, DOI 10.1158/1078-0432.CCR-10-0037; Learn CA, 2006, CLIN CANCER RES, V12, P7306, DOI 10.1158/1078-0432.CCR-06-1727; Leek RD, 1996, CANCER RES, V56, P4625; Liu J, 2006, J MOL DIAGN, V8, P551, DOI 10.2353/jmoldx.2006.060021; Mandruzzato S, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-50; Marshall KW, 2010, INT J CANCER, V126, P1177, DOI 10.1002/ijc.24910; Martens HA, 2009, ANN RHEUM DIS, V68, P715, DOI 10.1136/ard.2007.085688; McDonald SL, 2004, CANCER BIOL THER, V3, P110, DOI 10.4161/cbt.3.1.662; Nambiar S, 2005, ARCH DERMATOL, V141, P165, DOI 10.1001/archderm.141.2.165; Osman I, 2006, CLIN CANCER RES, V12, P3374, DOI 10.1158/1078-0432.CCR-05-2081; Parrish ML, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-87; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Potti A, 2006, BLOOD, V107, P1391, DOI 10.1182/blood-2005-07-2669; Rainen L, 2002, CLIN CHEM, V48, P1883; Ramanathan M, 2001, J NEUROIMMUNOL, V116, P213, DOI 10.1016/S0165-5728(01)00308-3; Ridley A, 2000, NATURE, V406, P466, DOI 10.1038/35020170; Roll RL, 2000, J CELL BIOL, V150, P1461, DOI 10.1083/jcb.150.6.1461; Schaefer KL, 2002, VIRCHOWS ARCH, V440, P476, DOI 10.1007/s00428-001-0558-9; Segal NH, 2003, J CLIN ONCOL, V21, P1775, DOI 10.1200/JCO.2003.10.108; Sheu BC, 2001, J IMMUNOL, V167, P2972, DOI 10.4049/jimmunol.167.5.2972; Showe MK, 2009, CANCER RES, V69, P9202, DOI 10.1158/0008-5472.CAN-09-1378; Spielman L, 2002, ACTA NEUROPATHOL, V103, P157, DOI 10.1007/s004010100447; Staudt LM, 2002, ANNU REV MED, V53, P303, DOI 10.1146/annurev.med.53.082901.103941; Tan TT, 2007, CURR OPIN IMMUNOL, V19, P209, DOI 10.1016/j.coi.2007.01.001; Tang BMP, 2009, CRIT CARE MED, V37, P882, DOI 10.1097/CCM.0b013e31819b52fd; Thompson LJ, 2009, P NATL ACAD SCI USA, V106, P22433, DOI 10.1073/pnas.0912386106; Twine NC, 2003, CANCER RES, V63, P6069; Vartanian K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-2; Weeraratna AT, 2005, CANCER METAST REV, V24, P237, DOI 10.1007/s10555-005-1574-z; Weeraratna AT, 2004, ONCOGENE, V23, P2264, DOI 10.1038/sj.onc.1207337; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Wright C, 2008, CLIN CHEM, V54, P396, DOI 10.1373/clinchem.2007.093419; Xu Tianwen, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P596	63	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20971	10.1371/journal.pone.0020971	http://dx.doi.org/10.1371/journal.pone.0020971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698244	gold, Green Published, Green Submitted			2022-12-25	WOS:000291730000034
J	Maestre, AM; Garzon, A; Rodriguez, D				Maestre, Ana M.; Garzon, Ana; Rodriguez, Dolores			Equine Torovirus (BEV) Induces Caspase-Mediated Apoptosis in Infected Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; ACTIVATED PROTEIN-KINASE; 28S RIBOSOMAL-RNA; VIRUS-INDUCED APOPTOSIS; CYTOCHROME-C RELEASE; DEPENDENT APOPTOSIS; DIFFERENTIAL REQUIREMENTS; CULTURED-CELLS; SARS-COV; IN-VITRO	Toroviruses are gastroenteritis causing agents that infect different animal species and humans. To date, very little is known about how toroviruses cause disease. Here, we describe for the first time that the prototype member of this genus, the equine torovirus Berne virus (BEV), induces apoptosis in infected cells at late times postinfection. Observation of BEV infected cells by electron microscopy revealed that by 24 hours postinfection some cells exhibited morphological characteristics of apoptotic cells. Based on this finding, we analyzed several apoptotic markers, and observed protein synthesis inhibition, rRNA and DNA degradation, nuclear fragmentation, caspase-mediated cleavage of PARP and eIF4GI, and PKR and eIF2 alpha phosphorylation, all these processes taking place after peak virus production. We also determined that both cell death receptor and mitochondrial pathways are involved in the apoptosis process induced by BEV. BEV-induced apoptosis at late times postinfection, once viral progeny are produced, could facilitate viral dissemination in vivo and contribute to viral pathogenesis.	[Maestre, Ana M.; Garzon, Ana; Rodriguez, Dolores] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Maestre, AM (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA.	drodrig@cnb.csic.es	Merens, Ana Maestre/I-2445-2019; Rodriguez, Dolores/ABF-9855-2020	Merens, Ana Maestre/0000-0002-2494-0879; Rodriguez, Dolores/0000-0001-6365-4501	Spanish Ministry of Science and Education (MEC) [BIO2002-03739, BIO2005-08449, BIO2006-10988, CONSOLIDER CSD2006-00007]; MEC [AP2002-1806]	Spanish Ministry of Science and Education (MEC)(Spanish Government); MEC(European Commission)	This work was supported by grants BIO2002-03739, BIO2005-08449, BIO2006-10988 and CONSOLIDER CSD2006-00007, all financed by the Spanish Ministry of Science and Education (MEC). A.M.M. was recipient of a predoctoral scholarship "Formacion del Profesorado Universitario" (FPU) AP2002-1806 from the MEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SW, 1999, J VIROL, V73, P7853, DOI 10.1128/JVI.73.9.7853-7859.1999; Balachandran S, 2000, J VIROL, V74, P1513, DOI 10.1128/JVI.74.3.1513-1523.2000; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Banerjee S, 2000, J VIROL, V74, P8793, DOI 10.1128/JVI.74.19.8793-8802.2000; Belyavskyi M, 1998, VIROLOGY, V250, P41, DOI 10.1006/viro.1998.9356; Benedict CA, 2003, CURR OPIN IMMUNOL, V15, P59, DOI 10.1016/S0952-7915(02)00018-3; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Best SM, 2004, VIROLOGY, V320, P191, DOI 10.1016/j.virol.2003.11.025; Bisbal C, 2007, BIOCHIMIE, V89, P789, DOI 10.1016/j.biochi.2007.02.006; Bordi L, 2006, ARCH VIROL, V151, P369, DOI 10.1007/s00705-005-0632-8; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Castelli JC, 1998, CELL DEATH DIFFER, V5, P313, DOI 10.1038/sj.cdd.4400352; Castello A, 2006, J BIOL CHEM, V281, P33206, DOI 10.1074/jbc.M604340200; CAVANAGH D, 1994, ARCH VIROL, V135, P227, DOI 10.1007/BF01309782; Chen CJ, 2002, VIROLOGY, V302, P321, DOI 10.1006/viro.2002.1626; Clemens MJ, 2000, CELL DEATH DIFFER, V7, P603, DOI 10.1038/sj.cdd.4400695; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Collins AR, 2002, CLIN DIAGN LAB IMMUN, V9, P1392, DOI 10.1128/CDLI.9.6.1392-1395.2002; *COR STUD GROUP, 2008, 11 INT S NID OXF UK; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; De Martino L, 2010, VET MICROBIOL, V141, P36, DOI 10.1016/j.vetmic.2009.09.001; DeDiego ML, 2007, J VIROL, V81, P1701, DOI 10.1128/JVI.01467-06; DELIC J, 1993, INT J RADIAT BIOL, V64, P39, DOI 10.1080/09553009314551091; DENBOON JA, 1991, VIROLOGY, V182, P655, DOI 10.1016/0042-6822(91)90606-C; Der SD, 1997, P NATL ACAD SCI USA, V94, P3279, DOI 10.1073/pnas.94.7.3279; DiazGuerra M, 1997, VIROLOGY, V236, P354, DOI 10.1006/viro.1997.8719; Donze O, 1999, VIROLOGY, V256, P322, DOI 10.1006/viro.1999.9618; Eleouet JF, 1998, J VIROL, V72, P4918, DOI 10.1128/JVI.72.6.4918-4924.1998; Eleouet JF, 2000, J VIROL, V74, P3975, DOI 10.1128/JVI.74.9.3975-3983.2000; FLOYDSMITH G, 1981, SCIENCE, V212, P1030, DOI 10.1126/science.6165080; Gaddy DF, 2007, J VIROL, V81, P2792, DOI 10.1128/JVI.01760-06; Garzon A, 2006, ADV EXP MED BIOL, V581, P175; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Haagmans BL, 1996, J VIROL, V70, P8977, DOI 10.1128/JVI.70.12.8977-8983.1996; Hay S, 2002, J GEN VIROL, V83, P1547, DOI 10.1099/0022-1317-83-7-1547; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hirata H, 1998, J EXP MED, V187, P587, DOI 10.1084/jem.187.4.587; Hoet Armando E., 2004, Animal Health Research Reviews, V5, P157, DOI 10.1079/AHR200498; HORZINEK MC, 1985, J GEN VIROL, V66, P1287, DOI 10.1099/0022-1317-66-6-1287; HOUGE G, 1995, MOL CELL BIOL, V15, P2051; HOUGE G, 1993, FEBS LETT, V315, P16, DOI 10.1016/0014-5793(93)81123-H; Ito T, 2010, J CLIN MICROBIOL, V48, P1795, DOI 10.1128/JCM.02339-09; Jacomy H, 2003, VIROLOGY, V315, P20, DOI 10.1016/S0042-6822(03)00323-4; Jeffrey IW, 2002, CANCER RES, V62, P2272; Kaufman RJ, 1999, P NATL ACAD SCI USA, V96, P11693, DOI 10.1073/pnas.96.21.11693; KAUFMAN RJ, 2000, DOUBLE STRANDED RNA; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim B, 2000, J COMP PATHOL, V123, P64, DOI 10.1053/jcpa.2000.0386; Koyama AH, 2000, MICROBES INFECT, V2, P1111, DOI 10.1016/S1286-4579(00)01265-X; Krahling V, 2009, J VIROL, V83, P2298, DOI 10.1128/JVI.01245-08; Kuwabara M, 2007, CLIN VACCINE IMMUNOL, V14, P998, DOI 10.1128/CVI.00475-06; LEE SB, 1994, VIROLOGY, V199, P491, DOI 10.1006/viro.1994.1151; LEE SK, 1994, J VET MED SCI, V56, P879, DOI 10.1292/jvms.56.879; LEVIN D, 1978, P NATL ACAD SCI USA, V75, P1121, DOI 10.1073/pnas.75.3.1121; Li FQ, 2007, VIROLOGY, V365, P435, DOI 10.1016/j.virol.2007.04.015; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liu C, 2001, J VIROL, V75, P6402, DOI 10.1128/JVI.75.14.6402-6409.2001; Liu Y, 2007, VIROLOGY, V360, P364, DOI 10.1016/j.virol.2006.10.044; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Marissen WE, 1998, MOL CELL BIOL, V18, P7565, DOI 10.1128/MCB.18.12.7565; Mizutani T, 2004, VIROLOGY, V327, P169, DOI 10.1016/j.virol.2004.07.005; Morley SJ, 2000, FEBS LETT, V477, P229, DOI 10.1016/S0014-5793(00)01805-6; Nadano D, 2000, J BIOL CHEM, V275, P13967, DOI 10.1074/jbc.275.18.13967; Pignatelli J, 2009, VIRUS RES, V143, P33, DOI 10.1016/j.virusres.2009.02.019; POHLENZ JFL, 1984, VET PATHOL, V21, P407, DOI 10.1177/030098588402100407; Ren LL, 2005, DNA CELL BIOL, V24, P496, DOI 10.1089/dna.2005.24.496; Ruggieri A, 2007, VET MICROBIOL, V121, P64, DOI 10.1016/j.vetmic.2006.12.016; Rusch L, 2000, J INTERF CYTOK RES, V20, P1091, DOI 10.1089/107999000750053762; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Slee EA, 1996, BIOCHEM J, V315, P21, DOI 10.1042/bj3150021; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; SNIJDER EJ, 1993, J GEN VIROL, V74, P2305, DOI 10.1099/0022-1317-74-11-2305; SNIJDER EJ, 1989, J GEN VIROL, V70, P3363, DOI 10.1099/0022-1317-70-12-3363; SNIJDER EJ, 1990, VIROLOGY, V178, P355, DOI 10.1016/0042-6822(90)90332-L; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Suzuki K, 2008, VET MICROBIOL, V129, P390, DOI 10.1016/j.vetmic.2007.11.034; TAKIZAWA T, 1995, VIROLOGY, V209, P288, DOI 10.1006/viro.1995.1260; Takizawa T, 1996, J VIROL, V70, P8128, DOI 10.1128/JVI.70.11.8128-8132.1996; Teodoro JG, 1997, J VIROL, V71, P1739, DOI 10.1128/JVI.71.3.1739-1746.1997; Thomson BJ, 2001, INT J EXP PATHOL, V82, P65, DOI 10.1111/j.1365-2613.2001.iep195.x; van Vliet ALW, 2002, EMBO J, V21, P6571, DOI 10.1093/emboj/cdf635; WEISS M, 1983, J GEN VIROL, V64, P1849, DOI 10.1099/0022-1317-64-9-1849; WEISS M, 1986, J GEN VIROL, V67, P1305, DOI 10.1099/0022-1317-67-7-1305; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; WOODE GN, 1984, J CLIN MICROBIOL, V19, P623, DOI 10.1128/JCM.19.5.623-630.1984; WOODE GN, 1982, VET MICROBIOL, V7, P221, DOI 10.1016/0378-1135(82)90036-0; Yan HM, 2004, J MED VIROL, V73, P323, DOI 10.1002/jmv.20094; Yi XL, 2003, J BIOL CHEM, V278, P16992, DOI 10.1074/jbc.M300039200; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D	92	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20972	10.1371/journal.pone.0020972	http://dx.doi.org/10.1371/journal.pone.0020972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698249	Green Published, gold			2022-12-25	WOS:000291730000035
J	Sueur, J; Mackie, D; Windmill, JFC				Sueur, Jerome; Mackie, David; Windmill, James F. C.			So Small, So Loud: Extremely High Sound Pressure Level from a Pygmy Aquatic Insect (Corixidae, Micronectinae)	PLOS ONE			English	Article							STRIDULATION; HETEROPTERA; GENERATION; EFFICIENCY; PREDATORS; SIGNALS; STICK; SLIP	To communicate at long range, animals have to produce intense but intelligible signals. This task might be difficult to achieve due to mechanical constraints, in particular relating to body size. Whilst the acoustic behaviour of large marine and terrestrial animals has been thoroughly studied, very little is known about the sound produced by small arthropods living in freshwater habitats. Here we analyse for the first time the calling song produced by the male of a small insect, the water boatman Micronecta scholtzi. The song is made of three distinct parts differing in their temporal and amplitude parameters, but not in their frequency content. Sound is produced at 78.9 (63.6-82.2) SPL rms re 2.10(-5) Pa with a peak at 99.2 (85.7-104.6) SPL re 2.10(-5) Pa estimated at a distance of one metre. This energy output is significant considering the small size of the insect. When scaled to body length and compared to 227 other acoustic species, the acoustic energy produced by M. scholtzi appears as an extreme value, outperforming marine and terrestrial mammal vocalisations. Such an extreme display may be interpreted as an exaggerated secondary sexual trait resulting from a runaway sexual selection without predation pressure.	[Sueur, Jerome] Museum Natl Hist Nat, Dept Syst & Evolut, UMR CNRS Origine Struct & Evolut Biodiversite 720, Paris, France; [Mackie, David; Windmill, James F. C.] Univ Strathclyde, Dept Elect & Elect Engn, Ctr Ultrason Engn, Glasgow G1 1XW, Lanark, Scotland	Museum National d'Histoire Naturelle (MNHN); University of Strathclyde	Sueur, J (corresponding author), Museum Natl Hist Nat, Dept Syst & Evolut, UMR CNRS Origine Struct & Evolut Biodiversite 720, Paris, France.	sueur@mnhn.fr	Sueur, Jerome/G-5364-2011; Windmill, James F C/I-1117-2019	Windmill, James F C/0000-0003-4878-349X	Royal Society (London) [JP080761]; BBSRC [BB/H004637/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H004637/1] Funding Source: researchfish	Royal Society (London)(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Royal Society (London) International Joint Project grant (JP080761). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN RB, 1982, ANIM BEHAV, V30, P54, DOI 10.1016/S0003-3472(82)80237-6; Aiken RB, 1985, BIOL REV, V65, P163; Alexander Richard D., 1997, P4, DOI 10.1017/CBO9780511721946.002; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1998, PRINCIPLES ANIMAL CO; [Anonymous], 1994, SEXUAL SELECTION; Au W. W., 1993, SONAR DOLPHINS; Bennet-Clark HC, 1999, J EXP BIOL, V202, P3347; Bennet-Clark HC, 1998, PHILOS T ROY SOC B, V353, P407, DOI 10.1098/rstb.1998.0219; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; DAMBACH M, 1995, J EXP BIOL, V198, P721; Duellman W. E., 1986, BIOL AMPHIBIANS; Fisher R.A., 1930, GENETICAL THEORY NAT; Fletcher N. H., 1992, ACOUSTIC SYSTEMS BIO; Fletcher NH, 2004, J ACOUST SOC AM, V115, P2334, DOI 10.1121/1.1694997; FORREST TG, 1991, BEHAV ECOL, V2, P327, DOI 10.1093/beheco/2.4.327; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Greenfield MD, 2002, SIGNALERS RECEIVERS; Hartmann WH., 1998, SIGNALS SOUND SENSAT; Hill Stephanie A., 2007, Journal of Orthoptera Research, V16, P35, DOI 10.1665/1082-6467(2007)16[35:SGIMRM]2.0.CO;2; JANSSON A, 1989, ANN ENTOMOL FENN, V55, P161; JANSSON A, 1973, BEHAVIOUR, V46, P1, DOI 10.1163/156853973X00157; King I. M., 1999, Bioacoustics, V10, P115; King Ian M., 1999, Bioacoustics, V10, P19; King Ian M., 1999, Bioacoustics, V9, P297; Lardner B, 2002, NATURE, V420, P475, DOI 10.1038/420475a; LEACH M, 2003, INTRO ELECTROACOUSTI; Limousin D, 2009, J EXP BIOL, V212, P4091, DOI 10.1242/jeb.035345; PARSONS M C, 1976, Psyche (Cambridge), V83, P132, DOI 10.1155/1976/95167; Patek SN, 2007, J EXP BIOL, V210, P3538, DOI 10.1242/jeb.009084; Patek SN, 2001, NATURE, V411, P153, DOI 10.1038/35075656; Poole JH, 1999, ANIM BEHAV, V58, P185, DOI 10.1006/anbe.1999.1117; PRAGER J, 1982, J COMP PHYSIOL, V148, P323, DOI 10.1007/BF00679017; Renaud O, 2010, J STAT PLAN INFER, V140, P1852, DOI 10.1016/j.jspi.2010.01.008; Specht R., 2004, AVISOFT SAS LAB PRO; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; THEISS J, 1982, BEHAV ECOL SOCIOBIOL, V10, P225, DOI 10.1007/BF00299689; Windmill JFC, 2006, CURR BIOL, V16, P2418, DOI 10.1016/j.cub.2006.09.066; YOHAI VJ, 1987, ANN STAT, V15, P642, DOI 10.1214/aos/1176350366; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412; Zuk M, 2006, BIOL LETTERS, V2, P521, DOI 10.1098/rsbl.2006.0539; [No title captured]; [No title captured]; [No title captured]; [No title captured]	45	30	30	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21089	10.1371/journal.pone.0021089	http://dx.doi.org/10.1371/journal.pone.0021089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698252	Green Accepted, Green Published, gold			2022-12-25	WOS:000291730000051
J	Gamble, LD; Kees, UR; Tweddle, DA; Lunec, J				Gamble, L. D.; Kees, U. R.; Tweddle, D. A.; Lunec, J.			MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63	ONCOGENE			English	Article						MYCN; neuroblastoma; MDM2-p53 antagonists; apoptosis; growth inhibition	DIRECT TRANSCRIPTIONAL TARGET; P53 GENE-MUTATIONS; N-MYC; P53-DEPENDENT APOPTOSIS; IN-VIVO; P53/MDM2/P14(ARF) PATHWAY; G(1) ARREST; DNA-DAMAGE; CELL-DEATH; AMPLIFICATION	MYCN amplification is a major biomarker of poor prognosis, occurring in 25-30% of neuroblastomas. MYCN has contradictory roles in promoting cell growth and sensitizing cells to apoptosis. We have recently shown that p53 is a direct transcriptional target of MYCN in neuroblastoma and that p53-mediated apoptosis may be an important mechanism of MYCN-induced apoptosis. Although p53 mutations are rare in neuroblastoma at diagnosis, the p53/MDM2/p14(ARF) pathway is often inactivated through MDM2 amplification or p14(ARF) inactivation. We hypothesized that reactivation of p53 by inhibition of its negative regulator MDM2, using the MDM2-p53 antagonists Nutlin-3 and MI-63, will result in p53-mediated growth arrest and apoptosis especially in MYCN-amplified cells. Using the SHEP Tet21N MYCN-regulatable system, MYCN(-) cells were more resistant to both Nutlin-3 and MI-63 mediated growth inhibition and apoptosis compared with MYCN(+) cells and siRNA-mediated knockdown of MYCN in four MYCN-amplified cell lines resulted in decreased p53 expression and activation, as well as decreased levels of apoptosis following treatment with MDM2-p53 antagonists. In a panel of 18 neuroblastoma cell lines treated with Nutlin-3 and MI-63, the subset amplified for MYCN had a significantly lower mean GI(50) value (50% growth inhibition) and increased caspase 3/7 activity compared with the non-MYCN-amplified group of cell lines, but p53 mutant cell lines were resistant to the antagonists regardless of MYCN status. We conclude that amplification or overexpression of MYCN sensitizes neuroblastoma cell lines with wild-type p53 to MDM2-p53 antagonists and that these compounds may therefore be particularly effective in treating high-risk MYCN-amplified disease. Oncogene (2012) 31, 752-763; doi:10.1038/onc.2011.270; published online 4 July 2011	[Lunec, J.] Newcastle Univ, Sch Med, No Inst Canc Res, Newcastle Canc Ctr, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Kees, U. R.] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia	Newcastle University - UK; Telethon Kids Institute; University of Western Australia	Lunec, J (corresponding author), Newcastle Univ, Sch Med, No Inst Canc Res, Newcastle Canc Ctr, Paul OGorman Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	John.Lunec@newcastle.ac.uk		Gamble, Laura D./0000-0001-8496-9705; Lunec, John/0000-0002-1878-8583	Cancer Research UK	Cancer Research UK(Cancer Research UK)	We thank the following for cell lines: Sue Cohn (NBLW and NBLS), Linda Harris (SJNB1), Penny Lovat (SHSY5Y, SHEP and IMR32), John Maris (NB69), Patrick Reynolds (SKNRA, SMSKCNR, LAN5, LAN6 and CHLA136), Manfred Schwab (LS and SHEP Tet21N), Rogier Versteeg (NGP), Barbara Spengler (SKNBe2C), Micro Ponzoni (GIMEN), Ursula Kees (PER108), Maria Lastowska (TR14), Clinton Stewart (NB1691) and Jean Benard (SKNAS, IGRN91). We are grateful to Mike Cole (Newcastle Cancer Centre, Newcastle University) for his statistical advice and to Cancer Research UK for funding this work. This study is supported by Cancer Research UK.	Alt JR, 2003, EMBO J, V22, P1442, DOI 10.1093/emboj/cdg133; Amente S, 2007, FEBS LETT, V581, P821, DOI 10.1016/j.febslet.2007.01.062; Barbieri E, 2006, MOL CANCER THER, V5, P2358, DOI 10.1158/1535-7163.MCT-06-0305; Bell E, 2006, CELL CYCLE, V5, P2639, DOI 10.4161/cc.5.22.3443; Canner JA, 2009, BRIT J CANCER, V101, P774, DOI 10.1038/sj.bjc.6605199; Carr J, 2006, CANCER RES, V66, P2138, DOI 10.1158/0008-5472.CAN-05-2623; Carr-Wilkinson J, 2010, CLIN CANCER RES, V16, P1108, DOI 10.1158/1078-0432.CCR-09-1865; Chen LD, 2010, CANCER RES, V70, P1377, DOI 10.1158/0008-5472.CAN-09-2598; Chen ZW, 2009, NEOPLASIA, V11, P753, DOI 10.1593/neo.09466; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Cohn SL, 2004, EUR J CANCER, V40, P2639, DOI 10.1016/j.ejca.2004.07.025; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; CORVI R, 1995, ONCOGENE, V10, P1081; Demidenko ZN, 2010, P NATL ACAD SCI USA, V107, P9660, DOI 10.1073/pnas.1002298107; Efeyan A, 2007, CANCER RES, V67, P7350, DOI 10.1158/0008-5472.CAN-07-0200; Fulda S, 2000, MED PEDIATR ONCOL, V35, P582, DOI 10.1002/1096-911X(20001201)35:6<582::AID-MPO19>3.0.CO;2-2; Goldman SC, 1996, AM J PATHOL, V148, P1381; Hogarty MD, 2003, CANCER LETT, V197, P173, DOI 10.1016/S0304-3835(03)00103-4; HOSOI G, 1994, CANCER, V73, P3087, DOI 10.1002/1097-0142(19940615)73:12<3087::AID-CNCR2820731230>3.0.CO;2-9; Kang JH, 2006, BIOCHEM BIOPH RES CO, V351, P192, DOI 10.1016/j.bbrc.2006.10.020; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160; Lutz W, 1996, ONCOGENE, V13, P803; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Michalak E, 2005, BIOCHEM BIOPH RES CO, V331, P786, DOI 10.1016/j.bbrc.2005.03.183; Muller CR, 2007, INT J CANCER, V121, P199, DOI 10.1002/ijc.22643; Petroni M, 2011, MOL CANCER RES, V9, P67, DOI 10.1158/1541-7786.MCR-10-0227; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Slack A, 2005, CELL CYCLE, V4, P857, DOI 10.4161/cc.4.7.1790; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Tweddle DA, 2003, CANCER LETT, V197, P93, DOI 10.1016/S0304-3835(03)00088-0; Tweddle DA, 2001, AM J PATHOL, V158, P2067, DOI 10.1016/S0002-9440(10)64678-0; Van Maerken T, 2006, CANCER RES, V66, P9646, DOI 10.1158/0008-5472.CAN-06-0792; Van Maerken T, 2011, MOL CANCER THER, V10, P983, DOI 10.1158/1535-7163.MCT-10-1090; van Noesel MM, 2004, GENE, V325, P1, DOI 10.1016/j.gene.2003.09.042; van Noesel MM, 2003, CANCER LETT, V197, P165, DOI 10.1016/S0304-3835(03)00101-0; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; VOGAN K, 1993, CANCER RES, V53, P5269; Wang P, 2006, ONCOGENE, V25, P3708, DOI 10.1038/sj.onc.1209411; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; WENZEL A, 1991, EMBO J, V10, P3703, DOI 10.1002/j.1460-2075.1991.tb04938.x; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	44	57	58	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2012	31	6					752	763		10.1038/onc.2011.270	http://dx.doi.org/10.1038/onc.2011.270			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MU	21725357	Green Accepted, Bronze			2022-12-25	WOS:000300222100008
J	Kais, Z; Chiba, N; Ishioka, C; Parvin, JD				Kais, Z.; Chiba, N.; Ishioka, C.; Parvin, J. D.			Functional differences among BRCA1 missense mutations in the control of centrosome duplication	ONCOGENE			English	Article						BRCA1; breast cancer; centrosomes; RING domain	POLYMERASE-II HOLOENZYME; UBIQUITIN-LIGASE; TRANSCRIPTIONAL ACTIVATION; CANCER SUSCEPTIBILITY; CELL-CYCLE; BREAST; IDENTIFICATION; AMPLIFICATION; INTERACT; BINDING	We analyzed the effects of 14 different missense mutations in the RING domain of BRCA1 on the function of the protein in the control of centrosome number in tissue culture cells. Whereas 2 of the 14 BRCA1 variant proteins were neutral in the centrosome duplication assay, missense mutations of zinc-coordinating residues (C24R, C27A, C39Y, H41F, C44F and C47G) and mutations encoding BRCA1 variants M18T and I42V resulted in BRCA1 proteins that caused centrosome amplification. BRCA1 variant proteins I21V, I31M, L52F and D67Y had an intermediate effect on centrosome duplication. In addition, one of the variants, L52F, caused a peculiar phenotype with amplified centrosomes but the centrioles remained paired. By comparison, other BRCA1 variants that caused centrosome amplification had clustering of supernumerary centrosomes with unpaired centrioles. This surprising phenotype suggests that the BRCA1 protein regulates two functions in the control of centrosome duplication: regulation of centrosome number and regulation of centriole pairing. The L52F is unusual as it is defective in only one of these processes. This study analyzes the function of BRCA1 missense mutations in the control of centrosome duplication, a critical step in the maintenance of genetic stability of mammary epithelial cells, and indicates a new function of BRCA1 in the control of centriole pairing. Oncogene (2012) 31, 799-804; doi:10.1038/onc.2011.271; published online 4 July 2011	[Kais, Z.; Parvin, J. D.] Ohio State Univ, Ctr Comprehens Canc, Dept Biomed Informat, Columbus, OH 43210 USA; [Chiba, N.] Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Immunol, Sendai, Miyagi 980, Japan; [Ishioka, C.] Tohoku Univ, Inst Dev Aging & Canc, Dept Clin Oncol, Sendai, Miyagi 980, Japan	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Tohoku University; Tohoku University	Parvin, JD (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Dept Biomed Informat, 904 Biomed Res Tower,460 W 12th Ave, Columbus, OH 43210 USA.	Jeffrey.Parvin@osumc.edu	Parvin, Jeffrey D/C-8955-2009	Ishioka, Chikashi/0000-0002-3023-1227	NIH [CA111480]; NATIONAL CANCER INSTITUTE [R01CA111480, P30CA016058] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH Grant CA111480 (JDP).	Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chiba N, 2002, CANCER RES, V62, P4222; D'Assoro AB, 2001, MARC MALPIG SYMP SER, V7, P103; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Haile DT, 1999, J BIOL CHEM, V274, P2113, DOI 10.1074/jbc.274.4.2113; Houvras Y, 2000, J BIOL CHEM, V275, P36230, DOI 10.1074/jbc.M002539200; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Kais Z, 2008, CANCER BIOL THER, V7, P1540, DOI 10.4161/cbt.7.10.7053; MacLachlan TK, 2000, J BIOL CHEM, V275, P2777, DOI 10.1074/jbc.275.4.2777; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Morris JR, 2006, HUM MOL GENET, V15, P599, DOI 10.1093/hmg/ddi476; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Pao GM, 2000, P NATL ACAD SCI USA, V97, P1020, DOI 10.1073/pnas.97.3.1020; Ransburgh DJR, 2010, CANCER RES, V70, P988, DOI 10.1158/0008-5472.CAN-09-2850; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Sankaran S, 2007, CANCER BIOL THER, V6, P1853, DOI 10.4161/cbt.6.12.5164; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Sinilnikova OM, 2006, FAM CANCER, V5, P15, DOI 10.1007/s10689-005-2571-7; Sluder G, 2004, CURR OPIN CELL BIOL, V16, P49, DOI 10.1016/j.ceb.2003.11.006; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Vega A, 2001, Hum Mutat, V17, P520, DOI 10.1002/humu.1136; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9	26	39	39	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2012	31	6					799	804		10.1038/onc.2011.271	http://dx.doi.org/10.1038/onc.2011.271			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MU	21725363	Green Accepted			2022-12-25	WOS:000300222100012
J	Luo, Y; Zheng, C; Zhang, J; Lu, D; Zhuang, J; Xing, S; Feng, J; Yang, D; Yan, X				Luo, Y.; Zheng, C.; Zhang, J.; Lu, D.; Zhuang, J.; Xing, S.; Feng, J.; Yang, D.; Yan, X.			Recognition of CD146 as an ERM-binding protein offers novel mechanisms for melanoma cell migration	ONCOGENE			English	Article						cell migration; CD146; ERM proteins; RhoA; RhoGDI1	PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE; ANTI-CD146 MONOCLONAL-ANTIBODY; PLASMA-MEMBRANE; INHIBITS ANGIOGENESIS; ADHESION MOLECULE; RHO-FAMILY; EXPRESSION; EZRIN/RADIXIN/MOESIN; ACTIVATION; MUC18	Tumor cell migration is a well-orchestrated multistep process that drives cancer development and metastasis. Previous data indicated that CD146 expression correlates with malignant progression and metastatic potential of human melanoma cells. However, the exact molecular mechanism of how CD146 promotes melanoma cell migration still remains poorly understood. Here, we report that CD146 physically interacts with actin-linking ezrin-radixin-moesin (ERM) proteins and recruits ERM proteins to cell protrusions, promoting the formation and elongation of microvilli. Moreover, CD146-promoted melanoma cell migration is linked to RhoA activation and ERM phosphorylation. CD146 recruits Rho guanine nucleotide dissociation inhibitory factors 1 (RhoGDI1) through ERM proteins and thus sequesters RhoGDI1 from RhoA, which leads to upregulated RhoA activity and increased melanoma cell motility. CD146-activated RhoA also promotes further ERM phosphorylation and activation through Rho-phosphatidylinositol-4-phosphate-5-kinase-phosphatidylinositol 4,5-biphosphate pathway, which reinforces CD146/ERM association. Thus, our results provide a mechanistic basis to understand the role of CD146 in regulating human melanoma cell motility. Oncogene (2012) 31, 306-321; doi:10.1038/onc.2011.244; published online 4 July 2011	[Luo, Y.; Zheng, C.; Zhang, J.; Lu, D.; Zhuang, J.; Xing, S.; Feng, J.; Yang, D.; Yan, X.] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Luo, Y.; Zheng, C.; Zhang, J.; Lu, D.; Zhuang, J.; Xing, S.; Feng, J.; Yang, D.; Yan, X.] Chinese Acad Sci, Inst Biophys, Chinese Acad Sci Univ Tokyo Joint Lab Struct Viro, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Yan, X (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	yanxy@ibp.ac.cn	Zheng, Chaogu/P-2753-2019; Lu, Di/D-9836-2018	Zheng, Chaogu/0000-0002-5048-4520; Lu, Di/0000-0002-4083-1656; Luo, Yongting/0000-0001-7834-8742	National 863 Grant [2006AA02A245]; National Basic Research Program of China (973 Program) [2009CB521704, 2011CB933503]; National Important Science and Technology Specific Projects [2008ZX10004-005, 2008ZX10002-017, 2009ZX09102-247]; National Natural Science Foundation of China [91029732]; Chinese Academy of Sciences [KSCX2-YW-R-121, KSCX2-YW-R-173, KSCX2-YW-M15]	National 863 Grant; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Important Science and Technology Specific Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank Dr J Johnson for providing the CD146-transfected Mel-888<SUP>CD146</SUP> cells and CD146 gene contained in pUC-CD146 plasmids. This work is partly supported by grants from the National 863 Grant (2006AA02A245), the National Basic Research Program of China (973 Program) (2009CB521704, 2011CB933503), the National Important Science and Technology Specific Projects (2008ZX10004-005, 2008ZX10002-017, 2009ZX09102-247), the National Natural Science Foundation of China (91029732) and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-YW-R-121, KSCX2-YW-R-173, KSCX2-YW-M15).	Aldovini D, 2006, INT J CANCER, V119, P1920, DOI 10.1002/ijc.22082; Lacalle RA, 2007, J CELL BIOL, V179, P1539, DOI 10.1083/jcb.200705044; Anfosso F, 1998, J BIOL CHEM, V273, P26852, DOI 10.1074/jbc.273.41.26852; Bani MR, 1996, CANCER RES, V56, P3075; Barreiro O, 2004, FRONT BIOSCI-LANDMRK, V9, P1849, DOI 10.2741/1285; Barrero-Villar M, 2008, J IMMUNOL, V181, P6882, DOI 10.4049/jimmunol.181.10.6882; Bartolome RA, 2008, CANCER RES, V68, P8221, DOI 10.1158/0008-5472.CAN-08-0561; Bidlingmaier S, 2009, CANCER RES, V69, P1570, DOI 10.1158/0008-5472.CAN-08-1363; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Bretscher A, 1997, J CELL SCI, V110, P3011; Bu PC, 2006, MOL CANCER THER, V5, P2872, DOI 10.1158/1535-7163.MCT-06-0260; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Gervais L, 2008, DEVELOPMENT, V135, P3829, DOI 10.1242/dev.029009; Guezguez B, 2006, FEBS LETT, V580, P3649, DOI 10.1016/j.febslet.2006.05.048; Hebert M, 2008, J IMMUNOL, V181, P5963, DOI 10.4049/jimmunol.181.9.5963; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Johnson JP, 1997, INT J CANCER, V73, P769; JOHNSON JP, 1993, MELANOMA RES, V3, P337, DOI 10.1097/00008390-199310000-00006; Kristiansen G, 2003, ANAL CELL PATHOL, V25, P77, DOI 10.1155/2003/574829; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Li G, 2002, CRIT REV ORAL BIOL M, V13, P62, DOI 10.1177/154411130201300107; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; LUCA M, 1993, MELANOMA RES, V3, P35, DOI 10.1097/00008390-199304000-00006; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Masiero L, 1999, J CELL SCI, V112, P3205; Matsui T, 1999, CURR BIOL, V9, P1259, DOI 10.1016/S0960-9822(99)80508-9; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; McClatchey AI, 2009, TRENDS CELL BIOL, V19, P198, DOI 10.1016/j.tcb.2009.02.006; Molina-Ortiz I, 2009, J BIOL CHEM, V284, P15147, DOI 10.1074/jbc.M807834200; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Oleksy A, 2006, J BIOL CHEM, V281, P32891, DOI 10.1074/jbc.M606220200; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Ouhtit A, 2009, BBA-REV CANCER, V1795, P130, DOI 10.1016/j.bbcan.2009.01.002; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Saci A, 2005, MOL CELL, V17, P205, DOI 10.1016/j.molcel.2004.12.012; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578, DOI 10.1074/jbc.272.12.7578; Shih IM, 1997, CANCER RES, V57, P3835; SHIH IM, 1994, CANCER RES, V54, P2514; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Wu GJ, 2004, GENE, V327, P201, DOI 10.1016/j.gene.2003.11.018; Wu GJ, 2001, GENE, V279, P17, DOI 10.1016/S0378-1119(01)00736-3; Xie SH, 1997, CANCER RES, V57, P2295; Yan XY, 2003, BLOOD, V102, P184, DOI 10.1182/blood-2002-04-1004; Yang NY, 2006, J BIOL CHEM, V281, P32574, DOI 10.1074/jbc.M604338200; Zheng CG, 2009, INT J BIOCHEM CELL B, V41, P2163, DOI 10.1016/j.biocel.2009.03.014	55	105	124	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	3					306	321		10.1038/onc.2011.244	http://dx.doi.org/10.1038/onc.2011.244			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	882DQ	21725352				2022-12-25	WOS:000299542100004
J	Decaillot, FM; Kazmi, MA; Lin, Y; Ray-Saha, S; Sakmar, TP; Sachdev, P				Decaillot, Fabien M.; Kazmi, Manija A.; Lin, Ying; Ray-Saha, Sarmistha; Sakmar, Thomas P.; Sachdev, Pallavi			CXCR7/CXCR4 Heterodimer Constitutively Recruits beta-Arrestin to Enhance Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR7; ERK ACTIVATION; EXPRESSION; BREAST; PROLIFERATION; LIGAND; MAPK; BETA-ARRESTIN-1; CXCL12/SDF-1; DIMERIZATION	G protein-coupled receptor hetero-oligomerization is emerging as an important regulator of ligand-dependent transmembrane signaling, but precisely how receptor heteromers affect receptor pharmacology remains largely unknown. In this study, we have attempted to identify the functional significance of the heteromeric complex between CXCR4 and CXCR7 chemokine receptors. We demonstrate that co-expression of CXCR7 with CXCR4 results in constitutive recruitment of beta-arrestin to the CXCR4 center dot CXCR7 complex and simultaneous impairment of G(i)-mediated signaling. CXCR7/CXCR4 co-expression also results in potentiation of CXCL12 (SDF-1)-mediated downstream beta-arrestin-dependent cell signaling pathways, including ERK1/2, p38 MAPK, and SAPK as judged from the results of experiments using siRNA knockdown to deplete beta-arrestin. Interestingly, CXCR7/CXCR4 co-expression enhances cell migration in response to CXCL12 stimulation. Again, inhibition of beta-arrestin using either siRNA knockdown or a dominant negative mutant abrogates the enhanced CXCL12-dependent migration of CXCR4/CXCR7-expressing cells. These results show how CXCR7, which cannot signal directly through G protein-linked pathways, can nevertheless affect cellular signaling networks by forming a heteromeric complex with CXCR4. The CXCR4 center dot CXCR7 heterodimer complex recruits beta-arrestin, resulting in preferential activation of beta-arrestin-linked signaling pathways over canonical G protein pathways. CXCL12-dependent signaling of CXCR4 and its role in cellular physiology, including cancer metastasis, should be evaluated in the context of potential functional hetero-oligomerization with CXCR7.	[Decaillot, Fabien M.; Kazmi, Manija A.; Lin, Ying; Ray-Saha, Sarmistha; Sakmar, Thomas P.; Sachdev, Pallavi] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA	Rockefeller University	Sakmar, TP (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, 1230 York Ave, New York, NY 10065 USA.	sakmar@rockefeller.edu; Pallavi_Sachdev@eisai.com	Sakmar, Thomas P/D-1833-2015	Sakmar, Thomas P/0000-0002-2836-8953	National Institutes of Health from NIDDK [5T32 DK07313]; Tri-Institutional Stem Cell Initiative; Murray Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007313] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Tri-Institutional Stem Cell Initiative; Murray Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5T32 DK07313 from NIDDK. This work was also supported by the Tri-Institutional Stem Cell Initiative and the Murray Foundation.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Alkhatib G, 2009, CURR OPIN HIV AIDS, V4, P96, DOI 10.1097/COH.0b013e328324bbec; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bjorndal A, 1997, J VIROL, V71, P7478; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Byers MA, 2008, J IMMUNOL, V181, P4723, DOI 10.4049/jimmunol.181.7.4723; Calatozzolo C, 2011, CANCER BIOL THER, V11, P242, DOI 10.4161/cbt.11.2.13951; Cheng ZJ, 2000, J BIOL CHEM, V275, P2479, DOI 10.1074/jbc.275.4.2479; Chu YW, 2007, CANCER IMMUNOL IMMUN, V56, P1539, DOI 10.1007/s00262-007-0296-1; D'Alterio C, 2010, CURR CANCER DRUG TAR, V10, P772, DOI 10.2174/156800910793605839; Decaillot FM, 2008, P NATL ACAD SCI USA, V105, P16045, DOI 10.1073/pnas.0804106105; do Carmo A, 2010, CANCER BIOL THER, V9, P56, DOI 10.4161/cbt.9.1.10342; Ehtesham M, 2009, CANCER LETT, V274, P305, DOI 10.1016/j.canlet.2008.09.034; El-Asmar L, 2005, MOL PHARMACOL, V67, P460, DOI 10.1124/mol.104.003624; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Fulton AM, 2009, CURR ONCOL REP, V11, P125, DOI 10.1007/s11912-009-0019-1; Ge L, 2004, J BIOL CHEM, V279, P55419, DOI 10.1074/jbc.M410312200; Ge L, 2003, J BIOL CHEM, V278, P34418, DOI 10.1074/jbc.M300573200; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gravel S, 2010, J BIOL CHEM, V285, P37939, DOI 10.1074/jbc.C110.147470; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Iwakiri S, 2009, CANCER-AM CANCER SOC, V115, P2580, DOI 10.1002/cncr.24281; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Lodowski DT, 2009, CURR OPIN HIV AIDS, V4, P88, DOI 10.1097/COH.0b013e3283223d8d; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Milligan G, 2007, ERNST SCHERING FOUND, V2, P145, DOI 10.1007/2789_2006_007; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy PM, 2000, PHARMACOL REV, V52, P145; Novi F, 2005, J BIOL CHEM, V280, P19768, DOI 10.1074/jbc.M411281200; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Raggo C, 2005, CANCER RES, V65, P5084, DOI 10.1158/0008-5472.CAN-04-2822; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rozenfeld R, 2007, FASEB J, V21, P2455, DOI 10.1096/fj.06-7793com; Salmaggi A, 2009, CANCER BIOL THER, V8, P1615, DOI 10.4161/cbt.8.17.9202; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Ulvmar MH, 2011, EXP CELL RES, V317, P556, DOI 10.1016/j.yexcr.2011.01.012; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Walser Tonya C, 2004, Breast Dis, V20, P137; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wu MH, 2008, J CELL PHYSIOL, V214, P65, DOI 10.1002/jcp.21163; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zlotnik A, 2006, CONTRIB MICROBIOL, V13, P191, DOI 10.1159/000092973; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024	66	259	265	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32188	32197		10.1074/jbc.M111.277038	http://dx.doi.org/10.1074/jbc.M111.277038			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21730065	Green Published, hybrid			2022-12-25	WOS:000294726800029
J	Ngo, S; Gu, L; Guo, ZF				Ngo, Sam; Gu, Lei; Guo, Zhefeng			Hierarchical Organization in the Amyloid Core of Yeast Prion Protein Ure2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN FIBRILS; BETA-SHEET STRUCTURE; SOLID-STATE NMR; SPIN-LABELED PROTEINS; SACCHAROMYCES-CEREVISIAE; STRUCTURAL FEATURES; SIDE-CHAINS; IN-VITRO; PARALLEL; DOMAIN	Formation of amyloid fibrils is involved in a range of fatal human disorders including Alzheimer, Parkinson, and prion diseases. Yeast prions, despite differences in sequence from their mammalian counterparts, share similar features with mammalian prions including infectivity, prion strain phenomenon, and species barrier and thus are good model systems for human prion diseases. Yeast prions normally have long prion domains that presumably form multiple beta strands in the fibril, and structural knowledge about the yeast prion fibrils has been limited. Here we use site-directed spin labeling and electron paramagnetic resonance (EPR) spectroscopy to investigate the structures of amyloid fibrils of Ure2 prion domain. We show that 15 spin-labeled Ure2 mutants, with spin labels at every 5th residue from position 5 to position 75, show a single-line or nearly single-line feature in their EPR spectra as a result of strong spin exchange interactions. These results suggest that a parallel in-register beta structure exists at these spin-labeled positions. More interestingly, we also show that residues in the segment 30-65 have stronger spin exchange interactions, higher local stability, and lower solvent accessibility than segments 5-25 and 70-75, suggesting different local environment at these segments. We propose a hierarchical organization in the amyloid core of Ure2, with the segment 30-65 forming an inner core and the segments 5-25 and 70-75 forming an outer core. The hierarchical organization in the amyloid core may be a structural origin for polymorphism in fibrils and prion strains.	[Ngo, Sam; Gu, Lei; Guo, Zhefeng] Univ Calif Los Angeles, Dept Neurol, Brain Res Inst, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Guo, ZF (corresponding author), Univ Calif Los Angeles, Dept Neurol, Brain Res Inst, Inst Mol Biol, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	zhefeng@ucla.edu	Guo, Zhefeng/A-2069-2013; Gu, Lei/GWQ-6785-2022	Guo, Zhefeng/0000-0003-1992-7255; 	Larry L. Hillblom Foundation; Alzheimer's Association	Larry L. Hillblom Foundation; Alzheimer's Association(Alzheimer's Association)	This work was supported by the Larry L. Hillblom Foundation and the Alzheimer's Association.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; Baxa U, 2007, BIOCHEMISTRY-US, V46, P13149, DOI 10.1021/bi700826b; Bousset L, 2001, STRUCTURE, V9, P39, DOI 10.1016/S0969-2126(00)00553-0; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Budil DE, 1996, J MAGN RESON SER A, V120, P155, DOI 10.1006/jmra.1996.0113; Chan JCC, 2005, BIOCHEMISTRY-US, V44, P10669, DOI 10.1021/bi050724t; Chen B, 2009, P NATL ACAD SCI USA, V106, P14339, DOI 10.1073/pnas.0907821106; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Columbus L, 2001, BIOCHEMISTRY-US, V40, P3828, DOI 10.1021/bi002645h; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Guo ZF, 2007, PROTEIN SCI, V16, P1069, DOI 10.1110/ps.062739107; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Jayasinghe SA, 2004, J BIOL CHEM, V279, P48420, DOI 10.1074/jbc.M406853200; Jiang Y, 2004, J BIOL CHEM, V279, P3361, DOI 10.1074/jbc.M310494200; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Langen R, 1999, BIOCHEMISTRY-US, V38, P7918, DOI 10.1021/bi990010g; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2006, J BIOL CHEM, V281, P37820, DOI 10.1074/jbc.M605336200; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Masison DC, 1997, P NATL ACAD SCI USA, V94, P12503, DOI 10.1073/pnas.94.23.12503; McCoy J, 2011, P NATL ACAD SCI USA, V108, P1331, DOI 10.1073/pnas.1017877108; Molin Y. N., 1980, SPIN EXCHANGE; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Perrett S, 1999, J MOL BIOL, V290, P331, DOI 10.1006/jmbi.1999.2872; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schneider D. J., 1989, BIOL MAGN RESON, V8, P1; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Soto C, 2004, NAT MED, V10, pS63, DOI 10.1038/nm1069; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Umland TC, 2001, P NATL ACAD SCI USA, V98, P1459, DOI 10.1073/pnas.041607898; VASSAR PS, 1959, ARCH PATHOL, V68, P487; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 1995, YEAST, V11, P1671, DOI 10.1002/yea.320111609; Wickner RB, 2008, P NATL ACAD SCI USA, V105, P2403, DOI 10.1073/pnas.0712032105; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Zielke V, 2008, ACTA CRYSTALLOGR C, V64, pO586, DOI 10.1107/S0108270108032113	60	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29691	29699		10.1074/jbc.M111.269092	http://dx.doi.org/10.1074/jbc.M111.269092			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21730048	Green Published, hybrid			2022-12-25	WOS:000294046600028
J	Ou, L; Ferreira, AM; Otieno, S; Xiao, LM; Bashford, D; Kriwacki, RW				Ou, Li; Ferreira, Antonio M.; Otieno, Steve; Xiao, Limin; Bashford, Donald; Kriwacki, Richard W.			Incomplete Folding upon Binding Mediates Cdk4/Cyclin D Complex Activation by Tyrosine Phosphorylation of Inhibitor p27 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; CELL-CYCLE; RETINOBLASTOMA PROTEIN; CDK INHIBITORS; P27(KIP1); ARREST; MOTIF; G1; SITE; IDENTIFICATION	p27(Kip1) (p27), an intrinsically disordered protein, regulates the various Cdk/cyclin complexes that control cell cycle progression. The kinase inhibitory domain of p27 contains a cyclin-binding subdomain (D1), a Cdk-binding subdomain (D2), and a linker helix subdomain that connects D1 and D2. Here, we report that, despite extensive sequence conservation between Cdk4/cyclin D1 (hereafter Cdk4/cyclin D) and Cdk2/cyclin A, the thermodynamic details describing how the individual p27 subdomains contribute to equally high affinity binding to these two Cdk/cyclin complexes are strikingly different. Differences in enthalpy/entropy compensation revealed that the D2 subdomain of p27 folds incompletely when binding Cdk4/cyclin D versus Cdk2/cyclin A. Incomplete binding-induced folding exposes tyrosine 88 of p27 for phosphorylation by the nonreceptor tyrosine kinase Abl. Importantly, tyrosine phosphorylation (of p27) relieves Cdk inhibition by p27, enabling cell cycle entry. Furthermore, the interaction between a conserved hydrophobic patch on cyclin D and subdomain D1 is much weaker than that with cyclin A; consequently, a construct containing subdomains D1 and LH (p27-D1LH) does not inhibit substrate binding to Cdk4/cyclin D as it does to Cdk2/cyclin A. Our results provide a mechanism by which Cdk4 (within the p27/Cdk4/cyclin D complex) is poised to be activated by extrinsic mitogenic signals that impinge upon p27 at the earliest stage of cell division. More broadly, our results further illustrate the regulatory versatility of intrinsically disordered proteins.	[Ou, Li; Ferreira, Antonio M.; Otieno, Steve; Xiao, Limin; Bashford, Donald; Kriwacki, Richard W.] St Jude Childrens Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Kriwacki, Richard W.] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Kriwacki, RW (corresponding author), 262 Danny Thomas Pl, Memphis, TN 38105 USA.	richard.kriwacki@stjude.org	Kriwacki, Richard/N-8154-2018; Ou, Li/F-8416-2012; Ferreira, Antonio/I-4423-2013; Bashford, Donald/F-5905-2011	Kriwacki, Richard/0000-0002-9798-6018; Bashford, Donald/0000-0001-5776-3744; Ferreira, Antonio/0000-0002-6581-6233	NCI, National Institutes of Health [R01 CA082491]; American Lebanese Syrian Associated Charities (ALSAC); Cancer Center [2P30CA021765]; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA082491] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grant R01 CA082491 (to R. W. K.). This work was also supported by the American Lebanese Syrian Associated Charities (ALSAC) and by Cancer Center Support Grant 2P30CA021765 (to St. Jude Children's Research Hospital).	Adams PD, 1999, MOL CELL BIOL, V19, P1068; Adams PD, 1996, MOL CELL BIOL, V16, P6623; CHAN FKM, 1995, MOL CELL BIOL, V15, P2682; Chan HM, 2001, ONCOGENE, V20, P6152, DOI 10.1038/sj.onc.1204793; Chen IT, 1996, ONCOGENE, V12, P595; Chen JJ, 1996, MOL CELL BIOL, V16, P4673; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Ezhevsky SA, 1997, P NATL ACAD SCI USA, V94, P10699, DOI 10.1073/pnas.94.20.10699; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; HARPER JW, 1993, CELL, V75, P805; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; James MK, 2008, MOL CELL BIOL, V28, P498, DOI 10.1128/MCB.02171-06; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; KATO JY, 1994, MOL CELL BIOL, V14, P2713, DOI 10.1128/MCB.14.4.2713; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Liu S, 2010, ACS CHEM BIOL, V5, P1169, DOI 10.1021/cb1001262; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Pan WJ, 2001, CANCER RES, V61, P2885; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Wang YF, 2011, NAT CHEM BIOL, V7, P214, DOI 10.1038/NCHEMBIO.536; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244	44	33	35	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30142	30151		10.1074/jbc.M111.244095	http://dx.doi.org/10.1074/jbc.M111.244095			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21715330	Green Published, hybrid			2022-12-25	WOS:000294046600071
J	Alboresi, A; Gerotto, C; Cazzaniga, S; Bassi, R; Morosinotto, T				Alboresi, Alessandro; Gerotto, Caterina; Cazzaniga, Stefano; Bassi, Roberto; Morosinotto, Tomas			A Red-shifted Antenna Protein Associated with Photosystem II in Physcomitrella patens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING ANTENNA; CHARGE-TRANSFER STATE; PIGMENT-BINDING; CHLAMYDOMONAS-REINHARDTII; MAXIMUM-LIKELIHOOD; CRYSTAL-STRUCTURE; COMPLEX; PLANTS; PHOTOSYNTHESIS; LHCA4	Antenna systems of plants and green algae are made up of pigment-protein complexes belonging to the light-harvesting complex (LHC) multigene family. LHCs increase the light-harvesting cross-section of photosystems I and II and catalyze photoprotective reactions that prevent light-induced damage in an oxygenic environment. The genome of the moss Physcomitrella patens contains two genes encoding LHCb9, a new antenna protein that bears an overall sequence similarity to photosystem II antenna proteins but carries a specific motif typical of photosystem I antenna proteins. This consists of the presence of an asparagine residue as a ligand for Chl 603 (A5) chromophore rather than a histidine, the common ligand in all other LHCbs. Asparagine as a Chl 603 (A5) ligand generates red-shifted spectral forms associated with photosystem I rather than with photosystem II, suggesting that in P. patens, the energy landscape of photosystem II might be different with respect to that of most green algae and plants. In this work, we show that the in vitro refolded LHCb9-pigment complexes carry a red-shifted fluorescence emission peak, different from all other known photosystem II antenna proteins. By using a specific antibody, we localized LHCb9 within PSII supercomplexes in the thylakoid membranes. This is the first report of red-shifted spectral forms in a PSII antenna system, suggesting that this biophysical feature might have a special role either in optimization of light use efficiency or in photoprotection in the specific environmental conditions experienced by this moss.	[Alboresi, Alessandro; Cazzaniga, Stefano; Bassi, Roberto] Univ Verona, Dipartimento Biotecnol, I-37134 Verona, Italy; [Gerotto, Caterina; Morosinotto, Tomas] Univ Padua, Dipartimento Biol, I-35121 Padua, Italy; [Bassi, Roberto] Phytosphare Forschungszentrum Julich, ICG 3, D-52425 Julich, Germany	University of Verona; University of Padua; Helmholtz Association; Research Center Julich	Bassi, R (corresponding author), Univ Verona, Dipartimento Biotecnol, Str Grazie 15, I-37134 Verona, Italy.	roberto.bassi@univr.it	Cazzaniga, Stefano/ABG-3898-2021; Morosinotto, Tomas/AAC-3188-2019; Alboresi, Alessandro/Z-1220-2019	Cazzaniga, Stefano/0000-0002-2824-7916; Morosinotto, Tomas/0000-0002-0803-7591; Alboresi, Alessandro/0000-0003-4818-7778; bassi, roberto/0000-0002-4140-8446; Gerotto, Caterina/0000-0001-7142-3535	Cassa di Risparmio di Padova e Rovigo (CaRiPaRo) Foundation, Universita di Padova [CPDA089403]; EEC Project Harvest; Fondo per gli Investimenti della Ricerca di Base-Parallelomics [RBIP06CTBR]	Cassa di Risparmio di Padova e Rovigo (CaRiPaRo) Foundation, Universita di Padova(Fondazione Cariparo); EEC Project Harvest; Fondo per gli Investimenti della Ricerca di Base-Parallelomics	This work was supported by the Cassa di Risparmio di Padova e Rovigo (CaRiPaRo) Foundation, Universita di Padova Grant CPDA089403, EEC Project Harvest and Fondo per gli Investimenti della Ricerca di Base-Parallelomics Grant RBIP06CTBR.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Alboresi A, 2010, P NATL ACAD SCI USA, V107, P11128, DOI 10.1073/pnas.1002873107; Alboresi A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-71; Alboresi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002033; ASHTON NW, 1979, PLANTA, V144, P427, DOI 10.1007/BF00380118; Ballottari M, 2004, EUR J BIOCHEM, V271, P4659, DOI 10.1111/j.1432-1033.2004.04426.x; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; Ballottari M, 2009, J BIOL CHEM, V284, P8103, DOI 10.1074/jbc.M808326200; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Boekema EJ, 1999, BIOCHEMISTRY-US, V38, P2233, DOI 10.1021/bi9827161; Boekema EJ, 1999, EUR J BIOCHEM, V266, P444, DOI 10.1046/j.1432-1327.1999.00876.x; Busch A, 2011, BBA-BIOENERGETICS, V1807, P864, DOI 10.1016/j.bbabio.2010.09.009; Caffarri S, 2004, BIOCHEMISTRY-US, V43, P9467, DOI 10.1021/bi036265i; Caffarri S, 2007, FEBS LETT, V581, P4704, DOI 10.1016/j.febslet.2007.08.066; Carbonera D, 2005, BIOCHEMISTRY-US, V44, P8337, DOI 10.1021/bi050260z; Castelletti S, 2003, BIOCHEMISTRY-US, V42, P4226, DOI 10.1021/bi027398r; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Croce R, 2007, BIOPHYS J, V93, P2418, DOI 10.1529/biophysj.107.106955; DAINESE P, 1990, PHOTOCHEM PHOTOBIOL, V51, P693, DOI 10.1111/php.1990.51.6.693; Durnford DG, 1999, J MOL EVOL, V48, P59, DOI 10.1007/PL00006445; Elrad D, 2004, CURR GENET, V45, P61, DOI 10.1007/s00294-003-0460-x; Gerotto C, 2011, PLANT CELL ENVIRON, V34, P922, DOI 10.1111/j.1365-3040.2011.02294.x; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Giuffra E, 1996, EUR J BIOCHEM, V238, P112, DOI 10.1111/j.1432-1033.1996.0112q.x; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HOBE S, 1995, BIOCHEMISTRY-US, V34, P10224, DOI 10.1021/bi00032a016; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Klimmek F, 2006, PLANT PHYSIOL, V140, P793, DOI 10.1104/pp.105.073304; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Matsubara S, 2007, PLANT PHYSIOL, V144, P926, DOI 10.1104/pp.107.099077; MELIS A, 1989, PHILOS T ROY SOC B, V323, P397, DOI 10.1098/rstb.1989.0019; Morosinotto T, 2005, J BIOL CHEM, V280, P20612, DOI 10.1074/jbc.M500705200; Morosinotto T, 2003, PHYSIOL PLANTARUM, V119, P347, DOI 10.1034/j.1399-3054.2003.00213.x; Morosinotto T, 2003, J BIOL CHEM, V278, P49223, DOI 10.1074/jbc.M309203200; Mozzo M, 2008, J BIOL CHEM, V283, P6184, DOI 10.1074/jbc.M708961200; Mozzo M, 2010, BBA-BIOENERGETICS, V1797, P212, DOI 10.1016/j.bbabio.2009.10.005; Neilson JAD, 2010, PHOTOSYNTH RES, V106, P57, DOI 10.1007/s11120-010-9576-2; Nelson N, 2005, BIOESSAYS, V27, P914, DOI 10.1002/bies.20278; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rivadossi A, 1999, PHOTOSYNTH RES, V60, P209, DOI 10.1023/A:1006236829711; Romero E, 2009, BIOPHYS J, V96, pL35, DOI 10.1016/j.bpj.2008.11.043; Ruban AV, 2006, J BIOL CHEM, V281, P14981, DOI 10.1074/jbc.M511415200; Schmid VHR, 2008, CELL MOL LIFE SCI, V65, P3619, DOI 10.1007/s00018-008-8333-6; Schmid VHR, 1997, P NATL ACAD SCI USA, V94, P7667, DOI 10.1073/pnas.94.14.7667; Schmid VHR, 2002, J BIOL CHEM, V277, P37307, DOI 10.1074/jbc.M205889200; Six C, 2005, MOL BIOL EVOL, V22, P2217, DOI 10.1093/molbev/msi220; TRISSL HW, 1993, PHOTOSYNTH RES, V35, P247, DOI 10.1007/BF00016556; Trouiller B, 2006, NUCLEIC ACIDS RES, V34, P232, DOI 10.1093/nar/gkj423; Watling JR, 1997, AUST J PLANT PHYSIOL, V24, P17, DOI 10.1071/PP96074; Zhang H, 1997, PLANT PHYSIOL, V115, P1525, DOI 10.1104/pp.115.4.1525	58	21	21	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28978	28987		10.1074/jbc.M111.226126	http://dx.doi.org/10.1074/jbc.M111.226126			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705318	Green Published, hybrid			2022-12-25	WOS:000293837000034
J	Fakas, S; Qiu, YX; Dixon, JL; Han, GS; Ruggles, KV; Garbarino, J; Sturley, SL; Carman, GM				Fakas, Stylianos; Qiu, Yixuan; Dixon, Joseph L.; Han, Gil-Soo; Ruggles, Kelly V.; Garbarino, Jeanne; Sturley, Stephen L.; Carman, George M.			Phosphatidate Phosphatase Activity Plays Key Role in Protection against Fatty Acid-induced Toxicity in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE ENCODES; NUCLEAR-MEMBRANE GROWTH; DYSTROPHY FLD MUTATION; PHOSPHOLIPID-SYNTHESIS; LIPID-METABOLISM; DIACYLGLYCEROL KINASE; ENDOPLASMIC-RETICULUM; MEDIATED REPRESSION; SIGNALING FUNCTIONS; GLOBAL ANALYSIS	The PAH1-encoded phosphatidate (PA) phosphatase in Saccharomyces cerevisiae is a pivotal enzyme that produces diacylglycerol for the synthesis of triacylglycerol (TAG) and simultaneously controls the level of PA used for phospholipid synthesis. Quantitative lipid analysis showed that the pah1 Delta mutation caused a reduction in TAG mass and an elevation in the mass of phospholipids and free fatty acids, changes that were more pronounced in the stationary phase. The levels of unsaturated fatty acids in the pah1 Delta mutant were unaltered, although the ratio of palmitoleic acid to oleic acid was increased with a similar change in the fatty acid composition of phospholipids. The pah1 Delta mutant exhibited classic hallmarks of apoptosis in stationary phase and a marked reduction in the quantity of cytoplasmic lipid droplets. Cells lacking PA phosphatase were sensitive to exogenous fatty acids in the order of toxicity palmitoleic acid > oleic acid > palmitic acid. In contrast, the growth of wild type cells was not inhibited by fatty acid supplementation. In addition, wild type cells supplemented with palmitoleic acid exhibited an induction in PA phosphatase activity and an increase in TAG synthesis. Deletion of the DGK1-encoded diacylglycerol kinase, which counteracts PA phosphatase in controlling PA content, suppressed the defect in lipid droplet formation in the pah1 Delta mutant. However, the sensitivity of the pah1 Delta mutant to palmitoleic acid was not rescued by the dgk1 Delta mutation. Overall, these findings indicate a key role of PA phosphatase in TAG synthesis for protection against fatty acid-induced toxicity.	[Fakas, Stylianos; Qiu, Yixuan; Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Dixon, Joseph L.] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; [Fakas, Stylianos; Qiu, Yixuan; Dixon, Joseph L.; Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Ruggles, Kelly V.; Garbarino, Jeanne; Sturley, Stephen L.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Ruggles, Kelly V.; Garbarino, Jeanne; Sturley, Stephen L.] Columbia Univ, Med Ctr, Inst Human Nutr, New York, NY 10032 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Columbia University; Columbia University	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu	Fakas, Stylianos/R-9908-2019; Fakas, Stylianos/AAQ-7594-2020	Fakas, Stylianos/0000-0001-8692-1326; Fakas, Stylianos/0000-0001-8692-1326; Ruggles, Kelly/0000-0002-0152-0863	National Institutes of Health [GM-28140, DK-54320, DK-007647]; National Center for Research Resources [RR-02415803, RR-021120]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054320, T32DK007647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R37GM028140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-28140 (to G. M. C.), DK-54320 (to S. L. S.), and DK-007647 (to J. G.); Clinical and Translational Science Award Training Grant RR-02415803 (to K. V. R.); and Grant RR-021120 from the National Center for Research Resources (for purchase of the liquid chromatography-mass spectrometry system).	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; BISHOP WR, 1986, J BIOL CHEM, V261, P6993; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; BOSSIE MA, 1989, J BACTERIOL, V171, P6409, DOI 10.1128/jb.171.12.6409-6413.1989; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; BRINDLEY DN, 1984, PROG LIPID RES, V23, P115, DOI 10.1016/0163-7827(84)90001-8; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; CHIRALA SS, 1992, P NATL ACAD SCI USA, V89, P10232, DOI 10.1073/pnas.89.21.10232; CHIRALA SS, 1994, NUCLEIC ACIDS RES, V22, P412, DOI 10.1093/nar/22.3.412; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Connerth M, 2010, J BIOL CHEM, V285, P26832, DOI 10.1074/jbc.M110.122085; Cowart LA, 2007, BBA-MOL CELL BIOL L, V1771, P421, DOI 10.1016/j.bbalip.2006.08.005; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Fuentes L, 2003, J BIOL CHEM, V278, P44683, DOI 10.1074/jbc.M307209200; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; Goodman JM, 2009, J LIPID RES, V50, P2148, DOI 10.1194/jlr.R001446; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Homan R, 1998, J CHROMATOGR B, V708, P21, DOI 10.1016/S0378-4347(97)00651-8; Howe AG, 2006, CAN J PHYSIOL PHARM, V84, P29, DOI 10.1139/Y05-138; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; Kohlwein SD, 2010, BBA-MOL CELL BIOL L, V1801, P222, DOI 10.1016/j.bbalip.2009.12.016; LANGNER CA, 1991, J BIOL CHEM, V266, P11955; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; LIN YP, 1989, J BIOL CHEM, V264, P8641; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; Nanjundan M, 2003, AM J PHYSIOL-LUNG C, V284, pL1, DOI 10.1152/ajplung.00029.2002; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; RATTRAY JBM, 1975, BACTERIOL REV, V39, P197, DOI 10.1128/MMBR.39.3.197-231.1975; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; Rockenfeller P, 2010, CELL CYCLE, V9, P2836, DOI 10.4161/cc.9.14.12346; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Schneiter Roger, 2006, Methods Mol Biol, V313, P41; SCHULLER HJ, 1992, EMBO J, V11, P107, DOI 10.1002/j.1460-2075.1992.tb05033.x; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; SMITH SW, 1957, J BIOL CHEM, V228, P915; Stukey J, 1997, PROTEIN SCI, V6, P469; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Ugrankar R, 2011, MOL CELL BIOL, V31, P1646, DOI 10.1128/MCB.01335-10; Unger RH, 2010, TRENDS ENDOCRIN MET, V21, P345, DOI 10.1016/j.tem.2010.01.009; Valente V, 2010, FEBS J, V277, P4775, DOI 10.1111/j.1742-4658.2010.07883.x; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	108	90	96	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29074	29085		10.1074/jbc.M111.258798	http://dx.doi.org/10.1074/jbc.M111.258798			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21708942	hybrid, Green Published			2022-12-25	WOS:000293837000044
J	Gonzalez-Bulnes, P; Bobenchik, AM; Augagneur, Y; Cerdan, R; Vial, HJ; Llebaria, A; Ben Mamoun, C				Gonzalez-Bulnes, Patricia; Bobenchik, April M.; Augagneur, Yoann; Cerdan, Rachel; Vial, Henri J.; Llebaria, Amadeu; Ben Mamoun, Choukri			PG12, a Phospholipid Analog with Potent Antimalarial Activity, Inhibits Plasmodium falciparum CTP:Phosphocholine Cytidylyltransferase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE; CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; CAENORHABDITIS-ELEGANS; INFECTED ERYTHROCYTES; TRYPANOSOMA-BRUCEI; MALARIA; PATHWAY; 1-O-OCTADECYL-2-O-METHYL-RAC-GLYCERO-3-PHOSPHOCHOLINE; LYSOPHOSPHATIDYLCHOLINE	In the human malaria parasite Plasmodium falciparum, the synthesis of the major and essential membrane phospholipid, phosphatidylcholine, occurs via the CDP-choline and the serine decarboxylase phosphoethanolamine methylation (SDPM) pathways, which are fueled by host choline, serine, and fatty acids. Both pathways share the final two steps catalyzed by two essential enzymes, P. falciparum CTP:phosphocholine cytidylyltransferase (PfCCT) and choline-phosphate transferase (PfCEPT). We identified a novel class of phospholipid mimetics, which inhibit the growth of P. falciparum as well as Leishmania and Trypanosoma species. Metabolic analyses showed that one of these compounds, PG12, specifically blocks phosphatidylcholine biosynthesis from both the CDP-choline and SDPM pathways via inhibition of PfCCT. In vitro studies using recombinant PfCCT showed a dose-dependent inhibition of the enzyme by PG12. The potent antimalarial of this compound, its low cytotoxicity profile, and its established mode of action make it an excellent lead to advance for further drug development and efficacy in vivo.	[Gonzalez-Bulnes, Patricia; Llebaria, Amadeu] CSIC, Res Unit BioAct Mol RUBAM, Dept Quim Biomed, Inst Quim Avanzada Cataluna IQAC, ES-08034 Barcelona, Spain; [Ben Mamoun, Choukri] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA; [Cerdan, Rachel; Vial, Henri J.] Univ Montpellier 2, CNRS, UMR 5235, F-34095 Montpellier, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Yale University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Llebaria, A (corresponding author), CSIC, Res Unit BioAct Mol RUBAM, Dept Quim Biomed, Inst Quim Avanzada Cataluna IQAC, Jordi Girona 18-26, ES-08034 Barcelona, Spain.	alsqob@cid.csic.es; Choukri.benmamoun@yale.edu	augagneur, yoann/L-2000-2015; Llebaria, Amadeu/C-4287-2015	augagneur, yoann/0000-0002-6816-5931; Llebaria, Amadeu/0000-0002-8200-4827; CERDAN, Rachel/0000-0001-8214-8006	National Institutes of Health, NIAID [AI51507]; Generalitat de Catalunya [2009SGR-1072]; "Ministerio de Ciencia e Innovacion," Spain [CTQ2008-01426/BQU]; Department of Defense [PR033005]; Burroughs Wellcome Fund; Burroughs Wellcome Award [1006267]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051507] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Generalitat de Catalunya(Generalitat de Catalunya); "Ministerio de Ciencia e Innovacion," Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Department of Defense(United States Department of Defense); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Burroughs Wellcome Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant AI51507 (to C. B. M.). This work was also supported by "Generalitat de Catalunya" Grant 2009SGR-1072 and "Ministerio de Ciencia e Innovacion," Spain (Project CTQ2008-01426/BQU and a fellowship to P. G. B.), Department of Defense Grant PR033005 (to C. B. M.), and the Burroughs Wellcome Fund (to C. B. M.).; Recipient of Burroughs Wellcome Award 1006267, Investigators of Pathogenesis of Infectious Diseases. To whom correspondence may be addressed: Dept. of Internal Medicine, Section of Infectious Disease, Yale University School of Medicine, P. O. Box 20822, 15 York Street, www-403D, New Haven, CT 06520. Tel./Fax:203-737-1972; E-mail: Choukri.benmamoun@yale.edu.	ANCELIN ML, 1989, BIOCHIM BIOPHYS ACTA, V1001, P82, DOI 10.1016/0005-2760(89)90310-X; Baburina I, 1998, J BIOL CHEM, V273, P2169, DOI 10.1074/jbc.273.4.2169; BALTZ T, 1985, EMBO J, V4, P1273, DOI 10.1002/j.1460-2075.1985.tb03772.x; Ben Mamoun C, 2010, DRUG DEVELOP RES, V71, P44, DOI 10.1002/ddr.20347; Biagini GA, 2004, BLOOD, V104, P3372, DOI 10.1182/blood-2004-03-1084; Bobenchik AM, 2011, FEMS MICROBIOL REV, V35, P609, DOI 10.1111/j.1574-6976.2011.00267.x; Bobenchik AM, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-4; Boggs K, 1998, BBA-LIPID LIPID MET, V1389, P1, DOI 10.1016/S0005-2760(97)00145-8; BOGGS KP, 1995, J BIOL CHEM, V270, P7757, DOI 10.1074/jbc.270.13.7757; Bolognese CP, 2000, PLANT PHYSIOL, V124, P1800, DOI 10.1104/pp.124.4.1800; Brendza KM, 2007, BIOCHEM J, V404, P439, DOI 10.1042/BJ20061815; Charron JBF, 2002, PLANT PHYSIOL, V129, P363, DOI 10.1104/pp.001776; Dua VK, 2011, J ETHNOPHARMACOL, V136, P123, DOI 10.1016/j.jep.2011.04.024; El Bissati K, 2008, MOL BIOCHEM PARASIT, V161, P130, DOI 10.1016/j.molbiopara.2008.06.012; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gonzalez-Bulnes P, 2010, BIOORGAN MED CHEM, V18, P8549, DOI 10.1016/j.bmc.2010.10.031; Hanada K, 2000, BIOCHEM J, V346, P671, DOI 10.1042/0264-6021:3460671; Hanada K, 2002, J EXP MED, V195, P23, DOI 10.1084/jem.20010724; HSIAO LL, 1991, BIOCHEM J, V274, P121, DOI 10.1042/bj2740121; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Matile H., 1990, PLASMODIUM FALCIPARU; Palavalli LH, 2006, BIOCHEMISTRY-US, V45, P6056, DOI 10.1021/bi060199d; Pessi G, 2005, J BIOL CHEM, V280, P12461, DOI 10.1074/jbc.M414626200; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Pessi G, 2006, FUTURE LIPIDOL, V1, P173, DOI 10.2217/17460875.1.2.173; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; Richier E, 2006, ANTIMICROB AGENTS CH, V50, P3381, DOI 10.1128/AAC.00443-06; SHERMAN IW, 1979, MICROBIOL REV, V43, P453, DOI 10.1128/MMBR.43.4.453-495.1979; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; Surolia N, 2001, NAT MED, V7, P167, DOI 10.1038/84612; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vial HJ, 2005, MOLECULAR APPROACHES TO MALARIA, P327; Vogler WR, 1996, LEUKEMIA RES, V20, P947, DOI 10.1016/S0145-2126(96)00070-7; Wengelnik K, 2002, SCIENCE, V295, P1311, DOI 10.1126/science.1067236; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Witola WH, 2008, J BIOL CHEM, V283, P27636, DOI 10.1074/jbc.M804360200; Yeo HJ, 1997, BIOCHEM J, V324, P903, DOI 10.1042/bj3240903	37	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28940	28947		10.1074/jbc.M111.268946	http://dx.doi.org/10.1074/jbc.M111.268946			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705805	Green Published, hybrid			2022-12-25	WOS:000293837000031
J	Mahmood, DFD; Jguirim-Souissi, I; Khadija, E; Blondeau, N; Diderot, V; Amrani, S; Slimane, MN; Syrovets, T; Simmet, T; Rouis, M				Mahmood, Dler Faieeq Darweesh; Jguirim-Souissi, Imene; Khadija, El-Hadri; Blondeau, Nicolas; Diderot, Vimala; Amrani, Souliman; Slimane, Mohamed-Naceur; Syrovets, Tatiana; Simmet, Thomas; Rouis, Mustapha			Peroxisome Proliferator-activated Receptor gamma Induces Apoptosis and Inhibits Autophagy of Human Monocyte-derived Macrophages via Induction of Cathepsin L POTENTIAL ROLE IN ATHEROSCLEROSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; LYSOSOMAL CYSTEINE PROTEASES; SMOOTH-MUSCLE-CELLS; PPAR-GAMMA; DEFICIENT MICE; TUMOR-SUPPRESSOR; LIPID-METABOLISM; GENE-EXPRESSION; KNOCKOUT MICE; UP-REGULATION	Macrophages play a pivotal role in the pathophysiology of atherosclerosis. These cells express cathepsin L (CatL), a cysteine protease that has been implicated in atherogenesis and the associated arterial remodeling. In addition, macrophages highly express peroxisome proliferator-activated receptor (PPAR) gamma, a transcription factor that regulates numerous genes important for lipid and lipoprotein metabolism, for glucose homeostasis, and inflammation. Hence, PPAR gamma might affect macrophage function in the context of chronic inflammation such as atherogenesis. In the present study, we examined the effect of PPAR gamma activation on the expression of CatL in human monocyte-derived macrophages (HMDM). Activation of PPAR gamma by the specific agonist GW929 concentration-dependently increased the levels of CatL mRNA and protein in HMDM. By promoter analysis, we identified a functional PPAR response element-like sequence that positively regulates CatL expression. In addition, we found that PPAR gamma-induced CatL promotes the degradation of Bcl2 without affecting Bax protein levels. Consistently, degradation of Bcl2 could be prevented by a specific CatL inhibitor, confirming the causative role of CatL. PPAR gamma-induced CatL was found to decrease autophagy through reduction of beclin 1 and LC3 protein levels. The reduction of these proteins involved in autophagic cell death was antagonized either by the CatL inhibitor or by CatL knockdown. In conclusion, our data show that PPAR gamma can specifically induce CatL, a proatherogenic protease, in HMDM. In turn, CatL inhibits autophagy and induces apoptosis. Thus, the proatherogenic effect of CatL could be neutralized by apoptosis, a beneficial phenomenon, at least in the early stages of atherosclerosis.	[Mahmood, Dler Faieeq Darweesh; Jguirim-Souissi, Imene; Khadija, El-Hadri; Diderot, Vimala; Rouis, Mustapha] Univ Paris 06, Unite Rech Vieillissement Stress & Inflammat, F-75252 Paris 5, France; [Blondeau, Nicolas] Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, UMR 6097, F-06560 Valbonne, France; [Amrani, Souliman] Fac Sci Oujda, Biochim Lab, Oujda 60000, Morocco; [Slimane, Mohamed-Naceur] Fac Med Monastir, Biochim Lab, Monastir 5000, Tunisia; [Syrovets, Tatiana; Simmet, Thomas] Univ Ulm, Inst Pharmacol Nat Prod & Clin Pharmacol, D-89081 Ulm, Germany	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Mohammed First University of Oujda; Universite de Monastir; Ulm University	Rouis, M (corresponding author), Univ Paris 06, Vieillissement Stress & Inflammat UR 04, Bat A 5Eme Etage Case Courrier 256-7, F-75252 Paris 5, France.	mustapha.rouis@snv.jussieu.fr	Rouis, Mustapha/E-4993-2016; Blondeau, Nicolas P/M-5002-2016; Syrovets, Tatiana/J-4594-2019; Blondeau, Nicolas/T-1136-2019; AMRANI, Souliman/AAK-7617-2020; Mahmood, Dler/G-9107-2015	Blondeau, Nicolas P/0000-0001-5954-4094; AMRANI, Souliman/0000-0003-0243-7583; EL HADRI, KHADIJA/0000-0002-1275-9861; Syrovets, Tatiana/0000-0002-6751-2233; Mahmood, Dler/0000-0002-6536-1427; Rouis, Mustapha/0000-0003-4197-6555	Fondation Coeur et Arteres; Fondation de France; Comite Mixte de Cooperation Universitaire exchange program between Tunisia and France	Fondation Coeur et Arteres; Fondation de France(Fondation de France); Comite Mixte de Cooperation Universitaire exchange program between Tunisia and France	This work was supported by Fondation Coeur et Arteres, Fondation de France, and the Comite Mixte de Cooperation Universitaire exchange program between Tunisia and France.	Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; Babaev VR, 2005, ARTERIOSCL THROM VAS, V25, P1647, DOI 10.1161/01.ATV.0000173413.31789.1a; Billiet L, 2008, J CELL PHYSIOL, V214, P183, DOI 10.1002/jcp.21179; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chen Z, 2001, ARTERIOSCL THROM VAS, V21, P372, DOI 10.1161/01.ATV.21.3.372; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Collins AR, 2001, ARTERIOSCL THROM VAS, V21, P365, DOI 10.1161/01.ATV.21.3.365; De Meyer GRY, 2009, BBA-MOL CELL RES, V1793, P1485, DOI 10.1016/j.bbamcr.2008.12.011; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Duval C, 2002, TRENDS MOL MED, V8, P422, DOI 10.1016/S1471-4914(02)02385-7; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; GEARING KL, 1993, P NATL ACAD SCI USA, V90, P1440, DOI 10.1073/pnas.90.4.1440; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Hamblin M, 2009, ANTIOXID REDOX SIGN, V11, P1415, DOI [10.1089/ars.2008.2280, 10.1089/ARS.2008.2280]; Han KH, 2000, J CLIN INVEST, V106, P793, DOI 10.1172/JCI10052; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Jackson SM, 1999, ARTERIOSCL THROM VAS, V19, P2094, DOI 10.1161/01.ATV.19.9.2094; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jormsjo S, 2002, AM J PATHOL, V161, P939, DOI 10.1016/S0002-9440(10)64254-X; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kim DE, 2010, ARTERIOSCL THROM VAS, V30, P449, DOI 10.1161/ATVBAHA.109.194613; Kitamoto S, 2007, CIRCULATION, V115, P2065, DOI 10.1161/CIRCULATIONAHA.107.688523; Kockx MM, 2000, CARDIOVASC RES, V45, P736, DOI 10.1016/S0008-6363(99)00235-7; Kockx MM, 1998, CIRC RES, V83, P378, DOI 10.1161/01.RES.83.4.378; Laumonnier Y, 2006, BLOOD, V107, P3342, DOI 10.1182/blood-2005-07-2840; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012; Liu J, 2005, ARTERIOSCL THROM VAS, V25, P174, DOI 10.1161/01.ATV.0000148548.47755.22; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; Martinet W, 2007, TRENDS CARDIOVAS MED, V17, P69, DOI 10.1016/j.tcm.2006.12.004; Marx N, 1998, CIRC RES, V83, P1097, DOI 10.1161/01.RES.83.11.1097; Mattock KL, 2010, ATHEROSCLEROSIS, V208, P83, DOI 10.1016/j.atherosclerosis.2009.07.022; Meuillet EJ, 2004, ARCH BIOCHEM BIOPHYS, V429, P123, DOI 10.1016/j.abb.2004.04.020; Oorni K, 2004, J BIOL CHEM, V279, P34776, DOI 10.1074/jbc.M310814200; Papaspyridonos M, 2006, ARTERIOSCL THROM VAS, V26, P1837, DOI 10.1161/01.ATV.0000229695.68416.76; Pasceri V, 2000, CIRCULATION, V101, P235, DOI 10.1161/01.CIR.101.3.235; Patel L, 2001, CURR BIOL, V11, P764, DOI 10.1016/S0960-9822(01)00225-1; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Ricote M, 1998, P NATL ACAD SCI USA, V95, P7614, DOI 10.1073/pnas.95.13.7614; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Salvesen GS, 2001, J CLIN INVEST, V107, P21, DOI 10.1172/JCI11829; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Schrijvers DM, 2005, ARTERIOSCL THROM VAS, V25, P1256, DOI 10.1161/01.ATV.0000166517.18801.a7; Steinberg D, 1997, CIRCULATION, V95, P1062; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; VUDAC N, 1995, J CLIN INVEST, V96, P741, DOI 10.1172/JCI118118; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	56	33	36	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28858	28866		10.1074/jbc.M111.273292	http://dx.doi.org/10.1074/jbc.M111.273292			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21700710	Green Published, hybrid			2022-12-25	WOS:000293837000023
J	Paavola, KJ; Stephenson, JR; Ritter, SL; Alter, SP; Hall, RA				Paavola, Kevin J.; Stephenson, Jason R.; Ritter, Stefanie L.; Alter, Shawn P.; Hall, Randy A.			The N Terminus of the Adhesion G Protein-coupled Receptor GPR56 Controls Receptor Signaling Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; ADRENERGIC-RECEPTOR; TRAFFICKING; UBIQUITINATION; ROLES; LONG; GPCR; MUTATIONS; FLAMINGO; ARRESTIN	GPR56 is an adhesionGprotein-coupled receptor that plays a key role in cortical development. Mutations to GPR56 in humans cause malformations of the cerebral cortex, but little is known about the normal function of the receptor. We found that the large N terminus (NT) of GPR56 is cleaved from the rest of the receptor during processing but remains non-covalently associated with the seven-transmembrane region of the receptor, as indicated by coimmunoprecipitation of the two GPR56 fragments from both transfected cells and native tissue. We also found that truncation of the GPR56 NT results in constitutive activation of receptor signaling, as revealed by increased GPR56-stimulated signaling upon transfection of HEK-293 cells with truncated GPR56, greatly enhanced binding of beta-arrestins by truncated GPR56 relative to the full-length receptor, extensive ubiquitination of truncated GPR56, and cytotoxicity induced by truncated GPR56 that could be rescued by cotransfection of cells with beta-arrestin 2. Furthermore, we found that the GPR56 NT is capable of homophilic trans-trans interactions that enhance receptor signaling activity. On the basis of these findings, we suggest a model of receptor activation in which the large N terminus of GPR56 constrains receptor activity but N-terminal interactions (GPR56 NT with an extracellular ligand and/or GPR56 NT homophilic trans-trans associations) can remove this inhibitory influence of the N terminus to activate receptor signaling.	[Paavola, Kevin J.; Stephenson, Jason R.; Ritter, Stefanie L.; Alter, Shawn P.; Hall, Randy A.] Emory Univ, Sch Med, Rollins Res Ctr, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Hall, RA (corresponding author), Emory Univ, Sch Med, Rollins Res Ctr, Dept Pharmacol, Room 5113,1510 Clifton Rd, Atlanta, GA 30322 USA.	rhall@pharm.emory.edu	Ritter, Stefanie L/D-9312-2012	Hall, Randy/0000-0002-8318-8728; Stephenson, Jason/0000-0002-7926-8055	National Institutes of Health [R21-NS063029, R01-NS072394, T32-GM008602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072394, R21NS063029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21-NS063029 and R01-NS072394 (to R. A. H.) and Training Grant T32-GM008602 (to K.J.P.).	Andersson H, 2003, MOL PHARMACOL, V64, P570, DOI 10.1124/mol.64.3.570; Carreira-Barbosa F, 2009, DEVELOPMENT, V136, P383, DOI 10.1242/dev.026542; Dale LB, 2000, J BIOL CHEM, V275, P38213, DOI 10.1074/jbc.M006075200; DIXON RAF, 1987, NATURE, V326, P73, DOI 10.1038/326073a0; Dunham JH, 2009, BIOCHEMISTRY-US, V48, P10286, DOI 10.1021/bi9013775; Ferrari SL, 2001, MOL ENDOCRINOL, V15, P149, DOI 10.1210/me.15.1.149; Fredriksson R, 2003, BIOCHEM BIOPH RES CO, V301, P725, DOI 10.1016/S0006-291X(03)00026-3; Hague C, 2004, J PHARMACOL EXP THER, V309, P388, DOI 10.1124/jpet.103.060509; Huang Y, 2008, MOL CELL BIOCHEM, V308, P133, DOI 10.1007/s11010-007-9621-4; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Innamorati G, 2001, J BIOL CHEM, V276, P13096, DOI 10.1074/jbc.M009780200; Jin ZH, 2007, HUM MOL GENET, V16, P1972, DOI 10.1093/hmg/ddm144; Ke N, 2008, BIOCHEM BIOPH RES CO, V366, P314, DOI 10.1016/j.bbrc.2007.11.071; Koirala S, 2009, J NEUROSCI, V29, P7439, DOI 10.1523/JNEUROSCI.1182-09.2009; Lelianova VG, 1997, J BIOL CHEM, V272, P21504, DOI 10.1074/jbc.272.34.21504; Lelouvier B, 2008, J NEUROSCI, V28, P4336, DOI 10.1523/JNEUROSCI.4379-07.2008; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; Little KD, 2004, MOL BIOL CELL, V15, P2375, DOI 10.1091/mbc.E03-12-0886; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Mhaouty-Kodja S, 1999, MOL PHARMACOL, V55, P339, DOI 10.1124/mol.55.2.339; Miura SI, 2000, EMBO J, V19, P4026, DOI 10.1093/emboj/19.15.4026; MULLER I, 2009, APPL BIOCH BIOTECHNO; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Quellari M, 2003, EUR J BIOCHEM, V270, P3486, DOI 10.1046/j.1432-1033.2003.03718.x; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Shashidhar S, 2005, ONCOGENE, V24, P1673, DOI 10.1038/sj.onc.1208395; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Shima Y, 2007, NAT NEUROSCI, V10, P963, DOI 10.1038/nn1933; Traynelis SF, 2007, CURR OPIN HEMATOL, V14, P230, DOI 10.1097/MOH.0b013e3280dce568; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Xu L, 2006, P NATL ACAD SCI USA, V103, P9023, DOI 10.1073/pnas.0602681103; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Yona S, 2008, FASEB J, V22, P741, DOI 10.1096/fj.07-9435com; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999; Zhang M, 2000, ENDOCRINOLOGY, V141, P3514, DOI 10.1210/en.141.9.3514	38	123	125	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28914	28921		10.1074/jbc.M111.247973	http://dx.doi.org/10.1074/jbc.M111.247973			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21708946	Green Published, hybrid			2022-12-25	WOS:000293837000028
J	Ruan, YB; Cheng, M; Ou, Y; Oko, R; van der Hoorn, FA				Ruan, Yibing; Cheng, Min; Ou, Young; Oko, Richard; van der Hoorn, Frans A.			Ornithine Decarboxylase Antizyme Oaz3 Modulates Protein Phosphatase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; ODC ACTIVITY; TESTIS; EXPRESSION; PHOSPHORYLATION; IDENTIFICATION; SUBUNIT; BINDING; CLONING; MYPT3	Ornithine decarboxylase antizyme 3 (Oaz3) is expressed in spermatids, makes up the antizyme family of Oaz genes with Oaz1 and Oaz2, and was proposed to encode a 22 kDa antizyme protein involved in polyamine regulation similar to the 22 kDa OAZ1 and OAZ2 proteins. Here we demonstrate however that the major product encoded by Oaz3 is a 12 kDa protein, p12, which lacks the antizyme domain that interacts with ornithine decarboxylase. We show that p12 does not affect ornithine decarboxylase levels, providing an explanation for the surprising observation made in Oaz3 knock-out male mice, which do not display altered testis polyamine metabolism. This suggested a novel activity for Oaz3 p12. Using immuno-electron microscopy we localized p12 to two structures in the mammalian sperm tail, viz. the outer dense fibers and fibrous sheath, as well as to the connecting piece linking head and tail. We identified myosin phosphatase targeting subunit 3 (MYPT3), a regulator of protein phosphatase PP1 beta, as a major p12-interacting protein, and show that MYPT3 is present in sperm tails and that its ankyrin repeat binds p12. We show that MYPT3 can also bind protein phosphatase PP1 gamma 2, the only protein phosphatase present in sperm tails, and that p12-MYPT3 interaction modulates the activity of both PP1 beta and PP1 gamma 2. This is, to our knowledge, the first demonstration of a novel activity for an Oaz-encoded protein.	[Ruan, Yibing; Cheng, Min; Ou, Young; van der Hoorn, Frans A.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Oko, Richard] Queens Univ, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada	University of Calgary; Queens University - Canada	van der Hoorn, FA (corresponding author), 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	fvdhoorn@ucalgary.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (to F. A. v. d. H. and R. O.).	ALCIVAR AA, 1989, BIOL REPROD, V41, P1133, DOI 10.1095/biolreprod41.6.1133; Bhullar B, 2003, J BIOL CHEM, V278, P16159, DOI 10.1074/jbc.M213126200; Chakrabarti R, 2007, ASIAN J ANDROL, V9, P445, DOI 10.1111/j.1745-7262.2007.00307.x; Chakrabarti R, 2007, BIOL REPROD, V76, P992, DOI 10.1095/biolreprod.106.058610; Chun YS, 2000, BIOCHEM BIOPH RES CO, V273, P972, DOI 10.1006/bbrc.2000.3045; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Fitzgerald C, 2006, J BIOL CHEM, V281, P38172, DOI 10.1074/jbc.M606010200; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Goto N, 2009, J REPROD DEVELOP, V55, P327, DOI 10.1262/jrd.20170; Howard MT, 2001, GENES CELLS, V6, P931, DOI 10.1046/j.1365-2443.2001.00477.x; ICHIBA T, 1994, BIOCHEM BIOPH RES CO, V200, P1721, DOI 10.1006/bbrc.1994.1651; Ivanov IP, 2000, P NATL ACAD SCI USA, V97, P4808, DOI 10.1073/pnas.070055897; Mangold U, 2005, IUBMB LIFE, V57, P671, DOI 10.1080/15216540500307031; Mishra S, 2003, BIOL REPROD, V69, P1572, DOI 10.1095/biolreprod.103.018739; Ou Y, 2009, EXP CELL RES, V315, P2802, DOI 10.1016/j.yexcr.2009.06.028; Shao XP, 1997, J BIOL CHEM, V272, P6105, DOI 10.1074/jbc.272.10.6105; Skinner JA, 2001, BIOCHEM J, V356, P257, DOI 10.1042/0264-6021:3560257; Snapir Z, 2009, BIOCHEM J, V419, P99, DOI 10.1042/BJ20081874; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Tokuhiro K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000712; Tosaka Y, 2000, GENES CELLS, V5, P265, DOI 10.1046/j.1365-2443.2000.00324.x; Vijayaraghavan Srinivasan, 2007, Soc Reprod Fertil Suppl, V63, P111; WEINER KXB, 1992, BIOL REPROD, V46, P617, DOI 10.1095/biolreprod46.4.617; Yong J, 2006, J BIOL CHEM, V281, P31202, DOI 10.1074/jbc.M607287200; Zarsky HA, 2003, BIOL REPROD, V68, P543, DOI [10.1095/BIOLREPROD.102.009076, 10.1095/biolreprod.102.009076]	25	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29417	29427		10.1074/jbc.M111.274647	http://dx.doi.org/10.1074/jbc.M111.274647			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21712390	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000293837000076
J	Sasahara, A; Nanatani, K; Enomoto, M; Kuwahara, S; Abe, K				Sasahara, Ayako; Nanatani, Kei; Enomoto, Masaru; Kuwahara, Shigefumi; Abe, Keietsu			Substrate Specificity of the Aspartate:Alanine Antiporter (AspT) of Tetragenococcus halophilus in Reconstituted Liposomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORTER CLASSIFICATION DATABASE; BACTERIAL ANION-EXCHANGE; AMINO-ACID ANTIPORTER; OXALOBACTER-FORMIGENES; ALANINE ANTIPORTER; ESCHERICHIA-COLI; AGMATINE ANTIPORTER; MEMBRANE TOPOLOGY; OXLT; MECHANISM	The aspartate: alanine antiporter (AspT) of the lactic acid bacterium Tetragenococcus halophilus is a member of the aspartate: alanine exchanger (AAEx) transporter family. T. halophilus AspT catalyzes the electrogenic exchange of L-aspartate(1-) with L-alanine(0). Although physiological functions of AspT were well studied, L-aspartate(1-) : L-alanine(0) antiport mechanisms are still unsolved. Here we report that the binding sites of L-aspartate and L-alanine are independently present in AspT by means of the kinetic studies. We purified His(6)-tagged T. halophilus AspT and characterized its kinetic properties when reconstituted in liposomes (K-m = 0.35 +/- 0.03 mM for L-aspartate, K-m = 0.098 +/- 0 mM for D-aspartate, K-m = 26 +/- 2 mM for L-alanine, K-m = 3.3 +/- 0.2 mM for D-alanine). Competitive inhibition by various amino acids of L-aspartate or L-alanine in self-exchange reactions revealed that L-cysteine selectively inhibited L-aspartate self-exchange but only weakly inhibited L-alanine self-exchange. Additionally, L-serine selectively inhibited L-alanine self-exchange but barely inhibited L-aspartate self-exchange. The aspartate analogs L-cysteine sulfinic acid, L-cysteic acid, and D-cysteic acid competitively and strongly inhibited L-aspartate self-exchange compared with L-alanine self-exchange. Taken together, these kinetic data suggest that the putative binding sites of L-aspartate and L-alanine are independently located in the substrate translocation pathway of AspT.	[Sasahara, Ayako; Abe, Keietsu] Tohoku Univ, Grad Sch Agr Sci, Dept Microbial Biotechnol, Appl Microbiol Lab, Sendai, Miyagi 9818555, Japan; [Enomoto, Masaru; Kuwahara, Shigefumi] Tohoku Univ, Grad Sch Agr Sci, Dept Appl Bioorgan Chem, Lab Appl Bioorgan Chem, Sendai, Miyagi 9818555, Japan; [Nanatani, Kei] Tohoku Univ, Grad Sch Engn, Lab Appl Biophys Chem, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan; [Abe, Keietsu] Tohoku Univ, New Ind Creat Hatchery Ctr, Microbial Genom Lab, Sendai, Miyagi 9808579, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Abe, K (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Dept Microbial Biotechnol, Appl Microbiol Lab, Sendai, Miyagi 9818555, Japan.	kabe@biochem.tohoku.ac.jp	Enomoto, Masaru/T-6967-2019	Enomoto, Masaru/0000-0001-6342-217X	Japan Society for the Promotion of Science (JSPS) [2265108]; Kato Memorial Bioscience Foundation; NISR (Noda Institute for Scientific Research); Grants-in-Aid for Scientific Research [23780073] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kato Memorial Bioscience Foundation; NISR (Noda Institute for Scientific Research); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-aid for challenging exploratory research from Japan Society for the Promotion of Science (JSPS) Grant 2265108 (to K. A.), the Kato Memorial Bioscience Foundation (to K. N.), and a NISR (Noda Institute for Scientific Research) Research grant (to K. A.).	Abe K, 1996, J BIOL CHEM, V271, P6789, DOI 10.1074/jbc.271.12.6789; Abe K, 2002, J BACTERIOL, V184, P2906, DOI 10.1128/JB.184.11.2906-2913.2002; Abe K, 1996, J BIOL CHEM, V271, P3079, DOI 10.1074/jbc.271.6.3079; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMBUDKAR SV, 1986, J BIOL CHEM, V261, P79; ANANTHARAM V, 1989, J BIOL CHEM, V264, P7244; Barabote RD, 2006, BBA-BIOMEMBRANES, V1758, P1557, DOI 10.1016/j.bbamem.2006.06.018; CLARKE HT, 1955, ORGANIC SYNTHESES CO, P226; CORNISHB.A, 1974, BIOCHEM J, V139, P721, DOI 10.1042/bj1390721; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Fujiki T, 2007, J BIOCHEM, V141, P85, DOI 10.1093/jb/mvm010; Fukui K, 2011, J BIOTECHNOL, V154, P25, DOI 10.1016/j.jbiotec.2011.03.010; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; MALONEY PC, 1992, J BIOL CHEM, V267, P10531; MALONEY PC, 1994, J EXP BIOL, V196, P471; Nanatani K, 2005, BIOCHEM BIOPH RES CO, V328, P20, DOI 10.1016/j.bbrc.2004.12.133; Nanatani K, 2007, J BACTERIOL, V189, P7089, DOI 10.1128/JB.00088-07; Nanatani K, 2009, J BACTERIOL, V191, P2122, DOI 10.1128/JB.00830-08; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Wang XC, 2006, BIOCHEMISTRY-US, V45, P10344, DOI 10.1021/bi060746v; Ye LW, 2002, J BIOL CHEM, V277, P20372, DOI 10.1074/jbc.M111140200	25	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29044	29052		10.1074/jbc.M111.260224	http://dx.doi.org/10.1074/jbc.M111.260224			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21719707	hybrid, Green Published			2022-12-25	WOS:000293837000041
J	Chen, YX; Wang, WH; Zhou, YY; Shields, R; Chanda, SK; Elston, RC; Li, J				Chen, Yixuan; Wang, Wenhui; Zhou, Yingyao; Shields, Robert; Chanda, Sumit K.; Elston, Robert C.; Li, Jing			In Silico Gene Prioritization by Integrating Multiple Data Sources	PLOS ONE			English	Article							DISEASE-GENES; FUNCTION PREDICTION; NETWORK; WALKING; MOUSE	Identifying disease genes is crucial to the understanding of disease pathogenesis, and to the improvement of disease diagnosis and treatment. In recent years, many researchers have proposed approaches to prioritize candidate genes by considering the relationship of candidate genes and existing known disease genes, reflected in other data sources. In this paper, we propose an expandable framework for gene prioritization that can integrate multiple heterogeneous data sources by taking advantage of a unified graphic representation. Gene-gene relationships and gene-disease relationships are then defined based on the overall topology of each network using a diffusion kernel measure. These relationship measures are in turn normalized to derive an overall measure across all networks, which is utilized to rank all candidate genes. Based on the informativeness of available data sources with respect to each specific disease, we also propose an adaptive threshold score to select a small subset of candidate genes for further validation studies. We performed large scale cross-validation analysis on 110 disease families using three data sources. Results have shown that our approach consistently outperforms other two state of the art programs. A case study using Parkinson disease (PD) has identified four candidate genes (UBB, SEPT5, GPR37 and TH) that ranked higher than our adaptive threshold, all of which are involved in the PD pathway. In particular, a very recent study has observed a deletion of TH in a patient with PD, which supports the importance of the TH gene in PD pathogenesis. A web tool has been implemented to assist scientists in their genetic studies.	[Chen, Yixuan; Wang, Wenhui; Shields, Robert; Li, Jing] Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA; [Zhou, Yingyao] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Chanda, Sumit K.] Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA USA; [Elston, Robert C.; Li, Jing] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Li, Jing] Jilin Univ, Joint Inst Syst Biol, Coll Comp Sci & Technol, Changchun 130023, Peoples R China	Case Western Reserve University; Novartis; Sanford Burnham Prebys Medical Discovery Institute; Case Western Reserve University; Jilin University	Chen, YX (corresponding author), Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA.	jingli@case.edu	Wang, Wenhui/A-8066-2011	Li, Jing/0000-0003-1160-6959; Wang, Wenhui/0000-0001-6681-1373	National Institutes of Health/National Library of Medicine [LM008991]; National Institutes of Health/National Center for Research Resources [RR03655]; Case Western Reserve University; Genomics Institute of the Novartis Research Foundation	National Institutes of Health/National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Case Western Reserve University; Genomics Institute of the Novartis Research Foundation	This research was supported by National Institutes of Health/National Library of Medicine [grant LM008991], National Institutes of Health/National Center for Research Resources [grant RR03655], and a joint summer fellowship program from Case Western Reserve University and Genomics Institute of the Novartis Research Foundation to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie EA, 2006, BIOINFORMATICS, V22, P773, DOI 10.1093/bioinformatics/btk031; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Ala U, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000043; Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Altshuler D, 2000, NAT GENET, V26, P135, DOI 10.1038/79839; Bademci G, 2010, HUM MUTAT, V31, pE1767, DOI 10.1002/humu.21351; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chen J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-392; Dennissen FJA, 2010, NEURODEGENER DIS, V7, P76, DOI 10.1159/000285510; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Freudenberg J, 2002, BIOINFORMATICS, V18, pS110, DOI 10.1093/bioinformatics/18.suppl_2.S110; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Marazziti D, 2009, FASEB J, V23, P1978, DOI 10.1096/fj.08-121210; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Pattin KA, 2008, HUM GENET, V124, P19, DOI 10.1007/s00439-008-0522-8; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Strohman R, 2002, SCIENCE, V296, P701, DOI 10.1126/science.1070534; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; Turner FS, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r75; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Zhou YY, 2005, BIOINFORMATICS, V21, P1237, DOI 10.1093/bioinformatics/bti111	34	40	41	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21137	10.1371/journal.pone.0021137	http://dx.doi.org/10.1371/journal.pone.0021137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731658	Green Published, gold			2022-12-25	WOS:000292036900012
J	Campbell-Smith, G; Campbell-Smith, M; Singleton, I; Linkie, M				Campbell-Smith, Gail; Campbell-Smith, Miran; Singleton, Ian; Linkie, Matthew			Raiders of the Lost Bark: Orangutan Foraging Strategies in a Degraded Landscape	PLOS ONE			English	Article							PONGO-PYGMAEUS; NATIONAL-PARK; TEMPORAL PATTERNS; VERVET MONKEYS; BEHAVIOR; ECOLOGY; AVAILABILITY; PERCEPTIONS; CONFLICT; WILDLIFE	Deforestation is rapidly transforming primary forests across the tropics into human-dominated landscapes. Consequently, conservationists need to understand how different taxa respond and adapt to these changes in order to develop appropriate management strategies. Our two year study seeks to determine how wild Sumatran orangutans (Pongo abelii) adapt to living in an isolated agroforest landscape by investigating the sex of crop-raiders related to population demographics, and their temporal variations in feeding behaviour and dietary composition. From focal animal sampling we found that nine identified females raided cultivated fruits more than the four males. Seasonal adaptations were shown through orangutan feeding habits that shifted from being predominantly fruit-based (56% of the total feeding time, then 22% on bark) to the fallback food of bark (44%, then 35% on fruits), when key cultivated resources such as jackfruit (Artocarpus integer), were unavailable. Cultivated fruits were mostly consumed in the afternoon and evening, when farmers had returned home. The finding that females take greater crop-raiding risks than males differs from previous human-primate conflict studies, probably because of the low risks associated (as farmers rarely retaliated) and low intraspecific competition between males. Thus, the behavioral ecology of orangutans living in this human-dominated landscape differs markedly from that in primary forest, where orangutans have a strictly wild food diet, even where primary rainforests directly borders farmland. The importance of wild food availability was clearly illustrated in this study with 21% of the total orangutan feeding time being allocated to feeding on cultivated fruits. As forests are increasingly converted to cultivation, humans and orangutans are predicted to come into conflict more frequently. This study reveals orangutan adaptations for coexisting with humans, e. g. changes in temporal foraging patterns, which should be used for guiding the development of specific human-wildlife conflict mitigation strategies to lessen future crop-raiding and conflicts.	[Campbell-Smith, Gail; Linkie, Matthew] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Campbell-Smith, Miran] Orangutan Informat Ctr, Human Orangutan Conflict & Mitigat Programme, Medan, North Sumatra, Indonesia; [Singleton, Ian] PanEco Fdn, Sumatran Orangutan Conservat Programme, Medan, North Sumatra, Indonesia; [Linkie, Matthew] Fauna & Flora Int, Cambridge, England	University of Kent	Campbell-Smith, G (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England.	primatelass@gmail.com			United States Fish and Wildlife Service [31221208, 31221435]; SeaWorld and Bush Gardens Conservation Fund; Born Free Foundation; Humane Society International; People's Trust for Endangered Species; PanEco; Orangutan Foundation; Primate Society of Great Britain; Orangutan Republik Education Initiative; Borneo Orangutan Society-Canada	United States Fish and Wildlife Service(US Fish & Wildlife Service); SeaWorld and Bush Gardens Conservation Fund; Born Free Foundation; Humane Society International; People's Trust for Endangered Species; PanEco; Orangutan Foundation; Primate Society of Great Britain; Orangutan Republik Education Initiative; Borneo Orangutan Society-Canada	This study was financially supported by the United States Fish and Wildlife Service Great Ape Conservation Fund (http://www.fws.gov/international/index.html) through grants #31221208 and #31221435 held by N. Leader-Williams at the Durrell Institute of Conservation and Ecology, University of Kent, and by funds awarded to G. Campbell-Smith by SeaWorld and Bush Gardens Conservation Fund (http://www.swbg-conservationfund.org), Born Free Foundation (http://www.bornfree.org.uk), Humane Society International (http://www.hsi.org), People's Trust for Endangered Species (http://www.ptes.org), PanEco (http://www.paneco.ch/content-n67-r-sD.html), Orangutan Foundation (http://www.orangutan.org.uk), Primate Society of Great Britain (http://www.psgb.org), Orangutan Republik Education Initiative (http://www.orangutanrepublik.org/ourei/), and Borneo Orangutan Society-Canada (http://www.orangutan.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; ALTMANN J, 1988, AM J PRIMATOL, V15, P213, DOI 10.1002/ajp.1350150304; Ancrenaz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011510; BARTON RA, 1992, ANIM BEHAV, V43, P831, DOI 10.1016/S0003-3472(05)80206-4; BRENNAN EJ, 1985, AFR J ECOL, V23, P35, DOI 10.1111/j.1365-2028.1985.tb00710.x; Campbell-Smith G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017210; Campbell-Smith G, 2010, AM J PRIMATOL, V72, P866, DOI 10.1002/ajp.20822; CANT JGH, 1987, AM J PRIMATOL, V12, P71, DOI 10.1002/ajp.1350120104; Chiyo PI, 2005, AFR J ECOL, V43, P48, DOI 10.1111/j.1365-2028.2004.00544.x; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; Delgado RA, 2000, EVOL ANTHROPOL, V9, P201; Doran D, 1997, INT J PRIMATOL, V18, P183, DOI 10.1023/A:1026368518431; Fox EA, 2004, AM J PHYS ANTHROPOL, V125, P162, DOI 10.1002/ajpa.10386; GALDIKAS BMF, 1988, INT J PRIMATOL, V9, P1, DOI 10.1007/BF02740195; HARRISON ME, 2008, AM J PRIMATOL, V70, P1; HARRISON MJS, 1983, ANIM BEHAV, V31, P969, DOI 10.1016/S0003-3472(83)80001-3; Hill CM, 1997, INT J PEST MANAGE, V43, P77, DOI 10.1080/096708797229022; Hoare, 1999, STANDARDISED DATA CO; Hockings K., 2009, BEST PRACTICE GUIDEL; Hockings KJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000886; Hockings KJ, 2009, AM J PRIMATOL, V71, P636, DOI 10.1002/ajp.20698; Kanamori T, 2010, AM J PRIMATOL, V72, P820, DOI 10.1002/ajp.20848; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; KNOTT CD, 1999, THESIS U HARVARD CAM; Leighton M., 1983, TROPICAL RAIN FOREST, P181; Linkie M, 2007, ANIM CONSERV, V10, P127, DOI 10.1111/j.1469-1795.2006.00083.x; MACKINNON J, 1974, ANIM BEHAV, V22, P3, DOI 10.1016/S0003-3472(74)80054-0; Meijaard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012813; MITANI JC, 1989, AM J PRIMATOL, V18, P87, DOI 10.1002/ajp.1350180203; Morrogh-Bernard H., 2002, LSB LEAK FDN OR CULT; Morrogh-Bernard Helen C., 2009, P119; Naughton-Treves L, 1998, J APPL ECOL, V35, P596, DOI 10.1046/j.1365-2664.1998.3540596.x; Naughton-Treves L, 1998, CONSERV BIOL, V12, P156, DOI 10.1046/j.1523-1739.1998.96346.x; PRISTON N, 2005, THESIS U CAMBRIDGE E; Priston NEC, 2009, INT J PEST MANAGE, V55, P243, DOI 10.1080/09670870902769955; Russon Anne E., 2009, P135; Saj T, 1999, INT J PRIMATOL, V20, P977, DOI 10.1023/A:1020886820759; Saj TL, 2001, AFR J ECOL, V39, P195, DOI 10.1046/j.0141-6707.2000.00299.x; Sha JCM, 2009, AM J PRIMATOL, V71, P825, DOI 10.1002/ajp.20710; Stephens D.W., 1986, pi; Wich SA, 2006, INT J PRIMATOL, V27, P1535, DOI 10.1007/s10764-006-9093-5; Yihune M, 2009, AFR J ECOL, V47, P276, DOI 10.1111/j.1365-2028.2007.00917.x; 2009, NATL NUTR DATABASE	43	60	62	2	157	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20962	10.1371/journal.pone.0020962	http://dx.doi.org/10.1371/journal.pone.0020962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731636	Green Published, gold, Green Submitted			2022-12-25	WOS:000292033700023
J	Cortes-Avizanda, A; Almaraz, P; Carrete, M; Sanchez-Zapata, JA; Delgado, A; Hiraldo, F; Donazar, JA				Cortes-Avizanda, Ainara; Almaraz, Pablo; Carrete, Martina; Sanchez-Zapata, Jose A.; Delgado, Antonio; Hiraldo, Fernando; Donazar, Jose A.			Spatial Heterogeneity in Resource Distribution Promotes Facultative Sociality in Two Trans-Saharan Migratory Birds	PLOS ONE			English	Article							KITES MILVUS-MILVUS; GEOGRAPHICAL VARIATION; MOVEMENT PATTERNS; BRAIN SIZE; RED KITES; POPULATION; EVOLUTION; FOOD; SURVIVAL; AVAILABILITY	Background: Migrant populations must cope not only with environmental changes in different biomes, but also with the continuous constraints imposed by human-induced changes through landscape transformation and resource patchiness. Theoretical studies suggest that changes in food distribution can promote changes in the social arrangement of individuals without apparent adaptive value. Empirical research on this subject has only been performed at reduced geographical scales and/or for single species. However, the relative contribution of food patchiness and predictability, both in space and time, to abundance and sociality can vary among species, depending on their degree of flexibility. Methodology/Principal Findings: By means of constrained zero-inflated Generalized Additive Models we analysed the spatial distribution of two trans-Saharan avian scavengers that breed (Europe) and winter (Africa) sympatrically, in relation to food availability. In the summering grounds, the probability of finding large numbers of both species increases close to predictable feeding sources, whereas in the wintering grounds, where food resources are widespread, we did not find such aggregation patterns, except for the black kite, which aggregated at desert locust outbreaks. The comparison of diets in both species through stable isotopes revealed that their diets overlapped during summering, but not during wintering. Conclusions/Significance: Our results suggest that bird sociality at feeding grounds is closely linked to the pattern of spatial distribution and predictability of trophic resources, which are ultimately induced by human activities. Migrant species can show adaptive foraging strategies to face changing distribution of food availability in both wintering and summering quarters. Understanding these effects is a key aspect for predicting the fitness costs and population consequences of habitat transformations on the viability of endangered migratory species.	[Cortes-Avizanda, Ainara; Carrete, Martina; Hiraldo, Fernando; Donazar, Jose A.] CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Almaraz, Pablo; Sanchez-Zapata, Jose A.] Univ Miguel Hernandez, Dept Appl Biol, Alicante, Spain; [Carrete, Martina] Univ Pablo de Olavide, Dept Phys Chem & Nat Syst, Seville, Spain; [Delgado, Antonio] CSIC, Estn Expt Zaidin, Lab Biogeoquim Isotopos Estables, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad Miguel Hernandez de Elche; Universidad Pablo de Olavide; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Cortes-Avizanda, A (corresponding author), CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain.	ainara@ebd.csic.es	Carrete, Martina/A-6376-2009; Cortés-Avizanda, Ainara/C-6634-2013; Carrete, Martina/D-2618-2017; Almaraz, Pablo/A-3683-2014; Hiraldo, Fernando/AAA-8314-2019; CORTES-AVIZANDA, AINARA/O-3248-2019; Sanchez-Zapata, Jose Antonio/H-1413-2015; Huertas, Antonio Delgado/F-6866-2011	Carrete, Martina/0000-0002-0491-2950; Cortés-Avizanda, Ainara/0000-0002-9674-6434; Almaraz, Pablo/0000-0003-1416-2695; CORTES-AVIZANDA, AINARA/0000-0002-9674-6434; Sanchez-Zapata, Jose Antonio/0000-0001-8230-4953; Huertas, Antonio Delgado/0000-0002-7240-1570; Donazar, Jose Antonio/0000-0002-9433-9755	Spanish Government [CGL2004-00270]	Spanish Government(Spanish GovernmentEuropean Commission)	This work was supported by the project CGL2004-00270 of Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal DK, 2002, ENVIRON ECOL STAT, V9, P341, DOI 10.1023/A:1020910605990; Anadon JD, 2010, ANIM CONSERV, V13, P495, DOI 10.1111/j.1469-1795.2010.00369.x; [Anonymous], 2010, R LANG ENV STAT COMP; Barry SC, 2002, ECOL MODEL, V157, P179, DOI 10.1016/S0304-3800(02)00194-1; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; BLANCO G, 1994, J RAPTOR RES, V28, P242; Blanco G, 1999, ANIM BEHAV, V57, P1219, DOI 10.1006/anbe.1999.1103; Blanco G, 2007, ENVIRON MICROBIOL, V9, P1738, DOI 10.1111/j.1462-2920.2007.01291.x; Bolnick DI, 2010, P ROY SOC B-BIOL SCI, V277, P1789, DOI 10.1098/rspb.2010.0018; Bowlin MS, 2010, INTEGR COMP BIOL, V50, P261, DOI 10.1093/icb/icq013; Burnham K. P., 1998, MODEL SELECTION INFE; Carrete M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018859; Carrete M, 2009, ECOL APPL, V19, P840, DOI 10.1890/07-2134.1; Chesser RT, 1998, AM NAT, V152, P311, DOI 10.1086/286171; Chiogna M, 2007, ENVIRONMETRICS, V18, P303, DOI 10.1002/env.830; Cortes-Avizanda A, 2010, BIOL CONSERV, V143, P1707, DOI 10.1016/j.biocon.2010.04.016; Cotton PA, 2003, P NATL ACAD SCI USA, V100, P12219, DOI 10.1073/pnas.1930548100; COX GW, 1985, AM NAT, V126, P451, DOI 10.1086/284432; Cramp S., 1980, HDB BIRDS EUROPE MID; Delibes-Mateos M, 2008, CONSERV BIOL, V22, P1106, DOI 10.1111/j.1523-1739.2008.00993.x; Donazar JA, 2009, SCIENCE, V326, P664, DOI 10.1126/science.326_664a; Donazar Jose Antonio, 1992, Ardeola, V39, P29; Donazar Sancho J.A., 1988, Ardeola, V35, P3; Eide NE, 2004, J ANIM ECOL, V73, P1056, DOI 10.1111/j.0021-8790.2004.00885.x; Forsman D., 2007, RAPTORS EUROPE MIDDL; Garcia-Ripolles C, 2010, BIRD STUDY, V57, P261, DOI 10.1080/00063650903505762; Grande JM, 2009, OIKOS, V118, P580, DOI 10.1111/j.1600-0706.2009.17218.x; Grimm V, 2005, CONSERV BIOL, V19, P578, DOI 10.1111/j.1523-1739.2005.000163.x; HIRALDO F, 1993, ETHOLOGY, V93, P117; Houston D. C., 1979, SERENGETI DYNAMICS E, P236; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Jenness J., 2004, NEAREST FEATURES NEA; Johnson DDP, 2002, TRENDS ECOL EVOL, V17, P563, DOI 10.1016/S0169-5347(02)02619-8; Krause J, 2002, LIVING GROUPS; Lefebvre L, 2004, BRAIN BEHAV EVOLUT, V63, P233, DOI 10.1159/000076784; Lemus JA, 2009, P ROY SOC B-BIOL SCI, V276, P2307, DOI 10.1098/rspb.2009.0071; Lemus JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001444; LEVEY DJ, 1992, AM NAT, V140, P447, DOI 10.1086/285421; Liu H, 2010, J STAT SOFTW, V35, P1; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; Marzluff JM, 1996, ANIM BEHAV, V51, P89, DOI 10.1006/anbe.1996.0008; Michener R, 2007, ECOL METHOD CONCEPT, pXVII; Mihoub JB, 2010, BIOL CONSERV, V143, P839, DOI 10.1016/j.biocon.2009.12.026; Monkkonen M, 2004, ECOGRAPHY, V27, P112, DOI 10.1111/j.0906-7590.2004.03705.x; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Newton I, 2004, IBIS, V146, P197, DOI 10.1111/j.1474-919X.2004.00293.x; Overington SE, 2008, BEHAV ECOL, V19, P836, DOI 10.1093/beheco/arn037; Perez-Tris J, 2002, J ANIM ECOL, V71, P211, DOI 10.1046/j.1365-2656.2002.00590.x; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Popa-Lisseanu AG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000205; Revilla E, 2002, J ANIM ECOL, V71, P497, DOI 10.1046/j.1365-2656.2002.00617.x; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Schaub M, 2005, J ANIM ECOL, V74, P656, DOI 10.1111/j.1365-2656.2005.00961.x; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Sol D, 2005, P ROY SOC B-BIOL SCI, V272, P1433, DOI 10.1098/rspb.2005.3099; Sol D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009617; Tokeshi M., 2009, SPECIES COEXISTENCE; VEIGA JP, 1990, HOLARCTIC ECOL, V13, P62; Villafuerte R, 1998, BIOL CONSERV, V84, P181, DOI 10.1016/S0006-3207(97)00094-3; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Wenger SJ, 2008, ECOLOGY, V89, P2953, DOI 10.1890/07-1127.1; Wichmann MC, 2005, GLOBAL PLANET CHANGE, V47, P273, DOI 10.1016/j.gloplacha.2004.10.016; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	74	30	30	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21016	10.1371/journal.pone.0021016	http://dx.doi.org/10.1371/journal.pone.0021016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731640	Green Published, gold, Green Submitted			2022-12-25	WOS:000292033700027
J	Jansa, SA; Voss, RS				Jansa, Sharon A.; Voss, Robert S.			Adaptive Evolution of the Venom-Targeted vWF Protein in Opossums that Eat Pitvipers	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; SNAKE BOTHROPS-ASPER; WARM-BLOODED ANIMALS; LECTIN-LIKE PROTEINS; POSITIVE SELECTION; ACETYLCHOLINE-RECEPTOR; PHYLOGENETIC ANALYSIS; VONWILLEBRAND-FACTOR; RAPID EVOLUTION; REPRODUCTIVE PROTEINS	The rapid evolution of venom toxin genes is often explained as the result of a biochemical arms race between venomous animals and their prey. However, it is not clear that an arms race analogy is appropriate in this context because there is no published evidence for rapid evolution in genes that might confer toxin resistance among routinely envenomed species. Here we report such evidence from an unusual predator-prey relationship between opossums (Marsupialia: Didelphidae) and pitvipers (Serpentes: Crotalinae). In particular, we found high ratios of replacement to silent substitutions in the gene encoding von Willebrand Factor (vWF), a venom-targeted hemostatic blood protein, in a clade of opossums known to eat pitvipers and to be resistant to their hemorrhagic venom. Observed amino-acid substitutions in venom-resistant opossums include changes in net charge and hydrophobicity that are hypothesized to weaken the bond between vWF and one of its toxic snake-venom ligands, the C-type lectin-like protein botrocetin. Our results provide the first example of rapid adaptive evolution in any venom-targeted molecule, and they support the notion that an evolutionary arms race might be driving the rapid evolution of snake venoms. However, in the arms race implied by our results, venomous snakes are prey, and their venom has a correspondingly defensive function in addition to its usual trophic role.	[Jansa, Sharon A.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Jansa, Sharon A.] Univ Minnesota, JF Bell Museum Nat Hist, St Paul, MN 55108 USA; [Voss, Robert S.] Amer Museum Nat Hist, Dept Mammal, New York, NY 10024 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; American Museum of Natural History (AMNH)	Jansa, SA (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	jansa003@umn.edu		Jansa, Sharon/0000-0002-8073-1262	National Science Foundation [DEB-0211952, DEB-0322253, DEB-0743062]; Division Of Environmental Biology [0743062] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation grants DEB-0211952, DEB-0322253, and DEB-0743062 (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1986, TRENDS ECOL EVOL, V1, P108, DOI 10.1016/0169-5347(86)90037-6; Almeida-Santos Selma Maria, 2000, Current Herpetology, V19, P1; Angulo Y, 2009, TOXICON, V54, P949, DOI 10.1016/j.toxicon.2008.12.014; Azara F., 1802, APUNTAMIENTOS HIST N; BARCHAN D, 1995, BIOCHEMISTRY-US, V34, P9172, DOI 10.1021/bi00028a029; BARCHAN D, 1992, P NATL ACAD SCI USA, V89, P7717, DOI 10.1073/pnas.89.16.7717; Barlow A, 2009, P ROY SOC B-BIOL SCI, V276, P2443, DOI 10.1098/rspb.2009.0048; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Bdolah A, 1997, TOXICON, V35, P1251, DOI 10.1016/S0041-0101(97)00019-6; Biardi J.E., 2008, BIOL RATTLESNAKES, P557; Biardi JE, 2000, TOXICON, V38, P713, DOI 10.1016/S0041-0101(99)00179-8; Braud S, 2000, BIOCHIMIE, V82, P851, DOI 10.1016/S0300-9084(00)01178-0; Brodie ED, 1999, BIOSCIENCE, V49, P557, DOI 10.2307/1313476; Cundall David, 2002, P149; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; DOMONT GB, 1991, TOXICON, V29, P1183, DOI 10.1016/0041-0101(91)90191-S; Drummond A., 2011, GENEIOUS V5 5; Du Xiao-Yan, 2010, P359; Duda TF, 1999, P NATL ACAD SCI USA, V96, P6820, DOI 10.1073/pnas.96.12.6820; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Fry BG, 2004, MOL BIOL EVOL, V21, P870, DOI 10.1093/molbev/msh091; Fry BG, 2008, MOL CELL PROTEOMICS, V7, P215, DOI 10.1074/mcp.M700094-MCP200; Fukuda K, 2005, NAT STRUCT MOL BIOL, V12, P152, DOI 10.1038/nsmb892; Fukuda K, 2002, STRUCTURE, V10, P943, DOI 10.1016/S0969-2126(02)00787-6; Gibbs HL, 2008, J MOL EVOL, V66, P151, DOI 10.1007/s00239-008-9067-7; Greene Harry W., 1992, P107; GREENE HW, 1988, BIOL REPTILIA, P16; Gutierrez Jose Maria, 2010, P115; Hanifin CT, 2008, PLOS BIOL, V6, P471, DOI 10.1371/journal.pbio.0060060; Hughes AL, 2007, HEREDITY, V99, P364, DOI 10.1038/sj.hdy.6801031; HUGHES AL, 1994, PHILOS T ROY SOC B, V346, P359, DOI 10.1098/rstb.1994.0153; Jackson K, 2003, ZOOL J LINN SOC-LOND, V137, P337, DOI 10.1046/j.1096-3642.2003.00052.x; Juarez P, 2008, MOL BIOL EVOL, V25, P2391, DOI 10.1093/molbev/msn179; KACHALSKY SG, 1995, P NATL ACAD SCI USA, V92, P10801, DOI 10.1073/pnas.92.23.10801; KILMON JA, 1976, TOXICON, V14, P337, DOI 10.1016/0041-0101(76)90032-5; KLAUBER L. M., 1972, RATTLESNAKES THEIR H, V2nd; KOCHVA E, 1987, TOXICON, V25, P65, DOI 10.1016/0041-0101(87)90150-4; Kordis D, 2000, GENE, V261, P43, DOI 10.1016/S0378-1119(00)00490-X; Kozminsky-Atias A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-333; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lu QM, 2005, TOXICON, V45, P1089, DOI 10.1016/j.toxicon.2005.02.022; Mackessy SP, 2010, HDB VENOMS TOXINS RE, P3; Mackessy SP, 2006, ZOOL ANZ, V245, P147, DOI 10.1016/j.jcz.2006.01.003; Gutierrez JM, 2009, TOXICON, V54, P976, DOI 10.1016/j.toxicon.2009.01.039; Markland FS, 1998, TOXICON, V36, P1749, DOI 10.1016/S0041-0101(98)00126-3; Matsui T, 2005, TOXICON, V45, P1075, DOI 10.1016/j.toxicon.2005.02.023; Mebs D, 1996, TOXICON, V34, P1313, DOI 10.1016/S0041-0101(96)00104-3; Morita T, 2005, TOXICON, V45, P1099, DOI 10.1016/j.toxicon.2005.02.021; MOUSSATCHE H, 1989, MEM I OSWALDO CRUZ, V84, P391, DOI 10.1590/S0074-02761989000800070; NEVESFERREIRA AGC, 2010, HDB VENOMS TOXINS RE, P259; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Ogawa T, 2005, TOXICON, V45, P1, DOI 10.1016/j.toxicon.2004.07.028; Oliveira ME, 1999, STUD NEOTROP FAUNA E, V34, P72, DOI 10.1076/snfe.34.2.72.2105; Ota R, 2000, MOL BIOL EVOL, V17, P798, DOI 10.1093/oxfordjournals.molbev.a026358; Perales J, 2005, TOXICON, V45, P1013, DOI 10.1016/j.toxicon.2005.02.028; PERALES J, 1994, TOXICON, V32, P1237, DOI 10.1016/0041-0101(94)90353-0; PEREZ JC, 1978, TOXICON, V16, P375, DOI 10.1016/0041-0101(78)90158-7; PEREZ JC, 1979, TOXICON, V17, P601, DOI 10.1016/0041-0101(79)90234-4; Perez JC, 1999, TOXICON, V37, P703, DOI 10.1016/S0041-0101(98)00205-0; READ MS, 1989, BLOOD, V74, P1031; Rucavado A, 2001, THROMB HAEMOSTASIS, V85, P710; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; SANDERS WE, 1988, LAB INVEST, V59, P443; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Thwin MM, 1998, TOXICON, V36, P1471, DOI 10.1016/S0041-0101(98)00137-8; Turner LM, 2008, INT J DEV BIOL, V52, P769, DOI 10.1387/ijdb.082577lt; USAMI Y, 1993, P NATL ACAD SCI USA, V90, P928, DOI 10.1073/pnas.90.3.928; VELLARD J., 1949, PUBL MUS HIST NAT JAVIER PRADO" SER A ZOOL, V1, P1; VERMEIJ GJ, 1994, ANNU REV ECOL SYST, V25, P219, DOI 10.1146/annurev.es.25.110194.001251; Voss RS, 2009, B AM MUS NAT HIST, P1; Weinberger H, 2010, MOL BIOL EVOL, V27, P1025, DOI 10.1093/molbev/msp310; WERNER RM, 1977, TOXICON, V15, P29, DOI 10.1016/0041-0101(77)90066-6; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	78	56	59	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20997	10.1371/journal.pone.0020997	http://dx.doi.org/10.1371/journal.pone.0020997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731638	Green Published, gold			2022-12-25	WOS:000292033700025
J	Li, Y; Zheng, HJ; Liu, Y; Jiang, YW; Xin, JQ; Chen, W; Song, ZQ				Li, Yuan; Zheng, Huajun; Liu, Yang; Jiang, Yanwei; Xin, Jiuqing; Chen, Wei; Song, Zhiqiang			The Complete Genome Sequence of Mycoplasma bovis Strain Hubei-1	PLOS ONE			English	Article							MULTIPLEX-PCR; CLPC ATPASE; BACTERIAL; PROTEIN; IDENTIFICATION; VIRULENCE; REPLICATION; PNEUMONIA; DATABASE; GENES	Infection by Mycoplasma bovis (M. bovis) can induce diseases, such as pneumonia and otitis media in young calves and mastitis and arthritis in older animals. Here, we report the finished and annotated genome sequence of M. bovis strain Hubei-1, a strain isolated in 2008 that caused calf pneumonia on a Chinese farm. The genome of M. bovis strain Hubei-1 contains a single circular chromosome of 953,114 bp with a 29.37% GC content. We identified 803 open reading frames (ORFs) that occupy 89.5% of the genome. While 34 ORFs were Hubei-1 specific, 662 ORFs had orthologs in the M. bovis type strain PG45 genome. Genome analysis validated lateral gene transfer between M. bovis and the Mycoplasma mycoides subspecies mycoides, while phylogenetic analysis found that the closest M. bovis neighbor is Mycoplasma agalactiae. Glycerol may be the main carbon and energy source of M. bovis, and most of the biosynthesis pathways were incomplete. We report that 47 lipoproteins, 12 extracellular proteins and 18 transmembrane proteins are phase-variable and may help M. bovis escape the immune response. Besides lipoproteins and phase-variable proteins, genomic analysis found two possible pathogenicity islands, which consist of four genes and 11 genes each, and several other virulence factors including hemolysin, lipoate protein ligase, dihydrolipoamide dehydrogenase, extracellular cysteine protease and 5'-nucleotidase.	[Li, Yuan; Liu, Yang; Xin, Jiuqing; Chen, Wei; Song, Zhiqiang] Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Bacterial Dis,State Key Lab Vet Biotechnol, Natl Contagious Bovine Pleuropneumonia Reference, Harbin, Peoples R China; [Zheng, Huajun; Jiang, Yanwei] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Li, Y (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Bacterial Dis,State Key Lab Vet Biotechnol, Natl Contagious Bovine Pleuropneumonia Reference, Harbin, Peoples R China.	xinjiuqing2001@126.com		Zheng, Huajun/0000-0002-9242-4040	National Natural Science Foundations of China; Harbin Science and Technology Program, China	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Harbin Science and Technology Program, China	Funding: National Natural Science Foundations of China and Harbin Science and Technology Program, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegboye DS, 1996, J AM VET MED ASSOC, V209, P647; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BHUGRA B, 1993, MOL MICROBIOL, V7, P577, DOI 10.1111/j.1365-2958.1993.tb01148.x; Borukhov S, 2005, MOL MICROBIOL, V55, P1315, DOI 10.1111/j.1365-2958.2004.04481.x; Burns EH, 1996, INFECT IMMUN, V64, P4744, DOI 10.1128/IAI.64.11.4744-4750.1996; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Caswell Jeff L., 2007, Animal Health Research Reviews, V8, P161, DOI 10.1017/S1466252307001351; Chambaud I, 2001, NUCLEIC ACIDS RES, V29, P2145, DOI 10.1093/nar/29.10.2145; Chang LJ, 2008, BIOCHEM BIOPH RES CO, V367, P213, DOI 10.1016/j.bbrc.2007.12.124; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dybvig K, 2008, INFECT IMMUN, V76, P4000, DOI 10.1128/IAI.00516-08; Foddai A, 2005, MOL CELL PROBE, V19, P207, DOI 10.1016/j.mcp.2004.11.007; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gates AE, 2008, VACCINE, V26, P2010, DOI 10.1016/j.vaccine.2008.02.010; Ghai R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-198; GOEBEL W, 1988, A VAN LEEUW J MICROB, V54, P453, DOI 10.1007/BF00461864; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo FB, 2003, NUCLEIC ACIDS RES, V31, P1780, DOI 10.1093/nar/gkg254; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Hotzel H, 1996, J APPL BACTERIOL, V80, P505, DOI 10.1111/j.1365-2672.1996.tb03249.x; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; KIRILLICHEVA GB, 1987, ZH MIKROBIOL EPIDEMI, V5, P76; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lysnyansky I, 1999, J BACTERIOL, V181, P5734, DOI 10.1128/JB.181.18.5734-5741.1999; Lysnyansky I, 2008, FEMS MICROBIOL LETT, V279, P234, DOI 10.1111/j.1574-6968.2007.01040.x; Mackiewicz P, 2004, NUCLEIC ACIDS RES, V32, P3781, DOI 10.1093/nar/gkh699; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Maunsell FP, 2009, VET CLIN N AM-FOOD A, V25, P139, DOI 10.1016/j.cvfa.2008.10.011; Maunsell FP, 2009, VACCINE, V27, P2781, DOI 10.1016/j.vaccine.2009.02.100; MILES H, 1992, J DAIRY SCI, V75, P596, DOI 10.3168/jds.S0022-0302(92)77797-2; Nair S, 2000, INFECT IMMUN, V68, P7061, DOI 10.1128/IAI.68.12.7061-7068.2000; Neyrolles O, 1999, INFECT IMMUN, V67, P1569; O'Riordan M, 2003, SCIENCE, V302, P462, DOI 10.1126/science.1088170; Pfutzner H, 1996, REV SCI TECH OIE, V15, P1477, DOI 10.20506/rst.15.4.987; Picardeau M, 1999, MOL MICROBIOL, V32, P437, DOI 10.1046/j.1365-2958.1999.01368.x; Pilo P, 2005, J BACTERIOL, V187, P6824, DOI 10.1128/JB.187.19.6824-6831.2005; POUMARAT F, 1991, VET MICROBIOL, V29, P329, DOI 10.1016/0378-1135(91)90140-B; Robino P, 2005, VET MICROBIOL, V109, P201, DOI 10.1016/j.vetmic.2005.05.007; ROTTEM S, 1964, J GEN MICROBIOL, V37, P123, DOI 10.1099/00221287-37-1-123; Rouquette C, 1998, MOL MICROBIOL, V27, P1235, DOI 10.1046/j.1365-2958.1998.00775.x; SANDERS JD, 1994, INFECT IMMUN, V62, P4515, DOI 10.1128/IAI.62.10.4515-4525.1994; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; Thomas A, 2004, VET MICROBIOL, V104, P213, DOI 10.1016/j.vetmic.2004.09.009; Thomas A, 2002, VET REC, V151, P472, DOI 10.1136/vr.151.16.472; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uchiyama I, 2003, NUCLEIC ACIDS RES, V31, P58, DOI 10.1093/nar/gkg109; van der Merwe J, 2010, INFECT IMMUN, V78, P4570, DOI 10.1128/IAI.00707-10; Walz PH, 1997, J VET DIAGN INVEST, V9, P250, DOI 10.1177/104063879700900305; Westberg J, 2004, GENOME RES, V14, P221, DOI 10.1101/gr.1673304	55	80	92	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20999	10.1371/journal.pone.0020999	http://dx.doi.org/10.1371/journal.pone.0020999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731639	gold, Green Submitted, Green Published			2022-12-25	WOS:000292033700026
J	Demeyer, M; De Graef, P; Verfaillie, K; Wagemans, J				Demeyer, Maarten; De Graef, Peter; Verfaillie, Karl; Wagemans, Johan			Perceptual Grouping of Object Contours Survives Saccades	PLOS ONE			English	Article							TRANSSACCADIC MEMORY; VISUAL MEMORY; EYE-MOVEMENTS; INFORMATION; REPRESENTATION; WORLD; ORGANIZATION; COMPRESSION; INTEGRATION; PROXIMITY	Human observers explore scenes by shifting their gaze from object to object. Before each eye movement, a peripheral glimpse of the next object to be fixated has however already been caught. Here we investigate whether the perceptual organization extracted from such a preview could guide the perceptual analysis of the same object during the next fixation. We observed that participants were indeed significantly faster at grouping together spatially separate elements into an object contour, when the same contour elements had also been grouped together in the peripheral preview display. Importantly, this facilitation occurred despite a change in the grouping cue defining the object contour (similarity versus collinearity). We conclude that an intermediate-level description of object shape persists in the visual system across gaze shifts, providing it with a robust basis for balancing efficiency and continuity during scene exploration.	[Demeyer, Maarten; De Graef, Peter; Verfaillie, Karl; Wagemans, Johan] Univ Leuven KU Leuven, Expt Psychol Lab, Leuven, Belgium	KU Leuven	Demeyer, M (corresponding author), Univ Leuven KU Leuven, Expt Psychol Lab, Leuven, Belgium.	maarten.demeyer@psy.kuleuven.be	Wagemans, Johan/M-3878-2019	Wagemans, Johan/0000-0002-7970-1541	Research Fund K.U. Leuven [GOA/2005/03-TBA]; European Community [IST-C-033816]; Methusalem grant [METH/08/02]	Research Fund K.U. Leuven(KU Leuven); European Community(European Commission); Methusalem grant	This research was supported by the Concerted Research Effort Convention GOA of the Research Fund K.U. Leuven (GOA/2005/03-TBA) granted to Gery d'Ydewalle, Karl Verfaillie, and Johan Wagemans; by the European Community through GazeCom project IST-C-033816 to Karl Verfaillie and Peter De Graef; and by a Methusalem grant to Johan Wagemans (METH/08/02). Maarten Demeyer is a postdoctoral research fellow of the Research Fund K. U. Leuven (PDMK/10/061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARLSONRADVANSKY LA, 1995, J EXP PSYCHOL LEARN, V21, P1441, DOI 10.1037/0278-7393.21.6.1441; Claessens PME, 2008, J VISION, V8, DOI 10.1167/8.7.33; De Graef P, 2002, PROG BRAIN RES, V140, P181; De Graef Peter, 2007, P165, DOI 10.1016/B978-008044980-7/50010-0; Demeyer M, 2010, VISION RES, V50, P1225, DOI 10.1016/j.visres.2010.04.008; Demeyer M, 2009, J VISION, V9, DOI 10.1167/9.4.28; Deubel H, 2002, PROG BRAIN RES, V140, P165; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Dumoulin SO, 2006, J NEUROPHYSIOL, V95, P3654, DOI 10.1152/jn.01156.2005; Einhauser W, 2008, J VISION, V8, DOI 10.1167/8.2.2; Fang F, 2008, J VISION, V8, DOI 10.1167/8.7.2; Germeys F, 2010, J VISION, V10, DOI 10.1167/10.10.9; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Hamker FH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040031; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Henderson JM, 2003, PERCEPT PSYCHOPHYS, V65, P58, DOI 10.3758/BF03194783; Henderson JM, 1997, PSYCHOL SCI, V8, P51, DOI 10.1111/j.1467-9280.1997.tb00543.x; Henderson JM, 2008, VISION RES, V48, P16, DOI 10.1016/j.visres.2007.10.008; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; IRWIN DE, 1990, PERCEPT PSYCHOPHYS, V47, P35, DOI 10.3758/BF03208162; IRWIN DE, 1992, J EXP PSYCHOL LEARN, V18, P307, DOI 10.1037/0278-7393.18.2.307; JONIDES J, 1983, SCIENCE, V222, P188, DOI 10.1126/science.6623072; Kimchi R, 2008, PSYCHOL SCI, V19, P660, DOI 10.1111/j.1467-9280.2008.02140.x; KOWLER E, 1995, VISION RES, V35, P1741, DOI 10.1016/0042-6989(94)00255-K; KUBOVY M, 1995, PSYCHOL SCI, V6, P225, DOI 10.1111/j.1467-9280.1995.tb00597.x; Landman R, 2004, PSYCHON B REV, V11, P254, DOI 10.3758/BF03196567; Landman R, 2003, VISION RES, V43, P149, DOI 10.1016/S0042-6989(02)00402-9; LEDERMAN SJ, 1972, PERCEPT PSYCHOPHYS, V12, P401, DOI 10.3758/BF03205850; Machilsen B, 2009, J VISION, V9, DOI 10.1167/9.12.11; Mathot S, 2010, PSYCHOL SCI, V21, P1793, DOI 10.1177/0956797610388813; Melcher D, 2005, CURR BIOL, V15, P1745, DOI 10.1016/j.cub.2005.08.044; Melcher D, 2007, NAT NEUROSCI, V10, P903, DOI 10.1038/nn1917; Melcher D, 2008, TRENDS COGN SCI, V12, P466, DOI 10.1016/j.tics.2008.09.003; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Op de Beeck HP, 2008, J NEUROSCI, V28, P10111, DOI 10.1523/JNEUROSCI.2511-08.2008; OREGAN JK, 1992, CAN J PSYCHOL, V46, P461, DOI 10.1037/h0084327; Panis S, 2009, J EXP PSYCHOL HUMAN, V35, P661, DOI 10.1037/a0013547; POLLATSEK A, 1984, J EXP PSYCHOL GEN, V113, P426, DOI 10.1037/0096-3445.113.3.426; Prime SL, 2007, EXP BRAIN RES, V180, P609, DOI 10.1007/s00221-007-0885-4; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Scholte HS, 2006, BRAIN RES, V1076, P106, DOI 10.1016/j.brainres.2005.10.051; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Sligte IG, 2009, J NEUROSCI, V29, P7432, DOI 10.1523/JNEUROSCI.0784-09.2009; Van Eccelpoel C, 2008, J VISION, V8, DOI 10.1167/8.14.29; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; Wilkinson F, 1998, VISION RES, V38, P3555, DOI 10.1016/S0042-6989(98)00039-X; Wolf W, 1997, SPATIAL VISION, V10, P323, DOI 10.1163/156856897X00249	48	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21257	10.1371/journal.pone.0021257	http://dx.doi.org/10.1371/journal.pone.0021257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782CL	21713007	gold, Green Submitted, Green Published			2022-12-25	WOS:000291985100021
J	van Hal, SJ; Jones, M; Gosbell, IB; Paterson, DL				van Hal, Sebastiaan J.; Jones, Mark; Gosbell, Iain B.; Paterson, David L.			Vancomycin Heteroresistance Is Associated with Reduced Mortality in ST239 Methicillin-Resistant Staphylococcus aureus Blood Stream Infections	PLOS ONE			English	Article							MINIMUM INHIBITORY CONCENTRATION; BACTERICIDAL ACTIVITY; CLINICAL-FEATURES; BACTEREMIA; SUSCEPTIBILITY; INTERMEDIATE; EFFICACY; STRAINS	Background: Despite hVISA infections being associated with vancomycin treatment failure, no previous study has been able to detect a mortality difference between heteroresistant vancomycin intermediate Staphylococcus aureus (hVISA) and vancomycin susceptible Staphylococcus aureus (VSSA) bloodstream infections (BSI). Methodology: Consecutive methicillin-resistant S. aureus (MRSA) BSI episodes between 1996 and 2008 were reviewed. Patient demographics, clinical presentation, treatment and overall mortality at 30 days were extracted from the medical records. All isolates underwent vancomycin minimum inhibitory concentration (VMIC) testing by broth microdilution and Etest. hVISA was confirmed by population analysis profiling using the area under the curve method (PAP-AUC). Principal Findings: 401 evaluable MRSA BSI episodes were identified over the 12 years. Of these, 46 (11.5%) and 2 (0.5%) were confirmed as hVISA and VISA by PAP-AUC respectively. hVISA predominantly occurred in ST239-like MRSA isolates with high VMIC (2 mg/L). Compared to VSSA, hVISA was associated with chronic renal failure (p<0.001), device related infections (haemodialysis access) (p<0.001) and previous vancomycin usage (p = 0.004). On multivariate analysis, independent predictors of mortality included age, presence of multiple co-morbidities, principal diagnosis, transit to ICU and severity of illness while infection related surgery and hVISA phenotype were associated with increased survival. Conclusions/Significance: The presence of hVISA is dependent on the appropriate interplay between host and pathogen factors. hVISA in ST239 MRSA is an independent predictor of survival. Whether these findings would be replicated across all MRSA clones is unknown and warrants further study.	[van Hal, Sebastiaan J.; Gosbell, Iain B.] Liverpool Hosp, Dept Microbiol & Infect Dis, Sydney S W Pathol Serv, Sydney, NSW, Australia; [van Hal, Sebastiaan J.; Gosbell, Iain B.] Univ Western Sydney, Sch Med, Microbiol & Infect Dis Unit, Penrith, NSW, Australia; [Jones, Mark] Univ Queensland, Ctr Healthcare Related Infect Surveillance & Prev, Queensland Hlth, Brisbane, Qld, Australia; [Jones, Mark] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Paterson, David L.] Univ Queensland, Ctr Clin Res UQCCR, Brisbane, Qld, Australia	Liverpool Hospital; Western Sydney University; Queensland Health; University of Queensland; University of Queensland; University of Queensland	van Hal, SJ (corresponding author), Liverpool Hosp, Dept Microbiol & Infect Dis, Sydney S W Pathol Serv, Sydney, NSW, Australia.	Sebastian.vanHal@sswahs.nsw.gov.au	Paterson, David L/A-9258-2010; Jones, Mark/I-2720-2016	Gosbell, Iain/0000-0001-5245-5152; van Hal, Sebastiaan/0000-0001-5852-4155; Jones, Mark/0000-0001-6858-9710; Paterson, David/0000-0003-2079-4437				Bae IG, 2009, J INFECT DIS, V200, P1355, DOI 10.1086/606027; Charles PGP, 2004, CLIN INFECT DIS, V38, P448, DOI 10.1086/381093; Chua K, 2009, CURR OPIN INFECT DIS, V22, P525, DOI 10.1097/QCO.0b013e328331fbcd; CLSI, 2018, PERFORMANCE STANDARD; Corey GR, 2009, CLIN INFECT DIS, V48, pS254, DOI 10.1086/598186; Hidayat LK, 2006, ARCH INTERN MED, V166, P2138, DOI 10.1001/archinte.166.19.2138; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; HOLMES N, 2010, INCREASED MORTALITY; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Horne KC, 2009, ANTIMICROB AGENTS CH, V53, P3447, DOI 10.1128/AAC.01365-08; Howden BP, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-39; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Jones RN, 2006, CLIN INFECT DIS, V42, pS13, DOI 10.1086/491710; Lesens O, 2003, INFECT CONT HOSP EP, V24, P890, DOI 10.1086/502156; Maor Y, 2009, J INFECT DIS, V199, P619, DOI 10.1086/596629; McCallum N, 2006, ANTIMICROB AGENTS CH, V50, P2352, DOI 10.1128/AAC.00073-06; Moise PA, 2007, ANTIMICROB AGENTS CH, V51, P2582, DOI 10.1128/AAC.00939-06; Musta AC, 2009, J CLIN MICROBIOL, V47, P1640, DOI 10.1128/JCM.02135-08; Neoh Hui-min, 2007, Ann Clin Microbiol Antimicrob, V6, P13, DOI 10.1186/1476-0711-6-13; Patel N, 2011, CLIN INFECT DIS, V52, P969, DOI 10.1093/cid/cir078; Peleg AY, 2009, J INFECT DIS, V199, P532, DOI 10.1086/596511; Rybak MJ, 2008, J CLIN MICROBIOL, V46, P2950, DOI 10.1128/JCM.00582-08; Sakoulas G, 2004, J CLIN MICROBIOL, V42, P2398, DOI 10.1128/JCM.42.6.2398-2402.2004; Sakoulas G, 2005, ANTIMICROB AGENTS CH, V49, P2687, DOI 10.1128/AAC.49.7.2687-2692.2005; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; Soriano A, 2008, CLIN INFECT DIS, V46, P193, DOI 10.1086/524667; TAKESUE Y, 2010, J INFECT CHEMOTHER; Turnidge JD, 2009, MED J AUSTRALIA, V191, P368, DOI 10.5694/j.1326-5377.2009.tb02841.x; van Hal SJ, 2011, ANTIMICROB AGENTS CH, V55, P405, DOI 10.1128/AAC.01133-10; van Hal SJ, 2011, J CLIN MICROBIOL, V49, P1489, DOI 10.1128/JCM.02302-10; VANHAL SJ, 2010, 50 INT C ANT AG CHEM; Vikram HR, 2003, JAMA-J AM MED ASSOC, V290, P3207, DOI 10.1001/jama.290.24.3207; Walsh TR, 2001, J ANTIMICROB CHEMOTH, V47, P357, DOI 10.1093/jac/47.3.357; Walsh TR, 2001, J CLIN MICROBIOL, V39, P2439, DOI 10.1128/JCM.39.7.2439-2444.2001	35	56	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21217	10.1371/journal.pone.0021217	http://dx.doi.org/10.1371/journal.pone.0021217			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713004	gold, Green Published, Green Submitted			2022-12-25	WOS:000291985100016
J	Linkner, J; Witte, G; Stradal, T; Curth, U; Faix, J				Linkner, Joern; Witte, Gregor; Stradal, Theresia; Curth, Ute; Faix, Jan			High-Resolution X-Ray Structure of the Trimeric Scar/WAVE-Complex Precursor Brk1	PLOS ONE			English	Article							ARP2/3 COMPLEX; WAVE-COMPLEX; CELLULAR CONTROL; REGULATES ACTIN; N-WASP; SCAR; PROTEIN; ULTRACENTRIFUGATION; BRICK1/HSPC300; ACTIVATION	The Scar/WAVE-complex links upstream Rho-GTPase signaling to the activation of the conserved Arp2/3-complex. Scar/WAVE-induced and Arp2/3-complex-mediated actin nucleation is crucial for actin assembly in protruding lamellipodia to drive cell migration. The heteropentameric Scar/WAVE-complex is composed of Scar/WAVE, Abi, Nap, Pir and a small polypeptide Brk1/HSPC300, and recent work suggested that free Brk1 serves as a homooligomeric precursor in the assembly of this complex. Here we characterized the Brk1 trimer from Dictyostelium by analytical ultracentrifugation and gelfiltration. We show for the first time its dissociation at concentrations in the nanomolar range as well as an exchange of subunits within different DdBrk1 containing complexes. Moreover, we determined the three-dimensional structure of DdBrk1 at 1.5 angstrom resolution by X-ray crystallography. Three chains of DdBrk1 are associated with each other forming a parallel triple coiled-coil bundle. Notably, this structure is highly similar to the heterotrimeric alpha-helical bundle of HSPC300/WAVE1/Abi2 within the human Scar/WAVE-complex. This finding, together with the fact that Brk1 is collectively sandwiched by the remaining subunits and also constitutes the main subunit connecting the triple-coil domain of the HSPC300/WAVE1/Abi2/heterotrimer to Sra1( Pir1), implies a critical function of this subunit in the assembly process of the entire Scar/WAVE-complex.	[Linkner, Joern; Curth, Ute; Faix, Jan] Hannover Med Sch, Inst Biophys Chem, D-3000 Hannover, Germany; [Witte, Gregor] Univ Munich, Gene Ctr, Munich, Germany; [Witte, Gregor] Univ Munich, Munich Ctr Adv Photon MAP, Dept Biochem, Munich, Germany; [Witte, Gregor] Univ Munich, Ctr Integrated Prot Sci Munich CIPSM, Munich, Germany; [Stradal, Theresia] Univ Munster, Inst Mol Cell Biol, Munster, Germany; [Stradal, Theresia] Helmholtz Ctr Infect Res HZI, Signaling & Motil Grp, Braunschweig, Germany	Hannover Medical School; University of Munich; University of Munich; University of Munich; University of Munster; Helmholtz Association; Helmholtz-Center for Infection Research	Linkner, J (corresponding author), Hannover Med Sch, Inst Biophys Chem, D-3000 Hannover, Germany.	witte@genzentrum.lmu.de; faix.jan@mh-hannover.de	Witte, Gregor/B-4635-2011	Witte, Gregor/0000-0003-0313-0962; Stradal, Theresia/0000-0002-0352-9474	Deutsche Forschungsgemeinschaft (DFG) [330/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a grant to J.F. (330/5-1) from the Deutsche Forschungsgemeinschaft. The article processing charges are funded by the Deutsche Forschungsgemeinschaft (DFG) "Open Access Publizieren" The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Basu D, 2005, PLANT CELL, V17, P502, DOI 10.1105/tpc.104.027987; Bear JE, 1998, J CELL BIOL, V142, P1325, DOI 10.1083/jcb.142.5.1325; Blagg SL, 2004, BIOCHEM SOC T, V32, P1113, DOI 10.1042/BST0321113; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Derivery E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002462; Derivery E, 2010, BIOESSAYS, V32, P119, DOI 10.1002/bies.200900123; Derivery E, 2009, CELL MOTIL CYTOSKEL, V66, P777, DOI 10.1002/cm.20342; Djakovic S, 2006, DEVELOPMENT, V133, P1091, DOI 10.1242/dev.02280; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gautreau A, 2004, P NATL ACAD SCI USA, V101, P4379, DOI 10.1073/pnas.0400628101; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Ibarra N, 2006, CURR BIOL, V16, P717, DOI 10.1016/j.cub.2006.02.068; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Ismail AM, 2009, NAT STRUCT MOL BIOL, V16, P561, DOI 10.1038/nsmb.1587; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kammerer RA, 2005, P NATL ACAD SCI USA, V102, P13891, DOI 10.1073/pnas.0502390102; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Le J, 2006, CURR BIOL, V16, P895, DOI 10.1016/j.cub.2006.03.061; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Mullins RD, 1999, CURR OPIN STRUC BIOL, V9, P244; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Parida, 1998, Genome Inform Ser Workshop Genome Inform, V9, P112; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Pollitt AY, 2008, CURR BIOL, V18, P203, DOI 10.1016/j.cub.2008.01.026; Pollitt AY, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-13; Qurashi A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-18; Rhodes DG, 2009, METHOD ENZYMOL, V463, P691, DOI 10.1016/S0076-6879(09)63039-1; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Veltman DM, 2010, MOL BIOL CELL, V21, P2880, DOI 10.1091/mbc.E10-04-0372; Walshaw J, 2003, J STRUCT BIOL, V144, P349, DOI 10.1016/j.jsb.2003.10.014; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133; Westphal M, 1997, CURR BIOL, V7, P176, DOI 10.1016/S0960-9822(97)70088-5; Winkler I, 2011, J BIOL CHEM, V286, P17326, DOI 10.1074/jbc.M110.187641; Witte G, 2005, NUCLEIC ACIDS RES, V33, P1662, DOI 10.1093/nar/gki310; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350; Zhang XG, 2005, PLANT CELL, V17, P2314, DOI 10.1105/tpc.104.028670	57	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21327	10.1371/journal.pone.0021327	http://dx.doi.org/10.1371/journal.pone.0021327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701600	Green Published, gold, Green Submitted			2022-12-25	WOS:000291983800042
J	Lee, SH; Jaganath, IB; Wang, SM; Sekaran, SD				Lee, Sau Har; Jaganath, Indu Bala; Wang, Seok Mui; Sekaran, Shamala Devi			Antimetastatic Effects of Phyllanthus on Human Lung (A549) and Breast (MCF-7) Cancer Cell Lines	PLOS ONE			English	Article							NF-KAPPA-B; DOWN-REGULATION; CYCLE ARREST; DIETARY PHYTOCHEMICALS; GALLIC ACID; INHIBITION; APOPTOSIS; MIGRATION; INVASION; METASTASIS	Background: Current chemotherapeutic drugs kill cancer cells mainly by inducing apoptosis. However, they become ineffective once cancer cell has the ability to metastasize, hence the poor prognosis and high mortality rate. Therefore, the purpose of this study was to evaluate the antimetastatic potential of Phyllanthus (P. niruri, P. urinaria, P. watsonii, and P. amarus) on lung and breast carcinoma cells. Methodology/Principal Findings: Cytotoxicity of Phyllanthus plant extracts were first screened using the MTS reduction assay. They were shown to inhibit MCF-7 (breast carcinoma) and A549 (lung carcinoma) cells growth with IC50 values ranging from 50-180 mu g/ml and 65-470 mu g/ml for methanolic and aqueous extracts respectively. In comparison, they have lower toxicity on normal cells with the cell viability percentage remaining above 50% when treated up to 1000 mu g/ml for both extracts. After determining the non-toxic effective dose, several antimetastasis assays were carried out and Phyllanthus extracts were shown to effectively reduce invasion, migration, and adhesion of both MCF-7 and A549 cells in a dose-dependent manner, at concentrations ranging from 20-200 mu g/ml for methanolic extracts and 50-500 mu g/ml for aqueous extracts. This was followed by an evaluation of the possible modes of cell death that occurred along with the antimetastatic activity. Phyllanthus was shown to be capable of inducing apoptosis in conjunction with its antimetastastic action, with more than three fold increase of caspases-3 and -7, the presence of DNA-fragmentation and TUNEL-positive cells. The ability of Phyllanthus to exert antimetastatic activities is mostly associated to the presence of polyphenol compounds in its extracts. Conclusions/Significance: The presence of polyphenol compounds in the Phyllanthus plant is critically important in the inhibition of the invasion, migration, and adhesion of cancer cells, along with the involvement of apoptosis induction. Hence, Phyllanthus could be a valuable candidate in the treatment of metastatic cancers.	[Lee, Sau Har; Wang, Seok Mui; Sekaran, Shamala Devi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Jaganath, Indu Bala] MARDI, Ctr Biotechnol, Serdang, Malaysia	Universiti Malaya; Institute Penyelidikan Dan Kemajuan Pertanian	Lee, SH (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	shamalamy@yahoo.com	Sekaran, Shamala Devi/B-8482-2008; Lee, Sau Har/L-2230-2013; Devi, Shamala Devi/B-9735-2010; wang, seok mui/C-3205-2011; Wang, Seok Mui/X-5856-2019	Sekaran, Shamala Devi/0000-0002-0478-0425; Devi, Shamala Devi/0000-0002-0478-0425; Wang, Seok Mui/0000-0002-3631-6504; , Sau Har/0000-0002-9803-8677; Jaganath, Indu/0000-0002-3272-9598	Malaysian Agriculture and Research Development Institute [53-02-03-1002]; UM [PS180/2010A]	Malaysian Agriculture and Research Development Institute; UM	This study was supported by the Malaysian Agriculture and Research Development Institute Grant (53-02-03-1002; www.mardi.gov.my) and the Postgraduate Research Fund, UM (PS180/2010A; www.um.edu.my). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros ME, 2003, UROL RES, V30, P374, DOI 10.1007/s00240-002-0285-y; Budzinski JW, 2000, PHYTOMEDICINE, V7, P273, DOI 10.1016/S0944-7113(00)80044-6; Chen CN, 2004, BIOCHEM PHARMACOL, V67, P53, DOI 10.1016/j.bcp.2003.07.020; Glinsky GV, 1997, CANCER LETT, V115, P185, DOI 10.1016/S0304-3835(97)04738-1; Gopalakrishnan A, 2008, FOOD CHEM TOXICOL, V46, P1257, DOI 10.1016/j.fct.2007.09.082; Ha KT, 2004, VASC PHARMACOL, V41, P83, DOI 10.1016/j.vph.2004.05.003; Harikumar KB, 2009, INTEGR CANCER THER, V8, P190, DOI 10.1177/1534735408330713; Ho HH, 2010, FOOD CHEM TOXICOL, V48, P2508, DOI 10.1016/j.fct.2010.06.024; Issa AY, 2006, J FOOD COMPOS ANAL, V19, P405, DOI 10.1016/j.jfca.2006.02.009; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jin UH, 2005, LIFE SCI, V77, P2760, DOI 10.1016/j.lfs.2005.02.028; Kim SC, 2010, FOOD CHEM TOXICOL, V48, P1478, DOI 10.1016/j.fct.2010.03.014; Lee JC, 2008, MOL NUTR FOOD RES, V52, P655, DOI 10.1002/mnfr.200700381; Lee M, 2010, INT J RADIAT ONCOL, V76, P1528, DOI 10.1016/j.ijrobp.2009.11.022; Lee YC, 2010, EUR J PHARMACOL, V632, P23, DOI 10.1016/j.ejphar.2010.01.009; Lin J, 2003, WORLD J GASTROENTERO, V9, P670, DOI 10.3748/wjg.v9.i4.670; Lin SY, 2008, FOOD CHEM TOXICOL, V46, P2485, DOI 10.1016/j.fct.2008.04.007; Lu Y, 2010, EUR J PHARMACOL, V641, P102, DOI 10.1016/j.ejphar.2010.05.043; Mollah ML, 2009, ONCOL RES, V18, P259, DOI 10.3727/096504009X12596189659321; Montague R, 2004, EUR UROL, V46, P389, DOI 10.1016/j.eururo.2004.04.022; Naik A D, 2003, Indian J Med Sci, V57, P387; PARANJAPE P, 2001, INDIAN MED PLANTS FO; Pinmai K, 2008, WORLD J GASTROENTERO, V14, P1491, DOI 10.3748/wjg.14.1491; Pojarova M, 2007, BIOORGAN MED CHEM, V15, P7368, DOI 10.1016/j.bmc.2007.07.046; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Qiu XB, 1998, FREE RADICAL BIO MED, V24, P848, DOI 10.1016/S0891-5849(97)00368-7; Rajkapoor B, 2007, BIOSCI BIOTECH BIOCH, V71, P2177, DOI 10.1271/bbb.70149; Rendon BE, 2007, J BIOL CHEM, V282, P29910, DOI 10.1074/jbc.M704898200; Russo GL, 2007, BIOCHEM PHARMACOL, V74, P533, DOI 10.1016/j.bcp.2007.02.014; Sabir SM, 2008, FOOD CHEM, V111, P845, DOI 10.1016/j.foodchem.2008.04.060; SALVATORE DB, 2004, MOL CANCER THER, V9, P1079; Song TY, 2008, J ETHNOPHARMACOL, V115, P50, DOI 10.1016/j.jep.2007.09.001; Sun J, 2006, CANCER LETT, V241, P124, DOI 10.1016/j.canlet.2005.10.027; TANG YQ, 2010, PLOS ONE, V9, P1; Tanimura S, 2005, BIOCHEM BIOPH RES CO, V330, P1306, DOI 10.1016/j.bbrc.2005.03.116; VASILIS A, 2008, BREAST CANCER RES, V3, P1; Vinatier D, 1996, EUR J OBSTET GYN R B, V67, P85, DOI 10.1016/0301-2115(96)02467-0; WANG YY, 2009, BMC CANCER, V174, P1; Woo HD, 2008, TOXICOL IN VITRO, V22, P1840, DOI 10.1016/j.tiv.2008.09.019; Wu CC, 2006, MUTAT RES-FUND MOL M, V601, P71, DOI 10.1016/j.mrfmmm.2006.06.015; Wu SJ, 2009, FOOD CHEM TOXICOL, V47, P1132, DOI 10.1016/j.fct.2009.01.044; Xia SH, 2005, CARCINOGENESIS, V26, P779, DOI 10.1093/carcin/bgi019; Xie KP, 2003, FREE RADICAL BIO MED, V34, P969, DOI 10.1016/S0891-5849(02)01364-3; Yang HL, 2006, CANCER LETT, V231, P215, DOI 10.1016/j.canlet.2005.02.004; Yang SF, 2008, ARCH ORAL BIOL, V53, P287, DOI 10.1016/j.archoralbio.2007.09.001; Yang YW, 2004, VACCINE, V22, P2316, DOI 10.1016/j.vaccine.2003.10.036	46	52	55	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20994	10.1371/journal.pone.0020994	http://dx.doi.org/10.1371/journal.pone.0020994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698198	Green Submitted, Green Published, gold			2022-12-25	WOS:000291734100042
J	Ribak, G; Weihs, D				Ribak, Gal; Weihs, Daniel			Jumping without Using Legs: The Jump of the Click-Beetles (Elateridae) Is Morphologically Constrained	PLOS ONE			English	Article							SPRINGTAILS; ENERGETICS; MECHANISM; MODEL; FLEA	To return to their feet, inverted click-beetles (Elateridae) jump without using their legs. When a beetle is resting on its dorsal side, a hinge mechanism is locked to store elastic energy in the body and releases it abruptly to launch the beetle into the air. While the functional morphology of the jumping mechanism is well known, the level of control that the beetle has over this jumping technique and the mechanical constraints governing the jumps are not entirely clear. Here we show that while body rotations in air are highly variable, the jumps are morphologically constrained to a constant "takeoff" angle (79.9 degrees +/- 1.56 degrees, n=9 beetles) that directs 98% of the jumping force vertically against gravity. A physical-mathematical model of the jumping action, combined with measurements from live beetle, imply that the beetle may control the speed at takeoff but not the jumping angle. In addition, the model shows that very subtle changes in the exact point of contact with the ground can explain the vigorous rotations of the body seen while the beetle is airborne. These findings suggest that the evolution of this unique non-legged jumping mechanism resulted in a jumping technique that is capable of launching the body high into the air but it is too constrained and unstable to allow control of body orientation at landing.	[Ribak, Gal] Technion Israel Inst Technol, Technion Autonomous Syst Program, Haifa, Israel; Technion Israel Inst Technol, Fac Aerosp Engn, Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology	Ribak, G (corresponding author), Technion Israel Inst Technol, Technion Autonomous Syst Program, Haifa, Israel.	gal.ribak@gmail.com	Weihs, Daniel/A-8172-2010	Ribak, Gal/0000-0002-6267-5471	Arlene and Arnold Goldstein UAV and Satellite center; Technion; Center for Absorption in Science, Ministry of Immigrant Absorption, State of Israel	Arlene and Arnold Goldstein UAV and Satellite center; Technion; Center for Absorption in Science, Ministry of Immigrant Absorption, State of Israel	The research was supported by the Arlene and Arnold Goldstein UAV and Satellite center. GR is supported in part at the Technion by a Fine fellowship and by the Center for Absorption in Science, Ministry of Immigrant Absorption, State of Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabyan A, 1998, BIOL CYBERN, V79, P393, DOI 10.1007/s004220050488; BENNETCLARK HC, 1967, J EXP BIOL, V47, P59; BENNETCLARK HC, 1975, J EXP BIOL, V63, P53; BRACKENBURY J, 1993, J ZOOL, V229, P217, DOI 10.1111/j.1469-7998.1993.tb02632.x; BRACKENBURY J, 1995, J EXP BIOL, V198, P1931; Burrows M, 2003, NATURE, V424, P509, DOI 10.1038/424509a; CHRISTIAN E, 1978, NATURWISSENSCHAFTEN, V65, P495, DOI 10.1007/BF00702849; Cofer D, 2010, J EXP BIOL, V213, P3378, DOI 10.1242/jeb.046367; d'Aguilar J., 1961, Annales des Epiphyties Paris (C), V11, P1; EVANS MEG, 1972, J ZOOL, V167, P319; EVANS MEG, 1973, J ZOOL, V169, P181; Gronenberg W, 1996, J COMP PHYSIOL A, V178, P727, DOI 10.1007/BF00225821; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Meriam J. L., 1993, ENG MECH DYNAMICS, V2; Yeadon MR, 1996, J BIOMECH, V29, P1341, DOI 10.1016/0021-9290(96)00034-6	15	22	24	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20871	10.1371/journal.pone.0020871	http://dx.doi.org/10.1371/journal.pone.0020871			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698194	Green Submitted, gold, Green Published			2022-12-25	WOS:000291734100027
J	Roberts, G; Vadrevu, IS; Madiraju, MV; Parish, T				Roberts, Gretta; Vadrevu, Indumathi S.; Madiraju, Murty V.; Parish, Tanya			Control of CydB and GltA1 Expression by the SenX3 RegX3 Two Component Regulatory System of Mycobacterium tuberculosis	PLOS ONE			English	Article							RESPONSE REGULATOR; INDUCIBLE ACETAMIDASE; GENE-EXPRESSION; VIRULENCE; SMEGMATIS; RESPIRATION; PERSISTENCE	Two component regulatory systems are used widely by bacteria to coordinate changes in global gene expression profiles in response to environmental signals. The SenX3-RegX3 two component system of Mycobacterium tuberculosis has previously been shown to play a role in virulence and phosphate-responsive control of gene expression. We demonstrate that expression of SenX3-RegX3 is controlled in response to growth conditions, although the absolute changes are small. Global gene expression profiling of a RegX3 deletion strain and wild-type strain in different culture conditions (static, microaerobic, anaerobic), as well as in an over-expressing strain identified a number of genes with changed expression patterns. Among those were genes previously identified as differentially regulated in aerobic culture, including ald (encoding alanine dehydrogenase) cyd, encoding a subunit of the cytochrome D ubiquinol oxidase, and gltA1, encoding a citrate synthase. Promoter activity in the upstream regions of both cydB and gltA1 was altered in the RegX3 deletion strain. DNA-binding assays confirmed that RegX3 binds to the promoter regions of ald, cydB and gltA1 in a phosphorylation-dependent manner. Taken together these data suggest a direct role for the SenX-RegX3 system in modulating expression of aerobic respiration, in addition to its role during phosphate limitation.	[Roberts, Gretta; Parish, Tanya] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England; [Vadrevu, Indumathi S.; Madiraju, Murty V.] Univ Texas Hlth Ctr Tyler, Tyler, TX USA; [Parish, Tanya] Infect Dis Res Inst, Seattle, WA USA	University of London; Queen Mary University London; University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Roberts, G (corresponding author), Univ Reading, Governance Directorate, Reading, Berks, England.	t.parish@qmul.ac.uk			GlaxoSmithKline; National Institutes of Health [AI41406, AI64502]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041406, R21AI064502] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the GlaxoSmithKline Action TB Programme, and supported in part by grants from the National Institutes of Health (AI41406, AI64502). NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The GlaxoSmithKline Action TB Programme provided funding for part of the study, as well as access and assistance with microarray studies and assistance with data analysis for microarrays.	Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Ewann F, 2002, INFECT IMMUN, V70, P2256, DOI 10.1128/IAI.70.5.2256-2263.2002; FEN ZY, 2002, J BACTERIOL, V184, P5001; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Fol M, 2006, MOL MICROBIOL, V60, P643, DOI 10.1111/j.1365-2958.2006.05137.x; Glover RT, 2007, J BACTERIOL, V189, P5495, DOI 10.1128/JB.00190-07; Himpens S, 2000, MICROBIOL-SGM, V146, P3091, DOI 10.1099/00221287-146-12-3091; Kana BD, 2001, J BACTERIOL, V183, P7076, DOI 10.1128/JB.183.24.7076-7086.2001; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; MAHENTHIRALINGAM E, 1993, J GEN MICROBIOL, V139, P575, DOI 10.1099/00221287-139-3-575; Malhotra V, 2004, FEMS MICROBIOL LETT, V231, P237, DOI 10.1016/S0378-1097(04)00002-3; Muttucumaru DGN, 2004, TUBERCULOSIS, V84, P239, DOI 10.1016/j.tube.2003.12.006; Parish T, 1997, MICROBIOL-UK, V143, P2267, DOI 10.1099/00221287-143-7-2267; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Parish T, 2003, MICROBIOL-SGM, V149, P1423, DOI 10.1099/mic.0.26245-0; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Rajagopalan M, 2010, J BIOL CHEM, V285, P15816, DOI 10.1074/jbc.M109.040097; Rickman L, 2004, BIOCHEM BIOPH RES CO, V314, P259, DOI 10.1016/j.bbrc.2003.12.082; Rifat D, 2009, J INFECT DIS, V200, P1126, DOI 10.1086/605700; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Stock AM, 2006, J BACTERIOL, V188, P7328, DOI 10.1128/JB.01268-06; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 2001, MYCOBACTERIUM TUBERC; WREN BW, 1992, FEMS MICROBIOL LETT, V99, P287, DOI 10.1016/0378-1097(92)90042-M	27	29	29	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21090	10.1371/journal.pone.0021090	http://dx.doi.org/10.1371/journal.pone.0021090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698211	gold, Green Published			2022-12-25	WOS:000291734100054
J	Saccenti, E; Westerhuis, JA; Smilde, AK; van der Werf, MJ; Hageman, JA; Hendriks, MMWB				Saccenti, Edoardo; Westerhuis, Johan A.; Smilde, Age K.; van der Werf, Mariet J.; Hageman, Jos A.; Hendriks, Margriet M. W. B.			Simplivariate Models: Uncovering the Underlying Biology in Functional Genomics Data	PLOS ONE			English	Article							MULTIPLE-REGRESSION; GENETIC ALGORITHMS; DECOMPOSITION; NUMBER; INDOLE	One of the first steps in analyzing high-dimensional functional genomics data is an exploratory analysis of such data. Cluster Analysis and Principal Component Analysis are then usually the method of choice. Despite their versatility they also have a severe drawback: they do not always generate simple and interpretable solutions. On the basis of the observation that functional genomics data often contain both informative and non-informative variation, we propose a method that finds sets of variables containing informative variation. This informative variation is subsequently expressed in easily interpretable simplivariate components. We present a new implementation of the recently introduced simplivariate models. In this implementation, the informative variation is described by multiplicative models that can adequately represent the relations between functional genomics data. Both a simulated and two real-life metabolomics data sets show good performance of the method.	[Saccenti, Edoardo; Westerhuis, Johan A.; Smilde, Age K.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Saccenti, Edoardo] Netherlands Bioinformat Ctr, Nijmegen, Netherlands; [van der Werf, Mariet J.] TNO Qual Life, Zeist, Netherlands; [Hendriks, Margriet M. W. B.] Wilhelmina Childrens Hosp, Lab Metab & Endocrine Dis, Utrecht Med Ctr, Utrecht, Netherlands; [Hendriks, Margriet M. W. B.] Netherlands Metabol Ctr, Leiden, Netherlands	University of Amsterdam; Netherlands Organization Applied Science Research; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Saccenti, E (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	e.saccenti@uva.nl	Hageman, Jos/N-1221-2015	Hageman, Jos/0000-0002-5868-587X; Smilde, Age/0000-0002-3052-4644; Saccenti, Edoardo/0000-0001-8284-4829	Netherlands Genomics Initiative (NGI)	Netherlands Genomics Initiative (NGI)	This work was part of the BioRange programme of the Netherlands Bioinformatics Centre (NBIC), which is supported by a BSIK grant through the Netherlands Genomics Initiative (NGI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DR, 1991, INTRO STAT CONCEPTS; Assfalg M, 2008, P NATL ACAD SCI USA, V105, P1420, DOI 10.1073/pnas.0705685105; Bernini P, 2009, J PROTEOME RES, V8, P4264, DOI 10.1021/pr900344m; BREIMAN L, 1985, J AM STAT ASSOC, V80, P580, DOI 10.2307/2288473; BUESCHKENS DH, 1984, APPL ENVIRON MICROB, V48, P601, DOI 10.1128/AEM.48.3.601-605.1984; BUKO AM, 1991, P NATL ACAD SCI USA, V88, P3992, DOI 10.1073/pnas.88.9.3992; Camacho D, 2005, METABOLOMICS, V1, P53, DOI 10.1007/s11306-005-1107-3; Chipman HA, 2005, J APPL STAT, V32, P969, DOI 10.1080/02664760500168648; DEJONG KA, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P124; Gao XX, 2008, HELICOBACTER, V13, P103, DOI 10.1111/j.1523-5378.2008.00590.x; GOLUB GH, 1970, NUMER MATH, V14, P403, DOI 10.1007/BF02163027; Gordon A.D., 1996, DATA KNOWLEDGE, P32, DOI DOI 10.1007/978-3-642-79999-0_3; Hageman JA, 2008, METABOLOMICS, V4, P141, DOI 10.1007/s11306-008-0105-7; Hageman JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003259; HALLGREN P, 1975, J BIOL CHEM, V250, P5312; Harrington PD, 2005, ANAL CHIM ACTA, V544, P118, DOI 10.1016/j.aca.2005.02.042; Jolliffe, 2002, PRINCIPAL COMPONENT; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Knijnenburg TA, 2009, BIOINFORMATICS, V25, pI161, DOI 10.1093/bioinformatics/btp211; Lazzeroni L, 2002, STAT SINICA, V12, P61; Livingstone DJ, 2005, J MED CHEM, V48, P661, DOI 10.1021/jm049111p; LUCASIUS CB, 1993, CHEMOMETR INTELL LAB, V19, P1, DOI 10.1016/0169-7439(93)80079-W; LUCASIUS CB, 1994, CHEMOMETR INTELL LAB, V25, P99, DOI 10.1016/0169-7439(94)85038-0; *MATHW INC, 2005, GEN ALG DIR SEARCH T; *MATHW INC, 2005, MATL 7 1 R14; MERLIN C, 2005, KIDNEY INT, V67, P2494; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; RAFTERY AE, 1986, AM SOCIOL REV, V51, P145, DOI 10.2307/2095483; Salvador S, 2004, PROC INT C TOOLS ART, P576; Sands CJ, 2009, ANAL CHEM, V81, P6458, DOI 10.1021/ac900828p; Schott J. R., 1997, MATRIX ANAL STAT; Selman B, 2008, NATURE, V451, P639, DOI 10.1038/451639a; Smilde AK, 2005, ANAL CHEM, V77, P6729, DOI 10.1021/ac051080y; Smilde AK, 2005, BIOINFORMATICS, V21, P3043, DOI 10.1093/bioinformatics/bti476; Steuer R, 2006, BRIEF BIOINFORM, V7, P151, DOI 10.1093/bib/bbl009; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; TOPLISS JG, 1972, J MED CHEM, V15, P1066, DOI 10.1021/jm00280a017; Turner HL, 2005, IEEE ACM T COMPUT BI, V2, P316, DOI 10.1109/TCBB.2005.49; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Van Deun K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-246; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; Wang YL, 2007, J PROTEOME RES, V6, P1846, DOI 10.1021/pr060685n; WATANABE T, 1972, P NATL ACAD SCI USA, V69, P1086, DOI 10.1073/pnas.69.5.1086; Wildman REC, 1999, ADV HUMAN NUTR; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; WOOD E, 2004, BIOCH MOL BIOL ED	48	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20747	10.1371/journal.pone.0020747	http://dx.doi.org/10.1371/journal.pone.0020747			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698241	Green Published, gold, Green Submitted			2022-12-25	WOS:000291734100017
J	Baine, M; Sahak, F; Lin, C; Chakraborty, S; Lyden, E; Batra, SK				Baine, Michael; Sahak, Freshta; Lin, Chi; Chakraborty, Subhankar; Lyden, Elizabeth; Batra, Surinder K.			Marital Status and Survival in Pancreatic Cancer Patients: A SEER Based Analysis	PLOS ONE			English	Article							BREAST-CANCER; MORTALITY; DIAGNOSIS; DISEASE; HEALTH; IMPACT; WOMEN	Background: Recent findings suggest that marital status affects survival in patients with different types of cancer. However, its role in the survival of patients with pancreatic ductal adenocarcinoma is unknown. In this study, we investigated whether there was an association between marital status and overall survival (OS) in patients with pancreatic ductal adenocarcinoma (PDAC). Methods: Adult patients diagnosed with PDAC between 1998 and 2003 with known marital statuses were identified from the Surveillance, Epidemiology, and End Results registry of the National Cancer Institute. OS for these patients was plotted using the Kaplan-Meier method. Comparative risks of mortality were evaluated by using univariate and multivariate-adjusted Cox regression models. Results: Using Kaplan-Meier analysis, we found that the median overall survival of patients was 4 months and 3 months (p<0.001) for married and unmarried patients, respectively. Subgroup analysis on patients with cancer-directed surgery showed that the median survival was 16 months and 13 months (P<0.0005) for married and unmarried groups, respectively. Multivariate analysis adjusting for age, race, sex, stage, year of diagnosis, radiation therapy and cancer-directed surgery showed that patients who were married at the time of diagnosis had a significantly decreased risk of death at both 2 months (15% risk reduction) and 3 years (13% risk reduction) post diagnosis. Conclusions: Marital status is an independent prognostic factor of both perioperative and long-term survival in patients with PDAC. This observation may suggest a suboptimally met psychosocial need among PDAC patients that is partially fulfilled by the support system provided by marriage.	[Baine, Michael; Batra, Surinder K.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Sahak, Freshta; Chakraborty, Subhankar; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Lin, Chi] Univ Nebraska Med Ctr, Dept Radiat Oncol, Omaha, NE USA; [Lyden, Elizabeth] Univ Nebraska Med Ctr, Coll Publ Hlth, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Baine, M (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	sbatra@unmc.edu	Lin, Chi/AAE-2495-2019		Department of Defense [BC074639, BC083295, BC09742]; National Institutes of Health [RO1 CA78590, EDRNUO1 CA111294, RO1 CA133774, RO1 CA131944, SPORE50 CA127297]; NATIONAL CANCER INSTITUTE [R01CA133774, U01CA111294, P50CA127297, R01CA078590, R01CA131944] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors on this work are supported, in part, by grants from the Department of Defense (BC074639, BC083295, and BC09742) and the National Institutes of Health (RO1 CA78590, EDRNUO1 CA111294, RO1 CA133774, RO1 CA131944, and SPORE50 CA127297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, CANC FACTS FIG 2009; Antoni MH, 2007, CURR DIR PSYCHOL SCI, V16, P42, DOI 10.1111/j.1467-8721.2007.00472.x; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Institute of Medicine (IOM, 2008, CANC CAR WHOL PAT M; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KAPLAN GA, 1988, AM J EPIDEMIOL, V128, P370, DOI 10.1093/oxfordjournals.aje.a114977; Kiecolt-Glaser JK, 2002, ANNU REV PSYCHOL, V53, P83, DOI 10.1146/annurev.psych.53.100901.135217; Kravdal O, 2001, SOC SCI MED, V52, P357, DOI 10.1016/S0277-9536(00)00139-8; Kroenke CH, 2006, J CLIN ONCOL, V24, P1105, DOI 10.1200/JCO.2005.04.2846; National Cancer Institute, SURV EP END RES CANC; Osborne C, 2005, BREAST CANCER RES TR, V93, P41, DOI 10.1007/s10549-005-3702-4; Patel MK, 2010, J LOW GENIT TRACT DI, V14, P329, DOI 10.1097/LGT.0b013e3181ddfa68; RYAN DP, 2010, CHEMOTHERAPY ADV PAN; Stack S, 1998, J MARRIAGE FAM, V60, P527, DOI 10.2307/353867; Wills TA, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P209; Yarcheski A, 2004, J NURS SCHOLARSHIP, V36, P102, DOI 10.1111/j.1547-5069.2004.04021.x	16	76	76	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21052	10.1371/journal.pone.0021052	http://dx.doi.org/10.1371/journal.pone.0021052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778TS	21698253	Green Submitted, Green Published, gold			2022-12-25	WOS:000291730000045
J	Kistler, AD; Siwy, J; Breunig, F; Jeevaratnam, P; Scherl, A; Mullen, W; Warnock, DG; Wanner, C; Hughes, DA; Mischak, H; Wuthrich, RP; Serra, AL				Kistler, Andreas D.; Siwy, Justyna; Breunig, Frank; Jeevaratnam, Praveen; Scherl, Alexander; Mullen, William; Warnock, David G.; Wanner, Christoph; Hughes, Derralynn A.; Mischak, Harald; Wuethrich, Rudolf P.; Serra, Andreas L.			A Distinct Urinary Biomarker Pattern Characteristic of Female Fabry Patients That Mirrors Response to Enzyme Replacement Therapy	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ONSET HYPERTROPHIC CARDIOMYOPATHY; MASS-SPECTROMETRY; ALPHA-GALACTOSIDASE; HEMODIALYSIS-PATIENTS; CLINICAL PROTEOMICS; YOUNG-PATIENTS; DISCOVERY; GLOBOTRIAOSYLCERAMIDE; PREVALENCE	Female patients affected by Fabry disease, an X-linked lysosomal storage disorder, exhibit a wide spectrum of symptoms, which renders diagnosis, and treatment decisions challenging. No diagnostic test, other than sequencing of the alpha-galactosidase A gene, is available and no biomarker has been proven useful to screen for the disease, predict disease course and monitor response to enzyme replacement therapy. Here, we used urine proteomic analysis based on capillary electrophoresis coupled to mass spectrometry and identified a biomarker profile in adult female Fabry patients. Urine samples were taken from 35 treatment-naive female Fabry patients and were compared to 89 age-matched healthy controls. We found a diagnostic biomarker pattern that exhibited 88.2% sensitivity and 97.8% specificity when tested in an independent validation cohort consisting of 17 treatment-naive Fabry patients and 45 controls. The model remained highly specific when applied to additional control patients with a variety of other renal, metabolic and cardiovascular diseases. Several of the 64 identified diagnostic biomarkers showed correlations with measures of disease severity. Notably, most biomarkers responded to enzyme replacement therapy, and 8 of 11 treated patients scored negative for Fabry disease in the diagnostic model. In conclusion, we defined a urinary biomarker model that seems to be of diagnostic use for Fabry disease in female patients and may be used to monitor response to enzyme replacement therapy.	[Kistler, Andreas D.; Wuethrich, Rudolf P.; Serra, Andreas L.] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Kistler, Andreas D.] Univ Miami, Miller Sch Med, Div Nephrol & Hypertens, Miami, FL 33136 USA; [Siwy, Justyna; Mischak, Harald] Mosaiques Diagnost & Therapeut AG, Hannover, Germany; [Breunig, Frank; Wanner, Christoph] Univ Hosp, Div Nephrol, Wurzburg, Germany; [Jeevaratnam, Praveen; Hughes, Derralynn A.] UCL, Sch Med, Dept Haematol, London W1N 8AA, England; [Scherl, Alexander] Univ Geneva, Fac Med, Prote Core Facil, Geneva, Switzerland; [Mullen, William] Univ Glasgow, Sch Life Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Warnock, David G.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Mischak, Harald] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland	University of Zurich; University Zurich Hospital; University of Miami; University of Wurzburg; University of London; University College London; UCL Medical School; University of Geneva; University of Glasgow; University of Alabama System; University of Alabama Birmingham; University of Glasgow	Kistler, AD (corresponding author), Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland.	akistler@med.miami.edu	Mullen, William/GWC-8078-2022; Scherl, Alexander/B-8910-2012; Mischak, Harald/E-8685-2011; Hughes, Derralynn/J-8012-2013	Hughes, Derralynn/0000-0003-4531-9173; Kistler, Andreas/0000-0002-4114-9560; Mullen, William/0000-0002-5685-1563; Siwy, Justyna/0000-0003-1407-2534; Mischak, Harald/0000-0003-0323-0306	Genzyme; Shire; Amgen; European Community [HEALTH-F2-2009-241544]; Genzyme Inc.; Shire HGT; Amicus therapeutics; Genzyme Corporation	Genzyme(Sanofi-AventisGenzyme Corporation); Shire; Amgen(Amgen); European Community(European Commission); Genzyme Inc.(Sanofi-AventisGenzyme Corporation); Shire HGT; Amicus therapeutics; Genzyme Corporation(Sanofi-AventisGenzyme Corporation)	Funding for this study was supported by unrestricted research grants provided by Genzyme (to ADK, RPW and ALS), Shire (to ADK, RPW and ALS) and Amgen (to RPW) and a European Community's 7th Framework Programme grant (to HM; grant agreement HEALTH-F2-2009-241544 (SysKID)). The funders had no role in study design, data collection and analysis, or preparation of the manuscript.; ADK has received travel grants from Shire HGT and honoraria from Genzyme Inc. HM is the founder and co-owner of Mosaiques Diagnostics, who developed the CE-MS technology. JS is an employee of Mosaiques Diagnostics. DAH has received research support, travel grants and honoraria for meetings and advisory boards from Genzyme Inc, Shire HGT and Amicus therapeutics. DGW is a consultant for Genzyme Corporation on Fabry disease, and has received research support from Genzyme Corporation and Amicus therapeutics. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andrade J, 2008, CLIN J AM SOC NEPHRO, V3, P139, DOI 10.2215/CJN.02490607; Auray-Blais C, 2010, CLIN CHIM ACTA, V411, P1906, DOI 10.1016/j.cca.2010.07.038; Baptista MV, 2010, STROKE, V41, P431, DOI 10.1161/STROKEAHA.109.570499; Brouns R, 2010, STROKE, V41, P863, DOI 10.1161/STROKEAHA.110.579409; Chimenti C, 2004, CIRCULATION, V110, P1047, DOI 10.1161/01.CIR.0000139847.74101.03; Coon JJ, 2008, PROTEOM CLIN APPL, V2, P964, DOI 10.1002/prca.200800024; Decramer S, 2006, NAT MED, V12, P398, DOI 10.1038/nm1384; DeLeo J. M., 1993, RECEIVER OPERATING C, P318; Delles C, 2010, J HYPERTENS, V28, P2316, DOI 10.1097/HJH.0b013e32833d81b7; Desnick RJ, 2003, ANN INTERN MED, V138, P338, DOI 10.7326/0003-4819-138-4-200302180-00014; Dobyns WB, 2004, AM J MED GENET A, V129A, P136, DOI 10.1002/ajmg.20004.a.30123; El Dib R.P., 2010, COCHRANE DB SYST REV, V5; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Gaspar P, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-19; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Guffon N, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e38; Haubitz M, 2009, MOL CELL PROTEOMICS, V8, P2296, DOI 10.1074/mcp.M800529-MCP200; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Kistler AD, 2009, KIDNEY INT, V76, P89, DOI 10.1038/ki.2009.93; Kitagawa T, 2005, MOL GENET METAB, V85, P196, DOI 10.1016/j.ymgme.2005.01.007; Kotanko P, 2004, J AM SOC NEPHROL, V15, P1323, DOI 10.1097/01.ASN.0000124671.61963.1E; Linthorst GE, 2005, CLIN CHIM ACTA, V353, P201, DOI 10.1016/j.cccn.2004.10.019; Mehta A, 2004, EUR J CLIN INVEST, V34, P236, DOI 10.1111/j.1365-2362.2004.01309.x; Merta M, 2007, NEPHROL DIAL TRANSPL, V22, P179, DOI 10.1093/ndt/gfl528; Metzger J, 2009, CRIT REV CL LAB SCI, V46, P129, DOI 10.1080/10408360902805261; Mischak H, 2007, PROTEOM CLIN APPL, V1, P148, DOI 10.1002/prca.200600771; Mischak H, 2009, MASS SPECTROM REV, V28, P703, DOI 10.1002/mas.20205; Moore DF, 2007, P NATL ACAD SCI USA, V104, P2873, DOI 10.1073/pnas.0611315104; NAKAO S, 1995, NEW ENGL J MED, V333, P288, DOI 10.1056/NEJM199508033330504; Neuhoff NV, 2004, RAPID COMMUN MASS SP, V18, P149, DOI 10.1002/rcm.1294; PASCHKE E, 2010, AM J KIDNEY DIS; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rolfs A, 2005, LANCET, V366, P1794, DOI 10.1016/S0140-6736(05)67635-0; Rossing K, 2008, J AM SOC NEPHROL, V19, P1283, DOI 10.1681/ASN.2007091025; Rozenfeld PA, 2009, CLIN CHIM ACTA, V403, P194, DOI 10.1016/j.cca.2009.02.016; Sachdev B, 2002, CIRCULATION, V105, P1407, DOI 10.1161/01.CIR.0000012626.81324.38; Schiffer E, 2009, CLIN CANCER RES, V15, P4935, DOI 10.1158/1078-0432.CCR-09-0226; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Tanaka M, 2005, CLIN NEPHROL, V64, P281; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Theodorescu D, 2005, ELECTROPHORESIS, V26, P2797, DOI 10.1002/elps.200400208; Thongboonkerd V, 2007, J PROTEOME RES, V6, P3881, DOI 10.1021/pr070328s; Vojtova L, 2010, RENAL FAILURE, V32, P1202, DOI 10.3109/0886022X.2010.516859; Vylet'al P, 2008, J INHERIT METAB DIS, V31, P508, DOI 10.1007/s10545-008-0900-3; Whitfield PD, 2005, J INHERIT METAB DIS, V28, P21, DOI 10.1007/s10545-005-4415-x; Whybra C, 2004, CLIN GENET, V65, P299, DOI 10.1111/j.1399-0004.2004.00219.x; Wilcox WR, 2008, MOL GENET METAB, V93, P112, DOI 10.1016/j.ymgme.2007.09.013; Wittke S, 2005, ELECTROPHORESIS, V26, P1476, DOI 10.1002/elps.200410140; Young E, 2005, ACTA PAEDIATR, V94, P51, DOI 10.1080/08035320510028111; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827	50	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20534	10.1371/journal.pone.0020534	http://dx.doi.org/10.1371/journal.pone.0020534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698285	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000291730000013
J	Ochala, J; Renaud, G; Diez, ML; Banduseela, VC; Aare, S; Ahlbeck, K; Radell, PJ; Eriksson, LI; Larsson, L				Ochala, Julien; Renaud, Guillaume; Diez, Monica Llano; Banduseela, Varuna C.; Aare, Sudhakar; Ahlbeck, Karsten; Radell, Peter J.; Eriksson, Lars I.; Larsson, Lars			Diaphragm Muscle Weakness in an Experimental Porcine Intensive Care Unit Model	PLOS ONE			English	Article							CONTROLLED MECHANICAL VENTILATION; SKELETAL-MUSCLE; RAT DIAPHRAGM; NEUROMUSCULAR-TRANSMISSION; PROTEIN-TURNOVER; CRITICAL ILLNESS; FIBERS; FORCE; CONTRACTILE; DYSFUNCTION	In critically ill patients, mechanisms underlying diaphragm muscle remodeling and resultant dysfunction contributing to weaning failure remain unclear. Ventilator-induced modifications as well as sepsis and administration of pharmacological agents such as corticosteroids and neuromuscular blocking agents may be involved. Thus, the objective of the present study was to examine how sepsis, systemic corticosteroid treatment (CS) and neuromuscular blocking agent administration (NMBA) aggravate ventilator-related diaphragm cell and molecular dysfunction in the intensive care unit. Piglets were exposed to different combinations of mechanical ventilation and sedation, endotoxin-induced sepsis, CS and NMBA for five days and compared with sham-operated control animals. On day 5, diaphragm muscle fibre structure (myosin heavy chain isoform proportion, cross-sectional area and contractile protein content) did not differ from controls in any of the mechanically ventilated animals. However, a decrease in single fibre maximal force normalized to cross-sectional area (specific force) was observed in all experimental piglets. Therefore, exposure to mechanical ventilation and sedation for five days has a key negative impact on diaphragm contractile function despite a preservation of muscle structure. Post-translational modifications of contractile proteins are forwarded as one probable underlying mechanism. Unexpectedly, sepsis, CS or NMBA have no significant additive effects, suggesting that mechanical ventilation and sedation are the triggering factors leading to diaphragm weakness in the intensive care unit.	[Ochala, Julien; Renaud, Guillaume; Diez, Monica Llano; Banduseela, Varuna C.; Aare, Sudhakar; Larsson, Lars] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Larsson, Lars] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA; [Ahlbeck, Karsten; Radell, Peter J.; Eriksson, Lars I.] Karolinska Inst, Sect Anesthesiol & Intens Care Med, Stockholm, Sweden	Uppsala University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Karolinska Institutet	Ochala, J (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	julien.ochala@neuro.uu.se	Ochala, Julien/K-4120-2017; Larsson, Lars/AAY-1347-2021	Ochala, Julien/0000-0002-6358-2920; Larsson, Lars/0000-0003-3722-035X	Swedish Research Council, Swedish Institute and Association Francaise contre les Myopathies; Swedish Research Council, Association Francaise contre les Myopathies, Swedish Cancer Foundation; European Commission [EC Fp7CT-223756]	Swedish Research Council, Swedish Institute and Association Francaise contre les Myopathies(Swedish Research Council); Swedish Research Council, Association Francaise contre les Myopathies, Swedish Cancer Foundation(Association Francaise contre les MyopathiesSwedish Research Council); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by grants from the Swedish Research Council, Swedish Institute and Association Francaise contre les Myopathies to J.O., and from the Swedish Research Council, Association Francaise contre les Myopathies, Swedish Cancer Foundation and European Commission (MyoAge, EC Fp7CT&-223756) to L.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzueto A, 1997, CRIT CARE MED, V25, P1187, DOI 10.1097/00003246-199707000-00021; BANDUSEELA VC, 2009, PHYSL GENOMICS; Bolton CF, 1996, INTENS CARE MED, V22, P841; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; Cooney RN, 1997, SHOCK, V7, P1, DOI 10.1097/00024382-199701000-00001; DEKHUIJZEN PNR, 1992, EUR RESPIR J, V5, P997; Ebihara S, 2002, AM J RESP CRIT CARE, V165, P221, DOI 10.1164/ajrccm.165.2.2108041; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Esteban A, 2000, AM J RESP CRIT CARE, V161, P1450, DOI 10.1164/ajrccm.161.5.9902018; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; Friedrich O, 2006, CURR OPIN CLIN NUTR, V9, P403, DOI 10.1097/01.mco.0000232900.59168.a0; Frontera WR, 1997, MUSCLE NERVE, V20, P948, DOI 10.1002/(SICI)1097-4598(199708)20:8<948::AID-MUS3>3.0.CO;2-6; Gayan-Ramirez G, 1999, AM J RESP CRIT CARE, V159, P283, DOI 10.1164/ajrccm.159.1.9803021; Horinouchi H, 2005, PATHOBIOLOGY, V72, P108, DOI 10.1159/000084113; Hudson LD, 2003, NEW ENGL J MED, V348, P745, DOI 10.1056/NEJMe020180; HUSSAIN SNA, 1985, J APPL PHYSIOL, V59, P365, DOI 10.1152/jappl.1985.59.2.365; LARSSON L, 1993, J PHYSIOL-LONDON, V472, P595, DOI 10.1113/jphysiol.1993.sp019964; LEBOURDELLES G, 1994, AM J RESP CRIT CARE, V149, P1539, DOI 10.1164/ajrccm.149.6.8004310; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Mantilla CB, 2009, RESP PHYSIOL NEUROBI, V169, P133, DOI 10.1016/j.resp.2009.09.002; MARTIN AF, 1981, J BIOL CHEM, V256, P964; Martyn DA, 2007, BIOPHYS J, V92, P4379, DOI 10.1529/biophysj.106.096768; MCDONALD KS, 1995, J APPL PHYSIOL, V79, P1796, DOI 10.1152/jappl.1995.79.5.1796; MOSS RL, 1979, J PHYSIOL-LONDON, V292, P177, DOI 10.1113/jphysiol.1979.sp012845; Nordquist J, 2007, MOL MED, V13, P461, DOI 10.2119/2006-00066.Nordquist; Norman H, 2006, PFLUG ARCH EUR J PHY, V453, P53, DOI 10.1007/s00424-006-0110-5; Norman H, 2006, ACTA ANAESTH SCAND, V50, P1058, DOI 10.1111/j.1399-6576.2006.01105.x; OCHALA J, 2009, PFLUGERS ARCH; Polla B, 2004, THORAX, V59, P808, DOI 10.1136/thx.2003.009894; Powers SK, 2002, J APPL PHYSIOL, V92, P1851, DOI 10.1152/japplphysiol.00881.2001; Radell PJ, 2002, INTENS CARE MED, V28, P358, DOI 10.1007/s00134-002-1207-8; Regnier M, 1998, BIOPHYS J, V74, P2005, DOI 10.1016/S0006-3495(98)77907-X; REID MB, 1993, J APPL PHYSIOL, V75, P1081, DOI 10.1152/jappl.1993.75.3.1081; Sassoon CSH, 2009, CRIT CARE, V13, DOI 10.1186/cc7971; Sassoon CSH, 2004, AM J RESP CRIT CARE, V170, P626, DOI 10.1164/rccm.200401-042OC; Shanely RA, 2004, AM J RESP CRIT CARE, V170, P994, DOI 10.1164/rccm.200304-575OC; Shanely RA, 2002, AM J RESP CRIT CARE, V166, P1369, DOI 10.1164/rccm.200202-088OC; SHINDOH C, 1994, TOHOKU J EXP MED, V173, P291, DOI 10.1620/tjem.173.291; Supinski G, 2000, AM J PHYSIOL-REG I, V278, pR891, DOI 10.1152/ajpregu.2000.278.4.R891; Testelmans D, 2006, CRIT CARE MED, V34, P3018, DOI 10.1097/01.CCM.0000245783.28478.AD; Yang LY, 2002, AM J RESP CRIT CARE, V166, P1135, DOI 10.1164/rccm.2202020; ZAK R, 1979, PHYSIOL REV, V59, P407, DOI 10.1152/physrev.1979.59.2.407; Zergeroglu MA, 2003, J APPL PHYSIOL, V95, P1116, DOI 10.1152/japplphysiol.00824.2002	43	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20558	10.1371/journal.pone.0020558	http://dx.doi.org/10.1371/journal.pone.0020558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698290	Green Published, Green Submitted, gold			2022-12-25	WOS:000291730000014
J	Pinc, L; Bartos, L; Reslova, A; Kotrba, R				Pinc, Ludvik; Bartos, Ludek; Reslova, Alice; Kotrba, Radim			Dogs Discriminate Identical Twins	PLOS ONE			English	Article							ODOR	Earlier studies have shown variation among experimental attempts to establish whether human monozygotic twins that are genetically identical also have identical individual scents. In none of the cases were the dogs able to distinguish all the individual scents of monozygotic twins living in the same environment if the scents were presented to them separately. Ten specially trained police German Shepherd dogs of three Czech Republic Police Regional Headquarters were used for scent identification in our study. The dogs were supposed to match scents of two monozygotic pairs (5 and 7 years old) and two dizygotic twin pairs (8 and 13 years old). Scents were collected on cotton squares stored in glass jars. Dog handlers were blind to the experiment details. In each trial (line-up), one scent was used as a starting scent and the dog was then sent to determine if any of the 7 presented glass jars contained a matching scent. Scents of children of similar ages were used as distractors. In the matching procedure, the dogs matched correctly the scent of one twin with the other, as well as two scents collected from every single identical and non-identical twin to prove their efficacy and likewise, the presence of the matching twin scent in any given glass jar. All dogs in all trials distinguished correctly the scents of identical as well as non-identical twins. All dogs similarly matched positively two scents collected from the same individuals. Our findings indicated that specially trained German Shepherd dogs are able to distinguish individual scents of identical twins despite the fact that they live in the same environment, eat the same food and even if the scents are not presented to them simultaneously.	[Pinc, Ludvik; Bartos, Ludek] Czech Univ Life Sci, Canine Behav Res Ctr, Dept Anim Sci & Ethol, Prague, Czech Republic; [Bartos, Ludek; Kotrba, Radim] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Reslova, Alice] Inst Criminalist, Prague, Czech Republic; [Kotrba, Radim] Czech Univ Life Sci, Inst Trop & Subtrop, Dept Anim Sci & Food Proc, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech Research Institute of Animal Science; Institute of Criminalistics Prague - Police of the Czech Republic; Czech University of Life Sciences Prague	Pinc, L (corresponding author), Czech Univ Life Sci, Canine Behav Res Ctr, Dept Anim Sci & Ethol, Prague, Czech Republic.	bartos@vuzv.cz	, Ludvik/AAX-9114-2021	Kotrba, Radim/0000-0001-5009-8454	Ministry of Agriculture [MZe 0002701404]; Ministry of Interior [MV c. VF20102015011]; Ministry of Education, Youth and Sports of the Czech Republic [MSMT 1321/213206]	Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Ministry of Interior; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	The Ministry of Agriculture (MZe 0002701404), the Ministry of Interior (MV c. VF20102015011), and the Ministry of Education, Youth and Sports (MSMT 1321/213206) of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Curran AM, 2005, FORENSIC SCI COMMUN, V7, P1; Eggert F, 1998, GENETICA, V104, P191, DOI 10.1023/A:1026402531196; Ferstl R, 1998, NEPHROL DIAL TRANSPL, V13, P1117, DOI 10.1093/ndt/13.5.1117; Harvey LM, 2006, J FORENSIC SCI, V51, P1109, DOI 10.1111/j.1556-4029.2006.00231.x; HEPPER PG, 1988, PERCEPTION, V17, P549, DOI 10.1068/p170549; Kaldenbach J., 1998, K9 SCENT DETECTION M; KALMUS H., 1955, BRIT JOUR ANIMAL BEHAVIOUR, V3, P25, DOI 10.1016/S0950-5601(55)80072-X; KLOUBEK M, 2008, AKTUALNI STAV UNPUB; KLOUBEK M, 2003, KRIMINALISTICKY SBOR, V10; Santos PSC, 2005, HORM BEHAV, V47, P384, DOI 10.1016/j.yhbeh.2004.11.005; Schoon A., 2002, K9 SUSPECT DISCRIMIN; SETTLE RH, 1994, ANIM BEHAV, V48, P1443, DOI 10.1006/anbe.1994.1380; SOMMERVILLE BA, 1990, CHEM SIGNAL, V5, P634; STOCKHAM RA, 2004, FOREN SCI COMM, V6; STRAUS J, KRIMINALISTICKA ODOR, P192; Teryngel J., 2002, TRESTNI PRAVO, V11, P9; Thom MD, 2005, CHEM SIGNAL, V10, P173, DOI 10.1007/0-387-25160-X_22; Thornhill R, 2003, BEHAV ECOL, V14, P668, DOI 10.1093/beheco/arg043; Tomaszewski T, 2006, FORENSIC SCI INT, V162, P191, DOI 10.1016/j.forsciint.2006.06.017	19	29	29	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20704	10.1371/journal.pone.0020704	http://dx.doi.org/10.1371/journal.pone.0020704			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698282	gold, Green Published, Green Submitted			2022-12-25	WOS:000291730000020
J	Yang, JH; Baskar, S; Kwong, KY; Kennedy, MG; Wiestner, A; Rader, C				Yang, Jiahui; Baskar, Sivasubramanian; Kwong, Ka Yin; Kennedy, Michael G.; Wiestner, Adrian; Rader, Christoph			Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in B-Cell Malignancies	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; CHIMERIC RABBIT/HUMAN FAB; PHAGE DISPLAY; MOUSE DEVELOPMENT; EXPRESSION; GENERATION; RITUXIMAB; FAMILY; INFECTIONS; PHENOTYPE	Background: Based on its selective cell surface expression in chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), receptor tyrosine kinase ROR1 has recently emerged as a promising target for therapeutic monoclonal antibodies (mAbs). To further assess the suitability of ROR1 for targeted therapy of CLL and MCL, a panel of mAbs was generated and its therapeutic utility was investigated. Methodology and Principal Findings: A chimeric rabbit/human Fab library was generated from immunized rabbits and selected by phage display. Chimeric rabbit/human Fab and IgG1 were investigated for their capability to bind to human and mouse ROR1, to mediate antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and internalization, and to agonize or antagonize apoptosis using primary CLL cells from untreated patients as well as MCL cell lines. A panel of mAbs demonstrated high affinity and specificity for a diverse set of epitopes that involve all three extracellular domains of ROR1, are accessible on the cell surface, and mediate internalization. The mAb with the highest affinity and slowest rate of internalization was found to be the only mAb that mediated significant, albeit weak, ADCC. None of the mAbs mediated CDC. Alone, they did not enhance or inhibit apoptosis. Conclusions and Significance: Owing to its relatively low cell surface density, ROR1 may be a preferred target for armed rather than naked mAbs. Provided is a panel of fully sequenced and thoroughly characterized anti-ROR1 mAbs suitable for conversion to antibody-drug conjugates, immunotoxins, chimeric antigen receptors, and other armed mAb entities for preclinical and clinical studies.	[Yang, Jiahui; Baskar, Sivasubramanian; Kwong, Ka Yin; Kennedy, Michael G.; Rader, Christoph] NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wiestner, Adrian] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Yang, JH (corresponding author), NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	raderc@mail.nih.gov		Rader, Christoph/0000-0001-9955-3454	Center for Cancer Research, National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010648] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006070] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawi R, 2001, DEV GENES EVOL, V211, P161, DOI 10.1007/s004270100140; Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823; Baskar S, 2009, BLOOD, V114, P4494, DOI 10.1182/blood-2009-05-222786; Borras L, 2010, J BIOL CHEM, V285, P9054, DOI 10.1074/jbc.M109.072876; Byrd JC, 2002, BLOOD, V99, P1038, DOI 10.1182/blood.V99.3.1038; Cheson BD, 2008, NEW ENGL J MED, V359, P613, DOI 10.1056/NEJMra0708875; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; D'Arena G, 2000, AM J HEMATOL, V64, P275; DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587; Dornan D, 2010, BLOOD, V116, P4212, DOI 10.1182/blood-2010-03-272765; Dreyling Martin, 2009, Hematology Am Soc Hematol Educ Program, P542, DOI 10.1182/asheducation-2009.1.542; Elter T, 2009, ANN HEMATOL, V88, P121, DOI 10.1007/s00277-008-0566-9; Farag SS, 2004, BLOOD, V103, P1472, DOI 10.1182/blood-2003-07-2548; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gea-Banacloche JC, 2010, SEMIN HEMATOL, V47, P187, DOI 10.1053/j.seminhematol.2010.01.002; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hallek M, 2011, BLOOD REV, V25, P1, DOI 10.1016/j.blre.2010.09.001; Hofer T, 2008, P NATL ACAD SCI USA, V105, P12451, DOI 10.1073/pnas.0800800105; Hofer T, 2007, J IMMUNOL METHODS, V318, P75, DOI 10.1016/j.jim.2006.10.007; Hudecek M, 2010, BLOOD, V116, P4532, DOI 10.1182/blood-2010-05-283309; Jaglowski SM, 2010, BLOOD, V116, P3705, DOI 10.1182/blood-2010-04-001230; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; Kabat EA, 1991, SEQUENCES PROTEINS I; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Kwong KY, 2008, J MOL BIOL, V384, P1143, DOI 10.1016/j.jmb.2008.09.008; Kwong KY, 2009, CURR PROTOC PROTEIN; Lapalombella R, 2010, BLOOD, V115, P2619, DOI 10.1182/blood-2009-09-242438; Levesque MC, 2001, LEUKEMIA, V15, P1305, DOI 10.1038/sj.leu.2402192; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Oishi I, 1999, GENES CELLS, V4, P41, DOI 10.1046/j.1365-2443.1999.00234.x; Pedersen MW, 2010, CANCER RES, V70, P588, DOI 10.1158/0008-5472.CAN-09-1417; PEREZGALAN P, 2010, BLOOD; Popkov M, 2004, J IMMUNOL METHODS, V288, P149, DOI 10.1016/j.jim.2004.03.005; Popkov M, 2003, J MOL BIOL, V325, P325, DOI 10.1016/S0022-2836(02)01232-9; Prat M, 1998, J CELL SCI, V111, P237; Rader C, 2000, J BIOL CHEM, V275, P13668, DOI 10.1074/jbc.275.18.13668; Rader C, 2009, METHOD MOL BIOL, V525, pxiv; Rader C, 2011, EXPERIMENTAL AND APPLIED IMMUNOTHERAPY, P59, DOI 10.1007/978-1-60761-980-2_3; Rader Christoph, 2009, V525, P101, DOI 10.1007/978-1-59745-554-1_5; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Smith MR, 2008, CURR OPIN HEMATOL, V15, P415, DOI 10.1097/MOH.0b013e328302c9c5; Stahl SJ, 2010, J MOL BIOL, V397, P697, DOI 10.1016/j.jmb.2010.01.061; Stein R, 2004, BLOOD, V104, P3705, DOI 10.1182/blood-2004-03-0890; Steinberger P, 2000, J BIOL CHEM, V275, P36073, DOI 10.1074/jbc.M002765200; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306	47	51	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21018	10.1371/journal.pone.0021018	http://dx.doi.org/10.1371/journal.pone.0021018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698301	Green Submitted, Green Published, gold			2022-12-25	WOS:000291730000039
J	Hunter, JE; Willmore, E; Irving, JAE; Hostomsky, Z; Veuger, SJ; Durkacz, BW				Hunter, J. E.; Willmore, E.; Irving, J. A. E.; Hostomsky, Z.; Veuger, S. J.; Durkacz, B. W.			NF-kappa B mediates radio-sensitization by the PARP-1 inhibitor, AG-014699	ONCOGENE			English	Article						PARP-1; NF-kappa B; radio-sensitization; AG-014699; PAR	CHRONIC LYMPHOCYTIC-LEUKEMIA; ADP-RIBOSE POLYMERASE-1; POLY(ADP-RIBOSE) POLYMERASE-1; IONIZING-RADIATION; TRANSCRIPTION FACTORS; DNA-DAMAGE; BINDING-ACTIVITY; CANCER THERAPY; CELL-LINES; ACTIVATION	The stress-inducible transcription factor, nuclear factor (NF)-kappa B induces genes involved in proliferation and apoptosis. Aberrant NF-kappa B activity is common in cancer and contributes to therapeutic-resistance. Poly(ADPribose) polymerase-1 (PARP-1) is activated during DNA strand break repair and is a known transcriptional co-regulator. Here, we investigated the role of PARP-1 function during NF-kappa B activation using p65 small interfering RNA (siRNA), PARP siRNA or the potent PARP-1 inhibitor, AG-014699. Survival and apoptosis assays showed that NF-kappa B p65(-/-) cells were more sensitive to ionizing radiation (IR) than p65(+/+) cells. Co-incubation with p65 siRNA, PARP siRNA or AG-014699 radio-sensitized p65(+/+), but not p65(-/-) cells, demonstrating that PARP-1 mediates its effects on survival via NF-kappa B. Single-strand break (SSB) repair kinetics, and the effect SSB repair inhibition by AG-014699 were similar in p65(+/+) and p65(-/-) cells. As preventing SSB repair did not radio-sensitize p65(-/-) cells, we conclude that radio-sensitization by AG-014699 is due to downstream inhibition of NF-kappa B activation, and independent of SSB repair inhibition. PARP-1 catalytic activity was essential for IR-induced p65 DNA binding and NF-kappa B-dependent gene transcription, whereas for tumor necrosis factor (TNF)-alpha-treated cells, PARP-1 protein alone was sufficient. We hypothesize that this stimulus-dependent differential is mediated via stimulation of the poly(ADP-ribose) polymer, which was induced following IR, not TNF-alpha. Targeting DNA damage-activated NF-kappa B using AG-014699 may therefore overcome toxicity observed with classical NF-kappa B inhibitors without compromising other vital inflammatory functions. These data highlight the potential of PARP-1 inhibitors to overcome NF-kappa B-mediated therapeutic resistance and widens the spectrum of cancers in which these agents may be utilized. Oncogene (2012) 31, 251-264; doi:10.1038/onc.2011.229; published online 27 June 2011	[Hunter, J. E.; Willmore, E.; Irving, J. A. E.; Veuger, S. J.; Durkacz, B. W.] Newcastle Univ, No Inst Canc Res, Newcastle Canc Ctr, Tyneside, England; [Hostomsky, Z.] Pfizer GRD, La Jolla, CA USA	Newcastle University - UK; Pfizer	Veuger, SJ (corresponding author), Newcastle Univ, Newcastle Canc Ctr, No Inst Canc Res, Sch Med, Paul OGorman Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	s.j.veuger@ncl.ac.uk	Hostomsky, Zdenek/G-3513-2011; Willmore, Elaine/B-4350-2009	Willmore, Elaine/0000-0002-4762-094X	Pfizer [AG-014699]; Cancer Research UK [C7369/A8048]	Pfizer(Pfizer); Cancer Research UK(Cancer Research UK)	We gratefully acknowledge Pfizer for the supply of AG-014699. This work was supported by Cancer Research UK, grant number C7369/A8048.	ALTHAUS FR, 1994, MOL CELL BIOCHEM, V138, P53, DOI 10.1007/BF00928443; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Bonicalzi ME, 2005, CELL MOL LIFE SCI, V62, P739, DOI 10.1007/s00018-004-4505-1; BRACH MA, 1991, J CLIN INVEST, V88, P691, DOI 10.1172/JCI115354; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; BURGER PC, 1985, CANCER, V56, P1106, DOI 10.1002/1097-0142(19850901)56:5<1106::AID-CNCR2820560525>3.0.CO;2-2; Chang WJ, 2001, J BIOL CHEM, V276, P47664, DOI 10.1074/jbc.M104666200; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Criswell T, 2003, ONCOGENE, V22, P5813, DOI 10.1038/sj.onc.1206680; Daniel RA, 2009, CLIN CANCER RES, V15, P1241, DOI 10.1158/1078-0432.CCR-08-1095; Drew Y, 2011, JNCI-J NATL CANCER I, V103, P334, DOI 10.1093/jnci/djq509; Drew Y, 2009, DRUG RESIST UPDATE, V12, P153, DOI 10.1016/j.drup.2009.10.001; DURKACZ BW, 1980, NATURE, V283, P593, DOI 10.1038/283593a0; Ghosh G., 1999, GENE THER MOL BIOL, V4, P75; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Grossmann M, 1999, P NATL ACAD SCI USA, V96, P11848, DOI 10.1073/pnas.96.21.11848; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Hassa PO, 1999, BIOL CHEM, V380, P953, DOI 10.1515/BC.1999.118; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; Hewamana S, 2008, BLOOD, V111, P4681, DOI 10.1182/blood-2007-11-125278; Hewamana S, 2009, J CLIN ONCOL, V27, P763, DOI 10.1200/JCO.2008.19.1114; Hewamana S, 2008, CLIN CANCER RES, V14, P8102, DOI 10.1158/1078-0432.CCR-08-1673; Jackson AL, 2004, TRENDS GENET, V20, P521, DOI 10.1016/j.tig.2004.08.006; Jung M, 2001, SEMIN RADIAT ONCOL, V11, P346, DOI 10.1053/srao.2001.26034; Kanzawa T, 2003, J BIOMED BIOTECHNOL, P25; Kauppinen UM, 2005, J IMMUNOL, V174, P2288, DOI 10.4049/jimmunol.174.4.2288; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Martin-Oliva D, 2006, CANCER RES, V66, P5744, DOI 10.1158/0008-5472.CAN-05-3050; Mulligan EA, 2010, BLOOD, V116, P1477; OGOREK B, 1985, MUTAT RES, V146, P63, DOI 10.1016/0167-8817(85)90056-2; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Plummer ER, 2005, CLIN CANCER RES, V11, P3402, DOI 10.1158/1078-0432.CCR-04-2353; Plummer R, 2005, J CLIN ONCOL, V23, p208S; Plummer R, 2008, CLIN CANCER RES, V14, P7917, DOI 10.1158/1078-0432.CCR-08-1223; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Russo SM, 2001, INT J RADIAT ONCOL, V50, P183, DOI 10.1016/S0360-3016(01)01446-8; SAHIJDAK WM, 1994, RADIAT RES, V138, pS47, DOI 10.2307/3578760; Shaw H, 2006, J CLIN ONCOL, V24, p127S; SLAMA JT, 1995, J MED CHEM, V38, P389, DOI 10.1021/jm00002a021; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032; Trucco C, 1998, NUCLEIC ACIDS RES, V26, P2644, DOI 10.1093/nar/26.11.2644; Tschaharganeh D, 2007, PATHOL ONCOL RES, V13, P84, DOI 10.1007/BF02893482; Turco MC, 2004, LEUKEMIA, V18, P11, DOI 10.1038/sj.leu.2403171; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.biochem.54.1.73; Veuger SJ, 2009, ONCOGENE, V28, P832, DOI 10.1038/onc.2008.439; Veuger SJ, 2003, CANCER RES, V63, P6008; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang HM, 2004, LAB INVEST, V84, P941, DOI 10.1038/labinvest.3700123; Wu JT, 2005, J SURG RES, V123, P158, DOI 10.1016/j.jss.2004.06.006; Zaremba T, 2009, BRIT J CANCER, V101, P256, DOI 10.1038/sj.bjc.6605166	57	27	30	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	2					251	264		10.1038/onc.2011.229	http://dx.doi.org/10.1038/onc.2011.229			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	879CN	21706052	Green Accepted			2022-12-25	WOS:000299307400010
J	Mathiasen, DP; Egebjerg, C; Andersen, SH; Rafn, B; Puustinen, P; Khanna, A; Daugaard, M; Valo, E; Tuomela, S; Bottzauw, T; Nielsen, CF; Willumsen, BM; Hautaniemi, S; Lahesmaa, R; Westermarck, J; Jaattela, M; Kallunki, T				Mathiasen, D. P.; Egebjerg, C.; Andersen, S. H.; Rafn, B.; Puustinen, P.; Khanna, A.; Daugaard, M.; Valo, E.; Tuomela, S.; Bottzauw, T.; Nielsen, C. F.; Willumsen, B. M.; Hautaniemi, S.; Lahesmaa, R.; Westermarck, J.; Jaattela, M.; Kallunki, T.			Identification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformation	ONCOGENE			English	Article						JNK knockout; CIP2A; ATF3; c-Myc; Ras transformation	PROTEIN-KINASE ACTIVATION; TRANSCRIPTION FACTOR; HA-RAS; NH2-TERMINAL KINASE; GENE-EXPRESSION; RESPONSE GENE; GROWTH; PHOSPHORYLATION; ATF3; JNK	Ras is one of the most frequently activated oncogenes in cancer. Two mitogen-activated protein kinases (MAPKs) are important for ras transformation: extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase 2 (JNK2). Here we present a downstream signal amplification cascade that is critical for ras transformation in murine embryonic fibroblasts. This cascade is coordinated by ERK and JNK2 MAPKs, whose Ras-mediated activation leads to the enhanced levels of three oncogenic transcription factors, namely, c-Myc, activating transcription factor 2 (ATF2) and ATF3, all of which are essential for ras transformation. Previous studies show that ERK-mediated serine 62 phosphorylation protects c-Myc from proteasomal degradation. ERK is, however, not alone sufficient to stabilize c-Myc but requires the cooperation of cancerous inhibitor of protein phosphatase 2A (CIP2A), an oncogene that counteracts protein phosphatase 2A-mediated dephosphorylation of c-Myc. Here we show that JNK2 regulates Cip2a transcription via ATF2. ATF2 and c-Myc cooperate to activate the transcription of ATF3. Remarkably, not only ectopic JNK2, but also ectopic ATF2, CIP2A, c-Myc and ATF3 are sufficient to rescue the defective ras transformation of JNK2-deficient cells. Thus, these data identify the key signal converging point of JNK2 and ERK pathways and underline the central role of CIP2A in ras transformation. Oncogene (2012) 31, 390-401; doi:10.1038/onc.2011.230; published online 27 June 2011	[Mathiasen, D. P.; Egebjerg, C.; Andersen, S. H.; Rafn, B.; Puustinen, P.; Daugaard, M.; Bottzauw, T.; Nielsen, C. F.; Jaattela, M.; Kallunki, T.] Danish Canc Soc, Inst Canc Biol, Apoptosis Dept, DK-2100 Copenhagen, Denmark; [Mathiasen, D. P.; Egebjerg, C.; Andersen, S. H.; Rafn, B.; Puustinen, P.; Daugaard, M.; Bottzauw, T.; Nielsen, C. F.; Jaattela, M.; Kallunki, T.] Danish Canc Soc, Inst Canc Biol, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; [Khanna, A.] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Valo, E.; Hautaniemi, S.] Univ Helsinki, Inst Biomed, Computat Syst Biol Lab, Helsinki, Finland; [Valo, E.; Hautaniemi, S.] Univ Helsinki, Genome Scale Biol Res Program, Helsinki, Finland; [Tuomela, S.; Lahesmaa, R.; Westermarck, J.] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Tuomela, S.; Lahesmaa, R.; Westermarck, J.] Abo Akad Univ, Turku, Finland; [Willumsen, B. M.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Westermarck, J.] Univ Turku, Dept Pathol, Turku, Finland	Danish Cancer Society; Danish Cancer Society; Tampere University; University of Helsinki; University of Helsinki; University of Turku; Abo Akademi University; University of Copenhagen; University of Turku	Kallunki, T (corresponding author), Danish Canc Soc, Inst Canc Biol, Apoptosis Dept, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.	tk@cancer.dk	Jäättelä, Marja/AAT-7932-2021; Hautaniemi, Sampsa/CAG-0362-2022; Nielsen, Christian Friberg/HHN-0347-2022; Westermarck, Jukka/AAL-6464-2020; Hautaniemi, Sampsa/A-3122-2009; Willumsen, Berthe M/H-1903-2012; Daugaard, Mads/Y-6483-2018	Jäättelä, Marja/0000-0001-5950-7111; Hautaniemi, Sampsa/0000-0002-7749-2694; Westermarck, Jukka/0000-0001-7478-3018; Hautaniemi, Sampsa/0000-0002-7749-2694; Willumsen, Berthe M/0000-0002-2277-6999; Nielsen, Christian Friberg/0000-0002-2886-317X; Valo, Erkka/0000-0003-0672-554X; Kallunki, Tuula/0000-0002-8571-383X; Daugaard, Mads/0000-0001-8383-055X	Danish Cancer Society; Danish Medical Research Council; Ellen and Aage Fausboll Helsefond; Danish National Research Foundation; Danish Cancer Research Foundation; Novo Nordisk Foundation; Academy of Finland; Pirkanmaa Hospital District; Finnish Cancer Society; Finnish Cancer Organizations; Finnish Microarray and Sequencing Centre at Turku Centre for Biotechnology; Cancer Foundation Finland sr [110134, 120139] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ellen and Aage Fausboll Helsefond; Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Cancer Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Academy of Finland(Academy of Finland); Pirkanmaa Hospital District; Finnish Cancer Society; Finnish Cancer Organizations; Finnish Microarray and Sequencing Centre at Turku Centre for Biotechnology; Cancer Foundation Finland sr	This work was supported by the Danish Cancer Society (TK, MJ), the Danish Medical Research Council (TK), Ellen and Aage Fausboll Helsefond (TK), the Danish National Research Foundation (MJ), Danish Cancer Research Foundation (CE), the Novo Nordisk Foundation (CE), the Academy of Finland (JW, RL, SH), Competetive Research Funding of the Pirkanmaa Hospital District (JW, AK), the Finnish Cancer Society (JW, SH) and the Finnish Cancer Organizations (RL) and the Finnish Microarray and Sequencing Centre at Turku Centre for Biotechnology. We additionally thank Dr G Nolan for the pB-puro and pB-hygro constructs, Dr H Land for the c-Myc pB-puro construct, Dr S Kitajima for the ATF3 reporter constructs and Dr T Hai for the ATF3 construct. We are thankful for KG Henriksen and P Rammer for excellent assistance and LB Larsen and L Jorgensen for the in vivo tumorigenicity assay.	Alarcon-Vargas D, 2004, J BIOL CHEM, V279, P5008, DOI 10.1074/jbc.M312054200; Amati B, 2001, BBA-REV CANCER, V1471, pM135, DOI 10.1016/S0304-419X(01)00020-8; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Berger AJ, 2003, CANCER RES, V63, P8103; Bhoumik A, 2004, CANCER RES, V64, P8222, DOI 10.1158/0008-5472.CAN-04-0714; Bhoumik A, 2008, CELL CYCLE, V7, P2341, DOI 10.4161/cc.6388; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; Bost F, 1999, MOL CELL BIOL, V19, P1938; BRUNET A, 1994, ONCOGENE, V9, P3379; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Chen NY, 2001, CANCER RES, V61, P3908; CIARDIELLO F, 1990, J CELL BIOCHEM, V42, P45, DOI 10.1002/jcb.240420105; Come C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dietrich N, 2004, CELL DEATH DIFFER, V11, P301, DOI 10.1038/sj.cdd.4401353; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Jacobsen K, 2002, ONCOGENE, V21, P3058, DOI 10.1038/sj.onc.1205423; Johnson R, 1996, MOL CELL BIOL, V16, P4504; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; KAWAGISHI J, 1995, GENOMICS, V30, P224, DOI 10.1006/geno.1995.9883; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Ke HN, 2010, CANCER RES, V70, P3080, DOI 10.1158/0008-5472.CAN-09-2923; Kemp CJ, 2005, SEMIN CANCER BIOL, V15, P460, DOI 10.1016/j.semcancer.2005.06.003; Khanna A, 2009, JNCI-J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; Krautwald S, 1996, MOL CELL BIOL, V16, P5955; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LAND H, 1986, MOL CELL BIOL, V6, P1917, DOI 10.1128/MCB.6.6.1917; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Lopez-Bergami P, 2010, J BIOL CHEM, V285, P903, DOI 10.1074/jbc.M109.075630; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Martinato F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003650; Mei Y, 2008, NEUROSCIENCE, V151, P771, DOI 10.1016/j.neuroscience.2007.10.057; Nielsen C, 2007, CANCER RES, V67, P178, DOI 10.1158/0008-5472.CAN-06-2801; Nielsen KH, 2001, ONCOGENE, V20, P2091, DOI 10.1038/sj.onc.1204306; Noguchi K, 1999, J BIOL CHEM, V274, P32580, DOI 10.1074/jbc.274.46.32580; Ovaska K, 2010, GENOME MED, V2, DOI 10.1186/gm186; Pearn L, 2007, BLOOD, V109, P4461, DOI 10.1182/blood-2006-09-047217; Perez S, 2001, ONCOGENE, V20, P1135, DOI 10.1038/sj.onc.1204200; Potapova O, 2000, J BIOL CHEM, V275, P24767, DOI 10.1074/jbc.M904591199; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Schimanski CC, 2010, INT J COLORECTAL DIS, V25, P181, DOI 10.1007/s00384-009-0843-7; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Sharma A, 2010, J BIOL CHEM, V285, P15724, DOI 10.1074/jbc.M109.100016; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; Teruel T, 1998, J CELL PHYSIOL, V176, P99, DOI 10.1002/(SICI)1097-4652(199807)176:1<99::AID-JCP12>3.3.CO;2-6; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; TROPPMAIR J, 1994, J BIOL CHEM, V269, P7030; Wang A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-268; Yao DC, 2010, DIABETES, V59, P249, DOI 10.2337/db09-0801; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	65	34	37	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	3					390	401		10.1038/onc.2011.230	http://dx.doi.org/10.1038/onc.2011.230			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	882DQ	21706057				2022-12-25	WOS:000299542100011
J	Danielsson, J; Kurnik, M; Lang, L; Oliveberg, M				Danielsson, Jens; Kurnik, Martin; Lang, Lisa; Oliveberg, Mikael			Cutting Off Functional Loops from Homodimeric Enzyme Superoxide Dismutase 1 (SOD1) Leaves Monomeric beta-Barrels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PANCREATIC TRYPSIN-INHIBITOR; MAGNETIC-RESONANCE RELAXATION; ISOTOPE EXCHANGE KINETICS; PULSED-FIELD GRADIENTS; MODEL-FREE APPROACH; HYDROGEN-EXCHANGE; NMR-SPECTROSCOPY; POSTTRANSLATIONAL MODIFICATIONS; CU,ZN-SUPEROXIDE DISMUTASE	Demetallation of the homodimeric enzyme Cu/Zn-superoxide dismutase (SOD1) is known to unleash pronounced dynamic motions in the long active-site loops that comprise almost a third of the folded structure. The resulting apo species, which shows increased propensity to aggregate, stands out as the prime disease precursor in amyotrophic lateral sclerosis (ALS). Even so, the detailed structural properties of the apoSOD1 framework have remained elusive and controversial. In this study, we examine the structural interplay between the central apoSOD1 barrel and the active-site loops by simply cutting them off; loops IV and VII were substituted with short Gly-Ala-Gly linkers. The results show that loop removal breaks the dimer interface and leads to soluble, monomeric beta-barrels with high structural integrity. NMR-detected nuclear Overhauser effects are found between all of the constituent beta-strands, confirming ordered interactions across the whole barrel. Moreover, the breathing motions of the SOD1 barrel are overall insensitive to loop removal and yield hydrogen/deuterium protection factors typical for cooperatively folded proteins (i.e. the active-site loops act as a "bolt-on" domain with little dynamic influence on its structural foundation). The sole exceptions are the relatively low protection factors in beta-strand 5 and the turn around Gly-93, a hot spot for ALS-provoking mutations, which decrease even further upon loop removal. Taken together, these data suggest that the cytotoxic function of apoSOD1 does not emerge from its folded ground state but from a high energy intermediate or even from the denatured ensemble.	[Danielsson, Jens; Kurnik, Martin; Lang, Lisa; Oliveberg, Mikael] Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden	Stockholm University	Oliveberg, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden.	mikael.oliveberg@dbb.su.se	Danielsson, Jens/AAG-6915-2021; Kurnik, Martin/AFZ-2568-2022	Kurnik, Martin/0000-0001-9255-9730; Danielsson, Jens/0000-0002-6048-6896	Swedish Research Council; Knut and Alice Wallenberg Foundation; Bertil Hallsten Foundation; Hjarnfonden; EC (EU-NMR) [RII3-026145]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Bertil Hallsten Foundation; Hjarnfonden; EC (EU-NMR)(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Bertil Hallsten Foundation, and Hjarnfonden. This work was also supported by the Access to Research Infrastructures Activity in the 6th Framework Program of the EC (Contract RII3-026145, EU-NMR) for conducting the research at CERM.	Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Banci L, 2003, BIOCHEMISTRY-US, V42, P9543, DOI 10.1021/bi034324m; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Berjanskii MV, 2008, J BIOMOL NMR, V40, P31, DOI 10.1007/s10858-007-9208-0; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; Daggett V, 2009, PROTEIN ENG DES SEL, V22, P445, DOI 10.1093/protein/gzp049; Danielsson J, 2002, MAGN RESON CHEM, V40, pS89, DOI 10.1002/mrc.1132; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; Ding F, 2008, P NATL ACAD SCI USA, V105, P19696, DOI 10.1073/pnas.0803266105; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Englander SW, 2007, Q REV BIOPHYS, V40, P287, DOI 10.1017/S0033583508004654; Englander SW, 2000, ANNU REV BIOPH BIOM, V29, P213, DOI 10.1146/annurev.biophys.29.1.213; Ferraro DM, 2004, BIOCHEMISTRY-US, V43, P587, DOI 10.1021/bi035943y; Ferraroni M, 1999, J MOL BIOL, V288, P413, DOI 10.1006/jmbi.1999.2681; Ferreiro DU, 2007, P NATL ACAD SCI USA, V104, P19819, DOI 10.1073/pnas.0709915104; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; FORMAN HJ, 1973, J BIOL CHEM, V248, P2645; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Friel CT, 2009, NAT STRUCT MOL BIOL, V16, P318, DOI 10.1038/nsmb.1562; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Furukawa Y, 2006, ANTIOXID REDOX SIGN, V8, P847, DOI 10.1089/ars.2006.8.847; Furukawa Y, 2010, J BIOL CHEM, V285, P22221, DOI 10.1074/jbc.M110.113597; FUSHMAN D, 1994, J BIOMOL STRUCT DYN, V11, P1377, DOI 10.1080/07391102.1994.10508074; Gosavi S, 2008, P NATL ACAD SCI USA, V105, P10384, DOI 10.1073/pnas.0801343105; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Haglund E, 2009, P NATL ACAD SCI USA, V106, P21619, DOI 10.1073/pnas.0907665106; Hamill SJ, 2000, J MOL BIOL, V297, P165, DOI 10.1006/jmbi.2000.3517; HILTON BD, 1979, BIOCHEMISTRY-US, V18, P5834, DOI 10.1021/bi00593a013; Hornberg A, 2007, J MOL BIOL, V365, P333, DOI 10.1016/j.jmb.2006.09.048; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Jaswal SS, 2007, PROTEIN SCI, V16, P2378, DOI 10.1110/ps.072994207; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kayatekin C, 2010, J MOL BIOL, V398, P320, DOI 10.1016/j.jmb.2010.02.034; Kayatekin C, 2008, J MOL BIOL, V384, P540, DOI 10.1016/j.jmb.2008.09.045; Leinartaite L, 2010, J AM CHEM SOC, V132, P13495, DOI 10.1021/ja1057136; LEVITT M, 1976, J MOL BIOL, V104, P59, DOI 10.1016/0022-2836(76)90004-8; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lynch SM, 2004, BIOCHEMISTRY-US, V43, P16525, DOI 10.1021/bi048831v; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; McParland VJ, 2002, NAT STRUCT BIOL, V9, P326, DOI 10.1038/nsb791; Museth AK, 2009, BIOCHEMISTRY-US, V48, P8817, DOI 10.1021/bi900703v; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nordlund A, 2006, P NATL ACAD SCI USA, V103, P10218, DOI 10.1073/pnas.0601696103; Nordlund A, 2009, P NATL ACAD SCI USA, V106, P9667, DOI 10.1073/pnas.0812046106; Oliveberg M, 2001, CURR OPIN STRUC BIOL, V11, P94, DOI 10.1016/S0959-440X(00)00171-8; Oliveberg M, 2010, NAT METHODS, V7, P187, DOI 10.1038/nmeth0310-187; Otzen DE, 2002, J MOL BIOL, V317, P613, DOI 10.1006/jmbi.2002.5423; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; PEDERSEN TG, 1993, J MOL BIOL, V230, P651, DOI 10.1006/jmbi.1993.1176; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; RODER H, 1985, BIOCHEMISTRY-US, V24, P7396, DOI 10.1021/bi00346a055; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; SCHLEUCHER J, 1993, ANGEW CHEM INT EDIT, V32, P1489, DOI 10.1002/anie.199314891; Stathopulos PB, 2006, J BIOL CHEM, V281, P6184, DOI 10.1074/jbc.M509496200; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Teilum K, 2009, P NATL ACAD SCI USA, V106, P18273, DOI 10.1073/pnas.0907387106; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; WOODWARD CK, 1980, BIOPHYS J, V32, P561, DOI 10.1016/S0006-3495(80)84990-3; Wright CF, 2004, PROTEIN ENG DES SEL, V17, P443, DOI 10.1093/protein/gzh052; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; WUTHRICH K, 1990, J BIOL CHEM, V265, P22059; Zetterstrom P, 2007, P NATL ACAD SCI USA, V104, P14157, DOI 10.1073/pnas.0700477104	78	47	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33070	33083		10.1074/jbc.M111.251223	http://dx.doi.org/10.1074/jbc.M111.251223			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21700707	Green Published, hybrid			2022-12-25	WOS:000294968800026
J	Szymanski, MR; Jezewska, MJ; Bujalowski, PJ; Bussetta, C; Ye, MY; Choi, KH; Bujalowski, W				Szymanski, Michal R.; Jezewska, Maria J.; Bujalowski, Paul J.; Bussetta, Cecile; Ye, Mengyi; Choi, Kyung H.; Bujalowski, Wlodzimierz			Full-length Dengue Virus RNA-dependent RNA Polymerase-RNA/DNA Complexes STOICHIOMETRIES, INTRINSIC AFFINITIES, COOPERATIVITIES, BASE, AND CONFORMATIONAL SPECIFICITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICASE DNAB PROTEIN; SINGLE-STRANDED-DNA; SWINE-FEVER VIRUS; DE-NOVO SYNTHESIS; NUCLEIC-ACID; QUANTITATIVE-ANALYSIS; SSDNA INTERACTIONS; LARGE LIGANDS; NONCOOPERATIVE BINDING; FUNCTIONAL STRUCTURE	Fundamental aspects of interactions of the Dengue virus type 3 full-length polymerase with the single-stranded and double-stranded RNA and DNA have been quantitatively addressed. The polymerase exists as a monomer with an elongated shape in solution. In the absence of magnesium, the total site size of the polymerase-ssRNA complex is 26 +/- 2 nucleotides. In the presence of Mg2+, the site size increases to 29 +/- 2 nucleotides, indicating that magnesium affects the enzyme global conformation. The enzyme shows a preference for the homopyrimidine ssRNAs. Positive cooperativity in the binding to homopurine ssRNAs indicates that the type of nucleic acid base dramatically affects the enzyme orientation in the complex. Both the intrinsic affinity and the cooperative interactions are accompanied by a net ion release. The polymerase binds the dsDNA with an affinity comparable with the ssRNAs affinity, indicating that the binding site has an open conformation in solution. The lack of detectable dsRNA or dsRNA-DNA hybrid affinities indicates that the entry to the binding site is specific for the sugar-phosphate backbone and/or conformation of the duplex.	[Szymanski, Michal R.; Jezewska, Maria J.; Bujalowski, Paul J.; Bussetta, Cecile; Ye, Mengyi; Choi, Kyung H.; Bujalowski, Wlodzimierz] Univ Texas Med Branch Galveston, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Bujalowski, Wlodzimierz] Univ Texas Med Branch Galveston, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Szymanski, Michal R.; Jezewska, Maria J.; Bujalowski, Paul J.; Bussetta, Cecile; Ye, Mengyi; Choi, Kyung H.; Bujalowski, Wlodzimierz] Univ Texas Med Branch Galveston, Sealy Ctr Struct Biol, Galveston, TX 77555 USA; [Szymanski, Michal R.; Jezewska, Maria J.; Bujalowski, Paul J.; Bujalowski, Wlodzimierz] Univ Texas Med Branch Galveston, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Bujalowski, W (corresponding author), Univ Texas Med Branch Galveston, Dept Biochem & Mol Biol, 301 Univ Blvd, Galveston, TX 77555 USA.	wbujalow@utmb.edu		Szymanski, Michal/0000-0001-9452-8508	National Institutes of Health [GM-58565, AI-087856]; Sealy Memorial Endowment Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sealy Memorial Endowment Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-58565 (to W. B.) and AI-087856. This work was also supported by a Sealy Memorial Endowment Fund research pilot grant (to K. C.).	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; BAKER BM, 1978, BIOPOLYMERS, V17, P1361, DOI 10.1002/bip.1978.360170519; BLOK J, 1985, J GEN VIROL, V66, P1323, DOI 10.1099/0022-1317-66-6-1323; Bujalowski W, 2006, CHEM REV, V106, P556, DOI 10.1021/cr040462l; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350; BUJALOWSKI W, 1989, BIOPOLYMERS, V28, P1637, DOI 10.1002/bip.360280912; Bujalowski W., 2000, SPECTROPHOTOMETRY SP, P141; BULL HB, 1968, ARCH BIOCHEM BIOPHYS, V128, P497, DOI 10.1016/0003-9861(68)90056-8; Cantor R. C., 1980, BIOPHYSICAL CHEM, VII, P591; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Choi KH, 2006, STRUCTURE, V14, P1107, DOI 10.1016/j.str.2006.05.020; Choi KH, 2009, CURR OPIN STRUC BIOL, V19, P746, DOI 10.1016/j.sbi.2009.10.015; Correia JJ, 2001, BIOCHEMISTRY-US, V40, P1473, DOI 10.1021/bi0019343; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; EISENBERG H, 1967, J MOL BIOL, V30, P17, DOI 10.1016/0022-2836(67)90240-9; EPSTEIN IR, 1978, BIOPHYS CHEM, V8, P327, DOI 10.1016/0301-4622(78)80015-5; Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002; Galletto R, 2004, BIOCHEMISTRY-US, V43, P11002, DOI 10.1021/bi049378q; Galletto R, 2004, BIOCHEMISTRY-US, V43, P10988, DOI 10.1021/bi049377y; Galletto R, 2003, J MOL BIOL, V329, P441, DOI 10.1016/S0022-2836(03)00435-2; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Halstead SB, 2002, CURR OPIN INFECT DIS, V15, P471, DOI 10.1097/00001432-200210000-00003; Jezewska MJ, 2007, BIOCHEMISTRY-US, V46, P12909, DOI 10.1021/bi700677j; Jezewska MJ, 2007, J MOL BIOL, V373, P75, DOI 10.1016/j.jmb.2007.06.054; Jezewska MJ, 1996, J BIOL CHEM, V271, P4261; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2117, DOI 10.1021/bi952344l; Jezewska MJ, 1998, BIOCHEMISTRY-US, V37, P3116, DOI 10.1021/bi972564u; Jezewska MJ, 2006, J MOL BIOL, V356, P121, DOI 10.1016/j.jmb.2005.10.061; Jezewska MJ, 2004, J MOL BIOL, V343, P115, DOI 10.1016/j.jmb.2004.08.021; Jezewska MJ, 2003, BIOCHEMISTRY-US, V42, P11864, DOI 10.1021/bi030111l; Jezewska MJ, 2003, CELL BIOCHEM BIOPHYS, V38, P125, DOI 10.1385/CBB:38:2:125; Jezewska MJ, 2001, J MOL BIOL, V313, P977, DOI 10.1006/jmbi.2001.5042; Jezewska MJ, 2000, J BIOL CHEM, V275, P27865; Jin ZN, 2011, J BIOL CHEM, V286, P2067, DOI 10.1074/jbc.M110.162685; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; KOWALCZYKOWSKI SC, 1981, J MOL BIOL, V145, P75, DOI 10.1016/0022-2836(81)90335-1; KRAKAUER H, 1971, BIOPOLYMERS, V10, P2459, DOI 10.1002/bip.360101209; KUNTZ ID, 1971, J AM CHEM SOC, V93, P514, DOI 10.1021/ja00731a036; LEDNEVA RK, 1978, NUCLEIC ACIDS RES, V5, P4225, DOI 10.1093/nar/5.11.4225; LOHMAN TM, 1991, METHOD ENZYMOL, V208, P258; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; Marcinowicz A, 2008, J MOL BIOL, V375, P386, DOI 10.1016/j.jmb.2007.06.051; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Nomaguchi M, 2003, J VIROL, V77, P8831, DOI 10.1128/JVI.77.16.8831-8842.2003; Rajendran S, 2001, BIOCHEMISTRY-US, V40, P11794, DOI 10.1021/bi011173j; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Roychowdhury A, 2009, BIOCHEMISTRY-US, V48, P6712, DOI 10.1021/bi900050x; Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Szymanski MR, 2010, J MOL BIOL, V398, P8, DOI 10.1016/j.jmb.2010.02.009; TOLMAN GL, 1974, BIOCHEMISTRY-US, V13, P4869, DOI 10.1021/bi00721a001; WESTAWAY EG, 1987, ADV VIRUS RES, V33, P45, DOI 10.1016/S0065-3527(08)60316-4; Yap LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012836; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06	59	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33095	33108		10.1074/jbc.M111.255034	http://dx.doi.org/10.1074/jbc.M111.255034			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21725087	Green Published, hybrid			2022-12-25	WOS:000294968800028
J	Maqbool, A; Levdikov, VM; Blagova, EV; Herve, M; Horler, RSP; Wilkinson, AJ; Thomas, GH				Maqbool, Abbas; Levdikov, Vladimir M.; Blagova, Elena V.; Herve, Mireille; Horler, Richard S. P.; Wilkinson, Anthony J.; Thomas, Gavin H.			Compensating Stereochemical Changes Allow Murein Tripeptide to Be Accommodated in a Conventional Peptide-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; GLUTAMYL-MESO-DIAMINOPIMELATE; L-ALANINE AMIDASE; LACTOCOCCUS-LACTIS; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; OPPA PROTEIN; TRANSPORT; SPECIFICITY; CRYSTALLIZATION	The oligopeptide permease (Opp) of Escherichia coli is an ATP-binding cassette transporter that uses the substrate-binding protein (SBP) OppA to bind peptides and deliver them to the membrane components (OppBCDF) for transport. OppA binds conventional peptides 2-5 residues in length regardless of their sequence, but does not facilitate transport of the cell wall component murein tripeptide (Mtp, L-Ala-gamma-D-Glu-meso-Dap), which contains a D-amino acid and a gamma-peptide linkage. Instead, MppA, a homologous substrate-binding protein, forms a functional transporter with OppBCDF for uptake of this unusual tripeptide. Here we have purified MppA and demonstrated biochemically that it binds Mtp with high affinity (K-D similar to 250 nM). The crystal structure of MppA in complex with Mtp has revealed that Mtp is bound in a relatively extended conformation with its three carboxylates projecting from one side of the molecule and its two amino groups projecting from the opposite face. Specificity for Mtp is conferred by charge-charge and dipole-charge interactions with ionic and polar residues of MppA. Comparison of the structure of MppA-Mtp with structures of conventional tripeptides bound to OppA, reveals that the peptide ligands superimpose remarkably closely given the profound differences in their structures. Strikingly, the effect of the D-stereochemistry, which projects the side chain of the D-Glu residue at position 2 in the direction of the main chain in a conventional tripeptide, is compensated by the formation of a gamma-linkage to the amino group of diaminopimelic acid, mimicking the peptide bond between residues 2 and 3 of a conventional tripeptide.	[Levdikov, Vladimir M.; Blagova, Elena V.; Wilkinson, Anthony J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England; [Maqbool, Abbas; Horler, Richard S. P.; Thomas, Gavin H.] Univ York, Dept Biol, Area 10, York YO10 5YW, N Yorkshire, England; [Herve, Mireille] Univ Paris 11, Lab Enveloppes Bacteriennes & Antibiot, IBBMC, UMR8619, F-91450 Orsay, France; [Herve, Mireille] CNRS, F-91405 Orsay, France	University of York - UK; University of York - UK; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Wilkinson, AJ (corresponding author), Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England.	ajw@ysbl.york.ac.uk; ght2@york.ac.uk	Thomas, Gavin H/E-5753-2011; Maqbool, Abbas/AAA-9052-2020; Levdikov, Vladimir/AAA-6139-2022; Maqbool, Abbas/G-3191-2016	Thomas, Gavin H/0000-0002-9763-1313; Levdikov, Vladimir/0000-0003-3041-1049; Maqbool, Abbas/0000-0002-6189-5560; Wilkinson, Anthony/0000-0003-4577-9479; Horler, Richard/0000-0002-9908-2469	Higher Education Commission Pakistan; Wellcome Trust [082829/Z/07/Z]; European Commission [LSHG-CT-2006-031220, BASYSBIO LSHG-CT-2006-037469]	Higher Education Commission Pakistan(Higher Education Commission of Pakistan); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a Higher Education Commission Pakistan studentship (to A. M.), Wellcome Trust Grant 082829/Z/07/Z (to V. L.), and European Commission SPINE2-COMPLEXES project Grants LSHG-CT-2006-031220 and BASYSBIO LSHG-CT-2006-037469 (to E. B.).	Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Berntsson RPA, 2009, EMBO J, V28, P1332, DOI 10.1038/emboj.2009.65; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brzozowski AM, 2001, J APPL CRYSTALLOGR, V34, P97, DOI 10.1107/S0021889800017362; Cuneo MJ, 2009, J BIOL CHEM, V284, P33217, DOI 10.1074/jbc.M109.041624; Detmers FJM, 2001, RES MICROBIOL, V152, P245, DOI 10.1016/S0923-2508(01)01196-2; Doeven MK, 2005, MOL MICROBIOL, V57, P640, DOI 10.1111/j.1365-2958.2005.04698.x; DUNTEN P, 1995, PROTEIN SCI, V4, P2327, DOI 10.1002/pro.5560041110; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fogg MJ, 2008, BIOCHEM SOC T, V36, P771, DOI 10.1042/BST0360771; GOODELL EW, 1985, J BACTERIOL, V162, P391, DOI 10.1128/JB.162.1.391-397.1985; GUYER CA, 1986, J BACTERIOL, V168, P775, DOI 10.1128/jb.168.2.775-779.1986; Herve M, 2007, J BACTERIOL, V189, P3987, DOI 10.1128/JB.00087-07; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Lanfermeijer FC, 1999, BIOCHEMISTRY-US, V38, P14440, DOI 10.1021/bi9914715; Leonard BAB, 1996, P NATL ACAD SCI USA, V93, P260, DOI 10.1073/pnas.93.1.260; Lessard IAD, 1998, CHEM BIOL, V5, P489, DOI 10.1016/S1074-5521(98)90005-9; Letoffe S, 2006, P NATL ACAD SCI USA, V103, P12891, DOI 10.1073/pnas.0605440103; Levdikov VM, 2005, J MOL BIOL, V345, P879, DOI 10.1016/j.jmb.2004.10.089; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nanavati DA, 2006, APPL ENVIRON MICROB, V72, P1336, DOI 10.1128/AEM.72.2.1336-1345.2006; Nickitenko AV, 1995, BIOCHEMISTRY-US, V34, P16585, DOI 10.1021/bi00051a006; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Park JT, 1998, J BACTERIOL, V180, P1215, DOI 10.1128/JB.180.5.1215-1223.1998; PAYNE JW, 1971, BIOCHEM J, V123, P245, DOI 10.1042/bj1230245; Pennartz A, 2009, ANTIMICROB AGENTS CH, V53, P2991, DOI 10.1128/AAC.01520-07; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Severi E, 2005, MOL MICROBIOL, V58, P1173, DOI 10.1111/j.1365-2958.2005.04901.x; Sleigh SH, 1999, J MOL BIOL, V291, P393, DOI 10.1006/jmbi.1999.2929; Sleigh SH, 1997, BIOCHEMISTRY-US, V36, P9747, DOI 10.1021/bi970457u; Smith MW, 1999, MICROBIOL-SGM, V145, P2891, DOI 10.1099/00221287-145-10-2891; Suzuki H, 2005, J BACTERIOL, V187, P5861, DOI 10.1128/JB.187.17.5861-5867.2005; Tame JRH, 1995, STRUCTURE, V3, P1395, DOI 10.1016/S0969-2126(01)00276-3; TAME JRH, 1994, SCIENCE, V264, P1578, DOI 10.1126/science.8202710; Thomas GH, 2006, MICROBIOL-SGM, V152, P187, DOI 10.1099/MIC.0.28334-0; Uehara T, 2007, J BACTERIOL, V189, P5634, DOI 10.1128/JB.00446-07; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Williams WA, 2004, BIOCHEMISTRY-US, V43, P16193, DOI 10.1021/bi048877o; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	39	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31512	31521		10.1074/jbc.M111.267179	http://dx.doi.org/10.1074/jbc.M111.267179			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21705338	hybrid, Green Published			2022-12-25	WOS:000294487500046
J	Chaya, T; Shibata, S; Tokuhara, Y; Yamaguchi, W; Matsumoto, H; Kawahara, I; Kogo, M; Ohoka, Y; Inagaki, S				Chaya, Taro; Shibata, Satoshi; Tokuhara, Yasunori; Yamaguchi, Wataru; Matsumoto, Hiroshi; Kawahara, Ichiro; Kogo, Mikihiko; Ohoka, Yoshiharu; Inagaki, Shinobu			Identification of a Negative Regulatory Region for the Exchange Activity and Characterization of T332I Mutant of Rho Guanine Nucleotide Exchange Factor 10 (ARHGEF10)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHWANN-CELL MIGRATION; PERIPHERAL NERVOUS-SYSTEM; ACTIN STRESS FIBERS; ACTIVATION; PROTEIN; GTPASES; KINASE; AUTOINHIBITION; CDC42; RAC1	The T332I mutation in Rho guanine nucleotide exchange factor 10 (ARHGEF10) was previously found in persons with slowed nerve conduction velocities and thin myelination of peripheral nerves. However, the molecular and cellular basis of the T332I mutant is not understood. Here, we show that ARHGEF10 has a negative regulatory region in the N terminus, in which residue 332 is located, and the T332I mutant is constitutively active. An N-terminal truncated ARHGEF10 mutant, ARHGEF10 Delta N (lacking amino acids 1-332), induced cell contraction that was inhibited by a Rho kinase inhibitor Y27632 and had higher GEF activity for RhoA than the wild type. The T332I mutant also showed the phenotype similar to the N-terminal truncated mutant. These data suggest that the ARHGEF10 T332I mutation-associated phenotype observed in the peripheral nerves is due to activated GEF activity of the ARHGEF10 T332I mutant.	[Chaya, Taro; Shibata, Satoshi; Tokuhara, Yasunori; Yamaguchi, Wataru; Matsumoto, Hiroshi; Kawahara, Ichiro; Ohoka, Yoshiharu; Inagaki, Shinobu] Osaka Univ, Grad Sch Med, Div Hlth Sci, Neurobiol Grp, Suita, Osaka 5650871, Japan; [Matsumoto, Hiroshi; Kawahara, Ichiro; Kogo, Mikihiko] Osaka Univ, Grad Sch Dent, Div Pathogenesis & Control Oral Dis, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Shibata, S (corresponding author), Osaka Univ, Grad Sch Med, Div Hlth Sci, Neurobiol Grp, Yamadaoka 1-7, Suita, Osaka 5650871, Japan.	sshibata@sahs.med.osaka-u.ac.jp; inagaki@sahs.med.osaka-u.ac.jp	Kogo, Mikihiko/ABD-7080-2020	Kogo, Mikihiko/0000-0002-4556-2491; Yamaguchi, Wataru/0000-0002-7840-4609; Tokuhara, Yasunori/0000-0002-8322-2543	Japan Ministry of Education, Culture, Sports, Science, and Technology	Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for general scientific research from the Japan Ministry of Education, Culture, Sports, Science, and Technology (to S.I.).	Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Aoki T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-56; Banerjee J, 2004, MOL BIOL CELL, V15, P1760, DOI 10.1091/mbc.E03-07-0527; Benninger Y, 2007, J CELL BIOL, V177, P1051, DOI 10.1083/jcb.200610108; Bi F, 2001, MOL CELL BIOL, V21, P1463, DOI 10.1128/MCB.21.5.1463-1474.2001; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Delague V, 2007, AM J HUM GENET, V81, P1, DOI 10.1086/518428; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Melendez-Vasquez CV, 2004, J NEUROSCI, V24, P3953, DOI 10.1523/JNEUROSCI.4920-03.2004; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Mohl M, 2006, N-S ARCH PHARMACOL, V373, P333, DOI 10.1007/s00210-006-0083-0; Murayama K, 2007, J BIOL CHEM, V282, P4238, DOI 10.1074/jbc.C600234200; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nodari A, 2007, J CELL BIOL, V177, P1063, DOI 10.1083/jcb.200610014; Obaishi H, 1998, J BIOL CHEM, V273, P18697, DOI 10.1074/jbc.273.30.18697; Pereira JA, 2009, J CELL BIOL, V185, P147, DOI 10.1083/jcb.200809008; Ren XD, 2000, METHOD ENZYMOL, V325, P264; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Stendel C, 2007, AM J HUM GENET, V81, P158, DOI 10.1086/518770; Umikawa M, 1999, J BIOL CHEM, V274, P25197, DOI 10.1074/jbc.274.36.25197; Verhoeven K, 2003, AM J HUM GENET, V73, P926, DOI 10.1086/378159; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P14889, DOI 10.1073/pnas.0507125102; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P5198, DOI 10.1073/pnas.0501160102; Yamauchi J, 2004, P NATL ACAD SCI USA, V101, P8774, DOI 10.1073/pnas.0402795101; Yamauchi J, 2008, J CELL BIOL, V181, P351, DOI 10.1083/jcb.200709033; Yohe ME, 2008, BIOCHEMISTRY-US, V47, P6827, DOI 10.1021/bi702543p; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; Zheng MY, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-36; Zhu KJ, 2000, J BIOL CHEM, V275, P25993, DOI 10.1074/jbc.M003780200	40	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29511	29520		10.1074/jbc.M111.236810	http://dx.doi.org/10.1074/jbc.M111.236810			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21719701	Green Published, hybrid			2022-12-25	WOS:000294046600008
J	White, CD; Li, ZG; Dillon, DA; Sacks, DB				White, Colin D.; Li, Zhigang; Dillon, Deborah A.; Sacks, David B.			IQGAP1 Protein Binds Human Epidermal Growth Factor Receptor 2 (HER2) and Modulates Trastuzumab Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; DEPENDENT KINASE INHIBITOR; ERBB RECEPTORS; METASTATIC BREAST; SYNERGISTICALLY INHIBIT; MONOCLONAL-ANTIBODY; SIGNALING PATHWAYS; SCAFFOLD PROTEINS; NEU ONCOGENE; PROLIFERATION	Human epidermal growth factor receptor 2 (HER2) is overexpressed in 20-25% of breast cancers. Increased HER2 expression is an adverse prognostic factor and correlates with decreased patient survival. HER2-positive (HER2(+)) breast cancer is treated with trastuzumab. Unfortunately, some patients are intrinsically refractory to therapy, and many who do respond initially become resistant within 1 year. Understanding the molecular mechanisms underlying HER2 signaling and trastuzumab resistance is essential to reduce breast cancer mortality. IQGAP1 is a ubiquitously expressed scaffold protein that contains multiple protein interaction domains. By regulating its binding partners IQGAP1 integrates signaling pathways, several of which contribute to breast tumorigenesis. We show here that IQGAP1 is overexpressed in HER2(+) breast cancer tissue and binds directly to HER2. Knockdown of IQGAP1 decreases HER2 expression, phosphorylation, signaling, and HER2-stimulated cell proliferation, effects that are all reversed by reconstituting cells with IQGAP1. Reducing IQGAP1 up-regulates p27, and blocking this increase attenuates the growth inhibitory effects of IQGAP1 knockdown. Importantly, IQGAP1 is overexpressed in trastuzumab-resistant breast epithelial cells, and reducing IQGAP1 both augments the inhibitory effects of trastuzumab and restores trastuzumab sensitivity to trastuzumab-resistant SkBR3 cells. These data suggest that inhibiting IQGAP1 function may represent a rational strategy for treating HER2(+) breast carcinoma.	[White, Colin D.] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [White, Colin D.; Li, Zhigang; Dillon, Deborah A.; Sacks, David B.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [White, Colin D.; Li, Zhigang; Dillon, Deborah A.; Sacks, David B.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Li, Zhigang; Sacks, David B.] NIH, Bethesda, MD 20892 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA	White, CD (corresponding author), Beth Israel Deaconess Med Ctr, 3 Blackfan Circle, Boston, MA 02115 USA.	cdwhite@bidmc.harvard.edu		Sacks, David/0000-0003-3100-0735	National Institutes of Health [R01CA075205-09]; Department of Defense [BC087504]; NATIONAL CANCER INSTITUTE [R01CA075205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA075205-09 (to D. B. S.). This work was also funded by the Department of Defense Breast Cancer Research Program (BC087504; to C. D. W.).	BARGMANN CI, 1988, P NATL ACAD SCI USA, V85, P5394, DOI 10.1073/pnas.85.15.5394; Baselga J, 2001, SEMIN ONCOL, V28, P4, DOI 10.1053/sonc.2001.28544; Baselga J, 1996, J CLIN ONCOL, V14, P737, DOI 10.1200/JCO.1996.14.3.737; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bertucci F, 2004, ONCOGENE, V23, P1377, DOI 10.1038/sj.onc.1207262; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Citri A, 2004, CELL CYCLE, V3, P51; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Com E, 2007, MOL CELL PROTEOMICS, V6, P1842, DOI 10.1074/mcp.M700119-MCP200; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; Dokmanovic M, 2009, MOL CANCER THER, V8, P1557, DOI 10.1158/1535-7163.MCT-09-0140; French PJ, 2005, CANCER RES, V65, P11335, DOI 10.1158/0008-5472.CAN-05-1886; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lane HA, 2000, MOL CELL BIOL, V20, P3210, DOI 10.1128/MCB.20.9.3210-3223.2000; Le XF, 2005, CELL CYCLE, V4, P87, DOI 10.4161/cc.4.1.1360; Le XF, 2003, J BIOL CHEM, V278, P23441, DOI 10.1074/jbc.M300848200; Li HB, 2004, BIOCHEM J, V381, P257, DOI 10.1042/BJ20040515; Li L, 2005, J BIOL CHEM, V280, P13097, DOI 10.1074/jbc.M410642200; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Lloyd RV, 1999, AM J PATHOL, V154, P313, DOI 10.1016/S0002-9440(10)65277-7; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Mataraza JM, 2003, BIOCHEM BIOPH RES CO, V305, P315, DOI 10.1016/S0006-291X(03)00759-9; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Meyer RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003848; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Nahta R, 2004, CANCER CHEMOTH PHARM, V53, P186, DOI 10.1007/s00280-003-0728-3; Nahta R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1612; Neve RM, 2000, ONCOGENE, V19, P1647, DOI 10.1038/sj.onc.1203470; Patel V, 2008, CLIN CANCER RES, V14, P1002, DOI 10.1158/1078-0432.CCR-07-1497; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sacks DB, 2006, BIOCHEM SOC T, V34, P833, DOI 10.1042/BST0340833; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Schaefer G, 1999, J BIOL CHEM, V274, P859, DOI 10.1074/jbc.274.2.859; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sliwkowski MX, 1999, SEMIN ONCOL, V26, P60; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Subramaniam Deepa S, 2005, Curr Treat Options Oncol, V6, P147, DOI 10.1007/s11864-005-0022-1; Sun WY, 2004, CANCER LETT, V212, P83, DOI 10.1016/j.canlet.2004.03.023; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Walch A, 2008, MODERN PATHOL, V21, P544, DOI 10.1038/modpathol.2008.3; Warren CM, 2006, CELL SIGNAL, V18, P923, DOI 10.1016/j.cellsig.2005.12.007; White CD, 2008, MOL ENDOCRINOL, V22, P2520, DOI 10.1210/me.2008-0122; White CD, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-125; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Wu KM, 2002, MOL CANCER THER, V1, P695; Yang HY, 2000, J BIOL CHEM, V275, P24735, DOI 10.1074/jbc.C000147200; Yang HY, 2001, ONCOGENE, V20, P3695, DOI 10.1038/sj.onc.1204472; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhou RX, 2000, DIFFERENTIATION, V66, P165, DOI 10.1046/j.1432-0436.2000.660402.x	70	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29734	29747		10.1074/jbc.M111.220939	http://dx.doi.org/10.1074/jbc.M111.220939			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21724847	Green Published, hybrid			2022-12-25	WOS:000294046600033
J	Yan, KL; Cao, Q; Reilly, CM; Young, NL; Garcia, BA; Mishra, N				Yan, Kailin; Cao, Qiang; Reilly, Christopher M.; Young, Nicolas L.; Garcia, Benjamin A.; Mishra, Nilamadhab			Histone Deacetylase 9 Deficiency Protects against Effector T Cell-mediated Systemic Autoimmunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; MRL-LPR/LPR MOUSE; MRL/LPR MICE; INDUCIBLE COSTIMULATOR; INTERFERON-GAMMA; RENAL-DISEASE; MURINE LUPUS; EXPRESSION; INHIBITION; RESPONSES	Co-repressor histone deacetylase 9 (HDAC9) plays a key role in the development and differentiation of many types of cells, including regulatory T cells. However, the biological function of HDAC9 in T effector cells is unknown. Systemic autoimmune diseases like lupus, diabetes, and rheumatoid arthritis have dysfunctional effector T cells. To determine the role of HDAC9 in systemic autoimmunity, we created MRL/lpr mice with HDAC9 deficiency that have aberrant effector T cell function. HDAC9 deficiency led to decreased lympho-proliferation, inflammation, autoantibody production, and increased survival in MRL/lpr mice. HDAC9-deficient mice manifested Th2 polarization, decreased T effector follicular cells positive for inducible co-stimulator, and activated T cells in vivo compared with HDAC9-intact MRL/lpr mice. HDAC9 deficiency also resulted in increased GATA3 and roquin and decreased BCL6 gene expression. HDAC9 deficiency was associated with increased site-specific lysine histone acetylation at H3 (H3K9, H3K14, and H3K18) globally that was localized to IL-4, roquin, and peroxisome proliferator-activated receptor-gamma promoters with increased gene expression, respectively. In kidney and spleen, HDAC9 deficiency decreased inflammation and cytokine and chemokine production due to peroxisome proliferator-activated receptor gamma overexpression. These findings suggest that HDAC9 acts as an epigenetic switch in effector T cell-mediated systemic autoimmunity.	[Yan, Kailin; Cao, Qiang; Mishra, Nilamadhab] Wake Forest Univ, Bowman Gray Sch Med, Sect Rheumatol & Immunol, Dept Internal Med, Winston Salem, NC 27157 USA; [Reilly, Christopher M.] Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA 24060 USA; [Reilly, Christopher M.] Edward Via Coll Osteopath Med, Blacksburg, VA 24060 USA; [Young, Nicolas L.; Garcia, Benjamin A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Wake Forest University; Wake Forest Baptist Medical Center; Virginia Polytechnic Institute & State University; Princeton University	Mishra, N (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Sect Rheumatol & Immunol, Dept Internal Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	nmishra@wfubmc.edu	Young, Nicolas/AAI-5242-2020	Young, Nicolas/0000-0002-3323-2815; Reilly, Chris/0000-0003-4787-7750	National Institutes of Health [RO1-HL 084592, RO1-HL084592 S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL 084592 and RO1-HL084592 S1 (to N. M.).	Akimova T, 2010, CLIN IMMUNOL, V136, P348, DOI 10.1016/j.clim.2010.04.018; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Crosby MB, 2006, CLIN IMMUNOL, V118, P276, DOI 10.1016/j.clim.2005.09.018; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Fairhurst AM, 2009, J IMMUNOL, V183, P6831, DOI 10.4049/jimmunol.0900742; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Garcia BA, 2005, J PROTEOME RES, V4, P2032, DOI 10.1021/pr050188r; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hill GS, 2000, KIDNEY INT, V58, P1160, DOI 10.1046/j.1523-1755.2000.00272.x; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Lu XD, 2008, J BIOL CHEM, V283, P13825, DOI 10.1074/jbc.M801275200; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mishra N, 2003, J CLIN INVEST, V111, P539, DOI 10.1172/JC1200316153; Mishra N, 2001, P NATL ACAD SCI USA, V98, P2628, DOI 10.1073/pnas.051507098; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Odegard JM, 2009, J IMMUNOL, V182, P4076, DOI 10.4049/jimmunol.0800758; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Parietti V, 2008, ARTHRITIS RHEUM-US, V58, P1751, DOI 10.1002/art.23464; Parra M, 2010, CURR OPIN PHARMACOL, V10, P454, DOI 10.1016/j.coph.2010.04.004; Peng SL, 1997, J CLIN INVEST, V99, P1936, DOI 10.1172/JCI119361; Plazas-Mayorca MD, 2009, J PROTEOME RES, V8, P5367, DOI 10.1021/pr900777e; Reddy P, 2004, P NATL ACAD SCI USA, V101, P3921, DOI 10.1073/pnas.0400380101; Reilly CM, 2008, J AUTOIMMUN, V31, P123, DOI 10.1016/j.jaut.2008.04.020; Reilly CM, 2004, J IMMUNOL, V173, P4171, DOI 10.4049/jimmunol.173.6.4171; Reilly CM, 2001, CLIN IMMUNOL, V98, P337, DOI 10.1006/clim.2000.4985; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Tada Y, 2006, CLIN IMMUNOL, V120, P179, DOI 10.1016/j.clim.2006.02.009; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Villagra A, 2010, ONCOGENE, V29, P157, DOI 10.1038/onc.2009.334; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; von Boehmer H, 2010, NAT IMMUNOL, V11, P14, DOI 10.1038/ni.1794; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Wang AH, 2005, J BIOL CHEM, V280, P29117, DOI 10.1074/jbc.M500295200; Wang LQ, 2009, NAT REV DRUG DISCOV, V8, P969, DOI 10.1038/nrd3031; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Xiao Y, 2010, CURR OPIN IMMUNOL, V22, P583, DOI 10.1016/j.coi.2010.08.013; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Yuan ZG, 2010, J BIOL CHEM, V285, P39329, DOI 10.1074/jbc.M110.179333; Zeller GC, 2006, J AM SOC NEPHROL, V17, P122, DOI 10.1681/ASN.2005080802; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	50	69	70	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28833	28843		10.1074/jbc.M111.233932	http://dx.doi.org/10.1074/jbc.M111.233932			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21708950	hybrid, Green Published			2022-12-25	WOS:000293837000021
J	Bella, SD; Palmer, C				Bella, Simone Dalla; Palmer, Caroline			Rate Effects on Timing, Key Velocity, and Finger Kinematics in Piano Performance	PLOS ONE			English	Article							PERSON IDENTIFICATION; STRING VIBRATIONS; FORCE PRODUCTION; MOTION; ACCURACY; TOUCH; HAND; FEEDBACK; GAIT	We examined the effect of rate on finger kinematics in goal-directed actions of pianists. In addition, we evaluated whether movement kinematics can be treated as an indicator of personal identity. Pianists' finger movements were recorded with a motion capture system while they performed melodies from memory at different rates. Pianists' peak finger heights above the keys preceding keystrokes increased as tempo increased, and were attained about one tone before keypress. These rate effects were not simply due to a strategy to increase key velocity (associated with tone intensity) of the corresponding keystroke. Greater finger heights may compensate via greater tactile feedback for a speed-accuracy tradeoff that underlies the tendency toward larger temporal variability at faster tempi. This would allow pianists to maintain high temporal accuracy when playing at fast rates. In addition, finger velocity and accelerations as pianists' fingers approached keys were sufficiently unique to allow pianists' identification with a neural-network classifier. Classification success was higher in pianists with more extensive musical training. Pianists' movement "signatures'' may reflect unique goal-directed movement kinematic patterns, leading to individualistic sound.	[Bella, Simone Dalla] Univ Finance & Management, Dept Cognit Psychol, Warsaw, Poland; [Palmer, Caroline] McGill Univ, Dept Psychol, Montreal, PQ, Canada	University of Finance & Management Warsaw; McGill University	Bella, SD (corresponding author), Univ Finance & Management, Dept Cognit Psychol, Warsaw, Poland.	sdallabella@vizja.pl		Palmer, Caroline/0000-0003-4816-8067	European Commission [14847]; Canada Research Chair; NSERC [298173]	European Commission(European CommissionEuropean Commission Joint Research Centre); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by an International Reintegration Grant 14847 from the European Commission to the first author and by a Canada Research Chair and NSERC Grant 298173 to the second author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASKENFELT A, 1991, J ACOUST SOC AM, V90, P2383, DOI 10.1121/1.402043; ASKENFELT A, 1990, J ACOUST SOC AM, V88, P52, DOI 10.1121/1.399933; Balasubramaniam R, 2004, EXP BRAIN RES, V159, P129, DOI 10.1007/s00221-004-2066-z; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; CUTTING JE, 1977, B PSYCHONOMIC SOC, V9, P353, DOI 10.3758/BF03337021; DEMUTH H, 2005, NEURONAL NETWORK TOO; Drake C, 2000, COGNITION, V74, P1, DOI 10.1016/S0010-0277(99)00061-X; Dryden I., 1998, STAT ANAL SHAPE; Engel KC, 1997, EXP BRAIN RES, V113, P189, DOI 10.1007/BF02450317; Gabrielsson A., 1996, PSYCHOL MUSIC, V24, P68, DOI DOI 10.1177/0305735696241007; Gabrielsson A., 1999, PSYCHOL MUSIC, P501, DOI [10.1016/B978-012213564-4/50015-9, DOI 10.1016/B978-012213564-4/50015-9]; Goebl W, 2005, J ACOUST SOC AM, V118, P1154, DOI 10.1121/1.1944648; Goebl W, 2008, EXP BRAIN RES, V186, P471, DOI 10.1007/s00221-007-1252-1; Goebl W, 2009, MUSIC PERCEPT, V26, P427, DOI 10.1525/MP.2009.26.5.427; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hardcastle W. J., 1999, COARTICULATION THEOR; Jackson PL, 2004, CURR OPIN NEUROBIOL, V14, P259, DOI 10.1016/j.conb.2004.01.020; Latash ML, 1998, EXP BRAIN RES, V122, P131, DOI 10.1007/s002210050500; Li ZN, 1998, EXP BRAIN RES, V122, P71, DOI 10.1007/s002210050492; Loehr JD, 2007, EXP BRAIN RES, V178, P518, DOI 10.1007/s00221-006-0760-8; Loehr JD, 2009, J MOTOR BEHAV, V41, P128, DOI 10.3200/JMBR.41.2.128-136; MACKENZIE CL, 1990, ATTENTION PERFORM, V8, P375; PALMER C, 1993, J EXP PSYCHOL LEARN, V19, P457, DOI 10.1037/0278-7393.19.2.457; Palmer C, 1996, MUSIC PERCEPT, V13, P433; Palmer C, 2003, PSYCHOL REV, V110, P683, DOI 10.1037/0033-295X.110.4.683; Palmer C., 2007, P INT C MUS COMM SCI, P119; Palmer C., 2006, MUSIC MOTOR CONTROL, P39, DOI [10.1093/acprof:oso/9780199298723.003.0003, DOI 10.1093/ACPROF:OSO/9780199298723.003.0003]; Palmer C, 2009, MUSIC PERCEPT, V26, P439, DOI 10.1525/MP.2009.26.5.439; Pfordresher PQ, 2007, COGNITIVE SCI, V31, P63, DOI 10.1080/03640210709336985; Ramsay JO, 2000, J AM STAT ASSOC, V95, P9; RAMSEY J. O., 2005, FUNCTIONAL DATA ANAL; RAMSEY JO, 2002, APPL FUNCTIONAL DATA; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rosenbaum DA, 2006, MOTOR CONTROL AND LEARNING, P9, DOI 10.1007/0-387-28287-4_2; Rosenbaum David A., 1996, P169, DOI 10.1016/B978-012759440-8/50013-X; RUSSIANOFF L, 1982, CLARINET METHOD BOOK, V2; Santello M, 2002, J NEUROSCI, V22, P1426, DOI 10.1523/JNEUROSCI.22-04-01426.2002; Santello M, 1998, J NEUROPHYSIOL, V79, P1307, DOI 10.1152/jn.1998.79.3.1307; Schmidt RA, 2005, MOTOR CONTROL LEARNI; Slobounov S, 2002, BRAIN RES, V954, P212, DOI 10.1016/S0006-8993(02)03288-2; Stevenage SV, 1999, APPL COGNITIVE PSYCH, V13, P513, DOI 10.1002/(SICI)1099-0720(199912)13:6<513::AID-ACP616>3.0.CO;2-8; TAYLOR K, 1983, PRINCIPLES PIANO TEC; Teal L., 1963, ART SAXOPHONE PLAYIN; Troje NF, 2005, PERCEPT PSYCHOPHYS, V67, P667, DOI 10.3758/BF03193523; Tsakiris M, 2005, COGN NEUROPSYCHOL, V22, P387, DOI 10.1080/02643290442000158; Westhoff C, 2007, PERCEPT PSYCHOPHYS, V69, P241, DOI 10.3758/BF03193746	46	28	28	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e20518	10.1371/journal.pone.0020518	http://dx.doi.org/10.1371/journal.pone.0020518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782TT	21731615	Green Published, gold, Green Submitted			2022-12-25	WOS:000292035400003
J	Yan, JQ; Xu, YQ; Zhu, CS; Zhang, LM; Wu, AM; Yang, Y; Xiong, ZJ; Deng, C; Huang, XF; Yenari, MA; Yang, YG; Ying, WH; Wang, Q				Yan, Junqiang; Xu, Yunqi; Zhu, Cansheng; Zhang, Limin; Wu, Aimin; Yang, Yu; Xiong, Zhaojun; Deng, Chao; Huang, Xu-Feng; Yenari, Midori A.; Yang, Yuan-Guo; Ying, Weihai; Wang, Qing			Simvastatin Prevents Dopaminergic Neurodegeneration in Experimental Parkinsonian Models: The Association with Anti-Inflammatory Responses	PLOS ONE			English	Article							NMDA RECEPTOR ANTAGONISTS; D-ASPARTATE RECEPTORS; ALZHEIMERS-DISEASE; GLUTAMATE RECEPTORS; PREFRONTAL CORTEX; CORTICAL-NEURONS; RAT-BRAIN; SYNAPTIC PLASTICITY; MESSENGER-RNA; BASAL GANGLIA	Background: In addition to their original applications to lowering cholesterol, statins display multiple neuroprotective effects. N-methyl-D-aspartate (NMDA) receptors interact closely with the dopaminergic system and are strongly implicated in therapeutic paradigms of Parkinson's disease (PD). This study aims to investigate how simvastatin impacts on experimental parkinsonian models via regulating NMDA receptors. Methodology/Principal Findings: Regional changes in NMDA receptors in the rat brain and anxiolytic-like activity were examined after unilateral medial forebrain bundle lesion by 6-hydroxydopamine via a 3-week administration of simvastatin. NMDA receptor alterations in the post-mortem rat brain were detected by [H-3]MK-801(Dizocilpine) binding autoradiography. 6-hydroxydopamine treated PC12 was applied to investigate the neuroprotection of simvastatin, the association with NMDA receptors, and the anti-inflammation. 6-hydroxydopamine induced anxiety and the downregulation of NMDA receptors in the hippocampus, CA1(Cornu Ammonis 1 Area), amygdala and caudate putamen was observed in 6-OHDA(6-hydroxydopamine) lesioned rats whereas simvastatin significantly ameliorated the anxiety-like activity and restored the expression of NMDA receptors in examined brain regions. Significant positive correlations were identified between anxiolytic-like activity and the restoration of expression of NMDA receptors in the hippocampus, amygdala and CA1 following simvastatin administration. Simvastatin exerted neuroprotection in 6-hydroxydopamine-lesioned rat brain and 6-hydroxydopamine treated PC12, partially by regulating NMDA receptors, MMP9 (matrix metalloproteinase-9), and TNF-a (tumour necrosis factor-alpha). Conclusions/Significance: Our results provide strong evidence that NMDA receptor modulation after simvastatin treatment could partially explain its anxiolytic-like activity and anti-inflammatory mechanisms in experimental parkinsonian models. These findings contribute to a better understanding of the critical roles of simvastatin in treating PD via NMDA receptors.	[Yan, Junqiang; Xu, Yunqi; Zhu, Cansheng; Zhang, Limin; Wu, Aimin; Yang, Yu; Wang, Qing] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Chao; Huang, Xu-Feng; Wang, Qing] Univ Wollongong, Sch Hlth Sci, Ctr Translat Neurosci, Wollongong, NSW 2522, Australia; [Xiong, Zhaojun] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China; [Yenari, Midori A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Yenari, Midori A.] San Francisco VA Med Ctr, San Francisco, CA USA; [Yang, Yuan-Guo; Ying, Weihai] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China	Sun Yat Sen University; University of Wollongong; Sun Yat Sen University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Shanghai Jiao Tong University	Yan, JQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	denniswq@yahoo.com	Huang, Xu-Feng/D-6053-2013; Deng, Chao/F-4417-2016; Huang, Xu-Feng/H-7408-2015	Huang, Xu-Feng/0000-0002-5895-2253; Deng, Chao/0000-0003-1147-5741; Huang, Xu-Feng/0000-0002-5895-2253; Wang, Qing/0000-0002-3882-6540	Third Affiliated Hospital of Sun Yat-Sen University; Fundamental Research Funds for the Central Universities [A77, 10ykzd08]; Program for New Century Excellent Talents in University (NCET2010, P.R. China); National Natural Science Foundation of China [81071031]; Australia National Health and Medical Research Council [NHMRC 514640]	Third Affiliated Hospital of Sun Yat-Sen University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University (NCET2010, P.R. China)(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Australia National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Grant-In-Aid from the Third Affiliated Hospital of Sun Yat-Sen University, Fundamental Research Funds for the Central Universities (Grant No. A77 and 10ykzd08), Program for New Century Excellent Talents in University (NCET2010, P.R. China), National Natural Science Foundation of China (81071031), and Australia National Health and Medical Research Council Grant (NHMRC 514640) to Q.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Araki T, 2000, EUR NEUROPSYCHOPHARM, V10, P365, DOI 10.1016/S0924-977X(00)00094-8; Armentero MT, 2006, NEUROBIOL DIS, V22, P1, DOI 10.1016/j.nbd.2005.09.010; Becker C, 2008, DRUG SAFETY, V31, P399, DOI 10.2165/00002018-200831050-00004; Betarbet R, 2004, EXP NEUROL, V187, P76, DOI 10.1016/j.expneurol.2003.12.012; Bi H, 2002, J NEUROL SCI, V200, P11, DOI 10.1016/S0022-510X(02)00087-4; Bibbiani F, 2005, EXP NEUROL, V196, P422, DOI 10.1016/j.expneurol.2005.08.017; Blundell J, 2007, BRAIN RES, V1136, P59, DOI 10.1016/j.brainres.2006.09.078; Byrnes EM, 2006, PSYCHONEUROENDOCRINO, V31, P988, DOI 10.1016/j.psyneuen.2006.05.008; Carlsson CM, 2008, J ALZHEIMERS DIS, V13, P187; Cramer C, 2008, NEUROLOGY, V71, P344, DOI 10.1212/01.wnl.0000319647.15752.7b; de Bartolomeis A, 2005, CURR PHARM DESIGN, V11, P3561, DOI 10.2174/138161205774414538; Dunah AW, 2000, MOL PHARMACOL, V57, P342; Espejo EF, 1997, BRAIN RES, V762, P281, DOI 10.1016/S0006-8993(97)00593-3; Fiorentini C, 2006, MOL PHARMACOL, V69, P805, DOI 10.1124/mol.105.016667; Fox SH, 2008, LANCET NEUROL, V7, P927, DOI 10.1016/S1474-4422(08)70214-X; Galic MA, 2009, NEUROBIOL DIS, V36, P343, DOI 10.1016/j.nbd.2009.07.025; Ghosh A, 2009, J NEUROSCI, V29, P13543, DOI 10.1523/JNEUROSCI.4144-09.2009; GREENAMYRE JT, 1991, ARCH NEUROL-CHICAGO, V48, P977, DOI 10.1001/archneur.1991.00530210109030; Hallett PJ, 2006, J NEUROSCI, V26, P4690, DOI 10.1523/JNEUROSCI.0792-06.2006; Hallett PJ, 2004, PHARMACOL THERAPEUT, V102, P155, DOI 10.1016/j.pharmthera.2004.04.001; Harre EM, 2008, EUR J NEUROSCI, V27, P644, DOI 10.1111/j.1460-9568.2008.06031.x; Hemandez-Romero MD, 2008, J NEUROCHEM, V105, P445, DOI 10.1111/j.1471-4159.2007.05148.x; Hirsch EC, 1998, ANN NEUROL, V44, pS115, DOI 10.1002/ana.410440717; Hu NW, 2009, P NATL ACAD SCI USA, V106, P20504, DOI 10.1073/pnas.0908083106; Iida J, 2007, MOL CELL BIOL, V27, P4388, DOI 10.1128/MCB.01901-06; Janssen WGM, 2005, EXP NEUROL, V191, pS28, DOI 10.1016/j.expneurol.2004.08.020; Johnson PL, 2006, J NEUROSCI, V26, P7093, DOI 10.1523/JNEUROSCI.0408-06.2006; Leentjens AFG, 2008, MOVEMENT DISORD, V23, P2015, DOI 10.1002/mds.22233; Michaluk P, 2009, J NEUROSCI, V29, P6007, DOI 10.1523/JNEUROSCI.5346-08.2009; Mishizen-Eberz AJ, 2004, NEUROBIOL DIS, V15, P80, DOI 10.1016/j.nbd.2003.09.016; Mogi M, 2007, NEUROSCI LETT, V414, P94, DOI 10.1016/j.neulet.2006.12.003; Niemann S, 2007, EUR J NEUROSCI, V26, P1407, DOI 10.1111/j.1460-9568.2007.05774.x; Nilsson A, 2007, BRAIN RES, V1186, P102, DOI 10.1016/j.brainres.2007.09.008; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pickel VM, 2006, NEUROSCIENCE, V142, P671, DOI 10.1016/j.neuroscience.2006.06.059; Rodriguez-Blanco J, 2008, J NEUROCHEM, V107, P127, DOI 10.1111/j.1471-4159.2008.05588.x; Sasaki J, 2010, NATURE, V465, P497, DOI 10.1038/nature09023; Selley ML, 2005, BRAIN RES, V1037, P1, DOI 10.1016/j.brainres.2004.02.083; Starr JM, 2004, INT J GERIATR PSYCH, V19, P327, DOI 10.1002/gps.1093; STARR MS, 1995, SYNAPSE, V19, P264, DOI 10.1002/syn.890190405; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; Tadaiesky MT, 2008, NEUROSCIENCE, V156, P830, DOI 10.1016/j.neuroscience.2008.08.035; Tian L, 2007, J CELL BIOL, V178, P687, DOI 10.1083/jcb.200612097; Tsang SWY, 2008, NEUROBIOL AGING, V29, P1524, DOI 10.1016/j.neurobiolaging.2007.03.014; Wang C, 2006, TOXICOL SCI, V91, P192, DOI 10.1093/toxsci/kfj144; Wang C, 2004, NEUROSCIENCE, V125, P473, DOI 10.1016/j.neuroscience.2004.02.003; Wang Q, 2005, BRAIN RES, V1045, P229, DOI 10.1016/j.brainres.2005.03.016; Wang Q, 2005, BRIT J PHARMACOL, V144, P933, DOI 10.1038/sj.bjp.0706106; WANG Q, 2010, EXP NEUROL IN PRESS; Wang Q, 2009, EXP NEUROL, V216, P132, DOI 10.1016/j.expneurol.2008.11.016; Wheeler D, 2009, J NEUROCHEM, V109, P1237, DOI 10.1111/j.1471-4159.2009.06038.x; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Yang CR, 2005, NEUROSCIENTIST, V11, P452, DOI 10.1177/1073858405279692; Yeh SH, 2008, J NEUROSCI, V28, P14259, DOI 10.1523/JNEUROSCI.4258-08.2008; Young-Xu Y, 2003, J AM COLL CARDIOL, V42, P690, DOI 10.1016/S0735-1097(03)00785-X; Yu SP, 1997, J PHYSIOL-LONDON, V499, P721, DOI 10.1113/jphysiol.1997.sp021964; Yu SP, 1999, SCIENCE, V284, P336, DOI 10.1126/science.284.5412.336; Yuan H, 2005, J NEUROSCI METH, V144, P35, DOI 10.1016/j.jneumeth.2004.10.004	59	77	80	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20945	10.1371/journal.pone.0020945	http://dx.doi.org/10.1371/journal.pone.0020945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731633	Green Submitted, Green Published, gold			2022-12-25	WOS:000292033700020
J	Poon, AFY; Aldous, JL; Mathews, WC; Kitahata, M; Kahn, JS; Saag, MS; Rodriguez, B; Boswell, SL; Frost, SDW; Haubrich, RH				Poon, Art F. Y.; Aldous, Jeannette L.; Mathews, W. Christopher; Kitahata, Mari; Kahn, James S.; Saag, Michael S.; Rodriguez, Benigno; Boswell, Stephen L.; Frost, Simon D. W.; Haubrich, Richard H.			Transmitted Drug Resistance in the CFAR Network of Integrated Clinical Systems Cohort: Prevalence and Effects on Pre-Therapy CD4 and Viral Load	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; REVERSE-TRANSCRIPTASE; ANTIRETROVIRAL TREATMENT; GENOTYPIC-RESISTANCE; REPLICATIVE FITNESS; M184V MUTATION; HIV-1 VARIANTS; VIRUS; INDIVIDUALS; POPULATIONS	Human immunodeficiency virus type 1 (HIV-1) genomes often carry one or more mutations associated with drug resistance upon transmission into a therapy-naive individual. We assessed the prevalence and clinical significance of transmitted drug resistance (TDR) in chronically-infected therapy-naive patients enrolled in a multi-center cohort in North America. Pre-therapy clinical significance was quantified by plasma viral load (pVL) and CD4+ cell count (CD4) at baseline. Naive bulk sequences of HIV-1 protease and reverse transcriptase (RT) were screened for resistance mutations as defined by the World Health Organization surveillance list. The overall prevalence of TDR was 14.2%. We used a Bayesian network to identify co-transmission of TDR mutations in clusters associated with specific drugs or drug classes. Aggregate effects of mutations by drug class were estimated by fitting linear models of pVL and CD4 on weighted sums over TDR mutations according to the Stanford HIV Database algorithm. Transmitted resistance to both classes of reverse transcriptase inhibitors was significantly associated with lower CD4, but had opposing effects on pVL. In contrast, position-specific analyses of TDR mutations revealed substantial effects on CD4 and pVL at several residue positions that were being masked in the aggregate analyses, and significant interaction effects as well. Residue positions in RT with predominant effects on CD4 or pVL (D67 and M184) were re-evaluated in causal models using an inverse probability-weighting scheme to address the problem of confounding by other mutations and demographic or risk factors. We found that causal effect estimates of mutations M184V/I (-1.7 log(10) pVL) and D67N/G (-2.1 3 root CD4 and +0.4 log(10) pVL) were compensated by K103N/S and K219Q/E/N/R. As TDR becomes an increasing dilemma in this modern era of highly-active antiretroviral therapy, these results have immediate significance for the clinical management of HIV-1 infections and our understanding of the ongoing adaptation of HIV-1 to human populations.	[Poon, Art F. Y.] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Aldous, Jeannette L.; Mathews, W. Christopher; Haubrich, Richard H.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Kitahata, Mari] Univ Washington, Seattle, WA 98195 USA; [Kahn, James S.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Saag, Michael S.] Univ Alabama, Birmingham, CA USA; [Rodriguez, Benigno] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Boswell, Stephen L.] Harvard Univ, Sch Med, Boston, MA USA; [Frost, Simon D. W.] Univ Cambridge, Cambridge, England	B.C. Centre for Excellence in HIV/AIDS; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; Case Western Reserve University; Harvard University; Harvard Medical School; University of Cambridge	Poon, AFY (corresponding author), BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	rhaubrich@ucsd.edu	Rodriguez, Benigno/C-3365-2009; Frost, Simon/F-3648-2010; Mathews, William C/E-4451-2010; Poon, Art/W-9811-2019	Rodriguez, Benigno/0000-0001-9736-7957; Frost, Simon/0000-0002-5207-9879; Mathews, William C/0000-0002-2352-0725; Poon, Art/0000-0003-3779-154X	National Institutes of Health (NIH) [R21 AI080397, AI064086 (K24), CNICS R24 AI067039, AI43638, AI47745, AI57167]; UCSD Center for AIDS Research (CFAR) [AI36214, AI027767]; San Diego ACTG CTU [AI69432]; NIH/National Center for Research Resources (NCRR) [RR024369]; NIH/National Institute of Allergy and Infectious Diseases (NIAID) [AI027763]; NIH Broad Agency [BAA-RM-04-23]; Royal Society Wolfson Research; Canadian Institutes of Health Research (CIHR) [200802HFE]; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR024369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214, R21AI047745, R01AI047745, U01AI043638, R21AI080397, R56AI047745, K24AI064086, R24AI067039, UM1AI069432, R01AI057167, P30AI027767, P30AI027763, U01AI069432] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD Center for AIDS Research (CFAR); San Diego ACTG CTU; NIH/National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Broad Agency; Royal Society Wolfson Research(Royal Society of London); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) Exploratory/Development Grant R21 AI080397 to RH; AI064086 (K24 to RH); CNICS R24 AI067039; UCSD Center for AIDS Research (CFAR) AI36214 and the San Diego ACTG CTU AI69432. Additionally, MSS was supported by CFAR grant (AI027767). JSK was supported by grants K24 NIH/National Center for Research Resources (NCRR) grant RR024369, NIH/National Institute of Allergy and Infectious Diseases (NIAID) grant AI027763, and NIH Broad Agency Announcement grant BAA-RM-04-23. SDWF was supported by NIH grants AI43638, AI47745, and AI57167, and also in part by a Royal Society Wolfson Research Merit Award. AFYP was supported by a Canadian Institutes of Health Research (CIHR) Fellowships Award (200802HFE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balotta C, 2000, ANTIVIR THER, V5, P7; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bezemer D, 2006, ANTIVIR THER, V11, P173; Booth CL, 2007, J ANTIMICROB CHEMOTH, V59, P1047, DOI 10.1093/jac/dkm082; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Castagna A, 2006, AIDS, V20, P795, DOI 10.1097/01.aids.0000218542.08845.b2; Collins JA, 2004, J VIROL, V78, P603, DOI 10.1128/JVI.78.2.603-611.2004; CONG M, 2007, J VIROL, V81; Devereux HL, 2001, J MED VIROL, V65, P218, DOI 10.1002/jmv.2023; Frost SDW, 2000, J VIROL, V74, P6262, DOI 10.1128/JVI.74.14.6262-6268.2000; Garcia-Lerma JG, 2004, J VIROL, V78, P7545, DOI 10.1128/JVI.78.14.7545-7552.2004; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Gotte M, 2000, J VIROL, V74, P3579, DOI 10.1128/JVI.74.8.3579-3585.2000; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Harrison L, 2010, AIDS, V24, P1917, DOI 10.1097/QAD.0b013e32833c1d93; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hogg RS, 2006, PLOS MED, V3, P1570, DOI 10.1371/journal.pmed.0030356; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kitahata MM, 2008, INT J EPIDEMIOL, V37, P948, DOI 10.1093/ije/dym231; Lecossier D, 2005, JAIDS-J ACQ IMM DEF, V38, P37, DOI 10.1097/00126334-200501010-00007; Little SJ, 2008, J VIROL, V82, P5510, DOI 10.1128/JVI.02579-07; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Mammano F, 2000, J VIROL, V74, P8524, DOI 10.1128/JVI.74.18.8524-8531.2000; Pao D, 2004, JAIDS-J ACQ IMM DEF, V37, P1570, DOI 10.1097/00126334-200412150-00006; Paredes R, 2009, J VIROL, V83, P2038, DOI 10.1128/JVI.02154-08; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Pillay D, 2006, AIDS, V20, P21, DOI 10.1097/01.aids.0000196172.35056.b7; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Poon AFY, 2007, J VIROL, V81, P13598, DOI 10.1128/JVI.01570-07; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Shet A, 2006, JAIDS-J ACQ IMM DEF, V41, P439, DOI 10.1097/01.qai.0000219290.49152.6a; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Taylor JMG, 2000, J ACQ IMMUN DEF SYND, V23, P160; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; VENABLES WN, MODERN APPL STAT S S; von Wyl V, 2010, J INFECT DIS, V201, P1054, DOI 10.1086/651168; Wainberg MA, 1996, SCIENCE, V271, P1282, DOI 10.1126/science.271.5253.1282; Wei X, 2003, VIROLOGY, V311, P202, DOI 10.1016/S0042-6822(03)00173-9; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Wilkin TJ, 2008, CLIN INFECT DIS, V47, P1580, DOI 10.1086/593311; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685	45	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21189	10.1371/journal.pone.0021189	http://dx.doi.org/10.1371/journal.pone.0021189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701595	Green Published, Green Submitted, gold			2022-12-25	WOS:000291983800029
J	Wu, H; Zeng, H; Lam, R; Tempel, W; Amaya, MF; Xu, C; Dombrovski, L; Qiu, W; Wang, YM; Min, JR				Wu, Hong; Zeng, Hong; Lam, Robert; Tempel, Wolfram; Amaya, Maria F.; Xu, Chao; Dombrovski, Ludmila; Qiu, Wei; Wang, Yanming; Min, Jinrong			Structural and Histone Binding Ability Characterizations of Human PWWP Domains	PLOS ONE			English	Article							STATE-SPECIFIC RECOGNITION; MOLECULAR-BASIS; DNA METHYLTRANSFERASES; CHROMO DOMAIN; TUDOR DOMAIN; ICF SYNDROME; H3 TAIL; METHYLATION; PROTEINS; DNMT3A	Background: The PWWP domain was first identified as a structural motif of 100-130 amino acids in the WHSC1 protein and predicted to be a protein-protein interaction domain. It belongs to the Tudor domain 'Royal Family', which consists of Tudor, chromodomain, MBT and PWWP domains. While Tudor, chromodomain and MBT domains have long been known to bind methylated histones, PWWP was shown to exhibit histone binding ability only until recently. Methodology/Principal Findings: The PWWP domain has been shown to be a DNA binding domain, but sequence analysis and previous structural studies show that the PWWP domain exhibits significant similarity to other 'Royal Family' members, implying that the PWWP domain has the potential to bind histones. In order to further explore the function of the PWWP domain, we used the protein family approach to determine the crystal structures of the PWWP domains from seven different human proteins. Our fluorescence polarization binding studies show that PWWP domains have weak histone binding ability, which is also confirmed by our NMR titration experiments. Furthermore, we determined the crystal structures of the BRPF1 PWWP domain in complex with H3K36me3, and HDGF2 PWWP domain in complex with H3K79me3 and H4K20me3. Conclusions: PWWP proteins constitute a new family of methyl lysine histone binders. The PWWP domain consists of three motifs: a canonical beta-barrel core, an insertion motif between the second and third beta-strands and a C-terminal alpha-helix bundle. Both the canonical beta-barrel core and the insertion motif are directly involved in histone binding. The PWWP domain has been previously shown to be a DNA binding domain. Therefore, the PWWP domain exhibits dual functions: binding both DNA and methyllysine histones.	[Wu, Hong; Zeng, Hong; Lam, Robert; Tempel, Wolfram; Amaya, Maria F.; Xu, Chao; Dombrovski, Ludmila; Qiu, Wei; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Wang, Yanming] Penn State Univ, Dept Biochem & Mol Biol, Ctr Gene Regulat, University Pk, PA 16802 USA; [Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; Structural Genomics Consortium; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Toronto	Wu, H (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	jr.min@utoronto.ca	Min, Jinrong/G-3449-2011; Xu, Chao/G-3885-2010	Min, Jinrong/0000-0001-5210-3130; Xu, Chao/0000-0003-0444-7080; Wang, Yanming/0000-0002-0710-043X	Structural Genomics Consortium, a registered charity [1097737]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institute; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; National Center for Research Resources [RR-15301]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; National Science Foundation [DMR-0936384]; National Institutes of Health; United States Department of Energy's Office of Science; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	Structural Genomics Consortium, a registered charity(University of Toronto); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institute(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy's Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institute, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. Results shown in this report are derived from work performed at Structural Biology Center and Northeastern Collaborative Access Team beamlines at the Advanced Photon Source, Argonne National Laboratory, with support from the National Center for Research Resources (RR-15301). Argonne National Laboratory is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research, under contract DE-AC02-06CH11357. Research was also conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation (DMR-0936384) and the National Institutes of Health, and also at the National Synchrotron Light Source at Brookhaven National Laboratory, funded by the United States Department of Energy's Office of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Cioaba MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013559; Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Bjarkam CR, 2009, BRAIN STRUCT FUNCT, V214, P37, DOI 10.1007/s00429-009-0219-3; Botbol YR, 2008, NUCLEIC ACIDS RES, V36, P1237, DOI 10.1093/nar/gkm1127; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; El-Tahir HM, 2009, J BIOL CHEM, V284, P11637, DOI 10.1074/jbc.M901101200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eryilmaz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007274; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Ge YZ, 2004, J BIOL CHEM, V279, P25447, DOI 10.1074/jbc.M312296200; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Laguri C, 2008, BIOCHEMISTRY-US, V47, P6199, DOI 10.1021/bi7024639; Lepourcelet M, 2005, DEVELOPMENT, V132, P415, DOI 10.1242/dev.01579; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Liu H, 2010, GENES DEV; Liu K, 2010, P NATL ACAD SCI USA, V107, P18398, DOI 10.1073/pnas.1013106107; Lukasik SM, 2006, PROTEIN SCI, V15, P314, DOI 10.1110/ps.051751706; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; OTWINOWSKI Z, PROCESSING XRAY DIFF, P307; Park J, 2008, J MOL MED, V86, P1269, DOI 10.1007/s00109-008-0392-5; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Qiu C, 2002, NAT STRUCT BIOL, V9, P217, DOI 10.1038/nsb759; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Shikauchi Y, 2009, MOL CELL BIOL, V29, P1944, DOI 10.1128/MCB.00840-08; Shun MC, 2008, J VIROL, V82, P11555, DOI 10.1128/JVI.01561-08; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; Sun BF, 2008, J BIOL CHEM, V283, P36504, DOI 10.1074/jbc.M806564200; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Wang Y, 2009, MOL CELL, V33, P428, DOI 10.1016/j.molcel.2009.02.002; Watanabe Y, 2010, ADV CLIN CHEM, V52, P145, DOI 10.1016/S0065-2423(10)52006-7; Wijmenga C, 1998, AM J HUM GENET, V63, P803, DOI 10.1086/302021; Xu C, 2008, STRUCTURE, V16, P1740, DOI 10.1016/j.str.2008.08.008; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Yang J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-101; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989	52	112	124	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e18919	10.1371/journal.pone.0018919	http://dx.doi.org/10.1371/journal.pone.0018919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21720545	gold, Green Published			2022-12-25	WOS:000291983800001
J	Hann, A; Gruner, A; Chen, Y; Gress, TM; Buchholz, M				Hann, Alexander; Gruner, Anja; Chen, Ying; Gress, Thomas M.; Buchholz, Malte			Comprehensive Analysis of Cellular Galectin-3 Reveals No Consistent Oncogenic Function in Pancreatic Cancer Cells	PLOS ONE			English	Article							67-KD LAMININ RECEPTOR; HUMAN BREAST-CARCINOMA; DIFFERENTIAL EXPRESSION; BINDING LECTIN; NEOPLASTIC PROGRESSION; DECREASED EXPRESSION; PROSTATE-CANCER; GASTRIC-CANCER; ADENOCARCINOMA; LOCALIZATION	Galectin-3 (Gal-3), a 31 kDa member of the family of beta-galactoside-binding proteins, has been implicated in the progression of different human cancers. However, the proposed roles differ widely, ranging from tumor-promoting cellular functions and negative impact on patient prognosis to tumor-suppressive properties and positive prognostic impact. We and others have previously identified Gal-3 as overexpressed in pancreatic cancer as compared to chronic pancreatitis and normal pancreatic tissue. The purpose of this study was thus the comprehensive analysis of putative cellular functions of Gal-3 by transient as well as stable silencing or overexpression of Gal-3 in a panel of 6 well-established pancreatic cancer cell lines. Our results confirm that galectin-3 is upregulated at the mRNA level in pancreatic cancer and strongly expressed in the majority of pancreatic cancer cell lines. In individual cell lines, transient knockdown of Gal-3 expression resulted in moderate inhibitory effects on proliferation, migration or anchorage-independent growth of the cells, but these effects were not consistent across the spectrum of analyzed cell lines. Moreover, functional effects of the modulation of Gal-3 expression were not observed in stable knockdown or overexpression approaches in vitro and did not alter the growth characteristics of nude mouse xenograft tumors in vivo. Our data thus do not support a direct functional role of Gal-3 in the malignant transformation of pancreatic epithelial cells, although paracrine or systemic effects of Gal-3 expression are not excluded.	[Hann, Alexander; Gruner, Anja; Chen, Ying; Gress, Thomas M.; Buchholz, Malte] Univ Marburg, Dept Gastroenterol Endocrinol & Metab, Marburg, Germany	Philipps University Marburg	Hann, A (corresponding author), Univ Marburg, Dept Gastroenterol Endocrinol & Metab, Marburg, Germany.	hanna@med.uni-marburg.de		Gress, Thomas/0000-0002-9333-5461	German federal ministry of education and research (BMBF) [PKB-01GS08]; EU [LSHB-CT-2006-018771]	German federal ministry of education and research (BMBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission)	This work was funded in part by the German federal ministry of education and research (BMBF) within the framework of the NGFN program of medical genome research (PaCa-Net; project ID PKB-01GS08) as well as EU FP6 grant LSHB-CT-2006-018771 (Integrated Project "MolDiag-Paca"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Baldus SE, 2000, TUMOR BIOL, V21, P258, DOI 10.1159/000030131; Berberat PO, 2001, J HISTOCHEM CYTOCHEM, V49, P539, DOI 10.1177/002215540104900414; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Buchholz M, 2003, CANCER RES, V63, P4945; Califice S, 2004, ONCOGENE, V23, P7527, DOI 10.1038/sj.onc.1207997; Canesin G, 2010, TUMOR BIOL, V31, P277, DOI 10.1007/s13277-010-0033-9; Castronovo V, 1996, J PATHOL, V179, P43, DOI 10.1002/(SICI)1096-9896(199605)179:1<43::AID-PATH541>3.0.CO;2-N; CASTRONOVO V, 1992, JNCI-J NATL CANCER I, V84, P1161, DOI 10.1093/jnci/84.15.1161; Cheong TC, 2010, CANCER SCI, V101, P94, DOI 10.1111/j.1349-7006.2009.01364.x; Dancer JY, 2010, ARCH PATHOL LAB MED, V134, P90, DOI 10.1043/2008-0392-OAR1.1; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Ellenrieder V, 2004, GASTROENTEROLOGY, V127, P607, DOI 10.1053/j.gastro.2004.05.018; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Honjo Y, 2001, CLIN CANCER RES, V7, P661; Hsu DK, 1999, INT J CANCER, V81, P519, DOI 10.1002/(SICI)1097-0215(19990517)81:4<519::AID-IJC3>3.3.CO;2-S; Idikio H, 1998, INT J ONCOL, V12, P1287; IRIMURA T, 1991, CANCER RES, V51, P387; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang HB, 2008, WORLD J GASTROENTERO, V14, P2023, DOI 10.3748/wjg.14.2023; Kobayashi T, 2011, INT J CANCER, V129, P2775, DOI 10.1002/ijc.25946; Lee JW, 2006, J CANCER RES CLIN, V132, P241, DOI 10.1007/s00432-005-0069-1; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; LOTAN R, 1994, INT J CANCER, V56, P474, DOI 10.1002/ijc.2910560404; LOTZ MM, 1993, P NATL ACAD SCI USA, V90, P3466, DOI 10.1073/pnas.90.8.3466; Lu ZH, 2004, PROTEOMICS, V4, P3975, DOI 10.1002/pmic.200300863; Matarrese P, 2000, INT J CANCER, V85, P545, DOI 10.1002/(SICI)1097-0215(20000215)85:4<545::AID-IJC17>3.0.CO;2-N; Matsuda Y, 2008, HEPATOL RES, V38, P1098, DOI 10.1111/j.1872-034X.2008.00387.x; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Nakamura M, 1999, INT J ONCOL, V15, P143; Okada K, 2006, ANTICANCER RES, V26, P1369; Sakaki M, 2010, J MED INVESTIG, V57, P152, DOI 10.2152/jmi.57.152; Sanjuan X, 1997, GASTROENTEROLOGY, V113, P1906, DOI 10.1016/S0016-5085(97)70010-6; Schaffert C, 1998, INT J PANCREATOL, V23, P1; SCHOEPPNER HL, 1995, CANCER, V75, P2818, DOI 10.1002/1097-0142(19950615)75:12<2818::AID-CNCR2820751206>3.0.CO;2-#; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Senapati S, 2011, CLIN CANCER RES, V17, P267, DOI 10.1158/1078-0432.CCR-10-1937; Shimamura T, 2002, CLIN CANCER RES, V8, P2570; TANIGUCHI S, 1992, CLIN EXP METASTAS, V10, P259; VANDENBRULE FA, 1994, EUR J CANCER, V30A, P1096, DOI 10.1016/0959-8049(94)90464-2; VandenBrule FA, 1996, HUM PATHOL, V27, P1185, DOI 10.1016/S0046-8177(96)90313-5; VILA MR, 1995, LAB INVEST, V72, P395; Wang Y, 2009, AM J PATHOL, V174, P1515, DOI 10.2353/ajpath.2009.080816	42	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20859	10.1371/journal.pone.0020859	http://dx.doi.org/10.1371/journal.pone.0020859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698183	Green Submitted, Green Published, gold			2022-12-25	WOS:000291734100025
J	Huang, CC; Liu, K; Pope, RM; Du, P; Lin, S; Rajamannan, NM; Huang, QQ; Jafari, N; Burke, GL; Post, W; Watson, KE; Johnson, C; Daviglus, ML; Lloyd-Jones, DM				Huang, Chiang-Ching; Liu, Kiang; Pope, Richard M.; Du, Pan; Lin, Simon; Rajamannan, Nalini M.; Huang, Qi-Quan; Jafari, Nadereh; Burke, Gregory L.; Post, Wendy; Watson, Karol E.; Johnson, Craig; Daviglus, Martha L.; Lloyd-Jones, Donald M.			Activated TLR Signaling in Atherosclerosis among Women with Lower Framingham Risk Score: The Multi-Ethnic Study of Atherosclerosis	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ACUTE CORONARY SYNDROMES; INTIMA-MEDIA THICKNESS; CAROTID ATHEROSCLEROSIS; RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; SYSTEMIC-LUPUS; T-CELLS	Background: Atherosclerosis is the leading cause of cardiovascular disease (CVD). Traditional risk factors can be used to identify individuals at high risk for developing CVD and are generally associated with the extent of atherosclerosis; however, substantial numbers of individuals at low or intermediate risk still develop atherosclerosis. Results: A case-control study was performed using microarray gene expression profiling of peripheral blood from 119 healthy women in the Multi-Ethnic Study of Atherosclerosis cohort aged 50 or above. All participants had low (< 10%) to intermediate (10% to 20%) predicted Framingham risk; cases (N=48) had coronary artery calcium (CAC) score > 100 and carotid intima-media thickness (IMT) > 1.0 mm, whereas controls (N=71) had CAC < 10 and IMT < 0.65 mm. We identified two major expression profiles significantly associated with significant atherosclerosis (odds ratio 4.85; P < 0.001); among those with Framingham risk score < 10%, the odds ratio was 5.30 (P < 0.001). Ontology analysis of the gene signature reveals activation of a major innate immune pathway, toll-like receptors and IL-1R signaling, in individuals with significant atherosclerosis. Conclusion: Gene expression profiles of peripheral blood may be a useful tool to identify individuals with significant burden of atherosclerosis, even among those with low predicted risk by clinical factors. Furthermore, our data suggest an intimate connection between atherosclerosis and the innate immune system and inflammation via TLR signaling in lower risk individuals.	[Huang, Chiang-Ching; Liu, Kiang; Daviglus, Martha L.; Lloyd-Jones, Donald M.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Pope, Richard M.; Huang, Qi-Quan] Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; [Rajamannan, Nalini M.; Lloyd-Jones, Donald M.] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA; [Burke, Gregory L.] Wake Forest Univ Hlth Sci, Div Publ Hlth Sci, Winston Salem, NC USA; [Post, Wendy] Johns Hopkins Univ, Baltimore, MD USA; [Watson, Karol E.] Univ Calif Los Angeles, Sch Med, Div Cardiol, Los Angeles, CA 90024 USA; [Johnson, Craig] Univ Washington, Collaborat Hlth Studies Coordinating Ctr, Seattle, WA 98195 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Wake Forest University; Wake Forest University School of Medicine; Johns Hopkins University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Washington; University of Washington Seattle	Huang, CC (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.	huangcc@northwestern.edu	Lloyd-Jones, Donald M/C-5899-2009; Watson, Karol/ABD-7425-2021	Pope, Richard M./0000-0003-2416-8660; Lloyd-Jones, Donald/0000-0003-0847-6110	National Institutes of Health [R01 HL086678, R01 AR055240]; National Heart, Lung, and Blood Institute, National Institutes of Health [N01-HC-95159, N01-HC-95166, N01-HC-95169];  [R01 HL081141]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095169, N01HC095162, N01HC095160, N01HC095163, N01HC095166, N01HC095161, N01HC095164, N01HC095159, N01HC095165] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081141, R43HL095169, R44HL095169, R01HL086678, R13HL095166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the National Institutes of Health (R01 HL086678; C.C.H. and R01 AR055240; R.M.P.). The CHAS was supported by grant R01 HL081141 (M.L.D.). The MESA was supported by contracts N01-HC-95159 through N01-HC-95166 and N01-HC-95169 from the National Heart, Lung, and Blood Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani UA, 2006, J AM COLL CARDIOL, V48, P1177, DOI 10.1016/j.jacc.2006.05.055; Ammirati E, 2008, ARTERIOSCL THROM VAS, V28, P2305, DOI 10.1161/ATVBAHA.108.174144; Ashida K, 2005, J ATHEROSCLER THROMB, V12, P53, DOI 10.5551/jat.12.53; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Hornef MW, 2008, CURR OPIN INFECT DIS, V21, P304, DOI 10.1097/QCO.0b013e3282f88ba3; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang QQ, 2010, J LEUKOCYTE BIOL, V88, P253, DOI 10.1189/jlb.0310126; Kamari Y, 2007, ATHEROSCLEROSIS, V195, P31, DOI 10.1016/j.atherosclerosis.2006.11.026; Kiechl S, 2001, CIRCULATION, V103, P1064, DOI 10.1161/01.CIR.103.8.1064; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Lakoski SG, 2007, ARCH INTERN MED, V167, P2437, DOI 10.1001/archinte.167.22.2437; Li MC, 2009, CURR MOL MED, V9, P365, DOI 10.2174/156652409787847137; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu X, 2008, ATHEROSCLEROSIS, V196, P146, DOI 10.1016/j.atherosclerosis.2007.03.025; Liuzzo G, 2005, LUPUS, V14, P732, DOI 10.1191/0961203305lu2210oa; Liuzzo G, 2001, CIRCULATION, V103, P2236; May AE, 2007, SEMIN THROMB HEMOST, V33, P123, DOI 10.1055/s-2007-969023; Methe H, 2005, CIRCULATION, V111, P2654, DOI 10.1161/CIRCULATIONAHA.104.498865; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Monaco C, 2009, CIRCULATION, V120, P2462, DOI 10.1161/CIRCULATIONAHA.109.851881; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075; Nucifora G, 2009, J NUCL CARDIOL, V16, P368, DOI 10.1007/s12350-009-9059-z; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; OLEARY DH, 1991, STROKE, V22, P1155, DOI 10.1161/01.STR.22.9.1155; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; POPE RM, 1993, J RHEUMATOL, V20, P17; Postley JE, 2009, J AM SOC ECHOCARDIOG, V22, P1145, DOI 10.1016/j.echo.2009.07.010; Roman MJ, 2006, ANN INTERN MED, V144, P249, DOI 10.7326/0003-4819-144-4-200602210-00006; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; Sinnaeve PR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007037; SMITH MD, 1989, ANN RHEUM DIS, V48, P108, DOI 10.1136/ard.48.2.108; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Versteeg D, 2008, HEART, V94, P770, DOI 10.1136/hrt.2007.117259; Weyand CM, 2001, MAYO CLIN PROC, V76, P1011, DOI 10.4065/76.10.1011; Wiedermann CJ, 1999, J AM COLL CARDIOL, V34, P1975, DOI 10.1016/S0735-1097(99)00448-9; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wingrove JA, 2008, CIRC-CARDIOVASC GENE, V1, P31, DOI 10.1161/CIRCGENETICS.108.782730	49	16	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21067	10.1371/journal.pone.0021067	http://dx.doi.org/10.1371/journal.pone.0021067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698167	Green Submitted, gold, Green Published			2022-12-25	WOS:000291734100050
J	Marsili, A; Aguayo-Mazzucato, C; Chen, T; Kumar, A; Chung, M; Lunsford, EP; Harney, JW; Thuy, VT; Gianetti, E; Ramadan, W; Chou, C; Bonner-Weir, S; Larsen, PR; Silva, JE; Zavacki, AM				Marsili, Alessandro; Aguayo-Mazzucato, Cristina; Chen, Ting; Kumar, Aditi; Chung, Mirra; Lunsford, Elaine P.; Harney, John W.; Thuy Van-Tran; Gianetti, Elena; Ramadan, Waile; Chou, Cyril; Bonner-Weir, Susan; Larsen, Philip Reed; Silva, Jorge Enrique; Zavacki, Ann Marie			Mice with a Targeted Deletion of the Type 2 Deiodinase Are Insulin Resistant and Susceptible to Diet Induced Obesity	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; THYROID-HORMONE ACTIVATION; LIFE-STYLE INTERVENTION; IODOTHYRONINE DEIODINASE; NUCLEAR 3,5,3'-TRIIODOTHYRONINE; THR92ALA POLYMORPHISM; ENERGY HOMEOSTASIS; SKELETAL-MUSCLE; MOLECULAR-BASIS; GENE	Background: The type 2 iodothyronine deiodinase (D2) converts the pro-hormone thyroxine into T3 within target tissues. D2 is essential for a full thermogenic response of brown adipose tissue (BAT), and mice with a disrupted Dio2 gene (D2KO) have an impaired response to cold. BAT is also activated by overfeeding. Methodology/Principal Findings: After 6-weeks of HFD feeding D2KO mice gained 5.6% more body weight and had 28% more adipose tissue. Oxygen consumption (V0(2)) was not different between genotypes, but D2KO mice had an increased respiratory exchange ratio (RER), suggesting preferential use of carbohydrates. Consistent with this, serum free fatty acids and b-hydroxybutyrate were lower in D2KO mice on a HFD, while hepatic triglycerides were increased and glycogen content decreased. Neither genotype showed glucose intolerance, but D2KO mice had significantly higher insulin levels during GTT independent of diet. Accordingly, during ITT testing D2KO mice had a significantly reduced glucose uptake, consistent with insulin resistance. Gene expression levels in liver, muscle, and brown and white adipose tissue showed no differences that could account for the increased weight gain in D2KO mice. However, D2KO mice have higher PEPCK mRNA in liver suggesting increased gluconeogenesis, which could also contribute to their apparent insulin resistance. Conclusions/Significance: We conclude that the loss of the Dio2 gene has significant metabolic consequences. D2KO mice gain more weight on a HFD, suggesting a role for D2 in protection from diet-induced obesity. Further, D2KO mice appear to have a greater reliance on carbohydrates as a fuel source, and limited ability to mobilize and to burn fat. This results in increased fat storage in adipose tissue, hepatic steatosis, and depletion of liver glycogen in spite of increased gluconeogenesis. D2KO mice are also less responsive to insulin, independent of diet-induced obesity.	[Marsili, Alessandro; Chen, Ting; Kumar, Aditi; Chung, Mirra; Harney, John W.; Thuy Van-Tran; Gianetti, Elena; Larsen, Philip Reed; Zavacki, Ann Marie] Brigham & Womens Hosp, Thyroid Sect, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Aguayo-Mazzucato, Cristina; Bonner-Weir, Susan] Joslin Diabet Ctr, Sect Islet Transplantat & Cell Biol, Boston, MA 02215 USA; [Lunsford, Elaine P.] Beth Israel Deaconess Med Ctr, Longwood Small Anim Imaging Facil, Boston, MA 02215 USA; [Ramadan, Waile; Chou, Cyril; Silva, Jorge Enrique] Baystate Med Ctr, Div Endocrinol Diabet & Metab, Springfield, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Beth Israel Deaconess Medical Center; Baystate Medical Center	Marsili, A (corresponding author), Brigham & Womens Hosp, Thyroid Sect, Div Endocrinol Diabet & Hypertens, 75 Francis St, Boston, MA 02115 USA.	azavacki@rics.bwh.harvard.edu		Bonner-Weir, Susan/0000-0003-4682-0656	National Institutes of Health (NIH)/NIDDK [DK076117, DK036256]; Harvard Medical School; Department of Endocrinology; Kidney of the University Hospital of Pisa; internal Baystate; University of Massachusetts; Department of Medicine of Baystate Medical Center; Academic Affairs Office of Baystate Health Inc.; Graetz Fund; Sheenan Family Fund; NIH/NCRR [S10-RR-023010];  [5P30 DK36836]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044128, R01DK093909, R01DK036256, R01DK076117, P30DK036836] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Harvard Medical School; Department of Endocrinology; Kidney of the University Hospital of Pisa; internal Baystate; University of Massachusetts; Department of Medicine of Baystate Medical Center; Academic Affairs Office of Baystate Health Inc.; Graetz Fund; Sheenan Family Fund; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH)/NIDDK grants DK076117 to AMZ and DK036256 to PRL, and the Dr. Lynn Reid/Drs. Eleanor and Miles Shore Fellowship from the Drs. Eleanor and Miles Shore 50th Anniversary Program for Scholars in Medicine Program of Harvard Medical School to AMZ. AM was supported in part by a fellowship from the Department of Endocrinology and Kidney of the University Hospital of Pisa. JES is supported by internal Baystate and University of Massachusetts joint grants. His research time is funded by the Department of Medicine of Baystate Medical Center, and the Academic Affairs Office of Baystate Health Inc. WR and CC are supported by the Academic Affairs Office of Baystate Health Inc. SBW and CAM are supported by the Graetz Fund and Sheenan Family Fund. The Joslin Diabetes Center Specialized Assay Core is supported by 5P30 DK36836 and the Longwood Small Animal Imaging Facility is supported by NIH/NCRR shared instrumentation grant S10-RR-023010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000035; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; BASSETT JH, 2002, P NATL ACAD SCI USA, V107, P7604; BIANCO AC, 1988, AM J PHYSIOL, V255, pE496, DOI 10.1152/ajpendo.1988.255.4.E496; BIANCO AC, 1987, ENDOCRINOLOGY, V120, P55, DOI 10.1210/endo-120-1-55; BIANCO AC, 1987, J CLIN INVEST, V79, P295, DOI 10.1172/JCI112798; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Canani LH, 2005, J CLIN ENDOCR METAB, V90, P3472, DOI 10.1210/jc.2004-1977; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Castillo M, 2011, DIABETES, V60, P1082, DOI 10.2337/db10-0758; Christoffolete MA, 2004, DIABETES, V53, P577, DOI 10.2337/diabetes.53.3.577; Christoffolete MA, 2007, ENDOCRINOLOGY, V148, P954, DOI 10.1210/en.2006-1042; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; da-Silva WS, 2011, FEBS LETT, V585, P539, DOI 10.1016/j.febslet.2010.12.044; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; Dentice M, 2005, NAT CELL BIOL, V7, P698, DOI 10.1038/ncb1272; Dentice M, 2010, J CLIN INVEST, V120, P4021, DOI 10.1172/JCI43670; Dora JM, 2010, EUR J ENDOCRINOL, V163, P427, DOI 10.1530/EJE-10-0419; Ferrannini E, 2011, MED CLIN N AM, V95, P327, DOI 10.1016/j.mcna.2010.11.005; Fujimoto T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004240; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Grozovsky R, 2009, ENDOCRINOLOGY, V150, P1976, DOI 10.1210/en.2008-0938; Hall JA, 2010, ENDOCRINOLOGY, V151, P4573, DOI 10.1210/en.2010-0511; Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560; HEIKKINEN S, 2007, CURRENT PROTOCOLS MO; Holness MJ, 2003, BIOCHEM J, V369, P687, DOI 10.1042/BJ20021509; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; *JACKS LAB, 2001, PROD CONG STAINS US; Jeoung NH, 2008, AM J PHYSIOL-ENDOC M, V295, pE46, DOI 10.1152/ajpendo.00536.2007; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kalsbeek A, 2004, J NEUROSCI, V24, P7604, DOI 10.1523/JNEUROSCI.5328-03.2004; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Lado-Abeal J, 2010, THYROID, V20, P419, DOI 10.1089/thy.2009.0267; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Liu YY, 2003, J BIOL CHEM, V278, P38913, DOI 10.1074/jbc.M306120200; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Lusk G, 1924, J BIOL CHEM, V59, P41; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; Maia AL, 2007, THYROID, V17, P199, DOI 10.1089/thy.2006.0298; Marsili A, 2010, ENDOCRINOLOGY, V151, P5952, DOI 10.1210/en.2010-0631; Mentuccia D, 2005, THYROID, V15, P1223, DOI 10.1089/thy.2005.15.1223; Mentuccia D, 2002, DIABETES, V51, P880, DOI 10.2337/diabetes.51.3.880; Molero JC, 2004, J CLIN INVEST, V114, P1326, DOI [10.1172/JCI200421480, 10.1172/JCI21480]; Ng L, 2004, P NATL ACAD SCI USA, V101, P3474, DOI 10.1073/pnas.0307402101; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; Pelletier P, 2008, ENDOCRINOLOGY, V149, P6471, DOI 10.1210/en.2008-0718; RAMADAN W, 2011, ENDOCRINOLO IN PRESS; Rochon C, 2003, CLIN SCI, V104, P7, DOI 10.1042/CS20020154; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Salvatore D, 1996, ENDOCRINOLOGY, V137, P3308, DOI 10.1210/en.137.8.3308; Schneider MJ, 2001, MOL ENDOCRINOL, V15, P2137, DOI 10.1210/me.15.12.2137; SILVA JE, 1977, SCIENCE, V198, P617, DOI 10.1126/science.199941; SILVA JE, 1985, J CLIN INVEST, V76, P2296, DOI 10.1172/JCI112239; Simmen FA, 2010, J NUTR BIOCHEM, V21, P1106, DOI 10.1016/j.jnutbio.2009.09.008; Sjogren M, 2007, EMBO J, V26, P4535, DOI 10.1038/sj.emboj.7601882; Sugden MC, 2000, BIOCHEM J, V352, P731, DOI 10.1042/0264-6021:3520731; Takahashi A, 1997, METABOLISM, V46, P897, DOI 10.1016/S0026-0495(97)90076-7; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Vianna CR, 2011, ENDOCRINOLOGY, V152, P11, DOI 10.1210/en.2010-0778; VISSER TJ, 1982, P NATL ACAD SCI-BIOL, V79, P5080, DOI 10.1073/pnas.79.16.5080; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Williamson DF, 2004, ANN INTERN MED, V140, P951, DOI 10.7326/0003-4819-140-11-200406010-00036; Yamauchi T, 1998, PFLUG ARCH EUR J PHY, V435, P368, DOI 10.1007/s004240050525; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zavacki AM, 2005, ENDOCRINOLOGY, V146, P1568, DOI 10.1210/en.2004-1392; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	68	68	68	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20832	10.1371/journal.pone.0020832	http://dx.doi.org/10.1371/journal.pone.0020832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698184	Green Published, gold, Green Submitted			2022-12-25	WOS:000291734100022
J	Goursaud, S; Focant, MC; Berger, JV; Nizet, Y; Maloteaux, JM; Hermans, E				Goursaud, Stephanie; Focant, Marylene C.; Berger, Julie V.; Nizet, Yannick; Maloteaux, Jean-Marie; Hermans, Emmanuel			The VPAC(2) agonist peptide histidine isoleucine (PHI) up-regulates glutamate transport in the corpus callosum of a rat model of amyotrophic lateral sclerosis (hSOD1(G93A)) by inhibiting caspase-3 mediated inactivation of GLT-1a	FASEB JOURNAL			English	Article						astrocytes; neurodegenerative disease; splice variants; white matter	CYCLASE-ACTIVATING POLYPEPTIDE; POSTNATAL EXCITOTOXIC DAMAGE; WHITE-MATTER; INTESTINAL-PEPTIDE; MULTIPLE-SCLEROSIS; ALTERED EXPRESSION; ISCHEMIC-INJURY; BRAIN-LESIONS; SPINAL-CORD; ASTROCYTES	Degeneration of corpus callosum appears in patients with amyotrophic lateral sclerosis (ALS) before clinical signs of upper motor neuron death. Considering the ALS-associated impairment of astrocytic glutamate uptake, we have characterized the expression and activity of the glutamate transporter isoforms GLT-1a and GLT-1b in the corpus callosum of transgenic rats expressing a mutated form of the human superoxide dismutase 1 (hSOD1(G93A)). We have also studied the effect of peptide histidine isoleucine (PHI), a vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating polypeptide (PACAP) receptor 2 (VPAC(2)) agonist on glutamate transporters both in vivo and in callosal astrocytes. Before the onset of motor symptoms, the expression of both transporter isoforms was correlated with a constitutive activity of caspase-3. This enzyme participates in the down-regulation of GLT-1 in ALS, and here we demonstrated its involvement in the selective degradation of GLT-1a in the white matter. A single stereotactic injection of PHI into the corpus callosum of symptomatic rats decreased caspase-3 activity and promoted GLT-1a expression and uptake activity. Together, with evidence for a reduced expression of prepro-VIP/PHI mRNA in the corpus callosum of transgenic animals, these data shed light on the modulatory role of the VIP/PHI system on the glutamatergic transmission in ALS.-Goursaud, S., Focant, M. C., Berger, J. V., Nizet, Y., Maloteaux, J.-M., Hermans, E. The VPAC(2) agonist peptide histidine isoleucine (PHI) up-regulates glutamate transport in the corpus callosum of a rat model of amyotrophic lateral sclerosis (hSOD1(G93A)) by inhibiting caspase-3 mediated inactivation of GLT-1a. FASEB J. 25, 3674-3686 (2011). www.fasebj.org	[Goursaud, Stephanie; Focant, Marylene C.; Berger, Julie V.; Maloteaux, Jean-Marie; Hermans, Emmanuel] Catholic Univ Louvain, Grp Neuropharmacol, Inst Neurosci, B-1200 Brussels, Belgium; [Nizet, Yannick] Catholic Univ Louvain, Expt Surg Lab, Inst Expt & Clin Res, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Hermans, E (corresponding author), Catholic Univ Louvain, Grp Neuropharmacol, Inst Neurosci, 54-10 Av,Hippocrate 54, B-1200 Brussels, Belgium.	emmanuel.hermans@uclouvain.be	Hermans, Emmanuel/A-1654-2015; Hermans, Emmanuel/V-3040-2019		National Fund for Scientific Research (Belgium, Conventions des Fonds de la Recherche Scientifique Medicale) [3.4560.07, 1.5.109.09.F]; DIANE research program of Belgium's Walloon region; Queen Elisabeth Medical Foundation; Association Belge pour les Maladies Neuromusculaires	National Fund for Scientific Research (Belgium, Conventions des Fonds de la Recherche Scientifique Medicale); DIANE research program of Belgium's Walloon region; Queen Elisabeth Medical Foundation; Association Belge pour les Maladies Neuromusculaires	This work was supported by the National Fund for Scientific Research (Belgium, Conventions des Fonds de la Recherche Scientifique Medicale 3.4560.07 and Credit au chercheur 1.5.109.09.F), by the DIANE research program of Belgium's Walloon region, by the Queen Elisabeth Medical Foundation, and by the Association Belge pour les Maladies Neuromusculaires. The authors thank A. Lebbe and R. Lenaert for their excellent technical assistance.	Acarin L, 2005, J NEUROTRAUM, V22, P189, DOI 10.1089/neu.2005.22.189; Acarin L, 2007, GLIA, V55, P954, DOI 10.1002/glia.20518; Baltan S, 2008, J NEUROSCI, V28, P1479, DOI 10.1523/JNEUROSCI.5137-07.2008; Bartels C, 2008, NEUROMUSCULAR DISORD, V18, P398, DOI 10.1016/j.nmd.2008.02.005; Bassan M, 2008, EUR J NEUROSCI, V27, P66, DOI 10.1111/j.1460-9568.2007.05986.x; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Boston-Howes W, 2006, J BIOL CHEM, V281, P14076, DOI 10.1074/jbc.M600653200; Botia B, 2008, J MOL NEUROSCI, V36, P61, DOI 10.1007/s12031-008-9075-5; Chen A, 2008, BRAIN RES, V1201, P187, DOI 10.1016/j.brainres.2008.01.066; Chen WZ, 2002, J NEUROSCI, V22, P2142, DOI 10.1523/JNEUROSCI.22-06-02142.2002; Dejda A, 2005, PHARMACOL REP, V57, P307; Dracheva S, 2003, J NEUROCHEM, V87, P1402, DOI 10.1046/j.1471-4159.2003.02115.x; Favrais G, 2007, PEPTIDES, V28, P1727, DOI 10.1016/j.peptides.2007.06.022; Figiel M, 2000, J NEUROSCI, V20, P3596, DOI 10.1523/JNEUROSCI.20-10-03596.2000; Filippini N, 2010, NEUROLOGY, V75, P1645, DOI 10.1212/WNL.0b013e3181fb84d1; Focant MC, 2011, NEUROCHEM INT, V58, P751, DOI 10.1016/j.neuint.2011.02.023; Gibb SL, 2007, J BIOL CHEM, V282, P32480, DOI 10.1074/jbc.M704314200; Goursaud S, 2008, J NEUROCHEM, V105, P1165, DOI 10.1111/j.1471-4159.2008.05231.x; Goursaud S, 2009, NEUROCHEM INT, V55, P28, DOI 10.1016/j.neuint.2009.02.003; Goursaud S, 2009, J NEUROCHEM, V108, P1442, DOI 10.1111/j.1471-4159.2009.05889.x; Gozes I, 1996, P NATL ACAD SCI USA, V93, P427, DOI 10.1073/pnas.93.1.427; Hassel B, 2003, J NEUROCHEM, V87, P230, DOI 10.1046/j.1471-4159.2003.01984.x; Hinoi E, 2005, BIOCHEM PHARMACOL, V70, P70, DOI 10.1016/j.bcp.2005.04.025; Holmseth S, 2009, NEUROSCIENCE, V162, P1055, DOI 10.1016/j.neuroscience.2009.03.048; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Iwasaki Y, 2001, NEUROL RES, V23, P851, DOI 10.1179/016164101101199298; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; Lee SH, 2008, NEUROPHARMACOLOGY, V55, P1329, DOI 10.1016/j.neuropharm.2008.08.028; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Maragakis NJ, 2004, ANN NEUROL, V55, P469, DOI 10.1002/ana.20003; Massie A, 2010, NEUROCHEM INT, V57, P572, DOI 10.1016/j.neuint.2010.07.004; Matsumoto A, 2006, J NEUROSCI RES, V83, P119, DOI 10.1002/jnr.20708; Rangon CM, 2005, J PHARMACOL EXP THER, V314, P745, DOI 10.1124/jpet.105.086405; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Reglodi D, 2006, ANN NY ACAD SCI, V1070, P518, DOI 10.1196/annals.1317.072; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Sach M, 2004, BRAIN, V127, P340, DOI 10.1093/brain/awh041; Sathasivam S, 2005, NEUROPATH APPL NEURO, V31, P467, DOI 10.1111/j.1365-2990.2005.00658.x; Senda J, 2009, AMYOTROPH LATERAL SC, V10, P288, DOI 10.3109/17482960802651717; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Sun D, 2010, J NEUROSCI, V30, P14008, DOI 10.1523/JNEUROSCI.3605-10.2010; Sun W, 2006, INT IMMUNOL, V18, P1691, DOI 10.1093/intimm/dxl103; Tamas A, 2004, NEUROSCI LETT, V372, P110, DOI 10.1016/j.neulet.2004.09.021; Tekkok SB, 2007, J CEREBR BLOOD F MET, V27, P1540, DOI 10.1038/sj.jcbfm.9600455; Trotti, 1999, Nat Neurosci, V2, P848, DOI 10.1038/12227; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Underwood CK, 2011, NEUROIMAGE, V55, P455, DOI 10.1016/j.neuroimage.2010.12.044; Vanoni C, 2004, J CELL SCI, V117, P5417, DOI 10.1242/jcs.01411; Vermeiren C, 2006, J NEUROCHEM, V96, P719, DOI 10.1111/j.1471-4159.2005.03577.x; WERDELIN L, 1989, ACTA NEUROL SCAND, V79, P177, DOI 10.1111/j.1600-0404.1989.tb03735.x; Wittstock M, 2007, CLIN NEUROPHYSIOL, V118, P301, DOI 10.1016/j.clinph.2006.09.026; Wolswijk G, 2000, BRAIN, V123, P105, DOI 10.1093/brain/123.1.105; Yang YJ, 2010, GLIA, V58, P277, DOI 10.1002/glia.20922; Yang YJ, 2009, NEURON, V61, P880, DOI 10.1016/j.neuron.2009.02.010; Yasuda M, 1995, NEUROPEPTIDES, V29, P325, DOI 10.1016/0143-4179(95)90003-9; Zhou JZ, 2004, J NEUROSCI, V24, P6301, DOI 10.1523/JNEUROSCI.1404-04.2004; ZHOU Y, 1995, NEUROSCI LETT, V195, P89, DOI 10.1016/0304-3940(94)11787-J	59	12	13	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2011	25	10					3674	3686		10.1096/fj.11-182337	http://dx.doi.org/10.1096/fj.11-182337			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21730107				2022-12-25	WOS:000295356400036
J	Chang, H; Jackson, DG; Kayne, PS; Ross-Macdonald, PB; Ryseck, RP; Siemers, NO				Chang, Han; Jackson, Donald G.; Kayne, Paul S.; Ross-Macdonald, Petra B.; Ryseck, Rolf-Peter; Siemers, Nathan O.			Exome Sequencing Reveals Comprehensive Genomic Alterations across Eight Cancer Cell Lines	PLOS ONE			English	Article							KINASE GENE FAMILY; SOMATIC MUTATIONS; BREAST-CANCER; LUNG-CANCER; COLORECTAL CANCERS; GEFITINIB; CETUXIMAB; PATTERNS; THERAPY	It is well established that genomic alterations play an essential role in oncogenesis, disease progression, and response of tumors to therapeutic intervention. The advances of next-generation sequencing technologies (NGS) provide unprecedented capabilities to scan genomes for changes such as mutations, deletions, and alterations of chromosomal copy number. However, the cost of full-genome sequencing still prevents the routine application of NGS in many areas. Capturing and sequencing the coding exons of genes (the "exome") can be a cost-effective approach for identifying changes that result in alteration of protein sequences. We applied an exome-sequencing technology (Roche Nimblegen capture paired with 454 sequencing) to identify sequence variation and mutations in eight commonly used cancer cell lines from a variety of tissue origins (A2780, A549, Colo205, GTL16, NCI-H661, MDA-MB468, PC3, and RD). We showed that this technology can accurately identify sequence variation, providing similar to 95% concordance with Affymetrix SNP Array 6.0 performed on the same cell lines. Furthermore, we detected 19 of the 21 mutations reported in Sanger COSMIC database for these cell lines. We identified an average of 2,779 potential novel sequence variations/mutations per cell line, of which 1,904 were non-synonymous. Many non-synonymous changes were identified in kinases and known cancer-related genes. In addition we confirmed that the read-depth of exome sequence data can be used to estimate high-level gene amplifications and identify homologous deletions. In summary, we demonstrate that exome sequencing can be a reliable and cost-effective way for identifying alterations in cancer genomes, and we have generated a comprehensive catalogue of genomic alterations in coding regions of eight cancer cell lines. These findings could provide important insights into cancer pathways and mechanisms of resistance to anti-cancer therapies.	[Chang, Han; Jackson, Donald G.; Kayne, Paul S.; Ross-Macdonald, Petra B.; Ryseck, Rolf-Peter; Siemers, Nathan O.] Bristol Myers Squibb Co, Res & Dev, Princeton, NJ 08540 USA	Bristol-Myers Squibb	Chang, H (corresponding author), Bristol Myers Squibb Co, Res & Dev, Princeton, NJ 08540 USA.	Han.Chang@bms.com		Jackson, Donald/0000-0002-0863-9031	Bristol-Myers Squibb Co.	Bristol-Myers Squibb Co.(Bristol-Myers Squibb)	This work was supported by Bristol-Myers Squibb Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelopoulos K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-78; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hedges D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008232; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Kimura T, 2006, ONCOL REP, V15, P1205; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; REGECAMBRIN G, 1992, CANCER GENET CYTOGEN, V64, P170, DOI 10.1016/0165-4608(92)90350-H; Robison K, 2010, BRIEF BIOINFORM, V11, P524, DOI 10.1093/bib/bbq013; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	27	22	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21097	10.1371/journal.pone.0021097	http://dx.doi.org/10.1371/journal.pone.0021097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701589	Green Submitted, Green Published, gold			2022-12-25	WOS:000291983800023
J	Al-Ghamdi, S; Albasri, A; Cachat, J; Ibrahem, S; Muhammad, BA; Jackson, D; Nateri, AS; Kindle, KB; Ilyas, M				Al-Ghamdi, Saleh; Albasri, Abdulkader; Cachat, Julien; Ibrahem, Salih; Muhammad, Belal A.; Jackson, Darryl; Nateri, Abdolrahman S.; Kindle, Karin B.; Ilyas, Mohammad			Cten Is Targeted by Kras Signalling to Regulate Cell Motility in the Colon and Pancreas	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; COLORECTAL-CANCER; TUMOR PROGRESSION; UP-REGULATION; TENSIN; RAS; ADENOCARCINOMA; MIGRATION; MUTATION	CTEN/TNS4 is an oncogene in colorectal cancer (CRC) which enhances cell motility although the mechanism of Cten regulation is unknown. We found an association between high Cten expression and KRAS/BRAF mutation in a series of CRC cell lines (p=0.03) and hypothesised that Kras may regulate Cten. To test this, Kras was knocked-down (using small interfering (si) RNA) in CRC cell lines SW620 and DLD1 (high Cten expressors and mutant for KRAS). In each cell line, Kras knockdown was mirrored by down-regulation of Cten Since Kras signals through Braf, we tested the effect of Kras knockdown in CRC cell line Colo205 (which shows high Cten expression and is mutant for BRAF but wild type for KRAS). Cten levels were unaffected by Kras knockdown whilst Braf knockdown resulted in reduced Cten expression suggesting that Kras signals via Braf to regulate Cten. Quantification of Cten mRNA and protein analysis following proteasome inhibition suggested that regulation was of Cten transcription. Kras knockdown inhibited cell motility. To test whether this could be mediated through Cten, SW620 cells were co-transfected with Kras specific siRNAs and a Cten expression vector. Restoring Cten expression was able to restore cell motility despite Kras knockdown (transwell migration and wounding assay, p < 0.001 for both). Since KRAS is mutated in many cancers, we investigated whether this relationship could be demonstrated in other tumour models. The experiments were repeated in the pancreatic cancer cell lines Colo357 & PSN-1(both high Cten expressors and mutant for KRAS). In both cell lines, Kras was shown to regulate Cten and forced expression of Cten was able to rescue loss of cell motility following Kras knockdown in PSN-1 (transwell migration assay, p < 0.001). We conclude that, in the colon and pancreas, Cten is a downstream target of Kras and may be a mechanism through which Kras regulates of cell motility.	[Al-Ghamdi, Saleh; Albasri, Abdulkader; Cachat, Julien; Ibrahem, Salih; Muhammad, Belal A.; Jackson, Darryl; Kindle, Karin B.; Ilyas, Mohammad] Univ Nottingham, Div Pathol, Nottingham NG7 2RD, England; [Muhammad, Belal A.; Nateri, Abdolrahman S.] Univ Nottingham, Div Preclin Oncol, Nottingham NG7 2RD, England; [Ilyas, Mohammad] Nottingham Univ Hosp NHS Trust, Queens Med Ctr, NIHR Biomed Res Unit, Nottingham Digest Dis Ctr, Nottingham, England	University of Nottingham; University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham	Al-Ghamdi, S (corresponding author), Univ Nottingham, Div Pathol, Nottingham NG7 2RD, England.	mohammad.ilyas@nottingham.ac.uk	Cachat, Jonathan M/B-3719-2010; Jackson, Darryl/GVS-2243-2022; AlGhamdi, Saleh/S-2515-2019; Ibrahem, Salih/ABF-3778-2020	Cachat, Jonathan M/0000-0002-6504-0869; Albasri, Abdulkader/0000-0002-1824-4025; Ibrahem, Salih/0000-0003-1089-651X; Shams Nateri, Abdolrahman/0000-0002-6422-6813; Garrie, Karin/0000-0003-2204-9975	University of Nottingham; National Association for Colitis and Crohn's Disease (NACC); Cost [IC0604]; Medical Research Council [G0700763] Funding Source: researchfish; MRC [G0700763] Funding Source: UKRI	University of Nottingham; National Association for Colitis and Crohn's Disease (NACC); Cost(European Cooperation in Science and Technology (COST)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the University of Nottingham. KBK is funded by the National Association for Colitis and Crohn's Disease (NACC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof I Tomlinson and Dr W Otto for kindly donating cell lines. Image analysis was supported by Cost action IC0604.	Ahmed MAH, 2010, INFLAMM BOWEL DIS, V16, P795, DOI 10.1002/ibd.21134; ALBASRI A, 2010, BREAST CANC RES TREA; Albasri A, 2009, J PATHOL, V218, P57, DOI 10.1002/path.2508; Barbieri I, 2010, CANCER RES, V70, P2558, DOI 10.1158/0008-5472.CAN-09-2840; Chen HY, 2000, BIOCHEM J, V351, P403, DOI 10.1042/0264-6021:3510403; Elsaba TMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010714; Fadhil W, 2010, J CLIN PATHOL, V63, P134, DOI 10.1136/jcp.2009.070508; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Liao YC, 2009, CANCER RES, V69, P4563, DOI 10.1158/0008-5472.CAN-09-0117; LO SH, 1994, J CELL BIOL, V125, P1067, DOI 10.1083/jcb.125.5.1067; Lo SH, 2004, INT J BIOCHEM CELL B, V36, P31, DOI 10.1016/S1357-2725(03)00171-7; Lo SH, 2002, CANCER RES, V62, P4217; MORGAN RT, 1980, INT J CANCER, V25, P591, DOI 10.1002/ijc.2910250507; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Sakashita K, 2008, ANN SURG ONCOL, V15, P2606, DOI 10.1245/s10434-008-9989-8; Sasaki H, 2003, TUMOR BIOL, V24, P271, DOI 10.1159/000076141; Sasaki H, 2003, LUNG CANCER, V40, P151, DOI 10.1016/S0169-5002(03)00037-0; Seth R, 2009, GUT, V58, P1234, DOI 10.1136/gut.2008.159137; Shulewitz M, 2006, ONCOGENE, V25, P4361, DOI 10.1038/sj.onc.1209470; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; YAMADA H, 1986, BIOCHEM BIOPH RES CO, V140, P167, DOI 10.1016/0006-291X(86)91072-7; Zuber J, 2000, NAT GENET, V24, P144, DOI 10.1038/72799	23	32	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20919	10.1371/journal.pone.0020919	http://dx.doi.org/10.1371/journal.pone.0020919			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698197	Green Published, gold, Green Submitted			2022-12-25	WOS:000291734100032
J	Ferdowsian, HR; Durham, DL; Kimwele, C; Kranendonk, G; Otali, E; Akugizibwe, T; Mulcahy, JB; Ajarova, L; Johnson, CM				Ferdowsian, Hope R.; Durham, Debra L.; Kimwele, Charles; Kranendonk, Godelieve; Otali, Emily; Akugizibwe, Timothy; Mulcahy, J. B.; Ajarova, Lilly; Johnson, Cassie Mere			Signs of Mood and Anxiety Disorders in Chimpanzees	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SELF-INJURIOUS-BEHAVIOR; PAN-TROGLODYTES; PSYCHIATRIC CONDITIONS; ABNORMAL-BEHAVIOR; RHESUS MACAQUES; RESOCIALIZATION; REGURGITATION; COMORBIDITY; DEPRESSION	Background: In humans, traumatic experiences are sometimes followed by psychiatric disorders. In chimpanzees, studies have demonstrated an association between traumatic events and the emergence of behavioral disturbances resembling posttraumatic stress disorder (PTSD) and depression. We addressed the following central question: Do chimpanzees develop posttraumatic symptoms, in the form of abnormal behaviors, which cluster into syndromes similar to those described in human mood and anxiety disorders? Methodology/Principal Findings: In phase 1 of this study, we accessed case reports of chimpanzees who had been reportedly subjected to traumatic events, such as maternal separation, social isolation, experimentation, or similar experiences. We applied and tested DSM-IV criteria for PTSD and major depression to published case reports of 20 chimpanzees identified through PrimateLit. Additionally, using the DSM-IV criteria and ethograms as guides, we developed behaviorally anchored alternative criteria that were applied to the case reports. A small number of chimpanzees in the case studies met DSM-IV criteria for PTSD and depression. Measures of inter-rater reliability, including Fleiss' kappa and percentage agreement, were higher with use of the alternative criteria for PTSD and depression. In phase 2, the alternative criteria were applied to chimpanzees living in wild sites in Africa (n = 196) and chimpanzees living in sanctuaries with prior histories of experimentation, orphanage, illegal seizure, or violent human conflict (n = 168). In phase 2, 58% of chimpanzees living in sanctuaries met the set of alternative criteria for depression, compared with 3% of chimpanzees in the wild (p = 0.04), and 44% of chimpanzees in sanctuaries met the set of alternative criteria for PTSD, compared with 0.5% of chimpanzees in the wild (p = 0.04). Conclusions/Significance: Chimpanzees display behavioral clusters similar to PTSD and depression in their key diagnostic criteria, underscoring the importance of ethical considerations regarding the use of chimpanzees in experimentation and other captive settings.	[Ferdowsian, Hope R.; Durham, Debra L.; Johnson, Cassie Mere] Phys Comm Responsible Med, Washington, DC USA; [Ferdowsian, Hope R.] George Washington Univ, Dept Med, Washington, DC USA; [Kimwele, Charles] Univ Nairobi Kenya, Dept Vet Anat & Physiol, Nairobi, Kenya; [Kranendonk, Godelieve] AAP Sanctuary Exot Anim, Almere, Netherlands; [Otali, Emily] Makerere Univ, Biol Field Stn, Kibale Chimpanzee Project, Kibale, Uganda; [Akugizibwe, Timothy] Wildlife Conservat Soc, Uganda Program, Kampala, Uganda; [Mulcahy, J. B.] Chimpanzee Sanctuary NW, Cle Elum, WA USA; [Ajarova, Lilly] Chimpanzee Sanctuary & Wildlife Conservat Trust, Entebbe, Uganda	George Washington University; University of Nairobi; Makerere University	Ferdowsian, HR (corresponding author), Phys Comm Responsible Med, Washington, DC USA.	hferdowsian@pcrm.org			Arcus Foundation	Arcus Foundation	The Arcus Foundation provided financial support for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXOPOULOS GS, 1988, BIOL PSYCHIAT, V23, P271, DOI 10.1016/0006-3223(88)90038-8; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BAKER K, 2005, NIH PUBLICATION; Bellanca RU, 2002, AM J PRIMATOL, V58, P57, DOI 10.1002/ajp.10052; Beran MJ, 2000, ANIM LEARN BEHAV, V28, P201, DOI 10.3758/BF03200255; Bourgeois SR, 2007, J APPL ANIM WELF SCI, V10, P123, DOI 10.1080/10888700701313454; Bourne G. H., 1970, THE CHIMPANZEE, V3, P337; Bradshaw GA, 2008, J TRAUMA DISSOCIATIO, V9, P9, DOI 10.1080/15299730802073619; Bradshaw GA, 2007, ETHOLOGY, V113, P426, DOI 10.1111/j.1439-0310.2007.01333.x; Bradshaw GA, 2006, AM SCI, V94, P487, DOI 10.1511/2006.62.487; Bradshaw GA, 2009, DEV PSYCHOL, V45, P1376, DOI 10.1037/a0015860; Bradshaw GA, 2005, NATURE, V433, P807, DOI 10.1038/433807a; Brady KT, 2000, J CLIN PSYCHIAT, V61, P22; BRENT L, 1989, LAB ANIM SCI, V39, P345; Breslau N, 1998, REV PSYCHIAT SER, V17, P1; Brune M, 2006, NEUROSCI BIOBEHAV R, V30, P1246, DOI 10.1016/j.neubiorev.2006.09.002; Brune M, 2008, TXB EVOLUTIONARY PSY; Butler A. B., 2005, COMP VERTEBRATE NEUR; Capitanio J.P., 1986, P411; Clarke A.S., 1982, Zoo Biology, V1, P371, DOI 10.1002/zoo.1430010411; Dehon C, 2006, J PEDIATR PSYCHOL, V31, P431, DOI 10.1093/jpepsy/jsj006; Fabrega H, 2004, PSYCHOPATHOLOGY, V37, P290, DOI 10.1159/000081986; GIACONIA RM, 1995, J AM ACAD CHILD PSY, V34, P1369, DOI 10.1097/00004583-199510000-00023; Goodall J., 1986, CHIMPANZEES GOMBE PA; Gregory NG, 2004, PHYSIOLOGY AND BEHAVIOUR OF ANIMAL SUFFERING, P1, DOI 10.1002/9780470752494; Hare B, 2006, COGNITION, V101, P495, DOI 10.1016/j.cognition.2005.01.011; Harlow H. F, 1986, LEARNING LOVE SELECT; HARLOW HF, 1965, P NATL ACAD SCI USA, V54, P90, DOI 10.1073/pnas.54.1.90; HIRAIWAHASEGAWA M, 1988, PRIMATES, V29, P319, DOI 10.1007/BF02380955; Hook MA, 2002, APPL ANIM BEHAV SCI, V76, P165, DOI 10.1016/S0168-1591(02)00005-9; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; Houlihan D., 1990, BEHAV INTERVENT, V5, P129; Howell SM, 1997, LAB ANIMAL, V26, P30; *I LAB AN RES COMM, 1996, GUID CAR US LAB AN; Inoue S, 2007, CURR BIOL, V17, pR1004, DOI 10.1016/j.cub.2007.10.027; International Primatological Society, 2007, IPS INT GUID ACQ CAR; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; King JE, 2008, J COMP PSYCHOL, V122, P418, DOI 10.1037/a0013125; King JE, 2003, J RES PERS, V37, P1, DOI 10.1016/S0092-6566(02)00527-5; King JE, 1997, J RES PERS, V31, P257, DOI 10.1006/jrpe.1997.2179; Koob GF, 1989, ANIMAL MODELS DEPRES; Lilienfeld SO, 1999, J COMP PSYCHOL, V113, P365; Lutz C, 2003, AM J PRIMATOL, V60, P1, DOI 10.1002/ajp.10075; MATSUZAWA T, COGNITIVE DEV CHIMPA; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; McEwen BS, 1997, MOL PSYCHIATR, V2, P255, DOI 10.1038/sj.mp.4000254; MCGREW WC, 1992, MAT CULTURE CHIMPANZ; McMillan FD, 2005, MENTAL HEALTH AND WELL-BEING IN ANIMALS, P1; McQuaid JR, 2001, PSYCHOL MED, V31, P1249, DOI 10.1017/S0033291701004202; MENZEL EW, 1963, J COMP PHYSIOL PSYCH, V56, P78, DOI 10.1037/h0047360; Nash LT, 1999, AM J PRIMATOL, V48, P15, DOI 10.1002/(SICI)1098-2345(1999)48:1<15::AID-AJP2>3.3.CO;2-I; NOON C, 1991, J MED PRIMATOL, V20, P375; Novak MA, 2003, AM J PRIMATOL, V59, P3, DOI 10.1002/ajp.10063; OCONNOR LE, 2001, CHIMP C P, P24; OROSZ SE, 2007, VET CLIN N AM EXOT A, V10, pR6; Orosz Susan E, 2007, Vet Clin North Am Exot Anim Pract, V10, P775, DOI 10.1016/j.cvex.2007.06.001; Overall KL, 2000, PROG NEURO-PSYCHOPH, V24, P727, DOI 10.1016/S0278-5846(00)00104-4; Parker S.T., 2006, SELF AWARENESS ANIMA; PEDERSON AK, 2003, J RES PERS, V39, P534; PFEIFFER AJ, 1978, J MED PRIMATOL, V7, P70; Povinelli DJ, 1996, PSYCHOL SCI, V7, P129, DOI 10.1111/j.1467-9280.1996.tb00345.x; Povinelli DJ, 2001, CAN J EXP PSYCHOL, V55, P185, DOI 10.1037/h0087365; RIDLEY RM, 1982, PSYCHOL MED, V12, P61, DOI 10.1017/S0033291700043294; Rommeck I, 2009, J APPL ANIM WELF SCI, V12, P61, DOI 10.1080/10888700802536798; Scheeringa M, 2003, J AM ACAD CHILD PSY, V42, P561, DOI 10.1097/01.CHI.0000046822.95464.14; SCHEERINGA MS, 1995, J AM ACAD CHILD PSY, V34, P191, DOI 10.1097/00004583-199502000-00014; SCOTT M, 2006, ASSESSING EFFECTS PR; Stevens A., 2000, EVOLUTIONARY PSYCHIA; Struck K, 2007, LAB ANIMAL, V36, P35, DOI 10.1038/laban0107-35; STRUTHERS EJ, 1990, BROWN U LAB PRIMATE, V29, P3; TINKLEPAUGH OTTO LEIF, 1928, JOUR MAMMALOGY, V9, P293, DOI 10.2307/1374083; Tomonaga M, 2006, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P182, DOI 10.1007/4-431-30248-4_12; TURNER CH, 1969, AM J PSYCHIAT, V125, P1531, DOI 10.1176/ajp.125.11.1531; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wildman DE, 2003, P NATL ACAD SCI USA, V100, P7181, DOI 10.1073/pnas.1232172100; Wilson JP, 2004, ASSESSING PSYCHOL TR, V2nd; Yerkes RM., 1943, CHIMPANZEES LAB COLO	77	63	65	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e19855	10.1371/journal.pone.0019855	http://dx.doi.org/10.1371/journal.pone.0019855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778UW	21698223	Green Published, gold			2022-12-25	WOS:000291734100002
J	Ferro, DP; Falconi, MA; Adam, RL; Ortega, MM; Lima, CP; de Souza, CA; Lorand-Metze, I; Metze, K				Ferro, Daniela P.; Falconi, Monica A.; Adam, Randall L.; Ortega, Manoela M.; Lima, Carmen P.; de Souza, Carmino A.; Lorand-Metze, Irene; Metze, Konradin			Fractal Characteristics of May-Grunwald-Giemsa Stained Chromatin Are Independent Prognostic Factors for Survival in Multiple Myeloma	PLOS ONE			English	Article							INTERNATIONAL STAGING SYSTEM; GOODNESS-OF-FIT; PLASMA-CELLS; NUCLEAR CHROMATIN; BONE-MARROW; DIMENSION; TEXTURE; PROLIFERATION; PROGRESSION; DIAGNOSIS	Background: The use of computerized image analysis for the study of nuclear texture features has provided important prognostic information for several neoplasias. Recently fractal characteristics of the chromatin structure in routinely stained smears have shown to be independent prognostic factors in acute leukemia. In the present study we investigated the influence of the fractal dimension (FD) of chromatin on survival of patients with multiple myeloma. Methodology: We analyzed 67 newly diagnosed patients from our Institution treated in the Brazilian Multiple Myeloma Study Group. Diagnostic work-up consisted of peripheral blood counts, bone marrow cytology, bone radiograms, serum biochemistry and cytogenetics. The International Staging System (ISS) was used. In every patient, at least 40 digital nuclear images from diagnostic May-Grunwald-Giemsa stained bone marrow smears were acquired and transformed into pseudo-3D images. FD was determined by the Minkowski-Bouligand method extended to three dimensions. Goodness-of-fit of FD was estimated by the R-2 values in the log-log plots. The influence of diagnostic features on overall survival was analyzed in Cox regressions. Patients that underwent autologous bone marrow transplantation were censored at the day of transplantation. Principal Findings: Median age was 56 years. According to ISS, 14% of the patients were stage I, 39% were stage II and 47% were stage III. Additional features of a bad prognosis were observed in 46% of the cases. When stratifying for ISS, both FD and its goodness-of-fit were significant prognostic factors in univariate analyses. Patients with higher FD values or lower goodness-of-fit showed a worse outcome. In the multivariate Cox-regression, FD, R-2, and ISS stage entered the final model, which showed to be stable in a bootstrap resampling study. Conclusions: Fractal characteristics of the chromatin texture in routine cytological preparations revealed relevant prognostic information in patients with multiple myeloma.	[Ferro, Daniela P.; Metze, Konradin] Univ Estadual Campinas, Dept Pathol, Campinas, SP, Brazil; [Falconi, Monica A.] Univ Estadual Campinas, Hematol Hemotherapy Ctr, Campinas, SP, Brazil; [Ortega, Manoela M.; Lima, Carmen P.; de Souza, Carmino A.; Lorand-Metze, Irene] Univ Estadual Campinas, Dept Internal Med, Campinas, SP, Brazil; [Adam, Randall L.] Univ Estadual Campinas, Inst Comp, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Ferro, DP (corresponding author), Univ Estadual Campinas, Dept Pathol, Campinas, SP, Brazil.	kmetze@pq.cnpq.br	Metze, Konradin/A-8703-2008; Ortega, Manoela/AAH-2106-2020; Ortega, Manoela/I-8430-2014	Metze, Konradin/0000-0003-0742-8846; Ortega, Manoela/0000-0003-4609-7074; Ortega, Manoela/0000-0002-7896-6142; De Souza, Carmino/0000-0001-8656-8374; Lorand-Metze, Irene/0000-0002-6516-1265	Sao Paulo Research Foundation [2007/52015-0]; National Council of Technological and Scientific Development (CNPq) [479074/2008-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This investigation was supported by the Sao Paulo Research Foundation (project 2007/52015-0) and the National Council of Technological and Scientific Development (CNPq) project 479074/2008-9. KM, IL-M, CSPL and CAS are researchers of CNPq. DPF recieved a grant as a postgraduate student from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No writing assistance was utilized in the production of this manuscript.	Adam RL, 2006, CELL ONCOL, V28, P55; Albregtsen F, 2009, CELL ONCOL, V31, P501, DOI 10.3233/CLO-2009-0506; Anagnostopoulos A, 2005, EUR J HAEMATOL, V75, P370, DOI 10.1111/j.1600-0609.2005.00532.x; Aon MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003624; AVETLOISEAU H, 2011, J CLIN ONCOL     APR; Bancaud A, 2009, EMBO J, V28, P3785, DOI 10.1038/emboj.2009.340; Bedin V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-260; Bollati V, 2009, CARCINOGENESIS, V30, P1330, DOI 10.1093/carcin/bgp149; Brigaudeau C, 1996, HEMATOL CELL THER, V38, P275, DOI 10.1007/s00282-996-0275-6; Cattani C, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/379873; De Bruyne E, 2008, CLIN CANCER RES, V14, P2918, DOI 10.1158/1078-0432.CCR-07-4489; De Capoa A, 1999, FASEB J, V13, P89; Delides A, 2005, ANTICANCER RES, V25, P2141; DESOUZA CA, 2008, HAEMATOLOGICA S1, V93, P434; DEY P, 2011, DIAGN CYTOPATHOL, V39, DOI DOI 10.1002/DC.21631; DUBUC B, 1989, PHYS REV A, V39, P1500, DOI 10.1103/PhysRevA.39.1500; Einstein AJ, 1998, J PATHOL, V185, P366; Elston LB, 2009, VET PATHOL, V46, P362, DOI 10.1354/vp.46-2-362; Faria Neice Müller Xavier, 2007, Ciênc. saúde coletiva, V12, P25, DOI 10.1590/S1413-81232007000100008; Ferreira RC, 2006, CELL ONCOL, V28, P331; GEBARA AB, 2011, B ENV CONTAM TOXICOL; Genty V, 2005, CANCER BIOL THER, V4, P832, DOI 10.4161/cbt.4.8.1890; Goasguen JE, 1999, LEUKEMIA RES, V23, P1133, DOI 10.1016/S0145-2126(99)00132-0; Goutzanis L, 2008, ORAL ONCOL, V44, P345, DOI 10.1016/j.oraloncology.2007.04.005; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Herreros FOC, 2007, ARCH DERMATOL RES, V299, P41, DOI 10.1007/s00403-007-0739-8; Hungria VTM, 2008, HAEMATOLOGICA, V93, P791, DOI 10.3324/haematol.11637; IRINOPOULOU T, 1993, ANAL QUANT CYTOL, V15, P341; Kayser K, 2007, ANAL QUANT CYTOL, V29, P296; Kayser K, 2008, ANAL QUANT CYTOL, V30, P323; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Lee WJ, 2004, AM J EPIDEMIOL, V159, P373, DOI 10.1093/aje/kwh040; Leleu X, 2005, LEUKEMIA RES, V29, P665, DOI 10.1016/j.leukres.2004.12.002; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lopes LF, 2002, LEUKEMIA RES, V26, P637, DOI 10.1016/S0145-2126(01)00187-4; Lopes R, 2009, MED IMAGE ANAL, V13, P634, DOI 10.1016/j.media.2009.05.003; Lorand-Metze I, 2004, CELL ONCOL, V26, P63; Lorand-Metze I, 2004, LEUKEMIA RES, V28, P587, DOI 10.1016/j.leukres.2003.11.001; Lorthois S, 2010, J THEOR BIOL, V262, P614, DOI 10.1016/j.jtbi.2009.10.037; Losa GA, 2005, CELL TISSUE RES, V322, P257, DOI 10.1007/s00441-005-0030-2; Losa GA, 1998, EUR J HISTOCHEM, V42, P21; Losa GA, 2009, RIV BIOL-BIOL FORUM, V102, P29; Maiolino A, 2008, BLOOD, V112, P1269, DOI 10.1182/blood.V112.11.3703.3703; MANDELBROT BB, 1975, P NATL ACAD SCI USA, V72, P3825, DOI 10.1073/pnas.72.10.3825; Mashiah A, 2008, ACTA HAEMATOL-BASEL, V119, P142, DOI 10.1159/000125551; McNally JG, 2010, EMBO J, V29, P2, DOI 10.1038/emboj.2009.375; Metze K, 2000, INT J CANCER, V89, P440, DOI 10.1002/1097-0215(20000920)89:5<440::AID-IJC7>3.0.CO;2-U; Metze K, 2005, CELL ONCOL, V27, P199; Metze K, 2008, CELL ONCOL, V30, P142; Metze K, 2008, PATHOL RES PRACT, V204, P213, DOI 10.1016/j.prp.2007.12.002; Metze K, 2010, STUD COMPUT INTELL, V314, P199; Metze K, 2010, EPIGENOMICS-UK, V2, P601, DOI 10.2217/EPI.10.50; Metze K, 2010, PATHOLOGY, V42, P609, DOI 10.3109/00313025.2010.508794; Metze K, 2009, DIS COLON RECTUM, V52, P1523, DOI 10.1007/DCR.0b013e3181ab822d; Metze K, 2009, CELL ONCOL, V31, P503, DOI 10.3233/CLO-2009-0505; Metze K, 2009, J CUTAN PATHOL, V36, P713, DOI 10.1111/j.1600-0560.2008.01177.x; Metze K, 2009, ANAL QUANT CYTOL, V31, P241; Michel J, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-7; Montironi R, 2007, CELL ONCOL, V29, P47; Nielsen B, 2001, ANAL CELL PATHOL, V23, P75, DOI 10.1155/2001/683747; NIELSEN B, 2005, FRACTALS BIOL MED, V3; NIELSEN B, 2005, FRACTALS BIOL MED, V4; Ortega MM, 2008, ANN ONCOL, V19, P230; Pereira FG, 2006, NEOPLASMA, V53, P155; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Rajkurnar SV, 2007, BEST PRACT RES CL HA, V20, P665, DOI 10.1016/j.beha.2007.10.002; Rego MFN, 2003, BRAZ J MED BIOL RES, V36, P331, DOI 10.1590/S0100-879X2003000300007; Renshaw C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-74; Rocha LB, 2008, MICROSC RES TECHNIQ, V71, P619, DOI 10.1002/jemt.20598; Rybka MO, 2008, INT J DERMATOL, V47, P1240, DOI 10.1111/j.1365-4632.2008.03808.x; Tambasco M, 2008, HUM PATHOL, V39, P740, DOI 10.1016/j.humpath.2007.10.001; Thamrin C, 2010, PAEDIATR RESPIR REV, V11, P123, DOI 10.1016/j.prrv.2010.02.001; Tinguely M, 2007, AM J SURG PATHOL, V31, P690, DOI 10.1097/01.pas.0000213399.87816.56; Wolfram S., 2002, NEW KIND SCI	74	45	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20706	10.1371/journal.pone.0020706	http://dx.doi.org/10.1371/journal.pone.0020706			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698234	Green Published, gold, Green Submitted			2022-12-25	WOS:000291734100015
J	Konnyu, B; Czaran, T				Koennyu, Balazs; Czaran, Tamas			The Evolution of Enzyme Specificity in the Metabolic Replicator Model of Prebiotic Evolution	PLOS ONE			English	Article							RNA WORLD; CHEMICAL EVOLUTION; NUCLEIC-ACIDS; AMINO-ACIDS; ORIGIN; CATALYSIS; RIBOZYMES; LIFE; 1ST; PROMISCUITY	The chemical machinery of life must have been catalytic from the outset. Models of the chemical origins have attempted to explain the ecological mechanisms maintaining a minimum necessary diversity of prebiotic replicator enzymes, but little attention has been paid so far to the evolutionary initiation of that diversity. We propose a possible first step in this direction: based on our previous model of a surface-bound metabolic replicator system we try to explain how the adaptive specialization of enzymatic replicator populations might have led to more diverse and more efficient communities of cooperating replicators with two different enzyme activities. The key assumptions of the model are that mutations in the replicator population can lead towards a) both of the two different enzyme specificities in separate replicators: efficient "specialists" or b) a "generalist" replicator type with both enzyme specificities working at less efficiency, or c) a fast-replicating, non-enzymatic "parasite". We show that under realistic trade-off constraints on the phenotypic effects of these mutations the evolved replicator community will be usually composed of both types of specialists and of a limited abundance of parasites, provided that the replicators can slowly migrate on the mineral surface. It is only at very weak trade-offs that generalists take over in a phase-transition-like manner. The parasites do not seriously harm the system but can freely mutate, therefore they can be considered as pre-adaptations to later, useful functions that the metabolic system can adopt to increase its own fitness.	[Koennyu, Balazs] Eotvos Lorand Univ, Dept Plant Taxon & Ecol, Inst Biol, Budapest, Hungary; [Czaran, Tamas] Eotvos Lorand Univ, Inst Biol, Theoret Biol & Ecol Res Grp, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Konnyu, B (corresponding author), Eotvos Lorand Univ, Dept Plant Taxon & Ecol, Inst Biol, Budapest, Hungary.	czaran@ludens.elte.hu	Czárán, Tamás/P-4297-2019; Czárán, Tamás/A-1169-2008; Könnyű, Balázs/A-1912-2010	Czárán, Tamás/0000-0002-2722-6208; Czárán, Tamás/0000-0002-2722-6208; Könnyű, Balázs/0000-0002-9729-1224	Hungarian Research Foundation (OTKA) [K67907]	Hungarian Research Foundation (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The project was supported by the Hungarian Research Foundation (OTKA) Grant No. K67907. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Bartel DP, 1999, TRENDS GENET, V15, pM9, DOI 10.1016/S0168-9525(99)01898-3; Bielski R, 2007, ORIGINS LIFE EVOL B, V37, P167, DOI 10.1007/s11084-006-9022-9; BOERLIJST MC, 1991, PHYSICA D, V48, P17, DOI 10.1016/0167-2789(91)90049-F; Burton AS, 2010, J MOL EVOL, V70, P233, DOI 10.1007/s00239-010-9325-3; Cech TR, 2009, CELL, V136, P599, DOI 10.1016/j.cell.2009.02.002; Chen X, 2007, CHEM BIODIVERS, V4, P633, DOI 10.1002/cbdv.200790055; Czaran T, 2000, GEOMETRY ECOLOGICAL, P116, DOI 10.1613/jair.301; Eigen M, 1979, HYPERCYCLE; Ferris JP, 2006, PHILOS T R SOC B, V361, P1777, DOI 10.1098/rstb.2006.1903; FERRIS JP, 1978, J MOL EVOL, V11, P293, DOI 10.1007/BF01733839; FERRIS JP, 1984, TETRAHEDRON, V40, P1093, DOI 10.1016/S0040-4020(01)99315-9; Ferris JP, 1996, NATURE, V381, P59, DOI 10.1038/381059a0; Franchi M, 2005, GENE, V346, P205, DOI 10.1016/j.gene.2004.11.002; Franchi M, 2003, ORIGINS LIFE EVOL B, V33, P1, DOI 10.1023/A:1023982008714; GARAY J, 2010, BIOSYSTEMS IN PRESS; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Hayden EJ, 2006, CHEM BIOL, V13, P909, DOI 10.1016/j.chembiol.2006.06.014; Hazen RM, 2001, P NATL ACAD SCI USA, V98, P5487, DOI 10.1073/pnas.101085998; Huang Z, 2009, NUCLEIC ACIDS RES, V37, P4022, DOI 10.1093/nar/gkp284; JOYCE GF, 1984, NATURE, V310, P602, DOI 10.1038/310602a0; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; KACSER H, 1984, J MOL EVOL, V20, P38, DOI 10.1007/BF02101984; Karolyi G, 2000, P NATL ACAD SCI USA, V97, P13661, DOI 10.1073/pnas.240242797; KAUFFMAN SA, 1986, J THEOR BIOL, V119, P1, DOI 10.1016/S0022-5193(86)80047-9; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Konnyu B, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-267; Kun A, 2005, NAT GENET, V37, P1008, DOI 10.1038/ng1621; Landweber LF, 1998, BIOSCIENCE, V48, P94, DOI 10.2307/1313134; Lilley DMJ, 2003, TRENDS BIOCHEM SCI, V28, P495, DOI 10.1016/S0968-0004(03)00191-9; Ma W, 2007, RNA, V13, P2012, DOI 10.1261/rna.658507; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; Maynard-Smith J., 1979, NATURE, V280, P445; McConnell TS, 1997, BIOCHEMISTRY-US, V36, P8293, DOI 10.1021/bi9700678; McGinness KE, 2003, CHEM BIOL, V10, P5, DOI 10.1016/S1074-5521(03)00003-6; MESZENA G, 2001, SELECTION, V2, P147; Nelson KE, 2000, P NATL ACAD SCI USA, V97, P3868, DOI 10.1073/pnas.97.8.3868; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Orgel LE, 2003, ORIGINS LIFE EVOL B, V33, P211, DOI 10.1023/A:1024616317965; Powner MW, 2010, J AM CHEM SOC, V132, P16677, DOI 10.1021/ja108197s; Powner MW, 2009, NATURE, V459, P239, DOI 10.1038/nature08013; Riley CA, 2003, CHEM BIOL, V10, P1233, DOI 10.1016/j.chembiol.2003.11.015; ROBERTSON MP, 2010, COLD SPRING HARBOR P, P1; Scheuring I, 2003, ORIGINS LIFE EVOL B, V33, P319, DOI 10.1023/A:1025742505324; Scheuring I., 2000, SELECTION, V1, P13; Schultes EA, 2000, SCIENCE, V289, P448, DOI 10.1126/science.289.5478.448; Schwartz AW, 2006, PHILOS T R SOC B, V361, P1743, DOI 10.1098/rstb.2006.1901; Szabo P, 2002, NATURE, V420, P340, DOI 10.1038/nature01187; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; Szathmary E, 2007, PHILOS T R SOC B, V362, P1781, DOI 10.1098/rstb.2007.2070; vonKiedrowski G, 1996, NATURE, V381, P20, DOI 10.1038/381020a0; WACHTERSHAUSER G, 1990, P NATL ACAD SCI USA, V87, P200, DOI 10.1073/pnas.87.1.200; Wachtershauser G, 2000, SCIENCE, V289, P1307, DOI 10.1126/science.289.5483.1307; Wachtershauser G, 2007, CHEM BIODIVERS, V4, P584, DOI 10.1002/cbdv.200790052; Weber AL, 2008, ORIGINS LIFE EVOL B, V38, P279, DOI 10.1007/s11084-008-9141-6; Wochner A, 2011, SCIENCE, V332, P209, DOI 10.1126/science.1200752; Zintzaras E, 2002, J THEOR BIOL, V217, P167, DOI 10.1006/jtbi.2002.3026	57	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20931	10.1371/journal.pone.0020931	http://dx.doi.org/10.1371/journal.pone.0020931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698204	Green Submitted, Green Published, gold			2022-12-25	WOS:000291734100033
J	Massinen, S; Hokkanen, ME; Matsson, H; Tammimies, K; Tapia-Paez, I; Dahlstrom-Heuser, V; Kuja-Panula, J; Burghoorn, J; Jeppsson, KE; Swoboda, P; Peyrard-Janvid, M; Toftgard, R; Castren, E; Kere, J				Massinen, Satu; Hokkanen, Marie-Estelle; Matsson, Hans; Tammimies, Kristiina; Tapia-Paez, Isabel; Dahlstrom-Heuser, Vanina; Kuja-Panula, Juha; Burghoorn, Jan; Jeppsson, Kristian E.; Swoboda, Peter; Peyrard-Janvid, Myriam; Toftgard, Rune; Castren, Eero; Kere, Juha			Increased Expression of the Dyslexia Candidate Gene DCDC2 Affects Length and Signaling of Primary Cilia in Neurons	PLOS ONE			English	Article							HIPPOCAMPAL NEUROGENESIS; DCX SUPERFAMILY; NERVOUS-SYSTEM; C-ELEGANS; MIGRATION; BRAIN; DOUBLECORTIN; DYSFUNCTION; PROTEIN; KINASE	DCDC2 is one of the candidate susceptibility genes for dyslexia. It belongs to the superfamily of doublecortin domain containing proteins that bind to microtubules, and it has been shown to be involved in neuronal migration. We show that the Dcdc2 protein localizes to the primary cilium in primary rat hippocampal neurons and that it can be found within close proximity to the ciliary kinesin-2 subunit Kif3a. Overexpression of DCDC2 increases ciliary length and activates Shh signaling, whereas downregulation of Dcdc2 expression enhances Wnt signaling, consistent with a functional role in ciliary signaling. Moreover, DCDC2 overexpression in C. elegans causes an abnormal neuronal phenotype that can only be seen in ciliated neurons. Together our results suggest a potential role for DCDC2 in the structure and function of primary cilia.	[Massinen, Satu; Kere, Juha] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Massinen, Satu; Kere, Juha] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Hokkanen, Marie-Estelle; Dahlstrom-Heuser, Vanina; Kuja-Panula, Juha; Castren, Eero; Kere, Juha] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Matsson, Hans; Tammimies, Kristiina; Tapia-Paez, Isabel; Burghoorn, Jan; Jeppsson, Kristian E.; Swoboda, Peter; Peyrard-Janvid, Myriam; Toftgard, Rune; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Burghoorn, Jan; Jeppsson, Kristian E.; Swoboda, Peter] Sodertorn Univ Coll, Sch Life Sci, Huddinge, Sweden; [Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Karolinska Institutet; Sodertorn University	Massinen, S (corresponding author), Univ Helsinki, Res Programs Unit, Helsinki, Finland.	eero.castren@helsinki.fi	Tapia-Páez, Isabel/N-1210-2013; Kere, Juha/A-9179-2008; Matsson, Hans/A-5787-2019; Matsson, Hans/A-2502-2013; Tapia-Páez, Isabel/ABD-7197-2021; Kere, Juha/AAX-9117-2021	Kere, Juha/0000-0003-1974-0271; Matsson, Hans/0000-0001-6161-1559; Matsson, Hans/0000-0002-8193-4029; Kere, Juha/0000-0003-1974-0271; Tammimies, Kristiina/0000-0002-8324-4697; Castren, Eero/0000-0002-1402-2791; Swoboda, Peter/0000-0001-6416-8572; Tapia-Paez, Isabel/0000-0002-0535-4233	Sigrid Juselius Foundation; Academy of Finland [1117899]; Academy of Finland Center of Excellence; Finnish Graduate School of Neuroscience; Helsinki Biomedical Graduate School; Neuroscience Center of University of Helsinki; Swedish Research Council; Hjarnfonden (Sweden); Swedish Royal Bank Tercentennial Foundation; Knut and Alice Wallenberg Foundation; Swedish Foundation for Strategic Research; Carl Trygger Foundation; Lars Hiertas Minne Foundation	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Academy of Finland Center of Excellence(Academy of Finland); Finnish Graduate School of Neuroscience; Helsinki Biomedical Graduate School; Neuroscience Center of University of Helsinki; Swedish Research Council(Swedish Research CouncilEuropean Commission); Hjarnfonden (Sweden); Swedish Royal Bank Tercentennial Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Carl Trygger Foundation; Lars Hiertas Minne Foundation	This study was supported by the Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation), Academy of Finland Neuroscience Research Program (grant number 1117899), Academy of Finland Center of Excellence Program (http://www.aka.fi/en-gb/A/), Finnish Graduate School of Neuroscience (http://www.brain-mind.fi/), Helsinki Biomedical Graduate School (http://www.hbgs.helsinki.fi/Home.html), Neuroscience Center of University of Helsinki (http://www.helsinki.fi/neurosci/), Swedish Research Council (http://www.vr.se/inenglish), Hjarnfonden (Sweden) (http://www.hjarnfonden.se/), Swedish Royal Bank Tercentennial Foundation (http://www.rj.se/english/) and Knut and Alice Wallenberg Foundation (http://www.wallenberg.com/kaw/in_english/), the Swedish Foundation for Strategic Research (http://www.stratresearch.se/en/), the Carl Trygger Foundation (http://www.carltryggersstiftelse.se/), and the Lars Hiertas Minne Foundation (http://www.larshiertasminne.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews W, 2006, DEVELOPMENT, V133, P2243, DOI 10.1242/dev.02379; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; Burbridge TJ, 2008, NEUROSCIENCE, V152, P723, DOI 10.1016/j.neuroscience.2008.01.020; Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Coquelle FM, 2006, CELL CYCLE, V5, P976, DOI 10.4161/cc.5.9.2715; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Duncan S, 2010, BMC BIOINFORMATICS, V11, DOI [10.1186/1471-2105-11-100, 10.1186/1471-2105-11-S4-P10]; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gonczy P, 2001, DEV CELL, V1, P363, DOI 10.1016/S1534-5807(01)00046-6; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hannula-Jouppi K, 2005, PLOS GENET, V1, P467, DOI 10.1371/journal.pgen.0010050; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Kere J, 2011, WIRES COGN SCI, V2, P441, DOI 10.1002/wcs.138; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; Mayer U, 2009, PROTEOMICS, V9, P322, DOI 10.1002/pmic.200800149; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Meng HY, 2005, P NATL ACAD SCI USA, V102, P17053, DOI 10.1073/pnas.0508591102; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Poelmans G, 2009, AM J MED GENET B, V150B, P140, DOI 10.1002/ajmg.b.30787; Reiner O, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-188; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Traiffort E, 2010, J NEUROCHEM, V113, P576, DOI 10.1111/j.1471-4159.2010.06642.x; Wang Y, 2006, NEUROSCIENCE, V143, P515, DOI 10.1016/j.neuroscience.2006.08.022; Wemmer KA, 2007, INT REV CYTOL, V260, P175, DOI 10.1016/S0074-7696(06)60004-1; Willaredt MA, 2008, J NEUROSCI, V28, P12887, DOI 10.1523/JNEUROSCI.2084-08.2008; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	41	80	82	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20580	10.1371/journal.pone.0020580	http://dx.doi.org/10.1371/journal.pone.0020580			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698230	Green Published, Green Submitted, gold			2022-12-25	WOS:000291734100009
J	Stuhrwohldt, N; Dahlke, RI; Steffens, B; Johnson, A; Sauter, M				Stuehrwohldt, Nils; Dahlke, Renate I.; Steffens, Bianka; Johnson, Amanda; Sauter, Margret			Phytosulfokine-alpha Controls Hypocotyl Length and Cell Expansion in Arabidopsis thaliana through Phytosulfokine Receptor 1	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; GROWTH; PEPTIDE; BINDING; PROLIFERATION; MAINTENANCE; PRECURSOR	The disulfated peptide growth factor phytosulfokine-alpha (PSK-alpha) is perceived by LRR receptor kinases. In this study, a role for PSK signaling through PSK receptor PSKR1 in Arabidopsis thaliana hypocotyl cell elongation is established. Hypocotyls of etiolated pskr1-2 and pskr1-3 seedlings, but not of pskr2-1 seedlings were shorter than wt due to reduced cell elongation. Treatment with PSK-alpha did not promote hypocotyl growth indicating that PSK levels were saturating. Tyrosylprotein sulfotransferase (TPST) is responsible for sulfation and hence activation of the PSK precursor. The tpst-1 mutant displayed shorter hypocotyls with shorter cells than wt. Treatment of tpst-1 seedlings with PSK-alpha partially restored elongation growth in a dose-dependent manner. Hypocotyl elongation was significantly enhanced in tpst-1 seedlings at nanomolar PSK-alpha concentrations. Cell expansion was studied in hypocotyl protoplasts. WT and pskr2-1 protoplasts expanded in the presence of PSK-alpha in a dose-dependent manner. By contrast, pskr1-2 and pskr1-3 protoplasts were unresponsive to PSK-alpha. Protoplast swelling in response to PSK-alpha was unaffected by ortho-vanadate, which inhibits the plasma membrane H+-ATPase. In maize (Zea mays L.), coleoptile protoplast expansion was similarly induced by PSK-alpha in a dose-dependent manner and was dependent on the presence of K+ in the media. In conclusion, PSK-alpha signaling of hypocotyl elongation and protoplast expansion occurs through PSKR1 and likely involves K+ uptake, but does not require extracellular acidification by the plasma membrane H+-ATPase.	[Stuehrwohldt, Nils; Dahlke, Renate I.; Steffens, Bianka; Johnson, Amanda; Sauter, Margret] Univ Kiel, Kiel, Germany	University of Kiel	Stuhrwohldt, N (corresponding author), Univ Kiel, Kiel, Germany.	msauter@bot.uni-kiel.de	Steffens, Bianka/A-7278-2014; Stührwohldt, Nils/U-6393-2019	Stuhrwohldt, Nils/0000-0003-4166-3786				Amano Y, 2007, P NATL ACAD SCI USA, V104, P18333, DOI 10.1073/pnas.0706403104; Ambesi A, 2000, J EXP BIOL, V203, P155; BOTTGER M, 1978, PLANTA, V140, P89, DOI 10.1007/BF00389385; CLELAND RE, 1976, BIOCHEM BIOPH RES CO, V69, P333, DOI 10.1016/0006-291X(76)90526-X; CLINT GM, 1989, PLANTA, V178, P495, DOI 10.1007/BF00963820; DUPONT FM, 1982, PLANT PHYSIOL, V70, P1694, DOI 10.1104/pp.70.6.1694; Elumalai RP, 2002, PLANT CELL, V14, P119, DOI 10.1105/tpc.010322; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Kanczewska J, 2005, P NATL ACAD SCI USA, V102, P11675, DOI 10.1073/pnas.0504498102; Karcz W, 2002, J EXP BOT, V53, P1089, DOI 10.1093/jexbot/53.371.1089; Kim TW, 2007, PLANT CELL ENVIRON, V30, P679, DOI 10.1111/j.1365-3040.2007.01659.x; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Komori R, 2009, P NATL ACAD SCI USA, V106, P15067, DOI 10.1073/pnas.0902801106; Kutschmar A, 2009, NEW PHYTOL, V181, P820, DOI 10.1111/j.1469-8137.2008.02710.x; Lorbiecke R, 2002, PLANT SCI, V163, P321, DOI 10.1016/S0168-9452(02)00101-2; MARRE E, 1979, ANNU REV PLANT PHYS, V30, P273, DOI 10.1146/annurev.pp.30.060179.001421; Matsubayashi Y, 2002, SCIENCE, V296, P1470, DOI 10.1126/science.1069607; Matsubayashi Y, 1999, EUR J BIOCHEM, V262, P666, DOI 10.1046/j.1432-1327.1999.00409.x; Matsubayashi Y, 1997, P NATL ACAD SCI USA, V94, P13357, DOI 10.1073/pnas.94.24.13357; Matsubayashi Y, 1996, P NATL ACAD SCI USA, V93, P7623, DOI 10.1073/pnas.93.15.7623; Matsubayashi Y, 2006, PLANT PHYSIOL, V142, P45, DOI 10.1104/pp.106.081109; Matsuzaki Y, 2010, SCIENCE, V329, P1065, DOI 10.1126/science.1191132; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; ONEILL SD, 1984, PLANT PHYSIOL, V75, P586, DOI 10.1104/pp.75.3.586; Pertl H, 2010, PLANT PHYSIOL, V154, P1921, DOI 10.1104/pp.110.165696; Philippar K, 2004, PLANT J, V37, P815, DOI 10.1111/j.1365-313X.2003.02006.x; Savaldi-Goldstein S, 2008, CURR OPIN PLANT BIOL, V11, P42, DOI 10.1016/j.pbi.2007.10.009; Shinohara H, 2007, J BIOL CHEM, V282, P124, DOI 10.1074/jbc.M604558200; Steffens B, 2000, PLANT GROWTH REGUL, V32, P115, DOI 10.1023/A:1010789125122; van den Wijngaard PWJ, 2005, PLANT J, V41, P43, DOI 10.1111/j.1365-313X.2004.02273.x; Vandenbussche F, 2005, BIOESSAYS, V27, P275, DOI 10.1002/bies.20199; Yang HP, 2000, PLANT CELL PHYSIOL, V41, P825, DOI 10.1093/pcp/pcd009; Yang HP, 2001, PLANT PHYSIOL, V127, P842, DOI 10.1104/pp.010452; Zhou WK, 2010, PLANT CELL, V22, P3692, DOI 10.1105/tpc.110.075721	34	59	61	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21054	10.1371/journal.pone.0021054	http://dx.doi.org/10.1371/journal.pone.0021054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698171	Green Published, Green Submitted, gold			2022-12-25	WOS:000291734100047
J	Cardoen, D; Ernst, UR; Van Vaerenbergh, M; Boerjan, B; de Graaf, DC; Wenseleers, T; Schoofs, L; Verleyen, P				Cardoen, Dries; Ernst, Ulrich R.; Van Vaerenbergh, Matthias; Boerjan, Bart; de Graaf, Dirk C.; Wenseleers, Tom; Schoofs, Liliane; Verleyen, Peter			Differential Proteomics in Dequeened Honeybee Colonies Reveals Lower Viral Load in Hemolymph of Fertile Worker Bees	PLOS ONE			English	Article							APIS-MELLIFERA L.; GENOME-WIDE ANALYSIS; BRAIN GENE-EXPRESSION; DEFORMED-WING-VIRUS; PICORNA-LIKE VIRUS; JUVENILE-HORMONE; OVARY DEVELOPMENT; THIOREDOXIN PEROXIDASE; VARROA DESTRUCTOR; INSECT SOCIETIES	The eusocial societies of honeybees, where the queen is the only fertile female among tens of thousands sterile worker bees, have intrigued scientists for centuries. The proximate factors, which cause the inhibition of worker bee ovaries, remain largely unknown; as are the factors which cause the activation of worker ovaries upon the loss of queen and brood in the colony. In an attempt to reveal key players in the regulatory network, we made a proteomic comparison of hemolymph profiles of workers with completely activated ovaries vs. rudimentary ovaries. An unexpected finding of this study is the correlation between age matched worker sterility and the enrichment of Picorna-like virus proteins. Fertile workers, on the other hand, show the upregulation of potential components of the immune system. It remains to be investigated whether viral infections contribute to worker sterility directly or are the result of a weaker immune system of sterile workers.	[Cardoen, Dries; Ernst, Ulrich R.; Boerjan, Bart; Schoofs, Liliane; Verleyen, Peter] Katholieke Univ Leuven, Res Grp Funct Genom & Prote, Leuven, Belgium; [Ernst, Ulrich R.; Wenseleers, Tom] Katholieke Univ Leuven, Entomol Lab, Leuven, Belgium; [Van Vaerenbergh, Matthias; de Graaf, Dirk C.] Univ Ghent, Lab Zoophysiol, B-9000 Ghent, Belgium	KU Leuven; KU Leuven; Ghent University	Cardoen, D (corresponding author), Katholieke Univ Leuven, Res Grp Funct Genom & Prote, Leuven, Belgium.	dries.cardoen@bio.kuleuven.be	Ernst, Uli/AAJ-6768-2020; schoofs, liliane/ABD-2943-2020; Wenseleers, Tom/J-3960-2013; de Graaf, Dirk C./HGD-4017-2022; Ernst, Ulrich R/C-2575-2011; Schoofs, Liliane/F-2815-2010	Ernst, Uli/0000-0002-6330-5341; Wenseleers, Tom/0000-0002-1434-861X; Ernst, Ulrich R/0000-0002-6330-5341; Schoofs, Liliane/0000-0002-1673-432X	Research Foundation of Flanders (FWO-Flanders) [G041708N, GO62811N]; K.U.Leuven Research Foundation [GOA 2010/14]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)	Research Foundation of Flanders (FWO-Flanders)(FWO); K.U.Leuven Research Foundation; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	The authors gratefully acknowledge the Research Foundation of Flanders (FWO-Flanders G041708N and GO62811N) and the K.U.Leuven Research Foundation (GOA 2010/14) for financial support. DC, UE and MVV are funded by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen). BB is an FWO fellow and PV an FWO postdoc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2009, GENES BRAIN BEHAV, V8, P309, DOI 10.1111/j.1601-183X.2009.00480.x; Amdam GV, 2005, EXP GERONTOL, V40, P939, DOI 10.1016/j.exger.2005.08.004; Baer B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r67; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogaerts A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-11; Bogaerts A, 2009, PROTEOMICS, V9, P3201, DOI 10.1002/pmic.200800604; Briand L, 2001, EUR J BIOCHEM, V268, P752, DOI 10.1046/j.1432-1327.2001.01927.x; Capella ICS, 1998, J INSECT PHYSIOL, V44, P385, DOI 10.1016/S0022-1910(98)00027-4; Chan QWT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r156; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Chen TH, 2011, VIROLOGY, V410, P410, DOI 10.1016/j.virol.2010.12.013; Collins AM, 2006, INSECT MOL BIOL, V15, P541, DOI 10.1111/j.1365-2583.2006.00674.x; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; Cristino AS, 2006, INSECT MOL BIOL, V15, P703, DOI 10.1111/j.1365-2583.2006.00696.x; Danty E, 1999, J NEUROSCI, V19, P7468, DOI 10.1523/JNEUROSCI.19-17-07468.1999; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Fujiyuki T, 2004, J VIROL, V78, P1093, DOI 10.1128/JVI.78.3.1093-1100.2004; Fujiyuki T, 2009, J VIROL, V83, P11560, DOI 10.1128/JVI.00519-09; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; Gauthier L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016217; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grozinger CM, 2007, MOL ECOL, V16, P4837, DOI 10.1111/j.1365-294X.2007.03545.x; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; Haenen S, 2010, J PROTEOME RES, V9, P5868, DOI 10.1021/pr100638m; Hartfelder K, 2000, BRAZ J MED BIOL RES, V33, P157, DOI 10.1590/S0100-879X2000000200003; Hartfelder K, 2002, INSECT BIOCHEM MOLEC, V32, P211, DOI 10.1016/S0965-1748(01)00100-X; HARTFELDER K, 1998, SOCIAL INSECT POLYMO; Hoover SER, 2003, NATURWISSENSCHAFTEN, V90, P477, DOI 10.1007/s00114-003-0462-z; Kocher SD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-232; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Lee KS, 2005, INSECT BIOCHEM MOLEC, V35, P73, DOI 10.1016/j.ibmb.2004.09.008; Maisonnasse A, 2009, APIDOLOGIE, V40, P562, DOI 10.1051/apido/2009024; Miller DG, 2001, INSECT SOC, V48, P178, DOI 10.1007/PL00001762; Mohammedi A, 1998, NATURWISSENSCHAFTEN, V85, P455, DOI 10.1007/s001140050531; Moore J, 2011, J GEN VIROL, V92, P156, DOI 10.1099/vir.0.025965-0; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; Peiren N, 2008, TOXICON, V52, P72, DOI 10.1016/j.toxicon.2008.05.003; Pelletier J, 2010, J CHEM ECOL, V36, P245, DOI 10.1007/s10886-010-9762-x; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; RACHINSKY A, 1990, GEN COMP ENDOCR, V79, P31, DOI 10.1016/0016-6480(90)90085-Z; Randolt K, 2008, ARCH INSECT BIOCHEM, V69, P155, DOI 10.1002/arch.20269; RATNIEKS FLW, 1993, BEHAV ECOL SOCIOBIOL, V32, P191, DOI 10.1007/BF00173777; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; Ratnieks FLW, 2008, TRENDS ECOL EVOL, V23, P45, DOI 10.1016/j.tree.2007.09.013; Robinson GE, 1997, ARCH INSECT BIOCHEM, V35, P559, DOI 10.1002/(SICI)1520-6327(1997)35:4<559::AID-ARCH13>3.0.CO;2-9; Roossinck MJ, 1997, ANNU REV PHYTOPATHOL, V35, P191, DOI 10.1146/annurev.phyto.35.1.191; Schmid MR, 2008, J INSECT PHYSIOL, V54, P439, DOI 10.1016/j.jinsphys.2007.11.002; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; Sullivan DT, 2003, J EXP BIOL, V206, P2031, DOI 10.1242/jeb.00367; Thompson GJ, 2008, INSECT MOL BIOL, V17, P657, DOI 10.1111/j.1365-2583.2008.00838.x; Thompson GJ, 2006, INSECT MOL BIOL, V15, P637, DOI 10.1111/j.1365-2583.2006.00678.x; Vierstraete E, 2004, P NATL ACAD SCI USA, V101, P470, DOI 10.1073/pnas.0304567101; VISSCHER PK, 1989, BEHAV ECOL SOCIOBIOL, V25, P247, DOI 10.1007/BF00300050; Wang Y, 2001, FREE RADICAL BIO MED, V31, P1448, DOI 10.1016/S0891-5849(01)00728-6; Wang Y, 2010, J INSECT PHYSIOL, V56, P1816, DOI 10.1016/j.jinsphys.2010.07.013; Wenseleers T, 2006, NATURE, V444, P50, DOI 10.1038/444050a; WILSONRICH N, 2010, J INSECT PHYSL, V54, P1392; Wolschin F, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-10; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zhang P, 1997, J BIOL CHEM, V272, P30615, DOI 10.1074/jbc.272.49.30615; Zou Z, 2006, INSECT MOL BIOL, V15, P603, DOI 10.1111/j.1365-2583.2006.00684.x	65	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20043	10.1371/journal.pone.0020043	http://dx.doi.org/10.1371/journal.pone.0020043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698281	gold, Green Published, Green Submitted			2022-12-25	WOS:000291730000007
J	Maccani, MA; Padbury, JF; Marsit, CJ				Maccani, Matthew A.; Padbury, James F.; Marsit, Carmen J.			miR-16 and miR-21 Expression in the Placenta Is Associated with Fetal Growth	PLOS ONE			English	Article							CIGARETTE-SMOKING; CELL; MICRORNAS; PTEN; PREGNANCY; OVARIAN; GENE	Background: Novel research has suggested that altered miRNA expression in the placenta is associated with adverse pregnancy outcomes and with potentially harmful xenobiotic exposures. We hypothesized that aberrant expression of miRNA in the placenta is associated with fetal growth, a measurable phenotype resulting from a number of intrauterine factors, and one which is significantly predictive of later life outcomes. Methodology/Principal Findings: We analyzed 107 primary, term, human placentas for expression of 6 miRNA reported to be expressed in the placenta and to regulate cell growth and development pathways: miR-16, miR-21, miR-93, miR-135b, miR-146a, and miR-182. The expression of miR-16 and miR-21 was markedly reduced in infants with the lowest birthweights (p < 0.05). Logistic regression models suggested that low expression of miR-16 in the placenta predicts an over 4-fold increased odds of small for gestational age (SGA) status (p = 0.009, 95% CI = 1.42, 12.05). Moreover, having both low miR-16 and low miR-21 expression in the placenta predicts a greater increase in odds for SGA than having just low miR-16 or miR-21 expression (p < 0.02), suggesting an additive effect of both of these miRNA. Conclusions/Significance: Our study is one of the first to investigate placental miRNA expression profiles associated with birthweight and SGA status. Future research on miRNA whose expression is associated with in utero exposures and markers of fetal growth is essential for better understanding the epigenetic mechanisms underlying the developmental origins of health and disease.	[Maccani, Matthew A.; Marsit, Carmen J.] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA; [Padbury, James F.] Brown Univ, Women & Infants Hosp, Dept Pediat, Providence, RI 02908 USA; [Marsit, Carmen J.] Brown Univ, Dept Community Hlth, Ctr Environm Hlth & Technol, Providence, RI 02912 USA	Brown University; Brown University; Women & Infants Hospital Rhode Island; Brown University	Maccani, MA (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	Carmen_Marsit@brown.edu		Marsit, Carmen/0000-0003-4566-150X	NIEHS [P42ES013660, T32ES007272]; NCRR [P20 RR018728]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007272, P42ES013660] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by National Institutes of Health grants from the NIEHS (P42ES013660 and T32ES007272 to MAM) and the NCRR (P20 RR018728). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1984, J PSYCHOACTIVE DRUGS, V16, P327, DOI 10.1080/02791072.1984.10472303; Argente J, 2010, PEDIATR NEPHROL, V25, P679, DOI 10.1007/s00467-009-1432-2; Avila L, 2010, PLACENTA, V31, P1070, DOI 10.1016/j.placenta.2010.09.011; Avissar-Whiting M, 2010, REPROD TOXICOL, V29, P401, DOI 10.1016/j.reprotox.2010.04.004; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bissels U, 2009, RNA, V15, P2375, DOI 10.1261/rna.1754109; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Chen RW, 2008, BLOOD, V112, P822, DOI 10.1182/blood-2008-03-142182; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Desai M, 2007, REPROD SCI, V14, P329, DOI 10.1177/1933719107303983; Du TT, 2007, CELL RES, V17, P661, DOI 10.1038/cr.2007.67; Esposito ER, 2008, TOXICOLOGY, V246, P193, DOI 10.1016/j.tox.2008.01.014; Fenton Tanis R, 2003, BMC Pediatr, V3, P13; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Kaddar T, 2009, BIOL CELL, V101, P511, DOI 10.1042/BC20080213; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Lou YH, 2010, INT J MOL MED, V26, P819, DOI 10.3892/ijmm_00000530; MACCANI MA, 2010, EPIGENETICS, V5; Maccani MA, 2010, EPIGENETICS-US, V5, P583, DOI 10.4161/epi.5.7.12762; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; Mouillet JF, 2010, FASEB J, V24, P2030, DOI 10.1096/fj.09-149724; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Shea AK, 2008, NICOTINE TOB RES, V10, P267, DOI 10.1080/14622200701825908; Shiverick KT, 1999, PLACENTA, V20, P265, DOI 10.1053/plac.1998.0377; Tamashiro KLK, 2010, PHYSIOL BEHAV, V100, P560, DOI 10.1016/j.physbeh.2010.04.008; Tokyol C, 2008, UPSALA J MED SCI, V113, P235, DOI 10.3109/2000-1967-231; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996	35	112	119	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21210	10.1371/journal.pone.0021210	http://dx.doi.org/10.1371/journal.pone.0021210			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698265	Green Submitted, gold, Green Published			2022-12-25	WOS:000291730000062
J	Henry, LK; Iwamoto, H; Field, JR; Kaufmann, K; Dawson, ES; Jacobs, MT; Adams, C; Felts, B; Zdravkovic, I; Armstrong, V; Combs, S; Solis, E; Rudnick, G; Noskov, SY; DeFelice, LJ; Meiler, J; Blakely, RD				Henry, L. Keith; Iwamoto, Hideki; Field, Julie R.; Kaufmann, Kristian; Dawson, Eric S.; Jacobs, Miriam T.; Adams, Chelsea; Felts, Bruce; Zdravkovic, Igor; Armstrong, Vanessa; Combs, Steven; Solis, Ernesto; Rudnick, Gary; Noskov, Sergei Y.; DeFelice, Louis J.; Meiler, Jens; Blakely, Randy D.			A Conserved Asparagine Residue in Transmembrane Segment 1 (TM1) of Serotonin Transporter Dictates Chloride-coupled Neurotransmitter Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; DOPAMINE TRANSPORTER; DOMAIN-I; MOLECULAR-MECHANISM; ALTERNATING ACCESS; SIDE-CHAIN; RAT-BRAIN; SUBSTRATE RECOGNITION; SCANNING MUTAGENESIS; PERMEATION PATHWAY	Na+- and Cl--dependent uptake of neurotransmitters via transporters of the SLC6 family, including the human serotonin transporter (SLC6A4), is critical for efficient synaptic transmission. Although residues in the human serotonin transporter involved in direct Cl- coordination of human serotonin transport have been identified, the role of Cl- in the transport mechanism remains unclear. Through a combination of mutagenesis, chemical modification, substrate and charge flux measurements, and molecular modeling studies, we reveal an unexpected role for the highly conserved transmembrane segment 1 residue Asn-101 in coupling Cl- binding to concentrative neurotransmitter uptake.	[Henry, L. Keith] Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58203 USA; [Zdravkovic, Igor; Noskov, Sergei Y.] Univ Calgary, Dept Biol Sci, Inst Biocomplex & Informat, Calgary, AB T2N 1N4, Canada; [Jacobs, Miriam T.; Rudnick, Gary] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Henry, L. Keith; Iwamoto, Hideki; Field, Julie R.; Solis, Ernesto; DeFelice, Louis J.; Meiler, Jens; Blakely, Randy D.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; [Kaufmann, Kristian; Combs, Steven; Meiler, Jens] Vanderbilt Univ, Sch Med, Dept Chem, Nashville, TN 37232 USA; [Dawson, Eric S.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Blakely, Randy D.] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37232 USA; [DeFelice, Louis J.; Blakely, Randy D.] Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Nashville, TN 37232 USA; [Henry, L. Keith; Dawson, Eric S.; Meiler, Jens] Vanderbilt Univ, Sch Med, Struct Biol Ctr, Nashville, TN 37232 USA; [Dawson, Eric S.] Vanderbilt Univ, Sch Med, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA	University of North Dakota Grand Forks; University of Calgary; Yale University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Henry, LK (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Ste 3700,501 N Columbia Rd, Grand Forks, ND 58203 USA.	keith.henry@med.und.edu; randy.blakely@vanderbilt.edu		De Felice, Louis/0000-0002-4594-3171; Solis, Jr., Ernesto/0000-0001-9406-9540; Meiler, Jens/0000-0001-8945-193X; Noskov, Sergei/0000-0001-7769-335X; Jacobs, Miriam/0000-0002-8831-7592	NIDA; NINDS; NIGMS; NARSAD; Center for Structural Biology at Vanderbilt University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008213] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NARSAD(NARSAD); Center for Structural Biology at Vanderbilt University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants from NIDA (to L.K.H., G.R., and R.D.B.), NINDS (to H.I. and L.J.D.), and NIGMS (to J.M.). This work was also supported by NARSAD (to L.K.H.) and the Center for Structural Biology at Vanderbilt University.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Adams SV, 2003, BIOPHYS J, V85, P1548, DOI 10.1016/S0006-3495(03)74587-1; Adams SV, 2002, BIOPHYS J, V83, P3268, DOI 10.1016/S0006-3495(02)75328-9; Adkins EM, 2001, MOL PHARMACOL, V59, P514, DOI 10.1124/mol.59.3.514; Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Anisimov VM, 2005, J CHEM THEORY COMPUT, V1, P153, DOI 10.1021/ct049930p; Barker EL, 1999, J NEUROSCI, V19, P4705; Barker EL, 1998, J BIOL CHEM, V273, P19459, DOI 10.1074/jbc.273.31.19459; Barker Eric L., 1995, P321; BAYLY CI, 1994, J AM CHEM SOC, V116, P697, DOI 10.1021/ja00081a034; Ben-Yona A, 2011, J BIOL CHEM, V286, P2826, DOI 10.1074/jbc.M110.149732; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Cao YW, 1998, J NEUROSCI, V18, P7739; Caplan DA, 2008, BIOPHYS J, V95, P4613, DOI 10.1529/biophysj.108.139741; Carvelli L, 2004, P NATL ACAD SCI USA, V101, P16046, DOI 10.1073/pnas.0403299101; Carvelli L, 2008, P NATL ACAD SCI USA, V105, P14192, DOI 10.1073/pnas.0802214105; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; Chang AS, 1998, J PHYSIOL-LONDON, V510, P903, DOI 10.1111/j.1469-7793.1998.903bj.x; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; COREY JL, 1994, P NATL ACAD SCI USA, V91, P1188, DOI 10.1073/pnas.91.3.1188; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Field JR, 2010, J BIOL CHEM, V285, P11270, DOI 10.1074/jbc.M109.093658; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Foloppe N, 2007, J MOL BIOL, V372, P798, DOI 10.1016/j.jmb.2007.05.101; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Galli A, 1998, P NATL ACAD SCI USA, V95, P13260, DOI 10.1073/pnas.95.22.13260; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Hilber B, 2005, NEUROPHARMACOLOGY, V49, P811, DOI 10.1016/j.neuropharm.2005.08.008; HOFFMAN BJ, 1989, FEBS LETT, V247, P453, DOI 10.1016/0014-5793(89)81390-0; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; Jang IS, 2001, J NEUROSCI, V21, P5962, DOI 10.1523/JNEUROSCI.21-16-05962.2001; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; KANAI Y, 1992, AM J PHYSIOL, V263, pF1087, DOI 10.1152/ajprenal.1992.263.6.F1087; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; Kaufmann KW, 2009, PROTEINS, V74, P630, DOI 10.1002/prot.22178; Li LB, 2008, J PHYS CHEM B, V112, P9574, DOI 10.1021/jp7114912; Lin F, 1996, BIOPHYS J, V71, P3126, DOI 10.1016/S0006-3495(96)79506-1; LINGJAERDE O, 1971, ACTA PHYSIOL SCAND, V81, P75, DOI 10.1111/j.1748-1716.1971.tb04878.x; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; Mager S, 1998, METHOD ENZYMOL, V296, P551; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mitchell SM, 2004, J BIOL CHEM, V279, P24089, DOI 10.1074/jbc.M311173200; NELSON MT, 1982, J MEMBRANE BIOL, V69, P213, DOI 10.1007/BF01870400; NELSON PJ, 1982, J BIOL CHEM, V257, P6151; Ni YS, 2001, J BIOL CHEM, V276, P27329, DOI 10.1074/jbc.M102258200; Noskov SY, 2008, PROTEINS, V73, P851, DOI 10.1002/prot.22108; Petersen CI, 1999, NAT NEUROSCI, V2, P605, DOI 10.1038/10158; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Quick MW, 2003, NEURON, V40, P537, DOI 10.1016/S0896-6273(03)00605-6; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Ramsey IS, 2002, J BIOL CHEM, V277, P14475, DOI 10.1074/jbc.M110783200; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Rudnick G., 2002, TRANSMEMBRANE TRANSP, P125; Schroeter S, 1996, ANN NY ACAD SCI, V801, P239, DOI 10.1111/j.1749-6632.1996.tb17446.x; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Simonson T, 2004, J AM CHEM SOC, V126, P4167, DOI 10.1021/ja039788m; Sonders MS, 1997, J NEUROSCI, V17, P960; Sung U, 2007, MOL CELL NEUROSCI, V34, P251, DOI 10.1016/j.mcn.2006.11.007; Swanson JMJ, 2004, BIOPHYS J, V86, P67, DOI 10.1016/S0006-3495(04)74084-9; Tavoulari S, 2011, J BIOL CHEM, V286, P2834, DOI 10.1074/jbc.M110.186064; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	76	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30823	30836		10.1074/jbc.M111.250308	http://dx.doi.org/10.1074/jbc.M111.250308			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730057	hybrid, Green Published			2022-12-25	WOS:000294283600062
J	Samant, GV; Schupp, MO; Francois, M; Moleri, S; Kothinti, RK; Chun, CZ; Sinha, I; Sellars, S; Leigh, N; Pramanik, K; Horswill, MA; Remadevi, I; Li, KG; Wilkinson, GA; Tabatabai, NM; Beltrame, M; Koopman, P; Ramchandran, R				Samant, Ganesh V.; Schupp, Marcus O.; Francois, Mathias; Moleri, Silvia; Kothinti, Rajendra K.; Chun, Chang Zoon; Sinha, Indranil; Sellars, Suzanna; Leigh, Noah; Pramanik, Kallal; Horswill, Mark A.; Remadevi, Indulekha; Li, Keguo; Wilkinson, George A.; Tabatabai, Niloofar M.; Beltrame, Monica; Koopman, Peter; Ramchandran, Ramani			Sox Factors Transcriptionally Regulate ROBO4 Gene Expression in Developing Vasculature in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUNDANT ROLES; LYMPHATIC VASCULATURE; NEURAL CREST; IN-VIVO; PROMOTER; BINDING; MICE; MUTATIONS; RECEPTOR; CADMIUM	Despite their importance as members of the Roundabout (Robo) family in the control of axonal and vascular patterning, the transcriptional regulation of these genes is poorly understood. In this study, we show that members of the Sry-related high mobility box (Sox) transcription factor family as being transcriptional regulators of roundabout4 (robo4), a Robo gene family member that participates in sprouting angiogenesis in vivo, in zebrafish. Double whole mount in situ hybridization analysis in zebrafish embryos revealed co-localization of the vascular relevant Sox factors sox7 or sox18 mRNA with robo4 transcripts in developing intersomitic vessels. A 3-kb human ROBO4 promoter element was able to drive reporter expression in zebrafish to recapitulate the endogenous temporal intersomitic vessel expression pattern of robo4. EMSA analysis confirmed binding of Sox18 to a canonical Sox binding site (from -1170 bp to -1176 bp) in the ROBO4 promoter (3 kb), and mutation analysis indicated that this site was partially responsible for ROBO4 promoter activity in ECs. A combination of gain-and loss-of-function analysis identified Sox7 and Sox18 co-regulation of robo4 but not fli1a transcripts in zebrafish. Finally, Sox-mediated robo4 transcriptional regulation is conserved across evolution. These studies imply Sox-mediated transcriptional regulation of Robo4 in the developing embryonic vasculature.	[Samant, Ganesh V.; Schupp, Marcus O.; Chun, Chang Zoon; Sinha, Indranil; Sellars, Suzanna; Leigh, Noah; Horswill, Mark A.; Remadevi, Indulekha; Li, Keguo; Wilkinson, George A.; Ramchandran, Ramani] Med Coll Wisconsin, Div Dev Biol, Dev Vasc Biol Program, Dept Pediat,Childrens Res Inst, Milwaukee, WI 53226 USA; [Francois, Mathias; Koopman, Peter] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Pramanik, Kallal] Prescient Life Sci, New Delhi 122002, India; [Moleri, Silvia; Beltrame, Monica] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-2620133 Milan, Italy; [Kothinti, Rajendra K.; Tabatabai, Niloofar M.] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Kothinti, Rajendra K.; Tabatabai, Niloofar M.] Med Coll Wisconsin, Kidney Dis Ctr, Milwaukee, WI 53226 USA	Medical College of Wisconsin; University of Queensland; University of Milan; Medical College of Wisconsin; Medical College of Wisconsin	Ramchandran, R (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	rramchan@mcw.edu	moleri, silvia/AAA-8523-2020; Koopman, Peter A/C-9416-2009; Beltrame, Monica/D-8093-2017; francois, mathias/A-9604-2014	Koopman, Peter A/0000-0001-6939-0914; francois, mathias/0000-0002-9846-6882; Beltrame, Monica/0000-0001-5094-3494; MOLERI, SILVIA/0000-0003-2277-1378	National Institutes of Health [HL090712]; Advancing Healthier Wisconsin grant; Children's Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Advancing Healthier Wisconsin grant; Children's Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL090712 and an administrative supplement to HL090712 (to R.R.). This work was also supported by an Advancing Healthier Wisconsin grant and Children's Research Institute seed funds (to R.R.).	Bedell VM, 2005, P NATL ACAD SCI USA, V102, P6373, DOI 10.1073/pnas.0408318102; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Francois M, 2010, INT J BIOCHEM CELL B, V42, P445, DOI 10.1016/j.biocel.2009.08.017; Herpers R, 2008, CIRC RES, V102, P12, DOI 10.1161/CIRCRESAHA.107.166066; Honore SM, 2003, DEV BIOL, V260, P79, DOI 10.1016/S0012-1606(03)00247-1; James K, 2003, GENESIS, V36, P1, DOI 10.1002/gene.10190; Kaus S, 2006, J BIOL CHEM, V281, P11347, DOI 10.1074/jbc.M508853200; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kothinti RK, 2010, TOXICOL APPL PHARM, V244, P254, DOI 10.1016/j.taap.2009.12.038; Okada Y, 2008, BLOOD, V112, P2336, DOI 10.1182/blood-2008-01-135079; Okada Y, 2007, CIRC RES, V100, P1712, DOI 10.1161/01.RES.0000269779.10644.dc; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Pendeville H, 2008, DEV BIOL, V317, P405, DOI 10.1016/j.ydbio.2008.01.028; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Pennisi D, 2000, MOL CELL BIOL, V20, P9331, DOI 10.1128/MCB.20.24.9331-9336.2000; Sakamoto Y, 2007, BIOCHEM BIOPH RES CO, V360, P539, DOI 10.1016/j.bbrc.2007.06.093; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Srinivasan RS, 2010, GENE DEV, V24, P696, DOI 10.1101/gad.1859310; Tabatabai NA, 2005, TOXICOLOGY, V207, P369, DOI 10.1016/j.tox.2004.10.007; Young N, 2006, J NATL CANCER I, V98, P1060, DOI 10.1093/jnci/djj299	25	14	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30740	30747		10.1074/jbc.M111.220665	http://dx.doi.org/10.1074/jbc.M111.220665			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730073	Green Published, hybrid			2022-12-25	WOS:000294283600054
J	Bayle, DJ; Schoendorff, B; Henaff, MA; Krolak-Salmon, P				Bayle, Dimitri J.; Schoendorff, Benjamin; Henaff, Marie-Anne; Krolak-Salmon, Pierre			Emotional Facial Expression Detection in the Peripheral Visual Field	PLOS ONE			English	Article							SPATIAL-FREQUENCY; FACE PERCEPTION; RECOGNITION; AMYGDALA; SYSTEM; FEAR; IMAGES; IDENTIFICATION; COMPONENT; CONTRAST	Background: In everyday life, signals of danger, such as aversive facial expressions, usually appear in the peripheral visual field. Although facial expression processing in central vision has been extensively studied, this processing in peripheral vision has been poorly studied. Methodology/Principal Findings: Using behavioral measures, we explored the human ability to detect fear and disgust vs. neutral expressions and compared it to the ability to discriminate between genders at eccentricities up to 40 degrees. Responses were faster for the detection of emotion compared to gender. Emotion was detected from fearful faces up to 40 degrees of eccentricity. Conclusions: Our results demonstrate the human ability to detect facial expressions presented in the far periphery up to 40 degrees of eccentricity. The increasing advantage of emotion compared to gender processing with increasing eccentricity might reflect a major implication of the magnocellular visual pathway in facial expression processing. This advantage may suggest that emotion detection, relative to gender identification, is less impacted by visual acuity and within-face crowding in the periphery. These results are consistent with specific and automatic processing of danger-related information, which may drive attention to those messages and allow for a fast behavioral reaction.	[Bayle, Dimitri J.; Henaff, Marie-Anne; Krolak-Salmon, Pierre] CNRS UMR5292, INSERM U1028, Lyon Neurosci Res Ctr, Brain Dynam & Cognit Team, Lyon, France; [Bayle, Dimitri J.; Schoendorff, Benjamin; Henaff, Marie-Anne; Krolak-Salmon, Pierre] Univ Lyon 1, F-69365 Lyon, France; [Bayle, Dimitri J.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Krolak-Salmon, Pierre] Hosp Civils Lyon, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); CHU Lyon	Bayle, DJ (corresponding author), CNRS UMR5292, INSERM U1028, Lyon Neurosci Res Ctr, Brain Dynam & Cognit Team, Lyon, France.	dimitri.bayle@inserm.fr	krolak-salmon, pierre/AAV-2152-2020	bayle, dimitri/0000-0003-1867-2721	French National Institute for Health and Medical Research	French National Institute for Health and Medical Research(Institut National de la Sante et de la Recherche Medicale (Inserm))	The research was supported by the French National Institute for Health and Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; BALABAN MT, 1994, BIOL PSYCHOL, V38, P117, DOI 10.1016/0301-0511(94)90033-7; Baudouin JY, 2006, PERCEPTION, V35, P531, DOI 10.1068/p3403; Bayle DJ, 2010, BRAIN RES, V1313, P113, DOI 10.1016/j.brainres.2009.11.060; Bayle DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008207; Bex PJ, 2002, J OPT SOC AM A, V19, P1096, DOI 10.1364/JOSAA.19.001096; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Calvo MG, 2008, J EXP PSYCHOL GEN, V137, P471, DOI 10.1037/a0012771; Calvo MG, 2008, EXP PSYCHOL, V55, P359, DOI 10.1027/1618-3169.55.6.359; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; Dolan RJ, 2003, ANN NY ACAD SCI, V985, P348, DOI 10.1111/j.1749-6632.2003.tb07093.x; Ekman P., 1976, PICTURES FACIAL AFFE; EKMAN P, 1971, DARWIN FACIAL EXPRES; Fridlund A.J., 1994, HUMAN FACIAL EXPRESS; Goren D, 2006, VISION RES, V46, P1253, DOI 10.1016/j.visres.2005.10.028; Hare TA, 2005, BIOL PSYCHIAT, V57, P624, DOI 10.1016/j.biopsych.2004.12.038; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KAPLAN E, 1986, P NATL ACAD SCI USA, V83, P2755, DOI 10.1073/pnas.83.8.2755; LeDoux J, 1996, PROG BRAIN RES, V107, P437; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Makela P, 2001, VISION RES, V41, P599, DOI 10.1016/S0042-6989(00)00259-5; Martelli M, 2005, J VISION, V5, P58, DOI 10.1167/5.1.6; McKone E, 2004, J EXP PSYCHOL LEARN, V30, P181, DOI 10.1037/0278-7393.30.1.181; Meissirel C, 1997, P NATL ACAD SCI USA, V94, P5900, DOI 10.1073/pnas.94.11.5900; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Palermo R, 2004, BEHAV RES METH INS C, V36, P634, DOI 10.3758/BF03206544; SCHILLER PH, 1979, J NEUROPHYSIOL, V42, P1124, DOI 10.1152/jn.1979.42.4.1124; Sere B, 2000, PERCEPTION, V29, P1403, DOI 10.1068/p2991; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057	32	45	45	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21584	10.1371/journal.pone.0021584	http://dx.doi.org/10.1371/journal.pone.0021584			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782UF	21720562	Green Published, Green Submitted, gold			2022-12-25	WOS:000292036900058
J	Ray, B; Long, JM; Sokol, DK; Lahiri, DK				Ray, Balmiki; Long, Justin M.; Sokol, Deborah K.; Lahiri, Debomoy K.			Increased Secreted Amyloid Precursor Protein-alpha (sAPP alpha) in Severe Autism: Proposal of a Specific, Anabolic Pathway and Putative Biomarker	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; AMINO-TERMINAL REGION; NEUROTROPHIC FACTOR; DIAGNOSTIC INTERVIEW; NEURITE OUTGROWTH; PROMOTER ACTIVITY; MESSENGER-RNA; APP GENE; 5'-UNTRANSLATED REGION; MENTAL-RETARDATION	Autism is a neurodevelopmental disorder characterized by deficits in verbal communication, social interactions, and the presence of repetitive, stereotyped and compulsive behaviors. Excessive early brain growth is found commonly in some patients and may contribute to disease phenotype. Reports of increased levels of brain-derived neurotrophic factor (BDNF) and other neurotrophic-like factors in autistic neonates suggest that enhanced anabolic activity in CNS mediates this overgrowth effect. We have shown previously that in a subset of patients with severe autism and aggression, plasma levels of the secreted amyloid-beta (A beta) precursor protein-alpha form (sAPP alpha) were significantly elevated relative to controls and patients with mild-to-moderate autism. Here we further tested the hypothesis that levels of sAPP alpha and sAPP beta (proteolytic cleavage products of APP by alpha-and beta-secretase, respectively) are deranged in autism and may contribute to an anabolic environment leading to brain overgrowth. We measured plasma levels of sAPP alpha, sAPP beta, A beta peptides and BDNF by corresponding ELISA in a well characterized set of subjects. We included for analysis 18 control, 6 mild-to-moderate, and 15 severely autistic patient plasma samples. We have observed that sAPPa levels are increased and BDNF levels decreased in the plasma of patients with severe autism as compared to controls. Further, we show that A beta 1-40, A beta 1-42, and sAPP beta levels are significantly decreased in the plasma of patients with severe autism. These findings do not extend to patients with mild-to-moderate autism, providing a biochemical correlate of phenotypic severity. Taken together, this study provides evidence that sAPP alpha levels are generally elevated in severe autism and suggests that these patients may have aberrant non-amyloidogenic processing of APP.	[Ray, Balmiki; Long, Justin M.; Lahiri, Debomoy K.] Indiana Univ Sch Med, Inst Psychiat Res, Dept Psychiat, Indianapolis, IN USA; [Sokol, Deborah K.] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN USA; [Lahiri, Debomoy K.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Ray, B (corresponding author), Indiana Univ Sch Med, Inst Psychiat Res, Dept Psychiat, Indianapolis, IN USA.	dlahiri@iupui.edu	Lahiri, Debomoy/AAZ-3322-2020	Long, Justin/0000-0003-0769-604X	National Institutes of Health [AG18379, AG18884]; NATIONAL INSTITUTE ON AGING [R01AG018379, R01AG018884] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by grant support from the National Institutes of Health (AG18379 and AG18884) to DKL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALAYAHDI L, 2011, COMMUNICATION; Alley GM, 2010, J NEUROSCI RES, V88, P143, DOI 10.1002/jnr.22172; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ARAKI W, 1991, BIOCHEM BIOPH RES CO, V181, P265, DOI 10.1016/S0006-291X(05)81412-3; Badcock C, 2008, NATURE, V454, P1054, DOI 10.1038/4541054a; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bailey AR, 2008, INT J CLIN EXP MED, V1, P338; Bauman M.L, 1994, NEUROBIOLOGY AUTISM, P119; Bell KFS, 2008, NEUROBIOL AGING, V29, P554, DOI 10.1016/j.neurobiolaging.2006.11.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; *CDCP, 2006, MMWR SURVEILL SUMM, V58, P1; Chen Chun-Wei David, 2006, Current Alzheimer Research, V3, P63, DOI 10.2174/156720506775697205; Conti E, 2010, ALZ DIS ASSOC DIS, V24, P96, DOI 10.1097/WAD.0b013e3181aba63a; Correia CT, 2010, GENES BRAIN BEHAV, V9, P841, DOI 10.1111/j.1601-183X.2010.00627.x; Courchesne E, 2004, CURR OPIN NEUROL, V17, P489, DOI 10.1097/01.wco.0000137542.14610.b4; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Crespi B, 2008, BEHAV BRAIN SCI, V31, P241, DOI 10.1017/S0140525X08004214; Croen LA, 2008, AUTISM RES, V1, P130, DOI 10.1002/aur.14; Dolen G, 2008, J PHYSIOL-LONDON, V586, P1503, DOI 10.1113/jphysiol.2008.150722; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Friedman SD, 2003, NEUROLOGY, V60, P100, DOI 10.1212/WNL.60.1.100; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Gakhar-Koppole N, 2008, EUR J NEUROSCI, V28, P871, DOI 10.1111/j.1460-9568.2008.06398.x; Ge YW, 2002, ANN NY ACAD SCI, V973, P463, DOI 10.1111/j.1749-6632.2002.tb04684.x; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; Hashimoto K, 2006, PROG NEURO-PSYCHOPH, V30, P1529, DOI 10.1016/j.pnpbp.2006.06.018; HAYASHI Y, 1994, BIOCHEM BIOPH RES CO, V205, P936, DOI 10.1006/bbrc.1994.2755; Hazlett HC, 2005, ARCH GEN PSYCHIAT, V62, P1366, DOI 10.1001/archpsyc.62.12.1366; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Hu VW, 2009, AUTISM RES, V2, P67, DOI 10.1002/aur.72; Ishida A, 1997, NEUROREPORT, V8, P2133, DOI 10.1097/00001756-199707070-00009; JIN LW, 1994, J NEUROSCI, V14, P5461; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kanner L, 1943, NERV CHILD, V2, P217; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Katoh-Semba R, 2007, INT J DEV NEUROSCI, V25, P367, DOI 10.1016/j.ijdevneu.2007.07.002; Kogan MD, 2009, PEDIATRICS, V124, P1395, DOI 10.1542/peds.2009-1522; Kwak YD, 2006, STEM CELLS DEV, V15, P381, DOI 10.1089/scd.2006.15.381; Lahiri DK, 2009, MOL PSYCHIATR, V14, P992, DOI 10.1038/mp.2009.82; Lahiri DK, 2003, CURR DRUG TARGETS, V4, P97, DOI 10.2174/1389450033346957; Lahiri DK, 2005, NEUROBIOL AGING, V26, P1329, DOI 10.1016/j.neurobiolaging.2004.11.005; LAHIRI DK, 1995, MOL BRAIN RES, V32, P233, DOI 10.1016/0169-328X(95)00078-7; Long JM, 2011, BIOCHEM BIOPH RES CO, V404, P889, DOI 10.1016/j.bbrc.2010.12.053; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Maenner MJ, 2010, PEDIATRICS, V126, pE1018, DOI 10.1542/peds.2010-1023; Maloney B, 2004, FASEB J, V18, P1288, DOI 10.1096/fj.03-1703fje; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Miyazaki K, 2004, BRAIN DEV-JPN, V26, P292, DOI 10.1016/S0387-7604(03)00168-2; Morimoto T, 1998, J NEUROSCI RES, V51, P185, DOI 10.1002/(SICI)1097-4547(19980115)51:2<185::AID-JNR7>3.0.CO;2-9; Mullen E. M., 1992, MULLEN SCALES EARLY; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Nelson KB, 2001, ANN NEUROL, V49, P597, DOI 10.1002/ana.1024.abs; Nelson PG, 2006, INT J DEV NEUROSCI, V24, P73, DOI 10.1016/j.ijdevneu.2005.10.003; Ohsawa I, 1999, EUR J NEUROSCI, V11, P1907, DOI 10.1046/j.1460-9568.1999.00601.x; OHSAWA I, 1995, BIOCHEM BIOPH RES CO, V213, P52, DOI 10.1006/bbrc.1995.2097; Ohsawa I, 1997, BIOCHEM BIOPH RES CO, V236, P59, DOI 10.1006/bbrc.1997.6903; Ray B, 2010, NEUROSCI LETT, V470, P1, DOI 10.1016/j.neulet.2009.11.016; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Rogers JT, 1999, J BIOL CHEM, V274, P6421, DOI 10.1074/jbc.274.10.6421; Ruiz-Leon Y, 2001, J NEUROCHEM, V79, P278, DOI 10.1046/j.1471-4159.2001.00547.x; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; Schopler E., 1988, CHILDHOOD AUTISM RAT; SCHUBERT D, 1989, NEURON, V3, P689, DOI 10.1016/0896-6273(89)90237-7; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; Sheikh AM, 2010, J NEUROSCI RES, V88, P2641, DOI 10.1002/jnr.22416; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; Sokol DK, 2006, J CHILD NEUROL, V21, P444, DOI 10.1177/08830738060210062201; Song WH, 1998, GENE, V217, P165, DOI 10.1016/S0378-1119(98)00340-0; Tadevosyan-Leyfer O, 2003, J AM ACAD CHILD PSY, V42, P864, DOI 10.1097/01.CHI.0000046870.56865.90; Taylor CJ, 2008, NEUROBIOL DIS, V31, P250, DOI 10.1016/j.nbd.2008.04.011; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Tsai SJ, 2005, MED HYPOTHESES, V65, P79, DOI 10.1016/j.mehy.2005.01.034; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Verhoeven JS, 2010, NEURORADIOLOGY, V52, P3, DOI 10.1007/s00234-009-0583-y; Vilardo E, 2010, J BIOL CHEM, V285, P18344, DOI 10.1074/jbc.M110.112664; Villa A, 2001, J NEUROCHEM, V77, P1077, DOI 10.1046/j.1471-4159.2001.00315.x; Wechsler D, 1974, WECHSLER INTELLIGENC; Weiler IJ, 2004, P NATL ACAD SCI USA, V101, P17504, DOI 10.1073/pnas.0407533101; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Westmark PR, 2006, NEUROBIOL AGING, V27, P787, DOI 10.1016/j.neurobiolaging.2006.03.003; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; ZAIDI SHE, 1994, J BIOL CHEM, V269, P24000; ZAIDI SHE, 1994, J BIOL CHEM, V269, P24007; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5	95	86	90	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20405	10.1371/journal.pone.0020405	http://dx.doi.org/10.1371/journal.pone.0020405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731612	gold, Green Published, Green Submitted			2022-12-25	WOS:000292033700007
J	Schmutz, I; Wendt, S; Schnell, A; Kramer, A; Mansuy, IM; Albrecht, U				Schmutz, Isabelle; Wendt, Sabrina; Schnell, Anna; Kramer, Achim; Mansuy, Isabelle M.; Albrecht, Urs			Protein Phosphatase 1 (PP1) Is a Post-Translational Regulator of the Mammalian Circadian Clock	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; PHASE-SHIFTS; MPER2; LIGHT; PHOSPHORYLATION; COMPONENT; CREB; TRANSCRIPTION; MUTATION	Circadian clocks coordinate the timing of important biological processes. Interconnected transcriptional and post-translational feedback loops based on a set of clock genes generate and maintain these rhythms with a period of about 24 hours. Many clock proteins undergo circadian cycles of post-translational modifications. Among these modifications, protein phosphorylation plays an important role in regulating activity, stability and intracellular localization of clock components. Several protein kinases were characterized as regulators of the circadian clock. However, the function of protein phosphatases, which balance phosphorylation events, in the mammalian clock mechanism is less well understood. Here, we identify protein phosphatase 1 (PP1) as regulator of period and light-induced resetting of the mammalian circadian clock. Down-regulation of PP1 activity in cells by RNA interference and in vivo by expression of a specific inhibitor in the brain of mice tended to lengthen circadian period. Moreover, reduction of PP1 activity in the brain altered light-mediated clock resetting behavior in mice, enhancing the phase shifts in either direction. At the molecular level, diminished PP1 activity increased nuclear accumulation of the clock component PER2 in neurons. Hence, PP1, may reduce PER2 phosphorylation thereby influencing nuclear localization of this protein. This may at least partially influence period and phase shifting properties of the mammalian circadian clock.	[Schmutz, Isabelle; Schnell, Anna; Albrecht, Urs] Univ Fribourg, Biochem Unit, Dept Biol, CH-1700 Fribourg, Switzerland; [Wendt, Sabrina; Kramer, Achim] Charite, Lab Chronobiol, D-13353 Berlin, Germany; [Mansuy, Isabelle M.] Univ Zurich, Fac Med, Brain Res Inst, Zurich, Switzerland; [Mansuy, Isabelle M.] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland	University of Fribourg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Geneva; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schmutz, I (corresponding author), Univ Fribourg, Biochem Unit, Dept Biol, CH-1700 Fribourg, Switzerland.	urs.albrecht@unifr.ch	Albrecht, Urs/A-9831-2011; Mansuy, Isabelle M/N-3042-2015	Albrecht, Urs/0000-0002-0663-8676; Mansuy, Isabelle M/0000-0001-7785-5371; Kramer, Achim/0000-0001-9671-6078; Schnell, Anna/0000-0002-3943-598X	Swiss National Science Foundation; Japanese-Swiss ST programme; European Union; Deutsche Forschungsgemeinschaft [SFB740/D2]; states of Fribourg and Zurich (Switzerland)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Japanese-Swiss ST programme; European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); states of Fribourg and Zurich (Switzerland)	This work was supported by the Swiss National Science Foundation, the Japanese-Swiss S&T programme, the European Union FP6 Integrated Project EUCLOCK, the Deutsche Forschungsgemeinschaft (SFB740/D2) and the states of Fribourg and Zurich (Switzerland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2001, J NEUROCHEM, V78, P499, DOI 10.1046/j.1471-4159.2001.00452.x; ALBERTS AS, 1994, MOL CELL BIOL, V14, P4398, DOI 10.1128/MCB.14.7.4398; Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Albrecht U, 2007, COLD SPRING HARB SYM, V72, P95, DOI 10.1101/sqb.2007.72.001; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; ALVAREZSAAVEDRA M, 2010, HUM MOL GENET; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Cohen PTW, 2002, J CELL SCI, V115, P241; Comolli J, 1996, PLANT PHYSIOL, V111, P285, DOI 10.1104/pp.111.1.285; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Fang YS, 2007, GENE DEV, V21, P1506, DOI 10.1101/gad.1541607; FOULKES JG, 1983, EUR J BIOCHEM, V132, P309, DOI 10.1111/j.1432-1033.1983.tb07363.x; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gallego M, 2006, BIOCHEM J, V399, P169, DOI 10.1042/BJ20060678; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hirota T, 2004, ZOOL SCI, V21, P359, DOI 10.2108/zsj.21.359; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; Jakubcakova V, 2007, NEURON, V54, P831, DOI 10.1016/j.neuron.2007.04.031; Jud C, 2005, BIOL PROCED ONLINE, V7, P101, DOI 10.1251/bpo109; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; KLEE WA, 1974, P NATL ACAD SCI USA, V71, P3474, DOI 10.1073/pnas.71.9.3474; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Koshibu K, 2009, J NEUROSCI, V29, P13079, DOI 10.1523/JNEUROSCI.3610-09.2009; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier B, 2009, GENE DEV, V23, P708, DOI 10.1101/gad.512209; Masubuchi S, 2010, P NATL ACAD SCI USA, V107, P1642, DOI 10.1073/pnas.0910292107; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Michalon A, 2005, GENESIS, V43, P205, DOI 10.1002/gene.20175; Motzkus D, 2000, FEBS LETT, V486, P315, DOI 10.1016/S0014-5793(00)02315-2; Oster H, 2003, CURR BIOL, V13, P725, DOI 10.1016/S0960-9822(03)00252-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JA, 2000, GENE DEV, V14, P679; Ripperger JA, 2010, PROTEIN REV, V12, P37, DOI 10.1007/978-1-4419-1262-6_2; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Tischkau SA, 2003, J BIOL CHEM, V278, P718, DOI 10.1074/jbc.M209241200; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VANSELOW JT, 2010, CIRCADIAN CLOCK; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Wakamatsu H, 2001, NEUROREPORT, V12, P127, DOI 10.1097/00001756-200101220-00033; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yan L, 2006, J NEUROSCI, V26, P9434, DOI 10.1523/JNEUROSCI.2538-06.2006; Yang YH, 2004, GENE DEV, V18, P255, DOI 10.1101/gad.1152604; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	63	28	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21325	10.1371/journal.pone.0021325	http://dx.doi.org/10.1371/journal.pone.0021325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712997	gold, Green Published, Green Accepted			2022-12-25	WOS:000291985100029
J	Iguchi, A; Shinzato, C; Foret, S; Miller, DJ				Iguchi, Akira; Shinzato, Chuya; Foret, Sylvain; Miller, David J.			Identification of Fast-Evolving Genes in the Scleractinian Coral Acropora Using Comparative EST Analysis	PLOS ONE			English	Article							POSITIVE SELECTION; EVOLUTIONARY HISTORY; ADAPTIVE EVOLUTION; BINDING LECTIN; RECOGNITION; PATHOGENS; ALIGNMENT; IMMUNITY; PATTERN	To identify fast-evolving genes in reef-building corals, we performed direct comparative sequence analysis with expressed sequence tag (EST) datasets from two acroporid species: Acropora palmata from the Caribbean Sea and A. millepora from the Great Barrier Reef in Australia. Comparison of 589 independent sequences from 1,421 A. palmata contigs, with 10,247 A. millepora contigs resulted in the identification of 196 putative homologues. Most of the homologous pairs demonstrated high amino acid similarities (over 90%). Comparisons of putative homologues showing low amino acid similarities (under 90%) among the Acropora species to the near complete datasets from two other cnidarians (Hydra magnipapillata and Nematostella vectensis) implied that some were non-orthologous. Within 86 homologous pairs, 39 exhibited dN/dS ratios significantly less than 1, suggesting that these genes are under purifying selection associated with functional constraints. Eight independent genes showed dN/dS ratios exceeding 1, while three deviated significantly from 1, suggesting that these genes may play important roles in the adaptive evolution of Acropora. Our results also indicated that CEL-III lectin was under positive selection, consistent with a possible role in immunity or symbiont recognition. Further studies are needed to clarify the possible functions of the genes under positive selection to provide insight into the evolutionary process of corals.	[Iguchi, Akira] Univ Ryukyus, Trop Biosphere Res Ctr, Sesoko Stn, Okinawa, Japan; [Shinzato, Chuya] Okinawa Inst Sci & Technol, Okinawa, Japan; [Foret, Sylvain; Miller, David J.] James Cook Univ, Sch Pharm & Mol Sci, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Foret, Sylvain; Miller, David J.] James Cook Univ, Sch Pharm & Mol Sci, Coral Genom Grp, Townsville, Qld 4811, Australia	University of the Ryukyus; Okinawa Institute of Science & Technology Graduate University; James Cook University; James Cook University	Iguchi, A (corresponding author), Univ Ryukyus, Trop Biosphere Res Ctr, Sesoko Stn, Okinawa, Japan.	iguchi.a0218@gmail.com	Iguchi, Akira/I-3180-2016; Shinzato, Chuya/G-2958-2015; FORET, Sylvain/B-9207-2012	Iguchi, Akira/0000-0002-8894-1977; 	Australian Research Council (ARC) via the Centre of Excellence for Coral Reef Studies; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [20121002, 21121505]; KAKENHI [21710199]; Japan Society for the Promotion of Science (JSPS); Okinawa International Exchange and Human Resources Development Foundation	Australian Research Council (ARC) via the Centre of Excellence for Coral Reef Studies(Australian Research Council); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Okinawa International Exchange and Human Resources Development Foundation	This study was supported by the Australian Research Council (ARC) directly to DJM via the Centre of Excellence for Coral Reef Studies, Grant-in-Aid for Scientific Research on Innovative Areas "Coral reef science for symbiosis and coexistence of human and ecosystem under combined stresses" (No. 20121002, No. 21121505 to CS) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, KAKENHI (21710199 to CS), and the Japan Society for the Promotion of Science (JSPS). AI and CS gratefully acknowledge the receipt of a scholarship from the Okinawa International Exchange and Human Resources Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Feder ME, 2003, NAT REV GENET, V4, P651, DOI 10.1038/nrg1128; Field SF, 2006, J MOL EVOL, V62, P332, DOI 10.1007/s00239-005-0129-9; Foret S, 2007, CORAL REEFS, V26, P475, DOI 10.1007/s00338-007-0206-1; Foret S, 2010, TRENDS GENET, V26, P154, DOI 10.1016/j.tig.2010.01.003; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HATAKEYAMA T, 1994, J BIOCHEM, V116, P209, DOI 10.1093/oxfordjournals.jbchem.a124495; Hatta M, 1999, MOL BIOL EVOL, V16, P1607, DOI 10.1093/oxfordjournals.molbev.a026073; Hayes ML, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-150; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes AL, 2007, HEREDITY, V99, P364, DOI 10.1038/sj.hdy.6801031; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Jimbo M, 2000, COMP BIOCHEM PHYS B, V125, P227, DOI 10.1016/S0305-0491(99)00173-X; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Kvennefors ECE, 2010, DEV COMP IMMUNOL, V34, P1219, DOI 10.1016/j.dci.2010.06.016; Lee CE, 2006, MOL ECOL, V15, P1193, DOI 10.1111/j.1365-294X.2006.02945.x; Marquez LM, 2002, MOL ECOL, V11, P1339, DOI 10.1046/j.1365-294X.2002.01526.x; Metz EC, 1996, MOL BIOL EVOL, V13, P397, DOI 10.1093/oxfordjournals.molbev.a025598; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Palumbi SR, 2009, HEREDITY, V102, P66, DOI 10.1038/hdy.2008.104; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-97; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Uchida T, 2004, J BIOL CHEM, V279, P37133, DOI 10.1074/jbc.M404065200; van Oppen MJH, 2001, MOL BIOL EVOL, V18, P1315, DOI 10.1093/oxfordjournals.molbev.a003916; Veron J.E.N, 2000, CORALS WORLD; Wallace Carden C., 1999, pi; Willis BL, 2006, ANNU REV ECOL EVOL S, V37, P489, DOI 10.1146/annurev.ecolsys.37.091305.110136; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	41	20	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20140	10.1371/journal.pone.0020140	http://dx.doi.org/10.1371/journal.pone.0020140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701682	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000291983800004
J	Pei, NC; Lian, JY; Erickson, DL; Swenson, NG; Kress, WJ; Ye, WH; Ge, XJ				Pei, Nancai; Lian, Ju-Yu; Erickson, David L.; Swenson, Nathan G.; Kress, W. John; Ye, Wan-Hui; Ge, Xue-Jun			Exploring Tree-Habitat Associations in a Chinese Subtropical Forest Plot Using a Molecular Phylogeny Generated from DNA Barcode Loci	PLOS ONE			English	Article							SPATIAL DISTRIBUTIONS; OVERDISPERSION; BIODIVERSITY; COMMUNITIES; DIVERSITY; PATTERNS; SCALE; TRAIT; SIZE	Elucidating the ecological mechanisms underlying community assembly in subtropical forests remains a central challenge for ecologists. The assembly of species into communities can be due to interspecific differences in habitat associations, and there is increasing evidence that these associations may have an underlying phylogenetic structure in contemporary terrestrial communities. In other words, by examining the degree to which closely related species prefer similar habitats and the degree to which they co-occur, ecologists are able to infer the mechanisms underlying community assembly. Here we implement this approach in a diverse subtropical tree community in China using a long-term forest dynamics plot and a molecular phylogeny generated from three DNA barcode loci. We find that there is phylogenetic signal in plant-habitat associations (i.e. closely related species tend to prefer similar habitats) and that patterns of co-occurrence within habitats are typically non-random with respect to phylogeny. In particular, we found phylogenetic clustering in valley and low-slope habitats in this forest, indicating a filtering of lineages plays a dominant role in structuring communities in these habitats and we found evidence of phylogenetic overdispersion in high-slope, ridge-top and high-gully habitats, indicating that distantly related species tended to co-occur in these high elevation habitats and that lineage filtering is less important in structuring these communities. Thus we infer that non-neutral niche-based processes acting upon evolutionarily conserved habitat preferences explain the assembly of local scale communities in the forest studied.	[Pei, Nancai; Lian, Ju-Yu; Ye, Wan-Hui; Ge, Xue-Jun] Chinese Acad Sci, S China Bot Garden, Key Lab Plant Resource Conservat & Sustainable Ut, Guangzhou, Guangdong, Peoples R China; [Pei, Nancai] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Erickson, David L.; Kress, W. John] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA; [Swenson, Nathan G.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Smithsonian Institution; Smithsonian National Museum of Natural History; Michigan State University	Pei, NC (corresponding author), Chinese Acad Sci, S China Bot Garden, Key Lab Plant Resource Conservat & Sustainable Ut, Guangzhou, Guangdong, Peoples R China.	why@scbg.ac.cn; xjge@scbg.ac.cn	Ge, Xue-Jun/AAP-5967-2020; Swenson, Nathan/A-3514-2012	Ge, Xue-Jun/0000-0002-5008-9475; Swenson, Nathan/0000-0003-3819-9767	National Basic Research Program of China (973 Program) [2007CB411600]; China National Program for R & D Infrastructure and Facility Development [2008BAC39B02]; Chinese Academy of Sciences [2009-LSF-GBOWS-01, KSCX2-YW-N-0807, KZCX2-YW-430]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); China National Program for R & D Infrastructure and Facility Development; Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was financially supported by National Basic Research Program of China (973 Program) (2007CB411600), China National Program for R & D Infrastructure and Facility Development (2008BAC39B02), the Research Fund for the Large-Scale Scientific Facilities of the Chinese Academy of Sciences (2009-LSF-GBOWS-01), Major Innovation Program of CAS (KSCX2-YW-N-0807) and Key Innovation Project of CAS (KZCX2-YW-430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Caley MJ, 1997, ECOLOGY, V78, P70; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Diamond J.M., 1975, P342; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Gotelli NJ, 2001, OECOLOGIA, V129, P281, DOI 10.1007/s004420100717; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Horner-Devine MC, 2006, ECOLOGY, V87, pS100, DOI 10.1890/0012-9658(2006)87[100:PCAOIB]2.0.CO;2; Hubbell S.P., 1983, TROPICAL RAIN FOREST, P25; Hubbell Stephen P., 2001, V32, pi; Jabot F, 2009, ECOL LETT, V12, P239, DOI 10.1111/j.1461-0248.2008.01280.x; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; KALUZNY SP, 1998, S SPATIALSTATS USERS; Kelly CK, 2008, ECOLOGY, V89, P962, DOI 10.1890/07-0322.1; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Li L, 2009, OIKOS, V118, P495, DOI 10.1111/j.1600-0706.2009.16753.x; Miller M. A., 2010, CIPRES PORTALS; PARADIS E, 2010, ANAL PHYLOGENETICS E; R Core Team, 2022, R LANG ENV STAT COMP; Rabosky DL, 2007, OECOLOGIA, V154, P561, DOI 10.1007/s00442-007-0849-1; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Schreeg LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013685; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Swenson NG, 2011, AM J BOT, V98, P472, DOI 10.3732/ajb.1000289; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Tilman D., 1982, Monographs in Population Biology, pi; Tilman David, 1993, P13; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; WANG ZG, 2007, THESIS CHINESE ACAD; Wang Z, 2009, BASIC APPL ECOL, V10, P648, DOI 10.1016/j.baae.2009.03.002; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Weiher E., 1999, ECOLOGICAL ASSEMBLY	41	60	77	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21273	10.1371/journal.pone.0021273	http://dx.doi.org/10.1371/journal.pone.0021273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701680	Green Published, Green Submitted, gold			2022-12-25	WOS:000291983800037
J	Liu, QY; Yao, YM; Yu, Y; Dong, N; Sheng, ZY				Liu, Qing-yang; Yao, Yong-ming; Yu, Yan; Dong, Ning; Sheng, Zhi-yong			Astragalus Polysaccharides Attenuate Postburn Sepsis via Inhibiting Negative Immunoregulation of CD4(+)CD25(high) T Cells	PLOS ONE			English	Article							MEMBRANACEUS; SUPPRESSION; INJURY; MECHANISMS; RECEPTORS; INDUCTION; TREGS	Backgroud: Astragalus polysaccharides (APS) isolated from one of the Chinese herbs, Astragalus mongholicus, are known to have a variety of immunomodulatory activities. However, it is not yet clear whether APS can exert an effect on the immune functions of regulatory T cells (Tregs). This study was carried out to investigate the effect of APS on the immune function of peripheral blood Tregs in postburn sepsis. Methodology/Principal Findings: BalB/c mice were randomly divided into six groups as follows: sham burn group, burn control(burn without infection animals) group, burn plus P. aeruginosa group, burn plus P. aeruginosa with APS (50 mg/kg) treatment group, burn plus P. aeruginosa with APS (100 mg/kg) treatment group, and burn plus P. aeruginosa with APS (200 mg/kg) treatment group, and they were sacrificed on postburn day 1, 3, 5, and 7, respectively, with seven animals at each time point. Magnetic microbeads were used to isolate peripheral blood Tregs and CD4(+) T cells. Phenotypes were analyzed by flow cytometry, and cytokine levels were determined with ELISA. In the burn plus P. aeruginosa group, forkhead/winged helix transcription factor p3 (Foxp3) expression on CD4(+)CD25(+)Tregs were strongly enhanced in comparison to the sham group, and the capacity of CD4(+)CD25(+)Tregs to produce interleukin (IL)-10 was markedly increased. Administration of APS to inhibit CD4(+)CD25(+)Tregs could significantly decrease expression of Foxp3 on CD4(+)CD25(+)Tregs, and IL-10 production in burned mice with P. aeruginosa infection. At the same time, proliferative activity and expression of IL-2 and IL-2R alpha on CD4(+) T cells were restored. In contrast, anti-Toll-like receptor 4 (TLR4) antibody could block the effect of APS on Tregs immune function. Conclusion: APS might suppress CD4(+)CD25(+)Treg activity, at least in part, via binding TLR4 on Tregs and trigger a shift of Th2 to Th1 with activation of CD4(+) T cells in burned mice with P. aeruginosa infection.	[Liu, Qing-yang; Yao, Yong-ming; Yu, Yan; Dong, Ning; Sheng, Zhi-yong] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Burns Inst, Dept Microbiol & Immunol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Liu, QY (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Burns Inst, Dept Microbiol & Immunol, Beijing, Peoples R China.	llqq2003yy@yahoo.com.cn			National Natural Science Foundation of China [81000847, 81071545]; National Basic Research Program of China [2005CB522602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was supported, in part, by grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default124.htm) (grant no. 81000847 to Q-yL; 81071545 to Yan Yu), and the National Basic Research Program of China (http://www.973.gov.cn/) (grant no. 2005CB522602 to Yan Yu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arazi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008447; Bacchetta R, 2005, AUTOIMMUN REV, V4, P491, DOI 10.1016/j.autrev.2005.04.005; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Chatila TA, 2005, J ALLERGY CLIN IMMUN, V116, P949, DOI 10.1016/j.jaci.2005.08.047; Chen W, 2010, J DIABETES COMPLICAT, V24, P199, DOI 10.1016/j.jdiacomp.2008.12.003; Cho WCS, 2007, J ETHNOPHARMACOL, V113, P132, DOI 10.1016/j.jep.2007.05.020; CHOILEAIN NN, 2006, J SURG RES, V130, P124; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Das G, 2001, J IMMUNOL, V167, P2004, DOI 10.4049/jimmunol.167.4.2004; Efron P, 2003, SHOCK, V20, P386, DOI 10.1097/01.SHK.0000092698.10326.6f; Goleva E, 2005, J ALLERGY CLIN IMMUN, V116, P1094, DOI 10.1016/j.jaci.2005.08.051; Jonuleit H, 2003, J IMMUNOL, V171, P6323, DOI 10.4049/jimmunol.171.12.6323; Kim S W, 2008, J Anim Sci, V86, pE138; Kuo YH, 2009, J ETHNOPHARMACOL, V122, P28, DOI 10.1016/j.jep.2008.11.025; Liu QY, 2011, J ETHNOPHARMACOL, V136, P457, DOI 10.1016/j.jep.2010.06.041; Liu QY, 2011, IMMUNOBIOLOGY, V216, P47, DOI 10.1016/j.imbio.2010.03.005; Ma XQ, 2002, J AGR FOOD CHEM, V50, P4861, DOI 10.1021/jf0202279; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Murphy TJ, 2005, J IMMUNOL, V174, P2957, DOI 10.4049/jimmunol.174.5.2957; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Patenaude J, 2005, J LEUKOCYTE BIOL, V77, P141, DOI 10.1189/jlb.0703314; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Purcell EM, 2006, SHOCK, V25, P135, DOI 10.1097/01.shk.0000190824.51653.32; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Shao BM, 2004, BIOCHEM BIOPH RES CO, V320, P1103, DOI 10.1016/j.bbrc.2004.06.065; Sunden-Cullberg J, 2006, CURR OPIN INFECT DIS, V19, P231, DOI 10.1097/01.qco.0000224816.96986.67; Thompson C, 2004, CURR OPIN PHARMACOL, V4, P408, DOI 10.1016/j.coph.2004.05.001; Tin MMY, 2007, CARCINOGENESIS, V28, P1347, DOI 10.1093/carcin/bgl238; TU WW, 1995, CHIN J IMMUNOL, V11, P34; Wisnoski N, 2007, SHOCK, V27, P251, DOI 10.1097/01.shk.0000239780.33398.e4; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Zheng SG, 2006, INT IMMUNOL, V18, P279, DOI 10.1093/intimm/dxh368	33	79	94	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e19811	10.1371/journal.pone.0019811	http://dx.doi.org/10.1371/journal.pone.0019811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698274	gold, Green Published, Green Submitted			2022-12-25	WOS:000291730000003
J	Olivera-Bravo, S; Fernandez, A; Sarlabos, MN; Rosillo, JC; Casanova, G; Jimenez, M; Barbeito, L				Olivera-Bravo, Silvia; Fernandez, Anabel; Noel Sarlabos, Maria; Carlos Rosillo, Juan; Casanova, Gabriela; Jimenez, Marcie; Barbeito, Luis			Neonatal Astrocyte Damage Is Sufficient to Trigger Progressive Striatal Degeneration in a Rat Model of Glutaric Acidemia-I	PLOS ONE			English	Article							WHITE-MATTER ASTROCYTES; MITOCHONDRIAL DYSFUNCTION; EXPRESSION; PROLIFERATION; PREVENTION; SURVIVAL; NEURONS; DISEASE; STRESS; CORTEX	Background: We have investigated whether an acute metabolic damage to astrocytes during the neonatal period may critically disrupt subsequent brain development, leading to neurodevelopmental disorders. Astrocytes are vulnerable to glutaric acid (GA), a dicarboxylic acid that accumulates in millimolar concentrations in Glutaric Acidemia I (GA-I), an inherited neurometabolic childhood disease characterized by degeneration of striatal neurons. While GA induces astrocyte mitochondrial dysfunction, oxidative stress and subsequent increased proliferation, it is presently unknown whether such astrocytic dysfunction is sufficient to trigger striatal neuronal loss. Methodology/Principal Findings: A single intracerebroventricular dose of GA was administered to rat pups at postnatal day 0 (P0) to induce an acute, transient rise of GA levels in the central nervous system (CNS). GA administration potently elicited proliferation of astrocytes expressing S100 beta followed by GFAP astrocytosis and nitrotyrosine staining lasting until P45. Remarkably, GA did not induce acute neuronal loss assessed by FluoroJade C and NeuN cell count. Instead, neuronal death appeared several days after GA treatment and progressively increased until P45, suggesting a delayed onset of striatal degeneration. The axonal bundles perforating the striatum were disorganized following GA administration. In cell cultures, GA did not affect survival of either striatal astrocytes or neurons, even at high concentrations. However, astrocytes activated by a short exposure to GA caused neuronal death through the production of soluble factors. Iron porphyrin antioxidants prevented GA-induced astrocyte proliferation and striatal degeneration in vivo, as well as astrocyte-mediated neuronal loss in vitro. Conclusions/Significance: Taken together, these results indicate that a transient metabolic insult with GA induces long lasting phenotypic changes in astrocytes that cause them to promote striatal neuronal death. Pharmacological protection of astrocytes with antioxidants during encephalopatic crisis may prevent astrocyte dysfunction and the ineluctable progression of disease in children with GA-I.	[Olivera-Bravo, Silvia; Noel Sarlabos, Maria; Jimenez, Marcie; Barbeito, Luis] Inst Clemente Estable, Cellular & Mol Neurobiol Dept, Montevideo, Uruguay; [Fernandez, Anabel; Carlos Rosillo, Juan] Univ Republica, Inst Clemente Estable, Cellular & Mol Neurophysiol Dept, Comparat Neuroanat Associated Unit,Sch Sci, Montevideo, Uruguay; [Casanova, Gabriela; Jimenez, Marcie] Univ Republica, Comparat Neuroanat Associated Unit, Electron Microscopy Unit, Sch Sci, Montevideo, Uruguay; [Barbeito, Luis] Inst Pasteur Montevideo, Montevideo, Uruguay	Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Olivera-Bravo, S (corresponding author), Inst Clemente Estable, Cellular & Mol Neurobiol Dept, Montevideo, Uruguay.	barbeito@pasteur.edu.uy		Barbeito, Luis/0000-0002-3047-232X	Consejo Nacional de Ciencia y Tecnologia [76/23]; Programa para el Desarrollo de las Ciencias Basicas, Biology option	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa para el Desarrollo de las Ciencias Basicas, Biology option	This work was funded by the Programa de Desarrollo Tecnologico Salud No 76/23 of the Consejo Nacional de Ciencia y Tecnologia to S.O.B., and the Programa para el Desarrollo de las Ciencias Basicas, Biology option. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abramov AY, 2005, PHILOS T R SOC B, V360, P2309, DOI 10.1098/rstb.2005.1766; Bain JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009567; Barbeito LH, 2004, BRAIN RES REV, V47, P263, DOI 10.1016/j.brainresrev.2004.05.003; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Brozzi F, 2009, J BIOL CHEM, V284, P8788, DOI 10.1074/jbc.M805897200; Cassina P, 2002, J NEUROSCI RES, V67, P21, DOI 10.1002/jnr.10107; Cassina P, 2008, J NEUROSCI, V28, P4115, DOI 10.1523/JNEUROSCI.5308-07.2008; Chatterjee S, 1999, GLIA, V27, P152; Crow JP, 2005, ANN NEUROL, V58, P258, DOI 10.1002/ana.20552; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Ferreira GD, 2005, NEUROCHEM RES, V30, P1123, DOI 10.1007/s11064-005-7711-9; Funk CBR, 2005, BRAIN, V128, P711, DOI 10.1093/brain/awh401; GOODMAN SI, 1995, HUM MOL GENET, V4, P1493; Haynes RL, 2009, ACTA NEUROPATHOL, V118, P391, DOI 10.1007/s00401-009-0540-1; Hoffmann GF, 1996, NEUROPEDIATRICS, V27, P115, DOI 10.1055/s-2007-973761; Kolker S, 2000, AMINO ACIDS, V18, P31, DOI 10.1007/s007260050003; KOLKER S, 2008, J INHERIT METAB DIS; LAMP J, 2011, J BIOL CHEM; Latini A, 2007, CELL MOL NEUROBIOL, V27, P423, DOI 10.1007/s10571-006-9134-9; LEIBEL RL, 1980, NEUROLOGY, V30, P1163, DOI 10.1212/WNL.30.11.1163; Olivera S, 2008, NEUROBIOL DIS, V32, P528, DOI 10.1016/j.nbd.2008.09.011; Paxinos G., 2004, J CHEM INF MODEL, V5th; Paxinos G., 1991, ATLAS DEV RAT BRAIN; Powell EM, 1999, GLIA, V26, P73, DOI 10.1002/(SICI)1098-1136(199903)26:1<73::AID-GLIA8>3.0.CO;2-S; Rosa RB, 2007, LIFE SCI, V81, P1668, DOI 10.1016/j.lfs.2007.09.021; SANETO RP, 1987, J NEUROSCI RES, V18, P147, DOI 10.1002/jnr.490180122; Sauer SW, 2006, J NEUROCHEM, V97, P899, DOI 10.1111/j.1471-4159.2006.03813.x; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Sharma R, 2010, ACTA NEUROPATHOL, V120, P223, DOI 10.1007/s00401-010-0704-z; SOFFER D, 1992, J NEUROL SCI, V107, P199, DOI 10.1016/0022-510X(92)90289-W; Stolp HB, 2009, NEUROSCI LETT, V451, P232, DOI 10.1016/j.neulet.2009.01.021; Strauss KA, 2003, AM J MED GENET C, V121C, P38, DOI 10.1002/ajmg.c.20007; Sullivan SM, 2010, BRAIN RES, V1319, P164, DOI 10.1016/j.brainres.2010.01.010; Vargas MR, 2008, J NEUROSCI RES, V86, P3515, DOI 10.1002/jnr.21797; VENTIMIGLIA R, 1995, EUR J NEUROSCI, V7, P213, DOI 10.1111/j.1460-9568.1995.tb01057.x; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zacharaki T, 2010, BRAIN RES, V1344, P62, DOI 10.1016/j.brainres.2010.05.021; Zhu CL, 2009, J CEREBR BLOOD F MET, V29, P342, DOI 10.1038/jcbfm.2008.124; Zinnanti WJ, 2007, J CLIN INVEST, V117, P3258, DOI 10.1172/JCI31617	43	47	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20831	10.1371/journal.pone.0020831	http://dx.doi.org/10.1371/journal.pone.0020831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698251	Green Submitted, Green Published, gold			2022-12-25	WOS:000291730000026
J	Steele, KT; Steenhoff, AP; Newcomb, CW; Rantleru, T; Nthobatsang, R; Lesetedi, G; Bellamy, SL; Nachega, JB; Gross, R; Bisson, GP				Steele, Katherine T.; Steenhoff, Andrew P.; Newcomb, Craig W.; Rantleru, Tumelo; Nthobatsang, Rudo; Lesetedi, Gloria; Bellamy, Scarlett L.; Nachega, Jean B.; Gross, Robert; Bisson, Gregory P.			Early Mortality and AIDS Progression Despite High Initial Antiretroviral Therapy Adherence and Virologic Suppression in Botswana	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; SUB-SAHARAN AFRICA; FOLLOW-UP; RISK-FACTORS; HIV-1-INFECTED PATIENTS; COMBINATION THERAPY; TREATMENT PROGRAMS; IMMUNOLOGICAL OUTCOMES; RURAL DISTRICT; NORTH-AMERICA	Background: Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are common in sub-Saharan Africa, despite reports of high levels of ART adherence in this setting. We sought to determine the relationship between very early ART adherence and early adverse outcomes in HIV-infected adults in Botswana. Methods: This prospective cohort study of 402 ART-naive, HIV-infected adults initiating ART at a public HIV clinic in Gaborone, Botswana evaluated the relationship between suboptimal early ART adherence and HIV treatment outcomes in the initial months after ART initiation. Early adherence during the interval between initial ART dispensation and first ART refill was calculated using pill counts. In the primary analysis patients not returning to refill and those with adherence <0.95 were considered to have suboptimal early adherence. The primary outcome was death or loss to follow-up during the first 6 months of ART; a secondary composite outcome included the primary outcome plus incident opportunistic illness (OIs) and virologic failure. We also calculated the percent of early adverse outcomes theoretically attributable to suboptimal early adherence using the population attributable risk percent (PAR%). Results: Suboptimal early adherence was independently associated with loss to follow-up and death (adjusted OR 2.3, 95% CI 1.1-4.8) and with the secondary composite outcome including incident OIs and virologic failure (adjusted OR 2.6, 95% CI 1.4-4.7). However, of those with early adverse outcomes, less than one-third had suboptimal adherence and approximately two-thirds achieved virologic suppression. The PAR% relating suboptimal early adherence and primary and secondary outcomes were 14.7% and 17.7%, respectively. Conclusions: Suboptimal early adherence was associated with poor outcomes, but most early adverse outcomes occurred in patients with optimal early adherence. Clinical care and research efforts should focus on understanding early adverse outcomes that occur despite optimal adherence.	[Steele, Katherine T.; Steenhoff, Andrew P.; Rantleru, Tumelo; Nthobatsang, Rudo; Lesetedi, Gloria; Gross, Robert; Bisson, Gregory P.] Botswana Univ Pennsylvania Partnership, Gaborone, Botswana; [Steele, Katherine T.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Steenhoff, Andrew P.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Steenhoff, Andrew P.] Univ Penn, Ctr AIDS Res, Philadelphia, PA 19104 USA; [Newcomb, Craig W.; Bellamy, Scarlett L.; Gross, Robert; Bisson, Gregory P.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Nachega, Jean B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Nachega, Jean B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Gross, Robert; Bisson, Gregory P.] Univ Penn, Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Pennsylvania	Steele, KT (corresponding author), Botswana Univ Pennsylvania Partnership, Gaborone, Botswana.	bisson@mail.med.upenn.edu		Nachega, Jean/0000-0002-2862-4443; Bellamy, Scarlett/0000-0002-2906-4046	Doris Duke Charitable Foundation, New York, NY; University of Pennsylvania Center for AIDS Research (CFAR), NIH [P30 AI 045008]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation, New York, NY(Doris Duke Charitable Foundation (DDCF)); University of Pennsylvania Center for AIDS Research (CFAR), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by an Operations Research on AIDS Care in Africa grant from the Doris Duke Charitable Foundation, New York, NY (GB), as well as core services and support from the University of Pennsylvania Center for AIDS Research (CFAR), an NIH-funded program (P30 AI 045008). The funding sources had no influence on study design, data collection and analysis, interpretation of the data, manuscript preparation or decision to submit for publication.	Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bisson GP, 2008, JAIDS-J ACQ IMM DEF, V49, P107, DOI 10.1097/QAI.0b013e3181820141; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Bourgarit A, 2006, AIDS, V20, pF1, DOI 10.1097/01.aids.0000202648.18526.bf; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; Djomand G, 2003, AIDS, V17, pS5, DOI 10.1097/00002030-200317003-00002; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Haddow LJ, 2009, CLIN INFECT DIS, V49, P1424, DOI 10.1086/630208; Hester EK, 1998, AIDS, V12, P439; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; Laurent C, 2002, AIDS, V16, P1363, DOI 10.1097/00002030-200207050-00008; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1; Leng K, 2008, INT J STD AIDS, V19, P642, DOI 10.1258/ijsa.2008.008062; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; Markowitz M, 2007, JAIDS-J ACQ IMM DEF, V46, P125, DOI 10.1097/QAI.0b013e318157131c; May MT, 2006, LANCET, V368, P451, DOI 10.1016/S0140-6736(06)69152-6; McMahon JH, 2011, CLIN INFECT DIS, V52, P493, DOI 10.1093/cid/ciq167; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Murdoch DA, 2008, AIDS, V22, P601, DOI 10.1097/QAD.0b013e3282f4a607; Muyingo SK, 2008, JAIDS-J ACQ IMM DEF, V48, P468, DOI 10.1097/QAI.0b013e31817dc3fd; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Nakanjako Damalie, 2008, AIDS Res Ther, V5, P23, DOI 10.1186/1742-6405-5-23; Park WB, 2007, J INTERN MED, V261, P268, DOI 10.1111/j.1365-2796.2006.01762.x; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Spire B, 2008, ANTIVIR THER, V13, P697; Ssali F, 2006, ANTIVIR THER, V11, P741; Wester CW, 2007, JAIDS-J ACQ IMM DEF, V46, P318, DOI 10.1097/QAI.0b013e3181568e3f; Wester CW, 2005, CLIN INFECT DIS, V40, P1041, DOI 10.1086/428352; Westreich D, 2009, AIDS, V23, P707, DOI 10.1097/QAD.0b013e328325d115; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2005, INT WHO CLIN STAG HI; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	42	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20010	10.1371/journal.pone.0020010	http://dx.doi.org/10.1371/journal.pone.0020010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698283	Green Published, Green Submitted, gold			2022-12-25	WOS:000291730000005
J	Ishida, Y; Oleksyk, TK; Georgiadis, NJ; David, VA; Zhao, K; Stephens, RM; Kolokotronis, SO; Roca, AL				Ishida, Yasuko; Oleksyk, Taras K.; Georgiadis, Nicholas J.; David, Victor A.; Zhao, Kai; Stephens, Robert M.; Kolokotronis, Sergios-Orestis; Roca, Alfred L.			Reconciling Apparent Conflicts between Mitochondrial and Nuclear Phylogenies in African Elephants	PLOS ONE			English	Article							TETRANUCLEOTIDE MICROSATELLITE LOCI; CYTONUCLEAR GENOMIC DISSOCIATION; CONTROL REGION SEQUENCES; SEX-BIASED DISPERSAL; POPULATION-STRUCTURE; WEST-AFRICA; INBREEDING AVOIDANCE; LOXODONTA-AFRICANA; GENETIC DIVERSITY; FOREST ELEPHANTS	Conservation strategies for African elephants would be advanced by resolution of conflicting claims that they comprise one, two, three or four taxonomic groups, and by development of genetic markers that establish more incisively the provenance of confiscated ivory. We addressed these related issues by genotyping 555 elephants from across Africa with microsatellite markers, developing a method to identify those loci most effective at geographic assignment of elephants (or their ivory), and conducting novel analyses of continent-wide datasets of mitochondrial DNA. Results showed that nuclear genetic diversity was partitioned into two clusters, corresponding to African forest elephants (99.5% Cluster-1) and African savanna elephants (99.4% Cluster-2). Hybrid individuals were rare. In a comparison of basal forest "F" and savanna "S" mtDNA clade distributions to nuclear DNA partitions, forest elephant nuclear genotypes occurred only in populations in which S clade mtDNA was absent, suggesting that nuclear partitioning corresponds to the presence or absence of S clade mtDNA. We reanalyzed African elephant mtDNA sequences from 81 locales spanning the continent and discovered that S clade mtDNA was completely absent among elephants at all 30 sampled tropical forest locales. The distribution of savanna nuclear DNA and S clade mtDNA corresponded closely to range boundaries traditionally ascribed to the savanna elephant species based on habitat and morphology. Further, a reanalysis of nuclear genetic assignment results suggested that West African elephants do not comprise a distinct third species. Finally, we show that some DNA markers will be more useful than others for determining the geographic origins of illegal ivory. These findings resolve the apparent incongruence between mtDNA and nuclear genetic patterns that has confounded the taxonomy of African elephants, affirm the limitations of using mtDNA patterns to infer elephant systematics or population structure, and strongly support the existence of two elephant species in Africa.	[Ishida, Yasuko; Zhao, Kai; Roca, Alfred L.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Oleksyk, Taras K.] Univ Puerto Rico, Dept Biol, Mayaguez, PR USA; [Georgiadis, Nicholas J.] Bole & Klingenstein Fdn, Cody, WY USA; [David, Victor A.] NCI, Lab Genom Divers, Frederick, MD 21701 USA; [Stephens, Robert M.] NCI, SAIC Frederick Inc, Adv Biomed Comp Ctr, Frederick, MD 21701 USA; [Kolokotronis, Sergios-Orestis] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Roca, Alfred L.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Puerto Rico; University of Puerto Rico Mayaguez; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; American Museum of Natural History (AMNH); University of Illinois System; University of Illinois Urbana-Champaign	Ishida, Y (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	taras.oleksyk@upr.edu; roca@illinois.edu	Kolokotronis, Sergios-Orestis/GWM-5773-2022; Taras, Oleksyk/J-8805-2013; Kolokotronis, Sergios-Orestis/A-1910-2009	Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Taras, Oleksyk/0000-0002-8148-3918; Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Roca, Alfred/0000-0001-9217-5593	U. S. Fish and Wildlife Service African Elephant Conservation Fund [AFE-0458-98210-8-G743]	U. S. Fish and Wildlife Service African Elephant Conservation Fund(US Fish & Wildlife Service)	Funding was provided by the U. S. Fish and Wildlife Service African Elephant Conservation Fund Grant no. AFE-0458-98210-8-G743. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archie EA, 2003, MOL ECOL NOTES, V3, P244, DOI 10.1046/j.1471-8286.2003.00412.x; Archie EA, 2007, MOL ECOL, V16, P4138, DOI 10.1111/j.1365-294X.2007.03483.x; Backhaus D., 1958, Saugetierkundliche Mitteilungen, V6, P166; Barker PA, 2001, SCIENCE, V292, P2307, DOI 10.1126/science.1059612; Barnes RFW, 1999, MAMMAL REV, V29, P175, DOI 10.1046/j.1365-2907.1999.00044.x; Barriel V, 1999, CR ACAD SCI III-VIE, V322, P447, DOI 10.1016/S0764-4469(99)80093-6; Belkhir K, 2004, GENETIX 4 05; Blanc Julian J., 2007, AFRICAN ELEPHANT STA; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; Buggs RJA, 2007, HEREDITY, V99, P301, DOI 10.1038/sj.hdy.6800997; Capelli C, 2006, MOL PHYLOGENET EVOL, V40, P620, DOI 10.1016/j.ympev.2006.03.015; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Comstock KE, 2003, CONSERV BIOL, V17, P1840, DOI 10.1111/j.1523-1739.2003.00358.x; Comstock KE, 2002, MOL ECOL, V11, P2489, DOI 10.1046/j.1365-294X.2002.01615.x; Coyne JA, 2004, SPECIATION, V37; Debruyne R, 2005, CLADISTICS, V21, P31, DOI 10.1111/j.1096-0031.2004.00044.x; Debruyne R, 2003, CR BIOL, V326, P687, DOI 10.1016/S1631-0691(03)00158-6; deMenocal P, 2000, SCIENCE, V288, P2198, DOI 10.1126/science.288.5474.2198; DESAEGER H, 1954, EXPLORATION PARC NAT, V1; DOUGLAS-HAMILTON I, 1987, Oryx, V21, P11; Eggert LS, 2003, MOL ECOL, V12, P1389, DOI 10.1046/j.1365-294X.2003.01822.x; Eggert LS, 2002, P ROY SOC B-BIOL SCI, V269, P1993, DOI 10.1098/rspb.2002.2070; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fernando PJ, 2001, MOL ECOL NOTES, V1, P232, DOI 10.1046/j.1471-8278.2001.00082.x; Frade F., 1934, B SOC PORT SCI NAT, V11, P135; GEORGIADIS N, 1994, J HERED, V85, P100, DOI 10.1093/oxfordjournals.jhered.a111405; Good JM, 2008, MOL ECOL, V17, P1313, DOI 10.1111/j.1365-294X.2007.03640.x; Groves Colin P., 2000, Elephant, V2, P7; Groves Colin P., 2000, Elephant, V2, P4; Grubb Peter, 2000, Elephant, V2, P1; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; HAUF J, 2000, ZOOLOGY, V102, P184; Hedrick PW, 2007, EVOLUTION, V61, P2750, DOI 10.1111/j.1558-5646.2007.00250.x; Hoelzer GA, 1997, EVOLUTION, V51, P622, DOI 10.1111/j.1558-5646.1997.tb02451.x; Hollister-Smith JA, 2007, ANIM BEHAV, V74, P287, DOI 10.1016/j.anbehav.2006.12.008; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Johnson MB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-244; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Karesh W., 1989, CONSERV BIOL, V1, P261; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kuntner M, 2011, ZOOL SCR, V40, P1, DOI 10.1111/j.1463-6409.2010.00452.x; Lei R, 2008, J ZOOL, V275, P252, DOI 10.1111/j.1469-7998.2008.00437.x; Lei RH, 2009, J HERED, V100, P675, DOI 10.1093/jhered/esp069; Mailand C, 2007, NAT PROTOC, V2, P2228, DOI 10.1038/nprot.2007.318; Matschie P., 1900, SITZUNGSBERICHTE GES, V8, P189; Mayr W., 1969, PRINCIPLES SYSTEMATI; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Menotti-Raymond MA, 2005, J FORENSIC SCI, V50, P1061, DOI 10.1520/JFS2004317; Morin PA, 2009, MOL ECOL RESOUR, V9, P1451, DOI 10.1111/j.1755-0998.2009.02672.x; Nyakaana S, 2002, HEREDITY, V89, P90, DOI 10.1038/sj.hdy.6800110; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Pfeffer P., 1989, VIE MORT GEANT ELEPH; Pritchard JK, 2000, GENETICS, V155, P945; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roca A. L., 2002, PACHYDERM, V33, P93; Roca AL, 2001, SCIENCE, V293, P1473, DOI 10.1126/science.1059936; Roca AL, 2005, CURR OPIN GENET DEV, V15, P652, DOI 10.1016/j.gde.2005.09.014; Roca AL, 2005, NAT GENET, V37, P96, DOI 10.1038/ng1485; Roca AL, 2008, TRENDS GENET, V24, P49, DOI 10.1016/j.tig.2007.11.005; Roca AL, 2007, QUATERN INT, V169, P4, DOI 10.1016/j.quaint.2006.08.008; Rohland N, 2007, PLOS BIOL, V5, P1663, DOI 10.1371/journal.pbio.0050207; Rohland N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000564; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; ROTH HH, 1991, MAMMALIA, V55, P489, DOI 10.1515/mamm.1991.55.4.489; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salzmann U, 2005, HOLOCENE, V15, P190, DOI 10.1191/0959683605hl799rp; Sambrook J., 2002, MOL CLONING LAB MANU; Sarno RJ, 2000, MOL ECOL, V9, P1922, DOI 10.1046/j.1365-294x.2000.01077-3.x; Shannon C., 1964, MATH THEORY COMMUNIC; Shriver MD, 1997, AM J HUM GENET, V60, P957; Smith MW, 2005, NAT REV GENET, V6, P623, DOI 10.1038/nrg1657; Species Survival Network, 2006, IV UPD; Stokes S, 1997, NATURE, V388, P154, DOI 10.1038/40596; Sukumar R., 2003, LIVING ELEPHANTS EVO; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Thompson LG, 2002, SCIENCE, V298, P589, DOI 10.1126/science.1073198; Wasser SK, 2008, CONSERV BIOL, V22, P1065, DOI 10.1111/j.1523-1739.2008.01012.x; Wasser SK, 2007, P NATL ACAD SCI USA, V104, P4228, DOI 10.1073/pnas.0609714104; Wasser SK, 2009, SCI AM, V301, P68, DOI 10.1038/scientificamerican0709-68; Wasser SK, 2004, P NATL ACAD SCI USA, V101, P14847, DOI 10.1073/pnas.0403170101; WHITE F, 1983, VEGETATION AFRICA; Winkler CA, 2010, ANNU REV GENOM HUM G, V11, P65, DOI 10.1146/annurev-genom-082509-141523; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x	85	35	37	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20642	10.1371/journal.pone.0020642	http://dx.doi.org/10.1371/journal.pone.0020642			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21701575	Green Submitted, Green Published, gold			2022-12-25	WOS:000291611500036
J	Chou, CH; Teng, CM; Tzen, KY; Chang, YC; Chen, JH; Cheng, JCH				Chou, C. H.; Teng, C-M; Tzen, K-Y; Chang, Y-C; Chen, J-H; Cheng, J. C-H			MMP-9 from sublethally irradiated tumor promotes Lewis lung carcinoma cell invasiveness and pulmonary metastasis	ONCOGENE			English	Article						MMP-9; radiation; Lewis lung carcinoma; invasiveness; metastasis	ENDOTHELIAL GROWTH-FACTOR; MARROW-DERIVED CELLS; MATRIX METALLOPROTEINASES; ANGIOGENESIS; MATRIX-METALLOPROTEINASE-9; CANCER; MICE; ANGIOSTATIN; EXPRESSION; CARCINOGENESIS	Matrix metalloproteinases (MMPs) associate with tumor progression and metastasis. We sought to investigate the role of MMP-9 from sublethally irradiated tumor in accelerated pulmonary metastasis of Lewis lung carcinoma (LLC-LM) and the corresponding anti-metastasis strategies in C57BL/6 mice. We used Matrigel-coated Boyden chamber assays and chicken chorioallantoic membrane assays to evaluate the invasion capability of irradiated LLC-LM cells (7.5 Gy), reverse transcription-polymerase chain reaction and the western blot assay to investigate the expression of MMPs by irradiated cells, and small interfering RNA duplexes to inhibit MMP-9 expression. LLC-LM cells differing in MMP-2 or -9 expression were subcutaneously injected into right thighs and the resulting tumors were irradiated (10 Gy x 5) to induce pulmonary metastasis. Radiation significantly enhanced MMP-9 at both the transcriptional and translational levels. MMP-9 siRNA significantly inhibited in vitro radiation-enhanced invasiveness. The number of radiation-accelerated pulmonary metastases was significantly reduced by MMP-9 knockdown and MMP-2/9 knockdown. Reverse transcription-polymerase chain reaction of LLC-LM cells in the blood and lung tissue revealed MMP-9 involvement in radiation-enhanced intravasation. Either higher-dose irradiation (30 Gy x 2) or pretreatment with prototypical MMP-9 inhibitor, zoledronic acid, significantly reduced the number of pulmonary metastases. The viability of irradiated tumor was seen on both positron emission tomography and magnetic resonance imaging, and tumor/serum MMP-9 levels suggested the association of local control of primary tumor and inhibition of time-dependent MMP-9 activities. Our results demonstrate that MMP-9 is crucially involved in radiation-enhanced LLC-LM cell invasiveness in vitro and in pulmonary metastasis from inadequately irradiated primary tumor in vivo. Oncogene (2012) 31, 458-468; doi: 10.1038/onc.2011.240; published online 27 June 2011	[Chou, C. H.; Cheng, J. C-H] Natl Taiwan Univ Hosp, Dept Oncol, Div Radiat Oncol, Taipei 100, Taiwan; [Chou, C. H.; Cheng, J. C-H] Natl Taiwan Univ, Grad Inst Oncol, Coll Med, Taipei 10764, Taiwan; [Teng, C-M] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan; [Tzen, K-Y] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei 100, Taiwan; [Tzen, K-Y] Natl Taiwan Univ, Mol Imaging Ctr, Taipei 10764, Taiwan; [Chang, Y-C] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei 100, Taiwan; [Chen, J-H; Cheng, J. C-H] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Coll Elect Engn & Comp Sci, Taipei 10764, Taiwan; [Cheng, J. C-H] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Cheng, JCH (corresponding author), Natl Taiwan Univ Hosp, Dept Oncol, Div Radiat Oncol, 7 Chung Shan S Rd, Taipei 100, Taiwan.	jasoncheng@ntu.edu.tw		TZEN, KAI-YUAN/0000-0002-5657-8579; TENG, CHE-MING/0000-0002-9719-7334; CHENG, JASON CHIA-HSIEN/0000-0002-2007-0220; CHANG, YEUN-CHUNG/0000-0001-9984-5713	National Science Council, Execute Yuan, Taiwan, ROC [NSC97-2314-B-002-113-MY3, NSC98-2627-B-002-017, NSC99-2627-B-002-008]; National Taiwan University Hospital [NTUH 98S1128]	National Science Council, Execute Yuan, Taiwan, ROC(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This work was supported by the National Science Council, Execute Yuan, Taiwan, ROC (Grant numbers NSC97-2314-B-002-113-MY3, NSC98-2627-B-002-017 and NSC99-2627-B-002-008), and the National Taiwan University Hospital (Grant number NTUH 98S1128). We appreciate the contribution of the Molecular Imaging Center, National Taiwan University, in providing the technical support of the dedicated small animal PET/CT scanner for imaging. We also thank Mr Samuel C Leu for his help with the PET/CT scans and image analysis.	Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Ahn GO, 2009, CELL CYCLE, V8, P970, DOI 10.4161/cc.8.7.8075; Basile DP, 2004, AM J PHYSIOL-RENAL, V286, pF893, DOI 10.1152/ajprenal.00328.2003; BERNHARD EJ, 1994, P NATL ACAD SCI USA, V91, P4293, DOI 10.1073/pnas.91.10.4293; Bode W, 2003, BIOL CHEM, V384, P863, DOI 10.1515/BC.2003.097; Camphausen K, 2001, CANCER RES, V61, P2207; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chen XW, 2005, INT J CANCER, V116, P52, DOI 10.1002/ijc.20997; Cheng JCH, 2006, ONCOGENE, V25, P7009, DOI 10.1038/sj.onc.1209706; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Dong ZY, 1997, CELL, V88, P801, DOI 10.1016/S0092-8674(00)81926-1; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Hartford AC, 2000, CANCER RES, V60, P2128; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Huang SY, 2002, J NATL CANCER I, V94, P1134; Jodele S, 2005, CANCER RES, V65, P3200, DOI 10.1158/0008-5472.CAN-04-3770; Leeman MF, 2003, J PATHOL, V201, P528, DOI 10.1002/path.1466; Martin FM, 1999, BIOORG MED CHEM LETT, V9, P2887, DOI 10.1016/S0960-894X(99)00494-1; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Osinsky SP, 2005, EXP ONCOL, V27, P202; Owen JL, 2003, J IMMUNOL, V171, P4340, DOI 10.4049/jimmunol.171.8.4340; Pozzi A, 2002, ONCOGENE, V21, P272, DOI 10.1038/sj.onc.1205045; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Thwin MM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2810; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Vihinen P, 2005, CURR CANCER DRUG TAR, V5, P203, DOI 10.2174/1568009053765799; Zhang Q, 2006, J BIOL CHEM, V281, P18145, DOI 10.1074/jbc.M512566200	29	42	45	3	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2012	31	4					458	468		10.1038/onc.2011.240	http://dx.doi.org/10.1038/onc.2011.240			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891LU	21706046				2022-12-25	WOS:000300219300005
J	Bahudhanapati, H; Zhang, YN; Sidhu, SS; Brew, K				Bahudhanapati, Harinath; Zhang, Yingnan; Sidhu, Sachdev S.; Brew, Keith			Phage Display of Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) IDENTIFICATION OF SELECTIVE INHIBITORS OF COLLAGENASE-1 (METALLOPROTEINASE 1 (MMP-1))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KUNITZ DOMAIN INHIBITORS; ALPHA-CONVERTING-ENZYME; FACTOR-FACTOR VIIA; MATRIX-METALLOPROTEINASES; CRYSTAL-STRUCTURE; ITERATIVE OPTIMIZATION; CATALYTIC DOMAIN; POTENT INHIBITOR; BREAST-CANCER; SWISS-MODEL	Tissue inhibitor of metalloproteinases-2 (TIMP-2) is a broad spectrum inhibitor of the matrix metalloproteinases (MMPs), which function in extracellular matrix catabolism. Here, phage display was used to identify variants of human TIMP-2 that are selective inhibitors of human MMP-1, a collagenase whose unregulated action is linked to cancer, arthritis, and fibrosis. Using hard randomization of residues 2, 4, 5, and 6 (L1) and soft randomization of residues 34-40 (L2) and 67-70 (L3), a library was generated containing 2 x 10(10) variants of TIMP-2. Five clones were isolated after five rounds of selection with MMP-1, using MMP-3 as a competitor. The enriched phages selectively bound MMP-1 relative to MMP-3 and contained mutations only in L1. The most selective variant (TM8) was used to generate a second library in which residues Cys(1)-Gln(9) were soft-randomized. Four additional clones, selected from this library, showed a similar affinity for MMP-1 as wild-type TIMP-2 but reduced affinity for MMP-3. Variants of the N-terminal domain of TIMP-2 (N-TIMP-2) with the sequences of the most selective clones were expressed and characterized for inhibitory activity against eight MMPs. All were effective inhibitors of MMP-1 with nanomolar K-i values, but TM8, containing Ser(2) to Asp and Ser(4) to Ala substitutions, was the most selective having a nanomolar K-i value for MMP-1 but no detectable inhibitory activity toward MMP-3 and MMP-14 up to 10 mu M. This study suggests that phage display and selection with other MMPs may be an effective method for discovering tissue inhibitor of metalloproteinase variants that discriminate between specified MMPs as targets.	[Bahudhanapati, Harinath; Brew, Keith] Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Basic Sci, Boca Raton, FL 33431 USA; [Zhang, Yingnan; Sidhu, Sachdev S.] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	State University System of Florida; Florida Atlantic University; Roche Holding; Genentech	Brew, K (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, Boca Raton, FL 33431 USA.	kbrew@fau.edu	Izal, María/B-7398-2011; Brew, Keith/W-1643-2019; Brew, Keith/A-6746-2009	Brew, Keith/0000-0003-1306-1032	National Institutes of Health [R01 AR40994]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR40994 (to K. B.).	Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arumugam S, 2003, J MOL BIOL, V327, P719, DOI 10.1016/S0022-2836(03)00180-3; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; DENNIS MS, 1994, J BIOL CHEM, V269, P22129; DENNIS MS, 1994, J BIOL CHEM, V269, P22137; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Gardsvoll H, 1998, FEBS LETT, V431, P170, DOI 10.1016/S0014-5793(98)00742-X; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Grossman M, 2010, BIOCHEMISTRY-US, V49, P6184, DOI 10.1021/bi902141x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; Iyer S, 2006, J MOL BIOL, V362, P78, DOI 10.1016/j.jmb.2006.06.079; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Markland W, 1996, BIOCHEMISTRY-US, V35, P8058, DOI 10.1021/bi952629y; Markland W, 1996, BIOCHEMISTRY-US, V35, P8045, DOI 10.1021/bi9526286; Maskos K, 2007, J MOL BIOL, V366, P1222, DOI 10.1016/j.jmb.2006.11.072; McCawley LJ, 2004, CANCER RES, V64, P6965, DOI 10.1158/0008-5472.CAN-04-0910; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Murray GI, 1996, NAT MED, V2, P461, DOI 10.1038/nm0496461; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Skelton NJ, 2003, J BIOL CHEM, V278, P7645, DOI 10.1074/jbc.M209751200; Stracke JO, 2000, J BIOL CHEM, V275, P14809, DOI 10.1074/jbc.275.20.14809; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Van Doren SR, 2008, BIOPOLYMERS, V89, P960, DOI 10.1002/bip.21043; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang CI, 1996, METHOD ENZYMOL, V267, P52; Wei S, 2005, J BIOL CHEM, V280, P32877, DOI 10.1074/jbc.C500220200; Wei S, 2003, BIOCHEMISTRY-US, V42, P12200, DOI 10.1021/bi035358x; Wei S, 2003, J BIOL CHEM, V278, P9831, DOI 10.1074/jbc.M211793200; Welch AR, 1996, BIOCHEMISTRY-US, V35, P10103, DOI 10.1021/bi9601969; Williamson RA, 2001, J BIOL CHEM, V276, P32966, DOI 10.1074/jbc.M101843200; WITTY JP, 1995, CANCER RES, V55, P1401; Wu Y, 2011, J BIOL CHEM, V286, P16891, DOI 10.1074/jbc.M111.222307; Zhang JP, 2005, BIOTECHNOL PROGR, V21, P1220, DOI 10.1021/bp0500359	41	28	30	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31761	31770		10.1074/jbc.M111.253328	http://dx.doi.org/10.1074/jbc.M111.253328			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21715326	Green Published, hybrid			2022-12-25	WOS:000294487500069
J	Ovadia, H; Haim, Y; Nov, O; Almog, O; Kovsan, J; Bashan, N; Benhar, M; Rudich, A				Ovadia, Hilla; Haim, Yulia; Nov, Ori; Almog, Orna; Kovsan, Julia; Bashan, Nava; Benhar, Moran; Rudich, Assaf			Increased Adipocyte S-Nitrosylation Targets Anti-lipolytic Action of Insulin RELEVANCE TO ADIPOSE TISSUE DYSFUNCTION IN OBESITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE-B/AKT; RECEPTOR SUBSTRATE-1; MACROPHAGE INFILTRATION; PHOSPHODIESTERASE 3B; DIABETES-MELLITUS; OXIDATIVE STRESS; REACTIVE OXYGEN; FAT TISSUE	Protein S-nitrosylation is a reversible protein modification implicated in both physiological and pathophysiological regulation of protein function. In obesity, skeletal muscle insulin resistance is associated with increased S-nitrosylation of insulin-signaling proteins. However, whether adipose tissue is similarly affected in obesity and, if so, what are the causes and functional consequences of increased S-nitrosylation in this tissue are unknown. Total protein S-nitrosylation was increased in intra-abdominal adipose tissue of obese humans and in high fat-fed or leptin-deficient ob/ob mice. Both the insulin receptor beta-subunit and Akt were S-nitrosylated, correlating with body weight. Elevated protein and RNA xpression of inducible NO synthase and decreased protein levels of thioredoxin reductase were associated with increased adipose tissue S-nitrosylation. Cultured differentiated pre-adipocyte cell lines exposed to the NO donors S-nitrosoglutathione (GSNO) or S-nitroso-N-acetylpenicillamine exhibited diminished insulin-stimulated phosphorylation of Akt but not of GSK3 nor of insulin-stimulated glucose uptake. Yet the anti-lipolytic action of insulin was markedly impaired in both cultured adipocytes and in mice injected with GSNO prior to administration of insulin. In cells, impaired ability of insulin to diminish phosphorylated PKA substrates in response to isoproterenol suggested impaired insulin-induced activation of PDE3B. Consistently, increased S-nitrosylation of PDE3B was detected in adipose tissue of high fat-fed obese mice. Site-directed mutagenesis revealed that Cys-768 and Cys-1040, two putative sites for S-nitrosylation adjacent to the substrate-binding site of PDE3B, accounted for similar to 50% of its GSNO-induced S-nitrosylation. Collectively, PDE3B and the anti-lipolytic action of insulin may constitute novel targets for increased S-nitrosylation of adipose tissue in obesity.	[Rudich, Assaf] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, IL-84103 Beer Sheva, Israel; [Benhar, Moran] Technion Israel Inst Technol, Rappaport Fac Med, Dept Biochem, IL-31096 Haifa, Israel; [Rudich, Assaf] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84103 Beer Sheva, Israel	Ben Gurion University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Ben Gurion University	Rudich, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, IL-84103 Beer Sheva, Israel.	rudich@bgu.ac.il	Benhar, Moran/AAV-5764-2020	Benhar, Moran/0000-0002-7094-3456; Rudich, Assaf/0000-0002-1366-1444	Israel Science Foundation [118-06, 1103-09]; Israeli Ministry of Health [3/5067]; Leslie and Susan Gonda (Goldschmid) Center for Diabetes Research and Education	Israel Science Foundation(Israel Science Foundation); Israeli Ministry of Health; Leslie and Susan Gonda (Goldschmid) Center for Diabetes Research and Education	This work was supported in part by Israel Science Foundation Grants 118-06 and 1103-09 (to A. R. and N. B.), Israeli Ministry of Health Grant 3/5067, and by the Leslie and Susan Gonda (Goldschmid) Center for Diabetes Research and Education.	Arner P, 2003, TRENDS ENDOCRIN MET, V14, P137, DOI 10.1016/S1043-2760(03)00024-9; Bashan N, 2007, ENDOCRINOLOGY, V148, P2955, DOI 10.1210/en.2006-1369; Bashan N, 2009, PHYSIOL REV, V89, P27, DOI 10.1152/physrev.00014.2008; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Bluher M, 2009, J CLIN ENDOCR METAB, V94, P2507, DOI 10.1210/jc.2009-0002; Brune B, 1996, REV PHYSIOL BIOCH P, V127, P1, DOI 10.1007/BFb0048263; Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959; Carvalho-Filho MA, 2006, AM J PHYSIOL-ENDOC M, V291, pE476, DOI 10.1152/ajpendo.00422.2005; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; Davi G, 2005, ANTIOXID REDOX SIGN, V7, P256, DOI 10.1089/ars.2005.7.256; Degerman E, 1998, METHODS, V14, P43, DOI 10.1006/meth.1997.0564; Elizalde M, 2000, J LIPID RES, V41, P1244; Engeli S, 2004, J LIPID RES, V45, P1640, DOI 10.1194/jlr.M300322-JLR200; Forrester MT, 2009, FREE RADICAL BIO MED, V46, P119, DOI 10.1016/j.freeradbiomed.2008.09.034; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kaneki M, 2007, ANTIOXID REDOX SIGN, V9, P319, DOI 10.1089/ars.2006.1464; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Kolditz CI, 2010, CURR OPIN CLIN NUTR, V13, P377, DOI 10.1097/MCO.0b013e32833bed6a; Konrad D, 2007, DIABETOLOGIA, V50, P833, DOI 10.1007/s00125-007-0596-1; Kovsan J, 2007, J BIOL CHEM, V282, P21704, DOI 10.1074/jbc.M702223200; Kovsan J, 2009, AM J PHYSIOL-ENDOC M, V296, pE315, DOI 10.1152/ajpendo.90486.2008; LANE P, 2001, SCI STKE, pRE1; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; LOTEN EG, 1991, INT J BIOCHEM, V23, P649, DOI 10.1016/0020-711X(91)90033-J; MANGANIELLO VC, 1995, ARCH BIOCHEM BIOPHYS, V322, P1, DOI 10.1006/abbi.1995.1429; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Nishikawa T, 2003, DIABETES CARE, V26, P1507, DOI 10.2337/diacare.26.5.1507; Pauli JR, 2008, J PHYSIOL-LONDON, V586, P659, DOI 10.1113/jphysiol.2007.142414; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Rehman A, 1999, FEBS LETT, V448, P120, DOI 10.1016/S0014-5793(99)00339-7; Scapin G, 2004, BIOCHEMISTRY-US, V43, P6091, DOI 10.1021/bi049868i; Souza SC, 1998, DIABETES, V47, P691, DOI 10.2337/diabetes.47.4.691; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Sugita H, 2005, J BIOL CHEM, V280, P14203, DOI 10.1074/jbc.M411226200; Tirosh A, 1999, J BIOL CHEM, V274, P10595, DOI 10.1074/jbc.274.15.10595; WEINBERG JB, 1995, BLOOD, V86, P1184; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200	47	39	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30433	30443		10.1074/jbc.M111.235945	http://dx.doi.org/10.1074/jbc.M111.235945			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21724851	hybrid, Green Published			2022-12-25	WOS:000294283600022
J	Botte, CY; Yamaryo-Botte, Y; Janouskovec, J; Rupasinghe, T; Keeling, PJ; Crellin, P; Coppel, RL; Marechal, E; McConville, MJ; McFadden, GI				Botte, Cyrille Y.; Yamaryo-Botte, Yoshiki; Janouskovec, Jan; Rupasinghe, Thusita; Keeling, Patrick J.; Crellin, Paul; Coppel, Ross L.; Marechal, Eric; McConville, Malcolm J.; McFadden, Geoffrey I.			Identification of Plant-like Galactolipids in Chromera velia, a Photosynthetic Relative of Malaria Parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; APICOMPLEXAN PARASITES; TOXOPLASMA-GONDII; DIGALACTOSYL-DIACYLGLYCEROL; PLASMODIUM-FALCIPARUM; PHOSPHATE DEPRIVATION; PLASMA-MEMBRANE; PHOTOSYSTEM-I; FATTY-ACIDS; CHLOROPLAST	Apicomplexa are protist parasites that include Plasmodium spp., the causative agents of malaria, and Toxoplasma gondii, responsible for toxoplasmosis. Most Apicomplexa possess a relict plastid, the apicoplast, which was acquired by secondary endosymbiosis of a red alga. Despite being nonphotosynthetic, the apicoplast is otherwise metabolically similar to algal and plant plastids and is essential for parasite survival. Previous studies of Toxoplasma gondii identified membrane lipids with some structural features of plastid galactolipids, the major plastid lipid class. However, direct evidence for the plant-like enzymes responsible for galactolipid synthesis in Apicomplexan parasites has not been obtained. Chromera velia is an Apicomplexan relative recently discovered in Australian corals. C. velia retains a photosynthetic plastid, providing a unique model to study the evolution of the apicoplast. Here, we report the unambiguous presence of plant-like monogalactosyldiacylglycerol and digalactosyldiacylglycerol in C. velia and localize digalactosyldiacylglycerol to the plastid. We also provide evidence for a plant-like biosynthesis pathway and identify candidate galactosyltran-ferases responsible for galactolipid synthesis. Our study provides new insights in the evolution of these important enzymes in plastid-containing eukaryotes and will help reconstruct the evolution of glycerolipid metabolism in important parasites such as Plasmodium and Toxoplasma.	[Botte, Cyrille Y.; McFadden, Geoffrey I.] Univ Melbourne, Sch Bot, Parkville, Vic 3010, Australia; [Botte, Cyrille Y.; Marechal, Eric] Univ Grenoble 1, UMR 5168, CNRS,Inst Rech & Technol Sci Vivant, Commissariat Energie Atom,Inst Natl Rech Agron, F-38054 Grenoble, France; [Yamaryo-Botte, Yoshiki; Crellin, Paul; Coppel, Ross L.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Yamaryo-Botte, Yoshiki; Rupasinghe, Thusita; McConville, Malcolm J.] Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Janouskovec, Jan; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada	University of Melbourne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Monash University; University of Melbourne; University of British Columbia	McFadden, GI (corresponding author), Univ Melbourne, Sch Bot, Parkville, Vic 3010, Australia.	gim@unimelb.edu.au	Janouškovec, Jan/ABA-2568-2021; Coppel, Ross L/A-6626-2008; Botte, Cyrille/G-1972-2014; McFadden, Geoffrey McFadden I/F-7667-2014	Janouškovec, Jan/0000-0001-6547-749X; Coppel, Ross L/0000-0002-4476-9124; Botte, Cyrille/0000-0002-2245-536X; McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Crellin, Paul K/0000-0002-2017-4935; Keeling, Patrick/0000-0002-7644-0745; Yamaryo-Botte, Yoshiki/0000-0002-9349-4411	European Research Council; National Health and Medical Research Council of Australia; CNRS; Agence Nationale de la Recherche	European Research Council(European Research Council (ERC)European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported in part by European Research Council FP7 Marie Curie Actions via an International Outgoing Fellowship Marie Curie fellowship (to C. Y. B.), National Health and Medical Research Council of Australia, CNRS, and Agence Nationale de la Recherche ReGal grant (to E. M.).	Andersson MX, 2005, J BIOL CHEM, V280, P27578, DOI 10.1074/jbc.M503273200; Andersson MX, 2003, FEBS LETT, V537, P128, DOI 10.1016/S0014-5793(03)00109-1; Awai K, 2001, P NATL ACAD SCI USA, V98, P10960, DOI 10.1073/pnas.181331498; Awai K, 2006, PLANT PHYSIOL, V141, P1120, DOI 10.1104/pp.106.082859; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; Bisanz C, 2006, BIOCHEM J, V394, P197, DOI 10.1042/BJ20050609; Botte C, 2005, J BIOL CHEM, V280, P34691, DOI 10.1074/jbc.M505622200; Botte C, 2008, J LIPID RES, V49, P746, DOI 10.1194/jlr.M700476-JLR200; Coutinho Pedro M., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P307; DORMANN P, 1995, PLANT CELL, V7, P1801, DOI 10.1105/tpc.7.11.1801; Dormann P, 2002, TRENDS PLANT SCI, V7, P112, DOI 10.1016/S1360-1385(01)02216-6; Dubots E, 2010, J BIOL CHEM, V285, P6003, DOI 10.1074/jbc.M109.071928; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; Guo JK, 2005, FEBS LETT, V579, P3619, DOI 10.1016/j.febslet.2005.05.049; Hartel H, 2000, P NATL ACAD SCI USA, V97, P10649, DOI 10.1073/pnas.180320497; Holzl G, 2005, PLANT CELL PHYSIOL, V46, P1766, DOI 10.1093/pcp/pci189; Ivanov AG, 2006, PLANT CELL PHYSIOL, V47, P1146, DOI 10.1093/pcp/pcj089; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Jouhet J, 2004, J CELL BIOL, V167, P863, DOI 10.1083/jcb.200407022; Jouhet J, 2007, PROG LIPID RES, V46, P37, DOI 10.1016/j.plipres.2006.06.002; Joyard J, 1998, PLANT PHYSIOL, V118, P715, DOI 10.1104/pp.118.3.715; Joyard J, 2010, PROG LIPID RES, V49, P128, DOI 10.1016/j.plipres.2009.10.003; Kalanon M, 2010, BIOCHEM SOC T, V38, P775, DOI 10.1042/BST0380775; Keeling PJ, 2004, AM J BOT, V91, P1481, DOI 10.3732/ajb.91.10.1481; Kelly AA, 2002, J BIOL CHEM, V277, P1166, DOI 10.1074/jbc.M110066200; KNUDSEN E, 1982, ARCH MICROBIOL, V132, P149, DOI 10.1007/BF00508721; Kobayashi K, 2007, P NATL ACAD SCI USA, V104, P17216, DOI 10.1073/pnas.0704680104; Leblond JD, 2000, J PHYCOL, V36, P1103, DOI 10.1046/j.1529-8817.2000.00018.x; Leblond JD, 2010, EUR J PHYCOL, V45, P13, DOI 10.1080/09670260903171650; LIVERMORE BP, 1974, J BACTERIOL, V120, P1268, DOI 10.1128/JB.120.3.1268-1273.1974; Marechal E, 2002, EUKARYOT CELL, V1, P653, DOI 10.1128/EC.1.4.653-656.2002; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P7385; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; Miege C, 1999, EUR J BIOCHEM, V265, P990, DOI 10.1046/j.1432-1327.1999.00801.x; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Moreau P, 1998, PROG LIPID RES, V37, P371, DOI 10.1016/S0163-7827(98)00016-2; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Steffen R, 2005, BIOCHEMISTRY-US, V44, P3123, DOI 10.1021/bi0484668; Welti R, 2007, BIOCHEMISTRY-US, V46, P13882, DOI 10.1021/bi7011993	39	38	38	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29893	29903		10.1074/jbc.M111.254979	http://dx.doi.org/10.1074/jbc.M111.254979			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21712377	hybrid, Green Published			2022-12-25	WOS:000294046600048
J	Cornelius, F; Mahmmoud, YA; Toyoshima, C				Cornelius, Flemming; Mahmmoud, Yasser A.; Toyoshima, Chikashi			Metal Fluoride Complexes of Na,K-ATPase CHARACTERIZATION OF FLUORIDE-STABILIZED PHOSPHOENZYME ANALOGUES AND THEIR INTERACTION WITH CARDIOTONIC STEROIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; SODIUM-POTASSIUM PUMP; DISSOCIATION RATE CONSTANTS; CALCIUM-PUMP; CRYSTAL-STRUCTURE; PHOSPHORYL TRANSFER; RECTAL GLANDS; PROTEINASE-K; BINDING SITE; ATPASE	The Na,K-ATPase belongs to the P-type ATPase family of primary active cation pumps. Metal fluorides like magnesium-, beryllium-, and aluminum fluoride act as phosphate analogues and inhibit P-type ATPases by interacting with the phosphorylation site, stabilizing conformations that are analogous to specific phosphoenzyme intermediates. Cardiotonic steroids like ouabain used in the treatment of congestive heart failure and arrhythmias specifically inhibit the Na,K-ATPase, and the detailed structure of the highly conserved binding site has recently been described by the crystal structure of the shark Na,K-ATPase in a state analogous to E2 center dot 2K(+)center dot P-1 with ouabain bound with apparently low affinity (1). In the present work inhibition, and subsequent reactivation by high Na+, after treatment of shark Na,K-ATPase with various metal fluorides are characterized. Half-maximal inhibition of Na,K-ATPase activity by metal fluorides is in the micromolar range. The binding of cardiotonic steroids to the metal fluoride-stabilized enzyme forms was investigated using the fluorescent ouabain derivative 9-anthroyl ouabain and compared with binding to phosphorylated enzyme. The fastest binding was to the Be-fluoride stabilized enzyme suggesting a preformed ouabain binding cavity, in accord with results for Ca-ATPase where Be-fluoride stabilizes the E2-P ground state with an open luminal ion access pathway, which in Na,K-ATPase could be a passage for ouabain. The Be-fluoride stabilized enzyme conformation closely resembles the E2-P ground state according to proteinase K cleavage. Ouabain, but not its aglycone ouabagenin, prevented reactivation of this metal fluoride form by high Na+ demonstrating the pivotal role of the sugar moiety in closing the extracellular cation pathway.	[Cornelius, Flemming; Mahmmoud, Yasser A.] Univ Aarhus, Dept Biomed, DK-8000 Aarhus C, Denmark; [Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	Aarhus University; University of Tokyo	Cornelius, F (corresponding author), Univ Aarhus, Dept Biomed, Ole Worms Alle 6,Bldg 1180, DK-8000 Aarhus C, Denmark.	fc@biophys.au.dk	Toyoshima, Chikashi/R-4153-2019; Cornelius, Flemming/C-1912-2019	Cornelius, Flemming/0000-0003-1566-0020; Toyoshima, Chikashi/0000-0001-9640-0778	Danish Medical Research Foundation; Danish Agency for Science Technology and Innovation; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency	Danish Medical Research Foundation; Danish Agency for Science Technology and Innovation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by The Danish Medical Research Foundation and by an FI/Danish-Japanese cooperation program from The Danish Agency for Science Technology and Innovation (to F. C.) and by a Specially Promoted Project Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by a Strategic Japanese-Danish Cooperative Program Grant from Japan Science and Technology Agency (to C. T.).	BAGINSKI ES, 1967, CLIN CHIM ACTA, V15, P155, DOI 10.1016/0009-8981(67)90340-3; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; Cornelius F, 2009, BIOCHEMISTRY-US, V48, P10056, DOI 10.1021/bi901212r; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; Fiske CH, 1925, J BIOL CHEM, V66, P375; FORTES PAG, 1977, BIOCHEMISTRY-US, V16, P531, DOI 10.1021/bi00622a030; GOLDSTEIN G, 1964, ANAL CHEM, V36, P243, DOI 10.1021/ac60207a074; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; Katz A, 2010, J BIOL CHEM, V285, P19582, DOI 10.1074/jbc.M110.119248; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahmmoud YA, 2000, J BIOL CHEM, V275, P35969, DOI 10.1074/jbc.M005168200; MINTZ E, 1990, J BIOL CHEM, V265, P18762; MISSIAEN L, 1988, BIOCHEM J, V253, P827, DOI 10.1042/bj2530827; MOCZYDLOWSKI EG, 1980, BIOCHEMISTRY-US, V19, P969, DOI 10.1021/bi00546a022; Montigny C, 2007, BIOCHEMISTRY-US, V46, P15162, DOI 10.1021/bi701855r; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; MURPHY AJ, 1992, J BIOL CHEM, V267, P16995; MURPHY AJ, 1993, J BIOL CHEM, V268, P23307; MURPHY AJ, 1992, J BIOL CHEM, V267, P16990; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; ROBINSON JD, 1982, J BIOENERG BIOMEMBR, V14, P319, DOI 10.1007/BF00743061; ROBINSON JD, 1986, J BIOENERG BIOMEMBR, V18, P521, DOI 10.1007/BF00743148; SCHATZMANN HJ, 1953, HELV PHYSIOL PHARM A, V11, P346; Schlichting I, 1999, NAT STRUCT BIOL, V6, P721, DOI 10.1038/11485; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SKOU JC, 1982, BIOCHIM BIOPHYS ACTA, V688, P369, DOI 10.1016/0005-2736(82)90348-0; SKOU JC, 1988, METHOD ENZYMOL, V156, P43; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; TROULLIER A, 1992, J BIOL CHEM, V267, P22821; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; YODA A, 1982, MOL PHARMACOL, V22, P700; YODA A, 1977, MOL PHARMACOL, V13, P352; YODA A, 1974, ANN NY ACAD SCI, V242, P598, DOI 10.1111/j.1749-6632.1974.tb19120.x	41	32	32	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29882	29892		10.1074/jbc.M111.259663	http://dx.doi.org/10.1074/jbc.M111.259663			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21708939	hybrid, Green Published			2022-12-25	WOS:000294046600047
J	Szczepanek, K; Chen, Q; Derecka, M; Salloum, FN; Zhang, QF; Szelag, M; Cichy, J; Kukreja, RC; Dulak, J; Lesnefsky, EJ; Larner, AC				Szczepanek, Karol; Chen, Qun; Derecka, Marta; Salloum, Fadi N.; Zhang, Qifang; Szelag, Magdalena; Cichy, Joanna; Kukreja, Rakesh C.; Dulak, Jozef; Lesnefsky, Edward J.; Larner, Andrew C.			Mitochondrial-targeted Signal Transducer and Activator of Transcription 3 (STAT3) Protects against Ischemia-induced Changes in the Electron Transport Chain and the Generation of Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCARDIAL-ISCHEMIA; OXIDATIVE STRESS; COMPLEX-III; SUBSARCOLEMMAL MITOCHONDRIA; HEART-MITOCHONDRIA; GENE-EXPRESSION; MOUSE HEART; INJURY; PHOSPHORYLATION; CARDIOMYOPATHY	Expression of the STAT3 transcription factor in the heart is cardioprotective and decreases the levels of reactive oxygen species. Recent studies indicate that a pool of STAT3 resides in the mitochondria where it is necessary for the maximal activity of complexes I and II of the electron transport chain. However, it has not been explored whether mitochondrial STAT3 modulates cardiac function under conditions of stress. Transgenic mice with cardiomyocyte-specific overexpression of mitochondria-targeted STAT3 with a mutation in the DNA-binding domain (MLS-STAT3E) were generated. We evaluated the role of mitochondrial STAT3 in the preservation of mitochondrial function during ischemia. Under conditions of ischemia heart mitochondria expressing MLS-STAT3E exhibited modest decreases in basal activities of complexes I and II of the electron transport chain. In contrast to WThearts, complex I-dependent respiratory rates were protected against ischemic damage in MLS-STAT3E hearts. MLS-STAT3E prevented the release of cytochrome c into the cytosol during ischemia. In contrast to WT mitochondria, ischemia did not augment reactive oxygen species production in MLS-STAT3E mitochondria likely due to an MLS-STAT3E-mediated partial blockade of electron transport through complex I. Given the caveat of STAT3 overexpression, these results suggest a novel protective mechanism mediated by mitochondrial STAT3 that is independent of its canonical activity as a nuclear transcription factor.	[Szczepanek, Karol; Derecka, Marta; Zhang, Qifang; Szelag, Magdalena; Lesnefsky, Edward J.; Larner, Andrew C.] Virginia Commonwealth Univ, Div Cardiol, Pauley Heart Ctr, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Szczepanek, Karol; Chen, Qun; Salloum, Fadi N.; Kukreja, Rakesh C.; Lesnefsky, Edward J.] Virginia Commonwealth Univ, Div Cardiol, Pauley Heart Ctr, Dept Internal Med, Richmond, VA 23298 USA; [Szczepanek, Karol; Szelag, Magdalena; Dulak, Jozef] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Med Biotechnol, PL-30387 Krakow, Poland; [Derecka, Marta; Cichy, Joanna] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Immunol, PL-30387 Krakow, Poland; [Lesnefsky, Edward J.] McGuire Dept Vet Affairs Med Ctr, Med Serv, Richmond, VA 23249 USA	Virginia Commonwealth University; Virginia Commonwealth University; Jagiellonian University; Jagiellonian University; Hunter Holmes McGuire Veterinary Affairs Medical Center	Larner, AC (corresponding author), Virginia Commonwealth Univ, Div Cardiol, Pauley Heart Ctr, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	alarner@vcu.edu	Salloum, Fadi N/C-2391-2008; zhang, qifang/H-5691-2013; zhang, qifang/F-9857-2013; Chen, Qun/HGD-0868-2022	Salloum, Fadi N/0000-0002-8947-9315; Cichy, Joanna/0000-0002-0552-8344; Derecka, Marta/0000-0001-6265-9781	National Institutes of Health [CA098924, 2PO1AG15885]; Office of Research and Development, Medical Research Service, Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA098924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Development, Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA098924 (to A. C. L.) and 2PO1AG15885 (to E. J. L.) and a grant from the Office of Research and Development, Medical Research Service, Department of Veterans Affairs (to E. J. L.).	Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Booz GW, 2002, J MOL CELL CARDIOL, V34, P1443, DOI 10.1006/jmcc.2002.2076; Butler KL, 2006, AM J PHYSIOL-HEART C, V291, pH797, DOI 10.1152/ajpheart.01334.2005; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cellbio.4.1.155; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chen Q, 2009, J INVEST MED, V57, P558; Chen Q, 2008, AM J PHYSIOL-CELL PH, V294, pC460, DOI 10.1152/ajpcell.00211.2007; Chen Q, 2006, J PHARMACOL EXP THER, V319, P1405, DOI 10.1124/jpet.106.110262; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DAS DK, 1995, J MOL CELL CARDIOL, V27, P181, DOI 10.1016/S0022-2828(08)80017-X; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Hattori R, 2001, J MOL CELL CARDIOL, V33, P1929, DOI 10.1006/jmcc.2001.1456; Hilfiker-Kleiner D, 2005, PHARMACOL THERAPEUT, V107, P131, DOI 10.1016/j.pharmthera.2005.02.003; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315; Lesnefsky EJ, 2004, J BIOL CHEM, V279, P47961, DOI 10.1074/jbc.M409720200; Lesnefsky EJ, 1997, AM J PHYSIOL-HEART C, V273, pH1544, DOI 10.1152/ajpheart.1997.273.3.H1544; Lesnefsky EJ, 2001, AM J PHYSIOL-HEART C, V280, pH2770; Lesnefsky EJ, 2001, ARCH BIOCHEM BIOPHYS, V385, P117, DOI 10.1006/abbi.2000.2066; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; Oshima Y, 2005, CARDIOVASC RES, V65, P428, DOI 10.1016/j.cardiores.2004.10.021; Phillips D, 2010, J BIOL CHEM, V285, P23532, DOI 10.1074/jbc.C110.152652; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; ROUSLIN W, 1983, AM J PHYSIOL, V244, pH743, DOI 10.1152/ajpheart.1983.244.6.H743; Salloum FN, 2008, AM J PHYSIOL-HEART C, V294, pH1398, DOI [10.1152/ajpheart.ajpheart.91438.2007, 10.1152/ajpheart.91438.2007]; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Smith RM, 2004, CARDIOVASC RES, V63, P611, DOI 10.1016/j.cardiores.2004.06.019; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Xiong Y, 2006, FREE RADICAL BIO MED, V41, P46, DOI 10.1016/j.freeradbiomed.2006.02.024; Yang E, 2003, J BIOL CHEM, V278, P15794, DOI 10.1074/jbc.M213073200; Zhang L, 2006, MOL CELL BIOCHEM, V288, P179, DOI 10.1007/s11010-006-9137-3	45	165	170	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29610	29620		10.1074/jbc.M111.226209	http://dx.doi.org/10.1074/jbc.M111.226209			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21715323	Green Published, hybrid			2022-12-25	WOS:000294046600019
J	Eberle, KE; Sansing, HA; Szaniszlo, P; Resto, VA; Berrier, AL				Eberle, Karen E.; Sansing, Hope A.; Szaniszlo, Peter; Resto, Vicente A.; Berrier, Allison L.			Carcinoma Matrix Controls Resistance to Cisplatin through Talin Regulation of NF-kB	PLOS ONE			English	Article							FOCAL ADHESION KINASE; KAPPA-B KINASE; EXTRACELLULAR-MATRIX; DRUG-RESISTANCE; HUMAN HEAD; CANCER; ACTIVATION; SRC; INTEGRINS; PATHWAYS	Extracellular matrix factors within the tumor microenvironment that control resistance to chemotherapeutics are poorly understood. This study focused on understanding matrix adhesion pathways that control the oral carcinoma response to cisplatin. Our studies revealed that adhesion of HN12 and JHU012 oral carcinomas to carcinoma matrix supported tumor cell proliferation in response to treatment with cisplatin. Proliferation in response to 30 mu M cisplatin was not observed in HN12 cells adherent to other purified extracellular matrices such as Matrigel, collagen I, fibronectin or laminin I. Integrin beta(1) was important for adhesion to carcinoma matrix to trigger proliferation after treatment with cisplatin. Disruption of talin expression in HN12 cells adherent to carcinoma matrix increased cisplatin induced proliferation. Pharmacological inhibitors were used to determine signaling events required for talin deficiency to regulate cisplatin induced proliferation. Pharmacological inhibition of NF-kB reduced proliferation of talin-deficient HN12 cells treated with 30 mu M cisplatin. Nuclear NF-kB activity was assayed in HN12 cells using a luciferase reporter of NF-kB transcriptional activity. Nuclear NF-kB activity was similar in HN12 cells adherent to carcinoma matrix and collagen I when treated with vehicle DMSO. Following treatment with 30 mM cisplatin, NF-kB activity is maintained in cells adherent to carcinoma matrix whereas NF-kB activity is reduced in collagen I adherent cells. Expression of talin was sufficient to trigger proliferation of HN12 cells adherent to collagen I following treatment with 1 and 30 mu M cisplatin. Talin overexpression was sufficient to trigger NF-kB activity following treatment with cisplatin in carcinoma matrix adherent HN12 cells in a process disrupted by FAK siRNA. Thus, adhesions within the carcinoma matrix create a matrix environment in which exposure to cisplatin induces proliferation through the function of integrin beta(1), talin and FAK pathways that regulate NF-kB nuclear activity.	[Eberle, Karen E.; Sansing, Hope A.; Berrier, Allison L.] Louisiana State Univ, Hlth Sci Ctr New Orleans, Sch Dent, Dept Oral & Craniofacial Biol, New Orleans, LA 70112 USA; [Szaniszlo, Peter; Resto, Vicente A.] Univ Texas Med Branch Hlth, Univ Texas Med Branch, Ctr Canc, Dept Otolaryngol, Galveston, TX 77555 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Texas System; University of Texas Medical Branch Galveston	Eberle, KE (corresponding author), Louisiana State Univ, Hlth Sci Ctr New Orleans, Sch Dent, Dept Oral & Craniofacial Biol, New Orleans, LA 70112 USA.	allison.berrier@gmail.com	Resto, Vicente/D-9891-2014		LSUHSC-NO School of Dentistry; National Cancer Institute [1K08CA132988-01A2]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [K08CA132988] Funding Source: NIH RePORTER	LSUHSC-NO School of Dentistry; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	ALB was supported by the LSUHSC-NO School of Dentistry and VAR by National Cancer Institute 1K08CA132988-01A2 and Howard Hughes Medical Institute Physician Scientist Early Career Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzeid WM, 2009, J CLIN INVEST, V119, P1974, DOI 10.1172/JCI33816; Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Aoki K, 2004, ONCOL REP, V11, P375; Benhar M, 2002, ONCOGENE, V21, P8723, DOI 10.1038/sj.onc.1205980; BENTON G, 2010, INT J CANC; Berrier A, 1998, J IMMUNOL, V161, P2267; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Berrier Allison L., 2004, V294, P55; Bharti AC, 2002, BIOCHEM PHARMACOL, V64, P883, DOI 10.1016/S0006-2952(02)01154-1; CARDINALI M, 1995, INT J CANCER, V61, P98, DOI 10.1002/ijc.2910610117; Castello-Cros R, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-94; Castello-Cros Remedios, 2009, V522, P275, DOI 10.1007/978-1-59745-413-1_19; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Chrenek MA, 2001, BREAST CANCER RES, V3, P224, DOI 10.1186/bcr300; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Egles C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010528; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Funk SD, 2010, CIRC RES, V106, P1394, DOI 10.1161/CIRCRESAHA.109.210286; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Green JA, 2009, J BIOL CHEM, V284, P8148, DOI 10.1074/jbc.M805934200; Hodkinson PS, 2007, INT J RADIAT BIOL, V83, P733, DOI 10.1080/09553000701570204; Kim HE, 2000, CLIN CANCER RES, V6, P4142; Kim W, 2004, J BIOL CHEM, V279, P8333, DOI 10.1074/jbc.M312026200; Kook S, 2000, MOL BIOL CELL, V11, P929, DOI 10.1091/mbc.11.3.929; Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x; LAI MT, 2011, J PATHOL; Lamar JM, 2008, CANCER RES, V68, P7371, DOI 10.1158/0008-5472.CAN-08-1080; Lee S, 2005, GYNECOL ONCOL, V97, P26, DOI 10.1016/j.ygyno.2004.11.051; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Liu SC, 2000, J CELL SCI, V113, P3563; Masumoto N, 1999, INT J CANCER, V80, P731, DOI 10.1002/(SICI)1097-0215(19990301)80:5<731::AID-IJC17>3.0.CO;2-H; Maubant S, 2002, B CANCER, V89, P923; Morin PJ, 2003, DRUG RESIST UPDATE, V6, P169, DOI 10.1016/S1368-7646(03)00059-1; Parsons JT, 2008, CLIN CANCER RES, V14, P627, DOI 10.1158/1078-0432.CCR-07-2220; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Peng X, 2011, CURR PROTEIN PEPT SC, V12, P52, DOI 10.2174/138920311795659452; Pengetnze Y, 2003, BIOCHEM BIOPH RES CO, V309, P377, DOI 10.1016/j.bbrc.2003.08.012; Peterson-Roth E, 2009, CANCER RES, V69, P3619, DOI 10.1158/0008-5472.CAN-08-0985; Petzold T, 2009, AM J PHYSIOL-CELL PH, V297, pC814, DOI 10.1152/ajpcell.00226.2009; Puigvert JC, 2009, MOL PHARMACOL, V75, P947, DOI 10.1124/mol.108.051649; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; SANSING HA, 2011, BIOCH BIOPHYS RES CO; Schultze A, 2010, EXPERT OPIN INV DRUG, V19, P777, DOI 10.1517/13543784.2010.489548; Serebriiskii I, 2008, MATRIX BIOL, V27, P573, DOI 10.1016/j.matbio.2008.02.008; Shamimi-Noori S, 2008, CANCER GENE THER, V15, P356, DOI 10.1038/sj.cgt.7701120; Sherman-Baust CA, 2003, CANCER CELL, V3, P377, DOI 10.1016/S1535-6108(03)00058-8; Snider JL, 2008, J BIOL CHEM, V283, P13952, DOI 10.1074/jbc.M800289200; Specenier PM, 2007, CANCER LETT, V256, P166, DOI 10.1016/j.canlet.2007.06.015; Tamatani T, 2004, INT J CANCER, V108, P912, DOI 10.1002/ijc.11640; Tamatani T, 2001, CANCER LETT, V171, P165, DOI 10.1016/S0304-3835(01)00611-5; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Van Waes C, 2007, CLIN CANCER RES, V13, P4956, DOI 10.1158/1078-0432.CCR-07-1287; Vlodavsky I, 2001, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1004s01; Wang JH, 2003, J IMMUNOL, V170, P795, DOI 10.4049/jimmunol.170.2.795; Woessmann W, 2002, CANCER CHEMOTH PHARM, V50, P397, DOI 10.1007/s00280-002-0502-y; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	61	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21496	10.1371/journal.pone.0021496	http://dx.doi.org/10.1371/journal.pone.0021496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720550	Green Published, gold, Green Submitted			2022-12-25	WOS:000292036900043
J	Ronchi, R; Revol, P; Katayama, M; Rossetti, Y; Farne, A				Ronchi, Roberta; Revol, Patrice; Katayama, Masahiro; Rossetti, Yves; Farne, Alessandro			Seeing Your Error Alters My Pointing: Observing Systematic Pointing Errors Induces Sensori-Motor After-Effects	PLOS ONE			English	Article							PRISM ADAPTATION; NEGLECT REHABILITATION; SPATIAL NEGLECT; VISION; COORDINATION; PROPRIOCEPTION; REPRESENTATION; CONSOLIDATION; INTERFERENCE; DISPLACEMENT	During the procedure of prism adaptation, subjects execute pointing movements to visual targets under a lateral optical displacement: As consequence of the discrepancy between visual and proprioceptive inputs, their visuo-motor activity is characterized by pointing errors. The perception of such final errors triggers error-correction processes that eventually result into sensori-motor compensation, opposite to the prismatic displacement (i.e., after-effects). Here we tested whether the mere observation of erroneous pointing movements, similar to those executed during prism adaptation, is sufficient to produce adaptation-like after-effects. Neurotypical participants observed, from a first-person perspective, the examiner's arm making incorrect pointing movements that systematically overshot visual targets location to the right, thus simulating a rightward optical deviation. Three classical after-effect measures (proprioceptive, visual and visual-proprioceptive shift) were recorded before and after first-person's perspective observation of pointing errors. Results showed that mere visual exposure to an arm that systematically points on the right-side of a target (i.e., without error correction) produces a leftward after-effect, which mostly affects the observer's proprioceptive estimation of her body midline. In addition, being exposed to such a constant visual error induced in the observer the illusion "to feel'' the seen movement. These findings indicate that it is possible to elicit sensori-motor after-effects by mere observation of movement errors.	[Ronchi, Roberta; Revol, Patrice; Rossetti, Yves; Farne, Alessandro] CNRS, INSERM, U1028, Lyon Neurosci Res Ctr,ImpAct Team,UMR5292, Lyon, France; [Ronchi, Roberta; Rossetti, Yves; Farne, Alessandro] Univ Lyon 1, F-69365 Lyon, France; [Revol, Patrice; Rossetti, Yves; Farne, Alessandro] Hop Neurol Mouvement & Handicap, Hosp Civils Lyon, Lyon, France; [Katayama, Masahiro] Senri Chuou Hosp, Dept Neurol, Toyonaka, Osaka, Japan; [Katayama, Masahiro] Kobe Univ, Grad Sch Med, Dept Community Med & Social Healthcare Sci, Chuo Ku, Kobe, Hyogo 657, Japan; [Ronchi, Roberta] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Ronchi, Roberta] IRCCS Ist Auxol Italiano, Osped S Luca, Neuropsychol Lab, Milan, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Kobe University; University of Milano-Bicocca; IRCCS Istituto Auxologico Italiano	Ronchi, R (corresponding author), CNRS, INSERM, U1028, Lyon Neurosci Res Ctr,ImpAct Team,UMR5292, Lyon, France.	r.ronchi@auxologico.it; yves.rossetti@inserm.fr	FARNE, ALESSANDRO/G-1238-2015; Rossetti, Yves/H-3693-2017	FARNE, ALESSANDRO/0000-0001-5769-3491; Rossetti, Yves/0000-0001-8867-4496	ANR [RPV08085CSA]; INSERM AVENIR [R05265CS]; Marie Curie RTN; Hospices Civiles de Lyon	ANR(French National Research Agency (ANR)); INSERM AVENIR(Institut National de la Sante et de la Recherche Medicale (Inserm)); Marie Curie RTN(European Commission); Hospices Civiles de Lyon	The study was supported by the ANR grant No. RPV08085CSA, the INSERM AVENIR grant No. R05265CS, the Marie Curie RTN grant Discos and the PHRC grant from the Hospices Civiles de Lyon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKETT PA, 1980, J EXP PSYCHOL HUMAN, V6, P433, DOI 10.1037/0096-1523.6.3.433; Belopolsky AV, 2008, ACTA PSYCHOL, V128, P56, DOI 10.1016/j.actpsy.2007.09.012; Bird G, 2005, BRIT J PSYCHOL, V96, P371, DOI 10.1348/000712605X47440; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Buccino G, 2007, NEUROIMAGE, V36, pT119, DOI 10.1016/j.neuroimage.2007.03.036; Cross ES, 2009, CEREB CORTEX, V19, P315, DOI 10.1093/cercor/bhn083; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; Dijkerman HC, 2007, EXP BRAIN RES, V176, P387, DOI 10.1007/s00221-006-0627-z; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dupierrix E, 2008, BRAIN RES, V1214, P127, DOI 10.1016/j.brainres.2008.01.021; Dupierrix E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004465; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Farne A, 2002, NEUROPSYCHOLOGIA, V40, P718, DOI 10.1016/S0028-3932(01)00186-5; Fernandez-Ruiz J, 2000, COGNITIVE BRAIN RES, V9, P223, DOI 10.1016/S0926-6410(99)00057-9; FINKE RA, 1979, COGNITIVE PSYCHOL, V11, P235, DOI 10.1016/0010-0285(79)90011-2; Fortis P, 2010, NEUROPSYCHOLOGY, V24, P681, DOI 10.1037/a0019476; Frassinetti F, 2002, BRAIN, V125, P608, DOI 10.1093/brain/awf056; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gianelli C, 2008, BRAIN RES, V1218, P166, DOI 10.1016/j.brainres.2008.04.046; Girardi M, 2004, NEUROPSYCHOLOGIA, V42, P1477, DOI 10.1016/j.neuropsychologia.2004.03.008; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; Hatada Y, 2006, EXP BRAIN RES, V169, P417, DOI 10.1007/s00221-005-0159-y; Hatada Y, 2006, EXP BRAIN RES, V173, P415, DOI 10.1007/s00221-006-0381-2; HELD R, 1963, SCIENCE, V142, P455, DOI 10.1126/science.142.3591.455; Heyes CM, 2002, Q J EXP PSYCHOL-A, V55, P593, DOI 10.1080/02724980143000389; Ingram HA, 2000, EXP BRAIN RES, V132, P114, DOI 10.1007/s002219900322; Jacquin-Courtois S, 2010, BRAIN, V133, P895, DOI 10.1093/brain/awp327; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; JEANNEROD M, 1993, BAILLIERE CLIN NEUR, V2, P439; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; KORNHEISER AS, 1976, PSYCHOL BULL, V83, P783, DOI 10.1037/0033-2909.83.5.783; Krakauer JW, 2006, TRENDS NEUROSCI, V29, P58, DOI 10.1016/j.tins.2005.10.003; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Luaute J, 2006, NEUROLOGY, V66, P1859, DOI 10.1212/01.wnl.0000219614.33171.01; Luaute J, 2009, J NEUROSCI, V29, P169, DOI 10.1523/JNEUROSCI.3054-08.2009; Massen C, 2007, J EXP PSYCHOL LEARN, V33, P1118, DOI 10.1037/0278-7393.33.6.1118; Mattar AAG, 2005, NEURON, V46, P153, DOI 10.1016/j.neuron.2005.02.009; Milner AD, 2005, CURR OPIN NEUROL, V18, P748, DOI 10.1097/01.wco.0000191512.60368.ee; Newport R, 2010, EXP BRAIN RES, V204, P385, DOI 10.1007/s00221-009-2104-y; Nys GMS, 2008, RESTOR NEUROL NEUROS, V26, P1; PICK HL, 1965, PERCEPT MOTOR SKILL, V20, P1070, DOI 10.2466/pms.1965.20.3c.1070; Pisella L, 2006, CURR OPIN NEUROL, V19, P534, DOI 10.1097/WCO.0b013e328010924b; Raos V, 2007, J NEUROSCI, V27, P12675, DOI 10.1523/JNEUROSCI.2988-07.2007; Redding GA, 2006, NEUROPSYCHOLOGIA, V44, P1, DOI 10.1016/j.neuropsychologia.2005.04.009; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; REDDING GM, 1988, J MOTOR BEHAV, V20, P242, DOI 10.1080/00222895.1988.10735444; REDDING GM, 1993, J MOTOR BEHAV, V25, P75, DOI 10.1080/00222895.1993.9941642; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Redding GM, 1997, J MOTOR BEHAV, V29, P119, DOI 10.1080/00222899709600827; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; ROSSETTI Y, 1993, PERCEPT PSYCHOPHYS, V54, P355, DOI 10.3758/BF03205270; ROSSETTI Y, 1995, J NEUROPHYSIOL, V74, P457, DOI 10.1152/jn.1995.74.1.457; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; Sarri M, 2008, NEUROPSYCHOLOGIA, V46, P1069, DOI 10.1016/j.neuropsychologia.2007.11.005; Serino A, 2009, STROKE, V40, P1392, DOI 10.1161/STROKEAHA.108.530485; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shiraishi H, 2008, NEUROREHABILITATION, V23, P137; Tsakiris M, 2007, CONSCIOUS COGN, V16, P645, DOI 10.1016/j.concog.2007.05.012; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; WELCH RB, 1972, PERCEPT PSYCHOPHYS, V12, P453, DOI 10.3758/BF03210933	62	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21070	10.1371/journal.pone.0021070	http://dx.doi.org/10.1371/journal.pone.0021070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782TT	21731649	Green Published, Green Submitted, gold			2022-12-25	WOS:000292035400008
J	Raichlen, DA; Gordon, AD				Raichlen, David A.; Gordon, Adam D.			Relationship between Exercise Capacity and Brain Size in Mammals	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RUNNING PERFORMANCE; NEUROTROPHIC FACTOR; NEUROGENESIS; INCREASES; EVOLUTION; MICE; ENCEPHALIZATION; INTELLIGENCE; REGRESSION	Background: A great deal of experimental research supports strong associations between exercise, cognition, neurogenesis and neuroprotection in mammals. Much of this work has focused on neurogenesis in individual subjects in a limited number of species. However, no study to date has examined the relationship between exercise and neurobiology across a wide range of mammalian taxa. It is possible that exercise and neurobiology are related across evolutionary time. To test this hypothesis, this study examines the association between exercise and brain size across a wide range of mammals. Methodology/Principal Findings: Controlling for associations with body size, we examined the correlation between brain size and a proxy for exercise frequency and capacity, maximum metabolic rate (MMR; ml O-2 min(-1)). We collected brain sizes and MMRs from the literature and calculated residuals from the least-squares regression line describing the relationship between body mass and each variable of interest. We then analyzed the correlation between residual brain size and residual MMR both before and after controlling for phylogeny using phylogenetic independent contrasts. We found a significant positive correlation between maximum metabolic rate and brain size across a wide range of taxa. Conclusions: These results suggest a novel hypothesis that links brain size to the evolution of locomotor behaviors in a wide variety of mammalian species. In the end, we suggest that some portion of brain size in nonhuman mammals may have evolved in conjunction with increases in exercise capacity rather than solely in response to selection related to cognitive abilities.	[Raichlen, David A.] Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA; [Gordon, Adam D.] SUNY Albany, Dept Anthropol, Albany, NY 12222 USA	University of Arizona; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Raichlen, DA (corresponding author), Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA.	raichlen@email.arizona.edu	Gordon, Adam/AAB-9006-2019	Gordon, Adam/0000-0002-1807-4644	Wenner Gren Foundation	Wenner Gren Foundation	This project was supported by a Wenner Gren Foundation Hunt Fellowship to D.R. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral SL, 2001, AM J PHYSIOL-HEART C, V281, pH1163, DOI 10.1152/ajpheart.2001.281.3.H1163; Ashwell KWS, 2008, BRAIN BEHAV EVOLUT, V71, P181, DOI 10.1159/000114406; BENNETT AF, 1979, SCIENCE, V206, P649, DOI 10.1126/science.493968; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; BRUMMELKAMP R, 1940, NEDERL AKAD WET VERH, V39, P1; BRUMMELKAMP R, 1937, NORMALE ABNORMALE HE; Burton RF, 2006, J ZOOL, V269, P225, DOI 10.1111/j.1469-7998.2006.00111.x; CAPPON J, 1994, J APPL PHYSIOL, V76, P2490, DOI 10.1152/jappl.1994.76.6.2490; CARRIER DR, 1984, CURR ANTHROPOL, V25, P483, DOI 10.1086/203165; Carro E, 2000, J NEUROSCI, V20, P2926; Chaddock L, 2010, BRAIN RES, V1358, P172, DOI 10.1016/j.brainres.2010.08.049; Chaddock L, 2010, DEV NEUROSCI-BASEL, V32, P249, DOI 10.1159/000316648; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chappell MA, 2007, J EXP BIOL, V210, P4179, DOI 10.1242/jeb.006163; CLUTTONBROCK TH, 1980, J ZOOL, V190, P309; COSKUN Y, TURK J ZOOL, V28, P205; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; COUNT EW, 1947, ANN NY ACAD SCI, V46, P993, DOI 10.1111/j.1749-6632.1947.tb36165.x; CRILE GEORGE, 1940, OHIO JOUR SCI, V40, P219; DANIELS JT, 1978, EUR J APPL PHYSIOL O, V39, P249, DOI 10.1007/BF00421448; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; EVANS DL, 1988, PFLUG ARCH EUR J PHY, V411, P316, DOI 10.1007/BF00585121; FABEL K, 2003, EUROPEAN J NEUROSCIE; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GITTLEMAN JL, 1986, J MAMMAL, V67, P23, DOI 10.2307/1380998; HAARMANN K, 1972, MITT HAMBURG ZOOL MU, V68, P231; Healy SD, 2007, P ROY SOC B-BIOL SCI, V274, P453, DOI 10.1098/rspb.2006.3748; Isler K, 2006, BIOL LETTERS, V2, P557, DOI 10.1098/rsbl.2006.0538; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Johnson RA, 2003, NEUROSCIENCE, V121, P1, DOI 10.1016/S0306-4522(03)00422-6; Johnson RA, 2003, BRAIN RES, V983, P108, DOI 10.1016/S0006-8993(03)03039-7; KOLB E, COMMUNICATION; Kolb EM, 2010, NEUROBIOLOGICAL PHYS; Kraus RM, 2004, J APPL PHYSIOL, V96, P1445, DOI 10.1152/japplphysiol.01031.2003; KRUSKA D, 1970, Z ANAT ENTWICKLUNGS, V131, P291; Kruska D, 1975, J Hirnforsch, V16, P469; KRUSKA D, 1973, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V11, P81; Lefebvre L, 2004, BRAIN BEHAV EVOLUT, V63, P233, DOI 10.1159/000076784; Lofqvist C, 2006, PEDIATRICS, V117, P1930, DOI 10.1542/peds.2005-1926; MACE GM, 1980, TRENDS NEUROSCI, V3, P193, DOI 10.1016/0166-2236(80)90071-5; MACE GM, 1982, BIOL J LINN SOC, V17, P243, DOI 10.1111/j.1095-8312.1982.tb02019.x; MACE GM, 1981, J ZOOL, V193, P333; Maddison WP, 2017, MESQUITE MODULAR SYS; MIDFORD P, 2003, PDAP PDTREE TRANSLAT; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; OBOUSSIER H, 1974, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V71, P235; Oboussier H., 1966, Zeitschrift fuer Saugietierkunde, V31, P464; OBOUSSIER H, 1955, ARCH ENTW MECH, V147, P405; Oboussier H., 1972, MITTEILUNGEN HAMBURG, V68, P271; OLFERT MI, 2010, MED SCI SPORTS EX S2, V42, P5; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; PURVIS A, 1995, PHILOS T R SOC LON B, V104, P5638; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Regal P.J., 1978, P183; Rezende EL, 2006, J EXP BIOL, V209, P115, DOI 10.1242/jeb.01883; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1006, DOI 10.1037/0735-7044.117.5.1006; RONNEFELD U, 1970, MORPHOL JB, V115, P163; SACHER GA, 1974, AM NAT, V108, P593, DOI 10.1086/282938; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; Sentilhes L, 2010, J NEUROPATH EXP NEUR, V69, P111, DOI 10.1097/NEN.0b013e3181ccc9a9; SHULTZ S, 2006, P ROY SOC LOND B BIO, V272, P2305; SILVA M, 1995, CRC HDB MAMMALIAN BO; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; SWALLOW JG, 1991, J EXP BIOL, V202, P2513; Tang K, 2004, PHYSIOL GENOMICS, V18, P63, DOI 10.1152/physiolgenomics.00023.2004; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; von Tyszka H., 1966, Mitteilungen der Hamburgischen Zoologischen Museum und Institut, V63, P121; Warncke Paul, 1908, Journal fuer Psychologie Leipzig, V13; Weibel ER, 2004, RESP PHYSIOL NEUROBI, V140, P115, DOI 10.1016/j.resp.2004.01.006; WILLERMAN L, 1991, INTELLIGENCE, V15, P223, DOI 10.1016/0160-2896(91)90031-8; Wilson DE, 2009, HDB MAMMALS WORLD, V1; WIRZ K, 1950, ACTA ANAT BASEL, V9; Witelson SF, 2006, BRAIN, V129, P386, DOI 10.1093/brain/awh696; Ye P, 1996, DEV BRAIN RES, V95, P44; [No title captured]	80	30	30	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20601	10.1371/journal.pone.0020601	http://dx.doi.org/10.1371/journal.pone.0020601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731619	Green Submitted, Green Published, gold			2022-12-25	WOS:000292033700011
J	Svensson, E; Olsen, L; Morck, C; Brackmann, C; Enejder, A; Faergeman, NJ; Pilon, M				Svensson, Emma; Olsen, Louise; Morck, Catarina; Brackmann, Christian; Enejder, Annika; Faergeman, Nils J.; Pilon, Marc			The Adiponectin Receptor Homologs in C-elegans Promote Energy Utilization and Homeostasis	PLOS ONE			English	Article							ADIPOSE-SPECIFIC PROTEIN; FATTY-ACID-COMPOSITION; CAENORHABDITIS-ELEGANS; DAF-16; ACTIVATION; OXIDATION; DECREASE; STORAGE; CLONING; NHR-49	Adiponectin is an adipokine with insulin-sensitising actions in vertebrates. Its receptors, AdipoR1 and AdipoR2, are PAQR-type proteins with 7-transmembrane domains and topologies reversed that of GPCR's, i.e. their C-termini are extracellular. We identified three adiponectin receptor homologs in the nematode C. elegans, named paqr-1, paqr-2 and paqr-3. These are differently expressed in the intestine (the main fat-storing tissue), hypodermis, muscles, neurons and secretory tissues, from which they could exert systemic effects. Analysis of mutants revealed that paqr-1 and -2 are novel metabolic regulators in C. elegans and that they act redundantly but independently from paqr-3. paqr-2 is the most important of the three paqr genes: mutants grow poorly, fail to adapt to growth at low temperature, and have a very high fat content with an abnormal enrichment in long (C20) poly-unsaturated fatty acids when combined with the paqr-1 mutation. paqr-2 mutants are also synthetic lethal with mutations in nhr-49, sbp-1 and fat-6, which are C. elegans homologs of nuclear hormone receptors, SREBP and FAT-6 (a Delta 9 desaturase), respectively. Like paqr-2, paqr-1 is also synthetic lethal with sbp-1. Mutations in aak-2, the C. elegans homolog of AMPK, or nhr-80, another nuclear hormone receptor gene, suppress the growth phenotype of paqr-2 mutants, probably because they restore the balance between energy expenditure and storage. We conclude that paqr-1 and paqr-2 are receptors that regulate fatty acid metabolism and cold adaptation in C. elegans, that their main function is to promote energy utilization rather than storage, and that PAQR class proteins have regulated metabolism in metazoans for at least 700 million years.	[Svensson, Emma; Morck, Catarina; Pilon, Marc] Univ Gothenburg, Dept Cell & Mol Biol, Gothenburg, Sweden; [Olsen, Louise; Faergeman, Nils J.] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Brackmann, Christian; Enejder, Annika] Chalmers Univ, Dept Chem & Biol Engn, Gothenburg, Sweden	University of Gothenburg; University of Southern Denmark; Chalmers University of Technology	Svensson, E (corresponding author), Univ Gothenburg, Dept Cell & Mol Biol, Gothenburg, Sweden.	marc.pilon@cmb.gu.se	Pilon, Marc/B-9955-2008; Enejder, Annika/J-1938-2012; Pilon, Marc/AAY-4082-2020	Pilon, Marc/0000-0003-3919-2882; Pilon, Marc/0000-0003-3919-2882; Brackmann, Christian/0000-0002-4816-9134; Faergeman, Nils/0000-0002-9281-5287	Ahlens Stiftelse; Swedish Research Council (Vetenskapradet); Cancerfonden; Magnus Bergvalls Stiftelse; Danish Research Council for Strategic Research	Ahlens Stiftelse; Swedish Research Council (Vetenskapradet)(Swedish Research Council); Cancerfonden(Swedish Cancer Society); Magnus Bergvalls Stiftelse; Danish Research Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was funded by the Ahlens Stiftelse, the Swedish Research Council (Vetenskapradet), Cancerfonden, Magnus Bergvalls Stiftelse, and the Danish Research Council for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Atherton HJ, 2008, FEBS LETT, V582, P1661, DOI 10.1016/j.febslet.2008.04.020; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Forrester WC, 1997, DEVELOPMENT, V124, P1831; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; GARWIN JL, 1980, J BACTERIOL, V141, P1457, DOI 10.1128/JB.141.3.1457-1459.1980; Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Holland WL, 2009, MOL PHARMACOL, V75, P740, DOI 10.1124/mol.109.054817; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Imai J, 2006, OBESITY, V14, P1132, DOI 10.1038/oby.2006.130; Imbeault P, 2009, METABOLISM, V58, P552, DOI 10.1016/j.metabol.2008.11.017; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Kadowaki T, 2008, FEBS LETT, V582, P74, DOI 10.1016/j.febslet.2007.11.070; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Kupchak BR, 2009, BIOCHEMISTRY-US, V48, P5504, DOI 10.1021/bi9006258; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; MANSER J, 1990, DEV GENET, V11, P49, DOI 10.1002/dvg.1020110107; McKay RM, 2003, DEV CELL, V4, P131, DOI 10.1016/S1534-5807(02)00411-2; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Morck C, 2009, P NATL ACAD SCI USA, V106, P18285, DOI 10.1073/pnas.0907117106; Murray P, 2007, P NATL ACAD SCI USA, V104, P5489, DOI 10.1073/pnas.0609590104; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Nomura T, 2010, GENES NUTR, V5, P17, DOI 10.1007/s12263-009-0157-y; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; POLYZOS SA, 2010, METABOLISM; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Savvidou S, 2009, J CLIN GASTROENTEROL, V43, P765, DOI 10.1097/MCG.0b013e31819e9048; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Tanaka T, 1996, LIPIDS, V31, P1173, DOI 10.1007/BF02524292; Tang YT, 2005, J MOL EVOL, V61, P372, DOI 10.1007/s00239-004-0375-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Villa NY, 2009, MOL PHARMACOL, V75, P866, DOI 10.1124/mol.108.049809; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012810; Zhang SBO, 2010, P NATL ACAD SCI USA, V107, P4640, DOI 10.1073/pnas.0912308107	59	37	46	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21343	10.1371/journal.pone.0021343	http://dx.doi.org/10.1371/journal.pone.0021343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712952	gold, Green Published, Green Submitted			2022-12-25	WOS:000291985100033
J	Takeuchi, H; Mizoguchi, H; Doi, Y; Jin, SJ; Noda, M; Liang, JF; Li, H; Zhou, Y; Mori, R; Yasuoka, S; Li, ED; Parajuli, B; Kawanokuchi, J; Sonobe, Y; Sato, J; Yamanaka, K; Sobue, G; Mizuno, T; Suzumura, A				Takeuchi, Hideyuki; Mizoguchi, Hiroyuki; Doi, Yukiko; Jin, Shijie; Noda, Mariko; Liang, Jianfeng; Li, Hua; Zhou, Yan; Mori, Rarami; Yasuoka, Satoko; Li, Endong; Parajuli, Bijay; Kawanokuchi, Jun; Sonobe, Yoshifumi; Sato, Jun; Yamanaka, Koji; Sobue, Gen; Mizuno, Tetsuya; Suzumura, Akio			Blockade of Gap Junction Hemichannel Suppresses Disease Progression in Mouse Models of Amyotrophic Lateral Sclerosis and Alzheimer's Disease	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; GLUTAMATE RELEASE; ACTIVATED MICROGLIA; IN-VITRO; BETA; BRAIN; NEUROTOXICITY; GLIA; ALS; ACCUMULATION	Background: Glutamate released by activated microglia induces excitotoxic neuronal death, which likely contributes to non-cell autonomous neuronal death in neurodegenerative diseases, including amyotrophic lateral sclerosis and Alzheimer's disease. Although both blockade of glutamate receptors and inhibition of microglial activation are the therapeutic candidates for these neurodegenerative diseases, glutamate receptor blockers also perturbed physiological and essential glutamate signals, and inhibitors of microglial activation suppressed both neurotoxic/neuroprotective roles of microglia and hardly affected disease progression. We previously demonstrated that activated microglia release a large amount of glutamate specifically through gap junction hemichannel. Hence, blockade of gap junction hemichannel may be potentially beneficial in treatment of neurodegenerative diseases. Methods and Findings: In this study, we generated a novel blood-brain barrier permeable gap junction hemichannel blocker based on glycyrrhetinic acid. We found that pharmacologic blockade of gap junction hemichannel inhibited excessive glutamate release from activated microglia in vitro and in vivo without producing notable toxicity. Blocking gap junction hemichannel significantly suppressed neuronal loss of the spinal cord and extended survival in transgenic mice carrying human superoxide dismutase 1 with G93A or G37R mutation as an amyotrophic lateral sclerosis mouse model. Moreover, blockade of gap junction hemichannel also significantly improved memory impairments without altering amyloid beta deposition in double transgenic mice expressing human amyloid precursor protein with K595N and M596L mutations and presenilin 1 with A264E mutation as an Alzheimer's disease mouse model. Conclusions: Our results suggest that gap junction hemichannel blockers may represent a new therapeutic strategy to target neurotoxic microglia specifically and prevent microglia-mediated neuronal death in various neurodegenerative diseases.	[Takeuchi, Hideyuki; Doi, Yukiko; Jin, Shijie; Noda, Mariko; Liang, Jianfeng; Li, Hua; Zhou, Yan; Yasuoka, Satoko; Li, Endong; Parajuli, Bijay; Kawanokuchi, Jun; Sonobe, Yoshifumi; Mizuno, Tetsuya; Suzumura, Akio] Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Nagoya, Aichi 464, Japan; [Mizoguchi, Hiroyuki; Mori, Rarami; Sato, Jun] Nagoya Univ, Futurist Environm Simulat Ctr, Environm Med Res Inst, Chikusa Ku, Nagoya, Aichi 464, Japan; [Yamanaka, Koji] RIKEN, Lab Motor Neuron Dis, Brain Sci Inst, Wako, Saitama, Japan; [Sobue, Gen] Nagoya Univ, Dept Neurol, Grad Sch Med, Showa Ku, Nagoya, Aichi 464, Japan	Nagoya University; Nagoya University; RIKEN; Nagoya University	Takeuchi, H (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Furo Cho, Nagoya, Aichi 464, Japan.	htake@riem.nagoya-u.ac.jp	Yamanaka, Koji/H-5806-2011; Yamanaka, Koji/ABD-1034-2020; Parajuli, Bijay/G-2961-2015; Li, Endong/J-4502-2013; Bijay, Parajuli/AAT-5590-2021	Yamanaka, Koji/0000-0003-4655-0035; Yamanaka, Koji/0000-0003-4655-0035; Parajuli, Bijay/0000-0003-3813-113X; Noda, Mariko/0000-0002-6066-1359; Takeuchi, Hideyuki/0000-0001-5912-7581; jin, shijie/0000-0001-5689-841X	National Institute of Biomedical Innovation; Uehara Memorial Foundation; Japan Research Foundation for Clinical Pharmacology; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan; New Energy and Industrial Technology Development Organization	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Research Foundation for Clinical Pharmacology; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by the Program for Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation; a grant from the Uehara Memorial Foundation; a grant from the Japan Research Foundation for Clinical Pharmacology; a Grant-in-Aid for the global Center of Excellence program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; grants from the Ministry of Health, Labour and Welfare of Japan; and a grant from New Energy and Industrial Technology Development Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barger SW, 2001, J NEUROCHEM, V76, P846, DOI 10.1046/j.1471-4159.2001.00075.x; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chanson M, 2005, BBA-BIOMEMBRANES, V1711, P197, DOI 10.1016/j.bbamem.2004.10.005; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Cotrina ML, 1998, J NEUROSCI, V18, P2520; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; DELISLE MB, 1984, J NEUROL SCI, V63, P241, DOI 10.1016/0022-510X(84)90199-0; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dickson TC, 1999, EXP NEUROL, V156, P100, DOI 10.1006/exnr.1998.7010; Doi Y, 2009, AM J PATHOL, V175, P2121, DOI 10.2353/ajpath.2009.090418; Eugenin EA, 2001, P NATL ACAD SCI USA, V98, P4190, DOI 10.1073/pnas.051634298; Frantseva MV, 2002, J CEREBR BLOOD F MET, V22, P453, DOI 10.1097/00004647-200204000-00009; Fujita K, 1998, NEUROCHEM INT, V33, P41, DOI 10.1016/S0197-0186(05)80007-5; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Haughey NJ, 2003, NEUROMOL MED, V3, P173, DOI 10.1385/NMM:3:3:173; Hayworth CR, 2009, NEUROSCIENCE, V164, P975, DOI 10.1016/j.neuroscience.2009.08.031; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; HORI N, 1994, EXP NEUROL, V129, P279, DOI 10.1006/exnr.1994.1170; Jin S, 2007, BRAIN RES, V1179, P140, DOI 10.1016/j.brainres.2007.08.055; Jin SJ, 2009, TOHOKU J EXP MED, V217, P87, DOI 10.1620/tjem.217.87; Juszczak GR, 2009, PROG NEURO-PSYCHOPH, V33, P181, DOI 10.1016/j.pnpbp.2008.12.014; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P14663, DOI 10.1073/pnas.0404842101; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; LAIRD DW, 2009, TRENDS CELL BIOL; Leigh PN, 2004, AMYOTROPH LATERAL SC, V5, P84, DOI 10.1080/14660820410020187; Liang JF, 2008, BRAIN RES, V1210, P11, DOI 10.1016/j.brainres.2008.03.012; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Mizoguchi H, 2007, J NEUROCHEM, V100, P1579, DOI 10.1111/j.1471-4159.2006.04288.x; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nelson PT, 2002, ANN MED, V34, P491, DOI 10.1080/078538902321117698; Newsholme EA, 1997, NUTRITION, V13, P728, DOI 10.1016/S0899-9007(97)83034-1; NEWSHOLME P, 1989, BIOCHEM J, V261, P211, DOI 10.1042/bj2610211; Nissim I, 1999, AM J PHYSIOL-RENAL, V277, pF493, DOI 10.1152/ajprenal.1999.277.4.F493; Orrell RW, 2010, BRIT MED BULL, V93, P145, DOI 10.1093/bmb/ldp049; Parsons CG, 2007, NEUROPHARMACOLOGY, V53, P699, DOI 10.1016/j.neuropharm.2007.07.013; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; PIANI D, 1992, EUR J IMMUNOL, V22, P2429, DOI 10.1002/eji.1830220936; Pop V, 2010, J NEUROSCI, V30, P9831, DOI 10.1523/JNEUROSCI.6194-09.2010; Prokai L, 2000, MED RES REV, V20, P367, DOI 10.1002/1098-1128(200009)20:5<367::AID-MED3>3.0.CO;2-P; Rawanduzy A, 1997, J NEUROSURG, V87, P916, DOI 10.3171/jns.1997.87.6.0916; Saito Y, 2003, J NEUROPATH EXP NEUR, V62, P644, DOI 10.1093/jnen/62.6.644; Schwab JM, 2004, CELL DEATH DIFFER, V11, P1245, DOI 10.1038/sj.cdd.4401487; SUZUMURA A, 1987, J NEUROIMMUNOL, V15, P263, DOI 10.1016/0165-5728(87)90121-4; Suzumura A, 2006, ANN NY ACAD SCI, V1088, P219, DOI 10.1196/annals.1366.012; Takahashi T, 1997, ACTA NEUROPATHOL, V94, P294, DOI 10.1007/s004010050707; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Takeuchi H, 2008, EXP NEUROL, V214, P144, DOI 10.1016/j.expneurol.2008.08.001; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Velazquez JLP, 2000, TRENDS NEUROSCI, V23, P68; Vernadakis A, 1996, PROG NEUROBIOL, V49, P185, DOI 10.1016/S0301-0082(96)00012-3; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Yamamoto M, 2008, EXPERT OPIN PHARMACO, V9, P1845, DOI 10.1517/14656566.9.11.1845 ; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yawata I, 2008, LIFE SCI, V82, P1111, DOI 10.1016/j.lfs.2008.03.010; Yudkoff M, 1997, GLIA, V21, P92, DOI 10.1002/(SICI)1098-1136(199709)21:1<92::AID-GLIA10>3.0.CO;2-W; Zietlow R, 1999, EUR J NEUROSCI, V11, P1657, DOI 10.1046/j.1460-9568.1999.00583.x	65	75	79	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21108	10.1371/journal.pone.0021108	http://dx.doi.org/10.1371/journal.pone.0021108			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712989	Green Submitted, Green Published, gold			2022-12-25	WOS:000291985100011
J	Ruttenberg, BI; Hamilton, SL; Walsh, SM; Donovan, MK; Friedlander, A; DeMartini, E; Sala, E; Sandin, SA				Ruttenberg, Benjamin I.; Hamilton, Scott L.; Walsh, Sheila M.; Donovan, Mary K.; Friedlander, Alan; DeMartini, Edward; Sala, Enric; Sandin, Stuart A.			Predator-Induced Demographic Shifts in Coral Reef Fish Assemblages	PLOS ONE			English	Article							SURGEONFISH ACANTHURUS-BAHIANUS; TROPHIC CASCADES; SIZE; CONSEQUENCES; RESILIENCE; COLLAPSE; ISLANDS; ECOLOGY; DENSITY; DECLINE	In recent years, it has become apparent that human impacts have altered community structure in coastal and marine ecosystems worldwide. Of these, fishing is one of the most pervasive, and a growing body of work suggests that fishing can have strong effects on the ecology of target species, especially top predators. However, the effects of removing top predators on lower trophic groups of prey fishes are less clear, particularly in highly diverse and trophically complex coral reef ecosystems. We examined patterns of abundance, size structure, and age-based demography through surveys and collection-based studies of five fish species from a variety of trophic levels at Kiritimati and Palmyra, two nearby atolls in the Northern Line Islands. These islands have similar biogeography and oceanography, and yet Kiritimati has similar to 10,000 people with extensive local fishing while Palmyra is a US National Wildlife Refuge with no permanent human population, no fishing, and an intact predator fauna. Surveys indicated that top predators were relatively larger and more abundant at unfished Palmyra, while prey functional groups were relatively smaller but showed no clear trends in abundance as would be expected from classic trophic cascades. Through detailed analyses of focal species, we found that size and longevity of a top predator were lower at fished Kiritimati than at unfished Palmyra. Demographic patterns also shifted dramatically for 4 of 5 fish species in lower trophic groups, opposite in direction to the top predator, including decreases in average size and longevity at Palmyra relative to Kiritimati. Overall, these results suggest that fishing may alter community structure in complex and non-intuitive ways, and that indirect demographic effects should be considered more broadly in ecosystem-based management.	[Ruttenberg, Benjamin I.; Hamilton, Scott L.; Donovan, Mary K.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Ruttenberg, Benjamin I.] SE Fisheries Sci Ctr, Natl Marine Fisheries Serv, Miami, FL USA; [Hamilton, Scott L.] Moss Landing Marine Labs, Moss Landing, CA 95039 USA; [Walsh, Sheila M.; Sandin, Stuart A.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Donovan, Mary K.; Friedlander, Alan] Univ Hawaii, US Geol Survey, Hawaii Cooperat Fishery Res Unit, Honolulu, HI 96822 USA; [DeMartini, Edward] Pacific Isl Fisheries Sci Ctr, Natl Marine Fisheries Serv, Aiea, HI USA; [Sala, Enric] CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain; [Sala, Enric] Natl Geog Soc, Washington, DC USA	University of California System; University of California Santa Barbara; National Oceanic Atmospheric Admin (NOAA) - USA; Moss Landing Marine Laboratories; University of California System; University of California San Diego; Scripps Institution of Oceanography; United States Department of the Interior; United States Geological Survey; University of Hawaii System; National Oceanic Atmospheric Admin (NOAA) - USA; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); National Geographic Society	Ruttenberg, BI (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.	ssandin@ucsd.edu	Ruttenberg, Benjamin I/D-2556-2012; Ruttenberg, Benjamin/O-7829-2019	Ruttenberg, Benjamin I/0000-0001-7874-1915; Ruttenberg, Benjamin/0000-0001-7874-1915	E. Scripps	E. Scripps	This work was funded by E. Scripps and other anonymous donors contributing money to the Scripps Institution of Oceanography. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TW, 1998, ENVIRON BIOL FISH, V51, P111, DOI 10.1023/A:1007355408723; Beckerman AP, 1997, P NATL ACAD SCI USA, V94, P10735, DOI 10.1073/pnas.94.20.10735; Burnham K. P., 1998, MODEL SELECTION INFE; Choat J. Howard, 2002, P57; Conover DO, 2009, P ROY SOC B-BIOL SCI, V276, P2015, DOI 10.1098/rspb.2009.0003; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; DeMartini EE, 2005, MAR ECOL PROG SER, V297, P259, DOI 10.3354/meps297259; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; FRANCIS RICC, 1988, CAN J FISH AQUAT SCI, V45, P936, DOI 10.1139/f88-115; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Gust N, 2002, MAR BIOL, V140, P1039, DOI 10.1007/s00227-001-0773-6; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Hamann IM, 2004, OCEAN DYNAM, V54, P460, DOI 10.1007/s1036-004-0091-x; Hamilton SL, 2007, ECOL APPL, V17, P2268, DOI 10.1890/06-1930.1; Hawkins JP, 2004, BIOL CONSERV, V115, P213, DOI 10.1016/S0006-3207(03)00119-8; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jennings S., 2001, MARINE FISHERIES ECO; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; KIMURA DK, 1980, FISH B-NOAA, V77, P765; Lafferty KD, 2008, ECOHEALTH, V5, P338, DOI 10.1007/s10393-008-0196-7; Madin EMP, 2010, ECOLOGY, V91, P3563, DOI 10.1890/09-2174.1; McClenachan L, 2009, CONSERV BIOL, V23, P636, DOI 10.1111/j.1523-1739.2008.01152.x; Meekan MG, 2001, MAR ECOL PROG SER, V212, P223, DOI 10.3354/meps212223; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Murawski SA, 2001, ICES J MAR SCI, V58, P1002, DOI 10.1006/jmsc.2001.1097; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Paddack MJ, 2006, CORAL REEFS, V25, P461, DOI 10.1007/s00338-006-0112-y; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pinnegar JK, 2000, ENVIRON CONSERV, V27, P179, DOI 10.1017/S0376892900000205; POWER ME, 1990, SCIENCE, V250, P811, DOI 10.1126/science.250.4982.811; R Development Core Team, 2009, R FDN STAT COMP; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Roberts C., 2007, UNNATURAL HIST SEA; Robertson DR, 2005, MAR ECOL PROG SER, V295, P245, DOI 10.3354/meps295245; Robertson DR, 2005, MAR ECOL PROG SER, V295, P229, DOI 10.3354/meps295229; Ruttenberg BI, 2005, OECOLOGIA, V145, P394, DOI 10.1007/s00442-005-0150-0; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sandin Stuart A., 2010, P71; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Stearns S.C., 1992, pi; Terborgh J., 2010, TROPHIC CASCADES PRE; Trip EL, 2008, MAR ECOL PROG SER, V373, P97, DOI 10.3354/meps07755; WALSH SM, 2009, THESIS U CALIFORNIA; Williams ID, 2011, J MAR BIOL, DOI DOI 10.1155/2011/826234	56	41	41	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21062	10.1371/journal.pone.0021062	http://dx.doi.org/10.1371/journal.pone.0021062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698165	Green Published, gold			2022-12-25	WOS:000291734100049
J	Vasseur, S; Afzal, S; Tomasini, R; Guillaumond, F; Tardivel-Lacombe, J; Mak, TW; Iovanna, JL				Vasseur, S.; Afzal, S.; Tomasini, R.; Guillaumond, F.; Tardivel-Lacombe, J.; Mak, T. W.; Iovanna, J. L.			Consequences of DJ-1 upregulation following p53 loss and cell transformation	ONCOGENE			English	Article						DJ-1; p53; transformation; Akt; ROS	DNA-DAMAGE RESPONSE; TUMOR-SUPPRESSOR; ANTIOXIDANT FUNCTION; PROTEIN; APOPTOSIS; PATHWAY; IDENTIFICATION; INHIBITION; EXPRESSION; ONCOGENE	p53 is a tumor suppressor that responds to various stress signals by initiating cell-cycle arrest, senescence and apoptosis. Mutations of the p53 gene are found in over 50% of human tumors, highlighting the importance of p53 in tumor suppression. Numerous studies have reported on the interactions between p53, IGF-1-AKT and mTOR pathways as potentially explaining some of the tumor suppressive activities of p53. To further understand the basis of these interactions, we analyzed the involvement of DJ-1, an oncogene known to drive AKT-mediated cell survival, in the p53-AKT axis. In this study, we show that DJ-1 and p53 are tightly 'linked': p53 prevents the accumulation of DJ-1 protein, whereas loss of p53 leads to stabilization and enhancement of DJ-1 expression. Interestingly, this increase in DJ-1 level is only observed when p53 loss is accompanied by transformation of cells. Moreover, DJ-1 seems to be required for the enhanced activation of AKT observed in p53-deficient cells. Such observation confers a new property to DJ-1 associated to transforming-process to its oncogenic ability to drive AKT activation. We also show that DJ-1 is necessary for p53 activation following oxidative stress, suggesting the existence of a finely regulated loop between these two proteins in transformed cells. Finally, we demonstrate that in the absence of p53, DJ-1 is stabilized by ROS accumulation, and surprisingly seems to be required for this high intracellular ROS production. These data offer new insights into the regulation of DJ-1 and suggest that DJ-1 is a target of p53. Importantly, our study highlights that during transformation, DJ-1 is having a key role in the p53-regulated AKT pathway and p53-driven oxidative-stress response. Oncogene (2012) 31, 664-670; doi:10.1038/onc.2011.268; published online 4 July 2011	[Vasseur, S.; Afzal, S.; Mak, T. W.] Univ Hlth Network, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 2C1, Canada; [Vasseur, S.; Tomasini, R.; Guillaumond, F.; Tardivel-Lacombe, J.; Iovanna, J. L.] Inst Natl Sante & Rech Med, U624, F-13288 Marseille 9, France	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Institut National de la Sante et de la Recherche Medicale (Inserm)	Mak, TW (corresponding author), Univ Hlth Network, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 2C1, Canada.	tmak@uhnresearch.ca; juan.iovanna@inserm.fr	Guillaumond, Fabienne/E-8265-2017; Iovanna, Juan/M-9805-2017; tomasini, richard/F-1130-2017; vasseur, sophie/O-9803-2017	Guillaumond, Fabienne/0000-0001-7456-7315; Iovanna, Juan/0000-0003-1822-2237; tomasini, richard/0000-0003-0869-0811; vasseur, sophie/0000-0002-2339-8854	Institute National de la Sante et de la Recherche Medicale France; Fondation Sante, Sport et developpement durable; Canadian Institute of Health Research; 'Ligue Contre le Cancer', France; 'Institut National du Cancer (INCa)', France	Institute National de la Sante et de la Recherche Medicale France; Fondation Sante, Sport et developpement durable; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); 'Ligue Contre le Cancer', France; 'Institut National du Cancer (INCa)', France(Institut National du Cancer (INCA) France)	We thank P Spoto and K Sari for technical assistance. S Vasseur, R Tomasini, and J Tardivel-Lacombe were supported by Institute National de la Sante et de la Recherche Medicale France. F Guillaumond was supported by the 'Fondation Sante, Sport et developpement durable'. S Vasseur and S Afzal were supported by the Canadian Institute of Health Research. This work was also supported by grants from the 'Ligue Contre le Cancer', France and the 'Institut National du Cancer (INCa)', France.	Aleyasin H, 2010, P NATL ACAD SCI USA, V107, P3186, DOI 10.1073/pnas.0914876107; Cano CE, 2009, CANCER RES, V69, P219, DOI 10.1158/0008-5472.CAN-08-2320; Dong PX, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-103; Fan J, 2008, FEBS LETT, V582, P1151, DOI 10.1016/j.febslet.2008.03.003; Feng ZH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001057; Giaime E, 2010, CELL DEATH DIFFER, V17, P158, DOI 10.1038/cdd.2009.116; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Hinkle DA, 2011, NEUROPATHOLOGY, V31, P29, DOI 10.1111/j.1440-1789.2010.01124.x; JOHNSON P, 1993, MOL CELL BIOL, V13, P1456, DOI 10.1128/MCB.13.3.1456; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Marcondes AM, 2010, BLOOD, V115, P1993, DOI 10.1182/blood-2009-08-236992; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Nister M, 2005, ONCOGENE, V24, P3563, DOI 10.1038/sj.onc.1208354; Rahman-Roblick R, 2008, ONCOGENE, V27, P4854, DOI 10.1038/onc.2008.124; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Shenkman M, 2007, BIOCHEM J, V404, P509, DOI 10.1042/BJ20061854; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Vasseur S, 2002, EMBO REP, V3, P165, DOI 10.1093/embo-reports/kvf023; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; You H, 2004, P NATL ACAD SCI USA, V101, P14057, DOI 10.1073/pnas.0406286101; Zhan H, 2010, J BIOL CHEM, V285, P29662, DOI 10.1074/jbc.M110.125138	28	37	41	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2012	31	5					664	670		10.1038/onc.2011.268	http://dx.doi.org/10.1038/onc.2011.268			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MS	21725356				2022-12-25	WOS:000300221800012
J	Wong, WT; Chan, KC; So, PK; Yap, HK; Chung, WH; Leung, YC; Wong, KY; Zhao, YX				Wong, Wai-Ting; Chan, Kwok-Chu; So, Pui-Kin; Yap, Hong-Kin; Chung, Wai-Hong; Leung, Yun-Chung; Wong, Kwok-Yin; Zhao, Yanxiang			Increased Structural Flexibility at the Active Site of a Fluorophore-conjugated beta-Lactamase Distinctively Impacts Its Binding toward Diverse Cephalosporin Antibiotics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-MOLECULE FLUORESCENCE; CONFORMATIONAL DYNAMICS; ACYL-ENZYME; AMINO-ACID; 3 DECADES; PROTEIN; BIOSENSOR; BENZYLPENICILLIN; INTERMEDIATE; SPECTROSCOPY	The Omega-loop at the active site of beta-lactamases exerts significant impact on the kinetics and substrate profile of these enzymes by forming part of the substrate binding site and posing as steric hindrance toward bulky substrates. Mutating certain residues on the Omega-loop has been a general strategy for molecular evolution of beta-lactamases to expand their hydrolytic activity toward extended-spectrum antibiotics through a mechanism believed to involve enhanced structural flexibility of the Omega-loop. Yet no structural information is available that demonstrates such flexibility or its relation to substrate profile and enzyme kinetics. Here we report an engineered beta-lactamase that contains an environment-sensitive fluorophore conjugated near its active site to probe the structural dynamics of the Omega-loop and to detect the binding of diverse substrates. Our results show that this engineered beta-lactamase has improved binding kinetics and positive fluorescence signal toward oxyimino-cephalosporins, but shows little such effect to non-oxyimino-cephalosporins. Structural studies reveal that the Omega-loop adopts a less stabilized structure, and readily undergoes conformational change to accommodate the binding of bulky oxyimino-cephalosporins while no such change is observed for non-oxyimino-cephalosporins. Mutational studies further confirm that this substrate-induced structural change is directly responsible for the positive fluorescence signal specific to oxyimino-cephalosporins. Our data provide mechanistic evidence to support the long-standing model that the evolutionary strategy of mutating the Omega-loop leads to increased structural flexibility of this region, which in turn facilitates the binding of extended spectrum beta-lactam antibiotics. The oxyimino-cephalosporin-specific fluorescence profile of our engineered beta-lactamase also demonstrates the possibility of designing substrate-selective biosensing systems.	[Wong, Wai-Ting; Chan, Kwok-Chu; So, Pui-Kin; Yap, Hong-Kin; Chung, Wai-Hong; Leung, Yun-Chung; Wong, Kwok-Yin; Zhao, Yanxiang] Hong Kong Polytech Univ, State Key Lab Chirosci, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Leung, YC (corresponding author), Hong Kong Polytech Univ, State Key Lab Chirosci, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China.	bctleung@inet.polyu.edu.hk; bckywong@inet.polyu.edu.hk; bcyxzhao@inet.polyu.edu.hk	Wong, Kwok-Yin/O-5948-2014; Wong, Wai Ting/E-5731-2014	Wong, Kwok-Yin/0000-0003-4984-7109; Wong, Wai Ting/0000-0002-9401-2752; Leung, Yun-chung/0000-0003-3590-7027; Zhao, Yanxiang/0000-0002-9408-9979	Research Grants Council [PolyU 5463/05M, PolyU 5380/04M, PolyU 5017/06P, PolyU 5641/08M, PolyU 5639/09M]; University Grants Committee [AoE/P-10/01]; Research Committee of the Hong Kong Polytechnic University	Research Grants Council(Hong Kong Research Grants Council); University Grants Committee; Research Committee of the Hong Kong Polytechnic University	This work was supported by the Research Grants Council (PolyU 5463/05M, PolyU 5380/04M, PolyU 5017/06P, PolyU 5641/08M, and PolyU 5639/09M), the Area of Excellence Fund of the University Grants Committee (AoE/P-10/01), and the Research Committee of the Hong Kong Polytechnic University.	Caselli E, 2001, CHEM BIOL, V8, P17, DOI 10.1016/S1074-5521(00)00052-1; Chan PH, 2008, J AM CHEM SOC, V130, P6351, DOI 10.1021/ja076111g; Chan PH, 2005, ANAL CHEM, V77, P5268, DOI 10.1021/ac0502605; Chan PH, 2004, J AM CHEM SOC, V126, P4074, DOI 10.1021/ja038409m; Chen CCH, 2001, BIOCHEMISTRY-US, V40, P2351, DOI 10.1021/bi002277h; Cohen BE, 2002, SCIENCE, V296, P1700, DOI 10.1126/science.1069346; Cohen BE, 2005, P NATL ACAD SCI USA, V102, P965, DOI 10.1073/pnas.0409469102; Crichlow GV, 2001, BIOCHEMISTRY-US, V40, P6233, DOI 10.1021/bi010131s; De Lorimier RM, 2002, PROTEIN SCI, V11, P2655, DOI 10.1110/ps.021860; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Fisher JF, 2009, CURR PROTEIN PEPT SC, V10, P401, DOI 10.2174/138920309789351967; Koehorst RBM, 2008, BIOPHYS J, V94, P3945, DOI 10.1529/biophysj.107.125807; Koehorst RBM, 2010, EUR BIOPHYS J BIOPHY, V39, P647, DOI 10.1007/s00249-009-0538-6; Loving G, 2008, J AM CHEM SOC, V130, P13630, DOI 10.1021/ja804754y; Loving G, 2009, BIOCONJUGATE CHEM, V20, P2133, DOI 10.1021/bc900319z; Michalet X, 2006, CHEM REV, V106, P1785, DOI 10.1021/cr0404343; Powers RA, 2001, BIOCHEMISTRY-US, V40, P9207, DOI 10.1021/bi0109358; Shimamura T, 2002, J BIOL CHEM, V277, P46601, DOI 10.1074/jbc.M207884200; STRYNADKA NCJ, 1994, NATURE, V368, P657, DOI 10.1038/368657a0; Vazquez ME, 2005, J AM CHEM SOC, V127, P1300, DOI 10.1021/ja0449168; Venkatraman P, 2007, NAT CHEM BIOL, V3, P222, DOI 10.1038/nchembio868; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Weiss S, 2000, NAT STRUCT BIOL, V7, P724, DOI 10.1038/78941	23	16	16	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31771	31780		10.1074/jbc.M110.198895	http://dx.doi.org/10.1074/jbc.M110.198895			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21705325	Green Published, hybrid			2022-12-25	WOS:000294487500070
J	Oh, HM; Yu, CR; Golestaneh, N; Amadi-Obi, A; Lee, YS; Eseonu, A; Mahdi, RM; Egwuagu, CE				Oh, Hyun-Mee; Yu, Cheng-Rong; Golestaneh, Nady; Amadi-Obi, Ahjoku; Lee, Yun Sang; Eseonu, Amarachi; Mahdi, Rashid M.; Egwuagu, Charles E.			STAT3 Protein Promotes T-cell Survival and Inhibits Interleukin-2 Production through Up-regulation of Class O Forkhead Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; DNA-BINDING; ACTIVATION; PROLIFERATION; SUPPRESSORS; EXPRESSION; CONTRIBUTE; GENES; IL-2	Much is known about the role of STAT3 in regulating differentiation of interleukin-17-producing Th17 cells, but its function in other lymphocyte subsets is not well understood. In this report, we reveal wide-ranging functions of STAT3 in T-cells and provide evidence that STAT3 is convergence point for mechanisms that regulate lymphocyte quiescence and those controlling T-cell activation and survival. We show here that STAT3 inhibits T-lymphocyte proliferation by up-regulating the expression of Class-O Forkhead transcription factors, which play essential roles in maintaining T-cells in quiescent state. We further show that STAT3 binds directly to FoxO1 or FoxO3a promoter and that STAT3-deficiency resulted in down-regulation of the expression of FoxO1, FoxO3a and FoxO-target genes (I kappa B and p27Kip1). Compared with wild-type T-cells, STAT3-deficient T-cells produced more IL-2, due in part, to marked decrease in I kappa B-mediated sequestration of NF-kappa B in the cytoplasm and resultant enhancement of NF-kappa B activation. However, the high level of IL-2 production by STAT3-deficient T-cells was partially restored to normal levels by overexpressing FoxO1. It is notable that their exaggerated increase in IL-2 production rendered STAT3-deficient lymphocytes more susceptible to activation-induced cell death, suggesting that STAT3 might protect T-cells from apoptosis by limiting their production of IL-2 through up-regulation of FoxO1/FoxO3a expression. Moreover, we found that STAT3 enhanced survival of activated T-cells by up-regulating OX-40 and Bcl-2 while down-regulating FasL and Bad expression, suggesting that similar to role of FoxOs in regulating the lifespan of worms, STAT3 and FoxO pathways converge to regulate lifespan of T-lymphocytes.	[Oh, Hyun-Mee; Yu, Cheng-Rong; Amadi-Obi, Ahjoku; Lee, Yun Sang; Mahdi, Rashid M.; Egwuagu, Charles E.] NEI, Mol Immunol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Golestaneh, Nady] Georgetown Univ, Sch Med, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA; [Eseonu, Amarachi] Harvard Univ, Harvard Coll, Dept Biomed Engn, Cambridge, MA 02138 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Georgetown University; Harvard University	Egwuagu, CE (corresponding author), NEI, Mol Immunol Sect, Immunol Lab, NIH, 10-10N116,10 Ctr Dr, Bethesda, MD 20892 USA.	egwuaguc@nei.nih.gov		Yu, Cheng-Rong/0000-0001-7246-0362	NEI, National Institutes of Health; NATIONAL EYE INSTITUTE [ZIAEY000315] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by NEI, National Institutes of Health Intramural Research Programs.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; Chen J, 2006, J IMMUNOL, V176, P2711, DOI 10.4049/jimmunol.176.5.2711; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Egwuagu CE, 2002, J IMMUNOL, V168, P3181, DOI 10.4049/jimmunol.168.7.3181; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Gaffen SL, 2004, CYTOKINE, V28, P109, DOI 10.1016/j.cyto.2004.06.010; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Hoyer KK, 2008, IMMUNOL REV, V226, P19, DOI 10.1111/j.1600-065X.2008.00697.x; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Li WM, 1999, DEV BIOL, V210, P44, DOI 10.1006/dbio.1999.9267; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Liu Jun O, 2005, Sci STKE, V2005, pre1; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Mertens C, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.033; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Rogers PR, 2001, IMMUNITY, V15, P445, DOI 10.1016/S1074-7613(01)00191-1; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Takeda K, 1998, J IMMUNOL, V161, P4652; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yu CR, 2004, J IMMUNOL, V173, P737, DOI 10.4049/jimmunol.173.2.737; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	31	71	71	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30888	30897		10.1074/jbc.M111.253500	http://dx.doi.org/10.1074/jbc.M111.253500			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730069	Green Published, hybrid			2022-12-25	WOS:000294283600068
J	Schollmeier, Y; Krause, JM; Kreye, S; Malsam, J; Sollner, TH				Schollmeier, Yvette; Krause, Jean Michel; Kreye, Susanne; Malsam, Joerg; Soellner, Thomas H.			Resolving the Function of Distinct Munc18-1/SNARE Protein Interaction Modes in a Reconstituted Membrane Fusion Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE FUSION; NEURONAL SNARE COMPLEX; SYNTAXIN 1A; N-PEPTIDE; CA2+-TRIGGERED EXOCYTOSIS; 3-DIMENSIONAL STRUCTURE; CONFORMATIONAL SWITCH; SEC1/MUNC18 PROTEINS; GENERAL SECRETION; TERMINAL DOMAIN	Sec1p/Munc18 proteins and SNAP receptors (SNAREs) are key components of the intracellular membrane fusion machinery. Compartment-specific v-SNAREs on a transport vesicle pair with their cognate t-SNAREs on the target membrane and drive lipid bilayer fusion. In a reconstituted assay that dissects the sequential assembly of t-SNARE (syntaxin 1.SNAP-25) and v-/t-SNARE (VAMP2.syntaxin 1.SNAP-25) complexes, and finally measures lipid bilayer merger, we resolved the inhibitory and stimulatory functions of the Sec1p/Munc18 protein Munc18-1 at the molecular level. Inhibition of membrane fusion by Munc18-1 requires a closed conformation of syntaxin 1. Remarkably, the concurrent preincubation of Munc18-1-inhibited syntaxin 1 liposomes with both VAMP2 liposomes and SNAP-25 at low temperature releases the inhibition and effectively stimulates membrane fusion. VAMP8 liposomes can neither release the inhibition nor exert the stimulatory effect, demonstrating the need for a specific Munc18-1/VAMP2 interaction. In addition, Munc18-1 binds to the N-terminal peptide of syntaxin 1, which is obligatory for a robust stimulation of membrane fusion. In contrast, this interaction is neither required for the inhibitory function of Munc18-1 nor for the release of this block. These results indicate that Munc18-1 and the neuronal SNAREs already have the inherent capability to function as a basic stage-specific off/on switch to control membrane fusion.	[Schollmeier, Yvette; Krause, Jean Michel; Kreye, Susanne; Malsam, Joerg; Soellner, Thomas H.] Univ Heidelberg, Biochem Ctr, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Sollner, TH (corresponding author), Univ Heidelberg, Biochem Ctr, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	thomas.soellner@bzh.uni-heidelberg.de			National Institutes of Health [NS0443391]; German Research Foundation [GRK1188, SFB/TRR83]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG))	This work was supported, in whole or in part, by National Institutes of Health Grant NS0443391 (to T. H. S.). This work was also supported by German Research Foundation Grants GRK1188 and SFB/TRR83 (to Y. S. and T. H. S.).	Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Connell E, 2007, EMBO REP, V8, P414, DOI 10.1038/sj.embor.7400935; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; Halachmi N, 1996, J NEUROCHEM, V66, P889; Han GA, 2010, J NEUROCHEM, V115, P1, DOI 10.1111/j.1471-4159.2010.06900.x; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Hu SH, 2011, P NATL ACAD SCI USA, V108, P1040, DOI 10.1073/pnas.0914906108; Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798; Jackson MB, 2008, NAT STRUCT MOL BIOL, V15, P684, DOI 10.1038/nsmb.1449; Jahn R, 2004, ANN NY ACAD SCI, V1014, P170, DOI 10.1196/annals.1294.018; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Johnson JR, 2009, BIOCHEM J, V418, P73, DOI 10.1042/BJ20081956; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; Lang T, 2008, PROG LIPID RES, V47, P461, DOI 10.1016/j.plipres.2008.08.002; Lang T, 2007, J PHYSIOL-LONDON, V585, P693, DOI 10.1113/jphysiol.2007.134346; Latham CF, 2007, J NEUROCHEM, V100, P1543, DOI 10.1111/j.1471-4159.2006.04286.x; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; MacDonald C, 2010, BIOCHEM SOC T, V38, P209, DOI 10.1042/BST0380209; Malintan NT, 2009, J BIOL CHEM, V284, P21637, DOI 10.1074/jbc.M109.013508; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Malsam J, 2009, P NATL ACAD SCI USA, V106, P2001, DOI 10.1073/pnas.0812813106; McEwen JM, 2008, MOL BIOL CELL, V19, P3836, DOI 10.1091/mbc.E08-02-0160; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Medine CN, 2007, J CELL SCI, V120, P4407, DOI 10.1242/jcs.020230; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Munson Mary, 2009, Biochem J, V418, pe1, DOI 10.1042/BJ20082389; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Peng RW, 2002, J CELL BIOL, V157, P645, DOI 10.1083/jcb.200202006; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Rickman C, 2010, J BIOL CHEM, V285, P3965, DOI 10.1074/jbc.M109.040402; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Rodkey TL, 2008, MOL BIOL CELL, V19, P5422, DOI 10.1091/mbc.E08-05-0538; Rowe J, 2001, J CELL SCI, V114, P3323; Rowe J, 1999, J CELL SCI, V112, P1865; Sassa T, 1999, J NEUROSCI, V19, P4772; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tareste D, 2008, P NATL ACAD SCI USA, V105, P2380, DOI 10.1073/pnas.0712125105; Toonen RFG, 2005, J NEUROCHEM, V93, P1393, DOI 10.1111/j.1471-4159.2005.03128.x; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330	78	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30582	30590		10.1074/jbc.M111.269886	http://dx.doi.org/10.1074/jbc.M111.269886			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730064	Green Published, hybrid			2022-12-25	WOS:000294283600037
J	Yu, X; Chen, M; Zhang, S; Yu, ZH; Sun, JP; Wang, LN; Liu, SJ; Imasaki, T; Takagi, Y; Zhang, ZY				Yu, Xiao; Chen, Ming; Zhang, Sheng; Yu, Zhi-Hong; Sun, Jin-Peng; Wang, Lina; Liu, Sijiu; Imasaki, Tsuyoshi; Takagi, Yuichiro; Zhang, Zhong-Yin			Substrate Specificity of Lymphoid-specific Tyrosine Phosphatase (Lyp) and Identification of Src Kinase-associated Protein of 55 kDa Homolog (SKAP-HOM) as a Lyp Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; GENETIC-VARIATION; PTPN22; VARIANT; POLYMORPHISM; INHIBITOR; ADHESION; COMPLEX; CLONING	A missense single-nucleotide polymorphism in the gene encoding the lymphoid-specific tyrosine phosphatase (Lyp) has been identified as a causal factor in a wide spectrum of autoimmune diseases. Interestingly, the autoimmune-predisposing variant of Lyp appears to represent a gain-of-function mutation, implicating Lyp as an attractive target for the development of effective strategies for the treatment of many autoimmune disorders. Unfortunately, the precise biological functions of Lyp in signaling cascades and cellular physiology are poorly understood. Identification and characterization of Lyp substrates will help define the chain of molecular events coupling Lyp dysfunction to diseases. In the current study, we identified consensus sequence motifs for Lyp substrate recognition using an "inverse alanine scanning" combinatorial library approach. The intrinsic sequence specificity data led to the discovery and characterization of SKAP-HOM, a cytosolic adaptor protein required for proper activation of the immune system, as a bona fide Lyp substrate. To determine the molecular basis for Lyp substrate recognition, we solved crystal structures of Lyp in complex with the consensus peptide as well as the phosphopeptide derived from SKAP-HOM. Together with the biochemical data, the structures define the molecular determinants for Lyp substrate specificity and provide a solid foundation upon which novel therapeutics targeting Lyp can be developed for multiple autoimmune diseases.	[Yu, Xiao; Chen, Ming; Zhang, Sheng; Yu, Zhi-Hong; Sun, Jin-Peng; Wang, Lina; Liu, Sijiu; Imasaki, Tsuyoshi; Takagi, Yuichiro; Zhang, Zhong-Yin] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Zhang, ZY (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	zyzhang@iupui.edu	SUN, JINPENG/F-9551-2013; sun, Jinpeng/AAR-9196-2020	Imasaki, Tsuyoshi/0000-0001-5462-1820; Yu, Xiao/0000-0003-1119-8334	National Institutes of Health [CA69202, CA126937]; NATIONAL CANCER INSTITUTE [R01CA069202, R01CA126937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA69202 and CA126937.	Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Black DS, 2000, CELL MICROBIOL, V2, P401, DOI 10.1046/j.1462-5822.2000.00061.x; BLISKA JB, 1992, J EXP MED, V176, P1625, DOI 10.1084/jem.176.6.1625; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carlton VEH, 2005, AM J HUM GENET, V77, P567, DOI 10.1086/468189; Cheung YW, 1997, J AM CHEM SOC, V119, P9568, DOI 10.1021/ja971825k; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Cohen S, 1999, BLOOD, V93, P2013, DOI 10.1182/blood.V93.6.2013.406k25_2013_2024; Curtis DJ, 2000, EXP HEMATOL, V28, P1250, DOI 10.1016/S0301-472X(00)00537-3; Espanel X, 2005, METHODS, V35, P64, DOI 10.1016/j.ymeth.2004.07.009; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Huyer G, 1998, ANAL BIOCHEM, V258, P19, DOI 10.1006/abio.1997.2541; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kouroku Y, 1998, BIOCHEM BIOPH RES CO, V252, P738, DOI 10.1006/bbrc.1998.9637; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Marie-Cardine A, 1998, FEBS LETT, V435, P55, DOI 10.1016/S0014-5793(98)01040-0; MarieCardine A, 1997, J BIOL CHEM, V272, P16077, DOI 10.1074/jbc.272.26.16077; Orru V, 2009, HUM MOL GENET, V18, P569, DOI 10.1093/hmg/ddn363; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellegrini MC, 1998, BIOCHEMISTRY-US, V37, P15598, DOI 10.1021/bi981427+; Ren LG, 2011, BIOCHEMISTRY-US, V50, P2339, DOI 10.1021/bi1014453; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Sarmiento M, 2000, BIOCHEMISTRY-US, V39, P8171, DOI 10.1021/bi000319w; Siminovitch KA, 2004, NAT GENET, V36, P1248, DOI 10.1038/ng1204-1248; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Stanford SM, 2010, SEMIN IMMUNOPATHOL, V32, P127, DOI 10.1007/s00281-010-0201-4; Sun HY, 2009, CHEM COMMUN, P677, DOI 10.1039/b817853d; Sun JP, 2003, J BIOL CHEM, V278, P12406, DOI 10.1074/jbc.M212491200; Swanson KD, 2008, MOL CELL, V32, P564, DOI 10.1016/j.molcel.2008.09.022; Togni M, 2005, MOL CELL BIOL, V25, P8052, DOI 10.1128/MCB.25.18.8052-8063.2005; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Vetter SW, 2000, J BIOL CHEM, V275, P2265, DOI 10.1074/jbc.275.4.2265; Walchli S, 2004, J BIOL CHEM, V279, P311, DOI 10.1074/jbc.M307617200; Wang HY, 2008, TRENDS CELL BIOL, V18, P486, DOI 10.1016/j.tcb.2008.07.005; Wang HY, 2003, NAT IMMUNOL, V4, P366, DOI 10.1038/ni913; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Xie LP, 2002, BIOCHEMISTRY-US, V41, P4032, DOI 10.1021/bi015904r; Yang J, 2000, J BIOL CHEM, V275, P4066, DOI 10.1074/jbc.275.6.4066; Yu X, 2007, P NATL ACAD SCI USA, V104, P19767, DOI 10.1073/pnas.0706233104; ZHANG ZY, 1993, P NATL ACAD SCI USA, V90, P4446, DOI 10.1073/pnas.90.10.4446; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P2285, DOI 10.1021/bi00174a040; ZHANG ZY, 1993, ANAL BIOCHEM, V211, P7, DOI 10.1006/abio.1993.1224; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616	48	24	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30526	30534		10.1074/jbc.M111.254722	http://dx.doi.org/10.1074/jbc.M111.254722			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21719704	Green Published, hybrid			2022-12-25	WOS:000294283600031
J	Mazier, S; Quick, M; Shi, L				Mazier, Sonia; Quick, Matthias; Shi, Lei			Conserved Tyrosine in the First Transmembrane Segment of Solute:Sodium Symporters Is Involved in Na+-coupled Substrate Co-transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; NA+/PROLINE TRANSPORTER; MOLECULAR CHARACTERIZATION; NA+/GLUCOSE COTRANSPORTER; CRYSTAL-STRUCTURE; ACID TRANSPORTER; PROLINE UPTAKE; SODIUM; BINDING; PROTEIN	Solute: sodium symporters (SSSs) transport vital molecules across the plasma membrane of all living organisms. vSGLT, the Na+/galactose transporter of Vibrio parahemeolyticus, is the only SSS for which high resolution structural information is available, revealing a LeuT-like fold and a Na+-binding site analogous to the Na2 site of LeuT. Whereas the core transmembrane segments (TMs) of SSSs share high structural similarity with other transporters of LeuT-like fold, TM1 does not correspond to any TM in those structural homologs and was only resolved for the backbone atoms in the initial vSGLT structure (Protein Data Bank code 3DH4). To assess the role of TM1 in Na+-coupled substrate symport by the SSSs, here we have studied the role of a conserved residue in TM1 by computational modeling in conjunction with radiotracer transport and binding studies. Based on our sequence alignment and much topological data for homologous PutP, the Na+/proline transporter, we have simulated a series of vSGLT models with shifted TM1 residue assignments. We show that in two converged vSGLT models that retained the original TM1 backbone conformation, a conserved residue, Tyr-19, is associated with the Na(+)binding interaction network. In silico and in vitro mutagenesis of homologous Tyr-14 in PutP revealed the involvement of this conserved residue in Na+-dependent substrate binding and transport. Thus, our combined computational and experimental data provide the first clues about the importance of a conserved residue in TM1, a unique TM in the proteins with LeuT-like fold, in the Na+-coupled symport mechanism of SSSs.	[Quick, Matthias] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Quick, Matthias] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Mazier, Sonia; Shi, Lei] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Shi, Lei] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10065 USA; New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA	Columbia University; Columbia University; Cornell University; Cornell University; New York State Psychiatry Institute	Quick, M (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, 650 W 168th St,BB1119, New York, NY 10032 USA.	mq2102@columbia.edu; les2007@med.cornell.edu	Shi, Lei/AAV-1321-2020	Shi, Lei/0000-0002-4137-096X	National Institutes of Health [P30ES09089, DA023694]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA023694, K99DA023694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants P30ES09089 (to Joseph H. Graziano) and DA023694 (to L. S.).	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bowers K.J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1109/SC.2006.54; Choe S, 2010, BIOPHYS J, V99, pL56, DOI 10.1016/j.bpj.2010.08.055; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dohan O, 2003, MOL CELL ENDOCRINOL, V213, P59, DOI 10.1016/j.mce.2003.10.059; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Jung H, 1998, J BIOL CHEM, V273, P26400, DOI 10.1074/jbc.273.41.26400; Jung H, 2002, FEBS LETT, V529, P73, DOI 10.1016/S0014-5793(02)03184-8; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; MYERS RS, 1988, MOL MICROBIOL, V2, P749, DOI 10.1111/j.1365-2958.1988.tb00086.x; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pirch T, 2002, J BIOL CHEM, V277, P8790, DOI 10.1074/jbc.M111008200; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Quick M, 1998, BIOCHEMISTRY-US, V37, P13800, DOI 10.1021/bi980562j; Quick M, 1996, EUR J BIOCHEM, V239, P732, DOI 10.1111/j.1432-1033.1996.0732u.x; Quick M, 1997, BIOCHEMISTRY-US, V36, P4631, DOI 10.1021/bi963063w; Quick M, 2001, J BIOL CHEM, V276, P1728, DOI 10.1074/jbc.M005521200; Reed-Tsur MD, 2008, ENDOCRINOLOGY, V149, P3077, DOI 10.1210/en.2008-0027; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Severi E, 2010, FEMS MICROBIOL LETT, V304, P47, DOI 10.1111/j.1574-6968.2009.01881.x; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shi L, 2010, BIOPHYS J, V99, pL103, DOI 10.1016/j.bpj.2010.10.003; Smirnova I, 2009, BIOCHEMISTRY-US, V48, P8852, DOI 10.1021/bi9011918; Turk E, 2000, J BIOL CHEM, V275, P25711, DOI 10.1074/jbc.M003127200; TURK E, 1991, NATURE, V350, P354, DOI 10.1038/350354a0; VALLARI DS, 1985, J BACTERIOL, V162, P1156, DOI 10.1128/JB.162.3.1156-1161.1985; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Xie ZY, 2000, J BIOL CHEM, V275, P25959, DOI 10.1074/jbc.M002687200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zomot E, 2010, MOL BIOSYST, V6, P1040, DOI 10.1039/b927492h	42	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29347	29355		10.1074/jbc.M111.263327	http://dx.doi.org/10.1074/jbc.M111.263327			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705334	Green Published, hybrid			2022-12-25	WOS:000293837000069
J	Tsubakiyama, R; Mizunuma, M; Gengyo, A; Yamamoto, J; Kume, K; Miyakawa, T; Hirata, D				Tsubakiyama, Ryohei; Mizunuma, Masaki; Gengyo, Anri; Yamamoto, Josuke; Kume, Kazunori; Miyakawa, Tokichi; Hirata, Dai			Implication of Ca2+ in the Regulation of Replicative Life Span of Budding Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE REGULATION; VACUOLAR H+-ATPASE; SACCHAROMYCES-CEREVISIAE; PROTEIN PHOSPHATASE; CALORIE RESTRICTION; SECRETORY PATHWAY; RIBOSOMAL DNA; CALCINEURIN; SIR2; GENES	In eukaryotic cells, Ca2+-triggered signaling pathways are used to regulate a wide variety of cellular processes. Calcineurin, a highly conserved Ca2+/calmodulin-dependent protein phosphatase, plays key roles in the regulation of diverse biological processes in organisms ranging from yeast to humans. We isolated a mutant of the SIR3 gene, implicated in the regulation of life span, as a suppressor of the Ca2+ sensitivity of zds1 Delta cells in the budding yeast Saccharomyces cerevisiae. Therefore, we investigated a relationship between Ca2+ signaling and life span in yeast. Here we show that Ca2+ affected the replicative life span (RLS) of yeast. Increased external and intracellular Ca2+ levels caused a reduction in their RLS. Consistently, the increase in calcineurin activity by either the zds1 deletion or the constitutively activated calcineurin reduced RLS. Indeed, the shortened RLS of zds1 Delta cells was suppressed by the calcineurin deletion. Further, the calcineurin deletion per se promoted aging without impairing the gene silencing typically observed in short-lived sir mutants, indicating that calcineurin plays an important role in a regulation of RLS even under normal growth condition. Thus, our results indicate that Ca2+ homeostasis/Ca2+ signaling are required to regulate longevity in budding yeast.	[Tsubakiyama, Ryohei; Mizunuma, Masaki; Gengyo, Anri; Yamamoto, Josuke; Kume, Kazunori; Miyakawa, Tokichi; Hirata, Dai] Hiroshima Univ, Dept Mol Biotechnol, Grad Sch Adv Sci Matter, Higashihiroshima 7398530, Japan	Hiroshima University	Mizunuma, M (corresponding author), Hiroshima Univ, Dept Mol Biotechnol, Grad Sch Adv Sci Matter, Higashihiroshima 7398530, Japan.	mmizu49120@hiroshima-u.ac.jp	Kume, Kazunori/T-4061-2018; Mizunuma, Masaki/V-2941-2017	Kume, Kazunori/0000-0002-0613-8081; Mizunuma, Masaki/0000-0002-1531-1763	Japan Society for the Promotion of Science [18688004, 21780095]; Ministry of Education, Science, and Culture of Japan; Grants-in-Aid for Scientific Research [21780095] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science for Young Scientists (A) and (B) 18688004 and 21780095 (to M. M.), and by Ministry of Education, Science, and Culture of Japan (to D. H.).	ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Aramburu J, 2000, CURR TOP CELL REGUL, V36, P237; Austriaco NR, 1997, P NATL ACAD SCI USA, V94, P9768, DOI 10.1073/pnas.94.18.9768; Bi EF, 1996, MOL CELL BIOL, V16, P5264; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; CUNNINGHAM KW, 1994, J EXP BIOL, V196, P157; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Cyert MS, 2001, ANNU REV GENET, V35, P647, DOI 10.1146/annurev.genet.35.102401.091302; Defossez PA, 2001, BIOESSAYS, V23, P327, DOI 10.1002/bies.1047; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Dwivedi M, 2009, AUTOPHAGY, V5, P604, DOI 10.4161/auto.5.5.8157; FARCASANU IC, 1995, EUR J BIOCHEM, V232, P712, DOI 10.1111/j.1432-1033.1995.tb20865.x; Fritze CE, 1997, EMBO J, V16, P6495, DOI 10.1093/emboj/16.21.6495; GARRETTENGELE P, 1995, MOL CELL BIOL, V15, P4103; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Griffioen G, 2003, J BIOL CHEM, V278, P23460, DOI 10.1074/jbc.M210691200; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Halachmi D, 1996, FEBS LETT, V392, P194, DOI 10.1016/0014-5793(96)00799-5; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, MECH AGEING DEV, V126, P491, DOI 10.1016/j.mad.2004.10.007; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kellermayer R, 2003, J CELL SCI, V116, P1637, DOI 10.1242/jcs.00372; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Ma XJ, 1996, GENE DEV, V10, P1327, DOI 10.1101/gad.10.11.1327; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Miyakawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P633, DOI 10.1271/bbb.60495; Mizunuma M, 2005, J CELL SCI, V118, P4219, DOI 10.1242/jcs.02535; Mizunuma M, 1998, NATURE, V392, P303, DOI 10.1038/32695; NAKAMURA T, 1993, EMBO J, V12, P4063, DOI 10.1002/j.1460-2075.1993.tb06090.x; Nakamura T, 1996, MOL GEN GENET, V251, P211; PETES TD, 1977, P NATL ACAD SCI USA, V74, P5091, DOI 10.1073/pnas.74.11.5091; Queralt E, 2008, J CELL BIOL, V182, P873, DOI 10.1083/jcb.200801054; Ray A, 2003, NAT GENET, V33, P522, DOI 10.1038/ng1132; RINE J, 1987, GENETICS, V116, P9; Rossio V, 2011, J CELL BIOL, V193, P445, DOI 10.1083/jcb.201101134; Roy N, 2000, CURR BIOL, V10, P111, DOI 10.1016/S0960-9822(00)00298-0; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; TANIDA I, 1995, J BIOL CHEM, V270, P10113, DOI 10.1074/jbc.270.17.10113; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 2004, MOL CELL BIOL, V24, P6931, DOI 10.1128/MCB.24.16.6931-6946.2004; Yadav J, 2007, MOL BIOL CELL, V18, P1480, DOI 10.1091/mbc.E06-11-1049; Yokoyama H, 2006, EMBO REP, V7, P519, DOI 10.1038/sj.embor.7400647; Yu YX, 1996, MOL CELL BIOL, V16, P5254; Zanelli CF, 2005, GENETICS, V171, P1571, DOI 10.1534/genetics.105.048082	58	5	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28681	28687		10.1074/jbc.M111.231415	http://dx.doi.org/10.1074/jbc.M111.231415			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21712379	Green Published, hybrid			2022-12-25	WOS:000293837000005
J	Jonasson, KA; Willis, CKR				Jonasson, Kristin A.; Willis, Craig K. R.			Changes in Body Condition of Hibernating Bats Support the Thrifty Female Hypothesis and Predict Consequences for Populations with White-Nose Syndrome	PLOS ONE			English	Article							GROUND-SQUIRRELS SLEEP; EVAPORATIVE WATER-LOSS; MYOTIS-LUCIFUGUS; BROWN BATS; MAMMALIAN HIBERNATION; ENERGY AVAILABILITY; ELECTRICAL-CONDUCTIVITY; PIPISTRELLE BATS; METABOLIC-RATE; LIFE-HISTORY	White-nose syndrome (WNS) is a new disease of bats that has devastated populations in eastern North America. Infection with the fungus, Geomyces destructans, is thought to increase the time bats spend out of torpor during hibernation, leading to starvation. Little is known about hibernation in healthy, free-ranging bats and more data are needed to help predict consequences of WNS. Trade-offs presumably exist between the energetic benefits and physiological/ecological costs of torpor, leading to the prediction that the relative importance of spring energy reserves should affect an individual's use of torpor and depletion of energy reserves during winter. Myotis lucifugus mate during fall and winter but females do not become pregnant until after spring emergence. Thus, female reproductive success depends on spring fat reserves while male reproductive success does not. Consequently, females should be "thrifty" in their use of fat compared to males. We measured body condition index (BCI; mass/forearm length) of 432 M. lucifugus in Manitoba, Canada during the winter of 2009/2010. Bats were captured during the fall mating period (n = 200), early hibernation (n = 125), and late hibernation (n = 128). Adult females entered hibernation with greater fat reserves and consumed those reserves more slowly than adult males and young of the year. Consequently, adult females may be more likely than males or young of the year to survive the disruption of energy balance associated with WNS, although surviving females may not have sufficient reserves to support reproduction.	[Jonasson, Kristin A.; Willis, Craig K. R.] Univ Winnipeg, Dept Biol, Ctr Forest Interdisciplinary Res, Winnipeg, MB R3B 2E9, Canada	University of Winnipeg	Jonasson, KA (corresponding author), Univ Winnipeg, Dept Biol, Ctr Forest Interdisciplinary Res, Winnipeg, MB R3B 2E9, Canada.	c.willis@uwinnipeg.ca	Willis, Craig K.R./F-5218-2013	Willis, Craig/0000-0002-0985-8607	Natural Sciences and Engineering Research Council (NSERC, Canada); Canada Foundation for Innovation (CFI); Manitoba Research and Innovation Fund; NSERC; Manitoba Graduate Scholarship; Bat Conservation International Student Research Scholarship	Natural Sciences and Engineering Research Council (NSERC, Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Manitoba Research and Innovation Fund; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Manitoba Graduate Scholarship; Bat Conservation International Student Research Scholarship	This work was supported by the Natural Sciences and Engineering Research Council (NSERC, Canada) Discovery Grant to CKRW; the Canada Foundation for Innovation (CFI) Leader's Opportunity Fund Grand to CKRW; the Manitoba Research and Innovation Fund Grant to CKRW; the NSERC Canada Graduate Scholarship to KAJ; the Manitoba Graduate Scholarship to KAJ; and the Bat Conservation International Student Research Scholarship to KAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RB, 1977, J COMP PHYSIOL, V119, P141, DOI 10.1007/BF00686562; ARNOLD W, 1990, BEHAV ECOL SOCIOBIOL, V27, P239; BEER JAMES R., 1956, JOUR MAMMAL, V37, P31, DOI 10.2307/1375523; BILECKI L, 2003, THESIS U MANITOBA WI; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boyles JG, 2007, J EXP BIOL, V210, P4345, DOI 10.1242/jeb.007294; Boyles JG, 2010, ECOL MODEL, V221, P1644, DOI 10.1016/j.ecolmodel.2010.03.018; Boyles JG, 2010, FRONT ECOL ENVIRON, V8, P92, DOI 10.1890/080187; Boyles JG, 2009, J MAMMAL, V90, P9, DOI 10.1644/08-MAMM-A-205.1; Brock Fenton M. B., 1970, Contr. Life Sci. Div. R. Ont. Mus., V77, P1; BUCHANAN GD, 1987, AM J ANAT, V178, P335, DOI 10.1002/aja.1001780405; Burton RS, 1999, FUNCT ECOL, V13, P232, DOI 10.1046/j.1365-2435.1999.00302.x; Choi IH, 1998, PHYSIOL ZOOL, V71, P257, DOI 10.1086/515915; DAAN S, 1991, NEUROSCI LETT, V128, P265, DOI 10.1016/0304-3940(91)90276-Y; Davis W. H., 1965, Journal of Mammalogy, V46, P296, DOI 10.2307/1377850; DAVIS WH, 1966, J MAMMAL, V47, P383, DOI 10.2307/1377679; Dunbar MB, 2006, J MAMMAL, V87, P1096, DOI 10.1644/05-MAMM-A-254R3.1; EWING WG, 1970, COMP BIOCHEM PHYSIOL, V36, P119, DOI 10.1016/0010-406X(70)90658-4; FENTON BM, 1980, MAMMALIAN SPECIES, V142, P1; FENTON MB, 1969, CAN J ZOOLOG, V47, P597, DOI 10.1139/z69-103; Frank CL, 2000, LIFE IN THE COLD, P207; FRENCH AR, 1985, J COMP PHYSIOL B, V156, P13, DOI 10.1007/BF00692921; FRENCH AR, 1982, J APPL PHYSIOL, V52, P216, DOI 10.1152/jappl.1982.52.1.216; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Grigg G, 2000, LIFE IN THE COLD, P5; GRINDAL SD, 1992, AM MIDL NAT, V128, P339, DOI 10.2307/2426468; GUSTAFSON AW, 1976, BIOL REPROD, V15, P9, DOI 10.1093/biolreprod/15.1.9; HOCK RJ, 1951, BIOL BULL-US, V101, P289, DOI 10.2307/1538547; HOLROYD SL, 1993, INFLUENCES SOME EXTR, P126; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P165, DOI 10.1086/367950; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P180, DOI 10.1086/367949; KING WJ, 1991, OECOLOGIA, V86, P528, DOI 10.1007/BF00318319; Kortner G, 1998, OECOLOGIA, V113, P170, DOI 10.1007/s004420050365; Kunz TH, 1998, ECOSCIENCE, V5, P8, DOI 10.1080/11956860.1998.11682443; Luis AD, 2006, FUNCT ECOL, V20, P471, DOI 10.1111/j.1365-2435.2006.01119.x; Lyman C.P., 1982, P54; MCMANUS JJ, 1974, J MAMMAL, V55, P844, DOI 10.2307/1379416; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; MICHENER GR, 1990, J MAMMAL, V71, P489, DOI 10.2307/1381787; Millesi E, 2001, J BIOL RHYTHM, V16, P264, DOI 10.1177/074873001129001971; Munro D, 2005, J ANIM ECOL, V74, P692, DOI 10.1111/j.1365-2656.2005.00968.x; MYERS P, 1978, AM NAT, V112, P701, DOI 10.1086/283312; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Pearce RD, 2008, ACTA CHIROPTEROL, V10, P153, DOI 10.3161/150811008X331171; PLOSKEY G R, 1979, Southwestern Naturalist, V24, P71, DOI 10.2307/3670626; POPOV VI, 1992, NEUROSCIENCE, V48, P45, DOI 10.1016/0306-4522(92)90336-Z; Prendergast BJ, 2002, AM J PHYSIOL-REG I, V282, pR1054, DOI 10.1152/ajpregu.00562.2001; RACEY PA, 1974, J ZOOL, V173, P264, DOI 10.1111/j.1469-7998.1974.tb03136.x; RACEY PA, 1981, J REPROD FERTIL, V61, P123; Randall D., 2001, ECKERT ANIMAL PHYSL; RANSOME RD, 1989, BIOL J LINN SOC, V38, P71, DOI 10.1111/j.1095-8312.1989.tb01564.x; REEDER DM, 2009, ALTERED AROUSAL PATT; Reynolds DS, 2009, J WILDLIFE MANAGE, V73, P1197, DOI 10.2193/2008-151; Ruczynski I, 2011, BIOL LETTERS, V7, P153, DOI 10.1098/rsbl.2010.0585; Ruediger J, 2007, SYNAPSE, V61, P343, DOI 10.1002/syn.20380; SCHOWALTER DB, 1980, J MAMMAL, V61, P350, DOI 10.2307/1380065; SCHOWALTER DB, 1979, CAN FIELD NAT, V93, P243; Sendor T, 2003, J ANIM ECOL, V72, P308, DOI 10.1046/j.1365-2656.2003.00702.x; SHAW WILLIAM T., 1926, JOUR MAMMAL, V7, P91, DOI 10.2307/1373674; SPEAKMAN JR, 1991, J APPL ECOL, V28, P1087, DOI 10.2307/2404227; Stawski C, 2010, NATURWISSENSCHAFTEN, V97, P29, DOI 10.1007/s00114-009-0606-x; Tannerfeldt M, 1998, OIKOS, V83, P545, DOI 10.2307/3546681; THOMAS DW, 1992, PHYSIOL ZOOL, V65, P443, DOI 10.1086/physzool.65.2.30158262; Thomas DW, 1997, FUNCT ECOL, V11, P585, DOI 10.1046/j.1365-2435.1997.00129.x; THOMAS DW, 1990, J MAMMAL, V71, P475, DOI 10.2307/1381967; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; TRACHSEL L, 1991, AM J PHYSIOL, V260, pR1123, DOI 10.1152/ajpregu.1991.260.6.R1123; TUTTLE MD, 2009, WHIT NOS SYNDR SCI S, V2; Wang LCH, 1978, STRATEGIES COLD NATU, P109; Watkins M. W., 2003, EFFECT SIZE CALCULAT; WHITAKER JO, 1993, AM MIDL NAT, V129, P200, DOI 10.2307/2426448; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x; WILLIAMS DF, 1979, AM MIDL NAT, V102, P113, DOI 10.2307/2425072; Willis CKR, 2009, J COMP PHYSIOL B, V179, P867, DOI 10.1007/s00360-009-0366-0; Wimsatt WA, 1944, ANAT REC, V88, P193, DOI 10.1002/ar.1090880206; WIMSATT WA, 1945, J MAMMAL, V26, P23, DOI 10.2307/1375029; WIMSATT WA, 1957, ANAT REC, V129, P115, DOI 10.1002/ar.1091290110	82	98	101	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21061	10.1371/journal.pone.0021061	http://dx.doi.org/10.1371/journal.pone.0021061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731647	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700032
J	Tian, Z; Shen, J; Wang, FF; Xiao, PG; Yang, JS; Lei, HT; Kazlauskas, A; Kohane, IS; Wu, EX				Tian, Ze; Shen, Jie; Wang, Fengfei; Xiao, Peigen; Yang, Junshan; Lei, Hetian; Kazlauskas, Andrius; Kohane, Isaac S.; Wu, Erxi			Cambogin Is Preferentially Cytotoxic to Cells Expressing PDGFR	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTORS; MULTIPLE-MYELOMA; TYROSINE KINASE; CYCLE ARREST; IN-VITRO; INHIBITOR; MEDULLOBLASTOMA; TUMORS; APOPTOSIS; EFFICACY	Platelet-derived growth factor receptors (PDGFRs) have been implicated in a wide array of human malignancies, including medulloblastoma (MB), the most common brain tumor of childhood. Although significant progress in MB biology and therapeutics has been achieved during the past decades, MB remains a horrible challenge to the physicians and researchers. Therefore, novel inhibitors targeting PDGFR signaling pathway may offer great promise for the treatment of MB. In the present study, we investigated the cytotoxicity and mechanisms of cambogin in Daoy MB cells. Our results show that cambogin triggers significant S phase cell cycle arrest and apoptosis via down regulation of cyclin A and E, and activation of caspases. More importantly, further mechanistic studies demonstrated that cambogin inhibits PDGFR signaling in Daoy and genetically defined mouse embryo fibroblast (MEF) cell lines. These results suggest that cambogin is preferentially cytotoxic to cells expressing PDGFR. Our findings may provide a novel approach by targeting PDGFR signaling against MB.	[Tian, Ze; Shen, Jie; Xiao, Peigen; Yang, Junshan; Lei, Hetian] Chinese Acad Med Sci, Inst Med Plant Dev, Peking Union Med Coll, Beijing 100730, Peoples R China; [Wang, Fengfei; Wu, Erxi] N Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA; [Lei, Hetian; Kazlauskas, Andrius] Harvard Univ, Sch Med, Schepens Eye Res Inst, Dept Ophthalmol, Boston, MA USA; [Tian, Ze; Kohane, Isaac S.] Harvard Univ, Childrens Hosp Boston, Sch Med, Informat Program, Boston, MA USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College; North Dakota State University Fargo; Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Boston Children's Hospital; Harvard Medical School	Tian, Z (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Peking Union Med Coll, Beijing 100730, Peoples R China.	ze_tian@dfci.harvard.edu; erxi.wu@ndsu.edu	Kohane, Isaac Kohane/K-3716-2012; tian, ze/HDM-4308-2022	Kohane, Isaac Kohane/0000-0003-2192-5160; Lei, Hetian/0000-0003-4091-1936; Wu, Erxi/0000-0002-1680-3639	Nancy Lurie Marks' foundation; ND EPSCoR; North Dakota State University; National Center for Research Resources (NCRR) [NIH P20 RR020151]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103505] Funding Source: NIH RePORTER	Nancy Lurie Marks' foundation; ND EPSCoR; North Dakota State University; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Nancy Lurie Marks' foundation (ISK), ND EPSCoR (EW), North Dakota State University faculty funds (EW), and Pilot Project Grant (EW) from the Centers of Biomedical Research Excellence (COBRE) grant NIH P20 RR020151 from the National Center for Research Resources (NCRR). NCRR is a component of the National Institutes of Health (NIH). The contents of this report are solely the responsibility of the authors and do not necessarily reflect the official views of the NIH or NCRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUANTOUN TJ, 2009, MOL CANC THER; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; CATENA R, CANC RES, V71, P164; Coluccia AML, 2008, BLOOD, V112, P1346, DOI 10.1182/blood-2007-10-116590; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; El-Sheikh A, 2010, PEDIATR BLOOD CANCER, V55, P35, DOI 10.1002/pbc.22465; ESSAT M, INT J CANC, V128, P2202; FLEMING TP, 1992, CANCER RES, V52, P4550; Gilbertson RJ, 2003, NAT GENET, V35, P197, DOI 10.1038/ng1103-197; GOOSKENS SL, PEDIAT BLOOD CANC, V55, P369; KINOSHITA K, INT J ONCOL, V37, P869; Kumar S, 2007, PLANTA MED, V73, P1452, DOI 10.1055/s-2007-990255; LANNANG AM, PLANTA MED, V76, P708; Li XR, 2010, ONCOTARGET, V1, P309, DOI 10.18632/oncotarget.141; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Perrone F, EUR J CANC, V46, P2837; Podar K, 2007, BLOOD, V109, P1669, DOI 10.1182/blood-2006-08-042747; Shen J, 2007, PHARMAZIE, V62, P549, DOI 10.1691/ph.2007.7.6580; Smits A, 1996, LAB INVEST, V74, P188; Tian Z, 2008, INT J CANCER, V122, P31, DOI 10.1002/ijc.23048; Tian Z, 2009, CANCER CHEMOTH PHARM, V63, P1131, DOI 10.1007/s00280-008-0832-5; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Wu EX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003794; XU G, J NAT PROD, V73, P104; Yang JL, 2008, CANCER, V113, P1532, DOI 10.1002/cncr.23778; Zuzak TJ, 2002, EUR J CANCER, V38, P83, DOI 10.1016/S0959-8049(01)00355-0	27	10	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21370	10.1371/journal.pone.0021370	http://dx.doi.org/10.1371/journal.pone.0021370			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712951	Green Published, gold, Green Submitted			2022-12-25	WOS:000291985100035
J	Collin, A; Archambault, P; Long, B				Collin, Antoine; Archambault, Phillippe; Long, Bernard			Predicting Species Diversity of Benthic Communities within Turbid Nearshore Using Full-Waveform Bathymetric LiDAR and Machine Learners	PLOS ONE			English	Article							DISTRIBUTION MODELS; ECOLOGICAL THEORY; HABITAT; FISH; ASSEMBLAGES; VEGETATION; ABUNDANCE; RICHNESS; PATTERNS; REEFS	Epi-macrobenthic species richness, abundance and composition are linked with type, assemblage and structural complexity of seabed habitat within coastal ecosystems. However, the evaluation of these habitats is highly hindered by limitations related to both waterborne surveys (slow acquisition, shallow water and low reactivity) and water clarity (turbid for most coastal areas). Substratum type/diversity and bathymetric features were elucidated using a supervised method applied to airborne bathymetric LiDAR waveforms over Saint-Simeon-Bonaventure's nearshore area (Gulf of Saint-Lawrence, Quebec, Canada). High-resolution underwater photographs were taken at three hundred stations across an 8-km(2) study area. Seven models based upon state-of-the-art machine learning techniques such as Naive Bayes, Regression Tree, Classification Tree, C 4.5, Random Forest, Support Vector Machine, and CN2 learners were tested for predicting eight epi-macrobenthic species diversity metrics as a function of the class number. The Random Forest outperformed other models with a three-discretized Simpson index applied to epi-macrobenthic communities, explaining 69% (Classification Accuracy) of its variability by mean bathymetry, time range and skewness derived from the LiDAR waveform. Corroborating marine ecological theory, areas with low Simpson epi-macrobenthic diversity responded to low water depths, high skewness and time range, whereas higher Simpson diversity relied upon deeper bottoms (correlated with stronger hydrodynamics) and low skewness and time range. The degree of species heterogeneity was therefore positively linked with the degree of the structural complexity of the benthic cover. This work underpins that fully exploited bathymetric LiDAR (not only bathymetrically derived by-products), coupled with proficient machine learner, is able to rapidly predict habitat characteristics at a spatial resolution relevant to epi-macrobenthos diversity, ranging from clear to turbid waters. This method might serve both to nurture marine ecological theory and to manage areas with high species heterogeneity where navigation is hazardous and water clarity opaque to passive optical sensors.	[Collin, Antoine; Long, Bernard] Univ Quebec, INRS, ETE, Dept Geosci, Quebec City, PQ, Canada; [Archambault, Phillippe] Univ Quebec, Inst Sci Mer, Rimouski, PQ G5L 3A1, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); University of Quebec	Collin, A (corresponding author), Univ Quebec, INRS, ETE, Dept Geosci, Quebec City, PQ, Canada.	antoinecollin1@gmail.com	Rogers, King/G-5482-2010; Collin, Antoine/L-1169-2013; Collin, Antoine/AAL-4560-2021	Collin, Antoine/0000-0001-9559-7572; Collin, Antoine/0000-0001-9559-7572; Archambault, Philippe/0000-0001-5986-6149	network of excellence GEOIDE (Canada); Fisheries and Oceans Canada; US Naval Hydrographic Service; Optech Int.	network of excellence GEOIDE (Canada); Fisheries and Oceans Canada; US Naval Hydrographic Service; Optech Int.	This study was supported by the network of excellence GEOIDE (Canada), Fisheries and Oceans Canada, US Naval Hydrographic Service, and Optech Int. The funders had no role in study design, decision to publish, or preparation of the manuscript. Optech Int. was involved in data collection and analysis.	Adjeroud M, 1997, MAR ECOL PROG SER, V159, P105, DOI 10.3354/meps159105; Anselin L., 2003, GEODA 0 9 USERS GUID; Archambault P, 2001, MAR ECOL PROG SER, V222, P51, DOI 10.3354/meps222051; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Austin MP, 1996, AUST J ECOL, V21, P154, DOI 10.1111/j.1442-9993.1996.tb00596.x; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; AUSTIN MP, 1989, BIOL CONSERV, V50, P13, DOI 10.1016/0006-3207(89)90003-7; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brier G.W., 1950, MON WEATHER REV, V78, P1, DOI [DOI 10.1175/1520-0493(1950)0782.0.CO;2, DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2]; Brock JC, 2006, REMOTE SENS ENVIRON, V104, P31, DOI 10.1016/j.rse.2006.04.017; Clark P., 1989, Machine Learning, V3, P261, DOI 10.1007/BF00116835; COLLIN A, 2011, REMOTE SENS EN UNPUB; Collin A, 2008, IEEE T GEOSCI REMOTE, V46, P2947, DOI 10.1109/TGRS.2008.920020; Collin A, 2010, REMOTE SENS ENVIRON, V114, P520, DOI 10.1016/j.rse.2009.10.011; Demsar J, 2004, LECT NOTES ARTIF INT, V3202, P537; ELITH J, 2009, DO THEY DO THEY WHY; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Galparsoro I, 2009, ECOL MODEL, V220, P556, DOI 10.1016/j.ecolmodel.2008.11.003; Gray J.S., 1974, Oceanography mar Biol, V12, P223; GUENTHER GC, 2000, EARSEL DRESD; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Harborne AR, 2006, ECOLOGY, V87, P2871, DOI 10.1890/0012-9658(2006)87[2871:MTBDOC]2.0.CO;2; Hewitt JE, 2005, ECOLOGY, V86, P1619, DOI 10.1890/04-1099; Hsu C.-W., 2010, PRACTICAL GUIDE SUPP; Irish J.L., 2000, B INT NAVIGATION ASS, V43-53, DOI [10.1016/S0924-2716(99)00003-9, DOI 10.1016/S0924-2716(99)00003-9]; Kobler A, 2006, ECOL MODEL, V191, P83, DOI 10.1016/j.ecolmodel.2005.08.002; KONONENKO I, 1991, MACH LEARN, V6, P67, DOI 10.1007/BF00153760; Leathwick JR, 1998, ECOGRAPHY, V21, P235, DOI 10.1111/j.1600-0587.1998.tb00561.x; Levesque Melanie, 2010, Canadian Technical Report of Fisheries and Aquatic Sciences, V2893, P1; LONG B, 2006, ETUDE HYDRODYNAMIQUE; LONG BF, 2009, P 2 FUDOTERAM WORKSH; MAC ARTHUR ROBERT H., 1967; MALANSON GP, 1992, ECOL MODEL, V64, P261, DOI 10.1016/0304-3800(92)90026-B; Maxwell DL, 2009, J SEA RES, V61, P258, DOI 10.1016/j.seares.2008.11.008; MINCHIN PR, 1989, VEGETATIO, V83, P97, DOI 10.1007/BF00031683; MITCHELL T, 1989, ANNU REV COMPUT SCI, V4, P417; Mumby PJ, 2001, OECOLOGIA, V128, P274, DOI 10.1007/s004420100643; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Petersen C.G.J., 1913, REP DAN BIOL ANN REV, V16, P229; Pittman SJ, 2007, ECOL MODEL, V204, P9, DOI 10.1016/j.ecolmodel.2006.12.017; Pittman SJ, 2009, J COASTAL RES, V25, P27, DOI [10.2112/SI53-004.1, 10.2112/S153-004.1]; Purkis SJ, 2008, CORAL REEFS, V27, P167, DOI 10.1007/s00338-007-0306-y; Quinlan JR, 1993, C4 5 PROGRAMS MACHIN; *RES SYST, 2005, ENVI US GUID ENVI VE; Ridgeway G., 2006, GEN BOOSTED REGRESSI; Rigby R., 2001, NEW TRENDS STAT MODE; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rydgren K, 2003, J VEG SCI, V14, P869, DOI 10.1111/j.1654-1103.2003.tb02220.x; *SAS I INC, 2009, JMP 8 US GUID; THORSON G, 1957, GEOL SOC AM MEM, V67, P461; Turner MG, 2001, LANDSCAPE ECOLOGY TH, DOI DOI 10.1007/B97434; Ward TJ, 1999, ECOL APPL, V9, P691; Wedding LM, 2008, REMOTE SENS ENVIRON, V112, P4159, DOI 10.1016/j.rse.2008.01.025; Wei CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015323; WOOD JD, 1996, THESIS U LEICESTER L	55	34	34	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21265	10.1371/journal.pone.0021265	http://dx.doi.org/10.1371/journal.pone.0021265			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701576	Green Published, gold, Green Accepted			2022-12-25	WOS:000291983800036
J	Fukushi, M; Ito, T; Oka, T; Kitazawa, T; Miyoshi-Akiyama, T; Kirikae, T; Yamashita, M; Kudo, K				Fukushi, Masaya; Ito, Tateki; Oka, Teruaki; Kitazawa, Toshio; Miyoshi-Akiyama, Tohru; Kirikae, Teruo; Yamashita, Makoto; Kudo, Koichiro			Serial Histopathological Examination of the Lungs of Mice Infected with Influenza A Virus PR8 Strain	PLOS ONE			English	Article							ACUTE RESPIRATORY-DISTRESS; H1N1; H5N1; SURFACTANT; PATHOLOGY; DISEASE; HUMANS; MODELS; SERUM	Avian influenza H5N1 and pandemic (H1N1) 2009 viruses are known to induce viral pneumonia and subsequent acute respiratory distress syndrome (ARDS) with diffuse alveolar damage (DAD). The mortality rate of ARDS/DAD is extremely high, at approximately 60%, and no effective treatment for ARDS/DAD has been established. We examined serial pathological changes in the lungs of mice infected with influenza virus to determine the progress from viral pneumonia to ARDS/DAD. Mice were intranasally infected with influenza A/Puerto Rico/8/34 (PR8) virus, and their lungs were examined both macro- and micro-pathologically every 2 days. We also evaluated general condition, survival rate, body weight, viral loads in lung, and surfactant proteins in serum. As a result, all infected mice died within 9 days postinfection. At 2 days postinfection, inflammation in alveolar septa, i.e., interstitial pneumonia, was observed around bronchioles. From 4 to 6 days postinfection, interstitial pneumonia with alveolar collapse expanded throughout the lungs. From 6 to 9 days postinfection, DAD with severe alveolar collapse was observed in the lungs of all of dying and dead mice. In contrast, DAD was not observed in the live infected-mice from 2 to 6 days postinfection, despite their poor general condition. In addition, histopathological analysis was performed in mice infected with a dose of PR8 virus which was 50% of the lethal dose for mice in the 20-day observation period. DAD with alveolar collapse was observed in all dead mice. However, in the surviving mice, instead of DAD, glandular metaplasia was broadly observed in their lungs. The present study indicates that DAD with severe alveolar collapse is associated with death in this mouse infection model of influenza virus. Inhibition of the development of DAD with alveolar collapse may decrease the mortality rate in severe viral pneumonia caused by influenza virus infection.	[Fukushi, Masaya; Oka, Teruaki; Kudo, Koichiro] Ctr Dis Control & Prevent, Natl Ctr Global Hlth & Med, Tokyo, Japan; [Fukushi, Masaya; Miyoshi-Akiyama, Tohru; Kirikae, Teruo] Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Tokyo, Japan; [Ito, Tateki; Kitazawa, Toshio] Natl Ctr Global Hlth & Med, Dept Diagnost Pathol, Tokyo, Japan; [Oka, Teruaki] Kanto Cent Hosp, Dept Pathol, Tokyo, Japan; [Yamashita, Makoto] Daiichi Sankyo Co Ltd, Biol Res Labs, Tokyo, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Daiichi Sankyo Company Limited	Fukushi, M (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Global Hlth & Med, Tokyo, Japan.	mfukushi@ri.ncgm.go.jp			Founding Research Centers for Emerging and Reemerging Infectious Diseases; Ministry of Education, Culture, Sports, Science and Technology of Japan	Founding Research Centers for Emerging and Reemerging Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by The Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHBAUGH DG, 1967, LANCET, V2, P319; Barnard DL, 2009, ANTIVIR RES, V82, pA110, DOI 10.1016/j.antiviral.2008.12.014; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P435, DOI DOI 10.1007/S00134-010-2021-3; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Deng GC, 2010, ARCH VIROL, V155, P187, DOI 10.1007/s00705-009-0560-0; Esteban A, 2004, ANN INTERN MED, V141, P440, DOI 10.7326/0003-4819-141-6-200409210-00009; Garigliany MM, 2010, EMERG INFECT DIS, V16, P595, DOI 10.3201/eid1604.091061; Gingrich JR, 1996, CANCER RES, V56, P4096; Gold WM, 2000, TXB RESP MED, P781; Greene KE, 1999, AM J RESP CRIT CARE, V160, P1843, DOI 10.1164/ajrccm.160.6.9901117; Griese M, 1999, EUR RESPIR J, V13, P1455, DOI 10.1183/09031936.99.13614779; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Katzenstein A., 2006, SURG PATHOLOGY NONNE; Kubo S, 2010, ANTIMICROB AGENTS CH, V54, P1256, DOI 10.1128/AAC.01311-09; Liem NT, 2008, JPN J INFECT DIS, V61, P157; Lucattelli M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-83; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; OKUNO Y, 1994, J VIROL, V68, P517, DOI 10.1128/JVI.68.1.517-520.1994; Pan TL, 2002, AM J PHYSIOL-LUNG C, V282, pL824, DOI 10.1152/ajplung.00421.2000; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Tomashefski JF, 2000, CLIN CHEST MED, V21, P435, DOI 10.1016/S0272-5231(05)70158-1; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; *WHO, WHO PAN H1N1 2009 UP; *WHO, WHO AV INFL REP; Xu T, 2006, AM J RESP CRIT CARE, V174, P1011, DOI 10.1164/rccm.200511-1751OC	35	59	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21207	10.1371/journal.pone.0021207	http://dx.doi.org/10.1371/journal.pone.0021207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701593	Green Published, Green Submitted, gold			2022-12-25	WOS:000291983800032
J	Muregi, FW; Ohta, I; Masato, U; Kino, H; Ishih, A				Muregi, Francis W.; Ohta, Isao; Masato, Uchijima; Kino, Hideto; Ishih, Akira			Resistance of a Rodent Malaria Parasite to a Thymidylate Synthase Inhibitor Induces an Apoptotic Parasite Death and Imposes a Huge Cost of Fitness	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; HUMAN-IMMUNODEFICIENCY-VIRUS; PLASMODIUM-FALCIPARUM MALARIA; DIHYDROFOLATE-REDUCTASE; CHLOROQUINE SENSITIVITY; DRUG-RESISTANCE; IN-VIVO; PYRIMETHAMINE RESISTANCE; CYTOCHROME-B; ANTIBIOTIC-RESISTANCE	Background: The greatest impediment to effective malaria control is drug resistance in Plasmodium falciparum, and thus understanding how resistance impacts on the parasite's fitness and pathogenicity may aid in malaria control strategy. Methodology/Principal Findings: To generate resistance, P. berghei NK65 was subjected to 5-fluoroorotate (FOA, an inhibitor of thymidylate synthase, TS) pressure in mice. After 15 generations of drug pressure, the 2% DT (the delay time for proliferation of parasites to 2% parasitaemia, relative to untreated wild-type controls) reduced from 8 days to 4, equalling the controls. Drug sensitivity studies confirmed that FOA-resistance was stable. During serial passaging in the absence of drug, resistant parasite maintained low growth rates (parasitaemia, 15.5%+/- 2.9, 7 dpi) relative to the wild-type (45.6%+/- 8.4), translating into resistance cost of fitness of 66.0%. The resistant parasite showed an apoptosis-like death, as confirmed by light and transmission electron microscopy and corroborated by oligonucleosomal DNA fragmentation. Conclusions/Significance: The resistant parasite was less fit than the wild-type, which implies that in the absence of drug pressure in the field, the wild-type alleles may expand and allow drugs withdrawn due to resistance to be reintroduced. FOA resistance led to depleted dTTP pools, causing thymineless parasite death via apoptosis. This supports the tenet that unicellular eukaryotes, like metazoans, also undergo apoptosis. This is the first report where resistance to a chemical stimulus and not the stimulus itself is shown to induce apoptosis in a unicellular parasite. This finding is relevant in cancer therapy, since thymineless cell death induced by resistance to TS-inhibitors can further be optimized via inhibition of pyrimidine salvage enzymes, thus providing a synergistic impact. We conclude that since apoptosis is a process that can be pharmacologically modulated, the parasite's apoptotic machinery may be exploited as a novel drug target in malaria and other protozoan diseases of medical importance.	[Muregi, Francis W.; Masato, Uchijima; Ishih, Akira] Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka 4313192, Japan; [Muregi, Francis W.] Kenya Med Res Inst KEMRI, Ctr Biotechnol Res & Dev, Nairobi, Kenya; [Ohta, Isao] Hamamatsu Univ Sch Med, Res Equipment Ctr, Lab Ultrastruct Res, Hamamatsu, Shizuoka 4313192, Japan; [Kino, Hideto] Hamamatsu Univ Sch Med, Inst Expt Anim, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Kenya Medical Research Institute; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Muregi, FW (corresponding author), Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka 4313192, Japan.	fmuregi@kemri.org			Japan Society for the Promotion of Science (JSPS) [21.09136]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The Japan Society for the Promotion of Science (JSPS) financially supported this work through the Postdoctoral Fellowship for Foreign Researchers program (Grant-in-Aid for Scientific Research No. 21.09136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Muhsin AMA, 2004, J INFECT DIS, V189, P1239, DOI 10.1086/382509; Abend M, 1998, J PATHOL, V185, P419; Akompong T, 1999, MOL BIOCHEM PARASIT, V101, P71, DOI 10.1016/S0166-6851(99)00056-0; Al-Olayan EM, 2002, INT J PARASITOL, V32, P1133, DOI 10.1016/S0020-7519(02)00087-5; Allen RT, 1997, J PHARMACOL TOX MET, V37, P215, DOI 10.1016/S1056-8719(97)00033-6; ARENDS MJ, 1994, AM J PATHOL, V144, P1045; Arnot DE, 1998, ANN TROP MED PARASIT, V92, P361, DOI 10.1080/00034989859357; AYUSAWA D, 1983, J BIOL CHEM, V258, P2448; Babiker HA, 2005, ACTA TROP, V94, P260, DOI 10.1016/j.actatropica.2005.04.007; Baton Luke A., 2008, P74, DOI 10.1007/978-0-387-76717-8_7; Benoit-Vical F, 2007, ANTIMICROB AGENTS CH, V51, P1463, DOI 10.1128/AAC.00967-06; Bhowmick IP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-179; Bjorkman J, 2000, DRUG RESIST UPDATE, V3, P237, DOI 10.1054/drup.2000.0147; Bjorkman J, 1998, P NATL ACAD SCI USA, V95, P3949, DOI 10.1073/pnas.95.7.3949; Borman AM, 1996, J GEN VIROL, V77, P419, DOI 10.1099/0022-1317-77-3-419; Brown AJL, 2003, J INFECT DIS, V187, P683, DOI 10.1086/367989; BURSCH W, 1990, BIOCHEM CELL BIOL, V68, P1071, DOI 10.1139/o90-160; Cheng Q, 1997, AM J TROP MED HYG, V57, P495, DOI 10.4269/ajtmh.1997.57.495; Chose O, 2003, ANN NY ACAD SCI, V1010, P121, DOI 10.1196/annals.1299.021; CHU E, 1994, J BIOL CHEM, V269, P20289; CORNILLON S, 1994, J CELL SCI, V107, P2691; COWMAN AF, 1988, P NATL ACAD SCI USA, V85, P9109, DOI 10.1073/pnas.85.23.9109; CURTIN NJ, 1991, CANCER RES, V51, P2346; De Souza EM, 2006, PARASITOLOGY, V133, P75, DOI 10.1017/S0031182006000084; Deponte M, 2004, TRENDS PARASITOL, V20, P165, DOI 10.1016/j.pt.2004.01.012; FISHER TC, 1993, CANCER RES, V53, P3321; Fohl LM, 2003, MOL MICROBIOL, V50, P1319, DOI 10.1046/j.1365-2958.2003.03756.x; FOOTE SJ, 1990, P NATL ACAD SCI USA, V87, P3014, DOI 10.1073/pnas.87.8.3014; Franke-Fayard B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001032; Garrity MM, 2003, MODERN PATHOL, V16, P389, DOI 10.1097/01.MP.0000062657.30170.92; Gatton ML, 2001, PARASITOLOGY, V123, P537, DOI 10.1017/S0031182001008824; Giha HA, 2006, ACTA TROP, V97, P181, DOI 10.1016/j.actatropica.2005.10.004; Grech K, 2006, J EVOLUTION BIOL, V19, P1620, DOI 10.1111/j.1420-9101.2006.01116.x; Gregson A, 2005, PHARMACOL REV, V57, P117, DOI 10.1124/pr.57.1.4; GUTTERIDGE WE, 1970, J PROTOZOOL, V17, P89, DOI 10.1111/j.1550-7408.1970.tb05163.x; Haldar Kasturi, 2001, P27; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hastings IM, 2006, TRENDS PARASITOL, V22, P71, DOI 10.1016/j.pt.2005.12.011; Hastings IM, 2003, TRENDS PARASITOL, V19, P70, DOI 10.1016/S1471-4922(02)00017-X; Hayward R, 2005, MOL MICROBIOL, V55, P1285, DOI 10.1111/j.1365-2958.2004.04470.x; Holzmuller P, 2002, INFECT IMMUN, V70, P3727, DOI 10.1128/IAI.70.7.3727-3735.2002; HOWIE SEM, 1994, CLIN EXP IMMUNOL, V95, P195; Huong NM, 2003, CLIN INFECT DIS, V37, P1461, DOI 10.1086/379323; Huong NM, 2001, T ROY SOC TROP MED H, V95, P325, DOI 10.1016/S0035-9203(01)90254-8; IVANETICH KM, 1990, FASEB J, V4, P1591, DOI 10.1096/fasebj.4.6.2180768; Jackman AL, 1995, ANN ONCOL, V6, P871, DOI 10.1093/oxfordjournals.annonc.a059353; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kempe DS, 2007, J MOL MED-JMM, V85, P269, DOI 10.1007/s00109-006-0123-8; KERR JFR, 1994, CANCER-AM CANCER SOC, V73, P2013, DOI 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J; Kim R, 2002, CANCER CHEMOTH PHARM, V50, P343, DOI 10.1007/s00280-002-0522-7; Kobayashi T, 2003, CELL DEATH DIFFER, V10, P634, DOI 10.1038/sj.cdd.4401216; Korsinczky M, 2000, ANTIMICROB AGENTS CH, V44, P2100, DOI 10.1128/AAC.44.8.2100-2108.2000; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Lang KS, 2005, CELL PHYSIOL BIOCHEM, V15, P195, DOI 10.1159/000086406; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; Lauer SA, 1997, SCIENCE, V276, P1122, DOI 10.1126/science.276.5315.1122; Levin BR, 2000, GENETICS, V154, P985; LINES JD, 1991, PARASITOLOGY, V102, P167, DOI 10.1017/S0031182000062454; LIU DQ, 1995, B WORLD HEALTH ORGAN, V73, P483; *LMRG, P BERGH MOD MAL; Lu J, 2004, J VIROL, V78, P4628, DOI 10.1128/JVI.78.9.4628-4637.2004; Mackinnon MJ, 2004, PLOS BIOL, V2, P1286, DOI 10.1371/journal.pbio.0020230; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; Massimine KM, 2006, ANTIMICROB AGENTS CH, V50, P3132, DOI 10.1128/AAC.00621-06; McGuire JJ, 2003, CURR PHARM DESIGN, V9, P2593, DOI 10.2174/1381612033453712; Meslin B, 2007, J INFECT DIS, V195, P1852, DOI 10.1086/518253; Mita T, 2003, AM J TROP MED HYG, V68, P413, DOI 10.4269/ajtmh.2003.68.413; Mita T, 2004, MOL BIOCHEM PARASIT, V135, P159, DOI 10.1016/j.molbiopara.2004.01.011; Muller A, 1996, INFECT IMMUN, V64, P4900; Muregi FW, 2008, EXP PARASITOL, V120, P286, DOI 10.1016/j.exppara.2008.08.006; Muregi FW, 2007, PHYTOTHER RES, V21, P337, DOI 10.1002/ptr.2067; Nagaev I, 2001, MOL MICROBIOL, V40, P433, DOI 10.1046/j.1365-2958.2001.02389.x; Nasirudeen AMA, 2004, MICROBIOL-SGM, V150, P33, DOI 10.1099/mic.0.26496-0; NEWBOLD CI, 1982, MOL BIOCHEM PARASIT, V5, P33, DOI 10.1016/0166-6851(82)90004-4; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; OBERHAMMER F, 1993, EMBO J, V12, P3679, DOI 10.1002/j.1460-2075.1993.tb06042.x; Peters GJ, 2000, EUR J CANCER, V36, P916, DOI 10.1016/S0959-8049(00)00026-5; Peters JM, 2002, ANTIMICROB AGENTS CH, V46, P2435, DOI 10.1128/AAC.46.8.2435-2441.2002; Peters W, 2000, ANN TROP MED PARASIT, V94, P23, DOI 10.1080/00034980057581; Peters W, 1999, ANN TROP MED PARASIT, V93, P325, DOI 10.1080/00034989958320; PETERSON DS, 1988, P NATL ACAD SCI USA, V85, P9114, DOI 10.1073/pnas.85.23.9114; Picot S, 1997, T ROY SOC TROP MED H, V91, P590, DOI 10.1016/S0035-9203(97)90039-0; Ramos E, 2007, EXP PARASITOL, V116, P257, DOI 10.1016/j.exppara.2007.01.011; RATHOD PK, 1992, ANTIMICROB AGENTS CH, V36, P704, DOI 10.1128/AAC.36.4.704; RATHOD PK, 1994, ANTIMICROB AGENTS CH, V38, P2871, DOI 10.1128/AAC.38.12.2871; RATHOD PK, 1991, EXP PARASITOL, V73, P512, DOI 10.1016/0014-4894(91)90075-8; RATHOD PK, 1989, ANTIMICROB AGENTS CH, V33, P1090, DOI 10.1128/AAC.33.7.1090; Totino PRR, 2008, EXP PARASITOL, V118, P478, DOI 10.1016/j.exppara.2007.10.017; ROSARIO VE, 1978, LANCET, V1, P185; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; SCHETTERS TPM, 1988, PARASITOL RES, V75, P69, DOI 10.1007/BF00931194; Scheuerlein R, 1995, J PHOTOCH PHOTOBIO B, V31, P113, DOI 10.1016/1011-1344(95)07186-5; Schlitzer M, 2007, CHEMMEDCHEM, V2, P944, DOI 10.1002/cmdc.200600240; Schneider P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-257; Schrag SJ, 1996, NATURE, V381, P120, DOI 10.1038/381120b0; SHINONDO CJ, 1994, EXP PARASITOL, V78, P194, DOI 10.1006/expr.1994.1019; Srivastava IK, 1999, MOL MICROBIOL, V33, P704, DOI 10.1046/j.1365-2958.1999.01515.x; Stein WD, 2009, TRENDS PARASITOL, V25, P441, DOI 10.1016/j.pt.2009.07.003; THAITHONG S, 1988, T ROY SOC TROP MED H, V82, P37, DOI 10.1016/0035-9203(88)90255-6; Thanh NV, 2001, T ROY SOC TROP MED H, V95, P513, DOI 10.1016/S0035-9203(01)90023-9; Van Triest B, 2000, ANN ONCOL, V11, P385, DOI 10.1023/A:1008351221345; Vardi A, 1999, CURR BIOL, V9, P1061, DOI 10.1016/S0960-9822(99)80459-X; Villalba JD, 2007, MICROBIOL-SGM, V153, P3852, DOI 10.1099/mic.0.2007/008599-0; *WAK, NIPP GEN WAK 2009 20; Walliker D, 2005, TRENDS PARASITOL, V21, P489, DOI 10.1016/j.pt.2005.08.017; Walliker D, 2005, ACTA TROP, V94, P251, DOI 10.1016/j.actatropica.2005.04.005; Wang XH, 2005, AM J TROP MED HYG, V72, P410, DOI 10.4269/ajtmh.2005.72.410; Welburn SC, 1997, PARASITOL TODAY, V13, P22, DOI 10.1016/S0169-4758(96)10076-4; Wu YM, 2003, GENOME RES, V13, P601, DOI 10.1101/gr.913403; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YIN MB, 1992, CANCER RES, V52, P5900; Yuvaniyama J, 2003, NAT STRUCT BIOL, V10, P357, DOI 10.1038/nsb921; Zhang K, 2002, SCIENCE, V296, P545, DOI 10.1126/science.1068274	114	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21251	10.1371/journal.pone.0021251	http://dx.doi.org/10.1371/journal.pone.0021251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698180	Green Submitted, Green Published, gold			2022-12-25	WOS:000291734100075
J	Williams, TA; Embley, TM; Heinz, E				Williams, Tom A.; Embley, T. Martin; Heinz, Eva			Informational Gene Phylogenies Do Not Support a Fourth Domain of Life for Nucleocytoplasmic Large DNA Viruses	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PROTEIN EVOLUTION; MIXTURE-MODELS; ORIGIN; TREE; RECONSTRUCTION; HYDROGENOSOMES; MICROSPORIDIA; SELECTION; PROVIDES	Mimivirus is a nucleocytoplasmic large DNA virus (NCLDV) with a genome size (1.2 Mb) and coding capacity (> 1000 genes) comparable to that of some cellular organisms. Unlike other viruses, Mimivirus and its NCLDV relatives encode homologs of broadly conserved informational genes found in Bacteria, Archaea, and Eukaryotes, raising the possibility that they could be placed on the tree of life. A recent phylogenetic analysis of these genes showed the NCLDVs emerging as a monophyletic group branching between Eukaryotes and Archaea. These trees were interpreted as evidence for an independent "fourth domain" of life that may have contributed DNA processing genes to the ancestral eukaryote. However, the analysis of ancient evolutionary events is challenging, and tree reconstruction is susceptible to bias resulting from non-phylogenetic signals in the data. These include compositional heterogeneity and homoplasy, which can lead to the spurious grouping of compositionally-similar or fast-evolving sequences. Here, we show that these informational gene alignments contain both significant compositional heterogeneity and homoplasy, which were not adequately modelled in the original analysis. When we use more realistic evolutionary models that better fit the data, the resulting trees are unable to reject a simple null hypothesis in which these informational genes, like many other NCLDV genes, were acquired by horizontal transfer from eukaryotic hosts. Our results suggest that a fourth domain is not required to explain the available sequence data.	[Williams, Tom A.; Embley, T. Martin; Heinz, Eva] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Williams, TA (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	eva.heinz@ncl.ac.uk	Heinz, Eva/I-2053-2014	Heinz, Eva/0000-0003-4413-3756; Williams, Tom/0000-0003-1072-0223; Embley, Thomas Martin/0000-0002-1484-340X	Royal Society	Royal Society(Royal Society of London)	This work was supported by a Royal Society Wolfson Research Merit Award (http://royalsociety.org/,502011.K631/bcw), to TME and a Marie Curie postdoctoral fellowship (http://cordis.europa.eu/fp7/home_en.html) to EH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Blanquart S, 2008, MOL BIOL EVOL, V25, P842, DOI 10.1093/molbev/msn018; Bollback JP, 2002, MOL BIOL EVOL, V19, P1171, DOI 10.1093/oxfordjournals.molbev.a004175; Boyer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015530; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cox CJ, 2008, P NATL ACAD SCI USA, V105, P20356, DOI 10.1073/pnas.0810647105; Dagan T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-118; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Embley TM, 2003, PHILOS T R SOC B, V358, P191, DOI 10.1098/rstb.2002.1190; EMBLEY TM, 1993, SYST APPL MICROBIOL, V16, P25; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Filee J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-320; Forterre P, 2006, P NATL ACAD SCI USA, V103, P3669, DOI 10.1073/pnas.0510333103; Foster PG, 2004, SYST BIOL, V53, P485, DOI 10.1080/10635150490445779; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Holland BR, 2006, MOL BIOL EVOL, V23, P848, DOI 10.1093/molbev/msj061; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; La Scola B, 2003, SCIENCE, V299, P2033; LAKE JA, 1984, P NATL ACAD SCI-BIOL, V81, P3786, DOI 10.1073/pnas.81.12.3786; LAKEJA, 1994, P NATL ACAD SCI USA, V91, P1455; Landan G, 2007, MOL BIOL EVOL, V24, P1380, DOI 10.1093/molbev/msm060; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Le SQ, 2008, PHILOS T R SOC B, V363, P3965, DOI 10.1098/rstb.2008.0180; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Miyamoto MM, 1996, SYST BIOL, V45, P568, DOI 10.2307/2413532; Mooers AO, 2000, TRENDS ECOL EVOL, V15, P365, DOI 10.1016/S0169-5347(00)01934-0; Moreira D, 2005, SCIENCE, V308, DOI 10.1126/science.1110820; Moreira D, 2000, MOL MICROBIOL, V35, P1, DOI 10.1046/j.1365-2958.2000.01692.x; Moreira D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-12; Moreira D, 2009, NAT REV MICROBIOL, V7, P306, DOI 10.1038/nrmicro2108; Nielsen R, 2002, SYST BIOL, V51, P729, DOI 10.1080/10635150290102393; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Philippe H, 2000, P ROY SOC B-BIOL SCI, V267, P1213, DOI 10.1098/rspb.2000.1130; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Quang LS, 2008, BIOINFORMATICS, V24, P2317, DOI 10.1093/bioinformatics/btn445; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Raoult D, 2008, NAT REV MICROBIOL, V6, P315, DOI 10.1038/nrmicro1858; Rivera MC, 2004, NATURE, V431, P152, DOI 10.1038/nature02848; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Susko E, 2007, MOL BIOL EVOL, V24, P2139, DOI 10.1093/molbev/msm144; VOSSBRINCK CR, 1987, NATURE, V326, P411, DOI 10.1038/326411a0; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088	55	57	58	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21080	10.1371/journal.pone.0021080	http://dx.doi.org/10.1371/journal.pone.0021080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698163	Green Published, Green Submitted, gold			2022-12-25	WOS:000291734100052
J	Ferreira, ME; Flaherty, K; Prochasson, P				Ferreira, Monica E.; Flaherty, Kacie; Prochasson, Philippe			The Saccharomyces cerevisiae Histone Chaperone Rtt106 Mediates the Cell Cycle Recruitment of SWI/SNF and RSC to the HIR-Dependent Histone Genes	PLOS ONE			English	Article							IN-VIVO; TRANSCRIPTIONAL REPRESSORS; REMODELING COMPLEX; CHROMATIN; YEAST; IDENTIFICATION; PROMOTERS; SUBUNITS; REVEALS; DOMAINS	Background: In Saccharomyces cerevisiae, three out of the four histone gene pairs (HTA1-HTB1, HHT1-HHF1, and HHT2-HHF2) are regulated by the HIR co-repressor complex. The histone chaperone Rtt106 has recently been shown to be present at these histone gene loci throughout the cell cycle in a HIR- and Asf1-dependent manner and involved in their transcriptional repression. The SWI/SNF and RSC chromatin remodeling complexes are both recruited to the HIR-dependent histone genes; SWI/SNF is required for their activation in S phase, whereas RSC is implicated in their repression outside of S phase. Even though their presence at the histone genes is dependent on the HIR complex, their specific recruitment has not been well characterized. In this study we focused on characterizing the role played by the histone chaperone Rtt106 in the cell cycle-dependent recruitment of SWI/SNF and RSC complexes to the histone genes. Methodology/Principal Findings: Using GST pull-down and co-immunoprecipitation assays, we showed that Rtt106 physically interacts with both the SWI/SNF and RSC complexes in vitro and in vivo. We then investigated the function of this interaction with respect to the recruitment of these complexes to HIR-dependent histone genes. Using chromatin immunoprecipitation assays (ChIP), we found that Rtt106 is important for the recruitment of both SWI/SNF and RSC complexes to the HIR-dependent histone genes. Furthermore, using synchronized cell cultures, we showed by ChIP assays that the Rtt106-dependent SWI/SNF recruitment to these histone gene loci is cell cycle regulated and restricted to late G1 phase just before the peak of histone gene expression in S phase. Conclusions/Significance: Overall, these data strongly suggest that the interaction between the histone chaperone Rtt106 and both the SWI/SNF and RSC chromatin remodeling complexes is important for the cell cycle regulated recruitment of these two complexes to the HIR-dependent histone genes.	[Ferreira, Monica E.; Flaherty, Kacie; Prochasson, Philippe] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Ferreira, ME (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	pprochasson@kumc.edu			K-INBRE [P20 RR016475]; Kansas Bioscience Authority (KBA); Kansas Medical Center Research Institute (KMCRI); Leukemia and Lymphoma Society; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	K-INBRE; Kansas Bioscience Authority (KBA); Kansas Medical Center Research Institute (KMCRI); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a K-INBRE grant (P20 RR016475), the Kansas Bioscience Authority (KBA), the Kansas Medical Center Research Institute (KMCRI), and the Leukemia and Lymphoma Society Special Fellowship to PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Anderson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013488; Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; Balaji S, 2009, MOL BIOSYST, V5, P269, DOI 10.1039/b816424j; Banumathy G, 2009, MOL CELL BIOL, V29, P758, DOI 10.1128/MCB.01047-08; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dimova D, 1999, MOL CELL, V4, P75, DOI 10.1016/S1097-2765(00)80189-6; ERIKSSON PR, 2010, MOL CELL BIOL; Ferreira ME, 2009, FEBS J, V276, P2557, DOI 10.1111/j.1742-4658.2009.06979.x; Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015; Fillingham J, 2009, MOL CELL, V35, P340, DOI 10.1016/j.molcel.2009.06.023; FREEMAN KB, 1992, MOL CELL BIOL, V12, P5455, DOI 10.1128/MCB.12.12.5455; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Graumann J, 2004, MOL CELL PROTEOMICS, V3, P226, DOI 10.1074/mcp.M300099-MCP200; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Gunjan A, 2005, BIOCHIMIE, V87, P625, DOI 10.1016/j.biochi.2005.02.008; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; Imbeault D, 2008, J BIOL CHEM, V283, P27350, DOI 10.1074/jbc.C800147200; LAMOUR V, 1995, HUM MOL GENET, V4, P791, DOI 10.1093/hmg/4.5.791; Lee KK, 2004, BIOCHEM SOC T, V32, P899, DOI 10.1042/BST0320899; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MORAN L, 1994, FACTORS INVOLVED TEM; Neely KE, 2002, MOL CELL BIOL, V22, P1615, DOI 10.1128/MCB.22.6.1615-1625.2002; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; OSLEY MA, 1986, CELL, V45, P537, DOI 10.1016/0092-8674(86)90285-0; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; OSLEY MA, 1987, MOL CELL BIOL, V7, P4204, DOI 10.1128/MCB.7.12.4204; Prochasson P, 2005, GENE DEV, V19, P2534, DOI 10.1101/gad.1341105; Prochasson P, 2003, MOL CELL, V12, P983, DOI 10.1016/S1097-2765(03)00366-6; Sharma VM, 2003, GENE DEV, V17, P502, DOI 10.1101/gad.1039503; Spector MS, 1997, MOL CELL BIOL, V17, P545, DOI 10.1128/MCB.17.2.545; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Sutton A, 2001, GENETICS, V158, P587; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; XU HX, 1992, MOL CELL BIOL, V12, P5249, DOI 10.1128/MCB.12.11.5249	37	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21113	10.1371/journal.pone.0021113	http://dx.doi.org/10.1371/journal.pone.0021113			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698254	Green Published, gold, Green Submitted			2022-12-25	WOS:000291730000054
J	Farabaugh, SM; Micalizzi, DS; Jedlicka, P; Zhao, R; Ford, HL				Farabaugh, S. M.; Micalizzi, D. S.; Jedlicka, P.; Zhao, R.; Ford, H. L.			Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-beta signaling, epithelial-mesenchymal transition, and cancer stem cell properties	ONCOGENE			English	Article						Six1; Eya; TGF-beta; epithelial-mesenchymal transition; cancer stem cells	BRANCHIOOTORENAL BOR SYNDROME; HOMEOBOX GENE-EXPRESSION; EYES-ABSENT; BREAST-CANCER; HOMEOPROTEIN SIX1; CARCINOMA CELLS; COFACTOR EYA2; TUMOR-GROWTH; MUTATIONS; PROTEIN	Six1 is a critical regulator of embryonic development that requires interaction with the Eya family of proteins (Eya1-4) to activate the transcription of genes involved in neurogenesis, myogenesis and nephrogenesis. Although expression of Six1 and Eya family members is predominantly observed in development, their overexpression is observed in numerous cancers. Importantly, both Six1 and Eya have independently been shown to mediate breast cancer metastasis, but whether they functionally interact during tumor progression has not been explored. Herein, we demonstrate that knockdown of Eya2 in MCF7 mammary carcinoma cells reverses the ability of Six1 to induce transforming growth factor-beta signaling, as well as to induce characteristics associated with epithelial-mesenchymal transition and cancer stem cells, suggesting that Six1 is dependent on Eya2 to mediate numerous pro-metastatic characteristics. The importance of the Six1-Eya interaction in human breast cancer is underscored by the finding that high levels of Six1 correlate with shortened time to relapse and metastasis as well as decreased survival only when co-expressed with high levels of Eya2. Overall, these data implicate Eya2 as a necessary co-factor for many of the metastasis promoting functions of Six1, suggesting that targeting the Six1-Eya interaction may inhibit breast cancer progression. As Six1 and Eya2 are not highly expressed in most adult tissues, the Six1-Eya interaction may be a valuable future therapeutic target whose inhibition would be expected to impair breast cancer progression while conferring limited side effects. Oncogene (2012) 31, 552-562; doi:10.1038/onc.2011.259; published online 27 June 2011	[Ford, H. L.] Univ Colorado, Sch Med, Dept Obstet & Gynecol, Aurora, CO 80045 USA; [Farabaugh, S. M.; Zhao, R.; Ford, H. L.] Univ Colorado, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Micalizzi, D. S.; Ford, H. L.] Univ Colorado, Program Mol Biol, Aurora, CO 80045 USA; [Micalizzi, D. S.; Ford, H. L.] Univ Colorado, Med Scientist Training Program, Aurora, CO 80045 USA; [Jedlicka, P.] Univ Colorado, Dept Pathol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Ford, HL (corresponding author), Univ Colorado, Sch Med, Dept Obstet & Gynecol, Anschutz Med Campus,RC1 N,Room 5102, Aurora, CO 80045 USA.	heide.ford@ucdenver.edu		Micalizzi, Douglas/0000-0002-0306-9914	National Cancer Institute [2RO1-CA095277]; American Cancer Society [RSG-07-183-01-DDC]; Department of Defense [BC084105, W81XWH-08-1-0332, W81XWH-06-1-0757]; NATIONAL CANCER INSTITUTE [R01CA157790, R01CA095277] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by grants from the National Cancer Institute (2RO1-CA095277) and the American Cancer Society (#RSG-07-183-01-DDC) to HLF, and the Department of Defense Breast Cancer Synergistic Idea Award (BC084105) to HLF and RZ. SMF and DSM were funded by predoctoral fellowships from the Department of Defense Breast Cancer Research Program (W81XWH-08-1-0332 and W81XWH-06-1-0757, respectively). We would like to thank Alana Welm for training in microarray datamining techniques, database sharing and helpful datamining discussions, and Katherine Martin, of Bioarray Therapeutics, for data analysis of the Wang data set.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Abdelhak S, 1997, HUM MOL GENET, V6, P2247, DOI 10.1093/hmg/6.13.2247; Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ando Z, 2005, FEBS J, V272, P3026, DOI 10.1111/j.1742-4658.2005.04716.x; Behbakht K, 2007, CANCER RES, V67, P3036, DOI 10.1158/0008-5472.CAN-06-3755; Cillo C, 1999, EXP CELL RES, V248, P1, DOI 10.1006/excr.1999.4451; Coletta RD, 2004, P NATL ACAD SCI USA, V101, P6478, DOI 10.1073/pnas.0401139101; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Embry AC, 2004, MOL PHARMACOL, V66, P1325, DOI 10.1124/mol.104.004093; Fan XM, 2000, J BIOL CHEM, V275, P32129, DOI 10.1074/jbc.M004577200; Ford HL, 1998, CELL BIOL INT, V22, P397, DOI 10.1006/cbir.1998.0329; Ford HL, 1998, P NATL ACAD SCI USA, V95, P12608, DOI 10.1073/pnas.95.21.12608; Ford HL, 2000, J BIOL CHEM, V275, P22245, DOI 10.1074/jbc.M002446200; Harrell JC, 2006, CANCER RES, V66, P9308, DOI 10.1158/0008-5472.CAN-06-1769; Jemc J, 2007, DEV BIOL, V310, P416, DOI 10.1016/j.ydbio.2007.07.024; Kochhar A, 2008, HUM MUTAT, V29, P565, DOI 10.1002/humu.20714; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krishnan N, 2009, J BIOL CHEM, V284, P16066, DOI 10.1074/jbc.C900032200; Laclef C, 2003, MECH DEVELOP, V120, P669, DOI 10.1016/S0925-4773(03)00065-0; Laclef C, 2003, DEVELOPMENT, V130, P2239, DOI 10.1242/dev.00440; Li CM, 2002, AM J PATHOL, V160, P2181, DOI 10.1016/S0002-9440(10)61166-2; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCoy EL, 2009, J CLIN INVEST, V119, P2663, DOI 10.1172/JCI37691; Micalizzi DS, 2010, CANCER RES, V70, P10371, DOI 10.1158/0008-5472.CAN-10-1354; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; Miller SJ, 2010, ONCOGENE, V29, P368, DOI 10.1038/onc.2009.360; Ng KT, 2006, BRIT J CANCER, V95, P1050, DOI 10.1038/sj.bjc.6603399; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Orten DJ, 2008, HUM MUTAT, V29, P537, DOI 10.1002/humu.20691; Osborn NK, 2006, CLIN GASTROENTEROL H, V4, P212, DOI 10.1016/j.cgh.2005.11.009; Ouyang GL, 2010, CELL MOL LIFE SCI, V67, P2605, DOI 10.1007/s00018-010-0338-2; Pandey RN, 2010, ONCOGENE, V29, P3715, DOI 10.1038/onc.2010.122; Patrick AN, 2009, J BIOL CHEM, V284, P20781, DOI 10.1074/jbc.M109.016832; Reichenberger KJ, 2005, CANCER RES, V65, P2668, DOI 10.1158/0008-5472.CAN-04-4286; Ruf RG, 2004, P NATL ACAD SCI USA, V101, P8090, DOI 10.1073/pnas.0308475101; Samuel S, 2005, EUR J CANCER, V41, P2428, DOI 10.1016/j.ejca.2005.08.014; Schonberger J, 2005, NAT GENET, V37, P418, DOI 10.1038/ng1527; Shtutman M, 2006, CANCER RES, V66, P11370, DOI 10.1158/0008-5472.CAN-06-2106; Taylor MA, 2010, J MAMMARY GLAND BIOL, V15, P169, DOI 10.1007/s10911-010-9181-1; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vincent C, 1997, EUR J HUM GENET, V5, P242, DOI 10.1159/000484770; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wayne S, 2001, HUM MOL GENET, V10, P195, DOI 10.1093/hmg/10.3.195; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Xiong WJ, 2009, DEV CELL, V16, P271, DOI 10.1016/j.devcel.2008.12.005; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Xu PX, 2003, DEVELOPMENT, V130, P3085, DOI 10.1242/dev.00536; Xu PX, 2002, DEVELOPMENT, V129, P3033; Yu YL, 2006, CANCER RES, V66, P1982, DOI 10.1158/0008-5472.CAN-05-2360; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zhang L, 2005, CANCER RES, V65, P925; Zhang YZ, 2004, JARO-J ASSOC RES OTO, V5, P295, DOI 10.1007/s10162-004-4044-3; Zheng XH, 2010, INT J GYNECOL CANCER, V20, P1587, DOI 10.1111/IGC.0b013e3181f9defb; Zou HZ, 2005, CANCER EPIDEM BIOMAR, V14, P830, DOI 10.1158/1055-9965.EPI-04-0506	57	91	97	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2012	31	5					552	562		10.1038/onc.2011.259	http://dx.doi.org/10.1038/onc.2011.259			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MS	21706047	Green Accepted			2022-12-25	WOS:000300221800002
J	Li, H; Wittwer, T; Weber, A; Schneider, H; Moreno, R; Maine, GN; Kracht, M; Schmitz, ML; Burstein, E				Li, H.; Wittwer, T.; Weber, A.; Schneider, H.; Moreno, R.; Maine, G. N.; Kracht, M.; Schmitz, M. L.; Burstein, E.			Regulation of NF-kappa B activity by competition between RelA acetylation and ubiquitination	ONCOGENE			English	Article						NF-kappa B; RelA; p65; acetylation; ubiquitination; transcription	TRANSCRIPTION FACTOR; DEPENDENT TRANSCRIPTION; CANCER DEVELOPMENT; P65 SUBUNIT; PHOSPHORYLATION; ACTIVATION; ALPHA; INFLAMMATION; DEGRADATION; PROGRESSION	The nuclear factor (NF)-kappa B transcription factor has essential roles in inflammation and oncogenesis. Its ubiquitous RelA subunit is regulated by several post-translational modifications, including phosphorylation, ubiquitination and acetylation. Ubiquitination promotes the termination of RelA-dependent transcription, but its regulation is incompletely understood. Through mass spectrometry analysis of ubiquitinated RelA, we identified seven lysines that were attached to degradative and non-degradative forms of polyubiquitin. Interestingly, lysines targeted for acetylation were among the residues identified as ubiquitin acceptor sites. Mutation of these particular sites resulted in decreased polyubiquitination. Acetylation and ubiquitination were found to inhibit each other, consistent with their use of overlapping sites. Reconstitution of rela(-/-) fibroblasts with wild-type and mutant forms of RelA revealed that modifications at these residues can have activating and inhibitory functions depending on the target gene context. Altogether, this study elucidates that ubiquitination and acetylation can modulate each other and regulate nuclear NF-kappa B function in a gene-specific manner. Oncogene (2012) 31, 611-623; doi:10.1038/onc.2011.253; published online 27 June 2011	[Li, H.; Burstein, E.] UT SW Med Ctr, Dept Internal Med, Dallas, TX 75230 USA; [Wittwer, T.; Moreno, R.; Schmitz, M. L.] Univ Giessen, Fac Med, Inst Biochem, D-35392 Giessen, Germany; [Weber, A.; Kracht, M.] Univ Giessen, Rudolf Buchheim Inst Pharmacol, D-35392 Giessen, Germany; [Schneider, H.] Hannover Med Sch, Inst Biochem, D-3000 Hannover, Germany; [Maine, G. N.] William Beaumont Hosp, Dept Clin Pathol, Royal Oak, MI 48072 USA; [Burstein, E.] UT SW Med Ctr, Dept Mol Biol, Dallas, TX 75230 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Justus Liebig University Giessen; Justus Liebig University Giessen; Hannover Medical School; Beaumont Health; University of Texas System; University of Texas Southwestern Medical Center Dallas	Burstein, E (corresponding author), UT SW Med Ctr, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75230 USA.	Lienhard.Schmitz@biochemie.med.uni-giessen.de; ezra.burstein@utsouthwestern.edu	Li, Haiying/B-1879-2012; Burstein, Ezra/B-7247-2016; Schmitz, M. Lienhard/D-9328-2017	Burstein, Ezra/0000-0003-4341-6367; Schmitz, M. Lienhard/0000-0002-6984-7192; Kracht, Michael/0000-0002-8501-043X	NIH [R01 DK073639]; CCFA; UTSW DOCS; DFG; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073639] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCFA; UTSW DOCS; DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Zhijian 'James' Chen, Maria S Soengas and Marty W Mayo for providing cell lines that were utilized in these studies. We also thank Doris Newel and Oliver Dittrich for their technical assistance with the microarray experiments. This work was supported by an NIH R01 DK073639, a CCFA Senior Research Award and a UTSW DOCS Award to EB. The work of MLS and MK is supported by grants from the DFG.	BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Buerki C, 2008, NUCLEIC ACIDS RES, V36, P1665, DOI 10.1093/nar/gkn003; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Fan YH, 2009, J BIOL CHEM, V284, P29290, DOI 10.1074/jbc.M109.018994; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Maine Gabriel N, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5318; Maine GN, 2010, NAT PROTOC, V5, P1447, DOI 10.1038/nprot.2010.109; Mao XC, 2009, GENE DEV, V23, P849, DOI 10.1101/gad.1748409; Moreno R, 2010, NUCLEIC ACIDS RES, V38, P6029, DOI 10.1093/nar/gkq439; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; Rothgiesser KM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-22; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Wright CW, 2009, SCIENCE, V323, P251, DOI 10.1126/science.1162818; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Yang XD, 2010, MOL CELL BIOL, V30, P2170, DOI 10.1128/MCB.01343-09; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	40	49	51	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2012	31	5					611	623		10.1038/onc.2011.253	http://dx.doi.org/10.1038/onc.2011.253			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MS	21706061	Green Accepted			2022-12-25	WOS:000300221800007
J	Smirnova, T; Zhou, ZN; Flinn, RJ; Wyckoff, J; Boimel, PJ; Pozzuto, M; Coniglio, SJ; Backer, JM; Bresnick, AR; Condeelis, JS; Hynes, NE; Segall, JE				Smirnova, T.; Zhou, Z. N.; Flinn, R. J.; Wyckoff, J.; Boimel, P. J.; Pozzuto, M.; Coniglio, S. J.; Backer, J. M.; Bresnick, A. R.; Condeelis, J. S.; Hynes, N. E.; Segall, J. E.			Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis	ONCOGENE			English	Article						ErbB3; breast cancer; metastasis; in vivo invasion; intravasation; PI3-Kinase	MAMMARY-TUMORS; ERBB2/ERBB3 CORECEPTOR; LUNG-CANCER; INTRAVASATION; ERBB3; INVASION; RECEPTOR; KINASE; INHIBITION; EXPRESSION	Many malignancies show increased expression of the epidermal growth factor (EGF) receptor family member ErbB3 (HER3). ErbB3 binds heregulin beta-1 (HRG beta 1) and forms a heterodimer with other ErbB family members, such as ErbB2 (HER2) or EGF receptor (EGFR; HER1), enhancing phosphorylation of specific C-terminal tyrosine residues and activation of downstream signaling pathways. ErbB3 contains six YXXM motifs that bind the p85 subunit of phosphoinositide 3 (PI3)-kinase. Previous studies demonstrated that overexpression of ErbB3 in mammary tumor cells can significantly enhance chemotaxis to HRG beta 1 and overall metastatic potential. We tested the hypothesis that ErbB3-mediated PI3-kinase signaling is critical for heregulin-induced motility, and therefore crucial for ErbB3-mediated invasion, intravasation and metastasis. The tyrosines in the six YXXM motifs on the ErbB3 C-terminus were replaced with phenylalanine. In contrast to overexpression of the wildtype ErbB3, overexpression of the mutant ErbB3 did not enhance chemotaxis towards HRGb1 in vitro or in vivo. We also observed reduced tumor cell motility in the primary tumor by multiphoton microscopy, as well as a dramatically reduced ability of these cells to cross the endothelium and intravasate into the circulation. Moreover, whereas mutation of the ErbB3 C-terminus had no effect on tumor growth, it had a dramatic effect on spontaneous metastatic potential. Treatment with the PI3-kinase inhibitor PIK-75 similarly inhibited motility and invasion in vitro and in vivo. Our results indicate that stimulation of the early metastatic steps of motility and invasion by ErbB3 requires activation of the PI3-kinase pathway by the ErbB3 receptor. Oncogene (2012) 31, 706-715; doi:10.1038/onc.2011.275; published online 4 July 2011	[Smirnova, T.; Zhou, Z. N.; Wyckoff, J.; Boimel, P. J.; Coniglio, S. J.; Condeelis, J. S.; Segall, J. E.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10801 USA; [Flinn, R. J.; Backer, J. M.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10801 USA; [Wyckoff, J.; Condeelis, J. S.; Segall, J. E.] Albert Einstein Coll Med, Gruss Lipper Ctr Biophoton, Bronx, NY 10801 USA; [Pozzuto, M.; Bresnick, A. R.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10801 USA; [Hynes, N. E.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Friedrich Miescher Institute for Biomedical Research	Segall, JE (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Price 201,1300 Morris Pk Ave, Bronx, NY 10801 USA.	jeffrey.segall@einstein.yu.edu		Boimel, Pamela/0000-0002-9771-1700	NIH [CA77522, CA100324, CA1U01105490, RO1 GM55692, P01 CA100324]; NATIONAL CANCER INSTITUTE [P01CA100324, U01CA105490, R01CA077522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055692, T32GM007288] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank John Koland and the members of the Segall, Condeelis, Cox, Hodgson, and Hynes laboratories for comments and suggestions. JES is the Betty and Sheldon Feinberg Senior Faculty Scholar in Cancer Research. This work was supported by grants from the NIH (JES: CA77522 and CA100324); CA1U01105490 and CA100324 (JS Condeelis and J Wyckoff); RO1 GM55692 (JB); NIH P01 CA100324 (JB and ARB).	Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Amin DN, 2010, SEMIN CELL DEV BIOL, V21, P944, DOI 10.1016/j.semcdb.2010.08.007; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Campbell MR, 2010, CLIN CANCER RES, V16, P1373, DOI 10.1158/1078-0432.CCR-09-1218; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chausovsky A, 2000, ONCOGENE, V19, P878, DOI 10.1038/sj.onc.1203410; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Chiu CG, 2010, ANN SURG, V251, P1107, DOI 10.1097/SLA.0b013e3181dbb77e; Di Cosimo S, 2010, NAT REV CLIN ONCOL, V7, P139, DOI 10.1038/nrclinonc.2009.234; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fiddes RJ, 1998, J BIOL CHEM, V273, P7717, DOI 10.1074/jbc.273.13.7717; Fujimoto N, 2005, CANCER RES, V65, P11478, DOI 10.1158/0008-5472.CAN-05-1977; Hayakawa M, 2007, BIOORGAN MED CHEM, V15, P5837, DOI 10.1016/j.bmc.2007.05.070; Hellyer NJ, 2001, J BIOL CHEM, V276, P42153, DOI 10.1074/jbc.M102079200; Hernandez L, 2009, METHODS MOL BIOL, V571, P227, DOI 10.1007/978-1-60761-198-1_15; Hernandez L, 2009, CANCER RES, V69, P3221, DOI 10.1158/0008-5472.CAN-08-2871; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Iivanainen E, 2007, EXP CELL RES, V313, P2896, DOI 10.1016/j.yexcr.2007.03.042; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kalinowski A, 2010, FASEB J, V24, P2567, DOI 10.1096/fj.08-129072; Kedrin D, 2009, CLIN CANCER RES, V15, P3733, DOI 10.1158/1078-0432.CCR-08-2163; Ky B, 2009, CIRCULATION, V120, P310, DOI 10.1161/CIRCULATIONAHA.109.856310; NERI A, 1982, J NATL CANCER I, V68, P507; Olayioye MA, 2001, EXP CELL RES, V267, P81, DOI 10.1006/excr.2001.5242; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Sassen A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1843; Schade B, 2007, CANCER RES, V67, P7579, DOI 10.1158/0008-5472.CAN-06-4724; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; Vijapurkar U, 2003, EXP CELL RES, V284, P291, DOI 10.1016/S0014-4827(02)00040-X; Wyckoff JB, 2000, CANCER RES, V60, P2504; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Xue CS, 2006, CANCER RES, V66, P1418, DOI 10.1158/0008-5472.CAN-05-0550; Zhang JF, 2006, ARTERIOSCL THROM VAS, V26, pE23, DOI 10.1161/01.ATV.0000202661.61837.93	37	48	49	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	6					706	715		10.1038/onc.2011.275	http://dx.doi.org/10.1038/onc.2011.275			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MU	21725367	Green Accepted			2022-12-25	WOS:000300222100004
J	Kao, LY; Kurtz, LM; Shao, XS; Papadopoulos, MC; Liu, L; Bok, D; Nusinowitz, S; Chen, B; Stella, SL; Andre, M; Weinreb, J; Luong, SS; Piri, N; Kwong, JMK; Newman, D; Kurtz, I				Kao, Liyo; Kurtz, Lisa M.; Shao, Xuesi; Papadopoulos, Marios C.; Liu, Li; Bok, Dean; Nusinowitz, Steven; Chen, Bryan; Stella, Salvatore L.; Andre, Mark; Weinreb, Josh; Luong, Serena S.; Piri, Natik; Kwong, Jacky M. K.; Newman, Debra; Kurtz, Ira			Severe Neurologic Impairment in Mice with Targeted Disruption of the Electrogenic Sodium Bicarbonate Cotransporter NBCe2 (Slc4a5 Gene)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL GANGLION-CELLS; MOUSE CHOROID-PLEXUS; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; EPITHELIAL-CELLS; BRAIN VENTRICLES; INNER-EAR; RAT; EXPRESSION; PROTEIN	The choroid plexus lining the four ventricles in the brain is where the majority of cerebrospinal fluid (CSF) is produced. The secretory function of the choroid plexus is mediated by specific transport systems that allow the directional flux of nutrients and ions into the CSF and the removal of toxins. Normal CSF dynamics and chemistry ensure that the environment for neural function is optimal. Here, we report that targeted disruption of the Slc4a5 gene encoding the electrogenic sodium bicarbonate cotransporter NBCe2 results in significant remodeling of choroid plexus epithelial cells, including abnormal mitochondrial distribution, cytoskeletal protein expression, and ion transporter polarity. These changes are accompanied by very significant abnormalities in intracerebral ventricle volume, intracranial pressure, and CSF electrolyte levels. The Slc4a5(-/-) mice are significantly more resistant to induction of seizure behavior than wild-type controls. In the retina of Slc4a5(-/-) mice, loss of photoreceptors, ganglion cells, and retinal detachment results in visual impairment assessed by abnormal electroretinogram waveforms. Our findings are the first demonstration of the fundamental importance of NBCe2 in the biology of the nervous system.	[Kao, Liyo; Andre, Mark; Weinreb, Josh; Newman, Debra; Kurtz, Ira] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Kurtz, Lisa M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Shao, Xuesi; Bok, Dean; Luong, Serena S.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; [Papadopoulos, Marios C.] St Georges Univ London, Acad Neurosurg Unit, London SW17 0RE, England; [Liu, Li] Columbia Univ Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Bok, Dean; Nusinowitz, Steven; Chen, Bryan; Piri, Natik; Kwong, Jacky M. K.] Univ Calif Los Angeles, Dept Ophthalmol, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Bok, Dean; Kurtz, Ira] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Stella, Salvatore L.] Univ Missouri, Dept Basic Med Sci, Kansas City, MO 64108 USA	University of California System; University of California Los Angeles; University of California System; University of California San Diego; University of California System; University of California Los Angeles; St Georges University London; Columbia University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Missouri System; University of Missouri Kansas City	Kurtz, I (corresponding author), Univ Calif Los Angeles, Dept Med, Rm 7-155,Factor Bldg, Los Angeles, CA 90095 USA.	ikurtz@mednet.ucla.edu		Papadopoulos, Marios/0000-0001-9174-4176; Stella Jr., Salvatore/0000-0003-1971-2537	National Institutes of Health [DK077162, DK058563]; NATIONAL EYE INSTITUTE [R01EY018644, P30EY000331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077162, R01DK058563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077162 and DK058563 (to I. K.).	Abuin A, 2007, Handb Exp Pharmacol, P129; Abuladze N, 2004, AM J PHYSIOL-CELL PH, V287, pC781, DOI 10.1152/ajpcell.00590.2003; Alvarez BV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000839; Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621; BARNES S, 1993, P NATL ACAD SCI USA, V90, P10081, DOI 10.1073/pnas.90.21.10081; Benfenati V, 2010, NEUROSCIENCE, V168, P926, DOI 10.1016/j.neuroscience.2009.12.017; Berry KL, 2003, SCIENCE, V302, P2134, DOI 10.1126/science.1087667; Binder DK, 2004, NEUROREPORT, V15, P259, DOI 10.1097/00001756-200402090-00009; Bok D, 2003, NAT GENET, V34, P313, DOI 10.1038/ng1176; Bouzinova EV, 2005, AM J PHYSIOL-CELL PH, V289, pC1448, DOI 10.1152/ajpcell.00313.2005; Chen LM, 2008, NEUROSCIENCE, V151, P374, DOI 10.1016/j.neuroscience.2007.10.015; Damkier HH, 2010, PHYSIOLOGY, V25, P239, DOI 10.1152/physiol.00011.2010; Damkier HH, 2009, AM J PHYSIOL-CELL PH, V296, pC1291, DOI 10.1152/ajpcell.00062.2009; DeLellis Stephen M, 2010, J Spec Oper Med, V10, P38; Foldvary-Schaefer N, 2003, NEUROLOGY, V61, pS2, DOI 10.1212/WNL.61.6_suppl_2.S2; Gao P, 1999, J HISTOCHEM CYTOCHEM, V47, P1255, DOI 10.1177/002215549904701005; GONZALEZMARTINEZ LM, 1994, BIOL CELL, V81, P215, DOI 10.1016/0248-4900(94)90003-5; Ishii Y, 2003, INVEST OPHTH VIS SCI, V44, P1982, DOI 10.1167/iovs.02-0912; Jacobs S, 2008, P NATL ACAD SCI USA, V105, P311, DOI 10.1073/pnas.0705487105; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Joshi MA, 2006, BIOCHEM J, V400, P153, DOI 10.1042/BJ20060869; Kahle KT, 2009, PHYSIOLOGY, V24, P257, DOI 10.1152/physiol.00015.2009; Kleger A, 2010, CIRCULATION, V122, P1823, DOI 10.1161/CIRCULATIONAHA.110.971721; Kong WC, 1999, LIFE SCI, V64, P1773, DOI 10.1016/S0024-3205(99)00115-0; Krizaj D, 2002, J COMP NEUROL, V451, P1, DOI 10.1002/cne.10281; Krizaj D, 2002, FRONT BIOSCI-LANDMRK, V7, pD2023, DOI 10.2741/krizaj; Kwong JMK, 2010, INVEST OPHTH VIS SCI, V51, P1052, DOI 10.1167/iovs.09-4098; Li X, 2009, NEUROSCIENCE, V162, P67, DOI 10.1016/j.neuroscience.2009.04.044; LINDSEY AE, 1990, P NATL ACAD SCI USA, V87, P5278, DOI 10.1073/pnas.87.14.5278; Lowery LA, 2005, DEVELOPMENT, V132, P2057, DOI 10.1242/dev.01791; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Majumdar D, 2010, NEUROSCIENCE, V171, P951, DOI 10.1016/j.neuroscience.2010.09.037; Marek KW, 2010, NAT NEUROSCI, V13, P944, DOI 10.1038/nn.2582; Merves M, 2003, JARO-J ASSOC RES OTO, V4, P264, DOI 10.1007/s10162-002-3033-7; Millar ID, 2008, BIOCHEM BIOPH RES CO, V373, P550, DOI 10.1016/j.bbrc.2008.06.053; Newton PN, 2002, CLIN INFECT DIS, V35, P769, DOI 10.1086/342299; Nielsen S, 1997, J NEUROSCI, V17, P171; Oshio K, 2004, FASEB J, V18, P76, DOI 10.1096/fj.04-1711fje; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; PARTON RG, 1991, J CELL BIOL, V113, P261, DOI 10.1083/jcb.113.2.261; Paul SM, 2003, DEVELOPMENT, V130, P4963, DOI 10.1242/dev.00691; PEDLEY TA, 1969, EXP NEUROL, V25, P207, DOI 10.1016/0014-4886(69)90045-4; Poca MA, 2005, EXPERT OPIN PHARMACO, V6, P1525, DOI 10.1517/14656566.6.9.1525; Praetorius J, 2006, AM J PHYSIOL-CELL PH, V291, pC59, DOI 10.1152/ajpcell.00433.2005; Pratico D, 2004, J ALZHEIMERS DIS, V6, P385; Preston JE, 2001, MICROSC RES TECHNIQ, V52, P31, DOI 10.1002/1097-0029(20010101)52:1<31::AID-JEMT5>3.3.CO;2-K; Pushkin A, 2000, BBA-GENE STRUCT EXPR, V1493, P215, DOI 10.1016/S0167-4781(00)00149-4; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P3717, DOI 10.1091/mbc.12.12.3717; REED DJ, 1967, EXP BRAIN RES, V3, P212; Reiss WG, 1996, ANN PHARMACOTHER, V30, P514, DOI 10.1177/106002809603000515; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Ryan DP, 2010, NEURON, V68, P282, DOI 10.1016/j.neuron.2010.10.008; SAITO Y, 1982, J PHYSIOL-LONDON, V328, P229, DOI 10.1113/jphysiol.1982.sp014261; Sassani P, 2002, AM J PHYSIOL-CELL PH, V282, pC408, DOI 10.1152/ajpcell.00409.2001; Shao XM, 2007, J NEUROSCI METH, V159, P108, DOI 10.1016/j.jneumeth.2006.07.001; Shu XD, 2003, DEVELOPMENT, V130, P6165, DOI 10.1242/dev.00844; Shuvaev VV, 2001, NEUROBIOL AGING, V22, P397, DOI 10.1016/S0197-4580(00)00253-0; Silverberg GD, 2003, LANCET NEUROL, V2, P506, DOI 10.1016/S1474-4422(03)00487-3; Trapp S, 1996, NEUROREPORT, V7, P2000, DOI 10.1097/00001756-199608120-00029; VOGH BP, 1975, AM J PHYSIOL, V228, P673, DOI 10.1152/ajplegacy.1975.228.3.673; Wolburg H, 2010, ACTA NEUROPATHOL, V119, P75, DOI 10.1007/s00401-009-0627-8; Wu XH, 2006, NEUROSCI LETT, V400, P146, DOI 10.1016/j.neulet.2006.02.031; Xiong ZQ, 2000, J NEUROSCI, V20, P1290	63	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32563	32574		10.1074/jbc.M111.249961	http://dx.doi.org/10.1074/jbc.M111.249961			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21705333	Green Published, hybrid			2022-12-25	WOS:000294726800066
J	Kowalczyk, C; Dunkel, N; Willen, L; Casal, ML; Mauldin, EA; Gaide, O; Tardivel, A; Badic, G; Etter, AL; Favre, M; Jefferson, DM; Headon, DJ; Demotz, S; Schneider, P				Kowalczyk, Christine; Dunkel, Nathalie; Willen, Laure; Casal, Margret L.; Mauldin, Elizabeth A.; Gaide, Olivier; Tardivel, Aubry; Badic, Giovanna; Etter, Anne-Lise; Favre, Manuel; Jefferson, Douglas M.; Headon, Denis J.; Demotz, Stephane; Schneider, Pascal			Molecular and Therapeutic Characterization of Anti-ectodysplasin A Receptor (EDAR) Agonist Monoclonal Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOHIDROTIC ECTODERMAL DYSPLASIA; TUMOR-NECROSIS-FACTOR; RECOMBINANT ECTODYSPLASIN; TNF SUPERFAMILY; TRANSGENIC MICE; GENE; MOUSE; MUTATIONS; INDUCTION; APOPTOSIS	The TNF family ligand ectodysplasin A (EDA) and its receptor EDAR are required for proper development of skin appendages such as hair, teeth, and eccrine sweat glands. Loss of function mutations in the Eda gene cause X-linked hypohidrotic ectodermal dysplasia (XLHED), a condition that can be ameliorated in mice and dogs by timely administration of recombinant EDA. In this study, several agonist anti-EDAR monoclonal antibodies were generated that cross-react with the extracellular domains of human, dog, rat, mouse, and chicken EDAR. Their half-life in adult mice was about 11 days. They induced tail hair and sweat gland formation when administered to newborn EDA-deficient Tabby mice, with an EC50 of 0.1 to 0.7 mg/kg. Divalency was necessary and sufficient for this therapeutic activity. Only some antibodies were also agonists in an in vitro surrogate activity assay based on the activation of the apoptotic Fas pathway. Activity in this assay correlated with small dissociation constants. When administered in utero in mice or at birth in dogs, agonist antibodies reverted several ectodermal dysplasia features, including tooth morphology. These antibodies are therefore predicted to efficiently trigger EDAR signaling in many vertebrate species and will be particularly suited for long term treatments.	[Kowalczyk, Christine; Dunkel, Nathalie; Willen, Laure; Tardivel, Aubry; Badic, Giovanna; Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Casal, Margret L.; Mauldin, Elizabeth A.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Gaide, Olivier] Univ Geneva, Dept Dermatol, CH-1211 Geneva, Switzerland; [Etter, Anne-Lise; Favre, Manuel; Demotz, Stephane] Apoxis SA, CH-1004 Lausanne, Switzerland; [Jefferson, Douglas M.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Jefferson, Douglas M.] Cell Essential, Boston, MA 02116 USA; [Headon, Denis J.] Univ Edinburgh, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [Headon, Denis J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9PS, Midlothian, Scotland; [Demotz, Stephane] Edimer Biotech, CH-1066 Epalinges, Switzerland	University of Lausanne; University of Pennsylvania; University of Geneva; Tufts University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Schneider, P (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	pascal.schneider@unil.ch		Schneider, Pascal/0000-0003-0677-9409	Swiss National Science Foundation; National Institutes of Health [RR02512]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the Swiss National Science Foundation (to P. S.) and by National Institutes of Health Grant RR02512 (to M.L.C.). P.S., M.L.C., O.G., and S.D. are shareholders of EdimerPharma.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ahrer K, 2003, J CHROMATOGR A, V1009, P89, DOI 10.1016/S0021-9673(03)00433-3; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Casal ML, 2007, AM J HUM GENET, V81, P1050, DOI 10.1086/521988; Casal ML, 2005, MAMM GENOME, V16, P524, DOI 10.1007/s00335-004-2463-4; Cui CY, 2003, HUM MOL GENET, V12, P2931, DOI 10.1093/hmg/ddg325; DHEIN J, 1992, J IMMUNOL, V149, P3166; Fadeel B, 1997, INT IMMUNOL, V9, P201, DOI 10.1093/intimm/9.2.201; Gaide O, 2003, NAT MED, V9, P614, DOI 10.1038/nm861; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Mauldin EA, 2009, AM J MED GENET A, V149A, P2045, DOI 10.1002/ajmg.a.32916; Mikkola ML, 2008, CYTOKINE GROWTH F R, V19, P219, DOI 10.1016/j.cytogfr.2008.04.008; Monreal AW, 1998, AM J HUM GENET, V63, P380, DOI 10.1086/301984; Mues G, 2010, EUR J HUM GENET, V18, P19, DOI 10.1038/ejhg.2009.127; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; NAKATA M, 1980, AM J HUM GENET, V32, P908; Newton K, 2004, MOL CELL BIOL, V24, P1608, DOI 10.1128/MCB.24.4.1608-1613.2004; PINHEIRO M, 1979, AM J MED GENET, V4, P113, DOI 10.1002/ajmg.1320040202; Rawlins EL, 2005, DEV DYNAM, V233, P1378, DOI 10.1002/dvdy.20461; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Schneider P, 2001, J BIOL CHEM, V276, P18819, DOI 10.1074/jbc.M101280200; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; SHAWLOT W, 1989, MOL BIOL MED, V6, P299; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; Swee LK, 2009, J BIOL CHEM, V284, P27567, DOI 10.1074/jbc.M109.042259; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Wang ZD, 2000, J IMMUNOL METHODS, V233, P167, DOI 10.1016/S0022-1759(99)00184-2; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747; Zankl A, 2001, EUR J PEDIATR, V160, P296, DOI 10.1007/s004310100738	32	29	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30769	30779		10.1074/jbc.M111.267997	http://dx.doi.org/10.1074/jbc.M111.267997			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730053	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000294283600057
J	Chung, YW; Kim, HK; Kim, IY; Yim, MB; Chock, PB				Chung, Youn Wook; Kim, Ha Kun; Kim, Ick Young; Yim, Moon B.; Chock, P. Boon			Dual Function of Protein Kinase C (PKC) in 12-O-Tetradecanoylphorbol-13-acetate (TPA)-induced Manganese Superoxide Dismutase (MnSOD) Expression ACTIVATION OF CREB AND FOXO3a BY PKC-alpha PHOSPHORYLATION AND BY PKC-MEDIATED INACTIVATION OF Akt, RESPECTIVELY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; FORKHEAD TRANSCRIPTION FACTOR; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; PROMOTER REVEAL; PHORBOL ESTER; CANCER-CELLS; FACTOR-ALPHA	12-O-tetradecanoylphorbol-13-acetate (TPA) has been shown to induce transcriptional activation of human manganese superoxide dismutase (MnSOD) mRNA in human lung carcinoma cells, A549, mediated by a protein kinase C (PKC)-dependent activation of cAMP-responsive element-binding protein (CREB)-1/ATF-1-like factors. In this study, we showed that MnSOD protein expression was elevated in response to TPA or TNF-alpha, but not to hydrogen peroxide treatment. TPA-induced generation of reactive oxygen species (ROS) was blocked by pretreatment of the PKC inhibitor BIM and NADPH oxidase inhibitor DPI. Small interfering RNA (siRNA) experiments indicated that knocking down the NADPH oxidase components e.g. Rac1, p22(phox), p67(phox), and NOXO1 in A549 cells impaired TPA-induced MnSOD expression. To identify the PKC isozyme involved, we used a sod2 gene response reporter plasmid, pSODLUC-3340-I2E-C, capable of sensing the effect of TNF-alpha and TPA, to monitor the effects of PKC isozyme-specific inhibitors and siRNA-induced knockdown of specific PKC isozyme. Our data indicate that TPA-induced MnSOD expression was independent of p53 and most likely mediated by PKC-alpha-, and -epsilon-dependent signaling pathways. Furthermore, siRNA-induced knock-down of CREB and Forkhead box class O (FOXO) 3a led to a reduction in TPA-induced MnSOD gene expression. Together, our results revealed that TPA up-regulates, in part, two PKC-dependent transcriptional pathways to induce MnSOD expression. One pathway involves PKC-alpha catalyzed phosphorylation of CREB and the other involves a PKC-mediated the PP2A catalyzed dephosphorylation of Akt at Ser(473) which in turn leads to FOXO3a Ser(253) dephosphorylation and its activation.	[Chung, Youn Wook; Kim, Ha Kun; Yim, Moon B.; Chock, P. Boon] NHLBI, Biochim Lab, NIH, Bethesda, MD 20892 USA; [Kim, Ick Young] Korea Univ, Sch Life Sci & Biotechnol, Lab Cellular & Mol Biochem, Seoul 136701, South Korea	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Korea University	Yim, MB (corresponding author), NHLBI, Biochim Lab, NIH, Bldg 50,Room 2134,MSC 8012, Bethesda, MD 20892 USA.	bchock@nih.gov		Chung, Youn Wook/0000-0002-4382-1410	NHLBI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000202] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the Intramural Research Program of NHLBI, National Institutes of Health.	AKASHI M, 1995, J BIOL CHEM, V270, P15864, DOI 10.1074/jbc.270.26.15864; BRINDLE P, 1993, NATURE, V364, P821, DOI 10.1038/364821a0; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433; Chun JY, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm051; Chung YW, 2002, BIOCHEM BIOPH RES CO, V293, P1248; CHURCH SL, 1993, P NATL ACAD SCI USA, V90, P3113, DOI 10.1073/pnas.90.7.3113; Das KC, 1998, J BIOL CHEM, V273, P34639, DOI 10.1074/jbc.273.51.34639; Dhar SK, 2006, J BIOL CHEM, V281, P21698, DOI 10.1074/jbc.M601083200; Dhar SK, 2004, J BIOL CHEM, V279, P28209, DOI 10.1074/jbc.M403553200; Drane P, 2001, ONCOGENE, V20, P430, DOI 10.1038/sj.onc.1204101; Enoksson M, 2004, J BIOL CHEM, V279, P49575, DOI 10.1074/jbc.C400374200; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; FUJII J, 1991, J BIOL CHEM, V266, P23142; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; HARRIS CA, 1991, J IMMUNOL, V147, P149; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Jeong DW, 2002, J BIOL CHEM, V277, P17871, DOI 10.1074/jbc.M200808200; Jones PL, 1997, MOL CELL BIOL, V17, P6970, DOI 10.1128/MCB.17.12.6970; Kim HP, 1999, J BIOL CHEM, V274, P37455, DOI 10.1074/jbc.274.52.37455; Kiningham KK, 2004, BIOCHEM J, V384, P543, DOI 10.1042/BJ20040714; Kiningham KK, 2001, BIOCHEM J, V353, P147, DOI 10.1042/bj3530147; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Li LW, 2006, J BIOL CHEM, V281, P3237, DOI 10.1074/jbc.M512167200; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Muthusamy N, 1998, J BIOL CHEM, V273, P22841, DOI 10.1074/jbc.273.35.22841; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; OBERLEY LW, 1987, ARCH BIOCHEM BIOPHYS, V254, P69, DOI 10.1016/0003-9861(87)90082-8; OBERLEY LW, 1979, CANCER RES, V39, P1141; Porntadavity S, 2001, DNA CELL BIOL, V20, P473, DOI 10.1089/104454901316976109; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Riganti C, 2004, J BIOL CHEM, V279, P47726, DOI 10.1074/jbc.M406314200; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Sierecki E, 2010, J MED CHEM, V53, P6899, DOI 10.1021/jm100331d; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; STCLAIR DK, 1992, MOL CARCINOGEN, V6, P238, DOI 10.1002/mc.2940060404; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; VISNER GA, 1990, J BIOL CHEM, V265, P2856; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; Wen HC, 2003, CELL SIGNAL, V15, P37, DOI 10.1016/S0898-6568(02)00047-5; WHITSETT JA, 1992, AM J PHYSIOL, V262, pL688, DOI 10.1152/ajplung.1992.262.6.L688; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Xu Y, 2002, BIOCHEM J, V362, P401, DOI 10.1042/0264-6021:3620401; Xu Y, 1999, ONCOGENE, V18, P93, DOI 10.1038/sj.onc.1202265; Xu Y, 2008, MOL CANCER RES, V6, P1881, DOI 10.1158/1541-7786.MCR-08-0253; Yeh CC, 1998, DNA CELL BIOL, V17, P921, DOI 10.1089/dna.1998.17.921; Zhu CH, 2001, J BIOL CHEM, V276, P14407, DOI 10.1074/jbc.M009708200	55	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29681	29690		10.1074/jbc.M111.264945	http://dx.doi.org/10.1074/jbc.M111.264945			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21705328	hybrid, Green Published			2022-12-25	WOS:000294046600027
J	Rahman, P; Huysmans, RD; Wiradjaja, F; Gurung, R; Ooms, LM; Sheffield, DA; Dyson, JM; Layton, MJ; Sriratana, A; Takada, H; Tiganis, T; Mitchell, CA				Rahman, Parvin; Huysmans, Richard D.; Wiradjaja, Fenny; Gurung, Rajendra; Ooms, Lisa M.; Sheffield, David A.; Dyson, Jennifer M.; Layton, Meredith J.; Sriratana, Absorn; Takada, Hidetoshi; Tiganis, Tony; Mitchell, Christina A.			Silencer of Death Domains (SODD) Inhibits Skeletal Muscle and Kidney Enriched Inositol 5-Phosphatase (SKIP) and Regulates Phosphoinositide 3-Kinase (PI3K)/Akt Signaling to the Actin Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; POLYPHOSPHATE 5-PHOSPHATASES; PROTEIN-KINASE; CHAPERONE REGULATORS; PLASMA-MEMBRANE; ADAPTER PROTEIN; MOTILITY; AKT; PHOSPHORYLATION; RECEPTOR	Phosphoinositide 3-kinase (PI3K) regulates cell polarity and migration by generating phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P-3) at the leading edge of migrating cells. The serine-threonine protein kinase Akt binds to PI(3,4,5)P-3, resulting in its activation. Active Akt promotes spatially regulated actin cytoskeletal remodeling and thereby directed cell migration. The inositol polyphosphate 5-phosphatases (5-ptases) degrade PI(3,4,5)P-3 to form PI(3,4)P-2, which leads to diminished Akt activation. Several 5-ptases, including SKIP and SHIP2, inhibit actin cytoskeletal reorganization by opposing PI3K/Akt signaling. In this current study, we identify a molecular co-chaperone termed silencer of death domains (SODD/BAG4) that forms a complex with several 5-ptase family members, including SKIP, SHIP1, and SHIP2. The interaction between SODD and SKIP exerts an inhibitory effect on SKIP PI(3,4,5)P-3 5-ptase catalytic activity and consequently enhances the recruitment of PI(3,4,5)P-3-effectors to the plasma membrane. In contrast, SODD-/- mouse embryonic fibroblasts exhibit reduced Akt-Ser(473) and -Thr(308) phosphorylation following EGF stimulation, associated with increased SKIP PI(3,4,5)P-3-5-ptase activity. SODD-/- mouse embryonic fibroblasts exhibit decreased EGF-stimulated F-actin stress fibers, lamellipodia, and focal adhesion complexity, a phenotype that is rescued by the expression of constitutively active Akt1. Furthermore, reduced cell migration was observed in SODD-/- macrophages, which express the three 5-ptases shown to interact with SODD (SKIP, SHIP1, and SHIP2). Therefore, this study identifies SODD as a novel regulator of PI3K/Akt signaling to the actin cytoskeleton.	[Rahman, Parvin; Huysmans, Richard D.; Wiradjaja, Fenny; Gurung, Rajendra; Ooms, Lisa M.; Sheffield, David A.; Dyson, Jennifer M.; Layton, Meredith J.; Sriratana, Absorn; Tiganis, Tony; Mitchell, Christina A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Takada, Hidetoshi] Univ Toronto, Campbell Family Inst Breast Canc Res, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M5G 2C1, Canada; [Takada, Hidetoshi] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada	Monash University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Mitchell, CA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	christina.mitchell@monash.edu	Tiganis, Tony/AAV-3495-2020; Ooms, Lisa/AGZ-7420-2022	Tiganis, Tony/0000-0002-8065-9942; Mitchell, Christina A/0000-0001-9372-3192; Ooms, Lisa Michelle/0000-0002-8918-9932	National Health and Medical Research Council (NHMRC) Australia [1010368, 384137]	National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC) Australia Grants 1010368 and 384137.	Affolter M, 2005, DEV CELL, V9, P19, DOI 10.1016/j.devcel.2005.06.003; Al-Lamki RS, 2003, AM J PATHOL, V163, P401, DOI 10.1016/S0002-9440(10)63670-X; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Antoku K, 2001, BIOCHEM BIOPH RES CO, V286, P1003, DOI 10.1006/bbrc.2001.5512; Bardelli A, 1996, EMBO J, V15, P6205, DOI 10.1002/j.1460-2075.1996.tb01009.x; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Bondar VM, 2002, MOL CANCER THER, V1, P989; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Cenni V, 2003, CELL MOL LIFE SCI, V60, P2710, DOI 10.1007/s00018-003-3349-4; Charest PG, 2007, BIOCHEM J, V401, P377, DOI 10.1042/BJ20061432; Cheng HL, 2000, MOL CELL ENDOCRINOL, V170, P211, DOI 10.1016/S0303-7207(00)00324-5; Costa C, 2007, P NATL ACAD SCI USA, V104, P14354, DOI 10.1073/pnas.0703175104; Cramer LP, 2002, CELL MOTIL CYTOSKEL, V51, P27, DOI 10.1002/cm.10013; Cross M, 2005, PROTEOMICS, V5, P4754, DOI 10.1002/pmic.200500058; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Dyson JM, 2001, J CELL BIOL, V155, P1065, DOI 10.1083/jcb.200104005; Endres R, 2003, MOL CELL BIOL, V23, P6609, DOI 10.1128/MCB.23.18.6609-6617.2003; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Gurung R, 2003, J BIOL CHEM, V278, P11376, DOI 10.1074/jbc.M209991200; Hawthorne VS, 2004, CANCER BIOL THER, V3, P776, DOI 10.4161/cbt.3.8.1031; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Ijuin T, 2000, J BIOL CHEM, V275, P10870, DOI 10.1074/jbc.275.15.10870; Ijuin T, 2003, MOL CELL BIOL, V23, P1209, DOI 10.1128/MCB.23.4.1209-1220.2003; Ijuin T, 2008, MOL CELL BIOL, V28, P5184, DOI 10.1128/MCB.01990-06; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Ivetac I, 2005, MOL BIOL CELL, V16, P2218, DOI 10.1091/mbc.e04-09-0799; Jackson TR, 2000, TRENDS BIOCHEM SCI, V25, P489, DOI 10.1016/S0968-0004(00)01644-3; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Jiang YP, 1999, SCIENCE, V283, P543, DOI 10.1126/science.283.5401.543; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kisseleva MV, 2000, J BIOL CHEM, V275, P20110, DOI 10.1074/jbc.M910119199; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Li J, 2005, DEV CELL, V9, P663, DOI 10.1016/j.devcel.2005.09.012; McKenna LB, 2007, CELL MOL LIFE SCI, V64, P2723, DOI 10.1007/s00018-007-7247-z; Mitchell CA, 2002, IUBMB LIFE, V53, P25, DOI 10.1080/15216540210815; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Oatey PB, 1999, BIOCHEM J, V344, P511, DOI 10.1042/0264-6021:3440511; Onnockx S, 2008, J CELL PHYSIOL, V214, P260, DOI 10.1002/jcp.21193; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Ozawa F, 2000, BIOCHEM BIOPH RES CO, V271, P409, DOI 10.1006/bbrc.2000.2610; Paez Juan, 2003, Cancer Treat Res, V115, P145; Prasad N, 2002, J CELL SCI, V115, P3807, DOI 10.1242/jcs.00070; Prasad N, 2001, MOL CELL BIOL, V21, P1416, DOI 10.1128/MCB.21.4.1416-1428.2001; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shatkina L, 2003, MOL CELL BIOL, V23, P7189, DOI 10.1128/MCB.23.20.7189-7197.2003; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Takada H, 2003, MOL CELL BIOL, V23, P4026, DOI 10.1128/MCB.23.11.4026-4033.2003; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Tao HF, 2007, J HUAZHONG U SCI-MED, V27, P326, DOI 10.1007/s11596-007-0328-2; Todd I, 2004, IMMUNOLOGY, V113, P65, DOI 10.1111/j.1365-2567.2004.01942.x; Vandermoere F, 2007, MOL CELL PROTEOMICS, V6, P114, DOI 10.1074/mcp.M600335-MCP200; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Woods YL, 2002, BIOCHEM SOC T, V30, P391, DOI 10.1042/bst0300391; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200	61	10	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29758	29770		10.1074/jbc.M111.263103	http://dx.doi.org/10.1074/jbc.M111.263103			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21712384	hybrid, Green Published			2022-12-25	WOS:000294046600035
J	Peng, AM; Wang, L; Fisher, LA				Peng, Aimin; Wang, Ling; Fisher, Laura A.			Greatwall and Polo-like Kinase 1 Coordinate to Promote Checkpoint Recovery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; PROTEIN PHOSPHATASE 2A; XENOPUS EGG EXTRACTS; AURORA-A; DEPENDENT DEGRADATION; MAMMALIAN-CELLS; MITOTIC ENTRY; ACTIVATION; MITOSIS; CLASPIN	Checkpoint recovery upon completion of DNA repair allows the cell to return to normal cell cycle progression and is thus a crucial process that determines cell fate after DNA damage. We previously studied this process in Xenopus egg extracts and established Greatwall (Gwl) as an important regulator. Here we show that preactivated Gwl kinase can promote checkpoint recovery independently of cyclin-dependent kinase 1 (Cdk1) or Plx1 (Xenopus polo-like kinase 1), whereas depletion of Gwl from extracts exhibits no synergy with that of Plx1 in delaying checkpoint recovery, suggesting a distinct but related relationship between Gwl and Plx1. In further revealing their functional relationship, we found mutual dependence for activation of Gwl and Plx1 during checkpoint recovery, as well as their direct association. We characterized the protein association in detail and recapitulated it in vitro with purified proteins, which suggests direct interaction. Interestingly, Gwl interaction with Plx1 and its phosphorylation by Plx1 both increase at the stage of checkpoint recovery. More importantly, Plx1-mediated phosphorylation renders Gwl more efficient in promoting checkpoint recovery, suggesting a functional involvement of such regulation in the recovery process. Finally, we report an indirect regulatory mechanism involving Aurora A that may account for Gwl-dependent regulation of Plx1 during checkpoint recovery. Our results thus reveal novel mechanisms underlying the involvement of Gwl in checkpoint recovery, in particular, its functional relationship with Plx1, a well characterized regulator of checkpoint recovery. Coordinated interplays between Plx1 and Gwl are required for reactivation of these kinases from the G(2)/M DNA damage checkpoint and efficient checkpoint recovery.	[Peng, Aimin; Wang, Ling; Fisher, Laura A.] Univ Nebraska Med Ctr, Coll Dent, Dept Oral Biol, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center	Peng, AM (corresponding author), Univ Nebraska Med Ctr, Coll Dent, Dept Oral Biol, Lincoln, NE 68583 USA.	Aimin.Peng@UNMC.edu			National Institutes of Health [P20 RR018759]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work is supported, in whole or in part, by National Institutes of Health Grant P20 RR018759 (to A. P.).	Archambault V, 2007, PLOS GENET, V3, P2163, DOI 10.1371/journal.pgen.0030200; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Castilho PV, 2009, MOL BIOL CELL, V20, P4777, DOI 10.1091/mbc.E09-07-0643; Chan EHY, 2008, CHROMOSOMA, V117, P457, DOI 10.1007/s00412-008-0165-5; Clemenson C, 2009, DNA REPAIR, V8, P1101, DOI 10.1016/j.dnarep.2009.04.008; Eckerdt F, 2009, CELL CYCLE, V8, P2413, DOI 10.4161/cc.8.15.9086; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; Goldberg ML, 2010, P NATL ACAD SCI USA, V107, P12409, DOI 10.1073/pnas.1006046107; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Guo ZJ, 2000, MOL BIOL CELL, V11, P1535, DOI 10.1091/mbc.11.5.1535; Jackson PK, 2006, MOL CELL, V22, P156, DOI 10.1016/j.molcel.2006.04.005; Krystyniak A, 2006, ONCOGENE, V25, P338, DOI 10.1038/sj.onc.1209056; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Lorca T, 2010, J CELL SCI, V123, P2281, DOI 10.1242/jcs.064527; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; Lupardus PJ, 2007, METHODS, V41, P222, DOI 10.1016/j.ymeth.2006.07.024; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Marumoto T, 2002, GENES CELLS, V7, P1173, DOI 10.1046/j.1365-2443.2002.00592.x; Maton G, 2003, J BIOL CHEM, V278, P21439, DOI 10.1074/jbc.M300811200; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Peng A, 2010, ONCOGENE, V29, P5977, DOI 10.1038/onc.2010.371; Peng A, 2007, MOL CELL BIOL, V27, P6852, DOI 10.1128/MCB.00195-07; Peng AM, 2010, CELL CYCLE, V9, P4364, DOI 10.4161/cc.9.21.13632; Peng AM, 2010, CURR BIOL, V20, P387, DOI 10.1016/j.cub.2010.01.020; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; Van Horn RD, 2010, J BIOL CHEM, V285, P21849, DOI 10.1074/jbc.M110.141010; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287; van Vugt MATM, 2004, CELL CYCLE, V3, P1383, DOI 10.4161/cc.3.11.1248; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Vigneron S, 2011, MOL CELL BIOL, V31, P2262, DOI 10.1128/MCB.00753-10; Virshup DM, 2010, SCIENCE, V330, P1638, DOI 10.1126/science.1199898; WANG L, 2011, HYBRIDOMA IN PRESS; Yong Z, 2008, MOL BIOL CELL, V19, P1317, DOI 10.1091/mbc.E07-11-1099; Yu JT, 2006, MOL CELL, V22, P83, DOI 10.1016/j.molcel.2006.02.022; Yu JT, 2004, J CELL BIOL, V164, P487, DOI 10.1083/JCB.200310059; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	43	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28996	29004		10.1074/jbc.M111.257121	http://dx.doi.org/10.1074/jbc.M111.257121			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21708943	Green Published, hybrid			2022-12-25	WOS:000293837000036
J	Baltanas, FC; Casafont, I; Lafarga, V; Weruaga, E; Alonso, JR; Berciano, MT; Lafarga, M				Baltanas, Fernando C.; Casafont, Inigo; Lafarga, Vanesa; Weruaga, Eduardo; Alonso, Jose R.; Berciano, Maria T.; Lafarga, Miguel			Purkinje Cell Degeneration in pcd Mice Reveals Large Scale Chromatin Reorganization and Gene Silencing Linked to Defective DNA Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT CEREBELLAR CORTEX; MUTANT MICE; NUCLEAR ARCHITECTURE; NEURON LOSS; MAMMALIAN-CELLS; MOLECULAR-BASIS; STRAND BREAKS; CAJAL BODIES; DAMAGE; ORGANIZATION	DNArepair protects neurons against spontaneous or disease-associated DNA damage. Dysfunctions of this mechanism underlie a growing list of neurodegenerative disorders. The Purkinje cell (PC) degeneration mutation causes the loss of nna1 expression and is associated with the postnatal degeneration of PCs. This PC degeneration dramatically affects nuclear architecture and provides an excellent model to elucidate the nuclear mechanisms involved in a whole array of neurodegenerative disorders. We used immunocytochemistry for histone variants and components of the DNA damage response, an in situ transcription assay, and in situ hybridization for telomeres to analyze changes in chromatin architecture and function. We demonstrate that the phosphorylation of H2AX, a DNA damage signal, and the trimethylation of the histone H4K20, a repressive mark, in extensive domains of genome are epigenetic hallmarks of chromatin in degenerating PCs. These histone modifications are associated with a large scale reorganization of chromatin, telomere clustering, and heterochromatin-induced gene silencing, all of them key factors in PC degeneration. Furthermore, ataxia telangiectasia mutated and 53BP1, two components of the DNA repair pathway, fail to be concentrated in the damaged chromatin compartments, even though the expression levels of their coding genes were slightly up-regulated. Although the mechanism by which Nna1 loss of function leads to PC neuro-degeneration is undefined, the progressive accumulation of DNA damage in chromosome territories irreversibly compromises global gene transcription and seems to trigger PC degeneration and death.	[Lafarga, Miguel] Univ Cantabria, Fac Med, Dept Anat & Cell Biol, Inst Formac & Invest Marques Valdecilla, E-39011 Santander, Spain; [Baltanas, Fernando C.; Weruaga, Eduardo; Alonso, Jose R.] Univ Salamanca, Lab Neural Plast & Neurorepair, Inst Neurosci Castilla & Leon, E-37007 Salamanca, Spain; [Casafont, Inigo; Berciano, Maria T.; Lafarga, Miguel] Univ Cantabria, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Dept Anat & Cell Biol, Inst Formac & Invest Marques de Valdecilla, E-39011 Santander, Spain; [Lafarga, Vanesa] Autonomous Univ Madrid, Dept Mol Biol, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Alonso, Jose R.] Univ Tarapaca, Inst Alta Invest, Arica 1520, Chile	Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; University of Salamanca; CIBERNED; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Universidad de Tarapaca	Lafarga, M (corresponding author), Univ Cantabria, Fac Med, Dept Anat & Cell Biol, Inst Formac & Invest Marques Valdecilla, Avd Cardenal Herrera Oria S-N, E-39011 Santander, Spain.	lafargam@unican.es	Baltanas, Fernando C./D-4756-2018; Baltanas, Fernando C./AAU-7451-2021; Weruaga, Eduardo/C-3102-2012; Lafarga, Miguel/K-3733-2014; Lafarga, Vanesa/ABF-9934-2021; Alonso, J. R./B-2523-2017	Baltanas, Fernando C./0000-0001-8110-0991; Baltanas, Fernando C./0000-0001-8110-0991; Weruaga, Eduardo/0000-0003-2887-5506; Alonso, J. R./0000-0001-5235-7616; CASAFONT, INIGO/0000-0001-5691-6841; Lafarga, Miguel/0000-0003-3402-1152; Berciano, Maria T./0000-0002-8225-6995	Direccion General de Investigacion [BFU2008-00175]; Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas [CB06/05/0037]; Instituto de Salud Carlos III, Ministerio de Ciencia y Tecnologa [BFU2010-18284]; Ministerio de Sanidad, Politica Social e Igualdad (Plan Nacional Sobre Drogas), Instituto de Formacion e Investigacion Marques de Valdecilla [FMV/UC09-02]; Junta de Castilla y Leon; Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y Leon	Direccion General de Investigacion(Spanish Government); Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas; Instituto de Salud Carlos III, Ministerio de Ciencia y Tecnologa(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Sanidad, Politica Social e Igualdad (Plan Nacional Sobre Drogas), Instituto de Formacion e Investigacion Marques de Valdecilla(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y Leon	This work was supported by Direccion General de Investigacion Grant BFU2008-00175, Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas Grant CB06/05/0037 from Instituto de Salud Carlos III, Ministerio de Ciencia y Tecnologa Grant BFU2010-18284, Ministerio de Sanidad, Politica Social e Igualdad (Plan Nacional Sobre Drogas), Instituto de Formacion e Investigacion Marques de Valdecilla Grant FMV/UC09-02, Junta de Castilla y Leon, and Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y Leon.	Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Baltanas FC, 2011, BRAIN PATHOL, V21, P374, DOI 10.1111/j.1750-3639.2010.00461.x; Berezniuk I, 2010, FASEB J, V24, P1813, DOI 10.1096/fj.09-147942; BLANKS JC, 1982, J COMP NEUROL, V212, P231, DOI 10.1002/cne.902120303; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Brasnjevic I, 2008, DNA REPAIR, V7, P1087, DOI 10.1016/j.dnarep.2008.03.010; Caldecott KW, 2004, DNA REPAIR, V3, P875, DOI 10.1016/j.dnarep.2004.04.011; Casafont I, 2006, NEUROSCIENCE, V140, P453, DOI 10.1016/j.neuroscience.2006.02.030; CHAKRABARTI L, 2009, BRAIN, V2, P24; Chakrabarti L, 2010, NEURON, V66, P835, DOI 10.1016/j.neuron.2010.05.024; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Dar I, 2011, J BIOL CHEM, V286, P15361, DOI 10.1074/jbc.M110.204172; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Dellaire G, 2009, CELL CYCLE, V8, P3750, DOI 10.4161/cc.8.22.10065; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dusart I, 2006, CEREBELLUM, V5, P163, DOI 10.1080/14734220600699373; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; GARCIASEGURA LM, 1989, J COMP NEUROL, V290, P440, DOI 10.1002/cne.902900311; GILLARDON F, 1995, NEUROREPORT, V6, P1766, DOI 10.1097/00001756-199509000-00014; GILLARDON F, 1995, J NEUROSCI RES, V41, P708, DOI 10.1002/jnr.490410517; Gonzalez-Suarez I, 2009, CELL CYCLE, V8, P3860, DOI 10.4161/cc.8.23.10092; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; GREER CA, 1982, BRAIN RES, V235, P156, DOI 10.1016/0006-8993(82)90206-2; Harris A, 2000, MOL CELL NEUROSCI, V16, P578, DOI 10.1006/mcne.2000.0900; Hetman M, 2010, J NEUROCHEM, V114, P1537, DOI 10.1111/j.1471-4159.2010.06859.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kong LJ, 2006, MOL CELL, V22, P63, DOI 10.1016/j.molcel.2006.02.016; Krantic S, 2005, TRENDS NEUROSCI, V28, P670, DOI 10.1016/j.tins.2005.09.011; Kyuhou S, 2006, NEUROSCI LETT, V396, P91, DOI 10.1016/j.neulet.2005.11.023; LAFARGA M, 1991, J NEUROCYTOL, V20, P533, DOI 10.1007/BF01215262; Lafarga M, 1997, CELL TISSUE RES, V289, P25, DOI 10.1007/s004410050849; Lafarga M, 2009, CHROMOSOMA, V118, P437, DOI 10.1007/s00412-009-0212-x; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; LANDIS SC, 1978, J COMP NEUROL, V177, P125, DOI 10.1002/cne.901770109; Lee Y, 2000, GENE DEV, V14, P2576, DOI 10.1101/gad.837100; Li GY, 2009, EXP EYE RES, V89, P581, DOI 10.1016/j.exer.2009.06.004; Li JX, 2010, NEURON, V68, P45, DOI 10.1016/j.neuron.2010.08.013; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Martou G, 2000, EXP CELL RES, V256, P131, DOI 10.1006/excr.1999.4793; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Molenaar C, 2003, EMBO J, V22, P6631, DOI 10.1093/emboj/cdg633; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Nouspikel T, 2007, NEUROSCIENCE, V145, P1213, DOI 10.1016/j.neuroscience.2006.07.006; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; OGORMAN S, 1985, J COMP NEUROL, V234, P277, DOI 10.1002/cne.902340302; PALAY SL, 1974, CYTOLOGY ORG; Paulson HL, 2005, NEURON, V46, P845, DOI 10.1016/j.neuron.2005.05.025; Pena E, 2001, J COMP NEUROL, V430, P250, DOI 10.1002/1096-9861(20010205)430:2<250::AID-CNE1029>3.0.CO;2-L; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Rutten BPF, 2007, NEUROBIOL AGING, V28, P91, DOI 10.1016/j.neurobiolaging.2005.10.019; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Shackelford DA, 2006, NEUROBIOL AGING, V27, P596, DOI 10.1016/j.neurobiolaging.2005.03.009; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Solovei I, 2004, CYTOGENET GENOME RES, V105, P302, DOI 10.1159/000078202; Soutoglou E, 2007, CURR OPIN GENET DEV, V17, P435, DOI 10.1016/j.gde.2007.08.004; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Suraweera A, 2007, J CELL BIOL, V177, P969, DOI 10.1083/jcb.200701042; Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Takizawa T, 2008, TRENDS NEUROSCI, V31, P343, DOI 10.1016/j.tins.2008.03.005; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Valero J, 2006, MOL CELL NEUROSCI, V33, P283, DOI 10.1016/j.mcn.2006.08.002; Wang TY, 2007, BRAIN RES, V1140, P26, DOI 10.1016/j.brainres.2006.07.065; Wang TY, 2006, MOL CELL NEUROSCI, V33, P200, DOI 10.1016/j.mcn.2006.07.009; Wang XY, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-4; WeruagaPrieto E, 1996, GLIA, V16, P117, DOI 10.1002/(SICI)1098-1136(199602)16:2<117::AID-GLIA4>3.0.CO;2-0; Zhang P, 2007, NEUROSCIENCE, V145, P1439, DOI 10.1016/j.neuroscience.2006.11.052; Zhivotovsky B, 1997, BIOCHEM BIOPH RES CO, V233, P96, DOI 10.1006/bbrc.1997.6411	75	39	39	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28287	28302		10.1074/jbc.M111.246041	http://dx.doi.org/10.1074/jbc.M111.246041			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21700704	Green Published, hybrid			2022-12-25	WOS:000293557800046
J	Roschzttardtz, H; Grillet, L; Isaure, MP; Conejero, G; Ortega, R; Curie, C; Mari, S				Roschzttardtz, Hannetz; Grillet, Louis; Isaure, Marie-Pierre; Conejero, Genevieve; Ortega, Richard; Curie, Catherine; Mari, Stephane			Plant Cell Nucleolus as a Hot Spot for Iron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-FLUORESCENCE; LOCALIZATION; METABOLISM; MICROSCOPY; PROTEINS; FERRITIN; DISEASE; STORAGE	Many central metabolic processes require iron as a cofactor and take place in specific subcellular compartments such as the mitochondrion or the chloroplast. Proper iron allocation in the different organelles is thus critical to maintain cell function and integrity. To study the dynamics of iron distribution in plant cells, we have sought to identify the different intracellular iron pools by combining three complementary imaging approaches, histochemistry, micro particle-induced x-ray emission, and synchrotron radiation micro X-ray fluorescence. Pea (Pisum sativum) embryo was used as a model in this study because of its large cell size and high iron content. Histochemical staining with ferrocyanide and diaminobenzidine (Perls/diaminobenzidine) strongly labeled a unique structure in each cell, which co-labeled with the DNA fluorescent stain DAPI, thus corresponding to the nucleus. The unexpected presence of iron in the nucleus was confirmed by elemental imaging using micro particle-induced x-ray emission. X-ray fluorescence on cryo-sectioned embryos further established that, quantitatively, the iron concentration found in the nucleus was higher than in the expected iron-rich organelles such as plastids or vacuoles. Moreover, within the nucleus, iron was particularly accumulated in a subcompartment that was identified as the nucleolus as it was shown to transiently disassemble during cell division. Taken together, our data uncover an as yet unidentified although abundant iron pool in the cell, which is located in the nuclei of healthy, actively dividing plant tissues. This result paves the way for the discovery of a novel cellular function for iron related to nucleus/nucleolus-associated processes.	[Roschzttardtz, Hannetz; Grillet, Louis; Conejero, Genevieve; Curie, Catherine; Mari, Stephane] Univ Montpellier 2, Lab Biochim & Physiol Mol Plantes, Inst Biol Integrat Plantes, Ecole Natl Super Agron,INRA,CNRS,UMR5004, F-34060 Montpellier 2, France; [Isaure, Marie-Pierre] Univ Pau & Pays Adour, CNRS, Inst Pluridisciplinaire Rech Environm & Mat, Lab Chim Analyt Bioinorgan & Environm,UMR5254, F-64063 Pau 9, France; [Ortega, Richard] Univ Bordeaux, Ctr Etud Nucl Bordeaux Gradignan, CNRS, UMR5797, F-33175 Gradignan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; Agrocampus Ouest; Montpellier SupAgro; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Pau et des Pays de l'Adour; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux	Mari, S (corresponding author), Univ Montpellier 2, Lab Biochim & Physiol Mol Plantes, Inst Biol Integrat Plantes, Ecole Natl Super Agron,INRA,CNRS,UMR5004, F-34060 Montpellier 2, France.	mari@supagro.inra.fr	Grillet, Louis/AFV-6693-2022	Grillet, Louis/0000-0002-2914-9023; ISAURE, Marie-Pierre/0000-0002-6557-5759; Ortega, Richard/0000-0003-1692-5406	Centre National de la Recherche Scientifique; l'Institut National de la Recherche Agronomique; Circulation of Iron within the Plant and Delivery to the Seed (CIDS) [23643]; Agence Nationale pour la Recherche [07-3-18-8-87 DISTRIMET]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); l'Institut National de la Recherche Agronomique; Circulation of Iron within the Plant and Delivery to the Seed (CIDS); Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by the Centre National de la Recherche Scientifique, l'Institut National de la Recherche Agronomique, and by Grant 23643 (Circulation of Iron within the Plant and Delivery to the Seed (CIDS)).; Supported by a postdoctoral fellowship from the Agence Nationale pour la Recherche (Program 07-3-18-8-87 DISTRIMET). Present address: Dept. of Botany, University of Wisconsin-Madison, B122 Birge Hall, 430 Lincoln Dr., Madison, WI 53706.	Berens C, 1998, CHEM BIOL, V5, P163, DOI 10.1016/S1074-5521(98)90061-8; Carmona A, 2008, ANAL BIOANAL CHEM, V390, P1585, DOI 10.1007/s00216-008-1866-6; Carmona A, 2008, J ANAL ATOM SPECTROM, V23, P1083, DOI 10.1039/b802242a; Gordon N, 2000, BRAIN DEV-JPN, V22, P465, DOI 10.1016/S0387-7604(00)00175-3; Honda K, 2005, J BIOL CHEM, V280, P20978, DOI 10.1074/jbc.M500526200; Jeong J, 2008, P NATL ACAD SCI USA, V105, P10619, DOI 10.1073/pnas.0708367105; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kurz T, 2008, HISTOCHEM CELL BIOL, V129, P389, DOI 10.1007/s00418-008-0394-y; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Matsuyama S, 2010, X-RAY SPECTROM, V39, P260, DOI 10.1002/xrs.1256; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Ortega R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000925; Quintana C, 2006, J STRUCT BIOL, V153, P42, DOI 10.1016/j.jsb.2005.11.001; Roschzttardtz H, 2009, PLANT PHYSIOL, V151, P1329, DOI 10.1104/pp.109.144444; Schroder JM, 2005, ACTA NEUROPATHOL, V109, P109, DOI 10.1007/s00401-004-0949-5; Vidal R, 2008, J NEUROSCI, V28, P60, DOI 10.1523/JNEUROSCI.3962-07.2008; Witting PK, 2006, BIOCHEMISTRY-US, V45, P12500, DOI 10.1021/bi0604375; Wollman FA, 1999, BBA-BIOENERGETICS, V1411, P21, DOI 10.1016/S0005-2728(99)00043-2; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	19	60	64	1	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27863	27866		10.1074/jbc.C111.269720	http://dx.doi.org/10.1074/jbc.C111.269720			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21719700	Green Published, hybrid			2022-12-25	WOS:000293557800003
J	Seo, J; Tsakem, EL; Breitman, M; Gurevich, VV				Seo, Jungwon; Tsakem, Elviche L.; Breitman, Maya; Gurevich, Vsevolod V.			Identification of Arrestin-3-specific Residues Necessary for JNK3 Kinase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; NUCLEAR EXPORT SIGNAL; CRYSTAL-STRUCTURE; BETA-ARRESTIN; NONVISUAL ARRESTINS; CLATHRIN ADAPTER; VISUAL ARRESTIN; CONE ARRESTIN; WILD-TYPE; BINDING	Arrestins bind active phosphorylated G protein-coupled receptors, blocking G protein activation and channeling the signaling to G protein-independent pathways. Free arrestin-3 and receptor-bound arrestin-3 scaffold the ASK1-MKK4-JNK3 module, promoting JNK3 phosphorylation, whereas highly homologous arrestin-2 does not. Here, we used arrestin-2/3 chimeras and mutants to identify key residues of arrestin-3 responsible for its ability to facilitate JNK3 activation. Our data demonstrate that both arrestin domains are involved in JNK3 activation, with the C-terminal domain being more important than the N-terminal domain. We found that Val-343 is the key contributor to this function, whereas Leu-278, Ser-280, His-350, Asp-351, His-352, and Ile-353 play supporting roles. We also show that the arrestin-3-specific difference in the arrangement of the beta-strands in the C-terminal domain that underlies its lower selectivity for active phosphoreceptors does not play an appreciable role in its ability to enhance JNK3 activation. Importantly, the strength of the binding of ASK1 or JNK3, as revealed by the efficiency of co-immunoprecipitation, does not correlate with the ability of arrestin proteins to promote ASK1-dependent JNK3 phosphorylation. Thus, multiple residues on the non-receptor-binding side of arrestin-3 are crucial for JNK3 activation, and this function and the receptor-binding characteristics of arrestin can be manipulated independently by targeted mutagenesis.	[Seo, Jungwon; Tsakem, Elviche L.; Breitman, Maya; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University	Gurevich, VV (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	vsevolod.gurevich@vanderbilt.edu	Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351	National Institutes of Health [GM077561, GM081756, EY011500]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081756, R01GM077561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM077561, GM081756, and EY011500 (to V. V. G.).	Ahmed MR, 2011, BIOCHEMISTRY-US, V50, P3749, DOI 10.1021/bi200175q; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2004, J NEUROCHEM, V91, P1404, DOI 10.1111/j.1471-4159.2004.02830.x; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001444; GUREVICH VV, 1993, J BIOL CHEM, V268, P16879; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P9765, DOI 10.1074/jbc.M510738200; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Miller WE, 2001, J BIOL CHEM, V276, P27770, DOI 10.1074/jbc.M102264200; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Shankar H, 2010, J BIOL CHEM, V285, P8316, DOI 10.1074/jbc.M109.062521; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Song X, 2007, J NEUROCHEM, V103, P1053, DOI 10.1111/j.1471-4159.2007.04842.x; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Wu N, 2006, J MOL BIOL, V364, P955, DOI 10.1016/j.jmb.2006.09.075; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034	38	40	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27894	27901		10.1074/jbc.M111.260448	http://dx.doi.org/10.1074/jbc.M111.260448			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21715332	Green Published, hybrid			2022-12-25	WOS:000293557800008
J	Gandhi, J; Cashman, SM; Kumar-Singh, R				Gandhi, Jarel; Cashman, Siobhan M.; Kumar-Singh, Rajendra			Soluble CD59 Expressed from an Adenovirus In Vivo Is a Potent Inhibitor of Complement Deposition on Murine Liver Vascular Endothelium	PLOS ONE			English	Article							MEMBRANE ATTACK COMPLEX; MACULAR DEGENERATION; REGULATOR CD59; TARGETED FORM; FACTOR-H; RECOMBINANT; DEFICIENCY; ACTIVATION; DISEASE; SYSTEM	Inappropriate activation of complement on the vascular endothelium of specific organs, or systemically, underlies the etiology of a number of diseases. These disorders include atypical hemolytic uremic syndrome, membranoproliferative glomerulonephritis, atherosclerosis, age-related macular degeneration, diabetic retinopathy, and transplant rejection. Inhibition of the terminal step of complement activation, i.e. formation of the membrane attack complex, using CD59 has the advantage of retaining the upstream processes of the complement cascade necessary for fighting pathogens and retaining complement's crucial role in tissue homeostasis. Previous studies have shown the necessity of membrane targeting of soluble CD59 in order for it to prove an effective inhibitor of complement deposition both in vitro and in vivo. In this study we have generated an in vivo model of human complement activation on murine liver vascular endothelium. This model should prove useful for the development of anti-complement therapies for complement-induced pathologies of vascular endothelium. Using this model, we have demonstrated the viability of a non membrane-targeted soluble CD59 to significantly inhibit complement deposition on the endothelium of murine liver vasculature when expressed in vivo from an adenovirus. This result, unanticipated based on prior studies, suggests that the use of non membrane-targeted sCD59 as an anti-complement therapy be re-visited.	[Gandhi, Jarel; Cashman, Siobhan M.; Kumar-Singh, Rajendra] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Tufts University	Gandhi, J (corresponding author), Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA.	rajendra.kumar-singh@tufts.edu		Kumar-Singh, Rajendra/0000-0002-7754-0713	The Ellison Foundation; Virginia B. Smith Trust; NIH/NEI [EY014991, EY013887]; Lions Eye Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY014991] Funding Source: NIH RePORTER	The Ellison Foundation(Lawrence Ellison Foundation); Virginia B. Smith Trust; NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Lions Eye Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by grants to R.K.-S. from The Ellison Foundation, The Virginia B. Smith Trust, NIH/NEI (EY014991 and EY013887) and grants to the Department of Ophthalmology at Tufts University from the Lions Eye Foundation and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Banz Y., 2011, ANN MED; BOGEN SA, 1992, AM J PATHOL, V141, P843; Bora NS, 2010, J BIOL CHEM, V285, P33826, DOI 10.1074/jbc.M110.153130; Cashman SM, 2007, MOL THER, V15, P1640, DOI 10.1038/sj.mt.6300203; Cashman SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019078; DAVIES A, 1989, J EXP MED, V170, P637, DOI 10.1084/jem.170.3.637; De Simoni MG, 2003, J CEREBR BLOOD F MET, V23, P232, DOI 10.1097/01.WCB.0000046146.31247.A1; Emlen W, 2010, SEMIN THROMB HEMOST, V36, P660, DOI 10.1055/s-0030-1262888; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Fijen CAP, 1999, CLIN INFECT DIS, V28, P98, DOI 10.1086/515075; Fijen CAP, 1998, J CLIN MICROBIOL, V36, P2342, DOI 10.1128/JCM.36.8.2342-2345.1998; Fraser DA, 2003, J BIOL CHEM, V278, P48921, DOI 10.1074/jbc.M302598200; Gerl VB, 2002, INVEST OPHTH VIS SCI, V43, P1104; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Homann C, 1997, GUT, V40, P544, DOI 10.1136/gut.40.4.544; Johnson M, 2006, HUM GENE THER, V17, P1262, DOI 10.1089/hum.2006.17.1262; Kim IH, 2001, P NATL ACAD SCI USA, V98, P13282, DOI 10.1073/pnas.241506298; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Licht C, 2009, THROMB HAEMOSTASIS, V101, P271, DOI 10.1160/TH08-09-0575; Ma KN, 2010, INVEST OPHTH VIS SCI, V51, P6776, DOI 10.1167/iovs.10-5887; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; MERI S, 1990, IMMUNOLOGY, V71, P1; Mizuno M, 2001, ARTHRITIS RHEUM-US, V44, P2425, DOI 10.1002/1529-0131(200110)44:10<2425::AID-ART407>3.0.CO;2-4; Pascher A, 1996, TRANSPLANT P, V28, P754; Pickering MC, 2008, CLIN EXP IMMUNOL, V151, P210, DOI 10.1111/j.1365-2249.2007.03574.x; Powell MB, 1997, J IMMUNOL, V158, P1692; Qin XB, 2009, AM J HEMATOL, V84, P65, DOI 10.1002/ajh.21319; Ramo K, 2008, INVEST OPHTH VIS SCI, V49, P4126, DOI 10.1167/iovs.08-2025; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; Satoh S, 1997, TRANSPLANTATION, V64, P1117, DOI 10.1097/00007890-199710270-00006; Song HB, 2003, J CLIN INVEST, V111, P1875, DOI 10.1172/JCI200317348; SUGITA Y, 1994, IMMUNOLOGY, V82, P34; SWEIGARD JH, 2011, GENE THER IN PRESS; Tian J, 2009, J VIROL, V83, P5648, DOI 10.1128/JVI.00082-09; Wu GX, 2009, CIRC RES, V104, P550, DOI 10.1161/CIRCRESAHA.108.191361; Zhang HF, 1999, J CLIN INVEST, V103, P55, DOI 10.1172/JCI4607; Zipfel PF, 2001, TRENDS IMMUNOL, V22, P345, DOI 10.1016/S1471-4906(01)01972-X	40	9	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21621	10.1371/journal.pone.0021621	http://dx.doi.org/10.1371/journal.pone.0021621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720565	Green Submitted, gold, Green Published			2022-12-25	WOS:000292036900061
J	Momose, F; Sekimoto, T; Ohkura, T; Jo, S; Kawaguchi, A; Nagata, K; Morikawa, Y				Momose, Fumitaka; Sekimoto, Tetsuya; Ohkura, Takashi; Jo, Shuichi; Kawaguchi, Atsushi; Nagata, Kyosuke; Morikawa, Yuko			Apical Transport of Influenza A Virus Ribonucleoprotein Requires Rab11-positive Recycling Endosome	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; MICROTUBULE-MEDIATED TRANSPORT; NUCLEAR IMPORT; MEMBRANE TRAFFICKING; STRUCTURAL BASIS; MATRIX PROTEIN; RNA SEGMENTS; RAB GTPASES; POLYMERASE; INFECTION	Influenza A virus RNA genome exists as eight-segmented ribonucleoprotein complexes containing viral RNA polymerase and nucleoprotein (vRNPs). Packaging of vRNPs and virus budding take place at the apical plasma membrane (APM). However, little is known about the molecular mechanisms of apical transport of newly synthesized vRNP. Transfection of fluorescent-labeled antibody and subsequent live cell imaging revealed that punctate vRNP signals moved along microtubules rapidly but intermittently in both directions, suggestive of vesicle trafficking. Using a series of Rab family protein, we demonstrated that progeny vRNP localized to recycling endosome (RE) in an active/GTP-bound Rab11-dependent manner. The vRNP interacted with Rab11 through viral RNA polymerase. The localization of vRNP to RE and subsequent accumulation to the APM were impaired by overexpression of Rab binding domains (RBD) of Rab11 family interacting proteins (Rab11-FIPs). Similarly, no APM accumulation was observed by overexpression of class II Rab11-FIP mutants lacking RBD. These results suggest that the progeny vRNP makes use of Rab11-dependent RE machinery for APM trafficking.	[Momose, Fumitaka; Sekimoto, Tetsuya; Ohkura, Takashi; Kawaguchi, Atsushi; Morikawa, Yuko] Kitasato Univ, Kitasato Inst Life Sci, Tokyo, Japan; [Jo, Shuichi; Kawaguchi, Atsushi; Nagata, Kyosuke] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan	Kitasato University; University of Tsukuba	Momose, F (corresponding author), Kitasato Univ, Kitasato Inst Life Sci, Tokyo, Japan.	fmomose@lisci.kitasato-u.ac.jp		Kawaguchi, Atsushi/0000-0002-5485-1578	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japanese Society for the Promotion of Science (JSPS); Kitasato University	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kitasato University	This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (FM KN YM), Research Fellowship of the Japanese Society for the Promotion of Science (JSPS) (AK), and by a Kitasato University Research Grant for Young Researchers (FM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Amorim MJ, 2011, J VIROL, V85, P4143, DOI 10.1128/JVI.02606-10; Babbey CM, 2006, MOL BIOL CELL, V17, P3156, DOI 10.1091/mbc.E05-08-0799; BLACK BC, 1979, NUCLEIC ACIDS RES, V6, P2339, DOI 10.1093/nar/6.6.2339; Brock SC, 2003, P NATL ACAD SCI USA, V100, P15143, DOI 10.1073/pnas.2434327100; BROWN DT, 1975, J VIROL, V16, P366, DOI 10.1128/JVI.16.2.366-387.1975; Bruce EA, 2010, J VIROL, V84, P5848, DOI 10.1128/JVI.00307-10; Bruce EA, 2009, VIROLOGY, V390, P268, DOI 10.1016/j.virol.2009.05.016; Bukrinskaya A, 1998, J EXP MED, V188, P2113, DOI 10.1084/jem.188.11.2113; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; Chambers R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010994; Chen BJ, 2008, VIROLOGY, V372, P221, DOI 10.1016/j.virol.2007.11.008; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; COMPANS RW, 1972, J VIROL, V10, P795, DOI 10.1128/JVI.10.4.795-800.1972; Cresawn KO, 2007, EMBO J, V26, P3737, DOI 10.1038/sj.emboj.7601813; Cui ZQ, 2005, NUCLEIC ACIDS RES, V33, P3245, DOI 10.1093/nar/gki629; Deng T, 2006, J VIROL, V80, P11911, DOI 10.1128/JVI.01565-06; DESSELBERGER U, 1980, GENE, V8, P315, DOI 10.1016/0378-1119(80)90007-4; DRIVAS GT, 1991, ONCOGENE, V6, P3; Duhaut SD, 2002, J GEN VIROL, V83, P403, DOI 10.1099/0022-1317-83-2-403; Duhaut SD, 1996, VIROLOGY, V216, P326, DOI 10.1006/viro.1996.0068; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Elster C, 1997, J GEN VIROL, V78, P1589, DOI 10.1099/0022-1317-78-7-1589; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Fujii Y, 2003, P NATL ACAD SCI USA, V100, P2002, DOI 10.1073/pnas.0437772100; FULLER S, 1984, CELL, V38, P65, DOI 10.1016/0092-8674(84)90527-0; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Gromov PS, 1998, FEBS LETT, V429, P359, DOI 10.1016/S0014-5793(98)00607-3; Hales CM, 2001, J BIOL CHEM, V276, P39067, DOI 10.1074/jbc.M104831200; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; Hollinshead M, 2001, J CELL BIOL, V154, P389, DOI 10.1083/jcb.200104124; Horgan CP, 2007, TRAFFIC, V8, P414, DOI 10.1111/j.1600-0854.2007.00543.x; Horgan CP, 2009, BIOCHEM SOC T, V37, P1032, DOI 10.1042/BST0371032; HSU MT, 1987, P NATL ACAD SCI USA, V84, P8140, DOI 10.1073/pnas.84.22.8140; Huet S, 2010, J VIROL, V84, P1254, DOI 10.1128/JVI.01533-09; Hunziker W, 1998, J BIOL CHEM, V273, P15734, DOI 10.1074/jbc.273.25.15734; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; Inoue H, 2008, MOL BIOL CELL, V19, P4224, DOI 10.1091/mbc.E08-03-0290; Jagoe WN, 2006, STRUCTURE, V14, P1273, DOI 10.1016/j.str.2006.06.010; Jin M, 2006, BBA-GENE STRUCT EXPR, V1759, P281, DOI 10.1016/j.bbaexp.2006.06.001; Jing J, 2009, HISTOL HISTOPATHOL, V24, P1171, DOI 10.14670/HH-24.1171; Jo S, 2010, MICROBES INFECT, V12, P1079, DOI 10.1016/j.micinf.2010.06.011; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; Krzyzaniak MA, 2009, TRAFFIC, V10, P1439, DOI 10.1111/j.1600-0854.2009.00967.x; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lee GE, 2006, J VIROL, V80, P4264, DOI 10.1128/JVI.80.9.4264-4275.2006; Lee JR, 2003, J BIOL CHEM, V278, P2624, DOI 10.1074/jbc.M211152200; Li E, 1998, J VIROL, V72, P8806, DOI 10.1128/JVI.72.11.8806-8812.1998; Lindsay AJ, 2002, J BIOL CHEM, V277, P12190, DOI 10.1074/jbc.M108665200; Marsh M, 1997, J CELL SCI, V110, P95; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; Mettenleiter TC, 2009, VIRUS RES, V143, P222, DOI 10.1016/j.virusres.2009.03.018; Momose F, 2007, MICROBES INFECT, V9, P1422, DOI 10.1016/j.micinf.2007.07.007; MURTI KG, 1988, VIROLOGY, V164, P562, DOI 10.1016/0042-6822(88)90574-0; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; NAKAJIMA K, 1979, J VIROL, V29, P1142, DOI 10.1128/JVI.29.3.1142-1148.1979; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Odagiri T, 1997, J VIROL, V71, P2138, DOI 10.1128/JVI.71.3.2138-2145.1997; ONEILL RE, 1995, J BIOL CHEM, V270, P22701, DOI 10.1074/jbc.270.39.22701; Patton GS, 2005, J VIROL, V79, P6392, DOI 10.1128/JVI.79.10.6392-6399.2005; PENFOLD MET, 1994, P NATL ACAD SCI USA, V91, P6529, DOI 10.1073/pnas.91.14.6529; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Prekeris R, 2000, MOL CELL, V6, P1437, DOI 10.1016/S1097-2765(00)00140-4; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; RESAINFANTE P, 2010, J VIROL, P11; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; ROBERTS SR, 1995, J VIROL, V69, P2667, DOI 10.1128/JVI.69.4.2667-2673.1995; RODRIGUEZBOULAN E, 1978, P NATL ACAD SCI USA, V75, P5071, DOI 10.1073/pnas.75.10.5071; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Rowe RK, 2008, VIROLOGY, V382, P239, DOI 10.1016/j.virol.2008.09.021; Santangelo PJ, 2007, NUCLEIC ACIDS RES, V35, P3602, DOI 10.1093/nar/gkm246; Schmitt AP, 2005, J VIROL, V79, P2988, DOI 10.1128/JVI.79.5.2988-2997.2005; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; SHAPIRO GI, 1987, J VIROL, V61, P764, DOI 10.1128/JVI.61.3.764-773.1987; Shiba T, 2006, P NATL ACAD SCI USA, V103, P15416, DOI 10.1073/pnas.0605357103; Sodeik B, 2000, TRENDS MICROBIOL, V8, P465, DOI 10.1016/S0966-842X(00)01824-2; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Stange A, 2005, J VIROL, V79, P5466, DOI 10.1128/JVI.79.9.5466-5476.2005; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tchatalbachev S, 2001, RNA, V7, P979, DOI 10.1017/S1355838201002424; Thomas JA, 2008, VIRUS RES, V134, P39, DOI 10.1016/j.virusres.2007.12.006; Torreira E, 2007, NUCLEIC ACIDS RES, V35, P3774, DOI 10.1093/nar/gkm336; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Utley TJ, 2008, P NATL ACAD SCI USA, V105, P10209, DOI 10.1073/pnas.0712144105; Wallace DME, 2002, BIOCHEM BIOPH RES CO, V299, P770, DOI 10.1016/S0006-291X(02)02720-1; Wang KN, 1998, J VIROL, V72, P3455, DOI 10.1128/JVI.72.4.3455-3458.1998; Wang XY, 2000, J BIOL CHEM, V275, P29138, DOI 10.1074/jbc.M004410200; Ward BM, 2001, J VIROL, V75, P11651, DOI 10.1128/JVI.75.23.11651-11663.2001; Watanabe K, 1996, J VIROL, V70, P241, DOI 10.1128/JVI.70.1.241-247.1996; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Ye ZP, 1999, J VIROL, V73, P7467, DOI 10.1128/JVI.73.9.7467-7473.1999; Zacchi P, 1998, J CELL BIOL, V140, P1039, DOI 10.1083/jcb.140.5.1039	96	85	89	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21123	10.1371/journal.pone.0021123	http://dx.doi.org/10.1371/journal.pone.0021123			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731653	gold, Green Published, Green Submitted			2022-12-25	WOS:000292033700037
J	Al Saleh, S; Al Mulla, F; Luqmani, YA				Al Saleh, Sanaa; Al Mulla, Fahd; Luqmani, Yunus A.			Estrogen Receptor Silencing Induces Epithelial to Mesenchymal Transition in Human Breast Cancer Cells	PLOS ONE			English	Article							ENDOCRINE THERAPY RESISTANCE; TGF-BETA; IN-VITRO; PROMOTES METASTASIS; SIGNALING PATHWAYS; TUMOR PROGRESSION; SLUG EXPRESSION; LUNG METASTASIS; CADHERIN; INVASION	We propose the hypothesis that loss of estrogen receptor function which leads to endocrine resistance in breast cancer, also results in trans-differentiation from an epithelial to a mesenchymal phenotype that is responsible for increased aggressiveness and metastatic propensity. siRNA mediated silencing of the estrogen receptor in MCF7 breast cancer cells resulted in estrogen/tamoxifen resistant cells (pII) with altered morphology, increased motility with rearrangement and switch from a keratin/actin to a vimentin based cytoskeleton, and ability to invade simulated components of the extracellular matrix. Phenotypic profiling using an Affymetrix Human Genome U133 plus 2.0 GeneChip indicated geometric fold changes >= 3 in approximately 2500 identifiable unique sequences, with about 1270 of these being up-regulated in pII cells. Changes were associated with genes whose products are involved in cell motility, loss of cellular adhesion and interaction with the extracellular matrix. Selective analysis of the data also showed a shift from luminal to basal cell markers and increased expression of a wide spectrum of genes normally associated with mesenchymal characteristics, with consequent loss of epithelial specific markers. Over-expression of several peptide growth factors and their receptors are indicative of an increased contribution to the higher proliferative rates of pII cells as well as aiding their potential for metastatic activity. Signalling molecules that have been identified as key transcriptional drivers of epithelial to mesenchymal transition were also found to be elevated in pII cells. These data support our hypothesis that induced loss of estrogen receptor in previously estrogen/antiestrogen sensitive cells is a trigger for the concomitant loss of endocrine dependence and onset of a series of possibly parallel events that changes the cell from an epithelial to a mesenchymal type. Inhibition of this transition through targeting of specific mediators may offer a useful supplementary strategy to circumvent the effects of loss of endocrine sensitivity.	[Al Saleh, Sanaa; Luqmani, Yunus A.] Kuwait Univ, Fac Pharm, Safat, Kuwait; [Al Saleh, Sanaa] Kuwait Univ, Coll Grad Studies, Safat, Kuwait; [Al Mulla, Fahd] Kuwait Univ, Fac Med, Safat, Kuwait	Kuwait University; Kuwait University; Kuwait University	Al Saleh, S (corresponding author), Kuwait Univ, Fac Pharm, Safat, Kuwait.	yunus@hsc.edu.kw	Al-Mulla, Fahd/E-2068-2015	Al-Mulla, Fahd/0000-0001-5409-3829	Kuwait University Research Administration [YM08/09, GM01/01, GM01/05]	Kuwait University Research Administration	This work was supported by grants YM08/09, GM01/01, and GM01/05 from the Kuwait University Research Administration (http://www.ovpr.kuniv.edu/research/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Saleh S, 2011, INT J ONCOL, V38, P1197, DOI 10.3892/ijo.2011.942; al-Mulla F, 2011, MOL BIOSYST, V7, P928, DOI 10.1039/c0mb00208a; ALAZMI A, 2006, THESIS KUWAIT U; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Bindels S, 2006, ONCOGENE, V25, P4975, DOI 10.1038/sj.onc.1209511; Care A, 1998, ONCOGENE, V16, P3285, DOI 10.1038/sj.onc.1201875; Care A, 2001, CANCER RES, V61, P6532; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Choi J, 2007, INVEST OPHTH VIS SCI, V48, P2708, DOI 10.1167/iovs.06-0639; Dandachi N, 2001, J PATHOL, V193, P181, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH752>3.0.CO;2-V; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Deng BQ, 2010, MOL CELL BIOCHEM, V340, P21, DOI 10.1007/s11010-010-0396-7; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; GILLES C, 1996, BREAST J, V2, P83; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Hayashida T, 2010, P NATL ACAD SCI USA, V107, P1100, DOI 10.1073/pnas.0912710107; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Howell A, 2008, ADV EXP MED BIOL, V617, P201, DOI 10.1007/978-0-387-69080-3_19; Huang HD, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r29; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; ISERI OD, 2010, DRUG RESISTANT MCF 7, DOI DOI 10.1016/J.BIOPHA.2010.10.004; Kim S, 2010, CARCINOGENESIS, V31, P597, DOI 10.1093/carcin/bgq024; Knowlden JM, 2005, ENDOCRINOLOGY, V146, P4609, DOI 10.1210/en.2005-0247; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Kun Y, 2003, HUM MOL GENET, V12, P3245, DOI 10.1093/hmg/ddg347; Landemaine T, 2008, CANCER RES, V68, P6092, DOI 10.1158/0008-5472.CAN-08-0436; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Lonning PE, 2001, ENDOCR-RELAT CANCER, V8, P259, DOI 10.1677/erc.0.0080259; Luqmani YA, 2009, INT J ONCOL, V34, P231, DOI 10.3892/ijo_00000145; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Navarro A, 2004, FASEB J, V18, P1801, DOI 10.1096/fj.04-2516rev; Nicholson RI, 2005, J STEROID BIOCHEM, V93, P257, DOI 10.1016/j.jsbmb.2004.12.006; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P721, DOI 10.1677/erc.1.00857; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Orlichenko LS, 2008, CLIN EXP METASTAS, V25, P593, DOI 10.1007/s10585-008-9143-9; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sarrio D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-74; Schiff R, 2004, CLIN CANCER RES, V10, p331S, DOI 10.1158/1078-0432.CCR-031212; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Sphyris N, 2009, CURR BREAST CANCER R, V1, P229, DOI 10.1007/s12609-009-0032-2; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; van den Abbeele A, 2007, CANCER LETT, V255, P57, DOI 10.1016/j.canlet.2007.03.023; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wiggins HL, 2010, BIOTECHNIQUES, V48, P120, DOI 10.2144/000113353; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Ye Y, 2008, BIOCHEM J, V416, P179, DOI 10.1042/BJ20080328; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	62	94	94	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e20610	10.1371/journal.pone.0020610	http://dx.doi.org/10.1371/journal.pone.0020610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713035	Green Published, gold, Green Submitted			2022-12-25	WOS:000291985100002
J	Biswas, S; Dicks, MDJ; Long, CA; Remarque, EJ; Siani, L; Colloca, S; Cottingham, MG; Holder, AA; Gilbert, SC; Hill, AVS; Draper, SJ				Biswas, Sumi; Dicks, Matthew D. J.; Long, Carole A.; Remarque, Edmond J.; Siani, Loredana; Colloca, Stefano; Cottingham, Matthew G.; Holder, Anthony A.; Gilbert, Sarah C.; Hill, Adrian V. S.; Draper, Simon J.			Transgene Optimization, Immunogenicity and In Vitro Efficacy of Viral Vectored Vaccines Expressing Two Alleles of Plasmodium falciparum AMA1	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; MEROZOITE SURFACE PROTEIN-1; NATURAL IMMUNE-RESPONSES; CYTOTOXIC T-LYMPHOCYTES; BLOOD-STAGE VACCINE; BAY COHORT PROJECT; MALARIA VACCINE; PROTECTIVE IMMUNITY; GROWTH-INHIBITION; RECOMBINANT ADENOVIRUSES	Background: Apical membrane antigen 1 (AMA1) is a leading candidate vaccine antigen against blood-stage malaria, although to date numerous clinical trials using mainly protein-in-adjuvant vaccines have shown limited success. Here we describe the pre-clinical development and optimization of recombinant human and simian adenoviral (AdHu5 and ChAd63) and orthopoxviral (MVA) vectors encoding transgene inserts for Plasmodium falciparum AMA1 (PfAMA1). Methodology/Principal Findings: AdHu5-MVA prime-boost vaccination in mice and rabbits using these vectors encoding the 3D7 allele of PfAMA1 induced cellular immune responses as well as high-titer antibodies that showed growth inhibitory activity (GIA) against the homologous but not heterologous parasite strains. In an effort to overcome the issues of PfAMA1 antigenic polymorphism and pre-existing immunity to AdHu5, a simian adenoviral (ChAd63) vector and MVA encoding two alleles of PfAMA1 were developed. This antigen, composed of the 3D7 and FVO alleles of PfAMA1 fused in tandem and with expression driven by a single promoter, was optimized for antigen secretion and transmembrane expression. These bi-allelic PfAMA1 vaccines, when administered to mice and rabbits, demonstrated comparable immunogenicity to the mono-allelic vaccines and purified serum IgG now showed GIA against the two divergent strains of P. falciparum encoded in the vaccine. CD8(+) and CD4(+) T cell responses against epitopes that were both common and unique to the two alleles of PfAMA1 were also measured in mice. Conclusions/Significance: Optimized transgene inserts encoding two divergent alleles of the same antigen can be successfully inserted into adeno-and pox-viral vaccine vectors. Adenovirus-MVA immunization leads to the induction of T cell responses common to both alleles, as well as functional antibody responses that are effective against both of the encoded strains of P. falciparum in vitro. These data support the further clinical development of these vaccine candidates in Phase I/IIa clinical trials.	[Biswas, Sumi; Dicks, Matthew D. J.; Cottingham, Matthew G.; Gilbert, Sarah C.; Hill, Adrian V. S.; Draper, Simon J.] Univ Oxford, Jenner Inst, Oxford, England; [Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Remarque, Edmond J.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Siani, Loredana; Colloca, Stefano] Okairos AG, Rome, Italy; [Holder, Anthony A.] Natl Inst Med Res, Div Parasitol, London NW7 1AA, England	University of Oxford; Jenner Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); MRC National Institute for Medical Research	Biswas, S (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	sumi.biswas@ndm.ox.ac.uk	Draper, Simon J/F-1758-2011; Remarque, Ed/AAE-8643-2020; Holder, Anthony A/A-7554-2013; Cottingham, Matthew/F-1218-2011; Gilbert, Sarah C./H-2857-2019	Draper, Simon J/0000-0002-9415-1357; Holder, Anthony A/0000-0002-8490-6058; Gilbert, Sarah C./0000-0002-6823-9750; Cottingham, Matthew/0000-0003-0766-6465; Dicks, Matthew/0000-0003-1909-7095	MalParTraining [MEST-CT-2005-020492]; PATH-MVI Malaria Vaccine Initiative (MVI); National Institutes of Health, National Institute of Allergy and Infectious Diseases; EMVDA (European Malaria Vaccine Development Association); UK Medical Research Council [U117532067]; Wellcome Trust; MRC [G1000527, MC_U117532067] Funding Source: UKRI; Medical Research Council [G1000527, MC_U117532067] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020] Funding Source: NIH RePORTER	MalParTraining; PATH-MVI Malaria Vaccine Initiative (MVI); National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EMVDA (European Malaria Vaccine Development Association); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SB was funded by MalParTraining, an FP6-funded Marie Curie Action under contract number MEST-CT-2005-020492. The GIA work was supported in part by the PATH-MVI Malaria Vaccine Initiative (MVI) and the Intramural Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases and in part by the EMVDA (European Malaria Vaccine Development Association, a European Commission FP6-funded consortium). AAH is funded by the UK Medical Research Council (U117532067). AVSH and SCG are Jenner Investigators and are funded by the Wellcome Trust. SJD is a Junior Research Fellow of Merton College, Oxford University. The funders (Okairos) had a role in study design. No additional external funding was received for this study.	Amante FH, 1997, J IMMUNOL, V159, P5535; [Anonymous], 2009, WORLD MAL REP 2009; Arnot DE, 2008, CLIN VACCINE IMMUNOL, V15, P1345, DOI 10.1128/CVI.00172-08; Ashok MS, 2002, VACCINE, V20, P1563, DOI 10.1016/S0264-410X(01)00492-3; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Bruder JT, 2010, VACCINE, V28, P3201, DOI 10.1016/j.vaccine.2010.02.024; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Chelimo K, 2005, PEDIATR INFECT DIS J, V24, P680, DOI 10.1097/01.inf.0000172151.28851.fd; Cheru L, 2010, VACCINE, V28, P4423, DOI 10.1016/j.vaccine.2010.04.036; Ciernik IF, 1996, J IMMUNOL, V156, P2369; Cortes A, 2005, INFECT IMMUN, V73, P422, DOI 10.1128/IAI.73.1.422-430.2005; Cortes A, 2003, INFECT IMMUN, V71, P1416, DOI 10.1128/IAI.71.3.1416-1426.2003; Crompton PD, 2010, INFECT IMMUN, V78, P737, DOI 10.1128/IAI.00960-09; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dent AE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003557; Douglas AD, 2010, VACCINE, V28, P7167, DOI 10.1016/j.vaccine.2010.08.068; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Draper SJ, 2010, J IMMUNOL, V185, P7583, DOI 10.4049/jimmunol.1001760; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Draper SJ, 2009, CELL HOST MICROBE, V5, P95, DOI 10.1016/j.chom.2008.12.004; Dudareva M, 2009, VACCINE, V27, P3501, DOI 10.1016/j.vaccine.2009.03.080; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Ellis RD, 2009, VACCINE, V27, P4104, DOI 10.1016/j.vaccine.2009.04.077; Escalante AA, 2001, MOL BIOCHEM PARASIT, V113, P279, DOI 10.1016/S0166-6851(01)00229-8; Fluck C, 2007, INFECT GENET EVOL, V7, P44, DOI 10.1016/j.meegid.2006.03.006; do Rosario APF, 2008, J IMMUNOL, V181, P8344, DOI 10.4049/jimmunol.181.12.8344; Good MF, 2011, NAT MED, V17, P49, DOI 10.1038/nm0111-49; Goodman AL, 2010, ANN TROP MED PARASIT, V104, P189, DOI 10.1179/136485910X12647085215534; Goodman AL, 2010, INFECT IMMUN, V78, P4601, DOI 10.1128/IAI.00315-10; Greenwood B, 2009, PARASITE IMMUNOL, V31, P582, DOI 10.1111/j.1365-3024.2009.01140.x; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Hill AV, 2010, HUM VACCIN, V6; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Joos C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009871; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kibuuka H, 2010, J INFECT DIS, V201, P600, DOI 10.1086/650299; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Kusi KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008110; Lal AA, 1996, INFECT IMMUN, V64, P1054, DOI 10.1128/IAI.64.3.1054-1059.1996; Luo MC, 2008, J VIROL METHODS, V154, P121, DOI 10.1016/j.jviromet.2008.08.011; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Miao J, 2006, VACCINE, V24, P6187, DOI 10.1016/j.vaccine.2006.05.099; Miura K, 2007, INFECT IMMUN, V75, P5827, DOI 10.1128/IAI.00593-07; Miura K, 2009, CLIN VACCINE IMMUNOL, V16, P963, DOI 10.1128/CVI.00042-09; Murhandarwati EEH, 2010, INFECT IMMUN, V78, P680, DOI 10.1128/IAI.00939-09; Pinzon-Charry A, 2010, J CLIN INVEST, V120, P2967, DOI 10.1172/JCI39222; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Polhemus ME, 2007, VACCINE, V25, P4203, DOI 10.1016/j.vaccine.2007.03.012; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Polley SD, 2001, GENETICS, V158, P1505; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Roestenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003960; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; Sumida SM, 2004, J VIROL, V78, P2666, DOI 10.1128/JVI.78.6.2666-2673.2004; Taylor-Robinson AW, 2010, EXP PARASITOL, V126, P406, DOI 10.1016/j.exppara.2010.01.028; Udhayakumar V, 2001, AM J TROP MED HYG, V65, P100, DOI 10.4269/ajtmh.2001.65.100; Xiang ZQ, 2006, EMERG INFECT DIS, V12, P1596, DOI 10.3201/eid1210.060078; Xu HJ, 2000, J IMMUNOL, V165, P389, DOI 10.4049/jimmunol.165.1.389; YANG YP, 1995, J VIROL, V69, P2004, DOI 10.1128/JVI.69.4.2004-2015.1995; YANG YP, 1994, IMMUNITY, V1, P433, DOI 10.1016/1074-7613(94)90074-4	66	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20977	10.1371/journal.pone.0020977	http://dx.doi.org/10.1371/journal.pone.0020977			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698193	Green Submitted, Green Published, gold			2022-12-25	WOS:000291734100037
J	Thapa, DR; Li, XM; Jamieson, BD; Martinez-Maza, O				Thapa, Dharma R.; Li, Xinmin; Jamieson, Beth D.; Martinez-Maza, Otoniel			Overexpression of MicroRNAs from the miR-17-92 Paralog Clusters in AIDS-Related Non-Hodgkin's Lymphomas	PLOS ONE			English	Article							DOWN-REGULATION; P53 PROTEIN; EXPRESSION; GENE; AMPLIFICATION; POLYCISTRON; MIR-155; RNA; IDENTIFICATION; DELETION	Background: Individuals infected by HIV are at an increased risk for developing non-Hodgkin's lymphomas (AIDS-NHL). In the highly active antiretroviral therapy (HAART) era, there has been a significant decline in the incidence of AIDS-associated primary central nervous system lymphoma (PCNSL). However, only a modest decrease in incidence has been reported for other AIDS-NHL subtypes. Thus, AIDS-NHLs remain a significant cause of morbidity and mortality in HIV infected individuals. Recently, much attention has been directed toward the role of miRNAs in cancer, including NHL. Several miRNAs, including those encoded by the miR-17-92 polycistron, have been shown to play significant roles in B cell tumorigenesis. However, the role of miRNAs in NHL in the setting of HIV infection has not been defined. Methodology/Principal Findings: We used quantitative realtime PCR to assess the expression of miRNAs from three different paralog clusters, miR-17-92, miR-106a-363, and miR-106b-25 in 24 cases of AIDS-NHLs representing four tumor types, Burkitt's lymphoma (BL, n = 6), diffuse large B-cell lymphoma (DLBCL, n = 8), primary central nervous system lymphoma (PCNSL, n = 5), and primary effusion lymphoma (PEL, n = 5). We also used microarray analysis to identify a differentiation specific miRNA signature of naive, germinal center, and memory B cell subsets from tonsils (n = 4). miRNAs from the miR-17-92 paralog clusters were upregulated by B cells, specifically during the GC differentiation stage. We also found overexpression of these miRNA clusters in all four AIDS-NHL subtypes. Finally, we also show that select miRNAs from these clusters (miR-17, miR-106a, and miR-106b) inhibited p21 in AIDS-BL and DLBCL cases, thus providing a mechanistic role for these miRNAs in AIDS-NHL pathogenesis. Conclusion: Dysregulation of miR-17-92 paralog clusters is a common feature of AIDS-associated NHLs.	[Thapa, Dharma R.; Martinez-Maza, Otoniel] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Li, Xinmin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Jamieson, Beth D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Martinez-Maza, Otoniel] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Martinez-Maza, Otoniel] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Martinez-Maza, Otoniel] Univ Calif Los Angeles, UCLA AIDS Inst, Los Angeles, CA USA; [Martinez-Maza, Otoniel] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Thapa, DR (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	omartinez@mednet.ucla.edu	Thapa, Dharma/C-2854-2012; Martinez-Maza, Otoniel/B-2667-2009	Martinez-Maza, Otoniel/0000-0003-1364-0675	California HIV Research Program (CHRP) [D08-LA-311]; National Institutes of Health [R01-CA57152, NCI U01-CA096230, P30-AI28697]; NCI [P30-AI28697, U01-AI35040, P30-CA016042]; James B. Pendleton Charitable Trust; McCarthy Family Foundation; NATIONAL CANCER INSTITUTE [R01CA057152, P30CA016042, U01CA096230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035040, P30AI028697] Funding Source: NIH RePORTER	California HIV Research Program (CHRP); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); James B. Pendleton Charitable Trust; McCarthy Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	DRT received fellowship support from the California HIV Research Program (CHRP) (D08-LA-311). These studies were supported by grants from the National Institutes of Health (R01-CA57152, and pilot project supplemental funds from the NCI to U01-AI35040, P30-AI28697 and P30-CA016042). Lymphoma specimens were provided by the AIDS and Cancer Specimen Resource (ACSR), which is supported by the NIH (NCI U01-CA096230). UCLA AIDS Institute Center for AIDS Research (CFAR) core facilities were used in this study and were supported by an NIH grant (P30-AI28697). This work was carried out in the facilities of the UCLA AIDS Institute, which were supported, in part, by funds from the James B. Pendleton Charitable Trust and the McCarthy Family Foundation. No additional external funding was received for this study. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	BALLERINI P, 1993, BLOOD, V81, P166; Baraniskin A, 2011, BLOOD; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; CALIN GA, 2006, NATURE REV, P847; Chen RW, 2008, BLOOD, V112, P822, DOI 10.1182/blood-2008-03-142182; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Crum-Cianflone N, 2009, AIDS, V23, P41, DOI 10.1097/QAD.0b013e328317cc2d; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Gaidano G, 1998, AM J PATHOL, V152, P623; Goedert JJ, 1998, LANCET, V351, P1833, DOI 10.1016/S0140-6736(97)09028-4; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Gottwein E, 2010, J VIROL, V84, P5229, DOI 10.1128/JVI.00202-10; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Inomata M, 2009, BLOOD, V113, P396, DOI 10.1182/blood-2008-07-163907; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jiang JM, 2006, GENE CHROMOSOME CANC, V45, P103, DOI 10.1002/gcc.20264; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kirk O, 2001, BLOOD, V98, P3406, DOI 10.1182/blood.V98.12.3406; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Kluiver J, 2006, GENE CHROMOSOME CANC, V45, P147, DOI 10.1002/gcc.20273; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li C, 2009, BLOOD, V113, P6681, DOI 10.1182/blood-2009-01-202028; Lin J, 2011, LEUKEMIA, V25, P145, DOI 10.1038/leu.2010.230; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Mao X, 2002, GENE CHROMOSOME CANC, V35, P144, DOI 10.1002/gcc.10104; Martin A, 1998, BRIT J HAEMATOL, V101, P311, DOI 10.1046/j.1365-2141.1998.00692.x; Mi SL, 2010, P NATL ACAD SCI USA, V107, P3710, DOI 10.1073/pnas.0914900107; Monni O, 1998, GENE CHROMOSOME CANC, V21, P298, DOI 10.1002/(SICI)1098-2264(199804)21:4<298::AID-GCC3>3.0.CO;2-U; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Neat MJ, 2001, GENE CHROMOSOME CANC, V32, P236, DOI 10.1002/gcc.1187; Nie K, 2008, AM J PATHOL, V173, P242, DOI 10.2353/ajpath.2008.080009; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; O'Hara AJ, 2008, BLOOD, V111, P2347, DOI 10.1182/blood-2007-08-104463; O'Hara AJ, 2009, BLOOD, V113, P5938, DOI 10.1182/blood-2008-09-179168; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Rao PH, 1998, BLOOD, V92, P234, DOI 10.1182/blood.V92.1.234.413k22_234_240; Raphael M, 2001, WHO CLASSIFICATION T, P260; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; TAN LP, 2009, LAB INVEST, P1; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; VILLUENDAS R, 1993, BLOOD, V82, P3151; Wong P, 2010, CANCER RES, V70, P3833, DOI 10.1158/0008-5472.CAN-09-3268; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Xia T, 2008, CANCER RES, V68, P1436, DOI 10.1158/0008-5472.CAN-07-5126; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Zhang J, 2009, BLOOD, V113, P4586, DOI 10.1182/blood-2008-09-178186	61	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20781	10.1371/journal.pone.0020781	http://dx.doi.org/10.1371/journal.pone.0020781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698185	Green Published, gold, Green Submitted			2022-12-25	WOS:000291734100021
J	Camm, EJ; Tijsseling, D; Richter, HG; Adler, A; Hansell, JA; Derks, JB; Cross, CM; Giussani, DA				Camm, Emily J.; Tijsseling, Deodata; Richter, Hans G.; Adler, Alexandra; Hansell, Jeremy A.; Derks, Jan B.; Cross, Christine M.; Giussani, Dino A.			Oxidative Stress in the Developing Brain: Effects of Postnatal Glucocorticoid Therapy and Antioxidants in the Rat	PLOS ONE			English	Article							NITRIC-OXIDE; VITAMIN-C; DEXAMETHASONE TREATMENT; NEONATAL DEXAMETHASONE; CORTICOSTEROID-THERAPY; ENDOTHELIAL-CELLS; CONTROLLED-TRIAL; LUNG-DISEASE; FETAL SHEEP; GROWTH	In premature infants, glucocorticoids ameliorate chronic lung disease, but have adverse effects on long-term neurological function. Glucocorticoid excess promotes free radical overproduction. We hypothesised that the adverse effects of postnatal glucocorticoid therapy on the developing brain are secondary to oxidative stress and that antioxidant treatment would diminish unwanted effects. Male rat pups received a clinically-relevant tapering course of dexamethasone (DEX; 0.5, 0.3, and 0.1 mg. kg(-1). day(-1)), with or without antioxidant vitamins C and E (DEXCE; 200 mg. kg(-1). day(-1) and 100 mg. kg(-1). day(-1), respectively), on postnatal days 1-6 (P1-6). Controls received saline or saline with vitamins. At weaning, relative to controls, DEX decreased total brain volume (704.4 +/- 34.7 mm(3) vs. 564.0 +/- 20.0 mm(3)), the soma volume of neurons in the CA1 (1172.6 +/- 30.4 mu m(3) vs. 1002.4 +/- 11.8 mu m(3)) and in the dentate gyrus (525.9 +/- 27.2 mu m(3) vs. 421.5 +/- 24.6 mu m(3)) of the hippocampus, and induced oxidative stress in the cortex (protein expression: heat shock protein 70 [Hsp70]: +68%; 4-hydroxynonenal [4-HNE]: +118% and nitrotyrosine [NT]: +20%). Dexamethasone in combination with vitamins resulted in improvements in total brain volume (637.5 +/- 43.1 mm(3)), and soma volume of neurons in the CA1 (1157.5 +/- 42.4 mu m(3)) and the dentate gyrus (536.1 +/- 27.2 mu m(3)). Hsp70 protein expression was unaltered in the cortex (+9%), however, 4-HNE (+95%) and NT (+24%) protein expression remained upregulated. Treatment of neonates with vitamins alone induced oxidative stress in the cortex (Hsp70: +67%; 4-HNE: +73%; NT: +22%) and in the hippocampus (NT: +35%). Combined glucocorticoid and antioxidant therapy in premature infants may be safer for the developing brain than glucocorticoids alone in the treatment of chronic lung disease. However, antioxidant therapy in healthy offspring is not recommended.	[Camm, Emily J.; Richter, Hans G.; Adler, Alexandra; Hansell, Jeremy A.; Cross, Christine M.; Giussani, Dino A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Tijsseling, Deodata; Derks, Jan B.] Univ Med Ctr, Dept Obstet, Utrecht, Netherlands	University of Cambridge; Utrecht University; Utrecht University Medical Center	Camm, EJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	dag26@cam.ac.uk	; Richter, Hans/D-6273-2013	Giussani, Dino/0000-0002-1308-1204; Richter, Hans/0000-0002-7224-9388	British Heart Foundation (BHF); Biotechnology and Biological Sciences Research Council (BBSRC); Fonds Internationalisering, University Medical Center, Utrecht	British Heart Foundation (BHF)(British Heart Foundation); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Fonds Internationalisering, University Medical Center, Utrecht	This study was supported by the British Heart Foundation (BHF), the Biotechnology and Biological Sciences Research Council (BBSRC) and the Fonds Internationalisering, University Medical Center, Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2010, NEONATOLOGY, V98, P73, DOI 10.1159/000275561; Ahlbom E, 2000, P NATL ACAD SCI USA, V97, P14726, DOI 10.1073/pnas.260501697; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Antonow-Schlorke I, 2003, J PHYSIOL-LONDON, V547, P117, DOI 10.1113/jphysiol.2002.025700; BADEN M, 1972, PEDIATRICS, V50, P526; Bal MP, 2005, PEDIATR RES, V58, P46, DOI 10.1203/01.PDR.0000163617.01673.9A; Behl C, 1997, ENDOCRINOLOGY, V138, P101, DOI 10.1210/en.138.1.101; Behl C, 1997, CELL TISSUE RES, V290, P471, DOI 10.1007/s004410050955; BURTON GW, 1994, P NUTR SOC, V53, P251, DOI 10.1079/PNS19940030; Cai S, 2002, CARDIOVASC RES, V55, P838, DOI 10.1016/S0008-6363(02)00460-1; Carr AC, 2000, CIRC RES, V87, P349, DOI 10.1161/01.RES.87.5.349; Chen K, 2004, ENDOTHELIUM-J ENDOTH, V11, P109, DOI 10.1080/10623320490482655; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; CUMMINGS JJ, 1989, NEW ENGL J MED, V320, P1505, DOI 10.1056/NEJM198906083202301; Daghini E, 2006, AM J PHYSIOL-REG I, V290, pR609, DOI 10.1152/ajpregu.00436.2005; DANIELS VG, 1973, J PHYSIOL-LONDON, V229, P681, DOI 10.1113/jphysiol.1973.sp010160; de la Monte SM, 2000, CELL MOL LIFE SCI, V57, P1471, DOI 10.1007/PL00000630; De Vries WB, 2002, PEDIATR RES, V52, P900, DOI 10.1203/01.PDR.0000036281.74804.27; Derks JB, 1997, J PHYSIOL-LONDON, V499, P217, DOI 10.1113/jphysiol.1997.sp021922; Duksal F, 2009, BRAIN RES, V1250, P75, DOI 10.1016/j.brainres.2008.10.051; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; EYSEL UT, 1984, J COMP NEUROL, V229, P301, DOI 10.1002/cne.902290214; Flagel SB, 2002, AM J PHYSIOL-REG I, V282, pR55, DOI 10.1152/ajpregu.2002.282.1.R55; Fletcher AJW, 2002, J PHYSIOL-LONDON, V545, P649, DOI 10.1113/jphysiol.2001.015693; Fowden AL, 2004, REPRODUCTION, V127, P515, DOI 10.1530/rep.1.00033; FREI B, 1989, P NATL ACAD SCI USA, V86, P6377, DOI 10.1073/pnas.86.16.6377; French NP, 1999, AM J OBSTET GYNECOL, V180, P114, DOI 10.1016/S0002-9378(99)70160-2; GEETHA A, 1989, Indian Journal of Physiology and Pharmacology, V33, P53; Grier DG, 2005, DRUGS, V65, P15, DOI 10.2165/00003495-200565010-00002; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Halliday HL, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001145.pub2, 10.1002/14651858.CD001146.pub2]; Halliday HL, 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001145, 10.1002/14651858.CD001145]; Halliday HL, 2003, COCHRANE DB SYST REV; Halliday HL, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001144; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; He J, 2004, AM J PHYSIOL-REG I, V287, pR198, DOI 10.1152/ajpregu.00349.2003; Heller R, 1999, J BIOL CHEM, V274, P8254, DOI 10.1074/jbc.274.12.8254; Huang WL, 1999, OBSTET GYNECOL, V94, P213, DOI 10.1016/S0029-7844(99)00265-3; Iuchi T, 2003, CIRC RES, V92, P81, DOI 10.1161/01.RES.0000050588.35034.3C; Jackson TS, 1998, CIRC RES, V83, P916; Johns DG, 2001, EXP BIOL MED, V226, P27, DOI 10.1177/153537020122600104; Kanagawa T, 2006, AM J OBSTET GYNECOL, V194, P231, DOI 10.1016/j.ajog.2005.06.015; Khassaf M, 2003, J PHYSIOL-LONDON, V549, P645, DOI 10.1113/jphysiol.2003.040303; KIERNAN JA, 1991, BRAIN, V114, P843, DOI 10.1093/brain/114.2.843; Lohle M, 2005, J PHYSIOL-LONDON, V564, P575, DOI 10.1113/jphysiol.2004.077537; McIntosh LJ, 1996, EXP NEUROL, V141, P201, DOI 10.1006/exnr.1996.0154; McIntosh LJ, 1998, BRAIN RES, V791, P209, DOI 10.1016/S0006-8993(98)00115-2; Mitsui T, 2002, ACTA NEUROPATHOL, V104, P260, DOI 10.1007/s00401-002-0553-5; MOUNTJOY CQ, 1983, NEUROBIOL AGING, V4, P1, DOI 10.1016/0197-4580(83)90048-9; MUNCK A, 1971, PERSPECT BIOL MED, V14, P265; Neal CR, 2004, AM J PHYSIOL-REG I, V287, pR375, DOI 10.1152/ajpregu.00012.2004; OLANOW CW, 1993, TRENDS NEUROSCI, V16, P439, DOI 10.1016/0166-2236(93)90070-3; Oncu M, 2002, HUM EXP TOXICOL, V21, P223, DOI 10.1191/0960327102ht225oa; Papile LA, 1998, NEW ENGL J MED, V338, P1112, DOI 10.1056/NEJM199804163381604; *PED AAO, 2002, PEDIATRICS, V109, P330; Radernaker KJ, 2008, ARCH DIS CHILD-FETAL, V93, pF58, DOI 10.1136/adc.2007.119545; Rajashree S, 1998, MOL CELL BIOCHEM, V181, P77, DOI 10.1023/A:1006833824163; Sahin N, 2009, BRIT POULTRY SCI, V50, P259, DOI 10.1080/00071660902758981; Schafer SC, 2005, AM J PHYSIOL-HEART C, V288, pH436, DOI 10.1152/ajpheart.00587.2004; Scheepens A, 2003, J PHYSIOL-LONDON, V552, P163, DOI 10.1113/jphysiol.2003.043414; Shinwell ES, 2000, ARCH DIS CHILD-FETAL, V83, pF177, DOI 10.1136/fn.83.3.F177; SICARD RE, 1992, PEDIATR RES, V31, P359, DOI 10.1203/00006450-199204000-00011; THIBEAULT DW, 1993, PEDIATR PULM, V16, P81, DOI 10.1002/ppul.1950160202; Thorp JA, 2002, OBSTET GYNECOL, V99, P109, DOI 10.1016/S0029-7844(01)01657-X; UNO H, 1994, HORM BEHAV, V28, P336, DOI 10.1006/hbeh.1994.1030; Versari D, 2006, HYPERTENSION, V47, P475, DOI 10.1161/01.HYP.0000201445.77125.26; Wagner JP, 1999, J NEUROSCI, V19, P6006, DOI 10.1523/JNEUROSCI.19-14-06006.1999; Wallerath T, 1999, P NATL ACAD SCI USA, V96, P13357, DOI 10.1073/pnas.96.23.13357; WEICHSEL ME, 1977, ANN NEUROL, V2, P364, DOI 10.1002/ana.410020503; Weiler HA, 1997, BIOL NEONATE, V71, P53, DOI 10.1159/000244397; Whitworth JA, 2002, J HYPERTENS, V20, P1035, DOI 10.1097/00004872-200206000-00003; Wilson JX, 2009, BIOFACTORS, V35, P5, DOI 10.1002/biof.7; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089; Zhang Y, 2004, AM J HYPERTENS, V17, P260, DOI 10.1016/j.amjhyper.2003.11.004	74	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21142	10.1371/journal.pone.0021142	http://dx.doi.org/10.1371/journal.pone.0021142			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698270	Green Published, Green Submitted, gold			2022-12-25	WOS:000291730000056
J	Pelikan-Conchaudron, A; Le Clainche, C; Didry, D; Carlier, MF				Pelikan-Conchaudron, Andrea; Le Clainche, Christophe; Didry, Dominique; Carlier, Marie-France			The IQGAP1 Protein Is a Calmodulin-regulated Barbed End Capper of Actin Filaments POSSIBLE IMPLICATIONS IN ITS FUNCTION IN CELL MIGRATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; N-WASP; CRYSTAL-STRUCTURE; INTEGRATES CA2+/CALMODULIN; PEDESTAL FORMATION; SHIGELLA-FLEXNERI; STRUCTURAL BASIS; HOMOLOGY DOMAIN; ACTOMYOSIN RING; F-ACTIN	IQGAP1 is a large modular protein that displays multiple partnership and is thought to act as a scaffold in coupling cell signaling to the actin and microtubule cytoskeletons in cell migration, adhesion, and cytokinesis. However the molecular mechanisms underlying the activities of IQGAP1 are poorly understood in part because of its large size, poor solubility and lack of functional assays to challenge biochemical properties in various contexts. We have purified bacterially expressed recombinant human IQGAP1. The protein binds Cdc42, Rac1, and the CRIB domain of N-WASP in a calmodulin-sensitive fashion. We further show that in addition to bundling of filaments via a single N-terminal calponin-homology domain, IQGAP1 actually regulates actin assembly. It caps barbed ends, with a higher affinity for ADP-bound terminal subunits (K-B = 4 nM). The barbed end capping activity is inhibited by calmodulin, consistent with calmodulin binding to IQGAP1 with a K-C of 40 nM, both in the absence and presence of Ca2+ ions. The barbed end capping activity resides in the C-terminal half of IQGAP1. It is possible that the capping activity of IQGAP1 accounts for its stimulation of cell migration. We further find that bacterially expressed recombinant IQGAP1 fragments easily co-purify with nucleic acids that turn out to activate N-WASP protein to branch filaments with Arp2/3 complex. The present results open perspectives for tackling the function of IQGAP1 in more complex reconstituted systems.	[Pelikan-Conchaudron, Andrea; Le Clainche, Christophe; Didry, Dominique; Carlier, Marie-France] CNRS, Cytoskeleton Dynam & Motil Grp, Lab Enzymol & Biochim Struct, UPR 3289, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Carlier, MF (corresponding author), CNRS, Cytoskeleton Dynam & Motil Grp, Lab Enzymol & Biochim Struct, UPR 3289, F-91198 Gif Sur Yvette, France.	carlier@lebs.cnrs-gif.fr	Le Clainche, Christophe/A-4782-2015	Le Clainche, Christophe/0000-0001-5659-677X	ANR-PCV; ERC; Ligue Nationale contre le Cancer (MFC is equipe labellisee Ligue); European Community [241548]; French Minister of Research; EU [241548]	ANR-PCV(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission); Ligue Nationale contre le Cancer (MFC is equipe labellisee Ligue)(Institut National du Cancer (INCA) France); European Community(European Commission); French Minister of Research; EU(European Commission)	This work was supported in part by ANR-PCV 2006, an ERC advanced grant (2009) (to M.-F.C.), the Ligue Nationale contre le Cancer (MFC is equipe labellisee Ligue), and the European Community's Seventh Framework Programme [FP7/2007-2013] under Grant agreement n<SUP>o</SUP> 241548.; Supported by a fellowship from the French Minister of Research and by EU FP7 Grant 241548.	Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Brown MD, 2008, J BIOL CHEM, V283, P35212, DOI 10.1074/jbc.M803477200; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; CASELLA JF, 1986, J BIOL CHEM, V261, P915; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Chereau D, 2006, J STRUCT BIOL, V155, P195, DOI 10.1016/j.jsb.2006.01.012; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Eng K, 1998, CURR BIOL, V8, P611, DOI 10.1016/S0960-9822(98)70248-9; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Grohmanova K, 2004, J BIOL CHEM, V279, P48495, DOI 10.1074/jbc.M408113200; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Heil A, 2011, J BIOL CHEM, V286, P7227, DOI 10.1074/jbc.M110.135095; Helfer E, 2006, EMBO J, V25, P1184, DOI 10.1038/sj.emboj.7601019; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Hertzog M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000387; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Husson C, 2010, ANN NY ACAD SCI, V1194, P44, DOI 10.1111/j.1749-6632.2010.05473.x; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Kim T, 2010, J MOL BIOL, V404, P794, DOI 10.1016/j.jmb.2010.10.017; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Kurella VB, 2009, J BIOL CHEM, V284, P14857, DOI 10.1074/jbc.M808974200; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V262, P1, DOI 10.1006/bbrc.1999.1122; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Le Clainche C, 2007, J BIOL CHEM, V282, P426, DOI 10.1074/jbc.M607711200; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; Machesky LM, 1998, CURR BIOL, V8, pR202, DOI 10.1016/S0960-9822(98)70125-3; Mateer SC, 2004, CELL MOTIL CYTOSKEL, V58, P231, DOI 10.1002/cm.20013; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Morrison EE, 2009, ADV EXP MED BIOL, V656, P41, DOI 10.1007/978-1-4419-1145-2_4; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Ren JG, 2008, J BIOL CHEM, V283, P22972, DOI 10.1074/jbc.M804626200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Rittmeyer EN, 2008, J CELL SCI, V121, P391, DOI 10.1242/jcs.016881; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Shannon KB, 1999, MOL BIOL CELL, V10, P283, DOI 10.1091/mbc.10.2.283; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Umemoto R, 2010, J BIOMOL NMR, V48, P59, DOI 10.1007/s10858-010-9434-8; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; Wiesner S, 2003, J CELL BIOL, V160, P387, DOI 10.1083/jcb.200207148; Yamashita A, 2003, EMBO J, V22, P1529, DOI 10.1093/emboj/cdg167	58	35	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35119	35128		10.1074/jbc.M111.258772	http://dx.doi.org/10.1074/jbc.M111.258772			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21730051	hybrid, Green Published			2022-12-25	WOS:000295406300065
J	May, LT; Bridge, LJ; Stoddart, LA; Briddon, SJ; Hill, SJ				May, Lauren T.; Bridge, Lloyd J.; Stoddart, Leigh A.; Briddon, Stephen J.; Hill, Stephen J.			Allosteric interactions across native adenosine-A(3) receptor homodimers: quantification using single-cell ligand-binding kinetics	FASEB JOURNAL			English	Article						dissociation; cooperativity; GPCRs	PROTEIN-COUPLED RECEPTORS; DRUG DISCOVERY; LIVING CELLS; MUSCARINIC RECEPTORS; TARGETS; COOPERATIVITY; ACTIVATION; OLIGOMERS; MODEL; GPCR	A growing awareness indicates that many G-protein-coupled receptors (GPCRs) exist as homodimers, but the extent of the cooperativity across the dimer interface has been largely unexplored. Here, measurement of the dissociation kinetics of a fluorescent agonist (ABA-X-BY630) from the human A(1) or A(3) adenosine receptors expressed in CHO-K1 cells has provided evidence for highly cooperative interactions between protomers of the A(3)-receptor dimer in single living cells. In the absence of competitive ligands, the dissociation rate constants of ABA-X-BY630 from A(1) and A(3) receptors were 1.45 +/- 0.05 and 0.57 +/- 0.07 min(-1), respectively. At the A(3) receptor, this could be markedly increased by both orthosteric agonists and antagonists [15-, 9-, and 19-fold for xanthine amine congener (XAC), 5'-(N-ethyl carboxamido)adenosine (NECA), and adenosine, respectively] and reduced by coexpression of a nonbinding (N250A) A(3)-receptor mutant. The changes in ABA-X-BY630 dissociation were much lower at the A(1) receptor (1.5-, 1.4-, and 1.5-fold). Analysis of the pEC(50) values of XAC, NECA, and adenosine for the ABA-X-BY630-occupied A(3)-receptor dimer yielded values of 6.0 +/- 0.1, 5.9 +/- 0.1, and 5.2 +/- 0.1, respectively. This study provides new insight into the spatial and temporal specificity of drug action that can be provided by allosteric modulation across a GPCR homodimeric interface.-May, L. T., Bridge, L. J., Stoddart, L. A., Briddon, S. J., Hill, S. J. Allosteric interactions across native adenosine-A(3) receptor homodimers: quantification using single-cell ligand-binding kinetics. FASEB J. 25, 3465-3476 (2011). www.fasebj.org	[May, Lauren T.; Bridge, Lloyd J.; Stoddart, Leigh A.; Briddon, Stephen J.; Hill, Stephen J.] Univ Nottingham, Sch Biomed Sci, Inst Cell Signalling, Nottingham NG7 2UH, England	University of Nottingham	Hill, SJ (corresponding author), Univ Nottingham, Sch Med, Queens Med Ctr, Inst Cell Signalling, Nottingham NG7 2UH, England.	stephen.hill@nottingham.ac.uk	Hill, Stephen J/M-6243-2018; Hill, Stephen/N-6753-2013	Hill, Stephen J/0000-0002-4424-239X; Hill, Stephen/0000-0002-4424-239X; Briddon, Stephen/0000-0001-8514-0827; Stoddart, Leigh/0000-0002-4469-0600; May, Lauren/0000-0002-4412-1707	UK Biotechnology and Biological Sciences Research Council [BB/D008522]; UK Medical Research Council [G0800006]; Biotechnology and Biological Sciences Research Council [BB/D008522/1] Funding Source: researchfish; Medical Research Council [G0800006] Funding Source: researchfish; BBSRC [BB/D008522/1] Funding Source: UKRI; MRC [G0800006] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank N.D. Holliday for useful discussions. This work was supported by the UK Biotechnology and Biological Sciences Research Council (BB/D008522) and the UK Medical Research Council (G0800006). L.T.M. is an Australian National Health and Medical Research Council Postdoctoral Research Fellow. L.T.M. designed and performed kinetic fluorescent ligand-binding assays and analysis. L.J.B. developed and performed parameter estimation methods. L.A.S., S.J.B., and S.J.H. generated the AR constructs. S.J.B. performed the BiFC experiments. L.T.M., L.J.B., S.J.B., and S.J.H. designed experiments and interpreted results. All authors participated in the writing and editing of the manuscript. S.J.H. managed the overall project.	Agnati LF, 2003, PHARMACOL REV, V55, P509, DOI 10.1124/pr.55.3.2; Armstrong D, 2001, J BIOL CHEM, V276, P22621, DOI 10.1074/jbc.M006936200; ATTWOOD TK, 1994, PROTEIN ENG, V7, P195, DOI 10.1093/protein/7.2.195; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Birdsall NJM, 2010, TRENDS PHARMACOL SCI, V31, P499, DOI 10.1016/j.tips.2010.08.003; Birdsall NJM, 2005, MINI-REV MED CHEM, V5, P523, DOI 10.2174/1389557054023251; Bortolato A, 2009, CURR PHARM DESIGN, V15, P4017, DOI 10.2174/138161209789824768; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Brea J, 2009, MOL PHARMACOL, V75, P1380, DOI 10.1124/mol.108.054395; Briddon SJ, 2008, BBA-MOL CELL RES, V1783, P2262, DOI 10.1016/j.bbamcr.2008.07.006; Casado V, 2009, PHARMACOL THERAPEUT, V124, P248, DOI 10.1016/j.pharmthera.2009.07.005; Chidiac P, 1997, BIOCHEMISTRY-US, V36, P7361, DOI 10.1021/bi961939t; Christopoulos A, 1997, BIOCHEM PHARMACOL, V53, P795, DOI 10.1016/S0006-2952(96)00814-3; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Cordeaux Y, 2008, FASEB J, V22, P850, DOI 10.1096/fj.07-8180com; Cordeaux Y, 2000, MOL PHARMACOL, V58, P1075, DOI 10.1124/mol.58.5.1075; Durroux T, 2005, TRENDS PHARMACOL SCI, V26, P376, DOI 10.1016/j.tips.2005.05.006; Franco R, 2005, TRENDS BIOCHEM SCI, V30, P360, DOI 10.1016/j.tibs.2005.05.010; Franco R, 2006, MOL PHARMACOL, V69, P1905, DOI 10.1124/mol.105.020685; Gao ZG, 2002, J BIOL CHEM, V277, P19056, DOI 10.1074/jbc.M110960200; Gao ZG, 2008, PHARMACOL RES, V57, P303, DOI 10.1016/j.phrs.2008.02.008; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Kenakin T, 2002, TRENDS PHARMACOL SCI, V23, P275, DOI 10.1016/S0165-6147(02)02036-9; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; May LT, 2010, MOL PHARMACOL, V77, P678, DOI 10.1124/mol.109.063065; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; May LT, 2010, MOL PHARMACOL, V78, P511, DOI 10.1124/mol.110.064493; Middleton RJ, 2007, J MED CHEM, V50, P782, DOI 10.1021/jm061279i; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rose RH, 2010, BRIT J PHARMACOL, V159, P738, DOI 10.1111/j.1476-5381.2009.00480.x; Rovira X, 2009, BRIT J PHARMACOL, V156, P28, DOI 10.1111/j.1476-5381.2008.00031.x; Rovira X, 2010, TRENDS PHARMACOL SCI, V31, P15, DOI 10.1016/j.tips.2009.10.008; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; WREGGETT KA, 1995, J BIOL CHEM, V270, P22488, DOI 10.1074/jbc.270.38.22488	47	74	74	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2011	25	10					3465	3476		10.1096/fj.11-186296	http://dx.doi.org/10.1096/fj.11-186296			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21715680	hybrid, Green Published			2022-12-25	WOS:000295356400017
J	Dorjbal, B; Derse, D; Lloyd, P; Soheilian, F; Nagashima, K; Heidecker, G				Dorjbal, Batsukh; Derse, David; Lloyd, Patricia; Soheilian, Ferri; Nagashima, Kunio; Heidecker, Gisela			The Role of ITCH Protein in Human T-cell Leukemia Virus Type 1 Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATE-BUDDING DOMAINS; NEDD4-LIKE UBIQUITIN LIGASE; INFECTIOUS-ANEMIA VIRUS; IMMUNODEFICIENCY-VIRUS; MULTIVESICULAR BODY; PARTICLE RELEASE; ESCRT MACHINERY; SORTING PATHWAY; MATRIX PROTEIN; HOST PROTEINS	Human T-cell leukemia virus type 1 (HTLV-1) has two late domain (LD) motifs, PPPY and PTAP, which are important for viral budding. Mutations in the PPPY motif are more deleterious for viral release than changes in the PTAP motif. Several reports have shown that the interaction of PPPY with the WW domains of a Nedd4 (neuronal precursor cell-expressed developmentally down-regulated-4) family ubiquitin ligase (UL) is a critical event in virus release. We tested nine members of the Nedd4 family ULs and found that ITCH is the main contributor to HTLV-1 budding. ITCH overexpression strongly inhibited release and infectivity of wild-type (wt) HTLV-1, but rescued the release of infectious virions with certain mutations in the PPPY motif. Electron microscopy showed either fewer or misshapen virus particles when wt HTLV-1 was produced in the presence of overexpressed ITCH, whereas mutants with changes in the PPPY motif yielded normal looking particles at wt level. The other ULs had significantly weaker or no effects on HTLV-1 release and infectivity except for SMURF-1, which caused enhanced release of wt and all PPPY- mutant particles. These particles were poorly infectious and showed abnormal morphology by electron microscopy. Budding and infectivity defects due to overexpression of ITCH and SMURF-1 were correlated with higher than normal ubiquitination of Gag. Only silencing of ITCH, but not of WWP1, WWP2, and Nedd4, resulted in a reduction of HTLV-1 budding from 293T cells. The binding efficiencies between the HTLV-1 LD and WW domains of different ULs as measured by mammalian two-hybrid interaction did not correlate with the strength of their effect on HTLV-1 budding.	[Dorjbal, Batsukh; Derse, David; Heidecker, Gisela] NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA; [Lloyd, Patricia] SAIC, Basic Res Program, Frederick, MD 21702 USA; [Soheilian, Ferri; Nagashima, Kunio] SAIC, Image Anal Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Science Applications International Corporation (SAIC); SAIC-Frederick	Heidecker, G (corresponding author), NCI, HIV Drug Resistance Program, POB B,Bldg 535,Rm 111, Frederick, MD 21702 USA.	heidecke@mail.nih.gov			National Institutes of Health, NCI, Center for Cancer Research	National Institutes of Health, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research.	Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Blot V, 2004, J CELL SCI, V117, P2357, DOI 10.1242/jcs.01095; Bouamr F, 2003, J VIROL, V77, P11882, DOI 10.1128/JVI.77.22.11882-11895.2003; Calistri A, 2009, J CELL PHYSIOL, V218, P175, DOI 10.1002/jcp.21587; Carlton JG, 2009, BIOCHEM SOC T, V37, P195, DOI 10.1042/BST0370195; Chen K, 2008, BIOCHEMISTRY-US, V47, P1928, DOI 10.1021/bi701984h; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; CURCIO MJ, 1991, P NATL ACAD SCI USA, V88, P936, DOI 10.1073/pnas.88.3.936; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Demirov DG, 2002, J VIROL, V76, P105, DOI 10.1128/JVI.76.1.105-117.2002; Derse D, 2001, J VIROL, V75, P8461, DOI 10.1128/JVI.75.18.8461-8468.2001; Dussupt V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000339; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Freed EO, 2002, J VIROL, V76, P4679, DOI 10.1128/JVI.76.10.4679-4687.2002; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gottwein E, 2003, J VIROL, V77, P9474, DOI 10.1128/JVI.77.17.9474-9485.2003; Gottwein E, 2006, J VIROL, V80, P6267, DOI 10.1128/JVI.02177-05; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Harty RN, 1999, J VIROL, V73, P2921, DOI 10.1128/JVI.73.4.2921-2929.1999; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Heidecker G, 2004, J VIROL, V78, P6636, DOI 10.1128/JVI.78.12.6636-6648.2004; Heidecker G, 2007, J VIROL, V81, P9769, DOI 10.1128/JVI.00642-07; HEIDMANN O, 1991, CELL, V64, P159, DOI 10.1016/0092-8674(91)90217-M; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Jadwin JA, 2010, J VIROL, V84, P704, DOI 10.1128/JVI.01319-09; Joshi A, 2008, TRAFFIC, V9, P1972, DOI 10.1111/j.1600-0854.2008.00817.x; Kikonyogo A, 2001, P NATL ACAD SCI USA, V98, P11199, DOI 10.1073/pnas.201268998; Le Blanc I, 2002, J VIROL, V76, P10024, DOI 10.1128/JVI.76.19.10024-10029.2002; Licata JM, 2003, J VIROL, V77, P1812, DOI 10.1128/JVI.77.3.1812-1819.2003; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Martin-Serrano J, 2007, TRAFFIC, V8, P1297, DOI 10.1111/j.1600-0854.2007.00609.x; Mazurov D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000788; Mitchell MS, 2007, J VIROL, V81, P4422, DOI 10.1128/JVI.02660-06; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ott DE, 1998, J VIROL, V72, P2962, DOI 10.1128/JVI.72.4.2962-2968.1998; Ott DE, 2002, J VIROL, V76, P3038, DOI 10.1128/JVI.76.6.3038-3044.2002; Patnaik A, 2000, P NATL ACAD SCI USA, V97, P13069, DOI 10.1073/pnas.97.24.13069; Pornillos O, 2002, TRENDS CELL BIOL, V12, P569, DOI 10.1016/S0962-8924(02)02402-9; PUTTERMAN D, 1990, VIROLOGY, V176, P633, DOI 10.1016/0042-6822(90)90035-P; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sette P, 2010, J VIROL, V84, P8181, DOI 10.1128/JVI.00634-10; Strack B, 2000, P NATL ACAD SCI USA, V97, P13063, DOI 10.1073/pnas.97.24.13063; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Urata S, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-66; Usami Y, 2008, J VIROL, V82, P4898, DOI 10.1128/JVI.02675-07; Usami Y, 2009, BIOCHEM SOC T, V37, P181, DOI 10.1042/BST0370181; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Wang HT, 2004, J VIROL, V78, P1503, DOI 10.1128/JVI.78.3.1503-1512.2004; Weiss ER, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001107; WORLK T, 2007, CELL DIV, V2, P11; Yasuda J, 2002, EMBO REP, V3, P636, DOI 10.1093/embo-reports/kvf132; Yuan B, 2000, J VIROL, V74, P7250, DOI 10.1128/JVI.74.16.7250-7260.2000; Zhadina M, 2007, P NATL ACAD SCI USA, V104, P20031, DOI 10.1073/pnas.0708002104; Zhadina M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001153; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	64	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31092	31104		10.1074/jbc.M111.259945	http://dx.doi.org/10.1074/jbc.M111.259945			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21724848	Green Published, hybrid			2022-12-25	WOS:000294487500004
J	Tanabe, Y; Maruyama, J; Yamaoka, S; Yahagi, D; Matsuo, I; Tsutsumi, N; Kitamoto, K				Tanabe, Yasuko; Maruyama, Jun-ichi; Yamaoka, Shohei; Yahagi, Daiki; Matsuo, Ichiro; Tsutsumi, Nobuhiro; Kitamoto, Katsuhiko			Peroxisomes Are Involved in Biotin Biosynthesis in Aspergillus and Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; FATTY-ACID SYNTHESIS; SACCHAROMYCES-CEREVISIAE; COLLETOTRICHUM-LAGENARIUM; PODOSPORA-ANSERINA; EMBRYO DEVELOPMENT; METABOLIC FUNCTION; PLANT PEROXISOMES; PROTEIN-TRANSPORT; GENE	Among the eukaryotes only plants and a number of fungi are able to synthesize biotin. Although initial events leading to the biosynthesis of biotin remain largely unknown, the final steps are known to occur in the mitochondria. Here we deleted the Aopex5 and Aopex7 genes encoding the receptors for peroxisomal targeting signals PTS1 and PTS2, respectively, in the filamentous fungus Aspergillus oryzae. In addition to exhibiting defects in the peroxisomal targeting of either PTS1 or PTS2 proteins, the deletion strains also displayed growth defects on minimal medium containing oleic acid as the sole carbon source. Unexpectedly, these peroxisomal transport-deficient strains also exhibited growth defects on minimal medium containing glucose as the sole carbon source that were remediated by the addition of biotin and its precursors, including 7-keto-8-aminopelargonic acid (KAPA). Genome database searches in fungi and plants revealed that BioF protein/KAPA synthase, one of the biotin biosynthetic enzymes, has a PTS1 sequence at the C terminus. Fungal Delta bioF strains expressing the fungal and plant BioF proteins lacking PTS1 still exhibited growth defects in the absence of biotin, indicating that peroxisomal targeting of KAPA synthase is crucial for the biotin biosynthesis. Furthermore, in the plant Arabidopsis thaliana, AtBioF localized to the peroxisomes through recognition of its PTS1 sequence, suggesting involvement of peroxisomes in biotin biosynthesis in plants. Taken together we demonstrate a novel role for peroxisomes in biotin biosynthesis and suggest the presence of as yet unidentified peroxisomal proteins that function in the earlier steps of biotin biosynthesis.	[Tanabe, Yasuko; Maruyama, Jun-ichi; Yahagi, Daiki; Kitamoto, Katsuhiko] Univ Tokyo, Dept Biotechnol, Tokyo 1138657, Japan; [Yamaoka, Shohei; Tsutsumi, Nobuhiro] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Yamaoka, Shohei] Kyoto Univ, Grad Sch Sci, Kyoto 6068502, Japan; [Matsuo, Ichiro] Gunma Univ, Dept Chem & Chem Biol, Gunma 3768515, Japan	University of Tokyo; University of Tokyo; Kyoto University; Gunma University	Maruyama, J (corresponding author), Bunkyo Ku, Tokyo 1138657, Japan.	amarujun@mail.ecc.u-tokyo.ac.jp	Tsutsumi, Nobuhiro/C-6051-2016	Tsutsumi, Nobuhiro/0000-0002-2610-6837	Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [23770043] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Young Scientist (to J. M. and S. Y.) and Research Fellowship for Young Scientist (to S. Y.) from the Japan Society for the Promotion of Science.	Al-Feel W, 2003, P NATL ACAD SCI USA, V100, P3095, DOI 10.1073/pnas.0538069100; Arnal N, 2006, PLANT MOL BIOL, V62, P471, DOI 10.1007/s11103-006-9034-x; Asakura M, 2006, APPL ENVIRON MICROB, V72, P6345, DOI 10.1128/AEM.00988-06; BAILEY A, 1995, MOL GEN GENET, V249, P191, DOI 10.1007/BF00290366; Baud S, 2003, PLANT J, V33, P75, DOI 10.1046/j.1365-313X.2003.016010.x; Bonnet C, 2006, MOL MICROBIOL, V62, P157, DOI 10.1111/j.1365-2958.2006.05353.x; BOWER S, 1995, J BACTERIOL, V177, P2572, DOI 10.1128/jb.177.9.2572-2575.1995; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Escano CS, 2009, EUKARYOT CELL, V8, P296, DOI 10.1128/EC.00197-08; Fan JL, 2005, PLANT PHYSIOL, V139, P231, DOI 10.1104/pp.105.066811; Girzalsky W, 2009, BIOL CHEM, V390, P745, DOI 10.1515/BC.2009.104; Gould SJ, 2000, TRENDS GENET, V16, P340, DOI 10.1016/S0168-9525(00)02056-4; Hall C, 2007, GENETICS, V177, P2293, DOI 10.1534/genetics.107.074963; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; Heiland I, 2005, FEBS J, V272, P2362, DOI 10.1111/j.1742-4658.2005.04690.x; Hu JP, 2002, SCIENCE, V297, P405, DOI 10.1126/science.1073633; Hynes MJ, 2008, GENETICS, V178, P1355, DOI 10.1534/genetics.107.085795; Idnurm A, 2007, EUKARYOT CELL, V6, P60, DOI 10.1128/EC.00214-06; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Kiel JAKW, 2005, FUNGAL GENET BIOL, V42, P154, DOI 10.1016/j.fgb.2004.10.010; Kimura A, 2001, PLANT CELL, V13, P1945, DOI 10.1105/tpc.13.8.1945; Kitamoto K, 2002, ADV APPL MICROBIOL, V51, P129, DOI 10.1016/S0065-2164(02)51004-2; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; Kunze M, 2002, EUR J BIOCHEM, V269, P915, DOI 10.1046/j.0014-2956.2001.02727.x; Kunze M, 2006, BBA-MOL CELL RES, V1763, P1441, DOI 10.1016/j.bbamcr.2006.09.009; Lin S, 2010, NAT CHEM BIOL, V6, P682, DOI [10.1038/nchembio.420, 10.1038/NCHEMBIO.420]; Liu FF, 2008, J CELL BIOL, V180, P325, DOI 10.1083/jcb.200705049; Mano S, 2005, VITAM HORM, V72, P111, DOI 10.1016/S0083-6729(05)72004-5; Mano S, 2006, PLANT J, V47, P604, DOI 10.1111/j.1365-313X.2006.02809.x; Muralla R, 2008, PLANT PHYSIOL, V146, P60, DOI 10.1104/pp.107.107409; OHSUGI M, 1988, J NUTR SCI VITAMINOL, V34, P343, DOI 10.3177/jnsv.34.343; Peraza-Reyes L, 2008, TRAFFIC, V9, P1998, DOI 10.1111/j.1600-0854.2008.00812.x; Pinon V, 2005, PLANT PHYSIOL, V139, P1666, DOI 10.1104/pp.105.070144; PLOUX O, 1992, BIOCHEM J, V283, P327, DOI 10.1042/bj2830327; Rebeille F, 2007, PHOTOSYNTH RES, V92, P149, DOI 10.1007/s11120-007-9167-z; Reumann S, 2006, BBA-MOL CELL RES, V1763, P1496, DOI 10.1016/j.bbamcr.2006.09.008; ROPER JA, 1950, NATURE, V166, P956, DOI 10.1038/166956b0; Schneiter R, 1996, MOL CELL BIOL, V16, P7161; Schneiter R, 2000, MOL CELL BIOL, V20, P2984, DOI 10.1128/MCB.20.9.2984-2995.2000; Schumann U, 2003, P NATL ACAD SCI USA, V100, P9626, DOI 10.1073/pnas.1633697100; Sparkes IA, 2003, PLANT PHYSIOL, V133, P1809, DOI 10.1104/pp.103.031252; Streit WR, 2003, APPL MICROBIOL BIOT, V61, P21, DOI 10.1007/s00253-002-1186-2; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; van der Klei IJ, 2006, BBA-MOL CELL RES, V1763, P1453, DOI 10.1016/j.bbamcr.2006.07.016; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Weber H, 2002, TRENDS PLANT SCI, V7, P217, DOI 10.1016/S1360-1385(02)02250-1; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Zempleni J, 2005, ANNU REV NUTR, V25, P175, DOI 10.1146/annurev.nutr.25.121304.131724	51	44	45	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30455	30461		10.1074/jbc.M111.247338	http://dx.doi.org/10.1074/jbc.M111.247338			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730067	hybrid, Green Published			2022-12-25	WOS:000294283600024
J	Tan, JQ; Zhang, TM; Jiang, L; Chi, JW; Hu, DS; Pan, Q; Wang, DL; Zhang, ZH				Tan, Jieqiong; Zhang, Tongmei; Jiang, Li; Chi, Jingwei; Hu, Dongshen; Pan, Qian; Wang, Danling; Zhang, Zhuohua			Regulation of Intracellular Manganese Homeostasis by Kufor-Rakeb Syndrome-associated ATP13A2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PALLIDO-PYRAMIDAL DEGENERATION; SUPRANUCLEAR UPGAZE PARESIS; ONSET PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; IRON TRANSPORT; BRAIN; MUTATIONS; DEMENTIA; APOPTOSIS; TOXICITY	Mutations in the ATP13A2 gene are associated with Kufor-Rakeb syndrome (KRS) and are found also in patients with various other types of parkinsonism. ATP13A2 encodes a predicted lysosomal P5-type ATPase that plays important roles in regulating cation homeostasis. Disturbance of cation homeostasis in brains is indicated in Parkinson disease pathogenesis. In this study, we explored the biological function of ATP13A2 as well as the pathogenic mechanism of KRS pathogenic ATP13A2 mutants. The results revealed that wild-type ATP13A2, but not the KRS pathogenic ATP13A2 mutants, protected cells from Mn2+-induced cell death in mammalian cell lines and primary rat neuronal cultures. In addition, wild-type ATP13A2 reduced intracellular manganese concentrations and prevented cytochrome c release from mitochondria compared with the pathogenic mutants. Furthermore, endogenous ATP13A2 was up-regulated upon Mn2+ treatment. Our results suggest that ATP13A2 plays important roles in protecting cells against manganese cytotoxicity via regulating intracellular manganese homeostasis. The study provides a potential mechanism of KRS and parkinsonism pathogenesis.	[Tan, Jieqiong; Zhang, Tongmei; Chi, Jingwei; Pan, Qian; Wang, Danling; Zhang, Zhuohua] Cent S Univ, Xiangya Med Sch, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Jiang, Li; Hu, Dongshen] Nanhai Entry Exit Inspect & Quarantine Bur, Foshan 528200, Peoples R China; [Zhang, Zhuohua] Burnham Inst Med Res, La Jolla, CA 92037 USA	Central South University; Sanford Burnham Prebys Medical Discovery Institute	Zhang, ZH (corresponding author), Cent S Univ, Xiangya Med Sch, State Key Lab Med Genet, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China.	zhangzhuohua@sklmg.edu.cn			National Institutes of Health [R01 NS057289, P01 ES016738]; Chinese National 973 Projects [2011CB510000]; Natural Science Foundation of China [30730052, 30971469, 30800586]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese National 973 Projects(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS057289 and P01 ES016738 (to Z. Z.). This work was also supported by Chinese National 973 Projects Grant 2011CB510000 (to Z. Z.) and Natural Science Foundation of China Grants 30730052 (to Z. Z.) and 30971469 and 30800586 (to D. W.).	ALDIN ASN, 1994, ACTA NEUROL SCAND, V89, P347; Bates S, 2005, J BIOL CHEM, V280, P23408, DOI 10.1074/jbc.M502162200; Behrens MI, 2010, MOVEMENT DISORD, V25, P1929, DOI 10.1002/mds.22996; CAI T, BRAIN RES, V1359, P201; Cho JH, 2005, FEBS LETT, V579, P778, DOI 10.1016/j.febslet.2004.12.032; DEXTER DT, 1987, LANCET, V2, P1219; Di Fonzo A, 2007, NEUROLOGY, V68, P1557, DOI 10.1212/01.wnl.0000260963.08711.08; Di Monte DA, 2003, LANCET NEUROL, V2, P531, DOI 10.1016/S1474-4422(03)00501-5; Djarmati A, 2009, MOVEMENT DISORD, V24, P2104, DOI 10.1002/mds.22728; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Furune T, 2008, GENES GENET SYST, V83, P373, DOI 10.1266/ggs.83.373; GAVIN CE, 1990, BIOCHEM J, V266, P329, DOI 10.1042/bj2660329; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Gorell JM, 1997, NEUROLOGY, V48, P650, DOI 10.1212/WNL.48.3.650; Guilarte TR, 2010, ENVIRON HEALTH PERSP, V118, P1071, DOI [10.1289/ehp.0901748, 10.1590/S1413-81232011001200028]; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hampshire DJ, 2001, J MED GENET, V38, P680, DOI 10.1136/jmg.38.10.680; HIRSCH EC, 1991, J NEUROCHEM, V56, P446, DOI 10.1111/j.1471-4159.1991.tb08170.x; Jabalquinto AM, 1999, J PROTEIN CHEM, V18, P659, DOI 10.1023/A:1020602222808; Johnson NA, 2009, ARCH BIOCHEM BIOPHYS, V481, P157, DOI 10.1016/j.abb.2008.11.010; KINNETT DG, 1982, INT J BIOCHEM, V14, P977, DOI 10.1016/0020-711X(82)90058-1; Lees AJ, 2007, NEUROLOGY, V68, P1553, DOI 10.1212/01.wnl.0000265228.66664.f4; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Li Y, 2010, BRAIN RES BULL, V81, P428, DOI 10.1016/j.brainresbull.2009.11.007; Lin CH, 2008, NEUROLOGY, V71, P1727, DOI 10.1212/01.wnl.0000335167.72412.68; Logroscino G, 1998, MOVEMENT DISORD, V13, P13; Malecki EA, 2001, BRAIN RES BULL, V55, P225, DOI 10.1016/S0361-9230(01)00456-7; Malecki EA, 1999, J NEUROSCI RES, V56, P113; Mao XY, 2010, PARKINSONISM RELAT D, V16, P235, DOI 10.1016/j.parkreldis.2009.11.010; Naranuntarat A, 2009, J BIOL CHEM, V284, P22633, DOI 10.1074/jbc.M109.026773; Ning YP, 2008, NEUROLOGY, V70, P1491, DOI 10.1212/01.wnl.0000310427.72236.68; Oikawa S, 2006, FREE RADICAL BIO MED, V41, P748, DOI 10.1016/j.freeradbiomed.2006.05.018; Prabhakaran K, 2009, NEUROTOXICOLOGY, V30, P414, DOI 10.1016/j.neuro.2009.02.012; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Ruivo R, 2009, BBA-MOL CELL RES, V1793, P636, DOI 10.1016/j.bbamcr.2008.12.008; Schmidt K, 2009, BIOCHEM BIOPH RES CO, V383, P198, DOI 10.1016/j.bbrc.2009.03.151; Schneider SA, 2010, MOVEMENT DISORD, V25, P979, DOI 10.1002/mds.22947; Schultheis PJ, 2004, BIOCHEM BIOPH RES CO, V323, P731, DOI 10.1016/j.bbrc.2004.08.156; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; Tamm C, 2008, TOXICOL SCI, V101, P310, DOI 10.1093/toxsci/kfm267; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Williams DR, 2005, MOVEMENT DISORD, V20, P1264, DOI 10.1002/mds.20511; Wu ZY, 2002, PLANT PHYSIOL, V130, P128, DOI 10.1104/pp.004440; Yokel RA, 2002, ENVIRON HEALTH PERSP, V110, P699, DOI 10.1289/ehp.02110s5699; Yokel RA, 2006, J ALZHEIMERS DIS, V10, P223; ZHANG P, 1994, NEUROSCIENCE, V61, P317, DOI 10.1016/0306-4522(94)90234-8; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208	51	113	116	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29654	29662		10.1074/jbc.M111.233874	http://dx.doi.org/10.1074/jbc.M111.233874			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21724849	Green Published, hybrid			2022-12-25	WOS:000294046600024
J	Nam, EA; Zhao, RX; Glick, GG; Bansbach, CE; Friedman, DB; Cortez, D				Nam, Edward A.; Zhao, Runxiang; Glick, Gloria G.; Bansbach, Carol E.; Friedman, David B.; Cortez, David			Thr-1989 Phosphorylation Is a Marker of Active Ataxia Telangiectasia-mutated and Rad3-related (ATR) Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; EARLY EMBRYONIC LETHALITY; DOUBLE-STRAND BREAKS; DNA-DAMAGE; CATALYTIC SUBUNIT; MRE11-RAD50-NBS1 COMPLEX; CHECKPOINT RESPONSE; CELL-CYCLE; IN-VITRO; ACTIVATION	The DNA damage response kinases ataxia telangiectasia-mutated (ATM), DNA-dependent protein kinase (DNA-PK), and ataxia telangiectasia-mutated and Rad3-related (ATR) signal through multiple pathways to promote genome maintenance. These related kinases share similar methods of regulation, including recruitment to specific nucleic acid structures and association with protein activators. ATM and DNA-PK also are regulated via phosphorylation, which provides a convenient biomarker for their activity. Whether phosphorylation regulates ATR is unknown. Here we identify ATR Thr-1989 as a DNA damage-regulated phosphorylation site. Selective inhibition of ATR prevents Thr-1989 phosphorylation, and phosphorylation requires ATR activation. Cells engineered to express only a non-phosphorylatable T1989A mutant exhibit a modest ATR functional defect. Our results suggest that, like ATM and DNA-PK, phosphorylation regulates ATR, and phospho-peptide specific antibodies to Thr-1989 provide a proximal marker of ATR activation.	[Zhao, Runxiang; Glick, Gloria G.; Bansbach, Carol E.; Friedman, David B.; Cortez, David] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Nam, Edward A.; Cortez, David] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 613 Light Hall, Nashville, TN 37232 USA.	david.cortez@vanderbilt.edu			National Institutes of Health [R01CA102729]; Vanderbilt-Ingram Cancer Center from the NCI, National Institutes of Health [CA06485]; Vanderbilt Center in Molecular Toxicology from the NIEHS, National Institutes of Health [P30ES000267]; NATIONAL CANCER INSTITUTE [R01CA102729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-Ingram Cancer Center from the NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Vanderbilt Center in Molecular Toxicology from the NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA102729 (to D.C.). This work was also supported by Vanderbilt-Ingram Cancer Center Grant CA06485 from the NCI, National Institutes of Health, and Vanderbilt Center in Molecular Toxicology Grant P30ES000267 from the NIEHS, National Institutes of Health.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Brown EJ, 2000, GENE DEV, V14, P397; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Douglas P, 2002, BIOCHEM J, V368, P243, DOI 10.1042/BJ20020973; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Kozlov SV, 2011, J BIOL CHEM, V286, P9107, DOI 10.1074/jbc.M110.204065; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Lewis KA, 2007, GENE CHROMOSOME CANC, V46, P1061, DOI 10.1002/gcc.20486; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Mordes DA, 2008, CELL CYCLE, V7, P2809, DOI 10.4161/cc.7.18.6689; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Myers JS, 2007, CANCER RES, V67, P6685, DOI 10.1158/0008-5472.CAN-07-0495; Nagasawa H, 2011, RADIAT RES, V175, P83, DOI 10.1667/RR2092.1; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Neal JA, 2011, MOL CELL BIOL, V31, P1719, DOI 10.1128/MCB.01298-10; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Pellegrini M, 2006, NATURE, V443, P222, DOI 10.1038/nature05112; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Yu DS, 2010, EMBO REP, V11, P876, DOI 10.1038/embor.2010.153; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zighelboim I, 2009, J CLIN ONCOL, V27, P3091, DOI 10.1200/JCO.2008.19.9802; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	52	83	84	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28707	28714		10.1074/jbc.M111.248914	http://dx.doi.org/10.1074/jbc.M111.248914			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705319	hybrid, Green Published			2022-12-25	WOS:000293837000008
J	Sarri, E; Sicart, A; Lazaro-Dieguez, F; Egea, G				Sarri, Elisabet; Sicart, Adria; Lazaro-Dieguez, Francisco; Egea, Gustavo			Phospholipid Synthesis Participates in the Regulation of Diacylglycerol Required for Membrane Trafficking at the Golgi Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; PLASMA-MEMBRANE; PHOSPHATIDYLCHOLINE SYNTHESIS; PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; PROTEIN-TRANSPORT; LIPID-METABOLISM; STIMULATED HUMAN; MAMMALIAN-CELLS; RAT-LIVER; RECEPTOR	The lipid metabolite diacylglycerol (DAG) is required for transport carrier biogenesis at the Golgi, although how cells regulate its levels is not well understood. Phospholipid synthesis involves highly regulated pathways that consume DAG and can contribute to its regulation. Here we altered phosphatidylcholine (PC) and phosphatidylinositol synthesis for a short period of time in CHO cells to evaluate the changes in DAG and its effects in membrane trafficking at the Golgi. We found that cellular DAG rapidly increased when PC synthesis was inhibited at the non-permissive temperature for the rate-limiting step of PC synthesis in CHO-MT58 cells. DAG also increased when choline and inositol were not supplied. The major phospholipid classes and triacylglycerol remained unaltered for both experimental approaches. The analysis of Golgi ultrastructure and membrane trafficking showed that 1) the accumulation of the budding vesicular profiles induced by propanolol was prevented by inhibition of PC synthesis, 2) the density of KDEL receptor-containing punctated structures at the endoplasmic reticulum-Golgi interface correlated with the amount of DAG, and 3) the post-Golgi transport of the yellow fluorescent temperature-sensitive G protein of stomatitis virus and the secretion of a secretory form of HRP were both reduced when DAG was lowered. We confirmed that DAG-consuming reactions of lipid synthesis were present in Golgi-enriched fractions. We conclude that phospholipid synthesis pathways play a significant role to regulate the DAG required in Golgi-dependent membrane trafficking.	[Sarri, Elisabet] Univ Barcelona, Dept Biol Cellular Immunol & Neurociencies, Fac Med, E-08036 Barcelona, Spain; Univ Barcelona, Inst Invest Biomed August Pi I Sunyer, E-08036 Barcelona, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Sarri, E (corresponding author), Univ Barcelona, Dept Biol Cellular Immunol & Neurociencies, Fac Med, C Casanova 143, E-08036 Barcelona, Spain.	elisabet.sarri@ub.edu	Sarri, Elisabet/AHA-6911-2022; Egea, Gustavo/I-2394-2014; Lázaro-Diéguez, Francisco/J-3491-2015	Sarri, Elisabet/0000-0002-2435-399X; Egea, Gustavo/0000-0001-5242-150X; Lázaro-Diéguez, Francisco/0000-0002-4970-8128	Ministerio de Ciencia e Innovacion [BFU2009-07186]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was funded by Ministerio de Ciencia e Innovacion Grant BFU2009-07186.	Asp L, 2009, MOL BIOL CELL, V20, P780, DOI 10.1091/mbc.E08-03-0256; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; Carvou N, 2010, J CELL SCI, V123, P1262, DOI 10.1242/jcs.061986; Caviglia JM, 2004, J LIPID RES, V45, P1500, DOI 10.1194/jlr.M400079-JLR200; Chen BB, 2011, MOL CELL BIOL, V31, P1905, DOI 10.1128/MCB.00723-10; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Fernandez-Ulibarri I, 2007, MOL BIOL CELL, V18, P3250, DOI 10.1091/mbc.E07-04-0334; Freyberg Z, 2002, MOL BIOL CELL, V13, P3930, DOI 10.1091/mbc.02-04-0059; Gasull T, 2003, J NEUROSCI, V23, P4100; GRIFFITHS G, 1994, J CELL BIOL, V127, P1557, DOI 10.1083/jcb.127.6.1557; Haynes LP, 2005, J BIOL CHEM, V280, P6047, DOI 10.1074/jbc.M413090200; Henneberry AL, 2002, MOL BIOL CELL, V13, P3148, DOI 10.1091/mbc.01-11-0540; Hui N, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P46; Huijbregts RPH, 2000, TRAFFIC, V1, P195, DOI 10.1034/j.1600-0854.2000.010301.x; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; JELSEMA CL, 1978, J BIOL CHEM, V253, P7960; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; KENNEDY ED, 1990, BIOCHEM J, V267, P781, DOI 10.1042/bj2670781; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kent C, 1999, TRENDS BIOCHEM SCI, V24, P146, DOI 10.1016/S0968-0004(99)01365-1; KTISTAKIS NT, 1995, P NATL ACAD SCI USA, V92, P4952, DOI 10.1073/pnas.92.11.4952; Kunkel MT, 2010, J BIOL CHEM, V285, P22746, DOI 10.1074/jbc.C110.123133; Lippincott-Schwartz J, 2010, ANNU REV BIOPHYS, V39, P559, DOI 10.1146/annurev.biophys.093008.131357; Litvak V, 2005, NAT CELL BIOL, V7, P225, DOI 10.1038/ncb1221; MATOZAKI T, 1991, J BIOL CHEM, V266, P22246; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; PREISS J, 1986, J BIOL CHEM, V261, P8597; RAGAN CI, 1988, BIOCHEM J, V249, P143, DOI 10.1042/bj2490143; Saini DK, 2010, P NATL ACAD SCI USA, V107, P11417, DOI 10.1073/pnas.1003042107; Sarri E, 2006, BIOCHEM J, V394, P325, DOI 10.1042/BJ20050834; Sarri E, 2003, BIOCHEM J, V369, P319, DOI 10.1042/BJ20021347; Shemesh T, 2003, BIOPHYS J, V85, P3813, DOI 10.1016/S0006-3495(03)74796-1; Simon JP, 1998, P NATL ACAD SCI USA, V95, P11181, DOI 10.1073/pnas.95.19.11181; SWEITZER TD, 1994, ARCH BIOCHEM BIOPHYS, V311, P107, DOI 10.1006/abbi.1994.1215; Testerink N, 2009, J LIPID RES, V50, P2182, DOI 10.1194/jlr.M800660-JLR200; Tian Y, 2008, J CELL BIOL, V181, P945, DOI 10.1083/jcb.200706152; van der Sanden MHM, 2004, BBA-MOL CELL BIOL L, V1636, P99, DOI 10.1016/j.bbalip.2003.08.008; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VICKERS JD, 1993, J PHARMACOL EXP THER, V266, P1156; VOZIYAN PA, 1993, BIOCHEM J, V295, P757, DOI 10.1042/bj2950757; WANG E, 1991, J BIOL CHEM, V266, P14486; Weibel ER, 1979, PRACTICAL METHODS BI, V1; Yang JS, 2008, NAT CELL BIOL, V10, P1146, DOI 10.1038/ncb1774	47	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28632	28643		10.1074/jbc.M111.267534	http://dx.doi.org/10.1074/jbc.M111.267534			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21700701	hybrid, Green Published			2022-12-25	WOS:000293557800077
J	Nyirandutiye, DH; Iknane, AA; Fofana, A; Brown, KH				Nyirandutiye, Daniele H.; Iknane, Akory Ag; Fofana, Amadou; Brown, Kenneth H.			Screening for Acute Childhood Malnutrition during the National Nutrition Week in Mali Increases Treatment Referrals	PLOS ONE			English	Article							CHILDREN	Objective: To evaluate a pilot intervention designed to integrate mid-upper arm circumference (MUAC) screening for acute malnutrition into the semi-annual Child Nutrition Week (Semaine d'Intensification des Activites de Nutrition, or "SIAN'') activities carried out in June 2008. Design: A cross-sectional survey was conducted in Kolokani and Nara, two health districts in the Koulikoro region of Mali, 4-5 months after the SIAN, using a population-proportionate, multi-stage random sample of: 1) health centers, and 2) households in communities linked to each of the selected health centers. Caregivers of 1543 children who were 6-59 months of age at the time of the SIAN, 17 community-based volunteers and 45 health center staff members were interviewed. Results: A total of 1278 children 6-59 months (83% of those studied) reportedly participated in SIAN. Of the participating children, 1258 received vitamin A (98% of SIAN participants; 82% of all eligible children), 945 received anti-helminth tablets (84% of participants; 71% of eligibles), and 669 were screened for acute malnutrition (52% of participants; 43% of eligibles). 186 of the children screened (27%) were reportedly identified as acutely malnourished. SIAN screening covered a significantly greater proportion of children than were examined in both community-based (22% of children) and health center-based screening activities (5% of children) combined during the 4-5 months after the SIAN (P<0.0001). In general, community volunteers and health personnel positively evaluated their experience adding MUAC screening to SIAN. Conclusion: Integrating MUAC screening for acute malnutrition in SIAN permits the assessment of a large number of children for acute malnutrition, and should be continued.	[Nyirandutiye, Daniele H.] US Congress, Hunger Ctr, Washington, DC USA; [Nyirandutiye, Daniele H.; Brown, Kenneth H.] Helen Keller Int, Reg Off Afr, Dakar, Senegal; [Iknane, Akory Ag] Inst Natl Rech Sante Publ, Bamako, Mali; [Fofana, Amadou] Cellule Planificat & Stat Sante, Bamako, Mali		Nyirandutiye, DH (corresponding author), US Congress, Hunger Ctr, Washington, DC USA.	kbrown@hki.org			The United States Agency for International Development/Office for Foreign Disaster Assistance [DFD-G-00-06-00203-01]; Richard and Rhoda Goldman Fund	The United States Agency for International Development/Office for Foreign Disaster Assistance(United States Agency for International Development (USAID)); Richard and Rhoda Goldman Fund	The study was supported by grants from The United States Agency for International Development/Office for Foreign Disaster Assistance under grant number DFD-G-00-06-00203-01, and the Richard and Rhoda Goldman Fund (http://www.goldmanfund.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoya MA, 2007, PUBLIC HEALTH NUTR, V10, P1241, DOI 10.1017/S1368980007687138; Berger SG, 2007, J NUTR, V137, P1328, DOI 10.1093/jn/137.5.1328; BOUARE M, 2008, SEMAINE INTENSIFICAT; CIA, 2009, CIA WORLD FACTBOOK; Cogill B, 2003, ANTHROPOMETRIC INDIC; Fiedler JL, 2008, HEALTH POLICY PLANN, V23, P222, DOI 10.1093/heapol/czn015; *H KELL INT, 2008, INT SURV TREATM PREV; *MACR, 2006, DEM HLTH SURV MAL 20; *MICR IN H KELL IN, 2006, INT VIT A SUPPL CDTI; *MIN SANT DIV NUTR, 2008, RES SIAN; Standardized Monitoring Assessment of Relief Transitions (SMART), 2006, MEAS MORT NUTR STAT; *UNDP, 2008, UNDP HUM DEV IND UPD; Valid International, 2006, COMM BAS THER CAR CT; Wallace A, 2009, TROP MED INT HEALTH, V14, P11, DOI 10.1111/j.1365-3156.2008.02196.x	14	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e14818	10.1371/journal.pone.0014818	http://dx.doi.org/10.1371/journal.pone.0014818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731602	Green Submitted, Green Published, gold			2022-12-25	WOS:000292035400002
J	Allard, M; Oger, R; Vignard, V; Percier, JM; Fregni, G; Perier, A; Caignard, A; Charreau, B; Bernardeau, K; Khammari, A; Dreno, B; Gervois, N				Allard, Mathilde; Oger, Romain; Vignard, Virginie; Percier, Jean-Michel; Fregni, Giulia; Perier, Aurelie; Caignard, Anne; Charreau, Beatrice; Bernardeau, Karine; Khammari, Amir; Dreno, Brigitte; Gervois, Nadine			Serum Soluble HLA-E in Melanoma: A New Potential Immune-Related Marker in Cancer	PLOS ONE			English	Article							PROVIDE TUMOR-CELLS; LEUKOCYTE ANTIGEN-G; CLASS-I MOLECULES; T-LYMPHOCYTES; MALIGNANT DISEASES; COLORECTAL-CANCER; ESCAPE MECHANISMS; IFN-GAMMA; NK CELLS; EXPRESSION	Background: Tumor-derived soluble factors, including soluble HLA molecules, can contribute to cancer immune escape and therefore impact on clinical course of malignant diseases. We previously reported that melanoma cells produce, in vitro, soluble forms of the non-classical MHC class I molecule HLA-E (sHLA-E). In order to investigate sHLA-E production by various tumors and to address its potential value as a tumor-associated marker, we developed a specific ELISA for the quantification of sHLA-E in biological fluids. Methodology/Principal Findings: We developed a sHLA-E specific and sensitive ELISA and we showed that serum sHLA-E levels were significantly elevated (P<0.01) in melanoma patients (n=127), compared with healthy donors (n=94). sHLA-E was also detected in the culture supernatants of a wide variety of tumor cell lines (n=98) including melanomas, kidney, colorectal and breast cancers. Cytokines regulation of sHLA-E production by tumor cells was also carried out. IFN-gamma, IFN-alpha and TNF-alpha were found to upregulate sHLA-E production by tumor cells. Conclusions/Significance: In view of the broad tumor tissue release of HLA-E and its up-regulation by inflammatory cytokines, sHLA-E should be studied for its involvement in immune responses against tumors. Interestingly, our results demonstrated a positive association between the presence of serum sHLA-E and melanoma. Therefore, the determination of sHLA-E levels, using ELISA approach, may be investigated as a clinical marker in cancer patients.	[Allard, Mathilde; Oger, Romain; Vignard, Virginie; Percier, Jean-Michel; Khammari, Amir; Dreno, Brigitte; Gervois, Nadine] INSERM, UMR, U892, Nantes, France; [Allard, Mathilde; Oger, Romain; Gervois, Nadine] Univ Nantes, Fac Sci, Nantes, France; [Fregni, Giulia; Perier, Aurelie; Caignard, Anne] Univ Paris 05, Inst Cochin, INSERM, CNRS,UMR 8104,U1016, Paris, France; [Charreau, Beatrice] INSERM, UMR, U643, Nantes, France; [Bernardeau, Karine] Recombinant Prot Prod Facil IFR 26, Nantes, France; [Khammari, Amir; Dreno, Brigitte] Ctr Hosp Univ Nantes, Unit Skin Canc, Nantes, France; [Khammari, Amir; Dreno, Brigitte] Ctr Hosp Univ Nantes, GMP Unit Cellular Therapy, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Allard, M (corresponding author), INSERM, UMR, U892, Nantes, France.	ngervois@nantes.inserm.fr	CHARREAU, Beatrice/AAK-8186-2020; OGER, Romain/K-7423-2015; Gervois, Nadine/K-6658-2015; Vignard, Virginie/K-7540-2015; Caignard, Anne/F-8159-2013; allard, mathilde/C-9577-2018	CHARREAU, Beatrice/0000-0001-5870-4615; Gervois, Nadine/0000-0002-0092-3919; Vignard, Virginie/0000-0002-6702-2824; Caignard, Anne/0000-0001-9923-6045; allard, mathilde/0000-0002-2217-1295; OGER, Romain/0000-0001-5012-6099	Ligue Nationale contre le Cancer	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants awarded by the "Ligue Nationale contre le Cancer'' (labellisation 2007). The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algarra I, 2004, CANCER IMMUNOL IMMUN, V53, P904, DOI 10.1007/s00262-004-0517-9; Arreygue-Garcia NA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-16; Bahri R, 2006, J IMMUNOL, V176, P1331, DOI 10.4049/jimmunol.176.3.1331; Bainbridge DRJ, 2000, J REPROD IMMUNOL, V48, P17, DOI 10.1016/S0165-0378(00)00070-X; Bangia N, 2006, IMMUNOL INVEST, V35, P485, DOI 10.1080/08820130600808246; Bracarda S, 2011, BJU INT, V107, P214, DOI 10.1111/j.1464-410X.2010.09707.x; Campoli M, 2008, ONCOGENE, V27, P5869, DOI 10.1038/onc.2008.273; Campoli M, 2008, TISSUE ANTIGENS, V72, P321, DOI 10.1111/j.1399-0039.2008.01106.x; Contini P, 2003, EUR J IMMUNOL, V33, P125, DOI 10.1002/immu.200390015; Coupel S, 2007, BLOOD, V109, P2806, DOI 10.1182/blood-2006-06-030213; Derre L, 2002, J IMMUNOL, V168, P4864, DOI 10.4049/jimmunol.168.10.4864; Derre L, 2006, J IMMUNOL, V177, P3100, DOI 10.4049/jimmunol.177.5.3100; Fournel S, 2000, J IMMUNOL, V164, P6100, DOI 10.4049/jimmunol.164.12.6100; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Gros F, 2008, EUR J IMMUNOL, V38, P742, DOI 10.1002/eji.200736918; Holdenrieder S, 2006, INT J CANCER, V118, P684, DOI 10.1002/ijc.21382; Holdenrieder S, 2006, CANCER IMMUNOL IMMUN, V55, P1584, DOI 10.1007/s00262-006-0167-1; Kholmanskikh O, 2010, INT J CANCER, V127, P1625, DOI 10.1002/ijc.25182; Kim R, 2007, IMMUNOLOGY, V121, P1, DOI 10.1111/j.1365-2567.2007.02587.x; Le Drean E, 1998, EUR J IMMUNOL, V28, P264, DOI 10.1002/(SICI)1521-4141(199801)28:01<264::AID-IMMU264>3.0.CO;2-O; Levy EM, 2008, INT J ONCOL, V32, P633, DOI 10.3892/ijo.32.3.633; Malmberg KJ, 2002, J CLIN INVEST, V110, P1515, DOI 10.1172/JC1200215564; Marin R, 2003, IMMUNOGENETICS, V54, P767, DOI 10.1007/s00251-002-0526-9; Michelin S, 2009, HUM IMMUNOL, V70, P1010, DOI 10.1016/j.humimm.2009.07.030; PERIER A, 2011, ONCOGENE; Rebmann V, 2003, SEMIN CANCER BIOL, V13, P371, DOI 10.1016/S1044-579X(03)00028-2; Rebmann V, 2007, SEMIN CANCER BIOL, V17, P430, DOI 10.1016/j.semcancer.2007.06.011; Rebmann V, 2007, SEMIN CANCER BIOL, V17, P422, DOI 10.1016/j.semcancer.2007.06.010; Rouas-Freiss N, 2005, CANCER RES, V65, P10139, DOI 10.1158/0008-5472.CAN-05-0097; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Schutt P, 2010, HUM IMMUNOL, V71, P489, DOI 10.1016/j.humimm.2010.02.015; Sebti Y, 2003, HUM IMMUNOL, V64, P1093, DOI 10.1016/j.humimm.2003.08.345; Seliger B, 2003, TRENDS IMMUNOL, V24, P82, DOI 10.1016/S1471-4906(02)00039-X; Singer G, 2003, CLIN CANCER RES, V9, P4460; Speiser DE, 1999, J EXP MED, V190, P775, DOI 10.1084/jem.190.6.775; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Tabayoyong WB, 2007, LEUKEMIA RES, V31, P121, DOI 10.1016/j.leukres.2006.06.008; Ugurel S, 2001, CANCER, V92, P369, DOI 10.1002/1097-0142(20010715)92:2<369::AID-CNCR1332>3.0.CO;2-U; Yeruva S, 2008, INT J COLORECTAL DIS, V23, P305, DOI 10.1007/s00384-007-0396-6; Zhang MH, 2009, TRANSPLANTATION, V87, P8, DOI 10.1097/TP.0b013e31818b6141; Zhu CB, 2011, INT J CANCER, V128, P617, DOI 10.1002/ijc.25372	41	39	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21118	10.1371/journal.pone.0021118	http://dx.doi.org/10.1371/journal.pone.0021118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712991	Green Published, Green Submitted, gold			2022-12-25	WOS:000291985100012
J	Gonzaga, VE; Ramos, M; Maves, RC; Freeman, R; Montgomery, JM				Gonzaga, Victor E.; Ramos, Mariana; Maves, Ryan C.; Freeman, Randal; Montgomery, Joel M.			Concurrent Outbreak of Norovirus Genotype I and Enterotoxigenic Escherichia coli on a US Navy Ship following a Visit to Lima, Peru	PLOS ONE			English	Article							VIRUS-INFECTION; UNITED-STATES; GASTROENTERITIS; TRAVELERS; DIARRHEA; DISEASE; PCR	An outbreak of norovirus (NoV) genotype I and Enterotoxigenic Escherichia coli (ETEC) occurred among US Navy Ship personnel following a visit to Lima, Peru, in June 2008. Visiting a specific area in Lima was significantly associated with illness. While ETEC and NoV are commonly recognized as causative agents of outbreaks, co-circulation of both pathogens has been rarely observed in shipboard outbreaks.	[Gonzaga, Victor E.; Ramos, Mariana; Maves, Ryan C.; Montgomery, Joel M.] United States Naval Med Res Unit Six NAMRU 6, Lima, Peru; [Freeman, Randal] USA, El Paso, TX USA		Gonzaga, VE (corresponding author), United States Naval Med Res Unit Six NAMRU 6, Lima, Peru.	jmontgomery@ke.cdc.gov	Maves, Ryan C/AGG-3988-2022	Maves, Ryan C/0000-0001-6234-6160	AFHSC-GEIS [847705 82000 25GB B0016]	AFHSC-GEIS	This study was supported by grant AFHSC-GEIS, work unit number 847705 82000 25GB B0016. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U. S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apelt N, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-131; Castilho JG, 2006, J CLIN MICROBIOL, V44, P3947, DOI 10.1128/JCM.00279-06; CDC, 2010, NOR TECHN FACT SHEET; Ferreira MSR, 2008, J MED VIROL, V80, P338, DOI 10.1002/jmv.21059; GALENO H, GASTROINTESTINAL DIS; Guion CE, 2008, J CLIN MICROBIOL, V46, P1752, DOI 10.1128/JCM.02341-07; Ko GP, 2005, J CLIN MICROBIOL, V43, P6126, DOI 10.1128/JCM.43.12.6126-6129.2005; LEVINE MM, 1980, AM J EPIDEMIOL, V111, P347, DOI 10.1093/oxfordjournals.aje.a112906; McCarthy M, 2000, J INFECT DIS, V181, pS387, DOI 10.1086/315582; Olsen K.E., 2010, EURO SURVEILL    JAN; Thornton S, 2002, MIL MED, V167, P826, DOI 10.1093/milmed/167.10.826; Trujillo AA, 2006, J CLIN MICROBIOL, V44, P1405, DOI 10.1128/JCM.44.4.1405-1412.2006; Vidal R, 2005, EMERG INFECT DIS, V11, P1134, DOI 10.3201/eid1107.041062; Widdowson MA, 2005, EMERG INFECT DIS, V11, P95, DOI 10.3201/eid1101.040426	14	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e20822	10.1371/journal.pone.0020822	http://dx.doi.org/10.1371/journal.pone.0020822			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713034	Green Submitted, Green Published, gold			2022-12-25	WOS:000291985100005
J	Guillemaud, T; Blin, A; Simon, S; Morel, K; Franck, P				Guillemaud, Thomas; Blin, Aurelie; Simon, Sylvaine; Morel, Karine; Franck, Pierre			Weak Spatial and Temporal Population Genetic Structure in the Rosy Apple Aphid, Dysaphis plantaginea, in French Apple Orchards	PLOS ONE			English	Article							CROSS-SPECIES AMPLIFICATION; PEACH-POTATO APHID; INSECTICIDE RESISTANCE; MICROSATELLITE LOCI; AUTUMN KAOLIN; HOST RACES; CULTIVARS; HOMOPTERA; PASSERINI; SOFTWARE	We used eight microsatellite loci and a set of 20 aphid samples to investigate the spatial and temporal genetic structure of rosy apple aphid populations from 13 apple orchards situated in four different regions in France. Genetic variability was very similar between orchard populations and between winged populations collected before sexual reproduction in the fall and populations collected from colonies in the spring. A very small proportion of individuals (similar to 2%) had identical multilocus genotypes. Genetic differentiation between orchards was low (F-ST<0.026), with significant differentiation observed only between orchards from different regions, but no isolation by distance was detected. These results are consistent with high levels of genetic mixing in holocyclic Dysaphis plantaginae populations (host alternation through migration and sexual reproduction). These findings concerning the adaptation of the rosy apple aphid have potential consequences for pest management.	[Guillemaud, Thomas; Blin, Aurelie] IBSV INRA UNSA CNRS, Equipe Biol Populat Interact, UMR 1301, Sophia Antipolis, France; [Franck, Pierre] INRA, Plantes & Syst Culture Horticoles UR1115, Avignon, France; [Simon, Sylvaine; Morel, Karine] INRA, Rech Integree UE695, Domaine De Gotheron, St Marcel Valen, France	Centre National de la Recherche Scientifique (CNRS); INRAE; INRAE; INRAE	Guillemaud, T (corresponding author), IBSV INRA UNSA CNRS, Equipe Biol Populat Interact, UMR 1301, Sophia Antipolis, France.	guillem@sophia.inra.fr	guillemaud, thomas/B-4899-2012	guillemaud, thomas/0000-0003-0451-1644; Franck, Pierre/0000-0002-1904-8325	French Program ECOGER [AO 2005]	French Program ECOGER	This work was funded by the French Program ECOGER AO 2005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli G, 2006, J PEST SCI, V79, P175, DOI 10.1007/s10340-006-0129-6; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blackman R.L., 1981, P75; Blommers LHM, 2004, J PEST SCI, V77, P155, DOI 10.1007/s10340-004-0046-5; Bonnemaison L., 1959, Annales des Epiphyties Paris (C), V10, P257; BONNEMAISON L, 1961, ENNEMIS ANNIMAUX PLA, P1; Brown MW, 2007, ENVIRON ENTOMOL, V36, P1131, DOI 10.1603/0046-225X(2007)36[1131:CBCORA]2.0.CO;2; Burgel K, 2005, J APPL ENTOMOL, V129, P311, DOI 10.1111/j.1439-0418.2005.00968.x; Butault J.P., 2010, SYNTHESE RAPPORT ET; Carletto J, 2009, MOL ECOL, V18, P2198, DOI 10.1111/j.1365-294X.2009.04190.x; Carletto J, 2010, PEST MANAG SCI, V66, P301, DOI 10.1002/ps.1874; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Cross JV, 2007, CROP PROT, V26, P1140, DOI 10.1016/j.cropro.2006.10.007; DeBarro PJ, 1995, P ROY SOC B-BIOL SCI, V262, P321, DOI 10.1098/rspb.1995.0212; Delmotte F, 2002, MOL ECOL, V11, P711, DOI 10.1046/j.1365-294X.2002.01478.x; DELORME R, 1999, PUCERON CENDRE POMMI; DELORME R, 1999, ANPP, P89; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FORREST JMS, 1975, ANN APPL BIOL, V81, P281, DOI 10.1111/j.1744-7348.1975.tb01643.x; Gauffre B, 2006, MOL ECOL NOTES, V6, P440, DOI 10.1111/j.1471-8286.2006.01264.x; Gomez A, 2000, MOL ECOL, V9, P203, DOI 10.1046/j.1365-294x.2000.00849.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Guillemaud T, 2003, HEREDITY, V91, P143, DOI 10.1038/sj.hdy.6800292; Halkett F, 2005, TRENDS ECOL EVOL, V20, P194, DOI 10.1016/j.tree.2005.01.001; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Harvey NG, 2003, MOL ECOL NOTES, V3, P111, DOI 10.1046/j.1471-8286.2003.00369.x; Hill D.S, 1987, AGR INSECT PESTS TEM; HULL LA, 1983, J ECON ENTOMOL, V76, P594, DOI 10.1093/jee/76.3.594; Jensen AB, 2008, AGR FOREST ENTOMOL, V10, P279, DOI 10.1111/j.1461-9563.2008.00383.x; LATHROP FRANK H., 1928, OHIO JOUR SCI, V28, P177; Lenormand T, 1998, P ROY SOC B-BIOL SCI, V265, P1985, DOI 10.1098/rspb.1998.0529; LOXDALE HD, 1993, BIOL REV, V68, P291, DOI 10.1111/j.1469-185X.1993.tb00998.x; LOXDALE HD, 1990, J ANIM ECOL, V59, P497, DOI 10.2307/4877; LYTH M, 1985, ANN APPL BIOL, V107, P155, DOI 10.1111/j.1744-7348.1985.tb01559.x; Marko V, 2008, J APPL ENTOMOL, V132, P26, DOI 10.1111/j.1439-0418.2007.01233.x; MartinezTorres D, 1997, J EVOLUTION BIOL, V10, P459, DOI 10.1007/s000360050036; Massonnet B, 2004, HEREDITY, V93, P577, DOI 10.1038/sj.hdy.6800559; Minarro M, 2007, ENVIRON ENTOMOL, V36, P1206, DOI 10.1603/0046-225X(2007)36[1206:ROACTD]2.0.CO;2; Minarro M, 2005, BIOCONTROL, V50, P403, DOI 10.1007/s10526-004-5527-1; Minarro M, 2008, CROP PROT, V27, P391, DOI 10.1016/j.cropro.2007.07.003; Papura D, 2003, HEREDITY, V90, P397, DOI 10.1038/sj.hdy.6800262; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pritchard JK, 2000, GENETICS, V155, P945; Qubbaj T, 2005, ENTOMOL EXP APPL, V115, P145, DOI 10.1111/j.1570-7458.2005.00255.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roughgarden J., 1996, THEORY POPULATION GE; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Simon JC, 2003, P ROY SOC B-BIOL SCI, V270, P1703, DOI 10.1098/rspb.2003.2430; Simon JC, 2002, TRENDS ECOL EVOL, V17, P34, DOI 10.1016/S0169-5347(01)02331-X; Simon JC, 1999, MOL ECOL, V8, P531, DOI 10.1046/j.1365-294x.1999.00583.x; Sokal R. R., 2012, BIOMETRY; SOLOMON MG, 2003, 10 14 MARCH 2002, P79; Sunnucks P, 1997, MOL ECOL, V6, P1059, DOI 10.1046/j.1365-294X.1997.00280.x; Sunnucks P, 1996, GENETICS, V144, P747; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vorburger C, 2006, J EVOLUTION BIOL, V19, P97, DOI 10.1111/j.1420-9101.2005.00985.x; Wilson ACC, 2004, MOL ECOL NOTES, V4, P104, DOI 10.1046/j.1471-8286.2004.00584.x; Wilson ACC, 2002, HEREDITY, V88, P258, DOI [10.1038/sj.hdy.6800037, 10.1038/sj/hdy/6800037]; Wright S., 1969, THEORY GENE FREQUENC; Wyss E, 2004, J APPL ENTOMOL, V128, P147, DOI 10.1111/j.1439-0418.2004.00825.x; Wyss E, 1999, ENTOMOL EXP APPL, V90, P167, DOI 10.1023/A:1003564714363; Zamoum T, 2005, HEREDITY, V94, P630, DOI 10.1038/sj.hdy.6800673	64	10	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21263	10.1371/journal.pone.0021263	http://dx.doi.org/10.1371/journal.pone.0021263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701679	Green Published, Green Submitted, gold			2022-12-25	WOS:000291983800035
J	Li, XH; Johnson, KR; Bryant, M; Elkahloun, AG; Amar, M; Remaley, AT; De Silva, R; Hallenbeck, JM; Quandt, JA				Li, Xinhui; Johnson, Kory R.; Bryant, Mark; Elkahloun, Abdel G.; Amar, Marcelo; Remaley, Alan T.; De Silva, Ranil; Hallenbeck, John M.; Quandt, Jacqueline A.			Intranasal Delivery of E-Selectin Reduces Atherosclerosis in ApoE-/- Mice	PLOS ONE			English	Article							RECEPTOR-DEFICIENT MICE; CORONARY-ARTERY-DISEASE; REGULATORY T-CELLS; SOLUBLE E-SELECTIN; MUCOSAL TOLERANCE; ORAL TOLERANCE; SUBARACHNOID HEMORRHAGE; ADHESION MOLECULES; LYMPHOID-TISSUE; CEREBROSPINAL-FLUID	Mucosal tolerance to E-selectin prevents stroke and protects against ischemic brain damage in experimental models of stroke studying healthy animals or spontaneously hypertensive stroke-prone rats. A reduction in inflammation and neural damage was associated with immunomodulatory or "tolerogenic" responses to E-selectin. The purpose of the current study on ApoE deficient mice is to assess the capacity of this stroke prevention innovation to influence atherosclerosis, a major underlying cause for ischemic strokes; human E-selectin is being translated as a potential clinical prevention strategy for secondary stroke. Female ApoE-/- mice received intranasal delivery of E-selectin prior to ( pre-tolerization) or simultaneously with initiation of a high-fat diet. After 7 weeks on the high-fat diet, lipid lesions in the aorta, serum triglycerides, and total cholesterol were assessed as markers of atherosclerosis development. We also assessed E-selectin-specific antibodies and cytokine responses, in addition to inflammatory responses that included macrophage infiltration of the aorta and altered gene expression profiles of aortic mRNA. Intranasal delivery of E-selectin prior to initiation of high-fat chow decreased atherosclerosis, serum total cholesterol, and expression of the leucocyte chemoattractant CCL21 that is typically upregulated in atherosclerotic lesions of ApoE-/- mice. This response was associated with the induction of E-selectin specific cells producing the immunomodulatory cytokine IL-10 and immunosuppressive antibody isotypes. Intranasal administration of E-selectin generates E-selectin specific immune responses that are immunosuppressive in nature and can ameliorate atherosclerosis, a major risk factor for ischemic stroke. These results provide additional preclinical support for the potential of induction of mucosal tolerance to E-selectin to prevent stroke.	[Li, Xinhui; Hallenbeck, John M.] NINDS, Stroke Branch, NIH, Bethesda, MD 20892 USA; [Johnson, Kory R.] NINDS, Bioinformat Sect, NIH, Bethesda, MD 20892 USA; [Bryant, Mark] NIH, Div Vet Resources, Off Res Support, Bethesda, MD 20892 USA; [Elkahloun, Abdel G.] NIH, Div Intramural Res Programs, Microarray Core Facil, Bethesda, MD 20892 USA; [Amar, Marcelo; Remaley, Alan T.; De Silva, Ranil] NHLBI, NIH, Bethesda, MD 20892 USA; [Quandt, Jacqueline A.] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Li, XH (corresponding author), NINDS, Stroke Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	hallenbj@ninds.nih.gov; jquandt@pathology.ubc.ca	Amar, Marcelo/AAD-5599-2019; Quandt, Jacqueline Alice/AHE-4020-2022	Quandt, Jacqueline Alice/0000-0003-1320-2819	National Institute of Neurological Disorders and Stroke; National Heart, Lung and Blood Institute, NIH, Bethesda, MD; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002924] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung and Blood Institute, NIH, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Stroke and Neuroimmunology Branches, Intramural Research Program of the National Institute of Neurological Disorders and Stroke and also a Bench to Bedside Award from the National Heart, Lung and Blood Institute, NIH, Bethesda, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2003, INT ARCH ALLERGY IMM, V130, P108, DOI 10.1159/000069012; Arumugam TV, 2004, SHOCK, V21, P401, DOI 10.1097/00024382-200405000-00002; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; Biber K, 2001, GLIA, V34, P121, DOI 10.1002/glia.1047; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Bogavac-Stanojevic N, 2003, CLIN CHEM LAB MED, V41, P893, DOI 10.1515/CCLM.2003.135; Broere F, 2008, J IMMUNOL, V181, P899, DOI 10.4049/jimmunol.181.2.899; Burchill MA, 2007, IMMUNOL LETT, V114, P1, DOI 10.1016/j.imlet.2007.08.005; Cao WX, 2005, EUR J IMMUNOL, V35, P2709, DOI 10.1002/eji.200425957; Chen SC, 2002, J IMMUNOL, V168, P1009, DOI 10.4049/jimmunol.168.3.1009; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15107, DOI 10.1073/pnas.2436538100; Clark-Greuel JN, 2007, ANN THORAC SURG, V83, P946, DOI 10.1016/j.athoracsur.2006.10.026; Damas JK, 2007, ARTERIOSCL THROM VAS, V27, P614, DOI 10.1161/01.ATV.0000255581.38523.7c; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Faria AMC, 1999, ADV IMMUNOL, V73, P153, DOI 10.1016/S0065-2776(08)60787-7; Feinberg MW, 2004, J BIOL CHEM, V279, P16388, DOI 10.1074/jbc.M309664200; Frangogiannis NG, 2006, CURR MED CHEM, V13, P1877, DOI 10.2174/092986706777585086; George J, 2004, CARDIOVASC RES, V62, P603, DOI 10.1016/j.cardiores.2004.01.028; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Han XB, 2009, J BIOL CHEM, V284, P32950, DOI 10.1074/jbc.M109.040899; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hansson GK, 2009, ATHEROSCLEROSIS, V202, P2, DOI 10.1016/j.atherosclerosis.2008.08.039; Hjelmstrom P, 2000, AM J PATHOL, V156, P1133, DOI 10.1016/S0002-9440(10)64981-4; Huehn J, 2005, TRENDS IMMUNOL, V26, P632, DOI 10.1016/j.it.2005.10.001; Hwang SJ, 1997, CIRCULATION, V96, P4219; Illoh K, 2006, J CEREBR BLOOD F MET, V26, P1538, DOI 10.1038/sj.jcbfm.9600308; Ishibashi S, 2009, J CEREBR BLOOD F MET, V29, P606, DOI 10.1038/jcbfm.2008.153; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; KLINGENBERG R, 2010, ARTERIOSCLER THROMB; Kozuka K, 2002, ATHEROSCLEROSIS, V161, P161, DOI 10.1016/S0021-9150(01)00635-9; Lan RY, 2008, J AUTOIMMUN, V31, P7, DOI 10.1016/j.jaut.2008.03.002; Liu Y, 2006, ATHEROSCLEROSIS, V188, P19, DOI 10.1016/j.atherosclerosis.2005.10.029; Lo JC, 2007, SCIENCE, V316, P285, DOI 10.1126/science.1137221; Malatino LS, 2007, J INTERN MED, V262, P479, DOI 10.1111/j.1365-2796.2007.01841.x; Maron R, 2002, CIRCULATION, V106, P1708, DOI 10.1161/01.CIR.0000029750.99462.30; Mayer L, 2004, NAT REV IMMUNOL, V4, P407, DOI 10.1038/nri1370; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nakayama T, 2007, BRAIN RES, V1132, P177, DOI 10.1016/j.brainres.2006.09.116; Oh IY, 2007, BLOOD, V110, P3891, DOI 10.1182/blood-2006-10-048991; Oksjoki R, 2007, FRONT BIOSCI-LANDMRK, V12, P4696, DOI 10.2741/2419; Peranteau WH, 2008, J INVEST DERMATOL, V128, P1852, DOI 10.1038/sj.jid.5701232; Polin RS, 1998, J NEUROSURG, V89, P559, DOI 10.3171/jns.1998.89.4.0559; Potteaux S, 2004, ARTERIOSCL THROM VAS, V24, P1474, DOI 10.1161/01.ATV.0000134378.86443.cd; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Samsom JN, 2004, CRIT REV IMMUNOL, V24, P157, DOI 10.1615/CritRevImmunol.v24.i3.10; Schonbeck U, 2000, P NATL ACAD SCI USA, V97, P7458, DOI 10.1073/pnas.97.13.7458; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Takeda H, 2002, STROKE, V33, P2156, DOI 10.1161/01.STR.0000029821.82531.8B; TSUKADA N, 1995, NEUROLOGY, V45, P1914, DOI 10.1212/WNL.45.10.1914; van Puijvelde GHM, 2006, CIRCULATION, V114, P1968, DOI 10.1161/CIRCULATIONAHA.106.615609; Wakita H, 2008, J CEREBR BLOOD F MET, V28, P341, DOI 10.1038/sj.jcbfm.9600528; Wang XL, 1997, CARDIOVASC RES, V34, P404, DOI 10.1016/S0008-6363(97)00033-3; Weiner HL, 2004, ANN NY ACAD SCI, V1029, P211, DOI 10.1196/annals.1309.053; *WHO, 2004, ATL HEART DIS STROK; XU S, 2009, CARDIOVASC PATHOL; Yoneyama H, 2001, J EXP MED, V193, P35, DOI 10.1084/jem.193.1.35; Yoshioka T, 2004, GENE THER, V11, P1772, DOI 10.1038/sj.gt.3302348	61	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20620	10.1371/journal.pone.0020620	http://dx.doi.org/10.1371/journal.pone.0020620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701687	gold, Green Published, Green Submitted			2022-12-25	WOS:000291983800008
J	Birkett, LP; Newton-Fisher, NE				Birkett, Lucy P.; Newton-Fisher, Nicholas E.			How Abnormal Is the Behaviour of Captive, Zoo-Living Chimpanzees?	PLOS ONE			English	Article							SELF-INJURIOUS-BEHAVIOR; PAN-TROGLODYTES; ENVIRONMENTAL ENRICHMENT; NONHUMAN-PRIMATES; LARGE-SAMPLE; WILD	Background: Many captive chimpanzees (Pan troglodytes) show a variety of serious behavioural abnormalities, some of which have been considered as possible signs of compromised mental health. The provision of environmental enrichments aimed at reducing the performance of abnormal behaviours is increasing the norm, with the housing of individuals in (semi-) natural social groups thought to be the most successful of these. Only a few quantitative studies of abnormal behaviour have been conducted, however, particularly for the captive population held in zoological collections. Consequently, a clear picture of the level of abnormal behaviour in zoo-living chimpanzees is lacking. Methods: We present preliminary findings from a detailed observational study of the behaviour of 40 socially-housed zoo-living chimpanzees from six collections in the United States of America and the United Kingdom. We determined the prevalence, diversity, frequency, and duration of abnormal behaviour from 1200 hours of continuous behavioural data collected by focal animal sampling. Results, Conclusion and Significance: Our overall finding was that abnormal behaviour was present in all sampled individuals across six independent groups of zoo-living chimpanzees, despite the differences between these groups in size, composition, housing, etc. We found substantial variation between individuals in the frequency and duration of abnormal behaviour, but all individuals engaged in at least some abnormal behaviour and variation across individuals could not be explained by sex, age, rearing history or background (defined as prior housing conditions). Our data support a conclusion that, while most behaviour of zoo-living chimpanzees is 'normal' in that it is typical of their wild counterparts, abnormal behaviour is endemic in this population despite enrichment efforts. We suggest there is an urgent need to understand how the chimpanzee mind copes with captivity, an issue with both scientific and welfare implications.	[Birkett, Lucy P.; Newton-Fisher, Nicholas E.] Univ Kent, Sch Anthropol & Conservat, Canterbury, Kent, England	University of Kent	Birkett, LP (corresponding author), Univ Kent, Sch Anthropol & Conservat, Canterbury, Kent, England.	n.e.newton-fisher@kent.ac.uk		Newton-Fisher, Nicholas/0000-0002-7657-2641	Christine and Ian Bolt Scholarship; University of Kent; Universities Federation for Animal Welfare	Christine and Ian Bolt Scholarship; University of Kent; Universities Federation for Animal Welfare	Lucy P. Birkett was supported by the Christine and Ian Bolt Scholarship, University of Kent, and the Universities Federation for Animal Welfare, http://www.ufaw.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Baker KC, 1996, APPL ANIM BEHAV SCI, V49, P403, DOI 10.1016/0168-1591(96)01061-1; BLOOMSMITH MA, 1995, APPL ANIM BEHAV SCI, V44, P65, DOI 10.1016/0168-1591(95)00570-I; BLOOMSTRAND M, 1986, ZOO BIOL, V5, P293, DOI 10.1002/zoo.1430050307; Boesch C, 2000, CHIMPANZEES TAI FORE; Bourgeois SR, 2007, J APPL ANIM WELF SCI, V10, P123, DOI 10.1080/10888700701313454; Bradshaw GA, 2008, J TRAUMA DISSOCIATIO, V9, P9, DOI 10.1080/15299730802073619; Bradshaw GA, 2009, DEV PSYCHOL, V45, P1376, DOI 10.1037/a0015860; Brune M, 2006, NEUROSCI BIOBEHAV R, V30, P1246, DOI 10.1016/j.neubiorev.2006.09.002; Brune M, 2004, SCIENCE, V306, P2039; Brune M, 2008, TXB EVOLUTIONARY PSY; Celli ML, 2003, APPL ANIM BEHAV SCI, V81, P171, DOI 10.1016/S0168-1591(02)00257-5; Clarke A.S., 1982, Zoo Biology, V1, P371, DOI 10.1002/zoo.1430010411; Davenport R.K., 1979, Perspectives on Human Evolution, V5, P341; DAVENPORT RK, 1963, ARCH GEN PSYCHIAT, V8, P99; DEWAAL FBM, 1989, J HUM EVOL, V18, P433, DOI 10.1016/0047-2484(89)90074-2; FRITZ J, 1992, AM J PRIMATOL, V27, P161, DOI 10.1002/ajp.1350270302; FRITZ J, 1992, ZOO BIOL, V11, P313, DOI 10.1002/zoo.1430110503; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; Garner JP, 2005, ILAR J, V46, P106, DOI 10.1093/ilar.46.2.106; Goodall J., 1986, CHIMPANZEES GOMBE PA; HIRAIWAHASEGAWA M, 1988, PRIMATES, V29, P319, DOI 10.1007/BF02380955; Hook MA, 2002, APPL ANIM BEHAV SCI, V76, P165, DOI 10.1016/S0168-1591(02)00005-9; Hosey GR, 2007, INT J PRIMATOL, V28, P1431, DOI 10.1007/s10764-007-9203-z; Hosey GR, 2005, APPL ANIM BEHAV SCI, V90, P107, DOI 10.1016/j.applanim.2004.08.015; Inoue S, 2007, CURR BIOL, V17, pR1004, DOI 10.1016/j.cub.2007.10.027; Lukas D, 2005, MOL ECOL, V14, P2181, DOI 10.1111/j.1365-294X.2005.02560.x; Lutz CK, 2005, ILAR J, V46, P178, DOI 10.1093/ilar.46.2.178; Martin JE, 2005, APPL ANIM BEHAV SCI, V90, P167, DOI 10.1016/j.applanim.2004.08.019; Martin JE, 2002, ANIM WELFARE, V11, P419; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Mason G, STEREOTYPIC ANIMAL B; MCGREW W, 1996, GREAT APE SOC; MCGREW WC, 1981, INT J STUD ANIM PROB, V2, P138; Muller MN, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P112, DOI 10.1017/CBO9780511606397.012; Murray L. E., 1998, International Zoo Yearbook, V36, P97, DOI 10.1111/j.1748-1090.1998.tb02890.x; Nash LT, 1999, AM J PRIMATOL, V48, P15, DOI 10.1002/(SICI)1098-2345(1999)48:1<15::AID-AJP2>3.3.CO;2-I; Newton-Fisher NE, 2004, PRIMATES, V45, P81, DOI 10.1007/s10329-003-0064-6; Newton-Fisher NE, 2011, ANIM BEHAV, V81, P439, DOI 10.1016/j.anbehav.2010.11.015; Nishida T, 1999, ANTHROPOL SCI, V107, P141, DOI 10.1537/ase.107.141; Nishida T., 1990, CHIMPANZEES MAHALE M; Nishida T., 2010, CHIMPANZEE BEHAV WIL; PAQUETTE D, 1988, ZOO BIOL, V7, P15, DOI 10.1002/zoo.1430070103; Parr LA, 2006, SOC COGN AFFECT NEUR, V1, P221, DOI 10.1093/scan/nsl031; Payne C.L.R., 2008, Pan Africa News, V15, P29; Pederson AK, 2005, J RES PERS, V39, P534, DOI 10.1016/j.jrp.2004.07.002; Rollin B. E, 2006, SCI ETHICS; ROLLIN BE, 1998, UNHEEDED CRY ANIMAL; Searle JohnR., 2002, CONSCIOUSNESS LANGUA; WALSH S, 1982, AM J PRIMATOL, V3, P315, DOI 10.1002/ajp.1350030131; Wrangham R.W., 1986, P352; Young RJ, 2003, ENV ENRICHMENT CAPTI, DOI DOI 10.1002/9780470751046; [No title captured]; [No title captured]; [No title captured]	55	70	71	2	178	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20101	10.1371/journal.pone.0020101	http://dx.doi.org/10.1371/journal.pone.0020101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778UW	21698219	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000291734100004
J	Bischof, J; Muller, A; Fander, M; Knippschild, U; Fischer, D				Bischof, Joachim; Mueller, Adrienne; Faender, Miriam; Knippschild, Uwe; Fischer, Dietmar			Neurite Outgrowth of Mature Retinal Ganglion Cells and PC12 Cells Requires Activity of CK1 delta and CK1 epsilon	PLOS ONE			English	Article							CASEIN-KINASE-I; STIMULATES AXON REGENERATION; LENS-INJURY; 1 DELTA; INFLAMMATORY STIMULATION; MOLECULAR-MECHANISMS; INDUCED APOPTOSIS; PROTEIN-KINASES; FACTOR RECEPTOR; DISEASE BRAIN	Mature retinal ganglion cells (RGCs) do not normally regenerate severed axons after optic nerve injury and show only little neurite outgrowth in culture. However, RGCs can be transformed into an active regenerative state after lens injury (LI) enabling these neurons to regrow axons in vitro and in vivo. In the current study we investigated the role of CK1 delta and CK1 epsilon activity in neurite outgrowth of LI stimulated RGCs and nerve growth factor (NGF) stimulated PC12 cells, respectively. In both cell types CK1 delta and epsilon were localized in granular particles aligned at microtubules in neurites and growth cones. Although LI treatment did not measurably affect the expression of CK1 delta and epsilon, it significantly elevated the specific kinase activity in the retina. Similarly, CK1 delta/epsilon specific kinase activity was also elevated in NGF treated PC12 cells compared with untreated controls. Neurite extension in PC12 cells was associated with a change in the activity of CK1 delta C-terminal targeting kinases, suggesting that activity of these kinases might be necessary for neurite outgrowth. Pharmacological inactivation of CK1 delta and epsilon markedly compromised neurite outgrowth of both, PC12 cells and LI stimulated RGCs in a concentration dependent manner. These data provide evidence for a so far unknown, but essential role of CK1 isoforms in neurite growth.	[Bischof, Joachim; Knippschild, Uwe] Univ Ulm, Dept Gen Visceral & Transplantat Surg, Ulm, Germany; [Mueller, Adrienne; Faender, Miriam; Fischer, Dietmar] Univ Ulm, Dept Expt Neurol, Ulm, Germany; [Fischer, Dietmar] Univ Dusseldorf, Dept Expt Neurol, Dusseldorf, Germany	Ulm University; Ulm University; Heinrich Heine University Dusseldorf	Bischof, J (corresponding author), Univ Ulm, Dept Gen Visceral & Transplantat Surg, Ulm, Germany.	uwe.knippschild@uniklinik-ulm.de; dietmar.fischer@uni-duesseldorf.de		Fischer, Dietmar/0000-0002-1816-3014	Deutsche Krebshilfe [10-2237-KN3, 108489]; University of Ulm	Deutsche Krebshilfe(Deutsche Krebshilfe); University of Ulm	Work in the lab of Uwe Knippschild is supported by the Deutsche Krebshilfe, Dr. Mildred Scheel Stiftung (10-2237-KN3 and 108489). Work in the lab of Dietmar Fischer is supported by funding of the University of Ulm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2010, J BIOL CHEM, V285, P41740, DOI 10.1074/jbc.M110.156489; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Asher RA, 2000, J NEUROSCI, V20, P2427; Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Behrend L, 2000, EUR J CELL BIOL, V79, P240, DOI 10.1078/S0171-9335(04)70027-8; BEYAERT R, 1995, J BIOL CHEM, V270, P23293, DOI 10.1074/jbc.270.40.23293; Bouquet C, 2007, ADV EXP MED BIOL, V621, P1, DOI 10.1007/978-0-387-76715-4_1; BROCKMAN JL, 1992, P NATL ACAD SCI USA, V89, P9454, DOI 10.1073/pnas.89.20.9454; Brockschmidt C, 2008, GUT, V57, P799, DOI 10.1136/gut.2007.123695; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Cheong JK, 2011, ONCOGENE, V30, P2558, DOI 10.1038/onc.2010.627; CHIJIWA T, 1989, J BIOL CHEM, V264, P4924; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Domeniconi M, 2005, J NEUROL SCI, V233, P43, DOI 10.1016/j.jns.2005.03.023; Duffy P, 2009, J NEUROSCI, V29, P15266, DOI 10.1523/JNEUROSCI.4650-09.2009; Fischer D, 2000, INVEST OPHTH VIS SCI, V41, P3943; Fischer D, 2004, J NEUROSCI, V24, P1646, DOI 10.1523/JNEUROSCI.5119-03.2004; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Fischer D, 2001, EXP NEUROL, V172, P257, DOI 10.1006/exnr.2001.7822; Fischer D, 2008, MOL CELL NEUROSCI, V37, P471, DOI 10.1016/j.mcn.2007.11.002; Fischer D, 2010, P NATL ACAD SCI USA, V107, pE8, DOI 10.1073/pnas.0912942107; FISH KJ, 1995, J BIOL CHEM, V270, P14875, DOI 10.1074/jbc.270.25.14875; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Giamas G, 2007, BIOCHEM J, V406, P389, DOI 10.1042/BJ20070091; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Grozdanov Veselin, 2010, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0322s53; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Hauk TG, 2008, EXP NEUROL, V209, P469, DOI 10.1016/j.expneurol.2007.09.020; Ikeda K, 2011, MOL BIOL CELL, V22, P1321, DOI 10.1091/mbc.E10-09-0741; Izeradjene K, 2004, CANCER RES, V64, P8036, DOI 10.1158/0008-5472.CAN-04-0762; Karino A, 1999, BBA-GEN SUBJECTS, V1472, P603, DOI 10.1016/S0304-4165(99)00187-7; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Knippschild U, 1996, ONCOGENE, V13, P1387; Knippschild U, 1997, ONCOGENE, V15, P1727, DOI 10.1038/sj.onc.1201541; Kuret J, 1997, J NEUROCHEM, V69, P2506; Leibinger M, 2009, J NEUROSCI, V29, P14334, DOI 10.1523/JNEUROSCI.2770-09.2009; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Li GB, 2004, J BIOL CHEM, V279, P15938, DOI 10.1074/jbc.M314116200; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lohler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004174; Loh SHY, 2008, CELL DEATH DIFFER, V15, P283, DOI 10.1038/sj.cdd.4402258; Lorber B, 2005, EUR J NEUROSCI, V21, P2029, DOI 10.1111/j.1460-9568.2005.04034.x; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Maritzen T, 2003, EUR J CELL BIOL, V82, P369, DOI 10.1078/0171-9335-00323; Martin L, 2011, NEUROCHEM INT, V58, P458, DOI 10.1016/j.neuint.2010.12.023; Mashhoon N, 2000, J BIOL CHEM, V275, P20052, DOI 10.1074/jbc.M001713200; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Milne DM, 2001, EXP CELL RES, V263, P43, DOI 10.1006/excr.2000.5100; MILNE DM, 1995, J BIOL CHEM, V270, P5511, DOI 10.1074/jbc.270.10.5511; Muller A, 2007, BRAIN, V130, P3308, DOI 10.1093/brain/awm257; Muller A, 2009, MOL CELL NEUROSCI, V41, P233, DOI 10.1016/j.mcn.2009.03.002; Myers RR, 2003, EXP NEUROL, V184, P606, DOI 10.1016/S0014-4886(03)00297-8; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Schmandke A, 2007, NEUROSCIENTIST, V13, P454, DOI 10.1177/1073858407303611; Schwab C, 2000, NEUROBIOL AGING, V21, P503, DOI 10.1016/S0197-4580(00)00110-X; Sengottuvel V, 2011, J NEUROSCI, V31, P2688, DOI 10.1523/JNEUROSCI.4885-10.2011; SINGH TJ, 1995, J NEUROCHEM, V64, P1420; Stoter M, 2005, ONCOGENE, V24, P7964, DOI 10.1038/sj.onc.1208941; Swiatek W, 2006, J BIOL CHEM, V281, P12233, DOI 10.1074/jbc.M510580200; Takenaka Y, 2004, MOL CELL BIOL, V24, P4395, DOI 10.1128/MCB.24.10.4395-4406.2004; Tillement V, 2008, EXP CELL RES, V314, P2811, DOI 10.1016/j.yexcr.2008.06.011; Utz AC, 2010, J HISTOCHEM CYTOCHEM, V58, P1, DOI 10.1369/jhc.2009.954628; Wolff S, 2005, BBA-MOL CELL RES, V1745, P196, DOI 10.1016/j.bbamcr.2005.05.004; Wolff S, 2006, FEBS LETT, V580, P6477, DOI 10.1016/j.febslet.2006.10.068; Yang P, 2010, NEUROSCI BULL, V26, P117, DOI 10.1007/s12264-010-1105-y; Yasojima K, 2000, BRAIN RES, V865, P116, DOI 10.1016/S0006-8993(00)02200-9; Yoshimura T, 2006, ANN NY ACAD SCI, V1086, P116, DOI 10.1196/annals.1377.013; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; ZHAI LM, 1995, J BIOL CHEM, V270, P12717, DOI 10.1074/jbc.270.21.12717; Zhao Y, 2004, J BIOL CHEM, V279, P30844, DOI 10.1074/jbc.M404651200; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882	79	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20857	10.1371/journal.pone.0020857	http://dx.doi.org/10.1371/journal.pone.0020857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698236	Green Published, gold, Green Submitted			2022-12-25	WOS:000291734100024
J	Marti-Lliteras, P; Lopez-Gomez, A; Mauro, S; Hood, DW; Viadas, C; Calatayud, L; Morey, P; Servin, A; Linares, J; Oliver, A; Bengoechea, JA; Garmendia, J				Marti-Lliteras, Pau; Lopez-Gomez, Antonio; Mauro, Silvia; Hood, Derek W.; Viadas, Cristina; Calatayud, Laura; Morey, Pau; Servin, Alain; Linares, Josefina; Oliver, Antonio; Antonio Bengoechea, Jose; Garmendia, Junkal			Nontypable Haemophilus influenzae Displays a Prevalent Surface Structure Molecular Pattern in Clinical Isolates	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; C-REACTIVE PROTEIN; EPITHELIAL-CELLS; OTITIS-MEDIA; PHASE VARIATION; BIOFILM COMMUNITIES; SERUM RESISTANCE; SIALIC-ACID; MIDDLE-EAR; INNER-CORE	Non-typable Haemophilus influenzae (NTHi) is a Gram negative pathogen that causes acute respiratory infections and is associated with the progression of chronic respiratory diseases. Previous studies have established the existence of a remarkable genetic variability among NTHi strains. In this study we show that, in spite of a high level of genetic heterogeneity, NTHi clinical isolates display a prevalent molecular feature, which could confer fitness during infectious processes. A total of 111 non-isogenic NTHi strains from an identical number of patients, isolated in two distinct geographical locations in the same period of time, were used to analyse nine genes encoding bacterial surface molecules, and revealed the existence of one highly prevalent molecular pattern (lgtF+, lic2A+, lic1D+, lic3A+, lic3B+, siaA-, lic2C+, ompP5+, oapA+) displayed by 94.6% of isolates. Such a genetic profile was associated with a higher bacterial resistance to serum mediated killing and enhanced adherence to human respiratory epithelial cells.	[Marti-Lliteras, Pau; Lopez-Gomez, Antonio; Mauro, Silvia; Viadas, Cristina; Morey, Pau; Antonio Bengoechea, Jose; Garmendia, Junkal] Fdn Caubet CIMERA, Programa Infecc &Inmunidad, Bunyola, Spain; [Antonio Bengoechea, Jose] Consejo Super Invest Cient CSIC, Madrid, Spain; [Marti-Lliteras, Pau; Lopez-Gomez, Antonio; Calatayud, Laura; Morey, Pau; Linares, Josefina; Antonio Bengoechea, Jose; Garmendia, Junkal] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Vitoria, Spain; [Hood, Derek W.] Univ Oxford, John Radcliffe Hosp, Dept Paediat, Weatherall Inst Mol Med,Mol Infect Dis Grp, Oxford OX3 9DU, England; [Calatayud, Laura; Linares, Josefina] Hosp Univ Bellvitge, Microbiol Serv, Barcelona, Spain; [Oliver, Antonio] Hosp Univ Son Espases, Microbiol Serv, Palma De Mallorca, Spain; [Garmendia, Junkal] Univ Publ Navarra Gobierno de Navarra, CSIC, Inst Agrobiotecnol, Mutilva, Spain; [Calatayud, Laura; Linares, Josefina] Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain; [Calatayud, Laura; Linares, Josefina] Univ Barcelona, Barcelona, Spain; [Servin, Alain] INSERM, UMR 756, Paris, France	Atencio Primaria de Menorca; Consejo Superior de Investigaciones Cientificas (CSIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Oxford; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Universitari Son Espases; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut National de la Sante et de la Recherche Medicale (Inserm)	Marti-Lliteras, P (corresponding author), Fdn Caubet CIMERA, Programa Infecc &Inmunidad, Bunyola, Spain.	juncal.garmendia@unavarra.es	Garmendia, Juncal/G-4360-2011; Oliver, Antonio/E-4048-2012; Oliver, Antonio/V-5541-2019; Liñares, Josefina/N-9450-2014; Morey, Pau/I-2521-2018	Garmendia, Juncal/0000-0002-7440-2737; Oliver, Antonio/0000-0001-9327-1894; Oliver, Antonio/0000-0001-9327-1894; Morey, Pau/0000-0003-3597-5054; Bengoechea, Jose/0000-0002-9677-8751	Instituto de Salud Carlos III (ISCIII, Spain) [CP05-0027, PI06-1251, PS09-0130, PS09-1904]; Fundacion Mutua Madrilena; Contrato Miguel Servet, Instituto Salud Carlos III (ISCIII, Spain); Govern Illes Balears, Spain	Instituto de Salud Carlos III (ISCIII, Spain)(Instituto de Salud Carlos III); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Contrato Miguel Servet, Instituto Salud Carlos III (ISCIII, Spain)(Instituto de Salud Carlos III); Govern Illes Balears, Spain	This work was supported by grants from Instituto de Salud Carlos III (ISCIII, Spain) with references CP05-0027, PI06-1251 and PS09-0130, and from Fundacion Mutua Madrilena 2008 to JG, and by a grant from Instituto de Salud Carlos III (ISCIII, Spain) with reference PS09-1904 to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. C. Juan for his help with PFGE. JG was a recipient of a Contrato Miguel Servet, Instituto Salud Carlos III (ISCIII, Spain). AL-G is a recipient of a Predoctoral Fellowship from Govern Illes Balears, Spain. CIBERES is an initiative of ISCIII.	Avadhanula V, 2006, J VIROL, V80, P1629, DOI 10.1128/JVI.80.4.1629-1636.2006; Deadman ME, 2006, J BIOL CHEM, V281, P29455, DOI 10.1074/jbc.M604908200; Dixon K, 2007, J BACTERIOL, V189, P511, DOI 10.1128/JB.00815-06; Duim B, 1997, INFECT IMMUN, V65, P1351, DOI 10.1128/IAI.65.4.1351-1356.1997; Ecevit IZ, 2004, J CLIN MICROBIOL, V42, P3065, DOI 10.1128/JCM.42.7.3065-3072.2004; Erwin AL, 2005, INFECT IMMUN, V73, P5853, DOI 10.1128/IAI.73.9.5853-5863.2005; Erwin AL, 2007, TRENDS MICROBIOL, V15, P355, DOI 10.1016/j.tim.2007.06.004; Fernaays MM, 2006, INFECT IMMUN, V74, P3366, DOI 10.1128/IAI.01904-05; Figueira MA, 2007, INFECT IMMUN, V75, P325, DOI 10.1128/IAI.01054-06; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Fox KL, 2008, INFECT IMMUN, V76, P588, DOI 10.1128/IAI.00748-07; Fox KL, 2006, J BIOL CHEM, V281, P40024, DOI 10.1074/jbc.M602314200; Foxwell AR, 1998, MICROBIOL MOL BIOL R, V62, P294, DOI 10.1128/MMBR.62.2.294-308.1998; Gilsdorf JR, 2004, INFECT IMMUN, V72, P2457, DOI 10.1128/IAI.72.5.2457-2461.2004; GrayOwen SD, 1997, EMBO J, V16, P3435, DOI 10.1093/emboj/16.12.3435; Hallstrom T, 2010, TRENDS MICROBIOL, V18, P258, DOI 10.1016/j.tim.2010.03.007; Hallstrom T, 2010, J CLIN MICROBIOL, V48, P921, DOI 10.1128/JCM.01654-09; Harrison A, 2005, J BACTERIOL, V187, P4627, DOI 10.1128/JB.187.13.4627-4636.2005; Harvey HA, 2001, J AUTOIMMUN, V16, P257, DOI 10.1006/jaut.2000.0477; High NJ, 1996, FEMS MICROBIOL LETT, V145, P325; Hill DJ, 2001, MOL MICROBIOL, V39, P850, DOI 10.1046/j.1365-2958.2001.02233.x; Ho DK, 2007, J IMMUNOL, V178, P1002, DOI 10.4049/jimmunol.178.2.1002; Hong WZ, 2007, J BACTERIOL, V189, P8300, DOI 10.1128/JB.00532-07; Hong WZ, 2007, INFECT IMMUN, V75, P958, DOI 10.1128/IAI.01691-06; Hood DW, 2004, MICROBIOL-SGM, V150, P2089, DOI 10.1099/mic.0.26912-0; Hood DW, 1999, MOL MICROBIOL, V33, P679, DOI 10.1046/j.1365-2958.1999.01509.x; Jones PA, 2002, J BIOL CHEM, V277, P14598, DOI 10.1074/jbc.M110986200; Jurcisek J, 2005, INFECT IMMUN, V73, P3210, DOI 10.1128/IAI.73.6.3210-3218.2005; Lamers RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016426; Lima JBT, 2010, J INFECT DIS, V202, P1577, DOI 10.1086/656778; Lysenko E, 2000, MOL MICROBIOL, V35, P234, DOI 10.1046/j.1365-2958.2000.01707.x; Marti-Lliteras P, 2009, INFECT IMMUN, V77, P4232, DOI 10.1128/IAI.00305-09; Morey P, 2011, MICROBIOL-SGM, V157, P234, DOI 10.1099/mic.0.040451-0; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Mullins MA, 2009, J BACTERIOL, V191, P5988, DOI 10.1128/JB.00469-09; Novotny LA, 2000, INFECT IMMUN, V68, P2119, DOI 10.1128/IAI.68.4.2119-2128.2000; Pettigrew MM, 2002, INFECT IMMUN, V70, P3551, DOI 10.1128/IAI.70.7.3551-3556.2002; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Power PM, 2009, INFECT GENET EVOL, V9, P216, DOI 10.1016/j.meegid.2008.11.006; Prasadarao NV, 1999, INFECT IMMUN, V67, P4153, DOI 10.1128/IAI.67.8.4153-4160.1999; Rao VK, 1999, FEMS MICROBIOL REV, V23, P99, DOI 10.1016/S0168-6445(98)00039-4; ROCHE RJ, 1994, FEMS MICROBIOL LETT, V120, P279; Rodriguez CA, 2003, INFECT IMMUN, V71, P1635, DOI 10.1128/IAI.71.4.1635-1642.2003; Satola SW, 2008, INFECT IMMUN, V76, P5221, DOI 10.1128/IAI.00672-08; Schweda EKH, 2007, INT J MED MICROBIOL, V297, P297, DOI 10.1016/j.ijmm.2007.03.007; Singer BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008747; Slevogt H, 2008, NAT IMMUNOL, V9, P1270, DOI 10.1038/ni.1661; St Geme JW, 2002, CELL MICROBIOL, V4, P191; Starner TD, 2002, INFECT IMMUN, V70, P5287, DOI 10.1128/IAI.70.9.5287-5289.2002; Swords WE, 2000, MOL MICROBIOL, V37, P13, DOI 10.1046/j.1365-2958.2000.01952.x; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Webb DC, 1998, J MED MICROBIOL, V47, P1059, DOI 10.1099/00222615-47-12-1059; Weiser JN, 1998, MOL MICROBIOL, V30, P767, DOI 10.1046/j.1365-2958.1998.01108.x; Weiser JN, 1998, J EXP MED, V187, P631, DOI 10.1084/jem.187.4.631; WEISER JN, 1995, MOL MICROBIOL, V17, P555, DOI 10.1111/j.1365-2958.1995.mmi_17030555.x; Weiser JN, 1997, INFECT IMMUN, V65, P943, DOI 10.1128/IAI.65.3.943-950.1997; Xie JP, 2006, J CLIN MICROBIOL, V44, P4316, DOI 10.1128/JCM.01331-06	57	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21133	10.1371/journal.pone.0021133	http://dx.doi.org/10.1371/journal.pone.0021133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698169	Green Published, gold, Green Submitted			2022-12-25	WOS:000291734100059
J	Zheng, YY; Xie, X; Ma, YT; Yang, YN; Fu, ZY; Li, XM; Ma, X; Chen, BD; Liu, F				Zheng, Ying-Ying; Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Fu, Zhen-Yan; Li, Xiao-Mei; Ma, Xiang; Chen, Bang-Dang; Liu, Fen			Relationship between a Novel Polymorphism of the C5L2 Gene and Coronary Artery Disease	PLOS ONE			English	Article							ACYLATION-STIMULATING PROTEIN; FAMILIAL COMBINED HYPERLIPIDEMIA; LIPOPROTEIN-LIPASE; MYOCARDIAL-INFARCTION; ASSOCIATION; RECEPTOR; RISK; ENDOCYTOSIS; POPULATION; PHENOTYPE	Background: C5L2 has been demonstrated to be a functional receptor of acylation-stimulating protein (ASP), which is a stimulator of triglyceride synthesis or glucose transport. However, little is known about the variations in the coding region of the C5L2 gene and their association with coronary artery disease (CAD). Methodology/Principal Findings: We identified a novel single nucleotide polymorphism (SNP), 698C > T (P233L), in exon 2 using a polymerase chain reaction direct-sequencing method. This nucleotide change causes the amino-acid order from proline to leucine at codon 233. We examined the role of this SNP for CAD using two independent case-control studies: one was in the Han population (492 CAD patients and 577 control subjects) and the other was in the Uygur population (319 CAD patients and 554 control subjects). Heterozygote carriers of the 698CT genotype were more frequent among CAD patients than among controls not only in the Han population (7.3% versus 1.7%) but also in the Uygur population (4.7% versus 1.6%). The odds ratio (OR) for carriers of the 698CT genotype for CAD was 4.484 (95% confidence interval (CI): 2.197-9.174) in the Han group and 2.989 (95% CI: 1.292-6.909) in the Uygur population. After adjustment of confounding factors such as sex, age, smoking, alcohol consumption, hypertension, diabetes, as well as serum levels of triglyceride, total cholesterol, high-density lipoprotein, the difference remained significant in the Han group (P < 0.001, OR=6.604, 95% CI: 2.776-15.711) and in the Uygur group (P=0.047, OR=2.602, 95% CI: 1.015-6.671). Conclusion/Significance: The 698CT genotype of C5L2 may be a genetic maker of CAD in the Han and Uygur population in western China.	[Zheng, Ying-Ying; Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Fu, Zhen-Yan; Li, Xiao-Mei; Ma, Xiang] Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China; [Zheng, Ying-Ying; Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Fu, Zhen-Yan; Li, Xiao-Mei; Ma, Xiang; Chen, Bang-Dang; Liu, Fen] Xinjiang Key Lab Cardiovasc Dis Res, Urumqi, Peoples R China	Xinjiang Medical University	Ma, YT (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China.	myt-xj@163.com	xie, xiang/AAG-2128-2021		Great Technology Special Item Foundation of Xinjiang, China [200733146-3]	Great Technology Special Item Foundation of Xinjiang, China	This work was supported financially by the Great Technology Special Item Foundation of Xinjiang, China (200733146-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuurad E, 2009, J LIPID RES, V50, P1472, DOI 10.1194/jlr.P900012-JLR200; Aouizerat BE, 1999, AM J HUM GENET, V65, P397, DOI 10.1086/302490; Arsenault BJ, 2010, CAN MED ASSOC J, V182, P1427, DOI 10.1503/cmaj.091276; Cianflone K, 2003, BBA-BIOMEMBRANES, V1609, P127, DOI 10.1016/S0005-2736(02)00686-7; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Clanflone K, 2003, CURR PHARM DESIGN, V9, P1397, DOI 10.2174/1381612033454784; Cui W, 2009, MOL IMMUNOL, V46, P3207, DOI 10.1016/j.molimm.2009.08.013; Cui W, 2009, MOL IMMUNOL, V46, P3086, DOI 10.1016/j.molimm.2009.06.007; Faraj M, 2004, J LIPID RES, V45, P657, DOI 10.1194/jlr.M300299-JLR200; GENEST JJ, 1992, CIRCULATION, V85, P2025, DOI 10.1161/01.CIR.85.6.2025; Goswami B, 2010, CARDIOVASC J AFR, V21, P41; *GUILD SUBC, 1999, J HYPERTENS, V17, P151; Huertas-Vazquez A, 2005, ARTERIOSCL THROM VAS, V25, P1985, DOI 10.1161/01.ATV.0000175297.37214.a0; Iatan I, 2009, CIRC-CARDIOVASC GENE, V2, P467, DOI 10.1161/CIRCGENETICS.109.877811; Kalant D, 2005, J BIOL CHEM, V280, P23936, DOI 10.1074/jbc.M406921200; Kyriakou T, 2007, HUM MOL GENET, V16, P1412, DOI 10.1093/hmg/ddm091; MacLaren R, 2007, BIOCHEM CELL BIOL, V85, P11, DOI 10.1139/O06-207; Marcil M, 2006, ARTERIOSCL THROM VAS, V26, P1619, DOI 10.1161/01.ATV.0000222907.72985.0b; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Maslowska M, 2005, VITAM HORM, V70, P309, DOI 10.1016/S0083-6729(05)70010-8; Paglialunga S, 2009, J LIPID RES, V50, P1109, DOI 10.1194/jlr.M800430-JLR200; Raz I, 2010, CARDIOLOGY, V116, P48, DOI 10.1159/000314330; Saleh J, 2009, EUR J ENDOCRINOL, V160, P301, DOI 10.1530/EJE-08-0784; van Wijngaarden RFAD, 2010, J CLIN ENDOCR METAB, V95, P1758, DOI 10.1210/jc.2009-0656; Wan J, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-13; Xiang SQ, 1999, J LIPID RES, V40, P1655; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015181; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013997; Xie X, 2009, CLIN APPL THROMB-HEM, V15, P574, DOI 10.1177/1076029608329581; Xie X, 2009, CLIN CHEM LAB MED, V47, P347, DOI 10.1515/CCLM.2009.078; Yang YN, 2010, CLIN APPL THROMB-HEM, V16, P579, DOI 10.1177/1076029610364522; Zee RYL, 2006, STROKE, V37, P2007, DOI 10.1161/01.STR.0000229905.25080.01	32	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20984	10.1371/journal.pone.0020984	http://dx.doi.org/10.1371/journal.pone.0020984			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698200	gold, Green Published			2022-12-25	WOS:000291734100038
J	Abramson, G; Soto, CAT; Ona, L				Abramson, Guillermo; Trejo Soto, Claudia A.; Ona, Leonardo			The Role of Asymmetric Interactions on the Effect of Habitat Destruction in Mutualistic Networks	PLOS ONE			English	Article							REPRODUCTIVE SUSCEPTIBILITY; SPECIALIZATION; POLLINATOR; FRAGMENTATION; SYSTEMS	Plant-pollinator mutualistic networks are asymmetric in their interactions: specialist plants are pollinated by generalist animals, while generalist plants are pollinated by a broad range involving specialists and generalists. It has been suggested that this asymmetric -or disassortative- assemblage could play an important role in determining the observed equal susceptibility of specialist and generalist plants under habitat destruction. At the core of the analysis of the phenomenon lies the observation that specialist plants, otherwise candidates to extinction, could cope with the disruption thanks to their interaction with a few generalist pollinators. We present a theoretical framework that supports this thesis. We analyze a dynamical model of a system of mutualistic plants and pollinators, subject to the destruction of their habitat. We analyze and compare two families of interaction topologies, ranging from highly assortative to highly disassortative ones, as well as real pollination networks. We found that several features observed in natural systems are predicted by the mathematical model. First, there is a tendency to increase the asymmetry of the network as a result of the extinctions. Second, an entropy measure of the differential susceptibility to extinction of specialist and generalist species show that they tend to balance when the network is disassortative. Finally, the disappearance of links in the network, as a result of extinctions, shows that specialist plants preserve more connections than the corresponding plants in an assortative system, enabling them to resist the disruption.	[Abramson, Guillermo] Ctr Atom Bariloche, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Abramson, Guillermo] Consejo Nacl Invest Cient & Tecn, San Carlos De Bariloche, Rio Negro, Argentina; [Abramson, Guillermo; Trejo Soto, Claudia A.] Inst Balseiro, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Ona, Leonardo] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany	Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision Nacional de Energia Atomica (CNEA); University Nacional Cuyo Mendoza; Instituto Balseiro; Max Planck Society	Abramson, G (corresponding author), Ctr Atom Bariloche, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.	abramson@cab.cnea.gov.ar	Trejo-Soto, Claudia Andrea/G-8551-2016	Trejo-Soto, Claudia Andrea/0000-0003-0267-3359; Ona, Leonardo/0000-0002-0883-7134	CONICET [PIP 112-200801-00076]; Universidad Nacional de Cuyo [06/C304]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de Cuyo	This work has been funded by CONICET through PIP 112-200801-00076 and by Universidad Nacional de Cuyo (06/C304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Aizen MA, 2002, J VEG SCI, V13, P885, DOI 10.1111/j.1654-1103.2002.tb02118.x; Ashworth L, 2004, J ECOL, V92, P717, DOI 10.1111/j.0022-0477.2004.00910.x; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 1996, J ANIM ECOL, V65, P465, DOI 10.2307/5781; BASCOMPTE J, 2006, ASYMMETRIC COEVOLUTI; Bascompte J, 2010, SCIENCE, V329, P765, DOI 10.1126/science.1194255; BOND WJ, 1994, PHILOS T R SOC B, V344, P83, DOI 10.1098/rstb.1994.0055; Ehrlich A.H., 1981, EXTINCTION; Fenster CB, 2001, ECOLOGY, V82, P844, DOI 10.2307/2680202; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; Fortuna MA, 2008, ECOL LETT, V11, P490, DOI 10.1111/j.1461-0248.2008.01167.x; Herrera Carlos M., 1996, P65; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; LEVINS R, 1971, P NATL ACAD SCI USA, V68, P1246, DOI 10.1073/pnas.68.6.1246; Morris William F., 2003, P260; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; OLSEN JM, 2009, ECOLOGY, V86, P1573; Perrings C. A., 1995, BIODIVERSITY LOSS EC; RENNER SS, 1999, DYNAMICS TROPICAL CO, P339; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; TILMAN D, 1997, SPATIAL ECOLOGY ROLE, P3; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Vazquez DP, 2002, AM NAT, V159, P606, DOI 10.1086/339991; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Wilson E.O., 1988, P3	28	14	14	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21028	10.1371/journal.pone.0021028	http://dx.doi.org/10.1371/journal.pone.0021028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698298	Green Published, Green Submitted, gold			2022-12-25	WOS:000291730000041
J	Balduini, A; Badalucco, S; Pugliano, MT; Baev, D; De Silvestri, A; Cattaneo, M; Rosti, V; Barosi, G				Balduini, Alessandra; Badalucco, Stefania; Pugliano, Maria Teresa; Baev, Denis; De Silvestri, Annalisa; Cattaneo, Marco; Rosti, Vittorio; Barosi, Giovanni			In Vitro Megakaryocyte Differentiation and Proplatelet Formation in Ph-Negative Classical Myeloproliferative Neoplasms: Distinct Patterns in the Different Clinical Phenotypes	PLOS ONE			English	Article							MOBILIZED PERIPHERAL-BLOOD; BONE-MARROW; ESSENTIAL THROMBOCYTHEMIA; IDIOPATHIC MYELOFIBROSIS; GROWTH; MUTATION; CELLS; JAK2; CLASSIFICATION; MECHANISMS	Background: Ph-negative myeloproliferative neoplasms (MPNs) are clonal disorders that include primary myelofibrosis (PMF), polycythemia vera (PV) and essential thrombocythemia (ET). Although the pathogenesis of MPNs is still incompletely understood, an involvement of the megakaryocyte lineage is a distinctive feature. Methodology/Principal Findings: We analyzed the in vitro megakaryocyte differentiation and proplatelet formation in 30 PMF, 8 ET, 8 PV patients, and 17 healthy controls (CTRL). Megakaryocytes were differentiated from peripheral blood CD34(+) or CD45(+) cells in the presence of thrombopoietin. Megakaryocyte output was higher in MPN patients than in CTRL with no correlation with the JAK2 V617F mutation. PMF-derived megakaryocytes displayed nuclei with a bulbous appearance, were smaller than ET- or PV-derived megakaryocytes and formed proplatelets that presented several structural alterations. In contrast, ET- and PV-derived megakaryocytes produced more proplatelets with a striking increase in bifurcations and tips compared to both control and PMF. Proplatelets formation was correlated with platelet counts in patient peripheral blood. Patients with pre-fibrotic PMF had a pattern of megakaryocyte proliferation and proplatelet formation that was similar to that of fibrotic PMF and different from that of ET. Conclusions/Significance: In conclusion, MPNs are associated with high megakaryocyte proliferative potential. Profound differences in megakaryocyte morphology and proplatelet formation distinguish PMF, both fibrotic and prefibrotic, from ET and PV.	[Balduini, Alessandra; Badalucco, Stefania] Univ Pavia, Dept Biochem, I-27100 Pavia, Italy; [Balduini, Alessandra] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Pugliano, Maria Teresa; Cattaneo, Marco] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, Unita Med 3, Azienda Osped San Paolo, Milan, Italy; [Baev, Denis] ViroStatics, Sassari, Italy; [De Silvestri, Annalisa] IRCCS Policlin S Matteo Fdn, Biometr Unit, Pavia, Italy; [Rosti, Vittorio; Barosi, Giovanni] IRCCS Policlin S Matteo Fdn, Clin Epidemiol Unit, Pavia, Italy; [Rosti, Vittorio; Barosi, Giovanni] IRCCS Policlin S Matteo Fdn, Ctr Study Myelofibrosis, Pavia, Italy	University of Pavia; Tufts University; University of Milan; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo	Balduini, A (corresponding author), Univ Pavia, Dept Biochem, Via Palestro 3, I-27100 Pavia, Italy.	alessandra.balduini@unipv.it	Rosti, Vittorio/K-1743-2018; BALDUINI, ALESSANDRA/AAC-3363-2022; Barosi, Giovanni/AAI-1714-2019; De Silvestri, Annalisa/I-6024-2014; Balduini, Alessandra/K-6802-2016; Cattaneo, Marco/AAT-4080-2020	Rosti, Vittorio/0000-0003-4195-2289; BALDUINI, ALESSANDRA/0000-0003-3145-1245; De Silvestri, Annalisa/0000-0003-3128-8441; Balduini, Alessandra/0000-0003-3145-1245; Pugliano, Mariateresa/0000-0003-0749-0172; Cattaneo, Marco/0000-0002-7343-4534	Cariplo Foundation [2006.0596/10.8485]; Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)	Cariplo Foundation(Fondazione Cariplo); Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Cariplo Foundation (2006.0596/10.8485) and was funded (in part) by a grant from Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano) "Special Program Molecular Clinical Oncology 5x1000" to AGIMM (AIRC-Gruppo Italiano Malattie Mieloproliferative). A detailed description of the AGIMM project is available at http://www.progettoagimm.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Balduini A, 2008, J THROMB HAEMOST, V6, P1900, DOI 10.1111/j.1538-7836.2008.03132.x; Balduini A, 2009, J THROMB HAEMOST, V7, P478, DOI 10.1111/j.1538-7836.2008.03255.x; Barosi G, 1999, J CLIN ONCOL, V17, P2954, DOI 10.1200/JCO.1999.17.9.2954; Barosi G, 2005, SEMIN HEMATOL, V42, P248, DOI 10.1053/j.seminhematol.2005.05.018; Barosi G, 2001, BLOOD, V98, P3249, DOI 10.1182/blood.V98.12.3249; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; BECKER RP, 1976, AM J ANAT, V145, P183, DOI 10.1002/aja.1001450204; Besancenot R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000476; Boveri E, 2008, BRIT J HAEMATOL, V140, P162, DOI 10.1111/j.1365-2141.2007.06885.x; Chaligne R, 2009, LEUKEMIA, V23, P1186, DOI 10.1038/leu.2009.22; Chang Q, 1997, EXP HEMATOL, V25, P423; Ciurea SO, 2007, BLOOD, V110, P986, DOI 10.1182/blood-2006-12-064626; Giraudier S, 2002, BLOOD, V100, P2932, DOI 10.1182/blood-2002-02-0485; Hartwig J, 2003, J THROMB HAEMOST, V1, P1580, DOI 10.1046/j.1538-7836.2003.00331.x; HAYLOCK DN, 1992, BLOOD, V80, P1405; Hoffman R, 2007, BIOL BLOOD MARROW TR, V13, P64, DOI 10.1016/j.bbmt.2006.11.003; Italiano JE, 2003, J THROMB HAEMOST, V1, P1174, DOI 10.1046/j.1538-7836.2003.00290.x; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674; Kaushansky K, 2006, CYTOKINE GROWTH F R, V17, P423, DOI 10.1016/j.cytogfr.2006.09.005; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Larson MK, 2006, BLOOD, V108, P1509, DOI 10.1182/blood-2005-11-011957; Lataillade JJ, 2008, BLOOD, V112, P3026, DOI 10.1182/blood-2008-06-158386; LEVINE R, 2006, AM SOC HEMATOL ED BO, P233; LEVINE RL, 2006, AM SOC HEMATOL ED PR, P510; LI J, BLOOD, V116, P1528; Muth M, 2010, LEUKEMIA RES, V34, P1424, DOI 10.1016/j.leukres.2010.03.040; Patel SR, 2005, J CLIN INVEST, V115, P3348, DOI 10.1172/JCI26891; Schulze H, 2005, J THROMB HAEMOST, V3, P1717, DOI 10.1111/j.1538-7836.2005.01426.x; Swerdlow E., 2008, WHO CLASSIFICATION T; Taksin AL, 1999, BLOOD, V93, P125, DOI 10.1182/blood.V93.1.125.401k32_125_139; Tefferi A, 2006, BLOOD, V108, P2493, DOI 10.1182/blood-2006-05-025544; THIELE J, 1982, VIRCHOWS ARCH B, V41, P67, DOI 10.1007/BF02890272; THIELE J, 2001, WHO CLASSIFICATION T, P35; Thiele J, 2005, HAEMATOLOGICA, V90, P1128; Thon JN, 2010, J CELL BIOL, V191, P861, DOI 10.1083/jcb.201006102; Vannucchi AM, 2005, BLOOD, V105, P3493, DOI 10.1182/blood-2004-04-1320; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Weisdorf DJ, 1997, AM J HEMATOL, V54, P202, DOI 10.1002/(SICI)1096-8652(199703)54:3<202::AID-AJH5>3.0.CO;2-#; WILLIAMS N, 1982, BRIT J HAEMATOL, V52, P173, DOI 10.1111/j.1365-2141.1982.tb03878.x	42	43	45	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21015	10.1371/journal.pone.0021015	http://dx.doi.org/10.1371/journal.pone.0021015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698292	Green Published, gold, Green Submitted			2022-12-25	WOS:000291730000038
J	De Cola, A; Bongiorno-Borbone, L; Bianchi, E; Barcaroli, D; Carletti, E; Knight, RA; Di Ilio, C; Melino, G; Sette, C; De Laurenzi, V				De Cola, A.; Bongiorno-Borbone, L.; Bianchi, E.; Barcaroli, D.; Carletti, E.; Knight, R. A.; Di Ilio, C.; Melino, G.; Sette, C.; De Laurenzi, V.			FLASH is essential during early embryogenesis and cooperates with p73 to regulate histone gene transcription	ONCOGENE			English	Article						Histone Locus Bodies; Cajal bodies; FLASH; NPAT	CYCLIN E/CDK2 SUBSTRATE; CELL-CYCLE; CAJAL BODIES; SELECTIVE DEGRADATION; MESSENGER-RNA; HINF-P; EXPRESSION; P220(NPAT); APOPTOSIS; TAP73	Replication-dependent histone gene expression is a fundamental process occurring in S-phase under the control of the cyclin-E/CDK2 complex. This process is regulated by a number of proteins, including Flice-Associated Huge Protein (FLASH) (CASP8AP2), concentrated in specific nuclear organelles known as HLBs. FLASH regulates both histone gene transcription and mRNA maturation, and its downregulation in vitro results in the depletion of the histone pull and cell-cycle arrest in S-phase. Here we show that the transcription factor p73 binds to FLASH and is part of the complex that regulates histone gene transcription. Moreover, we created a novel gene trap to disrupt FLASH in mice, and we show that homozygous deletion of FLASH results in early embryonic lethality, owing to arrest of FLASH(-/-) embryos at the morula stage. These results indicate that FLASH is an essential, non-redundant regulator of histone transcription and cell cycle during embryogenesis. Oncogene (2012) 31, 573-582; doi:10.1038/onc.2011.274; published online 4 July 2011	[De Laurenzi, V.] Univ G dAnnunzio, CeSI, Dipartimento Sci Biomed, I-66100 Chieti, Italy; [De Cola, A.; Bongiorno-Borbone, L.; Melino, G.] Univ Roma Tor Vergata, Dept Expt Med, IDI IRCCS Biochem Lab, Rome, Italy; [Bianchi, E.; Sette, C.] Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, Rome, Italy; [Bianchi, E.; Sette, C.] IRCCS Fdn Santa Lucia, Lab Neuroembryol, Rome, Italy; [Carletti, E.] Univ G dAnnunzio, Dipartimento Sci Movimento Umano, I-66100 Chieti, Italy; [Knight, R. A.; Melino, G.] Univ Leicester, Med Res Council, Toxicol Unit, Leicester, Leics, England; [Di Ilio, C.; De Laurenzi, V.] Fdn G DAnnunzio, CeSI, I-66100 Chieti, Italy	G d'Annunzio University of Chieti-Pescara; University of Rome Tor Vergata; University of Rome Tor Vergata; IRCCS Santa Lucia; G d'Annunzio University of Chieti-Pescara; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Leicester; G d'Annunzio University of Chieti-Pescara	De Laurenzi, V (corresponding author), Univ G dAnnunzio, CeSI, Dipartimento Sci Biomed, Via Colle Ara 1, I-66100 Chieti, Italy.	delaurenzi@unich.it	Bianchi, Enrica/P-2379-2019; Sette, Claudio/S-4307-2019; De Laurenzi, Vincenzo/K-7471-2016	Bianchi, Enrica/0000-0001-8124-7328; Sette, Claudio/0000-0003-2864-8266; De Laurenzi, Vincenzo/0000-0002-7506-1743; De Cola, Antonella/0000-0002-3202-5339	AIRC; MIUR; AIRC, EU-EPISTEM; FIRB, MIUR; MinSan; Telethon; Alleanza Contro il Cancro; FIRC; MRC [MC_U132670600] Funding Source: UKRI; Medical Research Council [MC_U132670600] Funding Source: researchfish	AIRC(Fondazione AIRC per la ricerca sul cancro); MIUR(Ministry of Education, Universities and Research (MIUR)); AIRC, EU-EPISTEM(Fondazione AIRC per la ricerca sul cancro); FIRB, MIUR(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); MinSan; Telethon(Fondazione Telethon); Alleanza Contro il Cancro; FIRC(Fondazione AIRC per la ricerca sul cancro); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from AIRC, MIUR, to VDL, and AIRC, EU-EPISTEM; FIRB, MIUR; MinSan; Telethon and Alleanza Contro il Cancro to GM. DB is supported by a FIRC scholarship.	Alizadeh Z, 2005, MOL REPROD DEV, V72, P281, DOI 10.1002/mrd.20340; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14802, DOI 10.1073/pnas.0604225103; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14808, DOI 10.1073/pnas.0604227103; Bongiorno-Borbone L, 2010, ONCOGENE, V29, P802, DOI 10.1038/onc.2009.388; Bongiorno-Borbone L, 2008, CELL CYCLE, V7, P2357, DOI 10.4161/cc.6344; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; DiFruscio M, 1997, MOL CELL BIOL, V17, P4080, DOI 10.1128/MCB.17.7.4080; Ghule PN, 2008, P NATL ACAD SCI USA, V105, P16964, DOI 10.1073/pnas.0809273105; Ghule PN, 2007, J CELL PHYSIOL, V213, P9, DOI 10.1002/jcp.21119; GIEBELHAUS DH, 1983, DEV BIOL, V98, P148, DOI 10.1016/0012-1606(83)90343-3; Gottifredi V, 1999, J VIROL, V73, P1427, DOI 10.1128/JVI.73.2.1427-1437.1999; GRAVES RA, 1985, P NATL ACAD SCI USA, V82, P5685, DOI 10.1073/pnas.82.17.5685; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Hall C, 2001, MOL CELL BIOL, V21, P1854, DOI 10.1128/MCB.21.5.1854-1865.2001; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Hogan B, 1994, MANIPULATING MOUSE E; Joyner AL, 2000, GENE TARGETING PRACT; Levrero M, 2000, J CELL SCI, V113, P1661; Liu JL, 2006, J CELL BIOL, V172, P875, DOI 10.1083/jcb.200511038; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; Maisse C, 2004, CELL DEATH DIFFER, V11, P685, DOI 10.1038/sj.cdd.4401376; Matera AG, 2006, J CELL BIOL, V172, P791, DOI 10.1083/jcb.200602002; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Melino G, 2003, TRENDS BIOCHEM SCI, V28, P663, DOI 10.1016/j.tibs.2003.10.004; Miele A, 2005, MOL CELL BIOL, V25, P6140, DOI 10.1128/MCB.25.14.6140-6153.2005; Mitra P, 2003, MOL CELL BIOL, V23, P8110, DOI 10.1128/MCB.23.22.8110-8123.2003; Munarriz E, 2004, MOL CELL BIOL, V24, P10593, DOI 10.1128/MCB.24.24.10593-10610.2004; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Paynton BV, 1998, DEV GENET, V23, P285, DOI 10.1002/(SICI)1520-6408(1998)23:4&lt;285::AID-DVG4&gt;3.0.CO;2-W; Ramadan S, 2005, BIOCHEM BIOPH RES CO, V331, P713, DOI 10.1016/j.bbrc.2005.03.156; Sayan AE, 2005, BIOCHEM BIOPH RES CO, V330, P186, DOI 10.1016/j.bbrc.2005.02.145; SILVER J, 1989, J VIROL, V63, P1924, DOI 10.1128/JVI.63.5.1924-1928.1989; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Tomasini R, 2008, TRENDS CELL BIOL, V18, P244, DOI 10.1016/j.tcb.2008.03.003; Tomasini R, 2009, P NATL ACAD SCI USA, V106, P797, DOI 10.1073/pnas.0812096106; Vernole P, 2009, CELL CYCLE, V8, P421, DOI 10.4161/cc.8.3.7623; Wei Y, 2003, MOL CELL BIOL, V23, P3669, DOI 10.1128/MCB.23.10.3669-3680.2003; Xie RL, 2009, P NATL ACAD SCI USA, V106, P12359, DOI 10.1073/pnas.0905651106; Yang XC, 2009, MOL CELL, V36, P267, DOI 10.1016/j.molcel.2009.08.016; Ye X, 2003, MOL CELL BIOL, V23, P8586, DOI 10.1128/MCB.23.23.8586-8600.2003; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zhao JY, 2004, CELL CYCLE, V3, P695	43	22	23	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	5					573	582		10.1038/onc.2011.274	http://dx.doi.org/10.1038/onc.2011.274			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MS	21725362				2022-12-25	WOS:000300221800004
J	Bergsmann, J; Derler, I; Muik, M; Frischauf, I; Fahrner, M; Pollheimer, P; Schwarzinger, C; Gruber, HJ; Groschner, K; Romanin, C				Bergsmann, Judith; Derler, Isabella; Muik, Martin; Frischauf, Irene; Fahrner, Marc; Pollheimer, Philipp; Schwarzinger, Clemens; Gruber, Hermann J.; Groschner, Klaus; Romanin, Christoph			Molecular Determinants within N Terminus of Orai3 Protein That Control Channel Activation and Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAST CA2+-DEPENDENT INACTIVATION; OPERATED CA2+ ENTRY; CRAC CHANNELS; CALCIUM-CHANNELS; PLASMA-MEMBRANE; STIM1; DEPLETION; BORATE; CELLS; CALMODULIN	STIM1 and Orai represent the key components of Ca2+ release-activated Ca2+ channels. Activation of Orai channels requires coupling of the C terminus of STIM1 to the N and C termini of Orai. Although the latter appears to be central in the interaction with STIM1, the role of the N terminus and particularly of the conserved region close to the first transmembrane sequence is less well understood. Here, we investigated in detail the functional role of this conserved region in Orai3 by stepwise deletions. Molecular determinants were mapped for the two modes of Orai3 activation via STIM1 or 2-aminoethoxydiphenyl borate (2-APB) and for current gating characteristics. Increasing N-terminal truncations revealed a progressive decrease of the specific fast inactivation of Orai3 concomitant with diminished binding to calmodulin. STIM1-dependent activation of Orai3 was maintained as long as the second half of this conserved N-terminal domain was present. Further truncations abolished it, whereas Orai3 stimulation via 2-APB was partially retained. In aggregate, the N-terminal conserved region plays a multifaceted role in Orai3 current gating with distinct structural requirements for STIM1- and 2-APB-stimulated activation.	[Bergsmann, Judith; Derler, Isabella; Muik, Martin; Frischauf, Irene; Fahrner, Marc; Pollheimer, Philipp; Gruber, Hermann J.; Romanin, Christoph] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Schwarzinger, Clemens] Univ Linz, Inst Chem Technol Organ Mat, A-4040 Linz, Austria; [Groschner, Klaus] Graz Univ, Dept Pharmaceut Sci Pharmacol & Toxicol, A-8010 Graz, Austria	Johannes Kepler University Linz; Johannes Kepler University Linz; University of Graz	Romanin, C (corresponding author), Univ Linz, Inst Biophys, Altenbergerstr 69, A-4040 Linz, Austria.	christoph.romanin@jku.at	Fahrner, Marc/AAI-7927-2021; Schwarzinger, Clemens/AAA-4193-2022; Romanin, Christoph/D-5399-2009; Groschner, Klaus/A-2550-2010; Derler, Isabella/B-7871-2019; Frischauf, Irene/AAG-2007-2019	Romanin, Christoph/0000-0003-3756-4136; Groschner, Klaus/0000-0002-8659-377X; Derler, Isabella/0000-0002-4768-146X; Frischauf, Irene/0000-0003-0661-2932; Schwarzinger, Clemens/0000-0002-8421-9063; Fahrner, Marc/0000-0002-2689-0158	Austrian Science Fund (FWF) [P211925, P22565]; Austrian Research Promotion Agency (FFG) Austrian Nanoscience Initiative, NSI-NABIOS [VO104-08-BI, 819703]; Hertha-Firnberg Scholarship [T466, T442]; Austrian Science Fund (FWF) [P 22565, P 21925] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Research Promotion Agency (FFG) Austrian Nanoscience Initiative, NSI-NABIOS; Hertha-Firnberg Scholarship(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by Austrian Science Fund (FWF) Projects P211925 (to K. G.) and P22565 (to C. R.) and Austrian Research Promotion Agency (FFG) Austrian Nanoscience Initiative VO104-08-BI Project 819703 NSI-NABIOS (to H. J. G.).; Supported by Hertha-Firnberg Scholarship T466. To whom correspondence may be addressed. E-mail: isabella. derler@jku.at.; Supported by Hertha-Firnberg Scholarship T442.	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Derler I, 2009, J BIOL CHEM, V284, P15903, DOI 10.1074/jbc.M808312200; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; Frischauf I, 2011, J BIOL CHEM, V286, P8577, DOI 10.1074/jbc.M110.187179; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Lis A, 2010, J GEN PHYSIOL, V136, P673, DOI 10.1085/jgp.201010484; Litjens T, 2004, J PHYSIOL-LONDON, V558, P85, DOI 10.1113/jphysiol.2004.065870; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Srikanth S, 2010, NAT CELL BIOL, V12, P436, DOI 10.1038/ncb2045; Srikanth S, 2010, J BIOL CHEM, V285, P5066, DOI 10.1074/jbc.M109.072736; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yamashita M, 2011, J BIOL CHEM, V286, P9429, DOI 10.1074/jbc.M110.189035; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	35	37	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31565	31575		10.1074/jbc.M111.227546	http://dx.doi.org/10.1074/jbc.M111.227546			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21724845	Green Published, hybrid			2022-12-25	WOS:000294487500051
J	Quinlan, CL; Gerencser, AA; Treberg, JR; Brand, MD				Quinlan, Casey L.; Gerencser, Akos A.; Treberg, Jason R.; Brand, Martin D.			The Mechanism of Superoxide Production by the Antimycin-inhibited Mitochondrial Q-cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME BC(1) COMPLEX; IRON-SULFUR PROTEIN; ELECTRON-TRANSFER CHAIN; STEADY-STATE KINETICS; PROTONMOTIVE Q-CYCLE; RHODOPSEUDOMONAS-SPHAEROIDES; RESPIRATORY-CHAIN; C REDUCTASE; Q(O) SITE; UBIQUINOL OXIDATION	Superoxide production from antimycin-inhibited complex III in isolated mitochondria first increased to a maximum then decreased as substrate supply was modulated in three different ways. In each case, superoxide production had a similar bell-shaped relationship to the reduction state of cytochrome b(566), suggesting that superoxide production peaks at intermediate Q-reduction state because it comes from a semiquinone in the outer quinone-binding site in complex III (Q(o)). Imposition of a membrane potential changed the relationships between superoxide production and b(566) reduction and between b(562) and b(566) redox states, suggesting that b(562) reduction also affects semiquinone concentration and superoxide production. To assess whether this behavior was consistent with the Q-cycle mechanism of complex III, we generated a kinetic model of the antimycin-inhibited Q(o) site. Using published rate constants (determined without antimycin), with unknown rate constants allowed to vary, the model failed to fit the data. However, when we allowed the rate constant for quinol oxidation to decrease 1000-fold and the rate constant for semiquinone oxidation by b(566) to depend on the b(562) redox state, the model fit the energized and de-energized data well. In such fits, quinol oxidation was much slower than literature values and slowed further when b(566) was reduced, and reduction of b(562) stabilized the semiquinone when b(566) was oxidized. Thus, superoxide production at Q(o) depends on the reduction states of b(566) and b(562) and fits the Q-cycle only if particular rate constants are altered when b oxidation is prevented by antimycin. These mechanisms limit superoxide production and short circuiting of the Q-cycle when electron transfer slows.	[Quinlan, Casey L.; Gerencser, Akos A.; Treberg, Jason R.; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Quinlan, CL (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	cquinlan@buckinstitute.org	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153; Treberg, Jason/0000-0001-5112-7325; Quinlan, Casey/0000-0002-7808-8271	National Institutes of Health [R01 AG033542, P01 AG025901, PL1 AG032118]; NATIONAL INSTITUTE ON AGING [PL1AG032118, P01AG025901, R01AG033542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG033542 (to C. L. Q., J. R. T., and M. D. B.), P01 AG025901 (to M. D. B.), and PL1 AG032118 (to A. A. G. and M. D. B.).	Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BOVERIS A, 1975, FEBS LETT, V54, P311, DOI 10.1016/0014-5793(75)80928-8; Brand M. D., 1995, BIOENERGETICS, V154, P62; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Brasseur G, 1996, BBA-BIOENERGETICS, V1275, P61, DOI 10.1016/0005-2728(96)00051-5; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; CHAPPELL JB, 1954, NATURE, V173, P1094, DOI 10.1038/1731094a0; Cooley JW, 2009, BIOCHEMISTRY-US, V48, P1888, DOI 10.1021/bi802216h; Cooley JW, 2005, BIOCHEMISTRY-US, V44, P10520, DOI 10.1021/bi050571+; Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15791, DOI 10.1021/bi990961u; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Crofts AR, 2003, J BIOL CHEM, V278, P36191, DOI 10.1074/jbc.M305461200; CROFTS AR, 1989, PHOTOSYNTH RES, V22, P69, DOI 10.1007/BF00114768; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; DEVRIES S, 1983, BIOCHIM BIOPHYS ACTA, V723, P91, DOI 10.1016/0005-2728(83)90013-0; DEVRIES S, 1982, BIOCHIM BIOPHYS ACTA, V681, P41, DOI 10.1016/0005-2728(82)90276-6; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; ERECINSKA M, 1976, ARCH BIOCHEM BIOPHYS, V174, P143, DOI 10.1016/0003-9861(76)90333-7; ESPOSTI MD, 1982, BIOCHIM BIOPHYS ACTA, V682, P189, DOI 10.1016/0005-2728(82)90098-6; ESPOSTI MD, 1991, ARCH BIOCHEM BIOPHYS, V289, P303, DOI 10.1016/0003-9861(91)90415-F; FATO R, 1993, BIOCHEM J, V290, P225, DOI 10.1042/bj2900225; Forquer I, 2006, J BIOL CHEM, V281, P38459, DOI 10.1074/jbc.M605119200; Funahashi Akira, 2007, In Silico Biology, V7, pS81; Harman D, 1998, J Int Fed Clin Chem, V10, P24; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; Izrailev S, 1999, BIOPHYS J, V77, P1753, DOI 10.1016/S0006-3495(99)77022-0; Junemann S, 1998, J BIOL CHEM, V273, P21603, DOI 10.1074/jbc.273.34.21603; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; LENAZ G, 1988, J MEMBRANE BIOL, V104, P193, DOI 10.1007/BF01872322; Link TA, 1997, FEBS LETT, V412, P257, DOI 10.1016/S0014-5793(97)00772-2; MEINHARDT SW, 1983, BIOCHIM BIOPHYS ACTA, V723, P219, DOI 10.1016/0005-2728(83)90121-4; MITCHELL P, 1975, FEBS LETT, V59, P137, DOI 10.1016/0014-5793(75)80359-0; Mulkidjanian AY, 2005, BBA-BIOENERGETICS, V1709, P5, DOI 10.1016/j.bbabio.2005.03.009; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; PASQUALI P, 1985, J BIOENERG BIOMEMBR, V17, P283, DOI 10.1007/BF00751105; ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0; Rottenberg H, 2009, J BIOL CHEM, V284, P19203, DOI 10.1074/jbc.M109.017376; Sarewicz M, 2010, BBA-BIOENERGETICS, V1797, P1820, DOI 10.1016/j.bbabio.2010.07.005; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Treberg JR, 2010, FEBS J, V277, P2766, DOI 10.1111/j.1742-4658.2010.07693.x; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; TRUMPOWER BL, 1976, BIOCHEM BIOPH RES CO, V70, P73, DOI 10.1016/0006-291X(76)91110-4; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; URBAN PF, 1969, EUR J BIOCHEM, V9, P519, DOI 10.1111/j.1432-1033.1969.tb00640.x; Van Remmen H, 2001, EXP GERONTOL, V36, P957; VANDENBERG WH, 1979, J BIOL CHEM, V254, P8594; WEST IC, 1988, BIOCHIM BIOPHYS ACTA, V933, P35, DOI 10.1016/0005-2728(88)90053-9	52	129	133	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31361	31372		10.1074/jbc.M111.267898	http://dx.doi.org/10.1074/jbc.M111.267898			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21708945	Green Published, hybrid			2022-12-25	WOS:000294487500031
J	Deng, T; Sieglaff, DH; Zhang, AJ; Lyon, CJ; Ayers, SD; Cvoro, A; Gupte, AA; Xia, XF; Baxter, JD; Webb, P; Hsueh, WA				Deng, Tuo; Sieglaff, Douglas H.; Zhang, Aijun; Lyon, Christopher J.; Ayers, Steven D.; Cvoro, Aleksandra; Gupte, Anisha A.; Xia, Xuefeng; Baxter, John D.; Webb, Paul; Hsueh, Willa A.			A Peroxisome Proliferator-activated Receptor gamma (PPAR gamma)/PPAR gamma Coactivator 1 beta Autoregulatory Loop in Adipocyte Mitochondrial Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; ADIPOSE-TISSUE; GENE-EXPRESSION; GLUCOSE-UPTAKE; GENOME-WIDE; OXIDATIVE-METABOLISM; INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; FAT; DIFFERENTIATION	Peroxisome proliferator-activated receptor gamma (PPAR gamma) activation induces adipogenesis and also enhances lipogenesis, mitochondrial activity, and insulin sensitivity in adipocytes. Whereas some studies implicate PPAR gamma coactivator 1 alpha (PGC-1 alpha) in the mitochondrial effect, the mechanisms involved in PPAR gamma regulation of adipocyte mitochondrial function are not resolved. PPAR gamma-activating ligands (thiazolidinediones (TZDs)) are important insulin sensitizers and were recently shown to indirectly induce PGC-1 beta transcription in osteoclasts. Here, we asked whether similar effects occur in adipocytes and show that TZDs also strongly induce PGC-1 beta in cultured 3T3-L1 cells. This effect, however, differs from the indirect effect proposed for bone and is rapid and direct and involves PPAR gamma interactions with an intronic PPAR gamma response element cluster in the PGC-1 beta locus. TZD treatment of cultured adipocytes results in up-regulation of mitochondrial marker genes, and increased mitochondrial activity and use of short interfering RNA confirms that these effects require PGC-1 beta. PGC-1 beta did not participate inPPAR gamma effects on adipogenesis or lipogenesis, and PGC-1 beta knockdown did not alter insulin-responsive glucose uptake into 3T3-L1 cells. Similar effects on PGC-1 beta and mitochondrial gene expression are seen in vivo; fractionation of obese mouse adipose tissue reveals that PPAR gamma and PGC-1 beta, but not PGC-1 alpha, are coordinately up-regulated in adipocytes relative to preadipocytes and that TZD treatment induces PGC-1 beta and mitochondrial marker genes in adipose tissue of obese mice. We propose that PPAR gamma directly induces PGC-1 beta expression in adipocytes and that this effect regulates adipocyte mitochondrial activity.	[Deng, Tuo; Sieglaff, Douglas H.; Zhang, Aijun; Lyon, Christopher J.; Ayers, Steven D.; Cvoro, Aleksandra; Gupte, Anisha A.; Xia, Xuefeng; Baxter, John D.; Webb, Paul; Hsueh, Willa A.] Methodist Hosp, Res Inst, Ctr Diabet Res, Weill Cornell Med Coll, Houston, TX 77030 USA	Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Hsueh, WA (corresponding author), Methodist Hosp, Res Inst, Ctr Diabet Res, Weill Cornell Med Coll, 6565 Fannin,F8-045, Houston, TX 77030 USA.	wahsueh@tmhs.org	Gupte, Anisha/D-6756-2015; Deng, Tuo/M-3176-2015; Ayers, Stephen D/O-4535-2014	Gupte, Anisha/0000-0002-5173-1773; Ayers, Stephen D/0000-0003-1390-8969	National Institutes of Health [1R24DK087723-01, U01 GM094614]; American Diabetes Association [7-07-CVD-12]; MacDonald Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK087723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); MacDonald Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R24DK087723-01 (to W.A.H. and J.D.B.) and U01 GM094614 (to P.W.). This work was also supported by American Diabetes Association Fellowship 7-07-CVD-12 (to T.D.) and the MacDonald Foundation (to W.A.H.).	Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Deng T, 2006, ENDOCRINOLOGY, V147, P875, DOI 10.1210/en.2005-0623; Fonseca V, 2003, AM J MED, V115, P42, DOI 10.1016/j.amjmed.2003.09.005; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Halleux CM, 1999, J CLIN ENDOCR METAB, V84, P4097, DOI 10.1210/jc.84.11.4097; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Heinaniemi M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r147; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; Hu X, 2007, DIABETOLOGIA, V50, P1048, DOI 10.1007/s00125-007-0622-3; Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lebovitz HE, 2002, DIABETES-METAB RES, V18, pS23, DOI 10.1002/dmrr.252; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344; Lopez-Solache I, 2002, ENDOCRINE, V19, P197, DOI 10.1385/ENDO:19:2:197; Mukherjee R, 2000, MOL ENDOCRINOL, V14, P1425, DOI 10.1210/me.14.9.1425; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nugent C, 2001, MOL ENDOCRINOL, V15, P1729, DOI 10.1210/me.15.10.1729; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Olswang Y, 2002, P NATL ACAD SCI USA, V99, P625, DOI 10.1073/pnas.022616299; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Shah P, 2010, EXPERT OPIN DRUG SAF, V9, P347, DOI 10.1517/14740331003623218; Shi XR, 2008, J BIOL CHEM, V283, P30658, DOI 10.1074/jbc.M800510200; Siersbaek R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010; Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752	37	23	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30723	30731		10.1074/jbc.M111.251926	http://dx.doi.org/10.1074/jbc.M111.251926			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21719705	Green Published, hybrid			2022-12-25	WOS:000294283600052
J	Ben-David, O; Pewzner-Jung, Y; Brenner, O; Laviad, EL; Kogot-Levin, A; Weissberg, I; Biton, IE; Pienik, R; Wang, E; Kelly, S; Alroy, J; Raas-Rothschild, A; Friedman, A; Brugger, B; Merrill, AH; Futerman, AH				Ben-David, Oshrit; Pewzner-Jung, Yael; Brenner, Ori; Laviad, Elad L.; Kogot-Levin, Aviram; Weissberg, Itai; Biton, Inbal E.; Pienik, Reut; Wang, Elaine; Kelly, Samuel; Alroy, Joseph; Raas-Rothschild, Annick; Friedman, Alon; Bruegger, Britta; Merrill, Alfred H., Jr.; Futerman, Anthony H.			Encephalopathy Caused by Ablation of Very Long Acyl Chain Ceramide Synthesis May Be Largely Due to Reduced Galactosylceramide Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED HIPPOCAMPAL-NEURONS; CENTRAL-NERVOUS-SYSTEM; MOUSE-BRAIN; SYNTHASE 2; SUBSTRATE-SPECIFICITY; FAMILY-MEMBERS; UDP-GALACTOSE; MYELIN SHEATH; GROWTH-FACTOR; NON-HYDROXY	Sphingolipids (SLs) act as signaling molecules and as structural components in both neuronal cells and myelin. We now characterize the biochemical, histological, and behavioral abnormalities in the brain of a mouse lacking very long acyl (C22-C24) chain SLs. This mouse, which is defective in the ability to synthesize C22-C24-SLs due to ablation of ceramide synthase 2, has reduced levels of galactosylceramide (GalCer), a major component of myelin, and in particular reduced levels of non-hydroxy-C22-C24-GalCer and 2-hydroxy-C22-C24-GalCer. Noteworthy brain lesions develop with a time course consistent with a vital role for C22-C24-GalCer in myelin stability. Myelin degeneration and detachment was observed as was abnormal motor behavior originating from a subcortical region. Additional abnormalities included bilateral and symmetrical vacuolization and gliosis in specific brain areas, which corresponded to some extent to the pattern of ceramide synthase 2 expression, with astrogliosis considerably more pronounced than microglial activation. Unexpectedly, unidentified storage materials were detected in lysosomes of astrocytes, reminiscent of the accumulation that occurs in lysosomal storage disorders. Together, our data demonstrate a key role in the brain for SLs containing very long acyl chains and in particular GalCer with a reduction in their levels leading to distinctive morphological abnormalities in defined brain regions.	[Ben-David, Oshrit; Pewzner-Jung, Yael; Laviad, Elad L.; Pienik, Reut; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Brenner, Ori; Biton, Inbal E.] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Kogot-Levin, Aviram; Raas-Rothschild, Annick] Hadassah Hebrew Univ, Med Ctr, Dept Human Genet & Metab Dis, IL-91120 Jerusalem, Israel; [Weissberg, Itai; Friedman, Alon] Ben Gurion Univ Negev, Dept Physiol & Neurobiol, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Wang, Elaine; Kelly, Samuel; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Wang, Elaine; Kelly, Samuel; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Alroy, Joseph] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 01536 USA; [Alroy, Joseph] Tufts Univ, Sch Med, Sch Vet Med, Boston, MA 01536 USA; [Alroy, Joseph] Tufts Med Ctr, Boston, MA 01536 USA; [Bruegger, Britta] Univ Heidelberg, Biochem Ctr, D-69120 Heidelberg, Germany	Weizmann Institute of Science; Weizmann Institute of Science; Hebrew University of Jerusalem; Hadassah University Medical Center; Ben Gurion University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Tufts University; Tufts University; Tufts Medical Center; Ruprecht Karls University Heidelberg	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il	Pewzner, Faivish/I-6225-2017; Weissberg, Itai/AGU-9930-2022	Pewzner, Faivish/0000-0002-7490-8121; Futerman, Anthony/0000-0003-0013-0115; Weissberg, Itai/0000-0002-5513-1599; Merrill, Alfred/0000-0002-6673-968X	National Institutes of Health [GM076217]; Israel Science Foundation [1404/07]; Minerva Foundation; Merck KGaA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Merck KGaA(Merck & Company); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM076217. This work was also supported by Israel Science Foundation Grant 1404/07, the Minerva Foundation, and Merck KGaA.	Baudry M, 2003, EXP NEUROL, V184, P887, DOI 10.1016/S0014-4886(03)00345-5; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Becker I, 2008, HISTOCHEM CELL BIOL, V129, P233, DOI 10.1007/s00418-007-0344-0; Beirowski B, 2010, J NEUROPATH EXP NEUR, V69, P455, DOI 10.1097/NEN.0b013e3181da84db; Ben-David O, 2010, NEUROMOL MED, V12, P341, DOI 10.1007/s12017-010-8114-x; Brann AB, 2002, J BIOL CHEM, V277, P9812, DOI 10.1074/jbc.M109862200; Brann AB, 1999, J NEUROSCI, V19, P8199; Brugger B, 2000, J CELL BIOL, V151, P507, DOI 10.1083/jcb.151.3.507; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; BURCK U, 1985, EUR J PEDIATR, V143, P203, DOI 10.1007/BF00442139; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; David Y, 2009, J NEUROSCI, V29, P10588, DOI 10.1523/JNEUROSCI.2323-09.2009; Dupree JL, 1999, J NEUROCYTOL, V28, P271, DOI 10.1023/A:1007049310758; Dupree JL, 1998, MICROSC RES TECHNIQ, V41, P431, DOI 10.1002/(SICI)1097-0029(19980601)41:5<431::AID-JEMT9>3.0.CO;2-S; Fewou SN, 2005, J NEUROCHEM, V94, P469, DOI 10.1111/j.1471-4159.2005.03221.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; FUJIWAKI T, 1995, CLIN CHIM ACTA, V234, P23, DOI 10.1016/0009-8981(94)05970-4; FURUYA S, 1995, J NEUROCHEM, V65, P1551; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; Ginzburg L, 2005, J NEUROCHEM, V95, P1619, DOI 10.1111/j.1471-4159.2005.03534.x; Gregory A, 2009, J MED GENET, V46, P73, DOI 10.1136/jmg.2008.061929; Hama H, 2010, BBA-MOL CELL BIOL L, V1801, P405, DOI 10.1016/j.bbalip.2009.12.004; Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Jana A, 2010, NEUROMOL MED, V12, P351, DOI 10.1007/s12017-010-8128-4; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; LEDEEN RW, 1992, TRENDS GLYCOSCI GLYC, V4, P174; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Li HH, 1999, P NATL ACAD SCI USA, V96, P14505, DOI 10.1073/pnas.96.25.14505; Marcus J, 2006, GLIA, V53, P372, DOI 10.1002/glia.20292; Matkowskyj KA, 1999, AM J PHYSIOL-GASTR L, V277, pG455, DOI 10.1152/ajpgi.1999.277.2.G455; Meixner M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-22; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Muller G, 2001, VET PATHOL, V38, P281, DOI 10.1354/vp.38-3-281; Muse ED, 2001, J NEUROCHEM, V76, P77, DOI 10.1046/j.1471-4159.2001.00015.x; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Novgorodov SA, 2011, J BIOL CHEM, V286, P4644, DOI 10.1074/jbc.M110.164392; PETUSHKOVA NA, 1992, PRENATAL DIAG, V12, P835, DOI 10.1002/pd.1970121010; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Pitsch J, 2007, NEUROBIOL DIS, V26, P623, DOI 10.1016/j.nbd.2007.03.003; PRENCE EM, 1992, CLIN CHEM, V38, P501; RAUCH HJ, 1983, AM J DERMATOPATH, V5, P263, DOI 10.1097/00000372-198306000-00013; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; SCHNAAR RL, 1994, METHOD ENZYMOL, V230, P348; SCHWARZ A, 1995, J BIOL CHEM, V270, P10990, DOI 10.1074/jbc.270.18.10990; Schwarz A, 1997, J NEUROSCI, V17, P2929; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; STEWART RJ, 1993, BIOCHEMISTRY-US, V32, P10666, DOI 10.1021/bi00091a017; Summers B. A., 1995, VET NEUROPATHOLOGY, P208; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; SVENNERHOLM L, 1963, J NEUROCHEM, V10, P455; Taniike M, 1998, J NEUROSCI RES, V51, P536, DOI 10.1002/(SICI)1097-4547(19980215)51:4<536::AID-JNR13>3.3.CO;2-F; van der Bijl P, 1996, BIOCHEM J, V317, P589, DOI 10.1042/bj3170589; van Zyl R, 2010, J NEUROCHEM, V112, P282, DOI 10.1111/j.1471-4159.2009.06458.x; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Walker FO, 2007, SEMIN NEUROL, V27, P143, DOI 10.1055/s-2007-971176; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Zoller I, 2008, J NEUROSCI, V28, P9741, DOI 10.1523/JNEUROSCI.0458-08.2008; Zoller I, 2005, GLIA, V52, P190, DOI 10.1002/glia.20230	65	53	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30022	30033		10.1074/jbc.M111.261206	http://dx.doi.org/10.1074/jbc.M111.261206			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21705317	hybrid, Green Published			2022-12-25	WOS:000294046600061
J	Beliveau, F; Brule, C; Desilets, A; Zimmerman, B; Laporte, SA; Lavoie, CL; Leduc, R				Beliveau, Francois; Brule, Cedric; Desilets, Antoine; Zimmerman, Brandon; Laporte, Stephane A.; Lavoie, Christine L.; Leduc, Richard			Essential Role of Endocytosis of the Type II Transmembrane Serine Protease TMPRSS6 in Regulating Its Functionality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-DEFICIENCY ANEMIA; CELL-SURFACE; HEPCIDIN EXPRESSION; MATRIPTASE-2; HEMOJUVELIN; ACTIVATION; MUTATIONS; IDENTIFICATION; PHOSPHORYLATION; TRAFFICKING	The type II transmembrane serine protease TMPRSS6 (also known as matriptase-2) controls iron homeostasis through its negative regulation of expression of hepcidin, a key hormone involved in iron metabolism. Upstream of the hepcidin-regulated signaling pathway, TMPRSS6 cleaves its target substrate hemojuvelin (HJV) at the plasma membrane, but the dynamics of the cell-surface expression of the protease have not been addressed. Here, we report that TMPRSS6 undergoes constitutive internalization in transfected HEK293 cells and in two human hepatic cell lines, HepG2 and primary hepatocytes, both of which express TMPRSS6 endogenously. Cell surface-labeled TMPRSS6 was internalized and was detected in clathrin-and AP-2-positive vesicles via a dynamin-dependent pathway. The endocytosed TMPRSS6 next transited in early endosomes and then to lysosomes. Internalization of TMPRSS6 is dependent on specific residues within its N-terminal cytoplasmic domain, as site-directed mutagenesis of these residues abrogated internalization and maintained the enzyme at the cell surface. Cells coexpressing these mutants and HJV produced significantly decreased levels of hepcidin compared with wild-type TMPRSS6 due to the sustained cleavage of HJV at the cell surface by TMPRSS6 mutants. Our results underscore for the first time the importance of TMPRSS6 trafficking at the plasma membrane in the regulation of hepcidin expression, an event that is essential for iron homeostasis.	[Beliveau, Francois; Brule, Cedric; Desilets, Antoine; Lavoie, Christine L.; Leduc, Richard] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada; [Zimmerman, Brandon; Laporte, Stephane A.] McGill Univ, Ctr Hlth, Res Inst, Dept Med, Montreal, PQ H3A 1A1, Canada; [Zimmerman, Brandon; Laporte, Stephane A.] McGill Univ, Ctr Hlth, Res Inst, Dept Pharmacol & Therapeut, Montreal, PQ H3A 1A1, Canada	University of Sherbrooke; McGill University; McGill University	Leduc, R (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada.	richard.leduc@usherbrooke.ca	Laporte, Stephane/ABC-4228-2021; Laporte, Stephane A/F-3282-2012	Laporte, Stephane/0000-0002-0633-543X; Beliveau, Francois/0000-0001-6324-2363; Desilets, Antoine/0000-0001-5081-5564	Canadian Institutes of Health Research; Banting and Best Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Banting and Best Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by a grant from the Canadian Institutes of Health Research (to R. L. and C. L. L.).; Recipient of a Banting and Best Canadian Institutes of Health Research studentship award.	Altamura S, 2010, BIOCHEM J, V431, P363, DOI 10.1042/BJ20100668; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Beliveau F, 2009, FEBS J, V276, P2213, DOI 10.1111/j.1742-4658.2009.06950.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brodeur J, 2009, TRAFFIC, V10, P1098, DOI 10.1111/j.1600-0854.2009.00933.x; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Fein E, 2007, PEPTIDES, V28, P951, DOI 10.1016/j.peptides.2007.01.016; Fessart D, 2007, J CELL SCI, V120, P1723, DOI 10.1242/jcs.03444; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Friis S, 2011, J BIOL CHEM, V286, P5793, DOI 10.1074/jbc.M110.186874; Guillem F, 2008, BLOOD, V112, P2089, DOI 10.1182/blood-2008-05-154740; Hooper JD, 2003, BIOCHEM J, V373, P689, DOI 10.1042/BJ20030390; JONES BG, 1995, EMBO J, V14, P5869, DOI 10.1002/j.1460-2075.1995.tb00275.x; Kozik P, 2010, TRAFFIC, V11, P843, DOI 10.1111/j.1600-0854.2010.01056.x; Maxson JE, 2010, J BIOL CHEM, V285, P39021, DOI 10.1074/jbc.M110.183160; Maxson JE, 2009, BLOOD, V113, P1786, DOI 10.1182/blood-2008-08-174565; Melis MA, 2008, HAEMATOL-HEMATOL J, V93, P1473, DOI 10.3324/haematol.13342; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Nemeth E, 2009, ACTA HAEMATOL-BASEL, V122, P78, DOI 10.1159/000243791; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Parr C, 2007, CLIN CANCER RES, V13, P3568, DOI 10.1158/1078-0432.CCR-06-2357; Pierre SV, 2011, AM J PHYSIOL-CELL PH, V300, pC42, DOI 10.1152/ajpcell.00386.2010; Posner BI, 2010, PROG BRAIN RES, V181, P1, DOI 10.1016/S0079-6123(08)81001-1; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ramsay AJ, 2008, FRONT BIOSCI-LANDMRK, V13, P569, DOI 10.2741/2702; Ramsay AJ, 2009, HUM MOL GENET, V18, P3673, DOI 10.1093/hmg/ddp315; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Sanders AJ, 2008, J CELL PHYSIOL, V216, P780, DOI 10.1002/jcp.21460; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Silvestri L, 2009, BLOOD, V113, P5605, DOI 10.1182/blood-2008-12-195594; Stirnberg M, 2010, BIOCHEM J, V430, P87, DOI 10.1042/BJ20091565; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Wickramasinghe RD, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-58	38	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29035	29043		10.1074/jbc.M111.223461	http://dx.doi.org/10.1074/jbc.M111.223461			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21724843	Green Published, hybrid			2022-12-25	WOS:000293837000040
J	Kuck, P; Garcia, FH; Misof, B; Meusemann, K				Kueck, Patrick; Garcia, Francisco Hita; Misof, Bernhard; Meusemann, Karen			Improved Phylogenetic Analyses Corroborate a Plausible Position of Martialis heureka in the Ant Tree of Life	PLOS ONE			English	Article							SEQUENCE ALIGNMENTS; BAYESIAN-INFERENCE; EARLY EVOLUTION; NEIGHBOR-NET; HYMENOPTERA; DIVERSIFICATION; RANDOMNESS; MRBAYES; AGE	Martialinae are pale, eyeless and probably hypogaeic predatory ants. Morphological character sets suggest a close relationship to the ant subfamily Leptanillinae. Recent analyses based on molecular sequence data suggest that Martialinae are the sister group to all extant ants. However, by comparing molecular studies and different reconstruction methods, the position of Martialinae remains ambiguous. While this sister group relationship was well supported by Bayesian partitioned analyses, Maximum Likelihood approaches could not unequivocally resolve the position of Martialinae. By re-analysing a previous published molecular data set, we show that the Maximum Likelihood approach is highly appropriate to resolve deep ant relationships, especially between Leptanillinae, Martialinae and the remaining ant subfamilies. Based on improved alignments, alignment masking, and tree reconstructions with a sufficient number of bootstrap replicates, our results strongly reject a placement of Martialinae at the first split within the ant tree of life. Instead, we suggest that Leptanillinae are a sister group to all other extant ant subfamilies, whereas Martialinae branch off as a second lineage. This assumption is backed by approximately unbiased (AU) tests, additional Bayesian analyses and split networks. Our results demonstrate clear effects of improved alignment approaches, alignment masking and data partitioning. We hope that our study illustrates the importance of thorough, comprehensible phylogenetic analyses using the example of ant relationships.	[Kueck, Patrick; Misof, Bernhard; Meusemann, Karen] Zool Forsch Museum Alexander Koenig ZFMK, Bonn, Germany; [Garcia, Francisco Hita] Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); California Academy of Sciences	Kuck, P (corresponding author), Zool Forsch Museum Alexander Koenig ZFMK, Bonn, Germany.	patrick_kueck@web.de	Meusemann, Karen/J-4027-2013; Garcia, Francisco Hita/C-9636-2015	Garcia, Francisco Hita/0000-0003-4709-3083	DFG [MI649/6-2, SPP 1174 (WA530/33)]	DFG(German Research Foundation (DFG))	The work of BM has been supported by the DFG (www.dfg.de) grant MI649/6-2, and PK is supported by a doctoral fellowship financed by the DFG, SPP 1174 (WA530/33), which is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOLTON B, 1990, SYST ENTOMOL, V15, P267, DOI 10.1111/j.1365-3113.1990.tb00063.x; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bryant D, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-8; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dinapoli A, 2011, J MOLLUS STUD, V77, P1, DOI 10.1093/mollus/eyq027; Douady CJ, 2003, MOL BIOL EVOL, V20, P248, DOI 10.1093/molbev/msg042; Dress AWM, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-7; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Golubchik T, 2007, MOL BIOL EVOL, V24, P2433, DOI 10.1093/molbev/msm176; Grimaldi D, 2000, P NATL ACAD SCI USA, V97, P13678, DOI 10.1073/pnas.240452097; Grimaldi David, 1997, American Museum Novitates, V3208, P1; Hartmann S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-95; Huelsenbeck JP, 2002, SYST BIOL, V51, P673, DOI 10.1080/10635150290102366; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kuck P., 2009, ALICUT PERLSCRIPT WH; Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024; Kuck P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-10; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; Moreau CS, 2009, MYRMECOL NEWS, V12, P201; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Murienne J, 2010, MOL PHYLOGENET EVOL, V57, P301, DOI 10.1016/j.ympev.2010.06.022; Nuin PAS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-471; Ott M, 2007, P ACM IEEE SUP C 200; Ouellette GD, 2006, MOL PHYLOGENET EVOL, V40, P359, DOI 10.1016/j.ympev.2006.03.017; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; PRATAS F, 2009, P ICPP 2009 VIENN AU; Rabeling C, 2008, P NATL ACAD SCI USA, V105, P14913, DOI 10.1073/pnas.0806187105; RAMBAUT A, J DA TRACER; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schwarzer J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-186; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Simon S, 2009, MOL BIOL EVOL, V26, P2719, DOI 10.1093/molbev/msp191; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; URBANI CB, 1992, SYST ENTOMOL, V17, P301, DOI 10.1111/j.1365-3113.1992.tb00553.x; Ward PS, 2010, ANT ECOLOGY, P3; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P7411, DOI 10.1073/pnas.0502264102	43	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21031	10.1371/journal.pone.0021031	http://dx.doi.org/10.1371/journal.pone.0021031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731644	Green Submitted, Green Published, gold			2022-12-25	WOS:000292036900009
J	Limana, F; Esposito, G; D'Arcangelo, D; Di Carlo, A; Romani, S; Melillo, G; Mangoni, A; Bertolami, C; Pompilio, G; Germani, A; Capogrossi, MC				Limana, Federica; Esposito, Grazia; D'Arcangelo, Daniela; Di Carlo, Anna; Romani, Sveva; Melillo, Guido; Mangoni, Antonella; Bertolami, Chiara; Pompilio, Giulio; Germani, Antonia; Capogrossi, Maurizio C.			HMGB1 Attenuates Cardiac Remodelling in the Failing Heart via Enhanced Cardiac Regeneration and miR-206-Mediated Inhibition of TIMP-3	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL-INFARCTION; TISSUE INHIBITORS; PROTEIN; EXPRESSION; MICRORNAS; RECEPTOR; METALLOPROTEINASES; ACTIVATION	Aims: HMGB1 injection into the mouse heart, acutely after myocardial infarction (MI), improves left ventricular (LV) function and prevents remodeling. Here, we examined the effect of HMGB1 in chronically failing hearts. Methods and Results: Adult C57 BL16 female mice underwent coronary artery ligation; three weeks later 200 ng HMGB1 or denatured HMGB1 (control) were injected in the peri-infarcted region of mouse failing hearts. Four weeks after treatment, both echocardiography and hemodynamics demonstrated a significant improvement in LV function in HMGB1-treated mice. Further, HMGB1-treated mice exhibited a similar to 23% reduction in LV volume, a similar to 48% increase in infarcted wall thickness and a similar to 14% reduction in collagen deposition. HMGB1 induced cardiac regeneration and, within the infarcted region, it was found a similar to 2-fold increase in c-kit(+) cell number, a similar to 13-fold increase in newly formed myocytes and a similar to 2-fold increase in arteriole length density. HMGB1 also enhanced MMP2 and MMP9 activity and decreased TIMP-3 levels. Importantly, miR-206 expression 3 days after HMGB1 treatment was 4-5-fold higher than in control hearts and 20-25 fold higher that in sham operated hearts. HMGB1 ability to increase miR-206 was confirmed in vitro, in cardiac fibroblasts. TIMP3 was identified as a potential miR-206 target by TargetScan prediction analysis; further, in cultured cardiac fibroblasts, miR-206 gain- and loss-of-function studies and luciferase reporter assays showed that TIMP3 is a direct target of miR-206. Conclusions: HMGB1 injected into chronically failing hearts enhanced LV function and attenuated LV remodelling; these effects were associated with cardiac regeneration, increased collagenolytic activity, miR-206 overexpression and miR-206 mediated inhibition of TIMP-3.	[Limana, Federica; Pompilio, Giulio] IRCCS, Ctr Cardiol Monzino, Lab Biol Vasc & Med Rigenerat, Milan, Italy; [Esposito, Grazia; D'Arcangelo, Daniela; Di Carlo, Anna; Melillo, Guido; Mangoni, Antonella; Bertolami, Chiara; Capogrossi, Maurizio C.] IRCCS, Ist Dermopat Immacolata, Lab Patol Vasc, Milan, Italy; [Romani, Sveva] Casa Sollievo Sofferenza IRCCS, Mendel Lab, San Giovanni Rotondo, Italy; [Germani, Antonia] Fdn Livio Patrizi, Rome, Italy	IRCCS Centro Cardiologico Monzino; IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel	Limana, F (corresponding author), IRCCS, Ctr Cardiol Monzino, Lab Biol Vasc & Med Rigenerat, Milan, Italy.	capogrossi@idi.it	Melillo, Guido/K-6341-2016; Di Carlo, Anna/AAY-4368-2021; Limana, Federica/AAB-2989-2021; D'Arcangelo, Daniela/K-6533-2016; Pompilio, Giulio/J-6701-2014	Melillo, Guido/0000-0002-2379-9471; Di Carlo, Anna/0000-0002-6037-6160; D'Arcangelo, Daniela/0000-0002-7862-3289; Pompilio, Giulio/0000-0003-2581-5735	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This research was supported by a grant from Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanell AM, 2011, SURGERY, V149, P329, DOI 10.1016/j.surg.2010.07.002; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; ANVERSA P, 2002, CARDIOVASCULAR SYSTE, P75; Barringhaus KG, 2009, CIRCULATION, V119, P2217, DOI 10.1161/CIRCULATIONAHA.107.715839; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chavakis E, 2007, CIRC RES, V100, P204, DOI 10.1161/01.RES.0000257774.55970.f4; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; De Mori R, 2007, ARTERIOSCL THROM VAS, V27, P2377, DOI 10.1161/ATVBAHA.107.153429; Ding HS, 2010, SAUDI MED J, V31, P486; Germani A, 2007, J LEUKOCYTE BIOL, V81, P41, DOI 10.1189/jlb.0306165; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Kang KH, 2008, CARDIOVASC RES, V79, P150, DOI 10.1093/cvr/cvn072; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kitahara T, 2008, CARDIOVASC RES, V80, P40, DOI 10.1093/cvr/cvn163; Kohno T, 2009, CARDIOVASC RES, V81, P565, DOI 10.1093/cvr/cvn291; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krum H, 2009, LANCET, V374, P1808, DOI 10.1016/S0140-6736(09)61992-9; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YY, 1998, CIRCULATION, V98, P1728, DOI 10.1161/01.CIR.98.17.1728; Limana F, 2005, CIRC RES, V97, pE73, DOI 10.1161/01.RES.0000186276.06104.04; Liu HJ, 2010, J CELL SCI, V123, P2914, DOI 10.1242/jcs.057620; Liu PL, 2010, AM J RESP CELL MOL, V43, P530, DOI 10.1165/rcmb.2009-0269OC; Lovelock JD, 2005, AM J PHYSIOL-HEART C, V288, pH461, DOI 10.1152/ajpheart.00402.2004; Mitola S, 2006, J IMMUNOL, V176, P12, DOI 10.4049/jimmunol.176.1.12; Oozawa S, 2008, CIRC J, V72, P1178, DOI 10.1253/circj.72.1178; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Palumbo R, 2007, J CELL BIOL, V179, P33, DOI 10.1083/jcb.200704015; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Qiu JH, 2010, STROKE, V41, P2077, DOI 10.1161/STROKEAHA.110.590463; Rossini A, 2008, J MOL CELL CARDIOL, V44, P683, DOI 10.1016/j.yjmcc.2008.01.009; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Satoh M, 2010, J CARD FAIL, V16, P404, DOI 10.1016/j.cardfail.2010.01.002; Schlueter C, 2005, AM J PATHOL, V166, P1259, DOI 10.1016/S0002-9440(10)62344-9; Schlueter J, 2006, DEV BIOL, V295, P546, DOI 10.1016/j.ydbio.2006.03.036; Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Takahashi K, 2008, CIRCULATION, V118, pS106, DOI 10.1161/CIRCULATIONAHA.107.757443; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tian H, 2007, J MOL CELL CARDIOL, V43, P733, DOI 10.1016/j.yjmcc.2007.09.003; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Vanhoutte D, 2010, J MOL CELL CARDIOL, V48, P445, DOI 10.1016/j.yjmcc.2009.09.013; Volz HC, 2010, BASIC RES CARDIOL, V105, P805, DOI 10.1007/s00395-010-0114-3	49	96	103	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e19845	10.1371/journal.pone.0019845	http://dx.doi.org/10.1371/journal.pone.0019845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731608	gold, Green Published			2022-12-25	WOS:000292033700005
J	Nowak, MD; Davis, AP; Anthony, F; Yoder, AD				Nowak, Michael D.; Davis, Aaron P.; Anthony, Francois; Yoder, Anne D.			Expression and Trans-Specific Polymorphism of Self-Incompatibility RNases in Coffea (Rubiaceae)	PLOS ONE			English	Article							F-BOX GENE; INBREEDING DEPRESSION; RECENT SPECIATION; POLLEN; EVOLUTION; RIBONUCLEASES; PHYLOGENY; ALLELES; LOCUS; COMPATIBILITY	Self-incompatibility (SI) is widespread in the angiosperms, but identifying the biochemical components of SI mechanisms has proven to be difficult in most lineages. Coffea (coffee; Rubiaceae) is a genus of old-world tropical understory trees in which the vast majority of diploid species utilize a mechanism of gametophytic self-incompatibility (GSI). The S-RNase GSI system was one of the first SI mechanisms to be biochemically characterized, and likely represents the ancestral Eudicot condition as evidenced by its functional characterization in both asterid (Solanaceae, Plantaginaceae) and rosid (Rosaceae) lineages. The S-RNase GSI mechanism employs the activity of class III RNase T2 proteins to terminate the growth of "self" pollen tubes. Here, we investigate the mechanism of Coffea GSI and specifically examine the potential for homology to S-RNase GSI by sequencing class III RNase T2 genes in populations of 14 African and Madagascan Coffea species and the closely related self-compatible species Psilanthus ebracteolatus. Phylogenetic analyses of these sequences aligned to a diverse sample of plant RNase T2 genes show that the Coffea genome contains at least three class III RNase T2 genes. Patterns of tissue-specific gene expression identify one of these RNase T2 genes as the putative Coffea S-RNase gene. We show that populations of SI Coffea are remarkably polymorphic for putative S-RNase alleles, and exhibit a persistent pattern of trans-specific polymorphism characteristic of all S-RNase genes previously isolated from GSI Eudicot lineages. We thus conclude that Coffea GSI is most likely homologous to the classic Eudicot S-RNase system, which was retained since the divergence of the Rubiaceae lineage from an ancient SI Eudicot ancestor, nearly 90 million years ago.	[Nowak, Michael D.; Yoder, Anne D.] Duke Univ, Dept Biol, Durham, NC USA; [Davis, Aaron P.] Royal Bot Gardens, Surrey, England; [Anthony, Francois] Ctr Montpellier, Inst Rech Dev, Unite Mixte Rech Resistance Plantes Bioagresseurs, Montpellier, France	Duke University; Royal Botanic Gardens, Kew; Institut de Recherche pour le Developpement (IRD)	Nowak, MD (corresponding author), Univ Algarve, Ctr Ciencias Mar Algarve, Campus Gambelas, Faro, Portugal.	michael.nowak@duke.edu	Nowak, Michael/M-3747-2017; Anthony, Francois F/A-9341-2008	Nowak, Michael/0000-0001-8924-6506; 	United States National Science Foundation [0849186]; Society of Systematic Biologists; American Society of Plant Taxonomists; Duke University Graduate School	United States National Science Foundation(National Science Foundation (NSF)); Society of Systematic Biologists; American Society of Plant Taxonomists; Duke University Graduate School	This work was supported by the United States National Science Foundation (www.nsf.gov; 0849186 to ADY), and graduate student research grants to MDN from the Society of Systematic Biologists (www.systbiol.org), American Society of Plant Taxonomists (www.aspt.net), and Duke University Graduate School (www.gradschool.duke.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALEXANDER MP, 1987, STAIN TECHNOL, V62, P107, DOI 10.3109/10520298709107976; Allen A. M., 2008, P73, DOI 10.1007/978-3-540-68486-2_4; Anderson CL, 2005, AM J BOT, V92, P1737, DOI 10.3732/ajb.92.10.1737; ANDERSON MA, 1989, PLANT CELL, V1, P483, DOI 10.1105/tpc.1.5.483; ANDERSON MA, 1986, NATURE, V321, P38, DOI 10.1038/321038a0; ANDERSON W R, 1973, Taxon, V22, P537, DOI 10.2307/1218628; Anthony F, 2010, PLANT SYST EVOL, V285, P51, DOI 10.1007/s00606-009-0255-8; BATEMAN AJ, 1952, HEREDITY, V6, P285, DOI 10.1038/hdy.1952.40; BERTHAUD J, 1980, CAFE CACAO THE, V24, P267; BERTHOU F, 1983, THEOR APPL GENET, V65, P77, DOI 10.1007/BF00276268; Bosch M, 2008, J EXP BOT, V59, P481, DOI 10.1093/jxb/erm195; Brandvain Y, 2005, AM NAT, V166, P330, DOI 10.1086/432036; Carvalho A, 1969, OUTLINES PERENNIAL C, V4, P189; Charlesworth D, 2005, NEW PHYTOL, V168, P61, DOI 10.1111/j.1469-8137.2005.01443.x; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; CHARLESWORTH D, 1995, BIOESSAYS, V17, P31, DOI 10.1002/bies.950170108; CHARRIER A, 1985, P13; CHARRIER A, 1979, MEMOIRES ORSTOM, V87; Chawla B, 1997, THEOR APPL GENET, V95, P992, DOI 10.1007/s001220050652; CLARK AG, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P79; Coulibaly I, 2002, THEOR APPL GENET, V105, P994, DOI 10.1007/s00122-002-1008-z; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis AP, 2007, AM J BOT, V94, P313, DOI 10.3732/ajb.94.3.313; Davis AP, 2006, BOT J LINN SOC, V152, P465, DOI 10.1111/j.1095-8339.2006.00584.x; deNettancourt D, 1997, SEX PLANT REPROD, V10, P185, DOI 10.1007/s004970050087; Devier B, 2009, GENETICS, V181, P209, DOI 10.1534/genetics.108.093708; FIGUEROA F, 1988, NATURE, V335, P265, DOI 10.1038/335265a0; Foxe JP, 2009, P NATL ACAD SCI USA, V106, P5241, DOI 10.1073/pnas.0807679106; Franklin-Tong N, 2003, TRENDS PLANT SCI, V8, P598, DOI 10.1016/j.tplants.2003.10.008; Franklin-Tong VE, 2007, J INTEGR PLANT BIOL, V49, P1219, DOI 10.1111/j.1672-9072.2007.00516.x; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Goldberg EE, 2010, SCIENCE, V330, P493, DOI 10.1126/science.1194513; Govaerts R., 2010, WORLD CHECKLIST RUBI; GREEN PJ, 1994, ANNU REV PLANT PHYS, V45, P421, DOI 10.1146/annurev.pp.45.060194.002225; Guo YL, 2009, P NATL ACAD SCI USA, V106, P5246, DOI 10.1073/pnas.0808012106; Husband BC, 1996, EVOLUTION, V50, P54, DOI [10.2307/2410780, 10.1111/j.1558-5646.1996.tb04472.x]; Igic B, 2004, NEW PHYTOL, V161, P97, DOI 10.1046/j.1469-8137.2003.00952.x; Igic B, 2001, P NATL ACAD SCI USA, V98, P13167, DOI 10.1073/pnas.231386798; Igic B, 2008, INT J PLANT SCI, V169, P93, DOI 10.1086/523362; IOERGER TR, 1990, P NATL ACAD SCI USA, V87, P9732, DOI 10.1073/pnas.87.24.9732; Irie M, 1999, PHARMACOL THERAPEUT, V81, P77, DOI 10.1016/S0163-7258(98)00035-7; Itagaki T, 2006, BIOL PHARM BULL, V29, P875, DOI 10.1248/bpb.29.875; Kao TH, 2004, PLANT CELL, V16, pS72, DOI 10.1105/tpc.016154; Kaothien-Nakayama P, 2010, PLANT DEVELOPMENTAL BIOLOGY - BIOTECHNOLOGICAL PERSPECTIVES, VOL 1, P459, DOI 10.1007/978-3-642-02301-9_22; Klein DE, 2009, SEX PLANT REPROD, V22, P121, DOI 10.1007/s00497-009-0097-0; Lai Z, 2002, PLANT MOL BIOL, V50, P29, DOI 10.1023/A:1016050018779; Lashermes P, 1999, MOL GEN GENET, V261, P259, DOI 10.1007/s004380050965; Lashermes P, 2001, GENOME, V44, P589, DOI 10.1139/gen-44-4-589; LEE HS, 1994, NATURE, V367, P560, DOI 10.1038/367560a0; Luhtala N, 2010, TRENDS BIOCHEM SCI, V35, P253, DOI 10.1016/j.tibs.2010.02.002; MacIntosh GC, 2010, MOL GENET GENOMICS, V283, P381, DOI 10.1007/s00438-010-0524-9; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Matton DP, 1997, PLANT CELL, V9, P1757, DOI 10.1105/tpc.9.10.1757; Maurin O, 2007, ANN BOT-LONDON, V100, P1565, DOI 10.1093/aob/mcm257; McClure BA, 2006, PLANTA, V224, P233, DOI 10.1007/s00425-006-0284-2; Miller JS, 2008, EVOLUTION, V62, P1052, DOI 10.1111/j.1558-5646.2008.00358.x; Miller JS, 2000, SCIENCE, V289, P2335, DOI 10.1126/science.289.5488.2335; Nasrallah JB, 2007, GENETICS, V175, P1965, DOI 10.1534/genetics.106.069393; Nylander J. A. A., 2004, MRMODELTEST V2; Paetsch M, 2010, EVOLUTION IN ACTION: CASE STUDIES IN ADAPTIVE RADIATION, SPECIATION AND THE ORIGIN OF BIODIVERSITY, P77, DOI 10.1007/978-3-642-12425-9_5; Plechakova O, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-123; Rambaut A, 2014, TRACER V1 6; Richman AD, 1999, P NATL ACAD SCI USA, V96, P168, DOI 10.1073/pnas.96.1.168; RIVEROS GM, 1995, PLANT SYST EVOL, V194, P1, DOI 10.1007/BF00983212; ROBERTSON K, 2010, COMP EVIDENCE CORREL; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sassa H, 1996, MOL GEN GENET, V250, P547; SCHEMSKE DW, 1985, EVOLUTION, V39, P41, DOI [10.2307/2408515, 10.1111/j.1558-5646.1985.tb04078.x]; Sherman-Broyles S., 2008, P123, DOI 10.1007/978-3-540-68486-2_6; Sloop CM, 2009, BIOL INVASIONS, V11, P1131, DOI 10.1007/s10530-008-9385-0; Stebbins G. L., 1970, ANNU REV ECOL SYST, V1, P307, DOI DOI 10.1146/ANNUREV.ES.01.110170.001515; Steinbachs JE, 2002, MOL BIOL EVOL, V19, P825, DOI 10.1093/oxfordjournals.molbev.a004139; Stoffelen P, 2009, TAXON, V58, P133, DOI 10.1002/tax.581014; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tosh J, 2009, ANN MO BOT GARD, V96, P194, DOI 10.3417/2006202; Ushijima K, 2003, PLANT CELL, V15, P771, DOI 10.1105/tpc.009290; Uyenoyama MK, 2003, THEOR POPUL BIOL, V63, P281, DOI 10.1016/S0040-5809(03)00020-0; Vega FE, 2003, NATURE, V425, P343, DOI 10.1038/425343a; VEKEMANS X, 1994, GENETICS, V137, P1157; Vieira CP, 2002, HEREDITY, V88, P172, DOI 10.1038/sj.hdy.6800024; Vieira J, 2008, J MOL EVOL, V67, P179, DOI 10.1007/s00239-008-9137-x; Vieira J, 2007, J MOL EVOL, V65, P175, DOI 10.1007/s00239-006-0285-6; Watanabe M., 2008, P151, DOI 10.1007/978-3-540-68486-2_7; Wheeler D, 2007, GENETICS, V177, P2171, DOI 10.1534/genetics.107.076885; WHITEHOUSE HLK, 1950, ANN BOT-LONDON, V14, P199, DOI 10.1093/oxfordjournals.aob.a083243; Wu X, 2010, PLANT BIOLOGY, V12, P484, DOI 10.1111/j.1438-8677.2009.00242.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yeung K, 2005, EVOLUTION, V59, P2048; Zhang Y., 2008, P193, DOI 10.1007/978-3-540-68486-2_9	91	45	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21019	10.1371/journal.pone.0021019	http://dx.doi.org/10.1371/journal.pone.0021019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731641	Green Published, gold			2022-12-25	WOS:000292033700028
J	Athanasiadou, S; Jones, LA; Burgess, STG; Kyriazakis, I; Pemberton, AD; Houdijk, JGM; Huntley, JF				Athanasiadou, Spiridoula; Jones, Leigh A.; Burgess, Stewart T. G.; Kyriazakis, Ilias; Pemberton, Alan D.; Houdijk, Jos G. M.; Huntley, John F.			Genome-Wide Transcriptomic Analysis of Intestinal Tissue to Assess the Impact of Nutrition and a Secondary Nematode Challenge in Lactating Rats	PLOS ONE			English	Article							AMINO-ACID REGULATION; NIPPOSTRONGYLUS-BRASILIENSIS; GENE-EXPRESSION; TELADORSAGIA-CIRCUMCINCTA; NEGATIVE REGULATOR; DIETARY-PROTEIN; T-CELLS; PARASITE; IMMUNITY; INFECTION	Background: Gastrointestinal nematode infection is a major challenge to the health and welfare of mammals. Although mammals eventually acquire immunity to nematodes, this breaks down around parturition, which renders periparturient mammals susceptible to re-infection and an infection source for their offspring. Nutrient supplementation reduces the extent of periparturient parasitism, but the underlying mechanisms remain unclear. Here, we use a genome wide approach to assess the effects of protein supplementation on gene expression in the small intestine of periparturient rats following nematode re-infection. Methodology/Principal Findings: The use of a rat whole genome expression microarray (Affymetrix Gene 1.0ST) showed significant differential regulation of 91 genes in the small intestine of lactating rats, re-infected with Nippostrongylus brasiliensis compared to controls; affected functions included immune cell trafficking, cell-mediated responses and antigen presentation. Genes with a previously described role in immune response to nematodes, such as mast cell proteases, and intelectin, and others newly associated with nematode expulsion, such as anterior gradient homolog 2 were identified. Protein supplementation resulted in significant differential regulation of 64 genes; affected functions included protein synthesis, cellular function and maintenance. It increased cell metabolism, evident from the high number of non-coding RNA and the increased synthesis of ribosomal proteins. It regulated immune responses, through T-cell activation and proliferation. The up-regulation of transcription factor forkhead box P1 in unsupplemented, parasitised hosts may be indicative of a delayed immune response in these animals. Conclusions/Significance: This study provides the first evidence for nutritional regulation of genes related to immunity to nematodes at the site of parasitism, during expulsion. Additionally it reveals genes induced following secondary parasite challenge in lactating mammals, not previously associated with parasite expulsion. This work is a first step towards defining disease predisposition, identifying markers for nutritional imbalance and developing sustainable measures for parasite control in domestic mammals.	[Athanasiadou, Spiridoula; Jones, Leigh A.; Kyriazakis, Ilias; Houdijk, Jos G. M.] Scottish Agr Coll, Anim Hlth Grp, Penicuik, Midlothian, Scotland; [Burgess, Stewart T. G.; Huntley, John F.] Moredun Res Inst, Div Parasitol, Penicuik, Midlothian, Scotland; [Kyriazakis, Ilias] Univ Thessaly, Fac Vet, Kardhitsa, Greece; [Pemberton, Alan D.] Univ Edinburgh, Roslin Inst, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland	Scottish Agricultural College; Moredun Research Institute; University of Thessaly; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Athanasiadou, S (corresponding author), Scottish Agr Coll, Anim Hlth Grp, Penicuik, Midlothian, Scotland.	spiridoula.athanasiadou@sac.ac.uk	Houdijk, Jos/AAG-8125-2021	burgess, stewart/0000-0002-9268-7641; Jones, Leigh Ann/0000-0002-1377-6831; Athanasiadou, Spiridoula/0000-0002-9188-837X	RCVS Trust [643]; BBSRC [BB/D017890/1]; Scottish Government; Biotechnology and Biological Sciences Research Council [BB/D017890/1] Funding Source: researchfish	RCVS Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors would like to thank the RCVS Trust for the Blue Sky award (Grant No: 643) which provided the resources for the microarray experiment and qPCR. The samples were collected during a BBSRC funded grant (Grant No: BB/D017890/1). The Scottish Agricultural College and the Moredun Research Institute receive funding from the Scottish Government. The funders had no role in study design, data colelection and analysis, decision to publish or preparation of the manuscript.	Athanasiadou S, 2008, VET RES, V39, DOI 10.1051/vetres:2008035; Barrans SL, 2004, BLOOD, V104, P2933, DOI 10.1182/blood-2004-03-1209; BATRA S, 1993, PARASITOLOGY, V106, P185, DOI 10.1017/S0031182000074989; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Berruyer C, 2006, J EXP MED, V203, P2817, DOI 10.1084/jem.20061640; Bruhat A, 2009, BIOFACTORS, V35, P249, DOI 10.1002/biof.40; Caldarola S, 2009, FEBS J, V276, P3199, DOI 10.1111/j.1742-4658.2009.07036.x; Cheung YY, 2007, J CLIN INVEST, V117, P784, DOI 10.1172/JCI30443; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Coop RL, 1999, VET PARASITOL, V84, P187, DOI 10.1016/S0304-4017(99)00070-9; Cunningham-Rundles S, 2005, J ALLERGY CLIN IMMUN, V115, P1119, DOI 10.1016/j.jaci.2005.04.036; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Diez-Tascon C, 2005, PHYSIOL GENOMICS, V21, P59, DOI 10.1152/physiolgenomics.00257.2004; Fafournoux P, 2000, BIOCHEM J, V351, P1, DOI 10.1042/0264-6021:3510001; Feng XM, 2010, BLOOD, V115, P510, DOI 10.1182/blood-2009-07-232694; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; French AT, 2007, VET IMMUNOL IMMUNOP, V120, P41, DOI 10.1016/j.vetimm.2007.07.014; GUERRINI L, 1993, MOL CELL BIOL, V13, P3202, DOI 10.1128/MCB.13.6.3202; Houdijk JGM, 2006, INT J PARASITOL, V36, P219, DOI 10.1016/j.ijpara.2005.09.014; Houdijk JGM, 2005, BRIT J NUTR, V93, P493, DOI 10.1079/BJN20041391; Houdijk JGM, 2003, BRIT J NUTR, V90, P809, DOI 10.1079/BJN2003961; Houdijk JGM, 2001, P NUTR SOC, V60, P515, DOI 10.1079/PNS2001114; Houdijk JGM, 2009, VET PARASITOL, V160, P258, DOI 10.1016/j.vetpar.2008.11.013; Ing R, 2000, P NATL ACAD SCI USA, V97, P7078, DOI 10.1073/pnas.97.13.7078; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jones LA, 2011, INT J PARASITOL, V41, P711, DOI 10.1016/j.ijpara.2011.01.011; Jones LA, 2009, PARASITE IMMUNOL, V31, P412, DOI 10.1111/j.1365-3024.2009.01121.x; Jousse C, 2004, BIOCHEM BIOPH RES CO, V313, P447, DOI 10.1016/j.bbrc.2003.07.020; Keane OM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-42; Khan WI, 2004, PARASITE IMMUNOL, V26, P319, DOI 10.1111/j.0141-9838.2004.00715.x; Kimball SR, 2006, AM J CLIN NUTR, V83, p500S; Komiya T, 1998, BIOCHEM BIOPH RES CO, V251, P759, DOI 10.1006/bbrc.1998.9513; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Li C, 2011, IMMUNOLOGY, V132, P104, DOI 10.1111/j.1365-2567.2010.03345.x; Li RW, 2009, INT J PARASITOL, V39, P813, DOI 10.1016/j.ijpara.2008.11.007; Menzies M, 2010, PARASITE IMMUNOL, V32, P36, DOI 10.1111/j.1365-3024.2009.01156.x; Minoo P, 2007, MOL CELL BIOL, V27, P2155, DOI 10.1128/MCB.01133-06; Modak C, 2010, WORLD J GASTROENTERO, V16, P2195, DOI 10.3748/wjg.v16.i18.2195; Normanton H, 2007, BRIT J NUTR, V97, P104, DOI 10.1017/S0007114507205781; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Pemberton AD, 2004, J IMMUNOL, V173, P1894, DOI 10.4049/jimmunol.173.3.1894; PINE AP, 1994, BRIT J NUTR, V72, P831, DOI 10.1079/BJN19940088; SAKKAS P, 2011, BR J NUT IN PRESS; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Seo YJ, 2011, CYTOKINE GROWTH F R, V22, P55, DOI 10.1016/j.cytogfr.2010.12.001; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Sui SJH, 2007, NUCLEIC ACIDS RES, V35, pW245, DOI 10.1093/nar/gkm427; Tu T, 2008, PARASITOLOGY, V135, P81, DOI 10.1017/S0031182007003617; Voehringer D, 2007, EXP PARASITOL, V116, P458, DOI 10.1016/j.exppara.2007.02.015; Vogt L, 2006, J CLIN INVEST, V116, P2817, DOI 10.1172/JCI25673; Volarevic V, 2010, AUTOIMMUNITY, V43, P255, DOI 10.3109/08916930903305641; Wang HP, 2010, EMBO J, V29, P1285, DOI 10.1038/emboj.2010.10; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; WITZGALL R, 1993, MOL CELL BIOL, V13, P1933, DOI 10.1128/MCB.13.3.1933; WOODBURY RG, 1984, NATURE, V312, P450, DOI 10.1038/312450a0	57	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20771	10.1371/journal.pone.0020771	http://dx.doi.org/10.1371/journal.pone.0020771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698235	Green Published, Green Submitted, gold			2022-12-25	WOS:000291734100020
J	Hayashi, I; Takatori, S; Urano, Y; Miyake, Y; Takagi, J; Sakata-Yanagimoto, M; Iwanari, H; Osawa, S; Morohashi, Y; Li, T; Wong, PC; Chiba, S; Kodama, T; Hamakubo, T; Tomita, T; Iwatsubo, T				Hayashi, I.; Takatori, S.; Urano, Y.; Miyake, Y.; Takagi, J.; Sakata-Yanagimoto, M.; Iwanari, H.; Osawa, S.; Morohashi, Y.; Li, T.; Wong, P. C.; Chiba, S.; Kodama, T.; Hamakubo, T.; Tomita, T.; Iwatsubo, T.			Neutralization of the gamma-secretase activity by monoclonal antibody against extracellular domain of nicastrin	ONCOGENE			English	Article						Notch; gamma-secretase; functional antibody; membrane protein; intramembrane cleavage	AMYLOID PRECURSOR PROTEIN; ACUTE LYMPHOBLASTIC-LEUKEMIA; BUDDED BACULOVIRUS; MEMBRANE-PROTEINS; BETA-APP; NOTCH; COMPLEX; PRESENILIN; CELLS; INHIBITION	Several lines of evidence suggest that aberrant Notch signaling contributes to the development of several types of cancer. Activation of Notch receptor is executed through intramembrane proteolysis by gamma-secretase, which is a multimeric membrane-embedded protease comprised of presenilin, nicastrin (NCT), anterior pharynx defective 1 and PEN-2. In this study, we report the neutralization of the gamma-secretase activity by a novel monoclonal antibody A5226A against the extracellular domain of NCT, generated by using a recombinant budded baculovirus as an immunogen. This antibody recognized fully glycosylated mature NCT in the active gamma-secretase complex on the cell surface, and inhibited the gamma-secretase activity by competing with the substrate binding in vitro. Moreover, A5226A abolished the gamma-secretase activity-dependent growth of cancer cells in a xenograft model. Our data provide compelling evidence that NCT is a molecular target for the mechanism-based inhibition of gamma-secretase, and that targeting NCT might be a novel therapeutic strategy against cancer caused by aberrant gamma-secretase activity and Notch signaling. Oncogene (2012) 31, 787-798; doi:10.1038/onc.2011.265; published online 4 July 2011	[Tomita, T.] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Bunkyo Ku, Tokyo 1130033, Japan; [Urano, Y.; Iwanari, H.; Kodama, T.; Hamakubo, T.] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Syst Biol & Med, Tokyo 1130033, Japan; [Miyake, Y.; Sakata-Yanagimoto, M.; Chiba, S.] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Clin & Expt Hematol, Tsukuba, Ibaraki, Japan; [Takagi, J.] Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, Osaka, Japan; [Iwanari, H.] Perseus Prote Inc, Tokyo, Japan; [Li, T.; Wong, P. C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Tomita, T.; Iwatsubo, T.] Japan Sci & Technol Agcy, Saitama, Japan; [Iwatsubo, T.] Univ Tokyo, Grad Sch Med, Dept Neuropathol, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; University of Tsukuba; Osaka University; Johns Hopkins University; Japan Science & Technology Agency (JST); University of Tokyo	Tomita, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	taisuke@mol.f.u-tokyo.ac.jp	Tomita, Taisuke/L-5427-2015; Mamiko, Sakata-yanagimoto/AAP-3298-2020	Tomita, Taisuke/0000-0002-0075-5943; Urano, Yasuomi/0000-0002-4901-1937	Japan Society for the Promotion of Science (JSPS); National Institute of Biomedical Innovation; Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT; MEXT, Japan; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23791068, 20221010] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to Drs T Fukuyama, S Yokoshima (The University of Tokyo), C Haass (Ludwig-Maximilians-University Munchen), H Natsugari (Teikyo University), R Kopan (Washington University in St Louis), G Thinakaran (The University of Chicago), M Vooijs (University Medical Center Southwestern Medical Center) for valuable reagents and our current and previous laboratory members for helpful discussions. We also would like to thank Keiko Tamura-Kawakami and Maiko Nampo for their excellent technical support. This work is supported in part by Grants-in-Aid for Young Scientists (S) (for TT) from Japan Society for the Promotion of Science (JSPS), by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (for TT, TI), Scientific Research on Priority Areas 'Research on Pathomechanisms of Brain Disorders' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (for TT, TI), by Targeted Proteins Research Program grant from the MEXT (for TT, TI, JT), by Core Research for Evolutional Science and Technology grant from the MEXT (for TT, TI), Japan. IH and ST were research fellows of JSPS.	Boesze-Battaglia Kathleen, 2006, V332, P169; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Dries DR, 2009, J BIOL CHEM, V284, P29714, DOI 10.1074/jbc.M109.038737; Dunn CD, 2010, P NATL ACAD SCI USA, V107, P5907, DOI 10.1073/pnas.1001647107; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Ferrando Adolfo A, 2009, Hematology Am Soc Hematol Educ Program, P353, DOI 10.1182/asheducation-2009.1.353; Filipovic A, 2011, BREAST CANCER RES TR, V125, P43, DOI 10.1007/s10549-010-0823-1; Hayashi I, 2004, J BIOL CHEM, V279, P38040, DOI 10.1074/jbc.M405597200; Hayashi I, 2009, J BIOL CHEM, V284, P27838, DOI 10.1074/jbc.M109.055061; Imamura Y, 2009, J AM CHEM SOC, V131, P7353, DOI 10.1021/ja9001458; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Kimura K, 2007, CANCER SCI, V98, P155, DOI 10.1111/j.1349-7006.2006.00369.x; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Li T, 2003, J NEUROSCI, V23, P3272; Luistro L, 2009, CANCER RES, V69, P7672, DOI 10.1158/0008-5472.CAN-09-1843; Masuda K, 2003, J BIOL CHEM, V278, P24552, DOI 10.1074/jbc.M302801200; Masuda S, 2009, CANCER SCI, V100, P2444, DOI 10.1111/j.1349-7006.2009.01328.x; Osipo C, 2008, ONCOGENE, V27, P5019, DOI 10.1038/onc.2008.149; Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823; Saitoh R, 2006, PROTEIN EXPRES PURIF, V46, P130, DOI 10.1016/j.pep.2005.08.008; Saitoh R, 2007, J IMMUNOL METHODS, V322, P104, DOI 10.1016/j.jim.2007.02.005; Samaranayake H, 2009, ANN MED, V41, P322, DOI 10.1080/07853890802698842; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Shirotani K, 2003, J BIOL CHEM, V278, P16474, DOI 10.1074/jbc.C300095200; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tarassishin L, 2004, P NATL ACAD SCI USA, V101, P17050, DOI 10.1073/pnas.0408007101; Tomita T, 2002, FEBS LETT, V520, P117, DOI 10.1016/S0014-5793(02)02802-8; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Urano Y, 2005, J LIPID RES, V46, P904, DOI 10.1194/jlr.M400333-JLR200; Urano Y, 2003, BIOCHEM BIOPH RES CO, V308, P191, DOI 10.1016/S0006-291X(03)01355-X; van Es JH, 2005, TRENDS MOL MED, V11, P496, DOI 10.1016/j.molmed.2005.09.008; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Vetrivel KS, 2010, BBA-MOL CELL BIOL L, V1801, P860, DOI 10.1016/j.bbalip.2010.03.007; Wakabayashi T, 2009, NAT CELL BIOL, V11, P1340, DOI 10.1038/ncb1978; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Yin L, 2010, BIOCHEM PHARMACOL, V80, P690, DOI 10.1016/j.bcp.2010.03.026; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhao GJ, 2010, J NEUROSCI, V30, P1648, DOI 10.1523/JNEUROSCI.3826-09.2010	46	55	58	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	6					787	798		10.1038/onc.2011.265	http://dx.doi.org/10.1038/onc.2011.265			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MU	21725355	Green Accepted			2022-12-25	WOS:000300222100011
J	Maquoi, E; Assent, D; Detilleux, J; Pequeux, C; Foidart, JM; Noel, A				Maquoi, E.; Assent, D.; Detilleux, J.; Pequeux, C.; Foidart, J-M; Noel, A.			MT1-MMP protects breast carcinoma cells against type I collagen-induced apoptosis	ONCOGENE			English	Article						breast cancer; MT1-MMP; apoptosis; type I collagen; BIK	MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; GROWTH-FACTOR; CANCER-CELLS; MESENCHYMAL TRANSITION; BH3-ONLY PROTEIN; UP-REGULATION; TUMOR-GROWTH; ACTIVATION	As invading breast carcinoma cells breach their underlying basement membrane, they become confronted with a dense three-dimensional reactive stroma dominated by type I collagen. To develop metastatic capabilities, invading tumor cells must acquire the capacity to negotiate this novel microenvironment. Collagen influences the fate of epithelial cells by inducing apoptosis. However, the mechanisms used by invading tumor cells to evade collagen-induced apoptosis remain to be defined. We demonstrate that membrane type-1 matrix metalloproteinase (MT1-MMP/MMP-14) confers breast cancer cells with the ability to escape apoptosis when embedded in a collagen gel and after orthotopic implantation in vivo. In the absence of MMP-14-dependent proteolysis, type I collagen triggers apoptosis by inducing the expression of the pro-apoptotic Bcl-2-interacting killer in luminal-like breast cancer cells. These findings reveal a new mechanism whereby MMP-14 activity promotes tumor progression by circumventing apoptosis. Oncogene (2012) 31, 480-493; doi: 10.1038/onc.2011.249; published online 27 June 2011	[Maquoi, E.; Assent, D.; Detilleux, J.; Pequeux, C.; Foidart, J-M; Noel, A.] Univ Liege, Lab Tumor & Dev Biol, GIGA Canc, Inst Pathol, B-4000 Liege, Belgium	University of Liege	Maquoi, E (corresponding author), Univ Liege, Lab Tumor & Dev Biol, GIGA Canc, Inst Pathol, CHU B23, B-4000 Liege, Belgium.	erik.maquoi@ulg.ac.be		Pequeux, Christel/0000-0001-8275-1489; Noel, Agnes/0000-0002-7670-6179	MICROENVIMET [FP7-HEALTH-2007-A, 201279]; Fonds de la Recherche Scientifique Medicale; Fonds de la Recherche Scientifique - FNRS (FRS-FNRS, Belgium); Foundation against Cancer (foundation of public interest, Belgium); CGRI-FNRS-INSERM Cooperation; Fonds speciaux de la Recherche (University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege); Direction Generale Operationnelle de l'Economie; SPW (Region Wallonne, Belgium); Fonds Social Europeen (FSE, Belgium); Fonds d'Investissements de la Recherche Scientifique (FIRS, CHU Liege, Belgium); Belgian Science Policy (Brussels, Belgium)	MICROENVIMET; Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fonds de la Recherche Scientifique - FNRS (FRS-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Foundation against Cancer (foundation of public interest, Belgium); CGRI-FNRS-INSERM Cooperation(Fonds de la Recherche Scientifique - FNRS); Fonds speciaux de la Recherche (University of Liege)(University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege)(University of Liege); Direction Generale Operationnelle de l'Economie; SPW (Region Wallonne, Belgium); Fonds Social Europeen (FSE, Belgium)(European Social Fund (ESF)); Fonds d'Investissements de la Recherche Scientifique (FIRS, CHU Liege, Belgium); Belgian Science Policy (Brussels, Belgium)(Belgian Federal Science Policy Office)	We thank M Fringuellini, P Gavitelli, E Konradovski and N Lefin for their excellent technical assistance. This work was supported by grants from the FP7-HEALTH-2007-A Proposal No 201279 'MICROENVIMET', the Fonds de la Recherche Scientifique Medicale, the Fonds de la Recherche Scientifique - FNRS (FRS-FNRS, Belgium), the Foundation against Cancer (foundation of public interest, Belgium), the CGRI-FNRS-INSERM Cooperation, the Fonds speciaux de la Recherche (University of Liege), the Centre Anticancereux pres l'Universite de Liege, the Fonds Leon Fredericq (University of Liege), the Direction Generale Operationnelle de l'Economie, de l'Emploi et de la Recherche from the SPW (Region Wallonne, Belgium), the Fonds Social Europeen (FSE, Belgium), the Fonds d'Investissements de la Recherche Scientifique (FIRS, CHU Liege, Belgium), the Interuniversity Attraction Poles Program - Belgian Science Policy (Brussels, Belgium). EM is a Research Associate from the F.R.S.-FNRS (Belgium).	Bao WJ, 2004, J CELL BIOL, V167, P745, DOI 10.1083/jcb.200404018; Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Bindels S, 2006, ONCOGENE, V25, P4975, DOI 10.1038/sj.onc.1209511; BIRKEDALHANSEN H, 1987, METHOD ENZYMOL, V144, P140; Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Butler GS, 2008, MOL CELL BIOL, V28, P4896, DOI 10.1128/MCB.01775-07; Chinnadurai G, 2008, ONCOGENE, V27, pS20, DOI 10.1038/onc.2009.40; Eccles SA, 1996, CANCER RES, V56, P2815; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Figueira RCS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-20; Fujisaki H, 2002, EXP CELL RES, V280, P255, DOI 10.1006/excr.2002.5639; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Giam M, 2008, ONCOGENE, V27, pS128, DOI 10.1038/onc.2009.50; Gingras D, 2010, BBA-MOL CELL RES, V1803, P142, DOI 10.1016/j.bbamcr.2009.04.011; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henriet P, 2000, P NATL ACAD SCI USA, V97, P10026, DOI 10.1073/pnas.170290997; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hotary KB, 2002, J EXP MED, V195, P295, DOI 10.1084/jem.20010815; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Hur JY, 2004, P NATL ACAD SCI USA, V101, P2351, DOI 10.1073/pnas.0307337101; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kauppila S, 1998, J PATHOL, V186, P262, DOI 10.1002/(SICI)1096-9896(1998110)186:3<262::AID-PATH191>3.0.CO;2-3; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim TY, 2006, CANCER RES, V66, P7490, DOI 10.1158/0008-5472.CAN-05-4552; Koshikawa N, 2011, CANCER SCI, V102, P111, DOI 10.1111/j.1349-7006.2010.01748.x; Lehti K, 2000, J BIOL CHEM, V275, P15006, DOI 10.1074/jbc.M910220199; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Lomonosova E, 2009, MOL CANCER RES, V7, P1268, DOI 10.1158/1541-7786.MCR-08-0183; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Mathai JP, 2005, J BIOL CHEM, V280, P23829, DOI 10.1074/jbc.M500800200; McGowan PM, 2008, ANN ONCOL, V19, P1566, DOI 10.1093/annonc/mdn180; Mizushima H, 2009, J CELL SCI, V122, P4277, DOI 10.1242/jcs.054551; MONTGOMERY AMP, 1994, P NATL ACAD SCI USA, V91, P8856, DOI 10.1073/pnas.91.19.8856; Morrison CJ, 2006, J BIOL CHEM, V281, P26528, DOI 10.1074/jbc.M603331200; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Naumann U, 2003, HUM GENE THER, V14, P1235, DOI 10.1089/104303403767740777; Noel A, 2008, SEMIN CELL DEV BIOL, V19, P52, DOI 10.1016/j.semcdb.2007.05.011; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; OKADA A, 1995, P NATL ACAD SCI USA, V92, P2730, DOI 10.1073/pnas.92.7.2730; Ota I, 2009, P NATL ACAD SCI USA, V106, P20318, DOI 10.1073/pnas.0910962106; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sabeh F, 2009, J BIOL CHEM, V284, P23001, DOI 10.1074/jbc.M109.002808; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sato H, 2005, CANCER SCI, V96, P212, DOI 10.1111/j.1349-7006.2005.00039.x; Sodek KL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-223; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sounni NE, 2004, J BIOL CHEM, V279, P13564, DOI 10.1074/jbc.M307688200; Sounni NE, 2002, FASEB J, V16, P555, DOI 10.1096/fj.01-0790com; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sturm I, 2006, CELL DEATH DIFFER, V13, P619, DOI 10.1038/sj.cdd.4401782; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zou YY, 2002, CANCER RES, V62, P8	65	43	43	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	4					480	493		10.1038/onc.2011.249	http://dx.doi.org/10.1038/onc.2011.249			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891LU	21706048				2022-12-25	WOS:000300219300007
J	Sun, L; Yao, Y; Liu, B; Lin, Z; Lin, L; Yang, M; Zhang, W; Chen, W; Pan, C; Liu, Q; Song, E; Li, J				Sun, L.; Yao, Y.; Liu, B.; Lin, Z.; Lin, L.; Yang, M.; Zhang, W.; Chen, W.; Pan, C.; Liu, Q.; Song, E.; Li, J.			MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1	ONCOGENE			English	Article						chemotherapy resistance; EMT; microRNA; BMI1; tongue squamous cell carcinoma	BREAST-CANCER; TAMOXIFEN RESISTANCE; MULTIDRUG-RESISTANCE; SELF-RENEWAL; EXPRESSION; MICRORNAS; APOPTOSIS; CHEMORESISTANCE; TUMORIGENICITY; OVEREXPRESSION	Chemotherapy has been reported to induce epithelial-mesenchymal transition (EMT) in tumor cells, which is a critical step in the process of metastasis leading to cancer spreading and treatment failure. However, the underlying mechanisms of chemotherapy-induced EMT remain unclear, and the involvement of microRNAs (miRNA) in this process is poorly understood. To address these questions, we established stable chemotherapy-resistant tongue squamous cell carcinoma (TSCC) cell lines CAL27-res and SCC25-res by exposing the parental CAL27 and SCC25 lines to escalating concentrations of cisplatin for 6 months. CAL27-res and SCC25-res cells displayed mesenchymal features with enhanced invasiveness and motility. MiRNA microarray illustrated that miR-200b and miR-15b were the most significantly downregulated microRNAs in CAL27-res cells. Ectopic expression of miR-200b and miR-15b with miRNA mimics effectively reversed the phenotype of EMT in CAL27-res and SCC25-res cells, and sensitized them to chemotherapy, but inhibition of miR-200b and miR-15b in the sensitive lines with anti-sense oligonucleotides induced EMT and conferred chemoresistance. Retrieving the expression of B lymphoma Mo-MLV insertion region 1 homolog (BMI1), a target for miR-200b and miR-15b, in the presence of the miRNA mimics by transfecting CAL27-res cells with pcDNA3.1-BMI1-carrying mutated seed sequences of miR-200b or miR-15b at its 3'-UTR recapitulated chemotherapy-induced EMT. In vivo, enforced miR-200b or miR-15b expression suppressed metastasis of TSCC xenografts established by CAL27-res cells. Clinically, reduced miR-200b or miR-15b expression was associated with chemotherapeutic resistance in TSCCs and poor patient survival. Our data suggest that reduced expression of miR-200b and miR-15b underscores the mechanisms of chemotherapy-induced EMT in TSCC, and may serve as therapeutic targets to reverse chemotherapy resistance in tongue cancers. Oncogene (2012) 31, 432-445; doi: 10.1038/onc.2011.263; published online 4 July 2011	[Sun, L.; Yao, Y.; Liu, B.; Lin, L.; Yang, M.; Song, E.] Sun Yat Sen Univ, Dept Breast Tumor Ctr, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Z.; Zhang, W.; Chen, W.; Pan, C.; Li, J.] Sun Yat Sen Univ, Dept Oral & Maxillofacial Surg, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Q.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Song, E.] Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, State Key Lab Biocontrol,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Sun Yat Sen University	Song, E (corresponding author), Sun Yat Sen Univ, Breast Tumor Ctr, Sun Yat Sen Mem Hosp, 107 Yanjiang W Rd, Gz 510120, Peoples R China.	songerwei02@yahoo.com.cn; lijinsong1967@163.com	Liu, Bodu/AAR-9402-2021; Liu, Bodu/G-5222-2016	Liu, Bodu/0000-0003-2097-725X; Liu, Bodu/0000-0003-2097-725X; Liu, Qiang/0000-0002-5451-4862; Sun, Lijuan/0000-0003-0080-7886	National Natural Science Foundation of China [81072225, 30921140312, 30831160515, 30830110, 81072177]; Natural Science Foundation of Guangdong Province [10251008901000022, 9151008901000201, 8251008901000011]; Guangzhou Science and Technology Bureau [2008Z1-E201]; Ministry of Science and Technology of China [2010CB912800, 2011CB504203, 2009CB521706]; Key Laboratory of malignant tumor gene regulation and target therapy of Guangdong Higher Education Institutes, Sun Yat-sen University [KLB09001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangzhou Science and Technology Bureau; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Key Laboratory of malignant tumor gene regulation and target therapy of Guangdong Higher Education Institutes, Sun Yat-sen University	This work was supported by Grants to JL from National Natural Science Foundation of China (81072225), Natural Science Foundation of Guangdong Province (10251008901000022, 9151008901000201) and Guangzhou Science and Technology Bureau (2008Z1-E201); and to ES from '973' Program Projects (2010CB912800, 2011CB504203, 2009CB521706) from Ministry of Science and Technology of China, National Natural Science Foundation of China (30921140312, 30831160515, 30830110), and Natural Science Foundation of Guangdong Province (8251008901000011), Key Laboratory of malignant tumor gene regulation and target therapy of Guangdong Higher Education Institutes, Sun Yat-sen University (KLB09001), and to LL from National Natural Science Foundation of China (81072177).	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Chua KN, 2008, DRUG DISCOV TODAY, V4, P261; Crea F, 2011, INT J CANCER, V128, P1946, DOI 10.1002/ijc.25522; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Gibson MK, 2005, J CLIN ONCOL, V23, P3562, DOI 10.1200/JCO.2005.01.057; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gosepath EM, 2008, INT J CANCER, V123, P2013, DOI 10.1002/ijc.23721; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Hiscox S, 2006, INT J CANCER, V118, P290, DOI 10.1002/ijc.21355; Jagani Z, 2010, CANCER RES, V70, P5528, DOI 10.1158/0008-5472.CAN-09-4229; Jeyaseelan K, 2007, EXPERT OPIN THER TAR, V11, P1119, DOI 10.1517/14728222.11.8.1119; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kajiyama H, 2007, INT J ONCOL, V31, P277; Kim JH, 2004, BREAST, V13, P383, DOI 10.1016/j.breast.2004.02.010; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Li J, 2010, AM J PATHOL, V176, P699, DOI 10.2353/ajpath.2010.090502; Li QQ, 2011, CELL DEATH DIFFER, V18, P16, DOI 10.1038/cdd.2010.103; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Mihic-Probst D, 2007, INT J CANCER, V121, P1764, DOI 10.1002/ijc.22891; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Seve P, 2005, CLIN CANCER RES, V11, P5481, DOI 10.1158/1078-0432.CCR-05-0285; Shida T, 2006, CANCER BIOL THER, V5, P1530, DOI 10.4161/cbt.5.11.3458; Song E, 2001, BRIT J CANCER, V85, P1047, DOI 10.1038/sj.bjc.6692042; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Toner M, 2009, HEAD NECK PATHOL, V3, P249, DOI 10.1007/s12105-009-0137-y; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yamauchi K, 2008, CANCER RES, V68, P516, DOI 10.1158/0008-5472.CAN-07-3063; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	43	210	223	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	4					432	445		10.1038/onc.2011.263	http://dx.doi.org/10.1038/onc.2011.263			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891LU	21725369				2022-12-25	WOS:000300219300003
J	Huang, WC; Tsai, CC; Chen, CL; Chen, TY; Chen, YP; Lin, YS; Lu, PJ; Lin, CM; Wang, SH; Tsao, CW; Wang, CY; Cheng, YL; Hsieh, CY; Tseng, PC; Lin, CF				Huang, Wei-Ching; Tsai, Cheng-Chieh; Chen, Chia-Ling; Chen, Tsai-Yun; Chen, Ya-Ping; Lin, Yee-Shin; Lu, Pei-Jung; Lin, Chun-Mao; Wang, Shwu-Huey; Tsao, Chiung-Wen; Wang, Chi-Yun; Cheng, Yi-Lin; Hsieh, Chia-Yuan; Tseng, Po-Chun; Lin, Chiou-Feng			Glucosylceramide synthase inhibitor PDMP sensitizes chronic myeloid leukemia T315I mutant to Bcr-Abl inhibitor and cooperatively induces glycogen synthase kinase-3-regulated apoptosis	FASEB JOURNAL			English	Article						drug resistance; gatekeeper mutation; ceramide	CHRONIC MYELOGENOUS LEUKEMIA; PHILADELPHIA-CHROMOSOME; TYROSINE PHOSPHORYLATION; MEMBRANE PERMEABILIZATION; GLYCOLIPID BIOSYNTHESIS; SPHINGOSINE 1-PHOSPHATE; DRUG-RESISTANCE; BREAST-CANCER; IMATINIB; CELLS	Inactivation of glycogen synthase kinase (GSK)-3 has been implicated in cancer progression. Previously, we showed an abundance of inactive GSK-3 in the human chronic myeloid leukemia (CML) cell line. CML is a hematopoietic malignancy caused by an oncogenic Bcr-Abl tyrosine kinase. In Bcr-Abl signaling, the role of GSK-3 is not well defined. Here, we report that enforced expression of constitutively active GSK-3 reduced proliferation and increased Bcr-Abl inhibitioninduced apoptosis by nearly 1-fold. Bcr-Abl inhibition activated GSK-3 and GSK-3-dependent apoptosis. Inactivation of GSK-3 by Bcr-Abl activity is, therefore, confirmed. To reactivate GSK-3, we used glucosylceramide synthase (GCS) inhibitor PDMP to accumulate endogenous ceramide, a tumor-suppressor sphingolipid and a potent GSK-3 activator. We found that either PDMP or silence of GCS increased Bcr-Abl inhibitioninduced GSK-3 activation and apoptosis. Furthermore, PDMP sensitized the most clinical problematic drug-resistant CML T315I mutant to Bcr-Abl inhibitor GNF2-, imatinib-, or nilotinib-induced apoptosis by >5-fold. Combining PDMP and GNF-2 eliminated transplanted-CML-T315I-mutants in vivo and dose dependently sensitized primary cells from CML T315I patients to GNF-2-induced proliferation inhibition and apoptosis. The synergistic efficacy was Bcr-Abl restricted and correlated to increased intracellular ceramide levels and acted through GSK-3-mediated apoptosis. This study suggests a feasible novel anti-CML strategy by accumulating endogenous ceramide to reactivate GSK-3 and abrogate drug resistance.-Huang, W.-C., Tsai, C.-C., Chen, C.-L., Chen, T.-Y., Chen, Y.-P., Lin, Y.-S., Lu, P.-J., Lin, C.-M., Wang, S.-W., Tsao, C.-W., Wang, C.-Y., Cheng, Y.-L., Hsieh, C.-Y., Tseng, P.-C., Lin, C.-F. Glucosylceramide synthase inhibitor PDMP sensitizes chronic myeloid leukemia T315I mutant to Bcr-Abl inhibitor and cooperatively induces glycogen synthase kinase-3-regulated apoptosis. FASEB J. 25, 3661-3673 (2011). www.fasebj.org	[Huang, Wei-Ching; Tsai, Cheng-Chieh; Chen, Ya-Ping; Lu, Pei-Jung; Wang, Chi-Yun; Cheng, Yi-Lin; Hsieh, Chia-Yuan; Tseng, Po-Chun; Lin, Chiou-Feng] Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan 701, Taiwan; [Huang, Wei-Ching; Tsai, Cheng-Chieh; Lin, Yee-Shin; Lu, Pei-Jung; Wang, Chi-Yun; Lin, Chiou-Feng] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan 701, Taiwan; [Huang, Wei-Ching; Chen, Chia-Ling; Lin, Yee-Shin; Lin, Chiou-Feng] Natl Cheng Kung Univ, Dept Microbiol & Immunol, Coll Med, Tainan 701, Taiwan; [Chen, Tsai-Yun; Chen, Ya-Ping] Natl Cheng Kung Univ, Dept Internal Med, Coll Med, Tainan 701, Taiwan; [Cheng, Yi-Lin] Natl Cheng Kung Univ, Dept Med Lab Sci & Biotechnol, Coll Med, Tainan 701, Taiwan; [Tsai, Cheng-Chieh; Tsao, Chiung-Wen] Chung Hwa Univ Med Technol, Dept Nursing, Tainan, Taiwan; [Lin, Chun-Mao] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Wang, Shwu-Huey] Taipei Med Univ, Core Facil Ctr, Off Res & Dev, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Chung Hua University; Taipei Medical University; Taipei Medical University	Lin, CF (corresponding author), Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan 701, Taiwan.	cflin@mail.ncku.edu.tw		Wang, Chi-Yun/0000-0003-0317-5378; Lin, Chun-Mao/0000-0002-8366-4026; Chen, Ya-Ping/0000-0001-6748-7448; Huang, Wei-Ching/0000-0003-1255-2067	National Health Research Institutes [NHRI-EX99-9917NC]; National Science Council, Taiwan [NSC 96-2320-B-006-018-MY3]; National Cheng Kung University	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Cheng Kung University	The authors thank the Immunobiology Core Laboratory, Research Center of Clinical Medicine, National Cheng Kung University Hospital, for providing services that include training, technical support, and assistance with experimental design and data analysis using Flow Cytometry Core facilities. The authors thank Dr. Huey-Kang Sytwu (Graduate Institute of Life Science, National Defense Medical Center, Taiwan) for materials for and assistance with lentiviral-based shRNA experiments. The authors thank Dr. Cheng-Ta Yang (Department of Respiratory Care, College of Medicine, Chang Gung University, Taoyuan, Taiwan) for the kind gift of gefitinibresistant H1975 cells. Use of the API 4000 triple-quadrupole mass spectrometer was supported by Yung Shin Pharmaceutical Co. (Taiwan). This work was supported by grants NHRI-EX99-9917NC from the National Health Research Institutes and NSC 96-2320-B-006-018-MY3 from the National Science Council, Taiwan, and by the Landmark Project C020 of National Cheng Kung University.	ABE A, 1995, J LIPID RES, V36, P611; Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Baran Y, 2007, J BIOL CHEM, V282, P10922, DOI 10.1074/jbc.M610157200; BARTRAM CR, 1983, NATURE, V306, P277, DOI 10.1038/306277a0; Basu M, 1998, ACTA BIOCHIM POL, V45, P327, DOI 10.18388/abp.1998_4228; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; Bieberich E, 1999, J NEUROCHEM, V72, P1040, DOI 10.1046/j.1471-4159.1999.0721040.x; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; Coluccia AML, 2007, EMBO J, V26, P1456, DOI 10.1038/sj.emboj.7601485; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gouaze V, 2005, CANCER RES, V65, P3861, DOI 10.1158/0008-5472.CAN-04-2329; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Huang WC, 2009, J PHARMACOL EXP THER, V329, P524, DOI 10.1124/jpet.108.148122; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kantarjian HM, 2003, BLOOD, V101, P97, DOI 10.1182/blood-2002-02-0545; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; Li QF, 2007, ONCOGENE, V26, P7904, DOI 10.1038/sj.onc.1210587; Lin CF, 2007, J CELL SCI, V120, P2935, DOI 10.1242/jcs.03473; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Mian AA, 2009, LEUKEMIA, V23, P2242, DOI 10.1038/leu.2009.194; O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936; Ottmann OG, 2002, BLOOD, V100, P1965, DOI 10.1182/blood-2001-12-0181; PLATT FM, 1994, J BIOL CHEM, V269, P8362; Puissant A, 2010, LEUKEMIA, V24, P115, DOI 10.1038/leu.2009.233; PUSHKAREVA M, 1995, IMMUNOL TODAY, V16, P294, DOI 10.1016/0167-5699(95)80184-7; RANI CSS, 1995, J BIOL CHEM, V270, P2859, DOI 10.1074/jbc.270.6.2859; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16; Salas A, 2011, BLOOD, V117, P5941, DOI 10.1182/blood-2010-08-300772; Samanta AK, 2006, CANCER RES, V66, P6468, DOI 10.1158/0008-5472.CAN-06-0025; Sawafuji K, 2003, LEUKEMIA LYMPHOMA, V44, P1987, DOI 10.1080/1042819031000122033; Schiffmann S, 2009, J LIPID RES, V50, P32, DOI 10.1194/jlr.M800122-JLR200; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; SKORSKI T, 1995, BLOOD, V86, P726, DOI 10.1182/blood.V86.2.726.bloodjournal862726; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Smith KM, 2003, MOL CELL, V12, P27, DOI 10.1016/S1097-2765(03)00274-0; Tamborini E, 2004, GASTROENTEROLOGY, V127, P294, DOI 10.1053/j.gastro.2004.02.021; Tamborini E, 2006, ONCOGENE, V25, P6140, DOI 10.1038/sj.onc.1209639; TENHOEVE J, 1994, BLOOD, V84, P1731; Tsai CC, 2009, J IMMUNOL, V183, P856, DOI 10.4049/jimmunol.0804033; von Bubnoff N, 2005, LEUKEMIA, V19, P286, DOI 10.1038/sj.leu.2403600; VUNNAM RR, 1980, CHEM PHYS LIPIDS, V26, P265; Wang SH, 2011, J LIPID RES, V52, P471, DOI 10.1194/jlr.M011015; Xie SH, 2001, ONCOGENE, V20, P6188, DOI 10.1038/sj.onc.1204834; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	57	34	37	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2011	25	10					3661	3673		10.1096/fj.10-180190	http://dx.doi.org/10.1096/fj.10-180190			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21705667				2022-12-25	WOS:000295356400035
J	Chen, L; Qanie, D; Jafari, A; Taipaleenmaki, H; Jensen, CH; Saamanen, AM; Sanz, MLN; Laborda, J; Abdallah, BM; Kassem, M				Chen, Li; Qanie, Diyako; Jafari, Abbas; Taipaleenmaki, Hanna; Jensen, Charlotte H.; Saamanen, Anna-Marja; Nueda Sanz, Maria Luisa; Laborda, Jorge; Abdallah, Basem M.; Kassem, Moustapha			Delta-like 1/Fetal Antigen-1 (Dlk1/FA1) Is a Novel Regulator of Chondrogenic Cell Differentiation via Inhibition of the Akt Kinase-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATERNAL UNIPARENTAL DISOMY; FOCAL ADHESION KINASE; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; STEM-CELLS; 1 FA1; GROWTH; PROTEIN; PREF-1; FETAL	Delta-like 1 (Dlk1, also known as fetal antigen-1, FA1) is a member of Notch/Delta family that inhibits adipocyte and osteoblast differentiation; however, its role in chondrogenesis is still not clear. Thus, we overexpressed Dlk1/FA1 in mouse embryonic ATDC5 cells and tested its effects on chondrogenic differentiation. Dlk1/FA1 inhibited insulin-induced chondrogenic differentiation as evidenced by reduction of cartilage nodule formation and gene expression of aggrecan, collagen Type II and X. Similar effects were obtained either by using Dlk1/FA1-conditioned medium or by addition of a purified, secreted, form of Dlk1 (FA1) directly to the induction medium. The inhibitory effects of Dlk1/FA1 were dose-dependent and occurred irrespective of the chondrogenic differentiation stage: proliferation, differentiation, maturation, or hypertrophic conversion. Overexpression or addition of the Dlk1/FA1 protein to the medium strongly inhibited the activation of Akt, but not the ERK1/2, or p38 MAPK pathways, and the inhibition of Akt by Dlk1/FA1 was mediated through PI3K activation. Interestingly, inhibition of fibronectin expression by siRNA rescued the Dlk1/FA1-mediated inhibition of Akt, suggesting interaction of Dlk1/FA1 and fibronectin in chondrogenic cells. Our results identify Dlk1/FA1 as a novel regulator of chondrogenesis and suggest Dlk1/FA1 acts as an inhibitor of the PI3K/Akt pathways that leads to its inhibitory effects on chondrogenesis.	[Chen, Li; Qanie, Diyako; Jafari, Abbas; Abdallah, Basem M.; Kassem, Moustapha] Univ So Denmark, Odense Univ Hosp, Mol Endocrinol Lab, DK-5000 Odense, Denmark; [Taipaleenmaki, Hanna; Saamanen, Anna-Marja] Univ Turku, Dept Med Biochem, FI-20520 Turku, Finland; [Taipaleenmaki, Hanna; Saamanen, Anna-Marja] Univ Turku, Dept Genet, FI-20520 Turku, Finland; [Jensen, Charlotte H.] Univ So Denmark, Dept Immunol, DK-5020 Odense, Denmark; [Nueda Sanz, Maria Luisa; Laborda, Jorge] Univ Castilla La Mancha, Sch Med, Reg Ctr Biomed Res CRIB, Albacete 02006, Spain; [Kassem, Moustapha] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia	University of Southern Denmark; Odense University Hospital; University of Turku; University of Turku; University of Southern Denmark; Universidad de Castilla-La Mancha; King Saud University	Kassem, M (corresponding author), Kloevervaenget 6,4th Floor, DK-5000 Odense C, Denmark.	mkassem@health.sdu.dk	Chen, Li/AAN-7309-2020; Nueda, María-Luisa/L-3044-2014; Kassem, Moustapha/O-3819-2019; Jafari, Abbas/AAF-6256-2019; Jensen, Charlotte Harken/AAZ-1738-2020; Jafari Kermani, Abbas/I-5074-2015; Jensen, Charlotte Harken/P-4612-2014; Abdallah, Basem/G-5667-2017; Laborda, Jorge/L-5726-2014	Nueda, María-Luisa/0000-0002-5456-5045; Kassem, Moustapha/0000-0003-1557-0869; Jensen, Charlotte Harken/0000-0001-9683-8761; Jafari Kermani, Abbas/0000-0003-2443-6231; Jensen, Charlotte Harken/0000-0001-9683-8761; Abdallah, Basem/0000-0003-0324-8055; Laborda, Jorge/0000-0002-9210-838X; Chen, Li/0000-0001-5561-7612; Saamanen, Anna-Marja/0000-0003-3963-6324; Taipaleenmaki, Hanna/0000-0002-8254-9333	Karen Elise Jensen's Foundation; Novo Nordisk foundation; region of Southern Denmark, Denmark, King Abdulaziz City for Science and Technology [09-BIO740-20]	Karen Elise Jensen's Foundation; Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); region of Southern Denmark, Denmark, King Abdulaziz City for Science and Technology	This work was supported by grants from the Karen Elise Jensen's Foundation, The Novo Nordisk foundation, and a local grant from the region of Southern Denmark, Denmark, King Abdulaziz City for Science and Technology (09-BIO740-20), KSA.	Abdallah BM, 2007, ENDOCRINOLOGY, V148, P3111, DOI 10.1210/en.2007-0171; Abdallah BM, 2007, J BIOL CHEM, V282, P7339, DOI 10.1074/jbc.M607530200; Abdallah BM, 2004, J BONE MINER RES, V19, P841, DOI 10.1359/JBMR.040118; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Baladron V, 2002, BIOCHEM BIOPH RES CO, V291, P193, DOI 10.1006/bbrc.2002.6431; Berends MJW, 1999, AM J MED GENET, V84, P76, DOI 10.1002/(SICI)1096-8628(19990507)84:1<76::AID-AJMG16>3.0.CO;2-F; Chen L, 2005, DIFFERENTIATION, V73, P350, DOI 10.1111/j.1432-0436.2005.00038.x; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Crameri RM, 2004, J PHYSIOL-LONDON, V558, P333, DOI 10.1113/jphysiol.2004.061846; FAY TN, 1988, EUR J OBSTET GYN R B, V29, P73, DOI 10.1016/0028-2243(88)90167-0; Floridon C, 2000, DIFFERENTIATION, V66, P49, DOI 10.1046/j.1432-0436.2000.066001049.x; Fujita T, 2004, J CELL BIOCHEM, V93, P374, DOI 10.1002/jcb.20192; Garces C, 1999, DIFFERENTIATION, V64, P103, DOI 10.1007/s002580050265; Guan JL, 1997, INT J BIOCHEM CELL B, V29, P1085, DOI 10.1016/S1357-2725(97)00051-4; Harkness L, 2009, STEM CELL REV REP, V5, P353, DOI 10.1007/s12015-009-9099-4; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hidaka K, 2001, INT J BIOCHEM CELL B, V33, P1094, DOI 10.1016/S1357-2725(01)00067-X; Hordijk R, 1999, J MED GENET, V36, P782, DOI 10.1136/jmg.36.10.782; Huang J, 2007, CARCINOGENESIS, V28, P1094, DOI 10.1093/carcin/bgl215; Jensen CH, 1997, CLIN CHIM ACTA, V268, P1, DOI 10.1016/S0009-8981(97)00152-6; JENSEN CH, 1994, EUR J BIOCHEM, V225, P83, DOI 10.1111/j.1432-1033.1994.00083.x; Kawakami T, 2006, HUM MOL GENET, V15, P821, DOI 10.1093/hmg/ddl001; LABORDA J, 1993, J BIOL CHEM, V268, P3817; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Lundholt BK, 2005, J BIOMOL SCREEN, V10, P20, DOI 10.1177/108705710429989; Mei BS, 2002, BIOCHEM J, V364, P137, DOI 10.1042/bj3640137; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Nakamura K, 1999, EXP CELL RES, V250, P351, DOI 10.1006/excr.1999.4535; Oh CD, 2003, J BIOL CHEM, V278, P36563, DOI 10.1074/jbc.M304857200; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Phornphutkul C, 2008, DEV DYNAM, V237, P702, DOI 10.1002/dvdy.21464; Sakajiri S, 2005, LEUKEMIA, V19, P1404, DOI 10.1038/sj.leu.2403832; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Smas CM, 1996, INT J OBESITY, V20, pS65; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Smas CM, 1997, CRIT REV EUKAR GENE, V7, P281, DOI 10.1615/CritRevEukarGeneExpr.v7.i4.10; Starkman BG, 2005, BIOCHEM J, V389, P723, DOI 10.1042/BJ20041636; STEIN GS, 1989, CONNECT TISSUE RES, V20, P3, DOI 10.3109/03008208909049996; Sul H. S, 2009, MOL CELL BIOL, V23, P1717; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Wang YH, 2010, MOL CELL BIOL, V30, P3480, DOI 10.1128/MCB.00057-10; Wang YH, 2009, CELL METAB, V9, P287, DOI 10.1016/j.cmet.2009.01.013; Wylie AA, 2000, GENOME RES, V10, P1711, DOI 10.1101/gr.161600; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yevtodiyenko A, 2006, DEV DYNAM, V235, P1115, DOI 10.1002/dvdy.20705	47	42	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32140	32149		10.1074/jbc.M111.230110	http://dx.doi.org/10.1074/jbc.M111.230110			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21724852	Green Published, hybrid			2022-12-25	WOS:000294726800024
J	Zhang, YX; Bonzo, JA; Gonzalez, FJ; Wang, L				Zhang, Yuxia; Bonzo, Jessica A.; Gonzalez, Frank J.; Wang, Li			Diurnal Regulation of the Early Growth Response 1 (Egr-1) Protein Expression by Hepatocyte Nuclear Factor 4 alpha (HNF4 alpha) and Small Heterodimer Partner (SHP) Cross-talk in Liver Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACID BIOSYNTHESIS; RECEPTOR-SHP; GENE-EXPRESSION; TARGET GENES; INJURY; CELLS; IDENTIFICATION; STIMULATION; FIBROBLASTS; METABOLISM	Early growth response 1 (Egr-1) protein is a critical regulator of genes contributing to liver fibrosis; however, little is known about the upstream transcriptional factors that control its expression. Here we show that Egr-1 expression is tightly regulated by nuclear receptor signaling. Hepatocyte nuclear factor 4 alpha (HNF4 alpha) activated the Egr-1 promoter through three DR1 response elements as identified by trans-activation assays. Deletion of these response elements or knockdown of HNF4 alpha using siRNA largely abrogated Egr-1 promoter activation. HNF4 alpha activity, as well as its enrichment on the Egr-1 promoter, were markedly repressed by small heterodimer partner (SHP) co-expression. Egr-1 mRNA and protein were transiently induced by HNF4 alpha. On the contrary, HNF4 alpha siRNA reduced Egr-1 expression at both the mRNA and protein levels, and overexpression of SHP reversed these effects. Conversely, knockdown of SHP by siRNA elevated Egr-1 protein. Interestingly, Egr-1 mRNA exhibited diurnal fluctuation, which was synchronized to the cyclic expression of SHP and HNF4 alpha after cells were released from serum shock. Unexpectedly, the levels of Egr-1 mRNA and protein were highly up-regulated in Hnf4 alpha(-/-) mice. Both HNF4 alpha and Egr-1 expression were dramatically increased in SHP-/- mice with bile duct ligation and in human cirrhotic livers, which was inversely correlated with diminished SHP expression. In conclusion, our study revealed control network for Egr-1 expression through a feedback loop between SHP and HNF4 alpha.	[Zhang, Yuxia; Wang, Li] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Med, Salt Lake City, UT 84132 USA; [Zhang, Yuxia; Wang, Li] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84132 USA; [Bonzo, Jessica A.; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wang, L (corresponding author), 30 North 1900 East,SOM 3C310, Salt Lake City, UT 84132 USA.	l.wang@hsc.utah.edu		Bonzo, Jessica/0000-0003-2403-9981	National Institutes of Health [DK080440, N01-DK-7-0004/HHSN267200700004C]; Multidisciplinary Cancer Research Training Program [T32CA092347]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multidisciplinary Cancer Research Training Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK080440 (to L. W.).; Supported by Multidisciplinary Cancer Research Training Program Grant T32CA092347.; We thank Dr. Scott Friedman for the LX2 cells and Drs. Frances Sladek and Akiyoshi Fukamizu for the HNF4 alpha constructs. Normal human liver and cirrhotic liver specimens were obtained through the Liver Tissue Cell Distribution System (Minneapolis, MN), which is funded by National Institutes of Health Contract N01-DK-7-0004/HHSN267200700004C.	ALLEN K, TOXICOL APPL PHARM, V243, P63; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Brady LM, 1996, BIOCHEM J, V316, P765, DOI 10.1042/bj3160765; Chen SJ, 2006, J BIOL CHEM, V281, P21183, DOI 10.1074/jbc.M603270200; Cho SJ, 2006, J BIOL CHEM, V281, P8161, DOI 10.1074/jbc.M506770200; DeLigio JT, 2009, CANCER BIOL THER, V8, P1889, DOI 10.4161/cbt.8.20.9804; Fiorucci S, 2004, GASTROENTEROLOGY, V127, P1497, DOI 10.1053/j.gastro.2004.08.001; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Humphries A, 2004, BIOCHEM BIOPH RES CO, V320, P551, DOI 10.1016/j.bbrc.2004.06.006; Hwang-Verslues WW, 2008, MOL ENDOCRINOL, V22, P78, DOI 10.1210/me.2007-0298; Inoue Y, 2006, J LIPID RES, V47, P215, DOI 10.1194/jlr.M500430-JLR200; Iwanaga R, 2006, ONCOGENE, V25, P1786, DOI 10.1038/sj.onc.1209210; Kemper JK, 2004, MOL CELL BIOL, V24, P7707, DOI 10.1128/MCB.24.17.7707-7719.2004; Kim ND, 2006, TOXICOL SCI, V90, P586, DOI 10.1093/toxsci/kfj111; Lee CG, 2004, J EXP MED, V200, P377, DOI 10.1084/jem.20040104; Naiki T, 2002, J BIOL CHEM, V277, P14011, DOI 10.1074/jbc.M105403200; Nakamura H, 2002, GENE THER, V9, P495, DOI 10.1038/sj.gt.3301681; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Pan XY, 2010, CELL METAB, V12, P174, DOI 10.1016/j.cmet.2010.05.014; Park YJ, 2008, HEPATOLOGY, V47, P1578, DOI 10.1002/hep.22196; Pritchard MT, 2005, ALCOHOL CLIN EXP RES, V29, p146S, DOI 10.1097/01.alc.0000189286.81943.51; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Tabbi-Anneni I, 2010, AM J PHYSIOL-ENDOC M, V298, pE961, DOI 10.1152/ajpendo.00655.2009; Tan FK, 2005, ARTHRITIS RHEUM-US, V52, P865, DOI 10.1002/art.20871; Wang L, 2003, J BIOL CHEM, V278, P44475, DOI 10.1074/jbc.M305258200; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Yasuoka H, 2009, AM J PATHOL, V175, P605, DOI 10.2353/ajpath.2009.080991; Yue HY, 2010, GUT, V59, P236, DOI 10.1136/gut.2008.174904; Zhang M, 2001, J BIOL CHEM, V276, P41690, DOI 10.1074/jbc.M105117200; Zhang YKJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016683; Zhang YX, 2011, BBA-MOL BASIS DIS, V1812, P893, DOI 10.1016/j.bbadis.2010.10.006; Zhang YX, 2011, FEBS LETT, V585, P1269, DOI 10.1016/j.febslet.2011.03.059; Zhang YX, 2010, MOL CELL BIOL, V30, P1341, DOI 10.1128/MCB.01076-09; Zhou TF, 2010, J BIOL CHEM, V285, P24871, DOI 10.1074/jbc.M110.133280	40	27	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29635	29643		10.1074/jbc.M111.253039	http://dx.doi.org/10.1074/jbc.M111.253039			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21725089	Green Published, hybrid			2022-12-25	WOS:000294046600022
J	Mendez, M; Gross, KW; Glenn, ST; Garvin, JL; Carretero, OA				Mendez, Mariela; Gross, Kenneth W.; Glenn, Sean T.; Garvin, Jeffrey L.; Carretero, Oscar A.			Vesicle-associated Membrane Protein-2 (VAMP2) Mediates cAMP-stimulated Renin Release in Mouse Juxtaglomerular Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC ACINAR-CELLS; COLLECTING DUCT CELLS; IN-VITRO; TETANUS TOXIN; RAT-KIDNEY; REGULATED EXOCYTOSIS; GLUT4 TRAFFICKING; ADENYLYL-CYCLASE; SNARE COMPLEX; MACULA DENSA	Renin is essential for blood pressure control. Renin is stored in granules in juxtaglomerular (JG) cells, located in the pole of the renal afferent arterioles. The second messenger cAMP stimulates renin release. However, it is unclear whether fusion and exocytosis of renin-containing granules is involved. In addition, the role of the fusion proteins, SNAREs (soluble N-ethylmaleimide-sensitive factor attachment proteins), in renin release from JG cells has not been studied. The vesicle SNARE proteins VAMP2 (vesicle associated membrane protein 2) and VAMP3 mediate cAMP-stimulated exocytosis in other endocrine cells. Thus, we hypothesized that VAMP2 and/or -3 mediate cAMP-stimulated renin release from JG cells. By fluorescence-activated cell sorting, we isolated JG cells expressing green fluorescent protein and compared the relative abundance of VAMP2/3 in JG cells versus total mouse kidney mRNA by quantitative PCR. We found that VAMP2 and VAMP3 mRNA are expressed and enriched in JG cells. Confocal imaging of primary cultures of JG cells showed that VAMP2 (but not VAMP3) co-localized with renin-containing granules. Cleavage of VAMP2 and VAMP3 with tetanus toxin blocked cAMP-stimulated renin release from JG cells by similar to 50% and impaired cAMP-stimulated exocytosis by similar to 50%, as monitored with FM1-43. Then we specifically knocked down VAMP2 or VAMP3 by adenoviral-mediated delivery of short hairpin silencing RNA. We found that silencing VAMP2 blocked cAMP-induced renin release by similar to 50%. In contrast, silencing VAMP3 had no effect on basal or cAMP-stimulated renin release. We conclude that VAMP2 and VAMP3 are expressed in JG cells, but only VAMP2 is targeted to renin-containing granules and mediates the stimulatory effect of cAMP on renin exocytosis.	[Mendez, Mariela; Garvin, Jeffrey L.; Carretero, Oscar A.] Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, Detroit, MI 48202 USA; [Garvin, Jeffrey L.] Wayne State Univ, Dept Physiol, Detroit, MI 48201 USA; [Gross, Kenneth W.; Glenn, Sean T.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA	Henry Ford Health System; Henry Ford Hospital; Wayne State University; Roswell Park Cancer Institute	Mendez, M (corresponding author), 2799 W Grand Blvd,E&R 7063, Detroit, MI 48202 USA.	mmendez1@hfhs.org	Mendez, Mariela/D-7033-2019	Mendez, Mariela/0000-0002-2537-7272	National Institutes of Health, National Research Service [F32 HL096346-01, 5R01HL48459-17]; National Kidney Foundation; NCI, National Institutes of Health [CA016056]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048459, F32HL096346] Funding Source: NIH RePORTER	National Institutes of Health, National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant National Research Service Awards F32 HL096346-01 (to M. M.) and 5R01HL48459-17 (to K. W. G.). This work also supported by a National Kidney Foundation fellowship grant.; We thank Craig Jones, MaryKay Ellsworth, and the Flow and Image Cytometry Resource at Roswell Park Cancer Institute, which is supported by NCI, National Institutes of Health-funded Cancer Center Support Grant CA016056. We also thank Dr. Pablo Ortiz for reading of the manuscript and suggestions.	Alexander EA, 1997, AM J PHYSIOL-RENAL, V273, pF1054, DOI 10.1152/ajprenal.1997.273.6.F1054; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Becherer U, 2003, NAT NEUROSCI, V6, P846, DOI 10.1038/nn1087; Beierwaltes WH, 2010, AM J PHYSIOL-RENAL, V298, pF1, DOI 10.1152/ajprenal.00143.2009; Brechler V, 1996, J BIOL CHEM, V271, P20636, DOI 10.1074/jbc.271.34.20636; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Butterworth MB, 2005, AM J PHYSIOL-RENAL, V289, pF969, DOI 10.1152/ajprenal.00390.2003; Cabaniols JP, 1999, MOL BIOL CELL, V10, P4033, DOI 10.1091/mbc.10.12.4033; Caceres PS, 2009, J BIOL CHEM, V284, P24965, DOI 10.1074/jbc.M109.037135; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Chieregatti E, 2004, MOL BIOL CELL, V15, P1918, DOI 10.1091/mbc.E03-09-0684; CHU WN, 1990, MOL ENDOCRINOL, V4, P1905, DOI 10.1210/mend-4-12-1905; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Cosen-Binker LI, 2008, WORLD J GASTROENTERO, V14, P2314, DOI 10.3748/wjg.14.2314; DEJONG W, 1969, P SOC EXP BIOL MED, V130, P85; Foster LJ, 1998, BIOCHEMISTRY-US, V37, P11089, DOI 10.1021/bi980253t; Friis UG, 1999, CIRC RES, V84, P929; Fujita-Yoshigaki J, 1998, EUR J MORPHOL, V36, P46; FujitaYoshigaki J, 1996, J BIOL CHEM, V271, P13130, DOI 10.1074/jbc.271.22.13130; GALLI T, 1994, J CELL BIOL, V125, P1015, DOI 10.1083/jcb.125.5.1015; GENEST J, 1973, CAN MED ASSOC J, V109, P475; Gil C, 2005, BIOCHEM BIOPH RES CO, V329, P117, DOI 10.1016/j.bbrc.2005.01.111; Glenn ST, 2008, PHYSIOL GENOMICS, V35, P243, DOI 10.1152/physiolgenomics.00017.2008; Gomez RA, 1997, MICROSC RES TECHNIQ, V39, P254, DOI 10.1002/(SICI)1097-0029(19971101)39:3<254::AID-JEMT5>3.0.CO;2-K; Gouraud S, 2002, J CELL SCI, V115, P3667, DOI 10.1242/jcs.00053; HACKENTHAL E, 1990, PHYSIOL REV, V70, P1067, DOI 10.1152/physrev.1990.70.4.1067; HACKENTHAL E, 1983, CLIN EXP HYPERTENS A, V5, P975, DOI 10.3109/10641968309048836; HACKENTHAL E, 1986, MOL CELL ENDOCRINOL, V47, P1, DOI 10.1016/0303-7207(86)90010-9; Hajduch E, 1997, BIOCHEM J, V321, P233, DOI 10.1042/bj3210233; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Hepp G, 2005, J BIOL CHEM, V280, P6610, DOI 10.1074/jbc.M412126200; Huang XH, 2001, PANCREAS, V23, P125, DOI 10.1097/00006676-200108000-00002; Humeau Y, 2000, BIOCHIMIE, V82, P427, DOI 10.1016/S0300-9084(00)00216-9; Inoue T, 1998, AM J PHYSIOL-RENAL, V275, pF752, DOI 10.1152/ajprenal.1998.275.5.F752; ITOH S, 1985, KIDNEY INT, V27, P762, DOI 10.1038/ki.1985.77; ITOH S, 1985, HYPERTENSION, V7, pI49, DOI 10.1161/01.HYP.7.3_Pt_2.I49; ITOH S, 1985, J CLIN INVEST, V76, P1412, DOI 10.1172/JCI112118; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jensen BL, 1996, AM J PHYSIOL-RENAL, V271, pF659, DOI 10.1152/ajprenal.1996.271.3.F659; JO IH, 1995, P NATL ACAD SCI USA, V92, P1876, DOI 10.1073/pnas.92.6.1876; Jutras I, 1999, FEBS LETT, V443, P48, DOI 10.1016/S0014-5793(98)01672-X; Kurtz A., 1991, CELL PHYSIOL BIOCHEM, V1, P98, DOI 10.1159/000154598; Lacombe MJ, 2005, J BIOL CHEM, V280, P4803, DOI 10.1074/jbc.M408658200; LARAGH JH, 1975, JOHNS HOPKINS MED J, V137, P184; Li GM, 2003, J BIOL CHEM, V278, P19791, DOI 10.1074/jbc.M212250200; Lopez MLSS, 2003, METH MOLEC MED, V86, P193; Lopez MLSS, 2004, DEV CELL, V6, P719; Low SH, 1998, J BIOL CHEM, V273, P3422, DOI 10.1074/jbc.273.6.3422; Mandon B, 1997, AM J PHYSIOL-RENAL, V273, pF718, DOI 10.1152/ajprenal.1997.273.5.F718; Mandon B, 1996, J CLIN INVEST, V98, P906, DOI 10.1172/JCI118873; Martin LB, 1998, J BIOL CHEM, V273, P1444, DOI 10.1074/jbc.273.3.1444; Martin S, 1996, J CELL BIOL, V134, P625, DOI 10.1083/jcb.134.3.625; MATSUDA M, 1994, ANN NY ACAD SCI, V710, P94, DOI 10.1111/j.1749-6632.1994.tb26617.x; Methot D, 2001, Curr Hypertens Rep, V3, P68, DOI 10.1007/s11906-001-0083-x; NIELSEN S, 1995, J CLIN INVEST, V96, P1834, DOI 10.1172/JCI118229; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Ortiz-Capisano MC, 2007, HYPERTENSION, V49, P618, DOI 10.1161/01.HYP.0000255172.84842.d2; Ortiz-Capisano MC, 2007, HYPERTENSION, V49, P162, DOI 10.1161/01.HYP.0000250708.04205.d4; PARK CS, 1978, AM J PHYSIOL, V234, pF506, DOI 10.1152/ajprenal.1978.234.6.F506; Pellizzari R, 1998, TOXICOL LETT, V103, P191, DOI 10.1016/S0378-4274(98)00306-3; Pennuto M, 2003, MOL BIOL CELL, V14, P4909, DOI 10.1091/mbc.E03-06-0380; Peti-Peterdi J, 2004, AM J PHYSIOL-RENAL, V287, pF329, DOI 10.1152/ajprenal.00420.2003; Reudelhuber TL, 1998, ADV EXP MED BIOL, V436, P229; REUDELHUBER TL, 1994, KIDNEY INT, V46, P1522, DOI 10.1038/ki.1994.435; SCHRICKER K, 1995, AM J PHYSIOL-RENAL, V269, pF64, DOI 10.1152/ajprenal.1995.269.1.F64; Sterling H, 2003, AM J PHYSIOL-RENAL, V284, pF510, DOI 10.1152/ajprenal.00309.2002; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; TAUGNER R, 1984, CELL TISSUE RES, V237, P459; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Turton K, 2002, TRENDS BIOCHEM SCI, V27, P552, DOI 10.1016/S0968-0004(02)02177-1; Verderio C, 1999, J NEUROCHEM, V73, P372, DOI 10.1046/j.1471-4159.1999.0730372.x; Weng N, 2007, J BIOL CHEM, V282, P9635, DOI 10.1074/jbc.M611108200; Williams D, 2008, J CELL BIOL, V180, P375, DOI 10.1083/jcb.200709108; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Zhao P, 2009, J CELL SCI, V122, P3472, DOI 10.1242/jcs.047449	76	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28608	28618		10.1074/jbc.M111.225839	http://dx.doi.org/10.1074/jbc.M111.225839			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21708949	hybrid, Green Published			2022-12-25	WOS:000293557800075
J	Sjodin, P; Francois, O				Sjodin, Per; Francois, Olivier			Wave-of-Advance Models of the Diffusion of the Y Chromosome Haplogroup R1b1b2 in Europe	PLOS ONE			English	Article							GENE POOL; MUTATION-RATE; MTDNA; DIVERSITY; FARMERS; DNA; EXPANSION; ADMIXTURE; LINEAGES; HISTORY	Whether or not the spread of agriculture in Europe was accompanied by movements of people is a long-standing question in archeology and anthropology, which has been frequently addressed with the help of population genetic data. Estimates on dates of expansion and geographic origins obtained from genetic data are however sensitive to the calibration of mutation rates and to the mathematical models used to perform inference. For instance, recent data on the Y chromosome haplogroup R1b1b2 (M269) have either suggested a Neolithic origin for European paternal lineages or a more ancient Paleolithic origin depending on the calibration of Y-STR mutation rates. Here we examine the date of expansion and the geographic origin of hgR1b1b2 considering two current estimates of mutation rates in a total of fourteen realistic wave-of-advance models. We report that a range expansion dating to the Paleolithic is unlikely to explain the observed geographical distribution of microsatellite diversity, and that whether the data is informative with respect to the spread of agriculture in Europe depends on the mutation rate assumption in a critical way.	[Sjodin, Per] Uppsala Univ, Evolutionary Biol Ctr, Dept Evolutionary Biol, Uppsala, Sweden; [Francois, Olivier] Univ Grenoble 1, CNRS, TIMC IMAG UMR 5525, Grenoble, France	Uppsala University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA)	Sjodin, P (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Evolutionary Biol, Uppsala, Sweden.	per.sjodins@ebc.uu.se	Francois, Olivier/AAQ-3137-2020; Francois, Olivier/A-6051-2012	Francois, Olivier/0000-0003-2402-2442; Francois, Olivier/0000-0003-2402-2442	Institute of Complex Systems (IXXI); STINT (The Swedish Foundation for International Cooperation in Research and Higher Education)	Institute of Complex Systems (IXXI); STINT (The Swedish Foundation for International Cooperation in Research and Higher Education)	OF received support from the Institute of Complex Systems (IXXI, www.ixxi.fr). PS was supported by an Institutional Grant for Younger Researchers from STINT (The Swedish Foundation for International Cooperation in Research and Higher Education, www.stint.se) to Mattias Jakobsson and Michael Blum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; AMMERMAN AJ, 1971, MAN, V6, P674, DOI 10.2307/2799190; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Barbujani G, 1998, AM J HUM GENET, V62, P488, DOI 10.1086/301719; Barker G., 2006, AGR REVOLUTION PREHI; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chiaroni J, 2009, P NATL ACAD SCI USA, V106, P20174, DOI 10.1073/pnas.0910803106; Chikhi L, 1998, P NATL ACAD SCI USA, V95, P9053, DOI 10.1073/pnas.95.15.9053; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Cruciani F, 2011, FORENSIC SCI INT-GEN, V5, pE49, DOI 10.1016/j.fsigen.2010.07.006; Currat M, 2005, P ROY SOC B-BIOL SCI, V272, P679, DOI 10.1098/rspb.2004.2999; Di Giacomo F, 2004, HUM GENET, V115, P357, DOI 10.1007/s00439-004-1168-9; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Dupanloup I, 2004, MOL BIOL EVOL, V21, P1361, DOI 10.1093/molbev/msh135; Francois O, 2010, MOL BIOL EVOL, V27, P1257, DOI 10.1093/molbev/msq010; Francois O, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000075; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; MARTIN TR, 1992, ANCIENT GREECE PREHI; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Morelli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010419; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Ray N, 2010, BIOINFORMATICS, V26, P2993, DOI 10.1093/bioinformatics/btq579; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 1996, AM J HUM GENET, V59, P185; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Shi WT, 2010, MOL BIOL EVOL, V27, P385, DOI 10.1093/molbev/msp243; Simoni L, 2000, AM J HUM GENET, V66, P262, DOI 10.1086/302706; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Whittle A, 2007, P BRIT ACAD, V144; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhivotovsky LA, 2006, MOL BIOL EVOL, V23, P2268, DOI 10.1093/molbev/msl105	38	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21592	10.1371/journal.pone.0021592	http://dx.doi.org/10.1371/journal.pone.0021592			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720564	Green Submitted, Green Published, gold			2022-12-25	WOS:000292036900060
J	Oshansky, CM; Pickens, JA; Bradley, KC; Jones, LP; Saavedra-Ebner, GM; Barber, JP; Crabtree, JM; Steinhauer, DA; Tompkins, SM; Tripp, RA				Oshansky, Christine M.; Pickens, Jennifer A.; Bradley, Konrad C.; Jones, Les P.; Saavedra-Ebner, Geraldine M.; Barber, James P.; Crabtree, Jackelyn M.; Steinhauer, David A.; Tompkins, S. Mark; Tripp, Ralph A.			Avian Influenza Viruses Infect Primary Human Bronchial Epithelial Cells Unconstrained by Sialic Acid alpha 2,3 Residues	PLOS ONE			English	Article							RECEPTOR-BINDING SPECIFICITY; HUMAN AIRWAY EPITHELIUM; I INTERFERON RESPONSE; A H5N1 VIRUSES; MAACKIA-AMURENSIS; CYTOKINE RESPONSES; GENE-EXPRESSION; HUMAN ALVEOLAR; HOST-RANGE; H1N1	Avian influenza viruses (AIV) are an important emerging threat to public health. It is thought that sialic acid (sia) receptors are barriers in cross-species transmission where the binding preferences of AIV and human influenza viruses are sias alpha 2,3 versus alpha 2,6, respectively. In this study, we show that a normal fully differentiated, primary human bronchial epithelial cell model is readily infected by low pathogenic H5N1, H5N2 and H5N3 AIV, which primarily bind to sia alpha 2,3 moieties, and replicate in these cells independent of specific sias on the cell surface. NHBE cells treated with neuraminidase prior to infection are infected by AIV despite removal of sia alpha 2,3 moieties. Following AIV infection, higher levels of IP-10 and RANTES are secreted compared to human influenza virus infection, indicating differential chemokine expression patterns, a feature that may contribute to differences in disease pathogenesis between avian and human influenza virus infections in humans.	[Oshansky, Christine M.; Pickens, Jennifer A.; Jones, Les P.; Saavedra-Ebner, Geraldine M.; Barber, James P.; Crabtree, Jackelyn M.; Tompkins, S. Mark; Tripp, Ralph A.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Bradley, Konrad C.; Steinhauer, David A.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	University System of Georgia; University of Georgia; Emory University	Oshansky, CM (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.	ratripp@uga.edu	Tompkins, Stephen/A-3317-2008; Tripp, Ralph/F-5218-2011	Tompkins, Stephen/0000-0002-1523-5588; Tripp, Ralph/0000-0002-2924-9956; Barber, James/0000-0003-3108-1002; Bradley, Konrad/0000-0001-8761-6219	Center of Excellence for Influenza Research and Surveillance (CEIRS) [HHSN266200700006C]; Georgia Research Alliance	Center of Excellence for Influenza Research and Surveillance (CEIRS); Georgia Research Alliance	This work was funded by the Center of Excellence for Influenza Research and Surveillance (CEIRS) contract HHSN266200700006C and the Georgia Research Alliance (http://www.gra.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Basler CF, 2008, ANTIVIR RES, V79, P166, DOI 10.1016/j.antiviral.2008.04.006; BAUM LG, 1990, ACTA HISTOCHEM, P35; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chan MCW, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-102; Chan RWY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008713; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Glaser L, 2007, VIRUS RES, V126, P9, DOI 10.1016/j.virusres.2007.01.011; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Ilyushina NA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000043; Imberty A, 2000, J BIOL CHEM, V275, P17541, DOI 10.1074/jbc.M000560200; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; KNIBBS RN, 1991, J BIOL CHEM, V266, P83; Kogure T, 2006, GLYCOCONJUGATE J, V23, P101, DOI 10.1007/s10719-006-5442-z; KONAMI Y, 1994, FEBS LETT, V342, P334, DOI 10.1016/0014-5793(94)80527-X; Krunkosky TM, 2000, AM J RESP CELL MOL, V22, P685, DOI 10.1165/ajrcmb.22.6.3925; Malakhov MP, 2006, ANTIMICROB AGENTS CH, V50, P1470, DOI 10.1128/AAC.50.4.1470-1479.2006; Malavia NK, 2009, AM J RESP CELL MOL, V41, P297, DOI 10.1165/rcmb.2008-0358OC; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich M, 2009, REV SCI TECH OIE, V28, P203, DOI 10.20506/rst.28.1.1870; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Oshansky CM, 2009, VIRAL IMMUNOL, V22, P147, DOI 10.1089/vim.2008.0098; Pappaioanou M, 2009, COMP IMMUNOL MICROB, V32, P287, DOI 10.1016/j.cimid.2008.01.003; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Ramos I, 2011, J VIROL, V85, P4421, DOI 10.1128/JVI.02356-10; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rose MC, 2000, J AEROSOL MED, V13, P245, DOI 10.1089/jam.2000.13.245; Schauer R, 2000, GLYCOCONJUGATE J, V17, P485, DOI 10.1023/A:1011062223612; SCHNITZLER SU, 2009, VIRUS GENES; Shelton H, 2011, J VIROL, V85, P1875, DOI 10.1128/JVI.01822-10; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; SPRINGER GF, 1969, P NATL ACAD SCI USA, V64, P634, DOI 10.1073/pnas.64.2.634; Stray SJ, 2000, GLYCOBIOLOGY, V10, P649, DOI 10.1093/glycob/10.7.649; SUZUKI Y, 1985, VACCINE, V3, P201, DOI 10.1016/0264-410X(85)90104-5; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; SUZUKI Y, 1985, J BIOL CHEM, V260, P1362; SUZUKI Y, 1986, J BIOL CHEM, V261, P7057; TATENO I, 1966, NEW ENGL J MED, V274, P237, DOI 10.1056/NEJM196602032740502; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; WANG WC, 1988, J BIOL CHEM, V263, P4576; Webby R, 2004, NAT MED, V10, pS77, DOI 10.1038/nm1151; WHO, 2010, CUM NUMB CONF HUM CA; *WHO, 2009, CUM NUMB CONF HUM CA; Xu Q, 2010, J VIROL, V84, P4936, DOI 10.1128/JVI.02489-09; Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07	64	39	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21183	10.1371/journal.pone.0021183	http://dx.doi.org/10.1371/journal.pone.0021183			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731666	Green Submitted, Green Published, gold			2022-12-25	WOS:000292035400012
J	Farmer, S; San-Segundo, PA; Aragon, L				Farmer, Sarah; San-Segundo, Pedro A.; Aragon, Luis			The Smc5-Smc6 Complex Is Required to Remove Chromosome Junctions in Meiosis	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DAMAGED REPLICATION FORKS; MEIOTIC CROSSING-OVER; SACCHAROMYCES-CEREVISIAE; DNA-REPAIR; SUMO LIGASE; HOMOLOGOUS RECOMBINATION; PACHYTENE CHECKPOINT; HOLLIDAY JUNCTIONS; JOINT MOLECULES	Meiosis, a specialized cell division with a single cycle of DNA replication round and two consecutive rounds of nuclear segregation, allows for the exchange of genetic material between parental chromosomes and the formation of haploid gametes. The structural maintenance of chromosome (SMC) proteins aid manipulation of chromosome structures inside cells. Eukaryotic SMC complexes include cohesin, condensin and the Smc5-Smc6 complex. Meiotic roles have been discovered for cohesin and condensin. However, although Smc5-Smc6 is known to be required for successful meiotic divisions, the meiotic functions of the complex are not well understood. Here we show that the Smc5-Smc6 complex localizes to specific chromosome regions during meiotic prophase I. We report that meiotic cells lacking Smc5-Smc6 undergo catastrophic meiotic divisions as a consequence of unresolved linkages between chromosomes. Surprisingly, meiotic segregation defects are not rescued by abrogation of Spo11-induced meiotic recombination, indicating that at least some chromosome linkages in smc5-smc6 mutants originate from other cellular processes. These results demonstrate that, as in mitosis, Smc5-Smc6 is required to ensure proper chromosome segregation during meiosis by preventing aberrant recombination intermediates between homologous chromosomes.	[Farmer, Sarah; Aragon, Luis] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, Cell Cycle Grp, London, England; [San-Segundo, Pedro A.] Univ Salamanca, CSIC, Inst Biol Func & Genom, E-37008 Salamanca, Spain	Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Farmer, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, Cell Cycle Grp, London, England.	luis.aragon@csc.mrc.ac.uk	San-Segundo, Pedro A/L-4539-2014	San-Segundo, Pedro A/0000-0002-5616-574X	Medical Research Council United Kingdom; Spanish Ministry of Education [BFU2009-07159]; Fundacion Ramon Areces; MRC [MC_U120074328] Funding Source: UKRI; Medical Research Council [MC_U120074328] Funding Source: researchfish	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Spanish Ministry of Education(Spanish Government); Fundacion Ramon Areces; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council United Kingdom Intramural Grant Programme to LA and grant BFU2009-07159 from the Spanish Ministry of Education and Fundacion Ramon Areces to PS-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; ATCHESON CL, 1987, P NATL ACAD SCI USA, V84, P8035, DOI 10.1073/pnas.84.22.8035; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Cha RS, 2000, GENE DEV, V14, P493; Cost GJ, 2006, GENETICS, V172, P2185, DOI 10.1534/genetics.105.053876; Cromie GA, 2006, CELL, V127, P1167, DOI 10.1016/j.cell.2006.09.050; de los Santos T, 2001, GENETICS, V159, P1511; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; Franklin AE, 1999, PLANT CELL, V11, P809, DOI 10.1105/tpc.11.5.809; Goldfarb T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000520; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Hochwagen A, 2006, CURR BIOL, V16, pR217, DOI 10.1016/j.cub.2006.03.009; Hong EJE, 2002, GENE DEV, V16, P363, DOI 10.1101/gad.938102; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Interthal H, 2000, MOL GEN GENET, V263, P812, DOI 10.1007/s004380000241; Jessop L, 2008, MOL CELL, V31, P313, DOI 10.1016/j.molcel.2008.05.021; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KLAPHOLZ S, 1980, GENETICS, V96, P567; KLAPHOLZ S, 1985, GENETICS, V110, P187; Lamb NE, 2005, CYTOGENET GENOME RES, V111, P250, DOI 10.1159/000086896; Lee B, 2001, CURR OPIN CELL BIOL, V13, P770, DOI 10.1016/S0955-0674(00)00282-9; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Martinez-Perez E, 2009, CURR OPIN GENET DEV, V19, P105, DOI 10.1016/j.gde.2009.02.005; Oh SD, 2008, MOL CELL, V31, P324, DOI 10.1016/j.molcel.2008.07.006; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Pebernard S, 2004, MOL BIOL CELL, V15, P4866, DOI 10.1091/mbc.E04-05-0436; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Rockmill B, 2003, CURR BIOL, V13, P1954, DOI 10.1016/j.cub.2003.10.059; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; San-Segundo PA, 1999, CELL, V97, P313, DOI 10.1016/S0092-8674(00)80741-2; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Sergeant J, 2005, MOL CELL BIOL, V25, P172, DOI 10.1128/MCB.25.1.172-184.2005; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Smith GR, 2003, GENETICS, V165, P2289; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Torres-Rosell J, 2007, SCIENCE, V315, P1411, DOI 10.1126/science.1134025; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	55	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20948	10.1371/journal.pone.0020948	http://dx.doi.org/10.1371/journal.pone.0020948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731634	Green Submitted, Green Published, gold			2022-12-25	WOS:000292033700021
J	Osthoff, M; Katan, M; Fluri, F; Schuetz, P; Bingisser, R; Kappos, L; Steck, AJ; Engelter, ST; Mueller, B; Christ-Crain, M; Trendelenburg, M				Osthoff, Michael; Katan, Mira; Fluri, Felix; Schuetz, Philipp; Bingisser, Roland; Kappos, Ludwig; Steck, Andreas J.; Engelter, Stefan T.; Mueller, Beat; Christ-Crain, Mirjam; Trendelenburg, Marten			Mannose-Binding Lectin Deficiency Is Associated With Smaller Infarction Size and Favorable Outcome in Ischemic Stroke Patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; REPERFUSION INJURY; COMPLEMENT ACTIVATION; MYOCARDIAL-INFARCTION; ADMISSION C; PATHWAY; THROMBOLYSIS; SEVERITY; TRANSPLANTATION; INFECTION	Background: The Mannose-binding lectin (MBL) pathway of complement plays a pivotal role in the pathogenesis of ischemia/reperfusion (I/R) injury after experimental ischemic stroke. As comparable data in human ischemic stroke are limited, we investigated in more detail the association of MBL deficiency with infarction volume and functional outcome in a large cohort of patients receiving intravenous thrombolysis or conservative treatment. Methodology/Principal Findings: In a post hoc analysis of a prospective cohort study, admission MBL concentrations were determined in 353 consecutive patients with an acute ischemic stroke of whom 287 and 66 patients received conservative and thrombolytic treatment, respectively. Stroke severity, infarction volume, and functional outcome were studied in relation to MBL concentrations at presentation to the emergency department. MBL levels on admission were not influenced by the time from symptom onset to presentation (p = 0.53). In the conservative treatment group patients with mild strokes at presentation, small infarction volumes or favorable outcomes after three months demonstrated 1.5 to 2.6-fold lower median MBL levels (p = 0.025, p = 0.0027 and p = 0.046, respectively) compared to patients with more severe strokes. Moreover, MBL deficient patients (<100 ng/ml) were subject to a considerably decreased risk of an unfavorable outcome three months after ischemic stroke (adjusted odds ratio 0.38, p<0.05) and showed smaller lesion volumes (mean size 0.6 vs. 18.4 ml, p = 0.0025). In contrast, no association of MBL concentration with infarction volume or functional outcome was found in the thrombolysis group. However, the small sample size limits the significance of this observation. Conclusions: MBL deficiency is associated with smaller cerebral infarcts and favorable outcome in patients receiving conservative treatment. Our data suggest an important role of the lectin pathway in the pathophysiology of cerebral I/R injury and might pave the way for new therapeutic interventions.	[Osthoff, Michael; Trendelenburg, Marten] Univ Basel Hosp, Dept Biomed, Clin Immunol Lab, CH-4031 Basel, Switzerland; [Osthoff, Michael; Trendelenburg, Marten] Univ Basel Hosp, Clin Internal Med, CH-4031 Basel, Switzerland; [Katan, Mira; Christ-Crain, Mirjam] Univ Basel Hosp, Dept Endocrinol, CH-4031 Basel, Switzerland; [Katan, Mira; Fluri, Felix; Kappos, Ludwig; Steck, Andreas J.; Engelter, Stefan T.] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Bingisser, Roland] Univ Basel Hosp, Dept Emergency Med, CH-4031 Basel, Switzerland; [Mueller, Beat] Kantonsspital, Med Univ Clin, Aarau, Switzerland; [Schuetz, Philipp] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of Basel; University of Basel; University of Basel; University of Basel; University of Basel; Kantonsspital Aarau AG (KSA); Harvard University; Harvard T.H. Chan School of Public Health	Osthoff, M (corresponding author), Univ Basel Hosp, Dept Biomed, Clin Immunol Lab, CH-4031 Basel, Switzerland.	mosthoff@uhbs.ch	Mueller, Beat/G-2662-2012; schuetz, philipp/C-8475-2013; Trendelenburg, Marten/AAM-1626-2020	schuetz, philipp/0000-0001-6400-4949; Trendelenburg, Marten/0000-0001-7036-8386; Katan, Mira/0000-0002-9265-8066; Bingisser, Roland/0000-0001-8223-9792; Osthoff, Michael/0000-0001-5439-957X; Christ-Crain, Mirjam/0000-0002-6336-0965; Engelter, Stefan/0000-0003-3855-6234	Swiss National Science Foundation [3232B0-107248/2, 324730-132955, PP00P3-12346]; University of Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Basel	This work was supported by a SCORE fellowship form the Swiss National Science Foundation to MT (Nr. 3232B0-107248/2 and 324730-132955), a grant to young researchers from the University of Basel to MK as well as a grant of the Swiss National Science Foundation to MCC (Nr. PP00P3-12346). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; AGOSTONI A, 1994, CIRCULATION, V90, P2666, DOI 10.1161/01.CIR.90.6.2666; Appelros P, 2003, STROKE, V34, P122, DOI 10.1161/01.STR.0000047852.05842.3C; Arumugam TV, 2004, SHOCK, V21, P401, DOI 10.1097/00024382-200405000-00002; Audebert HJ, 2004, STROKE, V35, P2128, DOI 10.1161/01.STR.0000137607.61697.77; Bouwman LH, 2006, HUM IMMUNOL, V67, P247, DOI 10.1016/j.humimm.2006.02.030; Busche MN, 2009, AM J PHYSIOL-HEART C, V297, pH1853, DOI 10.1152/ajpheart.00049.2009; Cervera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008433; Chan RK, 2006, J IMMUNOL, V177, P8080, DOI 10.4049/jimmunol.177.11.8080; de Vries B, 2004, AM J PATHOL, V165, P1677, DOI 10.1016/S0002-9440(10)63424-4; DeGraba TJ, 1999, STROKE, V30, P1208, DOI 10.1161/01.STR.30.6.1208; den Hertog H.M., 2009, J NEUROL; Elkind MSV, 2006, ARCH INTERN MED, V166, P2073, DOI 10.1001/archinte.166.19.2073; Fidler KJ, 2004, INTENS CARE MED, V30, P1438, DOI 10.1007/s00134-004-2303-8; Gadjeva M, 2004, MOL IMMUNOL, V41, P113, DOI 10.1016/j.molimm.2004.03.015; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4; Gesuete R, 2009, ANN NEUROL, V66, P332, DOI 10.1002/ana.21740; Hart ML, 2005, J IMMUNOL, V174, P6373, DOI 10.4049/jimmunol.174.10.6373; Herpers BL, 2009, CLIN EXP IMMUNOL, V156, P488, DOI 10.1111/j.1365-2249.2009.03929.x; Idicula TT, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-18; Jordan JE, 2001, CIRCULATION, V104, P1413, DOI 10.1161/hc3601.095578; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; LU J, 1990, J IMMUNOL, V144, P2287; Manuel O, 2007, TRANSPLANTATION, V83, P359, DOI 10.1097/01.tp.0000251721.90688.c2; Matthijsen RA, 2009, MOL IMMUNOL, V46, P2244, DOI 10.1016/j.molimm.2009.04.010; Mocco J, 2006, NEUROSURGERY, V59, P28, DOI [10.1227/01.NEU.0000219221.14280.65, 10.1227/01.neu.0000243280.75920.f4]; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Pedersen ED, 2004, CLIN EXP IMMUNOL, V137, P117, DOI 10.1111/j.1365-2249.2004.02489.x; Petersen SV, 2001, J IMMUNOL METHODS, V257, P107, DOI 10.1016/S0022-1759(01)00453-7; Potlukova E, 2010, CLIN IMMUNOL, V136, P123, DOI 10.1016/j.clim.2010.02.015; Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004; Szeplaki G, 2009, ATHEROSCLEROSIS, V204, P315, DOI 10.1016/j.atherosclerosis.2008.07.044; Topakian R, 2008, J NEUROL, V255, P1190, DOI 10.1007/s00415-008-0866-y; Trendelenburg M, 2010, EUR HEART J, V31, P1181, DOI 10.1093/eurheartj/ehp597; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Walsh MC, 2005, J IMMUNOL, V175, P541, DOI 10.4049/jimmunol.175.1.541; Whiteley W, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000145; 2008, CEREBROVASC DIS, V25, P457	39	74	79	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21338	10.1371/journal.pone.0021338	http://dx.doi.org/10.1371/journal.pone.0021338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712986	Green Published, Green Submitted, gold			2022-12-25	WOS:000291985100032
J	Li, W; Wang, Z; Li, J; Yang, HC; Cui, SJ; Wang, XX; Ma, LG				Li, Wei; Wang, Zheng; Li, Jian; Yang, Hongchun; Cui, Sujuan; Wang, Xiaoxue; Ma, Ligeng			Overexpression of AtBMI1C, a Polycomb Group Protein Gene, Accelerates Flowering in Arabidopsis	PLOS ONE			English	Article							LOCUS-C; HISTONE H2A; EXPRESSION; CHROMATIN; COMPLEX; FLC; VERNALIZATION; UBIQUITYLATION; REPRESSION; PATTERNS	Polycomb group protein (PcG)-mediated gene silencing is emerging as an essential developmental regulatory mechanism in eukaryotic organisms. PcGs inactivate or maintain the silenced state of their target chromatin by forming complexes, including Polycomb Repressive Complex 1 (PRC1) and 2 (PRC2). Three PRC2 complexes have been identified and characterized in Arabidopsis; of these, the EMF and VRN complexes suppress flowering by catalyzing the trimethylation of lysine 27 on histone H3 of FLOWER LOCUS T (FT) and FLOWER LOCUS C (FLC). However, little is known about the role of PRC1 in regulating the floral transition, although AtRING1A, AtRING1B, AtBMI1A, and AtBMI1B are believed to regulate shoot apical meristem and embryonic development as components of PRC1. Moreover, among the five RING finger PcGs in the Arabidopsis genome, four have been characterized. Here, we report that the fifth, AtBMI1C, is a novel, ubiquitously expressed nuclear PcG protein and part of PRC1, which is evolutionarily conserved with Psc and BMI1. Overexpression of AtBMI1C caused increased H2A monoubiquitination and flowering defects in Arabidopsis. Both the suppression of FLC and activation of FT were observed in AtBMI1C-overexpressing lines, resulting in early flowering. No change in the H3K27me3 level in FLC chromatin was detected in an AtBMI1C-overexpressing line. Our results suggest that AtBMI1C participates in flowering time control by regulating the expression of FLC; moreover, the repression of FLC by AtBMI1C is not due to the activity of PRC2. Instead, it is likely the result of PRC1 activity, into which AtBMI1C is integrated.	[Li, Wei; Wang, Zheng; Li, Jian; Cui, Sujuan; Ma, Ligeng] Hebei Normal Univ, Coll Biol Sci, Hebei Key Lab Mol Cell Biol, Shijiazhuang, Hebei, Peoples R China; [Wang, Zheng; Li, Jian; Yang, Hongchun; Wang, Xiaoxue] Natl Inst Biol Sci, Beijing, Peoples R China	Hebei Normal University; National Institute of Biological Sciences, Beijing	Li, W (corresponding author), Hebei Normal Univ, Coll Biol Sci, Hebei Key Lab Mol Cell Biol, Shijiazhuang, Hebei, Peoples R China.	xiaoxuewang6@163.com; ligeng.ma@mail.hebtu.edu.cn		Yang, Hongchun/0000-0002-8265-3958	China MOST [2008105]; Hebei Province Key Laboratory [109960121D]	China MOST(Ministry of Science and Technology, China); Hebei Province Key Laboratory	This work was supported by grants from the China MOST 863 Project (to LM, 2008105) and the Hebei Province Key Laboratory Program (to LM, 109960121D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Bratzel F, 2010, CURR BIOL, V20, P1853, DOI 10.1016/j.cub.2010.09.046; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cao Y, 2008, PLANT CELL, V20, P2586, DOI 10.1105/tpc.108.062760; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; He YH, 2005, TRENDS PLANT SCI, V10, P30, DOI 10.1016/j.tplants.2004.11.003; Hennig L, 2009, TRENDS GENET, V25, P414, DOI 10.1016/j.tig.2009.07.002; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; JURGENS G, 1985, NATURE, V316, P153, DOI 10.1038/316153a0; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; LINCOLN C, 1994, PLANT CELL, V6, P1859, DOI 10.1105/tpc.6.12.1859; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Luo M, 2000, P NATL ACAD SCI USA, V97, P10637, DOI 10.1073/pnas.170292997; Makarevich G, 2006, EMBO REP, V7, P947, DOI 10.1038/sj.embor.7400760; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; Michaels SD, 2005, PLANT PHYSIOL, V137, P149, DOI 10.1104/pp.104.052811; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; Sanchez-Pulido L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-308; Sawarkar R, 2010, DEV CELL, V19, P651, DOI 10.1016/j.devcel.2010.10.012; Schonrock N, 2006, GENE DEV, V20, P1667, DOI 10.1101/gad.377206; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Sheldon CC, 2008, P NATL ACAD SCI USA, V105, P2214, DOI 10.1073/pnas.0711453105; Spillane C, 2000, CURR BIOL, V10, P1535, DOI 10.1016/S0960-9822(00)00839-3; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRUERNIT E, 1995, PLANTA, V196, P564, DOI 10.1007/BF00203657; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Xu L, 2008, CURR BIOL, V18, P1966, DOI 10.1016/j.cub.2008.11.019; Yoshida N, 2001, PLANT CELL, V13, P2471, DOI 10.1105/tpc.13.11.2471; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283	43	29	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21364	10.1371/journal.pone.0021364	http://dx.doi.org/10.1371/journal.pone.0021364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701597	Green Published, Green Submitted, gold			2022-12-25	WOS:000291983800044
J	Rao, JU; Shah, KB; Puttaiah, J; Rudraiah, M				Rao, Jyotsna U.; Shah, Kunal B.; Puttaiah, Jayaram; Rudraiah, Medhamurthy			Gene Expression Profiling of Preovulatory Follicle in the Buffalo Cow: Effects of Increased IGF-I Concentration on Periovulatory Events	PLOS ONE			English	Article							GROWTH-FACTOR-I; BOVINE GRANULOSA-CELLS; MESSENGER-RIBONUCLEIC-ACID; VASCULAR ENDOTHELIAL-CELLS; FACTOR BINDING PROTEIN-4; INDUCED UP-REGULATION; GONADOTROPIN SURGE; STIMULATING-HORMONE; DOMINANT FOLLICLE; LUTEINIZING-HORMONE	The preovulatory follicle in response to gonadotropin surge undergoes dramatic biochemical, and morphological changes orchestrated by expression changes in hundreds of genes. Employing well characterized bovine preovulatory follicle model, granulosa cells (GCs) and follicle wall were collected from the preovulatory follicle before, 1, 10 and 22 h post peak LH surge. Microarray analysis performed on GCs revealed that 450 and 111 genes were differentially expressed at 1 and 22 h post peak LH surge, respectively. For validation, qPCR and immunocytochemistry analyses were carried out for some of the differentially expressed genes. Expression analysis of many of these genes showed distinct expression patterns in GCs and the follicle wall. To study molecular functions and genetic networks, microarray data was analyzed using Ingenuity Pathway Analysis which revealed majority of the differentially expressed genes to cluster within processes like steroidogenesis, cell survival and cell differentiation. In the ovarian follicle, IGF-I is established to be an important regulator of the above mentioned molecular functions. Thus, further experiments were conducted to verify the effects of increased intrafollicular IGF-I levels on the expression of genes associated with the above mentioned processes. For this purpose, buffalo cows were administered with exogenous bGH to transiently increase circulating and intrafollicular concentrations of IGF-I. The results indicated that increased intrafollicular concentrations of IGF-I caused changes in expression of genes associated with steroidogenesis (StAR, SRF) and apoptosis (BCL-2, FKHR, PAWR). These results taken together suggest that onset of gonadotropin surge triggers activation of various biological pathways and that the effects of growth factors and peptides on gonadotropin actions could be examined during preovulatory follicle development.	[Rao, Jyotsna U.; Shah, Kunal B.; Puttaiah, Jayaram; Rudraiah, Medhamurthy] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Rao, JU (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	rmm@mrdg.iisc.ernet.in			NAIP-ICAR [NAIP/C4/C1056]; DBT [BT/PR5362/AAQ/01/208/2004]	NAIP-ICAR(Indian Council of Agricultural Research (ICAR)); DBT(Department of Biotechnology (DBT) India)	This work was supported by NAIP-ICAR (NAIP/C4/C1056) (http://www.naip.icar.org.in/project.html) and DBT (BT/PR5362/AAQ/01/208/2004) (http://dbtindia.nic.in/uniquepage.asp?id_pk=68). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DT, 1996, BIOL REPROD, V54, P331, DOI 10.1095/biolreprod54.2.331; Austin EJ, 2001, BIOL REPROD, V64, P839, DOI 10.1095/biolreprod64.3.839; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Bakke LJ, 2004, BIOL REPROD, V71, P605, DOI 10.1095/biolreprod.104.027185; Bakke LJ, 2002, BIOL REPROD, V66, P1627, DOI 10.1095/biolreprod66.6.1627; Bedard J, 2003, MOL REPROD DEV, V64, P152, DOI 10.1002/mrd.10239; Beg MA, 2003, REPRODUCTION, V125, P847, DOI 10.1530/reprod/125.6.847; Beg MA, 2001, BIOL REPROD, V64, P432, DOI 10.1095/biolreprod64.2.432; Bridges PJ, 2007, MOL CELL ENDOCRINOL, V263, P1, DOI 10.1016/j.mce.2006.08.002; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cao MJ, 2006, REPRODUCTION, V131, P125, DOI 10.1530/rep.1.00849; Chrysis D, 2001, J NEUROSCI, V21, P1481, DOI 10.1523/JNEUROSCI.21-05-01481.2001; Claussen M, 1997, ENDOCRINOLOGY, V138, P3797, DOI 10.1210/en.138.9.3797; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; DeClerck YA, 1996, ENZYME PROTEIN, V49, P72, DOI 10.1159/000468617; delaSota RL, 1996, BIOL REPROD, V55, P803, DOI 10.1095/biolreprod55.4.803; Dow MPD, 2002, REPRODUCTION, V123, P711, DOI 10.1530/reprod/123.5.711; Dow MPD, 2002, BIOL REPROD, V66, P1413, DOI 10.1095/biolreprod66.5.1413; ECHTERNKAMP SE, 1994, BIOL REPROD, V51, P971, DOI 10.1095/biolreprod51.5.971; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; ENGELHARDT H, 1991, MOL CELL ENDOCRINOL, V75, P237, DOI 10.1016/0303-7207(91)90166-P; Evans ACO, 2004, BIOL REPROD, V70, P1475, DOI 10.1095/biolreprod.103.025114; Fan HY, 2010, MOL ENDOCRINOL, V24, P1529, DOI 10.1210/me.2010-0141; Fayad T, 2004, BIOL REPROD, V70, P523, DOI 10.1095/biolreprod.103.021709; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Forde N, 2008, PHYSIOL GENOMICS, V33, P193, DOI 10.1152/physiolgenomics.00274.2007; Fortune JE, 2001, BIOL REPROD, V65, P112, DOI 10.1095/biolreprod65.1.112; Funston RN, 1996, BIOL REPROD, V55, P1390, DOI 10.1095/biolreprod55.6.1390; Ginther OJ, 2004, BIOL REPROD, V70, P99, DOI 10.1095/biolreprod.103.021949; GONG JG, 1993, J ENDOCRINOL, V139, P67, DOI 10.1677/joe.0.1390067; Gonzalez IH, 2007, APOPTOSIS, V12, P769, DOI 10.1007/s10495-006-0019-7; Grado-Ahuir JA, 2009, J ANIM SCI, V87, P1921, DOI 10.2527/jas.2008-1222; Harlow CR, 2002, MOL CELL ENDOCRINOL, V187, P23, DOI 10.1016/S0303-7207(01)00702-X; Henry SP, 2001, J BIOL CHEM, V276, P12212, DOI 10.1074/jbc.M011290200; Hilmi C, 2008, J INVEST DERMATOL, V128, P1499, DOI 10.1038/sj.jid.5701185; HOLTORF AP, 1989, ENDOCRINOLOGY, V125, P2612, DOI 10.1210/endo-125-5-2612; HSIEH CL, 1989, SOMAT CELL MOLEC GEN, V15, P579, DOI 10.1007/BF01534919; Hsieh M, 2002, ENDOCRINOLOGY, V143, P898, DOI 10.1210/en.143.3.898; Hu CL, 2004, MOL ENDOCRINOL, V18, P326, DOI 10.1210/me.2003-0178; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwashita M, 1998, MOL HUM REPROD, V4, P401, DOI 10.1093/molehr/4.4.401; Jainudeen M. R., 1993, P315; Ji W, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh084; Jo M, 2002, BIOL REPROD, V67, P1981, DOI 10.1095/biolreprod.102.004366; Jyotsna UR, 2009, ANIM REPROD SCI, V113, P71, DOI 10.1016/j.anireprosci.2008.08.001; KEEL BA, 1995, ENDOCRINOLOGY, V136, P1197, DOI 10.1210/en.136.3.1197; Kirby CJ, 1996, BIOL REPROD, V55, P996, DOI 10.1095/biolreprod55.5.996; Klipper E, 2009, ENDOCRINOLOGY, V150, P413, DOI 10.1210/en.2008-0697; Kolle S, 1998, BIOL REPROD, V59, P836, DOI 10.1095/biolreprod59.4.836; Komar CM, 2001, BIOL REPROD, V64, P1797, DOI 10.1095/biolreprod64.6.1797; Li QL, 2009, REPRODUCTION, V137, P297, DOI 10.1530/REP-08-0308; Li QL, 2004, REPRODUCTION, V128, P555, DOI 10.1530/rep.1.00282; Lijnen HR, 1998, ARTERIOSCL THROM VAS, V18, P1035, DOI 10.1161/01.ATV.18.7.1035; Liu HF, 2007, BIOINFORMATICS, V23, P2385, DOI 10.1093/bioinformatics/btm360; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; LORENZO PL, 1994, J REPROD FERTIL, V101, P697, DOI 10.1530/jrf.0.1010697; Madan P, 2003, BIOL REPROD, V69, P1506, DOI 10.1095/biolreprod.102.013714; Makowski GS, 1998, INFLAMMATION, V22, P287, DOI 10.1023/A:1022300216202; Manna PR, 2006, MOL ENDOCRINOL, V20, P362, DOI 10.1210/me.2004-0526; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; MCARDLE CA, 1991, MOL CELL ENDOCRINOL, V78, P211, DOI 10.1016/0303-7207(91)90125-C; McLean PG, 2002, CIRC RES, V90, P465, DOI 10.1161/hh0402.105372; MEIDAN R, 1992, BIOL REPROD, V46, P715, DOI 10.1095/biolreprod46.4.715; Mihm M, 2008, REPRODUCTION, V135, P253, DOI 10.1530/REP-06-0193; Mihm M, 1997, BIOL REPROD, V57, P1328, DOI 10.1095/biolreprod57.6.1328; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Mirza H, 1996, J CLIN INVEST, V97, P1705, DOI 10.1172/JCI118597; Nagyova E, 1999, BIOL REPROD, V61, P569, DOI 10.1095/biolreprod61.3.569; Nakajima M, 2007, J BIOL CHEM, V282, P32185, DOI 10.1074/jbc.M700522200; Natesampillai S, 2008, AM J PHYSIOL-ENDOC M, V294, pE385, DOI 10.1152/ajpendo.00480.2007; Nazar RN, 2010, MOL BIOTECHNOL, V44, P8, DOI 10.1007/s12033-009-9212-6; Ndiaye K, 2005, BIOL REPROD, V73, P324, DOI 10.1095/biolreprod.104.038026; Nemcova L, 2007, BIOL REPROD, V76, P1016, DOI 10.1095/biolreprod.106.057927; Oshlack A, 2007, BIOINFORMATICS, V23, P1235, DOI 10.1093/bioinformatics/btm111; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Porter DA, 2001, REPRODUCTION, V121, P561, DOI 10.1530/rep.0.1210561; Priyanka S, 2009, ENDOCRINOLOGY, V150, P1473, DOI 10.1210/en.2008-0840; Pru JK, 2001, MOL ENDOCRINOL, V15, P845, DOI 10.1210/me.15.6.845; Quirk S M, 2004, J Anim Sci, V82 E-Suppl, pE40; Quirk SM, 2004, ENDOCRINOLOGY, V145, P5033, DOI 10.1210/en.2004-0140; Quirk SM, 2006, J ENDOCRINOL, V189, P441, DOI 10.1677/joe.1.06549; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rhoads ML, 2008, J DAIRY SCI, V91, P1802, DOI 10.3168/jds.2007-0664; Rhodes FM, 2001, REPRODUCTION, V122, P561, DOI 10.1530/rep.0.1220561; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Rieger D, 1998, J REPROD FERTIL, V112, P123, DOI 10.1530/jrf.0.1120123; Rivera GM, 2003, ENDOCRINOLOGY, V144, P2977, DOI 10.1210/en.2002-0077; Rivera GM, 2003, ENDOCRINOLOGY, V144, P437, DOI 10.1210/en.2002-220657; Rivera GM, 2001, BIOL REPROD, V65, P102, DOI 10.1095/biolreprod65.1.102; Robinson RS, 2009, REPRODUCTION, V138, P869, DOI 10.1530/REP-09-0283; SCHAMS D, 1988, J ENDOCRINOL, V116, P97, DOI 10.1677/joe.0.1160097; Schuur ER, 2001, J BIOL CHEM, V276, P33554, DOI 10.1074/jbc.M105555200; Sekar N, 2000, MOL CELL ENDOCRINOL, V159, P25, DOI 10.1016/S0303-7207(99)00203-8; Sekar N, 2000, ENDOCRINOLOGY, V141, P3983, DOI 10.1210/en.141.11.3983; Sharma SC, 2000, J BIOL CHEM, V275, P33718, DOI 10.1074/jbc.M003555200; Shi F, 2003, J ENDOCRINOL, V179, P195, DOI 10.1677/joe.0.1790195; Shimo T, 1999, J BIOCHEM-TOKYO, V126, P137, DOI 10.1093/oxfordjournals.jbchem.a022414; Singh B, 1997, BIOL REPROD, V56, P1370, DOI 10.1095/biolreprod56.6.1370; SIROIS J, 1994, ENDOCRINOLOGY, V135, P841, DOI 10.1210/en.135.3.841; Souza AH, 2009, THERIOGENOLOGY, V72, P271, DOI 10.1016/j.theriogenology.2009.02.016; Spicer LJ, 2007, BIOL REPROD, V77, P18, DOI 10.1095/biolreprod.106.058230; Spicer LJ, 1997, BIOL REPROD, V56, P1458, DOI 10.1095/biolreprod56.6.1458; SPICER LJ, 1988, BIOL REPROD, V39, P573, DOI 10.1095/biolreprod39.3.573; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; Stewart RE, 1995, J ANIM SCI, V73, P3719; Sudo N, 2007, MOL CELL ENDOCRINOL, V264, P197, DOI 10.1016/j.mce.2006.10.011; Tajima K, 2005, ENDOCRINOLOGY, V146, P2903, DOI 10.1210/en.2005-0093; TILLY JL, 1995, ENDOCRINOLOGY, V136, P232, DOI 10.1210/en.136.1.232; Tomoeda M, 2008, BIOCHEM BIOPH RES CO, V371, P191, DOI 10.1016/j.bbrc.2008.03.158; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Yadav VK, 2002, BIOL REPROD, V67, P752, DOI 10.1095/biolreprod.102.004077; Yang MY, 2000, BIOL REPROD, V62, P1209, DOI 10.1095/biolreprod62.5.1209; Zhao HH, 2001, J BIOL CHEM, V276, P27907, DOI 10.1074/jbc.M104278200; Zheng XF, 2009, REPRODUCTION, V137, P969, DOI 10.1530/REP-08-0365	115	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20754	10.1371/journal.pone.0020754	http://dx.doi.org/10.1371/journal.pone.0020754			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701678	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000291983800012
J	Elliott, J; Pedler, A; Kenardy, J; Galloway, G; Jull, G; Sterling, M				Elliott, James; Pedler, Ashley; Kenardy, Justin; Galloway, Graham; Jull, Gwendolen; Sterling, Michele			The Temporal Development of Fatty Infiltrates in the Neck Muscles Following Whiplash Injury: An Association with Pain and Posttraumatic Stress	PLOS ONE			English	Article							RESONANCE-IMAGING ASSESSMENT; CERVICAL EXTENSOR MUSCLES; PROGNOSTIC-FACTORS; ADIPOSE-TISSUE; DISORDERS WAD; ACTIVATION; DISABILITY; LIGAMENTS; SYMPTOMS	Background: Radiological findings associated with poor recovery following whiplash injury remain elusive. Muscle fatty infiltrates (MFI) in the cervical extensors on magnetic resonance imaging (MRI) in patients with chronic pain have been observed. Their association with specific aspects of pain and psychological factors have yet to be explored longitudinally. Materials and Findings: 44 subjects with whiplash injury were enrolled at 4 weeks post-injury and classified at 6 months using scores on the Neck Disability Index as recovered, mild and moderate/severe. A measure for MFI and patient self-report of pain, loss of cervical range of movement and posttraumatic stress disorder (PTSD) were collected at 4 weeks, 3 months and 6 months post-injury. The effects of time and group and the interaction of time by group on MFI were determined. We assessed the mediating effect of posttraumatic stress and cervical range of movement on the longitudinal relationship between initial pain intensity and MFI. There was no difference in MFI across all groups at enrollment. MFI values increased in the moderate/severe group and were significantly higher in comparison to the recovered and mild groups at 3 and 6 months. No differences in MFI values were found between the mild and recovered groups. Initial severity of PTSD symptoms mediated the relationship between pain intensity and MFI at 6 months. Initial ROM loss did not. Conclusions: MFI in the cervical extensors occur soon following whiplash injury and suggest the possibility for the occurrence of a more severe injury with subsequent PTSD in patients with persistent symptoms.	[Elliott, James; Jull, Gwendolen] Univ Queensland, Ctr Clin Res Excellence Spinal Pain Injury & Hlth, Sch Hlth & Rehabil Sci, Div Physiotherapy, Brisbane, Qld, Australia; [Elliott, James; Pedler, Ashley; Kenardy, Justin; Sterling, Michele] Univ Queensland, Ctr Natl Res Disabil & Rehabil Med, Brisbane, Qld, Australia; [Elliott, James; Galloway, Graham] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Elliott, James] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA	University of Queensland; University of Queensland; University of Queensland; Northwestern University; Feinberg School of Medicine	Elliott, J (corresponding author), Univ Queensland, Ctr Clin Res Excellence Spinal Pain Injury & Hlth, Sch Hlth & Rehabil Sci, Div Physiotherapy, Brisbane, Qld, Australia.	j-elliott@northwestern.edu	Galloway, Graham/D-2009-2011; Sterling, Michele/F-1679-2010; Jull, Gwendolen/F-4233-2010; Pedler, Ashley/B-5034-2011; Kenardy, Justin A/H-6603-2014; Kenardy, Justin/F-2085-2010	Galloway, Graham/0000-0002-0805-2775; Sterling, Michele/0000-0003-1772-2248; Jull, Gwendolen/0000-0003-2670-1318; Pedler, Ashley/0000-0003-0474-7155; Kenardy, Justin A/0000-0001-9475-8450; 	The Australian Physiotherapy Research Foundation; The Centre for National Research on Disability and Rehabilitation Medicine (CONROD), University of Queensland; National Health and Medical Research Council (NHMRC), Australia; The Centre for Research Excellence in Spinal Pain, Injury and Health (CCRE-Spine), University of Queensland	The Australian Physiotherapy Research Foundation; The Centre for National Research on Disability and Rehabilitation Medicine (CONROD), University of Queensland(University of Queensland); National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); The Centre for Research Excellence in Spinal Pain, Injury and Health (CCRE-Spine), University of Queensland(University of Queensland)	The Australian Physiotherapy Research Foundation and The Centre for National Research on Disability and Rehabilitation Medicine (CONROD), University of Queensland provided funding for this study. MS receives a fellowship from the National Health and Medical Research Council (NHMRC), Australia. JE received a fellowship from The Centre for Research Excellence in Spinal Pain, Injury and Health (CCRE-Spine), University of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDMAN B, 1986, 30 ANN C ASS ADV AUT, P439; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BLINCOE L, 2002, 194 NSTSA; Buitenhuis J, 2006, J PSYCHOSOM RES, V61, P681, DOI 10.1016/j.jpsychores.2006.07.008; Carroll LJ, 2009, J MANIP PHYSIOL THER, V32, pS97, DOI 10.1016/j.jmpt.2008.11.014; Chien A, 2010, MANUAL THER, V15, P48, DOI 10.1016/j.math.2009.05.012; COTE P, 2001, SPINE, V26, P445; DeLeo JA, 2001, PAIN, V90, P1, DOI 10.1016/S0304-3959(00)00490-5; Dulor JP, 1998, FEBS LETT, V439, P89, DOI 10.1016/S0014-5793(98)01216-2; Elliott J, 2008, CLIN RADIOL, V63, P681, DOI 10.1016/j.crad.2007.11.011; Elliott J, 2006, SPINE, V31, pE847, DOI 10.1097/01.brs.0000240841.07050.34; Elliott J, 2009, EUR SPINE J, V18, P1371, DOI 10.1007/s00586-009-1130-6; Ferrari R, 2001, J NEUROL NEUROSUR PS, V70, P722, DOI 10.1136/jnnp.70.6.722; Floss T, 1997, GENE DEV, V11, P2040, DOI 10.1101/gad.11.16.2040; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hubbard RD, 2005, SPINE, V30, P1924, DOI 10.1097/01.brs.0000176239.72928.00; INGEMANNHANSEN T, 1977, SCAND J REHABIL MED, V9, P67; Jenkins RR, 2000, AM J CLIN NUTR, V72, p670S, DOI 10.1093/ajcn/72.2.670S; Joslin CC, 2004, J BONE JOINT SURG BR, V86B, P1032, DOI 10.1302/0301-620X.86B7.14633; Kamper SJ, 2008, PAIN, V138, P617, DOI 10.1016/j.pain.2008.02.019; Kongsted A, 2008, EUR J PAIN, V12, P455, DOI 10.1016/j.ejpain.2007.07.008; Krakenes J, 2006, SPINE, V31, P2820, DOI 10.1097/01.brs.0000245871.15696.1f; Lee KE, 2008, J NEUROTRAUM, V25, P1383, DOI 10.1089/neu.2008.0700; Lefaucheur JP, 1996, J NEUROIMMUNOL, V70, P37, DOI 10.1016/S0165-5728(96)00099-9; MACINTYRE DL, 1995, SPORTS MED, V20, P24, DOI 10.2165/00007256-199520010-00003; Manini TM, 2007, AM J CLIN NUTR, V85, P377, DOI 10.1093/ajcn/85.2.377; Marshall RD, 2002, PSYCHIAT CLIN N AM, V25, P385, DOI 10.1016/S0193-953X(01)00005-3; Myran R, 2008, SPINE, V33, P2012, DOI 10.1097/BRS.0b013e31817bb0bd; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Nieto R, 2009, EUR J PAIN, V13, P518, DOI 10.1016/j.ejpain.2008.06.005; Paddon-Jones D, 2006, J CLIN ENDOCR METAB, V91, P4836, DOI 10.1210/jc.2006-0651; Passatore M, 2006, EUR J APPL PHYSIOL, V98, P423, DOI 10.1007/s00421-006-0312-8; Pettersson K, 1997, SPINE, V22, P283, DOI 10.1097/00007632-199702010-00010; Sara RPA, 2006, MANUAL THER, V11, P321, DOI 10.1016/j.math.2005.09.001; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Ronnen HR, 1996, RADIOLOGY, V201, P93, DOI 10.1148/radiology.201.1.8816527; Spitzer WO, 1995, SPINE S8, V20, P1, DOI DOI 10.1097/00007632-199504151-00001; Stalnacke BM, 2009, J REHABIL MED, V41, P353, DOI 10.2340/16501977-0349; Sterling M, 2005, PAIN, V114, P141, DOI 10.1016/j.pain.2004.12.005; Sterling M, 2003, PAIN, V104, P509, DOI 10.1016/S0304-3959(03)00078-2; STERLING M, 2006, PAIN; Sullivan MJL, 2009, PAIN, V145, P325, DOI 10.1016/j.pain.2009.06.031; TEBOUL L, 1995, J BIOL CHEM, V270, P28183, DOI 10.1074/jbc.270.47.28183; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; VETTI N, 2010, SPINE PHILA PA 1976; Walton DM, 2009, J ORTHOP SPORT PHYS, V39, P334, DOI 10.2519/jospt.2009.2765	47	71	74	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21194	10.1371/journal.pone.0021194	http://dx.doi.org/10.1371/journal.pone.0021194			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698170	Green Published, gold			2022-12-25	WOS:000291734100067
J	Jones, CL; Weiss, DS				Jones, Crystal L.; Weiss, David S.			TLR2 Signaling Contributes to Rapid Inflammasome Activation during F. novicida Infection	PLOS ONE			English	Article							VACCINE STRAIN INFECTION; INNATE IMMUNE-RESPONSE; GAMMA-INDUCING FACTOR; FRANCISELLA-TULARENSIS; AIM2 INFLAMMASOME; RECEPTOR AGONISTS; DENDRITIC CELLS; MELANOMA 2; RECOGNITION; REGULATOR	Background: Early detection of microorganisms by the innate immune system is provided by surface-expressed and endosomal pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs). Detection of microbial components by TLRs initiates a signaling cascade leading to the expression of proinflammatory cytokines including IL-6 and IL-1 beta. Some intracellular bacteria subvert the TLR response by rapidly escaping the phagosome and entering the cytosol. However, these bacteria may be recognized by the inflammasome, a multi-protein complex comprised of a sensor protein, ASC and the cysteine protease caspase-1. Inflammasome activation leads to release of the proinflammatory cytokines IL-1 beta and IL-18 and death of the infected cell, an important host defense that eliminates the pathogen's replicative niche. While TLRs and inflammasomes are critical for controlling bacterial infections, it is unknown whether these distinct host pathways cooperate to activate defenses against intracellular bacteria. Methodology/Significant Findings: Using the intracellular bacterium Francisella novicida as a model, we show that TLR2(-/-) macrophages exhibited delayed inflammasome activation compared to wild-type macrophages as measured by inflammasome assembly, caspase-1 activation, cell death and IL-18 release. TLR2 also contributed to inflammasome activation in response to infection by the cytosolic bacterium Listeria monocytogenes. Components of the TLR2 signaling pathway, MyD88 and NF-kappa B, were required for rapid inflammasome activation. Furthermore, TLR2(-/-) mice exhibited lower levels of cell death, caspase-1 activation, and IL-18 production than wild-type mice upon F. novicida infection. Conclusions/Significance: These results show that TLR2 is required for rapid inflammasome activation in response to infection by cytosolic bacterial pathogens. In addition to further characterizing the role of TLR2 in host defense, these findings broaden our understanding of how the host integrates signals from spatiotemporally separated PRRs to coordinate an innate response against intracellular bacteria.	[Jones, Crystal L.; Weiss, David S.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Jones, Crystal L.; Weiss, David S.] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA; [Weiss, David S.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA	Emory University; Emory University; Emory University	Jones, CL (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	david.weiss@emory.edu			National Institutes of Health (NIH) from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense [U54 AI057157]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant #U54 AI057157 from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense to DSW. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abplanalp AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007920; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Baron GS, 1998, MOL MICROBIOL, V29, P247, DOI 10.1046/j.1365-2958.1998.00926.x; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Cole LE, 2008, J IMMUNOL, V180, P6885, DOI 10.4049/jimmunol.180.10.6885; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Cole LE, 2006, J IMMUNOL, V176, P6888, DOI 10.4049/jimmunol.176.11.6888; Cole LE, 2010, J LEUKOCYTE BIOL, V87, P275, DOI 10.1189/jlb.0909619; Collazo CM, 2006, MICROBES INFECT, V8, P779, DOI 10.1016/j.micinf.2005.09.014; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fritz JH, 2005, EUR J IMMUNOL, V35, P2459, DOI 10.1002/eji.200526286; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; OWEN CR, 1964, J BACTERIOL, V87, P676, DOI 10.1128/JB.87.3.676-683.1964; Ozoren N, 2006, J IMMUNOL, V176, P4337, DOI 10.4049/jimmunol.176.7.4337; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2010, MICROBES INFECT, V12, P126, DOI 10.1016/j.micinf.2009.11.003; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Sumikawa Y, 2006, MICROBES INFECT, V8, P1513, DOI 10.1016/j.micinf.2006.01.008; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Thakran S, 2008, J BIOL CHEM, V283, P3751, DOI 10.1074/jbc.M706854200; Uehara A, 2005, CELL MICROBIOL, V7, P53, DOI 10.1111/j.1462-5822.2004.00433.x; Ulland TK, 2010, J IMMUNOL, V185, P2670, DOI 10.4049/jimmunol.1001610; van Heel DA, 2005, EUR J IMMUNOL, V35, P2471, DOI 10.1002/eji.200526296; Weiss DS, 2007, ANN NY ACAD SCI, V1105, P219, DOI 10.1196/annals.1409.005; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Wickstrum JR, 2009, INFECT IMMUN, V77, P4827, DOI 10.1128/IAI.00246-09; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x	51	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20609	10.1371/journal.pone.0020609	http://dx.doi.org/10.1371/journal.pone.0020609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698237	gold, Green Published, Green Submitted			2022-12-25	WOS:000291734100010
J	Vazeille, E; Bringer, MA; Gardarin, A; Chambon, C; Becker-Pauly, C; Pender, SLF; Jakob, C; Muller, S; Lottaz, D; Darfeuille-Michaud, A				Vazeille, Emilie; Bringer, Marie-Agnes; Gardarin, Aurelie; Chambon, Christophe; Becker-Pauly, Christoph; Pender, Sylvia L. F.; Jakob, Christine; Mueller, Stefan; Lottaz, Daniel; Darfeuille-Michaud, Arlette			Role of Meprins to Protect Ileal Mucosa of Crohn's Disease Patients from Colonization by Adherent-Invasive E. coli	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIAL-CELLS; URINARY-TRACT-INFECTIONS; ESCHERICHIA-COLI; ALPHA-SUBUNIT; STRAIN LF82; METALLOPROTEASE MEPRIN; ACTIVATION MECHANISM; BETA-SUBUNIT; TYPE-1 PILI	Ileal lesions in Crohn's disease (CD) patients are colonized by pathogenic adherent-invasive Escherichia coli (AIEC) able to adhere to and invade intestinal epithelial cells (IEC), and to survive within macrophages. The interaction of AIEC with IEC depends on bacterial factors mainly type 1 pili, flagella, and outer membrane proteins. In humans, proteases can act as host defence mechanisms to counteract bacterial colonization. The protease meprin, composed of multimeric complexes of the two subunits alpha and beta, is abundantly expressed in IECs. Decreased levels of this protease correlate with the severity of the inflammation in patients with inflammatory bowel disease. The aim of the present study was to analyze the ability of meprin to modulate the interaction of AIEC with IECs. In patients with ileal CD we observed decreased levels of meprins, in particular that of meprin beta. Dose-dependent inhibition of the abilities of AIEC strain LF82 to adhere to and invade intestinal epithelial T84 cells was observed when bacteria were pre-treated with both exogenous meprin alpha and meprin beta. Dose-dependent proteolytic degradation of type 1 pili was observed in the presence of active meprins, but not with heatinactivated meprins, and pretreatment of AIEC bacteria with meprins impaired their ability to bind mannosylated host receptors and led to decreased secretion of the pro-inflammatory cytokine IL-8 by infected T84 cells. Thus, decreased levels of protective meprins as observed in CD patients may contribute to increased AIEC colonization.	[Vazeille, Emilie; Bringer, Marie-Agnes; Gardarin, Aurelie; Darfeuille-Michaud, Arlette] JE2526 Univ Auvergne, Clermont Univ, Clermont Ferrand, France; [Vazeille, Emilie; Bringer, Marie-Agnes; Gardarin, Aurelie; Darfeuille-Michaud, Arlette] INRA USC 2018, Clermont Ferrand, France; [Chambon, Christophe] INRA, F-63122 St Genes Champanelle, France; [Becker-Pauly, Christoph] Johannes Gutenberg Univ Mainz, Inst Zool Cell & Matrix Biol, Mainz, Germany; [Pender, Sylvia L. F.] Univ Southampton, Sch Med, Div Infect Inflammat & Immun, Southampton, Hants, England; [Jakob, Christine; Mueller, Stefan] Univ Bern, Dept Clin Res, Div Gastroenterol, Bern, Switzerland; [Lottaz, Daniel] Univ Bern, Inselspital, Dept Rheumatol Clin Immunol & Allergol, CH-3010 Bern, Switzerland	INRAE; INRAE; Johannes Gutenberg University of Mainz; University of Southampton; University of Bern; University of Bern; University Hospital of Bern	Vazeille, E (corresponding author), JE2526 Univ Auvergne, Clermont Univ, Clermont Ferrand, France.	arlette.darfeuille-michaud@u-clermont1.fr	Becker-Pauly, Christoph/B-7569-2011; chambon, christophe/A-1788-2017; Bringer, Marie-Agnès/Q-1752-2018	chambon, christophe/0000-0003-0357-9807; Bringer, Marie-Agnès/0000-0002-3746-4998	Ministere de la Recherche et de la Technologie [JE2526]; INRA [USC 2018]; Association F. Aupetit (AFA); European Community [200931]	Ministere de la Recherche et de la Technologie; INRA; Association F. Aupetit (AFA); European Community(European Commission)	The research leading to these results has received funding from the Ministere de la Recherche et de la Technologie (JE2526), by the INRA (USC 2018), by grants from the Association F. Aupetit (AFA) and from the European Community's Seventh Framework Programme (FP7) under agreement No 200931 (project IBDase). IBDase Partners are D. Lottaz (University of Bern, Switzerland), S. Vermeire (Katholieke Universiteit Leuven, Leuven, Belgium), A. Darfeuille-Michaud (Universite d'Auvergne, Clermont-Ferrand, France), C. Becker-Pauly (Johannes Gutenberg Universitat Mainz, Germany), M. Artieda (Progenika Biopharma, S. A., Spain), M. Rescigno (Istituto Europeo di Oncologia, Italy), G. C. Hansson (University of Gothenburg, Sweden), S. L. F. Pender (University of Southampton, United Kingdom), G. Monteleone (University Tor Vergata of Rome, Italy), K. Leufgen (SCIPROM Sarl, Switzerland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee S, 2009, MUCOSAL IMMUNOL, V2, P220, DOI 10.1038/mi.2009.3; Banerjee S, 2011, AM J PHYSIOL-GASTR L, V300, pG273, DOI 10.1152/ajpgi.00504.2009; Barnich N, 2003, MOL MICROBIOL, V48, P781, DOI 10.1046/j.1365-2958.2003.03468.x; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; Betis F, 2003, INFECT IMMUN, V71, P1068, DOI 10.1128/IAI.71.3.1068-1074.2003; Bond JS, 2005, FEBS LETT, V579, P3317, DOI 10.1016/j.febslet.2005.03.045; Boudeau J, 2001, MOL MICROBIOL, V39, P1272, DOI 10.1046/j.1365-2958.2001.02315.x; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Carvalho FA, 2009, J EXP MED, V206, P2179, DOI 10.1084/jem.20090741; Chassaing B, 2011, J CLIN INVEST, V121, P966, DOI 10.1172/JCI44632; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; EAVESPYLES T, 2007, INT J MED MICROBIOL; Eldering JA, 1997, EUR J BIOCHEM, V247, P920, DOI 10.1111/j.1432-1033.1997.00920.x; GRUNBERG J, 1993, FEBS LETT, V335, P376, DOI 10.1016/0014-5793(93)80422-Q; Hendrixson DR, 2003, MOL MICROBIOL, V47, P607, DOI 10.1046/j.1365-2958.2003.03327.x; Herzog C, 2005, CYTOKINE, V31, P394, DOI 10.1016/j.cyto.2005.06.012; Herzog C, 2009, BIOCHEM BIOPH RES CO, V379, P904, DOI 10.1016/j.bbrc.2008.12.161; Johnson GD, 1997, J BIOL CHEM, V272, P28126, DOI 10.1074/jbc.272.44.28126; Kruse MN, 2004, BIOCHEM J, V378, P383, DOI 10.1042/BJ20031163; Lopez-Boado YS, 2001, J BIOL CHEM, V276, P41417, DOI 10.1074/jbc.M107121200; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; MARTINEZMEDINA M, 2009, INFLAMM BOWEL DIS; Ofek I, 2000, ADV EXP MED BIOL, V485, P183; Ohler A, 2010, BIOL CHEM, V391, P455, DOI 10.1515/BC.2010.023; Rolhion N, 2005, J BACTERIOL, V187, P2286, DOI 10.1128/JB.187.7.2286-2296.2005; Rolhion N, 2007, INFLAMM BOWEL DIS, V13, P1277, DOI 10.1002/ibd.20176; Rolhion N, 2010, GUT, V59, P1355, DOI 10.1136/gut.2010.207456; RUTGEERTS P, 1991, LANCET, V338, P771, DOI 10.1016/0140-6736(91)90663-A; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sasaki M, 2007, LAB INVEST, V87, P1042, DOI 10.1038/labinvest.3700661; Schutte A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008835; Steiner TS, 2000, J CLIN INVEST, V105, P1769, DOI 10.1172/JCI8892; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Villa JP, 2003, BIOCHEM SOC SYMP, V70, P53, DOI 10.1042/bss0700053; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	41	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21199	10.1371/journal.pone.0021199	http://dx.doi.org/10.1371/journal.pone.0021199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698174	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000291734100068
J	Sueyoshi, T; Green, WD; Vinal, K; Woodrum, TS; Moore, R; Negishi, M				Sueyoshi, Tatsuya; Green, William D.; Vinal, Kellie; Woodrum, Tyler S.; Moore, Rick; Negishi, Masahiko			Garlic Extract Diallyl Sulfide (DAS) Activates Nuclear Receptor CAR to Induce the Sult1e1 Gene in Mouse Liver	PLOS ONE			English	Article							CONSTITUTIVE ANDROSTANE RECEPTOR; DRUG-METABOLIZING-ENZYMES; ORGANOSULFUR COMPOUNDS; ESTROGEN SULFOTRANSFERASE; ENHANCER MODULE; 1E1 EXPRESSION; CANCER; RISK; POLYMORPHISMS; CYP1A1	Constituent chemicals in garlic extract are known to induce phase I and phase II enzymes in rodent livers. Here we have utilized Car(+/+) and Car(-/-) mice to demonstrate that the nuclear xenobiotic receptor CAR regulated the induction of the estrogen sulfotransferase Sult1e1 gene by diallyl sulfide (DAS) treatment in mouse liver. DAS treatment caused CAR accumulation in the nucleus, resulting in a remarkable increase of SULT1E1 mRNA (3,200 fold) and protein in the livers of Car(+/+) females but not of Car(-/-) female mice. DAS also induced other CAR-regulated genes such as Cyp2b10, Cyp3a11 and Gadd45 beta. Compared with the rapid increase of these mRNA levels, which began as early as 6 hourrs after DAS treatment, the levels of SULT1E1 mRNA began increasing after 24 hours. This slow response to DAS suggested that CAR required an additional factor to activate the Sult1e1 gene or that this activation was indirect. Despite the remarkable induction of SULT1E1, there was no decrease in the serum levels of endogenous E2 or increase of estrone sulfate while the clearance of exogenously administrated E2 was accelerated in DAS treated mice.	[Sueyoshi, Tatsuya; Green, William D.; Vinal, Kellie; Woodrum, Tyler S.; Moore, Rick; Negishi, Masahiko] Natl Inst Environm Hlth Sci, Pharmacogenet Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Sueyoshi, T (corresponding author), Natl Inst Environm Hlth Sci, Pharmacogenet Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC USA.	sueyoshi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928; Green, William/0000-0001-7472-8756	NIH, National Institute of Environmental Health Sciences (NIEHS) [Zo1Es71005-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040] Funding Source: NIH RePORTER	NIH, National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (NIEHS), Zo1Es71005-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnouti Y, 2008, J PHARMACOL EXP THER, V324, P612, DOI 10.1124/jpet.107.129650; Berges R, 2004, CARCINOGENESIS, V25, P1953, DOI 10.1093/carcin/bgh200; Bianchini F, 2001, ENVIRON HEALTH PERSP, V109, P893; Chang TKH, 2009, AAPS J, V11, P590, DOI 10.1208/s12248-009-9135-y; Choi JY, 2005, CANCER EPIDEM BIOMAR, V14, P1090, DOI 10.1158/1055-9965.EPI-04-0688; di Masi A, 2009, MOL ASPECTS MED, V30, P297, DOI 10.1016/j.mam.2009.04.002; Dong B, 2009, P NATL ACAD SCI USA, V106, P18831, DOI 10.1073/pnas.0909731106; Falany CN, 2009, J STEROID BIOCHEM, V114, P113, DOI 10.1016/j.jsbmb.2009.02.009; FALANY CN, 1995, J STEROID BIOCHEM, V52, P529, DOI 10.1016/0960-0760(95)00015-R; Falany CN, 2005, METHOD PHARMACOL TOX, P341; Fisher CD, 2007, DRUG METAB DISPOS, V35, P995, DOI 10.1124/dmd.106.014340; Fleischauer AT, 2001, J NUTR, V131, p1032S, DOI 10.1093/jn/131.3.1032S; Gong H, 2008, CANCER RES, V68, P7386, DOI 10.1158/0008-5472.CAN-08-1545; Guyonnet D, 2002, CARCINOGENESIS, V23, P1335, DOI 10.1093/carcin/23.8.1335; Guyonnet D, 2001, MUTAT RES-GEN TOX EN, V495, P135, DOI 10.1016/S1383-5718(01)00205-4; He D, 2008, BBA-MOL CELL RES, V1783, P2391, DOI 10.1016/j.bbamcr.2008.08.012; Hirata H, 2008, CANCER-AM CANCER SOC, V112, P1964, DOI 10.1002/cncr.23392; Honkakoski P, 2003, ANN MED, V35, P172, DOI 10.1080/07853890310008224; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520; Kakizaki S, 2008, CURR DRUG METAB, V9, P614, DOI 10.2174/138920008785821666; Kakuta Y, 1997, NAT STRUCT BIOL, V4, P904, DOI 10.1038/nsb1197-904; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kawamoto T, 2000, MOL ENDOCRINOL, V14, P1897, DOI 10.1210/me.14.11.1897; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931-7940.2004; Konno Y, 2008, DRUG METAB PHARMACOK, V23, P8, DOI 10.2133/dmpk.23.8; Ngo SNT, 2007, J NUTR, V137, P2264, DOI 10.1093/jn/137.10.2264; Petrotchenko EV, 1999, J BIOL CHEM, V274, P30019, DOI 10.1074/jbc.274.42.30019; Qatanani M, 2005, CURR DRUG METAB, V6, P329, DOI 10.2174/1389200054633899; Rebbeck TR, 2006, J NATL CANCER I, V98, P1311, DOI 10.1093/jnci/djj360; Song WC, 2001, ANN NY ACAD SCI, V948, P43; SONG WC, 1995, ENDOCRINOLOGY, V136, P2477, DOI 10.1210/en.136.6.2477; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Sugatani J, 2001, HEPATOLOGY, V33, P1232, DOI 10.1053/jhep.2001.24172; Swales K, 2004, MOL ENDOCRINOL, V18, P1589, DOI 10.1210/me.2003-0397; Tong MH, 2005, NAT MED, V11, P153, DOI 10.1038/nm1184; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; Urquhart BL, 2007, J CLIN PHARMACOL, V47, P566, DOI 10.1177/0091270007299930; Wada T, 2009, TRENDS ENDOCRIN MET, V20, P273, DOI 10.1016/j.tem.2009.03.003; Wang HB, 2004, J BIOL CHEM, V279, P29295, DOI 10.1074/jbc.M400580200; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Yamazaki Y, 2007, GUT, V56, P565, DOI 10.1136/gut.2006.093260; Yoshinari K, 2003, FEBS LETT, V548, P17, DOI 10.1016/S0014-5793(03)00720-8; Yoshinari K, 2010, BIOCHEM PHARMACOL, V79, P261, DOI 10.1016/j.bcp.2009.08.008; Zhang P, 2006, CARCINOGENESIS, V27, P2090, DOI 10.1093/carcin/bgl064	47	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21229	10.1371/journal.pone.0021229	http://dx.doi.org/10.1371/journal.pone.0021229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698271	Green Published, gold			2022-12-25	WOS:000291730000064
J	Klaus, A; Yu, S; Plenz, D				Klaus, Andreas; Yu, Shan; Plenz, Dietmar			Statistical Analyses Support Power Law Distributions Found in Neuronal Avalanches	PLOS ONE			English	Article							FLIGHT SEARCH PATTERNS; GIBRATS LAW; CORTICAL NETWORKS; LEVY; LIKELIHOOD; RANGE	The size distribution of neuronal avalanches in cortical networks has been reported to follow a power law distribution with exponent close to -1.5, which is a reflection of long-range spatial correlations in spontaneous neuronal activity. However, identifying power law scaling in empirical data can be difficult and sometimes controversial. In the present study, we tested the power law hypothesis for neuronal avalanches by using more stringent statistical analyses. In particular, we performed the following steps: (i) analysis of finite-size scaling to identify scale-free dynamics in neuronal avalanches, (ii) model parameter estimation to determine the specific exponent of the power law, and (iii) comparison of the power law to alternative model distributions. Consistent with critical state dynamics, avalanche size distributions exhibited robust scaling behavior in which the maximum avalanche size was limited only by the spatial extent of sampling ("finite size" effect). This scale-free dynamics suggests the power law as a model for the distribution of avalanche sizes. Using both the Kolmogorov-Smirnov statistic and a maximum likelihood approach, we found the slope to be close to -1.5, which is in line with previous reports. Finally, the power law model for neuronal avalanches was compared to the exponential and to various heavy-tail distributions based on the Kolmogorov-Smirnov distance and by using a log-likelihood ratio test. Both the power law distribution without and with exponential cut-off provided significantly better fits to the cluster size distributions in neuronal avalanches than the exponential, the lognormal and the gamma distribution. In summary, our findings strongly support the power law scaling in neuronal avalanches, providing further evidence for critical state dynamics in superficial layers of cortex.	[Klaus, Andreas; Yu, Shan; Plenz, Dietmar] NIMH, Sect Crit Brain Dynam, Bethesda, MD 20892 USA; [Klaus, Andreas] Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, S-10401 Stockholm, Sweden; [Klaus, Andreas] Stockholm Brain Inst, Stockholm, Sweden	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Karolinska Institutet	Klaus, A (corresponding author), NIMH, Sect Crit Brain Dynam, Bethesda, MD 20892 USA.	Andreas.Klaus@frontiersin.org	Yu, Shan/S-3123-2017; Klaus, Andreas/B-3392-2009	Klaus, Andreas/0000-0002-4133-351X; yu, shan/0000-0002-4385-6306	NIMH; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002797] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the NIMH Division of Intramural Research Programs. AK was in addition supported by the NIH-Karolinska Institute joint PhD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Eeckhout J, 2004, AM ECON REV, V94, P1429, DOI 10.1257/0002828043052303; Eeckhout J, 2009, AM ECON REV, V99, P1676, DOI 10.1257/aer.99.4.1676; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Goldstein ML, 2004, EUR PHYS J B, V41, P255, DOI 10.1140/epjb/e2004-00316-5; Hald A, 1999, STAT SCI, V14, P214, DOI 10.1214/ss/1009212248; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; JENSEN HJ, 1998, SELF ORG CRITICALITY, P1; Jones JH, 2003, P ROY SOC B-BIOL SCI, V270, P1123, DOI 10.1098/rspb.2003.2369; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Levy M, 2009, AM ECON REV, V99, P1672, DOI 10.1257/aer.99.4.1672; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; MALEVERGNE Y, 2009, ARXIV09091281; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; PAWITAN Y, 2001, ALL LIKELIHOOD STAT, P231; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Plenz D., 2009, ARXIV09125369; Plenz D, 2007, TRENDS NEUROSCI, V30, P101, DOI 10.1016/j.tins.2007.01.005; PRESS WH, 2007, NUMERICAL RECIPES AR, P502; Shew WL, 2011, J NEUROSCI, V31, P55, DOI 10.1523/JNEUROSCI.4637-10.2011; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Stewart CV, 2006, J NEUROSCI, V26, P8148, DOI 10.1523/JNEUROSCI.0723-06.2006; Tkaik G., 2009, ARXIV09125409; Touboul J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008982; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557	32	145	145	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19779	10.1371/journal.pone.0019779	http://dx.doi.org/10.1371/journal.pone.0019779			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21720544	Green Submitted, gold, Green Published			2022-12-25	WOS:000291052200015
J	Isogai, S; Morimoto, D; Arita, K; Unzai, S; Tenno, T; Hasegawa, J; Sou, Y; Komatsu, M; Tanaka, K; Shirakawa, M; Tochio, H				Isogai, Shin; Morimoto, Daichi; Arita, Kyohei; Unzai, Satoru; Tenno, Takeshi; Hasegawa, Jun; Sou, Yu-shin; Komatsu, Masaaki; Tanaka, Keiji; Shirakawa, Masahiro; Tochio, Hidehito			Crystal Structure of the Ubiquitin-associated (UBA) Domain of p62 and Its Interaction with Ubiquitin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE DETERMINATION; SELECTIVE AUTOPHAGY; RECOGNITION; SOFTWARE; PROTEINS; DEGRADATION; P62/SQSTM1; MECHANISM; DIMERIZATION; REFINEMENT	p62/SQSTM1/A170 is a multimodular protein that is found in ubiquitin-positive inclusions associated with neurodegenerative diseases. Recent findings indicate that p62 mediates the interaction between ubiquitinated proteins and autophagosomes, leading these proteins to be degraded via the autophagy-lysosomal pathway. This ubiquitin-mediated selective autophagy is thought to begin with recognition of the ubiquitinated proteins by the C-terminal ubiquitin-associated (UBA) domain of p62. We present here the crystal structure of the UBA domain of mouse p62 and the solution structure of its ubiquitin-bound form. The p62 UBA domain adopts a novel dimeric structure in crystals, which is distinctive from those of other UBA domains. NMR analyses reveal that in solution the domain exists in equilibrium between the dimer and monomer forms, and binding ubiquitin shifts the equilibrium toward the monomer to form a 1: 1 complex between the UBA domain and ubiquitin. The dimer-to-monomer transition is associated with a structural change of the very C-terminal end of the p62 UBA domain, although the UBA fold itself is essentially maintained. Our data illustrate that dimerization and ubiquitin binding of the p62 UBA domain are incompatible with each other. These observations reveal an autoinhibitory mechanism in the p62 UBA domain and suggest that autoinhibition plays a role in the function of p62.	[Isogai, Shin; Morimoto, Daichi; Arita, Kyohei; Shirakawa, Masahiro; Tochio, Hidehito] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Kyoto 6158510, Japan; [Tenno, Takeshi] Kobe Univ, Grad Sch Med, Div Struct Biol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Unzai, Satoru] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Hasegawa, Jun; Sou, Yu-shin; Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Prot Metab Project, Setagaya Ku, Tokyo 1568506, Japan; [Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan	Kyoto University; Kobe University; Yokohama City University; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science	Shirakawa, M (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Kyoto 6158510, Japan.	shirakawa@moleng.kyoto-u.ac.jp; tochio@moleng.kyoto-u.ac.jp	Arita, Kyohei/AAJ-6402-2020; Komatsu, Masaaki/B-8321-2011; Tochio, Hidehito/F-6109-2011; Tochio, Hidehito/GWV-0429-2022	Arita, Kyohei/0000-0002-9762-8405; Komatsu, Masaaki/0000-0001-7672-7722; Tochio, Hidehito/0000-0003-3843-3330; Morimoto, Daichi/0000-0002-7672-2136; Sou, Yu-shin/0000-0002-7219-9106; Isogai, Shin/0000-0002-3768-6427	Ministry of Education, Science, and Culture of Japan; Grants-in-Aid for Scientific Research [22113511] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research and the National Project on Protein Structural and Functional Analyses from the Ministry of Education, Science, and Culture of Japan.	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Heinen C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1179; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Long J, 2008, J BIOL CHEM, V283, P5427, DOI 10.1074/jbc.M704973200; Long J, 2010, J MOL BIOL, V396, P178, DOI 10.1016/j.jmb.2009.11.032; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Pohl C, 2009, NAT CELL BIOL, V11, P65, DOI 10.1038/ncb1813; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Rochus K., 2004, COMPUTER AIDED RESON; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Tan JMM, 2008, AUTOPHAGY, V4, P251, DOI 10.4161/auto.5444; Trempe JF, 2005, EMBO J, V24, P3178, DOI 10.1038/sj.emboj.7600797; Valafar H, 2004, J MAGN RESON, V167, P228, DOI 10.1016/j.jmr.2003.12.012; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang YX, 1998, J AM CHEM SOC, V120, P7385, DOI 10.1021/ja980862o; Wooten MW, 2008, J BIOL CHEM, V283, P6783, DOI 10.1074/jbc.M709496200; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	42	85	87	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31864	31874		10.1074/jbc.M111.259630	http://dx.doi.org/10.1074/jbc.M111.259630			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21715324	Green Published, hybrid			2022-12-25	WOS:000294487500079
J	Lubkowska, L; Maharjan, AS; Komissarova, N				Lubkowska, Lucyna; Maharjan, Anu S.; Komissarova, Natalia			RNA Folding in Transcription Elongation Complex IMPLICATION FOR TRANSCRIPTION TERMINATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; ESCHERICHIA-COLI; NASCENT RNA; DNA HYBRID; IN-VIVO; TRANSLATIONAL CONTROL; SECONDARY STRUCTURE; STEM-LOOP; 3 END; POLYMERASE	Intrinsic transcription termination signal in DNA consists of a short inverted repeat followed by a T-rich stretch. Transcription of this sequence by RNA polymerase (RNAP) results in formation of a "termination hairpin" (TH) in the nascent RNA and in rapid dissociation of the transcription elongation complex (EC) at termination points located 7-8 nt downstream of the base of TH stem. RNAP envelops 15 nt of the RNA following RNA growing 3'-end, suggesting that folding of the TH is impeded by a tight protein environment when RNAP reaches the termination points. To monitor TH folding under this constraint, we halted Escherichia coli ECs at various distances downstream from a TH and treated them with single-strand specific RNase T1. The EC interfered with TH formation when halted at 6, 7, and 8, but not 9, nt downstream from the base of the potential stem. Thus, immediately before termination, the downstream arm of the TH is protected from complementary interactions with the upstream arm. This protection makes TH folding extremely sensitive to the sequence context, because the upstream arm easily engages in competing interactions with the rest of the nascent RNA. We demonstrate that by de-synchronizing TH formation and transcription of the termination points, this subtle competition significantly affects the efficiency of transcription termination. This finding can explain previous puzzling observations that sequences far upstream of the TH or point mutations in the terminator that preserve TH stability affect termination. These results can help understand other time sensitive co-transcriptional processes in pro- and eukaryotes.	[Lubkowska, Lucyna; Komissarova, Natalia] NCI, Ctr Canc Res, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; [Maharjan, Anu S.; Komissarova, Natalia] NICHD, Program Genom & Differentiat, NIH, Bethesda, MD 20892 USA; [Maharjan, Anu S.] Smith Coll, Northampton, MA 01063 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Smith College	Komissarova, N (corresponding author), NCI, 37 Convent Dr, Bethesda, MD 20892 USA.	komissar@mail.nih.gov			National Cancer Institute, Center for Cancer Research; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health	National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health.	ARNDT KM, 1990, J MOL BIOL, V213, P79, DOI 10.1016/S0022-2836(05)80123-8; Balzer M, 1998, J MOL BIOL, V276, P547, DOI 10.1006/jmbi.1997.1556; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Besancon W, 1999, NUCLEIC ACIDS RES, V27, P4353, DOI 10.1093/nar/27.22.4353; Breaker RR, 2009, FUTURE MICROBIOL, V4, P771, DOI 10.2217/FMB.09.46; CARAFA YD, 1990, J MOL BIOL, V216, P835, DOI 10.1016/S0022-2836(99)80005-9; CESARENI G, 1985, TRENDS BIOCHEM SCI, V10, P303, DOI 10.1016/0968-0004(85)90168-9; Chan CL, 1997, J MOL BIOL, V268, P54, DOI 10.1006/jmbi.1997.0935; CHAO MY, 1995, NUCLEIC ACIDS RES, V23, P1691, DOI 10.1093/nar/23.10.1691; CHENG SWC, 1991, SCIENCE, V254, P1205, DOI 10.1126/science.1835546; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; EPERON LP, 1988, CELL, V54, P393, DOI 10.1016/0092-8674(88)90202-4; Epshtein V, 2007, MOL CELL, V28, P991, DOI 10.1016/j.molcel.2007.10.011; Geissmann T, 2009, RNA BIOL, V6, P153, DOI 10.4161/rna.6.2.8047; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; GOLIGER JA, 1989, J MOL BIOL, V205, P331, DOI 10.1016/0022-2836(89)90344-6; GROENEVELD H, 1995, RNA, V1, P79; Heilman-Miller SL, 2003, RNA, V9, P722, DOI 10.1261/rna.5200903; Hiller M, 2007, PLOS GENET, V3, P2147, DOI 10.1371/journal.pgen.0030204; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Kashlev M, 1996, METHOD ENZYMOL, V274, P326; Kashlev M, 2002, J BIOL CHEM, V277, P14501, DOI 10.1074/jbc.M200215200; King RA, 1996, CELL, V87, P893, DOI 10.1016/S0092-8674(00)81996-0; Komissarova N, 1998, P NATL ACAD SCI USA, V95, P14699, DOI 10.1073/pnas.95.25.14699; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KROGER M, 1982, GENE, V20, P25, DOI 10.1016/0378-1119(82)90084-1; Larson MH, 2008, CELL, V132, P971, DOI 10.1016/j.cell.2008.01.027; LEWICKI BTU, 1993, J MOL BIOL, V231, P581, DOI 10.1006/jmbi.1993.1311; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; Palangat M, 1998, MOL CELL, V1, P1033, DOI 10.1016/S1097-2765(00)80103-3; Pan T, 1999, P NATL ACAD SCI USA, V96, P9545, DOI 10.1073/pnas.96.17.9545; Potrykus K, 2010, NUCLEIC ACIDS RES, V38, P1636, DOI 10.1093/nar/gkp1150; Richardson J. P., 1996, ESCHERICHIA COLI SAL, P822; SCHMIDT MC, 1987, J MOL BIOL, V195, P809, DOI 10.1016/0022-2836(87)90486-4; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Spirin Alexander S, 2004, RNA Biol, V1, P3; TELESNITSKY APW, 1989, J MOL BIOL, V205, P315, DOI 10.1016/0022-2836(89)90343-4; TOMIZAWA J, 1982, CELL, V31, P575, DOI 10.1016/0092-8674(82)90313-0; Toulme F, 2005, J MOL BIOL, V351, P39, DOI 10.1016/j.jmb.2005.05.052; VONHIPPEL PH, 1987, ESCHERICHIA COLI SAL; Wee KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001844; WILSON KS, 1995, P NATL ACAD SCI USA, V92, P8793, DOI 10.1073/pnas.92.19.8793; Woodson SA, 2000, CELL MOL LIFE SCI, V57, P796, DOI 10.1007/s000180050042; YAGER TD, 1991, BIOCHEMISTRY-US, V30, P1097, DOI 10.1021/bi00218a032; Yanofsky C, 2007, RNA, V13, P1141, DOI 10.1261/rna.620507; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; ZAYCHIKOV E, 1995, P NATL ACAD SCI USA, V92, P1739, DOI 10.1073/pnas.92.5.1739; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	52	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31576	31585		10.1074/jbc.M111.249359	http://dx.doi.org/10.1074/jbc.M111.249359			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21730066	Green Published, hybrid			2022-12-25	WOS:000294487500052
J	Naseem, S; Gunasekera, A; Araya, E; Konopka, JB				Naseem, Shamoon; Gunasekera, Angelo; Araya, Esteban; Konopka, James B.			N-Acetylglucosamine (GlcNAc) Induction of Hyphal Morphogenesis and Transcriptional Responses in Candida albicans Are Not Dependent on Its Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-D-GLUCOSAMINE; ESCHERICHIA-COLI; CATABOLIC PATHWAY; PROTEIN-KINASE; GENE; VIRULENCE; IDENTIFICATION; EXPRESSION; MUTANTS; YEAST	N-Acetylglucosamine (GlcNAc) stimulates important signaling pathways in a wide range of organisms. In the human fungal pathogen Candida albicans, GlcNAc stimulates hyphal cell morphogenesis, virulence genes, and the genes needed to catabolize GlcNAc. Previous studies on the GlcNAc transporter (NGT1) indicated that GlcNAc has to be internalized to induce signaling. Therefore, the role of GlcNAc catabolism was examined by deleting the genes required to phosphorylate, deacetylate, and deaminate GlcNAc to convert it to fructose-6-PO4 (HXK1, NAG1, and DAC1). As expected, the mutants failed to utilize GlcNAc. Surprisingly, GlcNAc inhibited the growth of the nag1 Delta and dac1 Delta mutants in the presence of other sugars, suggesting that excess GlcNAc-6-PO4 is deleterious. Interestingly, both hxk1 Delta and an hxk1 Delta nag1 Delta dac1 Delta triple mutant could be efficiently stimulated by GlcNAc to form hyphae. These mutants could also be stimulated to express GlcNAc-regulated genes. Because GlcNAc must be phosphorylated by Hxk1 to be catabolized, and also for it to enter the anabolic pathways that form chitin, N-linked glycosylation, and glycosyl-phosphatidylinositol anchors, the mutant phenotypes indicate that GlcNAc metabolism is not needed to induce signaling in C. albicans. Thus, these studies in C. albicans reveal a novel role for GlcNAc in cell signaling that may also regulate critical pathways in other organisms.	[Naseem, Shamoon; Gunasekera, Angelo; Araya, Esteban; Konopka, James B.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Konopka, JB (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	jkonopka@ms.cc.sunysb.edu		Konopka, James/0000-0001-5989-4086	National Institutes of Health from USPHS [RO1 GM087368]; National Institutes of Health from the NCI [T32 CA009176]; NATIONAL CANCER INSTITUTE [T32CA009176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087368] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM087368 from USPHS (to J.B.K.).; Supported by a National Institutes of Health Training Grant T32 CA009176 from the NCI.	Alvarez FJ, 2007, MOL BIOL CELL, V18, P965, DOI 10.1091/mbc.E06-10-0931; Barnhart MM, 2006, J BACTERIOL, V188, P5212, DOI 10.1128/JB.00234-06; BERNHEIM NJ, 1970, J BACTERIOL, V101, P384, DOI 10.1128/JB.101.2.384-391.1970; Brown V, 2009, CURR BIOL, V19, P436, DOI 10.1016/j.cub.2009.01.056; Castilla R, 1998, CELL SIGNAL, V10, P713, DOI 10.1016/S0898-6568(98)00015-1; Chen X, 2004, MOL MICROBIOL, V51, P551, DOI 10.1046/j.1365-2958.2003.03852.x; DOUGLAS HC, 1954, J BACTERIOL, V68, P662, DOI 10.1128/JB.68.6.662-670.1954; Fitzpatrick DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-290; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; Gunasekera A, 2010, EUKARYOT CELL, V9, P1476, DOI 10.1128/EC.00178-10; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Huang GH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000806; Kumar MJ, 2000, P NATL ACAD SCI USA, V97, P14218, DOI 10.1073/pnas.250452997; Lay J, 1998, INFECT IMMUN, V66, P5301, DOI 10.1128/IAI.66.11.5301-5306.1998; Leberer E, 2001, MOL MICROBIOL, V42, P673, DOI 10.1046/j.1365-2958.2001.02672.x; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Martchenko M, 2007, CURR BIOL, V17, P1007, DOI 10.1016/j.cub.2007.05.017; Milewski S, 2006, YEAST, V23, P1, DOI 10.1002/yea.1337; Naderer T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001245; NATARAJAN K, 1993, J BIOL CHEM, V268, P9206; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Park H, 2005, CELL MICROBIOL, V7, P499, DOI 10.1111/j.1462-5822.2004.00476.x; Perez-Campo FM, 2001, CURR MICROBIOL, V43, P429, DOI 10.1007/s002840010333; Sellick CA, 2005, TRENDS BIOCHEM SCI, V30, P405, DOI 10.1016/j.tibs.2005.05.007; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIMONETTI N, 1974, NATURE, V250, P344, DOI 10.1038/250344a0; Singh P, 2001, INFECT IMMUN, V69, P7898, DOI 10.1128/IAI.69.12.7898-7903.2001; Singh V, 2007, FUNGAL GENET BIOL, V44, P563, DOI 10.1016/j.fgb.2006.11.006; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Wendland J, 2006, J BASIC MICROB, V46, P513, DOI 10.1002/jobm.200610167; Wendland J, 2009, APPL ENVIRON MICROB, V75, P5840, DOI 10.1128/AEM.00053-09; WHITE RJ, 1968, BIOCHEM J, V106, P847, DOI 10.1042/bj1060847; Whiteway M, 2004, CURR OPIN MICROBIOL, V7, P350, DOI 10.1016/j.mib.2004.06.005; Wilson RB, 2000, YEAST, V16, P65, DOI 10.1002/(SICI)1097-0061(20000115)16:1&lt;65::AID-YEA508&gt;3.0.CO;2-M; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Yamada-Okabe T, 2001, EUR J BIOCHEM, V268, P2498, DOI 10.1046/j.1432-1327.2001.02135.x; Zhang CD, 2010, EUKARYOT CELL, V9, P224, DOI 10.1128/EC.00327-09	40	60	72	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28671	28680		10.1074/jbc.M111.249854	http://dx.doi.org/10.1074/jbc.M111.249854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21700702	Green Published, hybrid			2022-12-25	WOS:000293837000004
J	Mul, JD; Nadra, K; Jagalur, NB; Nijman, IJ; Toonen, PW; Medard, JJ; Gres, S; de Bruin, A; Han, GS; Brouwers, JF; Carman, GM; Saulnier-Blache, JS; Meijer, D; Chrast, R; Cuppen, E				Mul, Joram D.; Nadra, Karim; Jagalur, Noorjahan B.; Nijman, Isaac J.; Toonen, Pim W.; Medard, Jean-Jacques; Gres, Sandra; de Bruin, Alain; Han, Gil-Soo; Brouwers, Jos F.; Carman, George M.; Saulnier-Blache, Jean-Sebastien; Meijer, Dies; Chrast, Roman; Cuppen, Edwin			A Hypomorphic Mutation in Lpin1 Induces Progressively Improving Neuropathy and Lipodystrophy in the Rat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID PHOSPHATASE; SCHWANN-CELL DIFFERENTIATION; PERIPHERAL NEUROPATHY; SUBCELLULAR-LOCALIZATION; QUANTITATIVE-ANALYSIS; EXPRESSION; LIPIN; GENE; PROTEIN; MYOGLOBINURIA	The Lpin1 gene encodes the phosphatidate phosphatase (PAP1) enzyme Lipin 1, which plays a critical role in lipid metabolism. In this study we describe the identification and characterization of a rat model with a mutated Lpin1 gene (Lpin1(1Hubr)), generated by N-ethyl-N-nitrosourea mutagenesis. Lpin1(1Hubr) rats are characterized by hindlimb paralysis and mild lipodystrophy that are detectable from the second postnatal week. Sequencing of Lpin1 identified a point mutation in the 5'-end splice site of intron 18 resulting in missplicing, a reading frameshift, and a premature stop codon. As this mutation does not induce nonsense-mediated decay, it allows the production of a truncated Lipin 1 protein lacking PAP1 activity. Lpin1(1Hubr) rats developed hypomyelination and mild lipodystrophy rather than the pronounced demyelination and adipocyte defects characteristic of Lpin1(fld/fld) mice, which carry a null allele for Lpin1. Furthermore, biochemical, histological, and molecular analyses revealed that these lesions improve in older Lpin1(1Hubr) rats as compared with young Lpin1(1Hubr) rats and Lpin1(fld/fld) mice. We observed activation of compensatory biochemical pathways substituting for missing PAP1 activity that, in combination with a possible non-enzymatic Lipin 1 function residing outside of its PAP1 domain, may contribute to the less severe phenotypes observed in Lpin1(1Hubr) rats as compared with Lpin1(fld/fld) mice. Although we are cautious in making a direct parallel between the presented rodent model and human disease, our data may provide new insight into the pathogenicity of recently identified human LPIN1 mutations.	[Nadra, Karim; Medard, Jean-Jacques; Chrast, Roman] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Mul, Joram D.; Nijman, Isaac J.; Toonen, Pim W.; Cuppen, Edwin] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Mul, Joram D.; Nijman, Isaac J.; Toonen, Pim W.; Cuppen, Edwin] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Jagalur, Noorjahan B.; Meijer, Dies] Erasmus MC Univ Med Ctr, Dept Cell Biol & Genet, NL-3015 GE Rotterdam, Netherlands; [Gres, Sandra; Saulnier-Blache, Jean-Sebastien] Univ Toulouse 3, Inst Malad Metab & Cardiovasc I2MC, INSERM U1048, F-31432 Toulouse 4, France; [de Bruin, Alain] Univ Utrecht, Dutch Mol Pathol Ctr, Fac Vet Med, NL-3584 CL Utrecht, Netherlands; [Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Brouwers, Jos F.] Univ Utrecht, Dept Biochem & Cell Biol, Fac Vet Med, NL-3508 TC Utrecht, Netherlands; [Cuppen, Edwin] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CX Utrecht, Netherlands	University of Lausanne; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Utrecht University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Utrecht University; Utrecht University; Utrecht University Medical Center	Nadra, K (corresponding author), Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland.	Karim.Nadra@unil.ch; Roman.Chrast@unil.ch	Meijer, Dies/C-7786-2012; Saulnier-Blache, Jean Sebastien/X-7729-2018; Cuppen, Edwin/F-5696-2011; Brouwers, Jos F/AAH-1444-2019; de Bruin, Alain/AAL-9195-2020; Cuppen, Edwin/H-2389-2016; Mul, Joram/C-3125-2011	Meijer, Dies/0000-0002-8461-6341; Cuppen, Edwin/0000-0002-0400-9542; Brouwers, Jos F/0000-0003-2924-3279; Cuppen, Edwin/0000-0002-0400-9542; de Bruin, Alain/0000-0001-8579-2649; Chrast, Roman/0000-0003-4189-3514; Mul, Joram/0000-0003-0453-2568; Nijman, Isaac/0000-0002-1840-1158; Saulnier-Blache, Jean Sebastien/0000-0002-8971-7723	National Institutes of Health [GM-28140]; Swiss National Science Foundation [PP00P3_124833/1]; INSERM; Fondation de la Recherche Medicale [DRM20101220459]; European Science Foundation EURYI; Dutch government; European community [NWO 918.66.616, FP7/2007-2013]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); European Science Foundation EURYI(European Science Foundation (ESF)); Dutch government; European community(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-28140 (to G. M. C.), Swiss National Science Foundation Grant PP00P3_124833/1 (to R. C.), INSERM and Fondation de la Recherche Medicale Grant DRM20101220459 (to J. S. S. B.), a grant from the European Science Foundation EURYI (to E. C.), and Dutch government and European community Grants NWO 918.66.616 and FP7/2007-2013 (to D. M.).	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brouwers J. F., 2011, BIOL REPROD IN PRESS; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; de Preux AS, 2007, MOL CELL NEUROSCI, V35, P525, DOI 10.1016/j.mcn.2007.04.010; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Douglas DS, 2009, J NEUROSCI, V29, P12089, DOI 10.1523/JNEUROSCI.2029-09.2009; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; FOWLER SD, 1985, J HISTOCHEM CYTOCHEM, V33, P833, DOI 10.1177/33.8.4020099; Frio TR, 2009, HUM MUTAT, V30, P1340, DOI 10.1002/humu.21071; Ghislain J, 2006, EMBO REP, V7, P52, DOI 10.1038/sj.embor.7400573; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Jaegle M, 1996, SCIENCE, V273, P507, DOI 10.1126/science.273.5274.507; Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09; LANGNER CA, 1991, J BIOL CHEM, V266, P11955; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Michot C, 2010, HUM MUTAT, V31, pE1564, DOI 10.1002/humu.21282; Mul JD, 2010, AM J PHYSIOL-ENDOC M, V298, pE477, DOI 10.1152/ajpendo.00154.2009; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Nijman IJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-95; Nohturfft A, 2009, ANNU REV CELL DEV BI, V25, P539, DOI 10.1146/annurev.cellbio.24.110707.175344; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Roberts RZ, 2000, BBA-MOL CELL BIOL L, V1487, P33, DOI 10.1016/S1388-1981(00)00081-0; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Smits BMG, 2006, PHARMACOGENET GENOM, V16, P159; Spiekerkoetter U, 2004, MUSCLE NERVE, V29, P66, DOI 10.1002/mus.10500; van Boxtel R, 2008, CARCINOGENESIS, V29, P1290, DOI 10.1093/carcin/bgn094; Verheijen MHG, 2003, GENE DEV, V17, P2450, DOI 10.1101/gad.1116203; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zorick TS, 1996, MOL CELL NEUROSCI, V8, P129, DOI 10.1006/mcne.1996.0052	39	24	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26781	26793		10.1074/jbc.M110.197947	http://dx.doi.org/10.1074/jbc.M110.197947			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21715287	Green Published, hybrid			2022-12-25	WOS:000293078200054
J	Slater, SC; Beachley, V; Hayes, T; Zhang, DM; Welsh, GI; Saleem, MA; Mathieson, PW; Wen, XJ; Su, B; Satchell, SC				Slater, Sadie C.; Beachley, Vince; Hayes, Thomas; Zhang, Daming; Welsh, Gavin I.; Saleem, Moin A.; Mathieson, Peter W.; Wen, Xuejun; Su, Bo; Satchell, Simon C.			An In Vitro Model of the Glomerular Capillary Wall Using Electrospun Collagen Nanofibres in a Bioartificial Composite Basement Membrane	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BLOOD-BRAIN-BARRIER; CELLS; EXPRESSION; VEGF; PROTEINURIA; COCULTURE; SCAFFOLDS; CULTURE; MATRIX	The filtering unit of the kidney, the glomerulus, contains capillaries whose walls function as a biological sieve, the glomerular filtration barrier. This comprises layers of two specialised cells, glomerular endothelial cells (GEnC) and podocytes, separated by a basement membrane. Glomerular filtration barrier function, and dysfunction in disease, remains incompletely understood, partly due to difficulties in studying the relevant cell types in vitro. We have addressed this by generation of unique conditionally immortalised human GEnC and podocytes. However, because the glomerular filtration barrier functions as a whole, it is necessary to develop three dimensional co-culture models to maximise the benefit of the availability of these cells. Here we have developed the first two tri-layer models of the glomerular capillary wall. The first is based on tissue culture inserts and provides evidence of cell-cell interaction via soluble mediators. In the second model the synthetic support of the tissue culture insert is replaced with a novel composite bioartificial membrane. This consists of a nanofibre membrane containing collagen I, electrospun directly onto a micro-photoelectroformed fine nickel supporting mesh. GEnC and podocytes grew in monolayers on either side of the insert support or the novel membrane to form a tri-layer model recapitulating the human glomerular capillary in vitro. These models will advance the study of both the physiology of normal glomerular filtration and of its disruption in glomerular disease.	[Slater, Sadie C.; Welsh, Gavin I.; Saleem, Moin A.; Mathieson, Peter W.; Satchell, Simon C.] Univ Bristol, Acad Renal Unit, Bristol, Avon, England; [Beachley, Vince; Wen, Xuejun] Clemson Univ, Dept Bioengn, Charleston, SC USA; [Hayes, Thomas; Zhang, Daming; Su, Bo] Univ Bristol, Dept Oral & Dent Sci, Bristol, Avon, England	University of Bristol; Clemson University; University of Bristol	Slater, SC (corresponding author), Univ Bristol, Acad Renal Unit, Bristol, Avon, England.	S.C.Satchell@bristol.ac.uk		Saleem, Moin/0000-0002-9808-4518; Su, Bo/0000-0003-1063-8182; Welsh, Gavin Iain/0000-0002-2148-6658	Wellcome Trust [075731]; Medical Research Council [G0500053]; Biotechnology and Biological Sciences Research Council [BB/G000077/1]; Biotechnology and Biological Sciences Research Council [BB/G012776/1] Funding Source: researchfish; Medical Research Council [G0800200, G0701836] Funding Source: researchfish; BBSRC [BB/G000077/1, BB/G012776/1] Funding Source: UKRI; MRC [G0701836, G0800200, G0500053] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a Wellcome Trust Fellowship to Dr. SC Satchell (075731), the Medical Research Council (G0500053) and the Biotechnology and Biological Sciences Research Council (BB/G000077/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT NJ, 1992, J CELL SCI, V103, P23; Bakunts K, 2008, BIOTECHNIQUES, V44, P341, DOI 10.2144/000112682; Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022; Bevan HS, 2008, NEPHRON PHYSIOL, V110, P57, DOI 10.1159/000177614; BIEGEL D, 1994, IN VITRO CELL DEV-AN, V30A, P581; Cui TG, 2004, AM J PHYSIOL-RENAL, V286, pF767, DOI 10.1152/ajprenal.00337.2003; Dai NT, 2005, BIOCHEM BIOPH RES CO, V329, P905, DOI 10.1016/j.bbrc.2005.02.059; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Davis B, 2007, J AM SOC NEPHROL, V18, P2320, DOI 10.1681/ASN.2006101093; Durbeej M, 1996, MATRIX BIOL, V15, P397, DOI 10.1016/S0945-053X(96)90159-6; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Foster RR, 2008, AM J PATHOL, V173, P938, DOI 10.2353/ajpath.2008.070416; HALL V, 1957, AM HEART J, V54, P1, DOI 10.1016/0002-8703(57)90073-X; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574; Hermanns MI, 2004, LAB INVEST, V84, P736, DOI 10.1038/labinvest.3700081; Hirschberg R, 2008, CELL TISSUE RES, V331, P485, DOI 10.1007/s00441-007-0526-z; Kefalides N A, 1973, Int Rev Connect Tissue Res, V6, P63; Kitahara T, 2005, NEPHROL DIAL TRANSPL, V20, P42, DOI 10.1093/ndt/gfh572; Lopez-Heredia MA, 2008, BIOMATERIALS, V29, P2608, DOI 10.1016/j.biomaterials.2008.02.021; Ma SH, 2005, LAB CHIP, V5, P74, DOI 10.1039/b405713a; MACARAK EJ, 1983, J CELL PHYSIOL, V116, P76, DOI 10.1002/jcp.1041160112; Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u; Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004; SAEKI T, 1991, AM J PATHOL, V139, P949; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Satchell SC, 2006, KIDNEY INT, V69, P1633, DOI 10.1038/sj.ki.5000277; Satchell SC, 2004, J AM SOC NEPHROL, V15, P566, DOI 10.1097/01.ASN.0000115397.22519.03; Satchell SC, 2007, J AM SOC NEPHROL, V18, P2875, DOI 10.1681/ASN.2006101104; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006; Wang PC, 2005, J BIOSCI BIOENG, V99, P529, DOI 10.1263/jbb.99.529; Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143; Williamson MR, 2006, BIOMATERIALS, V27, P3608, DOI 10.1016/j.biomaterials.2006.02.025; Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038; Zhong SP, 2005, BIOMACROMOLECULES, V6, P2998, DOI 10.1021/bm050318p	37	41	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e20802	10.1371/journal.pone.0020802	http://dx.doi.org/10.1371/journal.pone.0020802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731625	Green Published, gold, Green Submitted			2022-12-25	WOS:000292036900006
J	Bouche, P; Douglas-Hamilton, I; Wittemyer, G; Nianogo, AJ; Doucet, JL; Lejeune, P; Vermeulen, C				Bouche, Philippe; Douglas-Hamilton, Iain; Wittemyer, George; Nianogo, Aime J.; Doucet, Jean-Louis; Lejeune, Philippe; Vermeulen, Cedric			Will Elephants Soon Disappear from West African Savannahs?	PLOS ONE			English	Article							WAZA-NATIONAL-PARK; LARGE MAMMALS; BURKINA-FASO; TRENDS; POPULATIONS; OSTRICHES; CAMEROON	Precipitous declines in Africa's native fauna and flora are recognized, but few comprehensive records of these changes have been compiled. Here, we present population trends for African elephants in the 6,213,000 km 2 Sudano-Sahelian range of West and Central Africa assessed through the analysis of aerial and ground surveys conducted over the past 4 decades. These surveys are focused on the best protected areas in the region, and therefore represent the best case scenario for the northern savanna elephants. A minimum of 7,745 elephants currently inhabit the entire region, representing a minimum decline of 50% from estimates four decades ago for these protected areas. Most of the historic range is now devoid of elephants and, therefore, was not surveyed. Of the 23 surveyed elephant populations, half are estimated to number less than 200 individuals. Historically, most populations numbering less than 200 individuals in the region were extirpated within a few decades. Declines differed by region, with Central African populations experiencing much higher declines (-76%) than those in West Africa (-33%). As a result, elephants in West Africa now account for 86% of the total surveyed. Range wide, two refuge zones retain elephants, one in West and the other in Central Africa. These zones are separated by a large distance (similar to 900 km) of high density human land use, suggesting connectivity between the regions is permanently cut. Within each zone, however, sporadic contacts between populations remain. Retaining such connectivity should be a high priority for conservation of elephants in this region. Specific corridors designed to reduce the isolation of the surveyed populations are proposed. The strong commitment of governments, effective law enforcement to control the illegal ivory trade and the involvement of local communities and private partners are all critical to securing the future of elephants inhabiting Africa's northern savannas.	[Bouche, Philippe; Doucet, Jean-Louis; Lejeune, Philippe; Vermeulen, Cedric] Univ Liege Gembloux Agrobio Tech, Unite Gest Ressources Forestieres & Milieux Nat, Gembloux, Belgium; [Douglas-Hamilton, Iain; Wittemyer, George] Save Elephants, Nairobi, Kenya; [Wittemyer, George] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Nianogo, Aime J.] IUCN, PACO, Ouagadougou, Burkina Faso; [Douglas-Hamilton, Iain] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Liege; Colorado State University; University of Oxford	Bouche, P (corresponding author), Univ Liege Gembloux Agrobio Tech, Unite Gest Ressources Forestieres & Milieux Nat, Gembloux, Belgium.	ph_bouche@yahoo.com	Wittemyer, George/AFQ-1840-2022		African Development Bank; Agence Francaise de Developpement; Conservation International; European Union; Kingdom of Belgium; World Bank	African Development Bank(CGIAR); Agence Francaise de Developpement; Conservation International; European Union(European Commission); Kingdom of Belgium; World Bank(The World Bank India)	These surveys were funds by African Development Bank (www.afdb.org), Agence Francaise de Developpement (www.afd.fr), Conservation International (www.conservation.org), European Union (www.europa.eu), Kingdom of Belgium (www.belgium.be), World Bank (www.worldbank.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, STAT METHODS BIOL; Barnes RFW, 1999, MAMMAL REV, V29, P175, DOI 10.1046/j.1365-2907.1999.00044.x; BARNES RFW, 1998, AFRICAN ELEPHANT DAT; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; Blanc J.J., 2003, AFRICAN ELEPHANT STA; Blanc Julian J., 2007, AFRICAN ELEPHANT STA; Bouche P, 2004, PACHYDERM, V37, P85; Bouche P., 2009, PACHYDERM, V45, P47; Bouche Ph., 2002, Pachyderm, V32, P49; Bouche Ph., 2007, NAZINGA, P259; Bouche P, 2010, AFR J ECOL, V48, P994, DOI 10.1111/j.1365-2028.2009.01202.x; Bouche P, 2007, PACHYDERM, P58; Bouche P, 2007, PACHYDERM, P33; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; C?lix M., 2018, EUROPEAN RED LIST SA; Chardonnet Bertrand, 2000, Pachyderm, V28, P16; Chardonnet Ph, 2008, BOIS FOR TROP, V295, P91; Clerici N, 2007, J NAT CONSERV, V15, P26, DOI 10.1016/j.jnc.2006.08.003; Dejace P, 2000, REV ECOL-TERRE VIE, V55, P305; DOUGLAS-HAMILTON I, 1987, Oryx, V21, P11; Douglas-Hamilton I., 2009, PACHYDERM, V45, P154; Douglas -Hamilton I, 1981, ILCA MONOGRAPH; DOUGLASHAMILTON I, 1996, SERIE MANUELS TECHNI, V7, P31; DUPUY AR, 1971, B I FRANCAIS AFRIQ A, V33, P253; Eggert LS, 2002, P ROY SOC B-BIOL SCI, V269, P1993, DOI 10.1098/rspb.2002.2070; ESSER JD, 1979, TERRE VIE-REV ECOL A, V33, P3; Fischer Frauke, 2005, Pachyderm, V38, P64; Foguekem D, 2009, SCI RES ESSAYS, V4, P1423; HAESSLER C, 2003, SAVANES AFRICAINES E; JACHMANN H, 1991, AFR J ECOL, V29, P188, DOI 10.1111/j.1365-2028.1991.tb01001.x; Jeannin A., 1936, MAMMIFERES SAUVAGES; Milliken T., 2009, ELEPHANT TRADE INFOR; Nakande A, 2007, PACHYDERM, P81; NORTONGRIFFITHS M, 1978, HDB COUNTING ANIMALS, V1; Okoumassou K., 1998, Pachyderm, V26, P52; *PNUE, 2002, ET ENV MOND 2002; Poilecot P, 2010, BOIS FOR TROP, P93; PRINS HHT, 1992, ENVIRON CONSERV, V19, P117, DOI 10.1017/S0376892900030587; ROTH HH, 1991, MAMMALIA, V55, P489, DOI 10.1515/mamm.1991.55.4.489; SAID MY, 1995, AFRICAN ELEPHANT DAT; Sam M.K., 1998, Pachyderm, V26, P61; Sam Moses Kofi, 2002, Pachyderm, V33, P39; Sinclair ARE, 2006, WILDLIFE ECOLOGY CON; Tchamba MN, 1995, AFR J ECOL, V33, P366, DOI 10.1111/j.1365-2028.1995.tb01046.x; *UNEP, 2006, SUD POST CONFL ENV A; VERMEULEN C, 2004, BURKINA FASO PARES R, V59, P20; Western D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006140; White F., 1983, VEGETATION AFRICA DE	49	79	80	3	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20619	10.1371/journal.pone.0020619	http://dx.doi.org/10.1371/journal.pone.0020619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731620	Green Published, gold, Green Submitted			2022-12-25	WOS:000292033700012
J	Pan, YF; Robinett, CC; Baker, BS				Pan, Yufeng; Robinett, Carmen C.; Baker, Bruce S.			Turning Males On: Activation of Male Courtship Behavior in Drosophila melanogaster	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SEX-DETERMINATION GENE; REPRODUCTIVE-BEHAVIOR; NEURAL CIRCUITRY; DOUBLESEX GENE; VISUAL-SYSTEM; BIBIONIDAE DIPTERA; FEMALE DROSOPHILA; SENSORY NEURONS; FRUITLESS GENE	The innate sexual behaviors of Drosophila melanogaster males are an attractive system for elucidating how complex behavior patterns are generated. The potential for male sexual behavior in D. melanogaster is specified by the fruitless (fru) and doublesex (dsx) sex regulatory genes. We used the temperature-sensitive activator dTRPA1 to probe the roles of fru(M)- and dsx-expressing neurons in male courtship behaviors. Almost all steps of courtship, from courtship song to ejaculation, can be induced at very high levels through activation of either all fru(M) or all dsx neurons in solitary males. Detailed characterizations reveal different roles for fru(M) and dsx in male courtship. Surprisingly, the system for mate discrimination still works well when all dsx neurons are activated, but is impaired when all fru(M) neurons are activated. Most strikingly, we provide evidence for a fru(M)-independent courtship pathway that is primarily vision dependent.	[Pan, Yufeng; Robinett, Carmen C.; Baker, Bruce S.] Howard Hughes Med Inst, Ashburn, VA USA	Howard Hughes Medical Institute	Pan, YF (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	bakerb@janelia.hhmi.org	Pan, Yufeng/V-2376-2017; Robinett, Carmen/AAH-3177-2019	Pan, Yufeng/0000-0002-1535-9716; 	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This research was funded by Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2001, GENETICS, V158, P1569; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; BAKER BS, 1988, GENE DEV, V2, P477, DOI 10.1101/gad.2.4.477; BENNETCL.HC, 1967, NATURE, V215, P669, DOI 10.1038/215669a0; BERNSTEIN AS, 1992, J INSECT BEHAV, V5, P15, DOI 10.1007/BF01049155; Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Chan YB, 2007, P NATL ACAD SCI USA, V104, P19577, DOI 10.1073/pnas.0709803104; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Ditch LM, 2005, DEVELOPMENT, V132, P155, DOI 10.1242/dev.01568; DOWNES JA, 1969, ANNU REV ENTOMOL, V14, P271, DOI 10.1146/annurev.en.14.010169.001415; Ferveur J F, 1998, J Neurogenet, V12, P205; Gailey DA, 2006, MOL BIOL EVOL, V23, P633, DOI 10.1093/molbev/msj070; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Hasemeyer M, 2009, NEURON, V61, P511, DOI 10.1016/j.neuron.2009.01.009; HALL JC, 1977, BEHAV GENET, V7, P291, DOI 10.1007/BF01066800; HALL JC, 1979, GENETICS, V92, P437; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HAUSEN K, 1980, PROC R SOC SER B-BIO, V208, P57, DOI 10.1098/rspb.1980.0042; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Koganezawa M, 2010, CURR BIOL, V20, P1, DOI 10.1016/j.cub.2009.11.038; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Kvitsiani D, 2006, CURR BIOL, V16, pR355, DOI 10.1016/j.cub.2006.04.025; Lee G, 2002, J NEUROGENET, V16, P229, DOI 10.1080/01677060216292; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Manoli DS, 2004, NATURE, V430, P564, DOI 10.1038/nature02713; Mellert DJ, 2010, DEVELOPMENT, V137, P323, DOI 10.1242/dev.045047; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Rideout EJ, 2007, CURR BIOL, V17, P1473, DOI 10.1016/j.cub.2007.07.047; Rideout EJ, 2010, NAT NEUROSCI, V13, P458, DOI 10.1038/nn.2515; Robinett CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000365; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Sanders LE, 2008, DEV BIOL, V320, P378, DOI 10.1016/j.ydbio.2008.05.543; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; Shirangi TR, 2006, NAT GENET, V38, P1435, DOI 10.1038/ng1908; SHOREY HH, 1962, SCIENCE, V137, P677, DOI 10.1126/science.137.3531.677; Siwicki KK, 2009, CURR OPIN NEUROBIOL, V19, P200, DOI 10.1016/j.conb.2009.04.001; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; STRAUSFELD NJ, 1991, J COMP PHYSIOL A, V169, P379, DOI 10.1007/BF00197652; Usui-Aoki K, 2000, NAT CELL BIOL, V2, P500, DOI 10.1038/35019537; Villella A, 1996, GENETICS, V143, P331; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Yamamoto D, 2007, ADV GENET, V59, P39, DOI 10.1016/S0065-2660(07)59002-4; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025; ZEIL J, 1983, J COMP PHYSIOL, V150, P379, DOI 10.1007/BF00605027; ZEIL J, 1983, CELL TISSUE RES, V229, P591	59	61	62	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21144	10.1371/journal.pone.0021144	http://dx.doi.org/10.1371/journal.pone.0021144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731661	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700040
J	Vasquez, KO; Casavant, C; Peterson, JD				Vasquez, Kristine O.; Casavant, Chelsea; Peterson, Jeffrey D.			Quantitative Whole Body Biodistribution of Fluorescent-Labeled Agents by Non-Invasive Tomographic Imaging	PLOS ONE			English	Article							VIVO; QUANTIFICATION; ARTHRITIS	When small molecules or proteins are injected into live animals, their physical and chemical properties will significantly affect pharmacokinetics, tissue penetration, and the ultimate routes of metabolism and clearance. Fluorescence molecular tomography (FMT) offers the ability to non-invasively image and quantify temporal changes in fluorescence throughout the major organ systems of living animals, in a manner analogous to traditional approaches with radiolabeled agents. This approach is best used with biotherapeutics (therapeutic antibodies, or other large proteins) or large-scaffold drug-delivery vectors, that are minimally affected by low-level fluorophore conjugation. Application to small molecule drugs should take into account the significant impact of fluorophore labeling on size and physicochemical properties, however, the presents studies show that this technique is readily applied to small molecule agents developed for far-red (FR) or near infrared (NIR) imaging. Quantification by non-invasive FMT correlated well with both fluorescence from tissue homogenates as well as with planar (2D) fluorescence reflectance imaging of excised intact organs (r(2) = 0.996 and 0.969, respectively). Dynamic FMT imaging (multiple times from 0 to 24 h) performed in live mice after the injection of four different FR/NIR-labeled agents, including immunoglobulin, 20-50 nm nanoparticles, a large vascular imaging agent, and a small molecule integrin antagonist, showed clear differences in the percentage of injected dose per gram of tissue (%ID/g) in liver, kidney, and bladder signal. Nanoparticles and IgG1 favored liver over kidney signal, the small molecule integrin-binding agent favored rapid kidney and bladder clearance, and the vascular agent, showed both liver and kidney clearance. Further assessment of the volume of distribution of these agents by fluorescent volume added information regarding their biodistribution and highlighted the relatively poor extravasation into tissue by IgG1. These studies demonstrate the ability of quantitative FMT imaging of FR/NIR agents to non-invasively visualize and quantify the biodistribution of different agents over time.	[Vasquez, Kristine O.; Casavant, Chelsea; Peterson, Jeffrey D.] PerkinElmer Inc, Dept Appl Biol, Boston, MA USA		Vasquez, KO (corresponding author), PerkinElmer Inc, Dept Appl Biol, Boston, MA USA.	jeff.peterson@perkinelmer.com			PerkinElmer	PerkinElmer	Research was supported by internal funding from PerkinElmer, and there are no current external funding sources for this study. Because all authors are employed by the funder, the funder played a role in the decision to perform studies and in approval of the manuscript.	Ackerman ME, 2008, MOL CANCER THER, V7, P2233, DOI 10.1158/1535-7163.MCT-08-0067; Banzato A, 2009, NUCL MED BIOL, V36, P525, DOI 10.1016/j.nucmedbio.2009.02.005; Boss DS, 2008, ONCOLOGIST, V13, P25, DOI 10.1634/theoncologist.2007-0097; Buono C, 2009, J CLIN INVEST, V119, P1373, DOI 10.1172/JCI35548; Grimm J, 2005, P NATL ACAD SCI USA, V102, P14404, DOI 10.1073/pnas.0503920102; Hoyt R., 2007, MOUSE BIOMEDICAL RES, V2nd, P23; Kenanova V, 2005, CANCER RES, V65, P622; Korideck H, 2009, J PHARMACOL EXP THER, V329, P882, DOI 10.1124/jpet.108.147579; Kossodo S, 2010, MOL IMAGING BIOL, V12, P488, DOI 10.1007/s11307-009-0279-z; Kozloff KM, 2007, J BONE MINER RES, V22, P1208, DOI 10.1359/JBMR.070504; Mahmood U, 2003, MOL CANCER THER, V2, P489; Mohajerani P, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3149855; Montet X, 2007, RADIOLOGY, V242, P751, DOI 10.1148/radiol.2423052065; NAHRENDORF M, 2009, ARTERIOSCLER THROMB; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; Ntziachristos V, 2002, MOL IMAGING, V1, P82, DOI 10.1162/153535002320162732; Peterson JD, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3038; Priyadarshani A, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-10; Robe A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-111; Seo Y, 2008, CURR RADIOPHARM, V1, P17, DOI 10.2174/1874471010801010017; Stangenberg L, 2009, ARTHRITIS RHEUM-US, V60, P2314, DOI 10.1002/art.24704; Tabrizi M, 2010, AAPS J, V12, P33, DOI 10.1208/s12248-009-9157-5; Takakura Y, 1996, PHARMACEUT RES, V13, P820, DOI 10.1023/A:1016084508097; Wunder A, 2004, ARTHRITIS RHEUM-US, V50, P2459, DOI 10.1002/art.20379; Yang Z, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/16/165101; Yaseen MA, 2009, MOL PHARMACEUT, V6, P1321, DOI 10.1021/mp800270t; Zhang ZR, 2005, BIOCONJUGATE CHEM, V16, P1232, DOI 10.1021/bc050136s; Zilberman Y, 2008, J ORTHOP RES, V26, P522, DOI 10.1002/jor.20518	28	98	100	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20594	10.1371/journal.pone.0020594	http://dx.doi.org/10.1371/journal.pone.0020594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731618	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700010
J	Sonah, H; Deshmukh, RK; Sharma, A; Singh, VP; Gupta, DK; Gacche, RN; Rana, JC; Singh, NK; Sharma, TR				Sonah, Humira; Deshmukh, Rupesh K.; Sharma, Anshul; Singh, Vinay P.; Gupta, Deepak K.; Gacche, Raju N.; Rana, Jai C.; Singh, Nagendra K.; Sharma, Tilak R.			Genome-Wide Distribution and Organization of Microsatellites in Plants: An Insight into Marker Development in Brachypodium	PLOS ONE			English	Article							ORYZA-SATIVA L.; AGROBACTERIUM-MEDIATED TRANSFORMATION; EST-SSR MARKERS; MISMATCH REPAIR; DRAFT SEQUENCE; MODEL SYSTEM; DISTACHYON; DIVERSITY; MUTATION; DUPLICATIONS	Plant genomes are complex and contain large amounts of repetitive DNA including microsatellites that are distributed across entire genomes. Whole genome sequences of several monocot and dicot plants that are available in the public domain provide an opportunity to study the origin, distribution and evolution of microsatellites, and also facilitate the development of new molecular markers. In the present investigation, a genome-wide analysis of microsatellite distribution in monocots (Brachypodium, sorghum and rice) and dicots (Arabidopsis, Medicago and Populus) was performed. A total of 797,863 simple sequence repeats (SSRs) were identified in the whole genome sequences of six plant species. Characterization of these SSRs revealed that mono-nucleotide repeats were the most abundant repeats, and that the frequency of repeats decreased with increase in motif length both in monocots and dicots. However, the frequency of SSRs was higher in dicots than in monocots both for nuclear and chloroplast genomes. Interestingly, GC-rich repeats were the dominant repeats only in monocots, with the majority of them being present in the coding region. These coding GC-rich repeats were found to be involved in different biological processes, predominantly binding activities. In addition, a set of 22,879 SSR markers that were validated by e-PCR were developed and mapped on different chromosomes in Brachypodium for the first time, with a frequency of 101 SSR markers per Mb. Experimental validation of 55 markers showed successful amplification of 80% SSR markers in 16 Brachypodium accessions. An online database 'BraMi' (Brachypodium microsatellite markers) of these genome-wide SSR markers was developed and made available in the public domain. The observed differential patterns of SSR marker distribution would be useful for studying microsatellite evolution in a monocot-dicot system. SSR markers developed in this study would be helpful for genomic studies in Brachypodium and related grass species, especially for the map based cloning of the candidate gene(s).	[Sonah, Humira; Deshmukh, Rupesh K.; Sharma, Anshul; Singh, Vinay P.; Gupta, Deepak K.; Singh, Nagendra K.; Sharma, Tilak R.] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; [Rana, Jai C.] Natl Bur Plant Genet Resources, Reg Stn, Shimla, HP, India; [Deshmukh, Rupesh K.; Gacche, Raju N.] Swami Ramanand Teerth Marathwada Univ, Nanded, Maharashtra, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Swami Ramanand Teerth Marathwada University	Sonah, H (corresponding author), Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India.	trsharma@nrcpb.org	Deshmukh, Rupesh Kailasrao/C-6479-2012; Singh, Nouratan/N-9377-2017	Deshmukh, Rupesh Kailasrao/0000-0003-4167-6552; Singh, Nouratan/0000-0002-8063-8375; Sonah, Humira/0000-0003-4796-6120; /0000-0001-9732-7533	ICAR-NPTC [2049-3004]	ICAR-NPTC	ICAR-NPTC has funded this work with grant number 2049-3004, URL www.nrcpb.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves SC, 2009, NAT PROTOC, V4, P638, DOI 10.1038/nprot.2009.30; Anderson TJC, 2000, MOL ECOL, V9, P1599, DOI 10.1046/j.1365-294x.2000.01057.x; Asp T, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-36; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Chabane K, 2005, GENET RESOUR CROP EV, V52, P903, DOI 10.1007/s10722-003-6112-7; Chakraborty R, 1997, P NATL ACAD SCI USA, V94, P1041, DOI 10.1073/pnas.94.3.1041; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Garvin DF, 2008, CROP SCI, V48, pS69, DOI 10.2135/cropsci2007.06.0332tpg; Garvin DF, 2010, GENOME, V53, P1, DOI [10.1139/G09-079, 10.1139/g09-079]; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4; Hancock J.M., 1997, MICROSATELLITES EVOL, P1; Harr B, 2002, MOL CELL, V10, P199, DOI 10.1016/S1097-2765(02)00575-0; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li SX, 2011, MOL BREEDING, V27, P59, DOI 10.1007/s11032-010-9413-5; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Parida SK, 2006, THEOR APPL GENET, V112, P808, DOI 10.1007/s00122-005-0182-1; Parida SK, 2010, GENOME, V53, P55, DOI [10.1139/G09-084, 10.1139/g09-084]; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Riley DE, 2007, BIOCHEM BIOPH RES CO, V355, P619, DOI 10.1016/j.bbrc.2007.01.200; Saha MC, 2004, THEOR APPL GENET, V109, P783, DOI 10.1007/s00122-004-1681-1; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Singh H, 2010, MOL BREEDING, V25, P359, DOI 10.1007/s11032-009-9328-1; Sonah H, 2011, BIOTECHNOL ADV, V29, P199, DOI 10.1016/j.biotechadv.2010.11.002; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-88; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Whittaker JC, 2003, GENETICS, V164, P781; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Xu X, 2000, NAT GENET, V24, P396, DOI 10.1038/74238; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	41	157	171	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21298	10.1371/journal.pone.0021298	http://dx.doi.org/10.1371/journal.pone.0021298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713003	Green Submitted, Green Published, gold			2022-12-25	WOS:000291985100028
J	Vasan, SK; Neville, MJ; Antonisamy, B; Samuel, P; Fall, CH; Geethanjali, FS; Thomas, N; Raghupathy, P; Brismar, K; Karpe, F				Vasan, Senthil K.; Neville, Matt J.; Antonisamy, Belavendra; Samuel, Prasanna; Fall, Caroline H.; Geethanjali, Finney S.; Thomas, Nihal; Raghupathy, Palany; Brismar, Kerstin; Karpe, Fredrik			Absence of Birth-Weight Lowering Effect of ADCY5 and Near CCNL, but Association of Impaired Glucose-Insulin Homeostasis with ADCY5 in Asian Indians	PLOS ONE			English	Article							TYPE-2 DIABETES RISK; FASTING GLUCOSE; FETAL-GROWTH; GENE; POPULATION; MUTATIONS; COHORT; POLYMORPHISM; VARIANTS; ALLELES	Background: A feature of the Asian Indian phenotype is low birth weight with increased adult type 2 diabetes risk. Most populations show consistent associations between low birth weight and adult type 2 diabetes. Recently, two birth weight-lowering loci on chromosome 3 (near CCNL1 and ADCY5) were identified in a genome-wide association study, the latter of which is also a type 2 diabetes locus. We therefore tested the impact of these genetic variants on birth weight and adult glucose/insulin homeostasis in a large Indian birth cohort. Methodology/Principal Findings: Adults (n = 2,151) enrolled in a birth cohort (established 1969-73) were genotyped for rs900400 (near CCNL1) and rs9883204 (ADCY5). Associations were tested for birth weight, anthropometry from infancy to adulthood, and type 2 diabetes related glycemic traits. The average birth weight in this population was 2.79 +/- 0.47 kg and was not associated with genetic variation in CCNL1 (p = 0.87) or ADCY5 (p = 0.54). Allele frequencies for the 'birth weight-lowering' variants were similar compared with Western populations. There were no significant associations with growth or adult weight. However, the 'birth weight-lowering' variant of ADCY5 was associated with modest increase in fasting glucose (beta 0.041, p = 0.027), 2-hours glucose (beta 0.127, p = 0.019), and reduced insulinogenic index (beta -0.106, p = 0.050) and 2-hour insulin (beta -0.058, p = 0.010). Conclusions: The low birth weight in Asian Indians is not even partly explained by genetic variants near CCNL1 and ADCY5 which implies that non-genetic factors may predominate. However, the 'birth-weight-lowering' variant of ADCY5 was associated with elevated glucose and decreased insulin response in early adulthood which argues for a common genetic cause of low birth weight and risk of type 2 diabetes.	[Vasan, Senthil K.; Brismar, Kerstin] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Vasan, Senthil K.; Thomas, Nihal; Karpe, Fredrik] Christian Med Coll & Hosp, Dept Diabet Endocrinol & Metab, Vellore, Tamil Nadu, India; [Neville, Matt J.; Karpe, Fredrik] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Antonisamy, Belavendra; Samuel, Prasanna] Christian Med Coll & Hosp, Dept Biostat, Vellore, Tamil Nadu, India; [Fall, Caroline H.] MRC, Epidemiol Resource Ctr, Southampton, Hants, England; [Geethanjali, Finney S.] Christian Med Coll & Hosp, Dept Clin Biochem, Vellore, Tamil Nadu, India; [Raghupathy, Palany] Christian Med Coll & Hosp, Dept Child Hlth, Vellore, Tamil Nadu, India; [Karpe, Fredrik] Oxford Radcliffe Hosp ORH Trust, Oxford Biomed Res Ctr, NIHR, Oxford, England	Karolinska Institutet; Christian Medical College & Hospital (CMCH) Vellore; University of Oxford; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; University of Oxford	Vasan, SK (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	vaskan@ki.se; Fredrik.Karpe@ocdem.ox.ac.uk		Vasan, Senthil/0000-0002-3630-6568; Brismar, Kerstin/0000-0002-5241-514X; Fall, Caroline/0000-0003-4402-5552; Karpe, Fredrik/0000-0002-2751-1770	British Heart Foundation; Swedish Institutet, Stockholm, Sweden; Family Erling-Persson Foundation; Medical Research Council [G0400519, MC_UP_A620_1016, MR/J000094/1] Funding Source: researchfish; MRC [G0400519, MC_UP_A620_1016, MR/J000094/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Swedish Institutet, Stockholm, Sweden; Family Erling-Persson Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by the British Heart Foundation. S.V. is on a scholarship from the Swedish Institutet, Stockholm, Sweden and also supported by Family Erling-Persson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson EA, 2010, DIABETOLOGIA, V53, P1908, DOI 10.1007/s00125-010-1790-0; Antonisamy B, 2009, INT J EPIDEMIOL, V38, P663, DOI 10.1093/ije/dyn159; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386; DHAWAN S, 1995, BRIT MED J, V311, P86, DOI 10.1136/bmj.311.6997.86; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Edghill EL, 2006, DIABETIC MED, V23, P1301, DOI 10.1111/j.1464-5491.2006.01999.x; Freathy RM, 2007, AM J HUM GENET, V80, P1150, DOI 10.1086/518517; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Freathy RM, 2009, DIABETES, V58, P1428, DOI 10.2337/db08-1739; Harding S, 2004, INT J EPIDEMIOL, V33, P1279, DOI 10.1093/ije/dyh186; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Kinare AS, 2010, J ULTRAS MED, V29, P215, DOI 10.7863/jum.2010.29.2.215; Kuriyan R, 1998, INDIAN J MED RES, V107, P37; Leary S, 2006, ACTA OBSTET GYN SCAN, V85, P1080, DOI 10.1080/00016340600697447; Lindsay RS, 2003, DIABETES, V52, P187, DOI 10.2337/diabetes.52.1.187; Raghupathy P, 2010, DIABETES RES CLIN PR, V87, P283, DOI 10.1016/j.diabres.2009.11.015; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; SACHDEV HPS, 1997, MALNUTRITION S ASIA, P23; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Vaessen N, 2002, LANCET, V359, P1036, DOI 10.1016/S0140-6736(02)08067-4; Weedon MN, 2005, DIABETES, V54, P576, DOI 10.2337/diabetes.54.2.576; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886	25	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21331	10.1371/journal.pone.0021331	http://dx.doi.org/10.1371/journal.pone.0021331			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712988	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000291985100031
J	Zhang, W; Liu, GJ; Tang, F; Shao, J; Lu, Y; Bao, YL; Yao, HC; Lu, CP				Zhang, Wei; Liu, Guangjin; Tang, Fang; Shao, Jing; Lu, Yan; Bao, Yinli; Yao, Huochun; Lu, Chengping			Pre-Absorbed Immunoproteomics: A Novel Method for the Detection of Streptococcus suis Surface Proteins	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; SUBCELLULAR-LOCALIZATION; PROTEOME ANALYSIS; NORTH-AMERICA; IN-VIVO; IDENTIFICATION; SEROTYPE-2; VIRULENCE; TYPE-2; MUTANOLYSIN	Streptococcus suis serotype 2 (SS2) is a zoonotic pathogen that can cause infections in pigs and humans. Bacterial surface proteins are often investigated as potential vaccine candidates and biomarkers of virulence. In this study, a novel method for identifying bacterial surface proteins is presented, which combines immunoproteomic and immunoserologic techniques. Critical to the success of this new method is an improved procedure for generating two-dimensional electrophoresis gel profiles of S. suis proteins. The S. suis surface proteins identified in this study include muramidase-released protein precursor (MRP) and an ABC transporter protein, while MRP is thought to be one of the main virulence factors in SS2 located on the bacterial surface. Herein, we demonstrate that the ABC transporter protein can bind to HEp-2 cells, which strongly suggests that this protein is located on the bacterial cell surface and may be involved in pathogenesis. An immunofluorescence assay confirmed that the ABC transporter is localized to the bacterial outer surface. This new method may prove to be a useful tool for identifying surface proteins, and aid in the development of new vaccine subunits and disease diagnostics.	[Zhang, Wei; Liu, Guangjin; Tang, Fang; Shao, Jing; Lu, Yan; Bao, Yinli; Yao, Huochun; Lu, Chengping] Nanjing Agr Univ, Key Lab Anim Dis Diagnost & Immunol, Minist Agr, Nanjing, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Lu, CP (corresponding author), Nanjing Agr Univ, Key Lab Anim Dis Diagnost & Immunol, Minist Agr, Nanjing, Peoples R China.	lucp@njau.edu.cn	Lu, Yan/AAX-7831-2020	Lu, Yan/0000-0002-5893-6114	Youth Foundation of National Natural Science Foundation of China [30800815]; Foundation of National Natural Science Foundation of China [30671558]; Cloning and Identification of the resistance genes of swine against major pathogenic microorganism [2009ZX08009-1546]; Chinese Ministry of Agriculture [200803016, 200903055]	Youth Foundation of National Natural Science Foundation of China; Foundation of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cloning and Identification of the resistance genes of swine against major pathogenic microorganism; Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs)	This work was supported by the Youth Foundation of National Natural Science Foundation of China (No. 30800815), the Foundation of National Natural Science Foundation of China (No. 30671558), Cloning and Identification of the resistance genes of swine against major pathogenic microorganism (2009ZX08009-1546), the Special Fund for Public Welfare Industry of Chinese Ministry of Agriculture (200803016) and the Special Fund for Public Welfare Industry of Chinese Ministry of Agriculture (200903055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDS JP, 1988, REV INFECT DIS, V10, P131; Bonafonte MA, 2000, FEMS MICROBIOL LETT, V191, P31, DOI 10.1016/S0378-1097(00)00366-9; Cahill DJ, 2001, J IMMUNOL METHODS, V250, P81, DOI 10.1016/S0022-1759(01)00325-8; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Gu HW, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-201; Hamel J, 1997, MICROB PATHOGENESIS, V23, P11, DOI 10.1006/mpat.1996.0124; Hempel K, 2010, J PROTEOME RES, V9, P1579, DOI 10.1021/pr901143a; Jing HB, 2008, PROTEOMICS, V8, P333, DOI 10.1002/pmic.200600930; KAMPFER P, 1995, J MICROBIOL METH, V21, P55, DOI 10.1016/0167-7012(94)00033-4; Kim SW, 2007, MOL CELLS, V23, P239; KTIMPFER P, 1995, J MICROBIOLOGICAL ME, V21, P55; LINDENMAYER J, 1990, J CLIN MICROBIOL, V28, P92, DOI 10.1128/JCM.28.1.92-96.1990; MITTAL KR, 1982, J CLIN MICROBIOL, V15, P1019, DOI 10.1128/JCM.15.6.1019-1023.1982; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Shen HB, 2009, PROTEIN PEPTIDE LETT, V16, P1478, DOI 10.2174/092986609789839322; SIEGEL JL, 1981, INFECT IMMUN, V31, P808, DOI 10.1128/IAI.31.2.808-815.1981; Simpson RJ, 2003, PROTEINS PROTEOMICS; SMITH HE, 1992, INFECT IMMUN, V60, P2361, DOI 10.1128/IAI.60.6.2361-2367.1992; SPATAFORA G, 1995, INFECT IMMUN, V63, P2556, DOI 10.1128/IAI.63.7.2556-2563.1995; SUTCLIFFE IC, 1995, J BACTERIOL, V177, P1123, DOI 10.1128/jb.177.5.1123-1128.1995; Tjalsma H, 2008, PROTEOMICS, V8, P1415, DOI 10.1002/pmic.200700550; TROTTIER S, 1991, REV INFECT DIS, V13, P1251; VECHT U, 1989, AM J VET RES, V50, P1037; Vecht U, 1997, VET MICROBIOL, V58, P53, DOI 10.1016/S0378-1135(97)00131-4; Winterhoff N, 2002, J BACTERIOL, V184, P6768, DOI 10.1128/JB.184.24.6768-6776.2002; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Wu ZF, 2008, FEMS IMMUNOL MED MIC, V53, P52, DOI 10.1111/j.1574-695X.2008.00401.x; Yao HuoChun, 1999, Journal of Nanjing Agricultural University, V22, P67; YOKOGAWA K, 1974, ANTIMICROB AGENTS CH, V6, P156, DOI 10.1128/AAC.6.2.156; Zhang AD, 2008, PROTEOMICS, V8, P3506, DOI 10.1002/pmic.200800007; Zhang AD, 2009, VACCINE, V27, P1348, DOI 10.1016/j.vaccine.2008.12.047; Zhang W, 2007, PROTEOMICS, V7, P4468, DOI 10.1002/pmic.200700294; Zhou M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-173; Zhu HN, 2002, RAPID COMMUN MASS SP, V16, P2115, DOI 10.1002/rcm.831	37	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21234	10.1371/journal.pone.0021234	http://dx.doi.org/10.1371/journal.pone.0021234			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713002	Green Submitted, Green Published, gold			2022-12-25	WOS:000291985100019
J	Luu, B; Ellisor, D; Zervas, M				Luu, Brian; Ellisor, Debra; Zervas, Mark			The Lineage Contribution and Role of Gbx2 in Spinal Cord Development	PLOS ONE			English	Article							VENTRAL NEURAL-TUBE; PROGENITOR-CELL IDENTITY; NEURONAL IDENTITY; MOTOR-NEURONS; MID/HINDBRAIN ORGANIZER; TRANSCRIPTIONAL CODES; NEUROBLAST COMPETENCE; REGULATORY NETWORK; GENETIC LINEAGES; HOMEOBOX GENE	Background: Forging a relationship between progenitors with dynamically changing gene expression and their terminal fate is instructive for understanding the logic of how cell-type diversity is established. The mouse spinal cord is an ideal system to study these mechanisms in the context of developmental genetics and nervous system development. Here we focus on the Gastrulation homeobox 2 (Gbx2) transcription factor, which has not been explored in spinal cord development. Methodology/Principal Findings: We determined the molecular identity of Gbx2-expressing spinal cord progenitors. We also utilized genetic inducible fate mapping to mark the Gbx2 lineage at different embryonic stages in vivo in mouse. Collectively, we uncover cell behaviors, cytoarchitectonic organization, and the terminal cell fate of the Gbx2 lineage. Notably, both ventral motor neurons and interneurons are derived from the Gbx2 lineage, but only during a short developmental period. Short-term fate mapping during mouse spinal cord development shows that Gbx2 expression is transient and is extinguished ventrally in a rostral to caudal gradient. Concomitantly, a permanent lineage restriction boundary ensures that spinal cord neurons derived from the Gbx2 lineage are confined to a dorsal compartment that is maintained in the adult and that this lineage generates inhibitory interneurons of the spinal cord. Using lineage tracing and molecular markers to follow Gbx2-mutant cells, we show that the loss of Gbx2 globally affects spinal cord patterning including the organization of interneuron progenitors. Finally, long-term lineage analysis reveals that the presence and timing of Gbx2 expression in interneuron progenitors results in the differential contribution to subtypes of terminally differentiated interneurons in the adult spinal cord. Conclusions/Significance: We illustrate the complex cellular nature of Gbx2 expression and lineage contribution to the mouse spinal cord. In a broader context, this study provides a direct link between spinal cord progenitors undergoing dynamic changes in molecular identity and terminal neuronal fate.	[Luu, Brian; Ellisor, Debra; Zervas, Mark] Brown Univ, Div Biol & Med, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Brown University	Luu, B (corresponding author), Brown Univ, Div Biol & Med, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.	Mark_Zervas@brown.edu		Zervas, Mark/0000-0002-7027-4299	Brown University	Brown University	This project was supported by startup funds (MZ). BL was partially supported by Brown University Undergraduate Teaching and Research Awards (2007, 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalliu D, 2009, NEURON, V61, P708, DOI 10.1016/j.neuron.2008.12.026; Alvarez FJ, 2005, J COMP NEUROL, V493, P177, DOI 10.1002/cne.20711; Alvarez-Medina R, 2008, DEVELOPMENT, V135, P237, DOI 10.1242/dev.012054; Anderson KN, 2004, BRAIN RES PROTOC, V12, P132, DOI 10.1016/j.brainresprot.2003.10.001; ANTAL M, 1990, J COMP NEUROL, V295, P467, DOI 10.1002/cne.902950310; Avivi C, 1999, DEV BRAIN RES, V115, P89, DOI 10.1016/S0165-3806(99)00054-1; BOUILLET P, 1995, DEV DYNAM, V204, P372, DOI 10.1002/aja.1002040404; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brown Ashly, 2009, J Vis Exp, DOI 10.3791/1687; Burrill JD, 1997, DEVELOPMENT, V124, P4493; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Chapman G, 1997, GENOMICS, V46, P223, DOI 10.1006/geno.1997.4969; Chen L, 2009, DEVELOPMENT, V136, P1317, DOI 10.1242/dev.030510; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Cleary MD, 2006, GENE DEV, V20, P429, DOI 10.1101/gad.1382206; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Ellisor D, 2010, MOL CELL NEUROSCI, V45, P132, DOI 10.1016/j.mcn.2010.06.004; Ellisor D, 2009, GENE EXPR PATTERNS, V9, P475, DOI 10.1016/j.gep.2009.07.007; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Erskine L, 1998, DEV BIOL, V199, P26, DOI 10.1006/dbio.1998.8912; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; GILMAN S, 1992, ESSENTIALS CLIN NEUR; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Heimbucher T, 2007, MOL CELL BIOL, V27, P340, DOI 10.1128/MCB.00811-06; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; John A, 2005, DEV DYNAM, V234, P767, DOI 10.1002/dvdy.20568; Joyner AL, 2006, DEV DYNAM, V235, P2376, DOI 10.1002/dvdy.20884; Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026; LEBER SM, 1995, J NEUROSCI, V15, P1236; Lee S, 2008, DEV CELL, V14, P877, DOI 10.1016/j.devcel.2008.03.021; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Li JYH, 2001, DEVELOPMENT, V128, P4979; Li JYH, 2002, NEURON, V36, P31, DOI 10.1016/S0896-6273(02)00935-2; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; MacDonald SC, 2003, J NEUROSURG, V98, P1094, DOI 10.3171/jns.2003.98.5.1094; Mansouri A, 1998, MECH DEVELOP, V78, P171, DOI 10.1016/S0925-4773(98)00168-3; Matise MP, 1997, J NEUROSCI, V17, P7805; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Muroyama Y, 2002, GENE DEV, V16, P548, DOI 10.1101/gad.937102; Myers CP, 2005, NEURON, V46, P37, DOI 10.1016/j.neuron.2005.02.022; Nordstrom U, 2006, PLOS BIOL, V4, P1438, DOI 10.1371/journal.pbio.0040252; Paxinos G., 2004, RAT NERVOUS SYSTEM, V3rd; Pearson BJ, 2003, NATURE, V425, P624, DOI 10.1038/nature01910; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Ramon y Cajal S, 1995, HISTOLOGY NERVOUS SY; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Rottkamp CA, 2008, DEV BIOL, V314, P23, DOI 10.1016/j.ydbio.2007.10.046; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Wassarman KM, 1997, DEVELOPMENT, V124, P2923; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	56	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20940	10.1371/journal.pone.0020940	http://dx.doi.org/10.1371/journal.pone.0020940			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698205	gold, Green Submitted, Green Published			2022-12-25	WOS:000291734100034
J	Zhang, XP; Qu, SG				Zhang, Xiuping; Qu, Shaogang			Proximity of Transmembrane Segments 5 and 8 of the Glutamate Transporter GLT-1 Inferred from Paired Cysteine Mutagenesis	PLOS ONE			English	Article							AMINOBUTYRIC-ACID TRANSPORTER; RAT-BRAIN; STRUCTURAL REARRANGEMENTS; INDIVIDUAL SUBUNITS; MEMBRANE-VESICLES; REENTRANT LOOP; GLIAL-CELLS; SODIUM; SUBSTRATE; PORE	Background: GLT-1 is a glial glutamate transporter which maintains low synaptic concentrations of the excitatory neurotransmitter enabling efficient synaptic transmission. Based on the crystal structure of the bacterial homologue Glt(Ph), it has been proposed that the reentrant loop HP2, which connects transmembrane domains (TM) 7 and 8, moves to open and close access to the binding pocket from the extracellular medium. However the conformation change between TM5 and TM8 during the transport cycle is not clear yet. We used paired cysteine mutagenesis in conjunction with treatments with Copper(II)(1,10-Phenanthroline)(3) (CuPh), to verify the predicted proximity of residues located at these structural elements of GLT-1. Methodology/Principal Findings: To assess the proximity of transmembrane domain (TM) 5 relative to TM8 during transport by the glial glutamate transporter GLT-1/EAAT2, cysteine pairs were introduced at the extracellular ends of these structural elements. A complete inhibition of transport by Copper(II)(1,10-Phenanthroline)(3) is observed in the double mutants I295C/I463C and G297C/I463C, but not in the corresponding single mutants. Glutamate and potassium, both expected to increase the proportion of inward-facing transporters, significantly protected against the inhibition of transport activity of I295C/I463C and G297C/I463C by CuPh. Transport by the double mutants I295C/I463C and G297C/I463C also was inhibited by Cd(2+). Conclusions/Significance: Our results suggest that TM5 (Ile-295, Gly-297) is in close proximity to TM8 (Ile-463) in the mammalian transporter, and that the spatial relationship between these domains is altered during the transport cycle.	[Zhang, Xiuping] Guangdong Med Coll, China Amer Canc Res Inst, Dongguan, Guangdong, Peoples R China; [Qu, Shaogang] So Med Univ, Dept Immunol, Guangzhou, Guangdong, Peoples R China	Guangdong Medical University; Southern Medical University - China	Zhang, XP (corresponding author), Guangdong Med Coll, China Amer Canc Res Inst, Dongguan, Guangdong, Peoples R China.	sgq9528@fimmu.com			Southern Medical University [B1000420]	Southern Medical University	Funding was provided by Southern Medical University, SMU grant B1000420 (http://www.fimmu.com). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benitah JP, 1996, P NATL ACAD SCI USA, V93, P7392, DOI 10.1073/pnas.93.14.7392; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; GRUNEWALD M, 1995, J BIOL CHEM, V270, P17017, DOI 10.1074/jbc.270.28.17017; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Leighton BH, 2006, J BIOL CHEM, V281, P29788, DOI 10.1074/jbc.M604991200; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; PerezGarcia MT, 1996, P NATL ACAD SCI USA, V93, P300, DOI 10.1073/pnas.93.1.300; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; Qu SG, 2008, J BIOL CHEM, V283, P26391, DOI 10.1074/jbc.M802401200; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zomot E, 2005, J BIOL CHEM, V280, P25512, DOI 10.1074/jbc.M503864200	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21288	10.1371/journal.pone.0021288	http://dx.doi.org/10.1371/journal.pone.0021288			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698173	gold, Green Published, Green Submitted			2022-12-25	WOS:000291734100078
J	Strand, MF; Wilson, SR; Dembinski, JL; Holsworth, DD; Khvat, A; Okun, I; Petersen, D; Krauss, S				Strand, Martin F.; Wilson, Steven R.; Dembinski, Jennifer L.; Holsworth, Daniel D.; Khvat, Alexander; Okun, Ilya; Petersen, Dirk; Krauss, Stefan			A Novel Synthetic Smoothened Antagonist Transiently Inhibits Pancreatic Adenocarcinoma Xenografts in a Mouse Model	PLOS ONE			English	Article							HEDGEHOG SIGNALING PATHWAY; GLI-MEDIATED TRANSCRIPTION; TUMOR-SUPPRESSOR SUFU; BASAL-CELL CARCINOMAS; SONIC HEDGEHOG; PRIMARY CILIA; CANCER-CELLS; TUMORIGENESIS; CYCLOPAMINE; MECHANISMS	Background: Hedgehog (Hh) signaling is over-activated in several solid tumors where it plays a central role in cell growth, stroma recruitment and tumor progression. In the Hh signaling pathway, the Smoothened (SMO) receptor comprises a primary drug target with experimental small molecule SMO antagonists currently being evaluated in clinical trials. Principal Findings: Using Shh-Light II (Shh-L2) and alkaline phosphatase (AP) based screening formats on a "focused diversity" library we identified a novel small molecule inhibitor of the Hh pathway, MS-0022 (2-bromo-N-(4-(8-methylimidazo[1,2-a]pyridin-2-yl)phenyl)benzamide). MS-0022 showed effective Hh signaling pathway inhibition at the level of SMO in the low nM range, and Hh pathway inhibition downstream of Suppressor of fused (SUFU) in the low mu M range. MS-0022 reduced growth in the tumor cell lines PANC-1, SUIT-2, PC-3 and FEMX in vitro. MS-0022 treatment led to a transient delay of tumor growth that correlated with a reduction of stromal Gli1 levels in SUIT-2 xenografts in vivo. Significance: We document the in vitro and in vivo efficacy and bioavailability of a novel small molecule SMO antagonist, MS-0022. Although MS-0022 primarily interferes with Hh signaling at the level of SMO, it also has a downstream inhibitory effect and leads to a stronger reduction of growth in several tumor cell lines when compared to related SMO antagonists.	[Strand, Martin F.; Dembinski, Jennifer L.; Krauss, Stefan] Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Microbiol,Unit Cell Signalling, N-0027 Oslo, Norway; [Holsworth, Daniel D.; Khvat, Alexander; Okun, Ilya] ChemDiv Inc, San Diego, CA USA; [Wilson, Steven R.; Petersen, Dirk] Univ Oslo, Dept Chem, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo	Strand, MF (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Microbiol,Unit Cell Signalling, N-0027 Oslo, Norway.	martin.frank.strand@rr-research.no; stefan.krauss@rr-research.no	Okun, Ilya/F-9889-2014; Strand, Martin/AAQ-3908-2021; wilson, steven/D-6614-2012	Okun, Ilya/0000-0002-8562-4044; Strand, Martin/0000-0002-2588-5488; wilson, steven/0000-0002-9755-1188; Dembinski, Jennifer/0000-0001-9259-9572; Krauss, Stefan/0000-0001-6992-8091	Research Council of Norway; ChemDiv Inc.	Research Council of Norway(Research Council of Norway); ChemDiv Inc.	This study was funded by the Research Council of Norway (http://www.forskningsradet.no/), and by ChemDiv Inc. (http://www.chemdiv.com/). The Research Council of Norway had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. As indicated under the competing interests section, Drs. Alex Khvat, Ilya Okun and Dan Holsworth are employed by ChemDiv Inc., and ChemDiv Inc. had a partial role in the study design, execution of the experiments, data analysis, and decision to publish and in reviewing the manuscript. The MS-0022 chemotype has been patented by ChemDiv Inc. (PCT/IB2008/055258; WO 2009/077956 A2 and WO 2009/077956 A3).	Alieva I B, 1999, Membr Cell Biol, V12, P895; Altaba ARI, 2008, CANCER CELL, V14, P281, DOI 10.1016/j.ccr.2008.09.007; Bailey JM, 2009, ONCOGENE, V28, P3513, DOI 10.1038/onc.2009.220; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Bailey JM, 2007, J CELL BIOCHEM, V102, P829, DOI 10.1002/jcb.21509; Barakat MT, 2009, CANCER CELL, V16, P276, DOI 10.1016/j.ccr.2009.09.019; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Birnbaum DJ, 2011, GENE CHROMOSOME CANC, V50, P456, DOI 10.1002/gcc.20870; Borzillo GV, 2005, CURR TOP MED CHEM, V5, P147, DOI 10.2174/1568026053507732; Butz J, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-11; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cheng SY, 2008, ADV CANCER RES, V101, P29, DOI 10.1016/S0065-230X(08)00402-8; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Dembinski J. L., 2009, CLIN EXP METASTASIS; Dierks C, 2010, RECENT RESULTS CANC, V184, P235, DOI 10.1007/978-3-642-01222-8_17; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; FIETZ MJ, 1994, DEVELOPMENT, P43; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hidaka H, 2005, J EXP CLIN CANC RES, V24, P127; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kainuma O, 1997, PANCREAS, V15, P379, DOI 10.1097/00006676-199711000-00008; Katoh Y, 2009, INT J ONCOL, V35, P187, DOI 10.3892/ijo_00000328; Kean S, 2009, SCIENCE, V325, P1188, DOI 10.1126/science.325_1188; Kiselyov AS, 2006, CHEM BIOL DRUG DES, V68, P67, DOI 10.1111/j.1747-0285.2006.00409.x; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; NEESSE A, 2010, GUT             1021, DOI DOI 10.1136/GUT.2010.226092; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Robarge KD, 2009, BIOORG MED CHEM LETT, V19, P5576, DOI 10.1016/j.bmcl.2009.08.049; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sato N, 1998, FEBS LETT, V441, P318, DOI 10.1016/S0014-5793(98)01571-3; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; So PL, 2010, EXPERT OPIN INV DRUG, V19, P1099, DOI 10.1517/13543784.2010.504714; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; Toftgard R, 2009, NAT MED, V15, P994, DOI 10.1038/nm0909-994; Tremblay MR, 2009, J MED CHEM, V52, P4400, DOI 10.1021/jm900305z; Unden AB, 1996, CANCER RES, V56, P4562; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Walter K, 2010, CLIN CANCER RES, V16, P1781, DOI 10.1158/1078-0432.CCR-09-1913; Wilson CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005182; Wilson SR, 2005, J SEP SCI, V28, P1751, DOI 10.1002/jssc.200500062; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; YAUCH RL, 2009, SCIENCE; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yue S, 2009, ONCOGENE, V28, P492, DOI 10.1038/onc.2008.403; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225	69	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e19904	10.1371/journal.pone.0019904	http://dx.doi.org/10.1371/journal.pone.0019904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698280	Green Published, Green Submitted, gold			2022-12-25	WOS:000291730000004
J	Benes, CH; Poulogiannis, G; Cantley, LC; Soltoff, SP				Benes, C. H.; Poulogiannis, G.; Cantley, L. C.; Soltoff, S. P.			The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility	ONCOGENE			English	Article						signaling; mass spectrometry; SRC; adhesion; motility; metastasis	TYROSINE-PHOSPHATASE SHP-2; HUMAN COLORECTAL-CANCER; HUMAN-COLON CARCINOMA; FOCAL-ADHESION; KINASE-ACTIVITY; CELL-MIGRATION; SIGNAL-TRANSDUCTION; FAMILY KINASES; GROWTH-FACTOR; TUMOR-CELLS	Multiple SRC-family kinases (SFKs) are commonly activated in carcinoma and appear to have a role in metastasis through incompletely understood mechanisms. Recent studies have shown that CDCP1 (CUB (complement C1r/C1s, Uegf, Bmp1) Domain-Containing Protein-1) is a transmembrane protein and an SRC substrate potentially involved in metastasis. Here we show that increased SFK and CDCP1 tyrosine phosphorylation is, surprisingly, associated with a decrease in FAK phosphorylation. This appears to be true in human tumors as shown by our correlation analysis of a mass spectrometric data set of affinity-purified phosphotyrosine peptides obtained from normal and cancer lung tissue samples. Induction of tyrosine phosphorylation of CDCP1 in cell culture, including by a mAb that binds to its extracellular domain, promoted changes in SFK and FAK tyrosine phosphorylation, as well as in PKC (TM), a protein known to associate with CDCP1, and these changes are accompanied by increases in adhesion and motility. Thus, signaling events that accompany the CDCP1 tyrosine phosphorylation observed in cell lines and human lung tumors may explain how the CDCP1/SFK complex regulates motility and adhesion. Oncogene (2012) 31, 653-663; doi:10.1038/onc.2011.262; published online 4 July 2011	[Benes, C. H.; Poulogiannis, G.; Cantley, L. C.; Soltoff, S. P.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Dept Med, Boston, MA 02215 USA; [Poulogiannis, G.; Cantley, L. C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Soltoff, SP (corresponding author), Beth Israel Deaconess Med Ctr, Div Signal Transduct, Dept Med, 330 Brookline Ave,CLS-406, Boston, MA 02215 USA.	ssoltoff@bidmc.harvard.edu	Poulogiannis, George/AAE-1966-2019; Cantley, Lewis C/D-1800-2014; Poulogiannis, George/AAY-2210-2021	Poulogiannis, George/0000-0002-0529-8614; Cantley, Lewis C/0000-0002-1298-7653; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056203] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allgayer H, 2002, CANCER, V94, P344, DOI 10.1002/cncr.10221; Alvares SM, 2008, BBA-GEN SUBJECTS, V1780, P486, DOI 10.1016/j.bbagen.2008.01.010; Awakura Y, 2008, J CANCER RES CLIN, V134, P1363, DOI 10.1007/s00432-008-0412-4; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; BOLEN JB, 1987, P NATL ACAD SCI USA, V84, P2251, DOI 10.1073/pnas.84.8.2251; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; Brunton VG, 2005, CANCER RES, V65, P1335, DOI 10.1158/0008-5472.CAN-04-1949; Buhring HJ, 2004, STEM CELLS, V22, P334, DOI 10.1634/stemcells.22-3-334; CARTWRIGHT CA, 1989, J CLIN INVEST, V83, P2025, DOI 10.1172/JCI114113; Chan KT, 2009, J CELL BIOL, V185, P357, DOI 10.1083/jcb.200809110; Cooper JA, 2008, BIOCHEMISTRY-US, V47, P5681, DOI 10.1021/bi8003044; Courtneidge SA, 2002, BIOCHEM SOC T, V30, P11, DOI 10.1042/bst0300011; Deryugina EI, 2009, MOL CANCER RES, V7, P1197, DOI 10.1158/1541-7786.MCR-09-0100; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; He Y, 2010, J BIOL CHEM, V285, P26162, DOI 10.1074/jbc.M109.096453; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Ikeda JI, 2009, CANCER SCI, V100, P429, DOI 10.1111/j.1349-7006.2008.01066.x; ILLC D, 1995, NATURE, V377, P539; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Leroy C, 2009, CANCER RES, V69, P2279, DOI 10.1158/0008-5472.CAN-08-2354; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Manes S, 1999, MOL CELL BIOL, V19, P3125; MCGLADE J, 1992, P NATL ACAD SCI USA, V89, P8869, DOI 10.1073/pnas.89.19.8869; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Perry SE, 2007, FEBS LETT, V581, P1137, DOI 10.1016/j.febslet.2007.02.025; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Serrels A, 2006, MOL CANCER THER, V5, P3014, DOI 10.1158/1535-7163.MCT-06-0382; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Spassov DS, 2011, MOL CELL BIOL, V31, P766, DOI 10.1128/MCB.00841-10; Spassov DS, 2009, AM J PATHOL, V174, P1756, DOI 10.2353/ajpath.2009.080890; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Tilghman RW, 2005, J CELL SCI, V118, P2613, DOI 10.1242/jcs.02380; Uekita T, 2008, AM J PATHOL, V172, P1729, DOI 10.2353/ajpath.2008.070981; Uekita T, 2007, MOL CELL BIOL, V27, P7649, DOI 10.1128/MCB.01246-07; Vitale S, 2008, EUR J CELL BIOL, V87, P569, DOI 10.1016/j.ejcb.2008.04.002; Vultur A, 2008, MOL CANCER THER, V7, P1185, DOI 10.1158/1535-7163.MCT-08-0126; Wortmann A, 2009, IUBMB LIFE, V61, P723, DOI 10.1002/iub.198; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zheng YH, 2009, MOL CELL, V35, P11, DOI 10.1016/j.molcel.2009.06.013	52	25	26	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	5					653	663		10.1038/onc.2011.262	http://dx.doi.org/10.1038/onc.2011.262			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MS	21725358	Green Accepted			2022-12-25	WOS:000300221800011
J	Damiano, L; Le Devedec, SE; Di Stefano, P; Repetto, D; Lalai, R; Truong, H; Xiong, JL; Danen, EH; Yan, K; Verbeek, FJ; De Luca, E; Attanasio, F; Buccione, R; Turco, E; van de Water, B; Defilippi, P				Damiano, L.; Le Devedec, S. E.; Di Stefano, P.; Repetto, D.; Lalai, R.; Truong, H.; Xiong, J. L.; Danen, E. H.; Yan, K.; Verbeek, F. J.; De Luca, E.; Attanasio, F.; Buccione, R.; Turco, E.; van de Water, B.; Defilippi, P.			p140Cap suppresses the invasive properties of highly metastatic MTLn3-EGFR cells via impaired cortactin phosphorylation	ONCOGENE			English	Article						p140Cap; cortactin; tumor invasion; metastasis; breast cancer	ACTIN; DYNAMICS; INVADOPODIA; DEGRADATION; MOTILITY; SITES	We have recently shown that the adaptor protein p140Cap regulates tumor properties in terms of cell motility and growth. Here, by using the highly metastatic rat adenocarcinoma cell line MTLn3-epidermal growth factor receptor (EGFR), we assess the role of p140Cap in metastasis formation. Orthotopic transplantation of MTLn3-EGFR cells over-expressing p140Cap in Rag2(-/-)gamma(-/-)(c) mice resulted in normal primary tumor growth compared with the controls. Strikingly, p140Cap over-expression causes an 80% inhibition in the number of lung metastases. p140Cap over-expressing cells display a 50% reduction in directional cell migration, an increased number and size of focal adhesions, and a strong impairment in the ability to invade in a 3D matrix. p140Cap overexpression affects EGFR signaling and tyrosine phosphorylation of cortactin in response to EGF stimulation. Intriguingly, p140Cap associates with cortactin via interaction with its second proline-rich domain to the cortactin SH3 domain. The phosphomimetic cortactin tyrosine 421 mutant rescues migration and invasive properties in p140Cap over-expressing cells. Taken together, these data demonstrate that p140Cap suppresses the invasive properties of highly metastatic breast carcinoma cells by inhibiting cortactin-dependent cell motility. Oncogene (2012) 31, 624-633; doi:10.1038/onc.2011.257; published online 4 July 2011	[Le Devedec, S. E.; Lalai, R.; Truong, H.; Xiong, J. L.; Danen, E. H.; van de Water, B.] Leiden Univ, LACDR, Div Toxicol, Leiden, Netherlands; [Damiano, L.; Di Stefano, P.; Repetto, D.; De Luca, E.; Turco, E.; Defilippi, P.] Univ Turin, Dept Genet Biol & Biochem, Mol Biotechnol Ctr, I-10126 Turin, Italy; [Yan, K.; Verbeek, F. J.] Leiden Univ, Leiden Inst Adv Comp Sci, Leiden, Netherlands; [Attanasio, F.; Buccione, R.] Consorzio Mario Negri Sud, Tumour Cell Invas Lab, Chieti, Italy	Leiden University; Leiden University - Excl LUMC; University of Turin; Leiden University; Leiden University - Excl LUMC; Consorzio Mario Negri Sud	van de Water, B (corresponding author), Leiden Univ, LACDR, Div Toxicol, Leiden, Netherlands.	paola.defilippi@unito.it	DEFILIPPI, Paola/L-2232-2014; De Luca, Elisa/L-2491-2017	De Luca, Elisa/0000-0001-9849-0703; Le Devedec, Sylvia/0000-0002-0615-9616; Yan, Kuan/0000-0003-4143-3569; Defilippi, Paola/0000-0001-6427-4906; danen, erik/0000-0002-0491-6345; Buccione, Roberto/0000-0001-9210-5261	EU; AIRC; MUR (PRIN); Regione Piemonte - Progetti Sanita; Oncoprot; PiSTEM; Druidi; CIPE, Compagnia San Paolo, Torino; Dutch Cancer Society [UL 2006-3521, UL 2007-3860, UL 2010-4670]; Netherlands Genomics Initiative	EU; AIRC; MUR (PRIN); Regione Piemonte - Progetti Sanita; Oncoprot; PiSTEM; Druidi; CIPE, Compagnia San Paolo, Torino; Dutch Cancer Society; Netherlands Genomics Initiative	We thank Stefan Huveneers for help with the in vitro angiogenesis assay. This work was supported by EU FP7 Metafight project, AIRC, MUR (PRIN), Regione Piemonte - Progetti Sanita, Oncoprot, PiSTEM, Druidi and CIPE, Compagnia San Paolo, Torino, the Dutch Cancer Society (UL 2006-3521, UL 2007-3860 and UL 2010-4670) and the Netherlands Genomics Initiative grant to the Netherlands Toxicogenomics Center grant.	Ayala I, 2008, J CELL SCI, V121, P369, DOI 10.1242/jcs.008037; Baldassarre M, 2006, EUR J CELL BIOL, V85, P1217, DOI 10.1016/j.ejcb.2006.08.003; Bowden ET, 2001, METHOD CELL BIOL, V63, P613; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Chin LS, 2000, J BIOL CHEM, V275, P1191, DOI 10.1074/jbc.275.2.1191; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Damiano L, 2010, ONCOGENE, V29, P3677, DOI 10.1038/onc.2010.128; Di Stefano P, 2004, MOL BIOL CELL, V15, P787, DOI 10.1091/mbc.E03-09-0689; Di Stefano P, 2007, EMBO J, V26, P2843, DOI 10.1038/sj.emboj.7601724; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; ILLC D, 1995, NATURE, V377, P539; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Le Devedec SE, 2009, CLIN EXP METASTAS, V26, P673, DOI 10.1007/s10585-009-9267-6; Li YS, 2001, CANCER RES, V61, P6906; Lim ST, 2008, CELL CYCLE, V7, P2306, DOI 10.4161/cc.6367; Lorenz M, 2004, CELL MOTIL CYTOSKEL, V57, P207, DOI 10.1002/cm.10171; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; Marxfeld H, 2006, EXP TOXICOL PATHOL, V58, P133, DOI 10.1016/j.etp.2006.05.003; Mori S, 2009, ONCOGENE, V28, P2796, DOI 10.1038/onc.2009.139; NERI A, 1981, INT J CANCER, V28, P731, DOI 10.1002/ijc.2910280612; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Webb Donna J., 2004, V294, P3; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Wolfenson H, 2009, CELL MOTIL CYTOSKEL, V66, P1017, DOI 10.1002/cm.20410; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242	35	17	17	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	5					624	633		10.1038/onc.2011.257	http://dx.doi.org/10.1038/onc.2011.257			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MS	21725361				2022-12-25	WOS:000300221800008
J	Xing, F; Persaud, Y; Pratilas, CA; Taylor, BS; Janakiraman, M; She, QB; Gallardo, H; Liu, C; Merghoub, T; Hefter, B; Dolgalev, I; Viale, A; Heguy, A; De Stanchina, E; Cobrinik, D; Bollag, G; Wolchok, J; Houghton, A; Solit, DB				Xing, F.; Persaud, Y.; Pratilas, C. A.; Taylor, B. S.; Janakiraman, M.; She, Q-B; Gallardo, H.; Liu, C.; Merghoub, T.; Hefter, B.; Dolgalev, I.; Viale, A.; Heguy, A.; De Stanchina, E.; Cobrinik, D.; Bollag, G.; Wolchok, J.; Houghton, A.; Solit, D. B.			Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF	ONCOGENE			English	Article						BRAF; PTEN; RB1; MEK inhibitor; BRAF inhibitor; CDKN2A	RETINOBLASTOMA GENE-PRODUCT; METASTATIC MELANOMA; HUMAN CANCER; AZD6244 ARRY-142886; INHIBITOR PLX4032; CELL LINES; BRAF; KINASE; MUTATIONS; PROTEIN	Identifying the spectrum of genetic alterations that cooperate with critical oncogenes to promote transformation provides a foundation for understanding the diversity of clinical phenotypes observed in human cancers. Here, we performed integrated analyses to identify genomic alterations that co-occur with oncogenic BRAF in melanoma and abrogate cellular dependence upon this oncogene. We identified concurrent mutational inactivation of the PTEN and RB1 tumor suppressors as a mechanism for loss of BRAF/MEK dependence in melanomas harboring (V600E)BRAF mutations. RB1 alterations were mutually exclusive with loss of p16(INK4A), suggesting that whereas p16(INK4A) and RB1 may have overlapping roles in preventing tumor formation, tumors with loss of RB1 exhibit diminished dependence upon BRAF signaling for cell proliferation. These findings provide a genetic basis for the heterogeneity of clinical outcomes in patients treated with targeted inhibitors of the mitogen-activated protein kinase pathway. Our results also suggest a need for comprehensive screening for RB1 and PTEN inactivation in patients treated with RAF and MEK-selective inhibitors to determine whether these alterations are associated with diminished clinical benefit in patients whose cancers harbor mutant BRAF. Oncogene (2012) 31, 446-457; doi: 10.1038/onc.2011.250; published online 4 July 2011	[Merghoub, T.; Wolchok, J.; Solit, D. B.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Xing, F.; Persaud, Y.; Janakiraman, M.; Dolgalev, I.; Heguy, A.; Solit, D. B.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Pratilas, C. A.; Cobrinik, D.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA; [Pratilas, C. A.; She, Q-B; Hefter, B.; De Stanchina, E.] Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USA; [Taylor, B. S.] Mem Sloan Kettering Canc Ctr, Dept Computat Biol, New York, NY 10065 USA; [Gallardo, H.; Liu, C.; Merghoub, T.; Wolchok, J.; Houghton, A.] Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10065 USA; [Viale, A.] Mem Sloan Kettering Canc Ctr, Dept Mol Biol, New York, NY 10065 USA; [Bollag, G.] Plexxikon Inc, Berkeley, CA USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Plexxikon	Solit, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10065 USA.	solitd@mskcc.org	Dolgalev, Igor/AAY-6406-2020; Heguy, Adriana/GPP-3907-2022; Persaud, Yogindra/AAZ-7032-2021; Merghoub, Taha/ABD-8362-2021; Solit, David B./AAC-5309-2019	Dolgalev, Igor/0000-0003-4451-126X; Persaud, Yogindra/0000-0001-8266-9434; She, Qing-Bai/0000-0002-7207-0599; Janakiraman, Manickam/0000-0003-4423-6237	AstraZeneca; National Institutes of Health; Kimmel Foundation; Golfers-Against-Cancer; Melanoma Research Alliance; STARR Foundation; NATIONAL CANCER INSTITUTE [K08CA127350, P30CA008748, R01CA127240] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kimmel Foundation; Golfers-Against-Cancer; Melanoma Research Alliance; STARR Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	David Solit has received honoraria and research funding from AstraZeneca, and had an advisory role with Roche. Gideon Bollag is an employee of Plexxikon Inc.; We thank Drs Meenhard Herlyn and Kate Nathanson (University of Pennsylvania) and Dr Oystein Fodstad (Department of Tumor Biology of The Norwegian Radium Hospital, Norway) for kindly providing cell lines. This study was supported by grants from the National Institutes of Health (DBS), the Kimmel Foundation (DBS), Golfers-Against-Cancer (DBS), the Melanoma Research Alliance (DBS) and STARR Foundation (DBS). BST is the David H Koch Fellow in cancer genomics.	Adjei AA, 2008, J CLIN ONCOL, V26, P2139, DOI 10.1200/JCO.2007.14.4956; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Demers GW, 1996, J VIROL, V70, P6862, DOI 10.1128/JVI.70.10.6862-6869.1996; DRAPER GJ, 1986, BRIT J CANCER, V53, P661, DOI 10.1038/bjc.1986.110; Dummer R, 2008, J CLIN ONCOL S, V2; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; ENG C, 1993, JNCI-J NATL CANCER I, V85, P1121, DOI 10.1093/jnci/85.14.1121; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gonzalgo ML, 1997, CANCER RES, V57, P5336; Gopal YNV, 2010, CANCER RES, V70, P8736, DOI 10.1158/0008-5472.CAN-10-0902; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hingorani SR, 2003, CANCER RES, V63, P5198; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Kumar R, 1998, GENE CHROMOSOME CANC, V23, P273, DOI 10.1002/(SICI)1098-2264(199811)23:3<273::AID-GCC11>3.0.CO;2-N; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; NUSSE M, 1990, CYTOMETRY, V11, P813, DOI 10.1002/cyto.990110707; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; OHTA M, 1994, CANCER RES, V54, P5269; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Pratilas CA, 2008, CANCER RES, V68, P9375, DOI 10.1158/0008-5472.CAN-08-2223; Psyrri A, 2004, CANCER RES, V64, P3079, DOI 10.1158/0008-5472.CAN-03-3739; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Sebolt-Leopold JS, 2006, NATURE, V441, P457, DOI 10.1038/nature04874; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sondergaard JN, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-39; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tsai J, 2006, AACR M ABSTR, V2006, p571a; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433	43	142	143	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2012	31	4					446	457		10.1038/onc.2011.250	http://dx.doi.org/10.1038/onc.2011.250			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891LU	21725359	Green Accepted			2022-12-25	WOS:000300219300004
J	Guo, YD; Zhang, WL; Giroux, C; Cai, YL; Ekambaram, P; Dilly, AK; Hsu, A; Zhou, SL; Maddipati, KR; Liu, JJ; Joshi, S; Tucker, SC; Lee, MJ; Honn, KV				Guo, Yande; Zhang, Wenliang; Giroux, Craig; Cai, Yinlong; Ekambaram, Prasanna; Dilly, Ashok-kumar; Hsu, Andrew; Zhou, Senlin; Maddipati, Krishna Rao; Liu, Jingjing; Joshi, Sangeeta; Tucker, Stephanie C.; Lee, Menq-Jer; Honn, Kenneth V.			Identification of the Orphan G Protein-coupled Receptor GPR31 as a Receptor for 12-(S)-Hydroxyeicosatetraenoic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-TYPE 12-LIPOXYGENASE; TUMOR-CELL ADHESION; KINASE-C; 12(S)-HYDROXYEICOSATETRAENOIC ACID; LIPOXYGENASE METABOLITE; PROSTATE-CANCER; EXPRESSION; ACTIVATION; 12(S)-HETE; ANGIOGENESIS	Hydroxy fatty acids are critical lipid mediators involved in various pathophysiologic functions. We cloned and identified GPR31, a plasma membrane orphan G protein-coupled receptor that displays high affinity for the human 12-lipoxygenase-derived product 12-(S)-hydroxy-5,8,10,14-eicosatetraenoic acid (HETE). Thus, GPR31 is named 12-(S)-HETE receptor (12-HETER) in this study. The cloned 12-HETER demonstrated high affinity binding for 12-(S)-[H-3]HETE (K-d = 4.8 +/- 0.12 nM). Also, 12-(S)-HETE efficiently and selectively stimulated GTP gamma S coupling in the membranes of 12-HETER-transfected cells (EC50 = 0.28 +/- 1.26 nM). Activating GTP gamma S coupling with 12-(S)-HETE proved to be both regio- and stereospecific. Also, 12-(S)-HETE/12-HETER interactions lead to activation of ERK1/2, MEK, and NF kappa B. Moreover, knocking down 12-HRTER specifically inhibited 12-(S)-HETE-stimulated cell invasion. Thus, 12-HETER represents the first identified high affinity receptor for the 12-(S)-HETE hydroxyl fatty acids.	[Guo, Yande; Zhang, Wenliang; Cai, Yinlong; Ekambaram, Prasanna; Dilly, Ashok-kumar; Hsu, Andrew; Zhou, Senlin; Maddipati, Krishna Rao; Liu, Jingjing; Joshi, Sangeeta; Tucker, Stephanie C.; Lee, Menq-Jer; Honn, Kenneth V.] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48202 USA; [Giroux, Craig] Wayne State Univ, Sch Med, Dept Chem, Detroit, MI 48202 USA; [Honn, Kenneth V.] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI 48202 USA	Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Honn, KV (corresponding author), 5101 Cass Ave,431 Chem Bldg, Detroit, MI 48202 USA.	k.v.honn@wayne.edu	Ekambaram, Prasanna/I-5309-2019; Joshi, Sudhanshu/L-2284-2019; Maddipati, Krishna Rao/G-1859-2011; Maddipati, Krishna Rao/H-3569-2019; zhang, wenliang/A-7525-2011	Joshi, Sudhanshu/0000-0003-4748-5001; Maddipati, Krishna Rao/0000-0003-1445-791X; Maddipati, Krishna Rao/0000-0003-1445-791X; 	National Institutes of Health [CA029997, DoD W81XWH-06-1-0226, HL071071]; NATIONAL CANCER INSTITUTE [R01CA029997] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA029997, DoD W81XWH-06-1-0226 (to K. V. H.), and HL071071 (to M. J. L.).	ARENBERGER P, 1992, EUR J IMMUNOL, V22, P2469, DOI 10.1002/eji.1830220944; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; CHOPRA H, 1991, INT J CANCER, V49, P774, DOI 10.1002/ijc.2910490524; GROSSI IM, 1989, CANCER RES, V49, P1029; Hampson AJ, 2002, J NEUROSCI, V22, P257, DOI 10.1523/JNEUROSCI.22-01-00257.2002; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; Herbertsson H, 1999, ARCH BIOCHEM BIOPHYS, V367, P33, DOI 10.1006/abbi.1999.1233; Herbertsson H, 1998, J LIPID RES, V39, P237; HERBERTSSON H, 1995, BBA-GEN SUBJECTS, V1244, P191, DOI 10.1016/0304-4165(94)00223-K; HONN KV, 1994, CANCER METAST REV, V13, P365, DOI 10.1007/BF00666105; HONN KV, 1994, EXP CELL RES, V214, P120, DOI 10.1006/excr.1994.1240; HONN KV, 1994, CANCER RES, V54, P565; HONN KV, 1992, CANCER METAST REV, V11, P325, DOI 10.1007/BF01307186; HONN KV, 1992, PROSTAGLANDINS, V44, P413, DOI 10.1016/0090-6980(92)90137-I; Kandouz M, 2003, PROSTAG OTH LIPID M, V71, P189, DOI 10.1016/S1098-8823(03)00042-X; Kurahashi Y, 2000, P NATL ACAD SCI USA, V97, P5779, DOI 10.1073/pnas.97.11.5779; LIU B, 1991, CELL REGUL, V2, P1045, DOI 10.1091/mbc.2.12.1045; LIU B, 1995, P NATL ACAD SCI USA, V92, P9323, DOI 10.1073/pnas.92.20.9323; Liu XH, 1996, CLIN EXP METASTAS, V14, P145, DOI 10.1007/BF00121211; Matsuyama M, 2004, INT J ONCOL, V24, P821; Natarajan R, 1997, AM J PHYSIOL-HEART C, V273, pH2224, DOI 10.1152/ajpheart.1997.273.5.H2224; NATARAJAN R, 1994, HYPERTENSION, V23, pI142, DOI 10.1161/01.HYP.23.1_Suppl.I142; Nie D, 1998, CANCER RES, V58, P4047; Nie DT, 2006, J BIOL CHEM, V281, P18601, DOI 10.1074/jbc.M601887200; Pidgeon GP, 2003, CANCER RES, V63, P4258; Shappell SB, 2003, CANCER RES, V63, P2256; Szekeres CK, 2000, J BIOL CHEM, V275, P38831, DOI 10.1074/jbc.M002673200; Tang DG, 1997, ADV EXP MED BIOL, V400, P349; TANG DG, 1995, J CELL SCI, V108, P2629; TIMAR J, 1993, INT J CANCER, V55, P1003, DOI 10.1002/ijc.2910550621; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200; Zingoni A, 1997, GENOMICS, V42, P519, DOI 10.1006/geno.1997.4754	33	128	136	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33832	33840		10.1074/jbc.M110.216564	http://dx.doi.org/10.1074/jbc.M110.216564			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21712392	Green Published, hybrid			2022-12-25	WOS:000295159200014
J	Bos, MP; Tommassen, J				Bos, Martine P.; Tommassen, Jan			The LptD Chaperone LptE Is Not Directly Involved in Lipopolysaccharide Transport in Neisseria meningitidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL OUTER-MEMBRANE; CELL-ENVELOPE BIOGENESIS; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; INNER-MEMBRANE; LIPID-A; FUNCTIONAL-ANALYSIS; EXPORT PATHWAY; PROTEIN; BIOSYNTHESIS	The biosynthesis of lipopolysaccharide (LPS) in Gram-negative bacteria is well understood, in contrast to the transport to its destination, the outer leaflet of the outer membrane. In Escherichia coli, synthesis and transport of LPS are essential processes. Neisseria meningitidis, conversely, can survive without LPS and tolerates inactivation of genes involved in LPS synthesis and transport. Here, we analyzed whether the LptA, LptB, LptC, LptE, LptF, and LptG proteins, recently implicated in LPS transport in E. coli, function similarly in N. meningitidis. None of the analyzed proteins was essential in N. meningitidis, consistent with their expected roles in LPS transport and additionally demonstrating that they are not required for an essential process such as phospholipid transport. As expected, the absence of most of the Lpt proteins resulted in a severe defect in LPS transport. However, the absence of LptE did not disturb transport of LPS to the cell surface. LptE was found to be associated with LptD, and its absence affected total levels of LptD, suggesting a chaperone-like role for LptE in LptD biogenesis. The absence of a direct role of LptE in LPS transport was substantiated by bioinformatic analyses showing a low conservation of LptE in LPS-producing bacteria. Apparently, the role of LptE in N. meningitidis deviates from that in E. coli, suggesting that the Lpt system does not function in a completely conserved manner in all Gram-negative bacteria.	[Bos, Martine P.] Univ Utrecht, Dept Mol Microbiol, NL-3584 CH Utrecht, Netherlands; Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University	Bos, MP (corresponding author), Univ Utrecht, Dept Mol Microbiol, NL-3584 CH Utrecht, Netherlands.	M.Bos@uu.nl	Tommassen, Jan/I-1690-2016	Tommassen, Jan/0000-0001-7633-4945	Netherlands Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research	Netherlands Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research	This work was supported by the Netherlands Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research.	Albiger B, 2003, INFECT IMMUN, V71, P155, DOI 10.1128/IAI.71.1.155-162.2003; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Bos MP, 2005, INFECT IMMUN, V73, P6194, DOI 10.1128/IAI.73.9.6194-6197.2005; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Bowyer A, 2011, BIOCHEM BIOPH RES CO, V404, P1093, DOI 10.1016/j.bbrc.2010.12.121; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chng SS, 2010, BIOCHEMISTRY-US, V49, P4565, DOI 10.1021/bi100493e; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Cox AD, 2003, J BACTERIOL, V185, P3270, DOI 10.1128/JB.185.11.3270-3277.2003; DEKKER N, 1995, EUR J BIOCHEM, V232, P214, DOI 10.1111/j.1432-1033.1995.tb20801.x; Denoncin K, 2010, J BIOL CHEM, V285, P29425, DOI 10.1074/jbc.M110.119321; Doerrler WT, 2006, MOL MICROBIOL, V60, P542, DOI 10.1111/j.1365-2958.2006.05130.x; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; Haarmann R, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454124; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Long CD, 2003, INFECT IMMUN, V71, P6279, DOI 10.1128/IAI.71.11.6279-6291.2003; Ma B, 2008, P NATL ACAD SCI USA, V105, P13823, DOI 10.1073/pnas.0807028105; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P16574, DOI 10.1021/bi0518186; Narita S, 2009, FEBS LETT, V583, P2160, DOI 10.1016/j.febslet.2009.05.051; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Silander Olin K, 2009, BMC Res Notes, V2, P2, DOI 10.1186/1756-0500-2-2; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Sperandeo P, 2006, RES MICROBIOL, V157, P547, DOI 10.1016/j.resmic.2005.11.014; Sperandeo P, 2011, J BACTERIOL, V193, P1042, DOI 10.1128/JB.01037-10; Sperandeo P, 2009, BBA-MOL CELL BIOL L, V1791, P594, DOI 10.1016/j.bbalip.2009.01.011; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Steeghs L, 2002, CELL MICROBIOL, V4, P599, DOI 10.1046/j.1462-5822.2002.00214.x; Steeghs L, 1998, NATURE, V392, P449, DOI 10.1038/33046; Sutcliffe IC, 2010, TRENDS MICROBIOL, V18, P464, DOI 10.1016/j.tim.2010.06.005; Tefsen B, 2005, J BIOL CHEM, V280, P35961, DOI 10.1074/jbc.M509026200; Tefsen B, 2005, J BIOL CHEM, V280, P4504, DOI 10.1074/jbc.M409259200; Tran AX, 2008, J BIOL CHEM, V283, P20342, DOI 10.1074/jbc.M802503200; Tran AX, 2010, J BIOL CHEM, V285, P33529, DOI 10.1074/jbc.M110.144709; Tzeng YL, 2002, J BIOL CHEM, V277, P24103, DOI 10.1074/jbc.M200931200; Volokhina EB, 2011, J BACTERIOL, V193, P1612, DOI 10.1128/JB.00532-10; Volokhina EB, 2009, J BACTERIOL, V191, P7074, DOI 10.1128/JB.00737-09; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	46	34	34	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28688	28696		10.1074/jbc.M111.239673	http://dx.doi.org/10.1074/jbc.M111.239673			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705335	hybrid, Green Published			2022-12-25	WOS:000293837000006
J	Wang, SY; Thibault, G; Ng, DTW				Wang, Songyu; Thibault, Guillaume; Ng, Davis T. W.			Routing Misfolded Proteins through the Multivesicular Body (MVB) Pathway Protects against Proteotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE ATPASE; RETICULUM-ASSOCIATED DEGRADATION; DOA4 DEUBIQUITINATING ENZYME; AMINO-ACID PERMEASE; QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; YEAST VACUOLE; ESCRT-I; SORTING COMPLEX	The secretory pathway maintains multiple quality control checkpoints. Initially, endoplasmic reticulum-associated degradation pathways monitor protein folding to retain and eliminate aberrant products. Despite its broad client range, some molecules escape detection and traffic to Golgi membranes. There, a poorly understood mechanism termed Golgi quality control routes aberrant proteins for lysosomal/vacuolar degradation. To better understand Golgi quality control, we examined the processing of the obligate substrate Wsc1p. Misfolded Wsc1p does not use routes of typical vacuolar membrane proteins. Instead, it partitions into intralumenal vesicles of the multivesicular body (MVB) pathway, mediated by the E3 ubiquitin ligase Rsp5p. Its subsequent transport to the vacuolar lumen is essential for complete molecule breakdown. Surprisingly, the transport mode plays a second crucial function in neutralizing potential substrate toxicity. Eliminating the MVB sorting signal diverted molecules to the vacuolar limiting membrane, resulting in the generation of toxic by-products. These data demonstrate a new role of the MVB pathway in protein quality control.	[Wang, Songyu; Thibault, Guillaume; Ng, Davis T. W.] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; [Wang, Songyu; Ng, Davis T. W.] Natl Univ Singapore, Dept Biol Sci, Singapore 117604, Singapore	National University of Singapore; National University of Singapore	Ng, DTW (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore.	davis@tll.org.sg	Thibault, Guillaume/J-9730-2013	Thibault, Guillaume/0000-0002-7926-4812	Temasek Trust; Singapore Millennium Foundation	Temasek Trust; Singapore Millennium Foundation	This work was supported by funds from the Temasek Trust and by grants from the Singapore Millennium Foundation (predoctoral fellowship (to S. W.) and postdoctoral fellowship (to G. T.)).	Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Apaja PM, 2010, J CELL BIOL, V191, P553, DOI 10.1083/jcb.201006012; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Bache KG, 2006, MOL BIOL CELL, V17, P2513, DOI 10.1091/mbc.E05-10-0915; Baldys A, 2009, BIOCHEMISTRY-US, V48, P9321, DOI 10.1021/bi900865u; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; CHANG A, 1995, J CELL BIOL, V128, P39, DOI 10.1083/jcb.128.1.39; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Chu T, 2006, J CELL BIOL, V175, P815, DOI 10.1083/jcb.200608053; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Coughlan CM, 2004, J BIOL CHEM, V279, P15289, DOI 10.1074/jbc.M309673200; Cowles CR, 1997, EMBO J, V16, P2769, DOI 10.1093/emboj/16.10.2769; Curtiss M, 2007, MOL BIOL CELL, V18, P636, DOI 10.1091/mbc.E06-07-0588; DAVIS NG, 1993, J CELL BIOL, V122, P53, DOI 10.1083/jcb.122.1.53; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Gong XH, 2001, P NATL ACAD SCI USA, V98, P9104, DOI 10.1073/pnas.161282998; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hong E, 1996, J CELL BIOL, V135, P623, DOI 10.1083/jcb.135.3.623; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Jacoby JJ, 1998, MOL GEN GENET, V258, P148, DOI 10.1007/s004380050717; Jakob CA, 2001, EMBO REP, V2, P423; Jenness DD, 1997, MOL CELL BIOL, V17, P6236, DOI 10.1128/MCB.17.11.6236; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jorgensen MU, 1999, EUR J BIOCHEM, V260, P461, DOI 10.1046/j.1432-1327.1999.00176.x; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kanehara K, 2010, J CELL BIOL, V188, P707, DOI 10.1083/jcb.200907055; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Kincaid MM, 2007, MOL BIOL CELL, V18, P455, DOI 10.1091/mbc.E06-08-0696; Kunz JB, 2004, J BIOL CHEM, V279, P9987, DOI 10.1074/jbc.M307905200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu Y, 2006, J BIOL CHEM, V281, P31457, DOI 10.1074/jbc.M606643200; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Losko S, 2001, MOL BIOL CELL, V12, P1047, DOI 10.1091/mbc.12.4.1047; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Malkus P, 2002, J CELL BIOL, V159, P915, DOI 10.1083/jcb.200208074; Nakatsukasa K, 2004, J BIOL CHEM, V279, P49762, DOI 10.1074/jbc.M403234200; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Nikko E, 2007, TRAFFIC, V8, P566, DOI 10.1111/j.1600-0854.2007.00553.x; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Oestreich AJ, 2007, MOL BIOL CELL, V18, P646, DOI 10.1091/mbc.E06-07-0601; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Piper RC, 1997, J CELL BIOL, V138, P531, DOI 10.1083/jcb.138.3.531; Pizzirusso M, 2004, MOL BIOL CELL, V15, P2401, DOI 10.1091/mbc.E03-10-0727; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; Richter C, 2007, EMBO J, V26, P2454, DOI 10.1038/sj.emboj.7601692; Rieder SE, 1996, MOL BIOL CELL, V7, P985, DOI 10.1091/mbc.7.6.985; Risinger AL, 2008, MOL BIOL CELL, V19, P2962, DOI 10.1091/mbc.E07-06-0627; ROBERTS CJ, 1989, J CELL BIOL, V108, P1363, DOI 10.1083/jcb.108.4.1363; Rue SM, 2008, MOL BIOL CELL, V19, P475, DOI 10.1091/mbc.E07-07-0694; Sambrook J., 2002, MOL CLONING LAB MANU; SAWANO A, 2000, NUCLEIC ACIDS RES, V28, P78, DOI DOI 10.1093/NAR/28.16.E78; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Shiflett SL, 2004, J BIOL CHEM, V279, P10982, DOI 10.1074/jbc.M312669200; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; Spear ED, 2003, MOL BIOL CELL, V14, P2756, DOI 10.1091/mbc.E02-11-0717; SPORMANN DO, 1992, J BIOL CHEM, V267, P8021; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Stepp JD, 1997, J CELL BIOL, V139, P1761, DOI 10.1083/jcb.139.7.1761; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang SY, 2010, MOL BIOL CELL, V21, P1153, DOI 10.1091/mbc.E09-10-0910; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wooding S, 1998, MOL BIOL CELL, V9, P2667, DOI 10.1091/mbc.9.9.2667; Wright R, 2000, MICROSC RES TECHNIQ, V51, P496, DOI 10.1002/1097-0029(20001215)51:6<496::AID-JEMT2>3.3.CO;2-0	91	41	42	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29376	29387		10.1074/jbc.M111.233346	http://dx.doi.org/10.1074/jbc.M111.233346			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21708947	Green Published, hybrid			2022-12-25	WOS:000293837000072
J	Bedia, C; Casas, J; Andrieu-Abadie, N; Fabrias, G; Levade, T				Bedia, Carmen; Casas, Josefina; Andrieu-Abadie, Nathalie; Fabrias, Gemma; Levade, Thierry			Acid Ceramidase Expression Modulates the Sensitivity of A375 Melanoma Cells to Dacarbazine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAUNORUBICIN-INDUCED APOPTOSIS; MALIGNANT GLIOMA-CELLS; PROSTATE-CANCER; TUMOR-GROWTH; INDUCED CYTOTOXICITY; INDUCED AUTOPHAGY; UP-REGULATION; SPHINGOLIPIDS; DEATH; INHIBITION	Dacarbazine (DTIC) is the treatment of choice for metastatic melanoma, but its response in patients remains very poor. Ceramide has been shown to be a death effector and to play an important role in regulating cancer cell growth upon chemotherapy. Among ceramidases, the enzymes that catabolize ceramide, acid ceramidase (aCDase) has been implicated in cancer progression. Here we show that DTIC elicits a time-and dose-dependent decrease of aCDase activity and an increase of intracellular ceramide levels in human A375 melanoma cells. The loss of enzyme activity occurred as a consequence of reactive oxygen species-dependent activation of cathepsin B-mediated degradation of aCDase. These events preceded autophagic features and loss of cell viability. Down-regulation of acid but not neutral or alkaline ceramidase 2 resulted in elevated levels of ceramide and sensitization to the toxic effects of DTIC. Conversely, inducible overexpression of acid but not neutral ceramidase reduced ceramide levels and conferred resistance to DTIC. In conclusion, we report that increased levels of ceramide, due to enhanced degradation of aCDase, are in part responsible for the cell death effects of DTIC. These results suggest that down-regulation of aCDase alone or in combination with DTIC may represent a useful tool in the treatment of metastatic melanoma.	[Levade, Thierry] CHU Rangueil, Ctr Rech Cancerol Toulouse, Equipe 4, INSERM,UMR1037, F-31432 Toulouse 4, France; [Bedia, Carmen; Andrieu-Abadie, Nathalie; Levade, Thierry] Univ Toulouse 3, Ctr Rech Cancerol Toulouse, F-31062 Toulouse, France; [Casas, Josefina; Fabrias, Gemma] CSIC, Inst Quim Avancada Catalunya, Dept Biomed Chem, ES-08034 Barcelona, Spain; [Levade, Thierry] Hop Purpan, Inst Federatif Biol, Lab Biochim Metab, F-31059 Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); CHU de Toulouse	Levade, T (corresponding author), CHU Rangueil, Ctr Rech Cancerol Toulouse, Equipe 4, INSERM,UMR1037, BP 84225, F-31432 Toulouse 4, France.	thierry.levade@inserm.fr	Bedia, Carmen/D-3827-2013; Bedia, Carmen/H-9185-2015; Levade, Thierry/O-8948-2014; Casas, Josefina/L-7934-2014; Andrieu-Abadie, Nathalie/N-6793-2013	Bedia, Carmen/0000-0003-4584-5843; Andrieu-Abadie, Nathalie/0000-0003-2698-1970; Fabrias, Gemma/0000-0001-7162-3772	INSERM, Universite Paul Sabatier the Vaincre les Maladies Lysosomales Foundation; Spanish Ministry of Science and Innovation [SAF2008-00706]; Generalitat de Catalunya [2009-SGR-1072]; Obra Social La Caixa; Agencia de Gestio d Ajuts Universitaris i de Recerca [2007-BP-A00129]	INSERM, Universite Paul Sabatier the Vaincre les Maladies Lysosomales Foundation(Institut National de la Sante et de la Recherche Medicale (Inserm)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Obra Social La Caixa(La Caixa Foundation); Agencia de Gestio d Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	This work was supported in part by INSERM, Universite Paul Sabatier the Vaincre les Maladies Lysosomales Foundation, the Spanish Ministry of Science and Innovation (Grant SAF2008-00706), and the Generalitat de Catalunya (Grant 2009-SGR-1072).; Supported by the Obra Social La Caixa and Agencia de Gestio d Ajuts Universitaris i de Recerca (Grant 2007-BP-A00129), Generalitat de Catalunya. Present address: Dept. of Biomedicinal Chemistry, Institut de Quimica Avancada de Catalunya, CSIC, 08034 Barcelona, Spain.	Bedia C, 2010, J LIPID RES, V51, P3542, DOI 10.1194/jlr.D010033; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chauvier D, 2002, INT J ONCOL, V20, P855; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Djavaheri-Mergny M, 2007, CELL RES, V17, P576, DOI 10.1038/cr.2007.58; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Eisenberg-Lerner A, 2009, APOPTOSIS, V14, P376, DOI 10.1007/s10495-008-0307-5; Elojeimy S, 2006, FEBS LETT, V580, P4751, DOI 10.1016/j.febslet.2006.07.071; Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Jaffrezou JP, 1996, EMBO J, V15, P2417, DOI 10.1002/j.1460-2075.1996.tb00599.x; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Mahdy AEM, 2009, MOL THER, V17, P430, DOI 10.1038/mt.2008.281; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Middleton MR, 2000, J CLIN ONCOL, V18, P158, DOI 10.1200/JCO.2000.18.1.158; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Morales A, 2007, ONCOGENE, V26, P905, DOI 10.1038/sj.onc.1209834; Mouawad R, 2010, CRIT REV ONCOL HEMAT, V74, P27, DOI 10.1016/j.critrevonc.2009.08.005; Musumarra G, 2003, BIOL CHEM, V384, P321, DOI 10.1515/BC.2003.037; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Pattingre S, 2009, AUTOPHAGY, V5, P558, DOI 10.4161/auto.5.4.8390; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; Pourahmad J, 2009, CANCER CHEMOTH PHARM, V65, P89, DOI 10.1007/s00280-009-1007-8; Raisova M, 2002, FEBS LETT, V516, P47, DOI 10.1016/S0014-5793(02)02472-9; Saad AF, 2007, CANCER BIOL THER, V6, P1455; Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16; Samsel L, 2004, PROSTATE, V58, P382, DOI 10.1002/pros.10350; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Seelan RS, 2000, GENE CHROMOSOME CANC, V29, P137, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1018>3.0.CO;2-E; Selzner M, 2001, CANCER RES, V61, P1233; Shvets E, 2009, METHOD ENZYMOL, V452, P131, DOI 10.1016/S0076-6879(08)03609-4; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; STRUM JC, 1994, J BIOL CHEM, V269, P15493; Vazquez CL, 2009, METHOD ENZYMOL, V452, P85, DOI 10.1016/S0076-6879(08)03606-9; WENGER DA, 1991, TECHNIQUES DIAGNOSTI, P587	39	62	69	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28200	28209		10.1074/jbc.M110.216382	http://dx.doi.org/10.1074/jbc.M110.216382			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21700700	hybrid, Green Published			2022-12-25	WOS:000293557800038
J	Johnson, DDP; Weidmann, NB; Cederman, LE				Johnson, Dominic D. P.; Weidmann, Nils B.; Cederman, Lars-Erik			Fortune Favours the Bold: An Agent-Based Model Reveals Adaptive Advantages of Overconfidence in War	PLOS ONE			English	Article							COMPETITION; EVOLUTION	Overconfidence has long been considered a cause of war. Like other decision-making biases, overconfidence seems detrimental because it increases the frequency and costs of fighting. However, evolutionary biologists have proposed that overconfidence may also confer adaptive advantages: increasing ambition, resolve, persistence, bluffing opponents, and winning net payoffs from risky opportunities despite occasional failures. We report the results of an agent-based model of inter-state conflict, which allows us to evaluate the performance of different strategies in competition with each other. Counter-intuitively, we find that overconfident states predominate in the population at the expense of unbiased or underconfident states. Overconfident states win because: (1) they are more likely to accumulate resources from frequent attempts at conquest; (2) they are more likely to gang up on weak states, forcing victims to split their defences; and (3) when the decision threshold for attacking requires an overwhelming asymmetry of power, unbiased and underconfident states shirk many conflicts they are actually likely to win. These `` adaptive advantages'' of overconfidence may, via selection effects, learning, or evolved psychology, have spread and become entrenched among modern states, organizations and decision-makers. This would help to explain the frequent association of overconfidence and war, even if it no longer brings benefits today.	[Johnson, Dominic D. P.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Weidmann, Nils B.] Yale Univ, Jackson Inst Global Affairs, New Haven, CT USA; [Weidmann, Nils B.] Int Peace Res Inst, Ctr Study Civil War, Oslo, Norway; [Cederman, Lars-Erik] ETH, Zurich, Switzerland	University of Edinburgh; Yale University; Peace Research Institute Oslo (PRIO); Swiss Federal Institutes of Technology Domain; ETH Zurich	Johnson, DDP (corresponding author), Univ Edinburgh, Edinburgh, Midlothian, Scotland.	dominic.johnson@ed.ac.uk	Weidmann, Nils B/P-8172-2016; Johnson, Dominic/GXH-1117-2022	Weidmann, Nils B/0000-0002-4791-4913; 	Society in Science Branco Weiss Fellowship; ETH Zurich	Society in Science Branco Weiss Fellowship; ETH Zurich(ETH Zurich)	This study was generously supported by a Society in Science Branco Weiss Fellowship to DJ (http://www.society-in-science.org/) and by ETH Zurich for NW and LC (http://www.ethz.ch/index_EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, EMERGENT ACTORS WORL; Arreguin-Toft I., 2005, WEAK WIN WARS THEORY; Axelrod R., 1997, COMPLEXITY COOPERATI, DOI [10.1515/9781400822300, DOI 10.1515/9781400822300]; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BAUMEISTER RF, 1989, J SOC CLIN PSYCHOL, V8, P176, DOI 10.1521/jscp.1989.8.2.176; Bazerman MH, 2000, ANNU REV PSYCHOL, V51, P279, DOI 10.1146/annurev.psych.51.1.279; BENDAVID I, 2006, 81 DUK U FUQ SCH BUS; Blainey G., 1973, CAUSES WAR; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Burt A, 2006, GENES CONFLICT BIOL; Cederman LE, 2002, P NATL ACAD SCI USA, V99, P7296, DOI 10.1073/pnas.082081099; CHRISTENSEN TJ, 1990, INT ORGAN, V44, P137, DOI 10.1017/S0020818300035232; FEARON JD, 1995, INT ORGAN, V49, P379, DOI 10.1017/S0020818300033324; Fiske S.T., 1991, SOC COGNITION; Ganguly Sumit, 2001, CONFLICT UNENDING IN; Gilbert N., 2007, AGENT BASED MODELS; Hammond RA, 2006, J CONFLICT RESOLUT, V50, P926, DOI 10.1177/0022002706293470; Haselton MG, 2006, PERS SOC PSYCHOL REV, V10, P47, DOI 10.1207/s15327957pspr1001_3; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Hirshleifer J, 2001, DARK SIDE FORCE EC F; JAMES L, 2000, RAJ MAKING UNMAKING; Janis IL, 1972, VICTIMS GROUPTHINK P; Jervis Robert., 2017, PERCEPTION MISPERCEP; JOHNSON DDP, INT SECURIT IN PRESS; Johnson DDP., 2004, OVERCONFIDENCE WAR H; Johnson DDP, 2006, P ROY SOC B-BIOL SCI, V273, P2513, DOI 10.1098/rspb.2006.3606; Johnson DDP, 2008, NATURAL SECURITY: A DARWINIAN APPROACH TO A DANGEROUS WORLD, P209; Johnson Dominic D. P., 2006, FAILING WIN PERCEPTI; KAHNEMAN D, 2006, FOREIGN POLICY, V158, P34; Liberman Peter., 1998, DOES CONQUEST PAY EX; LINDLEY D, 2006, PHIL PA AM POL SCI A; LOEWENSTEIN G, 1993, J LEGAL STUD, V22, P135, DOI 10.1086/468160; MACK A, 1975, WORLD POLIT, V27, P175, DOI 10.2307/2009880; MALMENDIER U, 2004, 10807 NAT BUR EC RES; May E.R., 1973, LESSONS USE MISUSE H; MEARSHEIMER JJ, 1989, INT SECURITY, V13, P54, DOI 10.2307/2538780; Mearsheimer JohnJ., 2014, TRAGEDY GREAT POWER; Mueller J., 2004, REMNANTS WAR; Nettle D., 2004, EMOTION EVOLUTION RA, P193, DOI 10.1093/acprof:oso/9780198528975.003.0010; Pakenham Thomas, 1992, SCRAMBLE AFRICA; Paul, 1994, ASYMMETRIC CONFLICTS; Slantchev BL, 2003, AM POLIT SCI REV, V97, P621, DOI 10.1017/S0003055403000911; Smirnov O, 2007, J POLIT, V69, P927, DOI 10.1111/j.1468-2508.2007.00599.x; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; TAYLOR SE, 1994, PSYCHOL BULL, V116, P21, DOI 10.1037/0033-2909.116.1.21; Taylor SE, 1989, POSITIVE ILLUSIONS C; Trivers R, 2000, ANN NY ACAD SCI, V907, P114; Trivers Robert, 2011, DECEIT SELF DECEPTIO; US EPA O, 2014, MODERN INSURGENCY CO; Van Den Steen E, 2004, AM ECON REV, V94, P1141, DOI 10.1257/0002828042002697; Van Evera S, 1998, INT SECURITY, V22, P5, DOI 10.2307/2539239; Van Evera S, 2003, PERSPECTIVES ON STRUCTURAL REALISM, P163; Van Evera Stephen., 1999, CAUSES WAR POWER ROO; VERNER J, 1977, AM NAT, V111, P769, DOI 10.1086/283204; Walt StephenM., 1987, ORIGINS ALLIANCES; Waltz KennethN., 1979, THEORY INT POLITICS; WANG K, 1994, INT STUD QUART, V38, P139, DOI 10.2307/2600875; Weidmann NB, 2008, SOC SCI COMPUT REV, V26, P510, DOI 10.1177/0894439307313516; Wrangham R, 1999, EVOL HUM BEHAV, V20, P3, DOI 10.1016/S1090-5138(98)00040-3	60	23	25	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e20851	10.1371/journal.pone.0020851	http://dx.doi.org/10.1371/journal.pone.0020851			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782UF	21731627	Green Published, gold, Green Submitted			2022-12-25	WOS:000292036900007
J	Kisby, GE; Fry, RC; Lasarev, MR; Bammler, TK; Beyer, RP; Churchwell, M; Doerge, DR; Meira, LB; Palmer, VS; Ramos-Crawford, AL; Ren, XF; Sullivan, RC; Kavanagh, TJ; Samson, LD; Zarbl, H; Spencer, PS				Kisby, Glen E.; Fry, Rebecca C.; Lasarev, Michael R.; Bammler, Theodor K.; Beyer, Richard P.; Churchwell, Mona; Doerge, Daniel R.; Meira, Lisiane B.; Palmer, Valerie S.; Ramos-Crawford, Ana-Luiza; Ren, Xuefeng; Sullivan, Robert C.; Kavanagh, Terrance J.; Samson, Leona D.; Zarbl, Helmut; Spencer, Peter S.			The Cycad Genotoxin MAM Modulates Brain Cellular Pathways Involved in Neurodegenerative Disease and Cancer in a DNA Damage-Linked Manner	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PARKINSONISM-DEMENTIA COMPLEX; SPORADIC ALZHEIMERS-DISEASE; TRANSCRIPTION FACTORS; GENE-EXPRESSION; INDUCED COLON; P38 MAPK; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; 2 SIDES; TAU	Methylazoxymethanol (MAM), the genotoxic metabolite of the cycad azoxyglucoside cycasin, induces genetic alterations in bacteria, yeast, plants, insects and mammalian cells, but adult nerve cells are thought to be unaffected. We show that the brains of adult C57BL6 wild-type mice treated with a single systemic dose of MAM acetate display DNA damage (O-6-methyldeoxyguanosine lesions, O-6-mG) that remains constant up to 7 days post-treatment. By contrast, MAM-treated mice lacking a functional gene encoding the DNA repair enzyme O-6-mG DNA methyltransferase (MGMT) showed elevated O-6-mG DNA damage starting at 48 hours post-treatment. The DNA damage was linked to changes in the expression of genes in cell-signaling pathways associated with cancer, human neurodegenerative disease, and neurodevelopmental disorders. These data are consistent with the established developmental neurotoxic and carcinogenic properties of MAM in rodents. They also support the hypothesis that early-life exposure to MAM-glucoside (cycasin) has an etiological association with a declining, prototypical neurodegenerative disease seen in Guam, Japan, and New Guinea populations that formerly used the neurotoxic cycad plant for food or medicine, or both. These findings suggest environmental genotoxins, specifically MAM, target common pathways involved in neurodegeneration and cancer, the outcome depending on whether the cell can divide (cancer) or not (neurodegeneration). Exposure to MAM-related environmental genotoxins may have relevance to the etiology of related tauopathies, notably, Alzheimer's disease.	[Kisby, Glen E.; Lasarev, Michael R.; Palmer, Valerie S.; Ramos-Crawford, Ana-Luiza; Spencer, Peter S.] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA; [Fry, Rebecca C.; Meira, Lisiane B.; Samson, Leona D.] MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA; [Fry, Rebecca C.; Meira, Lisiane B.; Samson, Leona D.] MIT, Biol Engn Div, Cambridge, MA 02139 USA; [Bammler, Theodor K.; Beyer, Richard P.] Univ Washington, Dept Environm & Occupat Hlth Sci, Ctr Ecogenet & Environm Hlth, Seattle, WA 98195 USA; [Churchwell, Mona; Doerge, Daniel R.] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Palmer, Valerie S.; Spencer, Peter S.] Oregon Hlth & Sci Univ, Global Hlth Ctr, Portland, OR 97201 USA; [Sullivan, Robert C.; Zarbl, Helmut] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA	Oregon Health & Science University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle; US Food & Drug Administration (FDA); Oregon Health & Science University; Fred Hutchinson Cancer Center	Kisby, GE (corresponding author), Western Univ Hlth Sci, Coll Osteopath Med Pacific NW, Lebanon, OR USA.	gkisby@westernu.edu; spencer@ohsu.edu	Meira, Lisiane/AAA-4326-2020	Lasarev, Michael R/0000-0002-1896-2705; Fry, Rebecca/0000-0003-0899-9018; Meira, Lisiane/0000-0003-4289-2986	National Institutes of Environmental Health Sciences [ES11384 (OHSU), ES11399 (MIT), ES011387 (FHCRC/UW), ES07033 (UW)]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022, U19ES011384, U19ES011399, U19ES011387, P30ES007033, P30ES010126] Funding Source: NIH RePORTER	National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the National Institutes of Environmental Health Sciences: ES11384 (OHSU), ES11399 (MIT), ES011387 (FHCRC/UW) and ES07033 (UW) (http://www.niehs.nih.gov/research/supported/centers/trc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki W, 2009, BIOCHEM BIOPH RES CO, V380, P111, DOI 10.1016/j.bbrc.2009.01.044; Behrens MI, 2009, CURR ALZHEIMER RES, V6, P196, DOI 10.2174/156720509788486608; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bobola MS, 2007, DNA REPAIR, V6, P1127, DOI 10.1016/j.dnarep.2007.03.009; Bolos M, 2010, J BIOL CHEM, V285, P17693, DOI 10.1074/jbc.M109.096594; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BONFANTI M, 1991, NUCLEIC ACIDS RES, V19, P5739, DOI 10.1093/nar/19.20.5739; Boonen RACM, 2009, AGEING RES REV, V8, P71, DOI 10.1016/j.arr.2008.11.003; Borenstein AR, 2007, NEUROLOGY, V68, P1764, DOI 10.1212/01.wnl.0000262027.31623.b2; Caricasole A, 2005, BIOSCIENCE REP, V25, P309, DOI 10.1007/s10540-005-2893-6; Chaparro-Huerta V, 2008, INT J DEV NEUROSCI, V26, P487, DOI 10.1016/j.ijdevneu.2008.02.008; Chen JZ, 2009, CANCER BIOL THER, V8, P1313, DOI 10.4161/cbt.8.14.8983; Chen Y, 2009, J CELL BIOCHEM, V106, P353, DOI 10.1002/jcb.22020; Churchwell MI, 2006, J CHROMATOGR B, V844, P60, DOI 10.1016/j.jchromb.2006.06.042; CORREA P, 1975, LANCET, V2, P58; de la Monte SM, 2009, J ALZHEIMERS DIS, V17, P817, DOI 10.3233/JAD-2009-1098; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; de la Monte SM, 2009, J ALZHEIMERS DIS, V17, P519, DOI 10.3233/JAD-2009-1070; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Esclaire F, 1999, EXP NEUROL, V155, P11, DOI 10.1006/exnr.1998.6962; Ganjam GK, 2009, J BIOL CHEM, V284, P30783, DOI 10.1074/jbc.M109.045260; GARRUTO RM, 1981, ANN NEUROL, V10, P341, DOI 10.1002/ana.410100405; GARRUTO RM, 1980, ANN NEUROL, V8, P612, DOI 10.1002/ana.410080612; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh R, 1999, NUCLEIC ACIDS RES, V27, P3213, DOI 10.1093/nar/27.15.3213; Glassner BJ, 1999, MUTAGENESIS, V14, P339, DOI 10.1093/mutage/14.3.339; Haddock RL, 2009, ASIAN PAC J CANCER P, V10, P57; Hailer-Morrison MK, 2003, BIOCHEMISTRY-US, V42, P9761, DOI 10.1021/bi034546k; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JONES MZ, 1976, J NEUROPATH EXP NEUR, V35, P413, DOI 10.1097/00005072-197607000-00004; Kihira T, 2009, NEUROPATHOLOGY, V29, P548, DOI 10.1111/j.1440-1789.2009.01010.x; Kisby GE, 2009, DNA REPAIR, V8, P400, DOI 10.1016/j.dnarep.2008.12.002; Kisby GE, 2005, NEUROBIOL DIS, V19, P108, DOI 10.1016/j.nbd.2004.11.014; KISBY GE, 1992, NEUROLOGY, V42, P1336, DOI 10.1212/WNL.42.7.1336; KURLAND LT, 1972, FED PROC, V31, P1540; Kuzuhara S, 2001, ANN NEUROL, V49, P501, DOI 10.1002/ana.100; LAQUEUR GL, 1967, JNCI-J NATL CANCER I, V39, P355; LAQUEUR GL, 1963, J NATL CANCER I, V31, P919; MCGEER PL, 2011, PROG NEUROBIOL   APR; McKean JW, 2004, STAT SCI, V19, P562, DOI 10.1214/088342304000000549; Michigami Toshimi, 2010, Clin Calcium, V20, P1196, DOI CliCa100811961202; Miklossy J, 2008, ACTA NEUROPATHOL, V116, P625, DOI 10.1007/s00401-008-0439-2; Morris LGT, 2010, ONCOGENE, V29, P3453, DOI 10.1038/onc.2010.127; Munoz L, 2010, NEUROPHARMACOLOGY, V58, P561, DOI 10.1016/j.neuropharm.2009.11.010; Muyllaert D, 2008, GENES BRAIN BEHAV, V7, P57, DOI 10.1111/j.1601-183X.2007.00376.x; Nigro N D, 1985, Prog Clin Biol Res, V186, P161; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Park EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004284; Parsian AJ, 2002, MUTAT RES-FUND MOL M, V501, P105, DOI 10.1016/S0027-5107(02)00016-7; Plato CC, 2003, AM J EPIDEMIOL, V157, P149, DOI 10.1093/aje/kwf175; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; ROBISON SH, 1984, J NEUROL SCI, V64, P11, DOI 10.1016/0022-510X(84)90051-0; ROMAN GC, 1995, ETIOLOGY PARKINSONS, P203; Romanowska M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005354; Rosenberg DW, 2009, CARCINOGENESIS, V30, P183, DOI 10.1093/carcin/bgn267; Roth U, 2004, J BIOL CHEM, V279, P2623, DOI 10.1074/jbc.M308391200; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Salkovic-Petrisic M, 2009, J ALZHEIMERS DIS, V18, P729, DOI 10.3233/JAD-2009-1184; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Serrano J, 2010, ONCOGENE, V29, P2165, DOI 10.1038/onc.2009.503; SHIRAKE H, 1975, HDB CLIN NEUROLOGY 2, V22; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Silber JR, 1996, P NATL ACAD SCI USA, V93, P6941, DOI 10.1073/pnas.93.14.6941; Souter S, 2010, CURR ALZHEIMER RES, V7, P697, DOI 10.2174/156720510793611637; Spencer PS, 2005, MOVEMENT DISORD, V20, pS119, DOI 10.1002/mds.20552; SPENCER PS, 1991, NEUROLOGY, V41, P62, DOI 10.1212/WNL.41.5_Suppl_2.62; SPENCER PS, 1987, CAN J NEUROL SCI, V14, P347, DOI 10.1017/S0317167100037732; Staropoli JF, 2008, BIOESSAYS, V30, P719, DOI 10.1002/bies.20784; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Suzui M, 2001, MOL CARCINOGEN, V32, P206, DOI 10.1002/mc.10014; Suzuki M, 2010, ACTA NEUROL SCAND, V122, P367, DOI 10.1111/j.1600-0404.2010.01321.x; Takahashi M, 2004, CANCER SCI, V95, P475, DOI 10.1111/j.1349-7006.2004.tb03235.x; Terpstra JT, 2005, J STAT SOFTW, V14; Vadigepalli Rajanikanth, 2003, OMICS A Journal of Integrative Biology, V7, P235, DOI 10.1089/153623103322452378; WHITING MG, 1988, TRANSCR 4 CYC C; Winton MJ, 2006, ACTA NEUROPATHOL, V111, P401, DOI 10.1007/s00401-006-0053-0; Yamini B, 2007, CANCER RES, V67, P6889, DOI 10.1158/0008-5472.CAN-06-4496; Zhang RY, 2010, NEUROBIOL DIS, V38, P68, DOI 10.1016/j.nbd.2009.12.028; Zhang ZX, 1996, ACTA NEUROL SCAND, V94, P51, DOI 10.1111/j.1600-0404.1996.tb00039.x; R CODE IMPLEMENT RLM	86	38	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e20911	10.1371/journal.pone.0020911	http://dx.doi.org/10.1371/journal.pone.0020911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731631	Green Submitted, gold, Green Published			2022-12-25	WOS:000292035400006
J	Bowen, L; Ebrahim, S; De Stavola, B; Ness, A; Kinra, S; Bharathi, AV; Prabhakaran, D; Reddy, KS				Bowen, Liza; Ebrahim, Shah; De Stavola, Bianca; Ness, Andy; Kinra, Sanjay; Bharathi, A. V.; Prabhakaran, Dorairaj; Reddy, K. Srinath			Dietary Intake and Rural-Urban Migration in India: A Cross-Sectional Study	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; CORONARY-HEART-DISEASE; RISK-FACTORS; CARDIOVASCULAR-DISEASES; BLOOD-PRESSURE; CONSUMPTION; HABITS; FRUIT; REPRODUCIBILITY; TRANSITION	Background: Migration from rural areas of India contributes to urbanisation and lifestyle change, and dietary changes may increase the risk of obesity and chronic diseases. We tested the hypothesis that rural-to-urban migrants have different macronutrient and food group intake to rural non-migrants, and that migrants have a diet more similar to urban non-migrants. Methods and findings: The diets of migrants of rural origin, their rural dwelling sibs, and those of urban origin together with their urban dwelling sibs were assessed by an interviewer-administered semi-quantitative food frequency questionnaire. A total of 6,509 participants were included. Median energy intake in the rural, migrant and urban groups was 2731, 3078, and 3224 kcal respectively for men, and 2153, 2504, and 2644 kcal for women (p<0.001). A similar trend was seen for overall intake of fat, protein and carbohydrates (p<0.001), though differences in the proportion of energy from these nutrients were <2%. Migrant and urban participants reported up to 80% higher fruit and vegetable intake than rural participants (p<0.001), and up to 35% higher sugar intake (p<0.001). Meat and dairy intake were higher in migrant and urban participants than rural participants (p<0.001), but varied by region. Sibling-pair analyses confirmed these results. There was no evidence of associations with time in urban area. Conclusions: Rural to urban migration appears to be associated with both positive (higher fruit and vegetables intake) and negative (higher energy and fat intake) dietary changes. These changes may be of relevance to cardiovascular health and warrant public health interventions.	[Bowen, Liza; Ebrahim, Shah; De Stavola, Bianca; Kinra, Sanjay] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Ebrahim, Shah; Prabhakaran, Dorairaj] Publ Hlth Fdn India, S Asia Network Chron Dis, New Delhi, India; [Ness, Andy] Univ Bristol, Sch Oral & Dent Sci, Bristol, Avon, England; [Bharathi, A. V.] Indira Gandhi Natl Open Univ, Dept Food Sci & Nutr, New Delhi, India; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India	University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; University of Bristol	Bowen, L (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England.	lizabowen@gmail.com	Bowen, Liza/AAA-5502-2019; Berryman, Katie/J-4236-2014; Prabhakaran, Dorairaj/B-4147-2011; Ness, Andy R/M-7612-2013	Prabhakaran, Dorairaj/0000-0002-3172-834X; Ness, Andy R/0000-0003-3548-9523; Reddy, K Srinath/0000-0003-3416-3548; De Stavola, Bianca Lucia/0000-0001-7853-0528; Bowen, Liza/0000-0001-8318-8421	Wellcome Trust [GR070797MF]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work is funded by Wellcome Trust project grant GR070797MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal D., 2010, PUBLIC HEALTH NUTR, P1; Bjerregaard P, 2002, INT J OBESITY, V26, P1503, DOI 10.1038/sj.ijo.0802082; Bjerregaard P, 2007, SCAND J PUBLIC HEALT, V35, P380, DOI 10.1080/14034940701195214; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Elwood PC, 2004, EUR J CLIN NUTR, V58, P718, DOI 10.1038/sj.ejcn.1601869; Enas Enas A, 2008, Indian Heart J, V60, P161; Fall CHD, 2001, BRIT MED BULL, V60, P33, DOI 10.1093/bmb/60.1.33; *FAOSTAT, 2006, COR CONS DAT; *FOOD STAND AG, 2003, NAT DIET NUTR SURV A; Food Standards Agency, 2006, FSA NUTR FOOD BAS GU; Ghaffar A, 2004, BMJ-BRIT MED J, V328, P807, DOI 10.1136/bmj.328.7443.807; Goplan C, 1971, NUTR VALUE INDIAN FO, P58; Hammar N, 2009, EUR J CLIN NUTR, V63, P312, DOI 10.1038/sj.ejcn.1602931; HARDING WR, 1986, ECOL FOOD NUTR, V19, P83, DOI 10.1080/03670244.1986.9990951; HE J, 1991, HYPERTENSION, V17, P378, DOI 10.1161/01.HYP.17.3.378; He J, 1996, AM J EPIDEMIOL, V144, P839, DOI 10.1093/oxfordjournals.aje.a009018; Hebert JR, 1999, PUBLIC HEALTH NUTR, V2, P39, DOI 10.1017/S1368980099000051; Hebert JR, 1998, PUBLIC HEALTH NUTR, V1, P123, DOI 10.1079/PHN19980019; *IIPS, 2006, KEY FIND NFHS 3; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Jonnalagadda SS, 2002, J AM COLL NUTR, V21, P372, DOI 10.1080/07315724.2002.10719238; Kakar A, 2003, J Assoc Physicians India, V51, P87; Katan MB, 2010, JAMA-J AM MED ASSOC, V303, P65, DOI 10.1001/jama.2009.1912; Kouris-Blazos A, 2002, ASIA PAC J CLIN NUTR, V11, pS569, DOI 10.1046/j.1440-6047.11.supp3.2.x; KUSHI LH, 1985, NEW ENGL J MED, V312, P811, DOI 10.1056/NEJM198503283121302; LEE MM, 1994, INT J EPIDEMIOL, V23, P984, DOI 10.1093/ije/23.5.984; MENSINK RP, 1992, ARTERIOSCLER THROMB, V12, P911, DOI 10.1161/01.ATV.12.8.911; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Mohan V, 2004, J Assoc Physicians India, V52, P468; Mohan V, 2008, DIABETES RES CLIN PR, V80, P159, DOI 10.1016/j.diabres.2007.11.018; *NAT SAMP SURV ORG, 2007, NUTR INT IND 2004 20; Ness AR, 1999, J CARDIOVASC RISK, V6, P229; Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1; Ounpuu S, 2000, EUR HEART J, V21, P880, DOI 10.1053/euhj.1999.1880; Pandey D, 2005, NATL MED J INDIA, V18, P230; Patel JV, 2006, ATHEROSCLEROSIS, V185, P297, DOI 10.1016/j.atherosclerosis.2005.06.005; POULTER NR, 1990, BMJ-BRIT MED J, V300, P967, DOI 10.1136/bmj.300.6730.967; POWLES JW, 1993, J HUM HYPERTENS, V7, P419; Radhika G, 2008, BRIT J NUTR, V99, P398, DOI 10.1017/S0007114507803965; Raj S, 1999, J AM DIET ASSOC, V99, P1106, DOI 10.1016/S0002-8223(99)00266-7; Reddy KS, 2006, B WORLD HEALTH ORGAN, V84, P461, DOI 10.2471/BLT.05.027037; Reddy KS, 2009, NESTLE NUTR WORKS SE, V63, P15, DOI 10.1159/000209969; Reddy KS, 2004, PUBLIC HEALTH NUTR, V7, P167, DOI 10.1079/PHN2003587; Ruxton CHS, 2010, CRIT REV FOOD SCI, V50, P1, DOI 10.1080/10408390802248569; Shetty PS, 2002, PUBLIC HEALTH NUTR, V5, P175, DOI 10.1079/PHN2001291; Speedy AW, 2003, J NUTR, V133, p4048S, DOI 10.1093/jn/133.11.4048S; Stamler J., 2005, CORONARY HEART DIS E, V2, P18; Sudha V, 2006, INT J FOOD SCI NUTR, V57, P481, DOI 10.1080/09637480600969220; TILLOTSON JL, 1973, AM J CLIN NUTR, V26, P177, DOI 10.1093/ajcn/26.2.177; Torun B, 2002, INT J EPIDEMIOL, V31, P218, DOI 10.1093/ije/31.1.218; *USDA, NUTR DAT LAB; van Baak MA, 2009, OBES REV, V10, P9, DOI 10.1111/j.1467-789X.2008.00561.x; Welch AU., 1995, MCCANCE WIDDOWSONS C; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	55	83	85	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e14822	10.1371/journal.pone.0014822	http://dx.doi.org/10.1371/journal.pone.0014822			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731604	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000292033700002
J	DiMaio, F; Leaver-Fay, A; Bradley, P; Baker, D; Andre, I				DiMaio, Frank; Leaver-Fay, Andrew; Bradley, Phil; Baker, David; Andre, Ingemar			Modeling Symmetric Macromolecular Structures in Rosetta3	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; SEQUENCES	Symmetric protein assemblies play important roles in many biochemical processes. However, the large size of such systems is challenging for traditional structure modeling methods. This paper describes the implementation of a general framework for modeling arbitrary symmetric systems in Rosetta3. We describe the various types of symmetries relevant to the study of protein structure that may be modeled using Rosetta's symmetric framework. We then describe how this symmetric framework is efficiently implemented within Rosetta, which restricts the conformational search space by sampling only symmetric degrees of freedom, and explicitly simulates only a subset of the interacting monomers. Finally, we describe structure prediction and design applications that utilize the Rosetta3 symmetric modeling capabilities, and provide a guide to running simulations on symmetric systems.	[DiMaio, Frank; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Leaver-Fay, Andrew] Univ N Carolina, Dept Biochem, Chapel Hill, NC 27599 USA; [Bradley, Phil] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Andre, Ingemar] Lund Univ, Ctr Chem, Ctr Mol Prot Sci, Dept Biochem & Struct Biol, Lund, Sweden	University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; Fred Hutchinson Cancer Center; Lund University	DiMaio, F (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dimaio@u.washington.edu	André, Ingemar/O-4777-2014; Baker, David/K-8941-2012	André, Ingemar/0000-0002-4753-8233; Baker, David/0000-0001-7896-6217	NIH [P41RR002250, R01GM092802]; HHMI; Knut and Alice Wallenberg Foundation; Crafoord foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092802] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Crafoord foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	FD and DB acknowledge the NIH (P41RR002250, R01GM092802) and HHMI. IA was supported by the Knut and Alice Wallenberg Foundation and the Crafoord foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 1984, COMPUT CHEM, V8, P239, DOI 10.1016/0097-8485(84)85015-9; Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; Bradley P, 2006, PROTEINS, V65, P922, DOI 10.1002/prot.21133; Das R, 2009, P NATL ACAD SCI USA, V106, P18978, DOI 10.1073/pnas.0904407106; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Leaver-Fay A, 2005, LECT NOTES COMPUT SC, V3692, P389; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; MOULT J, 1995, PROTEINS, V23, pR2, DOI 10.1002/prot.340230303; Pierce NA, 2002, PROTEIN ENG, V15, P779, DOI 10.1093/protein/15.10.779; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; Sgourakis NG, 2011, J AM CHEM SOC, V133, P6288, DOI 10.1021/ja111318m; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050	12	136	140	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20450	10.1371/journal.pone.0020450	http://dx.doi.org/10.1371/journal.pone.0020450			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731614	Green Submitted, gold, Green Published			2022-12-25	WOS:000292033700008
J	Ohira, T; Terada, M; Kawano, F; Nakai, N; Ogura, A; Ohira, Y				Ohira, Takashi; Terada, Masahiro; Kawano, Fuminori; Nakai, Naoya; Ogura, Akihiko; Ohira, Yoshinobu			Region-Specific Responses of Adductor Longus Muscle to Gravitational Load-Dependent Activity in Wistar Hannover Rats	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; SKELETAL-MUSCLE; SOLEUS MUSCLE; HINDLIMB SUSPENSION; MECHANICAL-PROPERTIES; SPACEFLIGHT; RECOVERY; FIBER; SLOW; ACTIVATION	Response of adductor longus (AL) muscle to gravitational unloading and reloading was studied. Male Wistar Hannover rats (5-wk old) were hindlimb-unloaded for 16 days with or without 16-day ambulation recovery. The electromyogram (EMG) activity in AL decreased after acute unloading, but that in the rostral region was even elevated during continuous unloading. The EMG levels in the caudal region gradually increased up to 6th day, but decreased again. Approximately 97% of fibers in the caudal region were pure type I at the beginning of experiment. Mean percentage of type I fibers in the rostral region was 61% and that of type I+II and II fiber was 14 and 25%, respectively. The percent type I fibers decreased and de novo appearance of type I+II was noted after unloading. But the fiber phenotype in caudal, not rostral and middle, region was normalized after 16-day ambulation. Pronounced atrophy after unloading and re-growth following ambulation was noted in type I fibers of the caudal region. Sarcomere length in the caudal region was passively shortened during unloading, but that in the rostral region was unchanged or even stretched slightly. Growth-associated increase of myonuclear number seen in the caudal region of control rats was inhibited by unloading. Number of mitotic active satellite cells decreased after unloading only in the caudal region. It was indicated that the responses of fiber properties in AL to unloading and reloading were closely related to the region-specific neural and mechanical activities, being the caudal region more responsive.	[Ohira, Takashi; Terada, Masahiro; Ogura, Akihiko; Ohira, Yoshinobu] Osaka Univ, Grad Sch Frontier Biosci, Toyonaka, Osaka 560, Japan; [Kawano, Fuminori; Nakai, Naoya; Ohira, Yoshinobu] Osaka Univ, Grad Sch Med, Toyonaka, Osaka 560, Japan	Osaka University; Osaka University	Ohira, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Toyonaka, Osaka 560, Japan.	ohira@space.hss.osaka-u.ac.jp			Japan Society for the Promotion of Science [19100009]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was carried out as a part of a Grant-in-Aid for Scientific Research (S, 19100009) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/j-grantsinaid/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD EK, 1987, EXP NEUROL, V96, P635, DOI 10.1016/0014-4886(87)90225-1; Allen DL, 1996, J APPL PHYSIOL, V81, P145, DOI 10.1152/jappl.1996.81.1.145; CAIOZZO VJ, 1994, J APPL PHYSIOL, V76, P1764, DOI 10.1152/jappl.1994.76.4.1764; DAMELIO F, 1992, J NEUROPATH EXP NEUR, V51, P415, DOI 10.1097/00005072-199207000-00004; De-Doncker L, 2006, EXP NEUROL, V201, P368, DOI 10.1016/j.expneurol.2006.04.021; De-Doncker L, 2005, J EXP BIOL, V208, P4585, DOI 10.1242/jeb.01931; Desaphy JF, 2005, NEUROBIOL DIS, V18, P356, DOI 10.1016/j.nbd.2004.09.016; Edgerton VR, 1996, HDB PHYSL 4, P721; Enns DL, 2007, EUR J APPL PHYSIOL, V100, P445, DOI 10.1007/s00421-007-0445-4; Enns DL, 2006, CAN J PHYSIOL PHARM, V84, P601, DOI 10.1139/Y06-013; Ikemoto M, 2001, FASEB J, V15, P1279, DOI 10.1096/fj.00-0629fje; JIANG B, 1992, J APPL PHYSIOL, V73, pS58, DOI 10.1152/jappl.1992.73.2.S58; Kawano F, 2007, AM J PHYSIOL-CELL PH, V293, pC35, DOI 10.1152/ajpcell.00297.2006; Kawano F, 2004, JPN J PHYSIOL, V54, P229, DOI 10.2170/jjphysiol.54.229; Kawano F, 2004, AM J PHYSIOL-REG I, V287, pR76, DOI 10.1152/ajpregu.00694.2003; Kawano F, 2002, NEUROSCIENCE, V114, P1133, DOI 10.1016/S0306-4522(02)00304-4; MARTIN TP, 1988, J APPL PHYSIOL, V65, P2318, DOI 10.1152/jappl.1988.65.5.2318; MIU B, 1990, FASEB J, V4, P64, DOI 10.1096/fasebj.4.1.2136839; Ohira M, 2002, JPN J PHYSIOL, V52, P235, DOI 10.2170/jjphysiol.52.235; Ohira T., 2009, JPN J AEROSP ENV MED, V46, P21; Ohira Y, 2003, JPN J PHYSIOL, V53, P389, DOI 10.2170/jjphysiol.53.389; OHIRA Y, 1992, J APPL PHYSIOL, V73, pS51, DOI 10.1152/jappl.1992.73.2.S51; Ohira Y, 1997, ACTA ANAT, V159, P90; Ohira Y, 2001, AM J PHYSIOL-CELL PH, V280, pC1008, DOI 10.1152/ajpcell.2001.280.4.C1008; OHIRA Y, 1994, AM J PHYSIOL, V266, pC1257, DOI 10.1152/ajpcell.1994.266.5.C1257; Ohira Yoshinobu, 2002, J Gravit Physiol, V9, P49; RILEY DA, 1990, FASEB J, V4, P84, DOI 10.1096/fasebj.4.1.2153085; Riley DA, 1996, J APPL PHYSIOL, V81, P133, DOI 10.1152/jappl.1996.81.1.133; Riley DA, 2005, AM J PHYSIOL-CELL PH, V288, pC360, DOI 10.1152/ajpcell.00386.2004; RILEY DA, 1992, J APPL PHYSIOL, V73, pS33, DOI 10.1152/jappl.1992.73.2.S33; Sugiura T, 2005, AM J PHYSIOL-REG I, V288, pR1273, DOI 10.1152/ajpregu.00688.2004; THOMASON DB, 1987, J APPL PHYSIOL, V63, P138, DOI 10.1152/jappl.1987.63.1.138; THOMASON DB, 1987, J APPL PHYSIOL, V63, P130, DOI 10.1152/jappl.1987.63.1.130; Thompson JL, 1999, ANAT REC, V254, P39, DOI 10.1002/(SICI)1097-0185(19990101)254:1<39::AID-AR6>3.0.CO;2-K; Vermaelen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1723, DOI 10.1152/ajpcell.00398.2006; Wang XD, 2006, AM J PHYSIOL-CELL PH, V290, pC981, DOI 10.1152/ajpcell.00298.2005; WINIARSKI AM, 1987, EXP NEUROL, V96, P650, DOI 10.1016/0014-4886(87)90226-3	37	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21044	10.1371/journal.pone.0021044	http://dx.doi.org/10.1371/journal.pone.0021044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731645	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700031
J	Bueno, LL; Lobo, FP; Morais, CG; Mourao, LC; de Avila, RAM; Soares, IS; Fontes, CJ; Lacerda, MV; Olortegui, CC; Bartholomeu, DC; Fujiwara, RT; Braga, EM				Bueno, Lilian Lacerda; Lobo, Francisco Pereira; Morais, Cristiane Guimaraes; Mourao, Luiza Carvalho; Machado de Avila, Ricardo Andrez; Soares, Irene Silva; Fontes, Cor Jesus; Lacerda, Marcus Vinicius; Olortegui, Carlos Chavez; Bartholomeu, Daniella Castanheira; Fujiwara, Ricardo Toshio; Braga, Erika Martins			Identification of a Highly Antigenic Linear B Cell Epitope within Plasmodium vivax Apical Membrane Antigen 1 (AMA-1)	PLOS ONE			English	Article							MALARIA VACCINE CANDIDATE; ERYTHROCYTE INVASION; ANTIBODY-RESPONSE; CLINICAL-TRIAL; FULL-LENGTH; DOMAIN-II; FALCIPARUM; RECOMBINANT; PROTEIN; PROGRESS	Apical membrane antigen 1 (AMA-1) is considered to be a major candidate antigen for a malaria vaccine. Previous immunoepidemiological studies of naturally acquired immunity to Plasmodium vivax AMA-1 (PvAMA-1) have shown a higher prevalence of specific antibodies to domain II (DII) of AMA-1. In the present study, we confirmed that specific antibody responses from naturally infected individuals were highly reactive to both full-length AMA-1 and DII. Also, we demonstrated a strong association between AMA-1 and DII IgG and IgG subclass responses. We analyzed the primary sequence of PvAMA-1 for B cell linear epitopes co-occurring with intrinsically unstructured/ disordered regions (IURs). The B cell epitope comprising the amino acid sequence 290-307 of PvAMA-1 (SASDQPTQYEEEMTDYQK), with the highest prediction scores, was identified in domain II and further selected for chemical synthesis and immunological testing. The antigenicity of the synthetic peptide was identified by serological analysis using sera from P. vivax-infected individuals who were knowingly reactive to the PvAMA-1 ectodomain only, domain II only, or reactive to both antigens. Although the synthetic peptide was recognized by all serum samples specific to domain II, serum with reactivity only to the full-length protein presented 58.3% positivity. Moreover, IgG reactivity against PvAMA-1 and domain II after depletion of specific synthetic peptide antibodies was reduced by 18% and 33% (P = 0.0001 for both), respectively. These results suggest that the linear epitope SASDQPTQYEEEMTDYQK is highly antigenic during natural human infections and is an important antigenic region of the domain II of PvAMA-1, suggesting its possible future use in pre-clinical studies.	[Bueno, Lilian Lacerda; Lobo, Francisco Pereira; Morais, Cristiane Guimaraes; Mourao, Luiza Carvalho; Bartholomeu, Daniella Castanheira; Fujiwara, Ricardo Toshio; Braga, Erika Martins] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Machado de Avila, Ricardo Andrez; Olortegui, Carlos Chavez] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Soares, Irene Silva] Univ Sao Paulo, Dept Anal Clin & Toxicol, Sao Paulo, Brazil; [Fontes, Cor Jesus] Univ Fed Mato Grosso, Dept Clin Med, Cuiaba, Brazil; [Lacerda, Marcus Vinicius] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Fujiwara, Ricardo Toshio] Fiocruz MS, Inst Rene Rachou, Lab Imunol Celular & Mol, Belo Horizonte, MG, Brazil; [Bartholomeu, Daniella Castanheira] INCTV, Belo Horizonte, MG, Brazil; [Fujiwara, Ricardo Toshio] INCT DT, Salvador, BA, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Universidade Federal de Mato Grosso; Fundacao Oswaldo Cruz	Bueno, LL (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.	embraga@icb.ufmg.br	Fontes, Cor JF/G-7331-2018; Soares, Irene Silva/C-5974-2012; Chavez-Olortegui, Carlos/F-9227-2019; de Ávila, Ricardo Andrez Machado/J-8224-2015; Braga, Erika Martins/A-6776-2008; Bartholomeu, Daniella C./J-4714-2015; Fujiwara, Ricardo Toshio/J-7579-2012; Bueno, Lilian/AAQ-1939-2020; Lobo, Francisco Pereira/AAG-3118-2021; Soares, Irene/GQF-1984-2022	Fontes, Cor JF/0000-0003-2756-0588; Soares, Irene Silva/0000-0002-3336-6856; Chavez-Olortegui, Carlos/0000-0001-9390-7207; de Ávila, Ricardo Andrez Machado/0000-0002-1303-0490; Braga, Erika Martins/0000-0001-5550-7157; Bartholomeu, Daniella C./0000-0003-0974-7357; Fujiwara, Ricardo Toshio/0000-0002-4713-575X; Bueno, Lilian/0000-0003-3510-4590; Lobo, Francisco Pereira/0000-0002-9671-9313; 	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais/FAPEMIG [CBB APQ-0997-4.01/07]; CNPq/Brazil; PNPD/CAPES; Brazilian National Research Council (CNPq); Pro-Reitoria de Pesquisa of the Universidade Federal de Minas Gerais	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais/FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PNPD/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pro-Reitoria de Pesquisa of the Universidade Federal de Minas Gerais	This work was financially supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais/FAPEMIG (Grant # CBB APQ-0997-4.01/07). Lilian Bueno is supported by a Doctoral degree fellowship from CNPq/Brazil. Francisco Lobo is supported by a Post-doctoral fellowship from PNPD/CAPES. Irene Soares, Daniella Bartholomeu, Marcus Vinicius Lacerda, Carlos Chavez Olortegui, Ricardo Fujiwara and Erika Braga are supported by Brazilian National Research Council (CNPq) fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would also like to thank the financial support from Pro-Reitoria de Pesquisa of the Universidade Federal de Minas Gerais for English editing costs.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; Arevalo-Herrera M, 2010, HUM VACCINES, V6, P124, DOI 10.4161/hv.6.1.9931; ARIAS AE, 1989, TROP MED PARASITOL, V40, P21; Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chesne-Seck ML, 2005, MOL BIOCHEM PARASIT, V144, P55, DOI 10.1016/j.molbiopara.2005.07.007; COLLINS WE, 1994, AM J TROP MED HYG, V51, P711, DOI 10.4269/ajtmh.1994.51.711; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Donahue CG, 2000, MOL BIOCHEM PARASIT, V111, P15, DOI 10.1016/S0166-6851(00)00289-9; Doolan DL, 2011, INT J PARASITOL, V41, P3, DOI 10.1016/j.ijpara.2010.08.002; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; DRUILHE P, 1987, INFECT IMMUN, V55, P888, DOI 10.1128/IAI.55.4.888-891.1987; Feng ZP, 2005, J MOL BIOL, V350, P641, DOI 10.1016/j.jmb.2005.05.011; Fraser TS, 2001, MOL BIOCHEM PARASIT, V117, P49, DOI 10.1016/S0166-6851(01)00326-7; Gaffar FR, 2004, INFECT IMMUN, V72, P2947, DOI 10.1128/IAI.72.5.2947-2955.2004; GAUSEPOHL H, 1992, PEPTIDE RES, V5, P315; Gentil F, 2010, VACCINE, V28, P6183, DOI 10.1016/j.vaccine.2010.07.017; Good MF, 2005, TRENDS PARASITOL, V21, P29, DOI 10.1016/j.pt.2004.10.006; Good MF, 2010, IMMUNITY, V33, P555, DOI 10.1016/j.immuni.2010.10.005; Gunasekera AM, 2007, MOL BIOL EVOL, V24, P939, DOI 10.1093/molbev/msm013; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; Herrera S, 2007, TRENDS PARASITOL, V23, P122, DOI 10.1016/j.pt.2007.01.008; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Howell SA, 2003, J BIOL CHEM, V278, P23890, DOI 10.1074/jbc.M302160200; Howell SA, 2001, J BIOL CHEM, V276, P31311, DOI 10.1074/jbc.M103076200; Kato K, 2005, P NATL ACAD SCI USA, V102, P5552, DOI 10.1073/pnas.0501594102; Kimura Masatsugu, 1997, Parasitology International, V46, P91, DOI 10.1016/S1383-5769(97)00013-5; Kocken CHM, 1999, INFECT IMMUN, V67, P43, DOI 10.1128/IAI.67.1.43-49.1999; Lalitha PV, 2004, INFECT IMMUN, V72, P4464, DOI 10.1128/IAI.72.8.4464-4470.2004; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Li F, 2002, J BIOL CHEM, V277, P50303, DOI 10.1074/jbc.M207985200; List C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000771; Mahanty S, 2003, J EXP BIOL, V206, P3781, DOI 10.1242/jeb.00646; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Moorthy VS, 2004, LANCET, V363, P150, DOI 10.1016/S0140-6736(03)15267-1; MORAIS CG, 2005, RESPOSTA HUMORAL ISO, P102; Morais CG, 2006, AM J TROP MED HYG, V75, P582, DOI 10.4269/ajtmh.2006.75.582; Mufalo BC, 2008, MICROBES INFECT, V10, P1266, DOI 10.1016/j.micinf.2008.07.023; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; Ockenhouse CF, 1998, J INFECT DIS, V177, P1664, DOI 10.1086/515331; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Pain A, 2009, NAT REV MICROBIOL, V7, P180, DOI 10.1038/nrmicro2096; PETERSON MG, 1989, MOL CELL BIOL, V9, P3151, DOI 10.1128/MCB.9.7.3151; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Putaporntip C, 2009, INFECT GENET EVOL, V9, P1295, DOI 10.1016/j.meegid.2009.07.005; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Richie TL, 2002, NATURE, V415, P694, DOI 10.1038/415694a; Rodriguesa MHC, 2005, INT J PARASITOL, V35, P185, DOI 10.1016/j.ijpara.2004.11.003; Santiago HC, 2011, J ALLERGY CLIN IMMUN, V127, P479, DOI 10.1016/j.jaci.2010.11.007; Saul A, 2005, VACCINE, V23, P3076, DOI 10.1016/j.vaccine.2004.09.040; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Tan LKK, 2008, LANCET INFECT DIS, V8, P449, DOI 10.1016/S1473-3099(08)70153-1; THOMAS AW, 1994, AM J TROP MED HYG, V51, P730, DOI 10.4269/ajtmh.1994.51.730; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Udhayakumar V, 2001, AM J TROP MED HYG, V65, P100, DOI 10.4269/ajtmh.2001.65.100; Vekemans J, 2008, EXPERT REV VACCINES, V7, P223, DOI 10.1586/14760584.7.2.223; Wastling JM, 2009, INT J PARASITOL, V39, P135, DOI 10.1016/j.ijpara.2008.10.003; WATERS AP, 1990, J BIOL CHEM, V265, P17974; Webster D, 2003, B WORLD HEALTH ORGAN, V81, P902; Wykes M, 2007, INT J PARASITOL, V37, P705, DOI 10.1016/j.ijpara.2007.02.007	70	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21289	10.1371/journal.pone.0021289	http://dx.doi.org/10.1371/journal.pone.0021289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713006	Green Submitted, gold, Green Published			2022-12-25	WOS:000291985100027
J	Cervello, I; Mas, A; Gil-Sanchis, C; Peris, L; Faus, A; Saunders, PTK; Critchley, HOD; Simon, C				Cervello, Irene; Mas, Aymara; Gil-Sanchis, Claudia; Peris, Laura; Faus, Amparo; Saunders, Philippa T. K.; Critchley, Hilary O. D.; Simon, Carlos			Reconstruction of Endometrium from Human Endometrial Side Population Cell Lines	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; MESENCHYMAL STEM-CELLS; MENSTRUAL-CYCLE; STROMAL CELLS; PROGESTERONE-RECEPTOR; MOUSE ENDOMETRIUM; MARKERS; MICE; IDENTIFICATION; EXPRESSION	Endometrial regeneration is mediated, at least in part, by the existence of a specialized somatic stem cell (SSC) population recently identified by several groups using the side population (SP) technique. We previously demonstrated that endometrial SP displays genotypic, phenotypic and the functional capability to develop human endometrium after subcutaneous injection in NOD-SCID mice. We have now established seven human endometrial SP (hESP) cell lines (ICE 1-7): four from the epithelial and three from the stromal fraction, respectively. SP cell lines were generated under hypoxic conditions based on their cloning efficiency ability, cultured for 12-15 passages (20 weeks) and cryopreserved. Cell lines displayed normal 46XX karyotype, intermediate telomerase activity pattern and expressed mRNAs encoding proteins that are considered characteristic of undifferentiated cells (Oct-4, GDF3, DNMT3B, Nanog, GABR3) and those of mesodermal origin (WT1, Cardiac Actin, Enolase, Globin, REN). Phenotype analysis corroborated their epithelial (CD9+) or stromal (vimentin+) cell origin and mesenchymal (CD90+, CD73+ and CD45-) attributes. Markers considered characteristic of ectoderm or endoderm were not detected. Cells did not express either estrogen receptor alpha (ER alpha) or progesterone receptor (PR). The hESP cell lines were able to differentiate in vitro into adipocytes and osteocytes, which confirmed their mesenchymal origin. Finally, we demonstrated their ability to generate human endometrium when transplanted beneath the renal capsule of NOD-SCID mice. These findings confirm that SP cells exhibit key features of human endometrial SSC and open up new possibilities for the understanding of gynecological disorders such as endometriosis or Asherman syndrome. Our cell lines can be a valuable model to investigate new targets for endometrium proliferation in endometriosis.	[Cervello, Irene; Mas, Aymara; Gil-Sanchis, Claudia; Peris, Laura; Faus, Amparo; Simon, Carlos] Univ Valencia, Fdn IVI, Inst Univ IVI, INCLIVA, Valencia, Spain; [Saunders, Philippa T. K.; Critchley, Hilary O. D.] Univ Edinburgh, MRC, Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Simon, Carlos] UVEG, Unidad Mixta CIPF, Valencian Node Spanish Stem Cell Bank, Prince Felipe Res Ctr CIPF, Valencia, Spain	University of Valencia; University of Edinburgh; Prince Felipe Research Center; University of Valencia	Cervello, I (corresponding author), Univ Valencia, Fdn IVI, Inst Univ IVI, INCLIVA, Valencia, Spain.	csimon@ivi.es	Saunders, Philippa TK/C-7489-2013; Mas, Aymara/E-4409-2018; Simon, Carlos/G-2186-2014; CRITCHLEY, HILARY OD/C-7575-2013	Saunders, Philippa TK/0000-0001-9051-9380; Simon, Carlos/0000-0003-0902-9531; Mas, Aymara/0000-0002-5866-6732; Cervello, Irene/0000-0003-4801-5538; Cervello, Irene/0000-0002-7018-4971; CRITCHLEY, HILARY/0000-0003-1913-4044	Spanish Ministry of Science and Innovation [2008-02048]; Fundacio Gent per Gent [08/09]; Regional Valencian Ministry of Education [PROMETEO/2008/163]; Medical Research Council [G0600048, U1276.00.002.00005.01]; MRC [MC_U127685844, G1100356, G1002033, G0600048] Funding Source: UKRI; Medical Research Council [G1100356, G1002033, MC_U127685844] Funding Source: researchfish	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacio Gent per Gent; Regional Valencian Ministry of Education; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work has been funded by grants SAF (Plan Nacional de Biomedicina) 2008-02048 supported by the Spanish Ministry of Science and Innovation (PI: C. S.), by Fundacio Gent per Gent 08/09 (PI: C. S.) and by PROMETEO/2008/163 (PI: C. S.) supported by the Regional Valencian Ministry of Education. Support also from Medical Research Council (G0600048 to H.O.D.C.; U1276.00.002.00005.01 to P. T. K. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Gallardo C, 2010, IN VITRO CELL DEV-AN, V46, P317, DOI 10.1007/s11626-010-9285-3; Baer PC, 2011, METHODS MOL BIOL, V702, P289, DOI 10.1007/978-1-61737-960-4_21; Cervello I, 2007, HUM REPROD, V22, P45, DOI 10.1093/humrep/del332; Cervello I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010964; Cervello I, 2009, REPROD SCI, V16, P200, DOI 10.1177/1933719108329955; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; Chanda D, 2010, J CELL BIOCHEM, V111, P249, DOI 10.1002/jcb.22701; Cho NH, 2004, FERTIL STERIL, V81, P403, DOI 10.1016/j.fertnstert.2003.07.015; Choi YH, 2010, INT J BIOCHEM CELL B, V42, P662, DOI 10.1016/j.biocel.2009.12.011; Conneely OM, 2001, MOL CELL ENDOCRINOL, V179, P97, DOI 10.1016/S0303-7207(01)00465-8; Cooke PS, 1998, BIOL REPROD, V59, P470, DOI 10.1095/biolreprod59.3.470; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Critchley HD, 2002, J CLIN ENDOCR METAB, V87, P5265, DOI 10.1210/jc.2002-020502; Das B, 2008, STEM CELLS, V26, P1818, DOI 10.1634/stemcells.2007-0724; Dimitrov R, 2008, REPRODUCTION, V135, P551, DOI 10.1530/REP-07-0428; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Du H, 2009, REPROD SCI, V16, P126, DOI 10.1177/1933719108329956; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571; Huang L, 2004, BONE, V34, P393, DOI 10.1016/j.bone.2003.10.013; Iohara K, 2008, STEM CELLS, V26, P2408, DOI 10.1634/stemcells.2008-0393; Kaitu'u-Lino TJ, 2007, ENDOCRINOLOGY, V148, P5105, DOI 10.1210/en.2007-0716; Kato K, 2007, HUM REPROD, V22, P1214, DOI 10.1093/humrep/del514; Larderet G, 2006, STEM CELLS, V24, P965, DOI 10.1634/stemcells.2005-0196; Martin U, 2008, METHODS, V45, P121, DOI 10.1016/j.ymeth.2008.05.009; Masuda H, 2007, P NATL ACAD SCI USA, V104, P1925, DOI 10.1073/pnas.0604310104; Masuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010387; Meng XL, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-57; Musina RA, 2008, B EXP BIOL MED+, V145, P539, DOI 10.1007/s10517-008-0136-0; Okulicz WC, 1998, P SOC EXP BIOL MED, V218, P316; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; PADYKULA AH, 1991, ANN NY ACAD SCI, V622, P47; PRIANISHNIKOV VA, 1978, CONTRACEPTION, V18, P213, DOI 10.1016/S0010-7824(78)80015-8; Schwab KE, 2008, HUM REPROD, V23, P934, DOI 10.1093/humrep/den051; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Schwab KE, 2005, FERTIL STERIL, V84, P1124, DOI 10.1016/j.fertnstert.2005.02.056; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; SIMON C, 1993, J CLIN ENDOCR METAB, V77, P549, DOI 10.1210/jc.77.2.549; Smalley MJ, 2005, J MAMMARY GLAND BIOL, V10, P37, DOI 10.1007/s10911-005-2539-0; Tsuji S, 2008, FERTIL STERIL, V90, P1528, DOI 10.1016/j.fertnstert.2007.08.005; Wada-Hiraike O, 2006, P NATL ACAD SCI USA, V103, P18350, DOI 10.1073/pnas.0608861103; Winuthayanon W, 2010, P NATL ACAD SCI USA, V107, P19272, DOI 10.1073/pnas.1013226107; Wolff EF, 2007, REPROD SCI, V14, P524, DOI 10.1177/1933719107306896; Yarak S, 2010, AN BRAS DERMATOL, V85, P647, DOI 10.1590/S0365-05962010000500008; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	47	129	146	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21221	10.1371/journal.pone.0021221	http://dx.doi.org/10.1371/journal.pone.0021221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712999	gold, Green Published, Green Submitted			2022-12-25	WOS:000291985100018
J	Dinis, JM; Barton, DE; Ghadiri, J; Surendar, D; Reddy, K; Velasquez, F; Chaffee, CL; Lee, MCW; Gavrilova, H; Ozuna, H; Smits, SA; Ouverney, CC				Dinis, Jorge M.; Barton, David E.; Ghadiri, Jamsheed; Surendar, Deepa; Reddy, Kavitha; Velasquez, Fernando; Chaffee, Carol L.; Lee, Mei-Chong Wendy; Gavrilova, Helen; Ozuna, Hazel; Smits, Samuel A.; Ouverney, Cleber C.			In Search of an Uncultured Human-Associated TM7 Bacterium in the Environment	PLOS ONE			English	Article							MICROBIAL ECOLOGY; SEQUENCE DATA; DIVISION TM7; IN-SITU; DISEASE; ARCHAEA; IDENTIFICATION; COMMUNITIES; PHYLOGENY; DIVERSITY	We have identified an environmental bacterium in the Candidate Division TM7 with >= 98.5% 16S rDNA gene homology to a group of TM7 bacteria associated with the human oral cavity and skin. The environmental TM7 bacterium (referred to as TM7a-like) was readily detectable in wastewater with molecular techniques over two years of sampling. We present the first images of TM7a-like cells through FISH technique and the first images of any TM7 as viable cells through the STARFISH technique. In situ quantification showed TM7 concentration in wastewater up to five times greater than in human oral sites. We speculate that upon further characterization of the physiology and genetics of the TM7a-like bacterium from environmental sources and confirmation of its genomic identity to human-associated counterparts it will serve as model organisms to better understand its role in human health. The approach proposed circumvents difficulties imposed by sampling humans, provides an alternative strategy to characterizing some diseases of unknown etiology, and renders a much needed understanding of the ecophysiological role hundreds of unique Bacteria and Archaea strains play in mixed microbial communities.	[Dinis, Jorge M.; Barton, David E.; Ghadiri, Jamsheed; Surendar, Deepa; Reddy, Kavitha; Velasquez, Fernando; Gavrilova, Helen; Smits, Samuel A.; Ouverney, Cleber C.] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA; [Chaffee, Carol L.] Univ Florida, Dept Zool, Gainesville, FL 32611 USA; [Lee, Mei-Chong Wendy] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Ozuna, Hazel] Univ Metropolitana, Sci & Technol Dept, San Juan, PR USA	California State University System; San Jose State University; State University System of Florida; University of Florida; University of California System; University of California Santa Cruz; Universidad Metropolitana (UMET)	Dinis, JM (corresponding author), San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA.	cleber.ouverney@sjsu.edu	Chaffee, Carol/F-8852-2011; Barton, David E/B-9460-2008	Chaffee, Carol/0000-0002-2275-4853; Lee, Mei-Chong Wendy/0000-0002-8421-0536; Ozuna, Hazel/0000-0002-8786-2089; Ouverney, Cleber/0000-0002-4135-7562	NIH [SC3GM082291]; Howard Hughes Medical Institution [52006312]; NIH Minority Access to Research Career (MARC) [5T34GM008253]; NIH RISE [1R25GM071381]; NSF [REU-RUMBA DBI-0354149]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM082291, T34GM008253, R25GM071381] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institution(Howard Hughes Medical Institute); NIH Minority Access to Research Career (MARC); NIH RISE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this project was provided by the following agencies: NIH SC3GM082291, Howard Hughes Medical Institution 52006312, NIH Minority Access to Research Career (MARC) 5T34GM008253, NIH RISE 1R25GM071381, and NSF REU-RUMBA DBI-0354149. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; Awano S, 2008, J DENT RES, V87, P334, DOI 10.1177/154405910808700418; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Bik EM, ISME J; Brinig MM, 2003, APPL ENVIRON MICROB, V69, P1687, DOI 10.1128/AEM.69.3.1687-1694.2003; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Genco RJ, 2005, J PERIODONTOL, V76, P2075, DOI 10.1902/jop.2005.76.11-S.2075; Hugenholtz P, 2001, APPL ENVIRON MICROB, V67, P411, DOI 10.1128/AEM.67.1.411-419.2001; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Kovatcheva-Datchary Petia, 2009, Therap Adv Gastroenterol, V2, P9, DOI 10.1177/1756283X09337646; Kuehbacher T, 2008, J MED MICROBIOL, V57, P1569, DOI 10.1099/jmm.0.47719-0; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Ouverney CC, 2000, APPL ENVIRON MICROB, V66, P4829, DOI 10.1128/AEM.66.11.4829-4833.2000; Ouverney CC, 2003, APPL ENVIRON MICROB, V69, P6294, DOI 10.1128/AEM.69.10.6294-6298.2003; Ouverney CC, 1999, APPL ENVIRON MICROB, V65, P1746; OUVERNEY CC, 2004, MOL MICROBIAL ECOLOG, P1689; OUVERNEY CC, 2004, MOLE MICROBIAL ECOLO, P727; Podar M, 2007, APPL ENVIRON MICROB, V73, P3205, DOI 10.1128/AEM.02985-06; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Roh C, 2006, APPL BIOCHEM BIOTECH, V134, P97, DOI 10.1385/ABAB:134:2:97; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P6773, DOI 10.1128/AEM.00474-06; Schloss PD, 2004, APPL ENVIRON MICROB, V70, P5485, DOI 10.1128/AEM.70.9.5485-5492.2004; Smith CJ, 2009, FEMS MICROBIOL ECOL, V67, P6, DOI 10.1111/j.1574-6941.2008.00629.x; Smits SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012267; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Weng L, 2006, GENOME RES, V16, P316, DOI 10.1101/gr.3676406; Wilks M, 2007, EARLY HUM DEV, V83, P165, DOI 10.1016/j.earlhumdev.2007.01.007; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	40	41	44	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21280	10.1371/journal.pone.0021280	http://dx.doi.org/10.1371/journal.pone.0021280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701585	Green Published, gold			2022-12-25	WOS:000291983800039
J	Lee, ZW; Zhou, JB; Chen, CS; Zhao, YJ; Tan, CH; Li, L; Moore, PK; Deng, LW				Lee, Zheng Wei; Zhou, Jianbiao; Chen, Chien-Shing; Zhao, Yujun; Tan, Choon-Hong; Li, Ling; Moore, Philip Keith; Deng, Lih-Wen			The Slow-Releasing Hydrogen Sulfide Donor, GYY4137, Exhibits Novel Anti-Cancer Effects In Vitro and In Vivo	PLOS ONE			English	Article							OXIDATIVE STRESS; CELLS; INHIBITION; APOPTOSIS; CASPASE-3; P38	The slow-releasing hydrogen sulfide (H2S) donor, GYY4137, caused concentration-dependent killing of seven different human cancer cell lines (HeLa, HCT-116, Hep G2, HL-60, MCF-7, MV4-11 and U2OS) but did not affect survival of normal human lung fibroblasts (IMR90, WI-38) as determined by trypan blue exclusion. Sodium hydrosulfide (NaHS) was less potent and not active in all cell lines. A structural analogue of GYY4137 (ZYJ1122) lacking sulfur and thence not able to release H2S was inactive. Similar results were obtained using a clonogenic assay. Incubation of GYY4137 (400 mu M) in culture medium led to the generation of low (< 20 mM) concentrations of H2S sustained over 7 days. In contrast, incubation of NaHS (400 mu M) in the same way led to much higher (up to 400 mu M) concentrations of H2S which persisted for only 1 hour. Mechanistic studies revealed that GYY4137 (400 mu M) incubated for 5 days with MCF-7 but not IMR90 cells caused the generation of cleaved PARP and cleaved caspase 9, indicative of a pro-apoptotic effect. GYY4137 (but not ZYJ1122) also caused partial G(2)/M arrest of these cells. Mice xenograft studies using HL-60 and MV4-11 cells showed that GYY4137 (100-300 mg/kg/day for 14 days) significantly reduced tumor growth. We conclude that GYY4137 exhibits anti-cancer activity by releasing H2S over a period of days. We also propose that a combination of apoptosis and cell cycle arrest contributes to this effect and that H2S donors should be investigated further as potential anti-cancer agents.	[Lee, Zheng Wei; Deng, Lih-Wen] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Zhao, Yujun; Tan, Choon-Hong] Natl Univ Singapore, Dept Chem, Singapore 117548, Singapore; [Li, Ling; Moore, Philip Keith] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore; [Zhou, Jianbiao] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Chen, Chien-Shing] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Chen, Chien-Shing] Loma Linda Univ, Sch Med, Div Hematol & Oncol, Loma Linda, CA USA	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Loma Linda University	Lee, ZW (corresponding author), Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore.	dprmpk@nus.edu.sg; lih_wen_deng@nuhs.edu.sg	Lee, Zheng-Wei/ABI-3657-2020	Lee, Zheng-Wei/0000-0002-8062-7772; Deng, Lih-Wen/0000-0002-4985-7844	National University of Singapore [R-183-000-240-720, R183-000-240-101, R183-000-268-733]	National University of Singapore(National University of Singapore)	The work is supported by a National University of Singapore research grant to PKM, LWD and CHT (R-183-000-240-720, R183-000-240-101, R183-000-268-733). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Cai WJ, 2010, CELL BIOL INT, V34, P565, DOI 10.1042/CBI20090368; Cao QH, 2010, ANTIOXID REDOX SIGN, V12, P1101, DOI 10.1089/ars.2009.2915; Deplancke B, 2003, FASEB J, V17, P1310, DOI 10.1096/fj.02-0883fje; Fiedler N, 2008, ENVIRON HEALTH PERSP, V116, P78, DOI 10.1289/ehp.10531; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Hu LF, 2007, J NEUROCHEM, V100, P1121, DOI 10.1111/j.1471-4159.2006.04283.x; Hu LF, 2009, MOL PHARMACOL, V75, P27, DOI 10.1124/mol.108.047985; Huang SF, 2010, J MOL BIOL, V396, P708, DOI 10.1016/j.jmb.2009.11.058; Jha S, 2008, AM J PHYSIOL-HEART C, V295, pH801, DOI 10.1152/ajpheart.00377.2008; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Rinaldi L, 2006, LAB INVEST, V86, P391, DOI 10.1038/labinvest.3700391; Rose P, 2005, WORLD J GASTROENTERO, V11, P3990, DOI 10.3748/wjg.v11.i26.3990; Shen J, 2007, EXP HEMATOL, V35, P75; Taniguchi S, 2011, BRIT J PHARMACOL, V162, P1171, DOI 10.1111/j.1476-5381.2010.01119.x; Whiteman M, 2010, ANTIOXID REDOX SIGN, V12, P1147, DOI 10.1089/ars.2009.2899; Yang GD, 2004, FASEB J, V18, P1782, DOI 10.1096/fj.04-2279fje; Yonezawa D, 2007, TOXICOLOGY, V241, P11, DOI 10.1016/j.tox.2007.07.020	18	257	268	10	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21077	10.1371/journal.pone.0021077	http://dx.doi.org/10.1371/journal.pone.0021077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701688	Green Published, gold			2022-12-25	WOS:000291983800021
J	Shi, MM; Michalski, SG; Chen, XY; Durka, W				Shi, Miao-Miao; Michalski, Stefan G.; Chen, Xiao-Yong; Durka, Walter			Isolation by Elevation: Genetic Structure at Neutral and Putatively Non-Neutral Loci in a Dominant Tree of Subtropical Forests, Castanopsis eyrei	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; QUERCUS-ROBUR L.; MICROSATELLITE MARKERS; ALLOZYME VARIATION; NATURAL-SELECTION; CLIMATE-CHANGE; DIVERSITY; DIFFERENTIATION; FAGACEAE; PATTERNS	Background: The distribution of genetic diversity among plant populations growing along elevational gradients can be affected by neutral as well as selective processes. Molecular markers used to study these patterns usually target neutral processes only, but may also be affected by selection. In this study, the effects of elevation and successional stage on genetic diversity of a dominant tree species were investigated controlling for neutrality of the microsatellite loci used. Methodology/Principal Findings: Diversity and differentiation among 24 populations of Castanopsis eyrei from different elevations (251-920 m) and successional stages were analysed by eight microsatellite loci. We found that one of the loci (Ccu97H18) strongly deviated from a neutral model of differentiation among populations due to either divergent selection or hitchhiking with an unknown selected locus. The analysis showed that C. eyrei populations had a high level of genetic diversity within populations (A(R) = 7.6, H-E = 0.82). Genetic variation increased with elevation for both the putatively selected locus Ccu97H18 and the neutral loci. At locus Ccu97H18 one allele was dominant at low elevations, which was replaced at higher elevations by an increasing number of other alleles. The level of genetic differentiation at neutral loci was similar to that of other Fagaceae species (F-ST = 0.032, F'(ST) = 0.15). Population differentiation followed a model of isolation by distance but additionally, strongly significant isolation by elevation was found, both for neutral loci and the putatively selected locus. Conclusions/Significance: The results indicate higher gene flow among similar elevational levels than across different elevational levels and suggest a selective influence of elevation on the distribution of genetic diversity in C. eyrei. The study underlines the importance to check the selective neutrality of marker loci in analyses of population structure.	[Shi, Miao-Miao; Michalski, Stefan G.; Durka, Walter] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol BZF, Halle, Germany; [Chen, Xiao-Yong] E China Normal Univ, Sch Resources & Environm Sci, Tiantong Natl Stn Forest Ecosyst, Shanghai 200062, Peoples R China	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); East China Normal University	Shi, MM (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Community Ecol BZF, Halle, Germany.	miaomiao.shi@ufz.de	Michalski, Stefan G/O-5774-2015; Durka, Walter/E-4667-2010; Chen, Xiao-Yong/B-1467-2009	Michalski, Stefan G/0000-0002-8969-7355; Durka, Walter/0000-0002-6611-2246; Chen, Xiao-Yong/0000-0002-4795-8940	German Science Foundation (DFG) [FOR 891/1, Du 404/3]; China Scholarship Council [2008 3039]	German Science Foundation (DFG)(German Research Foundation (DFG)); China Scholarship Council(China Scholarship Council)	This work was funded by the German Science Foundation (DFG FOR 891/1, Du 404/3) and the China Scholarship Council (2008 3039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achere V, 2005, MOL ECOL, V14, P3191, DOI 10.1111/j.1365-294X.2005.02646.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Blakesley D, 2004, NEW FOREST, V27, P89, DOI 10.1023/A:1025016331835; Blionis GJ, 2001, ECOGRAPHY, V24, P696, DOI 10.1034/j.1600-0587.2001.240608.x; BORCHERT R, 1983, BIOTROPICA, V15, P81, DOI 10.2307/2387949; Bruelheide H, 2011, ECOL MONOGR, V81, P25, DOI 10.1890/09-2172.1; Byars SG, 2009, ANN BOT-LONDON, V103, P885, DOI 10.1093/aob/mcp018; Caetano S, 2008, MOL ECOL, V17, P3147, DOI 10.1111/j.1365-294X.2008.03817.x; Casa AM, 2005, THEOR APPL GENET, V111, P23, DOI 10.1007/s00122-005-1952-5; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chen XiaoYong, 1997, Acta Botanica Sinica, V39, P149; Cheng YP, 2001, J HERED, V92, P65, DOI 10.1093/jhered/92.1.65; Cheng YP, 2006, ANN BOT-LONDON, V98, P601, DOI 10.1093/aob/mcl135; Chung MY, 2002, AM J BOT, V89, P1229, DOI 10.3732/ajb.89.8.1229; Clarke LJ, 2008, J ECOL, V96, P378, DOI 10.1111/j.1365-2745.2007.01347.x; Coart E, 2002, THEOR APPL GENET, V105, P431, DOI 10.1007/s00122-002-0920-6; Cornuet JM, 1996, GENETICS, V144, P2001; Coyer JA, 2008, BIOL LETTERS, V4, P755, DOI 10.1098/rsbl.2008.0403; Edelist C, 2006, MOL ECOL, V15, P4623, DOI 10.1111/j.1365-294X.2006.03112.x; Gamperle E, 2002, FLORA, V197, P203, DOI 10.1078/0367-2530-00031; Goto S, 2009, ECOL RES, V24, P1267, DOI 10.1007/s11284-009-0611-8; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hazler K, 1997, SILVAE GENET, V46, P229; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Heller R, 2009, MOL ECOL, V18, P2080, DOI 10.1111/j.1365-294X.2009.04185.x; Herrera CM, 2008, HEREDITY, V100, P275, DOI 10.1038/sj.hdy.6801072; Hiraoka K, 2009, INT J PLANT SCI, V170, P748, DOI 10.1086/599072; Hiraoka K, 2009, J PLANT RES, V122, P269, DOI 10.1007/s10265-009-0217-9; Ingvarsson PK, 2010, MOL BIOL EVOL, V27, P650, DOI 10.1093/molbev/msp255; Jackson AL, 1998, P NATL ACAD SCI USA, V95, P12468, DOI 10.1073/pnas.95.21.12468; Jump AS, 2006, MOL ECOL, V15, P3469, DOI 10.1111/j.1365-294X.2006.03027.x; Kamiya K, 2002, GENES GENET SYST, V77, P177, DOI 10.1266/ggs.77.177; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kraj W, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008085; Lange R, 2010, MOL ECOL, V19, P4936, DOI 10.1111/j.1365-294X.2010.04877.x; Lazrek F, 2009, GENETICA, V135, P391, DOI 10.1007/s10709-008-9285-3; LeCorre V, 1997, MOL ECOL, V6, P519, DOI 10.1046/j.1365-294X.1997.00214.x; Lee YJ, 2006, J HERED, V97, P261, DOI 10.1093/jhered/esj030; Li Jian-hui, 2007, Shengtaixue Zazhi, V26, P509; Li JunMin, 2006, Journal of Zhejiang University (Agriculture and Life Sciences), V32, P232; Liu MH, 2008, PLANT ECOL, V197, P31, DOI 10.1007/s11258-007-9357-y; Maghuly F, 2006, FOREST ECOL MANAG, V222, P266, DOI 10.1016/j.foreco.2005.10.025; Mariette S, 2002, SILVAE GENET, V51, P72; Marsico TD, 2009, J BIOGEOGR, V36, P929, DOI 10.1111/j.1365-2699.2008.02049.x; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Michalski SG, 2010, THEOR APPL GENET, V120, P1151, DOI 10.1007/s00122-009-1242-8; Montalvo AM, 1997, AM J BOT, V84, P1553, DOI 10.2307/2446617; Nettel A, 2009, AM J BOT, V96, P2224, DOI 10.3732/ajb.0800339; Nielsen EE, 2006, MOL ECOL, V15, P3219, DOI 10.1111/j.1365-294X.2006.03025.x; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Ohsawa T, 2008, GLOBAL ECOL BIOGEOGR, V17, P152, DOI 10.1111/j.1466-8238.2007.00357.x; Peng SL, 2003, SILVAE GENET, V52, P60; Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x; Piotti A, 2009, HEREDITY, V103, P136, DOI 10.1038/hdy.2009.42; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Quiroga MP, 2007, J BIOGEOGR, V34, P447, DOI 10.1111/j.1365-2699.2006.01613.x; R Core Team, 2022, R LANG ENV STAT COMP; RUSCH VE, 1993, REV CHIL HIST NAT, V66, P131; Scascitelli M, 2010, MOL ECOL, V19, P521, DOI 10.1111/j.1365-294X.2009.04504.x; Stefenon VM, 2008, FOREST ECOL MANAG, V255, P2718, DOI 10.1016/j.foreco.2008.01.036; Tanaka T, 2005, BREEDING SCI, V55, P271, DOI 10.1270/jsbbs.55.271; Tomaru N, 1997, HEREDITY, V78, P241, DOI 10.1038/hdy.1997.38; Truong C, 2007, J EVOLUTION BIOL, V20, P369, DOI 10.1111/j.1420-9101.2006.01190.x; Ueno S, 2000, MOL ECOL, V9, P1188, DOI 10.1046/j.1365-294x.2000.00954-11.x; Ueno S, 2003, CONSERV GENET, V4, P813, DOI 10.1023/B:COGE.0000006120.99339.10; Ueno S, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009037; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vidhanaarachchi V. R. M., 2005, Japanese Journal of Tropical Agriculture, V49, P53; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wright S, 1943, GENETICS, V28, P114; Wright S, 1978, VARIABILITY NATURAL; [徐学红 Xu Xuehong], 2005, [生态学报, Acta Ecologica Sinica], V25, P645; Zhang X, 2006, NEW FOREST, V32, P347, DOI 10.1007/s11056-006-9008-5; Zhu QH, 2002, ACTA BOT SIN, V44, P1321; Zhu Y, 2010, OECOLOGIA, V162, P853, DOI 10.1007/s00442-009-1515-6	76	37	38	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21302	10.1371/journal.pone.0021302	http://dx.doi.org/10.1371/journal.pone.0021302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701584	Green Submitted, Green Published, gold			2022-12-25	WOS:000291983800040
J	Bellows, CF; Wheatley, BM; Moroz, K; Rosales, SC; Morici, LA				Bellows, Charles F.; Wheatley, Benjamin M.; Moroz, Krzysztof; Rosales, Stephanie C.; Morici, Lisa A.			The Effect of Bacterial Infection on the Biomechanical Properties of Biological Mesh in a Rat Model	PLOS ONE			English	Article							HERNIA REPAIR; MATRIX; DEFECTS	Background: The use of biologic mesh to repair abdominal wall defects in contaminated surgical fields is becoming the standard of practice. However, failure rates and infections of these materials persist clinically. The purpose of this study was to determine the mechanical properties of biologic mesh in response to a bacterial encounter. Methods: A rat model of Staphylococcus aureus colonization and infection of subcutaneously implanted biologic mesh was used. Samples of biologic meshes (acellular human dermis (ADM) and porcine small intestine submucosa (SIS)) were inoculated with various concentrations of methicillin-resistant Staphylococcus aureus [10(5), 10(9) colony-forming units] or saline (control) prior to wound closure (n = 6 per group). After 10 or 20 days, meshes were explanted, and cultured for bacteria. Histological changes and bacterial recovery together with biomechanical properties were assessed. Data were compared using a 1-way ANOVA or a Mann-Whitney test, with p<0.05. Results: The overall rate of staphylococcal mesh colonization was 81% and was comparable in the ADM and SIS groups. Initially (day 0) both biologic meshes had similar biomechanical properties. However after implantation, the SIS control material was significantly weaker than ADM at 20 days (p = 0.03), but their corresponding modulus of elasticity were similar at this time point (p>0.05). After inoculation with MRSA, a time, dose and material dependent decrease in the ultimate tensile strength and modulus of elasticity of SIS and ADM were noted compared to control values. Conclusion: The biomechanical properties of biologic mesh significantly decline after colonization with MRSA. Surgeons selecting a repair material should be aware of its biomechanical fate relative to other biologic materials when placed in a contaminated environment.	[Bellows, Charles F.; Wheatley, Benjamin M.] Tulane Univ, Hlth Sci Ctr, Dept Surg, New Orleans, LA 70118 USA; [Moroz, Krzysztof] Tulane Univ, Hlth Sci Ctr, Dept Pathol, New Orleans, LA 70118 USA; [Rosales, Stephanie C.; Morici, Lisa A.] Tulane Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, New Orleans, LA 70118 USA	Tulane University; Tulane University; Tulane University	Bellows, CF (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Surg, New Orleans, LA 70118 USA.	cbellows@tulane.edu		Wheatley, Benjamin/0000-0003-0105-8258	Tulane University [547258]	Tulane University	A Tulane University Research Enhancement Fund (#547258) funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciola CR, 2010, INT J ARTIF ORGANS, V33, P565, DOI 10.1177/039139881003300901; Awad SS, 2009, SURG INFECT, V10, P79, DOI 10.1089/sur.2008.082; Babylak S, 2001, J SURG RES, V99, P282; Bluebond-Langner R, 2008, ANN PLAS SURG, V60, P76, DOI 10.1097/SAP.0b013e31804efcbc; Burger JWA, 2004, ANN SURG, V240, P578; Carbonell AM, 2005, SURG ENDOSC, V19, P430, DOI 10.1007/s00464-004-8810-4; CHAND M, 2010, HERNIA          0911; Chavarriaga LF, 2010, AM SURGEON, V76, P96; Cobb WS, 2005, J SURG RES, V129, P231, DOI 10.1016/j.jss.2005.06.015; Connor J, 2009, REGEN MED, V4, P185, DOI 10.2217/17460751.4.2.185; Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001; Darouiche RO, 2005, J INFECTION, V50, P206, DOI 10.1016/j.jinf.2004.05.006; Falagas ME, 2005, CLIN MICROBIOL INFEC, V11, P3, DOI 10.1111/j.1469-0691.2004.01014.x; Geisler DJ, 2003, DIS COLON RECTUM, V46, P1118, DOI 10.1007/s10350-004-7290-x; Harth KC, 2009, SURG INNOV, V16, P324, DOI 10.1177/1553350609353609; HARTH KC, 2011, SURG ENDOSC     0207; Hodde J, 2006, ANZ J SURG, V76, P1096, DOI 10.1111/j.1445-2197.2006.03948.x; Konstantinovic ML, 2005, BJOG-INT J OBSTET GY, V112, P1554, DOI 10.1111/j.1471-0528.2005.00688.x; Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378; Milburn ML, 2008, SURG INFECT, V9, P433, DOI 10.1089/sur.2007.044; Rice RD, 2010, AESTHET PLAST SURG, V34, P290, DOI 10.1007/s00266-009-9449-2; Robinson TN, 2005, SURG ENDOSC, V19, P1556, DOI 10.1007/s00464-005-0120-y; SHAH BC, 2010, HERNIA          1228; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Utz ER, 2010, J SURG RES, V159, P633, DOI 10.1016/j.jss.2009.08.021; Wong AK, 2008, PLAST RECONSTR SURG, V121, P1144, DOI 10.1097/01.prs.0000302505.43942.07; Woodward J, 2010, SURG INFECT, V11, P405, DOI 10.1089/sur.2009.016; Xu H, 2008, TISSUE ENG PT A, V14, P2009, DOI 10.1089/ten.tea.2007.0316	28	38	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21228	10.1371/journal.pone.0021228	http://dx.doi.org/10.1371/journal.pone.0021228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698179	gold, Green Published, Green Submitted			2022-12-25	WOS:000291734100070
J	Kalisvaart, JP; Rampersad, SM; Goossens, J				Kalisvaart, Joke P.; Rampersad, Sumientra M.; Goossens, Jeroen			Binocular Onset Rivalry at the Time of Saccades and Stimulus Jumps	PLOS ONE			English	Article							NASO-TEMPORAL ASYMMETRY; EYE-MOVEMENTS; AMBIGUOUS PATTERNS; EXTRASTRIATE CORTEX; VISUAL-PERCEPTION; ATTENTION; AWARENESS; REPRESENTATION; ALTERNATIONS; COMPETITION	Recent studies suggest that binocular rivalry at stimulus onset, so called onset rivalry, differs from rivalry during sustained viewing. These observations raise the interesting question whether there is a relation between onset rivalry and rivalry in the presence of eye movements. We therefore studied binocular rivalry when stimuli jumped from one visual hemifield to the other, either through a saccade or through a passive stimulus displacement, and we compared rivalry after such displacements with onset and sustained rivalry. We presented opponent motion, orthogonal gratings and face/house stimuli through a stereoscope. For all three stimulus types we found that subjects showed a strong preference for stimuli in one eye or one hemifield (Experiment 1), and that these subject-specific biases did not persist during sustained viewing (Experiment 2). These results confirm and extend previous findings obtained with gratings. The results from the main experiment (Experiment 3) showed that after a passive stimulus jump, switching probability was low when the preferred eye was dominant before a stimulus jump, but when the non-preferred eye was dominant beforehand, switching probability was comparatively high. The results thus showed that dominance after a stimulus jump was tightly related to eye dominance at stimulus onset. In the saccade condition, however, these subject-specific biases were systematically reduced, indicating that the influence of saccades can be understood from a systematic attenuation of the subjects' onset rivalry biases. Taken together, our findings demonstrate a relation between onset rivalry and rivalry after retinal shifts and involvement of extra-retinal signals in binocular rivalry.	[Kalisvaart, Joke P.; Rampersad, Sumientra M.; Goossens, Jeroen] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Kalisvaart, JP (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	j.kalisvaart@donders.ru.nl	Goossens, Jeroen/D-7311-2010; Rampersad, Sumientra/Y-3536-2018	Goossens, Jeroen/0000-0001-5522-3437; Rampersad, Sumientra/0000-0001-9860-4459	NWO [864.06.005]; Radboud University Nijmegen Medical Centre	NWO(Netherlands Organization for Scientific Research (NWO)); Radboud University Nijmegen Medical Centre	This work is supported by NWO grant 864.06.005 (ALW VIDI) to JG (www.nwo.nl) and the Radboud University Nijmegen Medical Centre (www.ru.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Blake R, 2003, NEURON, V39, P869, DOI 10.1016/S0896-6273(03)00495-1; Blake R., 2001, BRAIN MIND, V2, P5, DOI [https://doi.org/10.1023/A:1017925416289, DOI 10.1023/A:1017925416289, 10.1023/A:1017925416289]; Blake R., 2005, BINOCULAR RIVALRY, P1; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; Carter O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000343; Chen XC, 2004, CURR BIOL, V14, P1013, DOI 10.1016/j.cub.2004.05.042; Chen XC, 2003, VISION RES, V43, P2207, DOI 10.1016/S0042-6989(03)00359-6; Chong SC, 2006, VISION RES, V46, P1794, DOI 10.1016/j.visres.2005.10.031; COLLEWIJN H, 1975, VISION RES, V15, P447, DOI 10.1016/0042-6989(75)90098-X; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; Davis ET, 2004, SPATIAL VISION, V17, P249, DOI 10.1163/1568568041920168; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; FAHLE M, 1988, VISION RES, V28, P293, DOI 10.1016/0042-6989(88)90157-5; FAHLE M, 1987, INVEST OPHTH VIS SCI, V28, P1016; Handa T, 2004, OPTOMETRY VISION SCI, V81, P377, DOI 10.1097/01.opx.0000135085.54136.65; Kanai R, 2005, PERCEPTION, V34, P803, DOI 10.1068/p5245; Kanal R, 2007, VISION RES, V47, P2675, DOI 10.1016/j.visres.2007.06.016; Klink PC, 2008, J VISION, V8, DOI 10.1167/8.5.16; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; Long GM, 2004, PSYCHOL BULL, V130, P748, DOI 10.1037/0033-2909.130.5.748; Maier A, 2003, CURR BIOL, V13, P1076, DOI 10.1016/S0960-9822(03)00414-7; Mamassian P, 2005, J VISION, V5, P361, DOI 10.1167/5.4.7; Melcher D, 2005, CURR BIOL, V15, P1745, DOI 10.1016/j.cub.2005.08.044; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Nishida S, 2003, VISION RES, V43, P639, DOI 10.1016/S0042-6989(03)00007-5; Noest AJ, 2007, J VISION, V7, DOI 10.1167/7.8.10; Ooi T L, 2001, Optometry, V72, P168; Ooi TL, 2006, PERCEPTION, V35, P581, DOI 10.1068/p5489; Pearson J, 2004, J VISION, V4, P196, DOI 10.1167/4.3.6; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; ROBBOY M W, 1990, CLAO Journal, V16, P299; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Ross J, 2004, NAT NEUROSCI, V7, P65, DOI 10.1038/nn1163; ROVAMO J, 1979, EXP BRAIN RES, V37, P495, DOI 10.1007/bf00236819; SCOTTO MA, 1990, PERCEPT MOTOR SKILL, V70, P1059; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Toppino TC, 2003, PERCEPT PSYCHOPHYS, V65, P1285, DOI 10.3758/BF03194852; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; van Boxtel JJA, 2008, J VISION, V8, DOI 10.1167/8.5.17; van Dam LCJ, 2006, VISION RES, V46, P787, DOI 10.1016/j.visres.2005.10.011; van Dam LCJ, 2006, J VISION, V6, P1172, DOI 10.1167/6.11.3; Viviani P, 1990, Rev Oculomot Res, V4, P353	47	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20017	10.1371/journal.pone.0020017	http://dx.doi.org/10.1371/journal.pone.0020017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778TS	21698288	gold, Green Published, Green Submitted			2022-12-25	WOS:000291730000006
J	Takeuchi, H; Iba, M; Inoue, H; Higuchi, M; Takao, K; Tsukita, K; Karatsu, Y; Iwamoto, Y; Miyakawa, T; Suhara, T; Trojanowski, JQ; Lee, VMY; Takahashi, R				Takeuchi, Hiroki; Iba, Michiyo; Inoue, Haruhisa; Higuchi, Makoto; Takao, Keizo; Tsukita, Kayoko; Karatsu, Yoshiko; Iwamoto, Yumiko; Miyakawa, Tsuyoshi; Suhara, Tetsuya; Trojanowski, John Q.; Lee, Virginia M. -Y.; Takahashi, Ryosuke			P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; PREPULSE INHIBITION; VENTRAL HIPPOCAMPUS; ALZHEIMERS-DISEASE; MOUSE MODEL; MEMORY; BEHAVIOR; AGGREGATION; MECHANISMS; RECEPTOR	Tauopathies are neurodegenerative disorders characterized by the accumulation of abnormal tau protein leading to cognitive and/or motor dysfunction. To understand the relationship between tau pathology and behavioral impairments, we comprehensively assessed behavioral abnormalities in a mouse tauopathy model expressing the human P301S mutant tau protein in the early stage of disease to detect its initial neurological manifestations. Behavioral abnormalities, shown by open field test, elevated plus-maze test, hot plate test, Y-maze test, Barnes maze test, Morris water maze test, and/or contextual fear conditioning test, recapitulated the neurological deficits of human tauopathies with dementia. Furthermore, we discovered that prepulse inhibition (PPI), a marker of sensorimotor gating, was enhanced in these animals concomitantly with initial neuropathological changes in associated brain regions. This finding provides evidence that our tauopathy mouse model displays neurofunctional abnormalities in prodromal stages of disease, since enhancement of PPI is characteristic of amnestic mild cognitive impairment, a transitional stage between normal aging and dementia such as Alzheimer's disease (AD), in contrast with attenuated PPI in AD patients. Therefore, assessment of sensorimotor gating could be used to detect the earliest manifestations of tauopathies exemplified by prodromal AD, in which abnormal tau protein may play critical roles in the onset of neuronal dysfunctions.	[Takeuchi, Hiroki; Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Sakyo Ku, Kyoto, Japan; [Takeuchi, Hiroki; Inoue, Haruhisa; Tsukita, Kayoko; Karatsu, Yoshiko; Iwamoto, Yumiko] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Sakyo Ku, Kyoto, Japan; [Iba, Michiyo; Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Sch Med, HUP, Ctr Neurodegenerat Dis Res,Inst Aging, Philadelphia, PA 19104 USA; [Iba, Michiyo; Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Sch Med, HUP, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Inoue, Haruhisa] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Higuchi, Makoto; Suhara, Tetsuya] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan; [Takao, Keizo] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Sect Behav Patterns, Aichi, Japan; [Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Aichi, Japan	Kyoto University; Kyoto University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Japan Science & Technology Agency (JST); National Institutes for Quantum Science & Technology; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Fujita Health University	Takeuchi, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Neurol, Sakyo Ku, Kyoto, Japan.	haruhisa@cira.kyoto-u.ac.jp	; Takao, Keizo/B-9527-2008; Miyakawa, Tsuyoshi/A-7741-2008	Inoue, Haruhisa/0000-0003-4736-9537; Takao, Keizo/0000-0002-4734-3583; Miyakawa, Tsuyoshi/0000-0003-0137-8200	National Institutes of Health (NIH), USA [AG-10124, AG-17586]; Japan Science and Technology Agency (JST); NATIONAL INSTITUTE ON AGING [P30AG010124, P01AG017586] Funding Source: NIH RePORTER	National Institutes of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants (number AG-10124 and AG-17586) of the National Institutes of Health (NIH), USA (http://grants.nih.gov/grants/oer.htm), and by a grant for Molecular Imaging Program of the Japan Science and Technology Agency (JST) (HI) (http://www.jst.go.jp/keytech/01bunshi/index.html). No current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ally Brandon A, 2006, Am J Alzheimers Dis Other Demen, V21, P439; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Assal F, 2002, CURR OPIN NEUROL, V15, P445, DOI 10.1097/00019052-200208000-00007; Ballard CG, 2009, NAT REV NEUROL, V5, P245, DOI 10.1038/nrneurol.2009.39; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Belleville S, 2008, PROG BRAIN RES, V169, P365, DOI 10.1016/S0079-6123(07)00023-4; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; de Silva R, 2006, ACTA NEUROPATHOL, V111, P329, DOI 10.1007/s00401-006-0048-x; De Vreese LP, 2001, INT J GERIATR PSYCH, V16, P794, DOI 10.1002/gps.428; Delobel P, 2008, AM J PATHOL, V172, P123, DOI 10.2353/ajpath.2008.070627; Denk F, 2009, NEUROBIOL AGING, V30, P1, DOI 10.1016/j.neurobiolaging.2007.05.010; Egashira N, 2005, BRAIN RES, V1059, P7, DOI 10.1016/j.brainres.2005.08.004; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Geyer MA, 2003, PROG NEURO-PSYCHOPH, V27, P1071, DOI 10.1016/j.pnpbp.2003.09.003; Hejl AM, 2004, NEUROBIOL AGING, V25, P1045, DOI 10.1016/j.neurobiolaging.2003.11.005; HERBERT H, 1991, J COMP NEUROL, V304, P103, DOI 10.1002/cne.903040108; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Iwatsubo T, 2006, NEUROPATHOLOGY, V26, P455, DOI 10.1111/j.1440-1789.2006.00667.x; Kaidanovich-Beilin O, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-35; Katsuno T, 2005, NEUROLOGY, V64, P687, DOI 10.1212/01.WNL.0000151958.79884.86; Kieffer BL, 1999, TRENDS PHARMACOL SCI, V20, P19, DOI 10.1016/S0165-6147(98)01279-6; Korczyn AD, 2009, J NEUROL SCI, V283, P139, DOI 10.1016/j.jns.2009.02.346; Kouzu Y, 2000, MOL BRAIN RES, V76, P142, DOI 10.1016/S0169-328X(99)00344-7; Li L, 2009, NEUROSCI BIOBEHAV R, V33, P1157, DOI 10.1016/j.neubiorev.2009.02.001; Lipska BK, 1995, PSYCHOPHARMACOLOGY, V122, P35, DOI 10.1007/BF02246439; Liu W, 2004, NEUROLOGY, V62, P742, DOI 10.1212/01.WNL.0000113729.77161.C9; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MELONI EC, 2007, J NEUROSCI, V20, P5274; Miller EJ, 2010, NEUROSCIENCE, V165, P601, DOI 10.1016/j.neuroscience.2009.10.036; Miyasaka T, 2001, AM J PATHOL, V158, P373, DOI 10.1016/S0002-9440(10)63979-X; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Niemann S, 2007, EUR J NEUROSCI, V26, P1407, DOI 10.1111/j.1460-9568.2007.05774.x; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; NUKINA N, 1987, P NATL ACAD SCI USA, V84, P3415, DOI 10.1073/pnas.84.10.3415; Pape HC, 2003, ANN NY ACAD SCI, V985, P92; Porter FL, 1996, PAIN, V68, P413, DOI 10.1016/S0304-3959(96)03210-1; Sahara N, 2008, CURR ALZHEIMER RES, V5, P591, DOI 10.2174/156720508786898442; Saint Marie RL, 2010, NEUROSCIENCE, V168, P498, DOI 10.1016/j.neuroscience.2010.03.037; Scattoni ML, 2010, BEHAV BRAIN RES, V208, P250, DOI 10.1016/j.bbr.2009.12.002; Seino Y, 2010, J NEUROSCI RES, V88, P3547, DOI 10.1002/jnr.22516; Shahani N, 2002, CELL MOL LIFE SCI, V59, P1668, DOI 10.1007/PL00012495; Shiarli AM, 2006, NEUROPATH APPL NEURO, V32, P374, DOI 10.1111/j.1365-2990.2006.00736.x; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; SUEMARU S, 1991, NEUROREPORT, V2, P337, DOI 10.1097/00001756-199106000-00009; Swerdlow NR, 2004, NEUROSCIENCE, V123, P675, DOI 10.1016/j.neuroscience.2003.08.028; Tabira T, 2009, ANN NEUROL, V65, P4, DOI 10.1002/ana.21599; Takahashi K, 2007, BIOL PSYCHIAT, V62, P148, DOI 10.1016/j.biopsych.2006.06.035; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Takao Keizo, 2006, J Vis Exp, P104, DOI 10.3791/104; Taniguchi T, 2005, FEBS LETT, V579, P5704, DOI 10.1016/j.febslet.2005.09.047; Tatebayashi Y, 2002, P NATL ACAD SCI USA, V99, P13896, DOI 10.1073/pnas.202205599; Trantham-Davidson H, 2008, BEHAV BRAIN RES, V189, P244, DOI 10.1016/j.bbr.2007.12.031; Tsuji T, 2002, NEUROCHEM RES, V27, P1245, DOI 10.1023/A:1020941929414; Ueki A, 2006, PSYCHIAT CLIN NEUROS, V60, P55, DOI 10.1111/j.1440-1819.2006.01460.x; Watanabe A, 2004, J NEUROCHEM, V90, P1302, DOI 10.1111/j.1471-4159.2004.02611.x; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang MR, 2004, J MED CHEM, V47, P2228, DOI 10.1021/jm0304919	64	184	185	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21050	10.1371/journal.pone.0021050	http://dx.doi.org/10.1371/journal.pone.0021050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698260	Green Published, gold, Green Submitted			2022-12-25	WOS:000291730000044
J	Mura, M; Swain, RK; Zhuang, X; Vorschmitt, H; Reynolds, G; Durant, S; Beesley, JFJ; Herbert, JMJ; Sheldon, H; Andre, M; Sanderson, S; Glen, K; Luu, NT; McGettrick, HM; Antczak, P; Falciani, F; Nash, GB; Nagy, Z; Bicknell, R				Mura, M.; Swain, R. K.; Zhuang, X.; Vorschmitt, H.; Reynolds, G.; Durant, S.; Beesley, J. F. J.; Herbert, J. M. J.; Sheldon, H.; Andre, M.; Sanderson, S.; Glen, K.; Luu, N-T; McGettrick, H. M.; Antczak, P.; Falciani, F.; Nash, G. B.; Nagy, Zs; Bicknell, R.			Identification and angiogenic role of the novel tumor endothelial marker CLEC14A	ONCOGENE			English	Article						tumor vasculature; gene expression; cell migration; shear stress	GENE-EXPRESSION; SOLID TUMORS; MAGIC ROUNDABOUT; CELL GENES; FLOW; THROMBOMODULIN; PROGRESSION; RESPONSES; RECEPTOR; SURFACE	Tumor endothelial markers (TEMs) that are highly expressed in human tumor vasculature compared with vasculature in normal tissue hold clear therapeutic potential. We report that the C-type lectin CLEC14A is a novel TEM. Immunohistochemical and immunofluorescence staining of tissue arrays has shown that CLEC14A is strongly expressed in tumor vasculature when compared with vessels in normal tissue. CLEC14A overexpression in tumor vessels was seen in a wide range of solid tumor types. Functional studies showed that CLEC14A induces filopodia and facilitates endothelial migration, tube formation and vascular development in zebrafish that is, CLEC14A regulates pro-angiogenic phenotypes. CLEC14A antisera inhibited cell migration and tube formation, suggesting that anti-CLEC14A antibodies may have anti-angiogenic activity. Finally, in endothelial cultures, expression of CLEC14A increased at low shear stress, and we hypothesize that low shear stress due to poor blood flow in the disorganized tumor vasculature induces expression of CLEC14A on tumor vessels and pro-angiogenic phenotypes. Oncogene (2012) 31, 293-305; doi:10.1038/onc.2011.233; published online 27 June 2011	[Mura, M.; Swain, R. K.; Zhuang, X.; Vorschmitt, H.; Durant, S.; Beesley, J. F. J.; Herbert, J. M. J.; Bicknell, R.] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect Sci, Angiogenesis Grp,Ctr Cardiovasc Sci,Inst Biomed R, Birmingham B15 2TT, W Midlands, England; [Mura, M.; Swain, R. K.; Zhuang, X.; Vorschmitt, H.; Durant, S.; Beesley, J. F. J.; Herbert, J. M. J.; Bicknell, R.] Univ Birmingham, Coll Med & Dent Sci, Sch Canc Sci, Angiogenesis Grp,Ctr Cardiovasc Sci,Inst Biomed R, Birmingham B15 2TT, W Midlands, England; [Reynolds, G.] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Liver Labs,Inst Biomed Res, Birmingham B15 2TT, W Midlands, England; [Sheldon, H.; Andre, M.; Sanderson, S.; Bicknell, R.] Univ Oxford, John Radcliffe Hosp, Inst Mol Med, Canc Res UK Angiogenesis Grp, Oxford OX3 9DU, England; [Glen, K.; Luu, N-T; McGettrick, H. M.; Nash, G. B.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Res, Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England; [Antczak, P.; Falciani, F.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Nagy, Zs] Univ Birmingham, Coll Med & Dent, Sch Clin & Expt Med, Neurodegenerat & Repair Grp, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Oxford; University of Birmingham; University of Birmingham; University of Birmingham	Bicknell, R (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect Sci, Angiogenesis Grp,Ctr Cardiovasc Sci,Inst Biomed R, Vincent Dr, Birmingham B15 2TT, W Midlands, England.	r.bicknell@bham.ac.uk	Reynolds, Gary/F-8641-2014; Nagy, Zsuzsanna/L-8446-2013; Nash, Gerard B/E-4182-2010; McGettrick, Helen M/H-3442-2011; Antczak, Philipp/L-5879-2019	Reynolds, Gary/0000-0002-3250-0582; Nagy, Zsuzsanna/0000-0002-6700-4829; Nash, Gerard B/0000-0002-5935-2831; McGettrick, Helen M/0000-0002-5950-8840; Antczak, Philipp/0000-0001-9600-7757; Swain, Rajeeb/0000-0003-4815-8221; Sheldon, Helen/0000-0002-0945-5496; Bicknell, Roy/0000-0002-0941-8919; Zhuang, Alan Xiaodong/0000-0002-6870-9003	Cancer Research UK [C4719/A6766, C4719/A9601]; British Heart Foundation; Medical Research Council [G9818340] Funding Source: researchfish; MRC [G9818340] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Professor Maria Grazia Lampugnani, IFOM-FIRC Institute for Molecular Oncology, Milan, for the gift of the BU9 anti-human VE cadherin mouse monoclonal antibody; and Dr Raj Mehta, Cancer Research Technology for helpful discussions. This work was supported by program grant number C4719/A6766 and project grant number C4719/A9601 from the Cancer Research UK to RB. RB and GBN acknowledge financial support from the British Heart Foundation. Umbilical cords were collected with the assistance of the Birmingham Women's Health Care NHS Trust.	Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; Armstrong LJ, 2008, ARTERIOSCL THROM VAS, V28, P1640, DOI 10.1161/ATVBAHA.108.162511; Bohlson SS, 2005, J IMMUNOL, V175, P1239, DOI 10.4049/jimmunol.175.2.1239; BURROWS FJ, 1993, P NATL ACAD SCI USA, V90, P8996, DOI 10.1073/pnas.90.19.8996; Chaplin DJ, 1997, TUMOUR ANGIOGENESIS, P61; Chen-Konak L, 2003, FASEB J, V17, P2121, DOI 10.1096/fj.02-1151fje; Chinnasamy D, 2010, J CLIN INVEST, V120, P3953, DOI 10.1172/JCI43490; Chu TJ, 2008, PHYSIOL GENOMICS, V34, P185, DOI 10.1152/physiolgenomics.90201.2008; Dachs GU, 1998, SEMIN RADIAT ONCOL, V8, P208, DOI 10.1016/S1053-4296(98)80046-5; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; ESMON CT, 1995, FASEB J, V9, P946, DOI 10.1096/fasebj.9.10.7615164; Gomez GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004994; Gullino PM., 1975, CANCER, V3, P327; He J, 2009, CLIN CANCER RES, V15, P6871, DOI 10.1158/1078-0432.CCR-09-1499; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Herbert JMJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-153; Ho M, 2003, PHYSIOL GENOMICS, V13, P249, DOI 10.1152/physiolgenomics.00186.2002; HOLTHOFER H, 1982, LAB INVEST, V47, P60; Huang XM, 1997, SCIENCE, V275, P547, DOI 10.1126/science.275.5299.547; Huijbers EJM, 2010, FASEB J, V24, P4535, DOI 10.1096/fj.10-163022; Huminiecki L, 2002, GENOMICS, V79, P547, DOI 10.1006/geno.2002.6745; Huminiecki L, 2000, GENOME RES, V10, P1796, DOI 10.1101/gr.150700; JAIN RK, 1988, CANCER RES, V48, P2641; MacFadyen JR, 2005, FEBS LETT, V579, P2569, DOI 10.1016/j.febslet.2005.03.071; MARUYAMA I, 1985, J CELL BIOL, V101, P363, DOI 10.1083/jcb.101.2.363; Matharu NM, 2008, J CELL PHYSIOL, V216, P732, DOI 10.1002/jcp.21457; McCormick SM, 2001, P NATL ACAD SCI USA, V98, P8955, DOI 10.1073/pnas.171259298; Nanda A, 2006, P NATL ACAD SCI USA, V103, P3351, DOI 10.1073/pnas.0511306103; Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580; Padera TP, 2004, NATURE, V427, P695, DOI 10.1038/427695a; Pham VN, 2007, DEV BIOL, V303, P772, DOI 10.1016/j.ydbio.2006.10.030; Porat RM, 2004, CIRC RES, V94, P394, DOI 10.1161/01.RES.0000111803.92923.D6; Reynolds GM, 2002, BRIT J HAEMATOL, V118, P195, DOI 10.1046/j.1365-2141.2002.03575.x; Rho SS, 2011, BIOCHEM BIOPH RES CO, V404, P103, DOI 10.1016/j.bbrc.2010.11.075; Seth P, 2005, BIOCHEM BIOPH RES CO, V332, P533, DOI 10.1016/j.bbrc.2005.03.250; Sheikh S, 2004, J IMMUNOL METHODS, V288, P35, DOI 10.1016/j.jim.2004.02.005; Siemann DW, 2011, CANCER TREAT REV, V37, P63, DOI 10.1016/j.ctrv.2010.05.001; St Croix B, 2000, SCIENCE, V289, P1197; Sumanas S, 2005, BLOOD, V106, P534, DOI 10.1182/blood-2004-12-4653; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tomar A, 2009, J CELL SCI, V122, P1852, DOI 10.1242/jcs.046870; van Beijnum JR, 2006, BLOOD, V108, P2339, DOI 10.1182/blood-2006-02-004291; Wasserman SM, 2004, VASC MED, V9, P35, DOI 10.1191/1358863x04vm521ra; Woo KV, 2011, J CLIN INVEST, V121, P1624, DOI 10.1172/JCI42040; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	46	77	82	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	3					293	305		10.1038/onc.2011.233	http://dx.doi.org/10.1038/onc.2011.233			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	882DQ	21706054				2022-12-25	WOS:000299542100003
J	Dobierzewska, A; Giltiay, NV; Sabapathi, S; Karakashian, AA; Nikolova-Karakashian, MN				Dobierzewska, Aneta; Giltiay, Natalia V.; Sabapathi, Sathish; Karakashian, Alexander A.; Nikolova-Karakashian, Mariana N.			Protein Phosphatase 2A and Neutral Sphingomyelinase 2 Regulate IRAK-1 Protein Ubiquitination and Degradation in Response to Interleukin-1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED KINASE; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; CYTOCHROME-P450 2C11 CYP2C11; IL-1 SIGNALING PATHWAY; FACTOR-ALPHA; TERMINAL KINASE; LYS63-LINKED POLYUBIQUITINATION; DIFFERENTIAL REGULATION; INDUCED APOPTOSIS	The IL-1 beta signaling cascade is initiated by the phosphorylation of IL-1 beta receptor-associated kinase-1 (IRAK-1), followed by its ubiquitination and degradation. This paper investigates the regulation of IRAK-1 degradation in primary hepatocytes and in HEK cells overexpressing the IL-1 beta receptor. We provide evidence that protein phosphatase 2A (PP2A) is a negative regulator of the phosphorylation, Lys(48)-linked ubiquitination, and degradation of IRAK-1. PP2A catalytic activity increased within 30 min of stimulation with IL-1 beta. siRNA against PP2A catalytic subunit (PP2Ac) or treatment with pharmacological inhibitor, okadaic acid, enhanced IRAK-1 Lys(48)-linked ubiquitination and degradation. Direct interaction between PP2Ac and IRAK-1 was observed, suggesting that IRAK-1 might be a PP2A substrate. The mechanisms of PP2A activation by IL-1 beta involved neutral sphingomyelinase-2 (NSMase-2) and an accumulation of ceramide. Overexpression of NSMase-2 delayed IRAK-1 degradation in a PP2A-dependent manner, whereas NSMase-2 silencing had the opposite effect. The addition of sphingomyelinase, ceramide, or a proteasome inhibitor all led to retention of IRAK-1 at the cell membrane and to increased JNK phosphorylation. This study suggests that NSMase-2- and PP2A-dependent regulation of IRAK-1 degradation is a novel mechanism to fine tune the magnitude of IL-1 beta response.	[Nikolova-Karakashian, Mariana N.] Univ Kentucky, Coll Med, Dept Physiol, AB Chandler Med Ctr, Lexington, KY 40536 USA	University of Kentucky	Nikolova-Karakashian, MN (corresponding author), Univ Kentucky, Coll Med, Dept Physiol, AB Chandler Med Ctr, 800 Rose St, Lexington, KY 40536 USA.	mnikolo@uky.edu	Giltiay, Natalia V./H-8655-2019; Giltiay, Natalia/AAH-2130-2019	Giltiay, Natalia/0000-0001-7284-514X	National Institutes of Health [AG 026711]; NATIONAL INSTITUTE ON AGING [R01AG019223, R56AG019223, R01AG026711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG 026711 (to M. N.-K.).	Adib-Conquy M, 2002, J BIOL CHEM, V277, P27927, DOI 10.1074/jbc.M200705200; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Brikos C, 2007, MOL CELL PROTEOMICS, V6, P1551, DOI 10.1074/mcp.M600455-MCP200; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chalfant CE, 2004, J LIPID RES, V45, P496, DOI 10.1194/jlr.M300347-JLR200; Chen BC, 2002, J BIOL CHEM, V277, P24169, DOI 10.1074/jbc.M106014200; CHEN JQ, 1995, J BIOL CHEM, V270, P25233, DOI 10.1074/jbc.270.42.25233; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; CORONEOS E, 1995, J BIOL CHEM, V270, P23305, DOI 10.1074/jbc.270.40.23305; Cuschieri J, 2004, CELL IMMUNOL, V227, P140, DOI 10.1016/j.cellimm.2004.03.005; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; De Palma C, 2006, ARTERIOSCL THROM VAS, V26, P99, DOI 10.1161/01.ATV.0000194074.59584.42; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; DRESSLER KA, 1992, SCIENCE, V255, P1715, DOI 10.1126/science.1313189; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fan GH, 2001, J BIOL CHEM, V276, P16960, DOI 10.1074/jbc.M009292200; Filosto S, 2010, J BIOL CHEM, V285, P10213, DOI 10.1074/jbc.M109.069963; Goswami R, 2005, J NEUROSCI RES, V81, P208, DOI 10.1002/jnr.20549; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6; Hayashi Y, 1997, J BIOL CHEM, V272, P18082, DOI 10.1074/jbc.272.29.18082; Henmi T, 2009, BIOCHEM J, V423, P71, DOI 10.1042/BJ20090208; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje; KIM MY, 1991, J BIOL CHEM, V266, P484; Kim WH, 2000, BIOCHEM CELL BIOL, V78, P127, DOI 10.1139/bcb-78-2-127; Kim WJ, 2008, BLOOD, V111, P4716, DOI 10.1182/blood-2007-10-113068; Kirk P, 2005, IMMUNITY, V23, P347, DOI 10.1016/j.immuni.2005.09.008; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Kray AE, 2005, J BIOL CHEM, V280, P35974, DOI 10.1074/jbc.M506093200; Krueger KM, 1997, J BIOL CHEM, V272, P5; Levade T, 1999, BBA-MOL CELL BIOL L, V1438, P1, DOI 10.1016/S1388-1981(99)00038-4; Levy M, 2006, BIOCHEM BIOPH RES CO, V344, P900, DOI 10.1016/j.bbrc.2006.04.013; Levy M, 2009, AM J PHYSIOL-LUNG C, V297, pL125, DOI 10.1152/ajplung.00031.2009; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 2001, P NATL ACAD SCI USA, V98, P4461, DOI 10.1073/pnas.071054198; Liu W, 2003, BIOORG MED CHEM LETT, V13, P1597, DOI 10.1016/S0960-894X(03)00105-7; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; McCluskey A, 2002, J MED CHEM, V45, P1151, DOI 10.1021/jm010066k; Mukhopadhyay A, 2009, FASEB J, V23, P751, DOI 10.1096/fj.08-120550; Neumann D, 2008, J LEUKOCYTE BIOL, V84, P807, DOI 10.1189/jlb.0507290; Neumann D, 2007, BIOCHEM BIOPH RES CO, V354, P1089, DOI 10.1016/j.bbrc.2007.01.104; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nikolova-Karakashian Mariana, 2008, V49, P469, DOI 10.1007/978-1-4020-8831-5_18; NikolovaKarakashian M, 1997, J BIOL CHEM, V272, P18718, DOI 10.1074/jbc.272.30.18718; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; O'Neill L, 2000, BIOCHEM SOC T, V28, P557, DOI 10.1042/bst0280557; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Peiser M, 2008, J LEUKOCYTE BIOL, V83, P1118, DOI 10.1189/jlb.0807567; Rutkute K, 2007, J LIPID RES, V48, P2443, DOI 10.1194/jlr.M700227-JLR200; Rutkute K, 2007, HEPATOLOGY, V46, P1166, DOI 10.1002/HEP.21777; Rutkute K, 2007, BIOCHEM BIOPH RES CO, V361, P263, DOI 10.1016/j.bbrc.2007.06.079; Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16; SCHUTZE S, 1994, J LEUKOCYTE BIOL, V56, P533, DOI 10.1002/jlb.56.5.533; Shanley TP, 2002, CRIT CARE MED, V30, pS80, DOI 10.1097/00003246-200201001-00011; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Smith H, 2009, P NATL ACAD SCI USA, V106, P4584, DOI 10.1073/pnas.0900774106; Tao WA, 2005, NAT METHODS, V2, P591, DOI 10.1038/NMETH776; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; WESTWICK JK, 1995, J BIOL CHEM, V270, P22689, DOI 10.1074/jbc.270.39.22689; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; WOLFF RA, 1994, J BIOL CHEM, V269, P19605; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xiao H, 2008, J BIOL CHEM, V283, P14654, DOI 10.1074/jbc.M706931200; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Yang JM, 2001, J BIOL CHEM, V276, P47828, DOI 10.1074/jbc.M106103200; Zhao B, 2008, SHOCK, V29, P181, DOI 10.1097/shk.0b013e318070c840	75	15	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32064	32073		10.1074/jbc.M111.238030	http://dx.doi.org/10.1074/jbc.M111.238030			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21708940	Green Published, hybrid			2022-12-25	WOS:000294726800016
J	Valentine, WJ; Godwin, VI; Osborne, DA; Liu, JX; Fujiwara, Y; Van Brocklyn, J; Bittman, R; Parrill, AL; Tigyi, G				Valentine, William J.; Godwin, Virginia I.; Osborne, Daniel A.; Liu, Jianxiong; Fujiwara, Yuko; Van Brocklyn, James; Bittman, Robert; Parrill, Abby L.; Tigyi, Gabor			FTY720 (Gilenya) Phosphate Selectivity of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P(1)) G Protein-coupled Receptor Requires Motifs in Intracellular Loop 1 and Transmembrane Domain 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID RECEPTORS; IMMUNOSUPPRESSIVE AGENT FTY720; DIFFERENTIATION GENE FAMILY; MULTIPLE-SCLEROSIS; SPHINGOSINE-1-PHOSPHATE; IDENTIFICATION; RECOGNITION; RESIDUES; PERMEABILITY; ANTAGONIST	FTY720 phosphate (FTY720P) is a high potency agonist for all the endothelial differentiation gene family sphingosine 1-phosphate (S1P) receptors except S1P receptor subtype 2 (S1P(2)). To map the distinguishing features of S1P(2) ligand recognition, we applied a computational modeling-guided mutagenesis strategy that was based on the high degree of sequence homology between S1P(1) and S1P(2). S1P(2) point mutants of the ligand-binding pocket were characterized. The head group-interacting residues Arg3.28, Glu3.29, and Lys7.34 were essential for activation. Mutation of residues Ala3.32, Leu3.36, Val5.41, Phe6.44, Trp6.48, Ser7.42, and Ser7.46, predicted to interact with the S1P hydrophobic tail, impaired activation by S1P. Replacing individual or multiple residues in the ligand-binding pocket of S1P(2) with S1P(1) sequence did not impart activation by FTY720P. Chimeric S1P(1)/S1P(2) receptors were generated and characterized for activation by S1P or FTY720P. The S1P(2) chimera with S1P(1) sequence from the N terminus to transmembrane domain 2 (TM2) was activated by FTY720P, and the S1P(2)(IC1-TM2)(S1P1) domain insertion chimera showed S1P(1)-like activation. Twelve residues in this domain, distributed in four motifs a-d, differ between S1P(1) and S1P(2). Insertion of (RPMYY)-R-78 in motif b alone or simultaneous swapping of five other residues in motifs c and d from S1P(1) into S1P(2) introduced FTY720P responsiveness. Molecular dynamics calculations indicate that FTY720P binding selectivity is a function of the entropic contribution to the binding free energy rather than enthalpic contributions and that preferred agonists retain substantial flexibility when bound. After exposure to FTY720P, the S1P(2)(IC1-TM2) S1P(1) receptor recycled to the plasma membrane, indicating that additional structural elements are required for the selective degradative trafficking of S1P(1).	[Valentine, William J.; Osborne, Daniel A.; Liu, Jianxiong; Fujiwara, Yuko; Tigyi, Gabor] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Coll Med, Memphis, TN 38163 USA; [Godwin, Virginia I.; Parrill, Abby L.] Univ Memphis, Computat Res Mat Inst, Dept Chem, Memphis, TN 38152 USA; [Van Brocklyn, James] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Bittman, Robert] CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University System of Ohio; Ohio State University; City University of New York (CUNY) System; Queens College NY (CUNY)	Tigyi, G (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Coll Med, 894 Union Ave, Memphis, TN 38163 USA.	gtigyi@uthsc.edu		Parrill, Abby/0000-0003-1658-8497	National Institutes of Health [CA-092160, HL-083187]; Van Vleet Oncology Research Endowment; National Science Foundation [CHE-0851880]; NATIONAL CANCER INSTITUTE [R01CA092160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL083187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Van Vleet Oncology Research Endowment; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-092160 (to G. T.) and HL-083187 (to R. B.). This work was also supported by the Van Vleet Oncology Research Endowment and National Science Foundation Grant CHE-0851880 (to A. P.).	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Fujiwara Y, 2005, J BIOL CHEM, V280, P35038, DOI 10.1074/jbc.M504351200; Fujiwara Y, 2007, J BIOL CHEM, V282, P2374, DOI 10.1074/jbc.M609648200; Graler MH, 2010, CELL PHYSIOL BIOCHEM, V26, P79, DOI 10.1159/000315108; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hla T, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e31820d5ec1; Hohlfeld R, 2011, NEUROLOGY, V76, pS28, DOI 10.1212/WNL.0b013e31820db40f; Inagaki Y, 2005, BIOCHEM J, V389, P187, DOI 10.1042/BJ20050046; Lee JF, 2009, AM J PHYSIOL-HEART C, V296, pH33, DOI 10.1152/ajpheart.00097.2008; Lu XQ, 2009, J ORG CHEM, V74, P3192, DOI 10.1021/jo900023u; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Mehling M, 2011, NEUROLOGY, V76, pS20, DOI 10.1212/WNL.0b013e31820db341; Ohmori T, 2003, CARDIOVASC RES, V58, P170, DOI 10.1016/S0008-6363(03)00260-8; OLIVERA A, 1994, ANAL BIOCHEM, V223, P306, DOI 10.1006/abio.1994.1589; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Parrill AL, 2004, SEMIN CELL DEV BIOL, V15, P467, DOI 10.1016/j.semcdb.2004.05.006; Parrill AL, 2000, J BIOL CHEM, V275, P39379, DOI 10.1074/jbc.M007680200; Peter BF, 2008, CIRC RES, V103, P315, DOI 10.1161/CIRCRESAHA.108.173575; Pham TCT, 2008, J MOL GRAPH MODEL, V26, P1189, DOI 10.1016/j.jmgm.2007.11.001; Ratnala VRP, 2009, METHODS MOL BIOL, V552, P67, DOI 10.1007/978-1-60327-317-6_5; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Sensken SC, 2008, CELL SIGNAL, V20, P1125, DOI 10.1016/j.cellsig.2008.01.019; Skoura A, 2007, J CLIN INVEST, V117, P2506, DOI 10.1172/JCI31123; Skoura A, 2009, CARDIOVASC RES, V82, P221, DOI 10.1093/cvr/cvp088; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Takuwa Y, 2002, BBA-MOL CELL BIOL L, V1582, P112, DOI 10.1016/S1388-1981(02)00145-2; Takuwa Y, 2008, BBA-MOL CELL BIOL L, V1781, P483, DOI 10.1016/j.bbalip.2008.04.003; Valentine WJ, 2008, J BIOL CHEM, V283, P12175, DOI 10.1074/jbc.M708847200; Valentine WJ, 2010, CELL SIGNAL, V22, P1543, DOI 10.1016/j.cellsig.2010.05.023; Wang DA, 2001, J BIOL CHEM, V276, P49213, DOI 10.1074/jbc.M107301200; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004	36	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30513	30525		10.1074/jbc.M111.263442	http://dx.doi.org/10.1074/jbc.M111.263442			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21719706	Green Published, hybrid			2022-12-25	WOS:000294283600030
J	Canonge, S; Deneubourg, JL; Sempo, G				Canonge, Stephane; Deneubourg, Jean-Louis; Sempo, Gregory			Group Living Enhances Individual Resources Discrimination: The Use of Public Information by Cockroaches to Assess Shelter Quality	PLOS ONE			English	Article							CONSENSUS DECISION-MAKING; COLLECTIVE BEHAVIOR; SOCIAL INFORMATION; AGGREGATION; DENSITY; INTEGRATION; SELECTION	In group-living organisms, consensual decision of site selection results from the interplay between individual responses to site characteristics and to group-members. Individuals independently gather personal information by exploring their environment. Through social interaction, the presence of others provides public information that could be used by individuals and modulates the individual probability of joining/leaving a site. The way that individual's information processing and the network of interactions influence the dynamics of public information (depending on population size) that in turn affect discrimination in site quality is a central question. Using binary choice between sheltering sites of different quality, we demonstrate that cockroaches in group dramatically outperform the problem-solving ability of single individual. Such use of public information allows animals to discriminate between alternatives whereas isolated individuals are ineffective (i.e. the personal discrimination efficiency is weak). Our theoretical results, obtained from a mathematical model based on behavioral rules derived from experiments, highlight that the collective discrimination emerges from competing amplification processes relying on the modulation of the individual sheltering time without shelters comparison and communication modulation. Finally, we well demonstrated here the adaptive value of such decision algorithm. Without any behavioral change, the system is able to shift to a more effective strategy when alternatives are present: the modification of the spatio-temporal distributions of individuals leading to the collective selection of the best resource. This collective discrimination implying such parsimonious and widespread mechanism must be shared by many group living-species.	[Canonge, Stephane; Deneubourg, Jean-Louis; Sempo, Gregory] Univ Libre Bruxelles, Unit Social Ecol, Brussels, Belgium	Universite Libre de Bruxelles	Canonge, S (corresponding author), Univ Libre Bruxelles, Unit Social Ecol, Brussels, Belgium.	scanonge@ulb.ac.be			FRS-FNRS (Belgium); Van Buuren Funds	FRS-FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS); Van Buuren Funds	The FRS-FNRS (Belgium) and the Van Buuren Funds supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; Bell W. J., 1981, AM COCKROACH; Bell W. J., 2007, COCKROACHES ECOLOGY; Boulinier T, 1997, EVOL ECOL, V11, P505, DOI 10.1007/s10682-997-1507-0; Camazine S., 2001, SELF ORG BIOLOGICAL, DOI DOI 10.1515/9780691212920; Canonge S, 2009, J INSECT PHYSIOL, V55, P976, DOI 10.1016/j.jinsphys.2009.06.011; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Costa J., 2006, OTHER INSECT SOC; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Dambach M, 1999, J INSECT PHYSIOL, V45, P423, DOI 10.1016/S0022-1910(98)00141-3; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Devigne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017389; Doligez B, 2004, J ANIM ECOL, V73, P75, DOI 10.1111/j.1365-2656.2004.00782.x; Donahue MJ, 2006, OECOLOGIA, V149, P33, DOI 10.1007/s00442-006-0419-y; Dussutour A, 2008, ANIM BEHAV, V76, P5, DOI 10.1016/j.anbehav.2007.12.009; Dyer JRG, 2009, PHILOS T R SOC B, V364, P781, DOI 10.1098/rstb.2008.0233; Fletcher RJ, 2007, J ANIM ECOL, V76, P598, DOI 10.1111/j.1365-2656.2007.01230.x; GIRALDEAU LA, 2010, PHILOS T R SOC B, V357, P1559; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; Holbrook GL, 2004, P NATL ACAD SCI USA, V101, P5595, DOI 10.1073/pnas.0400209101; Jeanson R, 2005, ANIM BEHAV, V69, P169, DOI 10.1016/j.anbehav.2004.02.009; Jeanson R, 2004, BEHAV ECOL SOCIOBIOL, V55, P388, DOI 10.1007/s00265-003-0716-y; King AJ, 2007, BIOL LETTERS, V3, P137, DOI 10.1098/rsbl.2007.0017; Krause J, 2010, TRENDS ECOL EVOL, V25, P28, DOI 10.1016/j.tree.2009.06.016; Lihoreau M, 2008, ANIM BEHAV, V75, P1965, DOI 10.1016/j.anbehav.2007.12.006; Michelena P, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016014, 10.1371/journal.pone.0018631]; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Nocera JJ, 2009, ECOGRAPHY, V32, P143, DOI 10.1111/j.1600-0587.2008.05614.x; Pratt SC, 2006, P NATL ACAD SCI USA, V103, P15906, DOI 10.1073/pnas.0604801103; Rands SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011705; Rust MK, 1995, UNDERSTANDING CONTRO; SANDLER MB, 1976, ANN ENTOMOL SOC AM, V69, P889, DOI 10.1093/aesa/69.5.889; Schmickl T, 2009, AUTON AGENT MULTI-AG, V18, P133, DOI 10.1007/s10458-008-9058-5; Sempo G, 2006, LECT NOTES COMPUT SC, V4095, P703; Sempo G, 2009, ETHOLOGY, V115, P1150, DOI 10.1111/j.1439-0310.2009.01699.x; SOLOMON J, 1997, ANN ENTOMO SOC AM, V70, P409; Stroeymeyt N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013059; Sumpter D. J. T., 2009, COLLECTIVE ANIMAL BE; Sumpter DJT, 2008, CURR BIOL, V18, P1773, DOI 10.1016/j.cub.2008.09.064; Valone TJ, 2007, BEHAV ECOL SOCIOBIOL, V62, P1, DOI 10.1007/s00265-007-0439-6; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108	42	40	40	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e19748	10.1371/journal.pone.0019748	http://dx.doi.org/10.1371/journal.pone.0019748			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701692	Green Published, Green Submitted, gold			2022-12-25	WOS:000291983800003
J	Borggren, M; Repits, J; Sterjovski, J; Uchtenhagen, H; Churchill, MJ; Karlsson, A; Albert, J; Achour, A; Gorry, PR; Fenyo, EM; Jansson, M				Borggren, Marie; Repits, Johanna; Sterjovski, Jasminka; Uchtenhagen, Hannes; Churchill, Melissa J.; Karlsson, Anders; Albert, Jan; Achour, Adnane; Gorry, Paul R.; Fenyo, Eva Maria; Jansson, Marianne			Increased Sensitivity to Broadly Neutralizing Antibodies of End-Stage Disease R5 HIV-1 Correlates with Evolution in Env Glycosylation and Charge	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; CORECEPTOR USAGE; ENVELOPE GLYCOPROTEINS; REPLICATIVE CAPACITY; RANTES SENSITIVITY; TYPE-1 HIV-1; IN-VIVO; VARIANTS; GP120	Background: Induction of broadly neutralizing antibodies, such as the monoclonal antibodies IgGb12, 2F5 and 2G12, is the objective of most antibody-based HIV-1 vaccine undertakings. However, despite the relative conserved nature of epitopes targeted by these antibodies, mechanisms underlying the sensitivity of circulating HIV-1 variants to broadly neutralizing antibodies are not fully understood. Here we have studied sensitivity to broadly neutralizing antibodies of HIV-1 variants that emerge during disease progression in relation to molecular alterations in the viral envelope glycoproteins (Env), using a panel of primary R5 HIV-1 isolates sequentially obtained before and after AIDS onset. Principal Findings: HIV-1 R5 isolates obtained at end-stage disease, after AIDS onset, were found to be more sensitive to neutralization by TriMab, an equimolar mix of the IgGb12, 2F5 and 2G12 antibodies, than R5 isolates from the chronic phase. The increased sensitivity correlated with low CD4(+) T cell count at time of virus isolation and augmented viral infectivity. Subsequent sequence analysis of multiple env clones derived from the R5 HIV-1 isolates revealed that, concomitant with increased TriMab neutralization sensitivity, end-stage R5 variants displayed envelope glycoproteins (Envs) with reduced numbers of potential N-linked glycosylation sites (PNGS), in addition to increased positive surface charge. These molecular changes in Env also correlated to sensitivity to neutralization by the individual 2G12 monoclonal antibody (mAb). Furthermore, results from molecular modeling suggested that the PNGS lost at end-stage disease locate in the proximity to the 2G12 epitope. Conclusions: Our study suggests that R5 HIV-1 variants with increased sensitivity to broadly neutralizing antibodies, including the 2G12 mAb, may emerge in an opportunistic manner during severe immunodeficiency as a consequence of adaptive molecular Env changes, including loss of glycosylation and gain of positive charge.	[Borggren, Marie; Repits, Johanna; Fenyo, Eva Maria; Jansson, Marianne] Lund Univ, Dept Lab Med, Lund, Sweden; [Sterjovski, Jasminka; Churchill, Melissa J.; Gorry, Paul R.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia; [Sterjovski, Jasminka; Churchill, Melissa J.; Gorry, Paul R.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Uchtenhagen, Hannes; Achour, Adnane] Karolinska Inst, Dept Med, CIM, Stockholm, Sweden; [Karlsson, Anders] Soder Sjukhuset, Dept Infect Med, Stockholm, Sweden; [Albert, Jan; Jansson, Marianne] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Gorry, Paul R.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	Lund University; Burnet Institute; Monash University; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; University of Melbourne	Borggren, M (corresponding author), Lund Univ, Dept Lab Med, Lund, Sweden.	Marianne.Jansson@med.lu.se		Churchill, Melissa/0000-0001-5510-7954; Sterjovski, Jasminka/0000-0002-2471-3000; Jansson, Marianne/0000-0001-6536-8146; Achour, Adnane/0000-0003-0432-710X	Swedish Research Council; Swedish International Development Agency/Department for Research Cooperation; European Community [2014332]; Physicians Against AIDS Research Foundation; Clas Groschinskys Foundation; Royal Physiographic Society in Lund and Crafoords Foundation; EC [037611]; Australian National Health and Medical Research Council [433915]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Agency/Department for Research Cooperation; European Community(European Commission); Physicians Against AIDS Research Foundation; Clas Groschinskys Foundation; Royal Physiographic Society in Lund and Crafoords Foundation; EC(European CommissionEuropean Commission Joint Research Centre); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by grants provided to MJ and AA from the Swedish Research Council, to MJ from the Swedish International Development Agency/Department for Research Cooperation, to EMF and JA from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n<SUP>o</SUP> 2014332. Grants were also provided by the Physicians Against AIDS Research Foundation, Clas Groschinskys Foundation, The Royal Physiographic Society in Lund and Crafoords Foundation. MB and HU are supported by the EC FP6 grant 037611 (EUROPRISE), PRG was supported in part by a grant from the Australian National Health and Medical Research Council (433915). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT J, 1990, AIDS, V4, P107, DOI 10.1097/00002030-199002000-00002; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P9339, DOI 10.1073/pnas.89.19.9339; Bjorndal A, 1997, J VIROL, V71, P7478; Borggren M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-28; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; Bunnik EM, 2009, VIROLOGY, V390, P348, DOI 10.1016/j.virol.2009.05.028; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Cheng-Mayer C, 1999, J VIROL, V73, P5294, DOI 10.1128/JVI.73.7.5294-5300.1999; Crawford JM, 1999, J VIROL, V73, P10199, DOI 10.1128/JVI.73.12.10199-10207.1999; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Duenas-Decamp MJ, 2010, J VIROL, V84, P9608, DOI 10.1128/JVI.00185-10; Edwards CTT, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-28; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23; Etemad-Moghadam B, 1999, J VIROL, V73, P8873, DOI 10.1128/JVI.73.10.8873-8879.1999; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Gorry PR, 2005, CURR HIV RES, V3, P53, DOI 10.2174/1570162052772951; Gray L, 2005, VIROLOGY, V337, P384, DOI 10.1016/j.virol.2005.04.034; HAHN BH, 1985, P NATL ACAD SCI USA, V82, P4813, DOI 10.1073/pnas.82.14.4813; Jansson M, 1996, P NATL ACAD SCI USA, V93, P15382, DOI 10.1073/pnas.93.26.15382; Jansson M, 1999, J HUMAN VIROL, V2, P325; KARLSSON A, 1994, J CLIN MICROBIOL, V32, P364, DOI 10.1128/JCM.32.2.364-370.1994; Karlsson I, 2004, J VIROL, V78, P11807, DOI 10.1128/JVI.78.21.11807-11815.2004; Koning FA, 2003, J INFECT DIS, V188, P864, DOI 10.1086/377105; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Kwa D, 2003, J INFECT DIS, V187, P1397, DOI 10.1086/374650; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Moog C, 1997, J VIROL, V71, P3734, DOI 10.1128/JVI.71.5.3734-3741.1997; MOORE JP, 1995, J VIROL, V69, P101, DOI 10.1128/JVI.69.1.101-109.1995; Naganawa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003206; Nakowitsch S, 2005, AIDS, V19, P1957, DOI 10.1097/01.aids.0000189856.13817.76; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pierson TC, 2003, CURR TOP MICROBIOL, V281, P1; Pietzsch J, 2010, J EXP MED, V207, P1995, DOI 10.1084/jem.20101176; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Purtscher M, 1996, AIDS, V10, P587, DOI 10.1097/00002030-199606000-00003; Quakkelaar ED, 2007, J VIROL, V81, P8533, DOI 10.1128/JVI.02816-06; Quakkelaar ED, 2007, VIROLOGY, V363, P447, DOI 10.1016/j.virol.2007.02.011; Quakkelaar ED, 2007, VIROLOGY, V359, P92, DOI 10.1016/j.virol.2006.09.021; Repits J, 2005, J GEN VIROL, V86, P2859, DOI 10.1099/vir.0.81111-0; Repits J, 2008, VIROLOGY, V379, P125, DOI 10.1016/j.virol.2008.06.014; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; SCARLATTI G, 1991, AIDS, V5, P1173, DOI 10.1097/00002030-199110000-00003; Shi Y, 2002, AIDS RES HUM RETROV, V18, P957, DOI 10.1089/088922202760265623; Sterjovski J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-89; SULLIVAN N, 1995, J VIROL, V69, P4413, DOI 10.1128/JVI.69.7.4413-4422.1995; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; van Opijnen T, 2005, REV MED VIROL, V15, P219, DOI 10.1002/rmv.472; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Wade J, 2010, VIROLOGY, V396, P246, DOI 10.1016/j.virol.2009.10.029; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005	61	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20135	10.1371/journal.pone.0020135	http://dx.doi.org/10.1371/journal.pone.0020135			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698221	Green Published, gold, Green Submitted			2022-12-25	WOS:000291734100005
J	Webster, MM; Atton, N; Hart, PJB; Ward, AJW				Webster, Mike M.; Atton, Nicola; Hart, Paul J. B.; Ward, Ashley J. W.			Habitat-Specific Morphological Variation among Threespine Sticklebacks (Gasterosteus aculeatus) within a Drainage Basin	PLOS ONE			English	Article							INFLUENCE ASSOCIATION PREFERENCES; SEXUAL-DIMORPHISM; BODY SHAPE; PHENOTYPIC PLASTICITY; SOCIAL RECOGNITION; ECOLOGICAL SPECIATION; INDUCIBLE DEFENSES; GENETIC-VARIATION; TRADE-OFFS; ENOS LAKE	Habitat-specific morphological variation, often corresponding to resource specialization, is well documented in freshwater fishes. In this study we used landmark based morphometric analyses to investigate morphological variation among threespine sticklebacks (Gasterosteus aculeatus L.) from four interconnected habitat types within a single lowland drainage basin in eastern England. These included the upper and lower reaches of the river, the estuary, a connected ditch network and a coastal salt marsh. We found significant habitat-specific differences in morphology, with three axes of variation describing differences in orbit diameter, body depth, caudal peduncle shape and pectoral fin positioning as well as variation in relative dorsal and pelvic spine size. Interestingly, the ditch system, an artificial and heavily managed habitat, is populated by sticklebacks with a characteristic morphology, suggesting that human management of habitats can in some circumstances lead to morphological variation among the animals that inhabit them. We discuss the mechanisms that conceivably underlie the observed morphological variation and the further work necessary to identify them. Finally, we consider the implications of habitat-specific body shape variation for the behavioural ecology of this ecologically generalist species.	[Webster, Mike M.; Atton, Nicola; Hart, Paul J. B.; Ward, Ashley J. W.] Univ Leicester, Sch Biol, Leicester, Leics, England; [Webster, Mike M.; Atton, Nicola] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland; [Ward, Ashley J. W.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Leicester; University of St Andrews; University of Sydney	Webster, MM (corresponding author), Univ Leicester, Sch Biol, Leicester, Leics, England.	mike.m.webster@gmail.com	Hart, Paul JB/A-1814-2008; Webster, Mike/C-5082-2008	Hart, Paul JB/0000-0002-9188-2437; Ward, Ashley/0000-0003-0842-533X; Webster, Mike/0000-0001-9597-6871	Natural Environment Research Council (NERC, UK); University of Sydney	Natural Environment Research Council (NERC, UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Sydney(University of Sydney)	MMW was funded by a Natural Environment Research Council studentship (NERC, UK) awarded to PJBH. AJWW was supported by a DVC Grant from the University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre WE, 2010, J FISH BIOL, V77, P802, DOI 10.1111/j.1095-8649.2010.02705.x; Aguirre WE, 2008, BIOL J LINN SOC, V95, P465, DOI 10.1111/j.1095-8312.2008.01075.x; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; Araujo MS, 2008, ECOLOGY, V89, P1981, DOI 10.1890/07-0630.1; Bell M.A., 1994, EVOLUTIONARY BIOL TH; BENTZEN P, 1984, CAN J ZOOL, V62, P2280, DOI 10.1139/z84-331; Berner D, 2009, EVOLUTION, V63, P1740, DOI 10.1111/j.1558-5646.2009.00665.x; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; BRONMARK C, 1992, SCIENCE, V258, P1348, DOI 10.1126/science.258.5086.1348; Burns JG, 2009, J FISH BIOL, V75, P1144, DOI 10.1111/j.1095-8649.2009.02314.x; Cresko WA, 1996, ENVIRON BIOL FISH, V45, P343, DOI 10.1007/BF00002526; DARBY H.C., 1940, DRAINING FENS; Dayton GH, 2005, OIKOS, V111, P582, DOI 10.1111/j.1600-0706.2005.14340.x; DeWitt TJ, 2000, EVOL ECOL RES, V2, P129; Eklov P, 2007, J FISH BIOL, V70, P155, DOI 10.1111/j.1095-8649.2006.01283.x; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; GUSTAFSSON L, 1988, ANIM BEHAV, V36, P696, DOI 10.1016/S0003-3472(88)80152-0; Hendry AP, 2004, EVOLUTION, V58, P2319; Herbert-Read JE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1107, DOI 10.1007/s00265-010-0925-0; HOOGLAND M, 1957, BEHAVIOUR, V10, P205; Januszkiewicz AJ, 2007, BIOL J LINN SOC, V90, P25, DOI 10.1111/j.1095-8312.2007.00708.x; JOHANSSON F, 1994, OECOLOGIA, V100, P74, DOI 10.1007/BF00317132; Johansson F, 2002, CAN J ZOOL, V80, P199, DOI 10.1139/Z01-225; Jones FC, 2006, J EVOLUTION BIOL, V19, P1531, DOI 10.1111/j.1420-9101.2006.01122.x; Kishida O, 2004, OECOLOGIA, V140, P414, DOI 10.1007/s00442-004-1609-0; Kishida O, 2006, J ANIM ECOL, V75, P705, DOI 10.1111/j.1365-2656.2006.01091.x; Kitano J, 2007, COPEIA, P336, DOI 10.1643/0045-8511(2007)7[336:SDITEM]2.0.CO;2; Langerhans RB, 2007, J EVOLUTION BIOL, V20, P1171, DOI 10.1111/j.1420-9101.2007.01282.x; Langerhans RB, 2008, INTEGR COMP BIOL, V48, P750, DOI 10.1093/icb/icn092; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Langerhans RB, 2003, BIOL J LINN SOC, V80, P689, DOI 10.1111/j.1095-8312.2003.00266.x; Lattuca ME, 2007, J APPL ICHTHYOL, V23, P25, DOI 10.1111/j.1439-0426.2006.00789.x; Magnhagen C, 2004, J FISH BIOL, V64, P612, DOI 10.1111/j.1095-8649.2004.00325.x; MCPHAIL JD, 1984, CAN J ZOOL, V62, P1402, DOI 10.1139/z84-201; MEYER A, 1990, BIOL J LINN SOC, V39, P279, DOI 10.1111/j.1095-8312.1990.tb00517.x; Mittelbach GC, 1999, EVOL ECOL RES, V1, P111; Nilsson PA, 2000, OIKOS, V88, P539, DOI 10.1034/j.1600-0706.2000.880310.x; Pettersson LB, 1999, OECOLOGIA, V121, P12, DOI 10.1007/s004420050901; Phillips BL, 2004, P NATL ACAD SCI USA, V101, P17150, DOI 10.1073/pnas.0406440101; Portz DE, 2004, ENVIRON BIOL FISH, V71, P233, DOI 10.1007/s10641-004-0300-y; PRICE T, 1987, ECOLOGY, V68, P1015, DOI 10.2307/1938373; Quevedo M, 2006, J FISH BIOL, V69, P141, DOI 10.1111/j.1095-8649.2006.01072.x; REIMCHEN TE, 1980, CAN J ZOOL, V58, P1232, DOI 10.1139/z80-173; Reimchen TE, 2004, EVOLUTION, V58, P1274, DOI 10.1111/j.0014-3820.2004.tb01706.x; REIMCHEN TE, 1984, CAN FIELD NAT, V98, P120; Riessen HP, 2009, ECOLOGY, V90, P3455, DOI 10.1890/08-1652.1; Robinson BW, 1996, ECOLOGY, V77, P170, DOI 10.2307/2265665; Robinson BW, 1996, EVOL ECOL, V10, P631, DOI 10.1007/BF01237711; Rohlf F.J., 2005, MORPHOMETRICS SUNY S; Schluter D, 1996, PHILOS T R SOC B, V351, P807, DOI 10.1098/rstb.1996.0075; SCHLUTER D, 1995, ECOLOGY, V76, P82, DOI 10.2307/1940633; SMARTT RA, 1980, AM NAT, V116, P891, DOI 10.1086/283679; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; Spoljaric MA, 2007, J FISH BIOL, V70, P1484, DOI 10.1111/j.1095-8649.2007.01425.x; Spoljaric MA, 2008, BIOL J LINN SOC, V95, P505, DOI 10.1111/j.1095-8312.2008.01068.x; Sumner J, 1999, BIOL CONSERV, V91, P159, DOI 10.1016/S0006-3207(99)00089-0; Svanback R, 2006, EVOL ECOL RES, V8, P37; Svanback R, 2003, OIKOS, V102, P273, DOI 10.1034/j.1600-0706.2003.12657.x; Tobler M, 2008, EVOLUTION, V62, P2643, DOI 10.1111/j.1558-5646.2008.00466.x; Walker JA, 2004, J EXP BIOL, V207, P1925, DOI 10.1242/jeb.00994; Ward AJW, 2009, BEHAV ECOL, V20, P511, DOI 10.1093/beheco/arp025; Ward AJW, 2005, BEHAV ECOL SOCIOBIOL, V57, P575, DOI 10.1007/s00265-004-0901-7; Ward AJW, 2004, BEHAV ECOL, V15, P925, DOI 10.1093/beheco/arh097; Ward AJW, 2007, P ROY SOC B-BIOL SCI, V274, P1071, DOI 10.1098/rspb.2006.0231; Webster MM, 2008, ANIM BEHAV, V76, P17, DOI 10.1016/j.anbehav.2007.12.010; Webster MM, 2008, P R SOC B, V275, P203, DOI 10.1098/rspb.2007.1178; Webster MM, 2007, BEHAVIOUR, V144, P1347, DOI 10.1163/156853907782418222; Webster MM, 2007, BEHAV ECOL SOCIOBIOL, V62, P273, DOI 10.1007/s00265-007-0462-7; [No title captured]	69	35	35	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21060	10.1371/journal.pone.0021060	http://dx.doi.org/10.1371/journal.pone.0021060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698269	Green Published, gold			2022-12-25	WOS:000291730000046
J	Xu, LL; Bao, LL; Zhou, JF; Wang, DY; Deng, W; Lv, Q; Ma, YL; Li, FD; Sun, HH; Zhan, LJ; Zhu, H; Ma, CM; Shu, YL; Qin, C				Xu, Lili; Bao, Linlin; Zhou, Jianfang; Wang, Dayan; Deng, Wei; Lv, Qi; Ma, Yila; Li, Fengdi; Sun, Huihui; Zhan, Lingjun; Zhu, Hua; Ma, Chunmei; Shu, Yuelong; Qin, Chuan			Genomic Polymorphism of the Pandemic A (H1N1) Influenza Viruses Correlates with Viral Replication, Virulence, and Pathogenicity In Vitro and In Vivo	PLOS ONE			English	Article							SINGLE-AMINO-ACID; A VIRUS; RESPIRATORY-FAILURE; ENHANCED VIRULENCE; MOLECULAR-BASIS; HEMAGGLUTININ; PROTEIN; ORIGIN; PATHOGENESIS; PB1-F2	The novel pandemic A (H1N1) virus was first identified in Mexico in April 2009 and quickly spread worldwide. Like all influenzas, the H1N1 strain-specific properties of replication, virulence, and pathogenicity are a result of the particular genomic sequence and concerted expression of multiple genes. Thus, specific mutations may support increased virulence and may be useful as biomarkers of potential threat to human health. We performed comparative genomic analysis of ten strains of the 2009 pandemic A (H1N1) influenza viruses to determine whether genotypes associated with clinical phenotypes, which ranged from mild to severe illness and up to lethal. Virus replication capacity was tested for each strain in vitro using cultured epithelial cells, while virulence and pathogenicity were investigated in vivo using the BALB/c mouse model. The results indicated that A/Sichuan/1/2009 strain had significantly higher replication ability and virulence than the other strains, and five unique non-synonymous mutations were identified in important gene-encoding sequences. These mutations led to amino acid substitutions in HA (L32I), PA (A343T), PB1 (K353R and T566A), and PB2 (T471M), and may be critical molecular determinants for replication, virulence, and pathogenicity. Our results suggested that the replication capacity in vitro and virulence in vivo of the 2009 pandemic A (H1N1) viruses were not associated with the clinical phenotypes. This study offers new insights into the transmission and evolution of the 2009 pandemic A (H1N1) virus.	[Xu, Lili; Bao, Linlin; Deng, Wei; Lv, Qi; Ma, Yila; Li, Fengdi; Sun, Huihui; Zhan, Lingjun; Zhu, Hua; Ma, Chunmei; Qin, Chuan] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100730, Peoples R China; [Xu, Lili; Bao, Linlin; Deng, Wei; Lv, Qi; Ma, Yila; Li, Fengdi; Sun, Huihui; Zhan, Lingjun; Zhu, Hua; Ma, Chunmei; Qin, Chuan] Minist Hlth, Key Lab Human Dis Comparat Med, Peking Union Med Coll, Comparat Med Ctr, Beijing, Peoples R China; [Zhou, Jianfang; Wang, Dayan; Shu, Yuelong] China CDC, Natl Inst Viral Dis Control & Prevent, Chinese Natl Influenza Ctr, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Xu, LL (corresponding author), Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100730, Peoples R China.	qinchuan@pumc.edu.cn	Deng, Wei/GWC-9207-2022		National Science and Technology Major Projects of Infectious Disease [2009ZX10004-016, 2009ZX10004-402]; Industry Foundation of the Ministry of Health [200802036]; Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health [DWS201112]	National Science and Technology Major Projects of Infectious Disease; Industry Foundation of the Ministry of Health; Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health	This work was supported by the National Science and Technology Major Projects of Infectious Disease (2009ZX10004-016 and 2009ZX10004-402), the Industry Foundation of the Ministry of Health (200802036), and Open Fund of the Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health (DWS201112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auewarakul P, 2007, J VIROL, V81, P9950, DOI 10.1128/JVI.00468-07; Bao LL, 2010, VIRUS RES, V151, P60, DOI 10.1016/j.virusres.2010.03.019; Belser JA, 2010, J VIROL, V84, P4194, DOI 10.1128/JVI.02742-09; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Chen H, 2007, VIRUS RES, V128, P159, DOI 10.1016/j.virusres.2007.04.017; Cheung TKW, 2007, ANN NY ACAD SCI, V1102, P1, DOI 10.1196/annals.1408.001; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Conenello GM, 2007, CELL HOST MICROBE, V2, P207, DOI 10.1016/j.chom.2007.09.010; DAVIES WL, 1964, SCIENCE, V144, P862, DOI 10.1126/science.144.3620.862; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; Hai R, 2010, J VIROL, V84, P4442, DOI 10.1128/JVI.02717-09; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V17, P865, DOI 10.1128/AAC.17.5.865; Herfst S, 2010, J VIROL, V84, P3752, DOI 10.1128/JVI.02634-09; Hulse-Post DJ, 2007, J VIROL, V81, P8515, DOI 10.1128/JVI.00435-07; Ikonen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013329; Jagger BW, 2010, MBIO, V1, DOI 10.1128/mBio.00067-10; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kilander A, 2010, EURO SURVEILL, V15; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Mak GC, 2010, EURO SURVEILL, V15; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; Melidou A, 2010, VIRUS RES, V151, P192, DOI 10.1016/j.virusres.2010.05.005; Nelson M., 2009, PLOS CURR, V1, DOI [DOI 10.1371/CURRENTS.RRN1126, 10.1371/currents.RRN1126]; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rello J, 2009, CRIT CARE, V13, DOI 10.1186/cc8044; Safronetz D, 2011, J VIROL, V85, P1214, DOI 10.1128/JVI.01848-10; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Skoner DP, 1999, J INFECT DIS, V180, P10, DOI 10.1086/314823; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Svitek N, 2008, VIROLOGY, V376, P53, DOI 10.1016/j.virol.2008.02.035; Taubenberger JK, 2006, P AM PHILOS SOC, V150, P86; Tumpey TM, 2004, P NATL ACAD SCI USA, V101, P3166, DOI 10.1073/pnas.0308391100; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; VAILLANT L, 2009, EURO SURVEILL, V14; Wanitchang A, 2010, VIRUS RES, V147, P145, DOI 10.1016/j.virusres.2009.10.010; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xu LL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-325; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zhou B, 2011, J VIROL, V85, P357, DOI 10.1128/JVI.01694-10; Zhu HC, 2010, VIROLOGY, V401, P1, DOI 10.1016/j.virol.2010.02.024	55	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20698	10.1371/journal.pone.0020698	http://dx.doi.org/10.1371/journal.pone.0020698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698272	Green Published, Green Submitted, gold			2022-12-25	WOS:000291730000019
J	Mathew, B; Jacobson, JR; Berdyshev, E; Huang, Y; Sun, XG; Zhao, YT; Gerhold, LM; Siegler, J; Evenoski, C; Wang, T; Zhou, T; Zaidi, R; Moreno-Vinasco, L; Bittman, R; Chen, CT; LaRiviere, PJ; Sammani, S; Lussier, YA; Dudek, SM; Natarajan, V; Weichselbaum, RR; Garcia, JGN				Mathew, Biji; Jacobson, Jeffrey R.; Berdyshev, Evgeny; Huang, Yong; Sun, Xiaoguang; Zhao, Yutong; Gerhold, Lynnette M.; Siegler, Jessica; Evenoski, Carrie; Wang, Ting; Zhou, Tong; Zaidi, Rafe; Moreno-Vinasco, Liliana; Bittman, Robert; Chen, Chin Tu; LaRiviere, Patrick J.; Sammani, Saad; Lussier, Yves A.; Dudek, Steven M.; Natarajan, Viswanathan; Weichselbaum, Ralph R.; Garcia, Joe G. N.			Role of sphingolipids in murine radiation-induced lung injury: protection by sphingosine 1-phosphate analogs	FASEB JOURNAL			English	Article						gene dysregulation; S1P receptors; fTysiponate; FTY720	ENDOTHELIAL-CELLS; ACID SPHINGOMYELINASE; BARRIER ENHANCEMENT; INDUCED APOPTOSIS; GENE-EXPRESSION; VASCULAR LEAK; CERAMIDE; PNEUMONITIS; RECEPTOR; ACTIVATION	Clinically significant radiation-induced lung injury (RILI) is a common toxicity in patients administered thoracic radiotherapy. Although the molecular etiology is poorly understood, we previously characterized a murine model of RILI in which alterations in lung barrier integrity surfaced as a potentially important pathobiological event and genome-wide lung gene mRNA levels identified dysregulation of sphingolipid metabolic pathway genes. We hypothesized that sphingolipid signaling components serve as modulators and novel therapeutic targets of RILI. Sphingolipid involvement in murine RILI was confirmed by radiation-induced increases in lung expression of sphingosine kinase (SphK) isoforms 1 and 2 and increases in the ratio of ceramide to sphingosine 1-phosphate (S1P) and dihydro-S1P (DHS1P) levels in plasma, bronchoalveolar lavage fluid, and lung tissue. Mice with a targeted deletion of SphK1 (SphK1(-/-)) or with reduced expression of S1P receptors (S1PR1(+/-), S1PR2(-/-), and S1PR3(-/-)) exhibited marked RILI susceptibility. Finally, studies of 3 potent vascular barrier-protective S1P analogs, FTY720, (S)-FTY720-phosphonate (fTyS), and SEW-2871, identified significant RILI attenuation and radiation-induced gene dysregulation by the phosphonate analog, fTyS (0.1 and 1 mg/kg i.p., 2x/wk) and to a lesser degree by SEW-2871 (1 mg/kg i.p., 2x/wk), compared with those in controls. These results support the targeting of S1P signaling as a novel therapeutic strategy in RILI.-Mathew, B., Jacobson, J. R., Berdyshev, E., Huang, Y., Sun, X., Zhao, Y., Gerhold, L. M., Siegler, J., Evenoski, C., Wang, T., Zhou, T., Zaidi, R., Moreno-Vinasco, L., Bittman, R., Chen, C. T., LaRiviere, P. J., Sammani, S., Lussier, Y. A., Dudek, S. M., Natarajan, V., Weichselbaum, R. R., Garcia, J. G. N. Role of sphingolipids in murine radiation-induced lung injury: protection by sphingosine 1-phosphate analogs. FASEB J. 25, 3388-3400 (2011). www. fasebj. org	[Garcia, Joe G. N.] Univ Illinois, Dept Med Pharmacol & Bioengn, Inst Personalized Resp Med, Sect Pulm Crit Care & Sleep Med, Chicago, IL 60612 USA; [Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Huang, Yong; Lussier, Yves A.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Gerhold, Lynnette M.; Chen, Chin Tu; LaRiviere, Patrick J.] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA; [Weichselbaum, Ralph R.] Univ Chicago, Dept Radiat Oncol, Chicago, IL 60637 USA; [Bittman, Robert] CUNY, Queens Coll, Dept Chem & Biochem, Flushing, NY USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Chicago; University of Chicago; City University of New York (CUNY) System; Queens College NY (CUNY)	Garcia, JGN (corresponding author), Univ Illinois, Dept Med Pharmacol & Bioengn, Inst Personalized Resp Med, Sect Pulm Crit Care & Sleep Med, 1737 W Polk St,305D AOB, Chicago, IL 60612 USA.	jggarcia@uic.edu	Lussier, Yves/N-4891-2017; Chen, Chin-Tu/K-3393-2014	Lussier, Yves/0000-0001-9854-1005; 	U.S. National Institutes of Health [R01 HL079396, P01 HL098050, HL083187, HL58094, HL09805, K22 LM008308-04, 5U54CA121852-05]; NATIONAL CANCER INSTITUTE [R01CA134680, U54CA121852] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079396, P01HL098050, R24HL083187] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors are grateful to Eddie T. Chiang for outstanding technical assistance. This work was supported by U.S. National Institutes of Health grants R01 HL079396 (V.N.), P01 HL098050 (V.N., J.G.N., S.D., J.R.J., and R.R.W.), HL083187 (R.B.), HL58094, HL09805, K22 LM008308-04, and 5U54CA121852-05. Microarray data have been submitted to the Gene Expression Omnibus repository of the National Center for Biotechnology Information (GSE25295).	Anscher MS, 1998, INT J RADIAT ONCOL, V41, P1029, DOI 10.1016/S0360-3016(98)00154-0; Benson HL, 2011, AM J RESP CELL MOL, V44, P700, DOI 10.1165/rcmb.2010-0125OC; Berdyshev EV, 2005, ANAL BIOCHEM, V339, P129, DOI 10.1016/j.ab.2004.12.006; Berdyshev EV, 2006, CELL SIGNAL, V18, P1779, DOI 10.1016/j.cellsig.2006.01.018; Camp SM, 2009, J PHARMACOL EXP THER, V331, P54, DOI 10.1124/jpet.109.153544; Carruthers SA, 2004, BRIT J CANCER, V90, P2080, DOI 10.1038/sj.bjc.6601751; Chen YY, 2002, SEMIN RADIAT ONCOL, V12, P26, DOI 10.1053/srao.2002.31360; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Dudek SM, 2004, J BIOL CHEM, V279, P24692, DOI 10.1074/jbc.M313969200; English D, 2000, FASEB J, V14, P2255, DOI 10.1096/fj.00-0134com; Forrest M, 2004, J PHARMACOL EXP THER, V309, P758, DOI 10.1124/jpet.103.062828; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Goggel R, 2004, NAT MED, V10, P155, DOI 10.1038/nm977; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Hale JJ, 2004, BIOORG MED CHEM LETT, V14, P3501, DOI 10.1016/j.bmcl.2004.04.070; Hong JH, 1999, INT J RADIAT BIOL, V75, P1421, DOI 10.1080/095530099139287; Jacobson JR, 2005, AM J PHYSIOL-LUNG C, V288, pL1026, DOI 10.1152/ajplung.00354.2004; Jacobson JR, 2004, AM J RESP CELL MOL, V30, P662, DOI 10.1165/rcmb.2003-0267OC; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kolesnick R, 2003, ONCOGENE, V22, P5897, DOI 10.1038/sj.onc.1206702; Kolosova IA, 2008, AM J PHYSIOL-LUNG C, V294, pL319, DOI 10.1152/ajplung.00283.2007; Kong FM, 2005, SEMIN ONCOL, V32, pS42, DOI 10.1053/j.seminoncol.2005.03.009; Korthagen NM, 2010, CLIN EXP IMMUNOL, V161, P342, DOI 10.1111/j.1365-2249.2010.04181.x; Kovarik JM, 2004, THER DRUG MONIT, V26, P585, DOI 10.1097/00007691-200412000-00001; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Li C., 2001, GENOME BIOL, V2, DOI [10.1186/gb-2001-2-8-research0032, DOI 10.1186/GB-2001-2-8-RESEARCH0032]; Liu F, 2001, AM J RESP CELL MOL, V24, P711, DOI 10.1165/ajrcmb.24.6.4323; Lu XQ, 2009, J ORG CHEM, V74, P3192, DOI 10.1021/jo900023u; Marathe S, 1998, J BIOL CHEM, V273, P4081, DOI 10.1074/jbc.273.7.4081; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Mathew B, 2011, AM J RESP CELL MOL, V44, P415, DOI 10.1165/rcmb.2010-0122OC; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McBride WH, 2000, INT J RADIAT BIOL, V76, P517, DOI 10.1080/095530000138529; McVerry BJ, 2004, AM J RESP CRIT CARE, V170, P987, DOI 10.1164/rccm.200405-684oc; Meyer NJ, 2009, FASEB J, V23, P1325, DOI 10.1096/fj.08-119073; Michael JM, 1997, CANCER RES, V57, P3600; Nonas SA, 2007, AM J PHYSIOL-LUNG C, V293, pL292, DOI 10.1152/ajplung.00481.2006; Ogata T, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-26; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; PEZNER RD, 1984, CHEST, V85, P816, DOI 10.1378/chest.85.6.816; Pollack A, 2009, CLIN CANCER RES, V15, P5478, DOI 10.1158/1078-0432.CCR-08-2704; Rabbani ZN, 2010, RADIAT RES, V173, P165, DOI 10.1667/RR1816.1; Rosenfeldt HM, 2003, FASEB J, V17, P1789, DOI 10.1096/fj.02-0836com; Roviezzo F, 2007, AM J RESP CELL MOL, V36, P757, DOI 10.1165/rcmb.2006-0383OC; RUBIN P, 1995, INT J RADIAT ONCOL, V33, P99, DOI 10.1016/0360-3016(95)00095-G; Sammani S, 2010, AM J RESP CELL MOL, V43, P394, DOI 10.1165/rcmb.2009-0223OC; Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127; Shikata Y, 2003, J APPL PHYSIOL, V94, P1193, DOI 10.1152/japplphysiol.00690.2002; Singleton P. A., 2010, AM J PHYSIOL-LUNG C, V104, P978; Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Undas Anetta, 2002, Clin Lab, V48, P287; Viemann D, 2007, BLOOD, V109, P2453, DOI 10.1182/blood-2006-08-040444; von Bismarck P, 2008, AM J RESP CRIT CARE, V177, P1233, DOI 10.1164/rccm.200705-752OC; von Bismarck P, 2007, CRIT CARE MED, V35, P2309, DOI 10.1097/01.CCM.0000281472.47067.45; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200	57	45	46	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3388	3400		10.1096/fj.11-183970	http://dx.doi.org/10.1096/fj.11-183970			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21712494	Green Published			2022-12-25	WOS:000295356400011
J	Fang, HL; Wu, YF; Huang, XH; Wang, WY; Ang, B; Cao, XT; Wan, T				Fang, Hongliang; Wu, Yanfeng; Huang, Xiaohui; Wang, Wenying; Ang, Bing; Cao, Xuetao; Wan, Tao			Toll-like Receptor 4 (TLR4) Is Essential for Hsp70-like Protein 1 (HSP70L1) to Activate Dendritic Cells and Induce Th1 Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION RECEPTORS; CANCER CELLS; VACCINE; ADJUVANT; PATHWAY; INNATE; TOLL-LIKE-RECEPTOR-4; LIPOPOLYSACCHARIDE; IDENTIFICATION; INTERFERON	Toll-like receptors (TLRs) play important roles in initiation of innate and adaptive immune responses. Emerging evidence suggests that TLR agonists can serve as potential adjuvant for vaccination. Heat shock proteins (HSPs), functionally serving as TLR4 agonists, have been proposed to act as Th1 adjuvant. We have identified a novel Hsp70 family member, termed Hsp70-like protein 1 (Hsp70L1), shown that Hsp70L1 is a potent T helper cell (Th1) polarizing adjuvant that contributes to antitumor immune responses. However, the underlying mechanism for how Hsp70L1 exerts its Th1 adjuvant activity remains to be elucidated. In this study, we found that Hsp70L1 binds directly to TLR4 on the surface of DCs, activates MAPK and NF-kappa B pathways, up-regulates I-a(b), CD40, CD80, and CD86 expression and promotes production of TNF-alpha, IL-1 beta, and IL-12p70. Hsp70L1 failed to induce such phenotypic maturation and cytokine production in TLR4-deficient DCs, indicating a role for TLR4 in mediating Hsp70L1-induced DC activation. Furthermore, more efficient induction of carcinoembryonic antigen (CEA)-specific Th1 immune response was observed in mice immunized by wild-type DCs pulsed with Hsp70L1-CEA(576-669) fusion protein as compared with TLR4-deficient DCs pulsed with same fusion protein. In addition, TLR4 antagonist impaired induction of CEA-specific human Th1 immune response in a coculture system of peripheral blood lymphocytes (PBLs) from HLAA2.1(+) healthy donors and autologous DCs pulsed with Hsp70L1-CEA(576- 669) in vitro. Taken together, these results demonstrate that TLR4 is a key receptor mediating the interaction of Hsp70L1 with DCs and subsequently enhancing the induction of Th1 immune response by Hsp70L1/antigen fusion protein.	[Fang, Hongliang; Wu, Yanfeng; Huang, Xiaohui; Wang, Wenying; Ang, Bing; Cao, Xuetao; Wan, Tao] Second Mil Med Univ, Natl Key Lab Med Immunol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China; [Fang, Hongliang; Wu, Yanfeng; Huang, Xiaohui; Wang, Wenying; Ang, Bing; Cao, Xuetao; Wan, Tao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.	caoxt@immunol.org; taowan@immunol.org			National Natural Science Foundation of China [30872296, 30772205]; National High Technology Research, Development Program of China [2007AA021105, 2009AA02Z102]; Shanghai Science and Technology Major Project [10DZ1910300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research, Development Program of China(National High Technology Research and Development Program of China); Shanghai Science and Technology Major Project	This work was supported by grants from the National Natural Science Foundation of China (30872296, 30772205), National High Technology Research, Development Program of China (2007AA021105 and 2009AA02Z102), and Shanghai Science and Technology Major Project (10DZ1910300).	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Capsoni F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2827; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Dybdahl B, 2002, CIRCULATION, V105, P685, DOI 10.1161/hc0602.103617; Fukuchi J, 2004, CANCER RES, V64, P7682, DOI 10.1158/0008-5472.CAN-04-2647; Garin A, 2010, IMMUNITY, V33, P84, DOI 10.1016/j.immuni.2010.07.005; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hoshino K, 1999, J IMMUNOL, V162, P3749; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lahiri A, 2008, VACCINE, V26, P6777, DOI 10.1016/j.vaccine.2008.09.045; Liu SX, 2008, MOL IMMUNOL, V46, P242, DOI 10.1016/j.molimm.2008.08.279; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Murata M, 2008, CANCER SCI, V99, P1435, DOI 10.1111/j.1349-7006.2008.00832.x; Peter ME, 2009, J IMMUNOL, V182, P7690, DOI 10.4049/jimmunol.0900819; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rhee EG, 2010, J VIROL, V84, P10413, DOI 10.1128/JVI.00928-10; Roelofs MF, 2006, J IMMUNOL, V176, P7021, DOI 10.4049/jimmunol.176.11.7021; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Testori A, 2008, J CLIN ONCOL, V26, P955, DOI 10.1200/JCO.2007.11.9941; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Wan T, 2004, BLOOD, V103, P1747, DOI 10.1182/blood-2003-08-2828; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wood C, 2008, LANCET, V372, P145, DOI 10.1016/S0140-6736(08)60697-2; Wu YF, 2005, CANCER RES, V65, P4947, DOI 10.1158/0008-5472.CAN-04-3912; Zhang T, 2009, BLOOD, V114, P4081, DOI 10.1182/blood-2009-05-219881	33	73	82	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30393	30400		10.1074/jbc.M111.266528	http://dx.doi.org/10.1074/jbc.M111.266528			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730052	hybrid, Green Published			2022-12-25	WOS:000294283600017
J	Cochran, R; Kalisiak, J; Kucukkilinc, T; Radic, Z; Garcia, E; Zhang, LM; Ho, KY; Amitai, G; Kovarik, Z; Fokin, VV; Sharpless, KB; Taylor, P				Cochran, Rory; Kalisiak, Jaroslaw; Kuecuekkilinc, Tuba; Radic, Zoran; Garcia, Edzna; Zhang, Limin; Ho, Kwok-Yiu; Amitai, Gabriel; Kovarik, Zrinka; Fokin, Valery V.; Sharpless, K. Barry; Taylor, Palmer			Oxime-assisted Acetylcholinesterase Catalytic Scavengers of Organophosphates That Resist Aging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE; ACTIVE-CENTER; CHOLINESTERASES; BIOSCAVENGER; REACTIVATION; TOXICITY; RESIDUES; PROTECTION; INHIBITOR; MUTATIONS	The cholinesterases, acetylcholinesterase (AChE) and butyrylcholinesterase, are primary targets of organophosphates (OPs). Exposure to OPs can lead to serious cardiovascular complications, respiratory compromise, and death. Current therapy to combat OP poisoning involves an oxime reactivator (2-PAM, obidoxime, TMB4, or HI-6) combined with atropine and on occasion an anticonvulsant. Butyrylcholinesterase, administered in the plasma compartment as a bio-scavenger, has also shown efficacy but is limited by its strict stoichiometric scavenging, slow reactivation, and a propensity for aging. Here, we characterize 10 human (h) AChE mutants that, when coupled with an oxime, give rise to catalytic reactivation and aging resistance of the soman conjugate. With the most efficient human AChE mutant Y337A/F338A, we show enhanced reactivation rates for several OP-hAChE conjugates compared with wild-type hAChE when reactivated with HI-6 (1-(2'-hydroxyiminomethyl-1'-pyridinium)-3-(4'-carbamoyl-1-pyridinium)). In addition, we interrogated an 840-member novel oxime library for reactivation of Y337A/F338A hAChE-OP conjugates to delineate the most efficient oxime-mutant enzyme pairs for catalytic bio-scavenging. Combining the increased accessibility of the Y337A mutation to oximes within the space-impacted active center gorge with the aging resistance of the F338A mutation provides increased substrate diversity in scavenging potential for aging-prone alkyl phosphate inhibitors.	[Cochran, Rory; Kuecuekkilinc, Tuba; Radic, Zoran; Garcia, Edzna; Zhang, Limin; Ho, Kwok-Yiu; Taylor, Palmer] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Kalisiak, Jaroslaw; Fokin, Valery V.; Sharpless, K. Barry] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Kalisiak, Jaroslaw; Fokin, Valery V.; Sharpless, K. Barry] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Amitai, Gabriel] Israel Inst Biol Res, Div Med Chem, IL-74100 Ness Ziona, Israel; [Kovarik, Zrinka] Inst Med Res & Occupat Hlth, HR-10001 Zagreb, Croatia	University of California System; University of California San Diego; Scripps Research Institute; Scripps Research Institute; Institute for Medical Research & Occupational Health (IMROH)	Taylor, P (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pwtaylor@ucsd.edu	KUCUKKILINC, ZEKIYE TUBA TUYLU/I-8426-2013	KUCUKKILINC, ZEKIYE TUBA TUYLU/0000-0003-1566-0717; Cochran, Rory/0000-0001-9123-4010	National Institutes of Health, NINDS [U01 NS 058046]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058046] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant U01 NS 058046 from USPHS CounterAct Program through the NINDS.	ALDRIDGE WN, 1972, ENZYME INHIBITORS SU, P1; Amitai G, 2007, TOXICOLOGY, V233, P187, DOI 10.1016/j.tox.2006.09.020; [Anonymous], ENZYMES 3E; ASHANI Y, 1995, J BIOL CHEM, V270, P6370, DOI 10.1074/jbc.270.11.6370; Cerasoli DM, 2005, CHEM-BIOL INTERACT, V157, P363, DOI 10.1016/j.cbi.2005.10.052; CRODDY E, 2005, WEAPONS MASS DESTRUC, P1; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FLEISHER JH, 1965, BIOCHEM PHARMACOL, V14, P641, DOI 10.1016/0006-2952(65)90082-1; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huang YJ, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-50; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5; Kovarik Z, 2004, BIOCHEMISTRY-US, V43, P3222, DOI 10.1021/bi036191a; Kovarik Z, 2003, BIOCHEM J, V373, P33, DOI 10.1042/BJ20021862; Kovarik Z, 2007, TOXICOLOGY, V233, P79, DOI 10.1016/j.tox.2006.08.032; Kucukkilinc T, 2010, CHEM-BIOL INTERACT, V187, P238, DOI 10.1016/j.cbi.2010.03.050; Mazor O, 2008, MOL PHARMACOL, V74, P755, DOI 10.1124/mol.108.047449; MCDONOUGH JH, 2007, CHEM WARFARE AGENTS, P71; Ordentlich A, 1999, BIOCHEMISTRY-US, V38, P3055, DOI 10.1021/bi982261f; ORDENTLICH A, 1993, J BIOL CHEM, V268, P17083; RADIC Z, 1992, BIOCHEMISTRY-US, V31, P9760, DOI 10.1021/bi00155a032; Raveh L, 1997, TOXICOL APPL PHARM, V145, P43, DOI 10.1006/taap.1997.8160; RAVEH L, 1993, BIOCHEM PHARMACOL, V45, P2465, DOI 10.1016/0006-2952(93)90228-O; Rosenberg YJ, 2010, CHEM-BIOL INTERACT, V187, P279, DOI 10.1016/j.cbi.2010.02.042; Saxena A, 1997, BIOCHEM PHARMACOL, V54, P269, DOI 10.1016/S0006-2952(97)00180-9; SAXENA A, 1993, BIOCHEM BIOPH RES CO, V197, P343, DOI 10.1006/bbrc.1993.2481; Shafferman A, 1996, BIOCHEM J, V318, P833, DOI 10.1042/bj3180833; Taylor P., 2011, GOODMAN GILMANS PHAR, V12th ed, P239; Taylor Palmer, 2007, Arhiv za Higijenu Rada i Toksikologiju, V58, P339, DOI 10.2478/v10004-007-0027-1; Taylor P, 2007, TOXICOLOGY, V233, P70, DOI 10.1016/j.tox.2006.11.061; Valle AM, 2011, J PHARMACOL EXP THER, V338, P125, DOI 10.1124/jpet.111.180091; WOLFE AD, 1992, TOXICOL APPL PHARM, V117, P189, DOI 10.1016/0041-008X(92)90236-L	31	48	49	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29718	29724		10.1074/jbc.M111.264739	http://dx.doi.org/10.1074/jbc.M111.264739			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21730071	Green Published, hybrid			2022-12-25	WOS:000294046600031
J	Long, XC; Miano, JM				Long, Xiaochun; Miano, Joseph M.			Transforming Growth Factor-beta 1 (TGF-beta 1) Utilizes Distinct Pathways for the Transcriptional Activation of MicroRNA 143/145 in Human Coronary Artery Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; SERUM RESPONSE FACTOR; NEOINTIMAL LESION FORMATION; EMBRYONIC STEM-CELLS; P38 MAP KINASE; GENE-EXPRESSION; TGF-BETA; MESENCHYMAL TRANSITION; PHENOTYPIC MODULATION; CONTRACTILE PHENOTYPE	MicroRNA 143/145 (miR143/145) is restricted to adult smooth muscle cell (SMC) lineages and mediates, in part, the expression of several SMC contractile genes. Although the function of miR143/145 has begun to be elucidated, its transcriptional regulation in response to various signaling inputs is poorly understood. In an effort to define a miR signature for SMC differentiation, we screened human coronary artery SMCs for miRs modulated by TGF-beta 1, a known stimulus for SMC differentiation. Array analysis revealed a number of TGF-beta 1-induced miRs, including miR143/145. Validation studies showed that TGF-beta 1 stimulated miR143/145 expression in a dose-and time-dependent manner. We utilized several chemical inhibitors and found that SB203580, a specific inhibitor of p38MAPK, significantly decreased TGF-beta 1-induced miR143/145 expression. siRNA studies demonstrated that the effect of TGF-beta 1 on miR143/145 was dependent upon the myocardin and serum response factor transcriptional switch as well as SMAD4. TGF-beta 1 stimulated a 580-bp human miR143/145 enhancer, and mutagenesis studies revealed a critical role for both a known CArG box and an adjacent SMAD-binding element for full TGF-beta 1-dependent activation of the enhancer. Chromatin immunoprecipitation assays documented TGF-beta 1-mediated enrichment of SMAD3 and SMAD4 binding over the enhancer region containing the SMAD-binding element. Pre-miR145 strongly promoted SMC differentiation, whereas an anti-miR145 partially blocked TGF-beta 1-induced SMC differentiation. These results demonstrate a dual pathway for TGF-beta 1-induced transcription of miR143/145, thus revealing a novel mechanism underlying TGF-beta 1-induced human vascular SMC differentiation.	[Long, Xiaochun] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Dept Med, Rochester, NY 14642 USA	University of Rochester	Long, XC (corresponding author), Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Dept Med, Box CVRI,601 Elmwood Ave, Rochester, NY 14642 USA.	xiaochun_long@urmc.rochester.edu; j.m.miano@rochester.edu	; Miano, Joseph/L-5634-2018	Long, Xiaochun/0000-0001-9714-0023; Miano, Joseph/0000-0001-7522-3207	National Institutes of Health [HL62572, HL091168]; American Heart Association [10SDG3670036]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091168, R01HL062572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL62572 and HL091168 (to J. M. M.). This work was also supported by American Heart Association Scientist Development Grant 10SDG3670036 (to X. L.).	Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Davis-Dusenbery BN, 2011, J BIOL CHEM, V286, P28097, DOI 10.1074/jbc.M111.236950; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Fujiu K, 2005, CIRC RES, V97, P1132, DOI 10.1161/01.RES.0000190613.22565.13; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Hayes SA, 2003, ONCOGENE, V22, P4841, DOI 10.1038/sj.onc.1206730; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Hendrix JA, 2005, J CLIN INVEST, V115, P418, DOI 10.1172/JCI200522648; Hirota JA, 2009, PULM PHARMACOL THER, V22, P370, DOI 10.1016/j.pupt.2008.12.004; Hirschi KK, 2002, J BIOL CHEM, V277, P6287, DOI 10.1074/jbc.M106649200; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC; Huang HR, 2010, J BIOL CHEM, V285, P9383, DOI [10.1074/jbc.M110.101543, 10.1074/jbc.M109.095612]; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; La Rocca G, 2011, J CELL PHYSIOL, V226, P602, DOI 10.1002/jcp.22368; Landry J, 1995, BIOCHEM CELL BIOL, V73, P703, DOI 10.1139/o95-078; Lee Y, 2008, NAT NEUROSCI, V11, P1137, DOI 10.1038/nn.2183; Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Long X, 2009, J BIOL CHEM, V284, P33671, DOI 10.1074/jbc.M109.050419; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Martin-Garrido A, 2011, FREE RADICAL BIO MED, V50, P354, DOI 10.1016/j.freeradbiomed.2010.11.007; Masszi A, 2003, AM J PHYSIOL-RENAL, V284, pF911, DOI 10.1152/ajprenal.00183.2002; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Park C, 2011, GASTROENTEROLOGY, V141, P164, DOI 10.1053/j.gastro.2011.03.058; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Streb JW, 2005, J BIOL CHEM, V280, P4125, DOI 10.1074/jbc.M412466200; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; Tharp DL, 2006, AM J PHYSIOL-HEART C, V291, pH2493, DOI 10.1152/ajpheart.01254.2005; Wang SH, 2009, INT J ONCOL, V34, P1461, DOI 10.3892/ijo_00000275; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; Xie CQ, 2011, STEM CELLS DEV, V20, P205, DOI 10.1089/scd.2010.0283; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	61	102	108	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30119	30129		10.1074/jbc.M111.258814	http://dx.doi.org/10.1074/jbc.M111.258814			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21712382	hybrid, Green Published			2022-12-25	WOS:000294046600069
J	Markowska, AI; Jefferies, KC; Panjwani, N				Markowska, Anna I.; Jefferies, Kevin C.; Panjwani, Noorjahan			Galectin-3 Protein Modulates Cell Surface Expression and Activation of Vascular Endothelial Growth Factor Receptor 2 in Human Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNEAL NEOVASCULARIZATION; BINDING LECTIN; VEGF-A; ANGIOGENESIS; CARCINOMA; MICE; GLYCOSYLATION; MEMBRANE; CANCER	Angiogenesis is heavily influenced by VEGF-A and its family of receptors, particularly VEGF receptor 2 (VEGF-R2). Like most cell surface proteins, VEGF-R2 is glycosylated, although the function of VEGF-R2 with respect to its glycosylation pattern is poorly characterized. Galectin-3, a glycan binding protein, interacts with the EGF and TGF beta receptors, retaining them on the plasma membrane and altering their signal transduction. Because VEGF-R2 is glycosylated and both galectin-3 and VEGF-R2 are involved with angiogenesis, we hypothesized that galectin-3 binds VEGF-R2 and modulates its signal transduction as well. Employing a Western blot analysis approach, we found that galectin-3 induces phosphorylation of VEGF-R2 in endothelial cells. Knockdown of galectin-3 and Mgat5, an enzyme that synthesizes high-affinity glycan ligands of galectin-3, reduced VEGF-A mediated angiogenesis in vitro. A direct interaction on the plasma membrane was detected between galectin-3 and VEGF-R2, and this interaction was dependent on the expression of Mgat5. Using immunofluorescence and cell surface labeling, we found an increase in the level of internalized VEGF-R2 in both Mgat5 and galectin-3 knockdown cells, suggesting that galectin-3 retains the receptor on the plasma membrane. Finally, we observed reduced suture-induced neovascularization in the corneas of Gal3(-/-) and Mgat5(-/-) mice. These findings are consistent with the hypothesis that, like its role with the EGF and TGF beta receptors, galectin-3 contributes to the plasma membrane retention and proangiogenic function of VEGF-R2.	[Markowska, Anna I.] Tufts Univ, Sackler Sch Grad Biomed Sci, Grad Program Biochem, Boston, MA 02111 USA; [Markowska, Anna I.; Jefferies, Kevin C.; Panjwani, Noorjahan] Tufts Univ, Dept Ophthalmol, Sch Med, Boston, MA 02111 USA; [Markowska, Anna I.; Panjwani, Noorjahan] Tufts Univ, Dept Biochem, Sch Med, Boston, MA 02111 USA; [Panjwani, Noorjahan] New England Eye Ctr, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University	Panjwani, N (corresponding author), 136 Harrison Ave,SC704, Boston, MA 02111 USA.	noorjahan.panjwani@tufts.edu			National Eye Institute [EY07088]; National Institutes of Health [P30 N5047243]; New England Corneal Transplant Fund; Massachusetts Lions Eye Research Fund; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY007088, F32EY007088, T35EY007088] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Corneal Transplant Fund; Massachusetts Lions Eye Research Fund; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute Grant EY07088 and by National Institutes of Health Grant P30 N5047243 for confocal microscopy performed at the Tufts Center for Neuroscience Research. This work was also supported, in part, by The New England Corneal Transplant Fund, the Massachusetts Lions Eye Research Fund, and an unrestricted grant from Research to Prevent Blindness to the New England Eye Center.	Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; ALTIN JG, 1995, ANAL BIOCHEM, V224, P382, DOI 10.1006/abio.1995.1054; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; Dennis JW, 2002, BBA-GEN SUBJECTS, V1573, P414, DOI 10.1016/S0304-4165(02)00411-7; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gan LS, 2004, ACTA OPHTHALMOL SCAN, V82, P557, DOI 10.1111/j.1600-0420.2004.00312.x; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gillenwater A, 1996, HEAD NECK-J SCI SPEC, V18, P422, DOI 10.1002/(SICI)1097-0347(199609/10)18:5<422::AID-HED5>3.3.CO;2-S; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Granovsky M, 2000, NAT MED, V6, P306; Hosseini H, 2007, MED HYPOTHESES, V68, P799, DOI 10.1016/j.mehy.2006.06.063; Hsu DK, 1999, INT J CANCER, V81, P519, DOI 10.1002/(SICI)1097-0215(19990517)81:4<519::AID-IJC3>3.3.CO;2-S; Inoue M, 2002, CANCER CELL, V1, P193, DOI 10.1016/S1535-6108(02)00031-4; IRIMURA T, 1991, CANCER RES, V51, P387; JOOEKO J, 2000, MED SCI MONITOR, V6, P1047; Korff T, 1999, J CELL SCI, V112, P3249; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; Meyer RD, 2003, J BIOL CHEM, V278, P16347, DOI 10.1074/jbc.M300259200; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pluda JM, 1997, SEMIN ONCOL, V24, P203; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; SCHOEPPNER HL, 1995, CANCER, V75, P2818, DOI 10.1002/1097-0142(19950615)75:12<2818::AID-CNCR2820751206>3.0.CO;2-#; Scott A, 2009, BIOCHEM SOC T, V37, P1184, DOI 10.1042/BST0371184; Stechly L, 2009, TRAFFIC, V10, P438, DOI 10.1111/j.1600-0854.2009.00882.x; Streilein JW, 1996, INVEST OPHTH VIS SCI, V37, P413; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; VAISMAN N, 1990, J BIOL CHEM, V265, P19461; XU XC, 1995, AM J PATHOL, V147, P815	38	154	160	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29913	29921		10.1074/jbc.M111.226423	http://dx.doi.org/10.1074/jbc.M111.226423			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21715322	Green Published, hybrid			2022-12-25	WOS:000294046600050
J	Gogada, R; Prabhu, V; Amadori, M; Scott, R; Hashmi, S; Chandra, D				Gogada, Raghu; Prabhu, Varun; Amadori, Michael; Scott, Rachael; Hashmi, Sana; Chandra, Dhyan			Resveratrol Induces p53-independent, X-linked Inhibitor of Apoptosis Protein (XIAP)-mediated Bax Protein Oligomerization on Mitochondria to Initiate Cytochrome c Release and Caspase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NASOPHARYNGEAL CARCINOMA-CELLS; BCL-2 FAMILY PROTEINS; COLON-CANCER CELLS; S-PHASE ARREST; CHEMOPREVENTIVE AGENT; PROAPOPTOTIC FUNCTION; ANTICANCER DRUGS; APOCYTOCHROME-C; LEUKEMIA CELLS; IN-VIVO	Resveratrol, a naturally occurring phytoalexin, is known to induce apoptosis in multiple cancer cell types, but the underlying molecular mechanisms remain unclear. Here, we show that resveratrol induced p53-independent, X-linked inhibitor of apoptosis protein (XIAP)-mediated translocation of Bax to mitochondria where it underwent oligomerization to initiate apoptosis. Resveratrol treatment promoted interaction between Bax and XIAP in the cytosol and on mitochondria, suggesting that XIAP plays a critical role in the activation and translocation of Bax to mitochondria. This process did not involve p53 but required accumulation of Bim and t-Bid on mitochondria. Bax primarily underwent homo-oligomerization on mitochondria and played a major role in release of cytochrome c to the cytosol. Bak, another key protein that regulates the mitochondrial membrane permeabilization, did not interact with p53 but continued to associate with Bcl-xL. Thus, the proapoptotic function of Bak remained suppressed during resveratrol-induced apoptosis. Caspase-9 silencing inhibited resveratrol-induced caspase activation, whereas caspase-8 knockdown did not affect caspase activity, suggesting that resveratrol induces caspase-9-dependent apoptosis. Together, our findings characterize the molecular mechanisms of resveratrol-induced caspase activation and subsequent apoptosis in cancer cells.	[Gogada, Raghu; Prabhu, Varun; Amadori, Michael; Scott, Rachael; Hashmi, Sana; Chandra, Dhyan] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Chandra, D (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA.	dhyan.chandra@roswellpark.org	Gogada, Raghu/AAG-6624-2019	Gogada, Raghu/0000-0003-0933-7999; Chandra, Dhyan/0000-0001-7272-9384	National Institutes of Health [CA123142]; NCI Center [CA016056]; NATIONAL CANCER INSTITUTE [P30CA016056, K01CA123142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health K01 Award CA123142 (to D. C.) and NCI Center Support Grant CA016056 (to the Roswell Park Cancer Institute).	Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Aziz MH, 2006, MOL CANCER THER, V5, P1335, DOI 10.1158/1535-7163.MCT-05-0526; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bishayee A, 2009, CANCER PREV RES, V2, P409, DOI 10.1158/1940-6207.CAPR-08-0160; Blagosklonny MV, 2002, INT J CANCER, V98, P161, DOI 10.1002/ijc.10158; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bogner C, 2010, CURR OPIN CELL BIOL, V22, P845, DOI 10.1016/j.ceb.2010.08.002; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cao XF, 2003, BLOOD, V102, P2605, DOI 10.1182/blood-2003-01-0211; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Cartron PF, 2002, HUM MOL GENET, V11, P675, DOI 10.1093/hmg/11.6.675; Chandra D, 2003, J BIOL CHEM, V278, P17408, DOI 10.1074/jbc.M300750200; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chandra D, 2005, J BIOL CHEM, V280, P19051, DOI 10.1074/jbc.M501391200; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Chandra D, 2006, CELL, V125, P1333, DOI 10.1016/j.cell.2006.05.026; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chow HHS, 2010, CANCER PREV RES, V3, P1168, DOI 10.1158/1940-6207.CAPR-09-0155; Chow SE, 2010, CANCER GENE THER, V17, P872, DOI 10.1038/cgt.2010.44; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Delmas D, 2003, J BIOL CHEM, V278, P41482, DOI 10.1074/jbc.M304896200; Di X, 2010, BREAST CANCER RES TR, V124, P349, DOI 10.1007/s10549-010-0765-7; Dorrie J, 2001, CANCER RES, V61, P4731; Essmann F, 2005, J BIOL CHEM, V280, P37169, DOI 10.1074/jbc.M502052200; Estrov Z, 2003, BLOOD, V102, P987, DOI 10.1182/blood-2002-11-3550; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; FORRESTER K, 1995, ONCOGENE, V10, P2103; Fulda S, 2004, CANCER RES, V64, P337, DOI 10.1158/0008-5472.CAN-03-1656; Ganapathy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015627; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Gill C, 2007, PROSTATE, V67, P1641, DOI 10.1002/pros.20653; Guha P, 2011, J PHARMACOL EXP THER, V336, P206, DOI 10.1124/jpet.110.171983; Heerdt BG, 1997, CELL GROWTH DIFFER, V8, P523; Honda T, 2004, CANCER GENE THER, V11, P249, DOI 10.1038/sj.cgt.7700684; Hsieh TC, 1999, CANCER RES, V59, P2596; Huang TT, 2011, J CELL PHYSIOL, V226, P720, DOI 10.1002/jcp.22391; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Joe AK, 2002, CLIN CANCER RES, V8, P893; Joshi B, 1999, CANCER RES, V59, P4343; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim MY, 2009, ANTICANCER RES, V29, P3733; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Mader I, 2010, FASEB J, V24, P1997, DOI 10.1096/fj.09-142943; Mahyar-Roemer M, 2004, ONCOGENE, V23, P6226, DOI 10.1038/sj.onc.1207637; Mahyar-Roemer M, 2001, INT J CANCER, V94, P615, DOI 10.1002/ijc.1516; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Mathew R, 2011, CURR OPIN GENET DEV, V21, P113, DOI 10.1016/j.gde.2010.12.008; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mohan J, 2006, J BIOL CHEM, V281, P17599, DOI 10.1074/jbc.M602641200; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Niles RM, 2003, CANCER LETT, V190, P157, DOI 10.1016/S0304-3835(02)00676-6; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Owens TW, 2010, J BIOL CHEM, V285, P1081, DOI 10.1074/jbc.M109.072322; Patel KR, 2010, CANCER RES, V70, P7392, DOI 10.1158/0008-5472.CAN-10-2027; Pavet V, 2010, CANCER RES, V70, P1101, DOI 10.1158/0008-5472.CAN-09-2889; Perez D, 2000, MOL CELL, V6, P53, DOI 10.1016/S1097-2765(00)00007-1; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Pietsch EC, 2008, J BIOL CHEM, V283, P21294, DOI 10.1074/jbc.M710539200; Poyton RO, 1996, ANNU REV BIOCHEM, V65, P563, DOI 10.1146/annurev.bi.65.070196.003023; Rushworth SA, 2009, BRIT J PHARMACOL, V157, P1186, DOI 10.1111/j.1476-5381.2009.00266.x; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Sanchez-Alcazar JA, 2000, CELL DEATH DIFFER, V7, P1090, DOI 10.1038/sj.cdd.4400740; Sanchez-Alcazar JA, 2001, CANCER RES, V61, P1038; Sareen D, 2007, MOL PHARMACOL, V72, P1466, DOI 10.1124/mol.107.039040; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; She QB, 2001, CANCER RES, V61, P1604; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; STUART RA, 1990, CELL, V60, P31, DOI 10.1016/0092-8674(90)90713-O; STUART RA, 1990, BIOCHIMIE, V72, P115, DOI 10.1016/0300-9084(90)90136-5; Tinhofer I, 2001, FASEB J, V15, P1613, DOI 10.1096/fj.00-0675fje; Van Ginkel PR, 2007, CLIN CANCER RES, V13, P5162, DOI 10.1158/1078-0432.CCR-07-0347; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; Yamaguchi H, 2004, J BIOL CHEM, V279, P39431, DOI 10.1074/jbc.M401530200; Yamaguchi H, 2009, J BIOL CHEM, V284, P11171, DOI 10.1074/jbc.M809268200; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhang Z, 2010, J BIOL CHEM, V285, P17614, DOI 10.1074/jbc.M110.113456; Zois CE, 2009, AUTOPHAGY, V5, P442, DOI 10.4161/auto.5.4.7667	91	63	68	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28749	28760		10.1074/jbc.M110.202440	http://dx.doi.org/10.1074/jbc.M110.202440			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21712378	Green Published, hybrid			2022-12-25	WOS:000293837000013
J	Schwan, C; Nolke, T; Kruppke, AS; Schubert, DM; Lang, AE; Aktories, K				Schwan, Carsten; Noelke, Thilo; Kruppke, Anna S.; Schubert, Daniel M.; Lang, Alexander E.; Aktories, Klaus			Cholesterol- and Sphingolipid-rich Microdomains Are Essential for Microtubule-based Membrane Protrusions Induced by Clostridium difficile Transferase (CDT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOTULINUM C2 TOXIN; CLATHRIN-INDEPENDENT ENDOCYTOSIS; LIPID RAFTS; PLASMA-MEMBRANE; BACTERIAL TOXINS; CELLS; ACTIN; CYCLODEXTRINS; MECHANISMS; CURVATURE	Clostridium difficile toxin (CDT) is a binary actin-ADP-ribosylating toxin that causes depolymerization of the actin cytoskeleton and formation of microtubule-based membrane protrusions, which are suggested to be involved in enhanced bacterial adhesion and colonization of hypervirulent C.difficile strains. Here, we studied the involvement of membrane lipid components of human colon adenocarcinoma (Caco-2) cells in formation of membrane protrusions. Depletion of cholesterol by methyl-beta-cyclodextrin inhibited protrusion formation in a concentration-dependent manner but had no major effect on the toxin-catalyzed modification of actin in target cells. Repletion of cholesterol reconstituted formation of protrusions and increased velocity and total amount of protrusion formation. Methyl-beta-cyclodextrin had no effect on the CDT-induced changes in the dynamics of microtubules. Formation of membrane protrusions was also inhibited by the cholesterol-binding polyene antibiotic nystatin. Degradation or inhibition of synthesis of sphingolipids by sphingomyelinase and myriocin, respectively, blocked CDT-induced protrusion formation. Benzyl alcohol, which increases membrane fluidity, prevented protrusion formation. CDT-induced membrane protrusions were stained by flotillin-2 and by the fluorescent-labeled lipid raft marker cholera toxin subunit B, which selectively interacts with GM1 ganglioside mainly located in lipid microdomains. The data suggest that formation and especially the initiation of CDT-induced microtubule-based membrane protrusions depend on cholesterol-and sphingolipid-rich lipid microdomains.	[Schwan, Carsten; Noelke, Thilo; Kruppke, Anna S.; Schubert, Daniel M.; Lang, Alexander E.; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany	University of Freiburg	Aktories, K (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Albertstr 25, D-79104 Freiburg, Germany.	Klaus.Aktories@pharmakol.uni-freiburg.de	Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436; Schwan, Carsten/0000-0003-3876-8739	Deutsche Forschungsgemeinschaft [AK 6-20/1]; BIOSS Program, Freiburg, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BIOSS Program, Freiburg, Germany	This work was supported by Deutsche Forschungsgemeinschaft Grant AK 6-20/1 and the BIOSS Program, Freiburg, Germany.	Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Aktories K, 2011, FEBS J, V278, P4526, DOI 10.1111/j.1742-4658.2011.08113.x; Barbieri JT, 2002, ANNU REV CELL DEV BI, V18, P315, DOI 10.1146/annurev.cellbio.18.012502.134748; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; BASSE F, 1992, EUR J BIOCHEM, V205, P155, DOI 10.1111/j.1432-1033.1992.tb16763.x; Christian AE, 1997, J LIPID RES, V38, P2264; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Danielsen EM, 2003, BBA-BIOMEMBRANES, V1617, P1, DOI 10.1016/j.bbamem.2003.09.005; Davies AH, 2011, BIOCHEM J, V436, P517, DOI 10.1042/BJ20110106; Devaux PF, 2004, TRAFFIC, V5, P241, DOI 10.1111/j.1600-0854.2004.0170.x; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Gibert M, 2011, CELL MICROBIOL, V13, P154, DOI 10.1111/j.1462-5822.2010.01527.x; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; Grimmer S, 2006, TRAFFIC, V7, P1243, DOI 10.1111/j.1600-0854.2006.00456.x; Gulke I, 2001, INFECT IMMUN, V69, P6004, DOI 10.1128/IAI.69.10.6004-6011.2001; Hammond AT, 2005, P NATL ACAD SCI USA, V102, P6320, DOI 10.1073/pnas.0405654102; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; Huttner WB, 2001, CURR OPIN CELL BIOL, V13, P478, DOI 10.1016/S0955-0674(00)00239-8; IKEZAWA H, 1978, BIOCHIM BIOPHYS ACTA, V528, P247; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Kelly CP, 2008, NEW ENGL J MED, V359; Larive RM, 2010, BBA-BIOMEMBRANES, V1798, P389, DOI 10.1016/j.bbamem.2009.11.016; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; Nagy E, 2007, P NATL ACAD SCI USA, V104, P7945, DOI 10.1073/pnas.0702557104; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Pietiainen V, 2004, MOL BIOL CELL, V15, P4911, DOI 10.1091/mbc.E04-01-0070; Poole K, 2004, FEBS LETT, V565, P53, DOI 10.1016/j.febslet.2004.03.095; Pust S, 2010, CELL MICROBIOL, V12, P1809, DOI 10.1111/j.1462-5822.2010.01512.x; Quinn PJ, 2009, BBA-BIOMEMBRANES, V1788, P33, DOI 10.1016/j.bbamem.2008.08.005; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Safouane M, 2010, TRAFFIC, V11, P1519, DOI 10.1111/j.1600-0854.2010.01116.x; Sandvig K, 2008, HISTOCHEM CELL BIOL, V129, P267, DOI 10.1007/s00418-007-0376-5; SCHMID A, 1994, J BIOL CHEM, V269, P16706; Schwan C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000626; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; Shvartsman DE, 2006, TRAFFIC, V7, P917, DOI 10.1111/j.1600-0854.2006.00437.x; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Solomon S, 2002, IMMUNOBIOLOGY, V205, P108, DOI 10.1078/0171-2985-00114; Stachowiak JC, 2010, P NATL ACAD SCI USA, V107, P7781, DOI 10.1073/pnas.0913306107; Stepanova T, 2003, J NEUROSCI, V23, P2655; Sterthoff C, 2010, INFECT IMMUN, V78, P1468, DOI 10.1128/IAI.01351-09; Uemstsu Y, 2007, BIOL CELL, V99, P141, DOI 10.1042/BC20060089; VANDEKERCKHOVE J, 1988, J BIOL CHEM, V263, P696; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	58	45	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29356	29365		10.1074/jbc.M111.261925	http://dx.doi.org/10.1074/jbc.M111.261925			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705797	Green Published, hybrid			2022-12-25	WOS:000293837000070
J	Smih, F; Desmoulin, F; Berry, M; Turkieh, A; Harmancey, R; Iacovoni, J; Trouillet, C; Delmas, C; Pathak, A; Lairez, O; Koukoui, F; Massabuau, P; Ferrieres, J; Galinier, M; Rouet, P				Smih, Fatima; Desmoulin, Franck; Berry, Matthieu; Turkieh, Annie; Harmancey, Romain; Iacovoni, Jason; Trouillet, Charlotte; Delmas, Clement; Pathak, Atul; Lairez, Olivier; Koukoui, Francois; Massabuau, Pierre; Ferrieres, Jean; Galinier, Michel; Rouet, Philippe			Blood Signature of Pre-Heart Failure: A Microarrays Study	PLOS ONE			English	Article							VENTRICULAR SYSTOLIC DYSFUNCTION; GENE-EXPRESSION; ECHOCARDIOGRAPHIC HEART; MONONUCLEAR-CELLS; TASK-FORCE; PREVALENCE; TRANSCRIPTOME; ASSOCIATION; POPULATION; GUIDELINES	Background: The preclinical stage of systolic heart failure (HF), known as asymptomatic left ventricular dysfunction (ALVD), is diagnosed only by echocardiography, frequent in the general population and leads to a high risk of developing severe HF. Large scale screening for ALVD is a difficult task and represents a major unmet clinical challenge that requires the determination of ALVD biomarkers. Methodology/Principal Findings: 294 individuals were screened by echocardiography. We identified 9 ALVD cases out of 128 subjects with cardiovascular risk factors. White blood cell gene expression profiling was performed using pangenomic microarrays. Data were analyzed using principal component analysis (PCA) and Significant Analysis of Microarrays (SAM). To build an ALVD classifier model, we used the nearest centroid classification method (NCCM) with the ClaNC software package. Classification performance was determined using the leave-one-out cross-validation method. Blood transcriptome analysis provided a specific molecular signature for ALVD which defined a model based on 7 genes capable of discriminating ALVD cases. Analysis of an ALVD patients validation group demonstrated that these genes are accurate diagnostic predictors for ALVD with 87% accuracy and 100% precision. Furthermore, Receiver Operating Characteristic curves of expression levels confirmed that 6 out of 7 genes discriminate for left ventricular dysfunction classification. Conclusions/Significance: These targets could serve to enhance the ability to efficiently detect ALVD by general care practitioners to facilitate preemptive initiation of medical treatment preventing the development of HF.	[Smih, Fatima; Desmoulin, Franck; Berry, Matthieu; Turkieh, Annie; Harmancey, Romain; Iacovoni, Jason; Trouillet, Charlotte; Delmas, Clement; Pathak, Atul; Lairez, Olivier; Koukoui, Francois; Massabuau, Pierre; Galinier, Michel; Rouet, Philippe] Univ Toulouse 3, INSERM, Inst Malad Metabol & Cardiovasc I2MC, UMR 1048, F-31062 Toulouse, France; [Berry, Matthieu; Trouillet, Charlotte; Delmas, Clement; Pathak, Atul; Lairez, Olivier; Massabuau, Pierre; Ferrieres, Jean; Galinier, Michel; Rouet, Philippe] Rangueil Hosp Univ, Dept Cardiol, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Smih, F (corresponding author), Univ Toulouse 3, INSERM, Inst Malad Metabol & Cardiovasc I2MC, UMR 1048, F-31062 Toulouse, France.	fatima.smith-rouet@inserm.fr	DESMOULIN, Franck/O-1895-2018; Clément, DELMAS/Q-5187-2019; desmoulin, franck/AAU-4544-2020; Pathak, Atul/ABC-5223-2020; O, Lairez/B-7152-2016; Ferrieres, Jean/S-7993-2016	DESMOULIN, Franck/0000-0003-0560-6266; Clément, DELMAS/0000-0001-9180-9128; desmoulin, franck/0000-0003-0560-6266; Pathak, Atul/0000-0001-6151-0096; O, Lairez/0000-0001-8141-6582; Rouet, Philippe/0000-0001-6204-2079; Ferrieres, Jean/0000-0001-6144-1297; TURKIEH, Annie/0000-0001-6968-4517; GALINIER, Michel/0000-0003-1735-3390	National Research Agency; Fondation de France	National Research Agency(French National Research Agency (ANR)); Fondation de France(Fondation de France)	This work was supported by the National Research Agency and Fondation de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betti I, 2009, J CARD FAIL, V15, P377, DOI 10.1016/j.cardfail.2008.12.002; Caporali A, 2009, PHYSIOL REV, V89, P279, DOI 10.1152/physrev.00007.2008; Cappuzzello C, 2009, PHYSIOL GENOMICS, V38, P233, DOI 10.1152/physiolgenomics.90364.2008; Dabney AR, 2006, BIOINFORMATICS, V22, P122, DOI 10.1093/bioinformatics/bti756; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Davies MK, 2001, LANCET, V358, P439, DOI 10.1016/S0140-6736(01)05620-3; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Fang ZY, 2005, AM HEART J, V149, P349, DOI 10.1016/j.ahj.2004.06.021; Gottdiener JS, 2002, ANN INTERN MED, V137, P631, DOI 10.7326/0003-4819-137-8-200210150-00006; Hobbs FDR, 2007, EUR HEART J, V28, P1128, DOI 10.1093/eurheartj/ehm102; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Kaye DM, 2000, CIRC RES, V86, pE80, DOI 10.1161/01.RES.86.7.e80; Konig R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh027; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Luers C, 2010, CLIN RES CARDIOL, V99, P217, DOI 10.1007/s00392-009-0108-z; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; McMurray JV, 1998, EUR HEART J, V19, P842, DOI 10.1093/eurheartj/19.6.842; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Philip-Couderc P, 2004, FASEB J, V18, P1539, DOI 10.1096/fj.03-1242fje; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Seiler PU, 2004, BASIC RES CARDIOL, V99, P230, DOI 10.1007/s00395-004-0467-6; SHARPE N, 1990, EUR HEART J, V11, P147, DOI 10.1093/eurheartj/11.suppl_B.147; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91; Verdecchia P, 2005, HYPERTENSION, V45, P412, DOI 10.1161/01.HYP.0000154822.37141.f6; Wang TJ, 2003, CIRCULATION, V108, P977, DOI 10.1161/01.CIR.0000085166.44904.79; Wang TJ, 2003, ANN INTERN MED, V138, P907, DOI 10.7326/0003-4819-138-11-200306030-00012; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Yndestad A, 2002, CARDIOVASC RES, V54, P175, DOI 10.1016/S0008-6363(02)00238-9	34	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e20414	10.1371/journal.pone.0020414	http://dx.doi.org/10.1371/journal.pone.0020414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731613	Green Published, gold			2022-12-25	WOS:000292036900004
J	Tati, R; Kristoffersson, AC; Stahl, AL; Morgelin, M; Motto, D; Satchell, S; Mathieson, P; Manea-Hedstrom, M; Karpman, D				Tati, Ramesh; Kristoffersson, Ann-Charlotte; Stahl, Anne-lie; Morgelin, Matthias; Motto, David; Satchell, Simon; Mathieson, Peter; Manea-Hedstrom, Minola; Karpman, Diana			Phenotypic Expression of ADAMTS13 in Glomerular Endothelial Cells	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; THROMBOTIC THROMBOCYTOPENIC PURPURA; SHIGA TOXIN; VONWILLEBRAND-FACTOR; VWF; CLEAVAGE; PLASMA; SYNTHESIZE; MUTATIONS	Background: ADAMTS13 is the physiological von Willebrand factor (VWF)-cleaving protease. The aim of this study was to examine ADAMTS13 expression in kidneys from ADAMTS13 wild-type (Adamts13(+/+)) and deficient (Adamts13(-/-)) mice and to investigate the expression pattern and bioactivity in human glomerular endothelial cells. Methodology/Principal Findings: Immunohistochemistry was performed on kidney sections from ADAMTS13 wild-type and ADAMTS13-deficient mice. Phenotypic differences were examined by ultramorphology. ADAMTS13 expression in human glomerular endothelial cells and dermal microvascular endothelial cells was investigated by real-time PCR, flow cytometry, immunofluorescence and immunoblotting. VWF cleavage was demonstrated by multimer structure analysis and immunoblotting. ADAMTS13 was demonstrated in glomerular endothelial cells in Adamts13(+/+) mice but no staining was visible in tissue from Adamts13(-/-) mice. Thickening of glomerular capillaries with platelet deposition on the vessel wall was detected in Adamts13(-/-) mice. ADAMTS13 mRNA and protein were detected in both human endothelial cells and the protease was secreted. ADAMTS13 activity was demonstrated in glomerular endothelial cells as cleavage of VWF. Conclusions/Significance: Glomerular endothelial cells express and secrete ADAMTS13. The proteolytic activity could have a protective effect preventing deposition of platelets along capillary lumina under the conditions of high shear stress present in glomerular capillaries.	[Tati, Ramesh; Kristoffersson, Ann-Charlotte; Stahl, Anne-lie; Manea-Hedstrom, Minola; Karpman, Diana] Lund Univ, Dept Pediat, Lund, Sweden; [Morgelin, Matthias] Lund Univ, Div Clin & Expt Infect Med, Lund, Sweden; [Motto, David] Univ Iowa, Coll Med, Dept Internal Med & Pediat, Iowa City, IA USA; [Satchell, Simon; Mathieson, Peter] Univ Bristol, Acad Renal Unit, Southmead Hosp, Bristol, Avon, England	Lund University; Lund University; University of Iowa; Southmead Hospital; University of Bristol	Tati, R (corresponding author), Lund Univ, Dept Pediat, Lund, Sweden.	Diana.Karpman@med.lu.se		Karpman, Diana/0000-0001-7220-7658; Aradottir, Sigridur Sunna/0000-0002-6898-3256	The Swedish Research Council [K2010-65X-14008, 2008-7480]; Torsten and Ragnar Soderberg Foundation; Crown Princess Lovisa's Society for Child Care; The Konung Gustaf V:s 80-arsfond; Fanny Ekdahl's Foundation; Greta and Johan Kock Foundation; Crafoord Foundation; Royal Swedish Academy of Sciences; Medical Research Council [G0800200] Funding Source: researchfish; MRC [G0800200] Funding Source: UKRI	The Swedish Research Council(Swedish Research Council); Torsten and Ragnar Soderberg Foundation; Crown Princess Lovisa's Society for Child Care; The Konung Gustaf V:s 80-arsfond; Fanny Ekdahl's Foundation; Greta and Johan Kock Foundation; Crafoord Foundation; Royal Swedish Academy of Sciences; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from The Swedish Research Council (K2010-65X-14008 to DK and 2008-7480 to MM), Torsten and Ragnar Soderberg Foundation, The Fund for Renal Research, Crown Princess Lovisa's Society for Child Care, The Konung Gustaf V:s 80-arsfond, and Fanny Ekdahl's Foundation (all to DK). Support was also provided by The Greta and Johan Kock Foundation and the Crafoord Foundation (to MM). DK is the recipient of a clinical-experimental research fellowship from the Royal Swedish Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya M, 2002, BLOOD, V99, P3971, DOI 10.1182/blood-2001-11-0060; Chauhan AK, 2006, J EXP MED, V203, P767, DOI 10.1084/jem.20051732; Chauhan AK, 2008, BLOOD, V111, P3452, DOI 10.1182/blood-2007-08-108571; DENT JA, 1990, P NATL ACAD SCI USA, V87, P6306, DOI 10.1073/pnas.87.16.6306; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Furlan M, 1997, BLOOD, V89, P3097, DOI 10.1182/blood.V89.9.3097; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; George JN, 2000, BLOOD, V96, P1223, DOI 10.1182/blood.V96.4.1223.h8001223_1223_1229; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Huang J, 2010, BLOOD, V116, P3653, DOI 10.1182/blood-2010-02-271957; JAFFE EA, 1974, P NATL ACAD SCI USA, V71, P1906, DOI 10.1073/pnas.71.5.1906; Keepers TR, 2006, J AM SOC NEPHROL, V17, P3404, DOI 10.1681/ASN.2006050419; Lanke E, 2008, THROMB HAEMOSTASIS, V100, P211, DOI 10.1160/TH08-03-0187; Lenz O, 1998, J AM SOC NEPHROL, V9, P2040; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Liu L, 2005, J THROMB HAEMOST, V3, P2536, DOI 10.1111/j.1538-7836.2005.01561.x; Manea M, 2007, BRIT J HAEMATOL, V138, P651, DOI 10.1111/j.1365-2141.2007.06694.x; Manea M, 2007, EUR J PEDIATR, V166, P249, DOI 10.1007/s00431-006-0354-2; Manea M, 2010, PEDIATR NEPHROL, V25, P87, DOI 10.1007/s00467-009-1262-2; MOAKE JL, 1986, BLOOD, V67, P1523; Motto DG, 2005, J CLIN INVEST, V115, P2752, DOI 10.1172/JCI26007; Nitsche DP, 2006, J BIOL CHEM, V281, P1670, DOI 10.1074/jbc.M506776200; Plaimauer B, 2002, BLOOD, V100, P3626, DOI 10.1182/blood-2002-05-1397; Powazniak Y, 2011, EUR J HAEMATOL, V86, P140, DOI 10.1111/j.1600-0609.2010.01545.x; Raife TJ, 2009, BLOOD, V114, P1666, DOI 10.1182/blood-2009-01-195461; Satchell SC, 2006, KIDNEY INT, V69, P1633, DOI 10.1038/sj.ki.5000277; Shamamian P, 2001, J CELL PHYSIOL, V189, P197, DOI 10.1002/jcp.10014; Shang DZ, 2006, BLOOD, V108, P2207, DOI 10.1182/blood-2006-02-002139; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; SPORN LA, 1985, J CLIN INVEST, V76, P1102, DOI 10.1172/JCI112064; Stahl AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006990; Suzuki M, 2004, BIOCHEM BIOPH RES CO, V313, P212, DOI 10.1016/j.bbrc.2003.11.111; TSAI HM, 1989, BLOOD, V73, P2074; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; Turner N, 2006, J THROMB HAEMOST, V4, P1396, DOI 10.1111/j.1538-7836.2006.01959.x; Turner NA, 2009, BLOOD, V114, P5102, DOI 10.1182/blood-2009-07-231597; Uemura M, 2005, BLOOD, V106, P922, DOI 10.1182/blood-2005-01-0152; Vaziri-Sani F, 2006, KIDNEY INT, V69, P981, DOI 10.1038/sj.ki.5000155; Vomund AN, 2009, J BIOL CHEM, V284, P30925, DOI 10.1074/jbc.M109.000927	40	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21587	10.1371/journal.pone.0021587	http://dx.doi.org/10.1371/journal.pone.0021587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720563	Green Published, gold, Green Submitted			2022-12-25	WOS:000292036900059
J	Stover, J; Korenromp, EL; Blakley, M; Komatsu, R; Viisainen, K; Bollinger, L; Atun, R				Stover, John; Korenromp, Eline L.; Blakley, Matthew; Komatsu, Ryuichi; Viisainen, Kirsi; Bollinger, Lori; Atun, Rifat			Long-Term Costs and Health Impact of Continued Global Fund Support for Antiretroviral Therapy	PLOS ONE			English	Article							PATIENT RETENTION; LOW-INCOME; FOLLOW-UP; HIV; MORTALITY; PROGRAMS; HIV/AIDS; ART; SERVICES; AFRICA	Background: By the end of 2011 Global Fund investments will be supporting 3.5 million people on antiretroviral therapy (ART) in 104 low-and middle-income countries. We estimated the cost and health impact of continuing treatment for these patients through 2020. Methods and Findings: Survival on first-line and second-line ART regimens is estimated based on annual retention rates reported by national AIDS programs. Costs per patient-year were calculated from country-reported ARV procurement prices, and expenditures on laboratory tests, health care utilization and end-of-life care from in-depth costing studies. Of the 3.5 million ART patients in 2011, 2.3 million will still need treatment in 2020. The annual cost of maintaining ART falls from $1.9 billion in 2011 to $1.7 billion in 2020, as a result of a declining number of surviving patients partially offset by increasing costs as more patients migrate to second-line therapy. The Global Fund is expected to continue being a major contributor to meeting this financial need, alongside other international funders and domestic resources. Costs would be $150 million less in 2020 with an annual 5% decline in first-line ARV prices and $150-370 million less with a 5%-12% annual decline in second-line prices, but $200 million higher in 2020 with phase out of stavudine (d4T), or $200 million higher with increased migration to second-line regimens expected if all countries routinely adopted viral load monitoring. Deaths postponed by ART correspond to 830,000 life-years saved in 2011, increasing to around 2.3 million life-years every year between 2015 and 2020. Conclusions: Annual patient-level direct costs of supporting a patient cohort remain fairly stable over 2011-2020, if current antiretroviral prices and delivery costs are maintained. Second-line antiretroviral prices are a major cost driver, underscoring the importance of investing in treatment quality to improve retention on first-line regimens.	[Stover, John; Bollinger, Lori] Futures Inst, Glastonbury, CT USA; [Korenromp, Eline L.; Blakley, Matthew; Komatsu, Ryuichi; Viisainen, Kirsi; Atun, Rifat] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Korenromp, Eline L.; Atun, Rifat] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, London, England	Erasmus University Rotterdam; Erasmus MC; Imperial College London	Stover, J (corresponding author), Futures Inst, Glastonbury, CT USA.	jstover@futuresinstitute.org	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983	The Global Fund	The Global Fund	The Global Fund commissioned this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; *AIDS 2031 COSTS F, 2010, COSTS CHOIC FIN LONG; [Anonymous], ANT MED LOW MIDDL IN; Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; BAUTISTA SA, 2003, COSTING HIV AIDS TRE; CHANDLER R, 2005, ESTIMATING RESOURCE; CHANG LW, 2010, COCHRANE DB SYST REV, V14; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; *EART LINC COLL, 2008, SEX TRANSM INFECT, V84, pI31; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Fox MP, 2010, TROP MED INT HEALTH, V15, P405, DOI 10.1111/j.1365-3156.2010.02473.x; GALARRAGA O, 2010, PHARMAC IN PRESS SEP; Galvao J, 2002, LANCET, V360, P1862, DOI 10.1016/S0140-6736(02)11775-2; *GLOB FUND FIGHT A, 2009, IMPR VAL MON GLOB FU; *GLOB FUND FIGHT A, 2010, KEY PERF IND 2010; *GLOB FUND FIGHT A, 2011, GLOB FUND RES REP 20; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; HARLING G, 2007, J ACQ IMMUN DEF SYND, V45, P3; Harries AD, 2010, TROP MED INT HEALTH, V15, P70, DOI 10.1111/j.1365-3156.2010.02506.x; Izazola-Licea JA, 2009, JAIDS-J ACQ IMM DEF, V52, pS119, DOI 10.1097/QAI.0b013e3181baeeda; Jack C, 2004, JAIDS-J ACQ IMM DEF, V36, P929, DOI 10.1097/00126334-200408010-00006; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; *KAIS FAM FDN, 2009, FIN RESP AIDS LOW MI; Kitajima T, 2003, AIDS, V17, P2375, DOI 10.1097/00002030-200311070-00013; KOENIG S, 2006, AIDS 2006 16 INT AID; KOENIG S, 2006, AIDS 16 INT AIDS C 2; Komatsu R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-109; KOMBE G, 2004, COSTS ANTIRETROVIRAL; Kombe G., 2005, HUMAN FINANCIAL RESO; Korenromp EL, 2005, EMERG INFECT DIS, V11, P1410, DOI 10.3201/eid1109.050337; Korenromp EL, 2011, AIDS, V25, P857, DOI 10.1097/QAD.0b013e3283454401; LABASTIDE W, 2002, INT C AIDS JUL 7 12, P14; LONG L, 2009, COSTING TREATMENT GU; Loubiere S, 2010, CURR OPIN HIV AIDS, V5, P225, DOI 10.1097/COH.0b013e3283384a9d; Marston M, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000299412.82893.62; Medecins Sans Frontieres, 2008, UNT WEB ANT PRIC RED; MEDINALARA A, 2009, 5 IAS C HIV PATH TRE; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Phillips AN, 2011, AIDS, V25, P843, DOI 10.1097/QAD.0b013e328344037a; *PHRPLUS, 2004, NIG RAP ASS HIV AIDS; Quentin W, 2008, TROP MED INT HEALTH, V13, P1245, DOI 10.1111/j.1365-3156.2008.02142.x; SILVESTRI A, 2009, EVALUATION ANTIRETRO; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; Stover J, 2006, SCIENCE, V311, P1474, DOI 10.1126/science.1121176; Stover J, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/738271; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2010, GLOB FUND RES REP 20; TODD K, 2007, AIDS S, V6, pS55; Tweya H, 2010, TROP MED INT HEALTH, V15, P82, DOI 10.1111/j.1365-3156.2010.02509.x; *UK DEP INT DEV, 2008, ACH UN ACC UK STRAT; *UNAIDS, GLOB EC CRIS HIV PRE; UNAIDS, 2009, WHAT COUNTR NEED INV; WHO, 2010, ANT THER HIV INF AD; WHO, 2004, MAL HIV AIDS INT IMP; *WHO, 2009, U ACC SCAL PRIOR HIV; World Health Organization, 2006, ANT THER HIV INF AD; World Health Organization UNAIDS and UNICEF, 2010, U ACC SCAL PRIOR HIV; 2010, REPORT C COSTS TREAT	57	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21048	10.1371/journal.pone.0021048	http://dx.doi.org/10.1371/journal.pone.0021048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731646	Green Published, gold, Green Submitted			2022-12-25	WOS:000292035400007
J	Zheng, CG; Feng, J; Lu, D; Wang, P; Xing, S; Coll, JL; Yang, DL; Yan, XY				Zheng, Chaogu; Feng, Jing; Lu, Di; Wang, Ping; Xing, Shu; Coll, Jean-Luc; Yang, Dongling; Yan, Xiyun			A Novel Anti-CEACAM5 Monoclonal Antibody, CC4, Suppresses Colorectal Tumor Growth and Enhances NK Cells-Mediated Tumor Immunity	PLOS ONE			English	Article							ANTIGEN CEA FAMILY; CARCINOEMBRYONIC ANTIGEN; TRANSGENIC MICE; CANCER IMMUNOSURVEILLANCE; INTERCELLULAR-ADHESION; EXPRESSION; CARCINOMA; MARKER; MEMBER; DIFFERENTIATION	Carcinoembryonic antigen (CEA, CEACAM5, and CD66e) has been found to be associated with various types of cancers, particularly colorectal carcinoma, and developed to be a molecular target for cancer diagnosis and therapy. In present study, we generated a novel anti-CEACAM5 monoclonal antibody, namely mAb CC4, by immunizing mice with living colorectal cancer LS174T cells. Immunohistochemical studies found that mAb CC4 specifically and strongly binds to tumor tissues, especially colorectal adenocarcinoma. In xenografted mice, mAb CC4 is specifically accumulated in tumor site and remarkably represses colorectal tumor growth. In vitro functional analysis showed that mAb CC4 significantly suppresses cell proliferation, migration and aggregation of colorectal cancer cells and also raises strong ADCC reaction. More interestingly, mAb CC4 is able to enhance NK cytotoxicity against MHC-I-deficient colorectal cancer cells by blocking intercellular interaction between epithelial CEACAM5 and NK inhibitory receptor CEACAM1. These data suggest that mAb CC4 has the potential to be developed as a novel tumor-targeting carrier and cancer therapeutic.	[Zheng, Chaogu; Feng, Jing; Lu, Di; Wang, Ping; Xing, Shu; Yang, Dongling; Yan, Xiyun] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Coll, Jean-Luc] Inst Albert Bonniot, Grp Rech Canc Poumon, Equipe INSERM 9924, Grenoble, France	Chinese Academy of Sciences; Institute of Biophysics, CAS; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Zheng, CG (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	fengjing@moon.ibp.ac.cn; yanxy@sun5.ibp.ac.cn	Zheng, Chaogu/P-2753-2019; Coll, Jean-Luc/G-2520-2013; Lu, Di/D-9836-2018	Zheng, Chaogu/0000-0002-5048-4520; Coll, Jean-Luc/0000-0002-2453-3552; Lu, Di/0000-0002-4083-1656	National High-Tech R&D Program of China (863 Program) [2006AA02A245]; National Basic Research Program of China (973 Program) [2009CB521704, 2011CB915502]; National S & T Major Project [2009ZX09102-247, 2008ZX10002-017, 2008ZX10004-005]; National Natural Science Foundation of China [30801378]; Chinese Academy of Sciences [KSCX2-YW-R-121, KSCX2-YW-R-173, KSCX2-YW-G-044]; Ministry of Education, Culture, Sports, Science and Technology	National High-Tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National S & T Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work is partially supported by the National High-Tech R&D Program of China (863 Program) (2006AA02A245), the National Basic Research Program of China (973 Program) (2009CB521704, 2011CB915502), National S & T Major Project (2009ZX09102-247, 2008ZX10002-017, 2008ZX10004-005), the National Natural Science Foundation of China (30801378) and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-YW-R-121, KSCX2-YW-R-173, KSCX2-YW-G-044). This work is also supported by a contract research fund from the Ministry of Education, Culture, Sports, Science and Technology for Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bading JR, 2008, CANCER BIOTHER RADIO, V23, P399, DOI 10.1089/cbr.2007.0457; BENCHIMOL S, 1989, CELL, V57, P327, DOI 10.1016/0092-8674(89)90970-7; Blumenthal RD, 2005, CANCER IMMUNOL IMMUN, V54, P315, DOI 10.1007/s00262-004-0597-6; Blumenthal RD, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-2; Chan CHF, 2006, CARCINOGENESIS, V27, P1909, DOI 10.1093/carcin/bgl040; Chan CHF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001353; Chester KA, 2000, CANCER CHEMOTH PHARM, V46, pS8, DOI 10.1007/PL00014055; Duffy MJ, 2001, CLIN CHEM, V47, P624; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; GASPARINI M, 1988, INT J CANCER, P81; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; GOLD P, 1965, J EXP MED, V122, P467, DOI 10.1084/jem.122.3.467; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; HASHINO J, 1994, CLIN EXP METASTAS, V12, P324, DOI 10.1007/BF01753839; HOSTETTER RB, 1990, ARCH SURG-CHICAGO, V125, P300; Ilantzis C, 2002, NEOPLASIA, V4, P151, DOI 10.1038/sj.neo.7900201; Imakiire T, 2004, INT J CANCER, V108, P564, DOI 10.1002/ijc.11608; Jin ZH, 2006, MOL IMAGING, V5, P188; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Markel G, 2002, J IMMUNOL, V168, P2803, DOI 10.4049/jimmunol.168.6.2803; Mayer A, 1999, J IMMUNOL METHODS, V231, P261, DOI 10.1016/S0022-1759(99)00162-3; Ordonez C, 2000, CANCER RES, V60, P3419; Seliger B, 2008, CANCER IMMUNOL IMMUN, V57, P1719, DOI 10.1007/s00262-008-0515-4; SHARMA SK, 1994, CELL BIOPHYS, V24-5, P219, DOI 10.1007/BF02789232; Stein R, 2004, MOL CANCER THER, V3, P1559; Stern N, 2005, J IMMUNOL, V174, P6692, DOI 10.4049/jimmunol.174.11.6692; Taheri M, 2000, J BIOL CHEM, V275, P26935; Taheri M, 2003, J BIOL CHEM, V278, P14632, DOI 10.1074/jbc.M212500200; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Xu XC, 2000, CANCER RES, V60, P4475	33	32	42	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21146	10.1371/journal.pone.0021146	http://dx.doi.org/10.1371/journal.pone.0021146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731662	gold, Green Published, Green Submitted			2022-12-25	WOS:000292033700041
J	Oak, SR; Murray, L; Herath, A; Sleeman, M; Anderson, I; Joshi, AD; Coelho, AL; Flaherty, KR; Toews, GB; Knight, D; Martinez, FJ; Hogaboam, CM				Oak, Sameer R.; Murray, Lynne; Herath, Athula; Sleeman, Matthew; Anderson, Ian; Joshi, Amrita D.; Coelho, Ana Lucia; Flaherty, Kevin R.; Toews, Galen B.; Knight, Darryl; Martinez, Fernando J.; Hogaboam, Cory M.			A Micro RNA Processing Defect in Rapidly Progressing Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; MESENCHYMAL TRANSITION; INTERSTITIAL PNEUMONIA; EARLY MORTALITY; DICER; ACTIVATION; PREDICTS; DIFFERENTIATION; MECHANISMS; EPITHELIUM	Background: Idiopathic pulmonary fibrosis exhibits differential progression from the time of diagnosis but the molecular basis for varying progression rates is poorly understood. The aim of the present study was to ascertain whether differential miRNA expression might provide one explanation for rapidly versus slowly progressing forms of IPF. Methodology and Principal Findings: miRNA and mRNA were isolated from surgical lung biopsies from IPF patients with a clinically documented rapid or slow course of disease over the first year after diagnosis. A quantitative PCR miRNA array containing 88 of the most abundant miRNA in the human genome was used to profile lung biopsies from 9 patients with rapidly progressing IPF, 6 patients with slowly progressing IPF, and 10 normal lung biopsies. Using this approach, 11 miRNA were significantly increased and 36 were significantly decreased in rapid biopsies compared with normal biopsies. Slowly progressive biopsies exhibited 4 significantly increased miRNA and 36 significantly decreased miRNA compared with normal lung. Among the miRNA present in IPF with validated mRNA targets were those with regulatory effects on epithelial-mesenchymal transition (EMT). Five miRNA (miR-302c, miR-423-5p, miR-210, miR-376c, and miR-185) were significantly increased in rapid compared with slow IPF lung biopsies. Additional analyses of rapid biopsies and fibroblasts grown from the same biopsies revealed that the expression of AGO1 and AGO2 (essential components of the miRNA processing RISC complex) were lower compared with either slow or normal lung biopsies and fibroblasts. Conclusion: These findings suggest that the development and/or clinical progression of IPF might be the consequence of aberrant miRNA processing.	[Oak, Sameer R.; Joshi, Amrita D.; Coelho, Ana Lucia; Hogaboam, Cory M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Murray, Lynne; Herath, Athula; Sleeman, Matthew; Anderson, Ian] MedImmune, Cambridge, England; [Flaherty, Kevin R.; Toews, Galen B.; Martinez, Fernando J.] Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, Dept Internal Med, Ann Arbor, MI USA; [Knight, Darryl] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, UBC James Hogg Res Ctr, Heart Lung Inst, Vancouver, BC V5Z 1M9, Canada	University of Michigan System; University of Michigan; AstraZeneca; Medimmune; University of Michigan System; University of Michigan; University of British Columbia	Oak, SR (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	hogaboam@med.umich.edu	Murray, Lynne/AAB-1793-2020; Hogaboam, Cory M./AAI-1433-2021; hogaboam, cory/M-3578-2014; Sleeman, Matthew A/E-6675-2016	Murray, Lynne/0000-0003-4879-966X; Hogaboam, Cory M./0000-0003-3366-4850; Herath, Athula/0000-0002-9465-7841	National Institutes of Health; University of Michigan Medical School	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Medical School	Funding was provided by the National Institutes of Health and the University of Michigan Medical School. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boon K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005134; Buckley ST, 2011, AM J PHYSIOL-LUNG C, V300, pL548, DOI 10.1152/ajplung.00230.2010; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Cowland JB, 2007, APMIS, V115, P1090, DOI 10.1111/j.1600-0463.2007.apm_775.xml.x; Cushing L, 2010, AM J RESP CELL MOL B; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Dutsch-Wicherek M, 2010, AM J REPROD IMMUNOL, V63, P181, DOI 10.1111/j.1600-0897.2009.00803.x; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Flaherty KR, 2004, AM J RESP CRIT CARE, V170, P904, DOI 10.1164/rccm.200402-147OC; Flaherty KR, 2003, THORAX, V58, P143, DOI 10.1136/thorax.58.2.143; Frankel SK, 2009, CURR OPIN PULM MED, V15, P463, DOI 10.1097/MCP.0b013e32832ea4b3; Garantziotis S, 2006, SEMIN RESP CRIT CARE, V27, P574, DOI 10.1055/s-2006-957329; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo CJ, 2009, FEBS J, V276, P5163, DOI 10.1111/j.1742-4658.2009.07213.x; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hardie WD, 2009, AM J PATHOL, V175, P3, DOI 10.2353/ajpath.2009.081170; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kasper M, 1996, HISTOL HISTOPATHOL, V11, P463; Kim Dong Soon, 2006, Proc Am Thorac Soc, V3, P285, DOI 10.1513/pats.200601-005TK; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kinder BW, 2008, CHEST, V133, P226, DOI 10.1378/chest.07-1948; Kinder BW, 2009, CHEST, V135, P1557, DOI 10.1378/chest.08-2209; Konishi K, 2009, AM J RESP CRIT CARE, V180, P167, DOI 10.1164/rccm.200810-1596OC; KRUPA A, 2010, J AM SOC NEPHROL; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Maatouk DM, 2008, BIOL REPROD, V79, P696, DOI 10.1095/biolreprod.108.067827; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Milosevic J, 2010, AM J RESP CRIT CARE, V181; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Oglesby IK, 2010, J IMMUNOL, V184, P1702, DOI 10.4049/jimmunol.0902669; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Prassel A, 2009, AM J RESP CRIT CARE, V179, P717, DOI 10.1164/rccm.200808-1201OC; Pratt AJ, 2009, J BIOL CHEM, V284, P17897, DOI 10.1074/jbc.R900012200; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Sumikawa H, 2008, AM J RESP CRIT CARE, V177, P433, DOI 10.1164/rccm.200611-1696OC; TSAI LM, 2009, CLIN EXP PHARM PHYSL; Tzilas V, 2009, AM J MED SCI, V338, P481, DOI 10.1097/MAJ.0b013e3181ad5984; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2009, CIRC RES, V104, P138, DOI 10.1161/CIRCRESAHA.108.192492; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yang IV, 2007, AM J RESP CRIT CARE, V175, P45, DOI 10.1164/rccm.200601-062OC; Yokoyama A, 1998, AM J RESP CRIT CARE, V158, P1680, DOI 10.1164/ajrccm.158.5.9803115	63	101	111	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21253	10.1371/journal.pone.0021253	http://dx.doi.org/10.1371/journal.pone.0021253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712985	gold, Green Published, Green Submitted			2022-12-25	WOS:000291985100020
J	Tapparel, C; Cordey, S; Junier, T; Farinelli, L; Van Belle, S; Soccal, PM; Aubert, JD; Zdobnov, E; Kaiser, L				Tapparel, Caroline; Cordey, Samuel; Junier, Thomas; Farinelli, Laurent; Van Belle, Sandra; Soccal, Paola M.; Aubert, John-David; Zdobnov, Evgeny; Kaiser, Laurent			Rhinovirus Genome Variation during Chronic Upper and Lower Respiratory Tract Infections	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG-TRANSPLANT RECIPIENTS; IMMUNODEFICIENT PATIENT; GENETIC DIVERSITY; VIRAL-INFECTIONS; HIGH-THROUGHPUT; SPECIES C; ASTHMA; CHILDREN; EXACERBATION	Routine screening of lung transplant recipients and hospital patients for respiratory virus infections allowed to identify human rhinovirus (HRV) in the upper and lower respiratory tracts, including immunocompromised hosts chronically infected with the same strain over weeks or months. Phylogenetic analysis of 144 HRV-positive samples showed no apparent correlation between a given viral genotype or species and their ability to invade the lower respiratory tract or lead to protracted infection. By contrast, protracted infections were found almost exclusively in immunocompromised patients, thus suggesting that host factors rather than the virus genotype modulate disease outcome, in particular the immune response. Complete genome sequencing of five chronic cases to study rhinovirus genome adaptation showed that the calculated mutation frequency was in the range observed during acute human infections. Analysis of mutation hot spot regions between specimens collected at different times or in different body sites revealed that non-synonymous changes were mostly concentrated in the viral capsid genes VP1, VP2 and VP3, independent of the HRV type. In an immunosuppressed lung transplant recipient infected with the same HRV strain for more than two years, both classical and ultra-deep sequencing of samples collected at different time points in the upper and lower respiratory tracts showed that these virus populations were phylogenetically indistinguishable over the course of infection, except for the last month. Specific signatures were found in the last two lower respiratory tract populations, including changes in the 5'UTR polypyrimidine tract and the VP2 immunogenic site 2. These results highlight for the first time the ability of a given rhinovirus to evolve in the course of a natural infection in immunocompromised patients and complement data obtained from previous experimental inoculation studies in immunocompetent volunteers.	[Tapparel, Caroline; Cordey, Samuel; Van Belle, Sandra; Kaiser, Laurent] Univ Hosp Geneva, Virol Lab, Div Infect Dis, Geneva, Switzerland; [Tapparel, Caroline; Cordey, Samuel; Van Belle, Sandra; Kaiser, Laurent] Univ Hosp Geneva, Div Lab Med, Geneva, Switzerland; [Junier, Thomas; Zdobnov, Evgeny] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Junier, Thomas; Zdobnov, Evgeny] Swiss Inst Bioinformat, Geneva, Switzerland; [Farinelli, Laurent] Fasteris SA, Plan Les Ouates, Switzerland; [Soccal, Paola M.] Univ Hosp Geneva, Div Pulm Med, Geneva, Switzerland; [Soccal, Paola M.] Univ Hosp Geneva, Clin Thorac Surg, Geneva, Switzerland; [Aubert, John-David] Univ Lausanne Hosp, Div Pulm Med, Lausanne, Switzerland	University of Geneva; University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Tapparel, C (corresponding author), Univ Hosp Geneva, Virol Lab, Div Infect Dis, Geneva, Switzerland.	caroline.tapparel@hcuge.ch	Zdobnov, Evgeny M/K-1133-2012; Aubert, John-David/H-5561-2019; Zdobnov, Evgeny/AAB-2745-2022; Cordey, Samuel/C-9240-2018	Aubert, John-David/0000-0001-8856-4000; Zdobnov, Evgeny/0000-0002-5178-1498; Cordey, Samuel/0000-0002-2684-5680; Kaiser, Laurent/0000-0002-0857-2252; Tapparel Vu, Caroline/0000-0002-0411-6567	Swiss National Science Foundation [310030-127159, 32003B_127160]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by the Swiss National Science Foundation (grant 310030-127159 to CT and grant 32003B_127160 to LK), with contributions from the Clinical Research Center, University Hospital and Faculty of Medicine, Geneva, the Louis-Jeantet Foundation and the Infectigen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 2007, J GEN VIROL, V88, P3043, DOI 10.1099/vir.0.82463-0; Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Bailly JL, 2000, J CLIN MICROBIOL, V38, P552, DOI 10.1128/JCM.38.2.552-557.2000; Cordey S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010588; Drake JW, 1999, ANN NY ACAD SCI, V870, P100, DOI 10.1111/j.1749-6632.1999.tb08870.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Garbino J, 2009, THORAX, V64, P399, DOI 10.1136/thx.2008.105155; Gern JE, 1999, CLIN MICROBIOL REV, V12, P9, DOI 10.1128/CMR.12.1.9; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harvala H, 2009, J CLIN VIROL, V45, P1, DOI 10.1016/j.jcv.2009.03.009; Hovi T, 2004, J GEN VIROL, V85, P369, DOI 10.1099/vir.0.19518-0; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006355; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654, DOI 10.1164/ajrccm.154.3.8810601; Junier T, 2010, BIOINFORMATICS, V26, P1669, DOI 10.1093/bioinformatics/btq243; Kaiser L, 2006, AM J RESP CRIT CARE, V174, P1392, DOI 10.1164/rccm.200604-489OC; Kew OM, 1998, J CLIN MICROBIOL, V36, P2893, DOI 10.1128/JCM.36.10.2893-2899.1998; Khetsuriani N, 2008, EMERG INFECT DIS, V14, P1793, DOI 10.3201/eid1411.080386; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Kistler AL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-40; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966; Lewis-Rogers N, 2009, MOL BIOL EVOL, V26, P969, DOI 10.1093/molbev/msp009; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; McErlean P, 2007, J CLIN VIROL, V39, P67, DOI 10.1016/j.jcv.2007.03.012; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Milano F, 2010, BLOOD, V115, P2088, DOI 10.1182/blood-2009-09-244152; Miller EK, 2009, J ALLERGY CLIN IMMUN, V123, P98, DOI 10.1016/j.jaci.2008.10.007; Odoom JK, 2008, J VIROL, V82, P9179, DOI 10.1128/JVI.00468-08; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Papadopoulos NG, 1999, J MED VIROL, V58, P100, DOI 10.1002/(SICI)1096-9071(199905)58:1&lt;100::AID-JMV16&gt;3.0.CO;2-D; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Renwick N, 2007, J INFECT DIS, V196, P1754, DOI 10.1086/524312; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Seemungal TAR, 2000, EUR RESPIR J, V16, P677, DOI 10.1034/j.1399-3003.2000.16d19.x; SHERRY B, 1986, J VIROL, V57, P246, DOI 10.1128/JVI.57.1.246-257.1986; Simmonds P, 2010, J GEN VIROL, V91, P2409, DOI 10.1099/vir.0.023994-0; Soccal PM, 2010, CLIN INFECT DIS, V51, P163, DOI 10.1086/653529; Tapparel C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-224; Tapparel C, 2009, EMERG INFECT DIS, V15, P719, DOI 10.3201/eid1505.081286; Tapparel C, 2009, J CLIN MICROBIOL, V47, P1742, DOI 10.1128/JCM.02339-08; Tapparel C, 2009, J CLIN VIROL, V45, P157, DOI 10.1016/j.jcv.2009.03.014; Wisdom A, 2009, J CLIN MICROBIOL, V47, P3958, DOI 10.1128/JCM.00993-09	45	48	51	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21163	10.1371/journal.pone.0021163	http://dx.doi.org/10.1371/journal.pone.0021163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713005	gold, Green Submitted, Green Published			2022-12-25	WOS:000291985100015
J	Zhang, DY; Wang, HJ; Tan, YZ				Zhang, Da-yong; Wang, Hai-jie; Tan, Yu-zhen			Wnt/beta-Catenin Signaling Induces the Aging of Mesenchymal Stem Cells through the DNA Damage Response and the p53/p21 Pathway	PLOS ONE			English	Article							CELLULAR SENESCENCE; STROMAL CELLS; BETA; NICHES; REJUVENATION; MAINTENANCE; PROGRESSION; P16(INK4A); ACTIVATION; EXPRESSION	Recent studies have demonstrated the importance of cellular extrinsic factors in the aging of adult stem cells. However, the effects of an aged cell-extrinsic environment on mesenchymal stem cell ( MSC) aging and the factors involved remain unclear. In the current study, we examine the effects of old rat serum (ORS) on the aging of MSCs, and explore the effects and mechanisms of Wnt/beta-catenin signaling on MSC aging induced by ORS treatment. Senescence-associated changes in the cells are examined with SA-beta-galactosidase staining and ROS staining. The proliferation ability is detected by MTT assay. The surviving and apoptotic cells are determined using AO/EB staining. The results suggest that ORS promotes MSC senescence and reduces the proliferation and survival of cells. The immunofluorescence staining shows that the expression of beta-catenin increases in MSCs of old rats. To identify the effects of Wnt/beta-catenin signaling on MSC aging induced with ORS, the expression of beta-catenin, GSK-3 beta, and c-myc are detected. The results show that the Wnt/beta-catenin signaling in the cells is activated after ORS treatment. Then we examine the aging, proliferation, and survival of MSCs after modulating Wnt/beta-catenin signaling. The results indicate that the senescence and dysfunction of MSCs in the medium containing ORS is reversed by the Wnt/beta-catenin signaling inhibitor DKK1 or by beta-catenin siRNA. Moreover, the expression of gamma-H2A.X, a molecular marker of DNA damage response, p16(INK4a), p53, and p21 is increased in senescent MSCs induced with ORS, and is also reversed by DKK1 or by beta-catenin siRNA. In summary, our study indicates the Wnt/beta-catenin signaling may play a critical role in MSC aging induced by the serum of aged animals and suggests that the DNA damage response and p53/p21 pathway may be the main mediators of MSC aging induced by excessive activation of Wnt/beta-catenin signaling.	[Zhang, Da-yong; Wang, Hai-jie; Tan, Yu-zhen] Fudan Univ, Shanghai Med Coll, Dept Anat & Histol & Embryol, Shanghai 200433, Peoples R China	Fudan University	Tan, YZ (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Anat & Histol & Embryol, Shanghai 200433, Peoples R China.	yztan@shmu.edu.cn	张, 大勇/AAH-4764-2020	张, 大勇/0000-0003-1537-1704	Natural Science Foundation of China [30470883, 30971674]; The Research Fund for the Doctoral Program of Higher Education of China [200802460044]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This work was supported by grants from Natural Science Foundation of China (30470883 and 30971674) and The Research Fund for the Doctoral Program of Higher Education of China (200802460044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkenist CJ, 2004, CANCER RES, V64, P3748, DOI 10.1158/0008-5472.CAN-04-0453; Binet R, 2009, CANCER RES, V69, P9183, DOI 10.1158/0008-5472.CAN-09-1016; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Carlson ME, 2007, AGING CELL, V6, P371, DOI 10.1111/j.1474-9726.2007.00286.x; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Collins CJ, 2003, AGING CELL, V2, P145, DOI 10.1046/j.1474-9728.2003.00048.x; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912; Guo HD, 2011, TISSUE ENG PT A, V17, P45, DOI [10.1089/ten.tea.2010.0124, 10.1089/ten.TEA.2010.0124]; Jaamaa S, 2010, CANCER RES, V70, P8630, DOI 10.1158/0008-5472.CAN-10-0937; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Ju ZY, 2007, ANN NY ACAD SCI, V1100, P333, DOI 10.1196/annals.1395.036; KIECHLE FL, 1993, AM J CLIN PATHOL, V100, P567, DOI 10.1093/ajcp/100.5.567; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707; Krampera Mauro, 2007, Blood Transfus, V5, P120, DOI 10.2450/2007.0029-07; Kretlow JD, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-60; Kyriakou C, 2008, HAEMATOL-HEMATOL J, V93, P1457, DOI 10.3324/haematol.12553; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Luo SJ, 2010, CELL, V143, P299, DOI 10.1016/j.cell.2010.09.013; Mao CD, 2001, J BIOL CHEM, V276, P26180, DOI 10.1074/jbc.M101188200; Marchand A, 2011, AGING CELL, V10, P220, DOI 10.1111/j.1474-9726.2010.00661.x; Martinez C, 2007, BLOOD, V109, P4245, DOI 10.1182/blood-2006-08-039347; Mayack SR, 2010, NATURE, V463, P495, DOI 10.1038/nature08749; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Purpura KA, 2004, STEM CELLS, V22, P39, DOI 10.1634/stemcells.22-1-39; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ryu BY, 2006, STEM CELLS, V24, P1505, DOI 10.1634/stemcells.2005-0580; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Seoane M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003632; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Snoeck HW, 2005, NAT BIOTECHNOL, V23, P434, DOI 10.1038/nbt0405-434; Wagner W, 2010, AGING-US, V2, P224, DOI 10.18632/aging.100136; Wallenfang MR, 2007, DEV CELL, V13, P603, DOI 10.1016/j.devcel.2007.10.011; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Xu M, 2008, MOL CELL BIOL, V28, P1713, DOI 10.1128/MCB.01360-07; Zhang H, 2005, AM J PHYSIOL-HEART C, V289, pH2089, DOI 10.1152/ajpheart.00019.2005	43	180	196	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21397	10.1371/journal.pone.0021397	http://dx.doi.org/10.1371/journal.pone.0021397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712954	Green Published, gold, Green Submitted			2022-12-25	WOS:000291985100038
J	Bonaventure, P; Aluisio, L; Shoblock, J; Boggs, JD; Fraser, IC; Lord, B; Lovenberg, TW; Galici, R				Bonaventure, Pascal; Aluisio, Leah; Shoblock, James; Boggs, Jamin D.; Fraser, Ian C.; Lord, Brian; Lovenberg, Timothy W.; Galici, Ruggero			Pharmacological Blockade of Serotonin 5-HT7 Receptor Reverses Working Memory Deficits in Rats by Normalizing Cortical Glutamate Neurotransmission	PLOS ONE			English	Article							METHYL-D-ASPARTATE; ANTIDEPRESSANT-LIKE BEHAVIOR; ANTAGONIST SB-269970; PREFRONTAL CORTEX; LEARNING-TASK; ANIMAL-MODELS; SCHIZOPHRENIA; MODULATION; INHIBITION; KETAMINE	The role of 5-HT7 receptor has been demonstrated in various animal models of mood disorders; however its function in cognition remains largely speculative. This study evaluates the effects of SB-269970, a selective 5-HT7 antagonist, in a translational model of working memory deficit and investigates whether it modulates cortical glutamate and/or dopamine neurotransmission in rats. The effect of SB-269970 was evaluated in the delayed non-matching to position task alone or in combination with MK-801, a non-competitive NMDA receptor antagonist, and, in separate experiments, with scopolamine, a non-selective muscarinic antagonist. SB-269970 (10 mg/kg) significantly reversed the deficits induced by MK-801 (0.1 mg/kg) but augmented the deficit induced by scopolamine (0.06 mg/kg). The ability of SB-269970 to modulate MK-801-induced glutamate and dopamine extracellular levels was separately evaluated using biosensor technology and microdialysis in the prefrontal cortex of freely moving rats. SB-269970 normalized MK-801 -induced glutamate but not dopamine extracellular levels in the prefrontal cortex. Rat plasma and brain concentrations of MK-801 were not affected by co-administration of SB-269970, arguing for a pharmacodynamic rather than a pharmacokinetic mechanism. These results indicate that 5-HT7 receptor antagonists might reverse cognitive deficits associated with NMDA receptor hypofunction by selectively normalizing glutamatergic neurotransmission.	[Bonaventure, Pascal; Aluisio, Leah; Shoblock, James; Boggs, Jamin D.; Fraser, Ian C.; Lord, Brian; Lovenberg, Timothy W.; Galici, Ruggero] Johnson & Johnson Pharmaceut Res & Dev LLC, San Diego, CA 92121 USA	Johnson & Johnson; Johnson & Johnson USA	Bonaventure, P (corresponding author), Johnson & Johnson Pharmaceut Res & Dev LLC, San Diego, CA 92121 USA.	Pbonave1@its.jnj.com	Shoblock, James/J-7926-2015; Bonaventure, Pascal/K-3052-2015	Shoblock, James/0000-0002-7956-9560; Bonaventure, Pascal/0000-0003-2971-6152	Johnson & Johnson Pharmaceutical Research and Development, L.L.C.	Johnson & Johnson Pharmaceutical Research and Development, L.L.C.(Johnson & JohnsonJohnson & Johnson USA)	This work was funded by Johnson & Johnson Pharmaceutical Research and Development, L.L.C.. The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLoS ONE policies.	Adams B, 1998, J NEUROSCI, V18, P5545, DOI 10.1523/JNEUROSCI.18-14-05545.1998; Ballaz SJ, 2007, NEUROSCIENCE, V149, P192, DOI 10.1016/j.neuroscience.2007.07.043; Barbier AJ, 2007, EUR J PHARMACOL, V576, P43, DOI 10.1016/j.ejphar.2007.08.009; Bonaventure P, 2007, J PHARMACOL EXP THER, V321, P690, DOI 10.1124/jpet.107.119404; Chudasama Y, 1997, PSYCHOPHARMACOLOGY, V134, P73, DOI 10.1007/s002130050427; Cifariello A, 2008, BEHAV BRAIN RES, V195, P171, DOI 10.1016/j.bbr.2007.12.012; Doyle KM, 1998, BEHAV PHARMACOL, V9, P671, DOI 10.1097/00008877-199812000-00003; DUNNETT SB, 1985, PSYCHOPHARMACOLOGY, V87, P357, DOI 10.1007/BF00432721; Galici R, 2008, BEHAV PHARMACOL, V19, P153, DOI 10.1097/FBP.0b013e3282f62d8c; Galici R, 2009, NEUROPHARMACOLOGY, V56, P1131, DOI 10.1016/j.neuropharm.2009.03.011; Gasbarri A, 2008, BEHAV BRAIN RES, V195, P164, DOI 10.1016/j.bbr.2007.12.020; Geyer MA, 2003, PROG NEURO-PSYCHOPH, V27, P1071, DOI 10.1016/j.pnpbp.2003.09.003; Hagan JJ, 2000, BRIT J PHARMACOL, V130, P539, DOI 10.1038/sj.bjp.0703357; Harsing LG, 2004, NEUROCHEM RES, V29, P1487; Hedlund PB, 2005, BIOL PSYCHIAT, V58, P831, DOI 10.1016/j.biopsych.2005.05.012; Hedlund PB, 2009, PSYCHOPHARMACOLOGY, V206, P345, DOI 10.1007/s00213-009-1626-0; HORIGUCHI M, 2010, NEUROPSYCHOPHARMACOL, V35; HORISAWA T, BEHAV BRAIN IN PRESS; Kristiansen LV, 2007, CURR OPIN PHARMACOL, V7, P48, DOI 10.1016/j.coph.2006.08.013; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Krystal JH, 2003, PSYCHOPHARMACOLOGY, V169, P215, DOI 10.1007/s00213-003-1582-z; Leopoldo M, 2011, PHARMACOL THERAPEUT, V129, P120, DOI 10.1016/j.pharmthera.2010.08.013; Lopez-Gil X, 2007, NEUROPSYCHOPHARMACOL, V32, P2087, DOI 10.1038/sj.npp.1301356; Lorrain DS, 2003, NEUROSCIENCE, V117, P697, DOI 10.1016/S0306-4522(02)00652-8; LOVENBERG TW, 1993, NEURON, V11, P449, DOI 10.1016/0896-6273(93)90149-L; Meneses A, 2004, BEHAV BRAIN RES, V155, P275, DOI 10.1016/j.bbr.2004.04.026; MNIEFILALI O, 2011, NEUROPSYCHOPHARMACOL; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Perez-Garcia G, 2006, BEHAV BRAIN RES, V169, P83, DOI 10.1016/j.bbr.2005.12.013; Perez-Garcia GS, 2005, BEHAV BRAIN RES, V163, P136, DOI 10.1016/j.bbr.2005.04.014; Pouzet B, 2002, PHARMACOL BIOCHEM BE, V71, P655, DOI 10.1016/S0091-3057(01)00744-4; Roberts C, 2004, NEUROPHARMACOLOGY, V46, P935, DOI 10.1016/j.neuropharm.2004.01.010; Robinson JK, 1997, BRAIN RES, V765, P51, DOI 10.1016/S0006-8993(97)00426-5; Sarkisyan G, 2010, BEHAV BRAIN RES, V209, P99, DOI 10.1016/j.bbr.2010.01.022; Semenova S, 2008, BIOL PSYCHIAT, V63, P98, DOI 10.1016/j.biopsych.2006.12.011; SMITH SM, 2010, 13 INT C IN VIV METH; Stahl SM, 2010, J CLIN PSYCHIAT, V71, P1414, DOI 10.4088/JCP.10bs06601gry; Stefani MR, 2005, BIOL PSYCHIAT, V57, P433, DOI 10.1016/j.biopsych.2004.11.031; Thomas DR, 2004, CNS NEUROL DISORD-DR, V3, P81, DOI 10.2174/1568007043482633; USLANER JM, NEUROPHARMA IN PRESS; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wesolowska A, 2006, NEUROPHARMACOLOGY, V51, P578, DOI 10.1016/j.neuropharm.2006.04.017; Wesolowska A, 2006, EUR J PHARMACOL, V553, P185, DOI 10.1016/j.ejphar.2006.09.064	44	44	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20210	10.1371/journal.pone.0020210	http://dx.doi.org/10.1371/journal.pone.0020210			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701689	Green Submitted, gold, Green Published			2022-12-25	WOS:000291983800005
J	Rayes, RF; Kalai, T; Kalman, H; Geeves, MA; Fajer, PG				Rayes, Roni F.; Kalai, Tamas; Kalman Hideg; Geeves, Michael A.; Fajer, Piotr G.			Dynamics of Tropomyosin in Muscle Fibers as Monitored by Saturation Transfer EPR of Bi-Functional Probe	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; RABBIT SKELETAL-MUSCLE; LABELED F-ACTIN; THIN-FILAMENTS; ROTATIONAL-DYNAMICS; ALPHA-TROPOMYOSIN; COILED-COIL; TIME RANGE; MYOSIN; TROPONIN	The dynamics of four regions of tropomyosin was assessed using saturation transfer electron paramagnetic resonance in the muscle fiber. In order to fully immobilize the spin probe on the surface of tropomyosin, a bi-functional spin label was attached to i,i+4 positions via cysteine mutagenesis. The dynamics of bi-functionally labeled tropomyosin mutants decreased by three orders of magnitude when reconstituted into "ghost muscle fibers". The rates of motion varied along the length of tropomyosin with the C-terminus position 268/272 being one order of magnitude slower then N-terminal domain or the center of the molecule. Introduction of troponin decreases the dynamics of all four sites in the muscle fiber, but there was no significant effect upon addition of calcium or myosin subfragment-1.	[Rayes, Roni F.; Fajer, Piotr G.] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Rayes, Roni F.; Fajer, Piotr G.] Natl High Magnet Field Lab, Tallahassee, FL USA; [Kalai, Tamas; Kalman Hideg] Univ Pecs, Dept Organ & Med Chem, Pecs, Hungary; [Geeves, Michael A.] Univ Kent, Sch Biosci, Canterbury, Kent, England	State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of Pecs; University of Kent	Rayes, RF (corresponding author), Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA.	fajer@magnet.fsu.edu	Geeves, Michael/F-7583-2011	Geeves, Michael/0000-0002-9364-8898	Hungarian Research Fund [OTKA K 81123]; NSF [MCP 0346650]	Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NSF(National Science Foundation (NSF))	This work was funded by the Hungarian Research Fund OTKA K 81123 to TK and KH, and the NSF MCP 0346650 grant to RR and PF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKHAYAT HA, 1995, J MOL BIOL, V252, P611, DOI 10.1006/jmbi.1995.0524; Allen DL, 1998, PROTEIN SCI, V7, P1262, DOI 10.1002/pro.5560070524; [Anonymous], 1976, SPIN LABELING THEORY, DOI DOI 10.1016/B978-0-12-092350-2.50008-4; BOYLAN D, 1986, BIOPHYS J, V49, P76, DOI 10.1016/S0006-3495(86)83599-8; Bridges MD, 2010, APPL MAGN RESON, V37, P363, DOI 10.1007/s00723-009-0079-2; CHACKO S, 1992, BIOPHYS J, V61, P1256, DOI 10.1016/S0006-3495(92)81934-3; Chandy IK, 1999, BIOCHEMISTRY-US, V38, P9286, DOI 10.1021/bi983073s; Chen YD, 2004, BIOCHEMISTRY-US, V43, P11491, DOI 10.1021/bi049186v; Craig R, 2001, J MOL BIOL, V311, P1027, DOI 10.1006/jmbi.2001.4897; EARLEY JJ, 1991, AM J PHYSIOL, V261, pC1184; FAJER P, 1982, J MAGN RESON, V49, P212, DOI 10.1016/0022-2364(82)90185-8; Greenfield NJ, 2002, BIOPHYS J, V83, P2754, DOI 10.1016/S0006-3495(02)75285-5; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Haselgrove J. C., 1972, COLD SPRING HARB SYM, V37, P341; Huxley H. E., 1972, COLD SPRING HARB SYM, V37, P361; HVIDT S, 1983, MACROMOLECULES, V16, P740, DOI 10.1021/ma00239a007; ISHII Y, 1990, BIOCHEMISTRY-US, V29, P1160, DOI 10.1021/bi00457a010; Kimura-Sakiyama C, 2008, J MOL BIOL, V376, P80, DOI 10.1016/j.jmb.2007.10.078; Lakkaraju SK, 2009, CELL MOL BIOENG, V2, P57, DOI 10.1007/s12195-009-0050-1; Li XE, J STRUCT BIOL, V170, P313; LI XE, BIOPHYS J, V100, P1005; Losel RM, 1999, BIOCONJUGATE CHEM, V10, P578, DOI 10.1021/bc980138v; LOWEY S, 1962, J MOL BIOL, V4, P293, DOI 10.1016/S0022-2836(62)80007-2; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MIHASHI K, 1983, J BIOCHEM-TOKYO, V93, P1705, DOI 10.1093/oxfordjournals.jbchem.a134312; Miki M, 1998, J BIOCHEM-TOKYO, V123, P1104; Miki M, 2004, J BIOCHEM, V136, P39, DOI 10.1093/jb/mvh090; MIKI M, 1990, EUR J BIOCHEM, V187, P155, DOI 10.1111/j.1432-1033.1990.tb15289.x; OSTAP EM, 1991, BIOPHYS J, V59, P1235, DOI 10.1016/S0006-3495(91)82338-4; PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5; Phillips GN, 1996, BIOPOLYMERS, V38, P89, DOI 10.1002/(SICI)1097-0282(199601)38:1<89::AID-BIP7>3.3.CO;2-X; PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7; PHILLIPS GN, 1980, BIOPHYS J, V32, P485, DOI 10.1016/S0006-3495(80)84985-X; POTTER JD, 1982, METHOD ENZYMOL, V85, P241; Prochniewicz E, 1996, J MOL BIOL, V255, P446, DOI 10.1006/jmbi.1996.0037; Schoffstall B, 2006, J PHYSIOL-LONDON, V577, P935, DOI 10.1113/jphysiol.2006.120105; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; SQUIER TC, 1986, BIOPHYS J, V49, P921, DOI 10.1016/S0006-3495(86)83720-1; STEWART M, 1983, J MOL BIOL, V166, P219, DOI 10.1016/S0022-2836(83)80008-4; SWENSON CA, 1989, BIOPOLYMERS, V28, P955, DOI 10.1002/bip.360280504; SZCZESNA D, 1995, BIOCHEMISTRY-US, V34, P3614, DOI 10.1021/bi00011a016; TAO T, 1983, BIOCHEMISTRY-US, V22, P3059, DOI 10.1021/bi00282a006; THOMAS DD, 1979, J MOL BIOL, V132, P257, DOI 10.1016/0022-2836(79)90259-6; THOMAS DD, 1976, J CHEM PHYS, V65, P18; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; WAHL P, 1978, EUR J BIOCHEM, V88, P421, DOI 10.1111/j.1432-1033.1978.tb12464.x; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; WHITE SP, 1987, NATURE, V325, P826, DOI 10.1038/325826a0; Xu C, 1999, BIOPHYS J, V77, P985, DOI 10.1016/S0006-3495(99)76949-3	51	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21277	10.1371/journal.pone.0021277	http://dx.doi.org/10.1371/journal.pone.0021277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701580	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000291983800038
J	Hong, Y; Chintapalli, SV; Ko, KD; Bhardwaj, G; Zhang, ZH; van Rossum, D; Patterson, RL				Hong, Yoojin; Chintapalli, Sree Vamsee; Ko, Kyung Dae; Bhardwaj, Gaurav; Zhang, Zhenhai; van Rossum, Damian; Patterson, Randen L.			Predicting Protein Folds with Fold-Specific PSSM Libraries	PLOS ONE			English	Article							PSI-BLAST; SEQUENCE; DATABASE; SEARCH; INFORMATION; ALIGNMENT	Accurately assigning folds for divergent protein sequences is a major obstacle to structural studies. Herein, we outline an effective method for fold recognition using sets of PSSMs, each of which is constructed for different protein folds. Our analyses demonstrate that FSL (Fold-specific Position Specific Scoring Matrix Libraries) can predict/relate structures given only their amino acid sequences of highly divergent proteins. This ability to detect distant relationships is dependent on low-identity sequence alignments obtained from FSL. Results from our experiments demonstrate that FSL perform well in recognizing folds from the "twilight-zone" SABmark dataset. Further, this method is capable of accurate fold prediction in newly determined structures. We suggest that by building complete PSSM libraries for all unique folds within the Protein Database (PDB), FSL can be used to rapidly and reliably annotate a large subset of protein folds at proteomic level. The related programs and fold-specific PSSMs for our FSL are publicly available at: http://ccp.psu.edu/download/FSLv1.0/.	[Hong, Yoojin] Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA; [Hong, Yoojin; Chintapalli, Sree Vamsee; Ko, Kyung Dae; Bhardwaj, Gaurav; Zhang, Zhenhai; van Rossum, Damian; Patterson, Randen L.] Penn State Univ, Ctr Computat Prote, University Pk, PA 16802 USA; [Chintapalli, Sree Vamsee; Ko, Kyung Dae; Bhardwaj, Gaurav; van Rossum, Damian] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Zhang, Zhenhai] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Patterson, Randen L.] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Sacramento, CA 95817 USA; [Patterson, Randen L.] Univ Calif Davis, Sch Med, Dept Biochem, Sacramento, CA 95817 USA; [Patterson, Randen L.] Univ Calif Davis, Sch Med, Genome Ctr, Sacramento, CA 95817 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Hong, Y (corresponding author), Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA.	dbv10@psu.edu; randen.patterson@ucdmc.ucdavis.edu	Zhang, Zhenhai/GRX-5887-2022	Zhang, Zhenhai/0000-0002-4310-0525; Bhardwaj, Gaurav/0000-0001-6554-2335; van Rossum, Damian/0000-0003-1011-2586	Searle Young Investigators Award; Pennsylvania State University; Huck Life Science Institute's Center for Computational Proteomics; Pennsylvania Department of Health; National Science Foundation [428-15 691M]; National Institutes of Health [R01 GM087410-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087410] Funding Source: NIH RePORTER	Searle Young Investigators Award; Pennsylvania State University; Huck Life Science Institute's Center for Computational Proteomics; Pennsylvania Department of Health; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Searle Young Investigators Award and start-up monies from Pennsylvania State University (R. L. P.), funds from the Huck Life Science Institute's Center for Computational Proteomics (R. L. P. and D. V. R.) and a grant from the Pennsylvania Department of Health using Tobacco Settlement Funds to D. V. R. The Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations, or conclusions. This work was also supported by The National Science Foundation 428-15 691M (RLP, DVR), and the National Institutes of Health R01 GM087410-01 (RLP, DVR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000; BHARDWAJ G, 2010, THEORIES PHYLOGENETI, P1; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Cheng JL, 2009, PROTEINS, V77, P181, DOI 10.1002/prot.22487; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ESWAR N, 2006, CURR PROTOC PROTEIN, V50; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Henikoff S, 1997, PROTEIN SCI, V6, P698; HONG Y, 2009, ARXIV09110650V1QBIOQ, P1; HONG Y, 2010, J INTEGRATE IN PRESS; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Karplus K, 2005, PROTEINS, V61, P135, DOI 10.1002/prot.20730; KO KD, 2008, ARXIV0806239QBIOQ PH; KO KD, 2009, ARXIV09110652V1QBIOQ, P1; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Schaffer AA, 1999, BIOINFORMATICS, V15, P1000; Van Walle I, 2005, BIOINFORMATICS, V21, P1267, DOI 10.1093/bioinformatics/bth493; Xu JB, 2003, PROTEINS, V53, P579, DOI 10.1002/prot.10531; Yona G, 2002, J MOL BIOL, V315, P1257, DOI 10.1006/jmbi.2001.5293	24	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20557	10.1371/journal.pone.0020557	http://dx.doi.org/10.1371/journal.pone.0020557			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698189	Green Submitted, gold, Green Published			2022-12-25	WOS:000291734100008
J	Mertins, V; Schote, AB; Hoffeld, W; Griessmair, M; Meyer, J				Mertins, Vanessa; Schote, Andrea B.; Hoffeld, Wolfgang; Griessmair, Michele; Meyer, Jobst			Genetic Susceptibility for Individual Cooperation Preferences: The Role of Monoamine Oxidase A Gene (MAOA) in the Voluntary Provision of Public Goods	PLOS ONE			English	Article							PROMOTER POLYMORPHISM; CONDITIONAL COOPERATION; MENTAL-HEALTH; DICTATOR GAME; A GENE; BEHAVIOR; EVOLUTION; GENOTYPE; RISK; HERITABILITY	In the context of social dilemmas, previous research has shown that human cooperation is mainly based on the social norm of conditional cooperation. While in most cases individuals behave according to such a norm, deviant behavior is no exception. Recent research further suggests that heterogeneity in social behavior might be associated with varying genetic predispositions. In this study, we investigated the relationship between individuals' behavior in a public goods experiment and the promoter-region functional repeat polymorphism in the monoamine oxidase A gene (MAOA). In a dynamic setting of increasing information about others' contributions, we analyzed differences in two main components of conditional cooperation, namely the players' own contribution and their beliefs regarding the contribution of other players. We showed that there is a significant association between individuals' behavior in a repeated public goods game and MAOA. Our results suggest that male carriers of the low activity alleles cooperate significantly less than those carrying the high activity alleles given a situation where subjects had to rely on their innate beliefs about others' contributions. With increasing information about the others' cooperativeness, the genetic effect diminishes. Furthermore, significant opposing effects for female subjects carrying two low activity alleles were observed.	[Mertins, Vanessa; Hoffeld, Wolfgang; Griessmair, Michele] Univ Trier, Inst Lab Law & Ind Relat European Community IAAEG, Trier, Germany; [Schote, Andrea B.; Meyer, Jobst] Univ Trier, Inst Psychobiol, Dept Neurobehav Genet, Trier, Germany	Universitat Trier; Universitat Trier	Mertins, V (corresponding author), Univ Trier, Inst Lab Law & Ind Relat European Community IAAEG, Trier, Germany.	mertins@iaaeg.de		Mertins, Vanessa/0000-0002-2843-7381	University of Trier	University of Trier	V.M. and J.M. gratefully acknowledge financial support by a University of Trier Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslund C, 2011, BEHAV GENET, V41, P262, DOI 10.1007/s10519-010-9356-y; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; Buckholtz JW, 2008, MOL PSYCHIATR, V13, P313, DOI 10.1038/sj.mp.4002020; Camerer C, 2005, J ECON LIT, V43, P9, DOI 10.1257/0022051053737843; Cesarini D, 2008, P NATL ACAD SCI USA, V105, P3721, DOI 10.1073/pnas.0710069105; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Cesarini D, 2009, ANN NY ACAD SCI, V1167, P66, DOI 10.1111/j.1749-6632.2009.04505.x; Chaudhuri A, 2011, EXP ECON, V14, P47, DOI 10.1007/s10683-010-9257-1; COKTURK C, 2008, ARCH WOMEN MENT HLTH, V11, P347; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Deckert J, 1999, HUM MOL GENET, V8, P621, DOI 10.1093/hmg/8.4.621; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fischbacher U, 2010, AM ECON REV, V100, P541, DOI 10.1257/aer.100.1.541; Foley DL, 2004, ARCH GEN PSYCHIAT, V61, P738, DOI 10.1001/archpsyc.61.7.738; Fowler JH, 2008, J POLIT, V70, P579, DOI 10.1017/S0022381608080638; Garpenstrand H, 2002, NEUROPSYCHOBIOLOGY, V46, P190, DOI 10.1159/000067804; Greiner B., 2004, U COLOGNE WORKING PA; Guala F., 2005, METHODOLOGY EXPT EC; HINES M, 2011, ANN REV NEU IN PRESS, V34; Israel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005535; Jaffee SR, 2005, DEV PSYCHOPATHOL, V17, P67, DOI 10.1017/S0954579405050042; Keser C, 2000, SCAND J ECON, V102, P23, DOI 10.1111/1467-9442.00182; Kim JJ, 1997, P NATL ACAD SCI USA, V94, P5929, DOI 10.1073/pnas.94.11.5929; Kim-Cohen J, 2006, MOL PSYCHIATR, V11, P903, DOI 10.1038/sj.mp.4001851; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; KUO J, 2010, BIOL SEX DIFFER, V1, P1; LEVY ER, 1989, GENOMICS, V5, P368, DOI 10.1016/0888-7543(89)90072-4; Mathews GA, 2009, HORM BEHAV, V55, P285, DOI 10.1016/j.yhbeh.2008.11.007; McDermott R, 2009, P NATL ACAD SCI USA, V106, P2118, DOI 10.1073/pnas.0808376106; Meyer-Lindenberg A, 2006, P NATL ACAD SCI USA, V103, P6269, DOI 10.1073/pnas.0511311103; Navarro A, 2009, ANN NY ACAD SCI, V1167, P57, DOI 10.1111/j.1749-6632.2009.04732.x; Neugebauer T, 2009, J ECON PSYCHOL, V30, P52, DOI 10.1016/j.joep.2008.04.005; Newman TK, 2005, BIOL PSYCHIAT, V57, P167, DOI 10.1016/j.biopsych.2004.10.012; Nilsson KW, 2011, ADDICT BIOL, V16, P347, DOI 10.1111/j.1369-1600.2010.00238.x; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; NOWELL C, 1994, J ECON BEHAV ORGAN, V25, P25, DOI 10.1016/0167-2681(94)90084-1; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; Philibert RA, 2008, AM J MED GENET B, V147B, P565, DOI 10.1002/ajmg.b.30778; PLOMIN R, 1992, PERS INDIV DIFFER, V13, P921, DOI 10.1016/0191-8869(92)90009-E; Raine A, 2008, CURR DIR PSYCHOL SCI, V17, P323, DOI 10.1111/j.1467-8721.2008.00599.x; Reif A, 2008, EUR J NEUROL, V15, P637, DOI 10.1111/j.1468-1331.2008.02142.x; Rieche-Rossler A, 2007, SWISS MED WKLY, V137, P565; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Samochowiec J, 1999, PSYCHIAT RES, V86, P67, DOI 10.1016/S0165-1781(99)00020-7; Schmidt LG, 2000, J NEURAL TRANSM, V107, P681, DOI 10.1007/s007020070069; SEIF I, 1995, SCIENCE, V270, P363; Shanahan MJ, 2005, J GERONTOL B-PSYCHOL, V60, P65, DOI 10.1093/geronb/60.Special_Issue_1.65; Shih JC, 1999, AM J HUM GENET, V65, P593, DOI 10.1086/302562; Sjoberg RL, 2007, AM J MED GENET B, V144B, P159, DOI 10.1002/ajmg.b.30360; Skuse DH, 2005, HUM MOL GENET, V14, pR27, DOI 10.1093/hmg/ddi112; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Suzuki S, 2011, SOC COGN AFFECT NEUR, V6, P338, DOI 10.1093/scan/nsq042; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Van Vugt M, 2007, PSYCHOL SCI, V18, P19, DOI 10.1111/j.1467-9280.2007.01842.x; Viding E, 2008, PHILOS T R SOC B, V363, P2519, DOI 10.1098/rstb.2008.0037; Wallace B, 2007, P NATL ACAD SCI USA, V104, P15631, DOI 10.1073/pnas.0706642104; Zak PJ, 2004, PHILOS T R SOC B, V359, P1737, DOI 10.1098/rstb.2004.1544; Zhong SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008516	65	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20959	10.1371/journal.pone.0020959	http://dx.doi.org/10.1371/journal.pone.0020959			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698196	gold, Green Published, Green Submitted			2022-12-25	WOS:000291734100035
J	Liu, JJ; Kohler, JE; Blass, AL; Moncaster, JA; Mocofanescu, A; Marcus, MA; Blakely, EA; Bjornstad, KA; Amarasiriwardena, C; Casey, N; Goldstein, LE; Soybel, DI				Liu, JingJing; Kohler, Jonathan E.; Blass, Amy L.; Moncaster, Juliet A.; Mocofanescu, Anca; Marcus, Matthew A.; Blakely, Eleanor A.; Bjornstad, Kathleen A.; Amarasiriwardena, Chitra; Casey, Noel; Goldstein, Lee E.; Soybel, David I.			Demand for Zn2+ in Acid-Secreting Gastric Mucosa and Its Requirement for Intracellular Ca2+	PLOS ONE			English	Article							ZINC TRANSPORTER EXPRESSION; HELICOBACTER-PYLORI; PARIETAL-CELLS; CALCIUM; DEFICIENCY; STIMULATION; PROGRESSION; INDICATORS; MEMBRANE; TOXICITY	Background and Aims: Recent work has suggested that Zn2+ plays a critical role in regulating acidity within the secretory compartments of isolated gastric glands. Here, we investigate the content, distribution and demand for Zn2+ in gastric mucosa under baseline conditions and its regulation during secretory stimulation. Methods and Findings: Content and distribution of zinc were evaluated in sections of whole gastric mucosa using X-ray fluorescence microscopy. Significant stores of Zn2+ were identified in neural elements of the muscularis, glandular areas enriched in parietal cells, and apical regions of the surface epithelium. In in vivo studies, extraction of the low abundance isotope, Zn-70(2+), from the circulation was demonstrated in samples of mucosal tissue 24 hours or 72 hours after infusion (250 mg/kg). In in vitro studies, uptake of Zn-70(2+) from media was demonstrated in isolated rabbit gastric glands following exposure to concentrations as low as 10 nM. In additional studies, demand of individual gastric parietal cells for Zn2+ was monitored using the fluorescent zinc reporter, fluozin-3, by measuring increases in free intracellular concentrations of Zn2+ {[Zn2+](i)} during exposure to standard extracellular concentrations of Zn2+ (10 mu M) for standard intervals of time. Under resting conditions, demand for extracellular Zn2+ increased with exposure to secretagogues (forskolin, carbachol/histamine) and under conditions associated with increased intracellular Ca2+ {[Ca2+](i)}. Uptake of Zn2+ was abolished following removal of extracellular Ca2+ or depletion of intracellular Ca2+ stores, suggesting that demand for extracellular Zn2+ increases and depends on influx of extracellular Ca2+. Conclusions: This study is the first to characterize the content and distribution of Zn2+ in an organ of the gastrointestinal tract. Our findings offer the novel interpretation, that Ca2+ integrates basolateral demand for Zn2+ with stimulation of secretion of HCl into the lumen of the gastric gland. Similar connections may be detectable in other secretory cells and tissues.	[Liu, JingJing; Kohler, Jonathan E.; Blass, Amy L.; Soybel, David I.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA; [Moncaster, Juliet A.; Mocofanescu, Anca; Casey, Noel; Goldstein, Lee E.] Boston Univ, Sch Med, Mol Aging & Dev Lab, Boston, MA 02118 USA; [Marcus, Matthew A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; [Marcus, Matthew A.; Blakely, Eleanor A.; Bjornstad, Kathleen A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Amarasiriwardena, Chitra] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Labs, Boston, MA 02115 USA; [Casey, Noel; Goldstein, Lee E.] Boston Univ, Ctr Biomet & Metall, Boston, MA 02215 USA; [Amarasiriwardena, Chitra] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University; Harvard University; Harvard T.H. Chan School of Public Health	Liu, JJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA.	dsoybel@partners.or	marcus, matthew/P-8023-2019	Moncaster, Juliet/0000-0002-7849-4325; Goldstein, Lee/0000-0001-8419-9800	American College of Surgeons [R01 T32 DK007754, R01 GM 75986, RO1 DK069929]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075986] Funding Source: NIH RePORTER	American College of Surgeons; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by the following grants: American College of Surgeons Resident Research Fellowship (JEK), R01 T32 DK007754 (JEK, DIS), R01 GM 75986 (LEG), and RO1 DK069929 (DIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARASIRIWARDENA CJ, 1992, J ANAL ATOM SPECTROM, V7, P915, DOI 10.1039/ja9920700915; ARSLAN P, 1985, J BIOL CHEM, V260, P2719; Azriel-Tamir H, 2004, J BIOL CHEM, V279, P51804, DOI 10.1074/jbc.M406581200; BERGLINDH T, 1976, ACTA PHYSIOL SCAND, V96, P150, DOI 10.1111/j.1748-1716.1976.tb10184.x; BERGLINDH T, 1976, ACTA PHYSIOL SCAND, V97, P401, DOI 10.1111/j.1748-1716.1976.tb10281.x; Bertsch PM, 2001, CHEM REV, V101, P1809, DOI 10.1021/cr990070s; Caroppo R, 2001, EMBO J, V20, P6316, DOI 10.1093/emboj/20.22.6316; Carter JW, 1997, NUTR CANCER, V27, P217, DOI 10.1080/01635589709514529; CHEW CS, 1983, AM J PHYSIOL, V245, pC371, DOI 10.1152/ajpcell.1983.245.5.C371; Cima RR, 2006, AM J PHYSIOL-GASTR L, V290, pG250, DOI 10.1152/ajpgi.00501.2004; deFoneska A, 2010, CURR OPIN GASTROEN, V26, P604, DOI 10.1097/MOG.0b013e32833f1222; Devinney MJ, 2005, CELL CALCIUM, V37, P225, DOI 10.1016/j.ceca.2004.10.003; Dovhanj J, 2010, CLIN LAB, V56, P137; Finney L, 2007, P NATL ACAD SCI USA, V104, P2247, DOI 10.1073/pnas.0607238104; Fong LYY, 2003, CANCER RES, V63, P4244; Fong LYY, 2003, CANCER RES, V63, P186; FROMMER DJ, 1975, MED J AUSTRALIA, V2, P793, DOI 10.5694/j.1326-5377.1975.tb106311.x; Gee KR, 2002, J AM CHEM SOC, V124, P776, DOI 10.1021/ja011774y; Geibel JP, 2001, J BIOL CHEM, V276, P39549, DOI 10.1074/jbc.M107315200; Gerbino A, 2004, GASTROENTEROLOGY, V126, P182, DOI 10.1053/j.gastro.2003.10.068; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; HAUGLAND RP, 2003, MOL PROBES PRODUCT I; HELANDER HF, 1974, GASTROENTEROLOGY, V67, P447; HERSEY SJ, 1985, AM J PHYSIOL, V248, pG561, DOI 10.1152/ajpgi.1985.248.5.G561; Hidalgo M, 2001, JNCI-J NATL CANCER I, V93, P178, DOI 10.1093/jnci/93.3.178; HOFER AM, 1993, P NATL ACAD SCI USA, V90, P2598, DOI 10.1073/pnas.90.7.2598; Hoque KM, 2006, GASTROENTEROLOGY, V130, P2201, DOI 10.1053/j.gastro.2006.02.062; ITO S, 1967, ALIMENTARY CANAL, P705; JANGHORBANI M, 1981, AM J CLIN NUTR, V34, P581, DOI 10.1093/ajcn/34.4.581; Jia YS, 2002, J PHYSIOL-LONDON, V543, P35, DOI 10.1113/jphysiol.2002.020172; JIMENEZ E, 1992, DIGESTION, V51, P18, DOI 10.1159/000200871; Joseph RM, 1999, ALIMENT PHARM THER, V13, P203; Jou MY, 2010, J PEDIATR GASTR NUTR, V50, P587, DOI 10.1097/MPG.0b013e3181d98e85; Jou MY, 2009, J NUTR, V139, P835, DOI 10.3945/jn.108.100974; KIRCHHOFF P, 2010, AM J GASTROENTE 0824; KOH JY, 1994, NEUROSCIENCE, V60, P1049, DOI 10.1016/0306-4522(94)90282-8; Kohler JE, 2010, AM J PHYSIOL-GASTR L, V299, pG170, DOI 10.1152/ajpgi.00355.2009; Kohler JE, 2009, J SURG RES, V153, P121, DOI 10.1016/j.jss.2008.05.021; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Lonnerdal B, 2009, ADV EXP MED BIOL, V639, P29, DOI 10.1007/978-1-4020-8749-3_3; MAGNESON GR, 1987, J BIOL CHEM, V262, P11140; Mahmood A, 2007, GUT, V56, P168, DOI 10.1136/gut.2006.099929; Marcus MA, 2004, J SYNCHROTRON RADIAT, V11, P239, DOI 10.1107/S0909049504005837; Maret W, 2001, P NATL ACAD SCI USA, V98, P12325, DOI 10.1073/pnas.231481398; Martin JL, 2006, CELL CALCIUM, V40, P393, DOI 10.1016/j.ceca.2006.04.008; MATHEW J, 2010, J SIGNAL RES, V144, P426; McCormick N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011078; MUALLEM S, 1985, AM J PHYSIOL, V248, pG216, DOI 10.1152/ajpgi.1985.248.2.G216; Naik HB, 2009, AM J PHYSIOL-CELL PH, V297, pC979, DOI 10.1152/ajpcell.00577.2008; NEGULESCU PA, 1993, AM J PHYSIOL, V264, pC843, DOI 10.1152/ajpcell.1993.264.4.C843; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Patel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010386; Perez-Zoghbi JF, 2008, AM J PHYSIOL-GASTR L, V295, pG671, DOI 10.1152/ajpgi.90224.2008; Scrimgeour AG, 2009, CURR OPIN CLIN NUTR, V12, P653, DOI 10.1097/MCO.0b013e3283308dd6; Sempertegui F, 2007, HELICOBACTER, V12, P43, DOI 10.1111/j.1523-5378.2007.00476.x; Sturniolo GC, 2002, J LAB CLIN MED, V139, P311, DOI 10.1067/mlc.2002.123624; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Walsh BM, 2007, AM J PHYSIOL-CELL PH, V293, pC1687, DOI 10.1152/ajpcell.00189.2006; Yang LC, 2005, P NATL ACAD SCI USA, V102, P11179, DOI 10.1073/pnas.0406547102; YOKOYAMA M, 1986, NEUROSCI LETT, V71, P351, DOI 10.1016/0304-3940(86)90646-4; Yu YY, 2007, J HISTOCHEM CYTOCHEM, V55, P223, DOI 10.1369/jhc.6A7032.2006	62	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e19638	10.1371/journal.pone.0019638	http://dx.doi.org/10.1371/journal.pone.0019638			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698273	gold, Green Published, Green Submitted			2022-12-25	WOS:000291730000001
J	Vinolo, MAR; Ferguson, GJ; Kulkarni, S; Damoulakis, G; Anderson, K; Bohlooly-Y, M; Stephens, L; Hawkins, PT; Curi, R				Vinolo, Marco A. R.; Ferguson, G. John; Kulkarni, Suhasini; Damoulakis, George; Anderson, Karen; Bohlooly-Y, Mohammad; Stephens, Len; Hawkins, Phillip T.; Curi, Rui			SCFAs Induce Mouse Neutrophil Chemotaxis through the GPR43 Receptor	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; FUNCTIONAL-CHARACTERIZATION; INFLAMMATORY RESPONSES; MIGRATION; IDENTIFICATION; PI(3)K-GAMMA; GAMMA; RAC2	Short chain fatty acids (SCFAs) have recently attracted attention as potential mediators of the effects of gut microbiota on intestinal inflammation. Some of these effects have been suggested to occur through the direct actions of SCFAs on the GPR43 receptor in neutrophils, though the precise role of this receptor in neutrophil activation is still unclear. We show that mouse bone marrow derived neutrophils (BMNs) can chemotax effectively through polycarbonate filters towards a source of acetate, propionate or butyrate. Moreover, we show that BMNs move with good speed and directionality towards a source of propionate in an EZ-Taxiscan chamber coated with fibrinogen. These effects of SCFAs were mimicked by low concentrations of the synthetic GPR43 agonist phenylacetamide-1 and were abolished in GPR43(-/-) BMNs. SCFAs and phenylacetamide-1 also elicited GPR43-dependent activation of PKB, p38 and ERK and these responses were sensitive to pertussis toxin, indicating a role for Gi proteins. Phenylacetamide-1 also elicited rapid and transient activation of Rac1/2 GTPases and phosphorylation of ribosomal protein S6. Genetic and pharmacological intervention identified important roles for PI3K gamma, Rac2, p38 and ERK, but not mTOR, in GPR43-dependent chemotaxis. These results identify GPR43 as a bona fide chemotactic receptor for neutrophils in vitro and start to define important elements in its signal transduction pathways.	[Vinolo, Marco A. R.; Curi, Rui] Univ Sao Paulo, Dept Physiol & Biophys, Inst Biomed Sci, Sao Paulo, Brazil; [Ferguson, G. John; Kulkarni, Suhasini; Damoulakis, George; Anderson, Karen; Stephens, Len; Hawkins, Phillip T.] Babraham Inst, Cambridge, England; [Bohlooly-Y, Mohammad] AstraZeneca Transgen & Comparat Genom R&D Molndal, Molndal, Sweden	Universidade de Sao Paulo; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; AstraZeneca	Vinolo, MAR (corresponding author), Univ Sao Paulo, Dept Physiol & Biophys, Inst Biomed Sci, Sao Paulo, Brazil.	len.stephens@bbsrc.ac.uk; philllip.hawkins@bbsrc.ac.uk; ruicuri@icb.usp.br	Curi, Rui/C-9351-2012; Vinolo, Marco Aurélio R/K-3753-2012	stephens, len/0000-0002-2771-3487; Hawkins, Phillip/0000-0002-6979-0464; Anderson, Karen/0000-0002-7394-6660; Vinolo, Marco Aurelio/0000-0003-1335-760X	Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP); Biotechnology and Biological Sciences Research Council (BBSRC) UK; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C218] Funding Source: researchfish; BBSRC [BBS/E/B/0000C218] Funding Source: UKRI	Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) and the Biotechnology and Biological Sciences Research Council (BBSRC) UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjursell M, 2011, AM J PHYSIOL-ENDOC M, V300, pE211, DOI 10.1152/ajpendo.00229.2010; Bocker U, 2003, CLIN EXP IMMUNOL, V131, P53, DOI 10.1046/j.1365-2249.2003.02056.x; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cavaglieri CR, 2003, LIFE SCI, V73, P1683, DOI 10.1016/S0024-3205(03)00490-9; CHRISTIANSEN NO, 1990, J LEUKOCYTE BIOL, V47, P60, DOI 10.1002/jlb.47.1.60; Condliffe AM, 1998, CLIN SCI, V94, P461, DOI 10.1042/cs0940461; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Filippi MD, 2004, NAT IMMUNOL, V5, P744, DOI 10.1038/ni1081; Halili MA, 2010, J LEUKOCYTE BIOL, V87, P1103, DOI 10.1189/jlb.0509363; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Hii CS, 2004, J BIOL CHEM, V279, P49825, DOI 10.1074/jbc.M406892200; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Kanegasaki S, 2003, J IMMUNOL METHODS, V282, P1, DOI 10.1016/j.jim.2003.07.008; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee T, 2008, MOL PHARMACOL, V74, P1599, DOI 10.1124/mol.108.049536; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mumy KL, 2009, CURR OPIN PHARMACOL, V9, P697, DOI 10.1016/j.coph.2009.10.004; Niederman R, 1997, J DENT RES, V76, P575, DOI 10.1177/00220345970760010801; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Ogawa H, 2004, AM J PHYSIOL-GASTR L, V287, pG1062, DOI 10.1152/ajpgi.00162.2004; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; STEPHENS L, 1993, EMBO J, V12, P2265, DOI 10.1002/j.1460-2075.1993.tb05880.x; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Vinolo MAR, 2009, CLIN SCI, V117, P331, DOI 10.1042/CS20080642; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Zicha D, 1997, Methods Mol Biol, V75, P449; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	30	182	193	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21205	10.1371/journal.pone.0021205	http://dx.doi.org/10.1371/journal.pone.0021205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698257	gold, Green Published, Green Submitted			2022-12-25	WOS:000291730000061
J	Wu, ZY; Zhao, JM; Gao, RF; Hu, GJ; Gai, JY; Xu, GH; Xing, H				Wu, Zhaoyun; Zhao, Jinming; Gao, Ruifang; Hu, Guanjun; Gai, Junyi; Xu, Guohua; Xing, Han			Molecular Cloning, Characterization and Expression Analysis of Two Members of the Pht1 Family of Phosphate Transporters in Glycine max	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; INORGANIC-PHOSPHATE; TRANSCRIPTIONAL REGULATION; SPATIAL EXPRESSION; KINETIC-PROPERTIES; PHOSPHORUS UPTAKE; PLANT; GENE; MUTANT; IDENTIFICATION	Background: Phosphorus is one of the macronutrients essential for plant growth and development. The acquisition and translocation of phosphate are pivotal processes of plant growth. In a large number of plants, phosphate uptake by roots and translocation within the plant are presumed to occur via a phosphate/proton cotransport mechanism. Principal Findings: We cloned two cDNAs from soybean (Glycine max), GmPT1 and GmPT2, which show homology to the phosphate/proton cotransporter PHO84 from the budding yeast Saccharomyces cerevisiae. The amino acid sequence of the products predicted from GmPT1 and GmPT2 share 61% and 63% identity, respectively, with the PHO84 in amino acid sequence. The deduced structure of the encoded proteins revealed 12 membrane-spanning domains with a central hydrophilic region. The molecular mass values are similar to 58.7 kDa for GmPT1 and similar to 58.6 kDa for GmPT2. Transiently expressed GFP-protein fusions provide direct evidence that the two Pi transporters are located in the plasma membrane. Uptake of radioactive orthophosphate by the yeast mutant MB192 showed that GmPT1 and GmPT2 are dependent on pH and uptake is reduced by the addition of uncouplers of oxidative phosphorylation. The K-m for phosphate uptake by GmPT1 and GmPT2 is 6.65 mM and 6.63 mM, respectively. A quantitative real time RT-PCR assay indicated that these two genes are expressed in the roots and shoots of seedlings whether they are phosphate-deficient or not. Deficiency of phosphorus caused a slight change of the expression levels of GmPT1 and GmPT2. Conclusions: The results of our experiments show that the two phosphate transporters have low affinity and the corresponding genes are constitutively expressed. Thereby, the two phosphate transporters can perform translocation of phosphate within the plant.	[Wu, Zhaoyun; Zhao, Jinming; Gao, Ruifang; Hu, Guanjun; Gai, Junyi; Xing, Han] Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Natl Ctr Soybean Improvement, Nanjing, Jiangsu, Peoples R China; [Xu, Guohua] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Wu, ZY (corresponding author), Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Natl Ctr Soybean Improvement, Nanjing, Jiangsu, Peoples R China.	hanx@njau.edu.cn	Xu, Guohua/J-1840-2012	Xu, Guohua/0000-0002-3283-2392	China transgenic Programme [2008ZX08004-002]; China 973 Programme [2009CB118400]; National public service sectors (agriculture) [nycytx-004]	China transgenic Programme; China 973 Programme(National Basic Research Program of China); National public service sectors (agriculture)	This work was supported by the China transgenic Programme (2008ZX08004-002), the China 973 Programme (2009CB118400), and National public service sectors (agriculture) special research (nycytx-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai PH, 2009, PLANT J, V57, P798, DOI 10.1111/j.1365-313X.2008.03726.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Auesukaree C, 2003, BIOCHEM BIOPH RES CO, V306, P843, DOI 10.1016/S0006-291X(03)01068-4; Bucher M, 2001, J PLANT NUTR SOIL SC, V164, P209, DOI 10.1002/1522-2624(200104)164:2<209::AID-JPLN209>3.0.CO;2-F; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; BunYa M, 1996, CURR GENET, V29, P344, DOI 10.1007/s002940050055; Chiou TJ, 2001, PLANT J, V25, P281, DOI 10.1046/j.1365-313x.2001.00963.x; Daram P, 1999, PLANT CELL, V11, P2153, DOI 10.1105/tpc.11.11.2153; Daram P, 1998, PLANTA, V206, P225, DOI 10.1007/s004250050394; Deleage G, 2001, COMPUT BIOL MED, V31, P259, DOI 10.1016/S0010-4825(01)00008-7; DELHAIZE E, 1995, PLANT PHYSIOL, V107, P207, DOI 10.1104/pp.107.1.207; Dong B, 1998, PLANTA, V205, P251, DOI 10.1007/s004250050318; EPSTEIN E, 1952, PLANT PHYSIOL, V27, P457, DOI 10.1104/pp.27.3.457; EPSTEIN E, 1963, P NATL ACAD SCI USA, V49, P684, DOI 10.1073/pnas.49.5.684; FURIHATA T, 1992, PLANT CELL PHYSIOL, V33, P1151; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gordon-Weeks R, 2003, J CELL SCI, V116, P3135, DOI 10.1242/jcs.00615; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; Hamburger D, 2002, PLANT CELL, V14, P889, DOI 10.1105/tpc.000745; Harrison MJ, 2002, PLANT CELL, V14, P2413, DOI 10.1105/tpc.004861; Jeschke WD, 1997, J EXP BOT, V48, P75, DOI 10.1093/jxb/48.1.75; Karandashov V, 2005, TRENDS PLANT SCI, V10, P22, DOI 10.1016/j.tplants.2004.12.003; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leggewie G, 1997, PLANT CELL, V9, P381, DOI 10.1105/tpc.9.3.381; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Liu CM, 1998, PLANT PHYSIOL, V116, P91, DOI 10.1104/pp.116.1.91; Liu F, 2010, PLANT J, V62, P508, DOI 10.1111/j.1365-313X.2010.04170.x; Liu H, 1998, MOL PLANT MICROBE IN, V11, P14, DOI 10.1094/MPMI.1998.11.1.14; Liu JQ, 2001, PLANT SOIL, V237, P257, DOI 10.1023/A:1013396825577; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marschner H., 1995, MINERAL NUTR HIGHER, Vsecond, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Muchhal US, 1999, P NATL ACAD SCI USA, V96, P5868, DOI 10.1073/pnas.96.10.5868; Muchhal US, 1996, P NATL ACAD SCI USA, V93, P10519, DOI 10.1073/pnas.93.19.10519; Mudge SR, 2002, PLANT J, V31, P341, DOI 10.1046/j.1365-313X.2002.01356.x; Nagy R, 2006, PLANT BIOLOGY, V8, P186, DOI 10.1055/s-2005-873052; Okumura S, 1998, DNA Res, V5, P261, DOI 10.1093/dnares/5.5.261; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Paszkowski U, 2002, P NATL ACAD SCI USA, V99, P13324, DOI 10.1073/pnas.202474599; POIRIER Y, 1991, PLANT PHYSIOL, V97, P1087, DOI 10.1104/pp.97.3.1087; Rae AL, 2003, PLANT MOL BIOL, V53, P27, DOI 10.1023/B:PLAN.0000009259.75314.15; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Rashid M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-337; Rausch C, 2002, PLANTA, V216, P23, DOI 10.1007/s00425-002-0921-3; Rausch C, 2001, NATURE, V414, P462, DOI 10.1038/35106601; RIESMEIER JW, 1992, EMBO J, V11, P4705, DOI 10.1002/j.1460-2075.1992.tb05575.x; SAKANO K, 1990, PLANT PHYSIOL, V93, P479, DOI 10.1104/pp.93.2.479; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shoemaker RC, 2006, CURR OPIN PLANT BIOL, V9, P104, DOI 10.1016/j.pbi.2006.01.007; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Smith FW, 2003, PLANT SOIL, V248, P71, DOI 10.1023/A:1022376332180; Smith FW, 1997, PLANT J, V11, P83, DOI 10.1046/j.1365-313X.1997.11010083.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; ULLRICHEBERIUS CI, 1984, PLANTA, V161, P46, DOI 10.1007/BF00951459; ULLRICHEBERIUS CI, 1981, PLANT PHYSIOL, V67, P797, DOI 10.1104/pp.67.4.797; Versaw WK, 2002, PLANT CELL, V14, P1751, DOI 10.1105/tpc.002220; Wykoff DD, 2001, GENETICS, V159, P1491; Yuan H, 2008, J INTEGR PLANT BIOL, V50, P849, DOI 10.1111/j.1744-7909.2008.00709.x; Zhao LM, 2003, NEW PHYTOL, V157, P291, DOI 10.1046/j.1469-8137.2003.00677.x	61	28	35	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e19752	10.1371/journal.pone.0019752	http://dx.doi.org/10.1371/journal.pone.0019752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698287	Green Submitted, Green Published, gold			2022-12-25	WOS:000291730000002
J	Arzumanyan, A; Friedman, T; Kotei, E; Ng, IOL; Lian, Z; Feitelson, MA				Arzumanyan, A.; Friedman, T.; Kotei, E.; Ng, I. O. L.; Lian, Z.; Feitelson, M. A.			Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer	ONCOGENE			English	Article						hepatocellular carcinoma; mSin3A; Snail-1; HDAC; miR-373	NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; CARRIER PATIENTS; GENE-EXPRESSION; DOWN-REGULATION; UP-REGULATION; IN-VIVO; PROTEIN; CELLS; SNAIL	Loss of E-cadherin is associated with acquisition of metastatic capacity. Numerous studies suggest that histone deacetylation and/or hypermethylation of CpG islands in E-cadherin gene (CDH1) are major mechanisms responsible for E-cadherin silencing in different tumors and cancer cell lines. The hepatitis B virus (HBV)-encoded X antigen, HBx, contributes importantly to the development of hepatocellular carcinoma using multiple mechanisms. Experiments were designed to test if in addition to CDH1 hypermethylation HBx promotes epigenetic modulation of E-cadherin transcriptional activity through histone deacetylation and miR-373. The relationships between HBx, E-cadherin, mSin3A, Snail-1 and miR-373 were evaluated in HBx expressing (HepG2X) and control (HepG2CAT) cells by western blotting, immunoprecipitation (IP), chromatin IP as well as by immunohistochemical staining of liver and tumor tissue sections from HBV-infected patients. In HepG2X cells, decreased levels of E-cadherin and elevated levels of mSin3A and Snail-1 were detected. Reciprocal IP with anti-HBx and anti-mSin3A demonstrated mutual binding. Furthermore, HBx-mSin3A colocalization was detected by immunofluorescent staining. HBx downregulated E-cadherin expression by the recruitment of the mSin3A/histone deacetylase complex to the Snail-binding sites in human CDH1. Histone deacetylation inhibition by Trichostatin-A treatment restored E-cadherin expression. Mir-373, a positive regulator of E-cadherin expression, was downregulated by HBx in HepG2X cells and tissue sections from HBV-infected patients. Thus, histone deacetylation of CDH1 and downregulation of miR-373, together with the previously demonstrated hypermethylation of CDH1 by HBx, may be important for the understanding of HBV-related carcinogenesis. Oncogene (2012) 31, 563-572; doi:10.1038/onc.2011.255; published online 27 June 2011	[Arzumanyan, A.; Friedman, T.; Kotei, E.; Lian, Z.; Feitelson, M. A.] Temple Univ, Coll Sci & Technol, Dept Biol, Philadelphia, PA 19122 USA; [Arzumanyan, A.; Feitelson, M. A.] Temple Univ, Coll Sci & Technol, Sbarro Hlth Res Org, Ctr Biotechnol, Philadelphia, PA 19122 USA; [Ng, I. O. L.] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Pokfulam, Hong Kong, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Hong Kong	Arzumanyan, A (corresponding author), Temple Univ, Coll Sci & Technol, Dept Biol, 1900 N 12th St,Suite 419,BioLife Sci Bldg, Philadelphia, PA 19122 USA.	alla.arzumanyan@temple.edu	Ibrahim, Essam Hassan/G-1960-2018; Lian, Zhaorui/AAW-2379-2020	Ibrahim, Essam Hassan/0000-0003-0130-2257; Ng, Irene Oi-lin/0000-0001-7532-2029	NIH [5R01CA104025, 5R01CA111427]; NATIONAL CANCER INSTITUTE [R01CA104025, R01CA111427] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH Grants 5R01CA104025 and 5R01CA111427 (to M Feitelson). We thank Drs Yongwen Chen and Cheng-ying Yang from the Third Military Medical University for the paraffin blocks of human liver tissue, and Dr Eugeney Bichenkov for assistance with the figures.	Agami R, 2010, EUR J CLIN INVEST, V40, P370, DOI 10.1111/j.1365-2362.2010.02279.x; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; Endo K, 2000, HUM PATHOL, V31, P558, DOI 10.1053/hp.2000.6683; FEITELSON MA, 1988, J MED VIROL, V24, P121, DOI 10.1002/jmv.1890240202; Giroldi LA, 1997, BIOCHEM BIOPH RES CO, V241, P453, DOI 10.1006/bbrc.1997.7831; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Haviv I, 1996, EMBO J, V15, P3413, DOI 10.1002/j.1460-2075.1996.tb00707.x; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Jiao W, 2002, BRIT J CANCER, V86, P98, DOI 10.1038/sj.bjc.6600017; Kanai Y, 1997, INT J CANCER, V71, P355; Keasler VV, 2009, VIROLOGY, V390, P122, DOI 10.1016/j.virol.2009.05.001; KEKULE AS, 1993, NATURE, V361, P742, DOI 10.1038/361742a0; Lee DK, 2001, GENE DEV, V15, P455, DOI 10.1101/gad.856201; Lee JO, 2005, ONCOGENE, V24, P6617, DOI 10.1038/sj.onc.1208827; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Lian ZR, 2006, HEPATOLOGY, V43, P415, DOI 10.1002/hep.21053; Lian ZR, 1999, ONCOGENE, V18, P1677, DOI 10.1038/sj.onc.1202470; Liu J, 2006, ONCOGENE, V25, P1008, DOI 10.1038/sj.onc.1209138; Lupberger J, 2007, WORLD J GASTROENTERO, V13, P74, DOI 10.3748/wjg.v13.i1.74; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nomura T, 1999, BBA-MOL BASIS DIS, V1453, P330, DOI 10.1016/S0925-4439(99)00004-6; Osada T, 1996, HEPATOLOGY, V24, P1460, DOI 10.1002/hep.510240627; Ou JN, 2007, BIOCHEM PHARMACOL, V73, P1297, DOI 10.1016/j.bcp.2006.12.032; Pan JB, 2004, J GEN VIROL, V85, P275, DOI 10.1099/vir.0.19650-0; Park IY, 2007, GASTROENTEROLOGY, V132, P1476, DOI 10.1053/j.gastro.2007.01.034; Park NH, 2006, POSTGRAD MED J, V82, P507, DOI 10.1136/pgmj.2006.047431; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; MacPherson MR, 2010, MOL BIOL CELL, V21, P244, DOI 10.1091/mbc.E09-06-0504; Rikimaru T, 2007, ONCOLOGY-BASEL, V72, P69, DOI 10.1159/000111106; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Shona JK, 2009, VIRUS RES, V139, P14, DOI 10.1016/j.virusres.2008.09.006; Sirma H, 1998, ONCOGENE, V16, P2051, DOI 10.1038/sj.onc.1201737; Sugimachi K, 2003, CLIN CANCER RES, V9, P2657; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Takeno S, 2004, AM J CLIN PATHOL, V122, P78, DOI 10.1309/WJL90JPEM17RBUHT; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; WANG WL, 1991, CANCER RES, V51, P4971; WANG WL, 1991, HEPATOLOGY, V14, P29, DOI 10.1002/hep.1840140106; Waris G, 2001, MOL CELL BIOL, V21, P7721, DOI 10.1128/MCB.21.22.7721-7730.2001; Weil R, 1999, MOL CELL BIOL, V19, P6345; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yoo YG, 2008, ONCOGENE, V27, P3405, DOI 10.1038/sj.onc.1211000; Yoo YD, 1996, J CLIN INVEST, V97, P388, DOI 10.1172/JCI118427; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zheng DL, 2009, J HEPATOL, V50, P377, DOI 10.1016/j.jhep.2008.10.019; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	55	87	95	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	5					563	572		10.1038/onc.2011.255	http://dx.doi.org/10.1038/onc.2011.255			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MS	21706058	Green Accepted			2022-12-25	WOS:000300221800003
J	Mor, I; Carlessi, R; Ast, T; Feinstein, E; Kimchi, A				Mor, I.; Carlessi, R.; Ast, T.; Feinstein, E.; Kimchi, A.			Death-associated protein kinase increases glycolytic rate through binding and activation of pyruvate kinase	ONCOGENE			English	Article						DAPk; PKM2; cancer metabolism; glycolysis	DAP-KINASE; CELL-METABOLISM; CANCER-THERAPY; TUMOR-GROWTH; M2; DOMAIN; PHOSPHORYLATION; APOPTOSIS; ISOFORM; PROMOTE	Death-associated protein kinase (DAPk), a multi-domain serine/threonine kinase, regulates numerous cell death mechanisms and harbors tumor suppressor functions. In this study, we report that DAPk directly binds and functionally activates pyruvate kinase M2 (PKM2), a key glycolytic enzyme, which contributes to the regulation of cancer cell metabolism. PKM2 was identified as a novel binding partner of DAPk by a yeast two-hybrid screen. This interaction was validated in vitro by enzyme-linked immunosorbent assay using purified proteins and in vivo by co-immunoprecipitation of the two endogenous proteins from cells. In vitro interaction with full-length DAPk resulted in a significant increase in the activity of PKM2. Conversely, a fragment of DAPk harboring only the functional kinase domain (KD) could neither bind PKM2 in cells nor activate it in vitro. Indeed, DAPk failed to phosphorylate PKM2. Notably, transfection of cells, with a truncated DAPk lacking the KD, elevated endogenous PKM2 activity, suggesting that PKM2 activation by DAPk occurs independently of its kinase activity. DAPk-transfected cells displayed changes in glycolytic activity, as reflected by elevated lactate production, whereas glucose uptake remained unaltered. A mild reduction in cell proliferation was detected as well in these transfected cells. Altogether, this work identifies a new role for DAPk as a metabolic regulator, suggesting the concept of direct interactions between a tumor suppressor and a key glycolytic enzyme to limit cell growth. Moreover, the work documents a unique function of DAPk that is independent of its catalytic activity and a novel mechanism to activate PKM2 by protein-protein interaction. Oncogene (2012) 31, 683-693; doi:10.1038/onc.2011.264; published online 4 July 2011	[Mor, I.; Carlessi, R.; Ast, T.; Feinstein, E.; Kimchi, A.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Kimchi, A (corresponding author), Weizmann Inst Sci, Dept Mol Genet, Belfer 209, IL-76100 Rehovot, Israel.	adi.kimchi@weizmann.ac.il	Carlessi, Rodrigo/J-1757-2012; Mor, Inbal/GON-5297-2022	Mor, Inbal/0000-0003-4564-9690; Carlessi, Rodrigo/0000-0003-0038-7391	Flight Attendant Medical Research Institute; European Union; Israel Science Foundation	Flight Attendant Medical Research Institute; European Union(European Commission); Israel Science Foundation(Israel Science Foundation)	We thank Dr Shani Bialik for critical reading of the manuscript. GFP-PKM2-containing plasmid was the kind gift of A Ullrich (Max Planck Institute, Martinsried, Germany). A549 cells were the kind gift of M Oren (Weizmann Institute of Science, Rehovot, Israel). This work was supported by the Center of Excellence grant from the Flight Attendant Medical Research Institute, by a grant from the European Union FP7 to APO-SYS and by a grant from the Israel Science Foundation. AK is the incumbent of Helena Rubinstein Chair of Cancer Research.	Bialik S, 2004, CELL DEATH DIFFER, V11, P631, DOI 10.1038/sj.cdd.4401386; Bialik S, 2008, MOL CELL PROTEOMICS, V7, P1089, DOI 10.1074/mcp.M700579-MCP200; Bialik S, 2010, CURR OPIN CELL BIOL, V22, P199, DOI 10.1016/j.ceb.2009.11.004; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Chen CH, 2005, EMBO J, V24, P294, DOI 10.1038/sj.emboj.7600510; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; Cohen O, 1997, EMBO J, V16, P998, DOI 10.1093/emboj/16.5.998; Cohen O, 1999, J CELL BIOL, V146, P141; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Eisenberg-Lerner A, 2007, CELL DEATH DIFFER, V14, P1908, DOI 10.1038/sj.cdd.4402212; FEINSTEIN E, 1995, TRENDS BIOCHEM SCI, V20, P342, DOI 10.1016/S0968-0004(00)89070-2; Goldschneider D, 2010, ONCOGENE, V29, P1865, DOI 10.1038/onc.2010.13; Gozuacik D, 2006, AUTOPHAGY, V2, P74, DOI 10.4161/auto.2.2.2459; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Llambi F, 2005, EMBO J, V24, P1192, DOI 10.1038/sj.emboj.7600584; Mason EF, 2011, BBA-MOL CELL RES, V1813, P645, DOI 10.1016/j.bbamcr.2010.08.011; Mazurek S, 2001, BIOCHEM J, V356, P247, DOI 10.1042/0264-6021:3560247; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Raveh T, 2000, P NATL ACAD SCI USA, V97, P1572, DOI 10.1073/pnas.020519497; Real-Hohn A, 2010, BIOCHIMIE, V92, P538, DOI 10.1016/j.biochi.2010.01.023; Spoden GA, 2008, INT J CANCER, V123, P312, DOI 10.1002/ijc.23512; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246	34	35	35	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	6					683	693		10.1038/onc.2011.264	http://dx.doi.org/10.1038/onc.2011.264			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MU	21725354				2022-12-25	WOS:000300222100002
J	Bhardwaj, A; Molineux, IJ; Casjens, SR; Cingolani, G				Bhardwaj, Anshul; Molineux, Ian J.; Casjens, Sherwood R.; Cingolani, Gino			Atomic Structure of Bacteriophage Sf6 Tail Needle Knob	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTOCOCCUS-LACTIS PHAGES; RECEPTOR-BINDING PROTEIN; 3-DIMENSIONAL STRUCTURE; DNA; REVEALS; EVOLUTION; BACTERIAL; COMMON; IDENTIFICATION; STABILIZATION	Podoviridae are double-stranded DNA bacteriophages that use short, non-contractile tails to adsorb to the host cell surface. Within the tail apparatus of P22-like phages, a dedicated fiber known as the "tail needle" likely functions as a cell envelope-penetrating device to promote ejection of viral DNA inside the host. In Sf6, a P22-like phage that infects Shigella flexneri, the tail needle presents a C-terminal globular knob. This knob, absent in phage P22 but shared in other members of the P22-like genus, represents the outermost exposed tip of the virion that contacts the host cell surface. Here, we report a crystal structure of the Sf6 tail needle knob determined at 1.0 angstrom resolution. The structure reveals a trimeric globular domain of the TNF fold structurally superimposable with that of the tail-less phage PRD1 spike protein P5 and the adenovirus knob, domains that in both viruses function in receptor binding. However, P22-like phages are not known to utilize a protein receptor and are thought to directly penetrate the host surface. At 1.0 angstrom resolution, we identified three equivalents of L-glutamic acid (L-Glu) bound to each subunit interface. Although intimately bound to the protein, L-Glu does not increase the structural stability of the trimer nor it affects its ability to self-trimerize in vitro. In analogy to P22 gp26, we suggest the tail needle of phage Sf6 is ejected through the bacterial cell envelope during infection and its C-terminal knob is threaded through peptidoglycan pores formed by glycan strands.	[Bhardwaj, Anshul; Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Molineux, Ian J.] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Casjens, Sherwood R.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA	Jefferson University; University of Texas System; University of Texas Austin; Utah System of Higher Education; University of Utah	Cingolani, G (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	gino.cingolani@jefferson.edu		Bhardwaj, Anshul/0000-0002-0897-979X	National Institutes of Health [1R56AI076509-01A1, AI074825]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074825, R56AI074825, R56AI076509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R56AI076509-01A1 (to G.C.) and AI074825 (to S.R.C.).	Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andres D, 2010, J BIOL CHEM, V285, P36768, DOI 10.1074/jbc.M110.169003; Andrews D, 2005, J BIOL CHEM, V280, P5929, DOI 10.1074/jbc.C400513200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baptista C, 2008, J BACTERIOL, V190, P4989, DOI 10.1128/JB.00349-08; Bebeacua C, 2010, J BIOL CHEM, V285, P39079, DOI 10.1074/jbc.M110.175646; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; Bhardwaj A, 2008, PROTEIN SCI, V17, P1475, DOI 10.1110/ps.036111.108; Bhardwaj A, 2007, J MOL BIOL, V371, P374, DOI 10.1016/j.jmb.2007.05.051; Bhardwaj A, 2009, J MOL BIOL, V391, P227, DOI 10.1016/j.jmb.2009.05.069; Casjens S, 2004, J MOL BIOL, V339, P379, DOI 10.1016/j.jmb.2004.03.068; Casjens SR, 2011, VIROLOGY, V411, P393, DOI 10.1016/j.virol.2010.12.046; CHELVANAYAGAM G, 1992, J MOL BIOL, V228, P220, DOI 10.1016/0022-2836(92)90502-B; Chen DH, 2011, P NATL ACAD SCI USA, V108, P1355, DOI 10.1073/pnas.1015739108; Chua JEH, 1999, MICROBIOL-UK, V145, P1649, DOI 10.1099/13500872-145-7-1649; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doerrler WT, 2006, MOL MICROBIOL, V60, P542, DOI 10.1111/j.1365-2958.2006.05130.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; ISRAEL V, 1977, J VIROL, V23, P91, DOI 10.1128/JVI.23.1.91-97.1977; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Lander GC, 2009, STRUCTURE, V17, P789, DOI 10.1016/j.str.2009.04.006; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Merckel MC, 2005, MOL CELL, V18, P161, DOI 10.1016/j.molcel.2005.03.019; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; Muller JJ, 2008, STRUCTURE, V16, P766, DOI 10.1016/j.str.2008.01.019; Olia AS, 2007, NAT STRUCT MOL BIOL, V14, P1221, DOI 10.1038/nsmb1317; Olia AS, 2007, BIOCHEMISTRY-US, V46, P8776, DOI 10.1021/bi700186e; Olia AS, 2006, J MOL BIOL, V363, P558, DOI 10.1016/j.jmb.2006.08.014; Olia AS, 2011, NAT STRUCT MOL BIOL, V18, P597, DOI 10.1038/nsmb.2023; Olia AS, 2009, PROTEIN SCI, V18, P537, DOI 10.1002/pro.53; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Sciara G, 2010, P NATL ACAD SCI USA, V107, P6852, DOI 10.1073/pnas.1000232107; Spinelli S, 2006, NAT STRUCT MOL BIOL, V13, P85, DOI 10.1038/nsmb1029; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; STRAUSS H, 1984, J MOL BIOL, V172, P523, DOI 10.1016/S0022-2836(84)80021-2; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tang JH, 2011, STRUCTURE, V19, P496, DOI 10.1016/j.str.2011.02.010; Teschke CM, 2010, VIROLOGY, V401, P119, DOI 10.1016/j.virol.2010.02.017; Tremblay DM, 2006, J BACTERIOL, V188, P2400, DOI 10.1128/JB.188.7.2400-2410.2006; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x	49	23	23	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30867	30877		10.1074/jbc.M111.260877	http://dx.doi.org/10.1074/jbc.M111.260877			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21705802	Green Published, hybrid			2022-12-25	WOS:000294283600066
J	Guntermann, S; Foley, E				Guntermann, Silvia; Foley, Edan			Protein Dredd Is an Essential Component of the c-Jun N-terminal Kinase Pathway in the Drosophila Immune Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B; ANTIBACTERIAL DEFENSE; INNATE IMMUNITY; DEFICIENCY IMD; NUCLEAR IMPORT; ACTIVATION; RELISH; GENE; JNK; PEPTIDOGLYCAN	The Drosophila immune deficiency (IMD) pathway mobilizes c-Jun N-terminal kinase (JNK), caspase, and nuclear factor-kappa B (NF-kappa B) modules to counter infection with Gram-negative bacteria. Dredd is an essential caspase in the IMD pathway, and it is widely established that NF-kappa B activation depends on Dredd. More recent cell culture studies suggested a role for Dredd in the activation of dJNK (Drosophila JNK). However, there are no epistatic or mechanistic data on the involvement of Dredd in dJNK activation. More importantly, there is no in vivo evidence to demonstrate a physiological requirement for Dredd in the IMD/dJNK pathway. We performed a comprehensive analysis of the role of Dredd in the IMD/dJNK pathway, and we demonstrated that Dredd is essential for the activation of IMD/dJNK in cell culture. We positioned Dredd activity at an early point of the IMD/dJNK pathway and uncovered a series of interactions between Dredd and additional proximal IMD pathway molecules. Mechanistically, we showed that the caspase activity inhibitor p35 blocked dJNK activation and the induction of dJNK-dependent genes in cell culture and in vivo. Most importantly, we demonstrated that dredd mutant flies are completely inhibited in their ability to activate dJNK or express dJNK-responsive target genes after bacterial infection in vivo. In conclusion, we established Dredd as an essential component of the IMD pathway required for the full activation of IMD/dJNK in cell culture and in vivo. Our data enhance our appreciation of Dredd-dependent IMD signal transduction events.	[Guntermann, Silvia; Foley, Edan] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada	University of Alberta	Foley, E (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada.	efoley@ualberta.ca			Natural Sciences and Engineering Research Council [RGPIN 371188]; Canada Foundation for Innovation; Alberta Science and Research Investment Program	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Science and Research Investment Program	This work was supported by Natural Sciences and Engineering Research Council Grant RGPIN 371188 (to E. F.).; p35 DNA was provided by Pascal Meier. Bruno Lemaitre and Jean Marc Reichhart provided the dredd<SUP>B118</SUP> and yolk-GAL4 fly stocks, respectively. Relish antibodies were provided by Neal Silverman. David Bond generated the pMT-HAdTAK1<SUP>CA</SUP> expression plasmid. Rejish Thomas assisted with the generation of expression plasmids. cDNA was obtained from Drosophila Genomics Resource Center, and flies were provided by the Bloomington Drosophila Stock Center. We are grateful to David Bond and Brendon Parsons for critical reading of the manuscript. Infrastructure funds were provided by the Canada Foundation for Innovation and the Alberta Science and Research Investment Program.	Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; Bond D, 2008, BIOL PROCED ONLINE, V10, P20, DOI 10.1251/bpo139; Bond D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000655; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen P, 1998, DEV BIOL, V201, P202, DOI 10.1006/dbio.1998.9000; Chen W, 2002, J BIOL CHEM, V277, P49105, DOI 10.1074/jbc.M204934200; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Delaney JR, 2006, EMBO J, V25, P3068, DOI 10.1038/sj.emboj.7601182; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; Erturk-Hasdemir D, 2009, P NATL ACAD SCI USA, V106, P9779, DOI 10.1073/pnas.0812022106; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Gesellchen V, 2005, EMBO REP, V6, P979, DOI 10.1038/sj.embor.7400530; Geuking P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007709; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hu SM, 2000, J BIOL CHEM, V275, P30761, DOI 10.1074/jbc.C000341200; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Janeway CA, 2001, MICROBES INFECT, V3, P1167, DOI 10.1016/S1286-4579(01)01477-0; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kleino A, 2005, EMBO J, V24, P3423, DOI 10.1038/sj.emboj.7600807; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; LEMAITRE B, 1995, EMBO J, V14, P536, DOI 10.1002/j.1460-2075.1995.tb07029.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Maelfait J, 2008, BIOCHEM PHARMACOL, V76, P1365, DOI 10.1016/j.bcp.2008.07.034; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Naitza S, 2002, IMMUNITY, V17, P575, DOI 10.1016/S1074-7613(02)00454-5; Paquette N, 2010, MOL CELL, V37, P172, DOI 10.1016/j.molcel.2009.12.036; Park JM, 2004, GENE DEV, V18, P584, DOI 10.1101/gad.1168104; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Riedl SJ, 2001, BIOCHEMISTRY-US, V40, P13274, DOI 10.1021/bi010574w; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shi YG, 2006, CURR OPIN CELL BIOL, V18, P677, DOI 10.1016/j.ceb.2006.09.006; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Wu LP, 1998, NATURE, V392, P93, DOI 10.1038/32195; Xu GZ, 2001, NATURE, V410, P494, DOI 10.1038/35068604; Zhou R, 2005, J BIOL CHEM, V280, P34048, DOI 10.1074/jbc.M506655200; Zhuang ZH, 2006, CELL SIGNAL, V18, P964, DOI 10.1016/j.cellsig.2005.08.020	62	17	17	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30284	30294		10.1074/jbc.M111.220285	http://dx.doi.org/10.1074/jbc.M111.220285			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730059	hybrid, Green Published			2022-12-25	WOS:000294283600006
J	Chan, CH; Yu, TH; Wong, KB				Chan, Chi-Ho; Yu, Tsz-Ha; Wong, Kam-Bo			Stabilizing Salt-Bridge Enhances Protein Thermostability by Reducing the Heat Capacity Change of Unfolding	PLOS ONE			English	Article							ELECTROSTATIC INTERACTIONS CONTRIBUTE; THERMAL-STABILITY; PHOSPHOGLYCERATE KINASE; STRUCTURE VALIDATION; SURFACE; MOLPROBITY; REMOVAL; NETWORK; STATE; L30E	Most thermophilic proteins tend to have more salt bridges, and achieve higher thermostability by up-shifting and broadening their protein stability curves. While the stabilizing effect of salt-bridge has been extensively studied, experimental data on how salt-bridge influences protein stability curves are scarce. Here, we used double mutant cycles to determine the temperature-dependency of the pair-wise interaction energy and the contribution of salt-bridges to Delta C-p in a thermophilic ribosomal protein L30e. Our results showed that the pair-wise interaction energies for the salt-bridges E6/R92 and E62/K46 were stabilizing and insensitive to temperature changes from 298 to 348 K. On the other hand, the pair-wise interaction energies between the control long-range ion-pair of E90/R92 were negligible. The Delta C-p of all single and double mutants were determined by Gibbs-Helmholtz and Kirchhoff analyses. We showed that the two stabilizing salt-bridges contributed to a reduction of Delta C-p by 0.8-1.0 kJ mol(-1) K-1. Taken together, our results suggest that the extra salt-bridges found in thermophilic proteins enhance the thermostability of proteins by reducing Delta C-p, leading to the up-shifting and broadening of the protein stability curves.	[Chan, Chi-Ho; Yu, Tsz-Ha; Wong, Kam-Bo] Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Chan, CH (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China.	kbwong@cuhk.edu.hk	Wong, Kam-Bo/G-4258-2013; Wong, Kam-Bo/AAU-9364-2021	Wong, Kam-Bo/0000-0002-6984-5373; Wong, Kam-Bo/0000-0002-6984-5373	Research Grants Council of Hong Kong [476307]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was funded by the General Research Fund of Research Grants Council of Hong Kong (Project no. 476307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; Beadle BM, 1999, BIOCHEMISTRY-US, V38, P2570, DOI 10.1021/bi9824902; Blasie CA, 1997, BIOCHEMISTRY-US, V36, P6218, DOI 10.1021/bi962805i; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P7142, DOI 10.1021/bi00243a015; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deutschman WA, 2001, BIOCHEMISTRY-US, V40, P13107, DOI 10.1021/bi010665t; Elcock AH, 1998, J MOL BIOL, V284, P489, DOI 10.1006/jmbi.1998.2159; ERWIN CR, 1990, PROTEIN ENG, V4, P87, DOI 10.1093/protein/4.1.87; FERSHT AR, 1993, CURR OPIN STRUC BIOL, V3, P75, DOI 10.1016/0959-440X(93)90205-Y; Filimonov VV, 1999, BIOPHYS CHEM, V77, P195, DOI 10.1016/S0301-4622(99)00025-3; Fukuchi S, 2001, J MOL BIOL, V309, P835, DOI 10.1006/jmbi.2001.4718; Ge M, 2008, J BIOL CHEM, V283, P31690, DOI 10.1074/jbc.M805750200; Grattinger M, 1998, J MOL BIOL, V280, P525, DOI 10.1006/jmbi.1998.1861; Gribenko AV, 2009, P NATL ACAD SCI USA, V106, P2601, DOI 10.1073/pnas.0808220106; Hendsch ZS, 1996, BIOCHEMISTRY-US, V35, P7621, DOI 10.1021/bi9605191; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; Hollien J, 1999, BIOCHEMISTRY-US, V38, P3831, DOI 10.1021/bi982684h; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; Ibarra-Molero B, 2004, J MOL BIOL, V336, P989, DOI 10.1016/j.jmb.2003.12.069; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; Kumar S, 2001, BIOCHEMISTRY-US, V40, P14152, DOI 10.1021/bi0106383; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lam SY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001027; Lassila KS, 2002, PROTEIN SCI, V11, P688, DOI 10.1110/ps.23502; Lee CF, 2005, BIOCHEMISTRY-US, V44, P16817, DOI 10.1021/bi0519654; Lee CF, 2005, J MOL BIOL, V348, P419, DOI 10.1016/j.jmb.2005.02.052; Luisi DL, 2003, BIOCHEMISTRY-US, V42, P7050, DOI 10.1021/bi027202n; Makhatadze GI, 2003, J MOL BIOL, V327, P1135, DOI 10.1016/S0022-2836(03)00233-X; MARQUSEE S, 1994, PROTEIN SCI, V3, P2217, DOI 10.1002/pro.5560031207; MATTHEWS BW, 1993, ANNU REV BIOCHEM, V62, P139, DOI 10.1146/annurev.bi.62.070193.001035; Motono C, 2001, PROTEIN ENG, V14, P961, DOI 10.1093/protein/14.12.961; MURPHY KP, 1990, SCIENCE, V247, P559, DOI 10.1126/science.2300815; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; NOJIMA H, 1977, J MOL BIOL, V116, P429, DOI 10.1016/0022-2836(77)90078-X; Pace C N, 1986, Methods Enzymol, V131, P266; PERUTZ MF, 1975, NATURE, V255, P256, DOI 10.1038/255256a0; PERUTZ MF, 1978, SCIENCE, V201, P1187, DOI 10.1126/science.694508; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Robic S, 2002, PROTEIN SCI, V11, P381, DOI 10.1110/ps.38602; Robic S, 2003, P NATL ACAD SCI USA, V100, P11345, DOI 10.1073/pnas.1635051100; SALI D, 1991, J MOL BIOL, V220, P779, DOI 10.1016/0022-2836(91)90117-O; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schweiker KL, 2007, PROTEIN SCI, V16, P2694, DOI 10.1110/ps.073091607; SERRANO L, 1990, BIOCHEMISTRY-US, V29, P9343, DOI 10.1021/bi00492a006; Spek EJ, 1998, PROTEIN SCI, V7, P2431, DOI 10.1002/pro.5560071121; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Strop P, 2000, BIOCHEMISTRY-US, V39, P1251, DOI 10.1021/bi992257j; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Takano K, 2000, BIOCHEMISTRY-US, V39, P12375, DOI 10.1021/bi000849s; Tissot AC, 1996, BIOCHEMISTRY-US, V35, P6786, DOI 10.1021/bi952930e; Uchiyama S, 2002, PROTEIN ENG, V15, P455, DOI 10.1093/protein/15.6.455; Vetriani C, 1998, P NATL ACAD SCI USA, V95, P12300, DOI 10.1073/pnas.95.21.12300; Vogt G, 1997, FOLD DES, V2, pS40, DOI 10.1016/S1359-0278(97)00062-X; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wong KB, 2003, PROTEIN SCI, V12, P1483, DOI 10.1110/ps.0302303; Zhou HX, 2002, BIOPHYS J, V83, P3126, DOI 10.1016/S0006-3495(02)75316-2	63	70	71	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21624	10.1371/journal.pone.0021624	http://dx.doi.org/10.1371/journal.pone.0021624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720566	Green Published, gold, Green Submitted			2022-12-25	WOS:000292036900062
J	Dandoy, P; Meunier, CF; Michiels, C; Su, BL				Dandoy, Philippe; Meunier, Christophe F.; Michiels, Carine; Su, Bao-Lian			Hybrid Shell Engineering of Animal Cells for Immune Protections and Regulation of Drug Delivery: Towards the Design of "Artificial Organs"	PLOS ONE			English	Article							MICROENCAPSULATION TECHNOLOGY; THP-1 CELLS; SILICA; ENCAPSULATION; ALGINATE; GEL; CYTOTOXICITY; ACTIVATION; VIABILITY; CAPSULES	Background: With the progress in medicine, the average human life expectancy is continuously increasing. At the same time, the number of patients who require full organ transplantations is augmenting. Consequently, new strategies for cell transplantation are the subject of great interest. Methodology/Principal Findings: This work reports the design, the synthesis and the characterisation of robust and biocompatible mineralised beads composed of two layers: an alginate-silica composite core and a Ca-alginate layer. The adequate choice of materials was achieved through cytotoxicity LDH release measurement and in vitro inflammatory assay (IL-8) to meet the biocompatibility requirements for medical purpose. The results obtained following this strategy provide a direct proof of the total innocuity of silica and alginate networks for human cells as underscored by the non-activation of immune defenders (THP-1 monocytes). The accessible pore size diameter of the mineralised beads synthesized was estimated between 22 and 30 nm, as required for efficient immuno-isolation without preventing the diffusion of nutrients and metabolites. The model human cells, HepG2, entrapped within these hybrid beads display a high survival rate over more than six weeks according to the measurements of intracellular enzymatic activity, respiration rate, as well as the "de novo" biosynthesis and secretion of albumin out of the beads. Conclusions/Significance: The current study shows that active mammalian cells can be protected by a silica-alginate hybrid shell-like system. The functionality of the cell strain can be maintained. Consequently, cells coated with an artificial and a biocompatible mineral shell could respond physiologically within the human body in order to deliver therapeutic agents in a controlled fashion (i.e. insulin), substituting the declining organ functions of the patient.	[Dandoy, Philippe; Meunier, Christophe F.; Su, Bao-Lian] Univ Namur FUNDP, Dept Chem, Lab Inorgan Mat Chem, Namur, Belgium; [Michiels, Carine] Univ Namur FUNDP, Dept Biol, Lab Biochem & Cellular Biol, Namur, Belgium; [Su, Bao-Lian] Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, Wuhan 430070, Peoples R China	University of Namur; University of Namur; Wuhan University of Technology	Dandoy, P (corresponding author), Univ Namur FUNDP, Dept Chem, Lab Inorgan Mat Chem, Namur, Belgium.	christophe.meunier@fundp.ac.be; bao-lian.su@fundp.ac.be		Su, Bao-Lian/0000-0001-8474-0652	Belgian FNRS (Fonds de la Recherche Scientifique - FNRS)	Belgian FNRS (Fonds de la Recherche Scientifique - FNRS)(Fonds de la Recherche Scientifique - FNRS)	Belgian FNRS (Fonds de la Recherche Scientifique - FNRS) http://www1.frs-fnrs.be/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; Amoura M, 2007, CHEM COMMUN, P4015, DOI 10.1039/b711380c; Arcangeli G, 2001, SCI TOTAL ENVIRON, V270, P135, DOI 10.1016/S0048-9697(00)00781-6; Bartkowiak A, 1999, ANN NY ACAD SCI, V875, P135, DOI 10.1111/j.1749-6632.1999.tb08499.x; BISCEGLIE V., 1933, ZEITSCHR KREBSFORSCH, V40, P122; Boninsegna S, 2003, J SOL-GEL SCI TECHN, V26, P1151, DOI 10.1023/A:1020731429533; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Carturan G, 2004, J MATER CHEM, V14, P2087, DOI 10.1039/b401450b; Carturan G, 1997, P SOC PHOTO-OPT INS, V3136, P366, DOI 10.1117/12.279168; Cirone P, 2002, HUM GENE THER, V13, P1157, DOI 10.1089/104303402320138943; Coiffier A, 2001, J MATER CHEM, V11, P2039, DOI 10.1039/b101308o; Coradin T, 2002, MATER RES SOC SYMP P, V724, P147; Coradin T, 2003, APPL MICROBIOL BIOT, V61, P429, DOI 10.1007/s00253-003-1308-5; de Vos P, 2002, DIABETOLOGIA, V45, P159, DOI 10.1007/s00125-001-0729-x; Desai TA, 1999, J MEMBRANE SCI, V159, P221, DOI 10.1016/S0376-7388(99)00062-9; DeVos P, 1997, DIABETOLOGIA, V40, P262; Di Pasqua AJ, 2008, J INORG BIOCHEM, V102, P1416, DOI 10.1016/j.jinorgbio.2007.12.028; Ferrer ML, 2002, CHEM MATER, V14, P3619, DOI 10.1021/cm025562r; Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3; FUKUSHIMA Y, 1988, BIOTECHNOL BIOENG, V32, P584, DOI 10.1002/bit.260320503; GOLDBERG EP, 1964, J POLYM SCI POL LETT, V2, P835, DOI 10.1002/pol.1964.110020818; Goneberg A, 1952, [No title captured], Patent No. [510419, BE 510419]; GREGORY JM, 2010, CLIN DIABETES, V28, P61; KONDORI N, 2001, INT C ANT AG CHEM 41, pJ133; Krimm H, 1962, [No title captured], Patent No. [DE 1136114, 1136114]; La Flamme Kristen E, 2005, Diabetes Technol Ther, V7, P684; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lee MJ, 2004, FLUID PHASE EQUILIBR, V221, P63, DOI 10.1016/j.fluid.2004.03.008; Leonard A, 2011, CHEM SOC REV, V40, P860, DOI 10.1039/c0cs00024h; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; Lohr M, 2001, LANCET, V357, P1591, DOI 10.1016/S0140-6736(00)04749-8; Meunier CF, 2010, J MATER CHEM, V20, P929, DOI 10.1039/b919763j; Meunier CF, 2010, LANGMUIR, V26, P6568, DOI 10.1021/la9039286; Meunier CF, 2009, J MATER CHEM, V19, P4131, DOI 10.1039/b821769f; Mitjans M, 2010, TOXICOL IN VITRO, V24, P1803, DOI 10.1016/j.tiv.2010.06.001; Morris PJ, 1996, TRENDS BIOTECHNOL, V14, P163, DOI 10.1016/0167-7799(96)10020-2; Murua A, 2008, J CONTROL RELEASE, V132, P76, DOI 10.1016/j.jconrel.2008.08.010; NAGY JA, 1989, CANCER RES, V49, P5448; Nassif N, 2002, NAT MATER, V1, P42, DOI 10.1038/nmat709; Nieto A, 2009, ACTA BIOMATER, V5, P3478, DOI 10.1016/j.actbio.2009.05.033; Nukada Y, 2008, J TOXICOL SCI, V33, P175, DOI 10.2131/jts.33.175; Orive G, 2003, TRENDS PHARMACOL SCI, V24, P207, DOI 10.1016/S0165-6147(03)00073-7; Perullini M, 2008, CHEM MATER, V20, P3015, DOI 10.1021/cm703075b; Prakash S, 1996, NAT MED, V2, P883, DOI 10.1038/nm0896-883; Qi M, 2004, BIOMATERIALS, V25, P5885, DOI 10.1016/j.biomaterials.2004.01.050; Rooke JC, 2008, J MATER CHEM, V18, P2833, DOI 10.1039/b802705f; Sakai S, 2005, BIOMATERIALS, V26, P4786, DOI 10.1016/j.biomaterials.2004.11.043; Sakai S, 2002, BIOTECHNOL PROGR, V18, P401, DOI 10.1021/bp010147+; Sakai S, 2001, BIOMATERIALS, V22, P2827, DOI 10.1016/S0142-9612(01)00016-3; Shimizu K, 2001, CHEM BIOL, V8, P1051, DOI 10.1016/S1074-5521(01)00072-2; Strand BL, 2001, CELL TRANSPLANT, V10, P263, DOI 10.3727/000000001783986800; Vaughn HA, 1965, [No title captured], Patent No. [GB 989379, 989379]	52	19	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20983	10.1371/journal.pone.0020983	http://dx.doi.org/10.1371/journal.pone.0020983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731637	Green Submitted, gold, Green Published			2022-12-25	WOS:000292033700024
J	Chopra, M; Golden, HB; Mullapudi, S; Dowhan, W; Dostal, DE; Sharma, AC				Chopra, Mani; Golden, Honey B.; Mullapudi, Srinivas; Dowhan, William; Dostal, David E.; Sharma, Avadhesh C.			Modulation of Myocardial Mitochondrial Mechanisms during Severe Polymicrobial Sepsis in the Rat	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; VENTRICULAR MYOCYTE CONTRACTILITY; BCL-2 FAMILY PROTEINS; K-ATP CHANNELS; CYTOCHROME-C; NITRIC-OXIDE; DYSFUNCTION; ENDOTHELIN; APOPTOSIS; RELEASE	Background: We tested the hypothesis that 5-Hydroxydecanoic acid (5HD), a putative mitoKATP channel blocker, will reverse sepsis-induced cardiodynamic and adult rat ventricular myocyte (ARVM) contractile dysfunction, restore mitochondrial membrane permeability alterations and improve survival. Methodology/Principal Findings: Male Sprague-Dawley rats (350-400 g) were made septic using 400 mg/kg cecal inoculum, ip. Sham animals received 5% dextrose water, ip. The Voltage Dependent Anion Channels (VDAC1), Bax and cytochrome C levels were determined in isolated single ARVMs obtained from sham and septic rat heart. Mitochondria and cytosolic fractions were isolated from ARVMs treated with norepinephrine (NE, 10 mu moles) in the presence/absence of 5HD (100 mmoles). A continuous infusion of 5HD using an Alzet pump reversed sepsis-induced mortality when administered at the time of induction of sepsis (-40%) and at 6 hr post-sepsis (-20%). Electrocardiography revealed that 5HD reversed sepsis-induced decrease in the average ejection fraction, Simpsons+m Mode (53.5 +/- 2.5 in sepsis and 69.2 +/- 1.2 at 24 hr in sepsis+5HD vs. 79.9 +/- 1.5 basal group) and cardiac output (63.3 +/- 1.2 mL/min sepsis and 79.3 +/- 3.9 mL/min at 24 hr in sepsis+5HD vs. 85.8 +/- 1.5 mL/min basal group). The treatment of ARVMs with 5HD also reversed sepsis-induced depressed contractility in both the vehicle and NE-treated groups. Sepsis produced a significant downregulation of VDAC1, and upregulation of Bax levels, along with mitochondrial membrane potential collapse in ARVMs. Pretreatment of septic ARVMs with 5HD blocked a NE-induced decrease in the VDAC1 and release of cytochrome C. Conclusion: The data suggest that Bax activation is an upstream event that may precede the opening of the mitoKATP channels in sepsis. We concluded that mitoKATP channel inhibition via decreased mitochondrial membrane potential and reduced release of cytochrome C provided protection against sepsis-induced ARVM and myocardial contractile dysfunction.	[Chopra, Mani; Sharma, Avadhesh C.] Texas A&M Hlth Sci Ctr, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX USA; [Golden, Honey B.; Dostal, David E.] Texas A&M Hlth Sci Ctr, Dept Mol Cardiol, Cardiovasc Res Inst, Coll Med, Temple, TX USA; [Mullapudi, Srinivas; Dowhan, William] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX USA; [Sharma, Avadhesh C.] Philadelphia Coll Osteopath Med, Sch Pharm, Dept Pharmaceut Sci, Cardionome Lab, Suwanee, GA USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Chopra, M (corresponding author), Texas A&M Hlth Sci Ctr, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX USA.	AvadheshSh@pcom.edu			National Institutes of Health (NHLBI) [HL 66016]; AHA [160444Z]; Texas A&M Health Science Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL066016] Funding Source: NIH RePORTER	National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AHA(American Heart Association); Texas A&M Health Science Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The present study was supported by funds obtained from the National Institutes of Health (NHLBI, HL 66016), AHA (160444Z) and in part by a grant from the Texas A&M Health Science Center Research Development and Enhancement Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardehali H, 2005, J MOL CELL CARDIOL, V39, P7, DOI 10.1016/j.yjmcc.2004.12.003; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2; Bernardi P, 1996, J BIOENERG BIOMEMBR, V28, P131, DOI 10.1007/BF02110643; Bouchier-Hayes L, 2005, J CLIN INVEST, V115, P2640, DOI 10.1172/JCI26274; Brahmbhatt S, 2005, MOL CELL BIOCHEM, V271, P225, DOI 10.1007/s11010-005-6416-3; Brealey D, 2004, AM J PHYSIOL-REG I, V286, pR491, DOI 10.1152/ajpregu.00432.2003; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Brenner C, 2006, ONCOGENE, V25, P4744, DOI 10.1038/sj.onc.1209609; Chernyak BV, 1996, EUR J BIOCHEM, V238, P623, DOI 10.1111/j.1432-1033.1996.0623w.x; Chopra M, 2007, LIFE SCI, V81, P306, DOI 10.1016/j.lfs.2007.05.021; Chopra M, 2007, FRONT BIOSCI-LANDMRK, V12, P3052, DOI 10.2741/2294; Chopra M, 2010, LIFE SCI, V87, P672, DOI 10.1016/j.lfs.2010.09.029; Chopra M, 2010, BRIT J PHARMACOL, V160, P93, DOI 10.1111/j.1476-5381.2010.00686.x; Chopra M, 2009, PHARMACOL RES, V60, P303, DOI 10.1016/j.phrs.2009.04.009; COLOMBINI M, 1979, NATURE, V279, P643, DOI 10.1038/279643a0; Cook SA, 1999, CIRC RES, V85, P940; Crouser ED, 2002, CRIT CARE MED, V30, P2722, DOI 10.1097/00003246-200212000-00017; Crouser ED, 2002, CRIT CARE MED, V30, P276, DOI 10.1097/00003246-200202000-00002; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P23, DOI 10.1016/S0005-2728(03)00108-7; Gupta A, 2005, FRONT BIOSCI-LANDMRK, V10, P3183, DOI 10.2741/1774; Gupta A, 2005, BBA-MOL BASIS DIS, V1741, P127, DOI 10.1016/j.bbadis.2005.03.006; Gupta A, 2005, J MOL CELL CARDIOL, V38, P527, DOI 10.1016/j.yjmcc.2005.01.002; Hanley PJ, 2002, J PHYSIOL-LONDON, V542, P735, DOI 10.1113/jphysiol.2002.023960; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hou Q, 2005, AM J PHYSIOL-HEART C, V289, pH477, DOI 10.1152/ajpheart.00879.2004; Hou Q, 2003, APOPTOSIS, V8, P617, DOI 10.1023/A:1026187526113; INOUE I, 1991, NATURE, V352, P244, DOI 10.1038/352244a0; Krishnagopalan Sreenandh, 2002, Curr Opin Crit Care, V8, P376, DOI 10.1097/00075198-200210000-00003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; PAUCEK P, 1992, J BIOL CHEM, V267, P26062; Peart JN, 2002, J CELL MOL MED, V6, P453, DOI 10.1111/j.1582-4934.2002.tb00449.x; Ren J, 2002, SHOCK, V18, P285, DOI 10.1097/00024382-200209000-00014; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Seharaseyon J, 2000, J MOL CELL CARDIOL, V32, P1923, DOI 10.1006/jmcc.2000.1226; Sharma AC, 1997, J MOL CELL CARDIOL, V29, P1469, DOI 10.1006/jmcc.1997.0386; Sharma AC, 2007, SHOCK, V28, P265, DOI 10.1097/01.shk.0000235090.30550.fb; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Tsujimoto Y, 2000, CELL DEATH DIFFER, V7, P1174, DOI 10.1038/sj.cdd.4400780; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Zang Q, 2007, J APPL PHYSIOL, V102, P103, DOI 10.1152/japplphysiol.00359.2006; Zang Qun, 2007, Surg Infect (Larchmt), V8, P41, DOI 10.1089/sur.2006.033	42	27	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21285	10.1371/journal.pone.0021285	http://dx.doi.org/10.1371/journal.pone.0021285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712982	gold, Green Published, Green Submitted			2022-12-25	WOS:000291985100024
J	De Santis, R; Anastasi, AM; Pelliccia, A; Rosi, A; Albertoni, C; Verdoliva, A; Petronzelli, F; D'Alessio, V; Serani, S; Nuzzolo, CA				De Santis, Rita; Anastasi, Anna Maria; Pelliccia, Angela; Rosi, Antonio; Albertoni, Claudio; Verdoliva, Antonio; Petronzelli, Fiorella; D'Alessio, Valeria; Serani, Serenella; Nuzzolo, Carlo Antonio			Chemical Linkage to Injected Tissues Is a Distinctive Property of Oxidized Avidin	PLOS ONE			English	Article							PROTEIN; ANTIBODY; ACTIVATION; ACID	We recently reported that the oxidized avidin, named AvidinOX (R), resides for weeks within injected tissues as a consequence of the formation of Schiff's bases between its aldehyde groups and tissue protein amino groups. We also showed, in a mouse pre-clinical model, the usefulness of AvidinOX for the delivery of radiolabeled biotin to inoperable tumors. Taking into account that AvidinOX is the first oxidized glycoprotein known to chemically link to injected tissues, we tested in the mouse a panel of additional oxidized glycoproteins, with the aim of investigating the phenomenon. We produced oxidized ovalbumin and mannosylated streptavidin which share with avidin glycosylation pattern and tetrameric structure, respectively and found that neither of them linked significantly to cells in vitro nor to injected tissues in vivo, despite the presence of functional aldehyde groups. The study, extended to additional oxidized glycoproteins, showed that the in vivo chemical conjugation is a distinctive property of the oxidized avidin. Relevance of the high cationic charge of avidin into the stable linkage of AvidinOX to tissues is demonstrated as the oxidized acetylated avidin lost the property. Plasmon resonance on matrix proteins and cellular impedance analyses showed in vitro that avidin exhibits a peculiar interaction with proteins and cells that allows the formation of highly stable Schiff's bases, after oxidation.	[De Santis, Rita; Anastasi, Anna Maria; Pelliccia, Angela; Rosi, Antonio; Albertoni, Claudio; Petronzelli, Fiorella; D'Alessio, Valeria; Serani, Serenella; Nuzzolo, Carlo Antonio] Sigma Tau Pharmaceut Co, Dept Immunol, Rome, Italy; [Verdoliva, Antonio] Tecnogen SpA, Dept Dev, Piana Monte Verna, Caserta, Italy	Leadiant Biosciences	De Santis, R (corresponding author), Sigma Tau Pharmaceut Co, Dept Immunol, Rome, Italy.	rita.desantis@sigma-tau.it		DE SANTIS, Rita/0000-0002-5037-0611	Sigma Tau SpA	Sigma Tau SpA	The work was funded by Sigma Tau SpA. All authors are employees of Sigma-Tau SpA and Tecnogen SpA and contributed to all aspects of the study.	AVIGAD G, 1983, ANAL BIOCHEM, V134, P499, DOI 10.1016/0003-2697(83)90330-5; BRUCH RC, 1982, BIOCHEMISTRY-US, V21, P5334, DOI 10.1021/bi00264a033; CHAIET L, 1964, ARCH BIOCHEM BIOPHYS, V106, P1, DOI 10.1016/0003-9861(64)90150-X; Charbonneau J, 1999, CELL ADHES COMMUN, V7, P233, DOI 10.3109/15419069909010805; Damen CWN, 2009, J AM SOC MASS SPECTR, V20, P2021, DOI 10.1016/j.jasms.2009.07.017; De Santis R, 2003, BRIT J CANCER, V88, P996, DOI 10.1038/sj.bjc.6600818; De Santis R, 2010, CANCER BIOTHER RADIO, V25, P143, DOI 10.1089/cbr.2009.0738; De Santis R, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/921434; GREEN NM, 1965, BIOCHEM J, V94, pC23, DOI 10.1042/bj0940023C; Helppolainen SH, 2008, BBA-PROTEINS PROTEOM, V1784, P1002, DOI 10.1016/j.bbapap.2008.04.010; Helppolainen SH, 2007, BIOCHEM J, V405, P397, DOI 10.1042/BJ20070076; Hytonen VP, 2004, J BIOL CHEM, V279, P9337, DOI 10.1074/jbc.M310989200; Hytonen VP, 2003, BIOCHEM J, V372, P219, DOI 10.1042/BJ20021531; Inforzato A, 2006, BIOCHEMISTRY-US, V45, P11540, DOI 10.1021/bi0607453; Jossinet Jacques, 2010, Stud Health Technol Inform, V152, P69; Kawada K, 2009, MOL CELL BIOL, V29, P4508, DOI 10.1128/MCB.00015-09; Laitinen OH, 2006, CELL MOL LIFE SCI, V63, P2992, DOI 10.1007/s00018-006-6288-z; Ma S, 1999, ANAL CHEM, V71, P5185, DOI 10.1021/ac990376z; Maatta JAE, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-63; MUZYKANTOV VR, 1991, BIOCHEM J, V273, P393, DOI 10.1042/bj2730393; Nordlund HR, 2005, J BIOL CHEM, V280, P13250, DOI 10.1074/jbc.M414336200; OSHANNESSY DJ, 1987, J IMMUNOL METHODS, V99, P153, DOI 10.1016/0022-1759(87)90120-7; Petronzelli F, 2011, BASIC CLIN PHARMACOL, V109, P145, DOI 10.1111/j.1742-7843.2011.00701.x; Raj GV, 2004, PROSTATE, V61, P105, DOI 10.1002/pros.20083; SASHIDHAR RB, 1994, J IMMUNOL METHODS, V167, P121, DOI 10.1016/0022-1759(94)90081-7; Tankrathok A, 2009, PREP BIOCHEM BIOTECH, V39, P380, DOI 10.1080/10826060903209646; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Urbano N, 2007, EUR J NUCL MED MOL I, V34, P68, DOI 10.1007/s00259-006-0124-4; Verdoliva A, 2010, J BIOL CHEM, V285, P9090, DOI 10.1074/jbc.M109.080457; YAMASHITA K, 1978, J BIOL CHEM, V253, P3862; Yao ZS, 1999, J NUCL MED, V40, P479; ZABORSKY OR, 1974, BIOCHEM BIOPH RES CO, V61, P210, DOI 10.1016/0006-291X(74)90554-3	32	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21075	10.1371/journal.pone.0021075	http://dx.doi.org/10.1371/journal.pone.0021075			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701578	Green Submitted, Green Published, gold			2022-12-25	WOS:000291983800020
J	Edwards, IP; Zak, DR; Kellner, H; Eisenlord, SD; Pregitzer, KS				Edwards, Ivan P.; Zak, Donald R.; Kellner, Harald; Eisenlord, Sarah D.; Pregitzer, Kurt S.			Simulated Atmospheric N Deposition Alters Fungal Community Composition and Suppresses Ligninolytic Gene Expression in a Northern Hardwood Forest	PLOS ONE			English	Article							MULTICOPPER OXIDASE GENES; NITROGEN DEPOSITION; NO3-DEPOSITION; TRANSCRIPTIONAL REGULATION; CARBON SEQUESTRATION; ENZYME-ACTIVITY; LEAF-LITTER; TEMPERATE; DEGRADATION; DIVERSITY	High levels of atmospheric nitrogen (N) deposition may result in greater terrestrial carbon (C) storage. In a northern hardwood ecosystem, exposure to over a decade of simulated N deposition increased C storage in soil by slowing litter decay rates, rather than increasing detrital inputs. To understand the mechanisms underlying this response, we focused on the saprotrophic fungal community residing in the forest floor and employed molecular genetic approaches to determine if the slower decomposition rates resulted from down-regulation of the transcription of key lignocellulolytic genes, by a change in fungal community composition, or by a combination of the two mechanisms. Our results indicate that across four Acer-dominated forest stands spanning a 500-km transect, community-scale expression of the cellulolytic gene cbhI under elevated N deposition did not differ significantly from that under ambient levels of N deposition. In contrast, expression of the ligninolytic gene lcc was significantly down-regulated by a factor of 2-4 fold relative to its expression under ambient N deposition. Fungal community composition was examined at the most southerly of the four sites, in which consistently lower levels of cbhI and lcc gene expression were observed over a two-year period. We recovered 19 basidiomycete and 28 ascomycete rDNA 28S operational taxonomic units; Athelia, Sistotrema, Ceratobasidium and Ceratosebacina taxa dominated the basidiomycete assemblage, and Leotiomycetes dominated the ascomycetes. Simulated N deposition increased the proportion of basidiomycete sequences recovered from forest floor, whereas the proportion of ascomycetes in the community was significantly lower under elevated N deposition. Our results suggest that chronic atmospheric N deposition may lower decomposition rates through a combination of reduced expression of ligninolytic genes such as lcc, and compositional changes in the fungal community.	[Edwards, Ivan P.; Zak, Donald R.; Kellner, Harald; Eisenlord, Sarah D.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Zak, Donald R.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Pregitzer, Kurt S.] Univ Idaho, Coll Nat Resources, Moscow, ID 83843 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Idaho; University of Idaho	Edwards, IP (corresponding author), Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA.	iedwards@umich.edu	Zak, Donald R/C-6004-2012; Kellner, Harald/B-8729-2009	Zak, Donald/0000-0002-9730-7337	National Science Foundation [DEB 061442, DEB 0814623]; Office of Science (BER) United States Department of Energy	National Science Foundation(National Science Foundation (NSF)); Office of Science (BER) United States Department of Energy(United States Department of Energy (DOE))	This work was supported by grants from the National Science Foundation (DEB 061442 and DEB 0814623) and by the Office of Science (BER) United States Department of Energy to DRZ and KSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2007, SOIL BIOL BIOCHEM, V39, P1878, DOI 10.1016/j.soilbio.2007.02.001; Aro N, 2005, FEMS MICROBIOL REV, V29, P719, DOI 10.1016/j.femsre.2004.11.006; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; Baldrian P, 2010, APPL SOIL ECOL, V46, P177, DOI 10.1016/j.apsoil.2010.08.013; Baldrian P, 2011, PLANT SOIL, V338, P111, DOI 10.1007/s11104-010-0324-3; Berg Bjorn, 1997, Environmental Reviews, V5, P1, DOI 10.1139/er-5-1-1; Binder M, 2005, SYST BIODIVERS, V3, P113, DOI 10.1017/S1477200005001623; Burton AJ, 2004, GLOBAL CHANGE BIOL, V10, P1080, DOI 10.1111/j.1365-2486.2004.00737.x; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Chen DM, 2003, NEW PHYTOL, V157, P547, DOI 10.1046/j.1469-8137.2003.00687.x; De Vries W, 2006, GLOBAL CHANGE BIOL, V12, P1151, DOI 10.1111/j.1365-2486.2006.01151.x; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; Edwards IP, 2008, APPL ENVIRON MICROB, V74, P3481, DOI 10.1128/AEM.02893-07; Edwards IP, 2011, GLOBAL CHANGE BIOL, V17, P2184, DOI 10.1111/j.1365-2486.2010.02376.x; Einax E, 2003, ORG DIVERS EVOL, V3, P185, DOI 10.1078/1439-6092-00069; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; Frankland JC, 1998, MYCOL RES, V102, P1, DOI 10.1017/S0953756297005364; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Hassett JE, 2009, MICROB ECOL, V57, P728, DOI 10.1007/s00248-008-9440-5; Ilmen M, 1997, APPL ENVIRON MICROB, V63, P1298; JEFFRIES TW, 1981, APPL ENVIRON MICROB, V42, P290, DOI 10.1128/AEM.42.2.290-296.1981; Katho K., 2002, NUCLEIC ACIDS RES, V30, P3059, DOI [DOI 10.1093/NAR/GKF436, 10.1093/nar/gkf436]; Kellner H, 2008, SOIL BIOL BIOCHEM, V40, P638, DOI 10.1016/j.soilbio.2007.09.013; Kellner H, 2007, FEMS MICROBIOL ECOL, V61, P153, DOI 10.1111/j.1574-6941.2007.00322.x; Kellner H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010971; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; LEATHAM GF, 1983, FEMS MICROBIOL LETT, V16, P65, DOI 10.1111/j.1574-6968.1983.tb00260.x; LI D, 1994, APPL ENVIRON MICROB, V60, P3447, DOI 10.1128/AEM.60.9.3447-3449.1994; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockington RA, 2002, FUNGAL GENET BIOL, V37, P190, DOI 10.1016/S1087-1845(02)00504-2; Luis P, 2005, GEODERMA, V128, P18, DOI 10.1016/j.geoderma.2004.12.023; Lyons JI, 2003, MICROB ECOL, V45, P270, DOI 10.1007/s00248-002-1055-7; Magnani F, 2007, NATURE, V447, P848, DOI 10.1038/nature05847; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; Osono T, 2002, MYCOLOGIA, V94, P421, DOI 10.2307/3761776; Osono T, 2001, EUR J SOIL BIOL, V37, P17, DOI 10.1016/S1164-5563(01)01066-4; Osono T, 2007, ECOL RES, V22, P955, DOI 10.1007/s11284-007-0390-z; Pointing SB, 2005, MYCOL RES, V109, P115, DOI 10.1017/S0953756204001376; Pregitzer KS, 2008, GLOBAL CHANGE BIOL, V14, P142, DOI 10.1111/j.1365-2486.2007.01465.x; Rayner A. D. M., 1988, Fungal decomposition of wood. Its biology and ecology.; Saiya-Cork KR, 2002, SOIL BIOL BIOCHEM, V34, P1309, DOI 10.1016/S0038-0717(02)00074-3; Sinsabaugh RL, 2002, BIOGEOCHEMISTRY, V60, P1, DOI 10.1023/A:1016541114786; Soden DM, 2001, MICROBIOL-SGM, V147, P1755, DOI 10.1099/00221287-147-7-1755; Spatafora JW, 2006, MYCOLOGIA, V98, P1018, DOI 10.3852/mycologia.98.6.1018; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Waldrop MP, 2004, ECOL APPL, V14, P1172, DOI 10.1890/03-5120; Worrall JJ, 1997, MYCOLOGIA, V89, P199, DOI 10.2307/3761073; Zak DR, 2008, ECOL APPL, V18, P2016, DOI 10.1890/07-1743.1	51	131	141	5	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20421	10.1371/journal.pone.0020421	http://dx.doi.org/10.1371/journal.pone.0020421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701691	Green Submitted, gold, Green Published			2022-12-25	WOS:000291983800006
J	Liesz, A; Sun, L; Zhou, W; Schwarting, S; Mracsko, E; Zorn, M; Bauer, H; Sommer, C; Veltkamp, R				Liesz, Arthur; Sun, Li; Zhou, Wei; Schwarting, Soenke; Mracsko, Eva; Zorn, Markus; Bauer, Henrike; Sommer, Clemens; Veltkamp, Roland			FTY720 Reduces Post-Ischemic Brain Lymphocyte Influx but Does Not Improve Outcome in Permanent Murine Cerebral Ischemia	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; MULTIPLE-SCLEROSIS; ARTERY OCCLUSION; T-LYMPHOCYTES; INFLAMMATORY MECHANISMS; QUANTITATIVE-EVALUATION; EXPERIMENTAL STROKE; FINGOLIMOD FTY720; NITRIC-OXIDE	Background: The contribution of neuroinflammation and specifically brain lymphocyte invasion is increasingly recognised as a substantial pathophysiological mechanism after stroke. FTY720 is a potent treatment for primary neuroinflammatory diseases by inhibiting lymphocyte circulation and brain immigration. Previous studies using transient focal ischemia models showed a protective effect of FTY720 but did only partially characterize the involved pathways. We tested the neuroprotective properties of FTY720 in permanent and transient cortical ischemia and analyzed the underlying neuroimmunological mechanisms. Methodology/Principal Findings: FTY720 treatment resulted in substantial reduction of circulating lymphocytes while blood monocyte counts were significantly increased. The number of histologically and flow cytometrically analyzed brain invading T-and B lymphocytes was significantly reduced in FTY720 treated mice. However, despite testing a variety of treatment protocols, infarct volume and behavioural dysfunction were not reduced 7d after permanent occlusion of the distal middle cerebral artery (MCAO). Additionally, we did not measure a significant reduction in infarct volume at 24h after 60 min filament-induced MCAO, and did not see differences in brain edema between PBS and FTY720 treatment. Analysis of brain cytokine expression revealed complex effects of FTY720 on postischemic neuroinflammation comprising a substantial reduction of delayed proinflammatory cytokine expression at 3d but an early increase of IL-1 beta and IFN-gamma at 24 h after MCAO. Also, serum cytokine levels of IL-6 and TNF-alpha were increased in FTY720 treated animals compared to controls. Conclusions/Significance: In the present study we were able to detect a reduction of lymphocyte brain invasion by FTY720 but could not achieve a significant reduction of infarct volumes and behavioural dysfunction. This lack of neuroprotection despite effective lymphopenia might be attributed to a divergent impact of FTY720 on cytokine expression and possible activation of innate immune cells after brain ischemia.	[Liesz, Arthur; Sun, Li; Zhou, Wei; Schwarting, Soenke; Mracsko, Eva; Veltkamp, Roland] Univ Heidelberg, Dept Neurol, Heidelberg, Germany; [Zorn, Markus] Univ Heidelberg, Dept Internal Med, D-6900 Heidelberg, Germany; [Bauer, Henrike; Sommer, Clemens] Univ Med Ctr Mainz, Dept Neuropathol, Mainz, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz	Liesz, A (corresponding author), Univ Heidelberg, Dept Neurol, Heidelberg, Germany.	Arthur.Liesz@med.uni-heidelberg.de	Liesz, Arthur/AAT-7147-2021	Liesz, Arthur/0000-0002-9069-2594	Else-Kroner-Memorial scholarship	Else-Kroner-Memorial scholarship	This study was supported by an Else-Kroner-Memorial scholarship to RV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas O, 2010, NAT REV NEUROL, V6, P373, DOI 10.1038/nrneurol.2010.76; Arumugam TV, 2005, NEUROMOL MED, V7, P229, DOI 10.1385/NMM:7:3:229; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; Becker K, 2001, STROKE, V32, P206, DOI 10.1161/01.STR.32.1.206; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Boutin H, 2001, J NEUROSCI, V21, P5528, DOI 10.1523/JNEUROSCI.21-15-05528.2001; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Brinkmann V, 2009, BRIT J PHARMACOL, V158, P1173, DOI 10.1111/j.1476-5381.2009.00451.x; Chao CC, 1995, BRAIN BEHAV IMMUN, V9, P355, DOI 10.1006/brbi.1995.1033; Czech B, 2009, BIOCHEM BIOPH RES CO, V389, P251, DOI 10.1016/j.bbrc.2009.08.142; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Davies CA, 1999, J CEREBR BLOOD F MET, V19, P87, DOI 10.1097/00004647-199901000-00010; del Zoppo GJ, 2001, ARCH NEUROL-CHICAGO, V58, P669, DOI 10.1001/archneur.58.4.669; Dirnagl U, 2004, E SCHERING RES FDN W, V47, P87; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Ecker RC, 2006, CYTOM PART A, V69A, P119, DOI 10.1002/cyto.a.20219; Engelhardt B, 2009, SEMIN IMMUNOPATHOL, V31, P497, DOI 10.1007/s00281-009-0177-0; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Fujino M, 2003, J PHARMACOL EXP THER, V305, P70, DOI 10.1124/jpet.102.045658; GARCIA JH, 1994, AM J PATHOL, V144, P188; Gee JM, 2007, STROKE, V38, P783, DOI 10.1161/01.STR.0000248425.59176.7b; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Hasegawa Y, 2010, STROKE, V41, P368, DOI 10.1161/STROKEAHA.109.568899; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Hughes JE, 2008, CIRC RES, V102, P950, DOI 10.1161/CIRCRESAHA.107.170779; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kataoka H, 2005, CELL MOL IMMUNOL, V2, P439; Kawai N, 2001, BRAIN RES, V895, P50, DOI 10.1016/S0006-8993(01)02026-1; Liesz A, 2011, BRAIN, V134, P704, DOI 10.1093/brain/awr008; Liesz A, 2009, STROKE, V40, P2849, DOI 10.1161/STROKEAHA.109.549618; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Massberg S, 2006, NEW ENGL J MED, V355, P1088, DOI 10.1056/NEJMp068159; Means CK, 2009, CARDIOVASC RES, V82, P193, DOI 10.1093/cvr/cvp086; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Michaud J, 2010, J IMMUNOL, V184, P1475, DOI 10.4049/jimmunol.0901586; Miron VE, 2008, J NEUROL SCI, V274, P13, DOI 10.1016/j.jns.2008.06.031; PAPADOPOULOS D, J NEUROSCI RES, V88, P346; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Rabb H, 2000, AM J PHYSIOL-RENAL, V279, pF525, DOI 10.1152/ajprenal.2000.279.3.F525; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Salomone S, 2008, BRIT J PHARMACOL, V153, P140, DOI 10.1038/sj.bjp.0707581; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schroeter M, 2005, NEUROMOL MED, V7, P183, DOI 10.1385/NMM:7:3:183; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; Turrin NP, 2006, J NEUROSCI, V26, P143, DOI 10.1523/JNEUROSCI.4032-05.2006; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; Vogel J, 1999, STROKE, V30, P1134, DOI 10.1161/01.STR.30.5.1134; WANG Q, 2006, J NEUROIMMUNOL; Webb M, 2004, J NEUROIMMUNOL, V153, P108, DOI 10.1016/j.jneuroim.2004.04.015; WEI Y, ANN NEUROL; Weigert A, 2009, IMMUNOBIOLOGY, V214, P748, DOI 10.1016/j.imbio.2009.06.003; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zwacka RM, 1997, J CLIN INVEST, V100, P279, DOI 10.1172/JCI119533	62	86	87	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21312	10.1371/journal.pone.0021312	http://dx.doi.org/10.1371/journal.pone.0021312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701599	Green Published, gold, Green Submitted			2022-12-25	WOS:000291983800041
J	Liu, XJ; Li, YY; Zhang, Y; Lu, Y; Guo, W; Liu, P; Zhou, JZ; Xiang, ZH; He, C				Liu, Xiujie; Li, Yuanyuan; Zhang, Yong; Lu, Yan; Guo, Wei; Liu, Peng; Zhou, Jiazhen; Xiang, Zhenghua; He, Cheng			SHP-2 Promotes the Maturation of Oligodendrocyte Precursor Cells Through Akt and ERK1/2 Signaling In Vitro	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; CENTRAL-NERVOUS-SYSTEM; THYROID-HORMONE; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; CNS MYELINATION; KINASE; DIFFERENTIATION; MICE; ACTIVATION	Background: Oligodendrocyte precursor cells (OPCs) differentiate into oligodendrocytes (OLs), which are responsible for myelination. Myelin is essential for saltatory nerve conduction in the vertebrate nervous system. However, the molecular mechanisms of maturation and myelination by oligodendrocytes remain elusive. Methods and Findings: In the present study, we showed that maturation of oligodendrocytes was attenuated by sodium orthovanadate (a comprehensive inhibitor of tyrosine phosphatases) and PTPi IV (a specific inhibitor of SHP-2). It is also found that SHP-2 was persistently expressed during maturation process of OPCs. Down-regulation of endogenous SHP-2 led to impairment of oligodendrocytes maturation and this effect was triiodo-L-thyronine (T3) dependent. Furthermore, overexpression of SHP-2 was shown to promote maturation of oligodendrocytes. Finally, it has been identified that SHP-2 was involved in activation of Akt and extracellular-regulated kinases 1 and 2 (ERK1/2) induced by T3 in oligodendrocytes. Conclusions: SHP-2 promotes oligodendrocytes maturation via Akt and ERK1/2 signaling in vitro.	[Liu, Xiujie; Li, Yuanyuan; Zhang, Yong; Lu, Yan; Guo, Wei; Liu, Peng; Zhou, Jiazhen; Xiang, Zhenghua; He, Cheng] Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Key Lab Mol Neurobiol,Inst Neurosci,Minist Educ, Shanghai, Peoples R China	Naval Medical University	Liu, XJ (corresponding author), Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Key Lab Mol Neurobiol,Inst Neurosci,Minist Educ, Shanghai, Peoples R China.	chenghe@smmu.edu.cn	Messier, Claude/A-2322-2008; li, yuanyuan/GZA-4435-2022	Messier, Claude/0000-0002-4791-1763; 	National Natural Science Foundation [30970999]; National Key Basic Research Program [2007CB947100, 2011CB504401]; Ministry of Science and Technology of China [2009ZX09311-001]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This study was supported by the National Natural Science Foundation (30970999), National Key Basic Research Program (2007CB947100, 2011CB504401), and the Ministry of Science and Technology of China (2009ZX09311-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura K, 1997, J NEUROCHEM, V68, P2281; Baas D, 1997, GLIA, V19, P324, DOI 10.1002/(SICI)1098-1136(199704)19:4<324::AID-GLIA5>3.0.CO;2-X; Baas D, 2002, P NATL ACAD SCI USA, V99, P2907, DOI 10.1073/pnas.052482299; Barros CS, 2009, DEVELOPMENT, V136, P2717, DOI 10.1242/dev.038679; Bibollet-Bahena O, 2009, J NEUROCHEM, V109, P1440, DOI 10.1111/j.1471-4159.2009.06071.x; Brinkmann BG, 2008, NEURON, V59, P581, DOI 10.1016/j.neuron.2008.06.028; Cao X, 2005, MOL ENDOCRINOL, V19, P102, DOI 10.1210/me.2004-0093; CARSON MJ, 1993, NEURON, V10, P729, DOI 10.1016/0896-6273(93)90173-O; Chew LJ, 2010, J NEUROSCI, V30, P11011, DOI 10.1523/JNEUROSCI.2546-10.2010; Chun SJ, 2003, J CELL BIOL, V163, P397, DOI 10.1083/jcb.200304154; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; Fraser MM, 2008, NEUROSCIENCE, V151, P476, DOI 10.1016/j.neuroscience.2007.10.048; Gao FB, 1998, DEV BIOL, V197, P54, DOI 10.1006/dbio.1998.8877; Gauthier AS, 2007, NEURON, V54, P245, DOI 10.1016/j.neuron.2007.03.027; Grossmann KS, 2009, P NATL ACAD SCI USA, V106, P16704, DOI 10.1073/pnas.0904336106; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Klinghoffer RA, 1996, MOL CELL BIOL, V16, P5905; Kuo E, 2010, J NEUROCHEM, V113, P200, DOI 10.1111/j.1471-4159.2010.06596.x; Lamprianou S, 2006, J MOL NEUROSCI, V29, P241, DOI 10.1385/JMN:29:3:241; Lei JX, 2004, J BIOL CHEM, V279, P47589, DOI 10.1074/jbc.M405497200; Mannell H, 2008, J VASC RES, V45, P153, DOI 10.1159/000110081; Massa PT, 2004, J NEUROSCI RES, V77, P15, DOI 10.1002/jnr.20155; McKinnon RD, 2005, J NEUROSCI, V25, P3499, DOI 10.1523/JNEUROSCI.5049-04.2005; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Miller RH, 2007, NAT NEUROSCI, V10, P1351, DOI 10.1038/nn1995; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Peretz A, 2000, EMBO J, V19, P4036, DOI 10.1093/emboj/19.15.4036; Ranjan M, 1996, MOL CELL NEUROSCI, V7, P404, DOI 10.1006/mcne.1996.0029; Relucio J, 2009, J NEUROSCI, V29, P11794, DOI 10.1523/JNEUROSCI.0888-09.2009; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Sperber BR, 2001, J NEUROSCI RES, V63, P303, DOI 10.1002/1097-4547(20010215)63:4<303::AID-JNR1024>3.0.CO;2-A; Stankoff B, 2002, J NEUROSCI, V22, P9221; Sukocheva OA, 2006, J ENDOCRINOL, V191, P447, DOI 10.1677/joe.1.07061; SWARUP G, 1982, BIOCHEM BIOPH RES CO, V107, P1104, DOI 10.1016/0006-291X(82)90635-0; Wang PS, 2009, J BIOL CHEM, V284, P33692, DOI 10.1074/jbc.M109.061770; Wu CJ, 2001, ONCOGENE, V20, P6018, DOI 10.1038/sj.onc.1204699; Younes-Rapozo V, 2009, INT J DEV NEUROSCI, V27, P757, DOI 10.1016/j.ijdevneu.2009.08.014; Zhu XQ, 2008, NEURON GLIA BIOL, V4, P19, DOI 10.1017/S1740925X09000015; Zhu Y, 2010, GLIA, V58, P1407, DOI 10.1002/glia.21016; Zito CI, 2004, J CELL PHYSIOL, V199, P227, DOI 10.1002/jcp.10446	40	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21058	10.1371/journal.pone.0021058	http://dx.doi.org/10.1371/journal.pone.0021058			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701583	Green Submitted, Green Published, gold			2022-12-25	WOS:000291983800019
J	Chang, XF; Ravi, R; Pham, V; Bedi, A; Chatterjee, A; Sidransky, D				Chang, Xiaofei; Ravi, Rajani; Pham, Vui; Bedi, Atul; Chatterjee, Aditi; Sidransky, David			Adenylate Kinase 3 Sensitizes Cells to Cigarette Smoke Condensate Vapor Induced Cisplatin Resistance	PLOS ONE			English	Article							ALVEOLAR EPITHELIAL-CELLS; HUMAN BLADDER-CANCER; TOBACCO-SMOKE; BREAST-CANCER; NECK-CANCER; MITOCHONDRIAL-DNA; OXIDATIVE STRESS; GLOTTIC CANCER; LOCAL-CONTROL; RISK-FACTORS	Background: The major established etiologic risk factor for bladder cancer is cigarette smoking and one of the major antineoplastic agents used for the treatment of advanced bladder cancer is cisplatin. A number of reports have suggested that cancer patients who smoke while receiving treatment have lower rates of response and decreased efficacy of cancer therapies. Methodology/Principal Findings: In this study, we investigated the effect of cigarette smoke condensate (CSC) vapor on cisplatin toxicity in urothelial cell lines SV-HUC-1 and SCaBER cells. We showed that chronic exposure to CSC vapor induced cisplatin resistance in both cell lines. In addition, we found that the expression of mitochondrial-resident protein adenylate kinase-3 (AK3) is decreased by CSC vapor. We further observed that chronic CSC vapor-exposed cells displayed decreased cellular sensitivity to cisplatin, decreased mitochondrial membrane potential (Delta Psi m) and increased basal cellular ROS levels compared to unexposed cells. Re-expression of AK3 in CSC vapor-exposed cells restored cellular sensitivity to cisplatin. Finally, CSC vapor increased the growth of the tumors and also curtail the response of tumor cells to cisplatin chemotherapy in vivo. Conclusions/Significance: The current study provides evidence that chronic CSC vapor exposure affects AK3 expression and renders the cells resistant to cisplatin.	[Chang, Xiaofei; Ravi, Rajani; Pham, Vui; Bedi, Atul; Chatterjee, Aditi; Sidransky, David] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA	Johns Hopkins University	Chang, XF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	chattad@jhmi.edu; dsidrans@jhmi.edu			FAMRI [072017_YCSA]	FAMRI	This research was supported by FAMRI-funded Young Clinical Scientist Award 072017_YCSA, titled "The effect of Adenylate Kinase 3 (AK3) on tobacco smoke - induced cisplatin resistance in bladder cells." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsanti KC, 2007, MAGN RESON CHEM, V45, P167, DOI 10.1002/mrc.1939; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Boffetta P, 2004, ONCOGENE, V23, P6392, DOI 10.1038/sj.onc.1207715; BROWMAN GP, 1993, NEW ENGL J MED, V328, P159, DOI 10.1056/NEJM199301213280302; CHANG SS, INT J CANC, V126, P19; Chatterjee A, 2008, ONCOGENE, V27, P3710, DOI 10.1038/onc.2008.3; Chatterjee A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-235; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; CherbonnelLasserre C, 1996, ONCOGENE, V13, P1489; Cho HJ, 2006, CANCER LETT, V237, P56, DOI 10.1016/j.canlet.2005.05.039; Choi MK, 2006, ARCH PHARM RES, V29, P1067, DOI 10.1007/BF02969293; Cullen KJ, 2007, J BIOENERG BIOMEMBR, V39, P43, DOI 10.1007/s10863-006-9059-5; De Flora S, 2008, MUTAT RES-REV MUTAT, V659, P137, DOI 10.1016/j.mrrev.2007.11.004; Dzeja PP, 1998, FASEB J, V12, P523, DOI 10.1096/fasebj.12.7.523; Fagerstrom K, 2002, DRUGS, V62, P1, DOI 10.2165/00003495-200262002-00001; Fanizza C, 2007, TOXICOL IN VITRO, V21, P586, DOI 10.1016/j.tiv.2006.12.002; Fleshner N, 1999, CANCER, V86, P2337, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2337::AID-CNCR23>3.0.CO;2-6; Fuertes MA, 2003, CURR MED CHEM, V10, P257, DOI 10.2174/0929867033368484; GALLUZZI L, CANC RES, V70, P1793; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hecht SS, 2002, CARCINOGENESIS, V23, P907, DOI 10.1093/carcin/23.6.907; Hecht SS, 2002, ENVIRON MOL MUTAGEN, V39, P119, DOI 10.1002/em.10071; Inouye S, 1998, J NEUROCHEM, V71, P125; Inouye S, 1999, BIOCHEM BIOPH RES CO, V254, P618, DOI 10.1006/bbrc.1998.0116; Izzotti A, 2008, MUTAT RES-FUND MOL M, V644, P38, DOI 10.1016/j.mrfmmm.2008.06.012; Jankovic S, 2007, TUMORI, V93, P4; Jiang XJ, 2007, CANCER RES, V67, P7540, DOI 10.1158/0008-5472.CAN-07-0048; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P23, DOI 10.1016/S0027-5107(01)00141-5; Knight-Lozano CA, 2002, CIRCULATION, V105, P849, DOI 10.1161/hc0702.103977; Lu X, 2003, ANAL CHEM, V75, P4441, DOI 10.1021/ac0264224; Mambo E, 2002, CANCER RES, V62, P1349; Marshak G, 1999, INT J RADIAT ONCOL, V43, P1009, DOI 10.1016/S0360-3016(98)00547-1; MATTENHEIMER H, 1975, Z KLIN CHEM KLIN BIO, V13, P325; Miro O, 1999, CARCINOGENESIS, V20, P1331, DOI 10.1093/carcin/20.7.1331; Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje; MURATA T, 1990, BIOCHEM INT, V20, P949; Nobumoto M, 1998, J BIOCHEM, V123, P128; Oh WK, 2000, UROLOGY, V55, P31, DOI 10.1016/S0090-4295(99)00408-2; Olivero OA, 1997, MUTAT RES-GEN TOX EN, V391, P79, DOI 10.1016/S0165-1218(97)00037-2; Olopade OI, 1997, CANCER J SCI AM, V3, P230; ORourke JF, 1996, EUR J BIOCHEM, V241, P403, DOI 10.1111/j.1432-1033.1996.00403.x; Rahman I, 1999, J BIOL CHEM, V274, P5088, DOI 10.1074/jbc.274.8.5088; Ravi R, 2002, CANCER RES, V62, P1583; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Rustemeier K, 2002, FOOD CHEM TOXICOL, V40, P93, DOI 10.1016/S0278-6915(01)00085-0; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Skipper PL, 2003, CANCER EPIDEM BIOMAR, V12, P503; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; SMITH JA, 1993, J IMMUNOL METHODS, V162, P261, DOI 10.1016/0022-1759(93)90391-J; TANABE T, 1993, J BIOCHEM-TOKYO, V113, P200, DOI 10.1093/oxfordjournals.jbchem.a124026; TSAI YC, 1990, CANCER RES, V50, P44; van der Toorn M, 2007, AM J PHYSIOL-LUNG C, V292, pL1211, DOI 10.1152/ajplung.00291.2006; van der Voet JCM, 1998, INT J RADIAT ONCOL, V42, P247, DOI 10.1016/S0360-3016(98)00226-0; Wickenden JA, 2003, AM J RESP CELL MOL, V29, P562, DOI 10.1165/rcmb.2002-0235OC; WILLIAMSON MP, 1995, HUM MOL GENET, V4, P1569, DOI 10.1093/hmg/4.9.1569; Yang A, 2002, CELL BIOL TOXICOL, V18, P97, DOI 10.1023/A:1015328100876; Yang ZJ, 2000, CANCER CHEMOTH PHARM, V46, P255, DOI 10.1007/s002800000167	58	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20806	10.1371/journal.pone.0020806	http://dx.doi.org/10.1371/journal.pone.0020806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698293	Green Published, gold, Green Submitted			2022-12-25	WOS:000291730000025
J	Xiong, J; Wang, H; Guo, GM; Wang, SZ; He, LQ; Chen, HF; Wu, J				Xiong, Ji; Wang, Hu; Guo, Guangming; Wang, Shuzeng; He, Liqun; Chen, Haifeng; Wu, Ji			Male Germ Cell Apoptosis and Epigenetic Histone Modification Induced by Tripterygium wilfordii Hook F	PLOS ONE			English	Article							SEX-CHROMOSOME INACTIVATION; SPERMATOGONIAL STEM-CELLS; REPRESSIVE COMPLEX 2; PB-CADHERIN; FORCE-FIELD; AUTOMATED DOCKING; SELF-RENEWAL; SPERMATOGENESIS; METHYLATION; EXPRESSION	Multiglycosides of Tripterygium wilfordii Hook f (GTW), a Chinese herb-derived medicine used as a remedy for rheumatoid arthritis, are considered to be a reversible anti-fertility drug affecting the mammalian spermatids. However, the mechanism behind this effect is still unknown. To study the possible mechanism behind the impact of GTW on spermatogenesis, we administered 4 groups of 4-week-old male mice with different doses of GTW. We found a dose-dependent decrease in the number of germ cells after 40 days of GTW treatment, and an increase in apoptotic cells from the low-dose to the high-dose group. During this same period the dimethylated level of histone H3 lysine 9 (H3K9me2) in GTW-treated testes germ cells declined. Additionally, spermatogonial stem cells (SSCs) from 6-day-old mice were isolated to evaluate the possible effect of GTW or triptolide on development of SSCs. We found a significantly higher incidence of apoptosis and lower dimethylation level of H3K9me2 in the SSCs of GTW or triptolide treatment than in controls. Thus, these data suggest that the GTW-induced apoptosis might be responsible for the fertility impairment in mice. This damage could be traced back to the early stages of spermatogenesis. GTW also affected the epigenetic modification of H3K9 in spermatogenesis. Molecular dynamics simulation suggested that triptolide and dimethylated or trimethylated H3K9 might have similar interaction mechanisms with EED (embryonic ectoderm development). These candidate activation mechanisms provide the first glimpse into the pathway of GTW-induced gonad toxicity, which is crucial for further research and clinical application.	[Xiong, Ji; Wang, Hu; Guo, Guangming; Wang, Shuzeng; Wu, Ji] Shanghai Jiao Tong Univ, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, BioX Res Inst, Shanghai 200030, Peoples R China; [Xiong, Ji; Wang, Hu; Guo, Guangming; Wang, Shuzeng; Wu, Ji] Shanghai Jiao Tong Univ, Dept Biol Sci & Biotechnol, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Chen, Haifeng] Shanghai Jiao Tong Univ, Dept Bioinformat & Biostat, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [He, Liqun] Shanghai Univ Tradit Chinese Med, Dept Nephrol, Key Lab Liver & Kidney Dis, Shanghai Shuguang Hosp,Minist Educ, Shanghai, Peoples R China; [He, Liqun] Shanghai Tradit Chinese Med Univ, E Inst Tradit Chinese Internal Med, Shanghai Municipal Educ Commiss, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai University of Traditional Chinese Medicine; Shanghai Municipal Education Commission (SHMEC)	Xiong, J (corresponding author), Shanghai Jiao Tong Univ, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, BioX Res Inst, Shanghai 200030, Peoples R China.	Heliqun59@yahoo.com.cn; haifengchen@sjtu.edu.cn; jiwu@sjtu.edu.cn	Chen, Haifeng/AAT-7444-2020	Wang, Hu/0000-0001-6132-8788	National Natural Science Foundation of China [30630012, 90919020]; National Basic Research Program of China [2010CB945001, 2011CB965104]; Ministry of Agriculture of the People's Republic of China [2009ZX08006-010B]; Program of Shanghai Subject Chief Scientist [10XD1402200]; Specialized Research Fund for the Doctoral Program of Higher Education in China [20090073110032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs); Program of Shanghai Subject Chief Scientist; Specialized Research Fund for the Doctoral Program of Higher Education in China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	Funding is from the Key Program and the Major Research Plan of the National Natural Science Foundation of China [no. 30630012 and 90919020], http://www.nsfc.gov.cn; the National Basic Research Program of China [no. 2010CB945001 and 2011CB965104], http://www.most.gov.cn; the Ministry of Agriculture of the People's Republic of China [no. 2009ZX08006-010B], http://www.moa.gov.cn/sjzz/jiaoyusi; the Program of Shanghai Subject Chief Scientist [no. 10XD1402200], http://www.stcsm.gov.cn/; and the Specialized Research Fund for the Doctoral Program of Higher Education in China [no. 20090073110032], http://www.moe.edu.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JP, 2002, CONTRACEPTION, V65, P441, DOI 10.1016/S0010-7824(02)00312-8; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bettegowda A, 2010, PHILOS T R SOC B, V365, P1637, DOI 10.1098/rstb.2009.0196; CASE DA, 2004, AMBER8; Chen HF, 2007, J AM CHEM SOC, V129, P2930, DOI 10.1021/ja0678774; CLERMONT Y, 1962, AM J ANAT, V111, P111, DOI 10.1002/aja.1001110202; Clermont Y., 1993, FRONT ENDOCRINOL, P332; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davis TL, 1999, GENOMICS, V58, P18, DOI 10.1006/geno.1999.5813; De Rooij DG, 2000, J ANDROL, V21, P776; HUCKINS C, 1978, ANAT REC, V190, P905, DOI 10.1002/ar.1091900410; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khalil AM, 2004, P NATL ACAD SCI USA, V101, P16583, DOI 10.1073/pnas.0406325101; Kollman PA, 1997, COMPUTER SIMULATION, P83; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Li Jie, 2009, Zhonghua Nan Ke Xue, V15, P569; Li JY, 2004, GENOMICS, V84, P952, DOI 10.1016/j.ygeno.2004.08.012; Liu ZL, 2010, J BIOL CHEM, V285, P2758, DOI 10.1074/jbc.M109.066845; LU QX, 1990, ACTA ACADEMIAE MED S, V12, P203; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nagano M, 1998, TISSUE CELL, V30, P389, DOI 10.1016/S0040-8166(98)80053-0; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Pasini D, 2008, COLD SH Q B, V73, P253, DOI 10.1101/sqb.2008.73.009; Payne C, 2006, DEV BIOL, V293, P461, DOI 10.1016/j.ydbio.2006.02.013; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Qian S., 1989, CHIN J ANDROL, V3, P129; Qin F, 2010, RNA, V16, P1053, DOI 10.1261/rna.2008110; Riising EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002704; RUSSELL LD, 1990, AM J ANAT, V188, P21, DOI 10.1002/aja.1001880104; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sharpe Richard M., 1994, P1363; STERN H, 1993, CELL MOL BIOL TESTIS, P296; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; TONG JS, 1988, STUD TRAD CHINESE ME, V1, P25; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Wu J, 2005, DEV BIOL, V284, P437, DOI 10.1016/j.ydbio.2005.05.042; Wu J, 2003, J ENDOCRINOL, V176, P381, DOI 10.1677/joe.0.1760381; Wu J, 2008, CELL SIGNAL, V20, P1052, DOI 10.1016/j.cellsig.2008.01.011; Wu R, 2005, MOL BIOL CELL, V16, P2872, DOI 10.1091/mbc.e04-11-0997; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; YANG JY, 2008, CARCINOGENESIS TERAT, V5, P393; Yang Zhi-xia, 2008, Zhongguo Yaolixue Tongbao, V24, P838; Ye W, 1991, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V13, P235; Yuan Z, 2009, CELL PROLIFERAT, V42, P123, DOI 10.1111/j.1365-2184.2009.00589.x; Zhang CT, 2008, J REPROD MED, V17, P118; ZHANG YH, 2007, CHINESE J DERMATOVEN, V6, P138; Zhang Y, 2011, J MOL CELL BIOL, V3, P132, DOI 10.1093/jmcb/mjq043; ZHEN QS, 1995, CONTRACEPTION, V51, P121, DOI 10.1016/0010-7824(94)00018-R; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869; 李凡, 2008, [生殖与避孕, Reproduction and Contraception], V28, P571	56	24	31	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20751	10.1371/journal.pone.0020751	http://dx.doi.org/10.1371/journal.pone.0020751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698297	Green Submitted, gold, Green Published			2022-12-25	WOS:000291730000023
J	Zhou, TH; Li, SQ; Zhong, WB; Vihervaara, T; Beaslas, O; Perttila, J; Luo, W; Jiang, YL; Lehto, M; Olkkonen, VM; Yan, DG				Zhou, Tianhong; Li, Shiqian; Zhong, Wenbin; Vihervaara, Terhi; Beaslas, Olivier; Perttila, Julia; Luo, Wei; Jiang, Yingliang; Lehto, Markku; Olkkonen, Vesa M.; Yan, Daoguang			OSBP-Related Protein 8 (ORP8) Regulates Plasma and Liver Tissue Lipid Levels and Interacts with the Nucleoporin Nup62	PLOS ONE			English	Article							OXYSTEROL-BINDING-PROTEIN; NUCLEAR-PORE COMPLEX; IMPORTIN-BETA; TRANSPORT FACTOR-2; STRUCTURAL BASIS; CHOLESTEROL; NTF2; EXPRESSION; FAMILY; ORGANIZATION	We earlier identified OSBP-related protein 8 (ORP8) as an endoplasmic reticulum oxysterol-binding protein implicated in cellular lipid homeostasis. We now investigated its action in hepatic cells in vivo and in vitro. Adenoviral overexpression of ORP8 in mouse liver induced a decrease of cholesterol, phospholipids, and triglycerides in serum (-34%, -26%, -37%, respectively) and liver tissue (-40%, -12%, -24%), coinciding with reduction of nuclear (n)SREBP-1 and -2 and mRNA levels of their target genes. Consistently, excess ORP8 reduced nSREBPs in HuH7 cells, and ORP8 overexpression or silencing by RNA interference moderately suppressed or induced the expression of SREBP-1 and SREBP-2 target genes, respectively. In accordance, cholesterol biosynthesis was reduced by ORP8 overexpression and enhanced by ORP8 silencing in [ 3 H] acetate pulse-labeling experiments. ORP8, previously shown to bind 25-hydroxycholesterol, was now shown to bind also cholesterol in vitro. Yeast two-hybrid, bimolecular fluorescence complementation (BiFC), and co-immunoprecipitation analyses revealed the nuclear pore component Nup62 as an interaction partner of ORP8. Co-localization of ORP8 and Nup62 at the nuclear envelope was demonstrated by BiFC and confocal immunofluorescence microscopy. Furthermore, the impact of overexpressed ORP8 on nSREBPs and their target mRNAs was inhibited in cells depleted of Nup62. Our results reveal that ORP8 has the capacity to modulate lipid homeostasis and SREBP activity, probably through an indirect mechanism, and provide clues of an entirely new mode of ORP action.	[Zhou, Tianhong; Li, Shiqian; Zhong, Wenbin; Luo, Wei; Jiang, Yingliang; Yan, Daoguang] Jinan Univ, Dept Biol, Guangzhou, Guangdong, Peoples R China; [Vihervaara, Terhi; Beaslas, Olivier; Perttila, Julia; Olkkonen, Vesa M.] Minerva Fdn, Biomedicum, Helsinki, Finland; [Lehto, Markku] Folkhalsan Inst Genet, Folkhalsan Res Ctr, Biomedicum, Helsinki, Finland; [Olkkonen, Vesa M.] Univ Helsinki, Inst Biomed Anat, Helsinki, Finland	Jinan University; University of Helsinki; Folkhalsan Research Center; University of Helsinki; University of Helsinki	Zhou, TH (corresponding author), Jinan Univ, Dept Biol, Guangzhou, Guangdong, Peoples R China.	vesa.olkkonen@helsinki.fi; tydg@jnu.edu.cn	Yan, Daoguang/A-4146-2013; Li, Shiqian/ABH-2154-2021	Olkkonen, Vesa/0000-0001-5553-7997	Academy of Finland [121457]; NSFC, China [30971104]; Fundamental Research Funds for the Central Universities, China; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; Novo Nordisk Foundation; Liv och Halsa Foundation; Magnus Ehrnrooth Foundation; European Union [202272]; Novo Nordisk Fonden [NNF11OC1014724] Funding Source: researchfish	Academy of Finland(Academy of Finland); NSFC, China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Liv och Halsa Foundation; Magnus Ehrnrooth Foundation; European Union(European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Academy of Finland (grant 121457 to V.M.O.), from NSFC, China (grant 30971104 to D.Y.), the Fundamental Research Funds for the Central Universities, China (to D.Y.), the Sigrid Juselius Foundation, the Finnish Foundation for Cardiovascular Research, The Novo Nordisk Foundation (V.M.O.), the Liv och Halsa Foundation, the Magnus Ehrnrooth Foundation (V.M.O.), and the European Union FP7 (LipidomicNet, agreement no. 202272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth W, 1999, BIOCHEM CELL BIOL, V77, P355, DOI 10.1139/bcb-77-4-355; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Bayliss R, 2002, EMBO J, V21, P2843, DOI 10.1093/emboj/cdf305; Blanquart C, 2002, J BIOL CHEM, V277, P37254, DOI 10.1074/jbc.M110598200; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; BUSS F, 1994, J CELL SCI, V107, P631; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; DAWSON PA, 1989, J BIOL CHEM, V264, P9046; Dietschy JM, 2002, J BIOL CHEM, V277, P3801, DOI 10.1074/jbc.R100057200; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Isgro TA, 2007, STRUCTURE, V15, P977, DOI 10.1016/j.str.2007.06.011; Isgro TA, 2007, J MOL BIOL, V366, P330, DOI 10.1016/j.jmb.2006.11.048; Jaworski CJ, 2001, GENOMICS, V78, P185, DOI 10.1006/geno.2001.6663; Johansson M, 2005, MOL BIOL CELL, V16, P5480, DOI 10.1091/mbc.E05-03-0189; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Lehto M, 2003, BBA-MOL CELL BIOL L, V1631, P1, DOI 10.1016/S1388-1981(02)00364-5; Lehto M, 2001, J LIPID RES, V42, P1203; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730; NAGELE U, 1984, J CLIN CHEM CLIN BIO, V22, P165; Nagoshi E, 1999, MOL BIOL CELL, V10, P2221, DOI 10.1091/mbc.10.7.2221; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Ngo M, 2009, MOL BIOL CELL, V20, P1388, DOI 10.1091/mbc.E08-09-0905; Otsuka S, 2008, P NATL ACAD SCI USA, V105, P16101, DOI 10.1073/pnas.0802647105; PASCHAL BM, 1995, J CELL BIOL, V129, P925, DOI 10.1083/jcb.129.4.925; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Ridgway ND, 2010, SUBCELL BIOCHEM, V51, P159, DOI 10.1007/978-90-481-8622-8_6; Schrader N, 2008, MOL CELL, V29, P46, DOI 10.1016/j.molcel.2007.10.022; SUBBAIAH PV, 2000, HDB LIPOPROTEIN TEST, P521; TAYLOR FR, 1984, J BIOL CHEM, V259, P2382; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Van Impe K, 2008, TRAFFIC, V9, P695, DOI 10.1111/j.1600-0854.2008.00720.x; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Yan DG, 2008, INT REV CYTOL, V265, P253, DOI 10.1016/S0074-7696(07)65007-4; Yan D, 2008, J BIOL CHEM, V283, P332, DOI 10.1074/jbc.M705313200; Yan DG, 2007, ARTERIOSCL THROM VAS, V27, P1108, DOI 10.1161/ATVBAHA.106.138545	51	37	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21078	10.1371/journal.pone.0021078	http://dx.doi.org/10.1371/journal.pone.0021078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698267	gold, Green Submitted, Green Published			2022-12-25	WOS:000291730000049
J	Chao, A; Lin, CY; Lee, YS; Tsai, CL; Wei, PC; Hsueh, S; Wu, TI; Tsai, CN; Wang, CJ; Chao, AS; Wang, TH; Lai, CH				Chao, A.; Lin, C-Y; Lee, Y-S; Tsai, C-L; Wei, P-C; Hsueh, S.; Wu, T-I; Tsai, C-N; Wang, C-J; Chao, A-S; Wang, T-H; Lai, C-H			Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2	ONCOGENE			English	Article						microRNA; miR-187; Dab2; epithelial-mesenchymal transition (EMT)	MESENCHYMAL TRANSITION; STEM-CELLS; EXPRESSION; CARCINOMA; EMT; GENE; OVEREXPRESSION; RESISTANCE; SIGNATURES; PROGNOSIS	MicroRNAs (miRNAs) play important roles in tumorigenesis by regulating oncogenes and tumor-suppressor genes. In this study, miR-187 and miR-200a were found to be expressed at higher levels in ovarian cancers than in benign tumors. In patients with ovarian cancer, however, higher levels of miR-187 and miR-200a expression were paradoxically associated with better OS and recurrence-free survival. Further, multivariate analysis showed that miR-187 served as an independent prognostic factor for patients with ovarian cancer (n = 176). Computational prediction and microarray results indicated that miR-187 directly targeted Disabled homolog-2 (Dab2), and luciferase reporter assays confirmed that the target site of miR-187 was located at the 3'-UTR of the Dab2 gene. Generally considered as a tumor-suppressor gene, Dab2 may actually promote tumor progression in advanced cancers through epithelial-to-mesenchymal transition (EMT). Ectopic expression of miR-187 in cancer cells promoted cell proliferation, but continued overexpression of miR-187 suppressed Dab2 and inhibited migration. Suppression of miR-187 upregulated Dab2, which, by inhibiting E-cadherin levels while stimulating vimentin and phospho-FAK levels, promoted EMT. Reduced ovarian cancer Dab2 histoscores correlated with high miR-187 levels and improved outcomes of patients. Collectively, these results demonstrate distinct dual roles of Dab2 in cell proliferation and tumor progression. In the initial steps of tumorigenesis, upregulated miR-187 suppresses Dab2, promoting cell proliferation. During the later stages, however, continued increased levels of miR-187 inhibits the Dab2-dependent EMT that is associated with tumor invasiveness, which is presumed to be the reason why cancers with high miR-187 levels were associated with better survivals. Oncogene (2012) 31, 764-775; doi:10.1038/onc.2011.269; published online 4 July 2011	[Chao, A.; Lin, C-Y; Tsai, C-L; Wei, P-C; Wu, T-I; Wang, C-J; Chao, A-S; Wang, T-H; Lai, C-H] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Tao Yuan 333, Taiwan; [Chao, A.; Lin, C-Y; Tsai, C-L; Wei, P-C; Hsueh, S.; Wu, T-I; Wang, C-J; Chao, A-S; Wang, T-H; Lai, C-H] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Lee, Y-S; Wang, T-H] Chang Gung Mem Hosp, Genom Med Res Core Lab, Gwei Shan, Taiwan; [Lee, Y-S] Ming Chuan Univ, Dept Biotechnol, Tao Yuan, Taiwan; [Wei, P-C; Wang, T-H] Chang Gung Univ, Grad Inst Biomed Sci, Gwei Shan, Taiwan; [Hsueh, S.] Chang Gung Mem Hosp, Dept Clin Pathol, Tao Yuan 333, Taiwan; [Tsai, C-N] Chang Gung Univ, Grad Inst Clin Med Sci, Gwei Shan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Ming Chuan University; Chang Gung Memorial Hospital	Wang, TH (corresponding author), Chang Gung Mem Hosp, Dept Obstet & Gynecol, 5 Fu Hsing St, Tao Yuan 333, Taiwan.	knoxtn@cgmh.org.tw; sh46erry@ms6.hinet.net	Tsai, Chi neu/C-3373-2011; Lai, Chyong-Huey/AAE-5731-2022; Tsai, Chi-Neu/AAZ-2558-2020	Tsai, Chi neu/0000-0002-5940-0696; Tsai, Chi-Neu/0000-0002-5940-0696; Lai, Chyong-Huey/0000-0002-9977-9645	National Science Council [NSC99-2314-B-182A-087-MY3]; National Research Program for Genomic Medicine [NSC97-3112-B-001-020]; Chang Gung Medical Foundation [CMRPG360953/4, 391451, 95-1364B, 97-1444C, 99-2072C, 99-2411C]; Department of Health [DOH99-TD-B-111-005, DOH99-TD-C-111-006]	National Science Council(Ministry of Science and Technology, Taiwan); National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); Chang Gung Medical Foundation; Department of Health	We thank Ching-Ling Wang, Jung-Erh Yang and Ying-Yu Lin for technical assistance; the Division of Gynecologic Oncology of Chang Gung Memorial Hospital for clinical data retrieval; Shih-Yee Mimi Wang (University of Illinois College of Medicine, Rockford) for language editing and Professor Ching-Ping Tseng (Chang Gung University) for discussion and advices. This study was supported by grants from the National Science Council (NSC99-2314-B-182A-087-MY3 to AC), the National Research Program for Genomic Medicine (NSC97-3112-B-001-020 to Y-SL), the Chang Gung Medical Foundation (CMRPG360953/4, 391451 to AC; IRB No. 95-1364B, 97-1444C, 99-2072C, 99-2411C) and the Department of Health (DOH99-TD-B-111-005 to C-HL; DOH99-TD-C-111-006 to AC and T-HW).	[Anonymous], 2007, PRED MICRORNA TARG; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Berek JS, 2010, BEREK HACKERS GYNECO, P444; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Chao A, 2006, INT J CANCER, V119, P91, DOI 10.1002/ijc.21813; Chao A, 2010, CANCER LETT, V291, P99, DOI 10.1016/j.canlet.2009.10.005; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Choi JH, 2006, ENDOCR-RELAT CANCER, V13, P641, DOI 10.1677/erc.1.01057; Chung CM, 2005, MOL CARCINOGEN, V43, P165, DOI 10.1002/mc.20098; Eitan R, 2009, GYNECOL ONCOL, V114, P253, DOI 10.1016/j.ygyno.2009.04.024; Fazili Z, 1999, ONCOGENE, V18, P3104, DOI 10.1038/sj.onc.1202649; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hannigan A, 2010, J CLIN INVEST, V120, P2842, DOI 10.1172/JCI36125; Hu XX, 2009, GYNECOL ONCOL, V114, P457, DOI 10.1016/j.ygyno.2009.05.022; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Lee YS, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp168; Liao CJ, 2011, GYNECOL ONCOL, V120, P135, DOI 10.1016/j.ygyno.2010.10.005; Lu L, 2007, CANCER RES, V67, P10117, DOI 10.1158/0008-5472.CAN-07-2544; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; MOK SC, 1994, GYNECOL ONCOL, V52, P247, DOI 10.1006/gyno.1994.1040; Mok SC, 1998, ONCOGENE, V16, P2381, DOI 10.1038/sj.onc.1201769; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsai MS, 2007, STEM CELLS, V25, P2511, DOI 10.1634/stemcells.2007-0023; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vetter G, 2010, ONCOGENE, V29, P4436, DOI 10.1038/onc.2010.181; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang TH, 1998, J BIOL CHEM, V273, P4928, DOI 10.1074/jbc.273.9.4928; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang DH, 2006, AM J PATHOL, V169, P258, DOI 10.2353/ajpath.2006.060036; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang WL, 2004, CANCER RES, V64, P1534, DOI 10.1158/0008-5472.CAN-03-2928	40	113	121	3	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2012	31	6					764	775		10.1038/onc.2011.269	http://dx.doi.org/10.1038/onc.2011.269			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MU	21725366				2022-12-25	WOS:000300222100009
J	Gu, Y; Lin, S; Li, JL; Nakagawa, H; Chen, Z; Jin, B; Tian, L; Ucar, DA; Shen, H; Lu, J; Hochwald, SN; Kaye, FJ; Wu, L				Gu, Y.; Lin, S.; Li, J-L; Nakagawa, H.; Chen, Z.; Jin, B.; Tian, L.; Ucar, D. A.; Shen, H.; Lu, J.; Hochwald, S. N.; Kaye, F. J.; Wu, L.			Altered LKB1/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion	ONCOGENE			English	Article						esophageal cancer; LKB1; CRTC co-activator; LYPD3; migration; invasion	PEUTZ-JEGHERS-SYNDROME; TUMOR-SUPPRESSOR; GENETIC ALTERATIONS; HUMAN HOMOLOG; LKB1; GROWTH; CREB; EXPRESSION; LKB1/STK11; TUMORIGENESIS	LKB1 is a tumor susceptibility gene for the Peutz-Jeghers cancer syndrome and is a target for mutational inactivation in sporadic human malignancies. LKB1 encodes a serine/threonine kinase that has critical roles in cell growth, polarity and metabolism. A novel and important function of LKB1 is its ability to regulate the phosphorylation of CREB-regulated transcription co-activators (CRTCs) whose aberrant activation is linked with oncogenic activities. However, the roles and mechanisms of LKB1 and CRTC in the pathogenesis of esophageal cancer have not been previously investigated. In this study, we observed altered LKB1-CRTC signaling in a subset of human esophageal cancer cell lines and patient samples. LKB1 negatively regulates esophageal cancer cell migration and invasion in vitro. Mechanistically, we determined that CRTC signaling becomes activated because of LKB1 loss, which results in the transcriptional activation of specific downstream targets including LYPD3, a critical mediator for LKB1 loss-of-function. Our data indicate that de-regulated LKB1-CRTC signaling might represent a crucial mechanism for esophageal cancer progression. Oncogene (2012) 31, 469-479; doi: 10.1038/onc.2011.247; published online 27 June 2011	[Gu, Y.; Lin, S.; Chen, Z.; Jin, B.; Tian, L.; Shen, H.; Wu, L.] Univ Florida, Dept Mol Genet & Microbiol, Shands Canc Ctr, Gainesville, FL 32610 USA; [Li, J-L] Sanford Burnham Med Res Inst Lake Nona, Orlando, FL USA; [Nakagawa, H.] Univ Penn, Dept Med, Div Gastroenterol, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Ucar, D. A.; Hochwald, S. N.] Univ Florida, Dept Surg, Shands Canc Ctr, Gainesville, FL 32610 USA; [Lu, J.] Univ Florida, Dept Biochem & Mol Biol, Shands Canc Ctr, Gainesville, FL 32610 USA; [Kaye, F. J.] Univ Florida, Dept Med, Shands Canc Ctr, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; Sanford Burnham Prebys Medical Discovery Institute; University of Pennsylvania; Pennsylvania Medicine; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Wu, L (corresponding author), Univ Florida, Dept Mol Genet & Microbiol, Shands Canc Ctr, 2033 Mowry Rd,Room 362, Gainesville, FL 32610 USA.	lzwu@ufl.edu	Li, J L/E-6100-2018; Li, Jian-Liang/AAE-9315-2019; chen, zirong/S-4042-2016; Lu, Jianrong/F-5240-2013	Li, J L/0000-0002-6487-081X; Li, Jian-Liang/0000-0002-6487-081X; chen, zirong/0000-0002-0589-4619; Lu, Jianrong/0000-0002-4969-6040; /0000-0002-0949-5068	University of Florida Shands Cancer Center	University of Florida Shands Cancer Center	We thank Jenny Huang for critical reading of our paper, Marda Jorgensen for helping with immunohistochemical staining and the University of Florida CTSI Biorepository for providing human esophageal tumor samples. This work was supported in part by the University of Florida Shands Cancer Center Startup fund (L Wu).	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; Breuillaud L, 2009, NAT MED, V15, P989, DOI 10.1038/nm0909-989; Carretero J, 2004, ONCOGENE, V23, P4037, DOI 10.1038/sj.onc.1207502; Carretero J, 2010, CANCER CELL, V17, P547, DOI 10.1016/j.ccr.2010.04.026; Chen Jie, 2010, Genes Cancer, V1, P822, DOI 10.1177/1947601910383564; Chen Y, 2005, CANCER RES, V65, P10838, DOI 10.1158/0008-5472.CAN-05-1091; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Coxon A, 2005, CANCER RES, V65, P7137, DOI 10.1158/0008-5472.CAN-05-1125; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Esteller M, 2000, ONCOGENE, V19, P164, DOI 10.1038/sj.onc.1203227; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Guldberg P, 1999, ONCOGENE, V18, P1777, DOI 10.1038/sj.onc.1202486; Hansen LV, 2008, INT J CANCER, V122, P734, DOI 10.1002/ijc.23082; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Klein CA, 2009, CANCER RES, V69, P5285, DOI 10.1158/0008-5472.CAN-08-4586; Komiya T, 2006, ONCOGENE, V25, P6128, DOI 10.1038/sj.onc.1209627; Komiya T, 2010, ONCOGENE, V29, P1672, DOI 10.1038/onc.2009.453; Kuwano H, 2005, SURG TODAY, V35, P7, DOI 10.1007/s00595-004-2885-3; Lam AKY, 2000, CRIT REV ONCOL HEMAT, V33, P71, DOI 10.1016/S1040-8428(99)00054-2; Launonen V, 2000, CANCER RES, V60, P546; Lee JJ, 2010, CARCINOGENESIS, V31, P427, DOI 10.1093/carcin/bgp326; Liu L, 2004, CANCER RES, V64, P3491, DOI 10.1158/0008-5472.CAN-03-2106; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Mahoney CL, 2009, BRIT J CANCER, V100, P370, DOI 10.1038/sj.bjc.6604886; Makowski L, 2008, BRIT J CANCER, V99, P683, DOI 10.1038/sj.bjc.6604515; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; NISHIHIRA T, 1993, J CANCER RES CLIN, V119, P441, DOI 10.1007/BF01215923; Paret C, 2005, INT J CANCER, V115, P724, DOI 10.1002/ijc.20977; Rodriguez Luis G., 2004, V294, P23; Rosel M, 1998, ONCOGENE, V17, P1989, DOI 10.1038/sj.onc.1202079; Rowan A, 1999, J INVEST DERMATOL, V112, P509, DOI 10.1046/j.1523-1747.1999.00551.x; Rustgi AK, 2006, SEMIN ONCOL, V33, pS57, DOI 10.1053/j.seminoncol.2006.10.013; Sanchez-Cespedes M, 2007, ONCOGENE, V26, P7825, DOI 10.1038/sj.onc.1210594; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Seiter S, 2001, J INVEST DERMATOL, V116, P344, DOI 10.1046/j.1523-1747.2001.01230.x; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Tiainen M, 2002, HUM MOL GENET, V11, P1497, DOI 10.1093/hmg/11.13.1497; Tonon G, 2003, NAT GENET, V33, P208, DOI 10.1038/ng1083; Vallbohmer D, 2010, J GASTROINTEST SURG, V14, P75, DOI 10.1007/s11605-009-1021-5; van Lier MGF, 2010, AM J GASTROENTEROL, V105, P1258, DOI 10.1038/ajg.2009.725; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Wu LZ, 2005, EMBO J, V24, P2391, DOI 10.1038/sj.emboj.7600719; Wurfel J, 2001, GENE, V262, P35, DOI 10.1016/S0378-1119(00)00515-1	54	67	70	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	4					469	479		10.1038/onc.2011.247	http://dx.doi.org/10.1038/onc.2011.247			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891LU	21706049				2022-12-25	WOS:000300219300006
J	Lee, AS; Xu, D; Plews, JR; Nguyen, PK; Nag, D; Lyons, JK; Han, L; Hu, SJ; Lan, F; Liu, JW; Huang, M; Narsinh, KH; Long, CT; de Almeida, PE; Levi, B; Kooreman, N; Bangs, C; Pacharinsak, C; Ikeno, F; Yeung, AC; Gambhir, SS; Robbins, RC; Longaker, MT; Wu, JC				Lee, Andrew S.; Xu, Dan; Plews, Jordan R.; Nguyen, Patricia K.; Nag, Divya; Lyons, Jennifer K.; Han, Leng; Hu, Shijun; Lan, Feng; Liu, Junwei; Huang, Mei; Narsinh, Kazim H.; Long, Charles T.; de Almeida, Patricia E.; Levi, Benjamin; Kooreman, Nigel; Bangs, Charles; Pacharinsak, Cholawat; Ikeno, Fumiaki; Yeung, Alan C.; Gambhir, Sanjiv S.; Robbins, Robert C.; Longaker, Michael T.; Wu, Joseph C.			Preclinical Derivation and Imaging of Autologously Transplanted Canine Induced Pluripotent Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; IN-VITRO; LINES; DIFFERENTIATION; EXPRESSION; SURVIVAL; GENE	Derivation of patient-specific induced pluripotent stem cells (iPSCs) opens a new avenue for future applications of regenerative medicine. However, before iPSCs can be used in a clinical setting, it is critical to validate their in vivo fate following autologous transplantation. Thus far, preclinical studies have been limited to small animals and have yet to be conducted in large animals that are physiologically more similar to humans. In this study, we report the first autologous transplantation of iPSCs in a large animal model through the generation of canine iPSCs (ciPSCs) from the canine adipose stromal cells and canine fibroblasts of adult mongrel dogs. We confirmed pluripotency of ciPSCs using the following techniques: (i) immunostaining and quantitative PCR for the presence of pluripotent and germ layer-specific markers in differentiated ciPSCs; (ii) microarray analysis that demonstrates similar gene expression profiles between ciPSCs and canine embryonic stem cells; (iii) teratoma formation assays; and (iv) karyotyping for genomic stability. Fate of ciPSCs autologously transplanted to the canine heart was tracked in vivo using clinical positron emission tomography, computed tomography, and magnetic resonance imaging. To demonstrate clinical potential of ciPSCs to treat models of injury, we generated endothelial cells (ciPSC-ECs) and used these cells to treat immunodeficient murine models of myocardial infarction and hindlimb ischemia.	[Lee, Andrew S.; Xu, Dan; Plews, Jordan R.; Nag, Divya; Han, Leng; Hu, Shijun; Lan, Feng; Liu, Junwei; Huang, Mei; Narsinh, Kazim H.; de Almeida, Patricia E.; Kooreman, Nigel; Gambhir, Sanjiv S.; Wu, Joseph C.] Stanford Univ, Sch Med, Mol Imaging Program, Dept Radiol, Stanford, CA 94305 USA; [Lee, Andrew S.; Xu, Dan; Plews, Jordan R.; Nguyen, Patricia K.; Nag, Divya; Han, Leng; Hu, Shijun; Lan, Feng; Liu, Junwei; Huang, Mei; Narsinh, Kazim H.; de Almeida, Patricia E.; Ikeno, Fumiaki; Yeung, Alan C.; Wu, Joseph C.] Stanford Univ, Sch Med, Div Cardiol, Dept Med, Stanford, CA 94305 USA; [Lyons, Jennifer K.; Long, Charles T.; Pacharinsak, Cholawat] Stanford Univ, Sch Med, Dept Vet Med, Stanford, CA 94305 USA; [Levi, Benjamin; Longaker, Michael T.] Stanford Univ, Sch Med, Dept Plast Surg, Stanford, CA 94305 USA; [Bangs, Charles] Stanford Univ, Sch Med, Dept Pathol Cytogenet, Stanford, CA 94305 USA; [Robbins, Robert C.] Stanford Univ, Sch Med, Dept Cardiothorac Surg, Stanford, CA 94305 USA; [Longaker, Michael T.; Wu, Joseph C.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Longaker, MT (corresponding author), 257 Campus Dr, Stanford, CA 94305 USA.	longaker@stanford.edu; joewu@stanford.edu	Lee, Andrew/GVU-2817-2022; Han, Leng/G-5093-2012; Hu, Shijun/I-5818-2012; Lan, Feng/I-2023-2012; Wu, Joseph/H-1067-2013	Lan, Feng/0000-0002-9038-4014; IKENO, FUMIAKI/0000-0003-2905-0311; Wu, Joseph/0000-0002-6068-8041; Han, Leng/0000-0002-7380-2640; Hu, Shijun/0000-0002-0068-8429	National Institutes of Health [DP2OD004437, HL089027, HL099117, EB009689, HL100490, HL099776]; Mallinckrodt Foundation; Howard Hughes Medical Institute; Radiological Society of North America; Stanford Bio-X Program; California Institute for Regenerative Medicine (CIRM) [T1-00001, CIRM RL1-00662-1]; Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099776, R21HL089027, RC1HL099117, R33HL089027, RC1HL100490, T32HL098049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009689] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mallinckrodt Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Radiological Society of North America; Stanford Bio-X Program; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants DP2OD004437, HL089027, HL099117, and EB009689 (to J. C. W.), HL100490 (to M. T. L.), and HL099776 (to R. C. R.). This work was also supported by the Mallinckrodt Foundation (to J. C. W.), the Howard Hughes Medical Institute (to A. S. L. and K. H. N.), the Radiological Society of North America (to A. S. L. and K. H. N.), the Stanford Bio-X Program (to A. S. L.), the California Institute for Regenerative Medicine (CIRM) T1-00001, CIRM RL1-00662-1, and and the Oak Foundation and the Hagey Laboratory for Pediatric Regenerative Medicine (to M. T. L.).	Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hayes B, 2008, STEM CELLS, V26, P465, DOI 10.1634/stemcells.2007-0640; Huang Ngan F, 2009, J Vis Exp, DOI 10.3791/1034; Keefer CL, 2007, ANIM REPROD SCI, V98, P147, DOI 10.1016/j.anireprosci.2006.10.009; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Li Z., 2011, STEM CELLS IN PRESS; Li ZJ, 2008, STEM CELLS, V26, P864, DOI 10.1634/stemcells.2007-0843; Li Z, 2007, CIRCULATION, V116, pI46, DOI 10.1161/CIRCULATIONAHA.106.680561; Li ZJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008443; Li ZJ, 2009, J AM COLL CARDIOL, V53, P1229, DOI 10.1016/j.jacc.2008.12.036; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Luo J., 2011, STEM CELLS IN PRESS; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Shimada H, 2010, MOL REPROD DEV, V77, P2, DOI 10.1002/mrd.21117; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vaags AK, 2009, STEM CELLS, V27, P329, DOI 10.1634/stemcells.2008-0433; Wilcox JT, 2009, STEM CELLS DEV, V18, P1167, DOI 10.1089/scd.2008.0336; Willmann JK, 2009, RADIOLOGY, V252, P117, DOI 10.1148/radiol.2513081616; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	30	73	74	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32697	32704		10.1074/jbc.M111.235739	http://dx.doi.org/10.1074/jbc.M111.235739			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21719696	Green Published, hybrid			2022-12-25	WOS:000294726800078
J	Wang, D; Zetterstrom, CE; Gabrielsen, M; Beckham, KSH; Tree, JJ; Macdonald, SE; Byron, O; Mitchell, TJ; Gally, DL; Herzyk, P; Mahajan, A; Uvell, H; Burchmore, R; Smith, BO; Elofsson, M; Roe, AJ				Wang, Dai; Zetterstrom, Caroline E.; Gabrielsen, Mads; Beckham, Katherine S. H.; Tree, Jai J.; Macdonald, Sarah E.; Byron, Olwyn; Mitchell, Tim J.; Gally, David L.; Herzyk, Pawel; Mahajan, Arvind; Uvell, Hanna; Burchmore, Richard; Smith, Brian O.; Elofsson, Mikael; Roe, Andrew J.			Identification of Bacterial Target Proteins for the Salicylidene Acylhydrazide Class of Virulence-blocking Compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; ENTEROHEMORRHAGIC ESCHERICHIA-COLI; ENTERICA SEROVAR TYPHIMURIUM; III SECRETION INHIBITORS; CHLAMYDIA-TRACHOMATIS; THIOL PEROXIDASE; DRUG DISCOVERY; YERSINIA; EXPRESSION; STRATEGIES	A class of anti-virulence compounds, the salicylidene acylhydrazides, has been widely reported to block the function of the type three secretion system of several Gram-negative pathogens by a previously unknown mechanism. In this work we provide the first identification of bacterial proteins that are targeted by this group of compounds. We provide evidence that their mode of action is likely to result from a synergistic effect arising from a perturbation of the function of several conserved proteins. We also examine the contribution of selected target proteins to the pathogenicity of Yersinia pseudotuberculosis and to expression of virulence genes in Escherichia coli O157.	[Zetterstrom, Caroline E.; Elofsson, Mikael] Umea Univ, Dept Chem, SE-90187 Umea, Sweden; [Wang, Dai; Gabrielsen, Mads; Beckham, Katherine S. H.; Macdonald, Sarah E.; Mitchell, Tim J.; Burchmore, Richard; Roe, Andrew J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G12 8QQ, Lanark, Scotland; [Byron, Olwyn; Smith, Brian O.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Herzyk, Pawel; Smith, Brian O.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [Uvell, Hanna; Elofsson, Mikael] Umea Univ, Umea Ctr Microbial Res, SE-90187 Umea, Sweden; [Uvell, Hanna; Elofsson, Mikael] Umea Univ, Labs Mol Infect Med Sweden, SE-90187 Umea, Sweden; [Elofsson, Mikael] Umea Univ, Labs Chem Biol Umea, Dept Chem, SE-90187 Umea, Sweden; [Tree, Jai J.; Gally, David L.; Mahajan, Arvind] Univ Edinburgh, Zoonot & Anim Pathogens Res Lab, Immun & Infect Div, Roslin Inst, Edinburgh EH16 4SB, Midlothian, Scotland; [Tree, Jai J.; Gally, David L.; Mahajan, Arvind] Univ Edinburgh, R D SVS, Edinburgh EH16 4SB, Midlothian, Scotland	Umea University; University of Glasgow; University of Glasgow; University of Glasgow; Umea University; Umea University; Umea University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Elofsson, M (corresponding author), Umea Univ, Dept Chem, SE-90187 Umea, Sweden.	Mikael.Elofsson@chem.umu.se; andrew.roe@glasgow.ac.uk	Smith, Brian O/J-1899-2015; Smith, Brian/AAJ-9393-2020; Burchmore, Richard/A-1896-2011	Smith, Brian O/0000-0003-3363-4168; Smith, Brian/0000-0003-3363-4168; Elofsson, Mikael/0000-0002-3219-4669; Tree, Jai/0000-0001-8233-0975; Mitchell, Timothy/0000-0002-8309-5556; Gabrielsen, Mads/0000-0002-9848-2276; Beckham, Kate/0000-0002-4929-6119; roe, andrew/0000-0003-3698-6134; Gally, David/0000-0002-2566-0844; Burchmore, Richard/0000-0003-1663-9004; Byron, Olwyn/0000-0001-7857-4520	Medical Research Scotland [223 ORG]; Biotechnology and Biological Sciences Research Council (Swindon, United Kingdom) [BB/G011389/1]; Swedish Research Council; Wellcome Trust; Knut and Alice Wallenberg Foundation; Vinnova; BBSRC [BB/G011389/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G011389/1] Funding Source: researchfish	Medical Research Scotland; Biotechnology and Biological Sciences Research Council (Swindon, United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Vinnova(Vinnova); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was generously supported by Medical Research Scotland Grant 223 ORG (to D. W., A. J. R. and R. B.) and Biotechnology and Biological Sciences Research Council (Swindon, United Kingdom) Grant BB/G011389/1 (to A. J. R. and M. G.).; Supported by the Swedish Research Council.; Supported by the Wellcome Trust.; Supported by the Knut and Alice Wallenberg Foundation and Vinnova.	Bailey L, 2007, FEBS LETT, V581, P587, DOI 10.1016/j.febslet.2007.01.013; Baker LMS, 2003, J BIOL CHEM, V278, P9203, DOI 10.1074/jbc.M209888200; Barker JJ, 2006, DRUG DISCOV TODAY, V11, P391, DOI 10.1016/j.drudis.2006.03.001; Baron C, 2010, CURR OPIN MICROBIOL, V13, P100, DOI 10.1016/j.mib.2009.12.003; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Chu H, 2010, INT J ANTIMICROB AG, V36, P145, DOI 10.1016/j.ijantimicag.2010.03.018; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Dahlgren MK, 2007, J MED CHEM, V50, P6177, DOI 10.1021/jm070741b; Dahlgren MK, 2010, MOLECULES, V15, P4423, DOI 10.3390/molecules15064423; Dahlgren MK, 2010, BIOORGAN MED CHEM, V18, P2686, DOI 10.1016/j.bmc.2010.02.022; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Escaich S, 2008, CURR OPIN CHEM BIOL, V12, P400, DOI 10.1016/j.cbpa.2008.06.022; Gabrielsen M, 2010, ACTA CRYSTALLOGR F, V66, P1606, DOI 10.1107/S1744309110039679; Guiffant Damien, 2007, Biotechnology Journal, V2, P68, DOI 10.1002/biot.200600223; Hall A, 2009, J MOL BIOL, V393, P867, DOI 10.1016/j.jmb.2009.08.040; Hillgren JM, 2010, MOLECULES, V15, P6019, DOI 10.3390/molecules15096019; Horst SA, 2010, J BACTERIOL, V192, P2929, DOI 10.1128/JB.01652-09; Hudson DL, 2007, ANTIMICROB AGENTS CH, V51, P2631, DOI 10.1128/AAC.01492-06; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Hung DT, 2006, CURR OPIN CHEM BIOL, V10, P321, DOI 10.1016/j.cbpa.2006.06.016; Iyoda S, 2006, J BACTERIOL, V188, P5682, DOI 10.1128/JB.00352-06; Kauppi AM, 2003, CHEM BIOL, V10, P241, DOI 10.1016/S1074-5521(03)00046-2; Kauppi AM, 2007, BIOORGAN MED CHEM, V15, P6994, DOI 10.1016/j.bmc.2007.07.047; Keyser P, 2008, J INTERN MED, V264, P17, DOI 10.1111/j.1365-2796.2008.01941.x; Leslie BJ, 2008, CHEM SOC REV, V37, P1347, DOI 10.1039/b702942j; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Linusson A, 2010, CURR MED CHEM, V17, P2001, DOI 10.2174/092986710791233661; Lynch SV, 2008, CURR OPIN CRIT CARE, V14, P593, DOI 10.1097/MCC.0b013e32830f1dd5; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Morphy R, 2009, CURR PHARM DESIGN, V15, P587, DOI 10.2174/138161209787315594; Muschiol S, 2006, P NATL ACAD SCI USA, V103, P14566, DOI 10.1073/pnas.0606412103; Nachin L, 2005, J BACTERIOL, V187, P6265, DOI 10.1128/JB.187.18.6265-6272.2005; Negrea A, 2007, ANTIMICROB AGENTS CH, V51, P2867, DOI 10.1128/AAC.00223-07; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Patridge EV, 2006, J BACTERIOL, V188, P3498, DOI 10.1128/JB.188.10.3498-3506.2006; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Ploom T, 1999, STRUCT FOLD DES, V7, P509, DOI 10.1016/S0969-2126(99)80067-7; Puri AW, 2009, ACS CHEM BIOL, V4, P603, DOI 10.1021/cb9001409; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Rietsch A, 2006, MOL MICROBIOL, V59, P807, DOI 10.1111/j.1365-2958.2005.04990.x; Roe AJ, 2003, BIOCHEM SOC T, V31, P98, DOI 10.1042/bst0310098; Roe AJ, 2007, MICROBIOL-SGM, V153, P1350, DOI 10.1099/mic.0.2006/003707-0; Sambrook S, 1989, MOL CLONING LAB MANU; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Simmons KJ, 2010, NAT REV MICROBIOL, V8, P501, DOI 10.1038/nrmicro2349; Slepenkin A, 2007, INFECT IMMUN, V75, P3478, DOI 10.1128/IAI.00023-07; Terstappen GC, 2007, NAT REV DRUG DISCOV, V6, P891, DOI 10.1038/nrd2410; Tree JJ, 2009, INFECT IMMUN, V77, P4209, DOI 10.1128/IAI.00562-09; Veenendaal AKJ, 2009, J BACTERIOL, V191, P563, DOI 10.1128/JB.01004-08; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wolf K, 2006, MOL MICROBIOL, V61, P1543, DOI 10.1111/j.1365-2958.2006.05347.x; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459	56	73	75	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29922	29931		10.1074/jbc.M111.233858	http://dx.doi.org/10.1074/jbc.M111.233858			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21724850	Green Published, hybrid			2022-12-25	WOS:000294046600051
J	Gould, CM; Antal, CE; Reyes, G; Kunkel, MT; Adams, RA; Ziyar, A; Riveros, T; Newton, AC				Gould, Christine M.; Antal, Corina E.; Reyes, Gloria; Kunkel, Maya T.; Adams, Ryan A.; Ziyar, Ahdad; Riveros, Tania; Newton, Alexandra C.			Active Site Inhibitors Protect Protein Kinase C from Dephosphorylation and Stabilize Its Mature Form	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE-DEPENDENT KINASE; CRYSTAL-STRUCTURE; IN-VIVO; BETA-II; PKC; PHOSPHORYLATION; ALPHA; AKT; AUTOPHOSPHORYLATION; ACTIVATION	Conformational changes acutely control protein kinase C (PKC). We have previously shown that the autoinhibitory pseudosubstrate must be removed from the active site in order for 1) PKC to be phosphorylated by its upstream kinase phosphoinositide-dependent kinase 1 (PDK-1), 2) the mature enzyme to bind and phosphorylate substrates, and 3) the mature enzyme to be dephosphorylated by phosphatases. Here we show an additional level of conformational control; binding of active site inhibitors locks PKC in a conformation in which the priming phosphorylation sites are resistant to dephosphorylation. Using homogeneously pure PKC, we show that the active site inhibitor Go 6983 prevents the dephosphorylation by pure protein phosphatase 1 (PP1) or the hydrophobic motif phosphatase, pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP). Consistent with results using pure proteins, treatment of cells with the competitive inhibitors Go 6983 or bisindolylmaleimide I, but not the uncompetitive inhibitor bisindolylmaleimide IV, prevents the dephosphorylation and down-regulation of PKC induced by phorbol esters. Pulse-chase analyses reveal that active site inhibitors do not affect the net rate of priming phosphorylations of PKC; rather, they inhibit the dephosphorylation triggered by phorbol esters. These data provide a molecular explanation for the recent studies showing that active site inhibitors stabilize the phosphorylation state of protein kinases B/Akt and C.	[Gould, Christine M.; Antal, Corina E.; Reyes, Gloria; Kunkel, Maya T.; Adams, Ryan A.; Ziyar, Ahdad; Riveros, Tania; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Gould, Christine M.; Antal, Corina E.; Riveros, Tania] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	anewton@ucsd.edu			National Institutes of Health [R01 GM43154]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM043154, R37GM043154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM43154 (to A.C.N.).	Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Behn-Krappa A, 1999, CURR BIOL, V9, P728, DOI 10.1016/S0960-9822(99)80332-7; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; Cameron AJ, 2007, BIOCHEM SOC T, V35, P1013, DOI 10.1042/BST0351013; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dutil EM, 2000, J BIOL CHEM, V275, P10697, DOI 10.1074/jbc.275.14.10697; DUTIL EM, 1994, J BIOL CHEM, V269, P29359; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Grodsky N, 2006, BIOCHEMISTRY-US, V45, P13970, DOI 10.1021/bi061128h; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hansra G, 1996, J BIOL CHEM, V271, P32785, DOI 10.1074/jbc.271.51.32785; Hansra G, 1999, BIOCHEM J, V342, P337, DOI 10.1042/0264-6021:3420337; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lee HW, 1996, J BIOL CHEM, V271, P20973, DOI 10.1074/jbc.271.35.20973; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Narayana N, 1999, BIOCHEMISTRY-US, V38, P2367, DOI 10.1021/bi9820659; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Sonnenburg ED, 2001, J BIOL CHEM, V276, P45289, DOI 10.1074/jbc.M107416200; Sossin WS, 2007, LEARN MEMORY, V14, P236, DOI 10.1101/lm.469707; Srivastava J, 2002, FEBS LETT, V516, P265, DOI 10.1016/S0014-5793(02)02500-0; Sweatt JD, 1998, J NEUROCHEM, V71, P1075; Takimura T, 2010, ACTA CRYSTALLOGR D, V66, P577, DOI 10.1107/S0907444910005639	40	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28922	28930		10.1074/jbc.M111.272526	http://dx.doi.org/10.1074/jbc.M111.272526			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21715334	Green Published, hybrid			2022-12-25	WOS:000293837000029
J	Keyamura, K; Katayama, T				Keyamura, Kenji; Katayama, Tsutomu			DnaA Protein DNA-binding Domain Binds to Hda Protein to Promote Inter-AAA plus Domain Interaction Involved in Regulatory Inactivation of DnaA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; REPLICATION INITIATION; CHROMOSOMAL REPLICATION; ATP HYDROLYSIS; SLIDING CLAMP; E. COLI; BACILLUS-SUBTILIS; STRUCTURAL BASIS; RNA-POLYMERASE; ADP-DNAA	Chromosomal replication is initiated from the replication origin oriC in Escherichia coli by the active ATP-bound form of DnaA protein. The regulatory inactivation of DnaA (RIDA) system, a complex of the ADP-bound Hda and the DNA-loaded replicase clamp, represses extra initiations by facilitating DnaA-bound ATP hydrolysis, yielding the inactive ADP-bound form of DnaA. However, the mechanisms involved in promoting the DnaA-Hda interaction have not been determined except for the involvement of an interaction between the AAA+ domains of the two. This study revealed that DnaA Leu-422 and Pro-423 residues within DnaA domain IV, including a typical DNA-binding HTH motif, are specifically required for RIDA-dependent ATP hydrolysis in vitro and that these residues support efficient interaction with the DNA-loaded clamp.Hda complex and with Hda in vitro. Consistently, substitutions of these residues caused accumulation of ATP-bound DnaA in vivo and oriC-dependent inhibition of cell growth. Leu-422 plays a more important role in these activities than Pro-423. By contrast, neither of these residues is crucial for DNA replication from oriC, although they are highly conserved in DnaA orthologues. Structural analysis of a DnaA.Hda complex model suggested that these residues make contact with residues in the vicinity of the Hda AAA+ sensor I that participates in formation of a nucleotide-interacting surface. Together, the results show that functional DnaA-Hda interactions require a second interaction site within DnaA domain IV in addition to the AAA+ domain and suggest that these interactions are crucial for the formation of RIDA complexes that are active for DnaA-ATP hydrolysis.	[Katayama, Tsutomu] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Katayama, T (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	katayama@phar.kyushu-u.ac.jp		Katayama, Tsutomu/0000-0001-9994-1684	Ministry of Education, Culture, Sports, Technology and Science of Japan	Ministry of Education, Culture, Sports, Technology and Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from Ministry of Education, Culture, Sports, Technology and Science of Japan.	Abe Y, 2007, J BIOL CHEM, V282, P17816, DOI 10.1074/jbc.M701841200; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Asklund M, 2005, J MOL BIOL, V345, P717, DOI 10.1016/j.jmb.2004.10.092; Camara JE, 2005, EMBO REP, V6, P736, DOI 10.1038/sj.embor.7400467; Collier J, 2009, J BACTERIOL, V191, P5706, DOI 10.1128/JB.00525-09; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; De Felice M, 2004, BIOCHEM J, V381, P645, DOI 10.1042/BJ20040280; Duderstadt KE, 2010, J BIOL CHEM, V285, P28229, DOI 10.1074/jbc.M110.147975; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Felczak MM, 2009, MOL MICROBIOL, V72, P1348, DOI 10.1111/j.1365-2958.2009.06724.x; Felczak MM, 2005, J BIOL CHEM, V280, P24627, DOI 10.1074/jbc.M503684200; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; Fujimitsu K, 2008, J BACTERIOL, V190, P5368, DOI 10.1128/JB.00044-08; Fujimitsu K, 2009, GENE DEV, V23, P1221, DOI 10.1101/gad.1775809; Gerega A, 2005, J BIOL CHEM, V280, P42856, DOI 10.1074/jbc.M510592200; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hayashi M, 2005, FEMS MICROBIOL LETT, V247, P73, DOI 10.1016/j.femsle.2005.04.028; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Katayama T, 2001, MOL MICROBIOL, V41, P9, DOI 10.1046/j.1365-2958.2001.02483.x; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; Kato J, 2001, EMBO J, V20, P4253, DOI 10.1093/emboj/20.15.4253; Kawakami H, 2005, J BIOL CHEM, V280, P27420, DOI 10.1074/jbc.M502764200; Keyamura K, 2007, GENE DEV, V21, P2083, DOI 10.1101/gad.1561207; Keyamura K, 2009, J BIOL CHEM, V284, P25038, DOI 10.1074/jbc.M109.002717; Kitagawa R, 1998, GENE DEV, V12, P3032, DOI 10.1101/gad.12.19.3032; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kondo H, 1997, NAT STRUCT BIOL, V4, P28, DOI 10.1038/nsb0197-28; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Kurz M, 2004, J BACTERIOL, V186, P3508, DOI 10.1128/JB.186.11.3508-3515.2004; Leonard AC, 2010, CURR OPIN MICROBIOL, V13, P766, DOI 10.1016/j.mib.2010.10.001; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; Makino K, 1996, J MOL BIOL, V259, P15, DOI 10.1006/jmbi.1996.0298; Makowska-Grzyska M, 2010, MOL CELL, V37, P90, DOI 10.1016/j.molcel.2009.12.031; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; Nakamura K, 2010, MOL MICROBIOL, V76, P302, DOI 10.1111/j.1365-2958.2010.07074.x; Neuwald AF, 1999, GENOME RES, V9, P27; Nievera C, 2006, MOL CELL, V24, P581, DOI 10.1016/j.molcel.2006.09.016; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Noirot-Gros MF, 2006, P NATL ACAD SCI USA, V103, P2368, DOI 10.1073/pnas.0506914103; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; Ralph E, 2006, EMBO REP, V7, P1134, DOI 10.1038/sj.embor.7400827; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Riber L, 2005, J BACTERIOL, V187, P5605, DOI 10.1128/JB.187.16.5605-5613.2005; Riber L, 2009, MOL MICROBIOL, V71, P107, DOI 10.1111/j.1365-2958.2008.06516.x; ROTH A, 1995, EMBO J, V14, P2106, DOI 10.1002/j.1460-2075.1995.tb07202.x; Roth A, 1998, MOL MICROBIOL, V28, P395, DOI 10.1046/j.1365-2958.1998.00813.x; SCHAPER S, 1995, J BIOL CHEM, V270, P17622, DOI 10.1074/jbc.270.29.17622; Seitz H, 2000, MOL MICROBIOL, V37, P1270, DOI 10.1046/j.1365-2958.2000.02096.x; Shin JH, 2003, J BIOL CHEM, V278, P49053, DOI 10.1074/jbc.M308599200; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Su'etsugu M, 2005, J BIOL CHEM, V280, P6528, DOI 10.1074/jbc.M412060200; Su'etsugu M, 2004, GENES CELLS, V9, P509, DOI 10.1111/j.1356-9597.2004.00741.x; Su'etsugu M, 2008, J BIOL CHEM, V283, P36118, DOI 10.1074/jbc.M803158200; THEISEN PW, 1993, MOL MICROBIOL, V10, P575, DOI 10.1111/j.1365-2958.1993.tb00929.x; Waldminghaus T, 2009, PLASMID, V61, P141, DOI 10.1016/j.plasmid.2009.02.004; Xu QP, 2009, J MOL BIOL, V385, P368, DOI 10.1016/j.jmb.2008.10.059; Yoshida Y, 2003, CELL MOL LIFE SCI, V60, P1998, DOI 10.1007/s00018-003-3176-7; YOSHIKAWA H, 1991, MOL MICROBIOL, V5, P2589, DOI 10.1111/j.1365-2958.1991.tb01967.x; Zakrzewska-Czerwinska J, 2007, FEMS MICROBIOL REV, V31, P378, DOI 10.1111/j.1574-6976.2007.00070.x	65	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29336	29346		10.1074/jbc.M111.233403	http://dx.doi.org/10.1074/jbc.M111.233403			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21708944	hybrid, Green Published			2022-12-25	WOS:000293837000068
J	Sun, XW; Essalmani, R; Susan-Resiga, D; Prat, A; Seidah, NG				Sun, Xiaowei; Essalmani, Rachid; Susan-Resiga, Delia; Prat, Annik; Seidah, Nabil G.			Latent Transforming Growth Factor beta-Binding Proteins-2 and-3 Inhibit the Proprotein Convertase 5/6A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; PROHORMONE CONVERTASE; EXTRACELLULAR-MATRIX; SKELETAL-MUSCLE; CDNA STRUCTURE; 7B2; FURIN; CELLS; MOUSE; DIFFERENTIATION	The basic amino acid-specific proprotein convertase 5/6 (PC5/6) is an essential secretory protease, as knock-out mice die at birth and exhibit multiple homeotic transformation defects, including impaired bone morphogenesis and lung structure. Some of the observed defects were attributed to impaired processing of the TGF beta-like growth differentiating factor 11 precursor (proGdf11). In this work we present evidence that the latent TGF beta-binding proteins 2 and 3 (LTBP-2 and -3) inhibit the extracellular processing of proGdf11 by PC5/6A. This is partly due to the binding of LTBPs in the endoplasmic reticulum to the zymogen proPC5/6A, thus allowing the complex to exit the endoplasmic reticulum and be sequestered as an inactive zymogen in the extracellular matrix but not at the cell surface. This results in lower levels of PC5/6A in the media, without affecting those of PACE4, Furin, or a soluble form of PC7. The secreted soluble protease-specific activity of PC5/6A or a variant lacking the C-terminal Cys-rich domain (PC5/6-Delta CRD) is significantly decreased when co-expressed with LTBPs in cells. A similar enzymatic inhibition seems to apply to PACE4 and Furin. In situ hybridization analyses revealed extensive co-localization of PC5/6 and LTBP-3 mRNAs in mice at embryonic day 15.5 and post partum day 1. In conclusion, this is the first time that a zymogen of the proprotein convertases was shown to exit the endoplasmic reticulum in the presence of LTBPs, representing a potential novel mechanism for the regulation of PC5/6A activity, e. g. in tissues such as bone and lung where LTBP-3 and PC5/6 co-localize.	[Sun, Xiaowei; Essalmani, Rachid; Susan-Resiga, Delia; Prat, Annik; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Seidah, NG (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013; Prat, Annik/S-6757-2018; Susan-Resiga@ircm.qc.ca, Delia/O-2548-2017	Seidah, Nabil/0000-0001-6503-9342; Prat, Annik/0000-0002-8007-5277; Susan-Resiga@ircm.qc.ca, Delia/0000-0002-4856-090X	Canadian Institutes of Health Research [MOP-44363]; Strauss Foundation; Canada Chair [216684]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Strauss Foundation; Canada Chair	This work was supported by Canadian Institutes of Health Research Grant MOP-44363, a Strauss Foundation grant, and Canada Chair Grant 216684.	Anderson SB, 2008, J BIOL CHEM, V283, P7027, DOI 10.1074/jbc.M706678200; Apletalina EV, 2000, BIOCHEM BIOPH RES CO, V267, P940, DOI 10.1006/bbrc.1999.2060; BEAUBIEN G, 1995, CELL TISSUE RES, V279, P539; BENJANNET S, 1995, J NEUROCHEM, V64, P2303; BENJANNET S, 1993, BIOCHEM J, V294, P735, DOI 10.1042/bj2940735; Bernot D, 2011, J CELL SCI, V124, P1224, DOI 10.1242/jcs.079889; Dabovic B, 2002, J ENDOCRINOL, V175, P129, DOI 10.1677/joe.0.1750129; DALLAS SL, 1995, J CELL BIOL, V131, P539, DOI 10.1083/jcb.131.2.539; DeBie I, 1996, J CELL BIOL, V135, P1261, DOI 10.1083/jcb.135.5.1261; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; Essalmani R, 2008, P NATL ACAD SCI USA, V105, P5750, DOI 10.1073/pnas.0709428105; Gamer LW, 1999, DEV BIOL, V208, P222, DOI 10.1006/dbio.1998.9191; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; Ho DM, 2010, MECH DEVELOP, V127, P485, DOI 10.1016/j.mod.2010.08.004; Hyytiainen M, 1998, J BIOL CHEM, V273, P20669, DOI 10.1074/jbc.273.32.20669; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; JEAN F, 1995, J BIOL CHEM, V270, P19225, DOI 10.1074/jbc.270.33.19225; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Koli K, 2005, EXP CELL RES, V310, P370, DOI 10.1016/j.yexcr.2005.08.008; Leighton M, 2003, J BIOL CHEM, V278, P18478, DOI 10.1074/jbc.M213021200; LINDBERG I, 1995, BIOCHEMISTRY-US, V34, P5486, DOI 10.1021/bi00016a020; Liu SG, 2009, MOL ENDOCRINOL, V23, P1505, DOI 10.1210/me.2009-0085; LUSSON J, 1993, P NATL ACAD SCI USA, V90, P6691, DOI 10.1073/pnas.90.14.6691; Marcinkiewicz M, 1999, J COMP NEUROL, V403, P471, DOI 10.1002/(SICI)1096-9861(19990125)403:4<471::AID-CNE4>3.0.CO;2-S; MARTENS GJM, 1994, P NATL ACAD SCI USA, V91, P5784, DOI 10.1073/pnas.91.13.5784; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; MBIKAY M, 1989, INT J PEPT PROT RES, V33, P39; Mbikay M, 2001, BIOCHEM J, V357, P329, DOI 10.1042/0264-6021:3570329; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; NAKAGAWA T, 1993, FEBS LETT, V327, P165, DOI 10.1016/0014-5793(93)80163-O; Nelsen SM, 2009, J BIOL CHEM, V284, P27157, DOI 10.1074/jbc.M109.028506; Nour N, 2005, MOL BIOL CELL, V16, P5215, DOI 10.1091/mbc.E05-06-0504; Nour N, 2003, J BIOL CHEM, V278, P2886, DOI 10.1074/jbc.M208009200; Oh SP, 2002, GENE DEV, V16, P2749, DOI 10.1101/gad.1021802; PAQUET L, 1994, J BIOL CHEM, V269, P19279; Parsi MK, 2010, MATRIX BIOL, V29, P393, DOI 10.1016/j.matbio.2010.03.005; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Rousselet E, 2011, J BIOL CHEM, V286, P2728, DOI 10.1074/jbc.M110.192344; Saharinen J, 2000, MOL BIOL CELL, V11, P2691, DOI 10.1091/mbc.11.8.2691; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; SEIDAH NG, 1983, ARCH BIOCHEM BIOPHYS, V225, P525, DOI 10.1016/0003-9861(83)90063-2; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; Szumska D, 2008, GENE DEV, V22, P1465, DOI 10.1101/gad.479408; Yuasa K, 2009, J BIOCHEM, V146, P407, DOI 10.1093/jb/mvp090; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	48	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29063	29073		10.1074/jbc.M111.242479	http://dx.doi.org/10.1074/jbc.M111.242479			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21700711	hybrid, Green Published			2022-12-25	WOS:000293837000043
J	Zong, F; Fthenou, E; Mundt, F; Szatmari, T; Kovalszky, I; Szilak, L; Brodin, D; Tzanakakis, G; Hjerpe, A; Dobra, K				Zong, Fang; Fthenou, Eleni; Mundt, Filip; Szatmari, Tunde; Kovalszky, Ilona; Szilak, Laszlo; Brodin, David; Tzanakakis, George; Hjerpe, Anders; Dobra, Katalin			Specific Syndecan-1 Domains Regulate Mesenchymal Tumor Cell Adhesion, Motility and Migration	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; BREAST-CARCINOMA CELLS; SUPPRESSOR 1 MTSS1; CORE PROTEIN; CD2 FAMILY; CANCER; METASTASIS; ECTODOMAIN; RECEPTOR; ALPHA(V)BETA(3)	Background: Syndecans are proteoglycans whose core proteins have a short cytoplasmic domain, a transmembrane domain and a large N-terminal extracellular domain possessing glycosaminoglycan chains. Syndecans are involved in many important cellular processes. Our recent publications have demonstrated that syndecan-1 translocates into the nucleus and hampers tumor cell proliferation. In the present study, we aimed to investigate the role of syndecan-1 in tumor cell adhesion and migration, with special focus on the importance of its distinct protein domains, to better understand the structure-function relationship of syndecan-1 in tumor progression. Methodology/Principal Findings: We utilized two mesenchymal tumor cell lines which were transfected to stably overexpress full-length syndecan-1 or truncated variants: the 78 which lacks the extracellular domain except the DRKE sequence proposed to be essential for oligomerization, the 77 which lacks the whole extracellular domain, and the RMKKK which serves as a nuclear localization signal. The deletion of the RMKKK motif from full-length syndecan-1 abolished the nuclear translocation of this proteoglycan. Various bioassays for cell adhesion, chemotaxis, random movement and wound healing were studied. Furthermore, we performed gene microarray to analyze the global gene expression pattern influenced by syndecan-1. Both full-length and truncated syndecan-1 constructs decrease tumor cell migration and motility, and affect cell adhesion. Distinct protein domains have differential effects, the extracellular domain is more important for promoting cell adhesion, while the transmembrane and cytoplasmic domains are sufficient for inhibition of cell migration. Cell behavior seems to depend also on the nuclear translocation of syndecan-1. Many genes are differentially regulated by syndecan-1 and a number of genes are actually involved in cell adhesion and migration. Conclusions/Significance: Our results demonstrate that syndecan-1 regulates mesenchymal tumor cell adhesion and migration, and different domains have differential effects. Our study provides new insights into better understanding of the role of syndecans in tumor progression.	[Zong, Fang; Mundt, Filip; Szatmari, Tunde; Hjerpe, Anders; Dobra, Katalin] Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden; [Fthenou, Eleni; Tzanakakis, George] Univ Crete, Sch Med, Dept Histol, Div Morphol, Iraklion, Greece; [Kovalszky, Ilona] Semmelweis Univ, Inst Pathol & Expt Canc Res 1, Budapest, Hungary; [Szilak, Laszlo] Western Hungarian Univ, Savaria Univ Ctr, Inst Biol, Szombathely, Hungary; [Brodin, David] Karolinska Inst, Dept Biosci & Nutr, Bioinformat & Express Anal Core Facil, Stockholm, Sweden	Karolinska Institutet; University of Crete; Semmelweis University; University of West Hungary; Karolinska Institutet	Zong, F (corresponding author), Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden.	Fang.Zong@ki.se	Szilak, Laszlo/T-1426-2017; Tzanakakis, George/ABH-7725-2020; zong, fang/GQZ-6104-2022; Szatmári, Tünde/AAC-5808-2020; Kovalszky, Ilona/ABH-2832-2020; Tzanakakis, George N/F-6955-2010	Szilak, Laszlo/0000-0003-0334-272X; Tzanakakis, George/0000-0001-5276-4764; Szatmári, Tünde/0000-0001-7727-9589; Kovalszky, Ilona/0000-0002-0179-3378; Tzanakakis, George N/0000-0001-5276-4764; Fthenou, Eleni/0000-0002-1178-6841	Swedish Heart and Lung Fund [20080549]; Swedish AFA [56301063]	Swedish Heart and Lung Fund; Swedish AFA	This research was funded by grants from the Swedish Heart and Lung Fund (20080549, http://www.hjart-lungfonden.se) and a Swedish AFA research grant (56301063, http://www.afa.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; ASUNDI VK, 1995, J BIOL CHEM, V270, P26404, DOI 10.1074/jbc.270.44.26404; Bailly M, 1998, EXP CELL RES, V241, P285, DOI 10.1006/excr.1998.4031; Bass MD, 2002, BIOCHEM J, V368, P1, DOI 10.1042/BJ20021228; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Beauvais DM, 2003, EXP CELL RES, V286, P219, DOI 10.1016/S0014-4827(03)00126-5; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Boles KS, 2001, IMMUNOGENETICS, V52, P302, DOI 10.1007/s002510000274; Bouchon A, 2001, J IMMUNOL, V167, P5517, DOI 10.4049/jimmunol.167.10.5517; Brockstedt U, 2002, EXP CELL RES, V274, P235, DOI 10.1006/excr.2002.5477; Burbach BJ, 2004, EXP CELL RES, V300, P234, DOI 10.1016/j.yexcr.2004.07.001; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0; Cattaruzza S, 2005, MATRIX BIOL, V24, P400, DOI 10.1016/j.matbio.2005.06.005; Chakravarti R, 2005, MOL BIOL CELL, V16, P3678, DOI 10.1091/mbc.E04-10-0907; Chakravarti R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-83; Chalkiadaki G, 2009, INT J BIOCHEM CELL B, V41, P1323, DOI 10.1016/j.biocel.2008.11.008; Chen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004947; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Dobra K, 2000, EXP CELL RES, V258, P12, DOI 10.1006/excr.2000.4915; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Harms BD, 2005, BIOPHYS J, V88, P1479, DOI 10.1529/biophysj.104.047365; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Ivanova AV, 2009, CLIN CANCER RES, V15, P2602, DOI 10.1158/1078-0432.CCR-08-2755; Izawa I, 2002, J BIOL CHEM, V277, P5345, DOI 10.1074/jbc.M110052200; JALKANEN M, 1987, J CELL BIOL, V105, P3087, DOI 10.1083/jcb.105.6.3087; Kirn-Safran C, 2009, CELL MOL LIFE SCI, V66, P3421, DOI 10.1007/s00018-009-0096-1; KLOMINEK J, 1989, CANCER RES, V49, P6118; Kumaresan PR, 2002, MOL IMMUNOL, V39, P1, DOI 10.1016/S0161-5890(02)00094-9; Langford JK, 2005, J BIOL CHEM, V280, P3467, DOI 10.1074/jbc.M412451200; Lee JK, 2007, J IMMUNOL, V179, P4672, DOI 10.4049/jimmunol.179.7.4672; Lee JH, 2009, J BIOL CHEM, V284, P27167, DOI 10.1074/jbc.M109.034678; Lee YG, 2002, NEOPLASIA, V4, P291, DOI 10.1038/sj.neo.7900231; Liu K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-428; Liu W, 1998, J BIOL CHEM, V273, P22825, DOI 10.1074/jbc.273.35.22825; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Ma S, 2007, HUM PATHOL, V38, P1201, DOI 10.1016/j.humpath.2007.01.004; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; Okina E, 2009, SCAND J MED SCI SPOR, V19, P479, DOI 10.1111/j.1600-0838.2009.00941.x; Parr C, 2009, EUR J CANCER, V45, P1673, DOI 10.1016/j.ejca.2009.02.019; Peterfia Balint, 2006, Magy Onkol, V50, P115; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; STANLEY MJ, 1995, J BIOL CHEM, V270, P5077, DOI 10.1074/jbc.270.10.5077; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; THURZO V, 1976, NEOPLASMA, V23, P577; Wang ZH, 2005, BIOCHEMISTRY-US, V44, P12355, DOI 10.1021/bi050620i; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Whiteford JR, 2007, EXP CELL RES, V313, P3902, DOI 10.1016/j.yexcr.2007.08.002; Wilcox-Adelman SA, 2002, GLYCOCONJUGATE J, V19, P305, DOI 10.1023/A:1025304602057; Woods A, 2001, CURR OPIN CELL BIOL, V13, P578, DOI 10.1016/S0955-0674(00)00254-4; Xian X., 2009, CELL TISSUE RES; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Zong F., 2009, CELL PROLIF; Zong F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007346	56	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e14816	10.1371/journal.pone.0014816	http://dx.doi.org/10.1371/journal.pone.0014816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731601	Green Published, Green Submitted, gold			2022-12-25	WOS:000292035400001
J	Boffetta, P; McLerran, D; Chen, Y; Inoue, M; Sinha, R; He, J; Gupta, PC; Tsugane, S; Irie, F; Tamakoshi, A; Gao, YT; Shu, XO; Wang, RW; Tsuji, I; Kuriyama, S; Matsuo, K; Satoh, H; Chen, CJ; Yuan, JM; Yoo, KY; Ahsan, H; Pan, WH; Gu, DF; Pednekar, MS; Sasazuki, S; Sairenchi, T; Yang, G; Xiang, YB; Nagai, M; Tanaka, H; Nishino, Y; You, SL; Koh, WP; Park, SK; Shen, CY; Thornquist, M; Kang, D; Rolland, B; Feng, ZD; Zheng, W; Potter, JD				Boffetta, Paolo; McLerran, Dale; Chen, Yu; Inoue, Manami; Sinha, Rashmi; He, Jiang; Gupta, Prakash Chandra; Tsugane, Shoichiro; Irie, Fujiko; Tamakoshi, Akiko; Gao, Yu-Tang; Shu, Xiao-Ou; Wang, Renwei; Tsuji, Ichiro; Kuriyama, Shinichi; Matsuo, Keitaro; Satoh, Hiroshi; Chen, Chien-Jen; Yuan, Jian-Min; Yoo, Keun-Young; Ahsan, Habibul; Pan, Wen-Harn; Gu, Dongfeng; Pednekar, Mangesh Suryakant; Sasazuki, Shizuka; Sairenchi, Toshimi; Yang, Gong; Xiang, Yong-Bing; Nagai, Masato; Tanaka, Hideo; Nishino, Yoshikazu; You, San-Lin; Koh, Woon-Puay; Park, Sue K.; Shen, Chen-Yang; Thornquist, Mark; Kang, Daehee; Rolland, Betsy; Feng, Ziding; Zheng, Wei; Potter, John D.			Body Mass Index and Diabetes in Asia: A Cross-Sectional Pooled Analysis of 900,000 Individuals in the Asia Cohort Consortium	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; INSULIN SENSITIVITY; GLUCOSE-TOLERANCE; ABDOMINAL OBESITY; FAT DISTRIBUTION; LIFE-STYLE; TYPE-2; PREVALENCE; MELLITUS; POPULATION	Background: The occurrence of diabetes has greatly increased in low- and middle-income countries, particularly in Asia, as has the prevalence of overweight and obesity; in European-derived populations, overweight and obesity are established causes of diabetes. The shape of the association of overweight and obesity with diabetes risk and its overall impact have not been adequately studied in Asia. Methods and Findings: A pooled cross-sectional analysis was conducted to evaluate the association between baseline body mass index (BMI, measured as weight in kg divided by the square of height in m) and self-reported diabetes status in over 900,000 individuals recruited in 18 cohorts from Bangladesh, China, India, Japan, Korea, Singapore and Taiwan. Logistic regression models were fitted to calculate cohort-specific odds ratios (OR) of diabetes for categories of increasing BMI, after adjustment for potential confounding factors. OR were pooled across cohorts using a random-effects meta-analysis. The sex- and age-adjusted prevalence of diabetes was 4.3% in the overall population, ranging from 0.5% to 8.2% across participating cohorts. Using the category 22.5-24.9 Kg/m(2) as reference, the OR for diabetes spanned from 0.58 (95% confidence interval [CI] 0.31, 0.76) for BMI lower than 15.0 kg/m(2) to 2.23 (95% CI 1.86, 2.67) for BMI higher than 34.9 kg/m(2). The positive association between BMI and diabetes prevalence was present in all cohorts and in all subgroups of the study population, although the association was stronger in individuals below age 50 at baseline (p-value of interaction <0.001), in cohorts from India and Bangladesh (p<0.001), in individuals with low education (p-value 0.02), and in smokers (p-value 0.03); no differences were observed by gender, urban residence, or alcohol drinking. Conclusions: This study estimated the shape and the strength of the association between BMI and prevalence of diabetes in Asian populations and identified patterns of the association by age, country, and other risk factors for diabetes.	[Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Boffetta, Paolo] Int Prevent Res Inst, Lyon, France; [McLerran, Dale; Thornquist, Mark; Rolland, Betsy; Feng, Ziding; Potter, John D.] Fred Hutchinson Canc Res Ctr, Dept Publ Hlth Sci, Seattle, WA 98104 USA; [Chen, Yu] NYU, Dept Environm Med, Sch Med, New York, NY 10016 USA; [Inoue, Manami; Tsugane, Shoichiro; Sasazuki, Shizuka] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Div, Tokyo 104, Japan; [Sinha, Rashmi] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Gupta, Prakash Chandra; Pednekar, Mangesh Suryakant] Healis Sekhsaria Inst Publ Hlth, Navi Mumbai, India; [Irie, Fujiko] Ibaraki Prefectural Govt, Dept Hlth & Social Serv, Ibaraki, Japan; [Tamakoshi, Akiko] Aichi Med Univ, Sch Med, Dept Publ Hlth, Aichi, Japan; [Gao, Yu-Tang; Xiang, Yong-Bing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Shu, Xiao-Ou; Yang, Gong; Zheng, Wei] Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Dept Med, Div Epidemiol, Nashville, TN USA; [Wang, Renwei] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA; [Tsuji, Ichiro; Kuriyama, Shinichi; Nagai, Masato] Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 980, Japan; [Matsuo, Keitaro; Tanaka, Hideo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Chen, Chien-Jen; You, San-Lin] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chen, Chien-Jen; Pan, Wen-Harn] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 10764, Taiwan; [Yoo, Keun-Young; Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Ahsan, Habibul] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Med & Human Genet, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA; [Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Pan, Wen-Harn] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan; [Gu, Dongfeng] Fuwai Hosp, Beijing, Peoples R China; [Gu, Dongfeng] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China; [Gu, Dongfeng] Peking Union Med Coll, China Natl Ctr Cardiovasc Dis, Beijing 100021, Peoples R China; [Sairenchi, Toshimi] Dokkyo Med Univ, Sch Med, Dept Publ Hlth, Mibu, Tochigi, Japan; [Nishino, Yoshikazu] Miyagi Canc Ctr, Res Inst, Div Epidemiol, Sendai, Miyagi, Japan; [Koh, Woon-Puay] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore; [Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Sue K.] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Park, Sue K.] Seoul Natl Univ, Inst Hlth Policy & Management, Seoul, South Korea; [Shen, Chen-Yang] Acad Sinica, Inst Biomed Sci, Taiwan Biobank, Taipei, Taiwan; [Shen, Chen-Yang] China Med Univ, Grad Inst Environm Sci, Taichung, Taiwan	Icahn School of Medicine at Mount Sinai; Fred Hutchinson Cancer Center; New York University; National Cancer Center - Japan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tulane University; Aichi Medical University; Shanghai Jiao Tong University; Vanderbilt University; University of Minnesota System; University of Minnesota Twin Cities; Tohoku University; Aichi Cancer Center; Academia Sinica - Taiwan; National Taiwan University; Seoul National University (SNU); University of Chicago; University of Chicago; University of Chicago; Academia Sinica - Taiwan; National Taiwan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Dokkyo Medical University; Miyagi Cancer Center; National University of Singapore; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Academia Sinica - Taiwan; China Medical University Taiwan	Boffetta, P (corresponding author), Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA.	paolo.boffetta@mssm.edu; jpotter@fhcrc.org	Matsuo, Keitaro/H-6758-2019; Park, Sue Kyung/J-2757-2012; Tsugane, Shoichiro/A-2424-2015; Yoo, Keun-Young/J-5548-2012; zhang, weihua/GXV-1334-2022; Gao, Yu/HGE-1937-2022; gao, yi/HCI-8298-2022; Kang, Dae Hee/E-8631-2012; Tanaka, Hideo/A-8145-2016; Nagai, Masato/ABC-6862-2020; Tamakoshi, Akiko/D-5105-2012; Sriwisit, Sukhumaphorn/G-1405-2011; Sinha, Rashmi/G-7446-2015; Shen, CY/F-6271-2010; Boffetta, Paolo/AAI-7767-2021; Chen, Chien-Jen/C-6976-2008; Zheng, Wei/O-3351-2013; Gao, Y./GWZ-3665-2022; He, Jiang/AAF-5303-2020; Chen, Chien-Jen/N-4723-2019	Matsuo, Keitaro/0000-0003-1761-6314; Tsugane, Shoichiro/0000-0003-4105-2774; Nagai, Masato/0000-0003-0818-3158; Sinha, Rashmi/0000-0002-2466-7462; Boffetta, Paolo/0000-0002-3811-2791; Zheng, Wei/0000-0003-1226-070X; He, Jiang/0000-0002-8286-9652; You, San-Lin/0000-0002-3192-3356; Chen, Yu/0000-0002-1519-4894; Sairenchi, Toshimi/0000-0001-8896-6501; Potter, John/0000-0001-5439-1500; Pednekar, Mangesh/0000-0001-6266-5356; Kang, Daehee/0000-0003-4031-5878; Yuan, Jian-Min/0000-0002-4620-3108	3-Prefecture Aichi, Ibaraki, Japan Collaborative Cohort Study (JACC); Japan Public Health Center-Based Study 1 (JPHC1); Japan Public Health Center-Based Study 2 (JPHC2); 3-Prefecture Miyagi, Miyagi, Ohsaki; Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan; China National Hypertension Survey Epidemiology Followup Study (CHEFS); American Heart Association [9750612N]; National Heart, Lung and Blood Institute [U01 HL072507]; National Institutes for Health [R01CA0403092, R01CA144034, RO1 CA 82729, R37CA70867, R01CA55069, R35CA53890, R01CA80205, P42ES010349, R01CA102484, R01CA107431]; National Science Council and Department of Health, Taiwan; Department of Health, Taiwan [DOH80-27, DOH81-021, DOH8202-1027, DOH83-TD-015, DOH84-TD-006]; Ministry of Education, Science and Technology, Korea [2009-0087452]; National Research Foundation of Korea [2009-0087452]; International Agency for Research on Cancer, Lyon, France; Clinical Trials Service Unit, Oxford, U.K; World Health Organisation, Geneva, Switzerland; NATIONAL CANCER INSTITUTE [R01CA144034, R01CA055069, R01CA102484, R01CA082729, R37CA070867, R01CA107431, R01CA080205, R35CA053890] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010349] Funding Source: NIH RePORTER	3-Prefecture Aichi, Ibaraki, Japan Collaborative Cohort Study (JACC); Japan Public Health Center-Based Study 1 (JPHC1); Japan Public Health Center-Based Study 2 (JPHC2); 3-Prefecture Miyagi, Miyagi, Ohsaki; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); China National Hypertension Survey Epidemiology Followup Study (CHEFS); American Heart Association(American Heart Association); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council and Department of Health, Taiwan; Department of Health, Taiwan; Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); International Agency for Research on Cancer, Lyon, France; Clinical Trials Service Unit, Oxford, U.K; World Health Organisation, Geneva, Switzerland(World Health Organization); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The cohorts participating in the pooled analysis were supported by the following grants: 3-Prefecture Aichi, Ibaraki, Japan Collaborative Cohort Study (JACC), Japan Public Health Center-Based Study 1 (JPHC1), Japan Public Health Center-Based Study 2 (JPHC2); 3-Prefecture Miyagi, Miyagi, Ohsaki: Grant in-aid for Cancer Research, Grant for the Third Term Comprehensive Control Research for Cancer, Grant for Health Services, Grant for Medical Services for Aged and Health Promotion, Grant for Comprehensive Research on Cardiovascular and Life-Style Related Diseases from the Ministry of Health, Labour and Welfare, Japan; Grant for the Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan; China National Hypertension Survey Epidemiology Followup Study (CHEFS): American Heart Association (9750612N); National Heart, Lung and Blood Institute (U01 HL072507); Chinese Academy of Medical Sciences Shanghai Cohort Study (SCS): National Institutes for Health (R01CA0403092, R01CA144034); Shanghai Men's Health Study (SMHS): National Institutes for Health (RO1 CA 82729) Shanghai Women's Health Study (SWHS): National Institutes for Health (R37CA70867); The Community-Based Cancer Screening Project (CBCSP): National Science Council and Department of Health, Taiwan; Disease risk FACtor Two-township Study (CVDFACTS): Department of Health, Taiwan (DOH80-27, DOH81-021, DOH8202-1027, DOH83-TD-015, and DOH84-TD-006); The Korea Multi-center Cancer Cohort (KMCC): Ministry of Education, Science and Technology, Korea (2009-0087452), National Research Foundation of Korea (2009-0087452); The Singapore Chinese Health Study (SCHS): National Institutes for Health (R01CA55069, R35CA53890, R01CA80205, R01CA144034); Health Effects of Arsenic Longitudinal Study ( HEALS): National Institutes for Health (P42ES010349, R01CA102484, R01CA107431); The Mumbai Cohort Study (MCS): International Agency for Research on Cancer, Lyon, France; Clinical Trials Service Unit, Oxford, U.K; World Health Organisation, Geneva, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE N, 1995, J CLIN INVEST, V96, P88, DOI 10.1172/JCI118083; Abate N, 2001, J DIABETES COMPLICAT, V15, P320, DOI 10.1016/S1056-8727(01)00161-1; Aekplakorn W, 2006, DIABETES CARE, V29, P1872, DOI 10.2337/dc05-2141; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DESPRES JP, 1989, DIABETES, V38, P304, DOI 10.2337/diabetes.38.3.304; Ge KeYou, 1997, Asia Pacific Journal of Clinical Nutrition, V6, P175; Goodpaster BH, 1997, DIABETES, V46, P1579, DOI 10.2337/diabetes.46.10.1579; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hussain A, 2005, DIABETIC MED, V22, P931, DOI 10.1111/j.1464-5491.2005.01558.x; *INT DIAB FED, 2006, INT DIAB FED DIAB AT; Janus ED, 2000, DIABETIC MED, V17, P741, DOI 10.1046/j.1464-5491.2000.00376.x; Karter AJ, 1996, DIABETES, V45, P1547, DOI 10.2337/diabetes.45.11.1547; Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Lu FH, 1998, DIABETIC MED, V15, P564, DOI 10.1002/(SICI)1096-9136(199807)15:7<564::AID-DIA615>3.0.CO;2-H; Matsumoto K, 1997, DIABETES CARE, V20, P1562, DOI 10.2337/diacare.20.10.1562; MCKEIGUE PM, 1992, DIABETOLOGIA, V35, P785; Mohan V, 2008, DIABETES RES CLIN PR, V80, P159, DOI 10.1016/j.diabres.2007.11.018; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Nakagami T, 2003, DIABETOLOGIA, V46, P1063, DOI 10.1007/s00125-003-1158-9; Nanri A, 2008, DIABETES CARE, V31, P1568, DOI 10.2337/dc08-0297; Ramachandran A, 2005, J Assoc Physicians India, V53, P34; Ramachandran A, 2008, DIABETES CARE, V31, P893, DOI 10.2337/dc07-1207; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Ramakrishnan U, 2004, AM J CLIN NUTR, V79, P17; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Rosenthal AD, 2004, INT J OBESITY, V28, P594, DOI 10.1038/sj.ijo.0802597; Sadikot SM, 2004, DIABETES RES CLIN PR, V66, P293, DOI 10.1016/j.diabres.2004.04.007; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Sasai H, 2010, MAYO CLIN PROC, V85, P36, DOI 10.4065/mcp.2009.0230; Schienkiewitz A, 2006, AM J CLIN NUTR, V84, P427; Son LENTD, 2004, DIABETIC MED, V21, P371, DOI 10.1111/j.1464-5491.2004.01159.x; Steyn NP, 2004, PUBLIC HEALTH NUTR, V7, P147, DOI 10.1079/PHN2003586; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Villegas R, 2009, NUTR METAB CARDIOVAS, V19, P190, DOI 10.1016/j.numecd.2008.06.003; Villegas R, 2007, ARCH INTERN MED, V167, P2310, DOI 10.1001/archinte.167.21.2310; Waki K, 2005, DIABETIC MED, V22, P323, DOI 10.1111/j.1464-5491.2004.01403.x; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; *WHO, WHO AS BMI CUT POINT; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; YAJNIK CS, 1995, DIABETIC MED, V12, P330, DOI 10.1111/j.1464-5491.1995.tb00487.x; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	49	115	118	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e19930	10.1371/journal.pone.0019930	http://dx.doi.org/10.1371/journal.pone.0019930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731609	Green Published, gold, Green Submitted			2022-12-25	WOS:000292033700006
J	Ferri, E; Bain, O; Barbuto, M; Martin, C; Lo, N; Uni, S; Landmann, F; Baccei, SG; Guerrero, R; Lima, SD; Bandi, C; Wanji, S; Diagne, M; Casiraghi, M				Ferri, Emanuele; Bain, Odile; Barbuto, Michela; Martin, Coralie; Lo, Nathan; Uni, Shigehiko; Landmann, Frederic; Baccei, Sara G.; Guerrero, Ricardo; Lima, Sueli de Souza; Bandi, Claudio; Wanji, Samuel; Diagne, Moustapha; Casiraghi, Maurizio			New Insights into the Evolution of Wolbachia Infections in Filarial Nematodes Inferred from a Large Range of Screened Species	PLOS ONE			English	Article							LITOMOSOIDES-SIGMODONTIS; BRUGIA-MALAYI; MOLECULAR-IDENTIFICATION; INTRACELLULAR BACTERIA; ENDOSYMBIONT-WOLBACHIA; N-SP; PHYLOGENETIC-RELATIONSHIPS; MONANEMA-MARTINI; GENE-SEQUENCES; FILARIOIDEA	Background: Wolbachia are intriguing symbiotic endobacteria with a peculiar host range that includes arthropods and a single nematode family, the Onchocercidae encompassing agents of filariases. This raises the question of the origin of infection in filariae. Wolbachia infect the female germline and the hypodermis. Some evidences lead to the theory that Wolbachia act as mutualist and coevolved with filariae from one infection event: their removal sterilizes female filariae; all the specimens of a positive species are infected; Wolbachia are vertically inherited; a few species lost the symbiont. However, most data on Wolbachia and filaria relationships derive from studies on few species of Onchocercinae and Dirofilariinae, from mammals. Methodology/Principal Findings: We investigated the Wolbachia distribution testing 35 filarial species, including 28 species and 7 genera and/or subgenera newly screened, using PCR, immunohistochemical staining, whole mount fluorescent analysis, and cocladogenesis analysis. (i) Among the newly screened Onchocercinae from mammals eight species harbour Wolbachia but for some of them, bacteria are absent in the hypodermis, or in variable density. (ii) Wolbachia are not detected in the pathological model Monanema martini and in 8, upon 9, species of Cercopithifilaria. (iii) Supergroup F Wolbachia is identified in two newly screened Mansonella species and in Cercopithifilaria japonica. (iv) Type F Wolbachia infect the intestinal cells and somatic female genital tract. (v) Among Oswaldofilariinae, Waltonellinae and Splendidofilariinae, from saurian, anuran and bird respectively, Wolbachia are not detected. Conclusions/Significance: The absence of Wolbachia in 63% of onchocercids, notably in the ancestral Oswaldofilariinae estimated 140 mya old, the diverse tissues or specimens distribution, and a recent lateral transfer in supergroup F Wolbachia, modify the current view on the role and evolution of the endosymbiont and their hosts. Further genomic analyses on some of the newly sampled species are welcomed to decipher the open questions.	[Ferri, Emanuele; Barbuto, Michela; Baccei, Sara G.; Casiraghi, Maurizio] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy; [Bain, Odile; Martin, Coralie] Museum Natl Hist Nat, CNRS, Parasitol Comparee UMR 7205, Paris, France; [Bain, Odile; Martin, Coralie] Museum Natl Hist Nat, CNRS, UMR 7245, Paris, France; [Lo, Nathan] Univ Sydney, Sch Biol Sci, Sydney, Australia; [Uni, Shigehiko] Osaka City Univ, Sch Med, Dept Med Zool, Osaka 545, Japan; [Landmann, Frederic] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Guerrero, Ricardo] Cent Univ Venezuela, Inst Zool Trop, Caracas, Venezuela; [Lima, Sueli de Souza] Univ Fed Juiz de Fora, Dept Zool, Juiz De Fora, MG, Brazil; [Bandi, Claudio] Univ Milan, Dipartimento Patol Anim Igiene & Sanita Pubbl Vet, Milan, Italy; [Wanji, Samuel] Res Fdn Trop Dis & Environm, Buea, Cameroon; [Diagne, Moustapha] Univ Cheikh Anta Diop Dakar, Dept Biol Anim, Dakar, Senegal	University of Milano-Bicocca; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); University of Sydney; Osaka Metropolitan University; University of California System; University of California Santa Cruz; University of Central Venezuela; Universidade Federal de Juiz de Fora; University of Milan; University Cheikh Anta Diop Dakar	Ferri, E (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy.	maurizio.casiraghi@unimib.it	martin, coralie/O-3983-2019; Bandi, Claudio/J-7835-2018; Guerrero, Ricardo/AAC-3490-2021; uni, shigehiko/A-8940-2012; Martin, Coralie/N-6293-2018; Lo, Nathan/E-6115-2010; Casiraghi, Maurizio/E-7273-2011	martin, coralie/0000-0003-3801-2595; Bandi, Claudio/0000-0002-0181-4618; Guerrero, Ricardo/0000-0003-0925-9476; Lo, Nathan/0000-0003-2176-2840; Casiraghi, Maurizio/0000-0002-2733-2094	European Community [INCO-CT-2006-032321]; French national grant Action Transversale du Museum; Italian national grant MIUR-PRIN	European Community(European Commission); French national grant Action Transversale du Museum; Italian national grant MIUR-PRIN	This work was supported by European Community Grant INCO-CT-2006-032321, a French national grant Action Transversale du Museum "Taxonomie moleculaire: DNA Barcode et gestion durable des collections" and by Italian national grant MIUR-PRIN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatsuma T, 2005, PARASITOL INT, V54, P195, DOI 10.1016/j.parint.2005.04.002; Anderson R. C., 2009, Keys to the nematode parasites of vertebrates: archival volume, P391, DOI 10.1079/9781845935726.0391; Attout T, 2005, PARASITOLOGY, V130, P421, DOI 10.1017/S0031182004006651; Attout T, 2008, PARASITOL INT, V57, P201, DOI 10.1016/j.parint.2008.01.001; Bain O, 2008, PARASITE, V15, P342, DOI 10.1051/parasite/2008153342; BAIN O, 1986, ANN PARASIT HUM COMP, V61, P465, DOI 10.1051/parasite/1986614465; Bain O, 2002, WORLD CL PARASITES, V5, P21; BAIN O, 1986, TROP MED PARASITOL, V37, P301; BAIN O, 1986, ANN PARASIT HUM COMP, V61, P81, DOI 10.1051/parasite/198661181; BAIN O, 1982, ANN PARASIT HUM COMP, V57, P593, DOI 10.1051/parasite/1982576593; Baldo L, 2007, CURR MICROBIOL, V55, P81, DOI 10.1007/s00284-007-0055-8; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; Bandi C, 2001, TRENDS PARASITOL, V17, P88, DOI 10.1016/S1471-4922(00)01812-2; Bazzocchi C, 2000, CURR MICROBIOL, V41, P96, DOI 10.1007/s002840010100; Blaxter M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001050; Bordenstein SR, 2009, MOL BIOL EVOL, V26, P231, DOI 10.1093/molbev/msn243; Bordenstein SR, 2003, J NEMATOL, V35, P266; Brattig NW, 2004, J IMMUNOL, V173, P437, DOI 10.4049/jimmunol.173.1.437; Brattig NW, 2001, MICROBES INFECT, V3, P439, DOI 10.1016/S1286-4579(01)01399-5; Buttner Dietrich W, 2003, Filaria J, V2, P10, DOI 10.1186/1475-2883-2-10; Casiraghi M., 2003, Parassitologia (Rome), V45, P13; Casiraghi M, 2005, MICROBIOL-SGM, V151, P4015, DOI 10.1099/mic.0.28313-0; Casiraghi M, 2004, INT J PARASITOL, V34, P191, DOI 10.1016/j.ijpara.2003.10.004; Casiraghi M, 2002, INT J PARASITOL, V32, P1457, DOI 10.1016/S0020-7519(02)00158-3; Casiraghi M, 2001, PARASITOL RES, V87, P417, DOI 10.1007/s004360000368; CHABAUD A-G, 1976, Annales de Parasitologie Humaine et Comparee, V51, P365; CHABAUD AG, 1994, INT J PARASITOL, V24, P1179, DOI 10.1016/0020-7519(94)90190-2; Chirgwin SR, 2002, J PARASITOL, V88, P1248, DOI 10.1645/0022-3395(2002)088[1248:TFEWSI]2.0.CO;2; CHITWOOD BG, 1950, INTRO NEMATOLOGY 1; EBERHARD ML, 1984, ANN PARASIT HUM COMP, V59, P483, DOI 10.1051/parasite/1984595483; Fenn K, 2006, TRENDS PARASITOL, V22, P60, DOI 10.1016/j.pt.2005.12.012; Fenn K, 2006, PLOS PATHOG, V2, P887, DOI 10.1371/journal.ppat.0020094; Ferri E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1; Fischer P, 2002, EXP PARASITOL, V102, P201, DOI 10.1016/S0014-4894(03)00058-4; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Foster JM, 2009, PARASITOL RES, V104, P1047, DOI 10.1007/s00436-008-1287-7; Gibbons L.M, 2010, KEYS NEMATODE PARASI; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gillette-Ferguson I, 2007, INFECT IMMUN, V75, P5908, DOI 10.1128/IAI.00991-07; Guerrero R, 2003, PARASITE, V10, P219, DOI 10.1051/parasite/2003103219; GUERRERO R, 2011, FOLIA PARAS IN PRESS, P58; Haegeman A, 2009, INT J PARASITOL, V39, P1045, DOI 10.1016/j.ijpara.2009.01.006; HANSEN RD, 2010, P BIOL SCI; Heider U, 2006, INT J MED MICROBIOL, V296, P287, DOI 10.1016/j.ijmm.2005.12.019; Higazi TB, 2005, MOL BIOCHEM PARASIT, V141, P109, DOI 10.1016/j.molbiopara.2005.02.006; Hoerauf A, 1999, J CLIN INVEST, V103, P11, DOI 10.1172/JCI4768; HOERAUF A, 2008, Z B MAHYVOL, V5, P150; Hoerauf A, 2008, CURR OPIN INFECT DIS, V21, P673, DOI 10.1097/QCO.0b013e328315cde7; HOLMAL AG, 2009, BMC MICROBIOL, V28, P243; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001296; Johnston KL, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-99; Junker K, 2009, PARASITE, V16, P43, DOI 10.1051/parasite/2009161043; Justine Jean-Lou, 2002, P73; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Keiser PB, 2008, MOL BIOCHEM PARASIT, V160, P123, DOI 10.1016/j.molbiopara.2008.04.012; Kramer LH, 2003, PARASITOL RES, V89, P381, DOI 10.1007/s00436-002-0765-6; Landmann F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000758; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lo N, 2007, INT J SYST EVOL MICR, V57, P654, DOI 10.1099/ijs.0.64515-0; Lo N, 2002, MOL BIOL EVOL, V19, P341, DOI 10.1093/oxfordjournals.molbev.a004087; MANZANELL R, 1986, ANN PARASIT HUM COMP, V61, P245; Martin DP, 2009, METHODS MOL BIOL, V537, P185, DOI 10.1007/978-1-59745-251-9_9; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; McNulty SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011029; ONEILL SL, 1993, MED VET ENTOMOL, V7, P377, DOI 10.1111/j.1365-2915.1993.tb00709.x; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raverdy S, 2008, MOL BIOCHEM PARASIT, V160, P163, DOI 10.1016/j.molbiopara.2008.04.014; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ros VID, 2009, APPL ENVIRON MICROB, V75, P1036, DOI 10.1128/AEM.01109-08; Rowley SM, 2004, CURR MICROBIOL, V49, P208, DOI 10.1007/s00284-004-4346-z; Saint Andre AV, 2002, SCIENCE, V295, P1892, DOI 10.1126/science.1068732; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SIMOES PM, 2011, MOL ECOL RE IN PRESS; Sironi M, 1995, MOL BIOCHEM PARASIT, V74, P223, DOI 10.1016/0166-6851(95)02494-8; SMITH JM, 1992, J MOL EVOL, V34, P126; Strubing U, 2010, INT J PARASITOL, V40, P1193, DOI 10.1016/j.ijpara.2010.03.004; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Taylor MJ, 1999, EXP PARASITOL, V91, P356, DOI 10.1006/expr.1998.4383; Turner JD, 2009, J BIOL CHEM, V284, P22364, DOI 10.1074/jbc.M901528200; Uni S, 2007, PARASITE, V14, P199, DOI 10.1051/parasite2007143199; Uni S, 2006, PARASITE, V13, P193, DOI 10.1051/parasite/2006133193; Uni S, 2004, PARASITE, V11, P131, DOI 10.1051/parasite/2004112131; Uni S, 2002, PARASITE, V9, P293, DOI 10.1051/parasite/2002094293; UNI S, 1983, ANN PARASIT HUM COMP, V58, P71, DOI 10.1051/parasite/1983581071; Volkmann L, 2003, TROP MED INT HEALTH, V8, P392, DOI 10.1046/j.1365-3156.2003.01040.x; VUONG PN, 1991, ANN PARASIT HUM COMP, V66, P109, DOI 10.1051/parasite/1991663109; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; WIEATANARATANAB.I, 2009, ZOO SCI, V28, P171	97	112	117	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20843	10.1371/journal.pone.0020843	http://dx.doi.org/10.1371/journal.pone.0020843			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731626	Green Published, gold			2022-12-25	WOS:000292033700016
J	Tsumoto, K; Kurosawa, G; Yoshinaga, T; Aihara, K				Tsumoto, Kunichika; Kurosawa, Gen; Yoshinaga, Tetsuya; Aihara, Kazuyuki			Modeling Light Adaptation in Circadian Clock: Prediction of the Response That Stabilizes Entrainment	PLOS ONE			English	Article							MOLECULAR-MECHANISM; SUPRACHIASMATIC NUCLEUS; KINASE ACTIVATION; GENE-EXPRESSION; NEUROSPORA; PHASE; DROSOPHILA; PROTEIN; PHOTOADAPTATION; TRANSCRIPTION	Periods of biological clocks are close to but often different from the rotation period of the earth. Thus, the clocks of organisms must be adjusted to synchronize with day-night cycles. The primary signal that adjusts the clocks is light. In Neurospora, light transiently up-regulates the expression of specific clock genes. This molecular response to light is called light adaptation. Does light adaptation occur in other organisms? Using published experimental data, we first estimated the time course of the up-regulation rate of gene expression by light. Intriguingly, the estimated up-regulation rate was transient during light period in mice as well as Neurospora. Next, we constructed a computational model to consider how light adaptation had an effect on the entrainment of circadian oscillation to 24-h light-dark cycles. We found that cellular oscillations are more likely to be destabilized without light adaption especially when light intensity is very high. From the present results, we predict that the instability of circadian oscillations under 24-h light-dark cycles can be experimentally observed if light adaptation is altered. We conclude that the functional consequence of light adaptation is to increase the adjustability to 24-h light-dark cycles and then adapt to fluctuating environments in nature.	[Tsumoto, Kunichika; Kurosawa, Gen; Aihara, Kazuyuki] Japan Sci & Technol Agcy, ERATO, Aihara Complex Modelling Project, Tokyo, Japan; [Yoshinaga, Tetsuya] Univ Tokushima, Inst Hlth Biosci, Tokushima 770, Japan; [Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Tokyo, Japan	Japan Science & Technology Agency (JST); Tokushima University; University of Tokyo	Tsumoto, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Pharmacol, Div Mol & Cellular Pharmacol, Osaka, Japan.	g.kurosawa@riken.jp	Kurosawa, Gen/AAC-9390-2022; Yoshinaga, Tetsuya/AAE-3319-2021	Yoshinaga, Tetsuya/0000-0003-4994-0522; Kurosawa, Gen/0000-0002-2151-783X; Tsumoto, Kunichika/0000-0001-7457-3125	Japan Science and Technology Agency; Osaka University; Japan Society for the Promotion of Science	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Osaka University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partially supported by ERATO Aihara Complexity Modelling Project, Japan Science and Technology Agency, the Global COE Program "in silico medicine" at Osaka University, and Aihara Project, the Japan Society for the Promotion of Science (FIRST Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Akman OE, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-88; Aschoff, 1965, CIRCADIAN CLOCKS, P95; Beersma DGM, 1999, J BIOL RHYTHM, V14, P320, DOI 10.1177/074873099129000740; Butcher GQ, 2005, J NEUROSCI, V25, P5305, DOI 10.1523/JNEUROSCI.4361-04.2005; Butcher GQ, 2003, J NEUROPHYSIOL, V90, P3854, DOI 10.1152/jn.00524.2003; Chen CH, 2010, P NATL ACAD SCI USA, V107, P16715, DOI 10.1073/pnas.1011190107; Comas M, 2008, J BIOL RHYTHM, V23, P425, DOI 10.1177/0748730408321567; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Drengstig T, 2008, J PHYS CHEM B, V112, P16752, DOI 10.1021/jp806818c; Dunlap J. C., 2003, CHRONOBIOLOGY BIOL T; Elvin M, 2005, GENE DEV, V19, P2593, DOI 10.1101/gad.349305; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Forger DB, 2003, P NATL ACAD SCI USA, V100, P14806, DOI 10.1073/pnas.2036281100; Francois P, 2005, BIOPHYS J, V88, P2369, DOI 10.1529/biophysj.104.053975; Glass L., 1988, CLOCKS CHAOS RHYTHMS; Gonze D, 2000, J STAT PHYS, V101, P649, DOI 10.1023/A:1026410121183; Granada AE, 2011, INTERFACE FOCUS, V1, P153, DOI 10.1098/rsfs.2010.0002; Granada AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007057; Guckenheimer J, 2013, APPL MATH SCI, V42; Hastings M.H., 1999, J NEUROSCI, V11, P1; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; KAWAKAMI H, 1984, IEEE T CIRCUITS SYST, V31, P248, DOI 10.1109/TCS.1984.1085495; KAWATO M, 1978, BIOL CYBERN, V30, P241, DOI 10.1007/BF00361045; KAWATO M, 1981, BIOL CYBERN, V40, P139, DOI 10.1007/BF00344292; KOCH K, 1998, METHODS NEURONAL MOD; Kojima S, 2007, P NATL ACAD SCI USA, V104, P1859, DOI 10.1073/pnas.0607567104; Kronauer RE, 1999, J BIOL RHYTHM, V14, P500, DOI 10.1177/074873099129001073; Kuznetsov, 2013, ELEMENTS APPL BIFURC; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Leloup JC, 2004, J THEOR BIOL, V230, P541, DOI 10.1016/j.jtbi.2004.04.040; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Leloup JC, 1999, J BIOL RHYTHM, V14, P433, DOI 10.1177/074873099129000948; Leloup JC, 2008, BIOESSAYS, V30, P590, DOI 10.1002/bies.20762; Lewis ZA, 2002, MOL MICROBIOL, V45, P917, DOI 10.1046/j.1365-2958.2002.03074.x; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Malzahn E, 2010, CELL, V142, P762, DOI 10.1016/j.cell.2010.08.010; Merrow M, 2001, EMBO J, V20, P307, DOI 10.1093/emboj/20.3.307; Messager S, 1999, P NATL ACAD SCI USA, V96, P9938, DOI 10.1073/pnas.96.17.9938; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Rand DA, 2006, J THEOR BIOL, V238, P616, DOI 10.1016/j.jtbi.2005.06.026; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ruoff P, 2001, J THEOR BIOL, V209, P29, DOI 10.1006/jtbi.2000.2239; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Shrode LB, 2001, FUNGAL GENET BIOL, V32, P169, DOI 10.1006/fgbi.2001.1264; Smolen P, 2001, J NEUROSCI, V21, P6644, DOI 10.1523/JNEUROSCI.21-17-06644.2001; SWADE RH, 1967, AM NAT, V101, P431, DOI 10.1086/282510; Takahashi JS, 2001, HDB BEHAV NEUROBIOLO; Tan Y, 2004, CURR BIOL, V14, P433, DOI 10.1016/j.cub.2004.02.035; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Tsumoto K, 2006, J THEOR BIOL, V239, P101, DOI 10.1016/j.jtbi.2005.07.017; von Holst E., 1939, ERGEBNISSE PHYSL, V42, P228, DOI [10.1007/BF02322567, DOI 10.1007/BF02322567]; Wilkins AK, 2007, PLOS COMPUT BIOL, V3, P2476, DOI 10.1371/journal.pcbi.0030242; Winfree A. T., 1980, GEOMETRY BIOL TIME, DOI 10.1007/978-1-4757-3484-3; Yan L, 1999, NEUROSCIENCE, V94, P141, DOI 10.1016/S0306-4522(99)00223-7; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	61	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20880	10.1371/journal.pone.0020880	http://dx.doi.org/10.1371/journal.pone.0020880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698191	Green Published, gold, Green Submitted			2022-12-25	WOS:000291734100028
J	Xie, F; Chu, X; Wu, H; Sun, WW; Shen, M; Yang, L; Wang, Y; Wang, Y; Shi, JX; Huang, W				Xie, Fang; Chu, Xun; Wu, Hong; Sun, Weiwei; Shen, Min; Yang, Lin; Wang, Ying; Wang, Yi; Shi, Jinxiu; Huang, Wei			Replication of Putative Susceptibility Loci from Genome-Wide Association Studies Associated with Coronary Atherosclerosis in Chinese Han Population	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; CHROMOSOME 9P21; ARTERY-DISEASE; MYOCARDIAL-INFARCTION; 4 SNPS; LIPID CONCENTRATIONS; RISK; ANRIL; GENE; PROGRESSION	Background: Coronary atherosclerosis, the main cause of cardiovascular disease, is a progressive disease. Recent Genome Wide Association Studies (GWASs) discovered several novel loci associated with coronary artery disease (CAD) or its main complication myocardial infarction (MI). In this study, we investigated the associations between previously reported CAD- and MI-associated variants and coronary atherosclerosis in Chinese Han population. Methodology/Principal Findings: We performed a case-control association study with 2,335 coronary atherosclerosis patients and 1,078 controls undergoing coronary angiography of Chinese Han from China. Fourteen single nucleotide polymorphisms (SNPs), located at 1p13.3, 1q41, 2q36.3, 6q25.1, 9p21.3, 10q11.21 and 15q22.33, were genotyped in our sample collection. Six SNPs at 9p21 were associated with coronary atherosclerosis susceptibility (P-trend<0.05) and rs10757274 showed the most significant association (P = 2.38x10(-08), OR = 1.34). These associations remained significant after adjustment for multiple comparisons. Rs17465637 at 1q41 (P-trend = 6.83x10(-03), OR = 0.86) also showed significant association with coronary atherosclerosis, but the association was not significant after multiple comparisons. Additionally, rs501120 (P = 8.36x10(-03), OR = 0.80) at 10q11.21 was associated with coronary atherosclerosis in females, but did not show association in males and all participants. Variants at 1p13.3, 2q36.3, 6q25.1 and 15q22.33 showed no associations with coronary atherosclerosis and main cardiovascular risk factors in our data. Conclusions/Significance: Our findings indicated variants at 9p21 were significantly associated with coronary atherosclerosis in Han Chinese. Variants at 1q41 showed suggestive evidence of association and variants at 10q11.21 showed suggestive evidence of association in females, which warrant further study in a larger sample.	[Xie, Fang; Chu, Xun; Huang, Wei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai 200030, Peoples R China; [Xie, Fang; Chu, Xun; Sun, Weiwei; Shen, Min; Yang, Lin; Wang, Ying; Wang, Yi; Shi, Jinxiu; Huang, Wei] Chinese Natl Human Genome Ctr, Shanghai MOST Key Lab Hlth & Dis Genom, Dept Genet, Shanghai, Peoples R China; [Wu, Hong] Second Mil Med Univ, Changhai Hosp, Dept Cardiol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Naval Medical University	Xie, F (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai 200030, Peoples R China.	shijx@chgc.sh.cn		Chu, Xun/0000-0002-7440-1371	Chinese High-Tech Program [2006AA020706, 2006AA02A406, 2009AA022709]; Shanghai Science and Technology Committee [09DZ2291900]	Chinese High-Tech Program; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was supported by grants from the Chinese High-Tech Program (2006AA020706, 2006AA02A406, 2009AA022709) and the Shanghai Science and Technology Committee (09DZ2291900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah KG, 2008, ANN HUM GENET, V72, P654, DOI 10.1111/j.1469-1809.2008.00454.x; Abi-Younes S, 2000, CIRC RES, V86, P131, DOI 10.1161/01.RES.86.2.131; Amouyel P, 2009, ARTERIOSCL THROM VAS, V29, P774, DOI 10.1161/ATVBAHA.108.181388; Arndt S, 2007, J LEUKOCYTE BIOL, V82, P1466, DOI 10.1189/jlb.0407219; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bosserhoff AK, 2004, GENE EXPR PATTERNS, V4, P473, DOI 10.1016/j.modgep.2003.12.002; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Ding H, 2009, CIRC-CARDIOVASC GENE, V2, P338, DOI 10.1161/CIRCGENETICS.108.810226; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Folkersen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007677; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hiura Y, 2008, CIRC J, V72, P1213, DOI 10.1253/circj.72.1213; Holdt LM, 2010, ARTERIOSCL THROM VAS, V30, P620, DOI 10.1161/ATVBAHA.109.196832; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kullo IJ, 2007, NAT CLIN PRACT CARD, V4, P558, DOI 10.1038/ncpcardio0982; LIN HF, 2011, J INVESTIG MED; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Lutucuta S, 2001, CIRC RES, V88, P969, DOI 10.1161/hh0901.090301; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Nakayama K, 2009, J MED GENET, V46, P370, DOI 10.1136/jmg.2008.064063; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; QUELLE DE, 1995, CELL, V83, P993; Samani NJ, 2008, J MOL MED, V86, P1233, DOI 10.1007/s00109-008-0387-2; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Shen GQ, 2008, J HUM GENET, V53, P144, DOI 10.1007/s10038-007-0230-6; Shen GQ, 2008, ARTERIOSCL THROM VAS, V28, P360, DOI 10.1161/ATVBAHA.107.157248; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Wang W, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-33; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; WHO publishes definitive atlas on global heart disease and stroke epidemic, 2004, INDIAN J MED SCI, V58, P405; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yang CS, 2008, MED HYPOTHESES, V71, P449, DOI 10.1016/j.mehy.2008.02.019; Ye S, 2008, J AM COLL CARDIOL, V52, P378, DOI 10.1016/j.jacc.2007.11.087; Zhang Q, 2009, ATHEROSCLEROSIS, V207, P26, DOI 10.1016/j.atherosclerosis.2009.04.017; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhou L, 2008, ARTERIOSCL THROM VAS, V28, P2085, DOI 10.1161/ATVBAHA.108.176065	48	28	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20833	10.1371/journal.pone.0020833	http://dx.doi.org/10.1371/journal.pone.0020833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698238	gold, Green Submitted, Green Published			2022-12-25	WOS:000291734100023
J	Chun-Lai, T; Padyukov, L; Dhaliwal, JS; Lundstrom, E; Yahya, A; Muhamad, NA; Klareskog, L; Alfredsson, L; Larsson, PT; Murad, S				Chun-Lai, Too; Padyukov, Leonid; Dhaliwal, Jasbir Singh; Lundstrom, Emeli; Yahya, Abqariyah; Muhamad, Nor Asiah; Klareskog, Lars; Alfredsson, Lars; Larsson, Per Tobias; Murad, Shahnaz		Malaysian Epidemiological Invest	Shared Epitope Alleles Remain A Risk Factor for Anti-Citrullinated Proteins Antibody (ACPA) - Positive Rheumatoid Arthritis in Three Asian Ethnic Groups	PLOS ONE			English	Article							HLA-DRB1 ALLELES; GENETIC SUSCEPTIBILITY; JAPANESE PATIENTS; PEPTIDE ANTIBODY; HLA; ASSOCIATION; SMOKING; POPULATION; HLA-DRB1-ASTERISK-0405; AUTOANTIBODIES	Background: To investigate the associations between HLA-DRB1 shared epitope (SE) alleles and rheumatoid arthritis in subsets of rheumatoid arthritis defined by autoantibodies in three Asian populations from Malaysia. Methods: 1,079 rheumatoid arthritis patients and 1,470 healthy controls were included in the study. Levels of antibodies to citrullinated proteins (ACPA) and rheumatoid factors were assessed and the PCR-SSO method was used for HLA-DRB1 genotyping. Results: The proportion of ACPA positivity among Malay, Chinese and Indian rheumatoid arthritis patients were 62.9%, 65.2% and 68.6%, respectively. An increased frequency of SE alleles was observed in ACPA-positive rheumatoid arthritis among the three Asian ethnic groups. HLA-DRB1*10 was highly associated with rheumatoid arthritis susceptibility in these Asian populations. HLA-DRB1*0405 was significantly associated with susceptibility to rheumatoid arthritis in Malays and Chinese, but not in Indians. HLA-DRB1*01 did not show any independent effect as a risk factor for rheumatoid arthritis in this study and HLA-DRB1*1202 was protective in Malays and Chinese. There was no association between SE alleles and ACPA-negative rheumatoid arthritis in any of the three Asian ethnic groups. Conclusion: The HLA-DRB1 SE alleles increase the risk of ACPA-positive rheumatoid arthritis in all three Asian populations from Malaysia.	[Chun-Lai, Too; Padyukov, Leonid; Lundstrom, Emeli; Klareskog, Lars; Larsson, Per Tobias] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Chun-Lai, Too; Dhaliwal, Jasbir Singh] Inst Med Res, Allergy & Immunol Res Ctr, Kuala Lumpur 50588, Malaysia; [Yahya, Abqariyah; Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Yahya, Abqariyah; Muhamad, Nor Asiah] Inst Med Res, Epidemiol & Biostat Unit, Kuala Lumpur 50588, Malaysia	Karolinska Institutet; Kementerian Kesihatan Malaysia; Karolinska Institutet; Kementerian Kesihatan Malaysia	Chun-Lai, T (corresponding author), Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden.	leonid.padyukov@ki.se	Yahya, Abqariyah/B-5638-2017; Too, Chun Lai/AAW-8967-2021; Alfredsson, Lars/AAC-9007-2019; Chun-Lai, Too/AAI-1878-2020; Padyukov, Leonid/A-4890-2009	Yahya, Abqariyah/0000-0001-9158-415X; Too, Chun Lai/0000-0002-4079-8454; Alfredsson, Lars/0000-0003-1688-6697; Padyukov, Leonid/0000-0003-2950-5670; Klareskog, Lars/0000-0001-9601-6186	Ministry of Health (MOH), Malaysia [MRG 7/2005, JPP-IMR 08-012 (NMRR-08-820-1975)]; Swedish Medical Research Council; Swedish Combine program	Ministry of Health (MOH), Malaysia; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Combine program	This study was financially supported by the Ministry of Health (MOH), Malaysia: MRG 7/2005 and JPP-IMR 08-012 (NMRR-08-820-1975) and by the Swedish Medical Research Council and the Swedish Combine program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Balsa A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2975; Bang SY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3051; Bengtsson C, 2010, SCAND J RHEUMATOL, V39, P344, DOI 10.3109/03009740903501634; Bowes J, 2008, RHEUMATOLOGY, V47, P399, DOI 10.1093/rheumatology/ken005; CHAN SH, 1994, BRIT J RHEUMATOL, V33, P713; DEIGHTON CM, 1989, CLIN GENET, V36, P178; Dhaliwal JS, 2007, ASIAN PAC J ALLERGY, V25, P47; Eberhardt K, 1996, ANN RHEUM DIS, V55, P34, DOI 10.1136/ard.55.1.34; Furuya T, 2007, CLIN EXP RHEUMATOL, V25, P219; Griffiths B, 2000, RHEUMATOLOGY, V39, P857, DOI 10.1093/rheumatology/39.8.857; Hughes LB, 2008, ARTHRITIS RHEUM-US, V58, P349, DOI 10.1002/art.23166; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2007, CURR OPIN RHEUMATOL, V19, P49, DOI 10.1097/BOR.0b013e32801127c8; Klareskog L, 2006, NAT CLIN PRACT RHEUM, V2, P425, DOI 10.1038/ncprheum0249; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Kong KF, 2002, AUTOIMMUNITY, V35, P235, DOI 10.1080/08916930290024179; Lee HS, 2004, ARTHRITIS RHEUM-US, V50, P3468, DOI 10.1002/art.20608; Lin L, 2007, BIOCHEM CELL BIOL, V85, P227, DOI 10.1139/O06-204; Linn-Rasker SP, 2006, ANN RHEUM DIS, V65, P366, DOI 10.1136/ard.2005.041079; Liu SC, 2007, J RHEUMATOL, V34, P674; Louzada P, 2008, BRAZ J MED BIOL RES, V41, P493, DOI 10.1590/S0100-879X2008005000021; Lundstrom E, 2009, ARTHRITIS RHEUM-US, V60, P924, DOI 10.1002/art.24410; Lundstrom E, 2009, ARTHRITIS RHEUM, V60, P1597, DOI 10.1002/art.24572; Okada Y, 2009, ARTHRITIS RHEUM-US, V60, P3582, DOI 10.1002/art.24939; Pimtanothai Nattiya, 2002, Journal of the Medical Association of Thailand, V85, pS366; Poor G, 2007, ANN NY ACAD SCI, V1110, P23, DOI 10.1196/annals.1423.004; SILMAN AJ, 1993, J RHEUMATOL, V20, P1815; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; van der Woude D, 2010, ARTHRITIS RHEUM-US, V62, P1236, DOI 10.1002/art.27366; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P2113, DOI 10.1002/art.20316; Wakitani S, 1998, SCAND J RHEUMATOL, V27, P146; Xue Y, 2008, SCAND J RHEUMATOL, V37, P183, DOI 10.1080/03009740701874444; YELAMOS J, 1993, ARTHRITIS RHEUM-US, V36, P811, DOI 10.1002/art.1780360611	34	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21069	10.1371/journal.pone.0021069	http://dx.doi.org/10.1371/journal.pone.0021069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698259	Green Submitted, Green Published, gold			2022-12-25	WOS:000291730000048
J	Wang, LF; Zhao, F; Li, M; Zhang, HM; Gao, Y; Cao, P; Pan, XW; Wang, ZH; Chang, WR				Wang, Longfei; Zhao, Fei; Li, Mei; Zhang, Hongmei; Gao, Yu; Cao, Peng; Pan, Xiaowei; Wang, Zhuanhua; Chang, Wenrui			Conformational Changes of rBTI from Buckwheat upon Binding to Trypsin: Implications for the Role of the P-8 ' Residue in the Potato Inhibitor I Family	PLOS ONE			English	Article							PROTEASE INHIBITORS; STABILITY; SITE; LOOP; ARG(50); GENE	BWI-1 (buckwheat trypsin inhibitor), a member of the potato inhibitor I family, suppresses the growth of T-acute lymphoblastic leukemia cells and induces apoptosis in human solid tumor cell lines. Here, we report the crystal structure of rBTI (recombinant buckwheat trypsin inhibitor), a recombinant protein of BWI-1, at 1.84 angstrom resolution and the structure of rBTI in complex with bovine trypsin at 2.26 angstrom resolution. A conformational change of Trp53 at the P-8' position in rBTI was observed upon its binding to trypsin, which is not seen in other members of the potato inhibitor I family reported previously. The role of the P-8' residue in the potato inhibitor I family was examined by measuring the association and dissociation rates of four rBTI mutants with different substitutions at the P-2 and P-8' positions when binding to trypsin. One of the mutants, P44T, was found to be a much stronger inhibitor than wild-type rBTI, with a picomolar (pM) dissociation constant. Our results could provide valuable insights for designing a new rBTI-based antitumor drug in the future.	[Wang, Longfei; Li, Mei; Zhang, Hongmei; Gao, Yu; Cao, Peng; Pan, Xiaowei; Chang, Wenrui] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Wang, Longfei] Chinese Acad Sci, Grad Univ, Beijing 100080, Peoples R China; [Zhao, Fei; Wang, Zhuanhua] Shanxi Univ, Inst Biotechnol, Key Lab Chem Biol & Mol Engn, Minist Educ, Taiyuan, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanxi University	Wang, LF (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	zhwang@sxu.edu.cn; wrchang@sun5.ibp.ac.cn		, Peng/0000-0002-2044-3074; Li, Mei/0000-0002-1742-2360	973 Project [2011CBA00902]; National Natural Science Foundation of China [31021062]; Chinese Academy of Sciences [KSCX2-YW-R-123, KSCX2-EW-J-3]	973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the 973 Project (Grant No. 2011CBA00902), the National Natural Science Foundation of China (Grant No. 31021062) and the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. KSCX2-YW-R-123 and KSCX2-EW-J-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BELOZERSKY MA, 1995, FEBS LETT, V371, P264, DOI 10.1016/0014-5793(95)00899-K; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai ML, 2002, BIOCHEMISTRY-US, V41, P9572, DOI 10.1021/bi0258952; Cai ML, 1996, BIOCHEMISTRY-US, V35, P4784, DOI 10.1021/bi953038a; Cierpicki T, 2000, J MOL BIOL, V302, P1179, DOI 10.1006/jmbi.2000.4116; Dunaevsky YE, 1996, BIOCHEM MOL BIOL INT, V40, P199; Dunaevsky YE, 1997, PHYSIOL PLANTARUM, V101, P483, DOI 10.1111/j.1399-3054.1997.tb01027.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Grzesiak A, 2000, J MOL BIOL, V301, P205, DOI 10.1006/jmbi.2000.3935; JACKSON SE, 1994, BIOCHEMISTRY-US, V33, P13880, DOI 10.1021/bi00250a042; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Khadeeva NV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P260, DOI 10.1134/S0006297909030031; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li YY, 2009, TOXICOL LETT, V189, P166, DOI 10.1016/j.toxlet.2009.05.018; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SS, 2004, APPL BIOCHEM BIOTECH, V117, P65, DOI 10.1385/ABAB:117:2:065; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Zhang Z, 2007, ACTA BIOCH BIOPH SIN, V39, P701, DOI 10.1111/j.1745-7270.2007.00332.x	26	10	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20950	10.1371/journal.pone.0020950	http://dx.doi.org/10.1371/journal.pone.0020950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698291	Green Published, gold, Green Submitted			2022-12-25	WOS:000291730000030
J	Momken, I; Stevens, L; Bergouignan, A; Desplanches, D; Rudwill, F; Chery, I; Zahariev, A; Zahn, S; Stein, TP; Sebedio, JL; Pujos-Guillot, E; Falempin, M; Simon, C; Coxam, V; Andrianjafiniony, T; Gauquelin-Koch, G; Picquet, F; Blanc, S				Momken, Iman; Stevens, Laurence; Bergouignan, Audrey; Desplanches, Dominique; Rudwill, Floriane; Chery, Isabelle; Zahariev, Alexandre; Zahn, Sandrine; Stein, T. Peter; Sebedio, Jean Louis; Pujos-Guillot, Estelle; Falempin, Maurice; Simon, Chantal; Coxam, Veronique; Andrianjafiniony, Tany; Gauquelin-Koch, Guillemette; Picquet, Florence; Blanc, Stephane			Resveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the rat	FASEB JOURNAL			English	Article						sedentary behavior; polyphenol; spaceflight; weightlessness	HUMAN SKELETAL-MUSCLE; BED-REST; OXIDATIVE STRESS; SOLEUS MUSCLE; SPACE-FLIGHT; ENERGY-EXPENDITURE; INSULIN-RESISTANCE; PROTEIN-SYNTHESIS; VITAMIN-E; GASTROCNEMIUS-MUSCLES	Long-term spaceflight induces hypokinesia and hypodynamia, which, along microgravity per se, result in a number of significant physiological alterations, such as muscle atrophy, force reduction, insulin resistance, substrate use shift from fats to carbohydrates, and bone loss. Each of these adaptations could turn to serious health deterioration during the longterm spaceflight needed for planetary exploration. We hypothesized that resveratrol (RES), a natural polyphenol, could be used as a nutritional countermeasure to prevent muscle metabolic and bone adaptations to 15 d of rat hindlimb unloading. RES treatment maintained a net protein balance, soleus muscle mass, and soleus muscle maximal force contraction. RES also fully maintained soleus mitochondrial capacity to oxidize palmitoyl-carnitine and reversed the decrease of the glutathione vs. glutathione disulfide ratio, a biomarker of oxidative stress. At the molecular level, the protein content of Sirt-1 and COXIV in soleus muscle was also preserved. RES further protected whole-body insulin sensitivity and lipid trafficking and oxidation, and this was likely associated with the maintained expression of FAT/CD36, CPT-1, and peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha) in muscle. Finally, chronic RES supplementation maintained the bone mineral density and strength of the femur. For the first time, we report a simple countermeasure that prevents the deleterious adaptations of the major physiological functions affected by mechanical unloading. RES could thus be envisaged as a nutritional countermeasure for spaceflight but remains to be tested in humans.-Momken, I., Stevens, L., Bergouignan, A., Desplanches, D., Rudwill, F., Chery, I., Zahariev, A., Zahn, S., Stein, T. P., Sebedio, J. L., Pujos-Guillot, E., Falempin, M., Simon, C., Coxam, V., Andrianjafiniony, T., Gauquelin-Koch, G., Picquet, F., Blanc, S. Resveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the rat. FASEB J. 25, 3646-3660 (2011). www.fasebj.org	[Momken, Iman; Bergouignan, Audrey; Rudwill, Floriane; Chery, Isabelle; Zahariev, Alexandre; Zahn, Sandrine; Blanc, Stephane] Univ Strasbourg, CNRS, IPHC, UMR 7178, Strasbourg, France; [Stevens, Laurence; Falempin, Maurice; Picquet, Florence] Univ Lille 1, Lab Activite Phys Muscle & Sante, Lille, France; [Desplanches, Dominique; Andrianjafiniony, Tany] Univ Lyon 1, CNRS, UMR 5534, F-69622 Villeurbanne, France; [Stein, T. Peter] Univ Med & Dent New Jersey, Dept Surg, Newark, NJ 07103 USA; [Sebedio, Jean Louis; Pujos-Guillot, Estelle] Univ Auvergne, UMR 1019, INRA, Clermont Ferrand, France; [Simon, Chantal] Fac Med Lyon Sud, INSERM, U870, INRA 1235, Lyon, France; [Coxam, Veronique] UMR 1019 Alimentat Squelette & Metab, Unite Nutr Humaine, St Genes Champanelle, France; [Gauquelin-Koch, Guillemette] CNES, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Rutgers State University New Brunswick; Rutgers State University Medical Center; INRAE; Universite Clermont Auvergne (UCA); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm)	Blanc, S (corresponding author), CNRS 7178, IPHC, Dept Ecol, 23 Rue Becquerel, F-67087 Strasbourg, France.	stephane.blanc@iphc.cnrs.fr	Stein, T. Peter/R-4244-2019; , simon/B-2895-2011; Bergouignan, Audrey/A-2750-2016	, simon/0000-0002-7820-3233; Bergouignan, Audrey/0000-0002-1266-5144; PUJOS-GUILLOT, Estelle/0000-0002-4693-5712	National Centre of French Space Study (CNES)	National Centre of French Space Study (CNES)(Centre National D'etudes Spatiales)	This work was supported by the National Centre of French Space Study (CNES) and a research fellowship to I. M. The authors appreciate the great help and guidance of Dr. Anne Garnier for RT-qPCR quantification and analysis. The authors thank Steven Wingling and Cedric Falter for their technical assistance. The authors also thank Antoine Stier and Celine Bret for their involvement in the cardiovascular tests as part of their bachelor of sciences degree.	ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; BALDWIN KM, 1993, J APPL PHYSIOL, V75, P2466, DOI 10.1152/jappl.1993.75.6.2466; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Belavy DL, 2011, OSTEOPOROSIS INT, V22, P1581, DOI 10.1007/s00198-010-1371-6; Bergouignan A, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010027; Bergouignan A, 2010, J CLIN ENDOCR METAB, V95, P1045, DOI 10.1210/jc.2009-1005; Bergouignan A, 2009, DIABETES, V58, P367, DOI 10.2337/db08-0263; Blanc S, 2002, COMP BIOCHEM PHYS A, V131, P683, DOI 10.1016/S1095-6433(01)00519-0; Blanc S, 2000, AM J PHYSIOL-REG I, V279, pR1964, DOI 10.1152/ajpregu.2000.279.6.R1964; Boissy P, 2005, CANCER RES, V65, P9943, DOI 10.1158/0008-5472.CAN-05-0651; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cavanagh Peter R, 2005, Gravit Space Biol Bull, V18, P39; CHEN H, 1995, FREE RADICAL RES, V22, P177, DOI 10.3109/10715769509147537; CONCON JM, 1973, ANAL BIOCHEM, V53, P35, DOI 10.1016/0003-2697(73)90405-3; Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, pH13, DOI 10.1152/ajpheart.00368.2009; Csukly K, 2005, EUR J APPL PHYSIOL, V95, P243, DOI 10.1007/s00421-005-1391-7; Dai Z, 2007, PHYTOMEDICINE, V14, P806, DOI 10.1016/j.phymed.2007.04.003; Falempin M, 1997, MUSCLE NERVE, V20, P172; Falempin M, 1999, J APPL PHYSIOL, V87, P3, DOI 10.1152/jappl.1999.87.1.3; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fitts RH, 2007, AM J PHYSIOL-CELL PH, V293, pC313, DOI 10.1152/ajpcell.00573.2006; Fitts RH, 2000, J APPL PHYSIOL, V89, P823, DOI 10.1152/jappl.2000.89.2.823; Fortney SM, 1998, AVIAT SPACE ENVIR MD, V69, P137; Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; Giroud S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008823; Gleeson M, 2000, J PHYSIOL-LONDON, V529, P1, DOI 10.1111/j.1469-7793.2000.00001.x; GOLDSPINK DF, 1986, PFLUG ARCH EUR J PHY, V407, P333, DOI 10.1007/BF00585311; GREENLEAF JE, 1989, J APPL PHYSIOL, V67, P507, DOI 10.1152/jappl.1989.67.2.507; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Heer M, 2002, NUTRITION, V18, P853, DOI 10.1016/S0899-9007(02)00905-X; Helge JW, 2003, J PHYSIOL-LONDON, V546, P299, DOI 10.1113/jphysiol.2002.030437; Hilder TL, 2005, J APPL PHYSIOL, V99, P2181, DOI 10.1152/japplphysiol.00743.2005; HOWELL RR, 1961, J CLIN INVEST, V40, P2076, DOI 10.1172/JCI104433; Iwamoto Jun, 2005, Keio Journal of Medicine, V54, P55, DOI 10.2302/kjm.54.55; Jackson JR, 2010, AM J PHYSIOL-REG I, V299, pR1572, DOI 10.1152/ajpregu.00489.2010; JASPERS SR, 1986, MUSCLE NERVE, V9, P554, DOI 10.1002/mus.880090613; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; KONDO H, 1993, AM J PHYSIOL, V265, pE839, DOI 10.1152/ajpendo.1993.265.6.E839; la Porte C, 2010, CLIN PHARMACOKINET, V49, P449, DOI 10.2165/11531820-000000000-00000; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; Lawler JM, 2003, FREE RADICAL BIO MED, V35, P9, DOI 10.1016/S0891-5849(03)00186-2; LEBLANC A, 1992, ACTA ASTRONAUT, V27, P89, DOI 10.1016/0094-5765(92)90182-I; LeBlanc A. D., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P33; Leonard SS, 2003, BIOCHEM BIOPH RES CO, V309, P1017, DOI 10.1016/j.bbrc.2003.08.105; Lew PS, 2009, CAN J PHYSIOL PHARM, V87, P839, DOI 10.1139/Y09-074; MACHO L, 1992, ACTA ASTRONAUT, V27, P51, DOI 10.1016/0094-5765(92)90175-I; Morey E R, 1979, Physiologist, V22, pS23; Morris CA, 2005, J APPL PHYSIOL, V99, P1719, DOI 10.1152/japplphysiol.01419.2004; Muller FL, 2008, BIOCHEM J, V409, P491, DOI 10.1042/BJ20071162; Murase T, 2009, BIOGERONTOLOGY, V10, P423, DOI 10.1007/s10522-008-9177-z; Paddon-Jones D, 2004, AM J PHYSIOL-ENDOC M, V286, pE321, DOI 10.1152/ajpendo.00368.2003; Paddon-Jones D, 2006, J CLIN ENDOCR METAB, V91, P4836, DOI 10.1210/jc.2006-0651; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Picquet F, 2003, EXP NEUROL, V182, P186, DOI 10.1016/S0014-4886(03)00111-0; PIERCE S, 1978, BIOCHIM BIOPHYS ACTA, V523, P27, DOI 10.1016/0005-2744(78)90005-0; RACETTE SB, 1994, AM J PHYSIOL-ENDOC M, V267, pE585, DOI 10.1152/ajpendo.1994.267.4.E585; Rathbone CR, 2009, EUR J CELL BIOL, V88, P35, DOI 10.1016/j.ejcb.2008.08.003; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Ryan MJ, 2010, J GERONTOL A-BIOL, V65, P815, DOI 10.1093/gerona/glq080; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; SANTIDRIAN S, 1981, METABOLISM, V30, P798, DOI 10.1016/0026-0495(81)90026-3; Servais S, 2007, FREE RADICAL BIO MED, V42, P627, DOI 10.1016/j.freeradbiomed.2006.12.001; SHANGRAW RE, 1988, AM J PHYSIOL, V255, pE548, DOI 10.1152/ajpendo.1988.255.4.E548; Smith BJ, 2005, CALCIFIED TISSUE INT, V76, P272, DOI 10.1007/s00223-004-0269-8; Smith SM, 2005, J BONE MINER RES, V20, P208, DOI 10.1359/JBMR.041105; SOUTHORN BG, 1990, BIOCHEM J, V272, P187, DOI 10.1042/bj2720187; Stein T P, 2002, J Gravit Physiol, V9, pP165; Stein T P, 1999, J Gravit Physiol, V6, pP85; Stein TP, 2005, J NUTR, V135, p1824S, DOI 10.1093/jn/135.7.1824S; Stein TP, 2002, J NUTR BIOCHEM, V13, P471, DOI 10.1016/S0955-2863(02)00195-X; STEIN TP, 1994, AVIAT SPACE ENVIR MD, V65, P1091; STUART CA, 1993, EXP TOXICOL PATHOL, V45, P291; STUART CA, 1988, METABOLISM, V37, P802, DOI 10.1016/0026-0495(88)90018-2; Supornsilchai V, 2005, HORM RES, V64, P280, DOI 10.1159/000089487; Trappe S, 2008, AM J PHYSIOL-REG I, V294, pR939, DOI 10.1152/ajpregu.00761.2007; Trappe S, 2009, J APPL PHYSIOL, V106, P1159, DOI 10.1152/japplphysiol.91578.2008; Ungvari Z, 2009, AM J PHYSIOL-HEART C, V297, pH1876, DOI 10.1152/ajpheart.00375.2009; VEKSLER V, 1994, MOL CELL BIOCHEM, V133, P287, DOI 10.1007/BF01267961; Williams LD, 2009, FOOD CHEM TOXICOL, V47, P2170, DOI 10.1016/j.fct.2009.06.002; Wyke SM, 2004, BRIT J CANCER, V91, P1742, DOI 10.1038/sj.bjc.6602165; YAMASHITA H, 1995, J APPL PHYSIOL, V78, P384, DOI 10.1152/jappl.1995.78.2.384; Yimlamai T, 2005, J APPL PHYSIOL, V99, P71, DOI 10.1152/japplphysiol.00448.2004; Zange J, 2009, EUR J APPL PHYSIOL, V105, P271, DOI 10.1007/s00421-008-0899-z	87	132	136	0	39	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2011	25	10					3646	3660		10.1096/fj.10-177295	http://dx.doi.org/10.1096/fj.10-177295			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21715682				2022-12-25	WOS:000295356400034
J	Alvarez, D; Briassouli, P; Clancy, RM; Zavadil, J; Reed, JH; Abellar, RG; Halushka, M; Fox-Talbot, K; Barrat, FJ; Buyon, JP				Alvarez, David; Briassouli, Paraskevi; Clancy, Robert M.; Zavadil, Jiri; Reed, Joanne H.; Abellar, Rosanna G.; Halushka, Marc; Fox-Talbot, Karen; Barrat, Franck J.; Buyon, Jill P.			A Novel Role of Endothelin-1 in Linking Toll-like Receptor 7-mediated Inflammation to Fibrosis in Congenital Heart Block	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC FIBROBLAST PROLIFERATION; GROWTH-FACTOR BETA-1; PROTEIN-KINASE-C; TGF-BETA; MYOCARDIAL-INFARCTION; COLLAGEN-SYNTHESIS; GENE-EXPRESSION; MATURE PEPTIDE; SSA/RO-SSB/LA; ANTI-SSA/RO	Autoimmune associated congenital heart block (CHB) may result from pathogenic cross-talk between inflammatory and profibrosing pathways. Incubation of macrophages with immune complexes (IC) composed of Ro60, a target of the pathologic maternal autoantibodies necessary for CHB, hY3 ssRNA, and affinity-purified anti-Ro60 antibody induces the Toll-like receptor 7 (TLR7)-dependent generation of supernatants that provoke a fibrosing phenotype in human fetal cardiac fibroblasts. We show herein that these cells are a major source of TGF beta and that endothelin-1 (ET-1) is one of the key components responsible for the profibrosing effects generated by stimulated macrophages. Supernatants from macrophages incubated with IC induced the fibroblast secretion of TGF beta, which was inhibited by treating the macrophages with an antagonist of TLR7. Under the same conditions, the induced fibroblast secretion of TGF beta was decreased by inhibitors of the ET-1 receptors ETa or ETb or by an anti-ET-1 antibody but not by an isotype control. Exogenous ET-1 induced a profibrosing phenotype, whereas fibroblasts transfected with either ETa or ETb siRNA were unresponsive to the profibrosing effects of the IC-generated macrophage supernatants. Immunohistochemistry of the hearts from two fetuses dying with CHB revealed the presence of ET-1-producing mononuclear cells in the septal region in areas of calcification and fibrosis. In conclusion, these data support a novel role of ET-1 in linking TLR7 inflammatory signaling to subsequent fibrosis and provide new insight in considering therapeutics for CHB.	[Alvarez, David; Briassouli, Paraskevi; Clancy, Robert M.; Zavadil, Jiri; Reed, Joanne H.; Buyon, Jill P.] NYU, Med Ctr, New York, NY 10016 USA; [Abellar, Rosanna G.] Columbia Univ, Med Ctr, New York, NY 10032 USA; [Barrat, Franck J.] Dynavax Technol, Berkeley, CA 94710 USA; [Halushka, Marc; Fox-Talbot, Karen] Johns Hopkins Med Inst, Baltimore, MD 21205 USA	New York University; Columbia University; Johns Hopkins University; Johns Hopkins Medicine	Buyon, JP (corresponding author), 560 1st Ave,TH-407, New York, NY 10016 USA.	Jill.Buyon@nyumc.org	Zavadil, Jiri/ABG-1780-2020	Zavadil, Jiri/0000-0003-0640-5562; Buyon, Jill/0000-0002-3852-7129; Halushka, Marc/0000-0002-7112-7389; Reed, Joanne/0000-0002-7585-7848	National Institutes of Health [AR-42455, N01-AR-4-2271]; Mary Kirkland Center for Lupus Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042455, R37AR042455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary Kirkland Center for Lupus Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR-42455 and N01-AR-4-2271 and a grant from the Mary Kirkland Center for Lupus Research.	Asano K, 2002, J MOL CELL CARDIOL, V34, P833, DOI 10.1006/jmcc.2002.2022; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Brucato A, 2001, ARTHRITIS RHEUM-US, V44, P1832, DOI 10.1002/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C; Buyon JP, 2005, AUTOIMMUN REV, V4, P1, DOI 10.1016/j.autrev.2004.04.003; Buyon JP, 2007, DUBOIS LUPUS ERYTHEM, P1058; Cambiaggi C, 2001, CYTOKINE, V14, P230, DOI 10.1006/cyto.2001.0865; Chintalgattu V, 2004, J PHARMACOL EXP THER, V311, P691, DOI 10.1124/jpet.104.070151; Clancy RM, 2004, ARTHRITIS RHEUM, V50, P173, DOI 10.1002/art.11430; Clancy RM, 2003, J IMMUNOL, V171, P3253, DOI 10.4049/jimmunol.171.6.3253; Clancy RM, 2002, J IMMUNOL, V169, P2156, DOI 10.4049/jimmunol.169.4.2156; Clancy RM, 2006, J CLIN INVEST, V116, P2413, DOI 10.1172/JCI27803; Clancy RM, 2010, J IMMUNOL, V184, P2148, DOI 10.4049/jimmunol.0902248; Divino JN, 2010, VET IMMUNOL IMMUNOP, V136, P127, DOI 10.1016/j.vetimm.2010.02.006; EHRENREICH H, 1990, J EXP MED, V172, P1741, DOI 10.1084/jem.172.6.1741; GRUSCHWITZ M, 1990, J INVEST DERMATOL, V94, P197, DOI 10.1111/1523-1747.ep12874503; GUARDA E, 1993, CARDIOVASC RES, V27, P2130, DOI 10.1093/cvr/27.12.2130; Hafizi S, 2004, CELL PHYSIOL BIOCHEM, V14, P285, DOI 10.1159/000080338; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; KANE CJM, 1991, J CELL PHYSIOL, V148, P157, DOI 10.1002/jcp.1041480119; Katwa LC, 2003, AM J PHYSIOL-HEART C, V285, pH1132, DOI 10.1152/ajpheart.01141.2002; Kuruvilla L, 2007, CELL BIOCHEM BIOPHYS, V47, P65, DOI 10.1385/CBB:47:1:65; Lagares D, 2010, ARTHRITIS RHEUM-US, V62, P878, DOI 10.1002/art.27307; Leask A, 2008, CELL SIGNAL, V20, P1409, DOI 10.1016/j.cellsig.2008.01.006; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; LEVIN ER, 1995, NEW ENGL J MED, V333, P356, DOI 10.1056/NEJM199508103330607; Massai L, 2003, AM J PHYSIOL-GASTR L, V284, pG340, DOI 10.1152/ajpgi.00262.2002; Mayyas F, 2010, CIRC-ARRHYTHMIA ELEC, V3, P369, DOI 10.1161/CIRCEP.109.924985; Miranda-Carus ME, 1998, J IMMUNOL, V161, P5886; Nield LE, 2002, J AM COLL CARDIOL, V40, P796, DOI 10.1016/S0735-1097(02)02004-1; Nishida M, 2007, J BIOL CHEM, V282, P23117, DOI 10.1074/jbc.M611780200; OBRIEN CA, 1994, GENE DEV, V8, P2891, DOI 10.1101/gad.8.23.2891; Ogata T, 2004, J CARDIOVASC PHARM, V44, pS279, DOI 10.1097/01.fjc.0000166274.24797.0e; PELTONEN J, 1990, J INVEST DERMATOL, V94, P365, DOI 10.1111/1523-1747.ep12874491; Piacentini L, 2000, J MOL CELL CARDIOL, V32, P565, DOI 10.1006/jmcc.2000.1109; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Shephard P, 2004, THROMB HAEMOSTASIS, V92, P262, DOI 10.1160/TH03-11-0669; Shi-Wen Xu, 2006, Mol Cell Biol, V26, P5518, DOI 10.1128/MCB.00625-06; Spirig R, 2009, MOL IMMUNOL, V46, P3178, DOI 10.1016/j.molimm.2009.05.179; Teder P, 2000, AM J RESP CELL MOL, V23, P7, DOI 10.1165/ajrcmb.23.1.f192; Theiss AL, 2005, J BIOL CHEM, V280, P36099, DOI 10.1074/jbc.M505291200; Widyantoro B, 2010, CIRCULATION, V121, P2407, DOI 10.1161/CIRCULATIONAHA.110.938217; Xu SW, 2007, ARTHRITIS RHEUM-US, V56, P4189, DOI 10.1002/art.23134; Xu SW, 2001, J INVEST DERMATOL, V116, P417, DOI 10.1046/j.1523-1747.2001.01256.x; Zolk O, 1999, CIRCULATION, V99, P2118, DOI 10.1161/01.CIR.99.16.2118	45	42	45	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30444	30454		10.1074/jbc.M111.263657	http://dx.doi.org/10.1074/jbc.M111.263657			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730058	Green Published, hybrid			2022-12-25	WOS:000294283600023
J	Kireeva, ML; Domecq, C; Coulombe, B; Burton, ZF; Kashlev, M				Kireeva, Maria L.; Domecq, Celine; Coulombe, Benoit; Burton, Zachary F.; Kashlev, Mikhail			Interaction of RNA Polymerase II Fork Loop 2 with Downstream Non-template DNA Regulates Transcription Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NTP-DRIVEN TRANSLOCATION; STRUCTURAL BASIS; ACTIVE-SITE; NUCLEOSIDE TRIPHOSPHATES; ALLOSTERIC BINDING; COMPLEX; RESOLUTION; MECHANISM; CATALYSIS; DYNAMICS	Fork loop 2 is a small semiconservative segment of the larger fork domain in the second largest Rpb2 subunit of RNA polymerase II (Pol II). This flexible loop, juxtaposed at the leading edge of transcription bubble, has been proposed to participate in DNA strand separation, translocation along DNA, and NTP loading to Pol II during elongation. Here we show that the Rpb2 mutant carrying a deletion of the flexible part of the loop is not lethal in yeast. The mutation exhibits no defects in DNA melting and translocation in vitro but confers a moderate decrease of the catalytic activity of the enzyme caused by the impaired sequestration of the NTP substrate in the active center prior to catalysis. In the structural model of the Pol II elongation complex, fork loop 2 directly interacts with an unpaired DNA residue in the non-template DNA strand one nucleotide ahead from the active center (the i + 2 position). We showed that elimination of this putative interaction by replacement of the i + 2 residue with an abasic site inhibits Pol II activity to the same degree as the deletion of fork loop 2. This replacement has no detectable effect on the activity of the mutant enzyme. We provide direct evidence that interaction of fork loop 2 with the non-template DNA strand facilitates NTP sequestration through interaction with the adjacent segment of the fork domain involved in the active center of Pol II.	[Kireeva, Maria L.; Kashlev, Mikhail] NCI Frederick, NIH, Ctr Canc Res, Frederick, MD 21702 USA; [Domecq, Celine; Coulombe, Benoit] Univ Montreal, Gene Transcript & Prote Lab, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Domecq, Celine; Coulombe, Benoit] Univ Montreal, Dept Biochem, Montreal, PQ H2W 1R7, Canada; [Burton, Zachary F.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Michigan State University	Kashlev, M (corresponding author), NCI Frederick, NIH, Ctr Canc Res, Frederick, MD 21702 USA.	kashlevm@mail.nih.gov	Kireeva, Maria/B-4391-2018	Kireeva, Maria/0000-0003-0527-3182	National Institutes of Health [R01 GM 092949]; NATIONAL CANCER INSTITUTE [ZIABC010795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM 092949 (to Z.F.B.).	Alexander R, 2010, BIOCHEM SOC T, V38, P1251, DOI 10.1042/BST0381251; Andrecka J, 2009, NUCLEIC ACIDS RES, V37, P5803, DOI 10.1093/nar/gkp601; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Burton ZF, 2005, BIOCHEM CELL BIOL, V83, P486, DOI 10.1139/O05-059; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; CHRISTIE KR, 1994, J BIOL CHEM, V269, P936; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Domecq C, 2010, PROTEIN EXPRES PURIF, V69, P83, DOI 10.1016/j.pep.2009.06.016; Ederth J, 2002, J BIOL CHEM, V277, P37456, DOI 10.1074/jbc.M207038200; Erie DA, 2009, CURR OPIN STRUC BIOL, V19, P708, DOI 10.1016/j.sbi.2009.10.008; Feig M, 2010, BIOPHYS J, V99, P2577, DOI 10.1016/j.bpj.2010.08.010; Foster JE, 2001, CELL, V106, P243, DOI 10.1016/S0092-8674(01)00420-2; Fujita T, 2010, J RECEPT SIG TRANSD, V30, P31, DOI 10.3109/10799890903517921; Garland CS, 1999, BIOCHEMISTRY-US, V38, P3421, DOI 10.1021/bi9820098; Gong XQ, 2005, MOL CELL, V18, P461, DOI 10.1016/j.molcel.2005.04.011; Holmes SF, 2003, J BIOL CHEM, V278, P35597, DOI 10.1074/jbc.M304496200; IZBAN MG, 1993, J BIOL CHEM, V268, P12874; Jeronimo C, 2004, MOL CELL BIOL, V24, P7043, DOI 10.1128/MCB.24.16.7043-7058.2004; Jovanovic M, 2011, J BIOL CHEM, V286, P14469, DOI 10.1074/jbc.M110.212902; Kashkina E, 2007, J BIOL CHEM, V282, P21578, DOI 10.1074/jbc.C700098200; Kennedy SR, 2011, P NATL ACAD SCI USA, V108, P6079, DOI 10.1073/pnas.1011274108; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kireeva M, 2009, METHODS, V48, P333, DOI 10.1016/j.ymeth.2009.04.008; Kireeva ML, 2008, MOL CELL, V30, P557, DOI 10.1016/j.molcel.2008.04.017; Kireeva ML, 2009, P NATL ACAD SCI USA, V106, P8900, DOI 10.1073/pnas.0900407106; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Langelier MF, 2005, NUCLEIC ACIDS RES, V33, P2629, DOI 10.1093/nar/gki570; Meyer PA, 2009, J BIOL CHEM, V284, P12933, DOI 10.1074/jbc.M809199200; Naji S, 2008, NUCLEIC ACIDS RES, V36, P676, DOI 10.1093/nar/gkm1086; Nedialkov YA, 2003, J BIOL CHEM, V278, P18303, DOI 10.1074/jbc.M301103200; Palangat M, 2004, J MOL BIOL, V341, P429, DOI 10.1016/j.jmb.2004.06.009; Pappas DL, 2000, MOL CELL BIOL, V20, P8343, DOI 10.1128/MCB.20.22.8343-8351.2000; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Seibold SA, 2010, BBA-GENE REGUL MECH, V1799, P575, DOI 10.1016/j.bbagrm.2010.05.002; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; TELESNITSKY A, 1989, BIOCHEMISTRY-US, V28, P5210, DOI 10.1021/bi00438a044; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; ZAYCHIKOV E, 1995, P NATL ACAD SCI USA, V92, P1739, DOI 10.1073/pnas.92.5.1739; Zhang CF, 2004, J MOL BIOL, V342, P1085, DOI 10.1016/j.jmb.2004.07.070	44	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30898	30910		10.1074/jbc.M111.260844	http://dx.doi.org/10.1074/jbc.M111.260844			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730074	hybrid, Green Published			2022-12-25	WOS:000294283600069
J	Xue, J; Graham, ME; Novelle, AE; Sue, N; Gray, N; McNiven, MA; Smillie, KJ; Cousin, MA; Robinson, PJ				Xue, Jing; Graham, Mark E.; Novelle, Aimee E.; Sue, Nancy; Gray, Noah; McNiven, Mark A.; Smillie, Karen J.; Cousin, Michael A.; Robinson, Phillip J.			Calcineurin Selectively Docks with the Dynamin Ixb Splice Variant to Regulate Activity-dependent Bulk Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; ACTIVATED T-CELLS; NERVE-TERMINALS; PHOSPHATASE-ACTIVITY; CHROMAFFIN CELLS; CENTRAL SYNAPSES; BINDING PROTEIN; NUCLEAR FACTOR; PHOSPHORYLATION; CALCIUM	Depolarization of nerve terminals stimulates rapid dephosphorylation of two isoforms of dynamin I (dynI), mediated by the calcium-dependent phosphatase calcineurin (CaN). Dephosphorylation at the major phosphorylation sites Ser-774/778 promotes a dynI-syndapin I interaction for a specific mode of synaptic vesicle endocytosis called activity-dependent bulk endocytosis (ADBE). DynI has two main splice variants at its extreme C terminus, long or short (dynIxa and dynIxb) varying only by 20 (xa) or 7 (xb) residues. Recombinant GST fusion proteins of dynIxa and dynIxb proline-rich domains (PRDs) were used to pull down interacting proteins from rat brain nerve terminals. Both bound equally to syndapin, but dynIxb PRD exclusively bound to the catalytic subunit of CaNA, which recruited CaNB. Binding of CaN was increased in the presence of calcium and was accompanied by further recruitment of calmodulin. Point mutations showed that the entire C terminus of dynIxb is a CaN docking site related to a conserved CaN docking motif (PXIXI(T/S)). This sequence is unique to dynIxb among all other dynamin variants or genes. Peptide mimetics of the dynIxb tail blocked CaN binding in vitro and selectively inhibited depolarization-evoked dynI dephosphorylation in nerve terminals but not of other dephosphins. Therefore, docking to dynIxb is required for the regulation of both dynI splice variants, yet it does not regulate the phosphorylation cycle of other dephosphins. The peptide blocked ADBE, but not clathrin-mediated endocytosis of synaptic vesicles. Our results indicate that Ca2+ influx regulates assembly of a fully active CaN-calmodulin complex selectively on the tail of dynIxb and that the complex is recruited to sites of ADBE in nerve terminals.	[Xue, Jing; Graham, Mark E.; Novelle, Aimee E.; Sue, Nancy; Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Wentworthville, NSW 2145, Australia; [Gray, Noah; McNiven, Mark A.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Smillie, Karen J.; Cousin, Michael A.] Univ Edinburgh, Ctr Integrat Physiol, Membrane Biol Grp, Edinburgh EH8 9XD, Midlothian, Scotland	Children's Medical Research Institute - Australia; University of Sydney; Mayo Clinic; University of Edinburgh	Robinson, PJ (corresponding author), Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Locked Bag 23, Wentworthville, NSW 2145, Australia.	probinson@cmri.org.au	Graham, Mark E/A-6480-2014; Robinson, Phillip J/G-4008-2011	Graham, Mark E/0000-0002-7290-1217; Robinson, Phillip J/0000-0002-7878-0313; Gray, Noah/0000-0002-4672-7403; Smillie, Karen/0000-0003-4369-0470; Cousin, Michael/0000-0002-1762-160X	NHMRC	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We thank Alan Prescott and John James for help with the electron microscopy analysis and the NHMRC for financial support.	Andersson F, 2008, J NEUROSCI, V28, P3925, DOI 10.1523/JNEUROSCI.1754-07.2008; Anggono V., 2009, ENCY NEUROSCIENCE; Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Bauerfeind R, 1997, J BIOL CHEM, V272, P30984, DOI 10.1074/jbc.272.49.30984; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Chan LS, 2010, J PROTEOME RES, V9, P4028, DOI 10.1021/pr100223n; Chan SA, 2003, PFLUG ARCH EUR J PHY, V445, P540, DOI 10.1007/s00424-002-0966-y; Chen-Hwang MC, 2002, J BIOL CHEM, V277, P17597, DOI 10.1074/jbc.M111101200; Cheung G, 2010, J NEUROSCI, V30, P8151, DOI 10.1523/JNEUROSCI.0293-10.2010; Clayton EL, 2008, NEUROCHEM INT, V53, P51, DOI 10.1016/j.neuint.2008.06.002; Clayton EL, 2008, J NEUROSCI, V28, P6627, DOI 10.1523/JNEUROSCI.1445-08.2008; Clayton EL, 2010, NAT NEUROSCI, V13, P845, DOI 10.1038/nn.2571; Clayton EL, 2009, J NEUROCHEM, V111, P901, DOI 10.1111/j.1471-4159.2009.06384.x; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; Cousin MA, 2003, J BIOL CHEM, V278, P29065, DOI 10.1074/jbc.M302386200; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Czirjak B, 2004, J BIOL CHEM, V279, P18550, DOI 10.1074/jbc.M312229200; Czirjak G, 2006, J BIOL CHEM, V281, P14677, DOI 10.1074/jbc.M602495200; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Engisch KL, 1998, J PHYSIOL-LONDON, V506, P591, DOI 10.1111/j.1469-7793.1998.591bv.x; Evans GJO, 2007, J NEUROSCI, V27, P401, DOI 10.1523/JNEUROSCI.3809-06.2007; Filosto S, 2010, J BIOL CHEM, V285, P10213, DOI 10.1074/jbc.M109.069963; Garcia-Cozar FJ, 1998, J BIOL CHEM, V273, P23877, DOI 10.1074/jbc.273.37.23877; Graham ME, 2007, J BIOL CHEM, V282, P14695, DOI 10.1074/jbc.M609713200; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Huang Y, 2004, BIOCHEMISTRY-US, V43, P10173, DOI 10.1021/bi036060+; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Jockusch WJ, 2005, NEURON, V46, P869, DOI 10.1016/j.neuron.2005.05.004; Jovanovic JN, 2001, J NEUROSCI, V21, P7944, DOI 10.1523/JNEUROSCI.21-20-07944.2001; Kasprowicz J, 2008, J CELL BIOL, V182, P1007, DOI 10.1083/jcb.200804162; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Lai MM, 2000, J BIOL CHEM, V275, P34017, DOI 10.1074/jbc.C000429200; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; LAPOINTE MC, 1990, HYPERTENSION, V15, P20, DOI 10.1161/01.HYP.15.1.20; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Okamoto PM, 1999, J BIOL CHEM, V274, P10277, DOI 10.1074/jbc.274.15.10277; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; ROBINSON PJ, 1985, J NEUROCHEM, V44, P338, DOI 10.1111/j.1471-4159.1985.tb05422.x; ROBINSON PJ, 1993, NATURE, V365, P163, DOI 10.1038/365163a0; Ruiz-Velasco V, 1998, CIRC RES, V82, P557, DOI 10.1161/01.RES.82.5.557; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Song HO, 2010, MOL CELLS, V30, P255, DOI 10.1007/s10059-010-0116-x; Stemmer P, 1991, Curr Opin Neurobiol, V1, P53, DOI 10.1016/0959-4388(91)90010-5; Sun T, 2010, J NEUROSCI, V30, P11838, DOI 10.1523/JNEUROSCI.1481-10.2010; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; WANG LH, 1995, J BIOL CHEM, V270, P10079, DOI 10.1074/jbc.270.17.10079; Wu LG, 2007, J NEUROSCI, V27, P11793, DOI 10.1523/JNEUROSCI.3471-07.2007; Ye QL, 2008, PROTEINS, V73, P19, DOI 10.1002/prot.22032; Yu HX, 2007, CARDIOVASC DRUG REV, V25, P175, DOI 10.1111/j.1527-3466.2007.00011.x; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373	58	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30295	30303		10.1074/jbc.M111.273110	http://dx.doi.org/10.1074/jbc.M111.273110			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730063	Green Published, hybrid			2022-12-25	WOS:000294283600007
J	Ewen, EP; Snyder, CM; Wilson, M; Desjardins, D; Naya, FJ				Ewen, Elizabeth P.; Snyder, Christine M.; Wilson, Megan; Desjardins, Danielle; Naya, Francisco J.			The Mef2A Transcription Factor Coordinately Regulates a Costamere Gene Program in Cardiac Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; STRIATED-MUSCLE; C-JUN; TARGET; EXPRESSION; ENHANCER; ANOIKIS; PROTEIN; MICE; CARDIOMYOCYTES	The Mef2 family of transcription factors regulates muscle differentiation, but the specific gene programs controlled by each member remain unknown. Characterization of Mef2A knockout mice has revealed severe myofibrillar defects in cardiac muscle indicating a requirement for Mef2A in cytoarchitectural integrity. Through comprehensive expression analysis of Mef2A-deficient hearts, we identified a cohort of dysregulated genes whose products localize to the peripheral Z-disc/costamere region. Many of these genes are essential for costamere integrity and function. Here we demonstrate that these genes are directly regulated by Mef2A, establishing a mechanism by which Mef2A controls the costamere. In an independent model system, acute knockdown of Mef2A in primary neonatal cardiomyocytes resulted in profound malformations of myofibrils and focal adhesions accompanied by adhesion-dependent programmed cell death. These findings indicate a role for Mef2A in cardiomyocyte survival through regulation of costamere integrity. Finally, bioinformatics analysis identified over-represented transcription factor-binding sites in this network of costamere promoters that may provide insight into the mechanism by which costamere genes are regulated by Mef2A. The global control of costamere gene expression adds another dimension by which this essential macromolecular complex may be regulated in health and disease.	[Ewen, Elizabeth P.; Snyder, Christine M.; Wilson, Megan; Desjardins, Danielle; Naya, Francisco J.] Boston Univ, Dept Biol, Program Cell & Mol Biol, Boston, MA 02215 USA	Boston University	Naya, FJ (corresponding author), Boston Univ, Dept Biol, Program Cell & Mol Biol, 24 Cummington St, Boston, MA 02215 USA.	fnaya@bu.edu			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by a National Institutes of Health Grant (to F. J. N.).	Akiyama T, 2009, MOL CANCER THER, V8, P3173, DOI 10.1158/1535-7163.MCT-09-0685; ANDRES V, 1995, J BIOL CHEM, V270, P23246, DOI 10.1074/jbc.270.40.23246; Balza RO, 2006, J BIOL CHEM, V281, P6498, DOI 10.1074/jbc.M509487200; BOLUYT MO, 1994, CIRC RES, V75, P23, DOI 10.1161/01.RES.75.1.23; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; DANOWSKI BA, 1992, J CELL BIOL, V118, P1411, DOI 10.1083/jcb.118.6.1411; Durham JT, 2006, J BIOL CHEM, V281, P6841, DOI 10.1074/jbc.M510499200; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Grote K, 2004, J BIOL CHEM, V279, P55675, DOI 10.1074/jbc.M406532200; Heidkamp MC, 2002, CIRC RES, V90, P1282, DOI 10.1161/01.RES.0000023201.41774.EA; Hervy M, 2006, CURR OPIN CELL BIOL, V18, P524, DOI 10.1016/j.ceb.2006.08.006; Hinits Y, 2007, DEVELOPMENT, V134, P2511, DOI 10.1242/dev.007088; Hoshijima M, 2006, AM J PHYSIOL-HEART C, V290, pH1313, DOI 10.1152/ajpheart.00816.2005; Huang HT, 2006, J BIOL CHEM, V281, P39370, DOI 10.1074/jbc.M603244200; Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Klamut HJ, 1997, NUCLEIC ACIDS RES, V25, P1618, DOI 10.1093/nar/25.8.1618; Li L, 2005, MOL CELL BIOL, V25, P10286, DOI 10.1128/MCB.25.23.10286-10300.2005; McCalmon SA, 2010, CIRC RES, V106, P952, DOI 10.1161/CIRCRESAHA.109.209007; Michel JB, 2003, ARTERIOSCL THROM VAS, V23, P2146, DOI 10.1161/01.ATV.0000099882.52647.E4; Nadruz W, 2005, CARDIOVASC RES, V68, P87, DOI 10.1016/j.cardiores.2005.05.011; Nadruz W, 2003, CIRC RES, V92, P243, DOI 10.1161/01.RES.0000053184.94618.97; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Quach NL, 2006, DEV BIOL, V293, P38, DOI 10.1016/j.ydbio.2005.12.040; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shalizi AK, 2005, CURR TOP DEV BIOL, V69, P239, DOI 10.1016/S0070-2153(05)69009-6; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Wang YX, 2005, FEBS LETT, V579, P4843, DOI 10.1016/j.febslet.2005.07.068	37	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29644	29653		10.1074/jbc.M111.268094	http://dx.doi.org/10.1074/jbc.M111.268094			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21724844	Green Published, hybrid			2022-12-25	WOS:000294046600023
J	Friedman, EJ; Wang, HX; Jiang, K; Perovic, I; Deshpande, A; Pochapsky, TC; Temple, BRS; Hicks, SN; Harden, TK; Jones, AM				Friedman, Erin J.; Wang, Helen X.; Jiang, Kun; Perovic, Iva; Deshpande, Aditi; Pochapsky, Thomas C.; Temple, Brenda R. S.; Hicks, Stephanie N.; Harden, T. Kendall; Jones, Alan M.			Acireductone Dioxygenase 1 (ARD1) Is an Effector of the Heterotrimeric G Protein beta Subunit in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE SALVAGE PATHWAY; KLEBSIELLA-PNEUMONIAE; MOLECULAR-BASIS; GAMMA-SUBUNITS; CELL-DIVISION; EXPRESSION; IDENTIFICATION; RESISTANCE; THALIANA; ENZYMES	Heterotrimeric G protein complexes are conserved from plants to mammals, but the complexity of each system varies. Arabidopsis thaliana contains one G alpha, one G beta (AGB1), and at least three G gamma subunits, allowing it to form three versions of the heterotrimer. This plant model is ideal for genetic studies because mammalian systems contain hundreds of unique heterotrimers. The activation of these complexes promotes interactions between both the G alpha subunit and the G beta gamma dimer with enzymes and scaffolds to propagate signaling to the cytoplasm. However, although effectors of G alpha and G beta are known in mammals, no G beta effectors were previously known in plants. Toward identifying AGB1 effectors, we genetically screened for dominant mutations that suppress G beta-null mutant (agb1-2) phenotypes. We found that overexpression of acireductone dioxygenase 1 (ARD1) suppresses the 2-day-old etiolated phenotype of agb1-2. ARD1 is homologous to prokaryotic and eukaryotic ARD proteins; one function of ARDs is to operate in the methionine salvage pathway. We show here that ARD1 is an active metalloenzyme, and AGB1 and ARD1 both control embryonic hypocotyl length by modulating cell division; they also may contribute to the production of ethylene, a product of the methionine salvage pathway. ARD1 physically interacts with AGB1, and ARD enzymatic activity is stimulated by AGB1 in vitro. The binding interface on AGB1 was deduced using a comparative evolutionary approach and tested using recombinant AGB1 mutants. A possible mechanism for AGB1 activation of ARD1 activity was tested using directed mutations in a loop near the substrate-binding site.	[Friedman, Erin J.; Wang, Helen X.; Jiang, Kun; Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Temple, Brenda R. S.] Univ N Carolina, RL Juliano Struct Bioinformat Core Facil, Chapel Hill, NC 27599 USA; [Temple, Brenda R. S.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Hicks, Stephanie N.; Harden, T. Kendall; Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Harden, T. Kendall] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Perovic, Iva; Pochapsky, Thomas C.] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA; [Deshpande, Aditi] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Wang, Helen X.] SmileNature Corp, San Diego, CA 92129 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Brandeis University; Brandeis University	Jones, AM (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	alan_jones@unc.edu		Pochapsky, Thomas/0000-0001-8995-1088	National Institutes of Health from NIGMS [R01GM065989, R01-GM44191]; Department of Energy [DE-FG02-05er15671]; National Science Foundation [MCB-0723515, MCB -0718202]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044191, R01GM065989] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM065989 from NIGMS (to the A.M.J. laboratory) and Grant R01-GM44191 (to the T. C. P. laboratory). This work was also supported by Department of Energy Grant DE-FG02-05er15671 and National Science Foundation Grants MCB-0723515 and MCB -0718202.	Avila MA, 2004, INT J BIOCHEM CELL B, V36, P2125, DOI 10.1016/j.biocel.2003.11.016; Burstenbinder K, 2010, PLANT J, V62, P977, DOI 10.1111/j.1365-313X.2010.04211.x; Chai SC, 2008, BIOCHEMISTRY-US, V47, P2428, DOI 10.1021/bi7004152; CHAKRAVORTY D, 2011, PLANT J IN PRESS; Chen JG, 2006, PLANT PHYSIOL, V141, P887, DOI 10.1104/pp.106.079202; Dai Y, 1999, J BIOL CHEM, V274, P1193, DOI 10.1074/jbc.274.3.1193; Dai Y, 2001, BIOCHEMISTRY-US, V40, P6379, DOI 10.1021/bi010110y; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gotoh I, 2007, GENES CELLS, V12, P105, DOI 10.1111/j.1365-2443.2006.01035.x; Grigston JC, 2008, FEBS LETT, V582, P3577, DOI 10.1016/j.febslet.2008.08.038; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Ju TT, 2006, J MOL BIOL, V363, P823, DOI 10.1016/j.jmb.2006.08.060; Kim JH, 2008, PLANT CELL PHYSIOL, V49, P1627, DOI 10.1093/pcp/pcn115; Lin T, 2005, GENE, V360, P27, DOI 10.1016/j.gene.2005.07.017; Llorente F, 2005, PLANT J, V43, P165, DOI 10.1111/j.1365-313X.2005.02440.x; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Oram SW, 2007, NEOPLASIA, V9, P643, DOI 10.1593/neo.07415; Oredsson SM, 2003, BIOCHEM SOC T, V31, P366, DOI 10.1042/BST0310366; Pirkov I, 2008, FEBS J, V275, P4111, DOI 10.1111/j.1742-4658.2008.06552.x; Pochapsky TC, 2006, J BIOMOL NMR, V34, P117, DOI 10.1007/s10858-005-5735-8; Pochapsky TC, 2002, NAT STRUCT BIOL, V9, P966, DOI 10.1038/nsb863; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Sauter M, 2005, PLANT J, V44, P718, DOI 10.1111/j.1365-313X.2005.02564.x; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Sundin AM, 2002, J CHROMATOGR B, V766, P115, DOI 10.1016/S0378-4347(01)00460-1; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trusov Y, 2009, PLANT J, V58, P69, DOI 10.1111/j.1365-313X.2008.03755.x; Tsuchisaka A, 2009, GENETICS, V183, P979, DOI 10.1534/genetics.109.107102; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Vogel JP, 1998, P NATL ACAD SCI USA, V95, P4766, DOI 10.1073/pnas.95.8.4766; Wang HX, 2006, MOL BIOL CELL, V17, P4257, DOI 10.1091/mbc.E06-01-0046; Woeste K, 1998, PHILOS T ROY SOC B, V353, P1431, DOI 10.1098/rstb.1998.0298; WRAY JW, 1995, J BIOL CHEM, V270, P3147, DOI 10.1074/jbc.270.7.3147; Xu QP, 2006, PROTEINS, V64, P808, DOI 10.1002/prot.20947; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang LG, 2008, DEV BIOL, V324, P68, DOI 10.1016/j.ydbio.2008.09.008; Zhang YL, 2004, BIOORGAN MED CHEM, V12, P3847, DOI 10.1016/j.bmc.2004.05.002	40	92	94	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30107	30118		10.1074/jbc.M111.227256	http://dx.doi.org/10.1074/jbc.M111.227256			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21712381	hybrid, Green Published			2022-12-25	WOS:000294046600068
J	Matoba, Y; Bando, N; Oda, K; Noda, M; Higashikawa, F; Kumagai, T; Sugiyama, M				Matoba, Yasuyuki; Bando, Naohiko; Oda, Kosuke; Noda, Masafumi; Higashikawa, Fumiko; Kumagai, Takanori; Sugiyama, Masanori			A Molecular Mechanism for Copper Transportation to Tyrosinase That Is Assisted by a Metallochaperone, Caddie Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ACTIVE-SITE; STREPTOMYCES-CASTANEOGLOBISPORUS; HEMOCYANIN; RESOLUTION; GENE; INHIBITORS; BIOLOGY; MODEL	The Cu(II)-soaked crystal structure of tyrosinase that is present in a complex with a protein, designated "caddie," which we previously determined, possesses two copper ions at its catalytic center. We had identified two copper-binding sites in the caddie protein and speculated that copper bound to caddie may be transported to the tyrosinase catalytic center. In our present study, at a 1.16-1.58 angstrom resolution, we determined the crystal structures of tyrosinase complexed with caddie prepared by altering the soaking time of the copper ion and the structures of tyrosinase complexed with different caddie mutants that display little or no capacity to activate tyrosinase. Based on these structures, we propose a molecular mechanism by which two copper ions are transported to the tyrosinase catalytic center with the assistance of caddie acting as a metallochaperone.	[Matoba, Yasuyuki; Bando, Naohiko; Oda, Kosuke; Noda, Masafumi; Higashikawa, Fumiko; Kumagai, Takanori; Sugiyama, Masanori] Hiroshima Univ, Dept Mol Microbiol & Biotechnol, Grad Sch Biomed Sci, Minami Ku, Hiroshima 7348551, Japan	Hiroshima University	Sugiyama, M (corresponding author), Hiroshima Univ, Dept Mol Microbiol & Biotechnol, Grad Sch Biomed Sci, Minami Ku, Kasumi 1-2-3, Hiroshima 7348551, Japan.	sugi@hiroshima-u.ac.jp	ODA, KOSUKE/ABD-2610-2021; Johnson, Michael D. L./B-4352-2012		National Project on Protein Structural and Functional Analyses, Japan; Ministry of Education, Science, and Culture of Japan; Grants-in-Aid for Scientific Research [22790068] Funding Source: KAKEN	National Project on Protein Structural and Functional Analyses, Japan; Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Project on Protein Structural and Functional Analyses, Japan (to M.S.) and a grant-in-aid for scientific research from the Ministry of Education, Science, and Culture of Japan (to M.S. and Y.M.).	BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Bubacco L, 2007, ARCH BIOCHEM BIOPHYS, V465, P320, DOI 10.1016/j.abb.2007.07.008; CHEN LY, 1992, J BIOL CHEM, V267, P20100; Claus H, 2006, SYST APPL MICROBIOL, V29, P3, DOI 10.1016/j.syapm.2005.07.012; Cuff ME, 1998, J MOL BIOL, V278, P855, DOI 10.1006/jmbi.1998.1647; Decker H, 2000, ANGEW CHEM INT EDIT, V39, P1591, DOI 10.1002/(SICI)1521-3773(20000502)39:9<1591::AID-ANIE1591>3.0.CO;2-H; Decker H, 2000, TRENDS BIOCHEM SCI, V25, P392, DOI 10.1016/S0968-0004(00)01602-9; Decker H, 2006, ANGEW CHEM INT EDIT, V45, P4546, DOI 10.1002/anie.200601255; Garcia-Molina F, 2007, J AGR FOOD CHEM, V55, P9739, DOI 10.1021/jf0712301; HAZES B, 1993, PROTEIN SCI, V2, P597; Ikeda K, 1996, APPL MICROBIOL BIOT, V45, P80, DOI 10.1007/s002530050652; Jeon HJ, 2006, J AGR FOOD CHEM, V54, P9827, DOI 10.1021/jf062315p; Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193; Kohashi PY, 2004, PROTEIN EXPRES PURIF, V34, P202, DOI 10.1016/j.pep.2003.11.015; Lamb AL, 1999, NAT STRUCT BIOL, V6, P724; LEE YHW, 1988, GENE, V65, P71, DOI 10.1016/0378-1119(88)90418-0; Low C, 2010, J MOL BIOL, V398, P375, DOI 10.1016/j.jmb.2010.03.014; MAGNUS KA, 1994, PROTEINS, V19, P302, DOI 10.1002/prot.340190405; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Oetting WS, 2000, PIGM CELL RES, V13, P320, DOI 10.1034/j.1600-0749.2000.130503.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Portnoy ME, 1999, J BIOL CHEM, V274, P15041, DOI 10.1074/jbc.274.21.15041; Remaut H, 2001, J BIOL CHEM, V276, P49365, DOI 10.1074/jbc.M108304200; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Srinivasan V, 2007, STRUCTURE, V15, P1246, DOI 10.1016/j.str.2007.08.009; VOLBEDA A, 1989, J MOL BIOL, V209, P249, DOI 10.1016/0022-2836(89)90276-3; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; WOOLERY GL, 1984, BIOCHIM BIOPHYS ACTA, V788, P155, DOI 10.1016/0167-4838(84)90257-7	30	36	37	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30219	30231		10.1074/jbc.M111.256818	http://dx.doi.org/10.1074/jbc.M111.256818			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21730070	Green Published, hybrid			2022-12-25	WOS:000294046600079
J	Zhu, B; Lee, SJ; Richardson, CC				Zhu, Bin; Lee, Seung-Joo; Richardson, Charles C.			Bypass of a Nick by the Replisome of Bacteriophage T7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION FORK; GENE 4 PROTEIN; STRAND-DISPLACEMENT; ESCHERICHIA-COLI; PRIMASE DOMAINS; BINDING PROTEIN; DEOXYRIBONUCLEIC-ACID; POLYMERASE-ACTIVITY; HELICASE ACTIVITY; SINGLE-MOLECULE	DNA polymerase and DNA helicase are essential components of DNA replication. The helicase unwinds duplex DNA to provide single-stranded templates for DNA synthesis by the DNA polymerase. In bacteriophage T7, movement of either the DNA helicase or the DNA polymerase alone terminates upon encountering a nick in duplex DNA. Using a minicircular DNA, we show that the helicase.polymerase complex can bypass a nick, albeit at reduced efficiency of 7%, on the non-template strand to continue rolling circle DNA synthesis. A gap in the non-template strand cannot be bypassed. The efficiency of bypass synthesis depends on the DNA sequence downstream of the nick. A nick on the template strand cannot be bypassed. Addition of T7 single-stranded DNA-binding protein to the complex stimulates nick bypass 2-fold. We propose that the association of helicase with the polymerase prevents dissociation of the helicase upon encountering a nick, allowing the helicase to continue unwinding of the duplex downstream of the nick.	[Zhu, Bin; Lee, Seung-Joo; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu	zhang, huidong/B-5667-2011		National Institutes of Health [GM54397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54397 (to C. C. R.).	Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267; BERNSTEIN JA, 1988, J BIOL CHEM, V263, P14891; BERNSTEIN JA, 1989, J BIOL CHEM, V264, P13066; BERNSTEIN JA, 1988, P NATL ACAD SCI USA, V85, P396, DOI 10.1073/pnas.85.2.396; CHA TA, 1989, J BIOL CHEM, V264, P12220; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Delagoutte E, 2001, BIOCHEMISTRY-US, V40, P4459, DOI 10.1021/bi001306l; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Ghosh S, 2009, J BIOL CHEM, V284, P30339, DOI 10.1074/jbc.M109.024059; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; KUZMINOV A, 1995, MOL MICROBIOL, V16, P373, DOI 10.1111/j.1365-2958.1995.tb02403.x; LECHNER RL, 1983, J BIOL CHEM, V258, P1174; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lee SJ, 2004, J BIOL CHEM, V279, P23384, DOI 10.1074/jbc.M400857200; MASAMUNE Y, 1971, J BIOL CHEM, V246, P2692; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MATSON SW, 1983, J BIOL CHEM, V258, P4009; McInerney P, 2007, J BIOL CHEM, V282, P25903, DOI 10.1074/jbc.M703777200; MOK M, 1987, J BIOL CHEM, V262, P16644; Nelson SW, 2010, J MOL BIOL, V401, P743, DOI 10.1016/j.jmb.2010.06.027; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Rezende LF, 2003, J BIOL CHEM, V278, P29098, DOI 10.1074/jbc.M303374200; Rezende LF, 2002, J BIOL CHEM, V277, P50643, DOI 10.1074/jbc.M207359200; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; Satapathy AK, 2010, P NATL ACAD SCI USA, V107, P6782, DOI 10.1073/pnas.1002734107; Schrock RD, 1996, J BIOL CHEM, V271, P16678, DOI 10.1074/jbc.271.28.16678; SOENGAS MS, 1992, EMBO J, V11, P4227, DOI 10.1002/j.1460-2075.1992.tb05517.x; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; TABOR S, 1987, J BIOL CHEM, V262, P16212; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; Zhang HD, 2011, P NATL ACAD SCI USA, V108, P9372, DOI 10.1073/pnas.1106678108; Zhu B, 2010, P NATL ACAD SCI USA, V107, P9099, DOI 10.1073/pnas.1004220107; Zhu B, 2009, J BIOL CHEM, V284, P23842, DOI 10.1074/jbc.M109.026104	44	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28488	28497		10.1074/jbc.M111.252023	http://dx.doi.org/10.1074/jbc.M111.252023			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21701044	Green Published, hybrid			2022-12-25	WOS:000293557800064
J	Andress, EJ; Holic, R; Edelmann, MJ; Kessler, BM; Yu, VPCC				Andress, Edward J.; Holic, Roman; Edelmann, Mariola J.; Kessler, Benedikt M.; Yu, Veronica P. C. C.			Dia2 Controls Transcription by Mediating Assembly of the RSC Complex	PLOS ONE			English	Article							NUCLEOSOME-REMODELING COMPLEX; REGULATES DNA-REPLICATION; GENOME-WIDE LOCATION; SACCHAROMYCES-CEREVISIAE; HISTONE HOMEOSTASIS; CELL-CYCLE; S-PHASE; PROTEIN; YEAST; INTEGRITY	Background: Dia2 is an F-box protein found in the budding yeast, S. cerevisiae. Together with Skp1 and Cul1, Dia2 forms the substrate-determining part of an E3 ubiquitin ligase complex, otherwise known as the SCF. Dia2 has previously been implicated in the control of replication and genome stability via its interaction with the replisome progression complex. Principal Findings: We identified components of the RSC chromatin remodelling complex as genetic interactors with Dia2, suggesting an additional role for Dia2 in the regulation of transcription. We show that Dia2 is involved in controlling assembly of the RSC complex. RSC belongs to a group of ATP-dependent nucleosome-remodelling complexes that controls the repositioning of nucleosomes. The RSC complex is expressed abundantly and its 17 subunits are recruited to chromatin in response to both transcription activation and repression. In the absence of Dia2, RSC-mediated transcription regulation was impaired, with concomitant abnormalities in nucleosome positioning. Conclusions: Our findings imply that Dia2 is required for the correct assembly and function of the RSC complex. Dia2, by controlling the RSC chromatin remodeller, fine-tunes transcription by controlling nucleosome positioning during transcriptional activation and repression.	[Andress, Edward J.; Holic, Roman; Yu, Veronica P. C. C.] Univ London Imperial Coll Sci Technol & Med, Eukaryot Chromatin Dynam Grp, MRC Clin Sci Ctr, London, England; [Edelmann, Mariola J.; Kessler, Benedikt M.] Univ Oxford, Ctr Cellular & Mol Physiol, Nuffield Dept Clin Med, Ubiquitin Proteolysis Grp, Oxford, England; [Yu, Veronica P. C. C.] Guys Hosp, Kings Coll London, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England	Imperial College London; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Andress, EJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Eukaryot Chromatin Dynam Grp, MRC Clin Sci Ctr, Hammersmith Campus, London, England.	veronica.yu@kcl.ac.uk	Roman, Holic/X-7500-2018; Holic, Roman/AAC-8402-2019; Kessler, Benedikt/AAY-8614-2021	Roman, Holic/0000-0003-1347-4785; Holic, Roman/0000-0003-1347-4785; Kessler, Benedikt/0000-0002-8160-2446; Edelmann, Mariola/0000-0003-0459-7716	Medical Research Council; MRC; Wellcome Trust; Biomedical Research Centre (NIHR), Oxford, United Kingdom; Computational Biology Research Group (CBRG) at the University of Oxford; Medical Research Council [G0501068, MC_U120085813] Funding Source: researchfish; MRC [G0501068, MC_U120085813] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Biomedical Research Centre (NIHR), Oxford, United Kingdom(National Institute for Health Research (NIHR)); Computational Biology Research Group (CBRG) at the University of Oxford; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Yu and the Kessler labs are both funded by the Medical Research Council (http://www.mrc.ac.uk/index.htm). EA was funded by an MRC PhD studentship. VY was supported by a Wellcome Trust fellowship. BMK is supported by the Biomedical Research Centre (NIHR), Oxford, United Kingdom. The Mascot server is supported by the Computational Biology Research Group (CBRG) at the University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bairwa NK, 2011, J BIOL CHEM, V286, P2445, DOI 10.1074/jbc.M110.189456; Batycka M, 2006, RAPID COMMUN MASS SP, V20, P2074, DOI 10.1002/rcm.2563; Blake D, 2006, GENETICS, V174, P1709, DOI 10.1534/genetics.106.057836; Bryant GO, 2008, PLOS BIOL, V6, P2928, DOI 10.1371/journal.pbio.0060317; Campsteijn C, 2007, PLOS GENET, V3, P947, DOI 10.1371/journal.pgen.0030092; Floer M, 2010, CELL, V141, P407, DOI 10.1016/j.cell.2010.03.048; Ginsburg DS, 2009, MOL CELL BIOL, V29, P6473, DOI 10.1128/MCB.01033-09; HEINTZ N, 1991, BIOCHIM BIOPHYS ACTA, V1088, P327, DOI 10.1016/0167-4781(91)90122-3; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Kabani M, 2005, BIOCHEM BIOPH RES CO, V332, P398, DOI 10.1016/j.bbrc.2005.04.158; Katayama S, 2002, MOL BIOL CELL, V13, P211, DOI 10.1091/mbc.01-07-0333; Kent NA, 2007, J BIOL CHEM, V282, P27693, DOI 10.1074/jbc.M704707200; Keogh Michael-Christopher, 2004, Methods Mol Biol, V257, P1, DOI 10.1385/1-59259-750-5:001; Kile AC, 2010, MOL CELL BIOL, V30, P160, DOI 10.1128/MCB.00612-09; Koepp DM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-8; Koepp DM, 2006, MOL BIOL CELL, V17, P1540, DOI 10.1091/mbc.E05-09-0884; Lehmann A, 2004, GENES CELLS, V9, P367, DOI 10.1111/j.1356-9597.2004.00730.x; Li SS, 2002, J BIOL CHEM, V277, P44651, DOI 10.1074/jbc.M206623200; Liang B, 2007, CURR BIOL, V17, P1432, DOI 10.1016/j.cub.2007.07.035; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorch Y, 2010, P NATL ACAD SCI USA, V107, P3458, DOI 10.1073/pnas.1000398107; Mimura S, 2009, EMBO J, V28, P3693, DOI 10.1038/emboj.2009.320; Morohashi H, 2009, CURR BIOL, V19, P1943, DOI 10.1016/j.cub.2009.09.062; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Parnell TJ, 2008, EMBO J, V27, P100, DOI 10.1038/sj.emboj.7601946; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; RAINBOW M, 1989, BIOCHEMISTRY-US, V28, P7486, DOI 10.1021/bi00444a048; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rose MD., 1990, METHODS YEAST GENETI; SMITH MM, 1983, J MOL BIOL, V169, P641, DOI 10.1016/S0022-2836(83)80163-6; Swaminathan S, 2007, MOL CELL BIOL, V27, P4674, DOI 10.1128/MCB.02052-06; Takayama Y, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-18; Takayama Y, 2010, DEV CELL, V18, P385, DOI 10.1016/j.devcel.2009.12.024; van Attikum H, 2005, CELL CYCLE, V4, P1011, DOI 10.4161/cc.4.8.1887; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilson B, 2006, GENETICS, V172, P795, DOI 10.1534/genetics.105.047589; Wong MCVL, 2002, MOL CELL BIOL, V22, P4218, DOI 10.1128/MCB.22.12.4218-4229.2002; Xu DM, 2008, MOL CELL PROTEOMICS, V7, P2215, DOI 10.1074/mcp.M800095-MCP200	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21172	10.1371/journal.pone.0021172	http://dx.doi.org/10.1371/journal.pone.0021172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701592	Green Published, Green Submitted, gold			2022-12-25	WOS:000291983800027
J	Garcia-Gamez, E; Reverter, A; Whan, V; McWilliam, SM; Arranz, JJ; Kijas, J				Garcia-Gamez, Elsa; Reverter, Antonio; Whan, Vicki; McWilliam, Sean M.; Jose Arranz, Juan; Kijas, James		Int Sheep Genomics Consortium	Using Regulatory and Epistatic Networks to Extend the Findings of a Genome Scan: Identifying the Gene Drivers of Pigmentation in Merino Sheep	PLOS ONE			English	Article							ASSOCIATION; EXPRESSION; BIOLOGY; ENVIRONMENT; MUTATIONS; PROFILES; WHITE; SKIN; CD9	Extending genome wide association analysis by the inclusion of gene expression data may assist in the dissection of complex traits. We examined piebald, a pigmentation phenotype in both human and Merino sheep, by analysing multiple data types using a systems approach. First, a case control analysis of 49,034 ovine SNP was performed which confirmed a multigenic basis for the condition. We combined these results with gene expression data from five tissue types analysed with a skin-specific microarray. Promoter sequence analysis of differentially expressed genes allowed us to reverse-engineer a regulatory network. Likewise, by testing two-loci models derived from all pair-wise comparisons across piebald-associated SNP, we generated an epistatic network. At the intersection of both networks, we identified thirteen genes with insulin-like growth factor binding protein 7 (IGFBP7), platelet-derived growth factor alpha (PDGFRA) and the tetraspanin platelet activator CD9 at the kernel of the intersection. Further, we report a number of differentially expressed genes in regions containing highly associated SNP including ATRN, DOCK7, FGFR1OP, GLI3, SILV and TBX15. The application of network theory facilitated co-analysis of genetic variation with gene expression, recapitulated aspects of the known molecular biology of skin pigmentation and provided insights into the transcription regulation and epistatic interactions involved in piebald Merino sheep.	[Garcia-Gamez, Elsa; Reverter, Antonio; Whan, Vicki; McWilliam, Sean M.; Kijas, James] CSIRO, Livestock Ind, Brisbane, Qld, Australia; [Garcia-Gamez, Elsa; Jose Arranz, Juan] Univ Leon, Dept Anim Prod, E-24071 Leon, Spain	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Universidad de Leon	Garcia-Gamez, E (corresponding author), CSIRO, Livestock Ind, Brisbane, Qld, Australia.	James.Kijas@csiro.au	McWilliam, Sean M/H-8978-2013; Kijas, James W/A-4656-2011; Reverter, Antonio/C-9699-2013; Simianer, Henner/A-6574-2015; Arranz, Juan-Jose/H-1225-2015; Garcia-Gamez, Elsa/D-9158-2011	McWilliam, Sean M/0000-0002-3148-0428; Kijas, James W/0000-0002-1417-8278; Reverter, Antonio/0000-0002-4681-9404; Simianer, Henner/0000-0002-7551-3797; Arranz, Juan-Jose/0000-0001-9058-131X; , International Journal of Business and Applied Social Science/0000-0001-7850-0193	Spanish Ministry of Science [AGL2009-07000]; Spanish Ministry of Education [AP2008-01410]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education(Spanish Government)	JJA and EGG were supported by the Spanish Ministry of Science (Project AGL2009-07000), EGG was funded by the Spanish Ministry of Education (AP2008-01410, FPU programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald AL, 2010, ANIM GENET, V41, P449, DOI 10.1111/j.1365-2052.2010.02100.x; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Baudoux B, 2000, EUR J CELL BIOL, V79, P41, DOI 10.1078/S0171-9335(04)70006-0; Becker D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008689; Blasius AL, 2009, P NATL ACAD SCI USA, V106, P2706, DOI 10.1073/pnas.0813208106; Bondanza S, 2007, J INVEST DERMATOL, V127, P676, DOI 10.1038/sj.jid.5700639; BOYD AW, 2001, SCI STKE, pRE20; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; BROOKER MG, 1969, AUST J AGR RES, V20, P523, DOI 10.1071/AR9690523; Buske FA, 2010, BIOINFORMATICS, V26, P860, DOI 10.1093/bioinformatics/btq049; Candille SI, 2004, PLOS BIOL, V2, P30, DOI 10.1371/journal.pbio.0020003; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; Diez D, 2010, MOL BIOSYST, V6, P289, DOI 10.1039/b912078e; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; FLEISCHMAN RA, 1991, P NATL ACAD SCI USA, V88, P10885, DOI 10.1073/pnas.88.23.10885; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Fortes MRS, 2010, P NATL ACAD SCI USA, V107, P13642, DOI 10.1073/pnas.1002044107; Gunn TM, 1999, NATURE, V398, P152, DOI 10.1038/18217; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; He L, 2001, NAT GENET, V27, P40, DOI 10.1038/83741; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hochberg M, 2007, BRIT J DERMATOL, V156, P289, DOI 10.1111/j.1365-2133.2006.07628.x; *INT FED PIGM CELL, INT FED PIGM CELL SO; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Lan CCE, 2006, J INVEST DERMATOL, V126, P2119, DOI 10.1038/sj.jid.5700372; LANZA F, 1991, J BIOL CHEM, V266, P10638; Li JJ, 2009, ONCOGENE, V28, P1759, DOI 10.1038/onc.2009.15; Matera I, 2008, HUM MOL GENET, V17, P2118, DOI 10.1093/hmg/ddn110; Norris BJ, 2008, GENOME RES, V18, P1282, DOI 10.1101/gr.072090.107; Parker HG, 2010, ANNU REV GENET, V44, P309, DOI 10.1146/annurev-genet-102808-115200; Peidis P, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-14; Penas PF, 2000, J INVEST DERMATOL, V114, P1126, DOI 10.1046/j.1523-1747.2000.00998.x; Reverter A, 2005, BIOINFORMATICS, V21, P1112, DOI 10.1093/bioinformatics/bti124; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Scurr LL, 2010, CELL, V141, P717, DOI 10.1016/j.cell.2010.04.021; Seo KS, 2007, VET DERMATOL, V18, P392, DOI 10.1111/j.1365-3164.2007.00634.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith WJM, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-27; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wu CS, 2006, ACTA DERM-VENEREOL, V86, P498, DOI 10.2340/00015555-0161; Xu SX, 2010, ACTA DERM-VENEREOL, V90, P131, DOI 10.2340/00015555-0820; Yang G, 2008, MOL CELL, V32, P554, DOI 10.1016/j.molcel.2008.11.002; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	46	27	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21158	10.1371/journal.pone.0021158	http://dx.doi.org/10.1371/journal.pone.0021158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701676	gold, Green Submitted, Green Published			2022-12-25	WOS:000291983800026
J	Hau, PM; Tsang, CM; Yip, YL; Huen, MSY; Tsao, SW				Hau, Pok Man; Tsang, Chi Man; Yip, Yim Ling; Huen, Michael S. Y.; Tsao, Sai Wah			Id1 Interacts and Stabilizes the Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) in Nasopharyngeal Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; LINES HNE-1; EXPRESSION; GROWTH; MEMBRANE-PROTEIN-1; LOOP; ESTABLISHMENT; CARCINOMA; ACTIVATION; PATHWAYS	The EBV-encoded latent membrane protein 1 (LMP1) functions as a constitutive active form of tumor necrosis factor receptor (TNFR) and activates multiple downstream signaling pathways similar to CD40 signaling in a ligand-independent manner. LMP1 expression in EBV-infected cells has been postulated to play an important role in pathogenesis of nasopharyngeal carcinoma. However, variable levels of LMP1 expression were detected in nasopharyngeal carcinoma. At present, the regulation of LMP1 levels in nasopharyngeal carcinoma is poorly understood. Here we show that LMP1 mRNAs are transcribed in an EBV-positive nasopharyngeal carcinoma (NPC) cell line (C666-1) and other EBV-negative nasopharyngeal carcinoma cells stably re-infected with EBV. The protein levels of LMP1 could readily be detected after incubation with proteasome inhibitor, MG132 suggesting that LMP1 protein is rapidly degraded via proteasome-mediated proteolysis. Interestingly, we observed that Id1 overexpression could stabilize LMP1 protein in EBV-infected cells. In contrary, Id1 knockdown significantly reduced LMP1 levels in cells. Co-immunoprecipitation studies revealed that Id1 interacts with LMP1 by binding to the CTAR1 domain of LMP1. N-terminal region of Id1 is required for the interaction with LMP1. Furthermore, binding of Id1 to LMP1 suppressed polyubiquitination of LMP1 and may be involved in stabilization of LMP1 in EBV-infected nasopharyngeal epithelial cells.	[Hau, Pok Man; Tsang, Chi Man; Yip, Yim Ling; Tsao, Sai Wah] Univ Hong Kong, Dept Anat, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Huen, Michael S. Y.] Univ Hong Kong, Dept Anat, Genome Stabil Res Lab, Hong Kong, Hong Kong, Peoples R China; [Huen, Michael S. Y.] Univ Hong Kong, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Hau, PM (corresponding author), Univ Hong Kong, Dept Anat, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	gswtsao@hkucc.hku.hk			Hong Kong General Research Fund [HKU 7770/07M]; AoE NPC [AoE/M-06/08]; University of Hong Kong; CRCG [200807176131]	Hong Kong General Research Fund; AoE NPC; University of Hong Kong(University of Hong Kong); CRCG	This work was supported by the Hong Kong General Research Fund, grant number HKU 7770/07M; the AoE NPC, grant number AoE/M-06/08; The University of Hong Kong CRCG Grant; and the CRCG Grant, grant number: 200807176131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand G, 1997, J BIOL CHEM, V272, P19140, DOI 10.1074/jbc.272.31.19140; Aviel S, 2000, J BIOL CHEM, V275, P23491, DOI 10.1074/jbc.M002052200; BARRANCO SC, 1983, CANCER RES, V43, P1703; BENEZRA R, 1990, ANN NY ACAD SCI, V599, P1, DOI 10.1111/j.1749-6632.1990.tb42359.x; BROOKS L, 1992, J VIROL, V66, P2689, DOI 10.1128/JVI.66.5.2689-2697.1992; Chen HL, 2003, J VIROL, V77, P4139, DOI 10.1128/JVI.77.7.4139-4148.2003; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Demetriades C, 2009, J VIROL, V83, P5269, DOI 10.1128/JVI.00097-09; EPSTEIN MA, 1964, LANCET, V1, P702, DOI 10.1016/s0140-6736(64)91524-7; Everly DN, 2008, VIROLOGY, V376, P258, DOI 10.1016/j.virol.2007.12.003; Everly DN, 2004, J VIROL, V78, P13470, DOI 10.1128/JVI.78.24.13470-13478.2004; GLASER R, 1989, P NATL ACAD SCI USA, V86, P9524, DOI 10.1073/pnas.86.23.9524; Goormachtigh G, 2006, J VIROL, V80, P7382, DOI 10.1128/JVI.02052-05; Hasskarl J, 2008, ONCOGENE, V27, P1657, DOI 10.1038/sj.onc.1210808; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Hila L, 2009, PATHOL BIOL, V57, P427, DOI 10.1016/j.patbio.2008.07.029; HU LF, 1995, EUR J CANCER, V31A, P658, DOI 10.1016/0959-8049(94)00468-K; HUANG DP, 1980, INT J CANCER, V26, P127, DOI 10.1002/ijc.2910260202; Ikeda M, 2001, J VIROL, V75, P5711, DOI 10.1128/JVI.75.12.5711-5718.2001; Johansson P, 2010, J VIROL, V84, P2787, DOI 10.1128/JVI.01052-09; Johansson P, 2009, J VIROL, V83, P1393, DOI 10.1128/JVI.01637-08; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Kwok WK, 2009, CANCER GENET CYTOGEN, V194, P58, DOI 10.1016/j.cancergencyto.2009.06.005; Lam N, 2003, EMBO J, V22, P3027, DOI 10.1093/emboj/cdg284; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Li HM, 2006, INT J CANCER, V119, P1567, DOI 10.1002/ijc.22032; Li HM, 2004, ONCOGENE, V23, P4488, DOI 10.1038/sj.onc.1207580; Lo AK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-155; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Lo AKF, 2006, NEOPLASIA, V8, P173, DOI 10.1593/neo.05625; Lui VWY, 2009, INT J CANCER, V125, P1884, DOI 10.1002/ijc.24567; Man C, 2008, MOL BIOL CELL, V19, P2389, DOI 10.1091/mbc.E07-09-0875; Manthey C, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-2; MISKIMINS WK, 1982, J CELL PHYSIOL, V112, P327, DOI 10.1002/jcp.1041120304; Panchanathan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010868; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Rocca A, 2008, CANCER CHEMOTH PHARM, V61, P965, DOI 10.1007/s00280-007-0551-3; Rothenberger S, 2003, ONCOGENE, V22, P5614, DOI 10.1038/sj.onc.1206497; Rothenberger S, 2002, CELL MOL LIFE SCI, V59, P171, DOI 10.1007/s00018-002-8413-y; Soni V, 2007, ADV EXP MED BIOL, V597, P173; TAKADA K, 1991, VIRUS GENES, V5, P147, DOI 10.1007/BF00571929; Tang WG, 2003, J BIOL CHEM, V278, P48942, DOI 10.1074/jbc.M307962200; Tsang CM, 2010, INT J CANCER, V127, P1570, DOI 10.1002/ijc.25173; TSANG CM, 2010, INT J CANC; YAO K, 1990, INT J CANCER, V45, P83, DOI 10.1002/ijc.2910450116; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; ZHANG SH, 1983, INT J CANCER, V31, P587, DOI 10.1002/ijc.2910310509	47	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21176	10.1371/journal.pone.0021176	http://dx.doi.org/10.1371/journal.pone.0021176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701587	Green Submitted, Green Published, gold			2022-12-25	WOS:000291983800028
J	Fowler, JC; Zecchini, VR; Jones, PH				Fowler, Joanna C.; Zecchini, Vincent R.; Jones, Philip H.			Intestinal Activation of Notch Signaling Induces Rapid Onset Hepatic Steatosis and Insulin Resistance	PLOS ONE			English	Article							FATTY LIVER-DISEASE; GUT MICROBIOME; KNOCKOUT MICE; EXPRESSION; RECEPTOR; PROTEIN; OBESITY; INACTIVATION; DYSLIPIDEMIA; ENDOTOXEMIA	Here we investigate the effects of expressing an activated mutant of Notch (ICD-E) in an inducible transgenic mouse model. Hepatic expression of ICD-E in adult animals has no detectable phenotype, but simultaneous induction of ICD-E in both the liver and small intestine results in hepatic steatosis, lipogranuloma formation and mild insulin resistance within 96 hours. This supports work that suggests that fatty liver disease may result from disruption of the gut-liver axis. In the intestine, ICD-E expression is known to produce a transient change in the proportion of goblet cells followed by shedding of the recombinant epithelium. We report additional intestinal transcriptional changes following ICD-E expression, finding significant transcriptional down-regulation of rpL29 (ribosomal protein L29), which is implicated in the regulation of intestinal flora. These results provide further evidence of a gut-liver axis in the development of fatty liver disease and insulin resistance and validate a new model for future studies of hepatic steatosis.	[Fowler, Joanna C.; Zecchini, Vincent R.; Jones, Philip H.] Med Res Council Canc Cell Unit, Cambridge, England		Fowler, JC (corresponding author), Med Res Council Canc Cell Unit, Cambridge, England.	phj20@hutchison-mrc.cam.ac.uk	Jones, Philip/D-2464-2009	Jones, Philip/0000-0002-5904-795X	Medical Research Council; MRC-Technology; MRC [MC_U105370181] Funding Source: UKRI; Medical Research Council [MC_U105370181] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC-Technology(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The project was funded by the Medical Research Council and MRC-Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012; Amar J, 2008, AM J CLIN NUTR, V87, P1219, DOI 10.1093/ajcn/87.5.1219; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brolinson A, 2008, ENDOCRINOLOGY, V149, P3158, DOI 10.1210/en.2007-1402; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; DARLINGTON GJ, 1980, J NATL CANCER I, V64, P809; Degrace P, 2006, J LIPID RES, V47, P2647, DOI 10.1194/jlr.M600140-JLR200; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Erion DM, 2009, CELL METAB, V10, P499, DOI 10.1016/j.cmet.2009.10.007; Feldstein AE, 2009, GUT, V58, P1538, DOI 10.1136/gut.2008.171280; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Ferrer I, 2005, HUM MOL GENET, V14, P3565, DOI 10.1093/hmg/ddi384; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Geisler F, 2008, HEPATOLOGY, V48, P607, DOI 10.1002/hep.22381; Heidenfelder BL, 2009, TOXICOL SCI, V108, P207, DOI 10.1093/toxsci/kfp005; Inoue Y, 2004, J BIOL CHEM, V279, P44740, DOI 10.1074/jbc.M405177200; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kodama Y, 2004, GASTROENTEROLOGY, V127, P1775, DOI 10.1053/j.gastro.2004.09.004; Lee JH, 2010, GASTROENTEROLOGY, V139, P653, DOI 10.1053/j.gastro.2010.03.033; Lemke U, 2008, CELL METAB, V8, P212, DOI 10.1016/j.cmet.2008.08.001; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li Y, 2009, DEV DYNAM, V238, P2388, DOI 10.1002/dvdy.22056; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Loomes KM, 2007, HEPATOLOGY, V45, P323, DOI 10.1002/hep.21460; McCright B, 2002, DEVELOPMENT, V129, P1075; Meyer-Hoffert U, 2008, FASEB J, V22, P2427, DOI 10.1096/fj.07-103440; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; NELSON WR, 1969, CLIN CHEM, V15, P1062; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Savage DB, 2010, CURR OPIN LIPIDOL, V21, P329, DOI 10.1097/MOL.0b013e32833b7782; Semela D, 2010, SIGNALING PATHWAYS IN LIVER DISEASES, SECOND EDITION, P421, DOI 10.1007/978-3-642-00150-5_28; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sparks EE, 2010, HEPATOLOGY, V51, P1391, DOI 10.1002/hep.23431; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stanger BZ, 2005, P NATL ACAD SCI USA, V102, P12443, DOI 10.1073/pnas.0505690102; Stappenbeck TS, 1998, CURR OPIN CELL BIOL, V10, P702, DOI 10.1016/S0955-0674(98)80110-5; Stoelting M, 2009, BIOCHEM BIOPH RES CO, V379, P81, DOI 10.1016/j.bbrc.2008.12.008; Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299, DOI 10.1016/S0171-2985(97)80050-2; Sundaram M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-35; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van der Vusse GJ, 2002, MOL CELL BIOCHEM, V239, P9, DOI 10.1023/A:1020538119691; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674; Zecchini V, 2005, GENE DEV, V19, P1686, DOI 10.1101/gad.341705; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	59	10	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20767	10.1371/journal.pone.0020767	http://dx.doi.org/10.1371/journal.pone.0020767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698231	Green Published, gold, Green Submitted			2022-12-25	WOS:000291734100019
J	Kuan, YC; Wu, TJ; Kuo, CY; Hsu, JC; Chang, WY; Sheu, F				Kuan, Yen-Chou; Wu, Tsai-Jen; Kuo, Che-Yu; Hsu, Ju-Chun; Chang, Wen-Ying; Sheu, Fuu			Molecular Cloning of a New Immunomodulatory Protein from Anoectochilus formosanus which Induces B Cell IgM Secretion through a T-Independent Mechanism	PLOS ONE			English	Article							SPECIES LISTERA-OVATA; EPIPACTIS-HELLEBORINE; IN-VITRO; ACTIVATION; EXTRACT; LECTIN; RATS; EXPRESSION; HAYATA; MURINE	An immunomodulatory protein (IPAF) was purified and cloned from Anoectochilus formosanus, an Orchidaceae herbal plant in Asia. The major targeting immune cells of IPAF and its modulating effects toward B lymphocytes were investigated. Rapid amplification of cDNA ends (RACE) was conducted to clone the IPAF gene, and the obtained sequence was BLAST compared on the NCBI database. MACS-purified mouse T and B lymphocytes were stimulated with IPAF and the cell proliferation, activation, and Igs production were examined. IPAF comprised a 25 amino acids signal peptide and a 138 amino acids protein which was homologous to the lectins from Orchidaceae plant. IPAF selectively induced the cell proliferation in mouse splenic B lymphocytes but not T lymphocytes. The IPAF-induced B cells exhibited increased CD69 and MHC class II expression, and a dose-and time-dependent enhancement in IgM production. These results suggested potential benefits of IPAF to strengthen the humoral immunity.	[Kuan, Yen-Chou; Wu, Tsai-Jen; Kuo, Che-Yu; Hsu, Ju-Chun; Chang, Wen-Ying; Sheu, Fuu] Natl Taiwan Univ, Dept Hort, Taipei 10764, Taiwan; [Sheu, Fuu] Natl Taiwan Univ, Ctr Biotechnol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Kuan, YC (corresponding author), Natl Taiwan Univ, Dept Hort, Taipei 10764, Taiwan.	fsheu@ntu.edu.tw	; HSU, JU-CHUN/K-2917-2012	Sheu, Fuu/0000-0001-9794-3483; HSU, JU-CHUN/0000-0002-8058-5090; Kuan, Yen-Chou/0000-0001-6870-0685	National Science Council of Taiwan [99-2628-B-002-003-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a grant (99-2628-B-002-003-MY3) from the National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clement F, 2010, INT IMMUNOPHARMACOL, V10, P316, DOI 10.1016/j.intimp.2009.12.002; Du XM, 2003, PHYTOTHER RES, V17, P30, DOI 10.1002/ptr.1057; Fang HL, 2008, PHYTOTHER RES, V22, P291, DOI 10.1002/ptr.2307; Gavrovic-Jankulovic M, 2008, INT J BIOCHEM CELL B, V40, P929, DOI 10.1016/j.biocel.2007.10.033; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Hsieh CC, 2010, PHYTOMEDICINE, V17, P557, DOI 10.1016/j.phymed.2009.12.012; Huang L, 2008, IMMUNOL LETT, V121, P148, DOI 10.1016/j.imlet.2008.10.004; Ikeuchi M, 2005, J NUTR SCI VITAMINOL, V51, P40, DOI 10.3177/jnsv.51.40; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CH, 2009, INT IMMUNOPHARMACOL, V9, P1555, DOI 10.1016/j.intimp.2009.09.011; Masuda K, 2008, J BONE MINER METAB, V26, P123, DOI 10.1007/s00774-007-0810-8; McHeyzer-Williams MG, 2003, CURR OPIN IMMUNOL, V15, P354, DOI 10.1016/S0952-7915(03)00046-3; MINGUET S, 2004, EURO J IMMUNOL, V38, P2475; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Ooi LSM, 2002, BIOCHEM CELL BIOL, V80, P271, DOI [10.1139/o01-240, 10.1139/O01-240]; PARHAM P, 2009, IMMUNE SYSTEM, P249; ROCK KL, 1984, J EXP MED, V160, P1102, DOI 10.1084/jem.160.4.1102; ROMAGNANI S, 1981, J IMMUNOL, V127, P1307; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Sheu F, 2009, J AGR FOOD CHEM, V57, P4130, DOI 10.1021/jf900469a; Shih CC, 2004, CLIN EXP PHARMACOL P, V31, P620, DOI 10.1111/j.1440-1681.2004.04062.x; Shih CC, 2002, CLIN EXP PHARMACOL P, V29, P684, DOI 10.1046/j.1440-1681.2002.03717.x; Shih CC, 2001, J ETHNOPHARMACOL, V77, P233, DOI 10.1016/S0378-8741(01)00302-6; Shyur LF, 2004, J BIOMED SCI, V11, P928, DOI 10.1159/000081840; Tseng CC, 2006, PHYTOMEDICINE, V13, P366, DOI 10.1016/j.phymed.2004.01.016; VANDAMME EJM, 1994, EUR J BIOCHEM, V221, P769, DOI 10.1111/j.1432-1033.1994.tb18790.x; VANDAMME EJM, 1994, GLYCOCONJUGATE J, V11, P321, DOI 10.1007/BF00731205; Vos Q, 2000, IMMUNOL REV, V176, P154; Wang HX, 2007, PLANT CELL REP, V26, P253, DOI 10.1007/s00299-006-0226-2; Wang LF, 2005, ANN NY ACAD SCI, V1042, P379, DOI 10.1196/annals.1338.060; Wang SY, 2002, J AGR FOOD CHEM, V50, P1859, DOI 10.1021/jf0113575; Wu JB, 2007, PHYTOTHER RES, V21, P58, DOI 10.1002/ptr.2025; YAMAGUCHI N, 1981, J IMMUNOL, V126, P2290	34	7	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21004	10.1371/journal.pone.0021004	http://dx.doi.org/10.1371/journal.pone.0021004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698210	gold, Green Published, Green Submitted			2022-12-25	WOS:000291734100043
J	Yan, HL; Choi, AJ; Lee, BH; Ting, AH				Yan, Hongli; Choi, Ae-Jin; Lee, Byron H.; Ting, Angela H.			Identification and Functional Analysis of Epigenetically Silenced MicroRNAs in Colorectal Cancer Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSIVE MICRORNAS; DNA METHYLATION; CITRON KINASE; EXPRESSION; INACTIVATION; GENES; DIFFERENTIATION; PRECURSORS; COOPERATE; MIR-34A	Abnormal microRNA (miRNA) expression has been linked to the development and progression of several human cancers, and such dysregulation can result from aberrant DNA methylation. While a small number of miRNAs is known to be regulated by DNA methylation, we postulated that such epigenetic regulation is more prevalent. By combining MBD-isolated Genome Sequencing (MiGS) to evaluate genome-wide DNA methylation patterns and microarray analysis to determine miRNA expression levels, we systematically searched for candidate miRNAs regulated by DNA methylation in colorectal cancer cell lines. We found 64 miRNAs to be robustly methylated in HCT116 cells; eighteen of them were located in imprinting regions or already reported to be regulated by DNA methylation. For the remaining 46 miRNAs, expression levels of 18 were consistent with their DNA methylation status. Finally, 8 miRNAs were up-regulated by 5-aza-2'-deoxycytidine treatment and identified to be novel miRNAs regulated by DNA methylation. Moreover, we demonstrated the functional relevance of these epigenetically silenced miRNAs by ectopically expressing select candidates, which resulted in inhibition of growth and migration of cancer cells. In addition to reporting these findings, our study also provides a reliable, systematic strategy to identify DNA methylation-regulated miRNAs by combining DNA methylation profiles and expression data.	[Yan, Hongli; Choi, Ae-Jin; Ting, Angela H.] Cleveland Clin Fdn, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44195 USA; [Lee, Byron H.] Cleveland Clin Fdn, Glickman Urol & Kidney Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Yan, HL (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Genom Med Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	tinga@ccf.org		Lee, Byron/0000-0002-8755-9688				Ando T, 2009, INT J CANCER, V124, P2367, DOI 10.1002/ijc.24219; Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chim CS, 2010, CARCINOGENESIS, V31, P745, DOI 10.1093/carcin/bgq033; Chudin E, 2006, J COMPUT BIOL, V13, P996, DOI 10.1089/cmb.2006.13.996; Duffy MJ, 2009, CLIN CANCER RES, V15, P1140, DOI 10.1158/1078-0432.CCR-08-1585; Feng J, 2009, BRIT J HAEMATOL, V145, P412, DOI 10.1111/j.1365-2141.2009.07632.x; Fu YH, 2011, MOL BIOL REP, V38, P693, DOI 10.1007/s11033-010-0156-5; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Gaetje R, 2007, GYNECOL ENDOCRINOL, V23, P567, DOI 10.1080/09513590701556921; Han L, 2007, CANCER BIOL THER, V6, P1284; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Liu HF, 2003, J BIOL CHEM, V278, P2541, DOI 10.1074/jbc.M210391200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Milde-Langosch K, 2004, BREAST CANCER RES TR, V86, P139, DOI 10.1023/B:BREA.0000032982.49024.71; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Najy AJ, 2008, CANCER RES, V68, P1092, DOI 10.1158/0008-5472.CAN-07-2432; Ng K., 2010, WSEAS T BIOL BIOMEDI, V7, P73; Paramasivam M, 2007, CELL CYCLE, V6, P1605, DOI 10.4161/cc.6.13.4356; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Zhang Y, 2010, RNA, V16, P1889, DOI 10.1261/rna.2226910	40	48	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20628	10.1371/journal.pone.0020628	http://dx.doi.org/10.1371/journal.pone.0020628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698188	Green Submitted, Green Published, gold			2022-12-25	WOS:000291734100012
J	Reales, E; Sharma, N; Low, SH; Folsch, H; Weimbs, T				Reales, Elena; Sharma, Nikunj; Low, Seng Hui; Foelsch, Heike; Weimbs, Thomas			Basolateral Sorting of Syntaxin 4 Is Dependent on Its N-terminal Domain and the AP1B Clathrin Adaptor, and Required for the Epithelial Cell Polarity	PLOS ONE			English	Article							MEMBRANE-FUSION; PLASMA-MEMBRANE; SEC1/MUNC18 PROTEINS; MDCK CELLS; TRAFFICKING; SNARE; LOCALIZATION; COMPLEX; MORPHOGENESIS; ACTIVATION	Generation of epithelial cell polarity requires mechanisms to sort plasma membrane proteins to the apical and basolateral domains. Sorting involves incorporation into specific vesicular carriers and subsequent fusion to the correct target membranes mediated by specific SNARE proteins. In polarized epithelial cells, the SNARE protein syntaxin 4 localizes exclusively to the basolateral plasma membrane and plays an important role in basolateral trafficking pathways. However, the mechanism of basolateral targeting of syntaxin 4 itself has remained poorly understood. Here we show that newly synthesized syntaxin 4 is directly targeted to the basolateral plasma membrane in polarized Madin-Darby canine kidney (MDCK) cells. Basolateral targeting depends on a signal that is centered around residues 24-29 in the N-terminal domain of syntaxin 4. Furthermore, basolateral targeting of syntaxin 4 is dependent on the epithelial cell-specific clathrin adaptor AP1B. Disruption of the basolateral targeting signal of syntaxin 4 leads to non-polarized delivery to both the apical and basolateral surface, as well as partial intercellular retention in the trans-Golgi network. Importantly, disruption of the basolateral targeting signal of syntaxin 4 leads to the inability of MDCK cells to establish a polarized morphology which suggests that restriction of syntaxin 4 to the basolateral domain is required for epithelial cell polarity.	[Reales, Elena; Sharma, Nikunj; Low, Seng Hui; Weimbs, Thomas] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Reales, Elena; Sharma, Nikunj; Low, Seng Hui; Weimbs, Thomas] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Foelsch, Heike] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Northwestern University	Reales, E (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	weimbs@lifesci.ucsb.edu		Folsch, Heike/0000-0003-0897-0311; REALES RODRIGUEZ, ELENA/0000-0001-6082-3306; Weimbs, Thomas/0000-0001-9423-5561	National Institutes of Health (NIH) [R01GM66785, GM070736]; American Heart Association; Spanish Ministry of Education and Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070736, R01GM066785] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Spanish Ministry of Education and Science(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health (NIH) to TW (R01GM66785), a pre-doctoral fellowship from the American Heart Association to NS and a postdoctoral fellowship from the Spanish Ministry of Education and Science to ER. HF was supported by a grant from the NIH (GM070736). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borner GHH, 2007, TRAFFIC, V8, P893, DOI 10.1111/j.1600-0854.2007.00576.x; BOSSHART H, 1994, J CELL BIOL, V126, P1157, DOI 10.1083/jcb.126.5.1157; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Fields IC, 2007, J CELL BIOL, V177, P477, DOI 10.1083/jcb.200610047; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Folsch H, 2005, TRENDS CELL BIOL, V15, P222, DOI 10.1016/j.tcb.2005.02.006; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Folsch H, 2009, TRAFFIC, V10, P972, DOI 10.1111/j.1600-0854.2009.00927.x; Gravotta D, 2007, P NATL ACAD SCI USA, V104, P1564, DOI 10.1073/pnas.0610700104; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Jahn R, 2004, ANN NY ACAD SCI, V1014, P170, DOI 10.1196/annals.1294.018; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; Latham CF, 2007, ACTA CRYSTALLOGR F, V63, P524, DOI 10.1107/S1744309107022361; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Li X, 2002, AM J PHYSIOL-RENAL, V283, pF1111, DOI 10.1152/ajprenal.00185.2002; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Low SH, 1996, MOL BIOL CELL, V7, P2007, DOI 10.1091/mbc.7.12.2007; Low SH, 2006, MOL BIOL CELL, V17, P977, DOI 10.1091/mbc.E05-05-0462; Low SH, 1998, J BIOL CHEM, V273, P3422, DOI 10.1074/jbc.273.6.3422; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; Ohno H, 2006, J CELL SCI, V119, P3719, DOI 10.1242/jcs.03085; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Rowe J, 1999, J CELL SCI, V112, P1865; Sharma N, 2006, J CELL BIOL, V173, P937, DOI 10.1083/jcb.200603132; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; ter Beest MBA, 2005, MOL BIOL CELL, V16, P5784, DOI 10.1091/mbc.E05-070-0661; Torres J, 2011, J BIOL CHEM, V286, P10834, DOI 10.1074/jbc.M110.186668; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330	40	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21181	10.1371/journal.pone.0021181	http://dx.doi.org/10.1371/journal.pone.0021181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698262	Green Published, Green Submitted, gold			2022-12-25	WOS:000291730000058
J	Sharma, K; Tripathi, S; Ranjan, P; Kumar, P; Garten, R; Deyde, V; Katz, JM; Cox, NJ; Lal, RB; Sambhara, S; Lal, SK				Sharma, Kulbhushan; Tripathi, Shashank; Ranjan, Priya; Kumar, Purnima; Garten, Rebecca; Deyde, Varough; Katz, Jacqueline M.; Cox, Nancy J.; Lal, Renu B.; Sambhara, Suryaprakash; Lal, Sunil K.			Influenza A Virus Nucleoprotein Exploits Hsp40 to Inhibit PKR Activation	PLOS ONE			English	Article							PROTEIN-KINASE PKR; KAPPA-B KINASE; NS1 PROTEIN; NUCLEAR EXPORT; RNA; INTERACTS; TRANSLATION; P58(IPK); PHOSPHORYLATION; INTERFERENCE	Background: Double-stranded RNA dependent protein kinase (PKR) is a key regulator of the anti-viral innate immune response in mammalian cells. PKR activity is regulated by a 58 kilo Dalton cellular inhibitor (P58(IPK)), which is present in inactive state as a complex with Hsp40 under normal conditions. In case of influenza A virus (IAV) infection, P58(IPK) is known to dissociate from Hsp40 and inhibit PKR activation. However the influenza virus component responsible for PKR inhibition through P58(IPK) activation was hitherto unknown. Principal Findings: Human heat shock 40 protein (Hsp40) was identified as an interacting partner of Influenza A virus nucleoprotein (IAV NP) using a yeast two-hybrid screen. This interaction was confirmed by co-immunoprecipitation studies from mammalian cells transfected with IAV NP expressing plasmid. Further, the IAV NP-Hsp40 interaction was validated in mammalian cells infected with various seasonal and pandemic strains of influenza viruses. Cellular localization studies showed that NP and Hsp40 co-localize primarily in the nucleus. During IAV infection in mammalian cells, expression of NP coincided with the dissociation of P58(IPK) from Hsp40 and decrease PKR phosphorylation. We observed that, plasmid based expression of NP in mammalian cells leads to decrease in PKR phosphorylation. Furthermore, inhibition of NP expression during influenza virus replication led to PKR activation and concomitant increase in eIF2 alpha phosphorylation. Inhibition of NP expression also led to reduced IRF3 phosphorylation, enhanced IFN beta production and concomitant reduction of virus replication. Taken together our data suggest that NP is the viral factor responsible for P58(IPK) activation and subsequent inhibition of PKR-mediated host response during IAV infection. Significance: Our findings demonstrate a novel role of IAV NP in inhibiting PKR-mediated anti-viral host response and help us understand P58(IPK) mediated inhibition of PKR activity during IAV infection.	[Sharma, Kulbhushan; Tripathi, Shashank; Kumar, Purnima; Lal, Sunil K.] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India; [Ranjan, Priya; Garten, Rebecca; Deyde, Varough; Katz, Jacqueline M.; Cox, Nancy J.; Lal, Renu B.; Sambhara, Suryaprakash] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Centers for Disease Control & Prevention - USA	Sharma, K (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India.	sunillal@icgeb.res.in	SHARMA, KULBHUSHAN/AAD-7713-2019; Sambhara, Suryaprakash/AAC-4428-2021	SHARMA, KULBHUSHAN/0000-0001-5226-4209; Tripp, Ralph/0000-0002-2924-9956; Tripathi, Shashank/0000-0002-5702-9248	ICGEB (International Centre for Genetic Engineering Biotechnology); Department of Biotechnology, Government of India; Centre for Disease Control (CDC), Atlanta	ICGEB (International Centre for Genetic Engineering Biotechnology); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Centre for Disease Control (CDC), Atlanta(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by internal funds from ICGEB (International Centre for Genetic Engineering & Biotechnology), a grant from the Department of Biotechnology, Government of India and a training grant from the Centre for Disease Control (CDC), Atlanta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], FIELDS VIROLOGY; Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Cheng XG, 2008, J VIROL, V82, P1229, DOI 10.1128/JVI.00540-07; Connor JH, 2005, J BIOL CHEM, V280, P13512, DOI 10.1074/jbc.M501156200; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Gale M, 1998, PHARMACOL THERAPEUT, V78, P29, DOI 10.1016/S0163-7258(97)00165-4; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Goodman AG, 2007, J VIROL, V81, P2221, DOI 10.1128/JVI.02151-06; Goodman AG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000438; Guan ZH, 2010, PROTEIN CELL, V1, P944, DOI 10.1007/s13238-010-0115-x; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; HATTORI H, 1993, J CELL SCI, V104, P629; Haye K, 2009, J VIROL, V83, P6849, DOI 10.1128/JVI.02323-08; Hirayama E, 2004, J VIROL, V78, P1263, DOI 10.1128/JVI.78.3.1263-1270.2004; Joly AL, 2010, J INNATE IMMUN, V2, P238, DOI 10.1159/000296508; KATZE MG, 1988, J VIROL, V62, P3710, DOI 10.1128/JVI.62.10.3710-3717.1988; Kumar M, 2005, J BIOL CHEM, V280, P40041, DOI 10.1074/jbc.M508904200; Lamb R.A., 2001, FIELDS VIROLOGY, P1487; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Lee T G, 1994, Prog Mol Subcell Biol, V14, P48; Li JZ, 2009, PROTEIN PEPTIDE LETT, V16, P606, DOI 10.2174/092986609788490159; LU Y, 1995, VIROLOGY, V214, P222, DOI 10.1006/viro.1995.9937; Melville MW, 1997, P NATL ACAD SCI USA, V94, P97, DOI 10.1073/pnas.94.1.97; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; MEURS EF, 1992, J VIROL, V66, P5805, DOI 10.1128/JVI.66.10.5805-5814.1992; Momose F, 2001, J VIROL, V75, P1899, DOI 10.1128/JVI.75.4.1899-1908.2001; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; Ng AKL, 2009, SCI CHINA SER C, V52, P439, DOI 10.1007/s11427-009-0064-x; Ohtsuka K, 2000, INT J HYPERTHER, V16, P231, DOI 10.1080/026567300285259; Polyak SJ, 1996, J BIOL CHEM, V271, P1702, DOI 10.1074/jbc.271.3.1702; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ranjan P, 2009, TRENDS MOL MED, V15, P359, DOI 10.1016/j.molmed.2009.06.003; Ratra R, 2008, BIOCHEMISTRY-US, V47, P1957, DOI 10.1021/bi7016552; Sambhara S, 2010, ANNU REV MED, V61, P187, DOI 10.1146/annurev.med.050908.132031; Servant MJ, 2002, BIOCHEM PHARMACOL, V64, P985, DOI 10.1016/S0006-2952(02)01165-6; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; Sohn SY, 2006, BIOCHEM BIOPH RES CO, V347, P764, DOI 10.1016/j.bbrc.2006.06.158; Surjit M, 2004, BIOCHEM BIOPH RES CO, V317, P1030, DOI 10.1016/j.bbrc.2004.03.154; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan SL, 1998, MOL CELL BIOL, V18, P2431, DOI 10.1128/MCB.18.5.2431; Wang P, 2009, J VIROL, V83, P7850, DOI 10.1128/JVI.00735-09; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; Weber F, 2004, VIRAL IMMUNOL, V17, P498, DOI 10.1089/vim.2004.17.498; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379	54	57	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20215	10.1371/journal.pone.0020215	http://dx.doi.org/10.1371/journal.pone.0020215			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698289	gold, Green Published, Green Submitted			2022-12-25	WOS:000291730000009
J	Zhuang, XJ; Hou, XJ; Liao, SY; Wang, XX; Cooke, HJ; Zhang, M; Han, CS				Zhuang, Xin-jie; Hou, Xiao-jun; Liao, Shang-Ying; Wang, Xiu-Xia; Cooke, Howard J.; Zhang, Ming; Han, Chunsheng			SLXL1, a Novel Acrosomal Protein, Interacts with DKKL1 and Is Involved in Fertilization in Mice	PLOS ONE			English	Article							GENE FAMILY XLR; MOUSE SPERMATOZOA; ZONA-PELLUCIDA; EXPRESSION; COMPLEX; SPERM; SYNAPSIS; SCP3; TRANSCRIPTS; DELETIONS	Background: Spermatogenesis is a complex cellular developmental process which involves diverse families of genes. The Xlr (X-linked, lymphocyte regulated) family includes multiple members, only a few of which have reported functions in meiosis, post-meiotic maturation, and fertilization of germ cells. Slx-like1 (Slxl1) is a member of the Xlr family, whose expression and function in spermatogenesis need to be elucidated. Methodology/Principal Findings: The mRNA and protein expression and localization of Slxl1 were investigated by RT-PCR, Western blotting and immunohistochemistry in different tissues and at different stages of spermatogenesis. The interacting partner of SLXL1 was examined by co-immunoprecipitation and co-localization. Assessment of the role of SLXL1 in capacitation, acrosome reaction, zona pellucida binding/penetration, and fertilization was carried out in vitro using blocking antisera. The results showed that Slxl1 mRNA and protein were specifically expressed in the testis. SLXL1 was exclusively located in the acrosome of post-meiotic germ cells and interacts with DKKL1 (Dickkopf-like1), which is an acrosome-associated protein and plays an important role in fertilization. The rates of zona pellucida binding/penetration and fertilization were significantly reduced by the anti-SLXL1 polyclonal antiserum. Conclusions/Significance: SLXL1 is the first identified member of the XLR family that is associated with acrosome and is involved in zona pellucid binding/penetration and subsequent fertilization. These results, together with previous studies, suggest that Xlr family members participate in diverse processes from meiosis to fertilization during spermatogenesis.	[Zhuang, Xin-jie; Zhang, Ming] Guangxi Univ, Anim Reprod Inst, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Guangxi, Peoples R China; [Zhuang, Xin-jie; Hou, Xiao-jun; Liao, Shang-Ying; Wang, Xiu-Xia; Han, Chunsheng] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Cooke, Howard J.] Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Guangxi University; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Edinburgh	Zhuang, XJ (corresponding author), Guangxi Univ, Anim Reprod Inst, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Guangxi, Peoples R China.	hancs@ioz.ac.cn			National Basic Research Program of China [2006CB944004]; National Natural Science Foundation of China [30871406]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (2006CB944004) and the National Natural Science Foundation of China (30871406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABA T, 1989, J BIOL CHEM, V264, P11920; Barraud-Lange V, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-102; Bendahmane M, 2002, ARCH BIOCHEM BIOPHYS, V404, P38, DOI 10.1016/S0003-9861(02)00278-3; Bendahmane M, 2001, ARCH BIOCHEM BIOPHYS, V390, P1, DOI 10.1006/abbi.2001.2364; Benoff S, 1997, MOL HUM REPROD, V3, P599, DOI 10.1093/molehr/3.7.599; CALENDA A, 1994, EMBO J, V13, P100, DOI 10.1002/j.1460-2075.1994.tb06239.x; Cocquet J, 2010, MOL BIOL CELL, V21, P3497, DOI 10.1091/mbc.E10-07-0601; Cocquet J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000244; COHEN DI, 1985, NATURE, V314, P372, DOI 10.1038/314372a0; Dakhova O, 2009, ENDOCRINOLOGY, V150, P404, DOI 10.1210/en.2008-0673; Ellis PJI, 2005, HUM MOL GENET, V14, P2705, DOI 10.1093/hmg/ddi304; Escalier D, 1999, J IMMUNOL, V162, P292; Gob E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012072; Hu XQ, 2010, FERTIL STERIL, V93, P1482, DOI 10.1016/j.fertnstert.2009.01.067; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kohn MJ, 2010, FERTIL STERIL, V93, P1533, DOI 10.1016/j.fertnstert.2009.06.010; Kohn MJ, 2005, MOL REPROD DEV, V71, P516, DOI 10.1002/mrd.20314; Li YC, 2006, FEBS LETT, V580, P4266, DOI 10.1016/j.febslet.2006.06.010; Loeser CR, 1999, BIOL REPROD, V60, P94, DOI 10.1095/biolreprod60.1.94; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Moreno RD, 2000, DEV BIOL, V219, P334, DOI 10.1006/dbio.2000.9606; Pelttari J, 2001, MOL CELL BIOL, V21, P5667, DOI 10.1128/MCB.21.16.5667-5677.2001; Primakoff P, 2002, SCIENCE, V296, P2183, DOI 10.1126/science.1072029; Reynard LN, 2007, BIOL REPROD, V77, P329, DOI 10.1095/biolreprod.107.061101; Reynard LN, 2009, BIOL REPROD, V81, P250, DOI 10.1095/biolreprod.108.075382; Scavetta RJ, 2010, MOL BIOL EVOL, V27, P1845, DOI 10.1093/molbev/msq064; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; SIEGEL JN, 1987, J EXP MED, V166, P1702, DOI 10.1084/jem.166.6.1702; Toure A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r102; WILLIAMS RM, 1993, J EXP ZOOL, V266, P65, DOI 10.1002/jez.1402660110; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Yuan L, 1998, J CELL BIOL, V142, P331, DOI 10.1083/jcb.142.2.331; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9	35	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20866	10.1371/journal.pone.0020866	http://dx.doi.org/10.1371/journal.pone.0020866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698294	Green Published, gold, Green Submitted			2022-12-25	WOS:000291730000028
J	Li, X; Law, JWS; Lee, AYW				Li, X.; Law, J. W. S.; Lee, A. Y. W.			Semaphorin 5A and plexin-B3 regulate human glioma cell motility and morphology through Rac1 and the actin cytoskeleton	ONCOGENE			English	Article						glioblastoma; invasion; glial differentiation; GTPases; fascin	FIBRILLARY ACIDIC PROTEIN; HUMAN ASTROCYTOMA-CELLS; AXON GUIDANCE; INDUCED ANGIOGENESIS; PANCREATIC-CANCER; COMPLEMENTARY-DNA; INVASIVE GROWTH; GENE-EXPRESSION; TUMOR-GROWTH; R-RAS	Semaphorins are implicated in glioma progression, although little is known about the underlying mechanisms. We have reported plexin-B3 expression in human gliomas, which upon stimulation by Sema5A causes significant inhibition of cell migration and invasion. The concomitant inactivation of Rac1 is of mechanistic importance because forced expression of constitutively active Rac1 abolishes these inhibitory effects. Furthermore, Sema5A induces prominent cell collapse and ramification of processes reminiscent of astrocytic morphology, which temporally associate with extensive disassembly of actin stress fibers and disruption of focal adhesions, followed by accumulation of actin patches in protrusions. Mechanistically, Sema5A induces transient protein kinase C (PKC) phosphorylation of fascin-1, which can reduce its actin-binding/bundling activities and temporally parallels its translocation from cell body to extending processes. PKC inhibition or fascin-1 knockdown is sufficient to abrogate Sema5A-induced morphological differentiation, whereas the process is hastened by forced expression of fascin-1. Intriguingly, Sema5A induces re-expression of glial fibrillary acidic protein (GFAP), which when silenced restricts differentiation of glioma cells to bipolar instead of multipolar morphology. Therefore, we hypothesize complementary functions of fascin-1 and GFAP in the early and late phases of Sema5A-induced astrocytic differentiation of gliomas, respectively. In summary, Sema5A and plexin-B3 impede motility but promote differentiation of human gliomas. These effects are plausibly compromised in high-grade human astrocytomas in which Sema5A expression is markedly reduced, hence leading to infiltrative and anaplastic characteristics. This is evident by increased invasiveness of glioma cells when endogenous Sema5A is silenced. Therefore, Sema5A and plexin-B3 represent potential novel targets in counteracting glioma progression. Oncogene (2012) 31, 595-610; doi:10.1038/onc.2011.256; published online 27 June 2011	[Lee, A. Y. W.] Natl Univ Singapore, Ctr Life Sci, Inst Life Sci, Dept Physiol,Yong Loo Lin Sch Med,Neurobiol Agein, Singapore 117456, Singapore	National University of Singapore	Lee, AYW (corresponding author), Natl Univ Singapore, Ctr Life Sci, Inst Life Sci, Dept Physiol,Yong Loo Lin Sch Med,Neurobiol Agein, 28 Med Dr, Singapore 117456, Singapore.	phsleeyw@nus.edu.sg	LEE, Alan Yiu Wah/AAE-1845-2022; Lee, Alan/E-8554-2011; Lee, Alan Yiu Wah/AAD-4541-2020	Lee, Alan Yiu Wah/0000-0003-0635-4179	National University of Singapore; Biomedical Research Council of Singapore	National University of Singapore(National University of Singapore); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR))	We are indebted to Dr David Srevatan for providing the Sema5A-Fc expression construct and to Dr Danijela Vignijevic for the pEGFP-fascin plasmid. This work was supported by research grants from the National University of Singapore and the Biomedical Research Council of Singapore.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Anilkumar N, 2003, EMBO J, V22, P5390, DOI 10.1093/emboj/cdg521; Artigiani S, 2004, EMBO REP, V5, P710, DOI 10.1038/sj.embor.7400189; Bagci T, 2009, ONCOGENE, V28, P3537, DOI 10.1038/onc.2009.204; Balakrishnan A, 2009, HUM MUTAT, V30, P1167, DOI 10.1002/humu.21017; Banu N, 2006, FASEB J, V20, P2150, DOI 10.1096/fj.05-5698fje; Barberis D, 2004, FASEB J, V18, P592, DOI 10.1096/fj.03-0957fje; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Brun M, 2009, J MOL BIOL, V391, P282, DOI 10.1016/j.jmb.2009.06.041; Castro-Rivera E, 2004, P NATL ACAD SCI USA, V101, P11432, DOI 10.1073/pnas.0403969101; Catalano A, 2004, FASEB J, V18, P1740, DOI 10.1096/fj.04-2258fje; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; Chedotal A, 2007, PROG EXP TUMOR RES, V39, P78, DOI 10.1159/000100048; Christensen C, 2005, CANCER RES, V65, P6167, DOI 10.1158/0008-5472.CAN-04-4309; Coma S, 2010, CANCER RES, V70, P3823, DOI 10.1158/0008-5472.CAN-09-3048; Conrotto P, 2004, ONCOGENE, V23, P5131, DOI 10.1038/sj.onc.1207650; Correa RG, 2001, GENOMICS, V73, P343, DOI 10.1006/geno.2001.6525; Crowe DL, 2004, ANTICANCER RES, V24, P593; DECK JHN, 1978, ACTA NEUROPATHOL, V42, P183, DOI 10.1007/BF00690355; Deryugina EI, 1997, J CELL SCI, V110, P2473; Dhanabal M, 2005, CANCER BIOL THER, V4, P659, DOI 10.4161/cbt.4.6.1733; Driessens MHE, 2002, FEBS LETT, V529, P168, DOI 10.1016/S0014-5793(02)03323-9; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; DUFFY PE, 1982, EXP CELL RES, V139, P145, DOI 10.1016/0014-4827(82)90328-7; Elobeid A, 2000, J NEUROSCI RES, V60, P245, DOI 10.1002/(SICI)1097-4547(20000415)60:2<245::AID-JNR14>3.0.CO;2-1; Feldkamp MM, 1999, ONCOGENE, V18, P7514, DOI 10.1038/sj.onc.1203105; Goldberg JL, 2004, J NEUROSCI, V24, P4989, DOI 10.1523/JNEUROSCI.4390-03.2004; Hilario JD, 2009, DEV BIOL, V326, P190, DOI 10.1016/j.ydbio.2008.11.007; Hu B, 2007, ONCOGENE, V26, P5577, DOI 10.1038/sj.onc.1210348; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; INAGAKI M, 1990, J BIOL CHEM, V265, P4722; Iwadate Y, 2004, CANCER RES, V64, P2496, DOI 10.1158/0008-5472.CAN-03-1254; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Karayan-Tapon L, 2008, BRIT J CANCER, V99, P1153, DOI 10.1038/sj.bjc.6604641; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Kusy S, 2005, NEOPLASIA, V7, P457, DOI 10.1593/neo.04721; Li XH, 2010, J BIOL CHEM, V285, P32436, DOI 10.1074/jbc.M110.120451; Lu TP, 2010, CANCER EPIDEM BIOMAR, V19, P2590, DOI 10.1158/1055-9965.EPI-10-0332; McDonough WS, 2005, NEOPLASIA, V7, P862, DOI 10.1593/neo.05190; Mondal S, 2010, BRAIN PATHOL, V20, P190, DOI 10.1111/j.1750-3639.2008.00261.x; Murakami M, 2001, INT J ONCOL, V18, P721; Nakada M, 2006, CANCER RES, V66, P8492, DOI 10.1158/0008-5472.CAN-05-4211; Nasarre C, 2009, CELL ADHES MIGR, V3, P383, DOI 10.4161/cam.3.4.9934; Neufeld G, 2005, FRONT BIOSCI-LANDMRK, V10, P751, DOI 10.2741/1569; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2006, J CELL BIOL, V173, P601, DOI 10.1083/jcb.200508204; Oster SF, 2003, DEVELOPMENT, V130, P775, DOI 10.1242/dev.00299; Pan GQ, 2009, WORLD J GASTROENTERO, V15, P2800, DOI 10.3748/wjg.15.2800; Pan GQ, 2010, LIFE SCI, V86, P139, DOI 10.1016/j.lfs.2009.12.004; Restrepo A, 2011, NEURO-ONCOLOGY, V13, P42, DOI 10.1093/neuonc/noq145; Rich JN, 2005, CANCER RES, V65, P4051, DOI 10.1158/0008-5472.CAN-04-3936; Rickman DS, 2001, CANCER RES, V61, P6885; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rieger J, 2003, GLIA, V42, P379, DOI 10.1002/glia.10210; Roberts DD, 1996, FASEB J, V10, P1183, DOI 10.1096/fasebj.10.10.8751720; RUTKA JT, 1993, CANCER RES, V53, P3624; RUTKA JT, 1994, CANCER RES, V54, P3267; Rutka JT, 1997, J NEUROSURG, V87, P420, DOI 10.3171/jns.1997.87.3.0420; Sadanandam A, 2007, OMICS, V11, P41, DOI 10.1089/omi.2006.0004; Sadanandam A, 2010, INT J CANCER, V127, P1373, DOI 10.1002/ijc.25166; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Swiercz JM, 2008, J BIOL CHEM, V283, P1893, DOI 10.1074/jbc.M706822200; Swiercz JM, 2004, J CELL BIOL, V165, P869, DOI 10.1083/jcb.200312094; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Walzer T, 2005, EUR J IMMUNOL, V35, P391, DOI 10.1002/eji.200425669; Webb DJ, 2003, CURR OPIN CELL BIOL, V15, P614, DOI 10.1016/S0955-0674(03)00105-4; Wick W, 2001, J NEURO-ONCOL, V53, P177, DOI 10.1023/A:1012209518843; Wong CCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002779; Woodhouse EC, 2003, P NATL ACAD SCI USA, V100, P11463, DOI 10.1073/pnas.2031202100; Yamashiro S, 1998, MOL BIOL CELL, V9, P993, DOI 10.1091/mbc.9.5.993; Zhuge Y, 2001, J BIOL CHEM, V276, P16248, DOI 10.1074/jbc.M010190200	73	39	46	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	5					595	610		10.1038/onc.2011.256	http://dx.doi.org/10.1038/onc.2011.256			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MS	21706053				2022-12-25	WOS:000300221800006
J	Huang, B; Qu, Z; Ong, CW; Tsang, YHN; Xiao, G; Shapiro, D; Salto-Tellez, M; Ito, K; Ito, Y; Chen, LF				Huang, B.; Qu, Z.; Ong, C. W.; Tsang, Y-H N.; Xiao, G.; Shapiro, D.; Salto-Tellez, M.; Ito, K.; Ito, Y.; Chen, L-F			RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor alpha	ONCOGENE			English	Article						breast cancer; degradation; ER alpha; RUNX3; tumor suppressor	EPITHELIAL-CELLS; EXPRESSION; PROTEASOME; BETA; TRANSACTIVATION; TUMORIGENESIS; TURNOVER; DEGRADATION; APOPTOSIS; GROWTH	Transcription factor RUNX3 is inactivated in a number of malignancies, including breast cancer, and is suggested to function as a tumor suppressor. How RUNX3 functions as a tumor suppressor in breast cancer remains undefined. Here, we show that about 20% of female Runx3(+/-) mice spontaneously developed ductal carcinoma at an average age of 14.5 months. Additionally, RUNX3 inhibits the estrogen-dependent proliferation and transformation potential of ER alpha-positive MCF-7 breast cancer cells in liquid culture and in soft agar and suppresses the tumorigenicity of MCF-7 cells in severe combined immunodeficiency mice. Furthermore, RUNX3 inhibits ER alpha-dependent transactivation by reducing the stability of ER alpha. Consistent with its ability to regulate the levels of ER alpha, expression of RUNX3 inversely correlates with the expression of ER alpha in breast cancer cell lines, human breast cancer tissues and Runx3(+/-) mouse mammary tumors. By destabilizing ER alpha, RUNX3 acts as a novel tumor suppressor in breast cancer. Oncogene (2012) 31, 527-534; doi: 10.1038/onc.2011.252; published online 27 June 2011	[Ito, K.] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528588, Japan; [Chen, L-F] Univ Illinois, Dept Biochem, Coll Med, Urbana, IL 61801 USA; [Qu, Z.; Xiao, G.] Univ Pittsburgh, Med Ctr, Inst Canc, Pittsburgh, PA USA; [Ong, C. W.; Salto-Tellez, M.] Natl Univ Singapore, Dept Pathol, Singapore 117548, Singapore; [Ong, C. W.; Salto-Tellez, M.; Ito, Y.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Tsang, Y-H N.; Ito, Y.] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore	Nagasaki University; University of Illinois System; University of Illinois Urbana-Champaign; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Ito, K (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528588, Japan.	itok@nagasaki-u.ac.jp; lfchen@life.illinois.edu		Salto-Tellez, Manuel/0000-0001-8586-282X	UIUC; NIH [DK-085158, CA116616, DK-071909]; NATIONAL CANCER INSTITUTE [R01CA116616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085158, R01DK071909] Funding Source: NIH RePORTER	UIUC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank W Xu for reagents; W Xu, A Nardulli and members in the Chen lab for discussion. This work is supported in part by fund provided by UIUC (to LFC) and NIH grants DK-085158 (to LFC), CA116616 (to GTX) and DK-071909 (to DS). YHT is an A*STAR-Illinois Partnership fellow.	Anderson E, 2002, BREAST CANCER RES, V4, P197, DOI 10.1186/bcr452; Cheskis BJ, 2007, J CELL PHYSIOL, V213, P610, DOI 10.1002/jcp.21253; Chi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005; Duong V, 2007, CANCER RES, V67, P5513, DOI 10.1158/0008-5472.CAN-07-0967; Ekena K, 1996, J BIOL CHEM, V271, P20053, DOI 10.1074/jbc.271.33.20053; Fan MY, 2004, MOL ENDOCRINOL, V18, P2603, DOI 10.1210/me.2004-0164; Frech MS, 2005, CANCER RES, V65, P681; Ito K, 2009, ONCOGENE, V28, P1379, DOI 10.1038/onc.2008.496; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; Jerry DJ, 2010, CELL MOL LIFE SCI, V67, P1017, DOI 10.1007/s00018-009-0244-7; Jiang Y, 2008, PATHOBIOLOGY, V75, P244, DOI 10.1159/000132385; Katzenellenbogen BS, 2000, BREAST CANCER RES, V2, P335, DOI 10.1186/bcr78; KHAN SA, 1994, CANCER RES, V54, P993; LaMarca HL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1740; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Sakuma A, 2008, MOL REPROD DEV, V75, P1653, DOI 10.1002/mrd.20904; Shoker BS, 2000, J CLIN PATHOL, V53, P778, DOI 10.1136/jcp.53.10.778; Subramaniam MM, 2009, BBA-REV CANCER, V1796, P315, DOI 10.1016/j.bbcan.2009.07.004; Subramaniam MM, 2009, BREAST CANCER RES TR, V113, P113, DOI 10.1007/s10549-008-9917-4; Tateishi Y, 2004, EMBO J, V23, P4813, DOI 10.1038/sj.emboj.7600472; Yamamura Y, 2006, J BIOL CHEM, V281, P5267, DOI 10.1074/jbc.M512151200; Yan PR, 2009, BLOOD, V113, P4370, DOI 10.1182/blood-2008-10-185660; Yano T, 2006, MOL CELL BIOL, V26, P4474, DOI 10.1128/MCB.01926-05; Zhang DH, 2003, LIFE SCI, V73, P3189, DOI 10.1016/j.lfs.2003.05.006	28	53	60	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2012	31	4					527	534		10.1038/onc.2011.252	http://dx.doi.org/10.1038/onc.2011.252			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891LU	21706051	Green Accepted			2022-12-25	WOS:000300219300011
J	Denda, K; Nakao-Wakabayashi, K; Okamoto, N; Kitamura, N; Ryu, JY; Tagawa, Y; Ichisaka, T; Yamanaka, S; Komada, M				Denda, Kimitoshi; Nakao-Wakabayashi, Kanako; Okamoto, Naoki; Kitamura, Naomi; Ryu, Je-Young; Tagawa, Yoh-ichi; Ichisaka, Tomoko; Yamanaka, Shinya; Komada, Masayuki			Nrk, an X-linked Protein Kinase in the Germinal Center Kinase Family, Is Required for Placental Development and Fetoplacental Induction of Labor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTURITION; MOUSE; MICE; CHROMOSOME; FETAL; EXPRESSION; APOPTOSIS; HORMONE; GROWTH; INACTIVATION	The complete mechanism of labor induction in eutherian mammals remains unclear. Although important roles for the fetus and placenta in triggering labor have been proposed, no gene has been shown to be required in the fetus/placenta for labor induction. Here we show that Nrk, an X-linked gene encoding a Ser/Thr kinase of the germinal center kinase family, is essential in the fetus/placenta for labor in mice. Nrk was specifically expressed in the spongiotrophoblast layer, a fetus-derived region of the placenta, and Nrk disruption caused dysregulated overgrowth of the layer. Due to preferential inactivation of the paternally derived X chromosome in placenta, Nrk heterozygous mutant placentas exhibited a similar defect to that in Nrk-null tissues when the wild-type allele was paternally derived. However, the phenotype was weaker than in Nrk-null placentas due to leaky Nrk expression from the inactivated X chromosome. Crossing of Nrk-null females to wild-type and Nrk-null males, as well as uterine transfer of Nrk-null fetuses to wild-type females, revealed that pregnant mice exhibit a severe defect in delivery when all fetuses/placentas are Nrk-null. In addition, Nrk was not expressed in female reproductive tissues such as the uterus and ovary, as well as the fetal amnion and yolk sac, in pregnant mice. Progesterone and estrogen levels in the maternal circulation and placenta, which control the timing of labor, were unaffected upon Nrk disruption. We thus provide evidence for a novel labor-inducing fetoplacental signal that depends on the X chromosome and possibly arises from the placenta.	[Komada, Masayuki] Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Ryu, Je-Young; Tagawa, Yoh-ichi] Tokyo Inst Technol, Dept Biomol Engn, Yokohama, Kanagawa 2268501, Japan; [Ichisaka, Tomoko; Yamanaka, Shinya] Kyoto Univ, Dept Reprogramming Sci, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Kyoto University	Komada, M (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Midori Ku, 4259-B16 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	makomada@bio.titech.ac.jp	Tagawa, Yoh-ichi/F-7216-2011	Tagawa, Yoh-ichi/0000-0002-7673-6781	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21025011, 21113505]; Grants-in-Aid for Scientific Research [23657086] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grants 21025011 and 21113505 to M. K.).	Arai S, 2010, STEROIDS, V75, P13, DOI 10.1016/j.steroids.2009.09.004; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Hemberger M, 2007, CELL MOL LIFE SCI, V64, P2422, DOI 10.1007/s00018-007-7113-z; Hogan B, 1994, MANIPULATING MOUSE E; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Kakinuma H, 2005, CELL SIGNAL, V17, P1439, DOI 10.1016/j.cellsig.2005.03.004; Kanai-Azuma M, 1999, MECH DEVELOP, V89, P155, DOI 10.1016/S0925-4773(99)00193-8; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; Korfhagen TR, 1996, P NATL ACAD SCI USA, V93, P9594, DOI 10.1073/pnas.93.18.9594; Kutsukake N, 2009, AM J PRIMATOL, V71, P696, DOI 10.1002/ajp.20708; Kyriakis JM, 1999, J BIOL CHEM, V274, P5259, DOI 10.1074/jbc.274.9.5259; LESCISIN KR, 1988, GENE DEV, V2, P1639, DOI 10.1101/gad.2.12a.1639; Li YH, 1998, NAT GENET, V20, P309, DOI 10.1038/3129; Mendelson CR, 2009, MOL ENDOCRINOL, V23, P947, DOI 10.1210/me.2009-0016; Mesiano S, 2007, SEMIN CELL DEV BIOL, V18, P321, DOI 10.1016/j.semcdb.2007.05.003; Mitchell BF, 2009, AM J PHYSIOL-REG I, V297, pR525, DOI 10.1152/ajpregu.00153.2009; MIYAZAWA K, 1989, BIOCHEM BIOPH RES CO, V163, P967, DOI 10.1016/0006-291X(89)92316-4; MUGLIA L, 1995, NATURE, V373, P427, DOI 10.1038/373427a0; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Nakano K, 2000, J BIOL CHEM, V275, P20533, DOI 10.1074/jbc.M001009200; Nakano K, 2003, EXP CELL RES, V287, P219, DOI 10.1016/S0014-4827(03)00136-8; Nathanielsz PW, 1996, AM SCI, V84, P562; Ratajczak CK, 2008, PEDIATR RES, V64, P581, DOI 10.1203/PDR.0b013e31818718d2; Reik W, 2005, NAT REV GENET, V6, P403, DOI 10.1038/nrg1602; Rodriguez TA, 2004, MOL CELL BIOL, V24, P228, DOI 10.1128/MCB.24.1.228-244.2004; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sabourin LA, 2000, MOL CELL BIOL, V20, P684, DOI 10.1128/MCB.20.2.684-696.2000; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sugimoto Y, 1997, SCIENCE, V277, P681, DOI 10.1126/science.277.5326.681; Tanaka S, 2001, BIOL REPROD, V65, P1813, DOI 10.1095/biolreprod65.6.1813; Vidaeff AC, 2008, CURR MED CHEM, V15, P614, DOI 10.2174/092986708783769786; Zeng ZY, 2008, BIOL REPROD, V78, P1029, DOI 10.1095/biolreprod.107.065821	37	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28802	28810		10.1074/jbc.M111.258160	http://dx.doi.org/10.1074/jbc.M111.258160			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21715335	Green Published, hybrid			2022-12-25	WOS:000293837000018
J	Fox, AM; Ciziene, D; McLaughlin, SH; Stewart, M				Fox, Abigail M.; Ciziene, Danguole; McLaughlin, Stephen H.; Stewart, Murray			Electrostatic Interactions Involving the Extreme C Terminus of Nuclear Export Factor CRM1 Modulate Its Affinity for Cargo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; STRUCTURAL BASIS; IMPORTIN-BETA; NUCLEOCYTOPLASMIC TRANSPORT; PORE COMPLEX; MECHANISM; SIGNALS; RANGTP; RECEPTOR; MUTANTS	The toroid-shaped nuclear protein export factor CRM1 is constructed from 21 tandem HEAT repeats, each of which contains an inner (B) and outer (A) alpha-helix joined by loops. Proteins targeted for export have a nuclear export signal (NES) that binds between the A-helices of HEAT repeats 11 and 12 on the outer surface of CRM1. RanGTP binding increases the affinity of CRM1 for NESs. In the absence of RanGTP, the CRM1 C-terminal helix, together with the HEAT repeat 9 loop, modulates its affinity for NESs. Here we show that there is an electrostatic interaction between acidic residues at the extreme distal tip of the C-terminal helix and basic residues on the HEAT repeat 12 B-helix that lies on the inner surface of CRM1 beneath the NES binding site. Small angle x-ray scattering indicates that the increased affinity for NESs generated by mutations in the C-terminal helix is not associated with large scale changes in CRM1 conformation, consistent with the modulation of NES affinity being mediated by a local change in CRM1 near the NES binding site. These data also suggest that in the absence of RanGTP, the C-terminal helix lies across the CRM1 toroid in a position similar to that seen in the CRM1-Snurportin crystal structure. By creating local changes that stabilize the NES binding site in its closed conformation and thereby reducing the affinity of CRM1 for NESs, the C-terminal helix and HEAT 9 loop facilitate release of NES-containing cargo in the cytoplasm and also inhibit their return to the nucleus.	[Fox, Abigail M.; Ciziene, Danguole; McLaughlin, Stephen H.; Stewart, Murray] MRC LMB, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Stewart, M (corresponding author), MRC LMB, Hills Rd, Cambridge CB2 0QH, England.	ms@mrc-lmb.cam.ac.uk		McLaughlin, Stephen/0000-0001-9135-6253	Wellcome Trust; MRC [MC_U105178939] Funding Source: UKRI; Medical Research Council [MC_U105178939] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by a Wellcome Trust programme grant (to M. S.).	Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; BISCHOFF FR, 1991, P NATL ACAD SCI USA, V88, P10830, DOI 10.1073/pnas.88.23.10830; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; Cook AG, 2010, CURR OPIN STRUC BIOL, V20, P247, DOI 10.1016/j.sbi.2010.01.012; Dong XH, 2009, NAT STRUCT MOL BIOL, V16, P558, DOI 10.1038/nsmb.1586; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuhara N, 2004, J BIOL CHEM, V279, P2176, DOI 10.1074/jbc.M309112200; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koyama M, 2010, EMBO J, V29, P2002, DOI 10.1038/emboj.2010.89; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Matsuura Y, 2003, EMBO J, V22, P5358, DOI 10.1093/emboj/cdg538; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Sokolova AV, 2003, J APPL CRYSTALLOGR, V36, P865, DOI 10.1107/S0021889803000220; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5	28	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29325	29335		10.1074/jbc.M111.245092	http://dx.doi.org/10.1074/jbc.M111.245092			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21708948	Green Published, hybrid			2022-12-25	WOS:000293837000067
J	Kaveh, DA; Bachy, VS; Hewinson, RG; Hogarth, PJ				Kaveh, Daryan A.; Bachy, Veronique S.; Hewinson, R. Glyn; Hogarth, Philip J.			Systemic BCG Immunization Induces Persistent Lung Mucosal Multifunctional CD4 T-EM Cells which Expand Following Virulent Mycobacterial Challenge	PLOS ONE			English	Article							TUBERCULOSIS INFECTION; BOVIS BCG; IFN-GAMMA; PROTECTIVE IMMUNITY; INTERFERON-GAMMA; IN-VIVO; MEMORY; MICE; RESPONSES; VACCINE	To more closely understand the mechanisms of how BCG vaccination confers immunity would help to rationally design improved tuberculosis vaccines that are urgently required. Given the established central role of CD4 T cells in BCG induced immunity, we sought to characterise the generation of memory CD4 T cell responses to BCG vaccination and M. bovis infection in a murine challenge model. We demonstrate that a single systemic BCG vaccination induces distinct systemic and mucosal populations of T effector memory (T-EM) cells in vaccinated mice. These CD4(+)CD44(hi)CD62L(lo)CD27(-) T cells concomitantly produce IFN-gamma and TNF-alpha, or IFN-gamma, IL-2 and TNF-alpha and have a higher cytokine median fluorescence intensity MFI or 'quality of response' than single cytokine producing cells. These cells are maintained for long periods (> 16 months) in BCG protected mice, maintaining a vaccine-specific functionality. Following virulent mycobacterial challenge, these cells underwent significant expansion in the lungs and are, therefore, strongly associated with protection against M. bovis challenge. Our data demonstrate that a persistent mucosal population of T-EM cells can be induced by parenteral immunization, a feature only previously associated with mucosal immunization routes; and that these multifunctional T-EM cells are strongly associated with protection. We propose that these cells mediate protective immunity, and that vaccines designed to increase the number of relevant antigen-specific T-EM in the lung may represent a new generation of TB vaccines.	[Kaveh, Daryan A.; Bachy, Veronique S.; Hewinson, R. Glyn; Hogarth, Philip J.] AHVLA, TB Res Grp, Surrey, England		Kaveh, DA (corresponding author), AHVLA, TB Res Grp, Surrey, England.	philip.hogarth@ahvla.gsi.gov.uk	Hogarth, Philip/C-6085-2011; Hewinson, Glyn/J-1902-2014; Hewinson, Glyn/F-7077-2010; Hewinson, Glyn/AAA-2364-2019	Hogarth, Philip/0000-0002-6343-7846; Kaveh, Daryan/0000-0002-1451-0082; Hewinson, Glyn/0000-0002-5517-4281	Department for Environment, Food and Rural Affairs, United Kingdom	Department for Environment, Food and Rural Affairs, United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA))	This work was supported by the Department for Environment, Food and Rural Affairs, United Kingdom (www.defra.gov.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Aldwell FE, 2006, VACCINE, V24, P2071, DOI 10.1016/j.vaccine.2005.11.017; Ashford DA, 2001, REV SCI TECH OIE, V20, P325, DOI 10.20506/rst.20.1.1266; Beamer GL, 2008, CLIN VACCINE IMMUNOL, V15, P474, DOI 10.1128/CVI.00408-07; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; BLOOM BR, 1994, TUBERCULOSIS PATHOGE; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Chen LH, 2004, INFECT IMMUN, V72, P238, DOI 10.1128/IAI.72.1.238-246.2004; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; DEJONG R, 1992, EUR J IMMUNOL, V22, P993, DOI 10.1002/eji.1830220418; Elias D, 2005, T ROY SOC TROP MED H, V99, P363, DOI 10.1016/j.trstmh.2004.08.006; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Fritsch RD, 2005, J IMMUNOL, V175, P6489, DOI 10.4049/jimmunol.175.10.6489; Fuller CL, 2003, INFECT IMMUN, V71, P7023, DOI 10.1128/IAI.71.12.7023-7034.2003; GALLAGHER J, 1977, J HYG-CAMBRIDGE, V79, P155, DOI 10.1017/S0022172400052943; Ghosh S, 2006, J IMMUNOL, V176, P4914, DOI 10.4049/jimmunol.176.8.4914; Goldsack L, 2007, TUBERCULOSIS, V87, P465, DOI 10.1016/j.tube.2007.07.001; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Henao-Tamayo MI, 2010, CLIN VACCINE IMMUNOL, V17, P618, DOI 10.1128/CVI.00368-09; Hervas-Stubbs S, 2006, INFECT IMMUN, V74, P3396, DOI 10.1128/IAI.02086-05; Hogarth PJ, 2006, J PHARM PHARMACOL, V58, P749, DOI 10.1211/jpp.58.6.0005; Kapina MA, 2007, J IMMUNOL, V178, P976, DOI 10.4049/jimmunol.178.2.976; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Kolibab K, 2010, CLIN VACCINE IMMUNOL, V17, P793, DOI 10.1128/CVI.00006-10; Leal IS, 2001, IMMUNOLOGY, V104, P157, DOI 10.1046/j.1365-2567.2001.01305.x; Lim J, 2009, CLIN VACCINE IMMUNOL, V16, P122, DOI 10.1128/CVI.00359-08; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Logan KE, 2008, TUBERCULOSIS, V88, P437, DOI 10.1016/j.tube.2008.05.005; Logan KE, 2005, VACCINE, V23, P5526, DOI 10.1016/j.vaccine.2005.07.037; Lyadova IV, 2004, CLIN EXP IMMUNOL, V138, P21, DOI 10.1111/j.1365-2249.2004.02573.x; Magalhaes I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003790; Majlessi L, 2006, INFECT IMMUN, V74, P2128, DOI 10.1128/IAI.74.4.2128-2137.2006; McShane H, 2005, MICROBES INFECT, V7, P962, DOI 10.1016/j.micinf.2005.03.009; Mikhak Z, 2006, J IMMUNOL, V176, P4959, DOI 10.4049/jimmunol.176.8.4959; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Mu JY, 2010, J GENE MED, V12, P693, DOI 10.1002/jgm.1487; Olsen AW, 2004, SCAND J IMMUNOL, V60, P273, DOI 10.1111/j.0300-9475.2004.01471.x; Orme IM, 2010, TUBERCULOSIS, V90, P329, DOI 10.1016/j.tube.2010.06.002; ORME IM, 1986, TUBERCLE, V67, P133, DOI 10.1016/0041-3879(86)90007-3; Pacheco KA, 1998, AM J RESP CELL MOL, V18, P286, DOI 10.1165/ajrcmb.18.2.2687; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Santosuosso M, 2005, J IMMUNOL, V174, P7986, DOI 10.4049/jimmunol.174.12.7986; Schiott A, 2004, IMMUNOLOGY, V113, P363, DOI 10.1111/j.1365-2567.2004.01974.x; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Skinner MA, 2003, IMMUNOLOGY, V108, P548, DOI 10.1046/j.1365-2567.2003.01589.x; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; WALRATH JR, 2010, AM J RESP CELL MOL B; Xu BH, 2003, J EXP MED, V197, P1255, DOI 10.1084/jem.20010685; Young JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011237	55	54	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21566	10.1371/journal.pone.0021566	http://dx.doi.org/10.1371/journal.pone.0021566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720558	Green Submitted, Green Published, gold			2022-12-25	WOS:000292036900054
J	Aymanns, S; Mauerer, S; van Zandbergen, G; Wolz, C; Spellerberg, B				Aymanns, Simone; Mauerer, Stefanie; van Zandbergen, Ger; Wolz, Christiane; Spellerberg, Barbara			High-Level Fluorescence Labeling of Gram-Positive Pathogens	PLOS ONE			English	Article							CAMP-FACTOR; STREPTOCOCCUS-AGALACTIAE; PROTEIN GFP; IN-VITRO; EXPRESSION; GENE; CELLS; PHAGOCYTOSIS; BACTERIA; GORDONII	Fluorescence labeling of bacterial pathogens has a broad range of interesting applications including the observation of living bacteria within host cells. We constructed a novel vector based on the E. coli streptococcal shuttle plasmid pAT28 that can propagate in numerous bacterial species from different genera. The plasmid harbors a promoterless copy of the green fluorescent variant gene egfp under the control of the CAMP-factor gene (cfb) promoter of Streptococcus agalactiae and was designated pBSU101. Upon transfer of the plasmid into streptococci, the bacteria show a distinct and easily detectable fluorescence using a standard fluorescence microscope and quantification by FACS-analysis demonstrated values that were 10-50 times increased over the respective controls. To assess the suitability of the construct for high efficiency fluorescence labeling in different gram-positive pathogens, numerous species were transformed. We successfully labeled Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae subsp. equisimilis, Enterococcus faecalis, Enterococcus faecium, Streptococcus mutans, Streptococcus anginosus and Staphylococcus aureus strains utilizing the EGFP reporter plasmid pBSU101. In all of these species the presence of the cfb promoter construct resulted in high-level EGFP expression that could be further increased by growing the streptococcal and enterococcal cultures under high oxygen conditions through continuous aeration.	[Aymanns, Simone; Mauerer, Stefanie; van Zandbergen, Ger; Spellerberg, Barbara] Univ Ulm, Inst Med Microbiol & Hyg, Ulm, Germany; [Wolz, Christiane] Univ Tubingen, Interfak Inst Mikrobiol & Infekt Med, Tubingen, Germany	Ulm University; Eberhard Karls University of Tubingen	Aymanns, S (corresponding author), Univ Ulm, Inst Med Microbiol & Hyg, Ulm, Germany.	barbara.spellerberg@uniklinik-ulm.de	Spellerberg, Barbara/D-3443-2011; van Zandbergen, Ger/M-1571-2013	Spellerberg, Barbara/0000-0001-7552-8764; Wolz, Christiane/0000-0003-3909-5281	University of Ulm	University of Ulm	University of Ulm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebo P, 2000, MICROBIOL-UK, V146, P1267, DOI 10.1099/00221287-146-6-1267; Aspiras MB, 2000, APPL ENVIRON MICROB, V66, P4074, DOI 10.1128/AEM.66.9.4074-4083.2000; AUGUSTIN J, 1990, FEMS MICROBIOL LETT, V66, P203, DOI 10.1016/0378-1097(90)90283-V; BOKMAN SH, 1981, BIOCHEM BIOPH RES CO, V101, P1372, DOI 10.1016/0006-291X(81)91599-0; Busque P, 1998, VET MICROBIOL, V63, P229, DOI 10.1016/S0378-1135(98)00216-8; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CODY CW, 1993, BIOCHEMISTRY-US, V32, P1212, DOI 10.1021/bi00056a003; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Eberhardt A, 2009, MOL MICROBIOL, V74, P395, DOI 10.1111/j.1365-2958.2009.06872.x; Fortineau N, 2000, RES MICROBIOL, V151, P353, DOI 10.1016/S0923-2508(00)00158-3; FRIESENEGGER A, 1991, FEMS MICROBIOL LETT, V79, P323, DOI 10.1016/0378-1097(91)90106-K; Gase K, 1999, INFECT IMMUN, V67, P4725, DOI 10.1128/IAI.67.9.4725-4731.1999; GLEICHTHEURER U, 2009, INFECT IMMUN; Hansen MC, 2001, MICROBIOL-SGM, V147, P1383, DOI 10.1099/00221287-147-5-1383; Hazelrigg T, 1998, DEV BIOL, V199, P245, DOI 10.1006/dbio.1998.8922; Johnson MJ, 2006, J BACTERIOL, V188, P7905, DOI 10.1128/JB.00997-06; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lang SH, 2003, J BIOL CHEM, V278, P38167, DOI 10.1074/jbc.M303544200; Lun SC, 2004, J MICROBIOL METH, V56, P401, DOI 10.1016/j.mimet.2003.11.012; PODBIELSKI A, 1994, MED MICROBIOL IMMUN, V183, P239, DOI 10.1007/BF00198458; Pron B, 1998, INFECT IMMUN, V66, P747, DOI 10.1128/IAI.66.2.747-755.1998; RICCI ML, 1994, FEMS MICROBIOL LETT, V119, P47; Rolls MM, 1999, J CELL BIOL, V146, P29, DOI 10.1083/jcb.146.1.29; ROZDZINSKI E, 1995, METHOD ENZYMOL, V253, P3; Scott KP, 2000, FEMS MICROBIOL LETT, V182, P23, DOI 10.1111/j.1574-6968.2000.tb08867.x; Smith CB, 2002, ENVIRON POLLUT, V120, P517, DOI 10.1016/S0269-7491(02)00227-0; Spellerberg B, 2002, INFECT IMMUN, V70, P2434, DOI 10.1128/IAI.70.5.2434-2440.2002; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P4296, DOI 10.1093/nar/18.14.4296; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Valdivia RH, 1996, MOL MICROBIOL, V22, P367, DOI 10.1046/j.1365-2958.1996.00120.x; Valdivia RH, 1997, SCIENCE, V277, P2007, DOI 10.1126/science.277.5334.2007; Weingart CL, 1999, INFECT IMMUN, V67, P4264, DOI 10.1128/IAI.67.8.4264-4267.1999; Yang TT, 1996, GENE, V173, P19, DOI 10.1016/0378-1119(95)00781-4; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	35	30	30	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e19822	10.1371/journal.pone.0019822	http://dx.doi.org/10.1371/journal.pone.0019822			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731607	Green Published, gold, Green Submitted			2022-12-25	WOS:000292033700004
J	Darcy, CJ; Davis, JS; Woodberry, T; McNeil, YR; Stephens, DP; Yeo, TW; Anstey, NM				Darcy, Christabelle J.; Davis, Joshua S.; Woodberry, Tonia; McNeil, Yvette R.; Stephens, Dianne P.; Yeo, Tsin W.; Anstey, Nicholas M.			An Observational Cohort Study of the Kynurenine to Tryptophan Ratio in Sepsis: Association with Impaired Immune and Microvascular Function	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE ACTIVITY; COLONY-STIMULATING FACTOR; DECREASES LYMPHOCYTE APOPTOSIS; VASCULAR ENDOTHELIAL FUNCTION; T-CELL PROLIFERATION; NITRIC-OXIDE; INTERFERON-GAMMA; IMPROVES SURVIVAL; DISEASE PROGRESSION; ORGAN DYSFUNCTION	Both endothelial and immune dysfunction contribute to the high mortality rate in human sepsis, but the underlying mechanisms are unclear. In response to infection, interferon-gamma activates indoleamine 2,3-dioxygenase (IDO) which metabolizes the essential amino acid tryptophan to the toxic metabolite kynurenine. IDO can be expressed in endothelial cells, hepatocytes and mononuclear leukocytes, all of which contribute to sepsis pathophysiology. Increased IDO activity (measured by the kynurenine to tryptophan [KT] ratio in plasma) causes T-cell apoptosis, vasodilation and nitric oxide synthase inhibition. We hypothesized that IDO activity in sepsis would be related to plasma interferon-gamma, interleukin-10, T cell lymphopenia and impairment of microvascular reactivity, a measure of endothelial nitric oxide bioavailability. In an observational cohort study of 80 sepsis patients (50 severe and 30 non-severe) and 40 hospital controls, we determined the relationship between IDO activity (plasma KT ratio) and selected plasma cytokines, sepsis severity, nitric oxide-dependent microvascular reactivity and lymphocyte subsets in sepsis. Plasma amino acids were measured by high performance liquid chromatography and microvascular reactivity by peripheral arterial tonometry. The plasma KT ratio was increased in sepsis (median 141 [IQR 64-235]) compared to controls (36 [28-52]); p<0.0001), and correlated with plasma interferon-gamma and interleukin-10, and inversely with total lymphocyte count, CD8+ and CD4+ T-lymphocytes, systolic blood pressure and microvascular reactivity. In response to treatment of severe sepsis, the median KT ratio decreased from 162 [IQR 100-286] on day 0 to 89 [65-139] by day 7; p = 0.0006) and this decrease in KT ratio correlated with a decrease in the Sequential Organ Failure Assessment score (p<0.0001). IDO-mediated tryptophan catabolism is associated with dysregulated immune responses and impaired microvascular reactivity in sepsis and may link these two fundamental processes in sepsis pathophysiology.	[Darcy, Christabelle J.; Davis, Joshua S.; Woodberry, Tonia; McNeil, Yvette R.; Yeo, Tsin W.; Anstey, Nicholas M.] Menzies Sch Hlth Res, Global Hlth Div, Darwin, NT, Australia; [Darcy, Christabelle J.; Davis, Joshua S.; Woodberry, Tonia; McNeil, Yvette R.; Yeo, Tsin W.; Anstey, Nicholas M.] Charles Darwin Univ, Darwin, NT 0909, Australia; [Davis, Joshua S.; Yeo, Tsin W.; Anstey, Nicholas M.] Royal Darwin Hosp, Div Med, Darwin, NT, Australia; [Stephens, Dianne P.] Royal Darwin Hosp, Intens Care Unit, Darwin, NT, Australia	Charles Darwin University; Menzies School of Health Research; Charles Darwin University	Darcy, CJ (corresponding author), Menzies Sch Hlth Res, Global Hlth Div, Darwin, NT, Australia.	Nicholas.anstey@menzies.edu.au	Yeo, Tsin Wen/F-9505-2015; Davis, Joshua/N-2288-2013	Davis, Joshua/0000-0001-9864-5699; Stephens, Dianne/0000-0002-3785-6828	National Health and Medical Research Council of Australia [290208, 496600]; Australian Postgraduate Award	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government)	The study was funded by the National Health and Medical Research Council of Australia (Program Grants 290208, 496600; Practitioner Fellowship to NMA, Scholarship to JSD) and an Australian Postgraduate Award to CJD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BARTH MC, 2009, J BIOL CHEM; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Bommhardt U, 2004, J IMMUNOL, V172, P7583, DOI 10.4049/jimmunol.172.12.7583; Bonaccorso S, 1998, AGING-CLIN EXP RES, V10, P316, DOI 10.1007/BF03339794; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bonetti PO, 2004, J AM COLL CARDIOL, V44, P2137, DOI 10.1016/j.jacc.2004.08.062; CARLIN JM, 1989, J LEUKOCYTE BIOL, V45, P29, DOI 10.1002/jlb.45.1.29; Celermajer DS, 2008, CIRCULATION, V117, P2428, DOI 10.1161/CIRCULATIONAHA.108.775155; Chiarugi A, 2003, J LEUKOCYTE BIOL, V73, P172, DOI 10.1189/jlb.0502220; Davis JS, 2009, CRIT CARE, V13, DOI 10.1186/cc8055; DAVIS JS, 2011, MED J AUST IN PRESS; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; ELLINGER P, 1947, NATURE, V160, P675, DOI 10.1038/160675b0; Fallarino F, 2002, INT IMMUNOL, V14, P65, DOI 10.1093/intimm/14.1.65; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Felmet KA, 2005, J IMMUNOL, V174, P3765, DOI 10.4049/jimmunol.174.6.3765; FERNSTROM JD, 1971, SCIENCE, V173, P149, DOI 10.1126/science.173.3992.149; Finfer S, 2004, INTENS CARE MED, V30, P589, DOI 10.1007/s00134-004-2157-0; Forouzandeh F, 2008, WOUND REPAIR REGEN, V16, P379, DOI 10.1111/j.1524-475X.2008.00377.x; Gibbons J.D., 2003, NONPARAMETRIC STAT I; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huang A, 2002, BRIT J CANCER, V86, P1691, DOI 10.1038/sj.bjc.6600336; Huengsberg M, 1998, CLIN CHEM, V44, P858; Hunsicker A, 1997, EUR J SURG, V163, P379; HUTTUNEN R, 2009, SHOCK; Ino K, 2008, CLIN CANCER RES, V14, P2310, DOI 10.1158/1078-0432.CCR-07-4144; Iwamoto N, 2009, LIVER INT, V29, P277, DOI 10.1111/j.1478-3231.2008.01748.x; Jung ID, 2009, J IMMUNOL, V182, P3146, DOI 10.4049/jimmunol.0803104; Kao CC, 2009, CLIN SCI, V117, P23, DOI 10.1042/CS20080444; Kudo Y, 2003, AM J OBSTET GYNECOL, V188, P719, DOI 10.1067/mob.2003.156; Kuvin JT, 2007, VASC MED, V12, P13, DOI 10.1177/1358863x06076227; Kuvin JT, 2003, AM HEART J, V146, P168, DOI 10.1016/S0002-8703(03)00094-2; Larrea E, 2007, J VIROL, V81, P3662, DOI 10.1128/JVI.02248-06; Le Tulzo Y, 2002, SHOCK, V18, P487, DOI 10.1097/00024382-200212000-00001; Lee GK, 2002, IMMUNOLOGY, V107, P452, DOI 10.1046/j.1365-2567.2002.01526.x; Lob S, 2009, NAT REV CANCER, V9, P445, DOI 10.1038/nrc2639; Luiking YC, 2009, AM J CLIN NUTR, V89, P142, DOI 10.3945/ajcn.2007.25765; MacKenzie CR, 1999, ADV EXP MED BIOL, V467, P533; MacKenzie CR, 1998, J INFECT DIS, V178, P875, DOI 10.1086/515347; MAES M, 1993, PSYCHIAT RES, V49, P151, DOI 10.1016/0165-1781(93)90102-M; Maneechotesuwan K, 2008, J ALLERGY CLIN IMMUN, V121, P43, DOI 10.1016/j.jaci.2007.10.011; Merino E, 2008, CURR OPIN MICROBIOL, V11, P78, DOI 10.1016/j.mib.2008.02.005; Mohib K, 2007, AM J PHYSIOL-RENAL, V293, pF801, DOI 10.1152/ajprenal.00044.2007; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; NELSON S, 1994, CLIN INFECT DIS, V18, pS197, DOI 10.1093/clinids/18.Supplement_2.S197; Nohria A, 2006, J APPL PHYSIOL, V101, P545, DOI 10.1152/japplphysiol.01285.2005; Odemuyiwa SO, 2004, J IMMUNOL, V173, P5909, DOI 10.4049/jimmunol.173.10.5909; Orabona C, 2008, P NATL ACAD SCI USA, V105, P20828, DOI 10.1073/pnas.0810278105; Pawlak D, 2003, J PHYSIOL PHARMACOL, V54, P175; Pawlak K, 2009, THROMB RES, V124, P452, DOI 10.1016/j.thromres.2009.04.011; Pellegrin K, 2005, SHOCK, V23, P209, DOI 10.1097/01.shk.000150773.16613.d3; Samelson-Jones BJ, 2006, BIOCHEMISTRY-US, V45, P8527, DOI 10.1021/bi060143j; Schefold JC, 2010, SCAND J INFECT DIS, V42, P164, DOI 10.3109/00365540903405768; Schefold JC, 2009, NEPHROL DIAL TRANSPL, V24, P1901, DOI 10.1093/ndt/gfn739; Schwulst SJ, 2008, SHOCK, V30, P127, DOI [10.1097/SHK.0b013e318162cf17, 10.1097/shk.0b013e318162cf17]; Sekkai D, 1997, ARCH BIOCHEM BIOPHYS, V340, P117, DOI 10.1006/abbi.1997.9913; Stephens DP, 2008, CRIT CARE MED, V36, P448, DOI 10.1097/01.CCM.0B013E318161E480; Suzuki Y, 2010, LUNG CANCER, V67, P361, DOI 10.1016/j.lungcan.2009.05.001; Tattevin P, 2010, J INFECT DIS, V201, P956, DOI 10.1086/650996; Torres MI, 2007, CLIN EXP IMMUNOL, V148, P419, DOI 10.1111/j.1365-2249.2007.03365.x; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; van der Sluijs KF, 2006, J INFECT DIS, V193, P214, DOI 10.1086/498911; van Wissen M, 2002, J IMMUNOL, V169, P7039, DOI 10.4049/jimmunol.169.12.7039; vanWandelen C, 1997, J CHROMATOGR A, V763, P11, DOI 10.1016/S0021-9673(96)00891-6; Vaudo G, 2008, ATHEROSCLEROSIS, V197, P747, DOI 10.1016/j.atherosclerosis.2007.07.009; Villalpando S, 2006, AM J CLIN NUTR, V84, P197, DOI 10.1093/ajcn/84.1.197; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; Widner B, 2000, IMMUNOBIOLOGY, V201, P621, DOI 10.1016/S0171-2985(00)80079-0; Yanagawa Y, 2009, IMMUNOLOGY, V127, P345, DOI 10.1111/j.1365-2567.2008.02986.x; YANOFSKY C, 1991, J BACTERIOL, V173, P6009, DOI 10.1128/jb.173.19.6009-6017.1991; YOSHIDA R, 1981, P NATL ACAD SCI-BIOL, V78, P129, DOI 10.1073/pnas.78.1.129; Zangerle R, 2002, CLIN IMMUNOL, V104, P242, DOI 10.1006/clim.2002.5231	81	58	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21185	10.1371/journal.pone.0021185	http://dx.doi.org/10.1371/journal.pone.0021185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731667	Green Published, gold, Green Submitted			2022-12-25	WOS:000292033700044
J	Sun, Z; Liu, Z; Meng, J; Meng, J; Duan, JH; Xie, SS; Lu, X; Zhu, ZH; Wang, C; Chen, SC; Xu, HY; Yang, XD				Sun, Zhao; Liu, Zhe; Meng, Jie; Meng, Jie; Duan, Jinhong; Xie, Sishen; Lu, Xin; Zhu, Zhaohui; Wang, Chen; Chen, Shuchang; Xu, Haiyan; Yang, Xian-Da			Carbon Nanotubes Enhance Cytotoxicity Mediated by Human Lymphocytes In Vitro	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; PROTEIN ENHANCE; PLASMID DNA; DELIVERY; CELLS; TRANSPORTERS; TOXICITY; GENE; BIODISTRIBUTION	With the expansion of the potential applications of carbon nanotubes (CNT) in biomedical fields, the toxicity and biocompatibility of CNT have become issues of growing concern. Since the immune system often mediates tissue damage during pathogenesis, it is important to explore whether CNT can trigger cytotoxicity through affecting the immune functions. In the current study, we evaluated the influence of CNT on the cytotoxicity mediated by human lymphocytes in vitro. The results showed that while CNT at low concentrations (0.001 to 0.1 mu g/ml) did not cause obvious cell death or apoptosis directly, it enhanced lymphocyte-mediated cytotoxicity against multiple human cell lines. In addition, CNT increased the secretion of IFN-gamma and TNF-alpha by the lymphocytes. CNT also upregulated the NF-kappa B expression in lymphocytes, and the blockage of the NF-kappa B pathway reduced the lymphocyte-mediated cytotoxicity triggered by CNT. These results suggest that CNT at lower concentrations may prospectively initiate an indirect cytotoxicity through affecting the function of lymphocytes.	[Sun, Zhao; Lu, Xin; Zhu, Zhaohui; Chen, Shuchang] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Sun, Zhao; Liu, Zhe; Meng, Jie; Duan, Jinhong; Lu, Xin; Zhu, Zhaohui; Chen, Shuchang; Xu, Haiyan; Yang, Xian-Da] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Zhe; Meng, Jie; Duan, Jinhong; Xu, Haiyan; Yang, Xian-Da] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Meng, Jie; Wang, Chen] Natl Ctr Nanosci & Technol, Beijing, Peoples R China; [Xie, Sishen] Chinese Acad Sci, Inst Phys, Beijing 100080, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Chinese Academy of Sciences; Institute of Physics, CAS	Sun, Z (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.	xuhy@pumc.edu.cn; ayangmd@gmail.com	Liu, Zhe/GQH-5005-2022; Zhu, Zhaohui/CAA-1003-2022	Liu, Zhe/0000-0002-8604-2433; 	Ministry of Science and Technology of China [2011CB933504, 2011CB911003, 2011CB911004]; Natural Science Foundation of China [81071870]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from the Ministry of Science and Technology of China (2011CB933504, 2011CB911003, 2011CB911004) and the Natural Science Foundation of China (81071870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco A, 2005, CHEM COMMUN, P571, DOI 10.1039/b410943k; Bianco A, 2005, CURR OPIN CHEM BIOL, V9, P674, DOI 10.1016/j.cbpa.2005.10.005; Cai D, 2005, NAT METHODS, V2, P449, DOI 10.1038/NMETH761; Chou CC, 2008, NANO LETT, V8, P437, DOI 10.1021/nl0723634; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Cui DX, 2005, TOXICOL LETT, V155, P73, DOI 10.1016/j.toxlet.2004.08.015; Davoren M, 2007, TOXICOL IN VITRO, V21, P438, DOI 10.1016/j.tiv.2006.10.007; Dumortier H, 2006, NANO LETT, V6, P1522, DOI 10.1021/nl061160x; Gao LZ, 2006, CHEMBIOCHEM, V7, P239, DOI 10.1002/cbic.200500227; Haas C, 2006, INT J CANCER, V118, P658, DOI 10.1002/ijc.21390; Heller DA, 2006, SCIENCE, V311, P508, DOI 10.1126/science.1120792; Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059; Kam NWS, 2006, ANGEW CHEM INT EDIT, V45, P577, DOI 10.1002/anie.200503389; Kam NWS, 2005, J AM CHEM SOC, V127, P6021, DOI 10.1021/ja050062v; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; Kostarelos K, 2007, NAT NANOTECHNOL, V2, P108, DOI 10.1038/nnano.2006.209; Li JG, 2009, J NANOSCI NANOTECHNO, V9, P1384, DOI 10.1166/jnn.2009.C162; Liu Y, 2005, ANGEW CHEM INT EDIT, V44, P4782, DOI 10.1002/anie.200500042; Liu Z, 2007, NAT NANOTECHNOL, V2, P47, DOI 10.1038/nnano.2006.170; Lu Q, 2004, NANO LETT, V4, P2473, DOI 10.1021/nl048326j; Mackay IR, 2008, J AUTOIMMUN, V30, P5, DOI 10.1016/j.jaut.2007.11.009; MAHOCK L, 2009, TOXICOL SCI; Manna SK, 2005, NANO LETT, V5, P1676, DOI 10.1021/nl0507966; Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988; Meng J, 2008, SMALL, V4, P1364, DOI 10.1002/smll.200701059; Ni YC, 2005, J NANOSCI NANOTECHNO, V5, P1707, DOI 10.1166/jnn.2005.189; Pacurari M, 2008, ENVIRON HEALTH PERSP, V116, P1211, DOI 10.1289/ehp.10924; Pantarotto D, 2004, ANGEW CHEM INT EDIT, V43, P5242, DOI 10.1002/anie.200460437; Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c; Raja PMV, 2007, TOXICOL LETT, V169, P51, DOI 10.1016/j.toxlet.2006.12.003; Schipper ML, 2008, NAT NANOTECHNOL, V3, P216, DOI 10.1038/nnano.2008.68; Singh R, 2005, J AM CHEM SOC, V127, P4388, DOI 10.1021/ja0441561; Singh R, 2006, P NATL ACAD SCI USA, V103, P3357, DOI 10.1073/pnas.0509009103; Sun YP, 2002, ACCOUNTS CHEM RES, V35, P1096, DOI 10.1021/ar010160v; Sun Z, 2010, CELL RES, V20, P1170, DOI 10.1038/cr.2010.133; Walker VG, 2009, TOXICOL APPL PHARM, V236, P319, DOI 10.1016/j.taap.2009.02.018; Williams KA, 2002, NATURE, V420, P761, DOI 10.1038/420761a; Wu W, 2005, ANGEW CHEM INT EDIT, V44, P6358, DOI 10.1002/anie.200501613; Yang ST, 2008, TOXICOL LETT, V181, P182, DOI 10.1016/j.toxlet.2008.07.020; Ye SF, 2009, BIOCHEM BIOPH RES CO, V379, P643, DOI 10.1016/j.bbrc.2008.12.137; Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e	41	42	42	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21073	10.1371/journal.pone.0021073	http://dx.doi.org/10.1371/journal.pone.0021073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731651	Green Submitted, Green Published, gold			2022-12-25	WOS:000292033700035
J	Takayanagi, Y; Takahashi, T; Orikabe, L; Mozue, Y; Kawasaki, Y; Nakamura, K; Sato, Y; Itokawa, M; Yamasue, H; Kasai, K; Kurachi, M; Okazaki, Y; Suzuki, M				Takayanagi, Yoichiro; Takahashi, Tsutomu; Orikabe, Lina; Mozue, Yuriko; Kawasaki, Yasuhiro; Nakamura, Kazue; Sato, Yoko; Itokawa, Masanari; Yamasue, Hidenori; Kasai, Kiyoto; Kurachi, Masayoshi; Okazaki, Yuji; Suzuki, Michio			Classification of First-Episode Schizophrenia Patients and Healthy Subjects by Automated MRI Measures of Regional Brain Volume and Cortical Thickness	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; 1ST EPISODE SCHIZOPHRENIA; MAGNETIC-RESONANCE IMAGES; VOXEL-BASED MORPHOMETRY; GRAY-MATTER; BIPOLAR DISORDER; SURFACE RECONSTRUCTION; GEOMETRICALLY ACCURATE; PATTERN-CLASSIFICATION; LIKELIHOOD ESTIMATION	Background: Although structural magnetic resonance imaging (MRI) studies have repeatedly demonstrated regional brain structural abnormalities in patients with schizophrenia, relatively few MRI-based studies have attempted to distinguish between patients with first-episode schizophrenia and healthy controls. Method: Three-dimensional MR images were acquired from 52 (29 males, 23 females) first-episode schizophrenia patients and 40 (22 males, 18 females) healthy subjects. Multiple brain measures (regional brain volume and cortical thickness) were calculated by a fully automated procedure and were used for group comparison and classification by linear discriminant function analysis. Results: Schizophrenia patients showed gray matter volume reductions and cortical thinning in various brain regions predominantly in prefrontal and temporal cortices compared with controls. The classifiers obtained from 66 subjects of the first group successfully assigned 26 subjects of the second group with accuracy above 80%. Conclusion: Our results showed that combinations of automated brain measures successfully differentiated first-episode schizophrenia patients from healthy controls. Such neuroimaging approaches may provide objective biological information adjunct to clinical diagnosis of early schizophrenia.	[Takayanagi, Yoichiro; Takahashi, Tsutomu; Kawasaki, Yasuhiro; Nakamura, Kazue; Kurachi, Masayoshi; Suzuki, Michio] Toyama Univ, Dept Neuropsychiat, Toyama 930, Japan; [Takayanagi, Yoichiro; Orikabe, Lina; Itokawa, Masanari; Okazaki, Yuji] Tokyo Metropolitan Matsuzawa Hosp, Dept Psychiat, Tokyo, Japan; [Orikabe, Lina; Yamasue, Hidenori; Kasai, Kiyoto] Univ Tokyo, Dept Neuropsychiat, Grad Sch Med, Tokyo, Japan; [Mozue, Yuriko] Tosa Hosp, Kochi, Japan; [Sato, Yoko] Tokyo Metropolitan Matsuzawa Hosp, Dept Radiol, Tokyo, Japan; [Takayanagi, Yoichiro; Itokawa, Masanari] Tokyo Inst Psychiat, Tokyo, Japan	University of Toyama; University of Tokyo; Tokyo Institute of Psychiatry	Takayanagi, Y (corresponding author), Toyama Univ, Dept Neuropsychiat, Toyama 930, Japan.	y-takayanagi@sky.707.to		Kasai, Kiyoto/0000-0002-4443-4535	Japanese Ministry of Health, Labour, and Welfare [21-001, 21-3]; Grants-in-Aid for Scientific Research [20591393] Funding Source: KAKEN	Japanese Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Health and Labor Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health (21-001) and a Research Grant for Nervous and Mental Disorders (21-3) from the Japanese Ministry of Health, Labour, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Antonova E, 2004, SCHIZOPHR RES, V70, P117, DOI 10.1016/j.schres.2003.12.002; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Borgwardt SJ, 2008, SCHIZOPHR RES, V106, P108, DOI 10.1016/j.schres.2008.08.007; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P1265, DOI 10.1002/hbm.20463; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Davatzikos C, 2005, ARCH GEN PSYCHIAT, V62, P1218, DOI 10.1001/archpsyc.62.11.1218; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fleck DE, 2001, SCHIZOPHR RES, V52, P251, DOI 10.1016/S0920-9964(01)00170-0; Fornito A, 2009, SCHIZOPHR RES, V108, P104, DOI 10.1016/j.schres.2008.12.011; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Goldman AL, 2009, ARCH GEN PSYCHIAT, V66, P467, DOI 10.1001/archgenpsychiatry.2009.24; Goldstein JM, 2002, ARCH GEN PSYCHIAT, V59, P154, DOI 10.1001/archpsyc.59.2.154; Haahr U, 2008, PSYCHOPATHOLOGY, V41, P322, DOI 10.1159/000146070; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Kawasaki Y, 2007, NEUROIMAGE, V34, P235, DOI 10.1016/j.neuroimage.2006.08.018; Kim JJ, 2007, SCHIZOPHR RES, V97, P226, DOI 10.1016/j.schres.2007.09.007; Koutsouleris N, 2009, ARCH GEN PSYCHIAT, V66, P700, DOI 10.1001/archgenpsychiatry.2009.62; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Lieberman JA, 2005, ARCH GEN PSYCHIAT, V62, P361, DOI 10.1001/archpsyc.62.4.361; McCarley RW, 1999, BIOL PSYCHIAT, V45, P1099, DOI 10.1016/S0006-3223(99)00018-9; Molina V, 2005, SCHIZOPHR RES, V80, P61, DOI 10.1016/j.schres.2005.07.031; Nakamura K, 2004, SCHIZOPHRENIA BULL, V30, P393, DOI 10.1093/oxfordjournals.schbul.a007087; Narr KL, 2005, CEREB CORTEX, V15, P708, DOI 10.1093/cercor/bhh172; Nesvag R, 2008, SCHIZOPHR RES, V98, P16, DOI 10.1016/j.schres.2007.09.015; Onitsuka T, 2007, SCHIZOPHR RES, V92, P197, DOI 10.1016/j.schres.2007.01.027; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Pantelis C, 2003, LANCET, V361, P281, DOI 10.1016/S0140-6736(03)12323-9; Pardo PJ, 2006, SCHIZOPHR RES, V87, P297, DOI 10.1016/j.schres.2006.05.007; Rimol LM, 2010, BIOL PSYCHIAT, V68, P41, DOI 10.1016/j.biopsych.2010.03.036; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Salvatore P, 2009, J CLIN PSYCHIAT, V70, P458, DOI 10.4088/JCP.08m04227; Schultz CC, 2010, SCHIZOPHR RES, V116, P204, DOI 10.1016/j.schres.2009.11.001; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sun DQ, 2009, BIOL PSYCHIAT, V66, P1055, DOI 10.1016/j.biopsych.2009.07.019; Takahashi T, 2002, SCHIZOPHR RES, V55, P69, DOI 10.1016/S0920-9964(01)00200-6; Takahashi T, 2009, ARCH GEN PSYCHIAT, V66, P366, DOI 10.1001/archgenpsychiatry.2009.12; Takayanagi Y, 2010, PROG NEURO-PSYCHOPH, V34, P10, DOI 10.1016/j.pnpbp.2009.09.004; Uetsuki M., 2007, SEISHIN IGAKU, V49, P17; van Haren NEM, 2007, NEUROPSYCHOPHARMACOL, V32, P2057, DOI 10.1038/sj.npp.1301347; Venkatasubramanian G, 2008, ACTA PSYCHIAT SCAND, V117, P420, DOI 10.1111/j.1600-0447.2008.01198.x; WHO, 2012, ICD 10 CLASS MENT BE; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Yoon U, 2007, NEUROIMAGE, V34, P1405, DOI 10.1016/j.neuroimage.2006.11.021	61	55	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21047	10.1371/journal.pone.0021047	http://dx.doi.org/10.1371/journal.pone.0021047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712987	Green Published, gold			2022-12-25	WOS:000291985100009
J	Kaufmann, A; Kenfak-Foguena, A; Andre, C; Canellini, G; Burgisser, P; Moradpour, D; Darling, KEA; Cavassini, M				Kaufmann, Annatina; Kenfak-Foguena, Alain; Andre, Cyril; Canellini, Giorgia; Buergisser, Philippe; Moradpour, Darius; Darling, Katharine E. A.; Cavassini, Matthias			Hepatitis E Virus Seroprevalence among Blood Donors in Southwest Switzerland	PLOS ONE			English	Article							IGG SEROPREVALENCE; UNITED-STATES; PREVALENCE; ANTIBODIES; ENGLAND; INFECTION	Aim: The aim of this study was to determine the seroprevalence of Hepatitis E virus (HEV) among blood donors in southwest Switzerland. Background: HEV is recognized as a food-borne disease in industrialized countries, transmitted mainly through pork meat. Cases of transmission through blood transfusion have also been reported. Recent studies have revealed seroprevalence rates of 13.5%, 16.6% and 20.6% among blood donors in England, France and Denmark, respectively. Methods: We analyzed 550 consecutive blood donor samples collected in the region of Lausanne, canton of Vaud, Switzerland, for the presence of anti-HEV IgG, using the MP Diagnostics HEV ELISA kit. For each donor, we documented age, sex and alanine aminotransferase (ALT) value. Results: The study panel was composed of 332 men (60.4%) and 218 women (39.6%). Overall, anti-HEV IgG was found in 27 of 550 samples (4.9%). The seroprevalence was 5.4% (18/332) in men and 4.1% (9/218) in women. The presence of anti-HEV IgG was not correlated with age, gender or ALT values. However, we observed a peak in seroprevalence of 5.3% in individuals aged 51 to 70 years old. Conclusions: Compared with other European countries, HEV seroprevalence among blood donors in southwest Switzerland is low. The low seroprevalence may be explained by the sensitivity of commercial tests used and/or the strict regulation of animal and meat imports. Data regarding HEV prevalence in Swiss livestock are lacking and merit exploration.	[Kaufmann, Annatina] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland; [Kenfak-Foguena, Alain; Darling, Katharine E. A.; Cavassini, Matthias] CHU Vaudois, Infect Dis Serv, Lausanne, Switzerland; [Andre, Cyril; Buergisser, Philippe] CHU Vaudois, Serv Immunol & Allergy, Lausanne, Switzerland; [Canellini, Giorgia] Serv Reg Vaudois Transfus Sanguine, Epalinges, Switzerland; [Moradpour, Darius] CHU Vaudois, Div Gastroenterol & Hepatol, Lausanne, Switzerland	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Kaufmann, A (corresponding author), Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland.		VALLET, Yannick/F-9979-2011; Moradpour, Darius/G-7918-2017; cavassini, matthias/F-8987-2017	Schnegg-Kaufmann, Annatina/0000-0001-7716-3340; Moradpour, Darius/0000-0003-1977-6792; Kenfak Foguena, Alain/0000-0002-8213-2490; cavassini, matthias/0000-0003-0933-7833; Darling, Katharine/0000-0003-1449-3873	Infectious Diseases Service, Clinique Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland	Infectious Diseases Service, Clinique Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland	All serology testing was funded by the Infectious Diseases Service, Clinique Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. The study had no external funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendall R, 2010, J MED VIROL, V82, P799, DOI 10.1002/jmv.21656; Boutrouille A, 2007, J CLIN MICROBIOL, V45, P2009, DOI 10.1128/JCM.00235-07; Bouwknegt M, 2007, J FOOD PROTECT, V70, P2889, DOI 10.4315/0362-028X-70.12.2889; Christensen PB, 2008, CLIN INFECT DIS, V47, P1026, DOI 10.1086/591970; Dalekos GN, 1998, TRANSFUSION, V38, P589, DOI 10.1046/j.1537-2995.1998.38698326339.x; Dalton HR, 2008, EUR J CLIN MICROBIOL, V27, P579, DOI 10.1007/s10096-008-0480-z; Dalton HR, 2008, EUR J GASTROEN HEPAT, V20, P784, DOI 10.1097/MEG.0b013e3282f5195a; FOGUENA AK, 2010, EMERG INFEC IN PRESS; Herremans M, 2007, CLIN VACCINE IMMUNOL, V14, P562, DOI 10.1128/CVI.00231-06; Ijaz S, 2005, J INFECT DIS, V192, P1166, DOI 10.1086/444396; Ijaz S, 2009, J CLIN VIROL, V44, P272, DOI 10.1016/j.jcv.2009.01.005; JAMEEL S, 1999, EXPERT REV MOL MED, P1; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Khuroo MS, 2008, CURR OPIN INFECT DIS, V21, P539, DOI 10.1097/QCO.0b013e32830ee08a; Kumar Arvind, 2004, Indian J Gastroenterol, V23, P59; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; LAVANCHY D, 1994, LANCET, V344, P747, DOI 10.1016/S0140-6736(94)92235-7; Lewis HC, 2010, EPIDEMIOL INFECT, V138, P145, DOI 10.1017/S0950268809990847; Mansuy JM, 2008, J MED VIROL, V80, P289, DOI 10.1002/jmv.21056; Mateos ML, 1998, VOX SANG, V75, P267; Meng XJ, 2002, J CLIN MICROBIOL, V40, P117, DOI 10.1128/JCM.40.1.117-122.2002; Okamoto H, 2007, VIRUS RES, V127, P216, DOI 10.1016/j.virusres.2007.02.002; Ollier L, 2009, ANN INTERN MED, V150, P430, DOI 10.7326/0003-4819-150-6-200903170-00026; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; ZAAIJER HL, 1993, LANCET, V341, P826, DOI 10.1016/0140-6736(93)90599-C; ZANETTI AR, 1994, J MED VIROL, V42, P318, DOI 10.1002/jmv.1890420321	26	76	78	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21150	10.1371/journal.pone.0021150	http://dx.doi.org/10.1371/journal.pone.0021150			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701586	gold, Green Published, Green Submitted			2022-12-25	WOS:000291983800025
J	Knol, MJ; Duijnhoven, RG; Grobbee, DE; Moons, KGM; Groenwold, RHH				Knol, Mirjam J.; Duijnhoven, Ruben G.; Grobbee, Diederick E.; Moons, Karel G. M.; Groenwold, Rolf H. H.			Potential Misinterpretation of Treatment Effects Due to Use of Odds Ratios and Logistic Regression in Randomized Controlled Trials	PLOS ONE			English	Article							COMMON OUTCOMES; HAZARD RATIO; RELATIVE RISK; CARDIAC-CATHETERIZATION; CLINICAL INVESTIGATORS; ENHANCE COMMUNICATION; COHORT; PREVALENCE; RACE; SEX	Background: In randomized controlled trials (RCTs), the odds ratio (OR) can substantially overestimate the risk ratio (RR) if the incidence of the outcome is over 10%. This study determined the frequency of use of ORs, the frequency of overestimation of the OR as compared with its accompanying RR in published RCTs, and we assessed how often regression models that calculate RRs were used. Methods: We included 288 RCTs published in 2008 in five major general medical journals (Annals of Internal Medicine, British Medical Journal, Journal of the American Medical Association, Lancet, New England Journal of Medicine). If an OR was reported, we calculated the corresponding RR, and we calculated the percentage of overestimation by using the formula ln (OR) - ln (RR)/ln (RR) * 100. Results: Of 193 RCTs with a dichotomous primary outcome, 24 (12.4%) presented a crude and/or adjusted OR for the primary outcome. In five RCTs (2.6%), the OR differed more than 100% from its accompanying RR on the log scale. Forty-one of all included RCTs (n = 288; 14.2%) presented ORs for other outcomes, or for subgroup analyses. Nineteen of these RCTs (6.6%) had at least one OR that deviated more than 100% from its accompanying RR on the log scale. Of 53 RCTs that adjusted for baseline variables, 15 used logistic regression. Alternative methods to estimate RRs were only used in four RCTs. Conclusion: ORs and logistic regression are often used in RCTs and in many articles the OR did not approximate the RR. Although the authors did not explicitly misinterpret these ORs as RRs, misinterpretation by readers can seriously affect treatment decisions and policy making.	[Knol, Mirjam J.; Duijnhoven, Ruben G.; Grobbee, Diederick E.; Moons, Karel G. M.; Groenwold, Rolf H. H.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Knol, MJ (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	m.j.knol@umcutrecht.nl	Grobbee, Diederick/C-7651-2014	Grobbee, Diederick/0000-0003-4472-4468; Groenwold, Rolf/0000-0001-9238-6999; Duijnhoven, Ruben/0000-0002-4784-4396	Escher project [T6-202]; Dutch Top Institute Pharma	Escher project; Dutch Top Institute Pharma	This study was performed in the context of the Escher project (T6-202), a project of the Dutch Top Institute Pharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 1998, BRIT MED J, V317, P1318, DOI 10.1136/bmj.317.7168.1318; Buyse M, 2008, CLIN TRIALS, V5, P641, DOI 10.1177/1740774508098328; Engels EA, 2000, STAT MED, V19, P1707, DOI 10.1002/1097-0258(20000715)19:13<1707::AID-SIM491>3.0.CO;2-P; Keene ON, 2002, STAT MED, V21, P3687, DOI 10.1002/sim.1312; Knol MJ, 2008, AM J EPIDEMIOL, V168, P1073, DOI 10.1093/aje/kwn217; Lumley T, 2006, UW BIOSTATISTICS WOR; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; McNutt LA, 1999, JAMA-J AM MED ASSOC, V282, P529, DOI 10.1001/jama.282.6.529; Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788; Moser BK, 2008, CLIN TRIALS, V5, P248, DOI 10.1177/1740774508091452; Petersen MR, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-9; Robbins AS, 2002, ANN EPIDEMIOL, V12, P452, DOI 10.1016/S1047-2797(01)00278-2; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Schwartz LM, 1999, NEW ENGL J MED, V341, P279, DOI 10.1056/NEJM199907223410411; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Spruance SL, 2004, ANTIMICROB AGENTS CH, V48, P2787, DOI 10.1128/AAC.48.8.2787-2792.2004; Wheeler DW, 2008, ANN INTERN MED, V148, P11, DOI 10.7326/0003-4819-148-1-200801010-00003; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	20	39	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21248	10.1371/journal.pone.0021248	http://dx.doi.org/10.1371/journal.pone.0021248			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698176	Green Submitted, Green Published, gold			2022-12-25	WOS:000291734100074
J	Gopalakrishna-Pillai, S; Iverson, LE				Gopalakrishna-Pillai, Sailesh; Iverson, Linda E.			A DNMT3B Alternatively Spliced Exon and Encoded Peptide Are Novel Biomarkers of Human Pluripotent Stem Cells	PLOS ONE			English	Article							DNA METHYLATION; GENE; CANCER	A major obstacle in human stem cell research is the limited number of reagents capable of distinguishing pluripotent stem cells from partially differentiated or incompletely reprogrammed derivatives. Although human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) express numerous alternatively spliced transcripts, little attention has been directed at developing splice variant-encoded protein isoforms as reagents for stem cell research. In this study, several genes encoding proteins involved in important signaling pathways were screened to detect alternatively spliced transcripts that exhibited differential expression in pluripotent stem cells (PSCs) relative to spontaneously differentiated cells (SDCs). Transcripts containing the alternatively spliced exon 10 of the de novo DNA methyltransferase gene, DNMT3B, were identified that are expressed in PSCs. To demonstrate the utility and superiority of splice variant specific reagents for stem cell research, a peptide encoded by DNMT3B exon 10 was used to generate an antibody, SG1. The SG1 antibody detects a single DNMT3B protein isoform that is expressed only in PSCs but not in SDCs. The SG1 antibody is also demonstrably superior to other antibodies at distinguishing PSCs from SDCs in mixed cultures containing both pluripotent stem cells and partially differentiated derivatives. The tightly controlled down regulation of DNMT3B exon 10 containing transcripts (and exon 10 encoded peptide) upon spontaneous differentiation of PSCs suggests that this DNMT3B splice isoform is characteristic of the pluripotent state. Alternatively spliced exons, and the proteins they encode, represent a vast untapped reservoir of novel biomarkers that can be used to develop superior reagents for stem cell research and to gain further insight into mechanisms controlling stem cell pluripotency.	[Gopalakrishna-Pillai, Sailesh; Iverson, Linda E.] City Hope Natl Med Ctr, Beckman Res Inst, Stem Cell Biol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Gopalakrishna-Pillai, S (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Stem Cell Biol, Duarte, CA 91010 USA.	liverson@coh.org						Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Beyrouthy MJ, 2009, CANCER RES, V69, P9360, DOI 10.1158/0008-5472.CAN-09-1490; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Gopalakrishna-Pillai S, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-12; Gopalakrishnan S, 2009, MOL CANCER RES, V7, P1622, DOI 10.1158/1541-7786.MCR-09-0018; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Kellner S, 2010, HISTOL HISTOPATHOL, V25, P405, DOI 10.14670/HH-25.405; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Nicholas CR, 2010, NATURE, V463, P1031, DOI 10.1038/4631031a; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Orengo JP, 2007, ADV EXP MED BIOL, V623, P212, DOI 10.1007/978-0-387-77374-2_13; Pritsker M, 2005, P NATL ACAD SCI USA, V102, P14290, DOI 10.1073/pnas.0502132102; Smith JA, 2010, AGING CELL, V9, P580, DOI 10.1111/j.1474-9726.2010.00585.x; Weisenberger DJ, 2004, MOL CANCER RES, V2, P62; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	27	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20663	10.1371/journal.pone.0020663	http://dx.doi.org/10.1371/journal.pone.0020663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698279	Green Published, gold, Green Submitted			2022-12-25	WOS:000291730000017
J	Walters, P; Schofield, P; Howard, L; Ashworth, M; Tylee, A				Walters, Paul; Schofield, Peter; Howard, Louise; Ashworth, Mark; Tylee, Andre			The Relationship between Asthma and Depression in Primary Care Patients: A Historical Cohort and Nested Case Control Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; PRACTICE RESEARCH DATABASE; MENTAL-DISORDERS; GENERAL-PRACTICE; SYMPTOMS; EPIDEMIOLOGY; COMMUNITY; OUTCOMES; ADULTS; IMPACT	Background and Objectives: Asthma and depression are common health problems in primary care. Evidence of a relationship between asthma and depression is conflicting. Objectives: to determine 1. The incidence rate and incidence rate ratio of depression in primary care patients with asthma compared to those without asthma, and 2. The standardized mortality ratio of depressed compared to non-depressed patients with asthma. Methods: A historical cohort and nested case control study using data derived from the United Kingdom General Practice Research Database. Participants: 11,275 incident cases of asthma recorded between 1/1/95 and 31/12/96 age, sex and practice matched with non-cases from the database (ratio 1: 1) and followed up through the database for 10 years. 1,660 cases were matched by date of asthma diagnosis with 1,660 controls. Main outcome measures: number of cases diagnosed with depression, the number of deaths over the study period. Results: The rate of depression in patients with asthma was 22.4/1,000 person years and without asthma 13.8 /1,000 person years. The incident rate ratio (adjusted for age, sex, practice, diabetes, cardiovascular disease, cerebrovascular disease, smoking) was 1.59 (95% CI 1.48-1.71). The increased rate of depression was not associated with asthma severity or oral corticosteroid use. It was associated with the number of consultations (odds ratio per visit 1.09; 95% CI 1.07-1.11). The age and sex adjusted standardized mortality ratio for depressed patients with asthma was 1.87 (95% CI: 1.54-2.27). Conclusions: Asthma is associated with depression. This was not related to asthma severity or oral corticosteroid use but was related to service use. This suggests that a diagnosis of depression is related to health seeking behavior in patients with asthma. There is an increased mortality rate in depressed patients with asthma. The cause of this needs further exploration. Consideration should be given to case-finding for depression in this population.	[Walters, Paul; Howard, Louise; Tylee, Andre] Kings Coll London, Hlth Serv, Inst Psychiat, London WC2R 2LS, England; [Walters, Paul; Howard, Louise; Tylee, Andre] Kings Coll London, Populat Res Dept, Inst Psychiat, London WC2R 2LS, England; [Schofield, Peter; Ashworth, Mark] Kings Coll London, Div Hlth & Social Care Res, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Walters, P (corresponding author), Kings Coll London, Hlth Serv, Inst Psychiat, London WC2R 2LS, England.	p.walters@iop.kcl.ac.uk	Howard, Louise/E-3495-2010; Walters, Paul/A-6752-2011; Tylee, Andre T/D-8468-2010; Schofield, Peter/B-7821-2011	Howard, Louise/0000-0001-9942-744X; Schofield, Peter/0000-0003-1201-527X; Ashworth, Mark/0000-0001-6514-9904	Medical Research Council (ISAC) [07_051R]; NIHR Mental Health Biomedical Research Centre, Institute of Psychiatry, King's College London; South London and Maudsley Foundation Trust	Medical Research Council (ISAC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Mental Health Biomedical Research Centre, Institute of Psychiatry, King's College London; South London and Maudsley Foundation Trust	The Medical Research Council (ISAC Protocol No. 07_051R), and the NIHR Mental Health Biomedical Research Centre, Institute of Psychiatry, King's College London and South London and Maudsley Foundation Trust jointly funded this research. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2004, THORAX, V59, P930, DOI 10.1136/thx.2003.010256; ANDERSON HR, 1994, HLTH CARE NEEDS ASSE, P256; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Chapman D. P., 2005, Preventing Chronic Disease, V2, pA14; Chapman KR, 2005, RESP MED, V99, P1350, DOI 10.1016/j.rmed.2005.03.020; Cluley S, 2001, RESP MED, V95, P37, DOI 10.1053/rmed.2000.0968; Eisner MD, 2005, ANN ALLERG ASTHMA IM, V94, P566, DOI 10.1016/S1081-1206(10)61135-0; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; Goldney RD, 2003, MED J AUSTRALIA, V178, P437, DOI 10.5694/j.1326-5377.2003.tb05285.x; Goodwin RD, 2004, PSYCHOL MED, V34, P1465, DOI 10.1017/S0033291704002739; Goodwin RD, 2003, ARCH GEN PSYCHIAT, V60, P1125, DOI 10.1001/archpsyc.60.11.1125; Hancox RJ, 2004, THORAX, V59, P376, DOI 10.1136/thx.2003.010363; Hansell A, 1999, THORAX, V54, P413, DOI 10.1136/thx.54.5.413; Health and Social Care Information Centre, 2005, STAT B HLTH SOC CAR; *INF CTR HLTH SOC, 2007, QOF; Mancuso CA, 2000, J GEN INTERN MED, V15, P301, DOI 10.1046/j.1525-1497.2000.07006.x; Nascimento I, 2002, PSYCHIAT RES, V110, P73, DOI 10.1016/S0165-1781(02)00029-X; NAZARETH I, 1993, BRIT MED J, V307, P910, DOI 10.1136/bmj.307.6909.910; Ng TP, 2007, INT J GERIATR PSYCH, V22, P668, DOI 10.1002/gps.1728; Opolski Melissa, 2005, Clin Pract Epidemiol Ment Health, V1, P18, DOI 10.1186/1745-0179-1-18; Perry J, 1978, OXMIS PROBLEM CODES; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Rudisch B, 2003, BIOL PSYCHIAT, V54, P227, DOI 10.1016/S0006-3223(03)00587-0; Scott KM, 2007, J AFFECT DISORDERS, V103, P113, DOI 10.1016/j.jad.2007.01.015; Scott KM, 2007, GEN HOSP PSYCHIAT, V29, P123, DOI 10.1016/j.genhosppsych.2006.12.006; Strong Mark, 2006, Int J Health Geogr, V5, P29, DOI 10.1186/1476-072X-5-29; Tata LJ, 2007, AM J RESP CRIT CARE, V175, P991, DOI 10.1164/rccm.200611-1641OC; USTUN TB, 1995, MENTAL ILLNESS GEN H; Walters P, 2008, BRIT J PSYCHIAT, V193, P235, DOI 10.1192/bjp.bp.107.038299; Weich S, 1997, PSYCHOL MED, V27, P73, DOI 10.1017/S0033291796004023; Wyke Sally, 2003, Eur J Gen Pract, V9, P48	31	49	51	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20750	10.1371/journal.pone.0020750	http://dx.doi.org/10.1371/journal.pone.0020750			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778TS	21698276	Green Published, gold, Green Submitted			2022-12-25	WOS:000291730000022
J	Arias, A; Lame, MW; Santarelli, L; Hen, R; Greene, LA; Angelastro, JM				Arias, A.; Lame, M. W.; Santarelli, L.; Hen, R.; Greene, L. A.; Angelastro, J. M.			Regulated ATF5 loss-of-function in adult mice blocks formation and causes regression/eradication of gliomas	ONCOGENE			English	Article						ATF5; PDGF-B; tumorigenesis; glioma	GROWTH-FACTOR-B; TRANSCRIPTION FACTOR ATF5; NEURAL PROGENITOR CELLS; GLIAL PROGENITORS; BRAIN-TUMORS; STEM-CELLS; AUTOCRINE STIMULATION; GENE-EXPRESSION; DNA-BINDING; GLIOBLASTOMA	Glioblastomas are among the most incurable cancers. Our past findings indicated that glioblastoma cells, but not neurons or glia, require the transcription factor ATF5 (activating transcription factor 5) for survival. However, it was unknown whether interference with ATF5 function can prevent or promote regression/eradication of malignant gliomas in vivo. To address this issue, we created a mouse model by crossing a human glial fibrillary acidic protein (GFAP) promoter-tetracycline transactivator mouse line with tetracycline operon-dominant negative-ATF5 (d/n-ATF5) mice to establish bi-transgenic mice. In this model, d/n-ATF5 expression is controlled by doxycycline and the promoter for GFAP, a marker for stem/progenitor cells as well as gliomas. Endogenous gliomas were produced with high efficiency by retroviral delivery of platelet-derived growth factor (PDGF)-B and p53-short hairpin RNA (shRNA) in adult bi-transgenic mice in which expression of d/n-ATF5 was spatially and temporally regulated. Induction of d/n-ATF5 before delivery of PDGF-B/p53-shRNA virus greatly reduced the proportion of mice that formed tumors. Moreover, d/n-ATF5 induction after tumor formation led to regression/eradication of detectable gliomas without evident damage to normal brain cells in all 24 mice assessed. Oncogene (2012) 31, 739-751; doi:10.1038/onc.2011.276; published online 4 July 2011	[Arias, A.; Lame, M. W.; Angelastro, J. M.] Univ Calif Davis, Davis Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Santarelli, L.; Hen, R.] Columbia Univ, Dept Neurosci, New York, NY USA; [Greene, L. A.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA	University of California System; University of California Davis; Columbia University; Columbia University	Angelastro, JM (corresponding author), Univ Calif Davis, Davis Sch Vet Med, Dept Mol Biosci, 2165 Haring Hall,1 Shields Ave, Davis, CA 95616 USA.	jmangelastro@ucdavis.edu			NIH [NS-33689]; Alexander and Margaret Stewart Trust; NIH-NCI [F31 CA123711-01A1, R21CA126924]; UCD Cancer Center [5P30CA093373-06S1]; NATIONAL CANCER INSTITUTE [R21CA126924, P30CA093373, F31CA123711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033689] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander and Margaret Stewart Trust; NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UCD Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NIH Grant NS-33689 and an award from the Alexander and Margaret Stewart Trust (to LAG); NIH-NCI F31 CA123711-01A1 (to ADA); and in part support of the UCD Cancer Center Support Grant 5P30CA093373-06S1 (to JMA) and in full NIH-NCI R21CA126924 (to JMA). We thank Benjamin Pyles for his technical assistance in management of the mouse colony, genotyping, surgeries and anesthesia, as well as planning experimental end points. We thank Dr Stephen Noctor for the use of the Olympus FV-1000 confocal microscope and Fluoview software. We are indebted to Dr Robert Higgins (Neuropathologist, DVM/PhD) for assessment and evaluation of gliomas in mice with and without induced expression of d/n-ATF5.	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Angelastro JM, 2003, J NEUROSCI, V23, P4590; Angelastro JM, 2006, ONCOGENE, V25, P907, DOI 10.1038/sj.onc.1209116; Angelastro JM, 2005, J NEUROSCI, V25, P3889, DOI 10.1523/JNEUROSCI.3447-04.2005; Assanah MC, 2009, GLIA, V57, P1835, DOI 10.1002/glia.20895; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; Canoll P, 2008, ACTA NEUROPATHOL, V116, P465, DOI 10.1007/s00401-008-0432-9; Ciaccio NA, 2008, PROTEIN EXPRES PURIF, V62, P235, DOI 10.1016/j.pep.2008.07.011; Ciaccio NA, 2009, MOL PHARMACEUT, V6, P1205, DOI 10.1021/mp900058t; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Concannon CG, 2001, GENE EXPRESSION, V9, P195, DOI 10.3727/000000001783992605; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Dai CK, 2001, BBA-REV CANCER, V1551, pM19, DOI 10.1016/S0304-419X(01)00027-0; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Dluzen D, 2011, J BIOL CHEM, V286, P7705, DOI 10.1074/jbc.M110.207639; Dong SM, 2005, J NEUROPATH EXP NEUR, V64, P948, DOI 10.1097/01.jnen.0000186940.14779.90; Elstrand MB, 2009, INT J GYNECOL PATHOL, V28, P211, DOI 10.1097/PGP.0b013e31818b0f5e; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Garrido C, 2003, CELL CYCLE, V2, P579, DOI 10.4161/cc.2.6.521; Ghashghaei HT, 2007, GENE DEV, V21, P3258, DOI 10.1101/gad.1580407; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gossen Manfred, 1994, Current Opinion in Biotechnology, V5, P516, DOI 10.1016/0958-1669(94)90067-1; Greene LA, 2009, J NEUROCHEM, V108, P11, DOI 10.1111/j.1471-4159.2008.05749.x; Hede SM, 2009, GLIA, V57, P1143, DOI 10.1002/glia.20837; Hesselager G, 2003, CANCER RES, V63, P4305; Jackson EL, 2008, CELLS TISSUES ORGANS, V188, P212, DOI 10.1159/000114541; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; KRYLOV D, 1995, EMBO J, V14, P5329, DOI 10.1002/j.1460-2075.1995.tb00217.x; Li GF, 2009, MOL CANCER RES, V7, P933, DOI 10.1158/1541-7786.MCR-08-0365; Mason JL, 2005, MOL CELL NEUROSCI, V29, P372, DOI 10.1016/j.mcn.2005.03.004; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Moll JR, 2000, J BIOL CHEM, V275, P34826, DOI 10.1074/jbc.M004545200; Monaco SE, 2007, INT J CANCER, V120, P1883, DOI 10.1002/ijc.22469; Mu YL, 2010, CURR OPIN NEUROBIOL, V20, P416, DOI 10.1016/j.conb.2010.04.010; Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.neu.0000316019.28421.95; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Persengiev SP, 2002, GENE DEV, V16, P1806, DOI 10.1101/gad.992202; Riquelme PA, 2008, PHILOS T R SOC B, V363, P123, DOI 10.1098/rstb.2006.2016; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schrot RJ, 2007, J NEURO-ONCOL, V85, P149, DOI 10.1007/s11060-007-9401-8; Sheng Z, 2010, NAT MED, V16, P671, DOI 10.1038/nm.2158; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Singh SK, 2003, CANCER RES, V63, P5821; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sweger EJ, 2007, J NEUROSCI, V27, P2309, DOI 10.1523/JNEUROSCI.4565-06.2007; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Uhrbom L, 1998, CANCER RES, V58, P5275; Uhrbom L, 2000, INT J CANCER, V85, P398, DOI 10.1002/(SICI)1097-0215(20000201)85:3<398::AID-IJC17>3.0.CO;2-L; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; VINSON CR, 1993, GENE DEV, V7, P1047, DOI 10.1101/gad.7.6.1047; Wang H, 2007, CELL BIOL INT, V31, P1309, DOI 10.1016/j.cellbi.2007.05.002; Wang Z, 2010, BBA-REV CANCER, V1806, P122, DOI 10.1016/j.bbcan.2010.04.003; Wei YY, 2010, J BIOCHEM, V148, P171, DOI 10.1093/jb/mvq047	54	27	29	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2012	31	6					739	751		10.1038/onc.2011.276	http://dx.doi.org/10.1038/onc.2011.276			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MU	21725368	hybrid, Green Published			2022-12-25	WOS:000300222100007
J	Sarkis, J; Hubert, JF; Legrand, B; Robert, E; Cheron, A; Jardin, J; Hitti, E; Le Rumeur, E; Vie, V				Sarkis, Joe; Hubert, Jean-Francois; Legrand, Baptiste; Robert, Estelle; Cheron, Angelique; Jardin, Julien; Hitti, Eric; Le Rumeur, Elisabeth; Vie, Veronique			Spectrin-like Repeats 11-15 of Human Dystrophin Show Adaptations to a Lipidic Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; AIR-WATER-INTERFACE; ROD DOMAIN; PROTEIN STRUCTURES; STABILITY PROPERTIES; IR SPECTROSCOPY; SKELETAL-MUSCLE; ATOMIC-FORCE; MONOLAYERS; MEMBRANE	Dystrophin is essential to skeletal muscle function and confers resistance to the sarcolemma by interacting with cytoskeleton and membrane. In the present work, we characterized the behavior of dystrophin 11-15 (DYS R11-15), five spectrin-like repeats from the central domain of human dystrophin, with lipids. DYSR11-15 displays an amphiphilic character at the liquid/air interface while maintaining its secondary alpha-helical structure. The interaction of DYS R11-15 with small unilamellar vesicles (SUVs) depends on the lipid nature, which is not the case with large unilamellar vesicles (LUVs). In addition, switching from anionic SUVs to anionic LUVs suggests the lipid packing as a crucial factor for the interaction of protein and lipid. The monolayer model and the modulation of surface pressure aim to mimic the muscle at work (i.e. dynamic changes of muscle membrane during contraction and relaxation) (high and low surface pressure). Strikingly, the lateral pressure modifies the protein organization. Increasing the lateral pressure leads the proteins to be organized in a regular network. Nevertheless, a different protein conformation after its binding to monolayer is revealed by trypsin proteolysis. Label-free quantification by nano-LC/MS/MS allowed identification of the helices in repeats 12 and 13 involved in the interaction with anionic SUVs. These results, combined with our previous studies, indicate that DYS R11-15 constitutes the only part of dystrophin that interacts with anionic as well as zwitterionic lipids and adapts its interaction and organization depending on lipid packing and lipid nature. We provide strong experimental evidence for a physiological role of the central domain of dystrophin in sarcolemma scaffolding through modulation of lipid-protein interactions.	[Vie, Veronique] Univ Rennes 1, CNRS, Inst Phys Rennes, UMR 6251, F-35042 Rennes, France; [Sarkis, Joe; Hubert, Jean-Francois; Legrand, Baptiste; Robert, Estelle; Cheron, Angelique; Jardin, Julien; Hitti, Eric; Le Rumeur, Elisabeth; Vie, Veronique] Univ Europeenne Bretagne, F-35000 Rennes, France; [Sarkis, Joe; Hubert, Jean-Francois; Legrand, Baptiste; Cheron, Angelique; Le Rumeur, Elisabeth] CNRS, Equipe RMN Interact Lipides Prot, Fac Med, UMR 6026,IFR 140,CS 34317, F-35043 Rennes, France; [Jardin, Julien] INRA, AGROCAMPUS OUEST, UMR Sci & Technol Lait & Oeuf 1253, F-35042 Rennes, France; [Hitti, Eric] INSERM 642, LTSI, F-35042 Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Rennes; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); INRAE; Institut Agro; Agrocampus Ouest; Institut National de la Sante et de la Recherche Medicale (Inserm)	Vie, V (corresponding author), Univ Rennes 1, CNRS, Inst Phys Rennes, UMR 6251, 263 Av Gen Leclerc,Bat 11A, F-35042 Rennes, France.	veronique.vie@univ-rennes1.fr	HITTI, Eric/ABC-7717-2020; Legrand, Baptiste/ABB-2552-2021; JARDIN, Julien/A-3241-2012	JARDIN, Julien/0000-0003-0520-9391; Legrand, Baptiste/0000-0001-8931-7757; Sarkis, Joe/0000-0002-9342-7198	Association Francaise contre les Myopathies; RTR-BRESMAT (Universite Europeenne de Bretagne)	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); RTR-BRESMAT (Universite Europeenne de Bretagne)	This work was supported by the "Association Francaise contre les Myopathies" and by RTR-BRESMAT (Universite Europeenne de Bretagne).	Amann KJ, 1998, J BIOL CHEM, V273, P28419, DOI 10.1074/jbc.273.43.28419; Azzam R. M. A., 1977, ELLIPSOMETRY POLARIZ, P340; Baker RD, 2001, LIFETIME DATA ANAL, V7, P65, DOI 10.1023/A:1009677227030; BERGE B, 1993, EUROPHYS LETT, V21, P773, DOI 10.1209/0295-5075/21/7/010; BLAUDEZ D, 1993, APPL SPECTROSC, V47, P869, DOI 10.1366/0003702934415273; Blaudez D, 1996, J CHEM SOC FARADAY T, V92, P525, DOI 10.1039/ft9969200525; Bottier C, 2008, LANGMUIR, V24, P10901, DOI 10.1021/la800697s; Boutrou R, 2008, J AGR FOOD CHEM, V56, P8166, DOI 10.1021/jf801140d; Brockman H, 1999, CURR OPIN STRUC BIOL, V9, P438, DOI 10.1016/S0959-440X(99)80061-X; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; CHI LF, 1993, SCIENCE, V259, P213, DOI 10.1126/science.259.5092.213; Chieze L, 2011, J MOL BIOL, V410, P60, DOI 10.1016/j.jmb.2011.04.006; Davis L, 2009, J BIOL CHEM, V284, P6982, DOI 10.1074/jbc.M809245200; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; DEMEL RA, 1987, BIOCHEMISTRY-US, V26, P8659, DOI 10.1021/bi00400a025; DeWolf C, 1997, BIOPHYS J, V72, P2599, DOI 10.1016/S0006-3495(97)78903-3; ERVASTI JM, 1991, J BIOL CHEM, V266, P9161; FIEHN W, 1971, J BIOL CHEM, V246, P5617; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; ISRAELACHVILI JN, 1977, BIOCHIM BIOPHYS ACTA, V470, P185, DOI 10.1016/0005-2736(77)90099-2; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Kearney P, 2003, J Bioinform Comput Biol, V1, P183, DOI 10.1142/S021972000300023X; KOENIG M, 1990, J BIOL CHEM, V265, P4560; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Krieger CC, 2010, CYTOSKELETON, V67, P796, DOI 10.1002/cm.20489; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Kusunoki H, 2004, STRUCTURE, V12, P645, DOI 10.1016/j.str.2004.02.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larios C, 2006, J PHYS CHEM B, V110, P23292, DOI 10.1021/jp0628582; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lavoie H, 2002, BIOPHYS J, V83, P3558, DOI 10.1016/S0006-3495(02)75356-3; Le Rumeur E, 2003, J BIOL CHEM, V278, P5993, DOI 10.1074/jbc.M207321200; Le Rumeur E, 2010, BBA-PROTEINS PROTEOM, V1804, P1713, DOI 10.1016/j.bbapap.2010.05.001; Legardinier S, 2008, BBA-PROTEINS PROTEOM, V1784, P672, DOI 10.1016/j.bbapap.2007.12.014; Legardinier S, 2009, J BIOL CHEM, V284, P8822, DOI 10.1074/jbc.M805846200; Legardinier S, 2009, J MOL BIOL, V389, P546, DOI 10.1016/j.jmb.2009.04.025; Liu MJ, 2005, MOL THER, V11, P245, DOI 10.1016/j.ymthe.2004.09.013; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Manno S, 2002, P NATL ACAD SCI USA, V99, P1943, DOI 10.1073/pnas.042688399; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MIKRUT JM, 1993, PHYS REV B, V48, P14479, DOI 10.1103/PhysRevB.48.14479; PEREZ JA, 1995, ANAL CHIM ACTA, V303, P65, DOI 10.1016/0003-2670(94)00570-C; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; PONS F, 1990, P NATL ACAD SCI USA, V87, P7851, DOI 10.1073/pnas.87.20.7851; Prins KW, 2009, J CELL BIOL, V186, P363, DOI 10.1083/jcb.200905048; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; SIPPL MJ, 1993, J COMPUT AID MOL DES, V7, P473, DOI 10.1007/BF02337562; Sospedra P, 1999, LANGMUIR, V15, P5111, DOI 10.1021/la981305i; Vie V, 2010, BBA-BIOMEMBRANES, V1798, P1503, DOI 10.1016/j.bbamem.2010.04.005; Vie V, 2001, J MEMBRANE BIOL, V180, P195, DOI 10.1007/s002320010070; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WINDER SJ, 1995, FEBS LETT, V369, P27, DOI 10.1016/0014-5793(95)00398-S	57	25	25	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30481	30491		10.1074/jbc.M111.243881	http://dx.doi.org/10.1074/jbc.M111.243881			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21712383	Green Published, hybrid			2022-12-25	WOS:000294283600027
J	Zeth, K; Pechlivanis, M; Samol, A; Pleiser, S; Vonrhein, C; Kerkhoff, E				Zeth, Kornelius; Pechlivanis, Markos; Samol, Annette; Pleiser, Sandra; Vonrhein, Clemens; Kerkhoff, Eugen			Molecular Basis of Actin Nucleation Factor Cooperativity CRYSTAL STRUCTURE OF THE SPIR-1 KINASE NON-CATALYTIC C-LOBE DOMAIN (KIND).FORMIN-2 FORMIN SPIR INTERACTION MOTIF (FSI) COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; VERY-KIND; DENDRITE GROWTH; EXCHANGE FACTOR; MICROTUBULE; CAPPUCCINO; ACTIVATION; SUBUNIT; GTPASES; OOCYTE	The distinct actin nucleation factors of the Spir and formin subgroup families cooperate in actin nucleation. The Spir/formin cooperativity has been identified to direct two essential steps in mammalian oocyte maturation, the asymmetric spindle positioning and polar body extrusion during meiosis. Understanding the nature and regulation of the Spir/Fmn cooperation is an important requirement to comprehend mammalian reproduction. Recently we dissected the structural elements of the Spir and Fmn family proteins, which physically link the two actin nucleation factors. The trans-regulatory interaction is mediated by the Spir kinase non-catalytic C-lobe domain (KIND) and the C-terminal formin Spir interaction motif (FSI). The interaction inhibits formin nucleation activity and enhances the Spir activity. To get insights into the molecular mechanism of the Spir/Fmn interaction, we determined the crystal structure of the KIND domain alone and in complex with the C-terminal Fmn-2 FSI peptide. Together they confirm the proposed structural homology of the KIND domain to the protein kinase fold and reveal the basis of the Spir/formin interaction. The complex structure showed a large interface with conserved and positively charged residues of the Fmn FSI peptide mediating major contacts to an acidic groove on the surface of KIND. Protein interaction studies verified the electrostatic nature of the interaction. The data presented here provide the molecular basis of the Spir/formin interaction and give a first structural view into the mechanisms of actin nucleation factor cooperativity.	[Pechlivanis, Markos; Samol, Annette; Pleiser, Sandra; Kerkhoff, Eugen] Univ Hosp Regensburg, Dept Neurol, Mol Cell Biol Lab, Bavarian Genome Res Network BayGene, D-93053 Regensburg, Germany; [Vonrhein, Clemens] Global Phasing Ltd, Cambridge CB3 0AX, England; [Zeth, Kornelius] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany	University of Regensburg; Global Phasing Limited; Max Planck Society	Kerkhoff, E (corresponding author), Univ Hosp Regensburg, Dept Neurol, Mol Cell Biol Lab, Bavarian Genome Res Network BayGene, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.	eugen.kerkhoff@klinik.uni-regensburg.de			Bavarian Genome Research Network (BayGene); German Research Foundation (DFG) [SPP 1135, SPP 1464]; Max Planck Society	Bavarian Genome Research Network (BayGene); German Research Foundation (DFG)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	This work was supported by the Bavarian Genome Research Network (BayGene) and the German Research Foundation (DFG SPP 1135, SPP 1464) (to E.K.) and DFG SPP 1464 and the Max Planck Society (to K.Z.).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Ciccarelli FD, 2003, TRENDS BIOCHEM SCI, V28, P349, DOI 10.1016/S0968-0004(03)00116-6; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; Dominguez R, 2010, CURR OPIN STRUC BIOL, V20, P217, DOI 10.1016/j.sbi.2009.12.012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erdmann KS, 2003, EUR J BIOCHEM, V270, P4789, DOI 10.1046/j.1432-1033.2003.03895.x; Huang J, 2007, J CELL BIOL, V179, P539, DOI 10.1083/jcb.200702036; Huang JH, 2011, FEBS J, V278, P1651, DOI 10.1111/j.1742-4658.2011.08085.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Keegan RM, 2011, ACTA CRYSTALLOGR D, V67, P313, DOI 10.1107/S0907444911007530; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; MANSEAU LJ, 1989, GENE DEV, V3, P1437, DOI 10.1101/gad.3.9.1437; Mees A, 2005, GENE EXPR PATTERNS, V6, P79, DOI 10.1016/j.modgep.2005.04.015; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Pechlivanis M, 2009, J BIOL CHEM, V284, P25324, DOI 10.1074/jbc.M109.030320; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Qualmann B, 2009, TRENDS CELL BIOL, V19, P276, DOI 10.1016/j.tcb.2009.03.004; Quinlan ME, 2008, NAT CELL BIOL, V10, P13, DOI 10.1038/ncb0108-13; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Rosales-Nieves AE, 2006, NAT CELL BIOL, V8, P367, DOI 10.1038/ncb1385; Stenzel N, 2009, J CELL SCI, V122, P3374, DOI 10.1242/jcs.046854; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wellington A, 1999, DEVELOPMENT, V126, P5267; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005; Zhou TJ, 2004, STRUCTURE, V12, P1891, DOI 10.1016/j.str.2004.07.021	32	24	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30732	30739		10.1074/jbc.M111.257782	http://dx.doi.org/10.1074/jbc.M111.257782			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21705804	Green Published, hybrid			2022-12-25	WOS:000294283600053
J	Das, S; Kelschenbach, J; Charboneau, R; Barke, RA; Roy, S				Das, Subhas; Kelschenbach, Jennifer; Charboneau, Richard; Barke, Roderick A.; Roy, Sabita			Morphine Withdrawal Stress Modulates Lipopolysaccharide-induced Interleukin 12 p40 (IL-12p40) Expression by Activating Extracellular Signal-regulated Kinase 1/2, Which Is Further Potentiated by Glucocorticoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NALOXONE-PRECIPITATED WITHDRAWAL; MESSENGER-RNA EXPRESSION; HUMAN MONOCYTIC CELLS; DEPENDENT RATS; TRANSCRIPTION FACTORS; CYTOKINE PATTERNS; IMMUNE FUNCTION; NEURAL SYSTEM; NITRIC-OXIDE; MICE	Withdrawal stress is a common occurrence in opioid users, yet very few studies have examined the effects of morphine withdrawal (MW) on immune functioning or the role of glucocorticoids in MW-induced immunomodulation. This study investigated for the first time the role of glucocorticoids in MW modulation of LPS-induced IL-12p40, a key cytokine playing a pivotal role in immunoprotection. Using WT and mu-opioid receptor knock-out mice, we show that MW in vivo significantly attenuated LPS-induced IL-12p40 mRNA and protein expression. The role of glucocorticoids in MW modulation of IL-12p40 was investigated using a murine macrophage cell line, CRL2019, in an in vitro MW model. Interestingly, MW alone in the absence of glucocorticoids resulted in a significant reduction in IL-12p40 promoter activity and mRNA and protein expression. EMSA revealed a concurrent decrease in consensus binding to transcription factors NF kappa B, Activator Protein-1, and CCAAT/enhancer-binding protein and Western blot analysis demonstrated a significant activation of LPS-induced ERK1/2 phosphorylation. Interestingly, although glucocorticoid treatment alone also modulated these transcription factors and ERK1/2 activation, the addition of glucocorticoids to MW samples resulted in a greater than additive reduction in the transcription factors and significant hyperactivation of LPS-induced ERK1/2 phosphorylation. ERK inhibitors reversed MW and MW plus corticosterone inhibition of LPS-induced IL-12p40. The potentiating effects of glucocorticoids were non-genomic because nuclear translocation of glucocorticoid receptor was not significantly different between MW and corticosterone treatment. This study demonstrates for the first time that MW and glucocorticoids independently modulate IL-12p40 production through a mechanism involving ERK1/2 hyperactivation and that glucocorticoids can significantly augment MW-induced inhibition of IL-12p40.	[Das, Subhas; Barke, Roderick A.; Roy, Sabita] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Kelschenbach, Jennifer; Roy, Sabita] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Charboneau, Richard; Barke, Roderick A.] Vet Affairs Med Ctr, Minneapolis, MN 55417 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Roy, S (corresponding author), Mayo Mail Code 195,420 Delaware St SE, Minneapolis, MN 55455 USA.	royxx002@umn.edu	Das, Subhas/AAA-4568-2022		National Institutes of Health [RO1 DA 12104, RO1 DA 022935, KO2 DA 015349, P50 DA11806]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022935, R01DA031202, T32DA007097, P50DA011806, K02DA015349, R01DA012104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DA 12104, RO1 DA 022935, KO2 DA 015349, and P50 DA11806 (to S. R.).	BHARGAVA HN, 1994, BRAIN RES, V642, P1, DOI 10.1016/0006-8993(94)90899-0; Boucher JG, 2010, VIRAL IMMUNOL, V23, P17, DOI 10.1089/vim.2009.0054; BRYANT HU, 1988, BIOCHEM PHARMACOL, V37, P3777, DOI 10.1016/0006-2952(88)90415-7; BRYANT HU, 1988, PSYCHOSOM MED, V50, P576, DOI 10.1097/00006842-198811000-00003; Cao JL, 2005, PAIN, V118, P336, DOI 10.1016/j.pain.2005.09.006; Cao JL, 2006, NEUROPHARMACOLOGY, V51, P315, DOI 10.1016/j.neuropharm.2006.03.028; Cardinaux JR, 2000, GLIA, V29, P91, DOI 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.0.CO;2-I; Casar B, 2009, CELL CYCLE, V8, P1007, DOI 10.4161/cc.8.7.8078; Casar B, 2009, MOL CELL BIOL, V29, P1338, DOI 10.1128/MCB.01359-08; Cleck JN, 2008, J CLIN INVEST, V118, P454, DOI 10.1172/JCI33946; Eisenstein TK, 2006, J NEUROIMMUNE PHARM, V1, P237, DOI 10.1007/s11481-006-9019-1; Feng P, 2005, INFECT IMMUN, V73, P7953, DOI 10.1128/IAI.73.12.7953-7959.2005; Feng P, 2005, J NEUROIMMUNOL, V164, P57, DOI 10.1016/j.jneuroim.2005.03.017; Haller J, 2008, FRONT NEUROENDOCRIN, V29, P273, DOI 10.1016/j.yfrne.2007.10.004; Kelschenbach J, 2005, J IMMUNOL, V175, P2655, DOI 10.4049/jimmunol.175.4.2655; KISHIOKA S, 1994, JPN J PHARMACOL, V66, P257, DOI 10.1254/jjp.66.257; Laorden ML, 2002, BRIT J PHARMACOL, V136, P67, DOI 10.1038/sj.bjp.0704684; Ma W, 2004, J IMMUNOL, V172, P318, DOI 10.4049/jimmunol.172.1.318; Ma W, 2007, J BIOL CHEM, V282, P13351, DOI 10.1074/jbc.M611522200; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Makara GB, 2001, PROG NEUROBIOL, V65, P367, DOI 10.1016/S0301-0082(01)00012-0; Milanes MV, 2002, NEUROSCI LETT, V334, P58, DOI 10.1016/S0304-3940(02)01036-4; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Nunez C, 2009, ENDOCRINOLOGY, V150, P3118, DOI 10.1210/en.2008-1732; PIRMEZ C, 1993, J CLIN INVEST, V91, P1390, DOI 10.1172/JCI116341; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; Rahim RT, 2005, J LEUKOCYTE BIOL, V78, P1185, DOI 10.1189/jlb.0304123; Rahim RT, 2004, J NEUROIMMUNOL, V147, P114, DOI 10.1016/j.jneuroim.2003.10.024; Rahim RT, 2003, J NEUROIMMUNOL, V144, P16, DOI 10.1016/S0165-5728(03)00273-X; Rahim TR, 2002, J NEUROIMMUNOL, V127, P88, DOI 10.1016/S0165-5728(02)00103-0; Roy S, 2001, J NEUROIMMUNOL, V116, P147, DOI 10.1016/S0165-5728(01)00299-5; Roy S, 2006, J NEUROIMMUNE PHARM, V1, P77, DOI 10.1007/s11481-005-9009-8; Sacerdote Paola, 2008, Curr Opin Support Palliat Care, V2, P14, DOI 10.1097/SPC.0b013e3282f5272e; Seder RA, 1996, J IMMUNOL, V157, P2745; SIELING PA, 1994, IMMUNOBIOLOGY, V191, P378, DOI 10.1016/S0171-2985(11)80443-2; Stewart J, 2003, AM J ADDICTION, V12, P1, DOI 10.1080/10550490390143330; Tengku-Muhammad TS, 2000, CYTOKINE, V12, P1430, DOI 10.1006/cyto.2000.0711; WAY EL, 1968, SCIENCE, V162, P1290, DOI 10.1126/science.162.3859.1290; Yang EV, 2002, INT IMMUNOPHARMACOL, V2, P315, DOI 10.1016/S1567-5769(01)00182-5; ZHANG M, 1994, J CLIN INVEST, V93, P1733, DOI 10.1172/JCI117157; Zhang Y, 2010, J IMMUNOL, V184, P3866, DOI 10.4049/jimmunol.0903417; Zhu C, 2001, J BIOL CHEM, V276, P18519, DOI 10.1074/jbc.M100440200	42	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29806	29817		10.1074/jbc.M111.271460	http://dx.doi.org/10.1074/jbc.M111.271460			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21730055	hybrid, Green Published			2022-12-25	WOS:000294046600040
J	Bermudez, VP; Farina, A; Raghavan, V; Tappin, I; Hurwitz, J				Bermudez, Vladimir P.; Farina, Andrea; Raghavan, Vineetha; Tappin, Inger; Hurwitz, Jerard			Studies on Human DNA Polymerase epsilon and GINS Complex and Their Role in DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROTHMUND-THOMSON-SYNDROME; XENOPUS EGG EXTRACTS; SACCHAROMYCES-CEREVISIAE; S-PHASE; CATALYTIC DOMAINS; CRYSTAL-STRUCTURE; DISTINCT ROLES; ALPHA-PRIMASE; BUDDING YEAST; POL EPSILON	In eukaryotic cells, DNA replication is carried out by the coordinated action of three DNA polymerases (Pols), Pol alpha, delta, and epsilon. In this report, we describe the reconstitution of the human four-subunit Pol epsilon and characterization of its catalytic properties in comparison with Pol alpha and Pol delta. Human Pol epsilon holoenzyme is a monomeric complex containing stoichiometric subunit levels of p261/Pol 2, p59, p17, and p12. We show that the Pol epsilon p261 N-terminal catalytic domain is solely responsible for its ability to catalyze DNA synthesis. Importantly, human Pol (hPol) epsilon was found more processive than hPol delta in supporting proliferating cell nuclear antigen-dependent elongation of DNA chains, which is in keeping with proposed roles for hPol epsilon and hPol delta in the replication of leading and lagging strands, respectively. Furthermore, GINS, a component of the replicative helicase complex that is composed of Sld5, Psf1, Psf2, and Psf3, was shown to interact weakly with all three replicative DNA Pols (alpha, delta, and epsilon) and to markedly stimulate the activities of Pol alpha and Pol epsilon. In vivo studies indicated that siRNA-targeted depletion of hPol delta and/or hPol epsilon reduced cell cycle progression and the rate of fork progression. Under the conditions used, we noted that depletion of Pol epsilon had a more pronounced inhibitory effect on cellular DNA replication than depletion of Pol delta. We suggest that reduction in the level of Pol delta may be less deleterious because of its collision-and-release role in lagging strand synthesis.	[Bermudez, Vladimir P.; Farina, Andrea; Raghavan, Vineetha; Tappin, Inger; Hurwitz, Jerard] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Hurwitz, J (corresponding author), 1275 York Ave, New York, NY 10021 USA.	j-hurwitz@ski.mskcc.org						Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; ARAKI H, 1991, NUCLEIC ACIDS RES, V19, P4867, DOI 10.1093/nar/19.18.4867; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Asturias FJ, 2006, NAT STRUCT MOL BIOL, V13, P35, DOI 10.1038/nsmb1040; Baker T. A., 2005, DNA REPLICATION; Bermudez VP, 2010, J BIOL CHEM, V285, P9493, DOI 10.1074/jbc.M109.093609; Bermudez VP, 2002, J BIOL CHEM, V277, P36853, DOI 10.1074/jbc.M202897200; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Chang YP, 2007, P NATL ACAD SCI USA, V104, P12685, DOI 10.1073/pnas.0705558104; Chilkova O, 2003, J BIOL CHEM, V278, P14082, DOI 10.1074/jbc.M211818200; Choi JM, 2007, GENE DEV, V21, P1316, DOI 10.1101/gad.1548107; De Falco M, 2007, EMBO REP, V8, P99, DOI 10.1038/sj.embor.7400870; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; Errico A, 2010, EMBO REP, V11, P270, DOI 10.1038/embor.2010.27; Feng WY, 2001, MOL CELL BIOL, V21, P4495, DOI 10.1128/MCB.21.14.4495-4504.2001; Fien K, 2004, J BIOL CHEM, V279, P16144, DOI 10.1074/jbc.M400142200; Fukui T, 2004, GENES CELLS, V9, P179, DOI 10.1111/j.1356-9597.2004.00716.x; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Iida T, 2004, MOL CELL BIOL, V24, P217, DOI 10.1128/MCB.24.1.217-227.2004; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Johansson E, 2001, J BIOL CHEM, V276, P43824, DOI 10.1074/jbc.M108842200; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Kamada K, 2007, NAT STRUCT MOL BIOL, V14, P388, DOI 10.1038/nsmb1231; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kang HY, 2000, GENETICS, V155, P1055; Kesti T, 1999, MOL CELL, V3, P679, DOI 10.1016/S1097-2765(00)80361-5; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Langston LD, 2008, J BIOL CHEM, V283, P29522, DOI 10.1074/jbc.M804488200; Lee JK, 2003, P NATL ACAD SCI USA, V100, P2334, DOI 10.1073/pnas.0237384100; Li Y, 1997, J BIOL CHEM, V272, P32337, DOI 10.1074/jbc.272.51.32337; Li Y, 2000, J BIOL CHEM, V275, P23247, DOI 10.1074/jbc.M002548200; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Marinsek N, 2006, EMBO REP, V7, P539, DOI 10.1038/sj.embor.7400649; Masuda Y, 2007, NUCLEIC ACIDS RES, V35, P6904, DOI 10.1093/nar/gkm822; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Ohya T, 2000, NUCLEIC ACIDS RES, V28, P3846, DOI 10.1093/nar/28.20.3846; PODUST VN, 1995, BIOCHEMISTRY-US, V34, P5003, DOI 10.1021/bi00015a011; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Sawyer SL, 2004, J MOL BIOL, V340, P195, DOI 10.1016/j.jmb.2004.04.066; Shikata Koh, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-21; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Waga S, 2001, P NATL ACAD SCI USA, V98, P4978, DOI 10.1073/pnas.081088798; Wang JF, 2010, BIOCHEM BIOPH RES CO, V395, P336, DOI 10.1016/j.bbrc.2010.04.006; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Wu JH, 2008, DEV BIOL, V323, P130, DOI 10.1016/j.ydbio.2008.08.006; Xie B, 2002, BIOCHEMISTRY-US, V41, P13133, DOI 10.1021/bi0262707; Yoshimochi T, 2008, J BIOL CHEM, V283, P1601, DOI 10.1074/jbc.M707654200; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607; Zuo SJ, 2000, J BIOL CHEM, V275, P5153, DOI 10.1074/jbc.275.7.5153	58	64	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28963	28977		10.1074/jbc.M111.256289	http://dx.doi.org/10.1074/jbc.M111.256289			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705323	Green Published, hybrid			2022-12-25	WOS:000293837000033
J	Chutkow, WA; Lee, RT				Chutkow, William A.; Lee, Richard T.			Thioredoxin Regulates Adipogenesis through Thioredoxin-interacting Protein (Txnip) Protein Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; BETA-ARRESTINS; DEFICIENCY; MICE; METABOLISM; ACTIVATION; DISULFIDE; DELETION; LIGASE	Txnip (thioredoxin-interacting protein) is a critical mediator of metabolism and adipogenesis in vivo. The mechanisms of action of Txnip are believed to operate at least in part by inhibiting the redox signaling functions of thioredoxin. We tested here whether Txnip suppressed adipogenesis by inhibiting thioredoxin and discovered a reversal of roles; Txnip inhibits adipogenesis directly, and thioredoxin binding regulates Txnip by enhancing Txnip protein stability. Unlike Txnip, a Txnip mutant that cannot bind thioredoxin (C247S) did not prevent adipocyte differentiation, but was degraded more quickly by proteasomal targeting. Finding that endogenous Txnip protein is also rapidly degraded at the onset of adipogenesis suggested that Txnip degradation is required for adipocyte differentiation. Thioredoxin overexpression stabilized Txnip protein levels to inhibit adipogenesis, and adipogenic stimulants such as insulin promoted Txnip-thioredoxin dissociation to the more labile free Txnip state. As an alpha-arrestin protein, Txnip has two C-terminal tail PPXY motifs that mediate E3 ubiquitin ligase binding and Txnip protein stability. Mutating the PPXY motifs prevented Txnip degradation, even when thioredoxin binding was lost, and restored the ability of C247S Txnip to inhibit adipogenesis. These studies present a novel reconsideration of Txnip-thioredoxin signaling by showing that thioredoxin regulates the intrinsic function of Txnip as an inhibitor of adipogenesis through protein stabilization.	[Chutkow, William A.; Lee, Richard T.] Brigham & Womens Hosp, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Chutkow, William A.; Lee, Richard T.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Chutkow, William A.] Vet Healthcare Syst, W Roxbury, MA 02132 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Chutkow, WA (corresponding author), 65 Landsdowne St,Rm 280, Cambridge, MA 02139 USA.	wchutkow@partners.org		Lee, Richard/0000-0003-4687-1381	National Institutes of Health [K08 HL088977, R01 HL048743, R01 HL103582]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743, R01HL103582, K08HL088977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 HL088977 (to W. A. C.) and R01 HL048743 and R01 HL103582 (to R. T. L.).	Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Blouet C, 2011, J NEUROSCI, V31, P6019, DOI 10.1523/JNEUROSCI.6498-10.2011; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chutkow WA, 2008, J BIOL CHEM, V283, P2397, DOI 10.1074/jbc.M708169200; Chutkow WA, 2010, DIABETES, V59, P1424, DOI 10.2337/db09-1212; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Hui TY, 2004, J BIOL CHEM, V279, P24387, DOI 10.1074/jbc.M401280200; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kim JR, 2006, EXP MOL MED, V38, P162, DOI 10.1038/emm.2006.20; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; Moon DO, 2007, INT IMMUNOPHARMACOL, V7, P222, DOI 10.1016/j.intimp.2006.10.001; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Reider A, 2011, J CELL SCI, V124, P1613, DOI 10.1242/jcs.073395; Shao WJ, 2010, CELL SIGNAL, V22, P1240, DOI 10.1016/j.cellsig.2010.04.001; Sheth SS, 2005, J LIPID RES, V46, P123, DOI 10.1194/jlr.M400341-JLR200; Yamanaka H, 2000, BIOCHEM BIOPH RES CO, V271, P796, DOI 10.1006/bbrc.2000.2699; Yoshioka J, 2007, CIRC RES, V101, P1328, DOI 10.1161/CIRCRESAHA.106.160515; Zhang PZ, 2010, J BIOL CHEM, V285, P8869, DOI 10.1074/jbc.M109.063321; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	30	42	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29139	29145		10.1074/jbc.M111.267666	http://dx.doi.org/10.1074/jbc.M111.267666			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705327	hybrid, Green Published			2022-12-25	WOS:000293837000050
J	Volonte, D; Galbiati, F				Volonte, Daniela; Galbiati, Ferruccio			Polymerase I and Transcript Release Factor (PTRF)/Cavin-1 Is a Novel Regulator of Stress-induced Premature Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR SENESCENCE; CAVEOLAE; FIBROBLASTS; P53; COMPLEXES; PROTEINS; CULTURE; BIOLOGY; GENES; PTRF	According to the "free radical theory" of aging, premature senescence induced by oxidative stress contributes to organismal aging. Polymerase I and transcript release factor (PTRF)/cavin-1 is a structural protein component of caveolae, invaginations of the plasma membrane involved in signal transduction. We show that oxidative stress up-regulates PTRF/cavin-1 protein expression and promotes the interaction between PTRF/cavin-1 and caveolin-1, another structural protein component of caveolae. Consistent with these data, the number of caveolae is dramatically increased in cells subjected to oxidative stress. We demonstrate that down-regulation of PTRF/cavin-1 by shRNA significantly inhibits oxidative stress-induced premature senescence. Mechanistically, we found that PTRF/cavin-1 expression is necessary for the oxidant-induced sequestration of Mdm2, a negative regulator of p53, into caveolar membranes, away from p53, and activation of the p53/p21(Waf1/Cip1) pathway. Expression of a mutant form of PTRF/cavin-1, which fails to localize to caveolar membranes after oxidative stress, inhibits oxidative stress-induced activation of p53 and induction of premature senescence. Thus, PTRF/cavin-1 is a novel regulator of oxidative stress-induced premature senescence by acting as a link between free radicals and activation of the p53/p21(Waf1/Cip1) pathway.	[Volonte, Daniela; Galbiati, Ferruccio] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Galbiati, F (corresponding author), 200 Lothrop St, Pittsburgh, PA 15261 USA.	feg5@pitt.edu	Galbiati, Ferruccio/AAF-3527-2020		National Institutes of Health through the NIA [R01-AG022548, R01-AG030636]; UPMC Health System; NATIONAL INSTITUTE ON AGING [R01AG022548, R01AG030636] Funding Source: NIH RePORTER	National Institutes of Health through the NIA; UPMC Health System; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AG022548 and R01-AG030636 (to F. G.) through the NIA and the Competitive Medical Research Fund of the UPMC Health System (to D.V.).	Bartholomew JN, 2009, CANCER RES, V69, P2878, DOI 10.1158/0008-5472.CAN-08-2857; Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Dasari A, 2006, CANCER RES, V66, P10805, DOI 10.1158/0008-5472.CAN-06-1236; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Jin SK, 2001, J CELL SCI, V114, P4139; Kishi S, 2004, ANN NY ACAD SCI, V1019, P521, DOI 10.1196/annals.1297.097; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Mason SW, 1997, EMBO J, V16, P163, DOI 10.1093/emboj/16.1.163; Matveev S, 2001, ADV DRUG DELIVER REV, V49, P237, DOI 10.1016/S0169-409X(01)00138-7; Muller KC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-32; Nyunoya T, 2006, AM J RESP CELL MOL, V35, P681, DOI 10.1165/rcmb.2006-0169OC; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Park WY, 2000, J BIOL CHEM, V275, P20847, DOI 10.1074/jbc.M908162199; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; SCHNITZER JE, 1995, J BIOL CHEM, V270, P14399, DOI 10.1074/jbc.270.24.14399; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Tsuji T, 2004, AM J RESP CELL MOL, V31, P643, DOI 10.1165/rcmb.2003-0290OC; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Volonte D, 2002, MOL BIOL CELL, V13, P2502, DOI 10.1091/mbc.01-11-0529; Volonte D, 2009, EMBO REP, V10, P1334, DOI 10.1038/embor.2009.215; Volonte D, 2009, J BIOL CHEM, V284, P5462, DOI 10.1074/jbc.C800225200; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Wynford-Thomas D, 1999, J PATHOL, V187, P100; Zhu H, 2011, J BIOL CHEM, V286, P12820, DOI 10.1074/jbc.C111.221440; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	35	38	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28657	28661		10.1074/jbc.C111.235119	http://dx.doi.org/10.1074/jbc.C111.235119			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705337	hybrid, Green Published			2022-12-25	WOS:000293837000002
J	Hou, R; Bao, ZM; Wang, S; Su, HL; Li, Y; Du, HX; Hu, JJ; Wang, S; Hu, XL				Hou, Rui; Bao, Zhenmin; Wang, Shan; Su, Hailin; Li, Yan; Du, Huixia; Hu, Jingjie; Wang, Shi; Hu, Xiaoli			Transcriptome Sequencing and De Novo Analysis for Yesso Scallop (Patinopecten yessoensis) Using 454 GS FLX	PLOS ONE			English	Article							GENE ONTOLOGY; SNP DISCOVERY; EST-SSRS; ANNOTATION; TOOL; BIVALVIA; BLAST2GO; HSP70; MAP	Background: Bivalves comprise 30,000 extant species, constituting the second largest group of mollusks. However, limited genetic research has focused on this group of animals so far, which is, in part, due to the lack of genomic resources. The advent of high-throughput sequencing technologies enables generation of genomic resources in a short time and at a minimal cost, and therefore provides a turning point for bivalve research. In the present study, we performed de novo transcriptome sequencing to first produce a comprehensive expressed sequence tag (EST) dataset for the Yesso scallop (Patinopecten yessoensis). Results: In a single 454 sequencing run, 805,330 reads were produced and then assembled into 32,590 contigs, with about six-fold sequencing coverage. A total of 25,237 unique protein-coding genes were identified from a variety of developmental stages and adult tissues based on sequence similarities with known proteins. As determined by GO annotation and KEGG pathway mapping, functional annotation of the unigenes recovered diverse biological functions and processes. Transcripts putatively involved in growth, reproduction and stress/immune-response were identified. More than 49,000 single nucleotide polymorphisms (SNPs) and 2,700 simple sequence repeats (SSRs) were also detected. Conclusion: Our data provide the most comprehensive transcriptomic resource currently available for P. yessoensis. Candidate genes potentially involved in growth, reproduction, and stress/immunity-response were identified, and are worthy of further investigation. A large number of SNPs and SSRs were also identified and ready for marker development. This resource should lay an important foundation for future genetic or genomic studies on this species.	[Hou, Rui; Bao, Zhenmin; Wang, Shan; Su, Hailin; Li, Yan; Du, Huixia; Hu, Jingjie; Wang, Shi; Hu, Xiaoli] Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding MGB, Qingdao, Peoples R China	Ocean University of China	Hou, R (corresponding author), Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding MGB, Qingdao, Peoples R China.	wangshanshine@hotmail.com; hxl707@ouc.edu.cn	Su, Hailin/D-1352-2017; xu, tao/K-6631-2016; wang, meng/GWZ-9558-2022	Su, Hailin/0000-0002-0284-2071; 	National Natural Science Foundation of China [31072190]; National Basic Research Program of China (973 Program) [2010CB126402, 2010CB126406]; Earmarked Fund for Modern Agro-industry Technology Research System	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Earmarked Fund for Modern Agro-industry Technology Research System	Financial support for this work was provided by National Natural Science Foundation of China (31072190), National Basic Research Program of China (973 Program, 2010CB126402 and 2010CB126406), and Earmarked Fund for Modern Agro-industry Technology Research System to Dr. Zhenmin Bao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelopoulou B, 2004, BBA-GENE STRUCT EXPR, V1676, P12, DOI 10.1016/j.bbaexp.2003.10.004; Anisimova AA, 2007, COMP CYTOGENET, V1, P63; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Bellin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-555; Bieler R, 2006, ZOOL J LINN SOC-LOND, V148, P223, DOI 10.1111/j.1096-3642.2006.00255.x; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Clark MS, 2009, MAR GENOM, V2, P11, DOI 10.1016/j.margen.2009.03.003; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa A., 2008, INT J PLANT GENOMICS; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Fraser KPP, 2007, J EXP BIOL, V210, P2691, DOI 10.1242/jeb.003715; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; HARTL FU, 1992, ANNU REV BIOPH BIOM, V21, P293, DOI 10.1146/annurev.bb.21.060192.001453; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Hooper SL, 2005, PHYSIOL REV, V85, P1417, DOI 10.1152/physrev.00027.2005; Hu XL, 2006, AQUAC RES, V37, P1187, DOI 10.1111/j.1365-2109.2006.01546.x; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; James P, 1997, SCIENCE, V275, P387, DOI 10.1126/science.275.5298.387; Jones-Rhoades MW, 2007, PLOS GENET, V3, P1848, DOI 10.1371/journal.pgen.0030171; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim KS, 2008, COMP BIOCHEM PHYS B, V151, P52, DOI 10.1016/j.cbpb.2008.05.009; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Liu Wei-Dong, 2009, Yichuan, V31, P629, DOI 10.3724/SP.J.1005.2009.00629; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; RUNNEGAR B, 1983, J PALEONTOL, V57, P73; Sarashina I, 2001, MAR BIOTECHNOL, V3, P362, DOI 10.1007/s10126-001-0013-6; Schwarz D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-633; SPIETH J, 1991, J MOL EVOL, V32, P429, DOI 10.1007/BF02101283; Sun CS, 2007, MOL ECOL NOTES, V7, P106, DOI 10.1111/j.1471-8286.2006.01545.x; Tang JF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-438; Vega-Arreguin JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-299; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang QC, 1984, FISHERIES SCI, V3, P24; WANG RC, 2008, MARINE SHELLFISH CUL; Wang XL, 2009, CONSERV GENET, V10, P1129, DOI 10.1007/s10592-008-9726-7; Xu KF, 2008, AQUAC RES, V40, P35, DOI 10.1111/j.1365-2109.2008.02058.x; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94	50	191	214	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21560	10.1371/journal.pone.0021560	http://dx.doi.org/10.1371/journal.pone.0021560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720557	Green Published, gold, Green Submitted			2022-12-25	WOS:000292036900053
J	Falconar, AKI; Martinez, F				Falconar, Andrew K. I.; Martinez, Fernando			The NS1 Glycoprotein Can Generate Dramatic Antibody-Enhanced Dengue Viral Replication in Normal Out-Bred Mice Resulting in Lethal Multi-Organ Disease	PLOS ONE			English	Article							NONSTRUCTURAL-1 PROTEIN NS1; FC-GAMMA RECEPTORS; ACUTE LUNG INJURY; HUMAN-IGG-FC; DEPENDENT ENHANCEMENT; YELLOW-FEVER; MONOCLONAL-ANTIBODIES; HEMORRHAGIC-FEVER; VIRUS-INFECTION; ATYPICAL MANIFESTATIONS	Antibody-enhanced replication (AER) of dengue type-2 virus (DENV-2) strains and production of antibody-enhanced disease (AED) was tested in out-bred mice. Polyclonal antibodies (PAbs) generated against the nonstructural-1 (NS1) glycoprotein candidate vaccine of the New Guinea-C (NG-C) or NSx strains reacted strongly and weakly with these antigens, respectively. These PAbs contained the IgG2a subclass, which cross-reacted with the virion-associated envelope (E) glycoprotein of the DENV-2 NSx strain, suggesting that they could generate its AER via all mouse Fc gamma-receptor classes. Indeed, when these mice were challenged with a low dose (<0.5 LD50) of the DENV-2 NSx strain, but not the NG-C strain, they all generated dramatic and lethal DENV-2 AER/AED. These AER/AED mice developed life-threatening acute respiratory distress syndrome (ARDS), displayed by diffuse alveolar damage (DAD) resulting from i) dramatic interstitial alveolar septa-thickening with mononuclear cells, ii) some hyperplasia of alveolar type-II pneumocytes, iii) copious intra-alveolar protein secretion, iv) some hyaline membrane-covered alveolar walls, and v) DENV-2 antigen-positive alveolar macrophages. These mice also developed meningo-encephalitis, with greater than 90,000-fold DENV-2 AER titers in microglial cells located throughout their brain parenchyma, some of which formed nodules around dead neurons. Their spleens contained infiltrated megakaryocytes with DENV-2 antigen-positive red-pulp macrophages, while their livers displayed extensive necrosis, apoptosis and macro-and micro-steatosis, with DENV-2 antigen-positive Kuppfer cells and hepatocytes. Their infections were confirmed by DENV-2 isolations from their lungs, spleens and livers. These findings accord with those reported in fatal human "severe dengue" cases. This DENV-2 AER/AED was blocked by high concentrations of only the NG-C NS1 glycoprotein. These results imply a potential hazard of DENV NS1 glycoprotein-based vaccines, particularly against DENV strains that contain multiple mutations or genetic recombination within or between their DENV E and NS1 glycoprotein-encoding genes. The model provides potential for assessing DENV strain pathogenicity and anti-DENV therapies in normal mice.	[Falconar, Andrew K. I.] Univ Norte, Dept Ciencias Basicas Med, Grp Invest Enfermedades Trop, Barranquilla, Colombia; [Falconar, Andrew K. I.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1, England; [Martinez, Fernando] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Universidad del Norte; University of London; London School of Hygiene & Tropical Medicine; University of Texas System; UTMD Anderson Cancer Center	Falconar, AKI (corresponding author), Univ Norte, Dept Ciencias Basicas Med, Grp Invest Enfermedades Trop, Barranquilla, Colombia.	afalconar@uninorte.edu.co			European Communities; Universidad del Norte	European Communities(European Commission); Universidad del Norte	This study was supported by the European Communities and the Universidad del Norte. The funders had no role in the design of the study, data generation or analysis or the preparation of the manuscript.	Andrew S M, 2001, Curr Protoc Immunol, VChapter 2, DOI [10.1002/0471142735.im0208s21, 10.1002/0471142735.im0209s21, 10.1002/0471142735.im0207s21]; Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183; Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416; Barth OM, 2006, MEM I OSWALDO CRUZ, V101, P905, DOI 10.1590/S0074-02762006000800014; Basílio-de-Oliveira C.A., 2005, Braz J Infect Dis, V9, P341, DOI 10.1590/S1413-86702005000400012; Baudino L, 2006, SPRINGER SEMIN IMMUN, V28, P175, DOI 10.1007/s00281-006-0037-0; Bhamarapravati Natth, 1997, P115; Bhoopat L, 1996, ASIAN PAC J ALLERGY, V14, P107; Blackley S, 2007, J VIROL, V81, P13325, DOI 10.1128/JVI.01568-07; Bosma KJ, 2007, EXPERT OPIN EMERG DR, V12, P461, DOI 10.1517/14728214.12.3.461; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Chau Tran Nguyen Bich, 2008, J Infect Dis, V198, P516, DOI 10.1086/590117; Chen SP, 2008, ARCH VIROL, V153, P1175, DOI 10.1007/s00705-008-0090-1; CHURDBOONCHART V, 1990, Southeast Asian Journal of Tropical Medicine and Public Health, V21, P614; Costa SM, 2006, VACCINE, V24, P4562, DOI 10.1016/j.vaccine.2005.08.022; de Macedo FC, 2006, DIAGN MOL PATHOL, V15, P223, DOI 10.1097/01.pdm.0000213462.60645.cd; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028; Falconar A. K. I., 1999, Recent Research Developments in Virology, V1, P437; Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127; Falconar AKI, 1999, ARCH VIROL, V144, P2313, DOI 10.1007/s007050050646; Falconar AKI, 2008, CLIN VACCINE IMMUNOL, V15, P549, DOI 10.1128/CVI.00351-07; Falconar AKI, 2007, CLIN VACCINE IMMUNOL, V14, P493, DOI 10.1128/CVI.00371-06; Falconar AKI, 2006, CLIN VACCINE IMMUNOL, V13, P1044, DOI 10.1128/CVI.00105-06; FALGOUT B, 1990, J VIROL, V64, P4356, DOI 10.1128/JVI.64.9.4356-4363.1990; Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999; Garcia-Rivera EJ, 2002, LANCET, V360, P261, DOI 10.1016/S0140-6736(02)09481-3; German AC, 2006, T ROY SOC TROP MED H, V100, P1135, DOI 10.1016/j.trstmh.2006.02.008; Gil L, 2009, INT IMMUNOL, V21, P1175, DOI 10.1093/intimm/dxp082; GOULD EA, 1989, J GEN VIROL, V70, P1605, DOI 10.1099/0022-1317-70-6-1605; GOULD EA, 1987, J GEN VIROL, V68, P3105, DOI 10.1099/0022-1317-68-12-3105; Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2; Gulati S, 2007, TROP MED INT HEALTH, V12, P1087, DOI 10.1111/j.1365-3156.2007.01891.x; HALL WC, 1991, AM J TROP MED HYG, V45, P408, DOI 10.4269/ajtmh.1991.45.408; HALSTEAD SB, 1973, J INFECT DIS, V128, P15, DOI 10.1093/infdis/128.1.15; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; HALSTEAD SB, 2004, TXB PEDIAT INFECT DI, V2, P2200; Hathirat P, 1993, Southeast Asian J Trop Med Public Health, V24 Suppl 1, P80; Hauser W, 1999, P NATL ACAD SCI USA, V96, P8120, DOI 10.1073/pnas.96.14.8120; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101; Huang KJ, 2006, J IMMUNOL, V176, P2825, DOI 10.4049/jimmunol.176.5.2825; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Huerre MR, 2001, VIRCHOWS ARCH, V438, P107; Innis Bruce L., 1995, P103; Jackson ST, 2008, W INDIAN MED J, V57, P373; JACOBS SC, 1994, J GEN VIROL, V75, P2399, DOI 10.1099/0022-1317-75-9-2399; Jefferis R, 2002, IMMUNOL LETT, V82, P57, DOI 10.1016/S0165-2478(02)00019-6; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Kamath Shrishu R., 2006, Indian Journal of Pediatrics, V73, P889, DOI 10.1007/BF02859281; KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444; KONTNY U, 1988, J VIROL, V62, P3928, DOI 10.1128/JVI.62.11.3928-3933.1988; Lazo L, 2007, VACCINE, V25, P1064, DOI 10.1016/j.vaccine.2006.09.068; Le VT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000854; Lee YR, 2005, INTERVIROLOGY, V48, P161, DOI 10.1159/000081744; Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999; LITTAUA R, 1990, J IMMUNOL, V144, P3183; LUM LCS, 1995, ANN TROP PAEDIATR, V15, P335, DOI 10.1080/02724936.1995.11747794; Malavige G N, 2007, Indian J Med Microbiol, V25, P143; MARIANI M, 1991, MOL IMMUNOL, V28, P69, DOI 10.1016/0161-5890(91)90088-2; Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Ong A, 2007, INT J INFECT DIS, V11, P263, DOI 10.1016/j.ijid.2006.02.012; Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008; Perez-Ramirez G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-260; Prestwood TR, 2008, J VIROL, V82, P8411, DOI 10.1128/JVI.00611-08; Quan Y, 2009, NEUROSCI LETT, V464, P29, DOI 10.1016/j.neulet.2009.08.013; Quaresma JAS, 2006, VIROLOGY, V345, P22, DOI 10.1016/j.virol.2005.09.058; Raghavendran K, 2008, CURR MED CHEM, V15, P1911, DOI 10.2174/092986708785132942; Ramos C, 1998, J NEUROVIROL, V4, P465, DOI 10.3109/13550289809114548; Rothman Alan L., 1997, P245; SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015; SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310; Shresta S, 2004, VIROLOGY, V319, P262, DOI 10.1016/j.virol.2003.09.048; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; Sittisombut N, 1997, AM J TROP MED HYG, V57, P100, DOI 10.4269/ajtmh.1997.57.100; Soares CN, 2011, J NEUROL SCI, V303, P75, DOI 10.1016/j.jns.2011.01.012; Song XY, 2002, INFECT IMMUN, V70, P5177, DOI 10.1128/IAI.70.9.5177-5184.2002; Srichaikul T, 2000, BEST PRACT RES CL HA, V13, P261, DOI 10.1053/beha.2000.0073; Stephenson JR, 2005, B WORLD HEALTH ORGAN, V83, P308; Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672; THEIN S, 1993, J MED VIROL, V40, P102, DOI 10.1002/jmv.1890400205; Thong MK, 1998, LANCET, V352, P1712, DOI 10.1016/S0140-6736(05)61496-1; Wasay M, 2008, CLIN NEUROL NEUROSUR, V110, P635, DOI 10.1016/j.clineuro.2008.03.011; World Health Organization, 1997, DENG HAEM FEV DIAGN, P12; Worobey M, 1999, P NATL ACAD SCI USA, V96, P7352, DOI 10.1073/pnas.96.13.7352; Yamanaka A, 2008, J VIROL, V82, P927, DOI 10.1128/JVI.00992-07; [No title captured]	92	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21024	10.1371/journal.pone.0021024	http://dx.doi.org/10.1371/journal.pone.0021024			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731643	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700030
J	Keeley, EC; Moorman, JR; Liu, L; Gimple, LW; Lipson, LC; Ragosta, M; Taylor, AM; Lake, DE; Burdick, MD; Mehrad, B; Strieter, RM				Keeley, Ellen C.; Moorman, J. Randall; Liu, Ling; Gimple, Lawrence W.; Lipson, Lewis C.; Ragosta, Michael; Taylor, Angela M.; Lake, Douglas E.; Burdick, Marie D.; Mehrad, Borna; Strieter, Robert M.			Plasma Chemokine Levels Are Associated with the Presence and Extent of Angiographic Coronary Collaterals in Chronic Ischemic Heart Disease	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ARTERY-DISEASE; DIABETES-MELLITUS; PROGNOSTIC-SIGNIFICANCE; ANGINA-PECTORIS; BYPASS SURGERY; OFF-PUMP; CIRCULATION; FLOW; OCCLUSION	Background: In patients with chronic ischemic heart disease (IHD), the presence and extent of spontaneously visible coronary collaterals are powerful determinants of clinical outcome. There is marked heterogeneity in the recruitment of coronary collaterals amongst patients with similar degrees of coronary artery stenoses, but the biological basis of this heterogeneity is not known. Chemokines are potent mediators of vascular remodeling in diverse biological settings. Their role in coronary collateralization has not been investigated. We sought to determine whether plasma levels of angiogenic and angiostatic chemokines are associated with of the presence and extent of coronary collaterals in patients with chronic IHD. Methodology/Principal Findings: We measured plasma concentrations of angiogenic and angiostatic chemokine ligands in 156 consecutive subjects undergoing coronary angiography with at least one >= 90% coronary stenosis and determined the presence and extent of spontaneously visible coronary collaterals using the Rentrop scoring system. Eighty-eight subjects (56%) had evidence of coronary collaterals. In a multivariable regression model, the concentration of the angiogenic ligands CXCL5, CXCL8 and CXCL12, hyperlipidemia, and an occluded artery were associated with the presence of collaterals; conversely, the concentration of the angiostatic ligand CXCL11, interferon-gamma, hypertension and diabetes were associated with the absence of collaterals (ROC area 0.91). When analyzed according to extent of collateralization, higher Rentrop scores were significantly associated with increased concentration of the angiogenic ligand CXCL1 (p<0.0001), and decreased concentrations of angiostatic ligands CXCL9 (p<0.0001), CXCL10 (p = 0.002), and CXCL11 (p = 0.0002), and interferon-gamma (p = 0.0004). Conclusions/Significance: Plasma chemokine concentrations are associated with the presence and extent of spontaneously visible coronary artery collaterals and may be mechanistically involved in their recruitment.	[Keeley, Ellen C.; Moorman, J. Randall; Liu, Ling; Gimple, Lawrence W.; Lipson, Lewis C.; Ragosta, Michael; Taylor, Angela M.; Lake, Douglas E.] Univ Virginia, Div Cardiol, Charlottesville, VA 22903 USA; [Keeley, Ellen C.; Moorman, J. Randall; Liu, Ling; Gimple, Lawrence W.; Lipson, Lewis C.; Ragosta, Michael; Taylor, Angela M.; Lake, Douglas E.; Burdick, Marie D.; Mehrad, Borna; Strieter, Robert M.] Univ Virginia, Dept Med, Charlottesville, VA USA; [Burdick, Marie D.; Mehrad, Borna; Strieter, Robert M.] Univ Virginia, Div Pulm & Crit Care Med, Charlottesville, VA USA; [Lake, Douglas E.] Univ Virginia, Dept Stat, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Keeley, EC (corresponding author), Univ Virginia, Div Cardiol, Charlottesville, VA 22903 USA.	Keeley@Virginia.edu	Mehrad, Borna/D-9363-2015; Mehrad, Borna/AAC-9876-2019; Mehrad, Borna/G-2659-2010; Moorman, J Randall/ABG-9946-2020	Mehrad, Borna/0000-0001-5198-065X; Mehrad, Borna/0000-0001-5198-065X; Taylor, Angela/0000-0003-4927-4320	National Institutes of Health [HL97074, HL73848, CA87879, HL66027, HL98526]; NATIONAL CANCER INSTITUTE [R01CA087879] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL097074, R01HL098329, R01HL073848, R01HL098526, K23HL093118, R01HL066027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (HL97074 to ECK, HL73848 to BM, and CA87879, HL66027 and HL98526 to RMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; Abbott JD, 2005, AM J CARDIOL, V96, P676, DOI 10.1016/j.amjcard.2005.04.043; Ardigo D, 2007, PHYSIOL GENOMICS, V31, P402, DOI 10.1152/physiolgenomics.00104.2007; Berry C, 2007, EUR HEART J, V28, P278, DOI 10.1093/eurheartj/ehl446; Billinger M, 2002, J AM COLL CARDIOL, V40, P1545, DOI 10.1016/S0735-1097(02)02378-1; Briguori C, 2006, AM J CARDIOL, V97, P472, DOI 10.1016/j.amjcard.2005.09.076; Caputo M, 2008, ANN THORAC SURG, V85, P71, DOI 10.1016/j.athoracsur.2007.08.026; Chung NA, 2003, HEART, V89, P1411, DOI 10.1136/heart.89.12.1411; COHEN M, 1989, J AM COLL CARDIOL, V13, P297, DOI 10.1016/0735-1097(89)90502-0; Damas JK, 2000, CARDIOVASC RES, V47, P778, DOI 10.1016/S0008-6363(00)00142-5; Desch S, 2010, AM J CARDIOL, V106, P605, DOI 10.1016/j.amjcard.2010.04.010; Dincer I, 2006, CORONARY ARTERY DIS, V17, P561; Elsman P, 2004, EUR HEART J, V25, P854, DOI 10.1016/j.ehj.2004.03.005; Fleisch M, 1999, CIRCULATION, V100, P1945, DOI 10.1161/01.CIR.100.19.1945; HABIB GB, 1991, CIRCULATION, V83, P739, DOI 10.1161/01.CIR.83.3.739; HIRAI T, 1989, CIRCULATION, V79, P791, DOI 10.1161/01.CIR.79.4.791; Hughes GC, 2005, EXPERT REV CARDIOVAS, V3, P521, DOI 10.1586/14779072.3.3.521; Ishihara M, 2005, AM J CARDIOL, V95, P622, DOI 10.1016/j.amjcard.2004.11.009; Keeley EC, 2008, ARTERIOSCL THROM VAS, V28, P1928, DOI 10.1161/ATVBAHA.108.162925; Kodama K, 1996, J AM COLL CARDIOL, V27, P1133, DOI 10.1016/0735-1097(95)00596-X; Koerselman J, 2005, AM J CARDIOL, V96, P390, DOI 10.1016/j.amjcard.2005.03.083; Koerselman J, 2003, CIRCULATION, V107, P2507, DOI 10.1161/01.CIR.0000065118.99409.5F; Kornowski R, 2003, CORONARY ARTERY DIS, V14, P61, DOI 10.1097/00019501-200302000-00007; Lakshminarayanan V, 2001, AM J PATHOL, V159, P1301, DOI 10.1016/S0002-9440(10)62517-5; LEVIN DC, 1974, CIRCULATION, V50, P831, DOI 10.1161/01.CIR.50.4.831; Mason MJ, 2000, CORONARY ARTERY DIS, V11, P573, DOI 10.1097/00019501-200012000-00001; Meier P, 2007, CIRCULATION, V116, P975, DOI 10.1161/CIRCULATIONAHA.107.703959; Nathoe HM, 2006, AM J CARDIOL, V98, P31, DOI 10.1016/j.amjcard.2006.01.050; Nathoe HM, 2004, CIRCULATION, V110, P1738, DOI 10.1161/01.CIR.0000143105.42988.FD; Nisanci Yilmaz, 2002, J Invasive Cardiol, V14, P118; Nurkalem Z, 2008, ACTA CARDIOL, V63, P141, DOI 10.2143/AC.63.2.2029519; Olijhoek JK, 2005, DIABETES CARE, V28, P683, DOI 10.2337/diacare.28.3.683; Panchal VR, 2004, J AM COLL CARDIOL, V43, P1383, DOI 10.1016/j.jacc.2003.10.063; Piek JJ, 1997, J AM COLL CARDIOL, V29, P275, DOI 10.1016/S0735-1097(96)00499-8; Pohl T, 2001, J AM COLL CARDIOL, V38, P1872, DOI 10.1016/S0735-1097(01)01675-8; Pourati I, 2003, AM HEART J, V146, P876, DOI 10.1016/S0002-8703(03)00413-7; Regieli JJ, 2009, INT J CARDIOL, V132, P257, DOI 10.1016/j.ijcard.2007.11.100; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Schultz A, 1999, CIRCULATION, V100, P547, DOI 10.1161/01.CIR.100.5.547; Seiler C, 2010, EUR J CLIN INVEST, V40, P465, DOI 10.1111/j.1365-2362.2010.02282.x; Sherman JA, 2006, AM J CARDIOL, V98, P1194, DOI 10.1016/j.amjcard.2006.05.046; Simonini A, 2000, CIRCULATION, V101, P1519, DOI 10.1161/01.CIR.101.13.1519; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; van Liebergen RAM, 1999, J AM COLL CARDIOL, V33, P670, DOI 10.1016/S0735-1097(98)00640-8; Waltenberger J, 2001, CARDIOVASC RES, V49, P554, DOI 10.1016/S0008-6363(00)00228-5; Werner GS, 2004, CIRCULATION, V110, P1940, DOI 10.1161/01.CIR.0000143624.72027.11; Zbinden R, 2005, HEART, V91, P1289, DOI 10.1136/hrt.2004.041236	48	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21174	10.1371/journal.pone.0021174	http://dx.doi.org/10.1371/journal.pone.0021174			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731663	gold, Green Submitted, Green Published			2022-12-25	WOS:000292033700042
J	Caspi-Fluger, A; Inbar, M; Mozes-Daube, N; Mouton, L; Hunter, MS; Zchori-Fein, E				Caspi-Fluger, Ayelet; Inbar, Moshe; Mozes-Daube, Netta; Mouton, Laurence; Hunter, Martha S.; Zchori-Fein, Einat			Rickettsia 'In' and 'Out': Two Different Localization Patterns of a Bacterial Symbiont in the Same Insect Species	PLOS ONE			English	Article							APHID ACYRTHOSIPHON-PISUM; PEA APHID; BEMISIA-TABACI; ENDOSYMBIOTIC BACTERIUM; WOLBACHIA; FITNESS; IDENTIFICATION; EVOLUTION; BIOLOGY	Intracellular symbionts of arthropods have diverse influences on their hosts, and their functions generally appear to be associated with their localization within the host. The effect of localization pattern on the role of a particular symbiont cannot normally be tested since the localization pattern within hosts is generally invariant. However, in Israel, the secondary symbiont Rickettsia is unusual in that it presents two distinct localization patterns throughout development and adulthood in its whitefly host, Bemisia tabaci (B biotype). In the "scattered'' pattern, Rickettsia is localized throughout the whitefly hemocoel, excluding the bacteriocytes, where the obligate symbiont Portiera aleyrodidarum and some other secondary symbionts are housed. In the "confined'' pattern, Rickettsia is restricted to the bacteriocytes. We examined the effects of these patterns on Rickettsia densities, association with other symbionts (Portiera and Hamiltonella defensa inside the bacteriocytes) and on the potential for horizontal transmission to the parasitoid wasp, Eretmocerus mundus, while the wasp larvae are developing within the whitefly nymph. Sequences of four Rickettsia genes were found to be identical for both localization patterns, suggesting that they are closely related strains. However, real-time PCR analysis showed very different dynamics for the two localization types. On the first day post-adult emergence, Rickettsia densities were 21 times higher in the "confined'' pattern vs. "scattered'' pattern whiteflies. During adulthood, Rickettsia increased in density in the "scattered'' pattern whiteflies until it reached the "confined'' pattern Rickettsia density on day 21. No correlation between Rickettsia densities and Hamiltonella or Portiera densities were found for either localization pattern. Using FISH technique, we found Rickettsia in the gut of the parasitoid wasps only when they developed on whiteflies with the "scattered'' pattern. The results suggest that the localization pattern of a symbiont may influence its dynamics within the host.	[Caspi-Fluger, Ayelet; Mozes-Daube, Netta; Zchori-Fein, Einat] ARO, Dept Entomol, Newe Yaar Res Ctr, Ramat Yishay, Israel; [Caspi-Fluger, Ayelet; Inbar, Moshe] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Mouton, Laurence] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR 5558, F-69622 Villeurbanne, France; [Hunter, Martha S.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	University of Haifa; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; University of Arizona	Caspi-Fluger, A (corresponding author), ARO, Dept Entomol, Newe Yaar Res Ctr, Ramat Yishay, Israel.	einat@volcani.agri.gov.il	Hunter, Martha/AAF-5288-2020; Hunter, Martha/B-7307-2012	Hunter, Martha/0000-0002-6342-675X; Hunter, Martha/0000-0002-6342-675X; Inbar, Moshe/0000-0002-4707-9508; Mouton, Laurence/0000-0002-2718-9953	BARD [US-4304-10 R]; United States-Israel Binational Agricultural Research and Development Fund; Israel Science Foundation [262/09]; STSM COST [FA0701-05091]	BARD(US-Israel Binational Science Foundation); United States-Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); STSM COST	This research was supported by Research Grant No. US-4304-10 R from BARD, the United States-Israel Binational Agricultural Research and Development Fund (http://www.bard-isus.com) E.Z.-F. and M. S. H., The Israel Science Foundation (http://www.isf.org.il/) Grant No. 262/09 to E.Z.-F., and by a STSM COST grant (http://www.cost-fa0701.com/) to N.M.-D. Grant No. FA0701-05091. The funders had no role in study design, data collection and analysis, decision to publidh, or preparation of the manuscript.	Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Braquart-Varnier C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003286; Bution ML, 2008, MICRON, V39, P1179, DOI 10.1016/j.micron.2008.05.003; Chen DQ, 1996, CURR MICROBIOL, V33, P123, DOI 10.1007/s002849900086; Chen DQ, 2000, ENTOMOL EXP APPL, V95, P315, DOI 10.1023/A:1004083324807; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chiel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004767; Chiel E, 2009, ANN ENTOMOL SOC AM, V102, P413, DOI 10.1603/008.102.0309; Ferrari J, 2004, ECOL ENTOMOL, V29, P60, DOI 10.1111/j.1365-2311.2004.00574.x; Fournier PE, 2003, J CLIN MICROBIOL, V41, P5456, DOI 10.1128/JCM.41.12.5456-5465.2003; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Fukatsu T, 2000, APPL ENVIRON MICROB, V66, P2748, DOI 10.1128/AEM.66.7.2748-2758.2000; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P1284, DOI 10.1128/AEM.67.3.1284-1291.2001; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; HENDI A, 1984, B ENTOMOL SOC EGYPT, V65, P101; Koga R, 2003, P ROY SOC B-BIOL SCI, V270, P2543, DOI 10.1098/rspb.2003.2537; Macaluso KR, 2008, VECTOR-BORNE ZOONOT, V8, P391, DOI 10.1089/vbz.2007.0218; Matalon Y, 2007, J INVERTEBR PATHOL, V96, P106, DOI 10.1016/j.jip.2007.02.010; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Mouton L, 2003, MOL ECOL, V12, P3459, DOI 10.1046/j.1365-294X.2003.02015.x; Nakabachi A, 2005, P NATL ACAD SCI USA, V102, P5477, DOI 10.1073/pnas.0409034102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; POWELL DA, 1992, J APPL ENTOMOL, V113, P68, DOI 10.1111/j.1439-0418.1992.tb00637.x; Rosenberg E, 2010, ENV MICROBIOL REP, V2, P500, DOI 10.1111/j.1758-2229.2010.00177.x; Roux V, 1997, INT J SYST BACTERIOL, V47, P252, DOI 10.1099/00207713-47-2-252; Russell JA, 2005, APPL ENVIRON MICROB, V71, P7987, DOI 10.1128/AEM.71.12.7987-7994.2005; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; Sinisterra XH, 2005, J GEN VIROL, V86, P1525, DOI 10.1099/vir.0.80665-0; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Tsuchida T, 2005, MICROB ECOL, V49, P126, DOI 10.1007/s00248-004-0216-2; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; Vautrin E, 2009, TRENDS MICROBIOL, V17, P95, DOI 10.1016/j.tim.2008.12.002; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Zchori-Fein E, 2001, P NATL ACAD SCI USA, V98, P12555, DOI 10.1073/pnas.221467498; Zchori-Fein E, 2012, FRONT MICROBIOL SER, pIX	43	51	57	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21096	10.1371/journal.pone.0021096	http://dx.doi.org/10.1371/journal.pone.0021096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712994	Green Published, gold, Green Submitted			2022-12-25	WOS:000291985100010
J	Dupin, M; Reynaud, P; Jarosik, V; Baker, R; Brunel, S; Eyre, D; Pergl, J; Makowski, D				Dupin, Maxime; Reynaud, Philippe; Jarosik, Vojtech; Baker, Richard; Brunel, Sarah; Eyre, Dominic; Pergl, Jan; Makowski, David			Effects of the Training Dataset Characteristics on the Performance of Nine Species Distribution Models: Application to Diabrotica virgifera virgifera	PLOS ONE			English	Article							WESTERN CORN-ROOTWORM; SAMPLE-SIZE; GEOGRAPHICAL-DISTRIBUTION; CLIMATE-CHANGE; CHRYSOMELIDAE; COLEOPTERA; INVASIONS; ACCURACY; TEMPERATURE; NORTHERN	Many distribution models developed to predict the presence/absence of invasive alien species need to be fitted to a training dataset before practical use. The training dataset is characterized by the number of recorded presences/absences and by their geographical locations. The aim of this paper is to study the effect of the training dataset characteristics on model performance and to compare the relative importance of three factors influencing model predictive capability; size of training dataset, stage of the biological invasion, and choice of input variables. Nine models were assessed for their ability to predict the distribution of the western corn rootworm, Diabrotica virgifera virgifera, a major pest of corn in North America that has recently invaded Europe. Twenty-six training datasets of various sizes (from 10 to 428 presence records) corresponding to two different stages of invasion (1955 and 1980) and three sets of input bioclimatic variables (19 variables, six variables selected using information on insect biology, and three linear combinations of 19 variables derived from Principal Component Analysis) were considered. The models were fitted to each training dataset in turn and their performance was assessed using independent data from North America and Europe. The models were ranked according to the area under the Receiver Operating Characteristic curve and the likelihood ratio. Model performance was highly sensitive to the geographical area used for calibration; most of the models performed poorly when fitted to a restricted area corresponding to an early stage of the invasion. Our results also showed that Principal Component Analysis was useful in reducing the number of model input variables for the models that performed poorly with 19 input variables. DOMAIN, Environmental Distance, MAXENT, and Envelope Score were the most accurate models but all the models tested in this study led to a substantial rate of mis-classification.	[Dupin, Maxime] INRA, UR Zool Forestiere, Orleans, France; [Dupin, Maxime] CIRAD, UMR Peuplement Vegetaux & Bio Agresseurs Milieu T, Montpellier, France; [Dupin, Maxime; Reynaud, Philippe] Anses, Lab Sante Vegetaux, Stn Angers, Angers, France; [Jarosik, Vojtech] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic; [Baker, Richard; Eyre, Dominic] Food & Environm Res Agcy, York, N Yorkshire, England; [Brunel, Sarah] EPPO OEPP, Paris, France; [Jarosik, Vojtech; Pergl, Jan] ASCR, Inst Bot, Pruhonice, Czech Republic; [Pergl, Jan] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Makowski, David] INRA, UMR INRA AgroParisTech 211, Thiverval Grignon, France	INRAE; CIRAD; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux; Charles University Prague; Food & Environment Research Agency; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of Bern; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Dupin, M (corresponding author), INRA, UR Zool Forestiere, Orleans, France.	makowski@grignon.inra.fr	Makowski, David/V-4233-2019; Pergl, Jan/H-1071-2011	Makowski, David/0000-0001-6385-3703; Pergl, Jan/0000-0002-0045-1974	European Commission [212459]; Czech Science Foundation [206/09/0563]; Ministry of Education, Youth and Sports of the Czech Republic [MSM0021620828, AV0Z60050516, LC06073]	European Commission(European CommissionEuropean Commission Joint Research Centre); Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was funded by the European project PRATIQUE (Framework Programme 7 of the European Commission Grant No 212459). VJ and JP acknowledge support by grant no. 206/09/0563 from the Czech Science Foundation, and long-term research plans nos. MSM0021620828, AV0Z60050516 and LC06073 from the Ministry of Education, Youth and Sports of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon P, 2010, J APPL ECOL, V47, P1026, DOI 10.1111/j.1365-2664.2010.01847.x; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; CAITHNESS N, 1995, THESIS U WITWATERSRA; CALKINS CO, 1969, J ECON ENTOMOL, V62, P541, DOI 10.1093/jee/62.3.541; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Carroll SS, 1998, ECOGRAPHY, V21, P401, DOI 10.1111/j.1600-0587.1998.tb00405.x; CHIANG HC, 1973, ANNU REV ENTOMOL, V18, P47, DOI 10.1146/annurev.en.18.010173.000403; Chilcott C, 2003, CLIMATE CHANGE IMPAC, P63; Ciosi M, 2008, MOL ECOL, V17, P3614, DOI 10.1111/j.1365-294X.2008.03866.x; Cumming GS, 2000, J BIOGEOGR, V27, P441, DOI 10.1046/j.1365-2699.2000.00408.x; *DAISIE, 2009, INV EC, V3; Davis PM, 1996, ENVIRON ENTOMOL, V25, P767, DOI 10.1093/ee/25.4.767; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Ellsbury MM, 2004, ENTOMOL EXP APPL, V111, P159, DOI 10.1111/j.0013-8703.2004.00163.x; GAVLOSKI JE, 1992, J ECON ENTOMOL, V85, P1434, DOI 10.1093/jee/85.4.1434; Giovanelli JGR, 2010, ECOL MODEL, V221, P215, DOI 10.1016/j.ecolmodel.2009.10.009; GODFREY LD, 1995, J ECON ENTOMOL, V88, P1445, DOI 10.1093/jee/88.5.1445; Hayes Keith R., 2003, P382; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, DIVA GIS VERSION 5 2; Hughes G, 1999, PLANT PATHOL, V48, P147, DOI 10.1046/j.1365-3059.1999.00327.x; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Kadmon R, 2003, ECOL APPL, V13, P853, DOI 10.1890/1051-0761(2003)013[0853:ASAOFA]2.0.CO;2; Kriticos D. J., 2001, Weed risk assessment, P61; KRYSAN JL, 1978, J INSECT PHYSIOL, V24, P535, DOI 10.1016/0022-1910(78)90055-0; LEVINE E, 1992, J ECON ENTOMOL, V85, P2425, DOI 10.1093/jee/85.6.2425; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Luoto M, 2005, GLOBAL ECOL BIOGEOGR, V14, P575, DOI 10.1111/j.1466-822x.2005.00186.x; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Magarey RD, 2007, PLANT DIS, V91, P336, DOI 10.1094/PDIS-91-4-0336; Marmion M, 2009, ECOL MODEL, V220, P3512, DOI 10.1016/j.ecolmodel.2008.10.019; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Munoz MES, 2009, GEOINFORMATICA; Murtaugh PA, 1996, ECOL APPL, V6, P132, DOI 10.2307/2269559; Nix H., 1986, ATLAS ELAPID SNAKES; Norman G., 2014, BIOSTATISTICS BARE E, V4; Pearce J, 2000, ECOL MODEL, V128, P127, DOI 10.1016/S0304-3800(99)00227-6; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pimentel D., 2002, BIOL INVASIONS EC EN; Pineiro R, 2007, MOL ECOL, V16, P2155, DOI 10.1111/j.1365-294X.2007.03280.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Robertson M. P., 2001, Diversity and Distributions, V7, P15, DOI 10.1046/j.1472-4642.2001.00094.x; SCHAAFSMA AW, 1991, CAN ENTOMOL, V123, P1183, DOI 10.4039/Ent1231183-6; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Spencer JL, 2005, WESTERN CORN ROOTWORM: ECOLOGY AND MANAGEMENT, P121, DOI 10.1079/9780851998176.0121; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2; Sutherst R.W., 2004, USE CLIMEX PEST RISK; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Toepfer S, 2006, J APPL ENTOMOL, V130, P193, DOI 10.1111/j.1439-0418.2006.01060.x; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Urban MC, 2007, P ROY SOC B-BIOL SCI, V274, P1413, DOI 10.1098/rspb.2007.0114; Vaclavik T, 2009, ECOL MODEL, V220, P3248, DOI 10.1016/j.ecolmodel.2009.08.013; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Winter M, 2009, P NATL ACAD SCI USA, V106, P21721, DOI 10.1073/pnas.0907088106; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Yuen JE, 2002, PLANT PATHOL, V51, P407, DOI 10.1046/j.0032-0862.2002.00741.x	71	51	55	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20957	10.1371/journal.pone.0020957	http://dx.doi.org/10.1371/journal.pone.0020957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701579	Green Published, Green Submitted, gold			2022-12-25	WOS:000291983800015
J	Logerot, P; Krutzfeldt, NOE; Wild, JM; Kubke, MF				Logerot, Priscilla; Kruetzfeldt, Nils O. E.; Wild, J. Martin; Kubke, M. Fabiana			Subdivisions of the Auditory Midbrain (N. Mesencephalicus Lateralis, pars dorsalis) in Zebra Finches Using Calcium-Binding Protein Immunocytochemistry	PLOS ONE			English	Article							OWL TYTO-ALBA; NUCLEUS ROBUSTUS-ARCHISTRIATALIS; CALBINDIN-LIKE IMMUNOREACTIVITY; AVIAN TORUS SEMICIRCULARIS; CHRYSEMYS-SCRIPTA-ELEGANS; HUMAN INFERIOR COLLICULUS; AREA OCTAVO-LATERALIS; RED-EARED TURTLE; BARN OWL; XENOPUS-LAEVIS	The midbrain nucleus mesencephalicus lateralis pars dorsalis (MLd) is thought to be the avian homologue of the central nucleus of the mammalian inferior colliculus. As such, it is a major relay in the ascending auditory pathway of all birds and in songbirds mediates the auditory feedback necessary for the learning and maintenance of song. To clarify the organization of MLd, we applied three calcium binding protein antibodies to tissue sections from the brains of adult male and female zebra finches. The staining patterns resulting from the application of parvalbumin, calbindin and calretinin antibodies differed from each other and in different parts of the nucleus. Parvalbumin-like immunoreactivity was distributed throughout the whole nucleus, as defined by the totality of the terminations of brainstem auditory afferents; in other words parvalbumin-like immunoreactivity defines the boundaries of MLd. Staining patterns of parvalbumin, calbindin and calretinin defined two regions of MLd: inner (MLd.I) and outer (MLd.O). MLd. O largely surrounds MLd. I and is distinct from the surrounding intercollicular nucleus. Unlike the case in some non-songbirds, however, the two MLd regions do not correspond to the terminal zones of the projections of the brainstem auditory nuclei angularis and laminaris, which have been found to overlap substantially throughout the nucleus in zebra finches.	[Logerot, Priscilla] Univ Auckland, Dept Anat Radiol, Fac Med & Hlth Sci, Auckland 1, New Zealand; Univ Auckland, Ctr Brain Res, Auckland 1, New Zealand	University of Auckland; University of Auckland	Logerot, P (corresponding author), Univ Auckland, Dept Anat Radiol, Fac Med & Hlth Sci, Auckland 1, New Zealand.	f.kubke@auckland.ac.nz	Kubke, Maria Fabiana/E-2472-2011; Kubke, M Fabiana/H-3320-2012	Kubke, Maria Fabiana/0000-0002-3351-5225	Marsden Fund [UOA-306, UOA-503]	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This work was funded by the Marsden Fund, administered by the Royal Society of New Zealand (http://www.royalsociety.org.nz/programmes/funds/marsden/) (contracts UOA-306 and UOA-503). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRESSEN C, 1993, CELL TISSUE RES, V271, P181, DOI 10.1007/BF00318606; ARENDS JJ, 1981, THESIS U LEIDEN LEID; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; Bass AH, 2005, INFERIOR COLLICULUS, P459, DOI 10.1007/0-387-27083-3_16; Belekhova M G, 2004, Dokl Biol Sci, V399, P451, DOI 10.1007/s10630-005-0009-x; Belekhova MG, 2010, BRAIN RES, V1345, P84, DOI 10.1016/j.brainres.2010.05.026; BRAUN K, 1985, CELL TISSUE RES, V240, P101, DOI 10.1007/BF00217563; BRAUN K, 1991, NEUROSCIENCE, V40, P853, DOI 10.1016/0306-4522(91)90017-I; BROWNER RH, 1981, J MORPHOL, V169, P207, DOI 10.1002/jmor.1051690207; BROWNER RH, 1977, J COMP NEUROL, V176, P539, DOI 10.1002/cne.901760406; BROWNER RH, 1983, HEARING RES, V12, P139, DOI 10.1016/0378-5955(83)90122-3; BUTLER AB, 1981, NEUROSCI LETT, V25, P221, DOI 10.1016/0304-3940(81)90395-5; Cant NB, 2005, INFERIOR COLLICULUS, P115, DOI 10.1007/0-387-27083-3_3; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; COLEMAN JR, 1992, EXP NEUROL, V115, P142, DOI 10.1016/0014-4886(92)90238-L; COLES RB, 1979, J COMP PHYSIOL, V134, P241, DOI 10.1007/BF00610398; CONLEE JW, 1986, BRAIN RES, V367, P96, DOI 10.1016/0006-8993(86)91583-0; CORREIA MJ, 1982, BRAIN RES, V234, P205, DOI 10.1016/0006-8993(82)90862-9; Covey E, 2005, INFERIOR COLLICULUS, P493, DOI 10.1007/0-387-27083-3_17; Diaz C, 2000, J NEUROCYTOL, V29, P569, DOI 10.1023/A:1011067918585; DRAKONTIDES AB, 1986, J COMP NEUROL, V248, P555, DOI 10.1002/cne.902480408; DURAND SE, 1992, J COMP NEUROL, V323, P495, DOI 10.1002/cne.903230404; Edwards CJ, 2001, J COMP NEUROL, V438, P148, DOI 10.1002/cne.1306; Ehret G, 2005, INFERIOR COLLICULUS, P312, DOI 10.1007/0-387-27083-3_11; Endepols H, 2001, J COMP PHYSIOL A, V186, P1119, DOI 10.1007/s003590000159; Endepols H, 2000, BRAIN RES REV, V33, P179, DOI 10.1016/S0165-0173(00)00029-1; FENG AS, 1991, J COMP NEUROL, V306, P613, DOI 10.1002/cne.903060407; FOSTER RE, 1978, J COMP NEUROL, V178, P783, DOI 10.1002/cne.901780412; FRIAUF E, 1994, J COMP NEUROL, V349, P193, DOI 10.1002/cne.903490204; Fukushima Y, 2000, ZOOL SCI, V17, P1231, DOI 10.2108/zsj.17.1231; Glezer II, 1998, J CHEM NEUROANAT, V15, P203, DOI 10.1016/S0891-0618(98)00022-2; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; HERMES DJ, 1981, HEARING RES, V5, P147, DOI 10.1016/0378-5955(81)90043-5; Hsu A, 2004, J NEUROSCI, V24, P9201, DOI 10.1523/JNEUROSCI.2449-04.2004; HUFFMAN RF, 1990, BRAIN RES REV, V15, P295, DOI 10.1016/0165-0173(90)90005-9; Idrizbegovic E, 1999, NEUROSCI LETT, V259, P49, DOI 10.1016/S0304-3940(98)00911-2; Karten H.J., 1967, STEREOTAXIC ATLAS BR; KARTEN HARVEY J., 1967, BRAIN RES, V6, P409, DOI 10.1016/0006-8993(67)90055-8; KELLEY PE, 1992, J COMP NEUROL, V320, P196, DOI 10.1002/cne.903200205; KENNEDY MC, 1981, J MORPHOL, V169, P259, DOI 10.1002/jmor.1051690302; KHACHUNTS AS, 1983, NEUROPHYSIOLOGY, V14, P191; KNUDSEN EI, 1978, J NEUROPHYSIOL, V41, P870, DOI 10.1152/jn.1978.41.4.870; KNUDSEN EI, 1983, J COMP NEUROL, V218, P174, DOI 10.1002/cne.902180205; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P1, DOI 10.1007/BF00663105; Konishi M, 2003, ANNU REV NEUROSCI, V26, P31, DOI 10.1146/annurev.neuro.26.041002.131123; Krutzfeldt NOE, 2010, J COMP NEUROL, V518, P2109, DOI 10.1002/cne.22334; Kubke MF, 1999, J COMP NEUROL, V415, P189, DOI 10.1002/(SICI)1096-9861(19991213)415:2<189::AID-CNE4>3.0.CO;2-E; KUNZLE H, 1986, BRAIN RES, V379, P307, DOI 10.1016/0006-8993(86)90785-7; KUNZLE H, 1982, J COMP NEUROL, V212, P349, DOI 10.1002/cne.902120404; LEIBLER LM, 1975, THESIS MIT CAMBRIDGE; LOGEROT P, 2009, AUSTR WINT C BRAIN R; Lohmann C, 1996, J COMP NEUROL, V367, P90, DOI 10.1002/(SICI)1096-9861(19960325)367:1<90::AID-CNE7>3.0.CO;2-E; LOWE DA, 1986, J COMP NEUROL, V245, P498, DOI 10.1002/cne.902450406; Luksch H, 1998, HEARING RES, V122, P1, DOI 10.1016/S0378-5955(98)00081-1; MANLEY JA, 1971, Z VERGL PHYSIOL, V71, P255, DOI 10.1007/BF00298138; MOHNEKE R, 1983, HEARING RES, V9, P91, DOI 10.1016/0378-5955(83)90137-5; MONTAGNESE CM, 1993, ANAT EMBRYOL, V188, P173; Nelson BS, 2004, J EXP BIOL, V207, P4121, DOI 10.1242/jeb.01230; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Oliver DL, 2005, INFERIOR COLLICULUS, P69, DOI 10.1007/0-387-27083-3_2; Paloff AM, 2004, ACTA HISTOCHEM, V106, P219, DOI 10.1016/j.acthis.2003.11.006; PARK TJ, 1991, J COMP PSYCHOL, V105, P125, DOI 10.1037/0735-7036.105.2.125; PAYNE RS, 1971, J EXP BIOL, V54, P535; PERSECHINI A, 1989, TRENDS NEUROSCI, V12, P462, DOI 10.1016/0166-2236(89)90097-0; Pinaud R, 2006, J NEUROBIOL, V66, P182, DOI 10.1002/neu.20211; Poirier C, 2009, J NEUROSCI, V29, P2252, DOI 10.1523/JNEUROSCI.4650-08.2009; POTTER HD, 1965, J NEUROPHYSIOL, V28, P1132, DOI 10.1152/jn.1965.28.6.1132; POTTER HD, 1965, J NEUROPHYSIOL, V28, P1155, DOI 10.1152/jn.1965.28.6.1155; PRITZ MB, 1974, J COMP NEUROL, V153, P179, DOI 10.1002/cne.901530204; Proctor L, 1997, P NATL ACAD SCI USA, V94, P10421, DOI 10.1073/pnas.94.19.10421; PUELLES L, 1994, J COMP NEUROL, V340, P98, DOI 10.1002/cne.903400108; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; RESIBOIS A, 1992, NEUROSCIENCE, V46, P101, DOI 10.1016/0306-4522(92)90012-Q; ROGERS JH, 1992, NEUROSCIENCE, V51, P843, DOI 10.1016/0306-4522(92)90525-7; SCHEICH H, 1977, J COMP PHYSIOL, V117, P245, DOI 10.1007/BF00612789; SETOOHSHIMA A, 1990, NEUROSCI LETT, V119, P60, DOI 10.1016/0304-3940(90)90755-X; Sharma V, 2009, J CHEM NEUROANAT, V37, P78, DOI 10.1016/j.jchemneu.2008.11.002; Simmons AM, 2000, JARO-J ASSOC RES OTO, V1, P2, DOI 10.1007/s101620010002; TAKAHASHI TT, 1988, J COMP NEUROL, V274, P212, DOI 10.1002/cne.902740207; TAKAHASHI TT, 1987, J NEUROSCI, V7, P1843; Tardif E, 2003, NEUROSCIENCE, V116, P1111, DOI 10.1016/S0306-4522(02)00774-1; VATER M, 1994, J COMP NEUROL, V341, P534, DOI 10.1002/cne.903410409; Vergne AL, 2009, BIOL REV, V84, P391, DOI 10.1111/j.1469-185X.2009.00079.x; VICARIO DS, 1991, J COMP NEUROL, V309, P486, DOI 10.1002/cne.903090405; Wagner H, 2003, J COMP NEUROL, V465, P145, DOI 10.1002/cne.10826; WAGNER H, 1987, J NEUROSCI, V7, P3105; WALKOWIAK W, 1994, AM ZOOL, V34, P685; Wang Y, 2010, J COMP NEUROL, V518, P1199, DOI 10.1002/cne.22269; WATSON JT, 1988, J COMP NEUROL, V274, P255, DOI 10.1002/cne.902740209; Wild JM, 2010, J COMP NEUROL, V518, P2149, DOI 10.1002/cne.22325; Wild JM, 1997, BRAIN RES, V759, P122, DOI 10.1016/S0006-8993(97)00253-9; WILD JM, 1987, BRAIN RES, V408, P303, DOI 10.1016/0006-8993(87)90393-3; Wild JM, 2001, BRAIN RES, V917, P235; WILD JM, 1993, J COMP NEUROL, V338, P225, DOI 10.1002/cne.903380207; WILD JM, 1995, J COMP NEUROL, V358, P465, DOI 10.1002/cne.903580402; WILL U, 1985, CELL TISSUE RES, V239, P147, DOI 10.1007/BF00214915; WILL U, 1985, CELL TISSUE RES, V239, P163, DOI 10.1007/BF00214916; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062; Woolley SMN, 2009, J NEUROSCI, V29, P2780, DOI 10.1523/JNEUROSCI.2042-08.2009; Woolley SMN, 2006, J NEUROSCI, V26, P2499, DOI 10.1523/JNEUROSCI.3731-05.2006; Woolley SMN, 2005, J NEUROPHYSIOL, V94, P1143, DOI 10.1152/jn.01064.2004; Woolley SMN, 2004, J NEUROPHYSIOL, V91, P136, DOI 10.1152/jn.00633.2003; YAN K, 2008, THESIS U MARYLAND CO; Yan K, 2010, J COMP NEUROL, V518, P3409, DOI 10.1002/cne.22428; Zeng SJ, 2008, BRAIN RES, V1206, P44, DOI 10.1016/j.brainres.2008.01.101; Zeng SJ, 2009, J COMP NEUROL, V515, P600, DOI 10.1002/cne.22076; Zeng SJ, 2008, BRAIN RES, V1216, P24, DOI 10.1016/j.brainres.2008.04.012; Zeng SJ, 2007, BRAIN BEHAV EVOLUT, V70, P1, DOI 10.1159/000101066; Zeng SJ, 2004, J COMP NEUROL, V470, P192, DOI 10.1002/cne.11042; Zettel ML, 1997, J COMP NEUROL, V386, P92, DOI 10.1002/(SICI)1096-9861(19970915)386:1<92::AID-CNE9>3.0.CO;2-8; ZETTEL ML, 1991, J COMP NEUROL, V313, P1, DOI 10.1002/cne.903130102	112	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20686	10.1371/journal.pone.0020686	http://dx.doi.org/10.1371/journal.pone.0020686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701681	Green Submitted, Green Published, gold			2022-12-25	WOS:000291983800011
J	Maruyama, R; Grevengoed, E; Stempniewicz, P; Andrew, DJ				Maruyama, Rika; Grevengoed, Elizabeth; Stempniewicz, Peter; Andrew, Deborah J.			Genome-Wide Analysis Reveals a Major Role in Cell Fate Maintenance and an Unexpected Role in Endoreduplication for the Drosophila FoxA Gene Fork Head	PLOS ONE			English	Article							SALIVARY-GLAND DETERMINATION; TRANSCRIPTION FACTORS; CAENORHABDITIS-ELEGANS; DEFINITIVE ENDODERM; VISCERAL MESODERM; EXPRESSION; MOUSE; ORGANOGENESIS; PROTEIN; HOMOLOG	Transcription factors drive organogenesis, from the initiation of cell fate decisions to the maintenance and implementation of these decisions. The Drosophila embryonic salivary gland provides an excellent platform for unraveling the underlying transcriptional networks of organ development because Drosophila is relatively unencumbered by significant genetic redundancy. The highly conserved FoxA family transcription factors are essential for various aspects of organogenesis in all animals that have been studied. Here, we explore the role of the single Drosophila FoxA protein Fork head (Fkh) in salivary gland organogenesis using two genome-wide strategies. A large-scale in situ hybridization analysis reveals a major role for Fkh in maintaining the salivary gland fate decision and controlling salivary gland physiological activity, in addition to its previously known roles in morphogenesis and survival. The majority of salivary gland genes (59%) are affected by fkh loss, mainly at later stages of salivary gland development. We show that global expression of Fkh cannot drive ectopic salivary gland formation. Thus, unlike the worm FoxA protein PHA-4, Fkh does not function to specify cell fate. In addition, Fkh only indirectly regulates many salivary gland genes, which is also distinct from the role of PHA-4 in organogenesis. Our microarray analyses reveal unexpected roles for Fkh in blocking terminal differentiation and in endoreduplication in the salivary gland and in other Fkh-expressing embryonic tissues. Overall, this study demonstrates an important role for Fkh in determining how an organ preserves its identity throughout development and provides an alternative paradigm for how FoxA proteins function in organogenesis.	[Maruyama, Rika; Grevengoed, Elizabeth; Stempniewicz, Peter; Andrew, Deborah J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA	Johns Hopkins University	Maruyama, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA.	dandrew@jhmi.edu	Maruyama, Rika/AAV-4358-2020	Maruyama, Rika/0000-0002-5656-6930	NIH [RO1 DE13899]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013899] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	NIH RO1 DE13899. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EW, 2006, DEVELOPMENT, V133, P3517, DOI 10.1242/dev.02525; Abrams EW, 2005, DEVELOPMENT, V132, P2743, DOI 10.1242/dev.01863; ANDREW DJ, 1994, METHOD CELL BIOL, V44, P353, DOI 10.1016/S0091-679X(08)60923-1; ANDREW DJ, 1994, EMBO J, V13, P1132, DOI 10.1002/j.1460-2075.1994.tb06362.x; Andrew DJ, 1997, DEVELOPMENT, V124, P181; ANG SL, 1993, DEVELOPMENT, V119, P1301; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Bartoszewski S, 2004, MECH DEVELOP, V121, P1259, DOI 10.1016/j.mod.2004.05.006; Bradley PL, 2003, DEV BIOL, V257, P249, DOI 10.1016/S0012-1606(03)00103-9; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cao CK, 2007, J CELL BIOL, V176, P843, DOI 10.1083/jcb.200611155; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 2007, J MOL BIOL, V366, P720, DOI 10.1016/j.jmb.2006.11.087; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Deng WM, 2001, DEVELOPMENT, V128, P4737; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eeckhoute J, 2009, GENOME RES, V19, P372, DOI 10.1101/gr.084582.108; Fernandes I, 2010, DEV CELL, V18, P64, DOI 10.1016/j.devcel.2009.11.009; Ferri ALM, 2007, DEVELOPMENT, V134, P2761, DOI 10.1242/dev.000141; Fox RM, 2010, J CELL BIOL, V191, P479, DOI 10.1083/jcb.201004062; Gao N, 2010, MOL ENDOCRINOL, V24, P1594, DOI 10.1210/me.2009-0513; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Haberman AS, 2003, DEV BIOL, V258, P443, DOI 10.1016/S0012-1606(03)00140-4; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Henderson KD, 2000, DEV BIOL, V217, P362, DOI 10.1006/dbio.1999.9560; Horner MA, 1998, GENE DEV, V12, P1947, DOI 10.1101/gad.12.13.1947; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isaac DD, 1996, GENE DEV, V10, P103, DOI 10.1101/gad.10.1.103; Kaestner KH, 2010, CURR OPIN GENET DEV, V20, P527, DOI 10.1016/j.gde.2010.06.005; Kalb JM, 1998, DEVELOPMENT, V125, P2171; KIDD S, 1989, GENE DEV, V3, P1113, DOI 10.1101/gad.3.8.1113; Kiefer JC, 2007, DEV BIOL, V303, P611, DOI 10.1016/j.ydbio.2006.11.042; Kume T, 2009, ADV EXP MED BIOL, V665, P63; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lee HH, 2004, DEV DYNAM, V229, P357, DOI 10.1002/dvdy.10443; LEHMANN R, 1994, METHOD CELL BIOL, V44, P575, DOI 10.1016/S0091-679X(08)60933-4; LIU S, 1992, DEV BIOL, V150, P133, DOI 10.1016/0012-1606(92)90013-7; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; Mango SE, 2009, ANNU REV CELL DEV BI, V25, P597, DOI 10.1146/annurev.cellbio.24.110707.175411; Mecklenburg L, 2005, EXP DERMATOL, V14, P797, DOI 10.1111/j.1600-0625.2005.00362.x; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; Myat MM, 2000, DEVELOPMENT, V127, P4217; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; PANZER S, 1992, DEVELOPMENT, V114, P49; Raharjo I, 2007, DEV BIOL, V302, P295, DOI 10.1016/j.ydbio.2006.09.036; Raharjo WH, 2010, DEV DYNAM, V239, P2219, DOI 10.1002/dvdy.22359; REUTER R, 1990, DEVELOPMENT, V110, P1031; SASAKI H, 1993, DEVELOPMENT, V118, P47; Seshaiah P, 1999, MOL BIOL CELL, V10, P1595, DOI 10.1091/mbc.10.5.1595; Seshaiah P, 2001, DEV BIOL, V239, P309, DOI 10.1006/dbio.2001.0429; Shibutani S, 2007, DEVELOPMENT, V134, P467, DOI 10.1242/dev.02738; Smit RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000222; SMITH AV, 1991, DEVELOPMENT, V112, P997; Takiya S, 2003, INSECT BIOCHEM MOLEC, V33, P1145, DOI 10.1016/s0965-1748(03)00134-6; Taniue K, 2010, DEVELOPMENT, V137, P1755, DOI 10.1242/dev.042077; Wan HJ, 2005, J BIOL CHEM, V280, P13809, DOI 10.1074/jbc.M414122200; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; Weiner L, 2007, CELL, V130, P932, DOI 10.1016/j.cell.2007.07.024; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Zhou B, 2001, DEV BIOL, V237, P54, DOI 10.1006/dbio.2001.0367	61	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20901	10.1371/journal.pone.0020901	http://dx.doi.org/10.1371/journal.pone.0020901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698206	Green Published, gold			2022-12-25	WOS:000291734100030
J	Yang, J; Bromage, TG; Zhao, Q; Xu, BH; Gao, WL; Tian, HF; Tang, HJ; Liu, DW; Zhao, XQ				Yang, Jie; Bromage, Timothy G.; Zhao, Qian; Xu, Bao Hong; Gao, Wei Li; Tian, Hui Fang; Tang, Hui Jun; Liu, Dian Wu; Zhao, Xin Quan			Functional Evolution of Leptin of Ochotona curzoniae in Adaptive Thermogenesis Driven by Cold Environmental Stress	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; MESSENGER-RNA EXPRESSION; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; ENERGY-METABOLISM; RECEPTOR-ALPHA; RECRUITMENT; PGC-1-ALPHA; SYSTEM; UCP1	Background: Environmental stress can accelerate the directional selection and evolutionary rate of specific stress-response proteins to bring about new or altered functions, enhancing an organism's fitness to challenging environments. Plateau pika (Ochotona curzoniae), an endemic and keystone species on Qinghai-Tibetan Plateau, is a high hypoxia and low temperature tolerant mammal with high resting metabolic rate and non-shivering thermogenesis to cope in this harsh plateau environment. Leptin is a key hormone related to how these animals regulate energy homeostasis. Previous molecular evolutionary analysis helped to generate the hypothesis that adaptive evolution of plateau pika leptin may be driven by cold stress. Methodology/Principal Findings: To test the hypothesis, recombinant pika leptin was first purified. The thermogenic characteristics of C57BL/6J mice injected with pika leptin under warm (23+/-1 degrees C) and cold (5+/-1 degrees C) acclimation is investigated. Expression levels of genes regulating adaptive thermogenesis in brown adipose tissue and the hypothalamus are compared between pika leptin and human leptin treatment, suggesting that pika leptin has adaptively and functionally evolved. Our results show that pika leptin regulates energy homeostasis via reduced food intake and increased energy expenditure under both warm and cold conditions. Compared with human leptin, pika leptin demonstrates a superior induced capacity for adaptive thermogenesis, which is reflected in a more enhanced beta-oxidation, mitochondrial biogenesis and heat production. Moreover, leptin treatment combined with cold stimulation has a significant synergistic effect on adaptive thermogenesis, more so than is observed with a single cold exposure or single leptin treatment. Conclusions/Significance: These findings support the hypothesis that cold stress has driven the functional evolution of plateau pika leptin as an ecological adaptation to the Qinghai-Tibetan Plateau.	[Yang, Jie; Tang, Hui Jun; Liu, Dian Wu] Hebei Med Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Shijiazhuang, Hebei, Peoples R China; [Bromage, Timothy G.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, Dept Biomat & Biomimet, New York, NY USA; [Zhao, Qian] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Xu, Bao Hong; Gao, Wei Li; Tian, Hui Fang] Shijiazhuang Ctr Dis Control & Prevent, Dept Microbiol, Shijiazhuang, Hebei, Peoples R China; [Zhao, Xin Quan] Chinese Acad Sci, NW Plateau Inst Biol, Key Lab Qinghai Tibetan Plateau Biol Evolut & Ada, Xining, Qinghai, Peoples R China	Hebei Medical University; New York University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Northwest Institute of Plateau Biology, CAS	Yang, J (corresponding author), Hebei Med Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Shijiazhuang, Hebei, Peoples R China.	dwliu56@yahoo.com.cn; xqzhao@nwipb.ac.cn	; bromage, timothy/H-8621-2015	Liu, Dian-wu/0000-0001-8037-4448; bromage, timothy/0000-0002-9843-7993	National Natural Science Foundation of China [30700073]; Max Planck Research Award; German Federal Ministry of Education and Research; Alexander von Humboldt Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Max Planck Research Award(Max Planck Society); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by the National Natural Science Foundation of China (30700073). Support for Timothy G. Bromage was provided by the 2010 Max Planck Research Award in respect of the Human Paleobiomics initiative, by endowment of the German Federal Ministry of Education and Research to the Max Planck Society and the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW TS, 1999, ANIMAL CONSERVATION, V2, P235; Bates SH, 2004, DIABETES, V53, P3067, DOI 10.2337/diabetes.53.12.3067; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Christoffolete MA, 2004, DIABETES, V53, P577, DOI 10.2337/diabetes.53.3.577; Cui H, 2006, FASEB J, V20, P2654, DOI 10.1096/fj.06-5989fje; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Fan W, 2005, PEPTIDES, V26, P1800, DOI 10.1016/j.peptides.2004.11.033; Fruhbeck G, 2009, TRENDS PHARMACOL SCI, V30, P387, DOI 10.1016/j.tips.2009.05.003; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Golozoubova V, 2006, AM J PHYSIOL-ENDOC M, V291, pE350, DOI 10.1152/ajpendo.00387.2005; Hanada R, 2010, BIOL CHEM, V391, P1365, DOI 10.1515/BC.2010.149; Hanada R, 2009, NATURE, V462, P505, DOI 10.1038/nature08596; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; Jakus PB, 2008, J LIPID RES, V49, P332, DOI 10.1194/jlr.M700316-JLR200; Jorgensen JA, 2007, AM J PHYSIOL-ENDOC M, V293, pE1159, DOI 10.1152/ajpendo.00213.2007; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lehr L, 2006, FEBS LETT, V580, P4661, DOI 10.1016/j.febslet.2006.07.037; Li QF, 2001, COMP BIOCHEM PHYS A, V129, P949, DOI 10.1016/S1095-6433(01)00357-9; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Nedergaard J, 2005, BBA-MOL BASIS DIS, V1740, P293, DOI 10.1016/j.bbadis.2005.02.003; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Oliveira RLGS, 2004, AM J PHYSIOL-ENDOC M, V287, pE686, DOI 10.1152/ajpendo.00103.2004; Peino R, 2000, EUR J ENDOCRINOL, V142, P195, DOI 10.1530/eje.0.1420195; Petrovic N, 2008, AM J PHYSIOL-ENDOC M, V295, pE287, DOI 10.1152/ajpendo.00035.2008; Sainz N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006808; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Suzuki D, 2006, EXP ANIM TOKYO, V55, P467, DOI 10.1538/expanim.55.467; Tang GB, 2009, AM J PHYSIOL-REG I, V297, pR1293, DOI 10.1152/ajpregu.00185.2009; Vergnes L, 2011, J BIOL CHEM, V286, P380, DOI 10.1074/jbc.M110.184754; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wang JM, 2006, OECOLOGIA, V149, P373, DOI 10.1007/s00442-006-0469-1; Wang SP, 2008, MOL GENET METAB, V95, P117, DOI 10.1016/j.ymgme.2008.06.012; Westerberg R, 2006, J BIOL CHEM, V281, P4958, DOI 10.1074/jbc.M511588200; Wright BE, 2004, MOL MICROBIOL, V52, P643, DOI 10.1111/j.1365-2958.2004.04012.x; Yamashita H, 2008, BIOCHEM BIOPH RES CO, V377, P632, DOI 10.1016/j.bbrc.2008.10.041; Yang J, 2006, BIOCHEM BIOPH RES CO, V345, P1405, DOI 10.1016/j.bbrc.2006.05.052; Yang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001472; Zhang YB, 2005, FASEB J, V19, P1482, DOI 10.1096/fj.05-3851com; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; ZHAO XQ, 2008, STUDY MOL EVOLUTION	41	10	14	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e19833	10.1371/journal.pone.0019833	http://dx.doi.org/10.1371/journal.pone.0019833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698227	Green Published, Green Submitted, gold			2022-12-25	WOS:000291734100001
J	Li, X; Qian, J; Wang, CQ; Zheng, K; Ye, L; Fu, Y; Han, N; Bian, HW; Pan, JW; Wang, JH; Zhu, MY				Li, Xuan; Qian, Jia; Wang, Chaoqun; Zheng, Ke; Ye, Lan; Fu, Yu; Han, Ning; Bian, Hongwu; Pan, Jianwei; Wang, Junhui; Zhu, Muyuan			Regulating Cytoplasmic Calcium Homeostasis Can Reduce Aluminum Toxicity in Yeast	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; ENDOPLASMIC-RETICULUM; ABC TRANSPORTER; SACCHAROMYCES-CEREVISIAE; CA2+ HOMEOSTASIS; OXIDATIVE STRESS; BCL-2 FAMILY; APOPTOSIS; TOLERANCE; GENE	Our previous study suggested that increased cytoplasmic calcium (Ca) signals may mediate aluminum (Al) toxicity in yeast (Saccharomyces cerevisiae). In this report, we found that a yeast mutant, pmc1, lacking the vacuolar calcium ion (Ca2+) pump Ca2+-ATPase (Pmc1p), was more sensitive to Al treatment than the wild-type strain. Overexpression of either PMC1 or an anti-apoptotic factor, such as Bcl-2, Ced-9 or PpBI-1, decreased cytoplasmic Ca2+ levels and rescued yeast from Al sensitivity in both the wild-type and pmc1 mutant. Moreover, pretreatment with the Ca2+ chelator BAPTA-AM sustained cytoplasmic Ca2+ at low levels in the presence of Al, effectively making the cells more tolerant to Al exposure. Quantitative RT-PCR revealed that the expression of calmodulin (CaM) and phospholipase C (PLC), which are in the Ca2+ signaling pathway, was down-regulated under Al stress. This effect was largely counteracted when cells overexpressed anti-apoptotic Ced-9 or were pretreated with BAPTA-AM. Taken together, our results suggest that the negative regulation of Al-induced cytoplasmic Ca signaling is a novel mechanism underlying internal resistance to Al toxicity.	[Li, Xuan; Qian, Jia; Wang, Chaoqun; Zheng, Ke; Ye, Lan; Fu, Yu; Han, Ning; Bian, Hongwu; Wang, Junhui; Zhu, Muyuan] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Key Lab Cell & Gene Engn Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China; [Pan, Jianwei] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China	Zhejiang University; Zhejiang Normal University	Li, X (corresponding author), Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Key Lab Cell & Gene Engn Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China.	hwbian@zju.edu.cn; myzhu@zju.edu.cn	Han, Ning/K-3220-2017	Han, Ning/0000-0001-9177-6792	National Science Foundation of China [30771347, 30870034]; National High Technology Research and Development Program of China (863 Program) [2007AA10Z141]; Key Program of Science and technology Department of Zhejiang Province [2009C12072, 2009C32064]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Key Program of Science and technology Department of Zhejiang Province	This work was supported by the National Science Foundation of China (Grant No. 30771347, No. 30870034), National High Technology Research and Development Program of China (863 Program) (No. 2007AA10Z141), and the Key Program of Science and technology Department of Zhejiang Province (No. 2009C12072, No. 2009C32064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anil VS, 2008, J BIOL CHEM, V283, P3497, DOI 10.1074/jbc.M700766200; Bacus SS, 2007, J CLIN ONCOL, V25; Boursiac Y, 2010, PLANT PHYSIOL, V154, P1158, DOI 10.1104/pp.110.159038; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Cessna SG, 1998, J BIOL CHEM, V273, P27286, DOI 10.1074/jbc.273.42.27286; CUNNINGHAM KW, 1994, J EXP BIOL, V196, P157; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; CUNNINGHAM KW, 2011, CELL CALCIU IN PRESS; Demaurex N, 2009, SCIENCE, V326, P57, DOI 10.1126/science.1180482; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Furukawa J, 2007, PLANT CELL PHYSIOL, V48, P1081, DOI 10.1093/pcp/pcm091; Gardarin A, 2010, MOL MICROBIOL, V76, P1034, DOI 10.1111/j.1365-2958.2010.07166.x; Geisler M, 2000, PLANT PHYSIOL, V124, P1814, DOI 10.1104/pp.124.4.1814; Ghribi O, 2002, J NEUROCHEM, V82, P137, DOI 10.1046/j.1471-4159.2002.00957.x; Gunawardena AHLAN, 2008, J EXP BOT, V59, P445, DOI 10.1093/jxb/erm189; Hirschi KD, 2000, PLANT PHYSIOL, V124, P125, DOI 10.1104/pp.124.1.125; Huang CF, 2009, PLANT CELL, V21, P655, DOI 10.1105/tpc.108.064543; Jiang L, 2010, J BIOL CHEM, V285, P30634, DOI 10.1074/jbc.M110.116681; Kakimoto M, 2005, BIOMETALS, V18, P467, DOI 10.1007/s10534-005-4663-0; Kashio Y, 2003, J IMMUNOL, V170, P3631, DOI 10.4049/jimmunol.170.7.3631; Kellermayer R, 2003, J CELL SCI, V116, P1637, DOI 10.1242/jcs.00372; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim MC, 2009, MOL PLANT, V2, P13, DOI 10.1093/mp/ssn091; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Kuo TH, 1998, ONCOGENE, V17, P1903, DOI 10.1038/sj.onc.1202110; Larsen PB, 2007, PLANTA, V225, P1447, DOI 10.1007/s00425-006-0452-4; Larsen PB, 2005, PLANT J, V41, P353, DOI 10.1111/j.1365-313X.2004.02306.x; Lauer CM, 2008, FEMS MICROBIOL LETT, V285, P79, DOI 10.1111/j.1574-6968.2008.01214.x; Liang QL, 2007, MOL BIOL CELL, V18, P4741, DOI 10.1091/mbc.E07-05-0431; Ma JF, 2005, SOIL SCI PLANT NUTR, V51, P609, DOI 10.1111/j.1747-0765.2005.tb00074.x; Ma JF, 2007, INT REV CYTOL, V264, P225, DOI 10.1016/S0074-7696(07)64005-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Magalhaes JV, 2007, NAT GENET, V39, P1156, DOI 10.1038/ng2074; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Muthukumar K, 2010, INDIAN J BIOCHEM BIO, V47, P383; Nargund AM, 2008, APOPTOSIS, V13, P811, DOI 10.1007/s10495-008-0215-8; Panda SK, 2009, PLANT SIGNAL BEHAV, V4, P592, DOI 10.4161/psb.4.7.8903; PEITER E, 2011, CELL CALCIU IN PRESS; PITTMAN JK, 2011, CELL CALCIU IN PRESS; Popa CV, 2010, FEBS J, V277, P4027, DOI 10.1111/j.1742-4658.2010.07794.x; Pottosin II, 2007, J EXP BOT, V58, P1559, DOI 10.1093/jxb/erm035; Pozos TC, 1996, MOL CELL BIOL, V16, P3730; Ramos-Diaz A, 2007, PLANTA, V225, P393, DOI 10.1007/s00425-006-0348-3; Reed JC, 2008, BLOOD, V111, P3322, DOI 10.1182/blood-2007-09-078162; Reimers K, 2008, CURR MOL MED, V8, P148, DOI 10.2174/156652408783769562; Sasaki T, 2004, PLANT J, V37, P645, DOI 10.1111/j.1365-313X.2003.01991.x; Scoltock AB, 2000, J BIOL CHEM, V275, P30586, DOI 10.1074/jbc.M004058200; Seo YW, 2009, CANCER RES, V69, P8356, DOI 10.1158/0008-5472.CAN-09-0349; Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x; Son YO, 2010, TOXICOL SCI, V113, P127, DOI 10.1093/toxsci/kfp259; Szegezdi E, 2009, AM J PHYSIOL-CELL PH, V296, pC941, DOI 10.1152/ajpcell.00612.2008; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Ton VK, 2004, AM J PHYSIOL-CELL PH, V287, pC580, DOI 10.1152/ajpcell.00135.2004; Vanden Abeele F, 2002, CANCER CELL, V1, P169; Wang SH, 2009, CHEM-BIOL INTERACT, V181, P45, DOI 10.1016/j.cbi.2009.05.004; Wang W, 2009, WIREL COMMUN MOB COM, V9, P383, DOI 10.1002/wcm.550; Watanabe N, 2008, J BIOL CHEM, V283, P3200, DOI 10.1074/jbc.M706659200; Westphalen BC, 2005, CELL DEATH DIFFER, V12, P304, DOI 10.1038/sj.cdd.4401547; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; Xu CY, 2008, J BIOL CHEM, V283, P11477, DOI 10.1074/jbc.M708385200; Yamaji N, 2009, PLANT CELL, V21, P3339, DOI 10.1105/tpc.109.070771; YOKOO T, 1993, P NATL ACAD SCI USA, V90, P1804, DOI 10.1073/pnas.90.5.1804; ZHANG B, 2007, INVEST OPHTH VIS SCI, V48, P573; Zhang YQ, 2008, CELL CYCLE, V7, P870, DOI 10.4161/cc.7.7.5616; Zhao D, 2010, INT J CARDIOL, V143, P86, DOI 10.1016/j.ijcard.2009.01.068; Zheng K, 2007, PLANT PHYSIOL, V143, P38, DOI 10.1104/pp.106.082495	69	12	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21148	10.1371/journal.pone.0021148	http://dx.doi.org/10.1371/journal.pone.0021148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698264	Green Published, Green Submitted, gold			2022-12-25	WOS:000291730000057
J	Wu, GD; Yi, NJ; Absher, D; Zhi, DG				Wu, Guodong; Yi, Nengjun; Absher, Devin; Zhi, Degui			Statistical Quantification of Methylation Levels by Next-Generation Sequencing	PLOS ONE			English	Article							CHIP-SEQ DATA; DNA METHYLATION; PROMOTER METHYLATION; GENOME; GLIOBLASTOMA; EPIGENOMICS; GENE; METHYLTRANSFERASES; CANCER; CELLS	Background/Aims: Recently, next-generation sequencing-based technologies have enabled DNA methylation profiling at high resolution and low cost. Methyl-Seq and Reduced Representation Bisulfite Sequencing (RRBS) are two such technologies that interrogate methylation levels at CpG sites throughout the entire human genome. With rapid reduction of sequencing costs, these technologies will enable epigenotyping of large cohorts for phenotypic association studies. Existing quantification methods for sequencing-based methylation profiling are simplistic and do not deal with the noise due to the random sampling nature of sequencing and various experimental artifacts. Therefore, there is a need to investigate the statistical issues related to the quantification of methylation levels for these emerging technologies, with the goal of developing an accurate quantification method. Methods: In this paper, we propose two methods for Methyl-Seq quantification. The first method, the Maximum Likelihood estimate, is both conceptually intuitive and computationally simple. However, this estimate is biased at extreme methylation levels and does not provide variance estimation. The second method, based on Bayesian hierarchical model, allows variance estimation of methylation levels, and provides a flexible framework to adjust technical bias in the sequencing process. Results: We compare the previously proposed binary method, the Maximum Likelihood (ML) method, and the Bayesian method. In both simulation and real data analysis of Methyl-Seq data, the Bayesian method offers the most accurate quantification. The ML method is slightly less accurate than the Bayesian method. But both our proposed methods outperform the original binary method in Methyl-Seq. In addition, we applied these quantification methods to simulation data and show that, with sequencing depth above 40-300 (which varies with different tissue samples) per cleavage site, Methyl-Seq offers a comparable quantification consistency as microarrays.	[Wu, Guodong; Yi, Nengjun; Zhi, Degui] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Absher, Devin] HudsonAlpha Inst Biotechnol, Huntsville, AL USA	University of Alabama System; University of Alabama Birmingham; HudsonAlpha Institute for Biotechnology	Wu, GD (corresponding author), Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA.	dzhi@ms.soph.uab.edu	zhi, Degui/B-1748-2008; Wu, Guodong/U-6549-2018	Wu, Guodong/0000-0003-1550-5952	NIH [R00 RR024163, R01 HL104135, 2R01 GM069430-06, GM077490]; NATIONAL CENTER FOR RESEARCH RESOURCES [R00RR024163] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069430, R01GM077490] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research is supported by NIH grants R00 RR024163, R01 HL104135, 2R01 GM069430-06, and GM077490. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; CATALANI M, 2002, ARXIVMATH0209090; Cohen J, 2002, APPL MULTIPLE REGRES; Donson AM, 2007, PEDIATR BLOOD CANCER, V48, P403, DOI 10.1002/pbc.20803; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fanelli M, 2008, ONCOGENE, V27, P358, DOI 10.1038/sj.onc.1210642; GELMAN JB, 2004, BAYESIAN DATA ANAL; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; LANDER E S, 1988, Genomics, V2, P231; LEHMANN EL, 1991, THEORY POINT ESTIMAT, V12; Li J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r50; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lister R, 2009, GENOME RES, V19, P959, DOI 10.1101/gr.083451.108; Mandrioli M, 2007, CELL MOL LIFE SCI, V64, P2522, DOI 10.1007/s00018-007-7231-7; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Morandi L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-48; Nakamura M, 2001, CARCINOGENESIS, V22, P1715, DOI 10.1093/carcin/22.10.1715; RESNICK SI, 1992, ADVENTURES STOCHASTI, V12; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Singer M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000888; Spiegelhalter DJ, 1999, WINBUGS VERSION 1 2; Spyrou C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-299; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Weber B, 2007, CELL CYCLE, V6, P1001, DOI 10.4161/cc.6.9.4209; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Zheng SK, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp282	30	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21034	10.1371/journal.pone.0021034	http://dx.doi.org/10.1371/journal.pone.0021034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698242	Green Submitted, gold, Green Published			2022-12-25	WOS:000291730000042
J	Asparuhova, MB; Ferralli, J; Chiquet, M; Chiquet-Ehrismann, R				Asparuhova, Maria B.; Ferralli, Jacqueline; Chiquet, Matthias; Chiquet-Ehrismann, Ruth			The transcriptional regulator megakaryoblastic leukemia-1 mediates serum response factor-independent activation of tenascin-C transcription by mechanical stress	FASEB JOURNAL			English	Article						myocardin-related transcription factors; extracellular matrix; mechanotransduction	SCAFFOLD ATTACHMENT FACTOR; CYCLIC TENSILE STRAIN; HUMAN BREAST-CANCER; GENE-EXPRESSION; TUMOR PROGRESSION; SKELETAL-MUSCLE; BINDING DOMAIN; IN-VITRO; SAF-A; ACTIN	The extracellular matrix protein tenascin-C (TNC) is up-regulated in processes influenced by mechanical stress, such as inflammation, tissue remodeling, wound healing, and tumorigenesis. Cyclic strain-induced TNC expression depends on RhoA-actin signaling, the pathway that regulates transcriptional activity of serum response factor (SRF) by its coactivator megakaryoblastic leukemia-1 (MKL1). Therefore, we tested whether MKL1 controls TNC transcription. We demonstrate that overexpression of MKL1 strongly induces TNC expression in mouse NIH3T3 fibroblasts and normal HC11 and transformed 4T1 mammary epithelial cells. Part of the induction was dependant on SRF and a newly identified atypical CArG box in the TNC promoter. Another part was independent of SRF but required the SAP domain of MKL1. An MKL1 mutant incapable of binding to SRF still strongly induced TNC, while induction of the SRF target c-fos was abolished. Cyclic strain failed to induce TNC in MKL1-deficient but not in SRF-deficient fibroblasts, and strain-induced TNC expression strongly depended on the SAP domain of MKL1. Promoter-reporter and chromatin immunoprecipitation experiments unraveled a SAP-dependent, SRF-independent interaction of MKL1 with the proximal promoter region of TNC, attributing for the first time a functional role to the SAP domain of MKL1 in regulating gene expression.-Asparuhova, M. B., Ferralli, J., Chiquet, M., Chiquet-Ehrismann, R. The transcriptional regulator megakaryoblastic leukemia-1 mediates serum response factor-independent activation of tenascin-C transcription by mechanical stress. FASEB J. 25, 3477-3488 (2011). www.fasebj.org	[Asparuhova, Maria B.; Ferralli, Jacqueline; Chiquet-Ehrismann, Ruth] Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Chiquet, Matthias] Univ Bern, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland; [Chiquet-Ehrismann, Ruth] Univ Basel, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Novartis; University of Bern; University of Basel	Chiquet-Ehrismann, R (corresponding author), Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	chiquet@fmi.ch		Chiquet, Matthias/0000-0001-7812-4853	Novartis Research Foundation; Swiss National Science Foundation [3100A0-120235]	Novartis Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Novartis Research Foundation and a grant from the Swiss National Science Foundation 3100A0-120235 to R.C.E. and M.C. The authors thank Silke Maier for her support in the cloning of an MKL1 cDNA, Hubertus Kohler for cell sorting, the Genomics Facility of the Friedrich Miescher Institute and Tim Roloff for the transcript profiling, and Richard P. Tucker for critical reading of the manuscript.	Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; AUFDERHEIDE E, 1988, J CELL BIOL, V107, P2341, DOI 10.1083/jcb.107.6.2341; Brandt DT, 2009, NAT CELL BIOL, V11, P557, DOI 10.1038/ncb1862; Brown THOMAS D., 2000, Comput Methods Biomech Biomed Engin, V3, P65, DOI 10.1080/10255840008915254; Busche S, 2008, J CELL SCI, V121, P1025, DOI 10.1242/jcs.014456; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Calvo A, 2008, ONCOGENE, V27, P5373, DOI 10.1038/onc.2008.155; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; CHAMMAS R, 1994, J CELL SCI, V107, P1031; Chiquet M, 2004, BBA-MOL CELL RES, V1693, P193, DOI 10.1016/j.bbamcr.2004.08.001; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; Chiquet-Ehrismann R, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004960; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; COPERTINO DW, 1995, P NATL ACAD SCI USA, V92, P2131, DOI 10.1073/pnas.92.6.2131; Dandachi N, 2001, J PATHOL, V193, P181, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH752>3.0.CO;2-V; De Wever O, 2004, FASEB J, V18, P1016, DOI 10.1096/fj.03-1110fje; Fluck M, 2000, J CELL SCI, V113, P3583; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gohring F, 1997, EMBO J, V16, P7361, DOI 10.1093/emboj/16.24.7361; Hanna M, 2009, J BIOL CHEM, V284, P23125, DOI 10.1074/jbc.M109.019059; Ishihara A, 1995, CLIN CANCER RES, V1, P1035; Iwasaki K, 2008, J BIOL CHEM, V283, P21230, DOI 10.1074/jbc.M710525200; Jarvinen TAH, 1999, J CELL SCI, V112, P3157; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.3.CO;2-7; Kipp M, 2000, MOL CELL BIOL, V20, P7480, DOI 10.1128/MCB.20.20.7480-7489.2000; Kipp M, 2000, J BIOL CHEM, V275, P5031, DOI 10.1074/jbc.275.7.5031; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kletsas D, 2002, J CELL PHYSIOL, V190, P313, DOI 10.1002/jcp.10052; Lee SM, 2010, J BIOL CHEM, V285, P22036, DOI 10.1074/jbc.M110.108878; LIGHTNER VA, 1994, EXP CELL RES, V210, P177, DOI 10.1006/excr.1994.1027; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackey AL, 2011, FASEB J, V25, P1943, DOI 10.1096/fj.10-176487; Magnusson SP, 2008, J PHYSIOL-LONDON, V586, P71, DOI 10.1113/jphysiol.2007.139105; Maier S, 2008, BBA-MOL CELL RES, V1783, P1150, DOI 10.1016/j.bbamcr.2008.01.013; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Midwood KS, 2009, J CELL COMMUN SIGNAL, V3, P287, DOI 10.1007/s12079-009-0075-1; Mikic B, 2000, J ORTHOPAED RES, V18, P406, DOI 10.1002/jor.1100180312; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Morita T, 2007, EXP CELL RES, V313, P3432, DOI 10.1016/j.yexcr.2007.07.008; Sarasa-Renedo A, 2006, EXP CELL RES, V312, P1361, DOI 10.1016/j.yexcr.2005.12.025; Sasazuki T, 2002, J BIOL CHEM, V277, P28853, DOI 10.1074/jbc.M203190200; Scherberich A, 2005, ONCOGENE, V24, P1525, DOI 10.1038/sj.onc.1208342; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang JHC, 2007, GENE, V391, P1, DOI 10.1016/j.gene.2007.01.014; Webb CMB, 1997, J BONE MINER RES, V12, P52, DOI 10.1359/jbmr.1997.12.1.52; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Zaromytidou AI, 2006, MOL CELL BIOL, V26, P4134, DOI 10.1128/MCB.01902-05; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586; Zipprich JT, 2009, RNA, V15, P781, DOI 10.1261/rna.1448009	58	45	46	3	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2011	25	10					3477	3488		10.1096/fj.11-187310	http://dx.doi.org/10.1096/fj.11-187310			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21705668				2022-12-25	WOS:000295356400018
J	Demidenko, AA; Lee, J; Powers, TR; Nibert, ML				Demidenko, Aleksander A.; Lee, Jinkee; Powers, Thomas R.; Nibert, Max L.			Effects of Viscogens on RNA Transcription inside Reovirus Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-CAPSID PROTEINS; DOUBLE-STRANDED DNA; CRYOELECTRON MICROSCOPY; IN-VITRO; IMAGE-RECONSTRUCTION; CORES; POLYMERASE; VISCOSITY; TRANSLOCATION; MOLECULE	The dsRNA genome of mammalian reovirus (MRV), like the dsDNA genomes of herpesviruses and many bacteriophages, is packed inside its icosahedral capsid in liquid-crystalline form, with concentrations near or more than 400 mg/ml. Viscosity in such environments must be high, but the relevance of viscosity for the macromolecular processes occurring there remains poorly characterized. Here, we describe the use of simple viscogens, glycerol and sucrose, to examine their effects on RNA transcription inside MRV core particles. Transcription inside MRV cores was strongly inhibited by these agents and to a greater extent than either predicted by theory or exhibited by a nonencapsidated transcriptase, suggesting that RNA transcription inside MRV cores is unusually sensitive to viscogen effects. The elongation phase of transcription was found to be a primary target of this inhibition. Similar results were obtained with particles of a second dsRNA virus, rhesus rotavirus, from a divergent taxonomic subfamily. Polymeric viscogens such as polyethylene glycol also inhibited RNA transcription inside MRV cores, but in a size-limited manner, suggesting that diffusion through channels in the MRV core is required for their activity. Modeling of the data suggested that the inherent intracapsid viscosity of both reo-and rotavirus is indeed high, two to three times the viscosity of water. The capacity for quantitative comparisons of intracapsid viscosity and effects of viscogens on macromolecular processes in confined spaces should be similarly informative in other systems.	[Demidenko, Aleksander A.; Nibert, Max L.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Lee, Jinkee; Powers, Thomas R.] Brown Univ, Div Engn, Providence, RI 02912 USA	Harvard University; Harvard Medical School; Brown University	Nibert, ML (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.	mnibert@hms.harvard.edu	Powers, Thomas R/K-1451-2015	Powers, Thomas/0000-0003-3432-8226; Lee, Jinkee/0000-0001-5590-0549	National Institutes of Health [R01 AI47904]; National Science Foundation [CBET-0854108]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant R01 AI47904 (to M. L. N.) and National Science Foundation Grant CBET-0854108 (to T. R. P.).	Allemand JF, 2009, FEMS MICROBIOL REV, V33, P593, DOI 10.1111/j.1574-6976.2009.00166.x; BANERJEE AK, 1970, J VIROL, V6, P1; BELLAMY AR, 1972, NATURE-NEW BIOL, V238, P49, DOI 10.1038/newbio238049a0; BHAT R, 1992, PROTEIN SCI, V1, P1133, DOI 10.1002/pro.5560010907; Bhattacharyya RP, 1999, BIOCHEMISTRY-US, V38, P2601, DOI 10.1021/bi982209j; Cerritelli ME, 1997, CELL, V91, P271, DOI 10.1016/S0092-8674(00)80409-2; Chandran K, 1999, J VIROL, V73, P3941, DOI 10.1128/JVI.73.5.3941-3950.1999; Cheng NS, 2008, IND ENG CHEM RES, V47, P3285, DOI 10.1021/ie071349z; COOKE R, 1974, ANNU REV BIOPHYS BIO, V3, P95, DOI 10.1146/annurev.bb.03.060174.000523; DAVISON PF, 1967, BIOPOLYMERS, V5, P715, DOI 10.1002/bip.1967.360050805; Demidenko AA, 2009, J VIROL, V83, P5659, DOI 10.1128/JVI.02192-08; Dryden KA, 1998, VIROLOGY, V245, P33, DOI 10.1006/viro.1998.9146; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; EARNSHAW WC, 1980, CELL, V21, P319, DOI 10.1016/0092-8674(80)90468-7; Esmann M, 2008, BIOPHYS J, V94, P2767, DOI 10.1529/biophysj.106.101774; FARRELL JA, 1974, VIROLOGY, V62, P145, DOI 10.1016/0042-6822(74)90310-9; Farsetta DL, 2000, J BIOL CHEM, V275, P39693, DOI 10.1074/jbc.M004562200; Fologea D, 2005, NANO LETT, V5, P1734, DOI 10.1021/nl051063o; Fuller DN, 2007, J MOL BIOL, V373, P1113, DOI 10.1016/j.jmb.2007.09.011; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; Grayson P, 2007, P NATL ACAD SCI USA, V104, P14652, DOI 10.1073/pnas.0703274104; Harada Y, 2001, NATURE, V409, P113, DOI 10.1038/35051126; HARVEY JD, 1981, VIROLOGY, V112, P240, DOI 10.1016/0042-6822(81)90629-2; HUNT AJ, 1994, BIOPHYS J, V67, P766, DOI 10.1016/S0006-3495(94)80537-5; Ivanovic T, 2007, J BIOL CHEM, V282, P12210, DOI 10.1074/jbc.M610258200; KAPULER AM, 1970, NATURE, V225, P1209, DOI 10.1038/2251209a0; KAWADE Y, 1956, BIOCHIM BIOPHYS ACTA, V19, P513, DOI 10.1016/0006-3002(56)90475-9; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Lee H, 2008, BIOPHYS J, V95, P1590, DOI 10.1529/biophysj.108.133025; LEPAULT J, 1987, EMBO J, V6, P1507, DOI 10.1002/j.1460-2075.1987.tb02393.x; Mathlouthi M., 1995, SUCROSE PROPERTIES A, P137; Noble S, 1997, J VIROL, V71, P2182, DOI 10.1128/JVI.71.3.2182-2191.1997; RATTI G, 1978, NUCLEIC ACIDS RES, V5, P3843, DOI 10.1093/nar/5.10.3843; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; SKEHEL JJ, 1969, VIROLOGY, V39, P822, DOI 10.1016/0042-6822(69)90019-1; Spencer SM, 1997, J STRUCT BIOL, V120, P11, DOI 10.1006/jsbi.1997.3902; Steitz TA, 2004, CURR OPIN STRUC BIOL, V14, P4, DOI 10.1016/j.sbi.2004.01.006; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Trask SD, 2006, J VIROL, V80, P11293, DOI 10.1128/JVI.01346-06; VANETTEN JL, 1980, J VIROL, V33, P769, DOI 10.1128/JVI.33.2.769-773.1980; YAMAKAWA M, 1981, J BIOL CHEM, V256, P6507; Zhang X, 2003, NAT STRUCT BIOL, V10, P1011, DOI 10.1038/nsb1009	43	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29521	29530		10.1074/jbc.M111.241703	http://dx.doi.org/10.1074/jbc.M111.241703			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21719697	Green Published, hybrid			2022-12-25	WOS:000294046600009
J	Pan, JJ; Qu, HQ; Rentfro, A; McCormick, JB; Fisher-Hoch, SP; Fallon, MB				Pan, Jen-Jung; Qu, Hui-Qi; Rentfro, Anne; McCormick, Joseph B.; Fisher-Hoch, Susan P.; Fallon, Michael B.			Prevalence of Metabolic Syndrome and Risks of Abnormal Serum Alanine Aminotransferase in Hispanics: A Population-Based Study	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; UNITED-STATES; VIRUS-INFECTION; HEPATITIS-C; DISEASE; ASSOCIATION; DEFINITION; ETHNICITY; IMPACT	Aim: Study the prevalence of metabolic syndrome (MS) and risk factors for and association with elevated alanine aminotransferase (ALT) as markers of hepatic injury in a large Hispanic health disparity cohort with high rates of obesity. Methods: Analysis of data from a prospective cross-sectional population based study. From 2004-7, we randomly recruited 2000 community participants to the Cameron County Hispanic Cohort collecting extensive socioeconomic, clinical and laboratory data. We excluded 153 subjects due to critical missing data. Pearson chi-square tests and Student's t-tests were used for categorical and continuous variable analysis, respectively. Logistic regression analysis was performed to determine the risk factors for elevated ALT. Results: The mean age of the cohort was 45 years and 67% were females. The majority of the cohort was either overweight (32.4%) or obese (50.7%). Almost half (43.7%) had MS and nearly one-third diabetes. Elevated ALT level was more prevalent in males than females. Obesity was a strong risk for abnormal ALT in both genders. Hypertriglyceridemia, hypercholesterolemia and young age were risks for elevated ALT in males only, whereas increased fasting plasma glucose was associated with elevated ALT in females only. Conclusion: We identified high prevalence of MS and markers of liver injury in this large Mexican American cohort with gender differences in prevalence and risk factors, with younger males at greatest risk.	[Pan, Jen-Jung; Fallon, Michael B.] Univ Texas Hlth Sci Ctr Houston, Div Gastroenterol Hepatol & Nutr, Dept Internal Med, Houston, TX 77030 USA; [Qu, Hui-Qi; McCormick, Joseph B.; Fisher-Hoch, Susan P.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Brownsville, TX 78520 USA; [Rentfro, Anne] Univ Texas Brownsville, Coll Nursing, Brownsville, TX 78520 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Rio Grande Valley	Pan, JJ (corresponding author), Univ Texas Hlth Sci Ctr Houston, Div Gastroenterol Hepatol & Nutr, Dept Internal Med, Houston, TX 77030 USA.	panjenjung@hotmail.com	Qu, Hui-Qi/B-4719-2009	Qu, Hui-Qi/0000-0001-9317-4488; McCormick, Joseph/0000-0002-5844-8102	National Center on Minority Health and Health disparities (NCMHD) [MD000170 P20]; National Center for Research Resources (NCRR) [1U54RR023417-01]; National Institute on Minority Health and Health Disparities [P20MD000170] Funding Source: NIH RePORTER	National Center on Minority Health and Health disparities (NCMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by MD000170 P20 funded from the National Center on Minority Health and Health disparities (NCMHD), and the Centers for Translational Science Award 1U54RR023417-01 from the National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Dong MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014254; Fisher-Hoch SP, 2010, PREV CHRONIC DIS, V7; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Kallwitz ER, 2008, DIGEST DIS SCI, V53, P1358, DOI 10.1007/s10620-008-0234-x; Kariv R, 2006, LIVER INT, V26, P445, DOI 10.1111/j.1478-3231.2006.01197.x; Kunde SS, 2005, HEPATOLOGY, V42, P650, DOI 10.1002/hep.20818; Machado M, 2006, J HEPATOL, V45, P600, DOI 10.1016/j.jhep.2006.06.013; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Miyazaki Y, 2002, AM J PHYSIOL-ENDOC M, V283, pE1135, DOI 10.1152/ajpendo.0327.2001; Omagari K, 2002, J GASTROEN HEPATOL, V17, P1098, DOI 10.1046/j.1440-1746.2002.02846.x; Perez A, 2004, J GASTROEN HEPATOL, V19, P289, DOI 10.1111/j.1440-1746.2003.03277.x; Piton A, 1998, HEPATOLOGY, V27, P1213, DOI 10.1002/hep.510270505; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; SALINAS J, 2010, AM J MENS HLTH  1007; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; Wasley A, 2010, J INFECT DIS, V202, P192, DOI 10.1086/653622; Weston SR, 2005, HEPATOLOGY, V41, P372, DOI 10.1002/hep.20554; 2010, DIABETES CARE S1, V33, pS11	24	35	37	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21515	10.1371/journal.pone.0021515	http://dx.doi.org/10.1371/journal.pone.0021515			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720553	gold, Green Submitted, Green Published			2022-12-25	WOS:000292036900047
J	Wei, YC; Multi, S; Yang, CR; Ma, JY; Zhang, QH; Wang, ZB; Li, M; Wei, L; Ge, ZJ; Zhang, CH; Ouyang, YC; Hou, Y; Schatten, H; Sun, QY				Wei, Yanchang; Multi, Saima; Yang, Cai-Rong; Ma, Junyu; Zhang, Qing-Hua; Wang, Zhen-Bo; Li, Mo; Wei, Liang; Ge, Zhao-Jia; Zhang, Chun-Hui; Ouyang, Ying-Chun; Hou, Yi; Schatten, Heide; Sun, Qing-Yuan			Spindle Assembly Checkpoint Regulates Mitotic Cell Cycle Progression during Preimplantation Embryo Development	PLOS ONE			English	Article							AGING-ASSOCIATED PHENOTYPES; MOUSE OOCYTE MEIOSIS; CHROMOSOME INSTABILITY; PREMATURE ANAPHASE; MAMMALIAN-CELLS; B DEGRADATION; BUDDING YEAST; MAD2; PROTEIN; MICE	Errors in chromosome segregation or distribution may result in aneuploid embryo formation, which causes implantation failure, spontaneous abortion, genetic diseases, or embryo death. Embryonic aneuploidy occurs when chromosome aberrations are present in gametes or early embryos. To date, it is still unclear whether the spindle assembly checkpoint ( SAC) is required for the regulation of mitotic cell cycle progression to ensure mitotic fidelity during preimplantation development. In this study, using overexpression and RNA interference (RNAi) approaches, we analyzed the role of SAC components (Bub3, BubR1 and Mad2) in mouse preimplantation embryos. Our data showed that overexpressed SAC components inhibited metaphase-anaphase transition by preventing sister chromatid segregation. Deletion of SAC components by RNAi accelerated the metaphase-anaphase transition during the first cleavage and caused micronuclei formation, chromosome misalignment and aneuploidy, which caused decreased implantation and delayed development. Furthermore, in the presence of the spindle-depolymerizing drug nocodazole, SAC depleted embryos failed to arrest at metaphase. Our results suggest that SAC is essential for the regulation of mitotic cell cycle progression in cleavage stage mouse embryos.	[Wei, Yanchang; Multi, Saima; Ma, Junyu; Zhang, Qing-Hua; Wang, Zhen-Bo; Li, Mo; Wei, Liang; Ge, Zhao-Jia; Zhang, Chun-Hui; Ouyang, Ying-Chun; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Yang, Cai-Rong; Ma, Junyu] NE Agr Univ China, Coll Life Sci, Harbin, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Northeast Agricultural University - China; University of Missouri System; University of Missouri Columbia	Wei, YC (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	sunqy@ioz.ac.cn	Yang, Cairong/AAB-1440-2021; Wei, Liang/U-4349-2017	Yang, Cairong/0000-0001-9594-0529; 	National Natural Science Foundation of China [30930065]; Ministry of Science and Technology, China [2011CB944501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, China(Ministry of Science and Technology, China)	This study was supported by National Natural Science Foundation of China (30930065) and Major State Basic Research Program of China Ministry of Science and Technology (2011CB944501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Baker DJ, 2006, J CELL BIOL, V172, P529, DOI 10.1083/jcb.200507081; Brunet S, 2003, REPRODUCTION, V126, P443, DOI 10.1530/rep.0.1260443; Burds AA, 2005, P NATL ACAD SCI USA, V102, P11296, DOI 10.1073/pnas.0505053102; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dai W, 2004, CANCER RES, V64, P440, DOI 10.1158/0008-5472.CAN-03-3119; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Gillett ES, 2004, J CELL BIOL, V164, P535, DOI 10.1083/jcb.200308100; Gorbsky GJ, 1998, J CELL BIOL, V141, P1193, DOI 10.1083/jcb.141.5.1193; Homer HA, 2005, REPRODUCTION, V130, P829, DOI 10.1530/rep.1.00856; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Kalitsis P, 2005, GENE CHROMOSOME CANC, V44, P29, DOI 10.1002/gcc.20215; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Lemaire-Adkins R, 1997, J CELL BIOL, V139, P1611, DOI 10.1083/jcb.139.7.1611; Li M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007701; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Logarinho E, 2008, MOL BIOL CELL, V19, P1798, DOI 10.1091/mbc.E07-07-0633; May KM, 2006, J CELL SCI, V119, P4139, DOI 10.1242/jcs.03165; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Morrow CJ, 2005, J CELL SCI, V118, P3639, DOI 10.1242/jcs.02487; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Niault T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001165; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Tsurumi C, 2004, J CELL BIOL, V167, P1037, DOI 10.1083/jcb.200405165; Wang Q, 2004, BLOOD, V103, P1278, DOI 10.1182/blood-2003-06-2158; Wang WH, 2006, FRONT BIOSCI-LANDMRK, V11, P620, DOI 10.2741/1822; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Wei L, 2010, CELL CYCLE, V9, P1112, DOI 10.4161/cc.9.6.10957; Yin S, 2008, CELL CYCLE, V7, P2997, DOI 10.4161/cc.7.19.6809; Yin S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003516; Zhang D, 2007, REPRODUCTION, V133, P685, DOI 10.1530/rep.1.01167	40	29	29	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21557	10.1371/journal.pone.0021557	http://dx.doi.org/10.1371/journal.pone.0021557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720555	gold, Green Submitted, Green Published			2022-12-25	WOS:000292036900051
J	Ali, MM; Amialchuk, A; Heiland, FW				Ali, Mir M.; Amialchuk, Aliaksandr; Heiland, Frank W.			Weight-Related Behavior among Adolescents: The Role of Peer Effects	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SOCIAL NETWORK; US CHILDREN; NATIONAL-HEALTH; OBESITY; GAIN; PREVALENCE; NUTRITION; CONSUMPTION; OVERWEIGHT	Purpose: To investigate whether social interactions in friendship networks influence the following weight-related behaviors of adolescents: exercising regularly, playing an active sport, hours of TV/Video viewing, sleeping six or fewer hours, eating breakfast on weekdays, frequency of eating at fast food restaurants, eating five servings of fruits/vegetables daily, and consuming calorie-dense snacks. Method: Data from a nationally representative sample of adolescents are used to examine the association between peer and individual weight-related behaviors. Evidence from multivariate regression analysis controlling for an extensive list of individual-and family-level factors as well as school-level unobserved heterogeneity is obtained. Results: We find a significant positive association between individuals' and friends' behaviors in terms of sports, exercise and fast food consumption. The estimated associations are robust to controls for individual-and family-level factors, unobserved heterogeneity at the school level and our attempts to account for non-random peer selection. Conclusions: The social transmission of weight-related behaviors is a viable explanation for the spread of obesity in friendship networks documented in recent research. Traditional weight reduction interventions may be fruitfully complemented with strategies that focus on harnessing peer support to modify behaviors.	[Ali, Mir M.; Amialchuk, Aliaksandr] Univ Toledo, Dept Econ, Toledo, OH 43606 USA; [Ali, Mir M.] US FDA, Off Regulat Policy & Social Sci, College Pk, MD USA; [Heiland, Frank W.] CUNY, Baruch Coll, Grad Ctr Econ, Inst Demog Res,Sch Publ Affairs, New York, NY 10021 USA	University System of Ohio; University of Toledo; US Food & Drug Administration (FDA); City University of New York (CUNY) System; Baruch College (CUNY)	Ali, MM (corresponding author), Univ Toledo, Dept Econ, 2801 W Bancroft St, Toledo, OH 43606 USA.	mir.ali@fda.hhs.gov			National Institute of Child Health and Human Development [P01-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The views expressed in this study are those of the authors and do not necessarily reflect the views of the Food and Drug Administration. The authors would like to thank Andrew Stivers (FDA-ORPSS) and Chung-Tung Jordan Lin (FDA-OPRSS) for helpful comments and suggestions. This research uses data from Add Health, a program project designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris, and funded by grant P01-HD31921 from the National Institute of Child Health and Human Development, with cooperative funding from 17 other agencies. Special acknowledgment is due to Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design. Persons interested in obtaining data files from Add Health should contact Add Health, Carolina Population Center, 123 W. Franklin Street, Chapel Hill, NC 27516-2524 (addhealth@unc.edu).	Adams J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-57; Alexander C, 2001, J ADOLESCENT HEALTH, V29, P22, DOI 10.1016/S1054-139X(01)00210-5; Ali MM, 2011, SOUTH ECON J, V77, P827, DOI 10.4284/0038-4038-77.4.827; Ali MM, 2011, J ADOLESCENCE, V34, P183, DOI 10.1016/j.adolescence.2009.12.008; Ali MM, 2010, ADDICT BEHAV, V35, P337, DOI 10.1016/j.addbeh.2009.12.002; Ali MM, 2009, J ADOLESCENT HEALTH, V45, P402, DOI 10.1016/j.jadohealth.2009.02.004; Andersen RE, 1998, JAMA-J AM MED ASSOC, V279, P938, DOI 10.1001/jama.279.12.938; BARNES MG, 2010, 20102 WSU SCH EC SCI; Boone JE, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-26; Burke MA, 2007, ECON INQ, V45, P571, DOI 10.1111/j.1465-7295.2007.00025.x; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Clark AE, 2007, J HEALTH ECON, V26, P763, DOI 10.1016/j.jhealeco.2006.11.005; Crespo CJ, 2001, ARCH PEDIAT ADOL MED, V155, P360, DOI 10.1001/archpedi.155.3.360; Davis B, 2009, AM J PUBLIC HEALTH, V99, P505, DOI 10.2105/AJPH.2008.137638; Deri C, 2005, J HEALTH ECON, V24, P1076, DOI 10.1016/j.jhealeco.2005.03.008; Fletcher J, 2006, ARCH PEDIAT ADOL MED, V160, P383, DOI 10.1001/archpedi.160.4.383; Gordon-Larsen P, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e83; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; Halliday TJ, 2009, ECON HUM BIOL, V7, P181, DOI 10.1016/j.ehb.2009.05.002; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Jahns L, 2001, J PEDIATR-US, V138, P493, DOI 10.1067/mpd.2001.112162; Lieberman M, 2001, Eat Behav, V2, P215, DOI 10.1016/S1471-0153(01)00030-7; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Mednick SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009775; Nelson MC, 2006, PEDIATRICS, V118, pE1627, DOI 10.1542/peds.2006-0926; Nicklas TA, 2003, AM J PREV MED, V25, P9, DOI 10.1016/S0749-3797(03)00098-9; Niemeier HM, 2006, J ADOLESCENT HEALTH, V39, P842, DOI 10.1016/j.jadohealth.2006.07.001; O'Malley AJ, 2011, STAT MED, V30, P950, DOI 10.1002/sim.4190; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Renna F, 2008, ECON HUM BIOL, V6, P377, DOI 10.1016/j.ehb.2008.06.005; Salvy SJ, 2007, APPETITE, V49, P177, DOI 10.1016/j.appet.2007.01.011; Siega-Riz AM, 1998, AM J CLIN NUTR, V67, p748S, DOI 10.1093/ajcn/67.4.748S; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Valente TW, 2009, J ADOLESCENT HEALTH, V45, P202, DOI 10.1016/j.jadohealth.2009.01.007; Wang SS, 2006, HEALTH PSYCHOL, V25, P658, DOI 10.1037/0278-6133.25.5.658	38	89	91	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21179	10.1371/journal.pone.0021179	http://dx.doi.org/10.1371/journal.pone.0021179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782TT	21731665	gold, Green Published, Green Submitted			2022-12-25	WOS:000292035400011
J	Nunes, B; Viboud, C; Machado, A; Ringholz, C; Rebelo-de-Andrade, H; Nogueira, P; Miller, M				Nunes, Baltazar; Viboud, Cecile; Machado, Ausenda; Ringholz, Corinne; Rebelo-de-Andrade, Helena; Nogueira, Paulo; Miller, Mark			Excess Mortality Associated with Influenza Epidemics in Portugal, 1980 to 2004	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL-VIRUS; UNITED-STATES; HOSPITAL ADMISSIONS; IMPACT; VACCINATION; DISEASE; POPULATION; PNEUMONIA; SURVEILLANCE; CHILDREN	Background: Influenza epidemics have a substantial impact on human health, by increasing the mortality from pneumonia and influenza, respiratory and circulatory diseases, and all causes. This paper provides estimates of excess mortality rates associated with influenza virus circulation for 7 causes of death and 8 age groups in Portugal during the period of 1980-2004. Methodology/Principal Findings: We compiled monthly mortality time series data by age for all-cause mortality, cerebrovascular diseases, ischemic heart diseases, diseases of the respiratory system, chronic respiratory diseases, pneumonia and influenza. We also used a control outcome, deaths from injuries. Age-and cause-specific baseline mortality was modelled by the ARIMA approach; excess deaths attributable to influenza were calculated by subtracting expected deaths from observed deaths during influenza epidemic periods. Influenza was associated with a seasonal average of 24.7 all-cause excess deaths per 100,000 inhabitants, approximately 90% of which were among seniors over 65 yrs. Excess mortality was 3-6 fold higher during seasons dominated by the A(H3N2) subtype than seasons dominated by A(H1N1)/B. High excess mortality impact was also seen in children under the age of four years. Seasonal excess mortality rates from all the studied causes of death were highly correlated with each other (Pearson correlation range, 0.65 to 0.95, P<0.001) and with seasonal rates of influenza-like-illness (ILI) among seniors over 65 years (Pearson correlation rho >0.64, P<0.05). By contrast, there was no correlation with excess mortality from injuries. Conclusions/Significance: Our excess mortality approach is specific to influenza virus activity and produces influenza-related mortality rates for Portugal that are similar to those published for other countries. Our results indicate that all-cause excess mortality is a robust indicator of influenza burden in Portugal, and could be used to monitor the impact of influenza epidemics in this country. Additional studies are warranted to confirm these findings in other settings.	[Nunes, Baltazar; Machado, Ausenda; Nogueira, Paulo] Inst Nacl Saude Dr Ricardo Jorge, Dept Epidemiol, Lisbon, Portugal; [Viboud, Cecile; Ringholz, Corinne; Miller, Mark] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Rebelo-de-Andrade, Helena] Inst Nacl Saude Dr Ricardo Jorge, Dept Doencas Infecciosas, Lisbon, Portugal; [Rebelo-de-Andrade, Helena] Univ Lisbon, Fac Farm, Lisbon, Portugal	Instituto Nacional de Saude Dr. Ricardo Jorge; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade de Lisboa	Nunes, B (corresponding author), Inst Nacl Saude Dr Ricardo Jorge, Dept Epidemiol, Lisbon, Portugal.	baltazar.nunes@insa.min-saude.pt	iMed.ULisboa, HPI/B-4239-2014; Machado, Ausenda/AAE-9913-2022; Nogueira, Paulo Jorge/AAR-5605-2020; Nunes, Baltazar/V-8903-2019; Rebelo-de-Andrade, Helena/E-1871-2014; Machado, Ausenda/ABP-0781-2022; Nogueira, Paulo/HDL-7482-2022	iMed.ULisboa, HPI/0000-0001-5934-0198; Nogueira, Paulo Jorge/0000-0001-8316-5035; Nunes, Baltazar/0000-0001-6230-7209; Rebelo-de-Andrade, Helena/0000-0002-0138-0944; Machado, Ausenda/0000-0002-1849-1499	Luso-American Foundation [1-13/08]; Instituto Nacional de Saude; International Influenza Unit, Office of Global Health Affairs, Department of Health and Human Services	Luso-American Foundation; Instituto Nacional de Saude; International Influenza Unit, Office of Global Health Affairs, Department of Health and Human Services	This project was initiated during a three-month visit by B. Nunes to the Fogarty International Center, United States National Institutes of Health, and supported by the Luso-American Foundation project 1-13/08 and the Instituto Nacional de Saude Dr. Ricardo Jorge. This research was conducted in the context of the MISMS Study, an ongoing international collaborative effort to understand influenza epidemiological and evolutionary patterns, led by the Fogarty International Center, National Institutes of Health (http://www.origem.info/misms/index.php). The MISMS study is funded by the International Influenza Unit, Office of Global Health Affairs, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltussen RMPM, 1998, EPIDEMIOL INFECT, V121, P129, DOI 10.1017/S0950268898008966; Beigel JH, 2008, CRIT CARE MED, V36, P2660, DOI 10.1097/CCM.0b013e318180b039; BRANCO MJ, 2003, QUE MAIS SE MORRE PO; Brinkhof MWG, 2006, SWISS MED WKLY, V136, P302; CARRAT F, 1995, J EPIDEMIOL COMMUN H, V49, P419, DOI 10.1136/jech.49.4.419; CHOI K, 1982, AM J PUBLIC HEALTH, V72, P1280, DOI 10.2105/AJPH.72.11.1280; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; FENTON LF, 1960, IRE T COMMUN, V8; Francisco PMSB, 2005, REV SAUDE PUBL, V39, P75, DOI 10.1590/S0034-89102005000100010; Hyndman R., 2008, J STAT SOFTWARE, V27; *I NAC EST, 2008, INF; *I NAC SAUD DR R J, 2009, MED SENT QUE SE FEZ; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Jansen AGSC, 2007, EUR RESPIR J, V30, P1158, DOI 10.1183/09031936.00034407; Kyncl J, 2005, EUR J EPIDEMIOL, V20, P365, DOI 10.1007/s10654-005-1067-y; Madjid M, 2004, TEX HEART I J, V31, P4; Mazick A, 2010, EURO SURVEILL, V15; Mazick A, 2007, EURO SURVEILL, V12; Meier CR, 2000, EUR J CLIN MICROBIOL, V19, P834, DOI 10.1007/s100960000376; Nguyen-Van-Tam JS, 2001, EPIDEMIOL INFECT, V126, P71, DOI 10.1017/S0950268801005076; Nogueira PJ, 2010, EURO SURVEILL, V15; NOGUEIRA PJ, 2009, EURO SURVEILL, V14; NUNES B, 2008, VACINA ANTIGRIPAL CO; NUNES B, 2010, STAT METHODS MED RES; Oropesa S, 2004, INT CONGR SER, V1263, P355, DOI 10.1016/j.ics.2004.04.004; *R DEC COR TEAM, 2008, R LANG ENV STAT COMP; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Richard SA, 2009, EPIDEMIOL INFECT, V137, P1062, DOI 10.1017/S0950268809002088; Rizzo C, 2006, VACCINE, V24, P6468, DOI 10.1016/j.vaccine.2006.06.052; Schanzer DL, 2007, EPIDEMIOL INFECT, V135, P1109, DOI 10.1017/S0950268807007923; SERFLING RE, 1967, AM J EPIDEMIOL, V86, P433, DOI 10.1093/oxfordjournals.aje.a120753; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Simonsen L, 2000, J INFECT DIS, V181, P831, DOI 10.1086/315320; SPRENGER MJW, 1993, INT J EPIDEMIOL, V22, P334, DOI 10.1093/ije/22.2.334; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; *UN POP DIV POP ES, 2008, WORLD POP PROSP 2008; WHO, 2006, MORT COUNTR FACT SHE; *WONCA INT CLASS C, 1999, ICPC 2 CLASS INT CUI; Yap FHY, 2004, J MED VIROL, V73, P617, DOI 10.1002/jmv.20135; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X; Zucs P, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-6	45	56	66	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e20661	10.1371/journal.pone.0020661	http://dx.doi.org/10.1371/journal.pone.0020661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782CL	21713040	Green Published, Green Submitted, gold			2022-12-25	WOS:000291985100003
J	Morcillo, S; Martin-Nunez, GM; Rojo-Martinez, G; Almaraz, MC; Garcia-Escobar, E; Mansego, ML; de Marco, G; Chaves, FJ; Soriguer, F				Morcillo, Sonsoles; Maria Martin-Nunez, Gracia; Rojo-Martinez, Gemma; Cruz Almaraz, Maria; Garcia-Escobar, Eva; Luisa Mansego, Maria; de Marco, Griselda; Chaves, Felipe J.; Soriguer, Federico			ELOVL6 Genetic Variation Is Related to Insulin Sensitivity: A New Candidate Gene in Energy Metabolism	PLOS ONE			English	Article							FATTY-ACID ELONGASES; OLEIC-ACID; RESISTANCE; POPULATION; PIZARRA; GLUCOSE; OBESITY	Background: The elongase of long chain fatty acids family 6 (ELOVL6) is an enzyme that specifically catalyzes the elongation of saturated and monounsaturated fatty acids with 12, 14 and 16 carbons. ELOVL6 is expressed in lipogenic tissues and it is regulated by sterol regulatory element binding protein 1 (SREBP-1). Objective: We investigated whether ELOVL6 genetic variation is associated with insulin sensitivity in a population from southern Spain. Design: We undertook a prospective, population-based study collecting phenotypic, metabolic, nutritional and genetic information. Measurements were made of weight and height and the body mass index (BMI) was calculated. Insulin resistance was measured by homeostasis model assessment. The type of dietary fat was assessed from samples of cooking oil taken from the participants' kitchens and analyzed by gas chromatography. Five SNPs of the ELOVL6 gene were analyzed by SNPlex. Results: Carriers of the minor alleles of the SNPs rs9997926 and rs6824447 had a lower risk of having high HOMA_IR, whereas carriers of the minor allele rs17041272 had a higher risk of being insulin resistant. An interaction was detected between the rs6824447 polymorphism and the intake of oil in relation with insulin resistance, such that carriers of this minor allele who consumed sunflower oil had lower HOMA_IR than those who did not have this allele (P = 0.001). Conclusions: Genetic variations in the ELOVL6 gene were associated with insulin sensitivity in this population-based study.	[Morcillo, Sonsoles; Maria Martin-Nunez, Gracia; Rojo-Martinez, Gemma; Cruz Almaraz, Maria; Garcia-Escobar, Eva; Soriguer, Federico] Hosp Carlos Haya, Endocrinol & Nutr Serv, Malaga, Spain; [Morcillo, Sonsoles; Maria Martin-Nunez, Gracia; Rojo-Martinez, Gemma; Cruz Almaraz, Maria; Garcia-Escobar, Eva; Luisa Mansego, Maria; de Marco, Griselda; Chaves, Felipe J.; Soriguer, Federico] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metabol Asociadas CIB, Barcelona, Spain; [Luisa Mansego, Maria; de Marco, Griselda; Chaves, Felipe J.] Hosp Clin Res Fdn Valencia INCLIVA, Unidad Genotipado & Diagnost Genet, Valencia, Spain	Hospital Carlos Haya; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III	Morcillo, S (corresponding author), Hosp Carlos Haya, Endocrinol & Nutr Serv, Malaga, Spain.	sonsoles75@gmail.com	Rojo-martínez, Gemma/E-3351-2010; Chaves-Martinez, Felipe Javier/ABC-3294-2021; MORCILLO, SONSOLES/N-9970-2017; MANSEGO, MARIA/A-5687-2011	Rojo-martínez, Gemma/0000-0003-2179-2134; Chaves-Martinez, Felipe Javier/0000-0001-8009-3689; Almaraz, Maria Cruz/0000-0002-4470-4515; Martin Nunez, Gracia Maria/0000-0001-7069-2960; MORCILLO, SONSOLES/0000-0001-6932-5637; GARCIA-ESCOBAR, EVA/0000-0002-0134-3473; MANSEGO, MARIA/0000-0001-8914-7890; De Marco, Griselda/0000-0003-2344-9348	Fondo de Investigacion Sanitaria [PI051307, PI09/2117, PI070497]; Junta de Andalucia [PI0192/2008]; CIBERDEM [CB-02/08/2009]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Junta de Andalucia(Junta de Andalucia); CIBERDEM	This study was funded by the Fondo de Investigacion Sanitaria (PI051307, PI09/2117, and PI070497), Junta de Andalucia (PI0192/2008) and CIBERDEM (INGENFRED Project CB-02/08/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartoli E, 2011, EUR J INTERN MED, V22, P8, DOI 10.1016/j.ejim.2010.07.008; BEDDINGFIELD H, 2005, IMPRINT, V52; DEFRONZO RA, 2010, DIABETOLOGIA; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Jump DB, 2005, J NUTR, V135, P2503, DOI 10.1093/jn/135.11.2503; Matsuzaka T, 2002, J LIPID RES, V43, P911; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Matsuzaka T, 2009, J MOL MED, V87, P379, DOI 10.1007/s00109-009-0449-0; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; MORCILLO S, 2009, J RHEUMATOL; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Riccardi G, 2004, CLIN NUTR, V23, P447, DOI 10.1016/j.clnu.2004.02.006; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Shimamura K, 2010, EUR J PHARMACOL, V630, P34, DOI 10.1016/j.ejphar.2009.12.033; Soriguer F, 2008, EUR J CLIN INVEST, V38, P126, DOI 10.1111/j.1365-2362.2007.01910.x; Soriguer F, 2004, EUR J ENDOCRINOL, V150, P33, DOI 10.1530/eje.0.1500033; SORIGUER F, 2009, EUR J CLIN NUTR; SORIGUER F, 2009, BR J NUTR, P1; Soriguer F, 2006, J NUTR, V136, P2325, DOI 10.1093/jn/136.9.2325; Sudhir Rajasekaran, 2002, Treat Endocrinol, V1, P105, DOI 10.2165/00024677-200201020-00004; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; Wang Y, 2005, J LIPID RES, V46, P706, DOI 10.1194/jlr.M400335-JLR200; Wang Y, 2006, J LIPID RES, V47, P2028, DOI 10.1194/jlr.M600177-JLR200; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	27	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21198	10.1371/journal.pone.0021198	http://dx.doi.org/10.1371/journal.pone.0021198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701577	Green Submitted, Green Published, gold			2022-12-25	WOS:000291983800031
J	Horste, GMZ; Mausberg, AK; Muller, JI; Lehmann, HC; Lober, S; Gmeiner, P; Hartung, HP; Stuve, O; Korth, C; Kieseier, BC				Hoerste, Gerd Meyer Zu; Mausberg, Anne K.; Mueller, Johanna I.; Lehmann, Helmar C.; Loeber, Stefan; Gmeiner, Peter; Hartung, Hans-Peter; Stueve, Olaf; Korth, Carsten; Kieseier, Bernd C.			Quinpramine Ameliorates Rat Experimental Autoimmune Neuritis and Redistributes MHC Class II Molecules	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; MOUSE SCHWANN-CELLS; DEMYELINATION; NEUROPATHIES; EXPRESSION; COMPOUND; SYSTEM	Activation of inflammatory cells is central to the pathogenesis of autoimmune demyelinating diseases of the peripheral nervous system. The novel chimeric compound quinpramine-generated from imipramine and quinacrine-redistributes cholesterol rich membrane domains to intracellular compartments. We studied the immunological and clinical effects of quinpramine in myelin homogenate induced Lewis rat experimental autoimmune neuritis (EAN), a model system for acute human inflammatory neuropathies, such as the Guillain-Barre syndrome. EAN animals develop paresis of all limbs due to autoimmune inflammation of peripheral nerves. Quinpramine treatment ameliorated clinical disease severity of EAN and infiltration of macrophages into peripheral nerves. It reduced expression of MHC class II molecules on antigen presenting cells and antigen specific T cell proliferation both in vitro and in vivo. Quinpramine exerted its anti-proliferatory effect on antigen presenting cells, but not on responder T cells. Our data suggest that quinpramine represents a candidate pharmaceutical for inflammatory neuropathies.	[Hoerste, Gerd Meyer Zu; Mausberg, Anne K.; Mueller, Johanna I.; Lehmann, Helmar C.; Hartung, Hans-Peter; Kieseier, Bernd C.] Univ Dusseldorf, Dept Neurol, Fac Med, D-4000 Dusseldorf, Germany; [Loeber, Stefan; Gmeiner, Peter] Univ Erlangen Nurnberg, Dept Med Chem, Erlangen, Germany; [Stueve, Olaf] Univ Texas SW, Dept Neurol, Dallas, TX USA; [Stueve, Olaf] VA N Texas Hlth Care Syst, Neurol Sect, Dallas, TX USA; [Korth, Carsten] Univ Dusseldorf, Inst Neuropathol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; University of Erlangen Nuremberg; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; Heinrich Heine University Dusseldorf	Horste, GMZ (corresponding author), Univ Dusseldorf, Dept Neurol, Fac Med, D-4000 Dusseldorf, Germany.	gerd.mzh@uni-duesseldorf.de	Gmeiner, Peter/N-5275-2015; Horste, Gerd Meyer zu/O-9549-2016; Lehmann, Helmar C/G-4998-2016	Horste, Gerd Meyer zu/0000-0002-4341-4719; Lehmann, Helmar C/0000-0001-6205-2293; Mausberg, Anne K/0000-0001-9026-1703; Gmeiner, Peter/0000-0002-4127-197X	Research Commission of the Heinrich-Heine-University Dusseldorf; Fritz-Thyssen foundation; Volkswagen Stiftung; European Union	Research Commission of the Heinrich-Heine-University Dusseldorf; Fritz-Thyssen foundation; Volkswagen Stiftung(Volkswagen); European Union(European Commission)	This study was funded in part by grants from the Research Commission of the Heinrich-Heine-University Dusseldorf (to G.M.z.H.) and from the Fritz-Thyssen foundation (to G.M.z.H.). This study was also funded in part by grants from the Volkswagen Stiftung (to P. G. and C. K.) and from the European Union - Frame Work Program 7 PRIORITY (to C. K.). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Dollinger S, 2006, J MED CHEM, V49, P6591, DOI 10.1021/jm060773j; GRIFFIN JW, 2005, PERIPHERAL NEUROPATH, P2197; Horste GMZ, 2007, NAT CLIN PRACT NEURO, V3, P198, DOI 10.1038/ncpneuro0452; Horste GMZ, 2010, DRUG NEWS PERSPECT, V23, P287, DOI 10.1358/dnp.2010.23.5.1447850; Horste GMZ, 2010, NEUROBIOL DIS, V37, P483, DOI 10.1016/j.nbd.2009.11.006; Horste GMZ, 2010, GLIA, V58, P80, DOI 10.1002/glia.20903; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004; Jung S, 1995, NEUROSCI LETT, V200, P167, DOI 10.1016/0304-3940(95)12115-K; Kabouridis PS, 2006, MOL MEMBR BIOL, V23, P49, DOI 10.1080/09687860500453673; KADLUBOWSKI M, 1980, J NEUROL SCI, V48, P171, DOI 10.1016/0022-510X(80)90198-7; Kieseier BC, 2000, J NEUROIMMUNOL, V110, P121, DOI 10.1016/S0165-5728(00)00323-4; Klingenstein R, 2006, J NEUROCHEM, V98, P748, DOI 10.1111/j.1471-4159.2006.03889.x; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Maurer M, 2002, CURR OPIN NEUROL, V15, P617, DOI 10.1097/00019052-200210000-00013; McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748; Horste GMZ, 2007, ANN NEUROL, V61, P61, DOI 10.1002/ana.21026; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; PRINEAS JW, 1981, ANN NEUROL, V9, P6, DOI 10.1002/ana.410090704; Razzaq TM, 2004, IMMUNOLOGY, V113, P413, DOI 10.1111/j.1365-2567.2004.01998.x; Saavedra JT, 2008, J NEUROSCI METH, V174, P25, DOI 10.1016/j.jneumeth.2008.06.029; Singh MP, 2009, EXP NEUROL, V215, P397, DOI 10.1016/j.expneurol.2008.10.001; van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	25	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21223	10.1371/journal.pone.0021223	http://dx.doi.org/10.1371/journal.pone.0021223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698177	Green Published, Green Submitted, gold			2022-12-25	WOS:000291734100069
J	De Repentigny, Y; Ferrier, A; Ryan, SD; Sato, T; Kothary, R				De Repentigny, Yves; Ferrier, Andrew; Ryan, Scott D.; Sato, Tadasu; Kothary, Rashmi			Motor Unit Abnormalities in Dystonia musculorum Mice	PLOS ONE			English	Article							VERTEBRATE NEUROMUSCULAR-JUNCTION; BULLOUS PEMPHIGOID ANTIGEN-1; POSSIBLE CELLULAR MECHANISM; MYELINATING SCHWANN-CELLS; CROSS-LINKING FACTOR; DORSAL-ROOT GANGLIA; MUTANT MICE; DT MICE; NEUROLOGIC DEGENERATION; NEURONAL DEGENERATION	Dystonia musculorum (dt) is a mouse inherited sensory neuropathy caused by mutations in the dystonin gene. While the primary pathology lies in the sensory neurons of dt mice, the overt movement disorder suggests motor neurons may also be affected. Here, we report on the contribution of motor neurons to the pathology in dt(27J) mice. Phenotypic dt(27J) mice display reduced alpha motor neuron cell number and eccentric alpha motor nuclei in the ventral horn of the lumbar L1 spinal cord region. A dramatic reduction in the total number of motor axons in the ventral root of postnatal day 15 dt(27J) mice was also evident. Moreover, analysis of the trigeminal nerve of the brainstem showed a 2.4 fold increase in number of degenerating neurons coupled with a decrease in motor neuron number relative to wild type. Aberrant phosphorylation of neurofilaments in the perikaryon region and axonal swellings within the pre-synaptic terminal region of motor neurons were observed. Furthermore, neuromuscular junction staining of dt(27J) mouse extensor digitorum longus and tibialis anterior muscle fibers showed immature endplates and a significant decrease in axon branching compared to wild type littermates. Muscle atrophy was also observed in dt(27J) muscle. Ultrastructure analysis revealed amyelinated motor axons in the ventral root of the spinal nerve, suggesting a possible defect in Schwann cells. Finally, behavioral analysis identified defective motor function in dt(27J) mice. This study reveals neuromuscular defects that likely contribute to the dt(27J) pathology and identifies a critical role for dystonin outside of sensory neurons.	[De Repentigny, Yves; Ferrier, Andrew; Ryan, Scott D.; Sato, Tadasu; Kothary, Rashmi] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Ferrier, Andrew; Kothary, Rashmi] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Ferrier, Andrew; Kothary, Rashmi] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	De Repentigny, Y (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.	rkothary@ohri.ca		Kothary, Rashmi/0000-0002-9239-7310; Ryan, Scott/0000-0001-9829-4649	Canadian Institute of Health Research (CIHR)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was funded by the Canadian Institute of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antolik C, 2007, NEUROSCIENCE, V145, P56, DOI 10.1016/j.neuroscience.2006.11.047; BEKOFF A, 1977, J PHYSIOL-LONDON, V271, P25, DOI 10.1113/jphysiol.1977.sp011988; Bernier G, 1995, MOL CELL NEUROSCI, V6, P509, DOI 10.1006/mcne.1995.0003; Bernier G, 1998, DEVELOPMENT, V125, P2135; BROWN A, 1995, GENOMICS, V29, P777, DOI 10.1006/geno.1995.9936; BROWN A, 1995, NAT GENET, V10, P301, DOI 10.1038/ng0795-301; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; Dalpe G, 1998, MOL CELL NEUROSCI, V10, P243, DOI 10.1006/mcne.1997.0660; Dalpe G, 1999, DEV BIOL, V210, P367, DOI 10.1006/dbio.1999.9263; De Repentigny Y, 2003, J NEUROCHEM, V86, P564, DOI 10.1046/j.1471-4159.2003.01861.x; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Dowling J, 1997, DEV BIOL, V187, P131, DOI 10.1006/dbio.1997.8567; Duchen L W, 1976, Adv Neurol, V14, P353; DUCHEN LW, 1964, BRAIN, V87, P367, DOI 10.1093/brain/87.2.367; Guillery RW, 2002, PROG BRAIN RES, V135, P25; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; JANOTA I, 1972, BRAIN, V95, P529, DOI 10.1093/brain/95.3.529; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Lalonde R, 2005, PHYSIOL BEHAV, V86, P46, DOI 10.1016/j.physbeh.2005.06.028; LALONDE R, 1993, PHYSIOL BEHAV, V54, P119, DOI 10.1016/0031-9384(93)90052-H; LANCEJONES C, 1982, DEV BRAIN RES, V4, P473, DOI 10.1016/0165-3806(82)90192-4; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Leung CL, 2002, TRENDS CELL BIOL, V12, P37, DOI 10.1016/S0962-8924(01)02180-8; Leung CL, 2001, J CELL BIOL, V154, P691, DOI 10.1083/jcb.200012098; Martini R, 2001, MUSCLE NERVE, V24, P456, DOI 10.1002/mus.1027; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; MESSER A, 1980, NEUROSCIENCE, V5, P543, DOI 10.1016/0306-4522(80)90051-2; Mirsky R, 1999, BRAIN PATHOL, V9, P293; Narver HL, 2008, ANN NEUROL, V64, P465, DOI 10.1002/ana.21449; Okumura M, 2002, J BIOL CHEM, V277, P6682, DOI 10.1074/jbc.M109209200; OPPENHEIM RW, 1992, NATURE, V360, P755, DOI 10.1038/360755a0; Pool M, 2005, MAMM GENOME, V16, P909, DOI 10.1007/s00335-005-0073-4; Popko B, 2010, NAT NEUROSCI, V13, P275, DOI 10.1038/nn0310-275; Prokop A, 1998, J CELL BIOL, V143, P1283, DOI 10.1083/jcb.143.5.1283; REXED B, 1952, J COMP NEUROL, V96, P415, DOI 10.1002/cne.900960303; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Ruegg MA, 1998, TRENDS NEUROSCI, V21, P22, DOI 10.1016/S0166-2236(97)01154-5; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; SOTELO C, 1988, NEUROSCIENCE, V27, P403, DOI 10.1016/0306-4522(88)90277-1; STANLEY JR, 1988, J CLIN INVEST, V82, P1864, DOI 10.1172/JCI113803; Tseng KW, 2008, J COMP NEUROL, V507, P1053, DOI 10.1002/cne.21606; Tseng KW, 2006, J NEUROPATH EXP NEUR, V65, P336, DOI 10.1097/01.jnen.0000218448.39944.f1; Witzemann V, 2006, CELL TISSUE RES, V326, P263, DOI 10.1007/s00441-006-0237-x; Young KG, 2008, EXP CELL RES, V314, P2750, DOI 10.1016/j.yexcr.2008.06.021; Young KG, 2007, CELL MOTIL CYTOSKEL, V64, P897, DOI 10.1002/cm.20235; Young KG, 2007, J NEUROPATH EXP NEUR, V66, P248, DOI 10.1097/01.jnen.0000248560.60703.45	55	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21093	10.1371/journal.pone.0021093	http://dx.doi.org/10.1371/journal.pone.0021093			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698255	Green Submitted, gold, Green Published			2022-12-25	WOS:000291730000052
J	Allen, MD; Neumann, S; Gershengorn, MC				Allen, Michael D.; Neumann, Susanne; Gershengorn, Marvin C.			Occupancy of both sites on the thyrotropin (TSH) receptor dimer is necessary for phosphoinositide signaling	FASEB JOURNAL			English	Article						GPCR; inositolphosphates; IP1; G(q/11) coupling	PHOSPHOLIPASE-C; FLUORESCENT PROTEIN; CYTOSOLIC CA-2+; PHARMACOLOGY; DIMERIZATION; TRANSDUCIN; MUTATIONS; RHODOPSIN; FAMILIES; PEPTIDE	The thyroid-stimulating hormone (TSH) receptor signals via Gs to produce cAMP and via G(q/11) to produce inositol-1,4,5-trisphosphate, which is degraded to inositol monophosphate (IP1; phosphoinositide signaling). The potency of TSH for cAMP signaling is higher than for phosphoinositide signaling, and it was suggested that there are "spare receptors" for cAMP signaling. In a human embryonic kidney macrophage scavenger receptor-expressing (HEK-EM) 293 model system, there are no spare receptors, but the cells still exhibited 100-fold differences in potencies. Dose responses for TSH-stimulated dissociation of prebound 125I-TSH (negative cooperativity; EC50 = 70 mU/ml), which requires TSH binding to both sites of the TSH receptor (TSHR) homodimer, and TSH-stimulated IP1 production (EC50 = 50 mU/ml) were indistinguishable. Fluorescence resonance energy transfer (FRET) using tagged receptors showed that TSHR formed homodimers and heterodimers with two binding-deficient mutant TSHRs, L252P and C41S. When L252P or C41S was expressed with TSHR, that is, when TSHR/L252P or TSHR/C41S heterodimers could only bind one TSH, TSH-stimulated IP1 production was decreased relative to cAMP production. The slopes of linear regression analyses comparing fold stimulation by TSH of IP1 vs. cAMP production were 0.044 +/- 0.0047, 0.0043 +/- 0.0041, and 0.0059 +/- 0.0014 for cells expressing TSHR alone, TSHR and L252P, or TSHR and C41S, respectively. We suggest that TSHR coupling to phosphoinositide signaling is dependent on binding 2 molecules of TSH to TSHR homodimer, causing a conformational change allowing coupling to G(q/11).Allen, M. D., Neumann, S., Gershengorn, M. C. Occupancy of both sites on the thyrotropin (TSH) receptor dimer is necessary for phosphoinositide signaling. FASEB J. 25, 3687-3694 (2011). www.fasebj.org	[Allen, Michael D.; Neumann, Susanne; Gershengorn, Marvin C.] NIDDK, CEB, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gershengorn, MC (corresponding author), NIDDK, CEB, NIH, 50 South Dr, Bethesda, MD 20892 USA.	marving@intra.niddk.nih.gov			National Institute of Diabetes and Digestive and Kidney Diseases, U.S. National Institutes of Health [Z01-DK011006]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK011006] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Stefano Costanzi and Jurgen Wess for helpful comments. This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (Z01-DK011006), U.S. National Institutes of Health.	CORDA D, 1985, J BIOL CHEM, V260, P9230; Dalrymple MB, 2008, PHARMACOL THERAPEUT, V118, P359, DOI 10.1016/j.pharmthera.2008.03.004; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; De Meyts P, 2009, ANN NY ACAD SCI, V1160, P45, DOI 10.1111/j.1749-6632.2009.03837.x; Deflorian F, 2008, PROTEINS, V71, P783, DOI 10.1002/prot.21763; deRoux N, 1996, J CLIN ENDOCR METAB, V81, P4229, DOI 10.1210/jc.81.12.4229; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Gao F, 2009, MOL PHARMACOL, V76, P264, DOI 10.1124/mol.109.055756; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Kuhn B, 1996, MOL ENDOCRINOL, V10, P1697, DOI 10.1210/me.10.12.1697; Latif R, 2001, J BIOL CHEM, V276, P45217, DOI 10.1074/jbc.M103727200; Laugwitz KL, 1996, P NATL ACAD SCI USA, V93, P116, DOI 10.1073/pnas.93.1.116; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Neumann S, 2009, P NATL ACAD SCI USA, V106, P12471, DOI 10.1073/pnas.0904506106; NUSSENZVEIG DR, 1994, J BIOL CHEM, V269, P28123; Offermanns S, 1996, MOL ENDOCRINOL, V10, P566, DOI 10.1210/me.10.5.566; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; Tonacchera M, 2004, J CLIN ENDOCR METAB, V89, P5787, DOI 10.1210/jc.2004-1243; TRIMBLE ER, 1986, BIOCHEM J, V239, P257, DOI 10.1042/bj2390257; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200	27	49	50	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3687	3694		10.1096/fj.11-188961	http://dx.doi.org/10.1096/fj.11-188961			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21705666	Green Published			2022-12-25	WOS:000295356400037
J	Wang, Q; Downey, GP; McCulloch, CA				Wang, Qin; Downey, Gregory P.; McCulloch, Christopher A.			Focal adhesions and Ras are functionally and spatially integrated to mediate IL-1 activation of ERK	FASEB JOURNAL			English	Article						fibroblasts; collagen; integrin	TYROSINE PHOSPHATASE-ALPHA; R-RAS; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; RAS/RAF/MEK/ERK PATHWAY; RHEUMATOID-ARTHRITIS; SMALL GTPASE; MAP KINASE; PROTEIN; MATRIX	In connective tissue cells, IL-1-induced ERK activation leading to matrix metalloproteinase (MMP)-3 expression is dependent on cooperative interactions between focal adhesions and the endoplasmic reticulum (ER). As Ras can be activated on the ER, we investigated the role of Ras in IL-1 signaling and focal adhesion formation. We found that constitutively active H-Ras, K-Ras or N-Ras enhanced focal adhesion maturation and beta 1-integrin activation. IL-1 promoted the accumulation of Ras isoforms in ER and focal adhesion fractions, as shown in cells cotransfected with GFP-tagged Ras isoforms and YFP-ER protein and by analysis of subcellular fractions enriched for ER or focal adhesion proteins. Dominant-negative H-Ras or K-Ras reduced accumulation of H-Ras and K-Ras in focal adhesions induced by IL-1 and also blocked ERK activation and focal adhesion maturation. Ras-GRF was enriched constitutively in focal adhesion fractions and was required for Ras recruitment to focal adhesions. We conclude that Ras activation and IL-1 signaling are interactive processes that regulate the maturation of focal adhesions, which, in turn, is required for ERK activation.-Wang, Q., Downey, G. P., McCulloch, C. A. Focal adhesions and Ras are functionally and spatially integrated to mediate IL-1 activation of ERK. FASEB J. 25, 3448-3464 (2011). www.fasebj.org	[Wang, Qin; McCulloch, Christopher A.] Univ Toronto, Matrix Dynam Grp, Toronto, ON M5S 3E2, Canada; [Downey, Gregory P.] Natl Jewish Hlth, Denver, CO USA	University of Toronto; National Jewish Health	McCulloch, CA (corresponding author), Univ Toronto, Matrix Dynam Grp, Rm 244,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	christopher.mcculloch@utoronto.ca		Downey, Gregory P/0000-0003-3253-5862	Canadian Institutes of Health Research [MOP-84254]; U.S. National Institutes of Health [HL090669]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090669] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Canadian Institutes of Health Research operating grant MOP-84254 to C.A.M. and by U.S. National Institutes of Health grant HL090669 to G.P.D.	Abreu JRF, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2785; Ada-Nguema AS, 2006, J CELL SCI, V119, P1307, DOI 10.1242/jcs.02835; Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Arora PD, 2008, MOL BIOL CELL, V19, P5032, DOI 10.1091/mbc.E08-04-0430; ARORA PD, 1995, J BIOL CHEM, V270, P6042, DOI 10.1074/jbc.270.11.6042; Bivona TG, 2003, CURR OPIN CELL BIOL, V15, P136, DOI 10.1016/S0955-0674(03)00016-4; Boeckeler K, 2010, J CELL SCI, V123, P2725, DOI 10.1242/jcs.062299; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Calvo F, 2010, BIOESSAYS, V32, P412, DOI 10.1002/bies.200900155; Carragher NO, 2003, CURR BIOL, V13, P1442, DOI 10.1016/S0960-9822(03)00544-X; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Clark EA, 1996, J BIOL CHEM, V271, P14814, DOI 10.1074/jbc.271.25.14814; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Fernandez-Medarde A, 2011, BBA-REV CANCER, V1815, P170, DOI 10.1016/j.bbcan.2010.11.001; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Fiordalis JJ, 2002, J BIOL CHEM, V277, P10813, DOI 10.1074/jbc.M107684200; Furuhjelm J, 2003, J CELL SCI, V116, P3729, DOI 10.1242/jcs.00689; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; Heo WD, 2003, CELL, V113, P315; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hughes PE, 2002, MOL BIOL CELL, V13, P2256, DOI 10.1091/mbc.01-10-0480; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Kinashi T, 2000, J BIOL CHEM, V275, P22590, DOI 10.1074/jbc.M000633200; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kwong L, 2003, MOL CELL BIOL, V23, P933, DOI 10.1128/MCB.23.3.933-949.2003; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Lo SH, 2006, DEV BIOL, V294, P280, DOI 10.1016/j.ydbio.2006.03.029; Lo YYC, 1998, J BIOL CHEM, V273, P7059, DOI 10.1074/jbc.273.12.7059; Luo L, 1997, BIOCHEM J, V324, P653, DOI 10.1042/bj3240653; MacGillivray M, 2003, J BIOL CHEM, V278, P27190, DOI 10.1074/jbc.M213083200; MacGillivray MK, 2000, J BIOL CHEM, V275, P23509, DOI 10.1074/jbc.M003186200; McCulloch CA, 2006, NAT REV DRUG DISCOV, V5, P864, DOI 10.1038/nrd2109; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Osada M, 1999, MOL CELL BIOL, V19, P6333; Plowman SJ, 2005, BBA-MOL CELL RES, V1746, P274, DOI 10.1016/j.bbamcr.2005.06.004; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; QWARNSTROM EE, 1991, P NATL ACAD SCI USA, V88, P1232, DOI 10.1073/pnas.88.4.1232; Raymond L, 2006, J CELL PHYSIOL, V207, P683, DOI 10.1002/jcp.20608; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Sethi T, 1999, MOL BIOL CELL, V10, P1799, DOI 10.1091/mbc.10.6.1799; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; van den Berg WB, 1999, Z RHEUMATOL, V58, P136, DOI 10.1007/s003930050163; Wang Q, 2006, J BIOL CHEM, V281, P31093, DOI 10.1074/jbc.M606392200; Wang Q, 2010, J BIOL CHEM, V285, P22308, DOI 10.1074/jbc.M110.102426; Wang Q, 2009, J BIOL CHEM, V284, P20763, DOI 10.1074/jbc.M808828200; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yao Z, 2009, BIOFACTORS, V35, P407, DOI 10.1002/biof.52; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X	53	4	4	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2011	25	10					3448	3464		10.1096/fj.11-183459	http://dx.doi.org/10.1096/fj.11-183459			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21719512	Green Published			2022-12-25	WOS:000295356400016
J	Liu, Q; Su, SF; Blackwelder, AJ; Minges, JT; Wilson, EM				Liu, Qiang; Su, Shifeng; Blackwelder, Amanda J.; Minges, John T.; Wilson, Elizabeth M.			Gain in Transcriptional Activity by Primate-specific Coevolution of Melanoma Antigen-A11 and Its Interaction Site in Androgen Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING-DOMAIN; COOH-TERMINAL INTERACTION; BULBAR MUSCULAR-ATROPHY; ACTIVATION FUNCTION 2; STRUCTURAL BASIS; PROSTATE-CANCER; INTERDOMAIN INTERACTION; PHOSPHORYLATION SITES; COREGULATOR MAGE-11; GENE-MUTATIONS	Male sex development and growth occur in response to high affinity androgen binding to the androgen receptor (AR). In contrast to complete amino acid sequence conservation in the AR DNA and ligand binding domains among mammals, a primate-specific difference in the AR NH2-terminal region that regulates the NH2- and carboxyl-terminal (N/C) interaction enables direct binding to melanoma antigen-A11 (MAGE-11), an AR coregulator that is also primate-specific. Human, mouse, and rat AR share the same NH2-terminal (23)FQNLF(27) sequence that mediates the androgen-dependent N/C interaction. However, the mouse and rat AR FXXLF motif is flanked by Ala(33) that evolved to Val(33) in primates. Human AR Val(33) was required to interact directly with MAGE-11 and for the inhibitory effect of the AR N/C interaction on activation function 2 that was relieved by MAGE-11. The functional importance of MAGE-11 was indicated by decreased human AR regulation of an androgen-dependent endogenous gene using lentivirus short hairpin RNAs and by the greater transcriptional strength of human compared with mouse AR. MAGE-11 increased progesterone and glucocorticoid receptor activity independently of binding an FXXLF motif by interacting with p300 and p160 coactivators. We conclude that the coevolution of the AR NH2-terminal sequence and MAGE-11 expression among primates provides increased regulatory control over activation domain dominance. Primate-specific expression of MAGE-11 results in greater steroid receptor transcriptional activity through direct interactions with the human AR FXXLF motif region and indirectly through steroid receptor-associated p300 and p160 coactivators.	[Liu, Qiang; Su, Shifeng; Blackwelder, Amanda J.; Minges, John T.; Wilson, Elizabeth M.] Univ N Carolina, Labs Reprod Biol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Liu, Qiang; Su, Shifeng; Blackwelder, Amanda J.; Minges, John T.; Wilson, Elizabeth M.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [Liu, Qiang; Su, Shifeng; Blackwelder, Amanda J.; Minges, John T.; Wilson, Elizabeth M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Liu, Qiang] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Shanghai Key Lab Mol Androl,Inst Biochem & Cell B, Shanghai 200031, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wilson, EM (corresponding author), Univ N Carolina, Labs Reprod Biol, Lineberger Comprehens Canc Ctr, CB7500, Chapel Hill, NC 27599 USA.	emw@med.unc.edu			National Institutes of Health [HD16910]; NICHD; NCI [P01-CA77739]; Fogarty International Center Training and Research in Population and Health [5D43-TW000627-15]; Eunice Kennedy Shriver NICHD as part of the Specialized Cooperative Centers [U54-HD35041]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD035041, R01HD016910, R37HD016910] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW000627] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fogarty International Center Training and Research in Population and Health; Eunice Kennedy Shriver NICHD as part of the Specialized Cooperative Centers; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant HD16910, United States Public Health Service grant from NICHD; Grant P01-CA77739 from the NCI; Grant 5D43-TW000627-15, a Fogarty International Center Training and Research in Population and Health grant; and Cooperative Agreement U54-HD35041 from the Eunice Kennedy Shriver NICHD as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research.	Albertelli MA, 2006, MOL ENDOCRINOL, V20, P1248, DOI 10.1210/me.2006-0021; Aprelikova O, 2009, CANCER RES, V69, P616, DOI 10.1158/0008-5472.CAN-08-0811; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Askew EB, 2010, J BIOL CHEM, V285, P21824, DOI 10.1074/jbc.M110.120600; Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Bai S, 2008, MOL HUM REPROD, V14, P107, DOI 10.1093/molehr/gam080; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Callewaert L, 2003, J BIOL CHEM, V278, P8212, DOI 10.1074/jbc.M210744200; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; CHAREST NJ, 1991, MOL ENDOCRINOL, V5, P573, DOI 10.1210/mend-5-4-573; Choong CS, 1998, J MOL EVOL, V47, P334, DOI 10.1007/PL00006391; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; Dehm SM, 2007, CANCER RES, V67, P10067, DOI 10.1158/0008-5472.CAN-07-1267; Delbridge Margaret L, 2007, Soc Reprod Fertil Suppl, V65, P1; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Fronsdal K, 1998, J BIOL CHEM, V273, P31853, DOI 10.1074/jbc.273.48.31853; Ghadessy FJ, 1999, J CLIN INVEST, V103, P1517, DOI 10.1172/JCI4289; Ghali SA, 2003, J CLIN ENDOCR METAB, V88, P2185, DOI 10.1210/jc.2002-021324; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; He B, 2002, J BIOL CHEM, V277, P25631, DOI 10.1074/jbc.M202809200; He B, 2006, J BIOL CHEM, V281, P6648, DOI 10.1074/jbc.M511738200; He B, 2004, J BIOL CHEM, V279, P30643, DOI 10.1074/jbc.M403117200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 2003, MOL CELL BIOL, V23, P2135, DOI 10.1128/MCB.23.6.2135-2150.2003; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Hu SG, 2010, MOL ENDOCRINOL, V24, P2392, DOI 10.1210/me.2010-0226; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; Irvine RA, 1999, IMMUNOGENETICS, V49, P585, DOI 10.1007/s002510050543; Jaaskelainen J, 2006, J MOL ENDOCRINOL, V36, P361, DOI 10.1677/jme.1.01885; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; KASPER S, 1994, J BIOL CHEM, V269, P31763; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lavery DN, 2008, BIOCHEMISTRY-US, V47, P3360, DOI 10.1021/bi702221e; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; Mancini D, 1997, AM J HUM GENET, V61, P80, DOI 10.1086/513898; Marcar L, 2010, CANCER RES, V70, P10362, DOI 10.1158/0008-5472.CAN-10-1341; Matsumoto K, 2001, GENE, V272, P173, DOI 10.1016/S0378-1119(01)00544-3; Orr CR, 2010, J BIOL CHEM, V285, P35567, DOI 10.1074/jbc.M110.146845; Quigley CA, 2004, MECH AGEING DEV, V125, P683, DOI 10.1016/j.mad.2004.08.007; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; RENNIE PS, 1993, MOL ENDOCRINOL, V7, P23, DOI 10.1210/me.7.1.23; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; TAN JA, 1988, MOL ENDOCRINOL, V2, P1276, DOI 10.1210/mend-2-12-1276; Thompson J, 2001, MOL ENDOCRINOL, V15, P923, DOI 10.1210/me.15.6.923; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Wilson EM, 2010, THER ADV UROL, V2, P105, DOI 10.1177/1756287210372380; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P605, DOI 10.1210/me.9.5.605	59	14	14	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29951	29963		10.1074/jbc.M111.244715	http://dx.doi.org/10.1074/jbc.M111.244715			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21730049	Green Published, hybrid			2022-12-25	WOS:000294046600054
J	Tsai, CY; Ngo, B; Tapadia, A; Hsu, PH; Wu, GK; Lee, WH				Tsai, Connie Y.; Ngo, Bryan; Tapadia, Anjali; Hsu, Pang-Hung; Wu, Guikai; Lee, Wen-Hwa			Aurora-A Phosphorylates Augmin Complex Component Hice1 Protein at an N-terminal Serine/Threonine Cluster to Modulate Its Microtubule Binding Activity during Spindle Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACTS; MITOTIC SPINDLE; KINASE PEG2; HUMAN-CELLS; CENTROSOME; GRADIENT; CYCLE; IDENTIFICATION; AMPLIFICATION; DESTRUCTION	Proper assembly of mitotic spindles requires Hice1, a spindle-associated protein. Hice1 possesses direct microtubule binding activity at its N-terminal region and contributes to intraspindle microtubule nucleation as a subunit of the Augmin complex. However, whether microtubule binding activity of Hice1 is modulated by mitotic regulators remains unexplored. Here, we found that Aurora-A kinase, a major mitotic kinase, specifically binds to and phosphorylates Hice1. We identified four serine/threonine clusters on Hice1 that can be phosphorylated by Aurora-A in vitro. Of the four clusters, the Ser/Thr-17-21 cluster was the most critical for bipolar spindle assembly, whereas other phospho-deficient point mutants had a minimal effect on spindle assembly. Immunostaining with a phospho-Ser-19/20 phospho-specific antibody revealed that phosphorylated Hice1 primarily localizes to spindle poles during prophase to metaphase but gradually diminishes after anaphase. Consistently, the phospho-mimic 17-21E mutant reduced microtubule binding activity in vitro and diminished localization to spindles in vivo. Furthermore, expression of the 17-21E mutant led to decreased association of Fam29a, an Augmin component, with spindles. On the other hand, expression of the phospho-deficient 17-21A mutant permitted intraspindle nucleation but delayed the separation of early mitotic spindle poles and the timely mitotic progression. Taken together, these results suggest that Aurora-A modulates the microtubule binding activity of Hice1 in a spatiotemporal manner for proper bipolar spindle assembly.	[Wu, Guikai] Univ Calif Irvine, Dept Biol Chem, Sch Med, Irvine, CA 92697 USA; [Hsu, Pang-Hung] Natl Taiwan Ocean Univ, Dept Life Sci, Keelung 20224, Taiwan; [Hsu, Pang-Hung] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung 20224, Taiwan	University of California System; University of California Irvine; National Taiwan Ocean University; National Taiwan Ocean University	Wu, GK (corresponding author), Univ Calif Irvine, Dept Biol Chem, Sch Med, 124 Sprague Hall, Irvine, CA 92697 USA.	gwu@uci.edu; whlee@uci.edu	Lee, Wen-Hwa/C-2519-2014; Hsu, Pang-Hung/C-5587-2018	Hsu, Pang-Hung/0000-0001-6873-6434; Ngo, Bryan/0000-0002-7733-2658	National Institutes of Health [CA107568]; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA107568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA107568 (to W.-H. L.).; Supported by a Department of Defense Congressionally Directed Medical Research Program Predoctoral Fellowship.	Arlot-Bonnemains Y, 2001, FEBS LETT, V508, P149, DOI 10.1016/S0014-5793(01)03048-4; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Cowley DO, 2009, MOL CELL BIOL, V29, P1059, DOI 10.1128/MCB.01062-08; Floyd S, 2008, CURR BIOL, V18, P1649, DOI 10.1016/j.cub.2008.09.058; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Goshima G, 2010, CURR OPIN CELL BIOL, V22, P44, DOI 10.1016/j.ceb.2009.11.012; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; HEALD R, 2009, KINETOCHORE, P1; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Jang CY, 2011, BIOCHEM BIOPH RES CO, V408, P174, DOI 10.1016/j.bbrc.2011.04.004; Jang CY, 2009, J CELL SCI, V122, P1334, DOI 10.1242/jcs.044321; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Katayama H, 2001, J BIOL CHEM, V276, P46219, DOI 10.1074/jbc.M107540200; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Liu Q, 2006, P NATL ACAD SCI USA, V103, P5811, DOI 10.1073/pnas.0601425103; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Meireles M, 2009, J CELL BIOL, V184, P777, DOI 10.1083/jcb.200811102; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Roghi C, 1998, J CELL SCI, V111, P557; Rome P, 2010, J CELL BIOL, V189, P651, DOI 10.1083/jcb.201001144; Rong R, 2007, ONCOGENE, V26, P7700, DOI 10.1038/sj.onc.1210575; Taguchi S, 2002, FEBS LETT, V519, P59, DOI 10.1016/S0014-5793(02)02711-4; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Wainman A, 2009, GENE DEV, V23, P1876, DOI 10.1101/gad.532209; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Wu GK, 2008, MOL CELL BIOL, V28, P3652, DOI 10.1128/MCB.01923-07; Wu GK, 2009, MOL BIOL CELL, V20, P4686, DOI 10.1091/mbc.E08-11-1123; Zhu H, 2009, MOL CELLS, V27, P1, DOI 10.1007/s10059-009-0014-2; Zhu H, 2008, J CELL BIOL, V183, P835, DOI 10.1083/jcb.200807046	40	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30097	30106		10.1074/jbc.M111.266767	http://dx.doi.org/10.1074/jbc.M111.266767			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21705324	hybrid, Green Published			2022-12-25	WOS:000294046600067
J	West, MB; Wickham, S; Quinalty, LM; Pavlovicz, RE; Li, CL; Hanigan, MH				West, Matthew B.; Wickham, Stephanie; Quinalty, Leslie M.; Pavlovicz, Ryan E.; Li, Chenglong; Hanigan, Marie H.			Autocatalytic Cleavage of Human gamma-Glutamyl Transpeptidase Is Highly Dependent on N-Glycosylation at Asparagine 95	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORMAL HUMAN TISSUE; ENDOPLASMIC-RETICULUM; ESCHERICHIA-COLI; TRANSFERASE TRANSPEPTIDASE; CRYSTAL-STRUCTURE; FORCE-FIELD; PROTEIN; IDENTIFICATION; BIOSYNTHESIS; INHIBITORS	gamma-Glutamyl transpeptidase (GGT) is a heterodimeric membrane enzyme that catalyzes the cleavage of extracellular glutathione and other gamma-glutamyl-containing compounds. GGT is synthesized as a single polypeptide (propeptide) that undergoes autocatalytic cleavage, which results in the formation of the large and small subunits that compose the mature enzyme. GGT is extensively N-glycosylated, yet the functional consequences of this modification are unclear. We investigated the effect of N-glycosylation on the kinetic behavior, stability, and functional maturation of GGT. Using site-directed mutagenesis, we confirmed that all seven N-glycosylation sites on human GGT are modified by N-glycans. Comparative enzyme kinetic analyses revealed that single substitutions are functionally tolerated, although the N95Q mutation resulted in a marked decrease in the cleavage efficiency of the propeptide. However, each of the single site mutants exhibited decreased thermal stability relative to wild-type GGT. Combined mutagenesis of all N-glycosylation sites resulted in the accumulation of the inactive propeptide form of the enzyme. Use of N-glycosylation inhibitors demonstrated that binding of the core N-glycans, not their subsequent processing, is the critical glycosylation event governing the autocleavage of GGT. Although N-glycosylation is necessary for maturation of the propeptide, enzymatic deglycosylation of the mature wild-type GGT does not substantially impact either the kinetic behavior or thermal stability of the fully processed human enzyme. These findings are the first to establish that co-translational N-glycosylation of human GGT is required for the proper folding and subsequent cleavage of the nascent propeptide, although retention of these N-glycans is not necessary for maintaining either the function or structural stability of the mature enzyme.	[West, Matthew B.; Wickham, Stephanie; Quinalty, Leslie M.; Hanigan, Marie H.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Pavlovicz, Ryan E.; Li, Chenglong] Ohio State Univ, Biophys Program, Columbus, OH 43210 USA; [Li, Chenglong] Ohio State Univ, Div Med Chem & Pharmacognosy, Coll Pharm, Columbus, OH 43210 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hanigan, MH (corresponding author), Stanton L Young Biomed Res Ctr, Rm 264,975 NE 10th St, Oklahoma City, OK 73104 USA.	marie-hanigan@ouhsc.edu	Li, Chenglong/E-7182-2010; Driskill, Leslie/AAI-8748-2021	Li, Chenglong/0000-0003-3174-8719; Driskill, Leslie/0000-0003-3484-2794	National Institutes of Health [RO1 CA57530, R56 CA57530, F32 CA128338]; NATIONAL CANCER INSTITUTE [R01CA057530, F32CA128338, R56CA057530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA57530 and R56 CA57530 (to M. H. H.) and F32 CA128338 (to M. B. W.).	ALLISON RD, 1985, METHOD ENZYMOL, V113, P419; ANGELE C, 1991, CLIN CHEM, V37, P662; BAROUKI R, 1984, J BIOL CHEM, V259, P7970; Bosques CJ, 2003, P NATL ACAD SCI USA, V100, P7593, DOI 10.1073/pnas.1232504100; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castonguay R, 2007, BIOCHEMISTRY-US, V46, P12253, DOI 10.1021/bi700956c; CURTHOYS NP, 1979, ENZYME, V24, P383, DOI 10.1159/000458694; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; ELCE JS, 1976, BIOCHEM J, V153, P223, DOI 10.1042/bj1530223; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GROSS V, 1986, BIOCHEM J, V236, P853, DOI 10.1042/bj2360853; Hanigan MH, 1999, CARCINOGENESIS, V20, P553, DOI 10.1093/carcin/20.4.553; Hanigan MH, 1996, J HISTOCHEM CYTOCHEM, V44, P1101, DOI 10.1177/44.10.8813074; HANIGAN MH, 1993, BIOCHEMISTRY-US, V32, P6302, DOI 10.1021/bi00075a026; Hanigan MH, 1999, HUM PATHOL, V30, P300, DOI 10.1016/S0046-8177(99)90009-6; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Herscovics A, 1999, BBA-GEN SUBJECTS, V1473, P96, DOI 10.1016/S0304-4165(99)00171-3; Hiramatsu K, 2007, ENDOCRINOLOGY, V148, P2708, DOI 10.1210/en.2007-0215; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; Inoue M, 2000, BIOCHEMISTRY-US, V39, P7764, DOI 10.1021/bi000220p; Keillor JW, 2005, METHOD ENZYMOL, V401, P449, DOI 10.1016/S0076-6879(05)01027-X; King JB, 2009, J BIOL CHEM, V284, P9059, DOI 10.1074/jbc.M809608200; Kinlough CL, 2005, METHOD ENZYMOL, V401, P426, DOI 10.1016/S0076-6879(05)01026-8; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; McCracken AA, 2003, BIOESSAYS, V25, P868, DOI 10.1002/bies.10320; MEREDITH MJ, 1991, BIOCHEM INT, V25, P321; Nakajima M, 2010, BIOCHEM PHARMACOL, V79, P1165, DOI 10.1016/j.bcp.2009.11.020; NEMESANSZKY E, 1985, CLIN CHEM, V31, P797; Okada T, 2007, J BIOL CHEM, V282, P2433, DOI 10.1074/jbc.M607490200; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sener A, 2005, J BIOCHEM MOL BIOL, V38, P343; SHAW LM, 1978, CLIN CHEM, V24, P905; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Skropeta D, 2009, BIOORGAN MED CHEM, V17, P2645, DOI 10.1016/j.bmc.2009.02.037; SMITH TK, 1994, FASEB J, V8, P661, DOI 10.1096/fasebj.8.9.7911768; Suzuki H, 2002, J BIOL CHEM, V277, P43536, DOI 10.1074/jbc.M207680200; THOMPSON GA, 1976, BIOCHEM BIOPH RES CO, V71, P32, DOI 10.1016/0006-291X(76)90245-X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wada K, 2010, FEBS J, V277, P1000, DOI 10.1111/j.1742-4658.2009.07543.x; Wei W, 2007, J BIOL CHEM, V282, P21729, DOI 10.1074/jbc.M703218200; West MB, 2010, J BIOL CHEM, V285, P29511, DOI 10.1074/jbc.M110.145938; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856	48	28	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28876	28888		10.1074/jbc.M111.248823	http://dx.doi.org/10.1074/jbc.M111.248823			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21712391	Green Published, hybrid			2022-12-25	WOS:000293837000025
J	Wu, SR; Li, CF; Hung, LY; Huang, AM; Tseng, JT; Tsou, JH; Wang, JM				Wu, Sin-Rong; Li, Chien-Feng; Hung, Liang-Yi; Huang, A-Mei; Tseng, Joseph T.; Tsou, Jen-Hui; Wang, Ju-Ming			CCAAT/Enhancer-binding Protein delta Mediates Tumor Necrosis Factor alpha-induced Aurora Kinase C Transcription and Promotes Genomic Instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL PASSENGER PROTEIN; CANCER-RELATED INFLAMMATION; B KINASE; CERVICAL-CANCER; C/EBP-DELTA; HISTONE H3; EXPRESSION; CELLS; GENE; LOCALIZATION	Epidemiologic and clinical research indicates that chronic inflammation increases the risk of certain cancers, possibly through chromosomal instability. However, the mechanism of inflammation-dependent chromosomal instability associated with tumorigenesis is not well characterized. The transcription factor CCAAT/enhancer-binding protein delta (C/EBP delta, CEBPD) is induced by tumor necrosis factor alpha (TNF alpha) and expressed in chronically inflamed tissue. In this study, we show that TNF alpha promotes aneuploidy. Loss of CEBPD attenuated TNF alpha-induced aneuploidy, and CEBPD caused centromere abnormality. Additionally, TNF alpha-induced CEBPD expression augmented anchorage-independent growth. We found that TNF alpha induced expression of aurora kinase C (AURKC) through CEBPD, and that AURKC also causes aneuploidy. Furthermore, high CEBPD expression correlated with AURKC expression in inflamed cervical tissue specimens. These data provide insight into a novel function for CEBPD in inducing genomic instability through the activation of AURKC expression in response to inflammatory signals.	[Wu, Sin-Rong; Hung, Liang-Yi; Tseng, Joseph T.; Tsou, Jen-Hui; Wang, Ju-Ming] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan 701, Taiwan; [Hung, Liang-Yi; Tseng, Joseph T.; Wang, Ju-Ming] Natl Cheng Kung Univ, Mol Inflammat Res Ctr, Coll Biosci & Biotechnol, Tainan 701, Taiwan; [Hung, Liang-Yi; Tseng, Joseph T.; Wang, Ju-Ming] Natl Cheng Kung Univ, Infect Dis & Signaling Res Ctr, Coll Med, Tainan 701, Taiwan; [Li, Chien-Feng] Chi Mei Med Ctr, Dept Pathol, Tainan 710, Taiwan; [Wang, Ju-Ming] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei 110, Taiwan; [Huang, A-Mei] Kaohsiung Med Univ, Dept Med, Grad Inst Biochem, Kaohsiung 807, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Chi Mei Hospital; Taipei Medical University; Kaohsiung Medical University	Wang, JM (corresponding author), Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan 701, Taiwan.	wwwjm4721@yahoo.com.tw	wang, ju-ming/A-1875-2011; Tseng, Joseph Ta-Chien/I-2850-2018; Hung, Liang-Yi/AAG-4174-2019	Tseng, Joseph Ta-Chien/0000-0002-3304-6086; , Liang-Yi/0000-0002-7284-2608; Huang, A-Mei/0000-0003-3723-0443	National Health Research Institutes [NHRI-EX99-9740NI]; National Cheng Kung University [C007]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan); National Cheng Kung University	This work was supported, in whole or in part, by National Health Research Institutes Grant NHRI-EX99-9740NI and National Cheng Kung University landmark Grant C007.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ahmad Aamir, 2009, Curr Aging Sci, V2, P174; AMES BN, 1995, P NATL ACAD SCI USA, V92, P5258, DOI 10.1073/pnas.92.12.5258; Balamurugan K, 2010, EMBO J, V29, P4106, DOI 10.1038/emboj.2010.280; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Castle PE, 2001, CANCER EPIDEM BIOMAR, V10, P1021; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chen JJ, 2005, MOL BIOL CELL, V16, P5579, DOI 10.1091/mbc.E05-08-0778; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Delhanty JDA, 2001, ANN HUM GENET, V65, P331, DOI 10.1017/S0003480001008739; HERRERO R, 1990, CANCER-AM CANCER SOC, V65, P380, DOI 10.1002/1097-0142(19900115)65:2<380::AID-CNCR2820650234>3.0.CO;2-9; Hour TC, 2010, BIOCHEM PHARMACOL, V80, P325, DOI 10.1016/j.bcp.2010.04.007; Hu HM, 2000, DNA CELL BIOL, V19, P679, DOI 10.1089/10445490050199063; Huang AM, 2004, ONCOGENE, V23, P1549, DOI 10.1038/sj.onc.1207285; JONES CJ, 1990, CANCER RES, V50, P3657; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Kimura M, 1999, J BIOL CHEM, V274, P7334, DOI 10.1074/jbc.274.11.7334; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; Ko CY, 2008, J BIOL CHEM, V283, P30919, DOI 10.1074/jbc.M804029200; Li XY, 2004, J BIOL CHEM, V279, P47201, DOI 10.1074/jbc.M403029200; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu D, 2009, BIOCHEM SOC T, V37, P976, DOI 10.1042/BST0370976; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Nguyen HG, 2009, FASEB J, V23, P2741, DOI 10.1096/fj.09-130963; Pan YC, 2010, CLIN CANCER RES, V16, P5770, DOI 10.1158/1078-0432.CCR-10-1025; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Reddy KV, 2003, J BIOL CHEM, V278, P13810, DOI 10.1074/jbc.M211102200; Sasai K, 2004, CELL MOTIL CYTOSKEL, V59, P249, DOI 10.1002/cm.20039; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Tang CJC, 2006, DEV BIOL, V290, P398, DOI 10.1016/j.ydbio.2005.11.036; Tatsuka M, 1998, CANCER RES, V58, P4811; Ulisse S, 2006, INT J CANCER, V119, P275, DOI 10.1002/ijc.21842; Wang JM, 2006, NUCLEIC ACIDS RES, V34, P217, DOI 10.1093/nar/gkj422; Wang WL, 2008, NUCLEIC ACIDS RES, V36, P6066, DOI 10.1093/nar/gkn607; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Yan B, 2006, CANCER RES, V66, P11565, DOI 10.1158/0008-5472.CAN-06-2540; Yan XM, 2005, GENES CELLS, V10, P617, DOI 10.1111/j.1365-2443.2005.00863.x	44	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28662	28670		10.1074/jbc.M111.270710	http://dx.doi.org/10.1074/jbc.M111.270710			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21715338	Green Published, hybrid			2022-12-25	WOS:000293837000003
J	Yang, YQ; Groshong, JS; Matta, H; Gopalakrishnan, R; Yi, H; Chaudhary, PM				Yang, Yanqiang; Groshong, Jason S.; Matta, Hittu; Gopalakrishnan, Ramakrishnan; Yi, Han; Chaudhary, Preet M.			Constitutive NF-kappa B Activation Confers Interleukin 6 (IL6) Independence and Resistance to Dexamethasone and Janus Kinase Inhibitor INCB018424 in Murine Plasmacytoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY EFFUSION LYMPHOMA; KAPOSIS-SARCOMA; MULTIPLE-MYELOMA; IL-6 EXPRESSION; HERPESVIRUS; APOPTOSIS; K13; PATHWAYS; ONCOPROTEIN; MUTATIONS	Myeloma cells are dependent on IL6 for their survival and proliferation during the early stages of disease, and independence from IL6 is associated with disease progression. The role of the NF-kappa B pathway in the IL6-independent growth of myeloma cells has not been studied. Because human herpesvirus 8-encoded K13 selectively activates the NF-kappa B pathway, we have used it as a molecular tool to examine the ability of the NF-kappa B pathway to confer IL6 independence on murine plasmacytomas. We demonstrated that ectopic expression of K13, but not its NF-kappa B-defective mutant or a structural homolog, protected plasmacytomas against IL6 withdrawal-induced apoptosis and resulted in emergence of IL6-independent clones that could proliferate long-term in vitro in the absence of IL6 and form abdominal plasmacytomas with visceral involvement when injected intraperitoneally into syngeneic mice. These IL6-independent clones were dependent on NF-kappa B activity for their survival and proliferation but were resistant to dexamethasone and INCB018424, a selective Janus kinase 1/2 inhibitor. Ectopic expression of human T cell leukemia virus 1-encoded Tax protein, which resembles K13 in inducing constitutive NF-kappa B activation, similarly protected plasmacytoma cells against IL6 withdrawal-induced apoptosis. Although K13 is known to up-regulate IL6 gene expression, its protective effect was not due to induction of endogenous IL6 production but instead was associated with sustained expression of several antiapoptotic members of the Bcl2 family upon IL6 withdrawal. Collectively, these results demonstrate that NF-kappa B activation cannot only promote the emergence of IL6 independence during myeloma progression but can also confer resistance to dexamethasone and INCB018424.	[Matta, Hittu; Gopalakrishnan, Ramakrishnan; Yi, Han; Chaudhary, Preet M.] Univ So Calif, Keck Sch Med, Jane Ann Nohl Div Hematol, Los Angeles, CA 90033 USA; [Matta, Hittu; Gopalakrishnan, Ramakrishnan; Yi, Han; Chaudhary, Preet M.] Univ So Calif, Keck Sch Med, Ctr Study Blood Dis, Los Angeles, CA 90033 USA; [Yang, Yanqiang; Groshong, Jason S.; Matta, Hittu; Chaudhary, Preet M.] Univ Pittsburgh, Dept Med, Div Hematol Oncol, Inst Canc, Pittsburgh, PA 15213 USA	University of Southern California; University of Southern California; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chaudhary, PM (corresponding author), Univ So Calif, Keck Sch Med, Jane Ann Nohl Div Hematol, Los Angeles, CA 90033 USA.	preet.chaudhary@med.usc.edu	Gopalakrishnan, Ramakrishnan/N-3454-2015; Chaudhary, Preet/E-1970-2018	Gopalakrishnan, Ramakrishnan/0000-0002-5068-6886; 	National Institutes of Health [CA85177, CA124621, CA139119]; Leukemia and Lymphoma Society; Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE [R01CA124621, R01CA085177, R01CA139119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA85177, CA124621, and CA139119. This work was also supported by the Leukemia and Lymphoma Society and the Multiple Myeloma Research Foundation.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Aggarwal BB, 2000, BIOCHEM PHARMACOL, V60, P1033, DOI 10.1016/S0006-2952(00)00393-2; An JB, 2003, ONCOGENE, V22, P3371, DOI 10.1038/sj.onc.1206407; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Asou H, 1998, BLOOD, V91, P2475, DOI 10.1182/blood.V91.7.2475.2475_2475_2481; Bertin J, 1997, P NATL ACAD SCI USA, V94, P1172, DOI 10.1073/pnas.94.4.1172; Billadeau D, 1997, CANCER RES, V57, P2268; BILLADEAU D, 1995, CANCER RES, V55, P3640; Bommert K, 2006, EUR J CANCER, V42, P1574, DOI 10.1016/j.ejca.2005.12.026; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Chu ZL, 1998, J BIOL CHEM, V273, P15891, DOI 10.1074/jbc.273.26.15891; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Foehr ED, 2000, J BIOL CHEM, V275, P34021, DOI 10.1074/jbc.C000507200; Fonseca Rafael, 2004, Cancer Research, V64, P1546, DOI 10.1158/0008-5472.CAN-03-2876; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hengge UR, 2002, LANCET INFECT DIS, V2, P344, DOI 10.1016/S1473-3099(02)00288-8; HILBERT DM, 1995, J EXP MED, V182, P243, DOI 10.1084/jem.182.1.243; Hu SM, 1997, J BIOL CHEM, V272, P9621; Jenner RG, 2003, P NATL ACAD SCI USA, V100, P10399, DOI 10.1073/pnas.1630810100; Jijon H, 2004, CELL SIGNAL, V16, P1023, DOI 10.1016/j.cellsig.2004.02.005; Kastrinakis NG, 2000, ANN ONCOL, V11, P1217, DOI 10.1023/A:1008331714186; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Keller SA, 2000, BLOOD, V96, P2537; Lattanzio G, 1997, AM J PATHOL, V151, P689; Li J, 2010, NEOPLASIA, V12, P28, DOI 10.1593/neo.91192; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Liu SQ, 2010, EUR J HAEMATOL, V84, P137, DOI 10.1111/j.1600-0609.2009.01365.x; Matta H, 2007, ONCOGENE, V26, P1656, DOI 10.1038/sj.onc.1209931; Matta H, 2003, J BIOL CHEM, V278, P52406, DOI 10.1074/jbc.M307308200; Matta H, 2003, CANCER BIOL THER, V2, P206, DOI 10.4161/cbt.2.2.348; Matta H, 2007, J BIOL CHEM, V282, P24858, DOI 10.1074/jbc.M700118200; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; NORDAN RP, 1986, SCIENCE, V233, P566, DOI 10.1126/science.3726549; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; Punj V, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-50; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Ramakrishnan V, 2010, AM J HEMATOL, V85, P675, DOI 10.1002/ajh.21785; Rawat R, 2000, BLOOD, V96, P3514; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Sun Q, 2006, ONCOGENE, V25, P2717, DOI 10.1038/sj.onc.1209298; Sun Q, 2003, BLOOD, V101, P1956, DOI 10.1182/blood-2002-07-2072; Sun SC, 2003, CANCER METAST REV, V22, P405, DOI 10.1023/A:1023733231406; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Trikha M, 2003, CLIN CANCER RES, V9, P4653; WEINBERG RA, 2007, BIOL CANC, P255; Xiao WH, 2004, CANCER BIOL THER, V3, P1007, DOI 10.4161/cbt.3.10.1141; Xie P, 2004, J EXP MED, V199, P661, DOI 10.1084/jem.20031255; Zhao JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001067	53	12	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27988	27997		10.1074/jbc.M110.213363	http://dx.doi.org/10.1074/jbc.M110.213363			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21705340	hybrid, Green Published			2022-12-25	WOS:000293557800017
J	Svenson, U; Nordfjall, K; Baird, D; Roger, L; Osterman, P; Hellenius, ML; Roos, G				Svenson, Ulrika; Nordfjall, Katarina; Baird, Duncan; Roger, Laureline; Osterman, Pia; Hellenius, Mai-Lis; Roos, Goran			Blood Cell Telomere Length Is a Dynamic Feature	PLOS ONE			English	Article							CHROMOSOME-SPECIFIC VARIATIONS; OXIDATIVE STRESS; MYOCARDIAL-INFARCTION; LONGITUDINAL FINDINGS; PREDISPOSITION FACTOR; NORMAL INDIVIDUALS; PHYSICAL-ACTIVITY; T-LYMPHOCYTES; HEART-DISEASE; AGE	There is a considerable heterogeneity in blood cell telomere length (TL) for individuals of similar age and recent studies have revealed that TL changes by time are dependent on TL at baseline. TL is partly inherited, but results from several studies indicate that e. g. life style and/or environmental factors can affect TL during life. Collectively, these studies imply that blood cell TL might fluctuate during a life time and that the actual TL at a defined time point is the result of potential regulatory mechanism(s) and environmental factors. We analyzed relative TL (RTL) in subsequent blood samples taken six months apart from 50 individuals and found significant associations between RTL changes and RTL at baseline. Individual RTL changes per month were more pronounced than the changes recorded in a previously studied population analyzed after 10 years' follow up. The data argues for an oscillating TL pattern which levels out at longer follow up times. In a separate group of five blood donors, a marked telomere loss was demonstrated within a six month period for one donor where after TL was stabilized. PCR determined RTL changes were verified by Southern blotting and STELA (single telomere elongation length analysis). The STELA demonstrated that for the donor with a marked telomere loss, the heterogeneity of the telomere distribution decreased considerably, with a noteworthy loss of the largest telomeres. In summary, the collected data support the concept that individual blood cell telomere length is a dynamic feature and this will be important to recognize in future studies of human telomere biology.	[Svenson, Ulrika; Nordfjall, Katarina; Osterman, Pia; Roos, Goran] Umea Univ, Dept Med Biosci, Umea, Sweden; [Baird, Duncan; Roger, Laureline] Cardiff Univ, Sch Med, Dept Pathol, Cardiff, S Glam, Wales; [Hellenius, Mai-Lis] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Cardiol Unit, Stockholm, Sweden	Umea University; Cardiff University; Karolinska Institutet; Karolinska University Hospital	Svenson, U (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	goran.roos@medbio.umu.se	Baird, Duncan M/C-9671-2011	Baird, Duncan M/0000-0001-8408-5467; Osterman, Pia/0000-0001-9360-0782	Swedish Cancer Society; Lion's Cancer Research Foundation, Umea; Swedish Research Council; County Council of VAosterbotten; Cancer Research UK; Swedish National Institute of Public Health; Swedish Heart and Lung Foundation; Tornspiran Foundation; Albert and Gerda Svensson Foundation; European Community [200950]; Worldwide Cancer Research [06-0914] Funding Source: researchfish	Swedish Cancer Society(Swedish Cancer Society); Lion's Cancer Research Foundation, Umea; Swedish Research Council(Swedish Research CouncilEuropean Commission); County Council of VAosterbotten; Cancer Research UK(Cancer Research UK); Swedish National Institute of Public Health; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Tornspiran Foundation; Albert and Gerda Svensson Foundation; European Community(European Commission); Worldwide Cancer Research	This study was supported by grants from the Swedish Cancer Society (GR), the Lion's Cancer Research Foundation, Umea (GR), the Swedish Research Council (GR), the County Council of VAosterbotten (GR), Cancer Research UK (DB), the Swedish National Institute of Public Health (M-LH), The Swedish Heart and Lung Foundation (M-LH), Tornspiran Foundation (M-LH) and The Albert and Gerda Svensson Foundation (M-LH). The research leading to these results has received funding from the European Community's Seventh Framework Program FP7/2007-2011 under grant agreement no. 200950 (GR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar AN, 2007, J IMMUNOL, V178, P6689, DOI 10.4049/jimmunol.178.11.6689; Akiyama M, 2002, CANCER RES, V62, P3876; Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; Babizhayev M.A., 2010, AM J THER; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Broberg K, 2005, CARCINOGENESIS, V26, P1263, DOI 10.1093/carcin/bgi063; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Brummendorf TH, 2001, ANN NY ACAD SCI, V938, P293; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; Chen W, 2011, J GERONTOL A-BIOL, V66, P312, DOI 10.1093/gerona/glq223; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Ehrlenbach S, 2009, INT J EPIDEMIOL, V38, P1725, DOI 10.1093/ije/dyp273; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Graakjaer J, 2006, ANN NY ACAD SCI, V1067, P311, DOI 10.1196/annals.1354.042; Graakjaer J, 2006, HUM GENET, V119, P344, DOI 10.1007/s00439-006-0137-x; Graakjaer J, 2003, MECH AGEING DEV, V124, P629, DOI 10.1016/S0047-6374(03)00081-2; Halaschek-Wiener J, 2008, MECH AGEING DEV, V129, P638, DOI 10.1016/j.mad.2008.07.004; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Itzkovitz S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.060902; Iwama H, 1998, HUM GENET, V102, P397, DOI 10.1007/s004390050711; Jeanclos E, 2000, HYPERTENSION, V36, P195, DOI 10.1161/01.HYP.36.2.195; Kallings LV, 2009, EUR J CARDIOV PREV R, V16, P80, DOI 10.1097/HJR.0b013e32831e953a; Kawauchi K, 2005, J IMMUNOL, V174, P5261, DOI 10.4049/jimmunol.174.9.5261; Kyo S, 1999, CANCER RES, V59, P5917; Martens UM, 2002, BRIT J HAEMATOL, V119, P810, DOI 10.1046/j.1365-2141.2002.03910.x; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Nordfjall K, 2005, P NATL ACAD SCI USA, V102, P16374, DOI 10.1073/pnas.0501724102; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; Nordfjall K, 2010, EUR J HUM GENET, V18, P385, DOI 10.1038/ejhg.2009.178; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; Robertson JD, 2000, BRIT J HAEMATOL, V109, P272, DOI 10.1046/j.1365-2141.2000.01970.x; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Saretzki G, 2002, ANN NY ACAD SCI, V959, P24, DOI 10.1111/j.1749-6632.2002.tb02079.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shao L, 2007, J UROLOGY, V178, P1492, DOI 10.1016/j.juro.2007.05.112; Shlush LI, 2011, MECH AGEING DEV, V132, P123, DOI 10.1016/j.mad.2011.01.005; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Spyridopoulos I, 2008, ARTERIOSCL THROM VAS, V28, P968, DOI 10.1161/ATVBAHA.107.160846; Starr JM, 2007, EXP GERONTOL, V42, P571, DOI 10.1016/j.exger.2006.12.002; Svenson U, 2009, BBA-MOL BASIS DIS, V1792, P317, DOI 10.1016/j.bbadis.2009.01.017; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011	47	94	95	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21485	10.1371/journal.pone.0021485	http://dx.doi.org/10.1371/journal.pone.0021485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720548	Green Published, Green Submitted, gold			2022-12-25	WOS:000292036900040
J	Shah, A; Verma, AS; Patel, KH; Noel, R; Rivera-Amill, V; Silverstein, PS; Chaudhary, S; Bhat, HK; Stamatatos, L; Singh, DP; Buch, S; Kumar, A				Shah, Ankit; Verma, Ashish S.; Patel, Kalpeshkumar H.; Noel, Richard; Rivera-Amill, Vanessa; Silverstein, Peter S.; Chaudhary, Suman; Bhat, Hari K.; Stamatatos, Leonidas; Singh, Dhirendra P.; Buch, Shilpa; Kumar, Anil			HIV-1 gp120 Induces Expression of IL-6 through a Nuclear Factor-Kappa B-Dependent Mechanism: Suppression by gp120 Specific Small Interfering RNA	PLOS ONE			English	Article							ENVELOPE GLYCOPROTEIN GP120; NECROSIS-FACTOR-ALPHA; OXIDATIVE STRESS; GENE-EXPRESSION; PROTEIN GP120; INFLAMMATORY CYTOKINES; FUNCTIONAL EXPRESSION; ALZHEIMERS-DISEASE; RAT ASTROCYTES; CELL CULTURES	In addition to its role in virus entry, HIV-1 gp120 has also been implicated in HIV-associated neurocognitive disorders. However, the mechanism(s) responsible for gp120-mediated neuroinflammation remain undefined. In view of increased levels of IL-6 in HIV-positive individuals with neurological manifestations, we sought to address whether gp120 is involved in IL-6 over-expression in astrocytes. Transfection of a human astrocyte cell line with a plasmid encoding gp120 resulted in increased expression of IL-6 at the levels of mRNA and protein by 51.3 +/- 2.1 and 11.6 +/- 2.2 fold respectively; this effect of gp120 on IL-6 expression was also demonstrated using primary human fetal astrocytes. A similar effect on IL-6 expression was observed when primary astrocytes were treated with gp120 protein derived from different strains of X4 and R5 tropic HIV-1. The induction of IL-6 could be abrogated by use of gp120-specific siRNA. Furthermore, this study showed that the NF-kappa B pathway is involved in gp120-mediated IL-6 over-expression, as IKK-2 and IKK beta inhibitors inhibited IL-6 expression by 56.5% and 60.8%, respectively. These results were also confirmed through the use of NF-kappa B specific siRNA. We also showed that gp120 could increase the phosphorylation of I kappa B alpha. Furthermore, gp120 transfection in the SVGA cells increased translocation of NF-kappa B from cytoplasm to nucleus. These results demonstrate that HIV-1 gp120-mediated over-expression of IL-6 in astrocytes is one mechanism responsible for neuroinflammation in HIV-infected individuals and this is mediated by the NF-kappa B pathway.	[Shah, Ankit; Verma, Ashish S.; Patel, Kalpeshkumar H.; Silverstein, Peter S.; Bhat, Hari K.; Kumar, Anil] Univ Missouri, Sch Pharm, Div Pharmacol, Kansas City, MO 64110 USA; [Noel, Richard; Rivera-Amill, Vanessa; Chaudhary, Suman] Ponce Sch Med, Ponce, PR USA; [Stamatatos, Leonidas] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Singh, Dhirendra P.; Buch, Shilpa] Univ Nebraska Med Ctr, Omaha, NE USA	University of Missouri System; University of Missouri Kansas City; Center for Infectious Disease Research; University of Nebraska System; University of Nebraska Medical Center	Shah, A (corresponding author), Univ Missouri, Sch Pharm, Div Pharmacol, Kansas City, MO 64110 USA.	kumaran@umkc.edu	KUMAR, ANIL/ACD-8340-2022; Boothapati, Anil Kumar/HHS-1813-2022	Buch, Shilpa/0000-0002-3103-6685	National Institute on Drug Abuse [DA025528, DA025011]; NATIONAL EYE INSTITUTE [R01EY013394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025528, R01DA025011] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute on Drug Abuse grants DA025528 and DA025011 to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL L, BRAIN RES, V1306, P116; AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; Avdoshina V, 2010, GLIA, V58, P1630, DOI 10.1002/glia.21035; Bansal AK, 2000, BRAIN RES, V879, P42, DOI 10.1016/S0006-8993(00)02725-6; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; BREEN EC, 1990, J IMMUNOL, V144, P480; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Edelman DA, 2007, J TRAUMA, V62, P89, DOI 10.1097/TA.0b013e31802dd712; Eggert D, 2009, J NEUROIMMUNOL, V213, P47, DOI 10.1016/j.jneuroim.2009.06.002; Garcia MG, 2005, LEUKEMIA RES, V29, P1425, DOI 10.1016/j.leukres.2005.05.004; Grundner C, 2005, VIROLOGY, V331, P33, DOI 10.1016/j.virol.2004.09.022; Hauser KF, 2006, J NEUROIMMUNE PHARM, V1, P98, DOI 10.1007/s11481-005-9000-4; Hawkins PG, 2009, NUCLEIC ACIDS RES, V37, P2984, DOI 10.1093/nar/gkp127; Hesselgesser J, 1999, J NEUROVIROL, V5, P13, DOI 10.3109/13550289909029741; Iskander S, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-7; Kim SS, 2011, METHODS MOL BIOL, V721, P339, DOI 10.1007/978-1-61779-037-9_21; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Kong LY, 1996, CELL IMMUNOL, V172, P77, DOI 10.1006/cimm.1996.0217; Lavi E, 1998, J NEUROVIROL, V4, P301, DOI 10.3109/13550289809114531; Lazzerini PE, 2007, CLIN EXP RHEUMATOL, V25, P696; Li JL, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-31; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louboutin JP, 2010, EXP NEUROL, V221, P231, DOI 10.1016/j.expneurol.2009.11.004; Maccioni RB, 2009, ANN NY ACAD SCI, V1153, P240, DOI 10.1111/j.1749-6632.2008.03972.x; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; Nath A, 2000, J PSYCHOPHARMACOL, V14, P222, DOI 10.1177/026988110001400305; Nukuna A, 2004, J NEUROVIROL, V10, P82, DOI 10.1080/13550280490268188; Panickar KS, 2005, GLIA, V50, P287, DOI 10.1002/glia.20181; Ronaldson PT, 2008, J NEUROCHEM, V106, P1298, DOI 10.1111/j.1471-4159.2008.05479.x; Ronaldson PT, 2006, MOL PHARMACOL, V70, P1087, DOI 10.1124/mol.106.025973; Ronaldson PT, 2010, MOL PHARMACOL, V77, P644, DOI 10.1124/mol.109.059410; Saha RN, 2003, J NEUROCHEM, V86, P1057, DOI 10.1046/j.1471-4159.2003.01942.x; Saile B, 2001, EUR J CELL BIOL, V80, P554, DOI 10.1078/0171-9335-00182; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Schoeniger-Skinner DK, 2007, BRAIN BEHAV IMMUN, V21, P660, DOI 10.1016/j.bbi.2006.10.010; Sellhorn G, 2009, VACCINE, V28, P430, DOI 10.1016/j.vaccine.2009.10.028; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Sinke AP, 2008, J NEUROCHEM, V106, P2302, DOI 10.1111/j.1471-4159.2008.05549.x; Thompson KA, 2004, ANN NEUROL, V56, P873, DOI 10.1002/ana.20304; Thompson WL, 2009, BRAIN RES, V1287, P47, DOI 10.1016/j.brainres.2009.06.081; Togo T, 2000, BRAIN RES, V885, P117, DOI 10.1016/S0006-8993(00)02984-X; Visalli V, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-106; Viviani B, 2006, J BIOL CHEM, V281, P30212, DOI 10.1074/jbc.M602156200; Wallace DR, 2006, SYNAPSE, V59, P51, DOI 10.1002/syn.20214; Wang AL, 2007, INT IMMUNOPHARMACOL, V7, P1552, DOI 10.1016/j.intimp.2007.07.030; Wu CX, 2009, MOL THER, V17, P2058, DOI 10.1038/mt.2009.225; YEUNG MC, 1995, AIDS, V9, P137, DOI 10.1097/00002030-199509020-00004; Younger ST, 2011, NUCL ACIDS RES; Zhang X, 2008, INFLAMM RES, V57, P524, DOI 10.1007/s00011-008-8007-8	55	56	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21261	10.1371/journal.pone.0021261	http://dx.doi.org/10.1371/journal.pone.0021261			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712995	Green Published, Green Submitted, gold			2022-12-25	WOS:000291985100022
J	Belisle, SE; Yin, JM; Shedlock, DJ; Dai, AL; Yan, J; Hirao, L; Kutzler, MA; Lewis, MG; Andersen, H; Lank, SM; Karl, JA; O'Connor, DH; Khan, A; Sardesai, N; Chang, J; Aicher, L; Palermo, RE; Weiner, DB; Katze, MG; Boyer, J				Belisle, Sarah E.; Yin, Jiangmei; Shedlock, Devon J.; Dai, Anlan; Yan, Jian; Hirao, Lauren; Kutzler, Michele A.; Lewis, Mark G.; Andersen, Hanne; Lank, Simon M.; Karl, Julie A.; O'Connor, David H.; Khan, Amir; Sardesai, Niranjan; Chang, Jean; Aicher, Lauri; Palermo, Robert E.; Weiner, David B.; Katze, Michael G.; Boyer, Jean			Long-Term Programming of Antigen-Specific Immunity from Gene Expression Signatures in the PBMC of Rhesus Macaques Immunized with an SIV DNA Vaccine	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; TYPE-1 INFECTION; CHEMOKINE RECEPTORS; HIV-1 INFECTION; DISEASE PROGRESSION; CUTTING EDGE; RANTES; REPLICATION; LYMPHOCYTES	While HIV-1-specific cellular immunity is thought to be critical for the suppression of viral replication, the correlates of protection have not yet been determined. Rhesus macaques (RM) are an important animal model for the study and development of vaccines against HIV/AIDS. Our laboratory has helped to develop and study DNA-based vaccines in which recent technological advances, including genetic optimization and in vivo electroporation (EP), have helped to dramatically boost their immunogenicity. In this study, RMs were immunized with a DNA vaccine including individual plasmids encoding SIV gag, env, and pol alone, or in combination with a molecular adjuvant, plasmid DNA expressing the chemokine ligand 5 (RANTES), followed by EP. Along with standard immunological assays, flow-based activation analysis without ex vivo restimulation and high-throughput gene expression analysis was performed. Strong cellular immunity was induced by vaccination which was supported by all assays including PBMC microarray analysis that identified the up-regulation of 563 gene sequences including those involved in interferon signaling. Furthermore, 699 gene sequences were differentially regulated in these groups at peak viremia following SIVmac251 challenge. We observed that the RANTES-adjuvanted animals were significantly better at suppressing viral replication during chronic infection and exhibited a distinct pattern of gene expression which included immune cell-trafficking and cell cycle genes. Furthermore, a greater percentage of vaccine-induced central memory CD8+ T-cells capable of an activated phenotype were detected in these animals as measured by activation analysis. Thus, co-immunization with the RANTES molecular adjuvant followed by EP led to the generation of cellular immunity that was transcriptionally distinct and had a greater protective efficacy than its DNA alone counterpart. Furthermore, activation analysis and high-throughput gene expression data may provide better insight into mechanisms of viral control than may be observed using standard immunological assays.	[Belisle, Sarah E.; Chang, Jean; Aicher, Lauri; Palermo, Robert E.; Katze, Michael G.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Yin, Jiangmei; Shedlock, Devon J.; Dai, Anlan; Yan, Jian; Hirao, Lauren; Weiner, David B.; Boyer, Jean] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Kutzler, Michele A.] Drexel Univ, Dept Med, Coll Med, Philadelphia, PA 19104 USA; [Lewis, Mark G.; Andersen, Hanne] Bioqual, Res Sect, Rockville, MD USA; [Lank, Simon M.; Karl, Julie A.; O'Connor, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Khan, Amir; Sardesai, Niranjan] Inovio Pharmaceut, Blue Bell, PA USA	University of Washington; University of Washington Seattle; University of Pennsylvania; Drexel University; BIOQUAL Inc.; University of Wisconsin System; University of Wisconsin Madison	Belisle, SE (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	boyerj@mail.med.upenn.edu	Yin, Jiangmei/G-1952-2011	Shedlock, Devon/0000-0003-1018-7510; o'connor, david/0000-0003-2139-470X; Sardesai, Niranjan/0000-0001-6920-1167; Elyard, Hanne/0000-0003-1103-9608; Kutzler, Michele/0000-0001-5692-5617	National Institute of Allergy and Infectious Diseases [N01-AI-60007]; National Institutes of Health/NIAID, Maryland (Division of AIDS) [N01-A30018]; National Center for Research Resources [P51RR00166-45, R24 RR021745-06]; NCRR/NIH [P51 RR000167]; Research Facilities Improvement Program [RR15459-01, RR020141-01]; NIH/NIAID/DAIDS [HHSN272200800063C];  [R01-AI-071886];  [P01-A1-071739]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR021745, C06RR015459, P51RR000166, P51RR000167, C06RR020141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071886] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health/NIAID, Maryland (Division of AIDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/NIAID/DAIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported in part by R01-AI-071886 to JB, P01-A1-071739 to DBW and National Institute of Allergy and Infectious Diseases Contract N01-AI-60007 to Bioqual. Funding was provided by the National Institutes of Health/NIAID Reagent Resource Support Program for AIDS Vaccine Development, Quality Biological, Gaithersburg, Maryland (Division of AIDS Contract N01-A30018). Funds were utilized from grants and National Center for Research Resources P51RR00166-45 and R24 RR021745-06 to DHO, and NCRR/NIH grant number P51 RR000167 to the Wisconsin National Primate Research Center, University of Wisconsin-Madison. This research was conducted in part at a facility constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01. AK and NS acknowledge funding in part from an NIH/NIAID/DAIDS - HIV Vaccine Design and Development Teams award to Inovio HHSN272200800063C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Batten M, 2008, J IMMUNOL, V180, P2752, DOI 10.4049/jimmunol.180.5.2752; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2000, J VIROL, V74, P9144, DOI 10.1128/JVI.74.19.9144-9151.2000; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Bosinger SE, 2004, J IMMUNOL, V173, P6858, DOI 10.4049/jimmunol.173.11.6858; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Cecchinato V, 2008, MUCOSAL IMMUNOL, V1, P279, DOI 10.1038/mi.2008.14; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Frauenschuh A, 2004, VACCINE, V23, P546, DOI 10.1016/j.vaccine.2004.06.024; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Giri MS, 2009, J IMMUNOL, V182, P4459, DOI 10.4049/jimmunol.0801450; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Hadida F, 1999, J IMMUNOL, V163, P1105; Hadida F, 1998, J EXP MED, V188, P609, DOI 10.1084/jem.188.3.609; Hirao LA, 2008, VACCINE, V26, P3112, DOI 10.1016/j.vaccine.2008.02.036; Imami N, 2002, J VIROL, V76, P9011, DOI 10.1128/JVI.76.18.9011-9023.2002; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Karl JA, 2009, METHODS, V49, P11, DOI 10.1016/j.ymeth.2009.05.002; Karlsson I, 2007, J VIROL, V81, P13456, DOI 10.1128/JVI.01619-07; Kim JJ, 1998, J CLIN INVEST, V102, P1112, DOI 10.1172/JCI3986; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kutzler MA, 2005, J IMMUNOL, V175, P112, DOI 10.4049/jimmunol.175.1.112; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Li QS, 2009, J IMMUNOL, V183, P1975, DOI 10.4049/jimmunol.0803222; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Loffredo JT, 2009, J IMMUNOL, V182, P7763, DOI 10.4049/jimmunol.0900111; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003; Musey L, 1997, NEW ENGL J MED, V337, P1267, DOI 10.1056/NEJM199710303371803; Nishimura Y, 2007, J VIROL, V81, P893, DOI 10.1128/JVI.01635-06; Ockenhouse CF, 2005, J INFECT DIS, V191, P2064, DOI 10.1086/430321; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Petrovas C, 2007, BLOOD, V110, P928, DOI 10.1182/blood-2007-01-069112; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Proudfoot AEI, 1999, BIOCHEM PHARMACOL, V57, P451; Prud'homme GJ, 2006, CURR GENE THER, V6, P243, DOI 10.2174/156652306776359504; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Romano JW, 2000, J VIROL METHODS, V86, P61, DOI 10.1016/S0166-0934(99)00184-6; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Sauermann U, 2008, GENES IMMUN, V9, P69, DOI 10.1038/sj.gene.6364448; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shimizu Y, 2007, VIROLOGY, V361, P68, DOI 10.1016/j.virol.2006.10.050; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sin JI, 2000, J VIROL, V74, P11173, DOI 10.1128/JVI.74.23.11173-11180.2000; Veazey RS, 2000, J VIROL, V74, P11001, DOI 10.1128/JVI.74.23.11001-11007.2000; Velu V, 2007, J VIROL, V81, P5819, DOI 10.1128/JVI.00024-07; Waterman PM, 2004, VIRAL IMMUNOL, V17, P545, DOI 10.1089/vim.2004.17.545; Wilson JDK, 2000, AIDS, V14, P225, DOI 10.1097/00002030-200002180-00003; Wiseman RW, 2009, NAT MED, V15, P1322, DOI 10.1038/nm.2038; Xin KQ, 1999, CLIN IMMUNOL, V92, P90, DOI 10.1006/clim.1999.4730; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; YASUTOMI Y, 1993, J VIROL, V67, P1707, DOI 10.1128/JVI.67.3.1707-1711.1993; Yin JM, 2009, VIROLOGY, V393, P49, DOI 10.1016/j.virol.2009.07.017	62	25	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e19681	10.1371/journal.pone.0019681	http://dx.doi.org/10.1371/journal.pone.0019681			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701683	Green Published, Green Submitted, gold			2022-12-25	WOS:000291983800002
J	Corigliano, MG; Maglioco, A; Becher, ML; Goldman, A; Martin, V; Angel, SO; Clemente, M				Corigliano, Mariana G.; Maglioco, Andrea; Laguia Becher, Melina; Goldman, Alejandra; Martin, Valentina; Angel, Sergio O.; Clemente, Marina			Plant Hsp90 Proteins Interact with B-Cells and Stimulate Their Proliferation	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; TOLL-LIKE RECEPTORS; IN-VITRO; LEISHMANIA-INFANTUM; DENDRITIC CELLS; TOXOPLASMA-GONDII; INNATE; HSP70; HSP83; LYMPHOCYTES	Background: The molecular chaperone heat shock protein 90 (Hsp90) plays an important role in folding stabilization and activation of client proteins. Besides, Hsp90 of mammals and mammalian pathogens displays immunostimulatory properties. Here, we investigated the role of plant-derived Hsp90s as B-cell mitogens by measuring their proliferative responses in vitro. Methodology: Plant cytosolic Hsp90 isoforms from Arabidopsis thaliana (AtHsp81.2) and Nicotiana benthamiana (NbHsp90.3) were expressed in E. coli. Over-expression of recombinant plant Hsp90s (rpHsp90s) was confirmed by SDS-PAGE and western blot using and anti-AtHsp81.2 polyclonal anti-body. Both recombinant proteins were purified by Ni-NTA affinity chromatography and their identity confirmed by MALDI-TOF-TOF. Recombinant AtHsp81.2 and NbHsp90.3 proteins induced prominent proliferative responses in spleen cells form BALB/c mice. Polymyxin-B, a potent inhibitor of lipopolysaccharide (LPS), did not eliminate the rpHsp90-induced proliferation. In addition, in vitro incubation of spleen cells with rpHsp90 led to the expansion of CD19-bearing populations, suggesting a direct effect of these proteins on B lymphocytes. This effect was confirmed by immunofluorescence analysis, where a direct binding of rpHsp90 to B-but not to T-cells was observed in cells from BALB/c and C3H/HeN mice. Finally, we examined the involvement of Toll Like Receptor 4 (TLR4) molecules in the rpHsp90s induction of B-cell proliferation. Spleen cells from C3H/HeJ mice, which carry a point mutation in the cytoplasmic region of TLR4, responded poorly to prAtHsp90. However, the interaction between rpHsp90 and B-cells from C3H/HeJ mice was not altered, suggesting that the mutation on TLR4 would be affecting the signal cascade but not the rpHsp90-TLR4 receptor interaction. Conclusions: Our results show for the first time that spleen cell proliferation can be stimulated by a non-pathogen-derived Hsp90. Furthermore, our data provide a new example of a non-pathogen-derived ligand for TLRs.	[Corigliano, Mariana G.; Laguia Becher, Melina; Clemente, Marina] CONICET UNSAM, IIB INTECH, Lab Biotecnol Vegetal, Chascomus, Buenos Aires, Argentina; [Maglioco, Andrea] Acad Nacl Medicina, Inst Leucemia Expt ILEX CONICET, Buenos Aires, DF, Argentina; [Angel, Sergio O.] CONICET UNSAM, IIB INTECH, Lab Parasitol Mol, Chascomus, Buenos Aires, Argentina; [Goldman, Alejandra; Martin, Valentina] UNSAM, Escuela Ciencia & Tecnol, CESyMA, San Martin, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Buenos Aires National Academy of Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Corigliano, MG (corresponding author), CONICET UNSAM, IIB INTECH, Lab Biotecnol Vegetal, Chascomus, Buenos Aires, Argentina.	mclemente@intech.gov.ar	Angel, Sergio/AAZ-2849-2020	Laguia Becher, Melina/0000-0003-1344-4973; Angel, Sergio/0000-0003-4871-3408	Universidad General San Martin (UNSAM, Argentina) [SC 055/08]; National Agency for Scientific and Technological Promotion (ANPCyT, Argentina) [PICT 691/07]	Universidad General San Martin (UNSAM, Argentina); National Agency for Scientific and Technological Promotion (ANPCyT, Argentina)(ANPCyT)	This work was supported by SC 055/08 of the Universidad General San Martin (UNSAM, Argentina) and PICT 691/07 of the National Agency for Scientific and Technological Promotion (ANPCyT, Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, ADV IMMUNOL, V78, P1, DOI 10.1016/S0065-2776(01)78001-7; Aosai F, 2002, CELL STRESS CHAPERON, V7, P357, DOI 10.1379/1466-1268(2002)007<0357:TGDHSP>2.0.CO;2; Arnold-Schild D, 1999, J IMMUNOL, V162, P3757; Baba AF, 2006, GEN PHYSIOL BIOPHYS, V25, P277; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Boshoff A, 2004, PROTEIN EXPRES PURIF, V38, P161, DOI 10.1016/j.pep.2004.06.039; BURIANI G, 2010, TRANSGENIC RES  0618; Calderwood SK, 2007, METHODS, V43, P199, DOI 10.1016/j.ymeth.2007.06.008; Callahan MK, 2006, J IMMUNOL, V177, P8393, DOI 10.4049/jimmunol.177.12.8393; Daniell H, 2009, TRENDS PLANT SCI, V14, P669, DOI 10.1016/j.tplants.2009.09.009; de Miguel N, 2009, BBA-MOL CELL RES, V1793, P1738, DOI 10.1016/j.bbamcr.2009.08.005; Echeverria P, 2001, IMMUNOL LETT, V76, P107, DOI 10.1016/S0165-2478(01)00179-1; Echeverria PC, 2006, VACCINE, V24, P4102, DOI 10.1016/j.vaccine.2006.02.039; Flohe SB, 2003, J IMMUNOL, V170, P2340, DOI 10.4049/jimmunol.170.5.2340; Gleba Y, 2005, VACCINE, V23, P2042, DOI 10.1016/j.vaccine.2005.01.006; Jackson SE, 2004, NAT STRUCT MOL BIOL, V11, P1152, DOI 10.1038/nsmb1204-1152; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Johnson JL, 2009, CELL STRESS CHAPERON, V14, P83, DOI 10.1007/s12192-008-0058-9; Kim Hanna Leah, 2008, Cancer Biol Ther, V7, P10; Krishna P, 2001, CELL STRESS CHAPERON, V6, P238, DOI 10.1379/1466-1268(2001)006<0238:THFOPI>2.0.CO;2; Laguia-Becher M, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-52; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li ZH, 2002, FRONT BIOSCI-LANDMRK, V7, pD731; More S, 1999, IMMUNOL LETT, V69, P275, DOI 10.1016/S0165-2478(99)00100-5; Osterloh A, 2008, MED MICROBIOL IMMUN, V197, P1, DOI 10.1007/s00430-007-0055-0; Paul M, 2010, EXPERT REV VACCINES, V9, P821, DOI [10.1586/erv.10.88, 10.1586/ERV.10.88]; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pockley AG, 2008, TRENDS BIOCHEM SCI, V33, P71, DOI 10.1016/j.tibs.2007.10.005; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2001, TRENDS PLANT SCI, V6, P54, DOI 10.1016/S1360-1385(00)01843-4; Prohaszka Z, 2004, MOL IMMUNOL, V41, P29, DOI 10.1016/j.molimm.2004.02.001; Prohaszka Z, 2007, ADV EXP MED BIOL, V594, P159; Quintana FJ, 2005, J IMMUNOL, V175, P2777, DOI 10.4049/jimmunol.175.5.2777; Rico AI, 2002, CELL STRESS CHAPERON, V7, P339, DOI 10.1379/1466-1268(2002)007<0339:THSPHA>2.0.CO;2; Rico AI, 1999, MOL IMMUNOL, V36, P1131, DOI 10.1016/S0161-5890(99)00136-4; Rowlands MG, 2004, ANAL BIOCHEM, V327, P176, DOI 10.1016/j.ab.2003.10.038; Rybicki EP, 2010, PLANT BIOTECHNOL J, V8, P620, DOI 10.1111/j.1467-7652.2010.00507.x; Scheibel T, 1999, MOL MICROBIOL, V34, P701, DOI 10.1046/j.1365-2958.1999.01632.x; Schild H, 2000, NAT IMMUNOL, V1, P100, DOI 10.1038/77770; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Sharma AK, 2009, BIOTECHNOL ADV, V27, P811, DOI 10.1016/j.biotechadv.2009.06.004; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Streatfield SJ, 2007, PLANT BIOTECHNOL J, V5, P2, DOI 10.1111/j.1467-7652.2006.00216.x; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Tiwari S, 2009, BIOTECHNOL ADV, V27, P449, DOI 10.1016/j.biotechadv.2009.03.006; Tobian AAR, 2004, J IMMUNOL, V173, P5130, DOI 10.4049/jimmunol.173.8.5130; Tsan MF, 2004, CELL MOL IMMUNOL, V1, P274; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wang YQ, 2008, IMMUNOL LETT, V119, P57, DOI 10.1016/j.imlet.2008.04.003; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1	53	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21231	10.1371/journal.pone.0021231	http://dx.doi.org/10.1371/journal.pone.0021231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701588	Green Submitted, Green Published, gold			2022-12-25	WOS:000291983800033
J	Deldicque, L; Bertrand, L; Patton, A; Francaux, M; Baar, K				Deldicque, Louise; Bertrand, Luc; Patton, Amy; Francaux, Marc; Baar, Keith			ER Stress Induces Anabolic Resistance in Muscle Cells through PKB-Induced Blockade of mTORC1	PLOS ONE			English	Article							P70 S6 KINASE; UNFOLDED PROTEIN RESPONSE; MAMMALIAN TARGET; BINDING PARTNER; AMINO-ACIDS; RAG GTPASES; L-LEUCINE; IN-VIVO; PHAS-I; PHOSPHORYLATION	Background: Anabolic resistance is the inability to increase protein synthesis in response to an increase in amino acids following a meal. One potential mediator of anabolic resistance is endoplasmic reticulum (ER) stress. The purpose of the present study was to test whether ER stress impairs the response to growth factors and leucine in muscle cells. Methods: Muscle cells were incubated overnight with tunicamycin or thapsigargin to induce ER stress and the activation of the unfolded protein response, mTORC1 activity at baseline and following insulin and amino acids, as well as amino acid transport were determined. Results: ER stress decreased basal phosphorylation of PKB and S6K1 in a dose-dependent manner. In spite of the decrease in basal PKB phosphorylation, insulin (10-50 nM) could still activate both PKB and S6K1. The leucine (2.5-5 mM)-induced phosphorylation of S6K1 on the other hand was repressed by low concentrations of both tunicamycin and thapsigargin. To determine the mechanism underlying this anabolic resistance, several inhibitors of mTORC1 activation were measured. Tunicamycin and thapsigargin did not change the phosphorylation or content of either AMPK or JNK, both increased TRB3 mRNA expression and thapsigargin increased REDD1 mRNA. Tunicamycin and thapsigargin both decreased the basal phosphorylation state of PRAS40. Neither tunicamycin nor thapsigargin prevented phosphorylation of PRAS40 by insulin. However, since PKB is not activated by amino acids, PRAS40 phosphorylation remained low following the addition of leucine. Blocking PKB using a specific inhibitor had the same effect on both PRAS40 and leucine-induced phosphorylation of S6K1. Conclusion: ER stress induces anabolic resistance in muscle cells through a PKB/PRAS40-induced blockade of mTORC1.	[Deldicque, Louise; Francaux, Marc] Catholic Univ Louvain, Inst Neurosci, Res Grp Muscle & Exercise Physiol, B-1348 Louvain, Belgium; [Deldicque, Louise] Katholieke Univ Leuven, Dept Biomed Kinesiol, Res Ctr Exercise & Hlth, Leuven, Belgium; [Bertrand, Luc] Catholic Univ Louvain, Inst Rech Expt & Clin, Woluwe St Lambert, Belgium; [Patton, Amy; Baar, Keith] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	Universite Catholique Louvain; KU Leuven; Universite Catholique Louvain; University of California System; University of California Davis	Deldicque, L (corresponding author), Catholic Univ Louvain, Inst Neurosci, Res Grp Muscle & Exercise Physiol, B-1348 Louvain, Belgium.	kbaar@ucdavis.edu		Baar, Keith/0000-0001-9337-6186; Deldicque, Louise/0000-0003-3393-5278; Bertrand, Luc/0000-0003-0655-7099; Francaux, Marc/0000-0001-8182-1588	Fonds National de la Recherche Scientifique Medicale (Belgium) [FRSM 3.4574.03]; UCLouvain (FSR)	Fonds National de la Recherche Scientifique Medicale (Belgium)(Fonds de la Recherche Scientifique - FNRS); UCLouvain (FSR)	This work was supported by the Fonds National de la Recherche Scientifique Medicale (FRSM 3.4574.03) (Belgium) and by the UCLouvain (FSR). LD and LB are Postdoctoral Researcher and Research Associate from the FRS-FNRS (Fonds de la Recherche Scientifique), Belgium, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery J, 2010, CIRC RES, V106, P1516, DOI 10.1161/CIRCRESAHA.109.211920; Baird FE, 2009, AM J PHYSIOL-ENDOC M, V297, pE822, DOI 10.1152/ajpendo.00330.2009; Bevington A, 2002, EUR J CLIN INVEST, V32, P590, DOI 10.1046/j.1365-2362.2002.01038.x; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Canedo CS, 2010, AM J PHYSIOL-ENDOC M, V298, pE761, DOI 10.1152/ajpendo.00421.2009; Chen CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001731; Cuthbertson D, 2004, FASEB J, V18, P422, DOI 10.1096/fj.04-2640fje; Deldicque L, 2008, AMINO ACIDS, V35, P147, DOI 10.1007/s00726-007-0607-z; Deldicque L, 2010, AM J PHYSIOL-ENDOC M, V299, pE695, DOI 10.1152/ajpendo.00038.2010; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; DUKSIN D, 1982, J BIOL CHEM, V257, P3105; Durham WJ, 2010, FASEB J, V24, P4117, DOI 10.1096/fj.09-150177; Estevez R, 1998, FASEB J, V12, P1319, DOI 10.1096/fasebj.12.13.1319; Gallardo MA, 1996, J MEMBRANE BIOL, V152, P57, DOI 10.1007/s002329900085; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Glover EI, 2008, J PHYSIOL-LONDON, V586, P6049, DOI 10.1113/jphysiol.2008.160333; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; HENDERSHOT LM, 1994, GENOMICS, V20, P281, DOI 10.1006/geno.1994.1166; Hyde Russell, 2005, FASEB J, V19, P461; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jin HO, 2009, FREE RADICAL BIO MED, V46, P1158, DOI 10.1016/j.freeradbiomed.2009.01.015; Kang YJ, 2011, CELL DEATH DIFFER, V18, P133, DOI 10.1038/cdd.2010.82; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Liu XM, 2004, FASEB J, V18, P768, DOI 10.1096/fj.03-0886fje; MCDOWELL HE, 1995, AM J PHYSIOL-CELL PH, V269, pC1287, DOI 10.1152/ajpcell.1995.269.5.C1287; Nascimento EBM, 2010, CELL SIGNAL, V22, P961, DOI 10.1016/j.cellsig.2010.02.002; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Peyrollier K, 2000, BIOCHEM J, V350, P361, DOI 10.1042/0264-6021:3500361; Rennie MJ, 2009, APPL PHYSIOL NUTR ME, V34, P377, DOI 10.1139/H09-012; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Sekulic A, 2000, CANCER RES, V60, P3504; Sitnick M, 2009, J PHYSIOL-LONDON, V587, P5753, DOI 10.1113/jphysiol.2009.180174; Taylor PM, 2009, BIOCHEM SOC T, V37, P237, DOI 10.1042/BST0370237; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Xu G, 1998, J BIOL CHEM, V273, P28178, DOI 10.1074/jbc.273.43.28178; Zhang K, 2006, HANDB EXP PHARM, V172, P69	49	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20993	10.1371/journal.pone.0020993	http://dx.doi.org/10.1371/journal.pone.0020993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698202	Green Published, Green Submitted, gold			2022-12-25	WOS:000291734100041
J	Sturm, GJ; Jin, CS; Kranzelbinder, B; Hemmer, W; Sturm, EM; Griesbacher, A; Heinemann, A; Vollmann, J; Altmann, F; Crailsheim, K; Focke, M; Aberer, W				Sturm, Gunter J.; Jin, Chunsheng; Kranzelbinder, Bettina; Hemmer, Wolfgang; Sturm, Eva M.; Griesbacher, Antonia; Heinemann, Akos; Vollmann, Jutta; Altmann, Friedrich; Crailsheim, Karl; Focke, Margarete; Aberer, Werner			Inconsistent Results of Diagnostic Tools Hamper the Differentiation between Bee and Vespid Venom Allergy	PLOS ONE			English	Article							BASOPHIL ACTIVATION TEST; REACTIVE CARBOHYDRATE DETERMINANTS; HYMENOPTERA-VENOM; IGE ANTIBODIES; CLINICAL-EVALUATION; IMMUNOGLOBULIN-E; SKIN-TESTS; BINDING; HISTAMINE; HONEYBEE	Background: Double sensitization (DS) to bee and vespid venom is frequently observed in the diagnosis of hymenoptera venom allergy, but clinically relevant DS is rare. Therefore it is sophisticated to choose the relevant venom for specific immunotherapy and overtreatment with both venoms may occur. We aimed to compare currently available routine diagnostic tests as well as experimental tests to identify the most accurate diagnostic tool. Methods: 117 patients with a history of a bee or vespid allergy were included in the study. Initially, IgE determination by the ImmunoCAP, by the Immulite, and by the ADVIA Centaur, as well as the intradermal test (IDT) and the basophil activation test (BAT) were performed. In 72 CAP double positive patients, individual IgE patterns were determined by western blot inhibition and component resolved diagnosis (CRD) with rApi m 1, nVes v 1, and nVes v 5. Results: Among 117 patients, DS was observed in 63.7% by the Immulite, in 61.5% by the CAP, in 47.9% by the IDT, in 20.5% by the ADVIA, and in 17.1% by the BAT. In CAP double positive patients, western blot inhibition revealed CCD-based DS in 50.8%, and the CRD showed 41.7% of patients with true DS. Generally, agreement between the tests was only fair and inconsistent results were common. Conclusion: BAT, CRD, and ADVIA showed a low rate of DS. However, the rate of DS is higher than expected by personal history, indicating that the matter of clinical relevance is still not solved even by novel tests. Furthermore, the lack of agreement between these tests makes it difficult to distinguish between bee and vespid venom allergy. At present, no routinely employed test can be regarded as gold standard to find the clinically relevant sensitization.	[Sturm, Gunter J.; Kranzelbinder, Bettina; Aberer, Werner] Med Univ Graz, Div Environm Dermatol & Venerol, Dept Dermatol, Graz, Austria; [Jin, Chunsheng; Altmann, Friedrich] Univ Nat Resources & Appl Life Sci, Dept Chem, Vienna, Austria; [Hemmer, Wolfgang] Floridsdorf Allergy Ctr, Vienna, Austria; [Sturm, Eva M.; Heinemann, Akos] Med Univ Graz, Inst Expt & Clin Pharmacol, Graz, Austria; [Griesbacher, Antonia] Med Univ Graz, Div Biostat, Med Res Ctr, Graz, Austria; [Vollmann, Jutta; Crailsheim, Karl] Graz Univ, Inst Zool, A-8010 Graz, Austria; [Focke, Margarete] Med Univ Vienna, Inst Pathophysiol, Vienna, Austria	Medical University of Graz; University of Natural Resources & Life Sciences, Vienna; Medical University of Graz; Medical University of Graz; University of Graz; Medical University of Vienna	Sturm, GJ (corresponding author), Med Univ Graz, Div Environm Dermatol & Venerol, Dept Dermatol, Graz, Austria.	gunter.sturm@medunigraz.at		Altmann, Friedrich/0000-0002-0112-7877; Heinemann, Akos/0000-0002-8554-2372; Sturm, Eva/0000-0003-4898-884X	Austrian Society for Dermatology and Venerology	Austrian Society for Dermatology and Venerology	The study is supported by a grant of the Austrian Society for Dermatology and Venerology (http://www.oegdv.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2001, ALLERGY, V56, P27, DOI 10.1034/j.1398-9995.2001.00909.x; Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Batanero E, 1999, J ALLERGY CLIN IMMUN, V103, P147, DOI 10.1016/S0091-6749(99)70538-5; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; Ebo DG, 2007, J INVEST ALLERG CLIN, V17, P357; Egner W, 1998, CLIN EXP ALLERGY, V28, P26, DOI 10.1046/j.1365-2222.1998.00176.x; Erdmann SM, 2004, ALLERGY, V59, P1102, DOI 10.1111/j.1398-9995.2004.00624.x; GEORGITIS JW, 1985, J ALLERGY CLIN IMMUN, V76, P803, DOI 10.1016/0091-6749(85)90752-3; Hemmer W, 2004, CLIN EXP ALLERGY, V34, P460, DOI 10.1111/j.1365-2222.2004.01897.x; Jin C, 2008, J ALLERGY CLIN IMMUN, V121, P185, DOI 10.1016/j.jaci.2007.07.047; Jin C, 2010, J ALLERGY CLIN IMMUN, V125, P184, DOI 10.1016/j.jaci.2009.08.037; Korosec P, 2009, CLIN EXP ALLERGY, V39, P1730, DOI 10.1111/j.1365-2222.2009.03347.x; LOCKEY RF, 1989, J ALLERGY CLIN IMMUN, V84, P967, DOI 10.1016/0091-6749(89)90396-5; Mertens M, 2010, CLIN EXP ALLERGY, V40, P1333, DOI 10.1111/j.1365-2222.2010.03535.x; Mittermann I, 2010, J ALLERGY CLIN IMMUN, V125, P1300, DOI 10.1016/j.jaci.2010.03.017; Mosbech H, 2000, ALLERGY, V55, P1005, DOI 10.1034/j.1398-9995.2000.00587.x; Muller UR, 2009, ALLERGY, V64, P543, DOI 10.1111/j.1398-9995.2008.01794.x; Paganelli R, 1998, ALLERGY, V53, P763; PASTORELLO EA, 1992, ALLERGY, V47, P463, DOI 10.1111/j.1398-9995.1992.tb00665.x; Petersen AB, 2004, CLIN BIOCHEM, V37, P882, DOI 10.1016/j.clinbiochem.2004.06.010; Pierson-Mullany LK, 2002, CLIN EXP ALLERGY, V32, P107, DOI 10.1046/j.0022-0477.2001.01244.x; Sainte-Laudy J, 2000, CLIN EXP ALLERGY, V30, P1166, DOI 10.1046/j.1365-2222.2000.00863.x; Schafer T, 1996, ALLERGY, V51, P372; Sturm GJ, 2009, ALLERGY, V64, P1319, DOI 10.1111/j.1398-9995.2009.02004.x; Sturm GJ, 2004, ALLERGY, V59, P1110, DOI 10.1111/j.1398-9995.2004.00400.x; Sturm GJ, 2009, INT ARCH ALLERGY IMM, V148, P261, DOI 10.1159/000161586; Wicklein D, 2004, BIOL CHEM, V385, P397, DOI 10.1515/BC.2004.044; Wilson IBH, 1998, GLYCOBIOLOGY, V8, P651, DOI 10.1093/glycob/8.7.651	28	60	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20842	10.1371/journal.pone.0020842	http://dx.doi.org/10.1371/journal.pone.0020842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698247	gold, Green Published, Green Submitted			2022-12-25	WOS:000291730000027
J	Conaway, HH; Pirhayati, A; Persson, E; Pettersson, U; Svensson, O; Lindholm, C; Henning, P; Tuckermann, J; Lerner, UH				Conaway, H. Herschel; Pirhayati, Amir; Persson, Emma; Pettersson, Ulrika; Svensson, Olle; Lindholm, Catharina; Henning, Petra; Tuckermann, Jan; Lerner, Ulf H.			Retinoids Stimulate Periosteal Bone Resorption by Enhancing the Protein RANKL, a Response Inhibited by Monomeric Glucocorticoid Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE CALVARIAL BONES; KAPPA-B LIGAND; VITAMIN-A; DNA-BINDING; INDUCED OSTEOPOROSIS; PARATHYROID-HORMONE; MINERAL DENSITY; ACID RECEPTOR; CATHEPSIN K; DIFFERENTIATION	Increased vitamin A (retinol) intake has been suggested to increase bone fragility. In the present study, we investigated effects of retinoids on bone resorption in cultured neonatal mouse calvarial bones and their interaction with glucocorticoids (GC). All-trans-retinoic acid (ATRA), retinol, retinalaldehyde, and 9-cis-retinoic acid stimulated release of Ca-45 from calvarial bones. The resorptive effect of ATRA was characterized by mRNA expression of genes associated with osteoclast differentiation, enhanced osteoclast number, and bone matrix degradation. In addition, the RANKL/OPG ratio was increased by ATRA, release of Ca-45 stimulated by ATRA was blocked by exogenous OPG, and mRNA expression of genes associated with bone formation was decreased by ATRA. All retinoid acid receptors (RAR alpha/beta/gamma) were expressed in calvarial bones. Agonists with affinity to all receptor subtypes or specifically to RAR alpha enhanced the release of Ca-45 and mRNA expression of Rankl, whereas agonists with affinity to RAR beta/gamma or RAR gamma had no effects. Stimulation of Rankl mRNA by ATRA was competitively inhibited by the RAR alpha antagonist GR110. Exposure of calvarial bones to GC inhibited the stimulatory effects of ATRA on 45Ca release and Rankl mRNA and protein expression. This inhibitory effect was reversed by the glucocorticoid receptor (GR) antagonist RU 486. Increased Rankl mRNA stimulated by ATRA was also blocked by GC in calvarial bones from mice with a GR mutation that blocks dimerization (GR(dim) mice). The data suggest that ATRA enhances periosteal bone resorption by increasing the RANKL/OPG ratio via RAR alpha receptors, a response that can be inhibited by monomeric GR.	[Pirhayati, Amir; Persson, Emma; Lerner, Ulf H.] Umea Univ, Dept Mol Periodontol, SE-90187 Umea, Sweden; [Pettersson, Ulrika] Umea Univ, Dept Clin Pharmacol, SE-90187 Umea, Sweden; [Svensson, Olle] Umea Univ, Dept Orthoped Surg, SE-90187 Umea, Sweden; [Conaway, H. Herschel] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Lindholm, Catharina; Henning, Petra; Lerner, Ulf H.] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Ctr Bone & Arthrit Res, SE-41345 Gothenburg, Sweden; [Tuckermann, Jan] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany	Umea University; Umea University; Umea University; University of Arkansas System; University of Arkansas Medical Sciences; University of Gothenburg; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Lerner, UH (corresponding author), Umea Univ, Dept Mol Periodontol, SE-90187 Umea, Sweden.	Ulf.Lerner@odont.umu.se		Lerner, Ulf/0000-0002-3579-1960; Pettersson Kymmer, Ulrika/0000-0002-0557-9803; Henning, Petra/0000-0002-9330-6265	Swedish Research Council; Royal 80 Year Fund of King Gustav V; Swedish Rheumatism Association, Combine; Medical Faculty at Umea University; County Council of Vasterbotten; ALF/TUA at Sahlgrenska University Hospital; Deutsche Forschungsgemeinschaft [Tu220/6, FOR 1486]; Boehringer Stiftung	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal 80 Year Fund of King Gustav V; Swedish Rheumatism Association, Combine; Medical Faculty at Umea University; County Council of Vasterbotten; ALF/TUA at Sahlgrenska University Hospital; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Stiftung	This work was supported by grants from the Swedish Research Council, the Royal 80 Year Fund of King Gustav V, the Swedish Rheumatism Association, Combine, the Medical Faculty at Umea University, the County Council of Vasterbotten, ALF/TUA at Sahlgrenska University Hospital, Deutsche Forschungsgemeinschaft (Grant Tu220/6, FOR 1486 Immunobone; to J. T.), and the Boehringer Stiftung (to J. T.).	Ahlen J, 2002, BONE, V31, P242, DOI 10.1016/S8756-3282(02)00784-6; *APPL BIOS, 1997, US B, V2; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; BRAND JS, 1972, ENDOCRINOLOGY, V90, P479, DOI 10.1210/endo-90-2-479; Caire-Juvera G, 2009, AM J CLIN NUTR, V89, P323, DOI 10.3945/ajcn.2008.26451; Canalis E, 2007, OSTEOPOROSIS INT, V18, P1319, DOI 10.1007/s00198-007-0394-0; CARANO A, 1990, J CLIN INVEST, V85, P456, DOI 10.1172/JCI114459; Compston J, 2010, NAT REV RHEUMATOL, V6, P82, DOI 10.1038/nrrheum.2009.259; Conaway HH, 2009, FASEB J, V23, P3526, DOI 10.1096/fj.09-132548; Conaway HH, 1997, J ENDOCRINOL, V155, P513, DOI 10.1677/joe.0.1550513; Del Fattore A, 2008, ARCH BIOCHEM BIOPHYS, V473, P147, DOI 10.1016/j.abb.2008.01.011; Fanjul AN, 1996, J BIOL CHEM, V271, P22441, DOI 10.1074/jbc.271.37.22441; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; GOLDMAN R, 1985, CANCER RES, V45, P3118; Herrlich P, 2001, ONCOGENE, V20, P2465, DOI 10.1038/sj.onc.1204388; Hofbauer LC, 2009, MOL ENDOCRINOL, V23, P1525, DOI 10.1210/me.2009-0069; Jacobson A, 2004, BIOCHEM BIOPH RES CO, V322, P162, DOI 10.1016/j.bbrc.2004.07.092; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; KINDMARK A, 1995, CALCIFIED TISSUE INT, V57, P242, DOI 10.1007/BF00310266; Kneissel M, 2005, BONE, V36, P202, DOI 10.1016/j.bone.2004.11.006; Lerner UH, 2004, CRIT REV ORAL BIOL M, V15, P64, DOI 10.1177/154411130401500202; Lerner UH, 1997, ACTA PHYSIOL SCAND, V161, P81, DOI 10.1046/j.1365-201X.1997.d01-1933.x; LERNER UH, 1987, J BONE MINER RES, V2, P375; Lind T, 2011, BONE, V48, P496, DOI 10.1016/j.bone.2010.10.169; Liu YCG, 2010, PERIODONTOL 2000, V52, P163, DOI 10.1111/j.1600-0757.2009.00321.x; LJUNGGREN O, 1991, J BONE MINER RES, V6, P543; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Melhus H, 1998, ANN INTERN MED, V129, P770, DOI 10.7326/0003-4819-129-10-199811150-00003; Mic FA, 2003, P NATL ACAD SCI USA, V100, P7135, DOI 10.1073/pnas.1231422100; Michaelsson K, 2003, NEW ENGL J MED, V348, P287, DOI 10.1056/NEJMoa021171; Moise AR, 2007, BIOCHEMISTRY-US, V46, P4449, DOI 10.1021/bi7003069; NG KW, 1989, MOL ENDOCRINOL, V3, P2079, DOI 10.1210/mend-3-12-2079; NIEMAN LK, 1985, J CLIN ENDOCR METAB, V61, P536, DOI 10.1210/jcem-61-3-536; OBERG KC, 1989, MOL ENDOCRINOL, V3, P915, DOI 10.1210/mend-3-6-915; Palmqvist P, 2006, J BIOL CHEM, V281, P2414, DOI 10.1074/jbc.M510160200; PHILIBERT D, 1991, FRONT HORM RES, V19, P1; Pignatello MA, 1997, TOXICOL APPL PHARM, V142, P319, DOI 10.1006/taap.1996.8047; Pino-Lagos K, 2008, ANN NY ACAD SCI, V1143, P170, DOI 10.1196/annals.1443.017; Piu F, 2005, BIOCHEM PHARMACOL, V71, P156, DOI 10.1016/j.bcp.2005.10.025; Promislow JHE, 2002, J BONE MINER RES, V17, P1349, DOI 10.1359/jbmr.2002.17.8.1349; Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Ribaya-Mercado JD, 2007, NUTR REV, V65, P425, DOI 10.1111/j.1753-4887.2007.tb00268.x; ROBERTS AB, 1984, CANCER RES, V44, P1635; Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022; Schwab AM, 2005, ENDOCRINOLOGY, V146, P4349, DOI 10.1210/en.2005-0601; Swanson C, 2006, ENDOCRINOLOGY, V147, P3613, DOI 10.1210/en.2005-0717; Tanaka K, 2010, BONE, V47, P1006, DOI 10.1016/j.bone.2010.08.016; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teng M, 1996, J MED CHEM, V39, P3035, DOI 10.1021/jm9603532; Toma S, 1998, INT J CANCER, V78, P86, DOI 10.1002/(SICI)1097-0215(19980925)78:1<86::AID-IJC14>3.0.CO;2-3; Tuckermann JP, 1999, J CELL BIOL, V147, P1365, DOI 10.1083/jcb.147.7.1365; VIOLETTE SM, 1989, J INVEST DERMATOL, V93, P165, DOI 10.1111/1523-1747.ep12277393; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; WENER JA, 1972, ENDOCRINOLOGY, V90, P752, DOI 10.1210/endo-90-3-752; Zenger S, 2007, BONE, V41, P820, DOI 10.1016/j.bone.2007.07.010	61	39	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31425	31436		10.1074/jbc.M111.247734	http://dx.doi.org/10.1074/jbc.M111.247734			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21715325	hybrid, Green Published			2022-12-25	WOS:000294487500037
J	Huang, WR; Wang, YC; Chi, PI; Wang, L; Wang, CY; Lin, CH; Liu, HJ				Huang, Wei R.; Wang, Ying C.; Chi, Pei I.; Wang, Lai; Wang, Chi Y.; Lin, Chi H.; Liu, Hung J.			Cell Entry of Avian Reovirus Follows a Caveolin-1-mediated and Dynamin-2-dependent Endocytic Pathway That Requires Activation of p38 Mitogen-activated Protein Kinase (MAPK) and Src Signaling Pathways as Well as Microtubules and Small GTPase Rab5 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGMA-C-PROTEIN; VIRUS ENTRY; RHO-GTPASES; MEDIATED ENDOCYTOSIS; EARLY ENDOSOMES; APOPTOSIS; CAVEOLAE; REPLICATION; INFLUENZA; P53	Very little is known about the mechanism of cell entry of avian reovirus (ARV). The aim of this study was to explore the mechanism of ARV entry and subsequent infection. Cholesterol mainly affected the early steps of the ARV life cycle, because the presence of cholesterol before and during viral adsorption greatly blocked ARV infectivity. Although we have demonstrated that ARV facilitating p38 MAPK is beneficial for virus replication, its mechanism remains unknown. Here, we show that ARV-induced phosphorylation of caveolin-1 (Tyr(14)), dynamin-2 expression, and Rac1 activation through activation of p38 MAPK and Src in the early stage of the virus life cycle is beneficial for virus entry and productive infection. The strong inhibition by dynasore, a specific inhibitor of dynamin-2, and depletion of endogenous caveolin-1 or dynamin-2 by siRNAs as well as the caveolin-1 colocalization study implicate caveolin-1-mediated and dynamin-2-dependent endocytosis as a significant avenue of ARV entry. By means of pharmacological inhibitors, dominant negative mutants, and siRNA of various cellular proteins and signaling molecules, phosphorylation of caveolin-1, dynamin-2 expression, and Rac1 activation were suppressed, suggesting that by orchestrating p38 MAPK, Src, and Rac1 signaling cascade in the target cells, ARV creates an appropriate intracellular environment facilitating virus entry and productive infection. Furthermore, disruption of microtubules, Rab5, or endosome acidification all inhibited ARV infection, suggesting that microtubules and small GTPase Rab5, which regulate transport to early endosome, are crucial for survival of ARV and that exposure of the virus to acidic pH is required for productive infection.	[Huang, Wei R.; Wang, Ying C.; Chi, Pei I.; Wang, Lai; Liu, Hung J.] Natl Chung Ching Univ, Inst Mol Biol, Taichung 402, Taiwan; [Wang, Ying C.; Chi, Pei I.] Natl Pingtung Univ Sci & Technol, Grad Inst Biotechnol, Pingtung 912, Taiwan; [Wang, Chi Y.] Natl Chung Ching Univ, Dept Vet Med, Taichung 402, Taiwan; [Lin, Chi H.] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 11221, Taiwan	National Pingtung University Science & Technology; National Yang Ming Chiao Tung University	Liu, HJ (corresponding author), Natl Chung Ching Univ, Inst Mol Biol, Taichung 402, Taiwan.	hjliu5257@nchu.edu.tw		Liu, Hung-Jen/0000-0002-1460-1494; Huang, Wei-Ru/0000-0002-2508-8374	National Science Council of Taiwan [NSC99-2321-B-005-015-MY3, NSC97-2313-B-005-048-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council of Taiwan Grants NSC99-2321-B-005-015-MY3 and NSC97-2313-B-005-048-MY3.	Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Banerjee S, 2002, J VIROL, V76, P5937, DOI 10.1128/JVI.76.12.5937-5948.2002; Barnard RJO, 2003, CURR TOP MICROBIOL, V281, P107; Bayer N, 2001, J BIOL CHEM, V276, P3952, DOI 10.1074/jbc.M004722200; Beer C, 2005, J VIROL, V79, P10776, DOI 10.1128/JVI.79.16.10776-10787.2005; Bousarghin L, 2003, J VIROL, V77, P3846, DOI 10.1128/JVI.77.6.3846-3850.2003; Briggs JAG, 2003, J GEN VIROL, V84, P757, DOI 10.1099/vir.0.18779-0; Brindley MA, 2005, J VIROL, V79, P14482, DOI 10.1128/JVI.79.23.14482-14488.2005; Campbell EM, 2004, J VIROL, V78, P5745, DOI 10.1128/JVI.78.11.5745-5755.2004; Candurra NA, 1999, J GEN VIROL, V80, P147, DOI 10.1099/0022-1317-80-1-147; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Chulu JLC, 2007, BIOCHEM BIOPH RES CO, V356, P529, DOI 10.1016/j.bbrc.2007.02.164; Chulu JLC, 2010, J VIROL, V84, P7683, DOI 10.1128/JVI.02604-09; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Drose S, 1997, J EXP BIOL, V200, P1; Duncan Roy, 1996, Virology, V219, P179; Empig CJ, 2002, J VIROL, V76, P5266, DOI 10.1128/JVI.76.10.5266-5270.2002; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Grande A, 2000, VIROLOGY, V274, P367, DOI 10.1006/viro.2000.0473; Grande A, 2002, J GEN VIROL, V83, P131, DOI 10.1099/0022-1317-83-1-131; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hambleton S, 2007, J VIROL, V81, P7548, DOI 10.1128/JVI.00486-07; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hommelgaard AM, 2005, TRAFFIC, V6, P720, DOI 10.1111/j.1600-0854.2005.00314.x; Hsu CJ, 2006, AVIAN PATHOL, V35, P320, DOI 10.1080/03079450600823386; Ji WT, 2009, J GEN VIROL, V90, P3002, DOI 10.1099/vir.0.013953-0; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; KEEN JH, 1990, J CELL BIOL, V59, P404; Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08; Lin HY, 2007, AVIAN PATHOL, V36, P155, DOI 10.1080/03079450701261262; Lin PY, 2009, VIROLOGY, V385, P323, DOI 10.1016/j.virol.2008.12.028; Liu HJ, 2005, BIOCHEM BIOPH RES CO, V336, P709, DOI 10.1016/j.bbrc.2005.08.149; Liu HJ, 2003, VIROLOGY, V314, P336, DOI 10.1016/S0042-6822(03)00415-X; Liu HJ, 2008, MOL CELLS, V26, P396; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002; McLean TI, 1999, J VIROL, V73, P8415, DOI 10.1128/JVI.73.10.8415-8426.1999; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Nakatsue T, 1998, BIOCHEM BIOPH RES CO, V253, P59, DOI 10.1006/bbrc.1998.9724; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pietiainen VM, 2005, ANN MED, V37, P394, DOI 10.1080/07853890510011976; Rahaus M, 2004, J GEN VIROL, V85, P3529, DOI 10.1099/vir.0.80347-0; Roohvand F, 2009, J BIOL CHEM, V284, P13778, DOI 10.1074/jbc.M807873200; Ruthel G, 2005, J VIROL, V79, P4709, DOI 10.1128/JVI.79.8.4709-4719.2005; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Salsman J, 2005, J VIROL, V79, P8090, DOI 10.1128/JVI.79.13.8090-8100.2005; Schimmoller F, 1998, J BIOL CHEM, V273, P22161, DOI 10.1074/jbc.273.35.22161; Shapiro L, 1998, P NATL ACAD SCI USA, V95, P7422, DOI 10.1073/pnas.95.13.7422; Shih WL, 2004, VIROLOGY, V321, P65, DOI 10.1016/j.virol.2003.12.004; Sieczkarski SB, 2005, ARCH VIROL, V150, P1783, DOI 10.1007/s00705-005-0558-1; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Westermann M, 2005, HISTOCHEM CELL BIOL, V123, P613, DOI 10.1007/s00418-004-0750-5; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75	63	51	52	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30780	30794		10.1074/jbc.M111.257154	http://dx.doi.org/10.1074/jbc.M111.257154			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21705803	Green Published, hybrid			2022-12-25	WOS:000294283600058
J	Gokey, NG; Lopez-Anido, C; Gillian-Daniel, AL; Svaren, J				Gokey, Nolan G.; Lopez-Anido, Camila; Gillian-Daniel, Anne Lynn; Svaren, John			Early Growth Response 1 (Egr1) Regulates Cholesterol Biosynthetic Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; PERIPHERAL-NERVE MYELINATION; FATTY-ACID SYNTHESIS; TRANSCRIPTION FACTOR; TRANSGENIC MICE; REDUCTASE PROMOTER; SQUALENE EPOXIDASE; DOWN-REGULATION; RECEPTOR GENE; C/EBP-BETA	The early growth response (EGR) family of transcription factors has been implicated in control of lipid biosynthetic genes. Egr1 is induced by insulin both in vitro and in vivo and is the most highly expressed family member in liver. In this study, we investigated whether Egr1 regulates cholesterol biosynthetic genes in liver. Using an insulin-sensitive liver cell line, we show that localization of Egr1 to cholesterol biosynthetic genes is induced by insulin treatment and that this localization precedes the induction of the genes. Reduction in Egr1 expression using targeted siRNA blunted the insulin-dependent induction of cholesterol genes. A similar reduction in squalene epoxidase expression was also observed in Egr1 null mice. In addition, application of chromatin immunoprecipitation (ChIP) samples to tiled gene microarrays revealed localization of Egr1 in promoter regions of many cholesterol gene loci. In vivo ChIP assays using liver tissue show that Egr1 localization to several cholesterol biosynthetic gene promoters is induced by feeding. Finally, analysis of plasma cholesterol in Egr1(-/-) mice indicated a significant decrease in serum cholesterol when compared with wild-type mice. Together these data point to Egr1 as a modulator of the cholesterol biosynthetic gene family in liver.	[Lopez-Anido, Camila; Svaren, John] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Gokey, Nolan G.] Univ Wisconsin, Comparat Biomed Sci Grad Program, Madison, WI 53705 USA; [Gillian-Daniel, Anne Lynn] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Svaren, John] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Svaren, J (corresponding author), Univ Wisconsin, Waisman Ctr, 1500 Highland Ave, Madison, WI 53705 USA.	jpsvaren@wisc.edu	Svaren, John/A-1605-2010	Svaren, John/0000-0003-2963-7921; Lopez-Anido, Camila/0000-0003-0601-3980	American Heart Association [0650102Z]; National Institutes of Health [DK59630]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059630, U2CDK059630] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grant-in-aid 0650102Z from the American Heart Association.; We thank Anju Singh for assistance in the mouse liver perfusions and David Hui, Dana Lee, and Linda Keller at the Mouse Metabolic Phenotyping Center at the University of Cincinnati for performing assays and analysis of cholesterol levels. The MMPC is supported by National Institutes of Health Grant DK59630.	Barroso I, 1999, J BIOL CHEM, V274, P17997, DOI 10.1074/jbc.274.25.17997; Bennett MK, 2008, J BIOL CHEM, V283, P15628, DOI 10.1074/jbc.M800391200; Brand E, 2000, J MOL MED-JMM, V78, P81, DOI 10.1007/s001090000074; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Dooley KA, 1999, J BIOL CHEM, V274, P5285, DOI 10.1074/jbc.274.9.5285; Figliola R, 2008, J MOL BIOL, V380, P265, DOI 10.1016/j.jmb.2008.05.004; Flowers MT, 2006, J LIPID RES, V47, P2668, DOI 10.1194/jlr.M600203-JLR200; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Harja E, 2004, CIRC RES, V94, P333, DOI 10.1161/01.RES.0000112405.61577.95; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Jang SW, 2006, J NEUROCHEM, V98, P1678, DOI 10.1111/j.1471-4159.2006.04069.x; Jang SW, 2010, J NEUROCHEM, V115, P1409, DOI 10.1111/j.1471-4159.2010.07045.x; Jee S, 2007, INT J MOL MED, V20, P829; Jones EA, 2011, J NEUROSCI, V31, P4242, DOI 10.1523/JNEUROSCI.5893-10.2011; JUREVICS HA, 1994, J LIPID RES, V35, P112; Kang J, 1999, KIDNEY INT, V56, P452, DOI 10.1046/j.1523-1755.1999.00562.x; Keeton AB, 2003, ENDOCRINOLOGY, V144, P5402, DOI 10.1210/en.2003-0592; Kishore R, 2002, AM J PHYSIOL-GASTR L, V282, pG6, DOI 10.1152/ajpgi.00328.2001; Korn BS, 1998, J CLIN INVEST, V102, P2050, DOI 10.1172/JCI5341; Lagor WR, 2005, J BIOL CHEM, V280, P36601, DOI 10.1074/jbc.M504346200; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; LeBlanc SE, 2005, J NEUROCHEM, V93, P737, DOI 10.1111/j.1471-4159.2005.03056.x; Lee SL, 1996, MOL CELL BIOL, V16, P4566; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Mayer SI, 2008, ENDOCRINOLOGY, V149, P6311, DOI 10.1210/en.2008-0251; McMullen MR, 2005, GASTROENTEROLOGY, V128, P2066, DOI 10.1053/j.gastro.2005.02.065; Murphy C, 2006, BBA-MOL CELL BIOL L, V1761, P1213, DOI 10.1016/j.bbalip.2006.08.015; Nagai M, 2002, BIOCHEM BIOPH RES CO, V295, P74, DOI 10.1016/S0006-291X(02)00623-X; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Naito M, 2009, AM J PATHOL, V174, P54, DOI 10.2353/ajpath.2009.080602; Nakanishi M, 2008, NUCLEIC ACIDS RES, V36, P3443, DOI 10.1093/nar/gkn066; Osborne AR, 2004, BIOCHEM BIOPH RES CO, V318, P814, DOI 10.1016/j.bbrc.2004.04.105; OSBORNE TF, 1988, J BIOL CHEM, V263, P3380; Rae FK, 2004, ONCOGENE, V23, P3067, DOI 10.1038/sj.onc.1207360; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Sakakura Y, 2001, BIOCHEM BIOPH RES CO, V286, P176, DOI 10.1006/bbrc.2001.5375; Seifert M, 2005, TRENDS GENET, V21, P553, DOI 10.1016/j.tig.2005.07.011; Seo YK, 2009, P NATL ACAD SCI USA, V106, P13765, DOI 10.1073/pnas.0904246106; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Thyss R, 2005, EMBO J, V24, P128, DOI 10.1038/sj.emboj.7600501; Tobin KAR, 2002, J BIOL CHEM, V277, P10691, DOI 10.1074/jbc.M109771200; Toews AD, 1997, MOL BRAIN RES, V49, P113, DOI 10.1016/S0169-328X(97)00132-0; Toews AD, 1996, J LIPID RES, V37, P2502; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Wolfe MW, 1999, MOL ENDOCRINOL, V13, P752, DOI 10.1210/me.13.5.752; Xie XF, 2009, MOL ENDOCRINOL, V23, P434, DOI 10.1210/me.2007-0531; Zhang F, 2003, J BIOL CHEM, V278, P44246, DOI 10.1074/jbc.M305564200; Zhang F, 2002, J LIPID RES, V43, P1477, DOI 10.1194/jlr.M200126-JLR200; Zhou Y, 2006, BIOCHEM J, V397, P101, DOI 10.1042/BJ20060044	61	36	36	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29501	29510		10.1074/jbc.M111.263509	http://dx.doi.org/10.1074/jbc.M111.263509			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21712389	Green Published, hybrid			2022-12-25	WOS:000294046600007
J	Saunders, LP; Cao, WX; Chang, WC; Albright, RA; Braddock, DT; De la Cruz, EM				Saunders, Lauren P.; Cao, Wenxiang; Chang, William C.; Albright, Ronald A.; Braddock, Demetrios T.; De La Cruz, Enrique M.			Kinetic Analysis of Autotaxin Reveals Substrate-specific Catalytic Pathways and a Mechanism for Lysophosphatidic Acid Distribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED NEUROPATHIC PAIN; LYSOPHOSPHOLIPASE-D; LPA; PHOSPHODIESTERASE; IDENTIFICATION; MOTILITY; SITE; MIGRATION; HELICASE; CANCER	Autotaxin (ATX) is a secreted lysophospholipase D that hydrolyzeslysophosphatidylcholine(LPC) intolysophosphatidic acid (LPA), initiating signaling cascades leading to cancer metastasis, wound healing, and angiogenesis. Knowledge of the pathway and kinetics of LPA synthesis by ATX is critical for developing quantitative physiological models of LPA signaling. We measured the individual rate constants and pathway of the LPA synthase cycle of ATX using the fluorescent lipid substrates FS-3 and 12-(N-methylN-(7-nitrobenz-2-oxa-1,3-diazol-4-yl))-LPC. FS-3 binds rapidly (k(1) >= 500 mu M-1 s(-1)) and is hydrolyzed slowly (k(2) = 0.024 s(-1)). Release of the first hydrolysis product is random and rapid (>= 1 s(-1)), whereas release of the second is slow and rate-limiting (0.005-0.007 s(-1)). Substrate binding and hydrolysis are slow and rate-limiting with LPC. Product release is sequential with choline preceding LPA. The catalytic pathway and kinetics depend strongly on the substrate, suggesting that ATX kinetics could vary for the various in vivo substrates. Slow catalysis with LPC reveals the potential for LPA signaling to spread to cells distal to the site of LPC substrate binding by ATX. An ATX mutant in which catalytic threonine at position 210 is replaced with alanine binds substrate weakly, favoring a role for Thr-210 in binding as well as catalysis. FTY720P, the bioactive form of a drug currently used to treat multiple sclerosis, inhibits ATX in an uncompetitive manner and slows the hydrolysis reaction, suggesting that ATX inhibition plays a significant role in lymphocyte immobilization in FTY720P-based therapeutics.	[Chang, William C.; Albright, Ronald A.; Braddock, Demetrios T.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Saunders, Lauren P.; Cao, Wenxiang; De La Cruz, Enrique M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University	Braddock, DT (corresponding author), Yale Univ, Sch Med, Dept Pathol, 310 Cedar St, New Haven, CT 06510 USA.	demetrios.braddock@yale.edu; enrique.delacruz@yale.edu			National Institutes of Health [GM071688]; American Heart Association [09PRE2080041]; Bayer Health Care Pharmaceutical Inc.; National Science Foundation [MCB-0546353]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Bayer Health Care Pharmaceutical Inc.; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071688 (to E. M. D. L. C.).; Supported in part by American Heart Association Predoctoral Fellowship Award 09PRE2080041.; Supported by a grant from Bayer Health Care Pharmaceutical Inc. To whom correspondence may be addressed: Dept. of Pathology, Yale University School of Medicine, 310 Cedar St., New Haven, CT 06510. Tel.: 203-737-1278; Fax: 203-785-6899; E-mail: demetrios.braddock@yale.edu.; American Heart Association Established Investigator 0940075N, recipient of National Science Foundation CAREER Award MCB-0546353, and a Hellman Family Fellow. To whom correspondence may be addressed: Dept. of Molecular Biophysics and Biochemistry, Yale University, P. O. Box 208114, New Haven, CT 06520-8114. Tel.: 203-432-5424; Fax: 203-432-1296; E-mail: enrique.delacruz@yale.edu.	Albers HMHG, 2010, P NATL ACAD SCI USA, V107, P7257, DOI 10.1073/pnas.1001529107; Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Choi JW, 2008, BBA-MOL CELL BIOL L, V1781, P531, DOI 10.1016/j.bbalip.2008.03.004; Clair T, 2003, CANCER RES, V63, P5446; Clair T, 1997, J BIOL CHEM, V272, P996, DOI 10.1074/jbc.272.2.996; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; Ferguson CG, 2006, ORG LETT, V8, P2023, DOI 10.1021/ol060414i; Gijsbers R, 2003, FEBS LETT, V538, P60, DOI 10.1016/S0014-5793(03)00133-9; Gijsbers R, 2001, J BIOL CHEM, V276, P1361, DOI 10.1074/jbc.M007552200; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Henn A, 2008, J MOL BIOL, V377, P193, DOI 10.1016/j.jmb.2007.12.046; Henn A, 2010, P NATL ACAD SCI USA, V107, P4046, DOI 10.1073/pnas.0913081107; Inoue M, 2008, NEUROSCIENCE, V152, P296, DOI 10.1016/j.neuroscience.2007.12.041; Inoue M, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-6; Jeffery DR, 2011, EXPERT REV NEUROTHER, V11, P165, DOI 10.1586/ERN.10.193; JOHNSON KA, 1986, METHOD ENZYMOL, V134, P677; Koh E, 2003, CANCER RES, V63, P2042; Lee HY, 1996, J BIOL CHEM, V271, P24408, DOI 10.1074/jbc.271.40.24408; Liu SY, 2009, CELL CYCLE, V8, P3695, DOI 10.4161/cc.8.22.9937; Ma L, 2010, J PHARMACOL EXP THER, V333, P540, DOI 10.1124/jpet.109.164830; Ma L, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-64; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Okita M, 1997, INT J CANCER, V71, P31, DOI 10.1002/(SICI)1097-0215(19970328)71:1<31::AID-IJC7>3.0.CO;2-4; OTTO MR, 1994, BIOPHYS J, V67, P2511, DOI 10.1016/S0006-3495(94)80741-6; Ptaszynska MM, 2010, MOL CANCER RES, V8, P309, DOI 10.1158/1541-7786.MCR-09-0288; Reitan NK, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2982530; Saunders LP, 2008, MOL CANCER THER, V7, P3352, DOI 10.1158/1535-7163.MCT-08-0463; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Tomsig JL, 2009, BIOCHEM J, V419, P611, DOI 10.1042/BJ20081888; Ueda H, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-11; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2005, J BIOL CHEM, V280, P21155, DOI 10.1074/jbc.M413183200; van Meeteren LA, 2008, CANCER LETT, V266, P203, DOI 10.1016/j.canlet.2008.02.052; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; YOUNG ME, 1980, BIOTECHNOL BIOENG, V22, P947, DOI 10.1002/bit.260220504	37	26	27	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30130	30141		10.1074/jbc.M111.246884	http://dx.doi.org/10.1074/jbc.M111.246884			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21719699	Green Published, hybrid			2022-12-25	WOS:000294046600070
J	Zaric, SS; Coulter, WA; Shelburne, CE; Fulton, CR; Zaric, MS; Scott, A; Lappin, MJ; Fitzgerald, DC; Irwin, CR; Taggart, CC				Zaric, Svetislav S.; Coulter, Wilson A.; Shelburne, Charles E.; Fulton, Catherine R.; Zaric, Marija S.; Scott, Aaron; Lappin, Mark J.; Fitzgerald, Denise C.; Irwin, Christopher R.; Taggart, Clifford C.			Altered Toll-like Receptor 2-mediated Endotoxin Tolerance Is Related to Diminished Interferon beta Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORPHYROMONAS-GINGIVALIS LIPOPOLYSACCHARIDE; GENE-EXPRESSION; SUSTAINING INFLAMMATION; BACTEROIDES-FRAGILIS; HELICOBACTER-PYLORI; PERIODONTAL-DISEASE; MULTIPLE-SCLEROSIS; MURINE MACROPHAGES; INTERLEUKIN-8 GENE; TLR4 AGONISTS	Induction of endotoxin tolerance leads to a reduced inflammatory response after repeated challenge by LPS and is important for resolution of inflammation and prevention of tissue damage. Enterobacterial LPS is recognized by the TLR4 signaling complex, whereas LPS of some non-enterobacterial organisms is capable of signaling independently of TLR4 utilizing TLR2-mediated signal transduction instead. In this study we report that Porphyromonas gingivalis LPS, a TLR2 agonist, fails to induce a fully endotoxin tolerant state in a human monocytic cell line (THP-1) and mouse bone marrow-derived macrophages. In contrast to significantly decreased production of human IL-8 and TNF-alpha and, in mice, keratinocyte-derived cytokine (KC), macrophage inflammatory protein-2 (MIP-2), and TNF-alpha after repeated challenge with Escherichia coli LPS, cells repeatedly exposed to P. gingivalis LPS responded by producing less TNF-alpha but sustained elevated secretion of IL-8, KC, and MIP-2. Furthermore, in endotoxin-tolerant cells, production of IL-8 is controlled at the signaling level and correlates well with NF-kappa B activation, whereas TNF-alpha expression is blocked at the gene transcription level. Interferon beta plays an important role in attenuation of chemokine expression in endotoxin-tolerized cells as shown in interferon regulatory factor-3 knock-out mice. In addition, human gingival fibroblasts, commonly known not to display LPS tolerance, were found to be tolerant to repeated challenge by LPS if pretreated with interferon beta. The data suggest that the inability of the LPS-TLR2 complex to induce full endotoxin tolerance in monocytes/macrophages is related to diminished production of interferon beta and may partly explain the involvement of these LPS isoforms in the pathogenesis of chronic inflammatory diseases.	[Zaric, Svetislav S.; Fulton, Catherine R.; Zaric, Marija S.; Scott, Aaron; Fitzgerald, Denise C.; Taggart, Clifford C.] Queens Univ Belfast, Ctr Infect & Immun, Belfast BT9 7BL, Antrim, North Ireland; [Coulter, Wilson A.; Lappin, Mark J.; Irwin, Christopher R.] Queens Univ Belfast, Sch Dent, Belfast BT12 6BP, Antrim, North Ireland; [Shelburne, Charles E.] Univ Michigan, Sch Dent, Ann Arbor, MI 48108 USA	Queens University Belfast; Queens University Belfast; University of Michigan System; University of Michigan	Zaric, SS (corresponding author), Queens Univ Belfast, Ctr Infect & Immun, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	szaric01@qub.ac.uk	Scott, Aaron/AAB-5203-2019; Taggart, Clifford C/G-4492-2014	Scott, Aaron/0000-0001-9325-5026; Taggart, Clifford/0000-0002-9930-2978; Zaric, Svetislav/0000-0003-4127-0253	Public Health Agency [COM/4275/10] Funding Source: researchfish	Public Health Agency		Adib-Conquy M, 2006, CRIT CARE MED, V34, P2377, DOI 10.1097/01.CCM.0000233875.93866.88; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Albrecht V, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-69; Aoshiba K, 1999, J IMMUNOL, V162, P1692; Ara T, 2009, J PERIODONTAL RES, V44, P21, DOI 10.1111/j.1600-0765.2007.01041.x; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Bendtzen K, 2010, J INTERF CYTOK RES, V30, P759, DOI 10.1089/jir.2010.0091; Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; Biswas SK, 2007, INT J BIOCHEM CELL B, V39, P1582, DOI 10.1016/j.biocel.2007.04.021; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Boyd CR, 2009, J IMMUNOL, V183, P7703, DOI 10.4049/jimmunol.0902780; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chaniotou Z, 2010, GASTROENTEROLOGY, V139, P2083, DOI 10.1053/j.gastro.2010.08.024; Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; De Nardo D, 2009, CELL SIGNAL, V21, P246, DOI 10.1016/j.cellsig.2008.10.009; Dieterle S, 2008, ANDROLOGIA, V40, P117, DOI 10.1111/j.1439-0272.2008.00833.x; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Drexler SK, 2010, INT J BIOCHEM CELL B, V42, P506, DOI 10.1016/j.biocel.2009.10.009; El Gazzar M, 2010, J BIOL CHEM, V285, P20940, DOI 10.1074/jbc.M110.115063; El Gazzar M, 2010, J BIOL CHEM, V285, P1259, DOI 10.1074/jbc.M109.067330; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; Erridge C, 2002, MICROBES INFECT, V4, P837, DOI 10.1016/S1286-4579(02)01604-0; Foster SL, 2009, CLIN IMMUNOL, V130, P7, DOI 10.1016/j.clim.2008.08.015; Freedman MS, 2006, EXPERT OPIN PHARMACO, V7, pS1, DOI 10.1517/14656566.7.1.S1; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kim YJ, 2009, DNA CELL BIOL, V28, P185, DOI 10.1089/dna.2008.0816; Kumada H, 2008, ORAL MICROBIOL IMMUN, V23, P60, DOI 10.1111/j.1399-302X.2007.00392.x; LEPPER PM, 2011, MEDIATORS I IN PRESS; Lindgren A, 2011, INNATE IMMUN-LONDON, V17, P191, DOI 10.1177/1753425909357970; Martin M, 2001, J IMMUNOL, V167, P5278, DOI 10.4049/jimmunol.167.9.5278; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Monneret G, 2010, EXPERT REV ANTI-INFE, V8, P1109, DOI [10.1586/eri.10.107, 10.1586/ERI.10.107]; Muthukuru M, 2005, INFECT IMMUN, V73, P687, DOI 10.1128/IAI.73.2.687-694.2005; Muthukuru M, 2008, INFECT IMMUN, V76, P477, DOI 10.1128/IAI.00100-07; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Nakayama K, 2004, J BIOL CHEM, V279, P6629, DOI 10.1074/jbc.M308620200; Pan HJ, 2010, J IMMUNOL, V184, P5502, DOI 10.4049/jimmunol.0901601; Pandey S, 2006, IMMUNOL CELL BIOL, V84, P333, DOI 10.1111/j.1440-1711.2006.01444.x; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Rhee KJ, 2009, INFECT IMMUN, V77, P1708, DOI 10.1128/IAI.00814-08; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Sakuta T, 1998, J DENT RES, V77, P1597, DOI 10.1177/00220345980770080701; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Shelburne CE, 2007, CELL MICROBIOL, V9, P1611, DOI 10.1111/j.1462-5822.2007.00897.x; TAKADA H, 1991, INFECT IMMUN, V59, P295, DOI 10.1128/IAI.59.1.295-301.1991; Toshchakov V, 2003, J ENDOTOXIN RES, V9, P169, DOI 10.1179/096805103125001577; Xiong YB, 2011, J BIOL CHEM, V286, P7905, DOI 10.1074/jbc.M110.182873; YANG IV, 2010, AM J RESP C IN PRESS; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Zaric S, 2009, J DENT RES, V88, P946, DOI 10.1177/0022034509344559; Zaric S, 2010, INFECT IMMUN, V78, P4151, DOI 10.1128/IAI.00600-10	54	19	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29492	29500		10.1074/jbc.M111.252791	http://dx.doi.org/10.1074/jbc.M111.252791			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21705332	Green Published, hybrid			2022-12-25	WOS:000294046600006
J	Lomashvili, KA; Wang, XN; Wallin, R; O'Neill, WC				Lomashvili, Koba A.; Wang, Xiaonan; Wallin, Reidar; O'Neill, W. Charles			Matrix Gla Protein Metabolism in Vascular Smooth Muscle and Role in Uremic Vascular Calcification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; AORTIC CALCIFICATION; ARTERY CALCIFICATION; POTENTIAL MECHANISM; CELL CALCIFICATION; KEUTEL-SYNDROME; RENAL-FAILURE; VITAMIN-K; IN-VITRO; PYROPHOSPHATE	Matrix Gla protein (MGP) is an inhibitor of vascular calcification but its mechanism of action and pathogenic role are unclear. This was examined in cultured rat aortas and in a model of vascular calcification in rats with renal failure. Both carboxylated (GlaMGP) and uncarboxylated (GluMGP) forms were present in aorta and disappeared during culture with warfarin. MGP was also released into the medium and removed by ultracentrifugation, and similarly affected by warfarin. In a high-phosphate medium, warfarin increased aortic calcification but only in the absence of pyrophosphate, another endogenous inhibitor of vascular calcification. Although GlaMGP binds and inactivates bone morphogenic protein (BMP)-2, a proposed mediator of vascular calcification through up-regulation of the osteogenic transcription factor runx2, neither warfarin, BMP-2, nor the BMP-2 antagonist noggin altered runx2 mRNA content in aortas, and noggin did not prevent warfarin-induced calcification. Aortic content of MGP mRNA was increased 5-fold in renal failure but did not differ between calcified and noncalcified aortas. Immunoblots showed increased GlaMGP in noncalcified (5-fold) and calcified (20-fold) aortas from rats with renal failure, with similar increases in GluMGP. We conclude that rat aortic smooth muscle produces both GlaMGP and GluMGP in tissue-bound and soluble, presumably vesicular, forms. MGP inhibits calcification independent of BMP-2-driven osteogenesis and only in the absence of pyrophosphate, consistent with direct inhibition of hydroxyapatite formation. Synthesis of MGP is increased in renal failure and deficiency of GlaMGP is not a primary cause of medial calcification in this condition.	[Lomashvili, Koba A.; Wang, Xiaonan; O'Neill, W. Charles] Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA; [Wallin, Reidar] Wake Forest Univ, Dept Med, Winston Salem, NC 27109 USA	Emory University; Wake Forest University	O'Neill, WC (corresponding author), WMB338,1639 Pierce Dr, Atlanta, GA 30322 USA.	woneill@emory.edu			National Institutes of Health [DK069681]; Amgen Junior Faculty Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen Junior Faculty Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK069681 (to W. C. O.) and an Amgen Junior Faculty Award (to K. A. L.).	Bostrom K, 2001, J BIOL CHEM, V276, P14044, DOI 10.1074/jbc.M008103200; Bro S, 2006, ARTERIOSCL THROM VAS, V26, P570, DOI 10.1161/01.ATV.0000201060.47945.cb; Brown MA, 2000, J BIOL CHEM, V275, P19795, DOI 10.1074/jbc.M002298200; Cogan EB, 1999, ANAL BIOCHEM, V271, P29, DOI 10.1006/abio.1999.4100; FLEISCH H, 1965, NATURE, V207, P1300, DOI 10.1038/2071300b0; Hackeng TM, 2001, PROTEIN SCI, V10, P864, DOI 10.1110/ps.44701; HAO H, 1995, ARTERIOSCL THROM VAS, V15, P1474, DOI 10.1161/01.ATV.15.9.1474; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Jiang GR, 2003, HYPERTENSION, V41, P1131, DOI 10.1161/01.HYP.0000066128.04083.CA; Johnson K, 2005, ARTERIOSCL THROM VAS, V25, P686, DOI 10.1161/01.ATV.0000154774.71187.f0; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Lomashvili KA, 2008, KIDNEY INT, V73, P1024, DOI 10.1038/ki.2008.26; Lomashvili KA, 2004, J AM SOC NEPHROL, V15, P1392, DOI 10.1097/01.ASN.0000128955.83129.9C; Lomashvili KA, 2005, J AM SOC NEPHROL, V16, P2495, DOI 10.1681/ASN.2004080694; Lomashvili KA, 2009, KIDNEY INT, V75, P617, DOI 10.1038/ki.2008.646; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Meier M, 2001, EUR RESPIR J, V17, P566, DOI 10.1183/09031936.01.17305660; MEYER JL, 1984, ARCH BIOCHEM BIOPHYS, V231, P1, DOI 10.1016/0003-9861(84)90356-4; Moe SM, 2003, KIDNEY INT, V63, P1003, DOI 10.1046/j.1523-1755.2003.00820.x; MOOREHEAD WR, 1974, CLIN CHEM, V20, P1458; Mori K, 1998, FEBS LETT, V433, P19, DOI 10.1016/S0014-5793(98)00870-9; Munroe PB, 1999, NAT GENET, V21, P142, DOI 10.1038/5102; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; O'Neill WC, 2011, KIDNEY INT, V79, P512, DOI 10.1038/ki.2010.461; Okada HKY, 1999, CLIN EXP NEPHROL, V3, P82; Price PA, 2006, KIDNEY INT, V70, P1577, DOI 10.1038/sj.ki.5001841; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400; Price PA, 2000, ARTERIOSCL THROM VAS, V20, P317, DOI 10.1161/01.ATV.20.2.317; Price PA, 2002, J BIOL CHEM, V277, P3926, DOI 10.1074/jbc.M106366200; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; ROMBERG RW, 1986, BIOCHEMISTRY-US, V25, P1176, DOI 10.1021/bi00353a035; Rosen V, 2006, ANN NY ACAD SCI, V1068, P19, DOI 10.1196/annals.1346.005; Roy ME, 2002, BONE, V31, P296, DOI 10.1016/S8756-3282(02)00821-9; Rutsch F, 2001, AM J PATHOL, V158, P543, DOI 10.1016/S0002-9440(10)63996-X; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schurgers LJ, 2007, J THROMB HAEMOST, V5, P2503, DOI 10.1111/j.1538-7836.2007.02758.x; Schurgers LJ, 2007, BLOOD, V109, P2823, DOI 10.1182/blood-2006-07-035345; Schurgers LJ, 2005, ARTERIOSCL THROM VAS, V25, P1629, DOI 10.1161/01.ATV.0000173313.46222.43; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; SPANAKIS E, 1993, NUCLEIC ACIDS RES, V21, P3809, DOI 10.1093/nar/21.16.3809; Spronk HMH, 2001, BIOCHEM BIOPH RES CO, V289, P485, DOI 10.1006/bbrc.2001.5996; Sweatt A, 2003, J THROMB HAEMOST, V1, P178, DOI 10.1046/j.1538-7836.2003.00023.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wallin R, 2000, THROMB HAEMOSTASIS, V84, P1039; YOKOZAWA T, 1986, NEPHRON, V44, P230, DOI 10.1159/000183992; Zebboudj AF, 2003, J CELL BIOCHEM, V90, P756, DOI 10.1002/jcb.10669; ZHANG PM, 1994, BLOOD, V84, P169	47	66	70	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28715	28722		10.1074/jbc.M111.251462	http://dx.doi.org/10.1074/jbc.M111.251462			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705322	Green Published, hybrid			2022-12-25	WOS:000293837000009
J	Cooper, J; Liu, L; Woodruff, EA; Taylor, HE; Goodwin, JS; D'Aquila, RT; Spearman, P; Hildreth, JEK; Dong, XH				Cooper, JoAnn; Liu, Ling; Woodruff, Elvin A.; Taylor, Harry E.; Goodwin, J. Shawn; D'Aquila, Richard T.; Spearman, Paul; Hildreth, James E. K.; Dong, Xinhong			Filamin A Protein Interacts with Human Immunodeficiency Virus Type 1 Gag Protein and Contributes to Productive Particle Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE-DERIVED MACROPHAGES; CALCIUM-SENSING RECEPTOR; HOST-CELL CYTOSKELETON; HIV-1 GAG; INTRACELLULAR TRAFFICKING; PLASMA-MEMBRANE; ACTIN-BINDING; SURFACE EXPRESSION; STRUCTURAL BASIS; DOMAIN	HIV-1 Gag precursor directs virus particle assembly and release. In a search for Gag-interacting proteins that are involved in late stages of the HIV-1 replication cycle, we performed yeast two-hybrid screening against a human cDNA library and identified the non-muscle actin filament cross-linking protein filamin A as a novel Gag binding partner. The 280-kDa filamin A regulates cortical actin network dynamics and participates in the anchoring of membrane proteins to the actin cytoskeleton. Recent studies have shown that filamin A facilitates HIV-1 cell-to-cell transmission by binding to HIV receptors and coreceptors and regulating their clustering on the target cell surface. Here we report a novel role for filamin A in HIV-1 Gag intracellular trafficking. We demonstrate that filamin A interacts with the capsid domain of HIV-1 Gag and that this interaction is involved in particle release in a productive manner. Disruption of this interaction eliminated Gag localization at the plasma membrane and induced Gag accumulation within internal compartments. Moreover, blocking clathrin-dependent endocytic pathways did not relieve the restriction to particle release induced by filamin A depletion. These results suggest that filamin A is involved in the distinct step of the Gag trafficking pathway. The discovery of the Gag-filamin A interaction may provide a new therapeutic target for the treatment of HIV infection.	[Cooper, JoAnn; Liu, Ling; Taylor, Harry E.; Hildreth, James E. K.; Dong, Xinhong] Meharry Med Coll, Ctr AIDS Hlth Dispar Res, Nashville, TN 37208 USA; [Cooper, JoAnn; Liu, Ling; Dong, Xinhong] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Goodwin, J. Shawn] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Woodruff, Elvin A.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [D'Aquila, Richard T.] Vanderbilt Univ, Dept Med, Div Infect Dis, Nashville, TN 37232 USA; [Spearman, Paul] Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA	Meharry Medical College; Meharry Medical College; Meharry Medical College; Vanderbilt University; Vanderbilt University; Emory University	Dong, XH (corresponding author), Meharry Med Coll, Ctr AIDS Hlth Dispar Res, 1005 Dr DB Todd Jr Blvd, Nashville, TN 37208 USA.	xdong@mmc.edu			National Institutes of Health [R21AI089330, U54RR019192, P30AI054999, U54RR026140]; NATIONAL CANCER INSTITUTE [U54CA163069] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025497, G12RR003032, U54RR019192, U54RR026140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI089330, R01AI040338, P30AI054999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R21AI089330, U54RR019192, P30AI054999, and U54RR026140.	Alroy I, 2005, P NATL ACAD SCI USA, V102, P1478, DOI 10.1073/pnas.0408717102; Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; Awata H, 2001, J BIOL CHEM, V276, P34871, DOI 10.1074/jbc.M100775200; Barrero-Villar M, 2009, J CELL SCI, V122, P103, DOI 10.1242/jcs.035873; Batonick M, 2005, VIROLOGY, V342, P190, DOI 10.1016/j.virol.2005.08.001; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Chan EY, 2007, J VIROL, V81, P7571, DOI 10.1128/JVI.00288-07; Chan EY, 2009, J VIROL, V83, P9283, DOI 10.1128/JVI.00814-09; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Derdowski A, 2004, J VIROL, V78, P1230, DOI 10.1128/JVI.78.3.1230-1242.2004; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Fackler OT, 2006, CURR OPIN MICROBIOL, V9, P409, DOI 10.1016/j.mib.2006.06.010; Feng SJ, 2005, J BIOL CHEM, V280, P6709, DOI 10.1074/jbc.M413590200; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fiori JL, 2009, ENDOCRINOLOGY, V150, P2551, DOI 10.1210/en.2008-1344; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Freed EO, 2004, TRENDS MICROBIOL, V12, P170, DOI 10.1016/j.tim.2004.02.001; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Huang Y, 2001, J VIROL, V75, P4947, DOI 10.1128/JVI.75.10.4947-4951.2001; Joshi A, 2008, MOL CELL, V30, P227, DOI 10.1016/j.molcel.2008.03.015; Jouve M, 2007, CELL HOST MICROBE, V2, P85, DOI 10.1016/j.chom.2007.06.011; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Kim EY, 2007, MOL PHARMACOL, V72, P622, DOI 10.1124/mol.107.038026; Lin RW, 2001, P NATL ACAD SCI USA, V98, P5258, DOI 10.1073/pnas.011538198; Liu BD, 1999, J VIROL, V73, P2901, DOI 10.1128/JVI.73.4.2901-2908.1999; Liu GP, 1997, J CELL BIOL, V139, P1719, DOI 10.1083/jcb.139.7.1719; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Naghavi MH, 2007, CURR OPIN IMMUNOL, V19, P402, DOI 10.1016/j.coi.2007.07.003; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Onoprishvili I, 2003, MOL PHARMACOL, V64, P1092, DOI 10.1124/mol.64.5.1092; Ott DE, 2008, REV MED VIROL, V18, P159, DOI 10.1002/rmv.570; Ott DE, 2000, VIROLOGY, V266, P42, DOI 10.1006/viro.1999.0075; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; Perotti ME, 1996, J VIROL, V70, P5916, DOI 10.1128/JVI.70.9.5916-5921.1996; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Resh MD, 2005, AIDS REV, V7, P84; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; Rey O, 1996, VIROLOGY, V220, P530, DOI 10.1006/viro.1996.0343; Ryo A, 2008, P NATL ACAD SCI USA, V105, P294, DOI 10.1073/pnas.0704831105; Ryzhova EV, 2006, J VIROL, V80, P2694, DOI 10.1128/JVI.80.6.2694-2704.2006; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; SASAKI H, 1995, P NATL ACAD SCI USA, V92, P2026, DOI 10.1073/pnas.92.6.2026; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Seck T, 2003, J BIOL CHEM, V278, P10408, DOI 10.1074/jbc.M209655200; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Sverdlov M, 2009, MOL BIOL CELL, V20, P4531, DOI 10.1091/mbc.E08-10-0997; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Votteler J, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-12; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; Wilk T, 1999, J VIROL, V73, P1931, DOI 10.1128/JVI.73.3.1931-1940.1999; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Wodrich H, 2000, NUCLEIC ACIDS RES, V28, P901, DOI 10.1093/nar/28.4.901; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Zhang LJ, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-12; Zhang ML, 2005, J BIOL CHEM, V280, P11140, DOI 10.1074/jbc.M412242200; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001	74	28	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28498	28510		10.1074/jbc.M111.239053	http://dx.doi.org/10.1074/jbc.M111.239053			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21705339	hybrid, Green Published			2022-12-25	WOS:000293557800065
J	Zhuang, LN; Hu, WX; Xin, SM; Zhao, J; Pei, G				Zhuang, Le-nan; Hu, Wen-xiang; Xin, Shun-mei; Zhao, Jian; Pei, Gang			beta-Arrestin-1 Protein Represses Adipogenesis and Inflammatory Responses through Its Interaction with Peroxisome Proliferator-activated Receptor-gamma (PPAR gamma)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; INSULIN-RESISTANCE; TRANSCRIPTION; COMPLEX; DIFFERENTIATION; ARRESTIN; OBESITY; FAT; FIBROBLASTS; BEHAVIOR	One of the master regulators of adipogenesis and macrophage function is peroxisome proliferator-activated receptor-gamma (PPAR gamma). Here, we report that a deficiency of beta-arrestin-1 expression affects PPAR gamma-mediated expression of lipid metabolic genes and inflammatory genes. Further mechanistic studies revealed that beta-arrestin-1 interacts with PPAR gamma. beta-Arrestin-1 suppressed the formation of a complex between PPAR gamma and 9-cis-retinoic acid receptor-alpha through its direct interaction with PPAR gamma. The interaction of beta-arrestin-1 with PPAR gamma repressed PPAR gamma/9-cis-retinoic acid receptor-alpha function but promoted PPAR gamma/nuclear receptor corepressor function in PPAR gamma-mediated adipogenesis and inflammatory gene expression. Consistent with these results, a deficiency of beta-arrestin-1 binding to PPAR gamma abolished its suppression of PPAR gamma-dependent adipogenesis and inflammatory responses. These results indicate that the regulation of PPAR gamma by beta-arrestin-1 is critical. Furthermore, in vivo expression of beta-arrestin-1 (but not the binding-deficient mutant) significantly repressed adipogenesis, macrophage infiltration, and diet-induced obesity and improved glucose tolerance and systemic insulin sensitivity. Therefore, our findings not only reveal a molecular mechanism for the modulation of obesity by beta-arrestin-1 but also suggest a potential tactical approach against obesity and its associated metabolic disorders.	[Zhuang, Le-nan; Hu, Wen-xiang; Xin, Shun-mei; Zhao, Jian; Pei, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; [Zhuang, Le-nan; Hu, Wen-xiang] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; [Pei, Gang] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Tongji University	Zhao, J (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	jzhao@sibs.ac.cn; gpei@sibs.ac.cn	Zhao, Jian/E-2008-2019; Hu, Wenxiang/W-3737-2017; Zhuang, Lenan/GZG-7254-2022	Zhao, Jian/0000-0002-8862-0591; Hu, Wenxiang/0000-0002-6754-5625; Zhuang, Lenan/0000-0001-9561-8396	Ministry of Science and Technology [2007CB947100, 2009CB940903, 2011CB910202]; National Natural Science Foundation of China [30871285, 90713047]; Chinese Academy of Sciences [XDA01010302]; Sanofi-Aventis-Shanghai Institutes for Biological Sciences	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Sanofi-Aventis-Shanghai Institutes for Biological Sciences	This work was supported in part by Ministry of Science and Technology Grants 2007CB947100, 2009CB940903, and 2011CB910202; National Natural Science Foundation of China Grants 30871285 and 90713047; and Chinese Academy of Sciences Grant XDA01010302.; Supported by the Sanofi-Aventis-Shanghai Institutes for Biological Sciences Scholarship Program.	Auwerx J, 1999, CELL, V97, P161; Baudry A, 2006, J CELL SCI, V119, P889, DOI 10.1242/jcs.02792; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; CHOI JH, NATURE, V466, P451; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; JUGEAUBRY CE, 1995, J BIOL CHEM, V270, P18117, DOI 10.1074/jbc.270.30.18117; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Lefebvre B, 2010, J CLIN INVEST, V120, P1454, DOI 10.1172/JCI38606; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; REED BC, 1977, P NATL ACAD SCI USA, V74, P4876, DOI 10.1073/pnas.74.11.4876; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Sonoda N, 2008, P NATL ACAD SCI USA, V105, P6614, DOI 10.1073/pnas.0710402105; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Zhang MF, 2010, DEV BIOL, V339, P407, DOI 10.1016/j.ydbio.2009.12.042; Zhuang LN, 2011, J BIOL CHEM, V286, P28396, DOI 10.1074/jbc.M111.223206	40	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28403	28413		10.1074/jbc.M111.256099	http://dx.doi.org/10.1074/jbc.M111.256099			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21700709	Green Published, hybrid			2022-12-25	WOS:000293557800056
J	Boeuf, P; Hasang, W; Hanssen, E; Glazier, JD; Rogerson, SJ				Boeuf, Philippe; Hasang, Wina; Hanssen, Eric; Glazier, Jocelyn D.; Rogerson, Stephen J.			Relevant Assay to Study the Adhesion of Plasmodium falciparum-Infected Erythrocytes to the Placental Epithelium	PLOS ONE			English	Article							CHONDROITIN SULFATE; GENE-EXPRESSION; MEMBRANE; PREGNANCY; ADHERENCE; TRANSPORT; BINDING; ACID	In placental malaria, Plasmodium falciparum-infected erythrocytes adhere to the apical plasma membrane of the placental epithelium, triggering an impairment of placental function detrimental to the fetus. The design of anti-adhesion intervention strategies requires a detailed understanding of the mechanisms involved. However, most adhesion assays lack in vivo relevance and are hardly quantitative. Here, we describe a flow cytometry-based adhesion assay that is fully relevant by using apical epithelial plasma membrane vesicles as the adhesion matrix, and being applicable to infected erythrocytes directly isolated from patients. Adhesion is measured both as the percentage of pathogens bound to epithelial membrane vesicles as well as the mean number of vesicles bound per infected erythrocytes. We show that adhesins alternative to those currently identified could be involved. This demonstrates the power of this assay to advance our understanding of epithelial adhesion of infected erythrocytes and in the design of intervention strategies.	[Boeuf, Philippe; Hasang, Wina; Rogerson, Stephen J.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, RMH WH, Melbourne, Vic 3050, Australia; [Hanssen, Eric] Univ Melbourne, Inst Bio21, Electron Microscopy Unit, Melbourne, Vic 3050, Australia; [Hanssen, Eric] La Trobe Univ, Dept Biochem, Melbourne, Vic, Australia; [Glazier, Jocelyn D.] Univ Manchester, St Marys Hosp, Maternal & Fetal Hlth Res Ctr, Sch Med,Manchester Acad Hlth Sci Ctr, Manchester M13 0JH, Lancs, England	Royal Melbourne Hospital; University of Melbourne; University of Melbourne; La Trobe University; University of Manchester	Boeuf, P (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, RMH WH, Melbourne, Vic 3050, Australia.	pboeuf@unimelb.edu.au	Hanssen, Eric/A-7217-2013	Hanssen, Eric/0000-0002-4064-1844; Rogerson, Stephen/0000-0003-4287-1982; Hasang, Wina/0000-0001-8664-7558; Harrison, Robert/0000-0003-1186-6056; Boeuf, Philippe/0000-0002-5851-3373	Australian NHMRC [509185]; ARC/NHMRC Research Network for Parasitology; University of Melbourne	Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC/NHMRC Research Network for Parasitology(Australian Research CouncilNational Health and Medical Research Council (NHMRC) of Australia); University of Melbourne(University of Melbourne)	The Australian NHMRC (http://www.nhmrc.gov.au; project grant 509185 to SJR and JDG), the ARC/NHMRC Research Network for Parasitology (http://parasite.org.au/arcnet; Researcher Exchange Award to PB) and an Early Career Researcher Grant from The University of Melbourne (http://www.unimelb.edu.au; to PB) funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril M, 2004, MICROBES INFECT, V6, P249, DOI 10.1016/j.micinf.2003.12.007; Beeson JG, 2007, J BIOL CHEM, V282, P22426, DOI 10.1074/jbc.M700231200; Beeson JG, 2004, J INFECT DIS, V189, P169, DOI 10.1086/380975; Biber J, 2007, NAT PROTOC, V2, P1356, DOI 10.1038/nprot.2007.156; Domenech P, 2009, MICROBIOL-SGM, V155, P3532, DOI 10.1099/mic.0.029199-0; Feltis BA, 2001, J SURG RES, V97, P97, DOI 10.1006/jsre.2001.6130; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Glazier JD, 2006, METH MOLEC MED, V122, P241; Goyal A, 2009, EXP PARASITOL, V123, P105, DOI 10.1016/j.exppara.2009.06.001; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; KESSLER M, 1978, BIOCHIM BIOPHYS ACTA, V506, P136, DOI 10.1016/0005-2736(78)90440-6; Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006; LOVELESS RW, 1992, INFECT IMMUN, V60, P4015, DOI 10.1128/IAI.60.10.4015-4023.1992; Madhunapantula SV, 2007, INFECT IMMUN, V75, P4409, DOI 10.1128/IAI.00478-07; Nochi T, 2007, J EXP MED, V204, P2789, DOI 10.1084/jem.20070607; PELLETIER X, 1986, BIOCHIM BIOPHYS ACTA, V856, P267, DOI 10.1016/0005-2736(86)90036-2; Pentecost M, 2006, PLOS PATHOG, V2, P29, DOI 10.1371/journal.ppat.0020003; Peters JM, 2007, J INFECT DIS, V195, P748, DOI 10.1086/511436; PEZZULO AA, 2010, AM J PHYSL LUNG CELL; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Sidhaye VK, 2008, P NATL ACAD SCI USA, V105, P3345, DOI 10.1073/pnas.0712287105; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Winter SE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001060; Wyatt SM, 2005, PLACENTA, V26, P372, DOI 10.1016/j.placenta.2004.07.003; Yeo TW, 2008, INT J PARASITOL, V38, pS35, DOI 10.1016/S0020-7519(07)00459-6; Yosaatmadja F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-51	29	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21126	10.1371/journal.pone.0021126	http://dx.doi.org/10.1371/journal.pone.0021126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731654	Green Published, gold			2022-12-25	WOS:000292036900010
J	Holmes, AB; Hawson, A; Liu, F; Friedman, C; Khiabanian, H; Rabadan, R				holmes, Antony B.; Hawson, Alexander; Liu, Feng; Friedman, Carol; Khiabanian, Hossein; Rabadan, Raul			Discovering Disease Associations by Integrating Electronic Clinical Data and Medical Literature	PLOS ONE			English	Article							KAWASAKI-DISEASE; HEALTH RECORDS; TRAUMATIC STRESS; KAPOSIS-SARCOMA; VACCINATION; SYSTEM; AUTISM; PATHOGENESIS; CHALLENGES; INFECTION	Electronic health record (EHR) systems offer an exceptional opportunity for studying many diseases and their associated medical conditions within a population. The increasing number of clinical record entries that have become available electronically provides access to rich, large sets of patients' longitudinal medical information. By integrating and comparing relations found in the EHRs with those already reported in the literature, we are able to verify existing and to identify rare or novel associations. Of particular interest is the identification of rare disease co-morbidities, where the small numbers of diagnosed patients make robust statistical analysis difficult. Here, we introduce ADAMS, an Application for Discovering Disease Associations using Multiple Sources, which contains various statistical and language processing operations. We apply ADAMS to the New York-Presbyterian Hospital's EHR to combine the information from the relational diagnosis tables and textual discharge summaries with those from PubMed and Wikipedia in order to investigate the co-morbidities of the rare diseases Kaposi sarcoma, toxoplasmosis, and Kawasaki disease. In addition to finding well-known characteristics of diseases, ADAMS can identify rare or previously unreported associations. In particular, we report a statistically significant association between Kawasaki disease and diagnosis of autistic disorder.	[holmes, Antony B.; Liu, Feng; Friedman, Carol; Khiabanian, Hossein; Rabadan, Raul] Columbia Univ Coll Phys & Surg, Dept Biomed Informat, New York, NY 10032 USA; [holmes, Antony B.; Hawson, Alexander; Khiabanian, Hossein; Rabadan, Raul] Columbia Univ Coll Phys & Surg, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Hawson, Alexander] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Holmes, AB (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biomed Informat, 630 W 168th St, New York, NY 10032 USA.	hossein@c2b2.columbia.edu	Rabadan, Raul/AAZ-7367-2020; Khiabanian, Hossein/N-7207-2019	Khiabanian, Hossein/0000-0003-1446-4394; Rabadan, Raul/0000-0001-7946-9255	Northeast Biodefense Center [U54-AI057158]; National Library of Medicine Eureka [1R01LM010140-01]; National Library of Medicine [LM008635]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010140, R01LM010016] Funding Source: NIH RePORTER	Northeast Biodefense Center; National Library of Medicine Eureka(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by awards from the Northeast Biodefense Center grant U54-AI057158, the National Library of Medicine Eureka grant 1R01LM010140-01 and the National Library of Medicine grant LM008635. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Carlo Lorena, 2010, AMIA Annu Symp Proc, V2010, P91; *CDCP, 2010, INT CLASS DIS ICD 9; Centers for Disease Control and Prevention, 1993, 1993 REV CLASS SYST; Chang Huan J, 2010, JAMA, V303, P1328, DOI 10.1001/jama.303.13.1328; Chase HS, 2010, J AM MED INFORM ASSN, V17, P588, DOI 10.1136/jamia.2009.001396; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; de los Reyes EC, 2010, ARCH NEUROL-CHICAGO, V67, P490, DOI 10.1001/archneurol.2010.57; ELKLIT A, 2010, BR J CLIN PSYCHOL; ENSOLI B, 1991, HEMATOL ONCOL CLIN N, V5, P281, DOI 10.1016/S0889-8588(18)30441-6; Fletcher S, 2010, AUST NZ J PSYCHIAT, V44, P1064, DOI 10.3109/00048674.2010.509858; FRIEDMAN C, 1994, J AM MED INFORM ASSN, V1, P161, DOI 10.1136/jamia.1994.95236146; Gallagher CM, 2010, J TOXICOL ENV HEAL A, V73, P1665, DOI 10.1080/15287394.2010.519317; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; Hendy J, 2005, BMJ-BRIT MED J, V331, P331, DOI 10.1136/bmj.331.7512.331; Hua W, 2009, PEDIATR INFECT DIS J, V28, P943, DOI 10.1097/INF.0b013e3181a66471; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Kaposi M., 1872, ARCH DERMATOL SYPHIL, V4, P265, DOI 10.1007/BF01830024; KASPER LH, 2008, TOXOPLASMA INFECTION, pCH207; KATO H, 2007, CARDIOVASCULAR MED, P979; KAWASAKI T, 1995, JPN HEART J, V36, P1; Khiabanian H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012658; Krallinger M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-224; LANGFORD CA, 2008, VASCULITIS SYNDROMES, pCH319; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Lim ST, 2005, CANCER-AM CANCER SOC, V103, P417, DOI 10.1002/cncr.20780; LINDBERG DAB, 1993, METHOD INFORM MED, V32, P281, DOI 10.1055/s-0038-1634945; Lobach DF, 2007, AM J PREV MED, V32, pS104, DOI 10.1016/j.amepre.2007.01.018; Majewska MD, 2010, ACTA NEUROBIOL EXP, V70, P196; McCarthy EP, 2000, MED CARE, V38, P868, DOI 10.1097/00005650-200008000-00010; *MEDIAWIKI, 2010, API; MORENS DM, 1980, PEDIATRICS, V65, P21; Mrozek-Budzyn D, 2010, PEDIATR INFECT DIS J, V29, P397, DOI 10.1097/INF.0b013e3181c40a8a; Navarro G, 2001, ACM COMPUT SURV, V33, P31, DOI 10.1145/375360.375365; OKOSIEME O, 2010, QJM, V103, P1; OKSENHENDLER E, 1994, AIDS, V8, P483, DOI 10.1097/00002030-199404000-00010; Robertson A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4564; Ruiz-Casado M, 2005, LECT NOTES COMPUT SC, V3528, P380; Rzhetsky A, 2004, J BIOMED INFORM, V37, P43, DOI 10.1016/j.jbi.2003.10.001; Sam LT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S2-S8; Schildcrout JS, 2010, J BIOMED INFORM, V43, P914, DOI 10.1016/j.jbi.2010.07.011; Shea S, 2010, NEW ENGL J MED, V362, P192, DOI 10.1056/NEJMp0910140; SIEGAL B, 1990, CANCER, V65, P492, DOI 10.1002/1097-0142(19900201)65:3<492::AID-CNCR2820650320>3.0.CO;2-C; Suri V, 2010, RHEUMATOL INT, V30, P1503, DOI 10.1007/s00296-009-1098-x; Tabarki B, 2001, PEDIATR NEUROL, V25, P239, DOI 10.1016/S0887-8994(01)00290-9; Thorp Jeremy, 2010, J AHIMA, V81, P56; Ursano RJ, 2010, ANN NY ACAD SCI, V1208, P72, DOI 10.1111/j.1749-6632.2010.05721.x; Wang XY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S9-S13; Weyand CM, 2003, NEW ENGL J MED, V349, P160, DOI 10.1056/NEJMra022694; Yeung RSM, 2010, CURR OPIN RHEUMATOL, V22, P551, DOI 10.1097/BOR.0b013e32833cf051; Zesch Torsten, 2007, BIANN C SOC COMP LIN	52	37	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21132	10.1371/journal.pone.0021132	http://dx.doi.org/10.1371/journal.pone.0021132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731656	Green Published, Green Submitted, gold			2022-12-25	WOS:000292035400009
J	Sundberg, E; Hultdin, J; Nilsson, S; Ahlm, C				Sundberg, Erik; Hultdin, Johan; Nilsson, Sofie; Ahlm, Clas			Evidence of Disseminated Intravascular Coagulation in a Hemorrhagic Fever with Renal Syndrome-Scoring Models and Severe Illness	PLOS ONE			English	Article							PUUMALA VIRUS-INFECTION; NEPHROPATHIA-EPIDEMICA; INTERNATIONAL-SOCIETY; DIAGNOSTIC-CRITERIA; HEMOSTASIS; THROMBOSIS; SYSTEM; PATHOGENESIS; THROMBOCYTOPENIA; DYSFUNCTION	Background: Viral hemorrhagic fevers (VHF) are considered to be a serious threat to public health worldwide with up to 100 million cases annually. The general hypothesis is that disseminated intravascular coagulation (DIC) is an important part of the pathogenesis. The study objectives were to study the variability of DIC in consecutive patients with acute hemorrhagic fever with renal syndrome (HFRS), and to evaluate if different established DIC-scores can be used as a prognostic marker for a more severe illness. Method and Findings: In a prospective study 2006-2008, data from 106 patients with confirmed HFRS were analyzed and scored for the presence of DIC according to six different templates based on criteria from the International Society on Thrombosis and Haemostasis (ISTH). The DIC-scoring templates with a fibrinogen/CRP-ratio were most predictive, with predictions for moderate/severe illness (p<0.01) and bleeding of moderate/major importance (p<0.05). With these templates, 18.9-28.3% of the patients were diagnosed with DIC. Conclusions: DIC was found in about one fourth of the patients and correlated with a more severe disease. This supports that DIC is an important part of the pathogenesis in HFRS. ISTH-scores including fibrinogen/CRP-ratio outperform models without. The high negative predictive value could be a valuable tool for the clinician. We also believe that our findings could be relevant for other VHFs.	[Sundberg, Erik; Ahlm, Clas] Umea Univ, Dept Clin Microbiol Infect Dis, Umea, Sweden; [Sundberg, Erik; Hultdin, Johan; Nilsson, Sofie] Umea Univ, Dept Med Biosci Clin Chem, Umea, Sweden	Umea University; Umea University	Sundberg, E (corresponding author), Umea Univ, Dept Clin Microbiol Infect Dis, Umea, Sweden.	erik.sundberg@climi.umu.se	Hultdin, Johan/AAD-4623-2021	Hultdin, Johan/0000-0002-9599-0961	Swedish Heart and Lung Foundation; Heart Foundation of Northern Sweden; Medical Faculty of Umea University, National Board of Health and Welfare, Sweden; County Councils of Northern Sweden; County Council of Vasterbotten	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Heart Foundation of Northern Sweden; Medical Faculty of Umea University, National Board of Health and Welfare, Sweden; County Councils of Northern Sweden; County Council of Vasterbotten	This work was supported by the Swedish Heart and Lung Foundation, the Heart Foundation of Northern Sweden, the Medical Faculty of Umea University, National Board of Health and Welfare, Sweden, the County Councils of Northern Sweden, and the County Council of Vasterbotten. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhtiari K, 2004, CRIT CARE MED, V32, P2416, DOI 10.1097/01.CCM.0000147769.07699.E3; Bray M, 2005, CURR OPIN IMMUNOL, V17, P399, DOI 10.1016/j.coi.2005.05.001; Chen JP, 2000, BLOOD COAGUL FIBRIN, V11, P461, DOI 10.1097/00001721-200007000-00010; Cohen J, 2004, PLOS MED, V1, P188, DOI 10.1371/journal.pmed.0010059; COSGRIFF TM, 1991, T ROY SOC TROP MED H, V85, P660, DOI 10.1016/0035-9203(91)90386-D; Dempfle CE, 2004, THROMB HAEMOSTASIS, V91, P812, DOI 10.1160/TH03-09-0577; Esmon CT, 2004, MATURITAS, V47, P305, DOI 10.1016/j.maturitas.2003.10.015; Evander M, 2007, J CLIN MICROBIOL, V45, P2491, DOI 10.1128/JCM.01902-06; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; FORSLUND T, 1992, J INTERN MED, V232, P87, DOI 10.1111/j.1365-2796.1992.tb00555.x; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Gowen BB, 2008, ANTIVIR RES, V78, P79, DOI 10.1016/j.antiviral.2007.10.002; Hjertqvist M, 2010, EMERG INFECT DIS, V16, P1584, DOI 10.3201/eid1610.100242; HUTTUNEN NP, 2011, SCAND J INF IN PRESS; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Kanerva M, 1996, CLIN NEPHROL, V46, P369; Khaiboullina SF, 2002, VIRAL IMMUNOL, V15, P609, DOI 10.1089/088282402320914548; Khemani R, 2009, INTENS CARE MED, V35, P327, DOI 10.1007/s00134-008-1280-8; Kim HK, 2007, ACTA HAEMATOL-BASEL, V117, P34, DOI 10.1159/000096786; Klingstrom J, 2006, J VIROL, V80, P8279, DOI 10.1128/JVI.00742-06; LAHDEVIRTA J, 1989, REV INFECT DIS, V11, pS860; Laine O, 2010, THROMB RES, V126, P154, DOI 10.1016/j.thromres.2010.05.025; Lee M, 1983, Bibl Haematol, P181; Levi M, 2006, CRIT CARE, V10, DOI 10.1186/cc4975; LINDERHOLM M, 1991, SCAND J INFECT DIS, V23, P501, DOI 10.3109/00365549109075100; Liu ZW, 2008, VIRAL IMMUNOL, V21, P255, DOI 10.1089/vim.2007.0098; Lutteke N, 2010, VIROLOGY, V405, P70, DOI 10.1016/j.virol.2010.05.028; Mackow ER, 2009, THROMB HAEMOSTASIS, V102, P1030, DOI 10.1160/TH09-09-0640; Mahanty S, 2004, LANCET INFECT DIS, V4, P487, DOI 10.1016/S1473-3099(04)01103-X; Oh D, 2010, THROMB RES, V126, P18, DOI 10.1016/j.thromres.2009.12.008; Ong A, 2007, INT J INFECT DIS, V11, P263, DOI 10.1016/j.ijid.2006.02.012; Peters CJ, 2002, CRIT CARE MED, V30, pS268, DOI 10.1097/00003246-200205001-00016; Pettersson L, 2008, EMERG INFECT DIS, V14, P808, DOI 10.3201/eid1405.071124; Rasche FM, 2004, EMERG INFECT DIS, V10, P1420, DOI 10.3201/eid1008.031069; Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; SETTERGREN B, 1983, LANCET, V2, P1419; Settergren B, 2000, SCAND J INFECT DIS, V32, P125, DOI 10.1080/003655400750045204; SETTERGREN B, 1989, REV INFECT DIS, V11, P921; Sironen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003035; Takemitsu T, 2011, THROMB HAEMOSTASIS, V105, P40, DOI 10.1160/TH10-05-0293; TAKEUCHI T, 1991, KIDNEY INT, V40, pS84; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Toh CH, 2007, J THROMB HAEMOST, V5, P604, DOI 10.1111/j.1538-7836.2007.02313.x; Toh CH, 2005, BLOOD COAGUL FIBRIN, V16, P69, DOI 10.1097/00001721-200501000-00011; VALTONEN M, 1995, SCAND J INFECT DIS, V27, P515, DOI 10.3109/00365549509047057; Vanderschueren S, 2000, CRIT CARE MED, V28, P1871, DOI 10.1097/00003246-200006000-00031; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6; Voves C, 2006, BLOOD COAGUL FIBRIN, V17, P445, DOI 10.1097/01.mbc.0000240916.63521.2e; Wada H, 2010, AM J HEMATOL, V85, P691, DOI 10.1002/ajh.21783; ZAKI SR, 1995, AM J PATHOL, V146, P552	53	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21134	10.1371/journal.pone.0021134	http://dx.doi.org/10.1371/journal.pone.0021134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731657	Green Published, gold, Green Submitted			2022-12-25	WOS:000292035400010
J	Gotoh, H; Cornette, R; Koshikawa, S; Okada, Y; Lavine, LC; Emlen, DJ; Miura, T				Gotoh, Hiroki; Cornette, Richard; Koshikawa, Shigeyuki; Okada, Yasukazu; Lavine, Laura Corley; Emlen, Douglas J.; Miura, Toru			Juvenile Hormone Regulates Extreme Mandible Growth in Male Stag Beetles	PLOS ONE			English	Article							TERMITE; DIFFERENTIATION; MORPHOGENESIS; EXPRESSION; ALLOMETRY; EVOLUTION; ISOPTERA	The morphological diversity of insects is one of the most striking phenomena in biology. Evolutionary modifications to the relative sizes of body parts, including the evolution of traits with exaggerated proportions, are responsible for a vast range of body forms. Remarkable examples of an insect trait with exaggerated proportions are the mandibular weapons of stag beetles. Male stag beetles possess extremely enlarged mandibles which they use in combat with rival males over females. As with other sexually selected traits, stag beetle mandibles vary widely in size among males, and this variable growth results from differential larval nutrition. However, the mechanisms responsible for coupling nutrition with growth of stag beetle mandibles (or indeed any insect structure) remain largely unknown. Here, we demonstrate that during the development of male stag beetles (Cyclommatus metallifer), juvenile hormone (JH) titers are correlated with the extreme growth of an exaggerated weapon of sexual selection. We then investigate the putative role of JH in the development of the nutritionally-dependent, phenotypically plastic mandibles, by increasing hemolymph titers of JH with application of the JH analog fenoxycarb during larval and prepupal developmental periods. Increased JH signaling during the early prepupal period increased the proportional size of body parts, and this was especially pronounced in male mandibles, enhancing the exaggerated size of this trait. The direction of this response is consistent with the measured JH titers during this same period. Combined, our results support a role for JH in the nutrition-dependent regulation of extreme mandible growth in this species. In addition, they illuminate mechanisms underlying the evolution of trait proportion, the most salient feature of the evolutionary diversification of the insects.	[Gotoh, Hiroki; Miura, Toru] Hokkaido Univ, Grad Sch Environm Sci, Lab Ecol Genet, Sapporo, Hokkaido, Japan; [Cornette, Richard] Natl Inst Agrobiol Sci, Anhydrobiosis Res Unit, Tsukuba, Ibaraki, Japan; [Koshikawa, Shigeyuki] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Okada, Yasukazu] Okayama Univ, Grad Sch Environm Sci, Lab Evolutionary Ecol, Okayama 7008530, Japan; [Lavine, Laura Corley] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Emlen, Douglas J.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	Hokkaido University; National Institute of Agrobiological Sciences - Japan; University of Wisconsin System; University of Wisconsin Madison; Okayama University; Washington State University; University of Montana System; University of Montana	Gotoh, H (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Lab Ecol Genet, Sapporo, Hokkaido, Japan.	miu@ees.hokudai.ac.jp	Miura, Toru/P-2456-2019; Gotoh, Hiroki/B-7568-2017; Koshikawa, Shigeyuki/D-3052-2012; Okada, Yasukazu/B-1590-2014	Miura, Toru/0000-0002-7456-4402; Koshikawa, Shigeyuki/0000-0003-2831-555X; Okada, Yasukazu/0000-0003-4528-2980; CORNETTE, Richard/0000-0002-0185-1443; Lavine, Laura/0000-0002-0262-359X	Ministry of Education, Culture, Sports, Science and Technology of Japan [21677001]; JSPS; Grants-in-Aid for Scientific Research [21677001, 10J04026] Funding Source: KAKEN; Direct For Biological Sciences [0919781] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0919730] Funding Source: National Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Grants-in-Aid for Young Scientists (No. 21677001) of the Ministry of Education, Culture, Sports, Science and Technology of Japan. HG, YO and SK were supported by JSPS Research Fellowships for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Cornette R, 2008, J INSECT PHYSIOL, V54, P922, DOI 10.1016/j.jinsphys.2008.04.017; Cotton S, 2004, P ROY SOC B-BIOL SCI, V271, P771, DOI 10.1098/rspb.2004.2688; Emlen DJ, 2003, INTEGR COMP BIOL, V43, P617, DOI 10.1093/icb/43.5.617; Emlen DJ, 1999, J INSECT PHYSIOL, V45, P45, DOI 10.1016/S0022-1910(98)00096-1; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; Gu LJ, 2007, GROWTH FACTORS, V25, P264, DOI 10.1080/08977190701773187; HARTFELDER K, 2005, COMPREHENSIVE MOL IN, V3, P651; JOHNSTONE RA, 1995, BIOL REV, V70, P1, DOI 10.1111/j.1469-185X.1995.tb01439.x; Koshikawa S, 2003, NATURWISSENSCHAFTEN, V90, P180, DOI 10.1007/s00114-003-0408-5; Minakuchi C, 2008, FEBS J, V275, P2919, DOI 10.1111/j.1742-4658.2008.06428.x; Miura T, 2000, P ROY SOC B-BIOL SCI, V267, P1185, DOI 10.1098/rspb.2000.1127; Moczek AP, 2005, EVOL DEV, V7, P175, DOI 10.1111/j.1525-142X.2005.05020.x; Nijhout H.F., 1994, INSECT HORMONES; Shingleton AW, 2008, P ROY SOC B-BIOL SCI, V275, P1875, DOI 10.1098/rspb.2008.0227; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; STAAL GB, 1986, ANNU REV ENTOMOL, V31, P391, DOI 10.1146/annurev.ento.31.1.391; Stern DL, 1999, DEVELOPMENT, V126, P1091; SUTTIE JM, 1989, J ENDOCRINOL, V121, P351, DOI 10.1677/joe.0.1210351; Truman JW, 2006, SCIENCE, V312, P1385, DOI 10.1126/science.1123652; Westerlund SA, 2004, ANAL BIOANAL CHEM, V379, P540, DOI 10.1007/s00216-004-2598-x; Zera AJ, 2007, EVOL DEV, V9, P499, DOI 10.1111/j.1525-142X.2007.00181.x	23	78	79	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21139	10.1371/journal.pone.0021139	http://dx.doi.org/10.1371/journal.pone.0021139			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731659	Green Published, gold			2022-12-25	WOS:000292033700038
J	Gunn, BF; Baudouin, L; Olsen, KM				Gunn, Bee F.; Baudouin, Luc; Olsen, Kenneth M.			Independent Origins of Cultivated Coconut (Cocos nucifera L.) in the Old World Tropics	PLOS ONE			English	Article							AUSTRONESIAN MIGRATION; POPULATION-STRUCTURE; GENETIC DIVERSITY; SOUTHEAST-ASIA; ISLAND; MICROSATELLITES; LINGUISTICS; INFERENCE; MALAGASY; PROGRAM	As a portable source of food, water, fuel, and construction materials, the coconut (Cocos nucifera L.) played a fundamental role in human migrations and the development of civilization across the humid tropics. Here we investigated the coconut's domestication history and its population genetic structure as it relates to human dispersal patterns. A sample of 1,322 coconut accessions, representing the geographical and phenotypic diversity of the species, was examined using ten microsatellite loci. Bayesian analyses reveal two highly genetically differentiated subpopulations that correspond to the Pacific and Indo-Atlantic oceanic basins. This pattern suggests independent origins of coconut cultivation in these two world regions, with persistent population structure on a global scale despite long-term human cultivation and dispersal. Pacific coconuts show additional genetic substructure corresponding to phenotypic and geographical subgroups; moreover, the traits that are most clearly associated with selection under human cultivation (dwarf habit, self-pollination, and "niu vai" fruit morphology) arose only in the Pacific. Coconuts that show evidence of genetic admixture between the Pacific and Indo-Atlantic groups occur primarily in the southwestern Indian Ocean. This pattern is consistent with human introductions of Pacific coconuts along the ancient Austronesian trade route connecting Madagascar to Southeast Asia. Admixture in coastal east Africa may also reflect later historic Arab trading along the Indian Ocean coastline. We propose two geographical origins of coconut cultivation: island Southeast Asia and southern margins of the Indian subcontinent.	[Gunn, Bee F.] Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia; [Baudouin, Luc] CIRAD, Montpellier, France; [Olsen, Kenneth M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Australian National University; CIRAD; Washington University (WUSTL)	Gunn, BF (corresponding author), Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia.	kolsen@wustl.edu		Gunn, Bee/0000-0002-9591-3085; Olsen, Kenneth/0000-0002-8338-3638; Baudouin, Luc/0000-0003-2620-7125	National Geographic Society [CRE 8178-07]; COGENT network; CGIAR	National Geographic Society(National Geographic Society); COGENT network; CGIAR(CGIAR)	The study was funded by a National Geographic Society (CRE 8178-07) grant to KMO and BFG, http://www.nationalgeographic.com/field/, and COGENT network and the CGIAR Generation Challenge Progamme to LB, http://www.inibap.org/cogent/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allibert C, 2008, DIOGENES, V55, P7, DOI 10.1177/0392192108090734; Battail G., 1997, THEORIE INFORM APPL; Baudouin L, 2002, DEV MICROSATELLITE K; BAUDOUIN L, 2005, COCONUT GENETIC RESO, P268; Baudouin L, 2008, EUPHYTICA, V161, P353, DOI 10.1007/s10681-007-9568-2; Baudouin L, 2009, GENET RESOUR CROP EV, V56, P257, DOI 10.1007/s10722-008-9362-6; Bourdeix Roland, 2001, P106; CHESTER KS, 1951, ORIGIN VARIATION IMM; Cooper Zarine, 2002, ARCHEOLOGY HIST EARL; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fuller DQ, 2007, VERTEBR PALEOBIOL PA, P393, DOI 10.1007/1-4020-5562-5_18; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; HARRIES HC, 1990, PLANT DIVERSITY OF MALESIA, P351; HARRIES HC, 1978, BOT REV, V44, P265, DOI 10.1007/BF02957852; HARRIES HC, 1981, ANN BOT-LONDON, V48, P873, DOI 10.1093/oxfordjournals.aob.a086195; Harries HC, 2004, ETHNOBOTANY RES APPL, V2, P37; Hurles ME, 2005, AM J HUM GENET, V76, P894, DOI 10.1086/430051; Hurles ME, 2003, TRENDS ECOL EVOL, V18, P531, DOI 10.1016/S0169-5347(03)00245-3; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2009, MOL ECOL, V18, P2088, DOI 10.1111/j.1365-294X.2009.04186.x; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Lebrun P, 1998, EUPHYTICA, V101, P103, DOI 10.1023/A:1018323721803; Lebrun Patricia, 2003, P219; Martinez RT, 2010, TREE GENET GENOMES, V6, P73, DOI 10.1007/s11295-009-0229-6; Mather KA, 2010, MOL ECOL, V19, P4892, DOI 10.1111/j.1365-294X.2010.04845.x; Mauro-Herrera M, 2010, GENET RESOUR CROP EV, V57, P203, DOI 10.1007/s10722-009-9463-x; Meerow AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007353; Menon K.P.V., 1958, COCONUT PALM MONOGRA; Oliver J, 2005, COCONUT GENETIC RESO; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perera L, 2003, EUPHYTICA, V132, P121, DOI 10.1023/A:1024696303261; Perera L, 1999, MOL ECOL, V8, P344; Perera L., 2011, CORD, V27, P9; Pritchard JK, 2000, GENETICS, V155, P945; Rajesh MK, 2008, SCI HORTIC-AMSTERDAM, V118, P282, DOI 10.1016/j.scienta.2008.06.017; RIGBY JF, 1995, GLOBAL ENV DIVERSIFI, P379; Rivera R, 1999, GENOME, V42, P668, DOI 10.1139/gen-42-4-668; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sauer J, 1971, MAN SEA, P309; Schuiling M., 1994, Principes, V38, P4; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Spriggs M., 1997, ISLAND MELANESIANS; Teulat B, 2000, THEOR APPL GENET, V100, P764, DOI 10.1007/s001220051350; TRIPATHI R.P., 1999, PALEOBOTANIST, V48, P251; Walshaw SC, 2010, WORLD ARCHAEOL, V42, P137, DOI 10.1080/00438240903430399; WARD RG, 1992, J BIOGEOGR, V19, P467, DOI 10.2307/2845766; Wheeler R., 1946, ANCIENT INDIA, V2, P17; WHITEHEAD RAW, 1966, SAMPLE SURVEY COLLEC; ZizumboVillarreal D, 1996, GENET RESOUR CROP EV, V43, P505, DOI 10.1007/BF00138827	53	102	111	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21143	10.1371/journal.pone.0021143	http://dx.doi.org/10.1371/journal.pone.0021143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731660	Green Published, gold			2022-12-25	WOS:000292033700039
J	Guo, L; Yang, Q; Lu, JF; Li, HL; Ge, QY; Gu, WJ; Bai, YF; Lu, ZH				Guo, Li; Yang, Qi; Lu, Jiafeng; Li, Hailing; Ge, Qinyu; Gu, Wanjun; Bai, Yunfei; Lu, Zuhong			A Comprehensive Survey of miRNA Repertoire and 3 ' Addition Events in the Placentas of Patients with Pre-Eclampsia from High-Throughput Sequencing	PLOS ONE			English	Article							MICRORNA EXPRESSION; SMALL RNAS; ADENYLATION; CHROMOSOME-19; URIDYLATION; REGIONS; CLUSTER; SIRNAS	Background: To gain insight into potential roles of isomiR spectrum and isomiRs with 3' additions in pre-eclampsia, we performed a comprehensive survey of miRNA repertoire and 3' addition events from placental samples with different degrees of pre-eclampsia by applying SOLiD sequencing platform. Principal Findings: Over 30% isomiRs were detected with 3' non-template additional nucleotides, especially for additional nucleotide of adenosine. However, these modified isomiRs showed a lower percentage of total miRNA expression (<15%). Generally, 1-3 abundant isomiRs from a given miRNA locus were identified, but none of them was detected with 3' additions. Different miRNAs indicated various isomiR spectrums and expression patterns. The most abundant isomiR spectrum, isomiR profile and expression pattern always were stability, but herein we found several exceptions across samples, especially between normal and diseased samples. At isomiR level, we detected a distinct subset of differentially expressed modified isomiRs between normal and diseased samples or between mild and severe samples. Gene Ontology analysis of their experimentally validated target genes revealed enrichment for specific biological process categories. Conclusions: The phenomenon of multiple isomiRs, especially for isomiRs with 3' additions, is not a random event during pre-miRNA processing. Varieties of isomiRs and expression patterns reveal potential functional implication and should be taken into account. The study enriches association of miRNAs and human disease, including potential roles of various miRNA variants and 3' addition events.	[Guo, Li; Yang, Qi; Lu, Jiafeng; Li, Hailing; Bai, Yunfei; Lu, Zuhong] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Peoples R China; [Ge, Qinyu; Gu, Wanjun; Lu, Zuhong] Southeast Univ, Minist Educ, Key Lab Child Dev & Learning Sci, Nanjing, Peoples R China	Southeast University - China; Southeast University - China	Guo, L (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Peoples R China.	gl8008@163.com; zhlu@seu.edu.cn	Gu, Wanjun/P-5389-2019; Ge, Qinyu/B-5055-2012; Lu, Zuhong/A-5448-2013; Gu, Wanjun/B-3998-2010	Gu, Wanjun/0000-0003-4501-0539; Lu, Zuhong/0000-0003-3332-2615	National Natural Science Foundation of China [30871393, 30900836, 60971021]; Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-Discipline Foundation; Innovation Project for Graduate Students of Jiangsu Province [CX10B_081Z]; Scientific Research Foundation of Graduate School of Southeast University [201001095]; Southeast University [KJ2010442]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-Discipline Foundation; Innovation Project for Graduate Students of Jiangsu Province; Scientific Research Foundation of Graduate School of Southeast University; Southeast University	This work was supported by projects 30871393, 30900836 and 60971021 of the National Natural Science Foundation of China and funded by Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-Discipline Foundation. The work was also supported by a research grant from the Innovation Project for Graduate Students of Jiangsu Province (No. CX10B_081Z), the Scientific Research Foundation of Graduate School of Southeast University, Science and Technology Project in Nanjing (201001095) and Pre-Research Project for National Natural Science Foundation supported by Southeast University (KJ2010442). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Enquobahrie DA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.004; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo L, 2010, COMPUT BIOL CHEM, V34, P165, DOI 10.1016/j.compbiolchem.2010.06.001; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Hu YL, 2009, CLIN CHEM LAB MED, V47, P923, DOI 10.1515/CCLM.2009.228; Ishibashi O, 2010, PLACENTA, V31, pA120; Ishibashi O, 2010, PLACENTA, V31, pA9; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; KAI ZS, NATURE STRUCTURAL MO, V17, P5; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langenberger D, 2009, BIOINFORMATICS, V25, P2298, DOI 10.1093/bioinformatics/btp419; Langmead B., 2009, GENOME BIOL, V10, P212, DOI DOI 10.1186/gb-2009-10-3-212; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lu SF, 2009, NUCLEIC ACIDS RES, V37, P1878, DOI 10.1093/nar/gkp031; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; O'Toole AS, 2006, NUCLEIC ACIDS RES, V34, P3338, DOI 10.1093/nar/gkl428; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Reid JG, 2008, GENOME RES, V18, P1571, DOI 10.1101/gr.078246.108; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Roman A, 2008, AM J OBSTET GYNECOL, V199, pS78, DOI 10.1016/j.ajog.2008.09.265; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Shi WY, 2009, NAT STRUCT MOL BIOL, V16, P183, DOI 10.1038/nsmb.1536; Umbach JL, 2010, J VIROL, V84, P695, DOI 10.1128/JVI.02013-09; Weidhaas J, 2010, LANCET ONCOL, V11, P106, DOI 10.1016/S1470-2045(09)70386-9; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045	46	82	89	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21072	10.1371/journal.pone.0021072	http://dx.doi.org/10.1371/journal.pone.0021072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731650	gold, Green Published, Green Submitted			2022-12-25	WOS:000292033700034
J	Peng, JB; Gobert, GN; Hong, Y; Jiang, WB; Han, HX; McManus, DP; Wang, XZ; Liu, JM; Fu, ZQ; Shi, YJ; Lin, JJ				Peng, Jinbiao; Gobert, Geoffrey N.; Hong, Yang; Jiang, Weibin; Han, Hongxiao; McManus, Donald P.; Wang, Xinzhi; Liu, Jinming; Fu, Zhiqiang; Shi, Yaojun; Lin, Jiaojiao			Apoptosis Governs the Elimination of Schistosoma japonicum from the Non-Permissive Host Microtus fortis	PLOS ONE			English	Article							PARASITE INTERPLAY; EXPRESSION; CLONING; CELLS	The reed vole, Microtus fortis, is the only known mammalian host in which schistosomes of Schistosoma japonicum are unable to mature and cause significant pathogenesis. However, little is known about how Schistosoma japonicum maturation (and, therefore, the development of schistosomiasis) is prevented in M. fortis. In the present study, the ultrastructure of 10 days post infection schistosomula from BALB/c mice and M. fortis were first compared using scanning electron microscopy and transmission electron microscopy. Electron microscopic investigations showed growth retardation and ultrastructural differences in the tegument and sub-tegumental tissues as well as in the parenchymal cells of schistosomula from M. fortis compared with those in BALB/c mice. Then, microarray analysis revealed significant differential expression between the schistosomula from the two rodents, with 3,293 down-regulated (by >= 2-fold) and 71 up-regulated (>= 2 fold) genes in schistosomula from the former. The up-regulated genes included a proliferation-related gene encoding granulin (Grn) and tropomyosin. Genes that were down-regulated in schistosomula from M. fortis included apoptosis-inhibited genes encoding a baculoviral IAP repeat-containing protein (SjIAP) and cytokine-induced apoptosis inhibitor (SjCIAP), genes encoding molecules involved in insulin metabolism, long-chain fatty acid metabolism, signal transduction, the transforming growth factor (TGF) pathway, the Wnt pathway and in development. TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) and PI/Annexin V-FITC assays, caspase 3/7 activity analysis, and flow cytometry revealed that the percentages of early apoptotic and late apoptotic and/or necrotic cells, as well as the level of caspase activity, in schistosomula from M. fortis were all significantly higher than in those from BALB/c mice.	[Peng, Jinbiao; Hong, Yang; Jiang, Weibin; Han, Hongxiao; Wang, Xinzhi; Liu, Jinming; Fu, Zhiqiang; Shi, Yaojun; Lin, Jiaojiao] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr, Shanghai, Peoples R China; [Gobert, Geoffrey N.; McManus, Donald P.] Queensland Inst Med Res, Herston, Qld 4006, Australia	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; QIMR Berghofer Medical Research Institute	Peng, JB (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr, Shanghai, Peoples R China.	ebiao4215@sina.com	Gobert, Geoffrey/V-2985-2019; McManus, Donald P./G-2678-2013; McManus, Don/AAC-5394-2020	McManus, Don/0000-0001-6443-1449; Gobert, Geoffrey/0000-0001-5884-6453	National Basic Research Program of China [2007CB513108]; Special Fund for Agri-Scientific Research in the Public Interest [200903036]; National High Technology Research and Development Program of China [2006AA10A207]; NHMRC [496600]	National Basic Research Program of China(National Basic Research Program of China); Special Fund for Agri-Scientific Research in the Public Interest; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Basic Research Program of China (No. 2007CB513108) (http://www.973.gov.cn/ReadItem.aspx?itemid=578), Special Fund for Agri-Scientific Research in the Public Interest (200903036) (http://www.moa.gov.cn/sjzz/jiaoyusi/), National High Technology Research and Development Program of China (No. 2006AA10A207) (http://www.863.org.cn/), NHMRC Program Grant (496600) (http://www.nhmrc.gov.au) and the Sandler Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao JP, 2002, CHINESE MED J-PEKING, V115, P1465; Chai M, 2006, CELL MOL LIFE SCI, V63, P919, DOI 10.1007/s00018-005-5578-1; Chen L, 2002, J BIOL CHEM, V277, P34329, DOI 10.1074/jbc.M201344200; Dong HF, 2002, ACTA TROP, V82, P225, DOI 10.1016/S0001-706X(02)00014-1; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Freitas TC, 2007, PLOS PATHOG, V3, P489, DOI 10.1371/journal.ppat.0030052; Gobert GN, 2006, EXP PARASITOL, V114, P160, DOI 10.1016/j.exppara.2006.03.003; Gobert GN, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000469; Gobert GN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-128; He YX, 2001, TRENDS PARASITOL, V17, P320, DOI 10.1016/S1471-4922(01)01904-3; Hu W, 2003, NAT GENET, V35, P139, DOI 10.1038/ng1236; JIA RC, 2008, CHIN J BIOTECH, V24, P733; Jiang WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013494; LI FK, 1965, ACTA PARASITOL SIN, V2, P103; Li H., 2000, CHIN J VET PARASITOL, V8, P12; Li HF, 2010, PARASITOL RES, V107, P795, DOI 10.1007/s00436-010-1933-8; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; Liu JinMing, 2001, Acta Parasitologica et Medica Entomologica Sinica, V8, P212; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Peng JB, 2010, PARASITOL RES, V106, P967, DOI 10.1007/s00436-010-1752-y; SHARON R, 2000, J BIOL CHEM, V275, P5760; Smout MJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000611; SUN H, 2008, CHIN J VET PARASIT, V16, P529; [孙军 Sun Jun], 2004, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V40, P532; Wang LD, 2008, LANCET, V372, P1793, DOI 10.1016/S0140-6736(08)61358-6; Wang XZ, 2009, MOL BIOCHEM PARASIT, V166, P62, DOI 10.1016/j.molbiopara.2009.02.016; You H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009868; You H, 2009, INT J PARASITOL, V39, P1551, DOI 10.1016/j.ijpara.2009.06.006; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	30	38	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21109	10.1371/journal.pone.0021109	http://dx.doi.org/10.1371/journal.pone.0021109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731652	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700036
J	de Ynigo-Mojado, L; Martin-Ruiz, I; Sutherland, JD				de Ynigo-Mojado, Laura; Martin-Ruiz, Itziar; Sutherland, James D.			Efficient Allele-Specific Targeting of LRRK2 R1441 Mutations Mediated by RNAi	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; HUNTINGTONS-DISEASE; KINASE-ACTIVITY; LEUCINE-RICH-REPEAT-KINASE-2 LRRK2; TRANSGENIC MICE; ALPHA-SYNUCLEIN; GTP-BINDING; MUTANT SOD1; RAT MODEL; GENE	Since RNA interference (RNAi) has the potential to discriminate between single nucleotide changes, there is growing interest in the use of RNAi as a promising therapeutical approach to target dominant disease-associated alleles. Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been linked to dominantly inherited Parkinson's disease (PD). We focused on three LRRK2 mutations (R1441G/C and the more prevalent G2109S) hoping to identify shRNAs that would both recognize and efficiently silence the mutated alleles preferentially over the wild-type alleles. Using a luciferase-based reporter system, we identified shRNAs that were able to specifically target the R1441G and R1441C alleles with 80% silencing efficiency. The same shRNAs were able to silence specifically mRNAs encoding either partial or full-length mutant LRRK2 fusion proteins, while having a minimal effect on endogenous wild-type LRRK2 expression when transfected in 293FT cells. Shifting of the mutant recognition site (MRS) from position 11 to other sites (4 and 16, within the 19-mer window of our shRNA design) reduced specificity and overall silencing efficiency. Developing an allele- specific RNAi of G2019S was problematic. Placement of the MRS at position 10 resulted in efficient silencing of reporters (75-80%), but failed to discriminate between mutant and wild-type alleles. Shifting of the MRS to positions 4, 5, 15, 16 increased the specificity of the shRNAs, but reduced the overall silencing efficiency. Consistent with previous reports, these data confirm that MRS placement influences both allele- specificity and silencing strength of shRNAs, while further modification to hairpin design or MRS position may lead to the development of effective G2019S shRNAs. In summary, the effective shRNA against LRRK2 R1441 alleles described herein suggests that RNAi-based therapy of inherited Parkinson's disease is a viable approach towards developing effective therapeutic interventions for this serious neurodegenerative disease.	[de Ynigo-Mojado, Laura; Martin-Ruiz, Itziar; Sutherland, James D.] CIC bioGUNE, Prote Unit, Derio, Bizkaia, Spain	CIC bioGUNE	Sutherland, JD (corresponding author), CIC bioGUNE, Prote Unit, Derio, Bizkaia, Spain.	jsutherland@cicbiogune.es	Sutherland, James D/K-2686-2014	Sutherland, James D/0000-0003-3229-793X	Ramon y Cajal; Spanish MICINN [RYC2005002168, PI070094]; Department of Industry of the Basque Country	Ramon y Cajal(Spanish Government); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Department of Industry of the Basque Country	Funding for this project was provided by the Ramon y Cajal and FIS programs of the Spanish MICINN (RYC2005002168, PI070094) with core support from Bizkaia County and the Etortek Program of Department of Industry of the Basque Country. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaneya Y, 2010, METHODS MOL BIOL, V623, P313, DOI 10.1007/978-1-60761-588-0_20; Alves S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003341; Andres-Mateos E, 2009, J NEUROSCI, V29, P15846, DOI 10.1523/JNEUROSCI.4357-09.2009; Boudreau RL, 2006, CURR TOP DEV BIOL, V75, P73, DOI 10.1016/S0070-2153(06)75003-7; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Covy JP, 2009, BIOCHEM BIOPH RES CO, V378, P473, DOI 10.1016/j.bbrc.2008.11.048; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Di Fonzo A, 2006, EUR J HUM GENET, V14, P322, DOI 10.1038/sj.ejhg.5201539; Ding HL, 2003, AGING CELL, V2, P209, DOI 10.1046/j.1474-9728.2003.00054.x; Feng XR, 2006, GENE, V371, P68, DOI 10.1016/j.gene.2005.11.006; Franich NR, 2008, MOL THER, V16, P947, DOI 10.1038/mt.2008.50; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hsu CH, 2010, J NEUROCHEM, V112, P1593, DOI 10.1111/j.1471-4159.2010.06568.x; Ishihara L, 2006, ARCH NEUROL-CHICAGO, V63, P1250, DOI 10.1001/archneur.63.9.1250; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Klein CL, 2009, J NEUROCHEM, V111, P703, DOI 10.1111/j.1471-4159.2009.06358.x; Kubodera T, 2005, OLIGONUCLEOTIDES, V15, P298, DOI 10.1089/oli.2005.15.298; KUBODERA T, 2010, HUM GENE THER; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; LI X, 2010, J BIOL CHEM; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Li YC, 2009, BBA-MOL BASIS DIS, V1792, P1194, DOI 10.1016/j.bbadis.2009.09.010; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Lingor P, 2007, MOL BIOSYST, V3, P773, DOI 10.1039/b701169e; Lombardi MS, 2009, EXP NEUROL, V217, P312, DOI 10.1016/j.expneurol.2009.03.004; Mata IF, 2005, NEUROGENETICS, V6, P171, DOI 10.1007/s10048-005-0005-1; Miller VM, 2004, NUCLEIC ACIDS RES, V32, P661, DOI 10.1093/nar/gkh208; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; NICHOLS J, 2010, BIOCH J; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Ohnishi Yusuke, 2006, J RNAi Gene Silencing, V2, P154; Ohnishi Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002248; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Paisan-Ruiz C, 2009, HUM MUTAT, V30, P1153, DOI 10.1002/humu.21038; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; Qing H, 2009, BIOCHEM BIOPH RES CO, V390, P1229, DOI 10.1016/j.bbrc.2009.10.126; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Rodriguez-Lebron E, 2009, MOL THER, V17, P1563, DOI 10.1038/mt.2009.123; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sapru MK, 2006, EXP NEUROL, V198, P382, DOI 10.1016/j.expneurol.2005.12.024; Scholefield J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007232; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Towne C, 2008, MOL THER, V16, P1018, DOI 10.1038/mt.2008.73; Towne C, 2009, METHODS MOL BIOL, V555, P87, DOI 10.1007/978-1-60327-295-7_7; van Bilsen PHJ, 2008, HUM GENE THER, V19, P710, DOI 10.1089/hum.2007.116; Venderova K, 2009, HUM MOL GENET, V18, P4390, DOI 10.1093/hmg/ddp394; Wang YL, 2005, NEUROSCI RES, V53, P241, DOI 10.1016/j.neures.2005.06.021; Weiss B, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.123pe27; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Westerlund M, 2008, NEUROSCIENCE, V152, P429, DOI 10.1016/j.neuroscience.2007.10.062; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Xia XG, 2005, J NEUROCHEM, V92, P362, DOI 10.1111/j.1471-4159.2004.02860.x; Xia XG, 2006, NEUROBIOL DIS, V23, P578, DOI 10.1016/j.nbd.2006.04.019; Zabetian CP, 2005, NEUROLOGY, V65, P741, DOI 10.1212/01.WNL.0000172630.22804.73; Zechel S, 2010, INT J DEV NEUROSCI, V28, P391, DOI 10.1016/j.ijdevneu.2010.04.002; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	76	27	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21352	10.1371/journal.pone.0021352	http://dx.doi.org/10.1371/journal.pone.0021352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712955	Green Published, gold, Green Submitted			2022-12-25	WOS:000291985100034
J	Lu, P; Zhang, GR; Song, XH; Zou, XH; Wang, LL; Ouyang, HW				Lu, Ping; Zhang, Guo Rong; Song, Xing Hui; Zou, Xiao Hui; Wang, Lin Lin; Ouyang, Hong Wei			Col V siRNA Engineered Tenocytes for Tendon Tissue Engineering	PLOS ONE			English	Article							MEDIAL COLLATERAL LIGAMENT; RAPID COLORIMETRIC ASSAY; COLLAGEN FIBRILLOGENESIS; FIBRIL MORPHOLOGY; RNA INTERFERENCE; I COLLAGEN; ACHILLES-TENDON; SKIN FRAGILITY; STEM-CELLS; MATRIX	The presence of uniformly small collagen fibrils in tendon repair is believed to play a major role in suboptimal tendon healing. Collagen V is significantly elevated in healing tendons and plays an important role in fibrillogenesis. The objective of this study was to investigate the effect of a particular chain of collagen V on the fibrillogenesis of Sprague-Dawley rat tenocytes, as well as the efficacy of Col V siRNA engineered tenocytes for tendon tissue engineering. RNA interference gene therapy and a scaffold free tissue engineered tendon model were employed. The results showed that scaffold free tissue engineered tendon had tissue-specific tendon structure. Down regulation of collagen V alpha 1 or alpha 2 chains by siRNAs (Col5 alpha 1 siRNA, Col5 alpha 2 siRNA) had different effects on collagen I and decorin gene expressions. Col5 alpha 1 siRNA treated tenocytes had smaller collagen fibrils with abnormal morphology; while those Col5 alpha 2 siRNA treated tenocytes had the same morphology as normal tenocytes. Furthermore, it was found that tendons formed by coculture of Col5 alpha 1 siRNA treated tenocytes with normal tenocytes at a proper ratio had larger collagen fibrils and relative normal contour. Conclusively, it was demonstrated that Col V siRNA engineered tenocytes improved tendon tissue regeneration. And an optimal level of collagen V is vital in regulating collagen fibrillogenesis. This may provide a basis for future development of novel cellular-and molecular biology-based therapeutics for tendon diseases.	[Lu, Ping; Zhang, Guo Rong; Song, Xing Hui; Zou, Xiao Hui; Wang, Lin Lin; Ouyang, Hong Wei] Zhejiang Univ, Sch Med, Ctr Stem Cell & Tissue Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Lu, Ping; Song, Xing Hui; Wang, Lin Lin; Ouyang, Hong Wei] Zhejiang Univ, Sch Med, Inst Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Zou, Xiao Hui] Zhejiang Univ, Sch Med, Women Hosp, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Lu, P (corresponding author), Zhejiang Univ, Sch Med, Ctr Stem Cell & Tissue Engn, Hangzhou 310003, Zhejiang, Peoples R China.	wanglinlin2007@gmail.com; hwouyang@gmail.com		Lu, Ping/0000-0002-8953-1494	National Natural Science Foundation of China [81071461, J0830833]; Zhejiang Province grants [Z2100086, 2009C13044, Y200908872]; Program for New Century Excellent Talents in University [NCET-08-0487]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province grants; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents	This study was funded by National Natural Science Foundation of China (81071461, J0830833), URL: http://www.nsfc.gov.cn/Portal0/default124.htm; Zhejiang Province grants (Z2100086, 2009C13044, Y200908872), URL: http://www.zjnsf.net/; Program for New Century Excellent Talents in University (NCET-08-0487), URL: http://www.moe.edu.cn/; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents, URL: http://www.zjwst.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI E, 1986, CONNECT TISSUE RES, V14, P257, DOI 10.3109/03008208609017469; Birk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3; BIRK DE, 1990, J CELL SCI, V95, P649; Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chanut-Delalande H, 2004, MOL CELL BIOL, V24, P6049, DOI 10.1128/MCB.24.13.6049-6057.2004; Chanut-Delalande H, 2001, J BIOL CHEM, V276, P24352, DOI 10.1074/jbc.M101182200; Chen X, 2008, BIOMATERIALS, V29, P3683, DOI 10.1016/j.biomaterials.2008.05.017; Chen X, 2009, STEM CELLS, V27, P1276, DOI 10.1002/stem.61; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; DAVID EB, 1986, J CELL BIOL, V103, P231; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; DOILLON CJ, 1985, COLLAGEN REL RES, V5, P481; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Favata M, 2006, J ORTHOP RES, V24, P2124, DOI 10.1002/jor.20271; FESSLER LI, 1981, J BIOL CHEM, V256, P9646; Frank C, 1997, CONNECT TISSUE RES, V36, P261, DOI 10.3109/03008209709160226; Galatz LM, 2004, J BONE JOINT SURG AM, V86A, P219, DOI 10.2106/00004623-200402000-00002; Hall GW, 1999, J BIOMECH, V32, P203, DOI 10.1016/S0021-9290(98)00167-5; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; JIMENEZ SA, 1978, BIOCHEM BIOPH RES CO, V81, P1298, DOI 10.1016/0006-291X(78)91277-9; KADLER KE, 1987, J BIOL CHEM, V262, P15696; KELLEY PM, 1980, J BIOL CHEM, V255, P3230; Lianxu C, 2006, OSTEOARTHR CARTILAGE, V14, P367, DOI 10.1016/j.joca.2005.10.009; LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181; Maffulli N, 1999, CLIN J SPORT MED, V9, P157, DOI 10.1097/00042752-199907000-00007; Marchant JK, 1996, J CELL BIOL, V135, P1415, DOI 10.1083/jcb.135.5.1415; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; Mizuno K, 1996, J BIOCHEM-TOKYO, V120, P934; MORRIS NP, 1990, J BIOL CHEM, V265, P10081; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Neame PJ, 2000, CELL MOL LIFE SCI, V57, P859, DOI 10.1007/s000180050048; Niyibizi C, 1995, MATRIX BIOL, V14, P743, DOI 10.1016/S0945-053X(05)80017-4; Niyibizi C, 2000, KNEE SURG SPORT TR A, V8, P281, DOI 10.1007/s001670000134; NIYIBIZI C, 1994, EUR J BIOCHEM, V224, P943, DOI 10.1111/j.1432-1033.1994.00943.x; Ouyang HW, 2006, TRANSPLANTATION, V82, P170, DOI 10.1097/01.tp.0000226232.79106.72; PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107; Ramirez F, 2003, MATRIX BIOL, V22, P101, DOI 10.1016/S0945-053X(03)00002-7; Redaelli A, 2003, J BIOMECH, V36, P1555, DOI 10.1016/S0021-9290(03)00133-7; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Rumian AP, 2007, J ORTHOP RES, V25, P458, DOI 10.1002/jor.20218; Scatena R, 2004, J BIOCHEM MOL BIOL, V37, P454; SCOTT JE, 1988, BIOCHEM J, V253, P607, DOI 10.1042/bj2530607; Shimomura T, 2003, CONNECT TISSUE RES, V44, P167, DOI 10.1080/03008200390215872; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Wenstrup RJ, 2004, J CELL BIOCHEM, V92, P113, DOI 10.1002/jcb.20024; Woo SLY, 2000, ANNU REV BIOMED ENG, V2, P83, DOI 10.1146/annurev.bioeng.2.1.83; Woo SLY, 2006, TISSUE ENG, V12, P159, DOI 10.1089/ten.2006.12.159; Zamore PD, 2001, NAT STRUCT BIOL, V8, P746, DOI 10.1038/nsb0901-746	50	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21154	10.1371/journal.pone.0021154	http://dx.doi.org/10.1371/journal.pone.0021154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713001	Green Submitted, Green Published, gold			2022-12-25	WOS:000291985100013
J	Dudareva, S; Schweiger, B; Thamm, M; Hoehle, M; Stark, K; Krause, G; Buda, S; Haas, W				Dudareva, Sandra; Schweiger, Brunhilde; Thamm, Michel; Hoehle, Michael; Stark, Klaus; Krause, Gerard; Buda, Silke; Haas, Walter			Prevalence of Antibodies to 2009 Pandemic Influenza A (H1N1) Virus in German Adult Population in Pre- and Post-Pandemic Period	PLOS ONE			English	Article							PREEXISTING IMMUNITY; INFECTION; EMERGENCE; RESPONSES; SERUM	Background: In order to detect levels of pre-existing cross-reactive antibodies in different age groups and to measure age-specific infection rates of the influenza A (H1N1) 2009 pandemic in Germany, we conducted a seroprevalence study based on samples from an ongoing nationwide representative health survey. Methodology/Principal Findings: We analysed 845 pre-pandemic samples collected between 25 Nov 2008 and 28 Apr 2009 and 757 post-pandemic samples collected between 12 Jan 2010 and 24 Apr 2010. Reactive antibodies against 2009 pandemic influenza A (H1N1) virus (pH1N1) were detected using a haemagglutination inhibition test (antigen A/California/7/2009). Proportions of samples with antibodies at titre >= 40 and geometric mean of the titres (GMT) were calculated and compared among 6 age groups (18-29, 30-39, 40-49, 50-59, 60-69, >= 70 years). The highest proportions of cross-reactive antibodies at titre >= 40 before the pandemic were observed among 18-29 year olds, 12.5% (95% CI 7.3-19.5%). The highest increase in seroprevalence between pre- and post-pandemic was also observed among 18-29 year olds, 29.9% (95% CI 16.7-43.2%). Effects of sampling period (pre- and post-pandemic), age, sex, and prior influenza immunization on titre were investigated with Tobit regression analysis using three birth cohorts (after 1976, between 1957 and 1976, and before 1957). The GMT increased between the pre- and post-pandemic period by a factor of 10.2 (95% CI 5.0-20.7) in the birth cohort born after 1976, 6.3 (95% CI 3.3-11.9) in those born between 1957 and 1976 and 2.4 (95% CI 1.3-4.3) in those born before 1957. Conclusions/Significance: We demonstrate that infection rates differed among age groups and that the measured pre-pandemic level of cross-reactive antibodies towards pH1N1 did not add information in relation to protection and prediction of the most affected age groups among adults in the pandemic.	[Dudareva, Sandra] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden; [Dudareva, Sandra] Robert Koch Inst, Postgrad Training Appl Epidemiol PAE, German FETP, D-1000 Berlin, Germany; [Schweiger, Brunhilde] Robert Koch Inst, Dept Infect Dis, Natl Reference Ctr Influenza, D-1000 Berlin, Germany; [Thamm, Michel] Robert Koch Inst, Dept Epidemiol & Hlth Reporting, D-1000 Berlin, Germany; [Hoehle, Michael; Stark, Klaus; Krause, Gerard; Buda, Silke; Haas, Walter] Robert Koch Inst, Dept Infect Dis Epidemiol, D-1000 Berlin, Germany	European Centre for Disease Prevention & Control; Robert Koch Institute; Robert Koch Institute; Robert Koch Institute; Robert Koch Institute	Dudareva, S (corresponding author), European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden.	DudarevaS@rki.de	Höhle, Michael/AFM-0575-2022	Höhle, Michael/0000-0002-0423-6702; Dudareva, Sandra/0000-0003-1803-704X; Krause, Gerard/0000-0003-3328-8808				Allwinn R, 2010, MED MICROBIOL IMMUN, V199, P117, DOI 10.1007/s00430-010-0143-4; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453; [Anonymous], 2010, R LANG ENV STAT COMP; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Boon ACM, 2004, J IMMUNOL, V172, P4435, DOI 10.4049/jimmunol.172.7.4435; Buda S, 2010, BUNDESGESUNDHEITSBLA, V53, P1223, DOI 10.1007/s00103-010-1158-0; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Cordova J. A., 2009, Morbidity and Mortality Weekly Report, V58, P585; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Gatherer D, 2009, J CLIN VIROL, V45, P174, DOI 10.1016/j.jcv.2009.06.004; Gilbert GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012562; Gilsdorf A, 2009, EUROSURVEILLANCE, V14, P2; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; Meijer A, 2006, Euro Surveill, V11, P9, DOI 10.2807/esm.11.05.00623-en; Meijer A, 2007, Euro Surveill, V12, pE11; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Paget W J, 2005, Euro Surveill, V10, P107, DOI 10.2807/esm.10.04.00529-en; Poggensee G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-155; Pons O, 2007, ELECTRON J STAT, V1, P381, DOI 10.1214/07-EJS033; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Stephenson I, 2007, VACCINE, V25, P4056, DOI 10.1016/j.vaccine.2007.02.039; Stephenson I, 2009, EMERG INFECT DIS, V15, P1250, DOI 10.3201/eid1508.081754; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; WHO, 2010, WKLY EPIDEMIOL REC, V85, P229; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Zarocostas J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2425; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	40	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21340	10.1371/journal.pone.0021340	http://dx.doi.org/10.1371/journal.pone.0021340			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701598	Green Published, Green Submitted, gold			2022-12-25	WOS:000291983800043
J	Proenca-Modena, JL; Gagliardi, TB; de Paula, FE; Iwamoto, MA; Criado, MF; Camara, AA; Acrani, GO; Cintra, OAL; Cervi, MC; Arruda, LKD; Arruda, E				Proenca-Modena, Jose Luiz; Gagliardi, Talita Bianca; de Paula, Flavia Escremim; Iwamoto, Marisa Akiko; Criado, Miria Ferreira; Camara, Ataide A.; Acrani, Gustavo Olszanski; Leite Cintra, Otavio Augusto; Cervi, Maria Celia; de Paula Arruda, Luisa Karla; Arruda, Eurico			Detection of Human Bocavirus mRNA in Respiratory Secretions Correlates with High Viral Load and Concurrent Diarrhea	PLOS ONE			English	Article							REAL-TIME PCR; EPIDEMIOLOGIC PROFILE; ACUTE GASTROENTERITIS; YOUNG-CHILDREN; TRACT SAMPLES; INFECTIONS; VIRUS; PARVOVIRUS; FREQUENT; BRAZIL	Human bocavirus (HBoV) is a parvovirus recently identified in association with acute respiratory infections (ARI). Despite its worldwide occurrence, little is known on the pathogenesis of HBoV infections. In addition, few systematic studies of HBoV in ARI have been conducted in Latin America. Therefore, in order to test whether active viral replication of human bocavirus is associated with respiratory diseases and to understand the clinical impact of this virus in patients with these diseases, we performed a 3-year retrospective hospital-based study of HBoV in outpatients and inpatients with symptoms of Acute Respiratory Infections (ARI) in Brazil. Nasopharyngeal aspirates (NPAs) from 1015 patients with respiratory symptoms were tested for HBoV DNA by PCR. All samples positive for HBoV were tested by PCR for all other respiratory viruses, had HBoV viral loads determined by quantitative real time PCR and, when possible, were tested by RT-PCR for HBoV VP1 mRNA, as evidence of active viral replication. HBoV was detected in 4.8% of patients, with annual rates of 10.0%, 3.0% and 3.0% in 2005, 2006 and 2007, respectively. The range of respiratory symptoms was similar between HBoV-positive and HBoV-negative ARI patients. However, a higher rate of diarrhea was observed in HBoV-positive patients. High HBoV viral loads (> 10(8) copies/mL) and diarrhea were significantly more frequent in patients with exclusive infection by HBoV and in patients with detection of HBoV VP1 mRNA than in patients with viral co-infection, detected in 72.9% of patients with HBoV. In summary, our data demonstrated that active HBoV replication was detected in a small percentage of patients with ARI and was correlated with concurrent diarrhea and lack of other viral co-infections.	[Proenca-Modena, Jose Luiz; Gagliardi, Talita Bianca; de Paula, Flavia Escremim; Criado, Miria Ferreira; Acrani, Gustavo Olszanski; Arruda, Eurico] Univ Sao Paulo, Sch Med, Dept Cell Biol, Sao Paulo, Brazil; [de Paula Arruda, Luisa Karla] Univ Sao Paulo, Sch Med, Dept Internal Med, Sao Paulo, Brazil; [Leite Cintra, Otavio Augusto; Cervi, Maria Celia] Univ Sao Paulo, Sch Med, Dept Pediat, Sao Paulo, Brazil; [Proenca-Modena, Jose Luiz; Gagliardi, Talita Bianca; de Paula, Flavia Escremim; Iwamoto, Marisa Akiko; Criado, Miria Ferreira; Acrani, Gustavo Olszanski; Arruda, Eurico] Univ Sao Paulo, Sch Med, Virol Res Ctr, Sao Paulo, Brazil; [Camara, Ataide A.] Santa Lydia Hosp, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Proenca-Modena, JL (corresponding author), Univ Sao Paulo, Sch Med, Dept Cell Biol, Sao Paulo, Brazil.	jlmodena@usp.br	Gagliardi, Talita/V-1342-2019; Arruda, Eurico/E-4101-2012; Arruda, L. Karla/D-5845-2013; Cervi, Maria Celia/P-2567-2016; Proenca-Modena, Jose Luiz/C-8231-2014; Acrani, Gustavo/M-3885-2014	Gagliardi, Talita/0000-0003-4953-7135; Arruda, L. Karla/0000-0002-7505-210X; Cervi, Maria Celia/0000-0002-6563-6507; Proenca-Modena, Jose Luiz/0000-0002-4996-3153; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/50617-6, 2009/52388-7, 2009/51818-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [141654/2005-8]; Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/50617-6, 2009/52388-7, 2009/51818-8], the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [141654/2005-8] and the Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT A, 1984, BIOMETRIKA, V71, P1; Albuquerque MCM, 2007, EMERG INFECT DIS, V13, P1756, DOI 10.3201/eid1311.070671; Albuquerque MCM, 2009, EMERG INFECT DIS, V15, P806, DOI 10.3201/eid1505.081603; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Bastien N, 2006, EMERG INFECT DIS, V12, P848, DOI 10.3201/eid1205.051424; Bonzel L, 2008, PEDIATR INFECT DIS J, V27, P589, DOI 10.1097/INF.0b013e3181694fb9; Camara AA, 2004, J ALLERGY CLIN IMMUN, V113, P551, DOI 10.1016/j.jaci.2003.11.027; Cheng WX, 2008, CLIN INFECT DIS, V47, P161, DOI 10.1086/589244; Chow BDW, 2009, CLIN LAB MED, V29, P695, DOI 10.1016/j.cll.2009.07.010; *CIIAGRO, 2010, MON CLIM ANT 2005 20; Dijkman R, 2009, J VIROL, V83, P7739, DOI 10.1128/JVI.00614-09; DURIGON GS, J HOSP INFECT, V76, P171; Esposito S, 2008, J CLIN MICROBIOL, V46, P1337, DOI 10.1128/JCM.02160-07; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Gagliardi TB, 2009, EPIDEMIOL INFECT, V137, P1032, DOI 10.1017/S0950268808001842; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kesebir D, 2006, J INFECT DIS, V194, P1276, DOI 10.1086/508213; Lee JI, 2007, J INFECT DIS, V196, P994, DOI 10.1086/521366; LONGTIN J, J INFECT DIS, V202, P1618; LONGTIN J, J INFECT DIS, V202, P1617; Longtin J, 2008, EMERG INFECT DIS, V14, P217, DOI 10.3201/eid1402.070851; Lu XY, 2008, EMERG INFECT DIS, V14, P1332, DOI 10.3201/eid1408.080300; Maggi F, 2007, J CLIN VIROL, V38, P321, DOI 10.1016/j.jcv.2007.01.008; Manning A, 2006, J INFECT DIS, V194, P1283, DOI 10.1086/508219; Manteufel J, 2008, INTERVIROLOGY, V51, P328, DOI 10.1159/000173734; Martin ET, 2010, J INFECT DIS, V201, P1625, DOI 10.1086/652405; Monteny M, 2007, EMERG INFECT DIS, V13, P180, DOI 10.3201/eid1301.060819; Neske F, 2007, J CLIN MICROBIOL, V45, P2116, DOI 10.1128/JCM.00027-07; Regamey N, 2008, PEDIATR INFECT DIS J, V27, P100, DOI 10.1097/INF.0b013e31815922c8; Regamey N, 2007, PEDIATR INFECT DIS J, V26, P177, DOI 10.1097/01.inf.0000250623.43107.bc; Russell KL, 2006, J INFECT DIS, V194, P877, DOI 10.1086/507426; Santos N, 2010, J CLIN VIROL, V48, P127, DOI 10.1016/j.jcv.2010.03.014; Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07; Soderlund-Venermo M, 2009, EMERG INFECT DIS, V15, P1423, DOI 10.3201/eid1509.090204; Souza EL, 2009, J TROP PEDIAT; Tozer SJ, 2009, J MED VIROL, V81, P488, DOI 10.1002/jmv.21409; Vicente D, 2007, EMERG INFECT DIS, V13, P636, DOI 10.3201/eid1304.061501; Walsh EE, 1997, J INFECT DIS, V175, P814, DOI 10.1086/513976; Wong S, 2008, J MED VIROL, V80, P856, DOI 10.1002/jmv.21136	42	32	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21083	10.1371/journal.pone.0021083	http://dx.doi.org/10.1371/journal.pone.0021083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701591	Green Submitted, Green Published, gold			2022-12-25	WOS:000291983800022
J	Mariam, SH; Werngren, J; Aronsson, J; Hoffner, S; Andersson, DI				Mariam, Solomon H.; Werngren, Jim; Aronsson, Joakim; Hoffner, Sven; Andersson, Dan I.			Dynamics of Antibiotic Resistant Mycobacterium tuberculosis during Long-Term Infection and Antibiotic Treatment	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; CATALASE-PEROXIDASE GENE; DRUG-RESISTANCE; COMPENSATORY EVOLUTION; ISONIAZID RESISTANCE; MULTIDRUG-RESISTANT; RIFAMPIN RESISTANCE; MIXED INFECTION; BIOLOGICAL COST; MUTATIONS	For an infecting bacterium the human body provides several potential ecological niches with both internally (e. g. host immunity) and externally (e.g. antibiotic use) imposed growth restrictions that are expected to drive adaptive evolution in the bacterium, including the development of antibiotic resistance. To determine the extent and pattern of heterogeneity generated in a bacterial population during long-term antibiotic treatment, we examined in a monoclonal Mycobacterium tuberculosis infection antibiotic resistant mutants isolated from one patient during a 9-years period. There was a progressive accumulation of resistance mutations in the infecting clone. Furthermore, apparent clonal sweeps as well as co-existence of different resistant mutants were observed during this time, demonstrating that during treatment there is a high degree of dynamics in the bacterial population. These findings have important implications for diagnostics and treatment of drug resistant tuberculosis infections.	[Mariam, Solomon H.; Werngren, Jim; Hoffner, Sven] Swedish Inst Infect Dis Control, Solna, Sweden; [Mariam, Solomon H.] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Aronsson, Joakim; Andersson, Dan I.] Cty Hosp Ryhov, Dept Infect Dis, Jonkoping, Sweden; [Andersson, Dan I.] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Swedish Institute for Infectious Disease Control; Addis Ababa University; Uppsala University	Mariam, SH (corresponding author), Swedish Inst Infect Dis Control, Solna, Sweden.	Dan.Andersson@imbim.uu.se		Andersson, Dan/0000-0001-6640-2174; H. Mariam, Solomon/0000-0002-5213-6044	Swedish Research Council; Swedish International Development Cooperation Agency	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency	This work was supported by the Swedish Research Council and the Swedish International Development Cooperation Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alangaden GJ, 1998, ANTIMICROB AGENTS CH, V42, P1295, DOI 10.1128/AAC.42.5.1295; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Bjorkholm B, 2001, P NATL ACAD SCI USA, V98, P14607, DOI 10.1073/pnas.241517298; Bjorkman J, 2000, SCIENCE, V287, P1479, DOI 10.1126/science.287.5457.1479; Bjorkman J, 1998, P NATL ACAD SCI USA, V95, P3949, DOI 10.1073/pnas.95.7.3949; Bottger EC, 2008, EUR J PEDIATR, V167, P141, DOI 10.1007/s00431-007-0606-9; Bottger EC, 1998, NAT MED, V4, P1343, DOI 10.1038/3906; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; FINKEN M, 1993, MOL MICROBIOL, V9, P1239, DOI 10.1111/j.1365-2958.1993.tb01253.x; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Gillespie SH, 2002, ANTIMICROB AGENTS CH, V46, P267, DOI 10.1128/AAC.46.2.267-274.2002; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Goude R, 2009, ANTIMICROB AGENTS CH, V53, P4138, DOI 10.1128/AAC.00162-09; Handel A, 2009, J THEOR BIOL, V256, P655, DOI 10.1016/j.jtbi.2008.10.025; HEYM B, 1995, MOL MICROBIOL, V15, P235, DOI 10.1111/j.1365-2958.1995.tb02238.x; Hurdle JG, 2004, ANTIMICROB AGENTS CH, V48, P4366, DOI 10.1128/AAC.48.11.4366-4376.2004; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Lemey P, 2006, AIDS REV, V8, P125; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Maisnier-Patin S, 2002, MOL MICROBIOL, V46, P355, DOI 10.1046/j.1365-2958.2002.03173.x; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; Meacci F, 2005, J CLIN MICROBIOL, V43, P3114, DOI 10.1128/JCM.43.7.3114-3120.2005; MELANCON P, 1988, NUCLEIC ACIDS RES, V16, P9631, DOI 10.1093/nar/16.20.9631; Nagaev I, 2001, MOL MICROBIOL, V40, P433, DOI 10.1046/j.1365-2958.2001.02389.x; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Prammananan T, 1998, J INFECT DIS, V177, P1573, DOI 10.1086/515328; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Quinones-Mateu ME, 2006, CURR TOP MICROBIOL, V299, P83; Ramaswamy SV, 2000, ANTIMICROB AGENTS CH, V44, P326, DOI 10.1128/AAC.44.2.326-336.2000; Reynolds MG, 2000, GENETICS, V156, P1471; Sander P, 2002, ANTIMICROB AGENTS CH, V46, P1204, DOI 10.1128/AAC.46.5.1204-1211.2002; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Shamputa IC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-99; Shcherbakov D, 2010, MOL MICROBIOL, V77, P830, DOI 10.1111/j.1365-2958.2010.07218.x; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567; van Doorn HR, 2001, J CLIN MICROBIOL, V39, P1591, DOI 10.1128/JCM.39.4.1591-1594.2001; van Rie A, 2005, AM J RESP CRIT CARE, V172, P636, DOI 10.1164/rccm.200503-449OC; van Soolingen D, 2000, J INFECT DIS, V182, P1788, DOI 10.1086/317598; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Vilcheze C, 2005, ANTIMICROB AGENTS CH, V49, P708, DOI 10.1128/AAC.49.2.708-720.2005; *WHO, 2009, WHO REP 2009 GLOB TU; Wilder CN, 2009, INFECT IMMUN, V77, P5631, DOI 10.1128/IAI.00755-09; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	54	32	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21147	10.1371/journal.pone.0021147	http://dx.doi.org/10.1371/journal.pone.0021147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698208	Green Submitted, Green Published, gold			2022-12-25	WOS:000291734100061
J	Bertrand, J; Despeaux, M; Joly, S; Bourogaa, E; Gallay, N; Demur, C; Bonnevialle, P; Louache, F; Maguer-Satta, V; Vergnolle, N; Payrastre, B; Racaud-Sultan, C				Bertrand, J.; Despeaux, M.; Joly, S.; Bourogaa, E.; Gallay, N.; Demur, C.; Bonnevialle, P.; Louache, F.; Maguer-Satta, V.; Vergnolle, N.; Payrastre, B.; Racaud-Sultan, C.			Sex differences in the GSK3 beta-mediated survival of adherent leukemic progenitors	ONCOGENE			English	Article						cell survival; cell adhesion; GSK3 beta; leukemia	ACUTE MYELOID-LEUKEMIA; GLYCOGEN-SYNTHASE KINASE-3; RECEPTOR-ALPHA CHAIN; STEM-CELLS; EXPRESSION; INTEGRIN; INHIBITION; PROTEIN; MICROENVIRONMENT; PROLIFERATION	Therapeutic resistance of acute myeloid leukemia stem cells, enriched in the CD34(+)38(-)123(+) progenitor population, is supported by extrinsic factors such as the bone marrow niche. Here, we report that when adherent onto fibronectin or osteoblast components, CD34(+)38(-)123(+) progenitors survive through an integrin-dependent activation of glycogen synthase kinase 3 beta (GSK3 beta) by serine 9-dephosphorylation. Strikingly, GSK3 beta-mediated survival was restricted to leukemic progenitors from female patients. GSK3 beta inhibition restored sensitivity to etoposide, and impaired the clonogenic capacities of adherent leukemic progenitors from female patients. In leukemic progenitors from female but not male patients, the scaffolding protein RACK1, activated downstream of alpha 5 beta 1- integrin engagement, was specifically upregulated and controlled GSK3 beta activation through the phosphatase protein phosphatase 2A (PP2A). In a mirrored manner, survival of adherent progenitors (CD34(+)38(-)) from male but not female healthy donors was partially dependent on this pathway. We conclude that the GSK3 beta-dependent survival pathway might be sex-specific in normal immature population and flip-flopped upon leukemogenesis. Taken together, our results strengthen GSK3 beta as a promising target for leukemic stem cell therapy and reveal gender differences as a new parameter in anti-leukemia therapy. Oncogene (2012) 31, 694-705; doi:10.1038/onc.2011.258; published online 4 July 2011	[Bertrand, J.; Despeaux, M.; Bourogaa, E.; Gallay, N.; Vergnolle, N.; Racaud-Sultan, C.] Univ Toulouse UPS, Inserm U1043, CNRS U5282, CPTP, F-31024 Toulouse 3, France; [Joly, S.; Maguer-Satta, V.] CRCL, CNRS U5286, Inserm U1052, Lyon, France; [Demur, C.] Univ Toulouse, Ctr Rech Cancerol Toulouse, Inserm UMR1037, CNRS ERL5294, Toulouse, France; [Demur, C.; Payrastre, B.] CHU Toulouse, Hematol Lab, Toulouse, France; [Bonnevialle, P.] CHU Toulouse, Serv Clin Chirurg Orthoped & Traumatol, Toulouse, France; [Louache, F.] Inst Gustave Roussy, Inserm U790, Villejuif, France; [Payrastre, B.] Univ Toulouse UPS, Inserm U1048, Inst Malad Metab & Cardiovasc, F-31024 Toulouse 3, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE)	Racaud-Sultan, C (corresponding author), Univ Toulouse UPS, CHU Purpan, Hop Purpan, INSERM U1043,CNRS U5282,CPTP, Pl Dr Baylac, F-31024 Toulouse 3, France.	claire.racaud@inserm.fr	Vergnolle, Nathalie/C-7677-2018; Payrastre, Bernard/M-5295-2014; Maguer-Satta, Veronique/U-8857-2019	Vergnolle, Nathalie/0000-0003-1825-6015; Maguer-Satta, Veronique/0000-0002-1556-068X; , Nathalie GALLAY/0000-0002-4236-4780; , Bernard/0000-0002-8693-0190; Racaud-Sultan, Claire/0000-0002-6549-1088	Association de Recherche contre le Cancer [3638, 8407]; Institut National du Cancer [07/3D1616/IABC-23-8/NC-NG]; DGRSRT/INSERM cooperation	Association de Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); DGRSRT/INSERM cooperation(Institut National de la Sante et de la Recherche Medicale (Inserm))	We thank Dr Jean-Emmanuel Sarry for critical reading of the manuscript and the 'plateforme de cytometrie' of IFR150. Association de Recherche contre le Cancer (Contract Nos. 3638 and 8407), Institut National du Cancer (Contract no. 07/3D1616/IABC-23-8/NC-NG), DGRSRT/INSERM cooperation.	Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088; Bhatia R, 1996, BLOOD, V87, P3883, DOI 10.1182/blood.V87.9.3883.bloodjournal8793883; De Toni F, 2006, ONCOGENE, V25, P3113, DOI 10.1038/sj.onc.1209346; De Toni-Costes F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009807; de Vries JF, 2006, HAEMATOL-HEMATOL J, V91, P912; Del Vecchio I, 2009, GENE, V430, P17, DOI 10.1016/j.gene.2008.10.005; Despeaux M, 2011, LEUKEMIA, V25, P1789, DOI 10.1038/leu.2011.145; Dick JE, 2005, INT J HEMATOL, V82, P389, DOI 10.1532/IJH97.05144; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Edderkaoui M, 2007, J BIOL CHEM, V282, P26646, DOI 10.1074/jbc.M702836200; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Holmes T, 2008, STEM CELLS, V26, P1288, DOI 10.1634/stemcells.2007-0600; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Kiely PA, 2008, J BIOL CHEM, V283, P22952, DOI 10.1074/jbc.M800802200; Kornblau SM, 2009, BLOOD, V113, P154, DOI 10.1182/blood-2007-10-119438; Kubota T, 2002, J VIROL, V76, P12676, DOI 10.1128/JVI.76.24.12676-12682.2002; Li ZW, 2006, BLOOD REV, V20, P333, DOI 10.1016/j.blre.2005.08.003; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; Mayack SR, 2010, NATURE, V463, P495, DOI 10.1038/nature08749; Ougolkov AV, 2007, BLOOD, V110, P735, DOI 10.1182/blood-2006-12-060947; Papasozomenos SC, 2002, P NATL ACAD SCI USA, V99, P1140, DOI 10.1073/pnas.032646799; Recher C, 2004, CANCER RES, V64, P3191, DOI 10.1158/0008-5472.CAN-03-3005; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Sampaio ALF, 2010, J LEUKOCYTE BIOL, V87, P877, DOI 10.1189/jlb.1009670; SCHILLER G, 1994, LEUKEMIA LYMPHOMA, V15, P85, DOI 10.3109/10428199409051682; Sun M, 2008, CELL DEATH DIFFER, V15, P1887, DOI 10.1038/cdd.2008.124; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Vialle-Castellano A, 2004, LEUKEMIA, V18, P426, DOI 10.1038/sj.leu.2403273; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; Wang Z, 2010, CANCER CELL, V17, P597, DOI 10.1016/j.ccr.2010.04.024; Xu Q, 2005, BLOOD, V106, P4261, DOI 10.1182/blood-2004-11-4468; Ysebaert L, 2006, LEUKEMIA, V20, P1211, DOI 10.1038/sj.leu.2404239	38	15	15	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	6					694	705		10.1038/onc.2011.258	http://dx.doi.org/10.1038/onc.2011.258			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MU	21725365				2022-12-25	WOS:000300222100003
J	Bulut, G; Hong, SH; Chen, K; Beauchamp, EM; Rahim, S; Kosturko, GW; Glasgow, E; Dakshanamurthy, S; Lee, HS; Daar, I; Toretsky, JA; Khanna, C; Uren, A				Bulut, G.; Hong, S-H; Chen, K.; Beauchamp, E. M.; Rahim, S.; Kosturko, G. W.; Glasgow, E.; Dakshanamurthy, S.; Lee, H-S; Daar, I.; Toretsky, J. A.; Khanna, C.; Ueren, A.			Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells	ONCOGENE			English	Article						ezrin; osteosarcoma; metastasis; small molecule screening; drug discovery	ERM PROTEINS; OSTEOGENIC-SARCOMA; PLASMA-MEMBRANE; BINDING-SITE; LINKER EZRIN; METASTASIS; EXPRESSION; SURVIVAL; IDENTIFICATION; CHEMOTHERAPY	Ezrin is a multifunctional protein that connects the actin cytoskeleton to the extracellular matrix through transmembrane proteins. High ezrin expression is associated with lung metastasis and poor survival in cancer. We screened small molecule libraries for compounds that directly interact with ezrin protein using surface plasmon resonance to identify lead compounds. The secondary functional assays used for lead compound selection included ezrin phosphorylation as measured by immunoprecipitation and in vitro kinase assays, actin binding, chemotaxis, invasion into an endothelial cell monolayer, zebrafish and Xenopus embryonic development, mouse lung organ culture and an in vivo lung metastasis model. Two molecules, NSC305787 and NSC668394, that directly bind to ezrin with low micromolar affinity were selected based on inhibition of ezrin function in multiple assays. They inhibited ezrin phosphorylation, ezrin-actin interaction and ezrin-mediated motility of osteosarcoma (OS) cells in culture. NSC305787 mimicked the ezrin morpholino phenotype, and NSC668394 caused a unique developmental defect consistent with reduced cell motility in zebrafish. Following tail vein injection of OS cells into mice, both molecules inhibited lung metastasis of ezrinsensitive cells, but not ezrin-resistant cells. The small molecule inhibitors NSC305787 and NSC668394 demonstrate a novel targeted therapy that directly inhibits ezrin protein as an approach to prevent tumor metastasis. Oncogene (2012) 31, 269-281; doi:10.1038/onc.2011.245; published online 27 June 2011	[Ueren, A.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, NRB, Washington, DC 20057 USA; [Hong, S-H; Khanna, C.] NCI, Tumor & Metastasis Biol Sect, Ctr Canc Res, Bethesda, MD 20892 USA; [Lee, H-S; Daar, I.] NCI, Lab Cell & Dev Signaling, Frederick, MD 21701 USA	Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Uren, A (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, NRB, 3970 Reservoir Rd NW,Room E312, Washington, DC 20057 USA.	au26@georgetown.edu	BULUT, GULAY/J-3180-2012; Lee, Hyun-Shik/G-3555-2011; Dakshanamurthy, Sivanesan/CAF-4258-2022	Dakshanamurthy, Sivanesan/0000-0003-3681-4121; Daar, Ira/0000-0003-2657-526X; Glasgow, Eric/0000-0001-7729-3954	Children's Cancer Foundation of Baltimore; US Department of Defense [W81XWH-10-1-0137]; Brandon Carrington Lee Foundation; Go4theGoal; Dani's Foundation; Alex's Lemonade Stand Foundation; Liddy Shriver Sarcoma Initiative; Burroughs Wellcome Clinical Scientist Award in Translational Research; NIH [R01CA133662, R01CA138212]; Cancer Center [P30 CA051008]; NATIONAL CANCER INSTITUTE [R01CA138212, T32CA009686, ZIABC010006, P30CA051008, ZIABC011024, ZIABC010566, R01CA133662, ZIABC010958] Funding Source: NIH RePORTER	Children's Cancer Foundation of Baltimore; US Department of Defense(United States Department of Defense); Brandon Carrington Lee Foundation; Go4theGoal; Dani's Foundation; Alex's Lemonade Stand Foundation; Liddy Shriver Sarcoma Initiative; Burroughs Wellcome Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for our work came from the Children's Cancer Foundation of Baltimore (AU), US Department of Defense (W81XWH-10-1-0137, AU), Brandon Carrington Lee Foundation (G.K., AU), Go4theGoal, Dani's Foundation, Alex's Lemonade Stand Foundation, Liddy Shriver Sarcoma Initiative, Burroughs Wellcome Clinical Scientist Award in Translational Research (JT), and the NIH R01CA133662 (JT), R01CA138212 (JT) and Cancer Center Support Grant P30 CA051008 for use of Biacore Molecular Interaction Shared Resource. We would like to thank to Dr Anthony Bretscher (Cornell University) for providing the WT Ezrin construct, Developmental Therapeutics Program, NCI for providing the small molecule libraries.	Bacci G, 2006, CANCER-AM CANCER SOC, V106, P2701, DOI 10.1002/cncr.21937; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BOGER DL, 1987, J MED CHEM, V30, P1918, DOI 10.1021/jm00393a040; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; CASE DA, 2004, AMBER 8; Chen K, 2008, PEDIATR BLOOD CANCER, V51, P349, DOI 10.1002/pbc.21595; DUNN D, 1977, CANCER-AM CANCER SOC, V40, P3054, DOI 10.1002/1097-0142(197712)40:6<3054::AID-CNCR2820400644>3.0.CO;2-A; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Elzagheid A, 2008, HUM PATHOL, V39, P1737, DOI 10.1016/j.humpath.2008.04.020; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Ferrari S, 2007, CURR OPIN ONCOL, V19, P341, DOI 10.1097/CCO.0b013e328122d73f; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Fivash M, 1998, CURR OPIN BIOTECH, V9, P97, DOI 10.1016/S0958-1669(98)80091-8; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Gautreau A, 1999, P NATL ACAD SCI USA, V96, P7300, DOI 10.1073/pnas.96.13.7300; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Geiger KD, 2000, AM J PATHOL, V157, P1785, DOI 10.1016/S0002-9440(10)64816-X; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Khanna C, 2001, CANCER RES, V61, P3750; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kobel M, 2006, INT J GYNECOL PATHOL, V25, P121, DOI 10.1097/01.pgp.0000185410.39050.ac; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; Link V, 2006, J CELL SCI, V119, P2073, DOI 10.1242/jcs.02928; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Longhi A, 2006, CANCER TREAT REV, V32, P423, DOI 10.1016/j.ctrv.2006.05.005; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Makitie T, 2001, INVEST OPHTH VIS SCI, V42, P2442; Malmqvist M, 1999, BIOCHEM SOC T, V27, P335, DOI 10.1042/bst0270335; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Mendoza A, 2010, J CLIN INVEST, V120, P2979, DOI 10.1172/JCI40252; OHNMACHT CJ, 1971, J MED CHEM, V14, P926; Pang ST, 2004, UROLOGY, V63, P609, DOI 10.1016/j.urology.2003.09.068; Park HR, 2006, PATHOL RES PRACT, V202, P509, DOI 10.1016/j.prp.2006.01.015; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Ren L, 2009, ONCOGENE, V28, P792, DOI 10.1038/onc.2008.437; ROSEN G, 1982, CANCER-AM CANCER SOC, V49, P1221, DOI 10.1002/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO;2-E; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; Wan X, 2009, ONCOGENE, V28, P3401, DOI 10.1038/onc.2009.206; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weng WH, 2005, CLIN CANCER RES, V11, P6198, DOI 10.1158/1078-0432.CCR-05-0548; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zhang PY, 2008, CLIN CANCER RES, V14, P2962, DOI 10.1158/1078-0432.CCR-07-1992	44	110	119	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2012	31	3					269	281		10.1038/onc.2011.245	http://dx.doi.org/10.1038/onc.2011.245			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	882DQ	21706056	Bronze, Green Accepted			2022-12-25	WOS:000299542100001
J	Acin-Perez, R; Russwurm, M; Gunnewig, K; Gertz, M; Zoidl, G; Ramos, L; Buck, J; Levin, LR; Rassow, J; Manfredi, G; Steegborn, C				Acin-Perez, Rebeca; Russwurm, Michael; Guennewig, Kathrin; Gertz, Melanie; Zoidl, Georg; Ramos, Lavoisier; Buck, Jochen; Levin, Lonny R.; Rassow, Joachim; Manfredi, Giovanni; Steegborn, Clemens			A Phosphodiesterase 2A Isoform Localized to Mitochondria Regulates Respiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE ADENYLYL-CYCLASE; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; GUANYLYL CYCLASE; RAT-BRAIN; STIMULATED PHOSPHODIESTERASE; CRYSTAL-STRUCTURE; GAF DOMAINS; CAMP; PROTEIN; CGMP	Mitochondria are central organelles in cellular energy metabolism, apoptosis, and aging processes. A signaling network regulating these functions was recently shown to include soluble adenylyl cyclase as a local source of the second messenger cAMP in the mitochondrial matrix. However, a mitochondrial cAMP degrading phosphodiesterase (PDE) necessary for switching off this cAMP signal has not yet been identified. Here, we describe the identification and characterization of a PDE2A isoform in mitochondria from rodent liver and brain. We find that mitochondrial PDE2A is located in the matrix and that the unique N terminus of PDE2A isoform 2 specifically leads to mitochondrial localization of this isoform. Functional assays show that mitochondrial PDE2A forms a local signaling system with soluble adenylyl cyclase in the matrix, which regulates the activity of the respiratory chain. Our findings complete a cAMP signaling cascade in mitochondria and have implications for understanding the regulation of mitochondrial processes and for their pharmacological modulation.	[Gertz, Melanie; Rassow, Joachim; Steegborn, Clemens] Univ Bayreuth, Dept Biochem, D-95447 Bayreuth, Germany; [Acin-Perez, Rebeca; Manfredi, Giovanni] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA; [Zoidl, Georg] Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, D-44780 Bochum, Germany; [Russwurm, Michael] Ruhr Univ Bochum, Dept Pharmacol & Toxicol, D-44780 Bochum, Germany; [Guennewig, Kathrin; Gertz, Melanie] Ruhr Univ Bochum, Dept Physiol Chem, D-44780 Bochum, Germany; [Ramos, Lavoisier; Buck, Jochen; Levin, Lonny R.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA	University of Bayreuth; Cornell University; Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Cornell University	Steegborn, C (corresponding author), Univ Bayreuth, Dept Biochem, Univ Str 30, D-95447 Bayreuth, Germany.	Clemens.Steegborn@uni-bayreuth.de	Acin-Perez, Rebeca/AAU-4913-2020; Acin-Perez, Rebeca/H-6160-2015	Acin-Perez, Rebeca/0000-0001-9553-8337; Acin-Perez, Rebeca/0000-0001-9553-8337; Levin, Lonny/0000-0002-5204-6356	National Institutes of Health [R01 GM088999, R01 GM62328, NS552555]; Muscular Dystrophy Association; United Mitochondrial Disease Foundation; Deutsche Forschungsgemeinschaft; Forschungsreferat Ruhr-Universitat Bochum Medizin [F630-2008]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088999, R01GM062328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); United Mitochondrial Disease Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungsreferat Ruhr-Universitat Bochum Medizin; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM088999 (to G. M.) and R01 GM62328 and NS552555 (to L. R. L. and J. B.). This work was also supported by grants from the Muscular Dystrophy Association (to G. M.), the United Mitochondrial Disease Foundation (to R. A.-P.), Deutsche Forschungsgemeinschaft (Grant Ko1157) (to M. R.), and Forschungsreferat Ruhr-Universitat Bochum Medizin (Grant F630-2008) (to M. R. and C. S.).	Acin-Perez R, 2009, EMBO MOL MED, V1, P392, DOI 10.1002/emmm.200900046; Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; AZILA N, 1989, BIOCHEM INT, V19, P1077; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; BEAVO JA, 1971, J BIOL CHEM, V246, P3841; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bender AT, 2004, NEUROCHEM INT, V45, P853, DOI 10.1016/j.neuint.2004.03.015; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Boess FG, 2004, NEUROPHARMACOLOGY, V47, P1081, DOI 10.1016/j.neuropharm.2004.07.040; BUNDEY RA, 2004, SCI STKE, pPE19; Cammarota M, 1999, J NEUROCHEM, V72, P2272, DOI 10.1046/j.1471-4159.1999.0722272.x; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; D'Angelo A, 2004, CANCER CELL, V5, P137, DOI 10.1016/S1535-6108(04)00021-2; de Alda JAGO, 2000, J BACTERIOL, V182, P3839, DOI 10.1128/JB.182.13.3839-3842.2000; Domanska G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000878; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Fischer LR, 2011, BRAIN, V134, P196, DOI 10.1093/brain/awq314; Gertz M, 2008, P NATL ACAD SCI USA, V105, P5705, DOI 10.1073/pnas.0800691105; Gertz M, 2010, ANTIOXID REDOX SIGN, V13, P1417, DOI 10.1089/ars.2010.3147; Goldenthal MJ, 2004, MOL CELL BIOCHEM, V262, P1, DOI 10.1023/B:MCBI.0000038228.85494.3b; Hedges SB, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-4; Hofhaus G, 1996, Methods Enzymol, V264, P476, DOI 10.1016/S0076-6879(96)64043-9; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Jager R, 2010, BRIT J PHARMACOL, V161, P1645, DOI 10.1111/j.1476-5381.2010.00977.x; Jeon YH, 2005, CELL MOL LIFE SCI, V62, P1198, DOI 10.1007/s00018-005-4533-5; Jin SLC, 1998, J BIOL CHEM, V273, P19672, DOI 10.1074/jbc.273.31.19672; Juilfs D M, 1999, Rev Physiol Biochem Pharmacol, V135, P67, DOI 10.1007/BFb0033670; Juilfs DM, 1997, P NATL ACAD SCI USA, V94, P3388, DOI 10.1073/pnas.94.7.3388; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kumar S, 2009, J BIOL CHEM, V284, P14760, DOI 10.1074/jbc.M900925200; Lakshminarasimhan M, 2011, EXP GERONTOL, V46, P174, DOI 10.1016/j.exger.2010.08.024; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Martinez SE, 2005, P NATL ACAD SCI USA, V102, P3082, DOI 10.1073/pnas.0409913102; Matthiesen K, 2009, BIOCHEM J, V423, P401, DOI 10.1042/BJ20090982; Middelhaufe S, 2007, BIOCHEM J, V407, P199, DOI 10.1042/BJ20070408; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Mullershausen F, 2001, J CELL BIOL, V155, P271, DOI 10.1083/jcb.200107001; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Papatheodorou P, 2006, CELL MICROBIOL, V8, P677, DOI 10.1111/j.1462-5822.2005.00660.x; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105; REPASKE DR, 1993, NEUROSCIENCE, V56, P673, DOI 10.1016/0306-4522(93)90364-L; Rosman GJ, 1997, GENE, V191, P89, DOI 10.1016/S0378-1119(97)00046-2; Russwurm C, 2009, J BIOL CHEM, V284, P25782, DOI 10.1074/jbc.M109.017194; Ryu H, 2005, P NATL ACAD SCI USA, V102, P13915, DOI 10.1073/pnas.0502878102; Sardanelli AM, 2006, FEBS LETT, V580, P5690, DOI 10.1016/j.febslet.2006.09.020; Schlicker C, 2009, J MOL BIOL, V385, P1207, DOI 10.1016/j.jmb.2008.11.037; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; SONNENBURG WK, 1991, J BIOL CHEM, V266, P17655; Steegborn C, 2005, NAT STRUCT MOL BIOL, V12, P32, DOI 10.1038/nsmb880; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Wang HC, 2008, BIOCHEMISTRY-US, V47, P12760, DOI 10.1021/bi801487x; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; YAMAMOTO T, 1983, J BIOL CHEM, V258, P2526; YANG Q, 1994, BIOCHEM BIOPH RES CO, V205, P1850, DOI 10.1006/bbrc.1994.2886; Yousif LF, 2009, CHEMBIOCHEM, V10, P1939, DOI 10.1002/cbic.200900185; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2001, TRENDS ENDOCRIN MET, V12, P366, DOI 10.1016/S1043-2760(01)00454-4; Zoraghi R, 2004, MOL PHARMACOL, V65, P267, DOI 10.1124/mol.65.2.267	68	97	97	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30423	30432		10.1074/jbc.M111.266379	http://dx.doi.org/10.1074/jbc.M111.266379			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21724846	Green Published, hybrid			2022-12-25	WOS:000294283600021
J	Mizuguchi, H; Terao, T; Kitai, M; Ikeda, M; Yoshimura, Y; Das, AK; Kitamura, Y; Takeda, N; Fukui, H				Mizuguchi, Hiroyuki; Terao, Takuma; Kitai, Mika; Ikeda, Mitsuhiro; Yoshimura, Yoshiyuki; Das, Asish Kumar; Kitamura, Yoshiaki; Takeda, Noriaki; Fukui, Hiroyuki			Involvement of Protein Kinase C delta/Extracellular Signal-regulated Kinase/Poly(ADP-ribose) Polymerase-1 (PARP-1) Signaling Pathway in Histamine-induced Up-regulation of Histamine H-1 Receptor Gene Expression in HeLa Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MESSENGER-RNA EXPRESSION; NASAL EPITHELIAL-CELLS; TRANSCRIPTION FACTOR; NUCLEAR-FACTOR; PKC-DELTA; POLY(ADP-RIBOSE) POLYMERASE-1; TYROSINE PHOSPHORYLATION; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS	The histamine H-1 receptor (H1R) gene is up-regulated in patients with allergic rhinitis. However, the mechanism and reason underlying this up-regulation are still unknown. Recently, we reported that the H1R expression level is strongly correlated with the severity of allergic symptoms. Therefore, understanding the mechanism of this up-regulation will help to develop new anti-allergic drugs targeted for H1R gene expression. Here we studied the molecular mechanism of H1R up-regulation in HeLa cells that express H1R endogenously in response to histamine and phorbol 12-myristate 13-acetate (PMA). In HeLa cells, histamine stimulation caused up-regulation of H1R gene expression. Rottlerin, a PKC delta-selective inhibitor, inhibited up-regulation of H1R gene expression, but Go6976, an inhibitor of Ca2+-dependent PKCs, did not. Histamine or PMA stimulation resulted in PKC delta phosphorylation at Tyr(311) and Thr(505). Activation of PKC delta by H2O2 resulted in H1R mRNA up-regulation. Overexpression of PKC delta enhanced up-regulation of H1R gene expression, and knockdown of the PKC delta gene suppressed this up-regulation. Histamine or PMA caused translocation PKC delta from the cytosol to the Golgi. U0126, an MEK inhibitor, and DPQ, a poly(ADP-ribose) polymerase-1 inhibitor, suppressed PMA-induced up-regulation of H1R gene expression. These results were confirmed by a luciferase assay using the H1R promoter. Phosphorylation of ERK and Raf-1 in response to PMA was also observed. However, real-time PCR analysis showed no inhibition of H1R mRNA up-regulation by a Raf-1 inhibitor. These results suggest the involvement of the PKC delta/ERK/poly(ADP-ribose) polymerase-1 signaling pathway in histamine-or PMA-induced up-regulation of H1R gene expression in HeLa cells.	[Mizuguchi, Hiroyuki; Terao, Takuma; Kitai, Mika; Ikeda, Mitsuhiro; Das, Asish Kumar; Fukui, Hiroyuki] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Mol Pharmacol, Tokushima 7708505, Japan; [Yoshimura, Yoshiyuki] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Med Pharmacol, Tokushima 7708505, Japan; [Kitamura, Yoshiaki; Takeda, Noriaki] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Otolaryngol, Tokushima 7708505, Japan	Tokushima University; Tokushima University; Tokushima University	Fukui, H (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Mol Pharmacol, 1-78-1 Shyomachi, Tokushima 7708505, Japan.	hfukui@ph.tokushima-u.ac.jp	Mizuguchi, Hiroyuki/B-5676-2013	Mizuguchi, Hiroyuki/0000-0001-7055-316X	Ministry of Health Labour and Welfare of Japan [10103185]; Japan Society for the Promotion of Science [22580132]; Osaka Medical Research Foundation for Incurable Diseases	Ministry of Health Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Osaka Medical Research Foundation for Incurable Diseases	This work was supported by Grant-in-aid for Research on Allergic Disease and Immunology from the Ministry of Health Labour and Welfare of Japan 10103185 (to H. F.), Grant-in-aid for Scientific Research (C) from Japan Society for the Promotion of Science 22580132 (to H. M.), and by a grant from the Osaka Medical Research Foundation for Incurable Diseases.	Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; Anderson MG, 2000, J VIROL, V74, P2169, DOI 10.1128/JVI.74.5.2169-2177.2000; Bakker RA, 2001, MOL PHARMACOL, V60, P1133, DOI 10.1124/mol.60.5.1133; Boss V, 1998, MOL PHARMACOL, V54, P264, DOI 10.1124/mol.54.2.264; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Cervellera MN, 2000, J BIOL CHEM, V275, P10692, DOI 10.1074/jbc.275.14.10692; CHENG HF, 1995, J CLIN INVEST, V95, P2012, DOI 10.1172/JCI117886; Cohen A, 2006, J GEN VIROL, V87, P795, DOI 10.1099/vir.0.81619-0; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Das AK, 2007, J PHARMACOL SCI, V103, P374, DOI 10.1254/jphs.FP0061411; Das Asish Kumar, 2009, Allergology International, V58, P81, DOI 10.2332/allergolint.O-07-526; De Backer MD, 1998, BIOCHEM J, V335, P663, DOI 10.1042/bj3350663; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Dev S, 2009, J PHARMACOL SCI, V109, P606, DOI 10.1254/jphs.09003FP; Devi S, 2008, J PHARMACOL SCI, V107, P159, DOI 10.1254/jphs.08028FP; Dinh QT, 2005, CLIN EXP ALLERGY, V35, P1443, DOI 10.1111/j.1365-2222.2005.02359.x; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Fukunaga M, 2001, BIOCHEM BIOPH RES CO, V289, P573, DOI 10.1006/bbrc.2001.6025; Gomel R, 2007, MOL CANCER RES, V5, P627, DOI 10.1158/1541-7786.MCR-06-0255; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Hamano N, 1998, INT ARCH ALLERGY IMM, V115, P220, DOI 10.1159/000023904; Hao F, 2008, J BIOL CHEM, V283, P26928, DOI 10.1074/jbc.M803071200; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Hermoso M, 2004, J BIOL CHEM, V279, P17681, DOI 10.1074/jbc.M304506200; Iriyoshi N, 1996, CLIN EXP ALLERGY, V26, P379, DOI 10.1111/j.1365-2222.1996.tb00553.x; Kajimoto T, 2004, J BIOL CHEM, V279, P12668, DOI 10.1074/jbc.M312350200; Kajimoto T, 2001, MOL CELL BIOL, V21, P1769, DOI 10.1128/MCB.21.5.1769-1783.2001; Kannan P, 1999, NUCLEIC ACIDS RES, V27, P866, DOI 10.1093/nar/27.3.866; Kheifets V, 2006, J BIOL CHEM, V281, P23218, DOI 10.1074/jbc.M602075200; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kitamura Y, 2004, ACTA OTO-LARYNGOL, V124, P1053, DOI 10.1080/00016480410022525; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Masaki T, 2011, MOL BIOL CELL, V22, P2144, DOI 10.1091/mbc.E10-11-0875; Matsubara M, 2006, INT ARCH ALLERGY IMM, V139, P279, DOI 10.1159/000091599; Matsubara M, 2005, BIOCHEM PHARMACOL, V69, P433, DOI 10.1016/j.bcp.2004.10.006; Matsushita C., 2008, Journal of Traditional Medicines, V25, P133; Megson AC, 2001, MOL PHARMACOL, V59, P1012, DOI 10.1124/mol.59.5.1012; Mizuguchi H, 2010, METHOD FIND EXP CLIN, V32, P745, DOI 10.1358/mf.2010.32.10.1533687; Mizuguchi H, 2008, J PHARMACOL SCI, V108, P480, DOI 10.1254/jphs.08222FP; Muscella A, 2004, J CELL PHYSIOL, V200, P428, DOI 10.1002/jcp.20033; Nakasaki T, 1999, PROSTAG OTH LIPID M, V58, P29, DOI 10.1016/S0090-6980(99)00021-0; Nie J, 1998, FEBS LETT, V424, P27, DOI 10.1016/S0014-5793(98)00131-8; Notcovich C, 2010, EXP CELL RES, V316, P401, DOI 10.1016/j.yexcr.2009.11.002; Oei SL, 1997, BIOCHEM BIOPH RES CO, V240, P108, DOI 10.1006/bbrc.1997.7621; Ohuchi Y, 1998, INT J MOL MED, V1, P355; Rawling JM, 1997, BIOCHEM J, V324, P249, DOI 10.1042/bj3240249; Ren YM, 2008, CELL SIGNAL, V20, P518, DOI 10.1016/j.cellsig.2007.11.010; Schanstra JP, 1998, J CLIN INVEST, V101, P2080, DOI 10.1172/JCI1359; Shahriar M, 2009, J IMMUNOL, V183, P2133, DOI 10.4049/jimmunol.0901058; STARR S, 1995, J NEUROCHEM, V65, P569; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Terada N, 1999, CLIN EXP ALLERGY, V29, P52; THOMAS RF, 1992, P NATL ACAD SCI USA, V89, P4490, DOI 10.1073/pnas.89.10.4490; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; Yoshida K, 2007, CELL SIGNAL, V19, P892, DOI 10.1016/j.cellsig.2007.01.027	58	41	42	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30542	30551		10.1074/jbc.M111.253104	http://dx.doi.org/10.1074/jbc.M111.253104			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21730054	Green Published, hybrid			2022-12-25	WOS:000294283600033
J	Li, SQ; Zhu, F; Zykova, T; Kim, MO; Cho, YY; Bode, AM; Peng, C; Ma, WY; Carper, A; Langfald, A; Dong, ZG				Li, Shengqing; Zhu, Feng; Zykova, Tatyana; Kim, Myoung Ok; Cho, Yong Yeon; Bode, Ann M.; Peng, Cong; Ma, Weiya; Carper, Andria; Langfald, Alyssa; Dong, Zigang			T-LAK Cell-originated Protein Kinase (TOPK) Phosphorylation of MKP1 Protein Prevents Solar Ultraviolet Light-induced Inflammation through Inhibition of the p38 Protein Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATASE-MEDIATED CROSSTALK; COLORECTAL-CANCER CELLS; RPMI7951 MELANOMA-CELLS; MAP KINASE; INDUCED APOPTOSIS; BREAST-CANCER; P38-ALPHA; SKIN; MICE; PROLIFERATION	Solar UV radiation is a major environmental factor that causes DNA damage, inflammation, and even skin cancer. T-LAK cell-originated protein kinase (TOPK) is expressed widely in both normal and cancer cells and functions to inhibit apoptosis and promote carcinogenesis. However, its function in inflammation is not known. The p38 MAPK signaling pathway plays an important role in solar UVlight-induced inflammation. In this study, we found that TOPK negatively regulated the activity of p38 alpha by phosphorylating the p38 alpha-specific phosphatase MKP1 and enhancing the stability of MKP1. Notably, the absence of TOPK in mice resulted in a striking increase in skin inflammation. Therefore, we conclude that TOPK has a protective function in solar UV light-induced inflammation.	[Li, Shengqing; Zhu, Feng; Zykova, Tatyana; Kim, Myoung Ok; Cho, Yong Yeon; Bode, Ann M.; Peng, Cong; Ma, Weiya; Carper, Andria; Langfald, Alyssa; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Cho, Yong Yeon; Dong, Zigang] Catholic Univ Korea, Coll Pharm, Puchon, Gyeonggi Do, South Korea	University of Minnesota System; Catholic University of Korea	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	ZHU, Feng/G-3567-2010; peng, cong/A-9454-2012; Cho, Yong-Yeon/AAD-4263-2020; ZHU, Feng/C-1303-2010	Cho, Yong-Yeon/0000-0003-1107-2651; Zhu, Feng/0000-0003-1172-0102	National Institutes of Health [CA120388, R37 CA081064, ES016548]; Hormel Foundation; NATIONAL CANCER INSTITUTE [R01CA120388, R37CA081064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA120388, R37 CA081064, and ES016548. This work was also supported by The Hormel Foundation.	Abe Y, 2000, J BIOL CHEM, V275, P21525, DOI 10.1074/jbc.M909629199; BODE AM, 2003, SCI STKE, pRE2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Cole N, 2010, INT ARCH ALLERGY IMM, V152, P87, DOI 10.1159/000265530; Comes F, 2007, CELL DEATH DIFFER, V14, P693, DOI 10.1038/sj.cdd.4402076; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Gambichler T, 2005, ARCH DERMATOL RES, V297, P218, DOI 10.1007/s00403-005-0604-6; Hildesheim J, 2004, J INVEST DERMATOL, V122, P497, DOI 10.1111/j.1523-1747.2004.22229.x; HRUZA LL, 1993, J INVEST DERMATOL, V100, pS35, DOI 10.1111/1523-1747.ep12355240; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Jin XJ, 2010, J KOREAN MED SCI, V25, P930, DOI 10.3346/jkms.2010.25.6.930; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Lee EJ, 2010, FREE RADICAL BIO MED, V48, P1133, DOI 10.1016/j.freeradbiomed.2010.01.034; LEY RD, 1993, P NATL ACAD SCI USA, V90, P4337, DOI 10.1073/pnas.90.10.4337; Li G, 2006, ANN HEMATOL, V85, P583, DOI 10.1007/s00277-006-0137-x; Li JL, 2007, J BIOMED SCI, V14, P303, DOI 10.1007/s11373-007-9148-4; Li LW, 2009, INT J CLIN EXP MED, V2, P48; Matsumoto S, 2004, BIOCHEM BIOPH RES CO, V325, P997, DOI 10.1016/j.bbrc.2004.10.133; Mendoza RA, 2011, J ENDOCRINOL, V208, P11, DOI 10.1677/JOE-10-0237; Park JH, 2006, CANCER RES, V66, P9186, DOI 10.1158/0008-5472.CAN-06-1601; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Reimold AM, 2001, INT IMMUNOL, V13, P241, DOI 10.1093/intimm/13.2.241; Remy G, 2010, CELL SIGNAL, V22, P660, DOI 10.1016/j.cellsig.2009.11.020; Schieven GL, 2009, CURR TOP MED CHEM, V9, P1038, DOI 10.2174/156802609789630974; Schieven GL, 2005, CURR TOP MED CHEM, V5, P921, DOI 10.2174/1568026054985902; Sgambato A, 2010, EUR REV MED PHARMACO, V14, P263; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Vermeulen L, 2009, TRENDS BIOCHEM SCI, V34, P311, DOI 10.1016/j.tibs.2009.02.007; Vicentini FTMC, 2010, J PHARM PHARM SCI, V13, P274, DOI 10.18433/J3830G; Waas WF, 2001, J BIOL CHEM, V276, P5676, DOI 10.1074/jbc.M008787200; Wang Z, 2006, INVEST OPHTH VIS SCI, V47, P5267, DOI 10.1167/iovs.06-0642; Zhu F, 2007, GASTROENTEROLOGY, V133, P219, DOI 10.1053/j.gastro.2007.04.048; Zykova TA, 2006, CLIN CANCER RES, V12, P6884, DOI 10.1158/1078-0432.CCR-06-0410; Zykova TA, 2010, J BIOL CHEM, V285, P29138, DOI 10.1074/jbc.M110.135905; 1992, IARC MONOGR EVAL CAR, V55, P1	36	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29601	29609		10.1074/jbc.M111.225813	http://dx.doi.org/10.1074/jbc.M111.225813			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21715333	hybrid, Green Published			2022-12-25	WOS:000294046600018
J	Mnatsakanyan, N; Kemboi, SK; Salas, J; Weber, J				Mnatsakanyan, Nelli; Kemboi, Silas K.; Salas, Jasmin; Weber, Joachim			The beta Subunit Loop That Couples Catalysis and Rotation in ATP Synthase Has a Critical Length	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; PROTON MOTIVE FORCE; ESCHERICHIA-COLI; EPSILON-SUBUNIT; FOF1-ATP SYNTHASE; DELSEED MOTIF; F-1-ATPASE; RESOLUTION; HYDROLYSIS; MECHANISM	ATP synthase uses a unique rotational mechanism to convert chemical energy into mechanical energy and back into chemical energy. The helix-turn-helix structure in the C-terminal domain of the beta subunit containing the conserved DELSEED motif, termed "DELSEED-loop," was suggested to be involved in coupling between catalysis and rotation. If this is indeed the role of the loop, it must have a critical length, the minimum length required to sustain its function. Here, the critical length of the DELSEED-loop was determined by functional analysis of mutants of Bacillus PS3 ATP synthase that had 7-14 amino acids within the loop deleted. A 10 residue deletion lost the ability to catalyze ATP synthesis, but was still an active ATPase. Deletion of 14 residues abolished any enzymatic activity. Modeling indicated that in both deletion mutants the DELSEED-loop was shortened by similar to 10 angstrom; fluorescence resonance energy transfer experiments confirmed the modeling results. This appears to define the minimum length for DELSEED-loop required for coupling of catalysis and rotation. In addition, we could demonstrate that the loss of high-affinity binding to the catalytic site(s) that had been observed previously in two deletion mutants with 3-4 residues removed was not due to the loss of negative charged residues of the DELSEED motif in these mutants. An AALSAAA mutant in which all negative charges of the DELSEED motif were removed showed a normal pattern for MgATP binding to the catalytic sites, with a clearly present high-affinity site.	[Weber, Joachim] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; Texas Tech Univ, Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Weber, J (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Box 41061, Lubbock, TX 79409 USA.	joachim.weber@ttuhsc.edu			National Institutes of Health [GM071462]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071462 (including ARRA Administrative Supplement) (to J. W.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2003, METHOD ENZYMOL, V361, P211; Aggeler R, 1996, J BIOL CHEM, V271, P13888, DOI 10.1074/jbc.271.23.13888; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Bulygin VV, 1998, J BIOL CHEM, V273, P31765, DOI 10.1074/jbc.273.48.31765; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; Gao YQ, 2005, CELL, V123, P195, DOI 10.1016/j.cell.2005.10.001; Gao YQ, 2003, P NATL ACAD SCI USA, V100, P11339, DOI 10.1073/pnas.1334188100; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Hara KY, 2001, J BIOL CHEM, V276, P23969, DOI 10.1074/jbc.M009303200; Hara KY, 2000, J BIOL CHEM, V275, P14260, DOI 10.1074/jbc.275.19.14260; HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kato-Yamada Y, 1999, J BIOL CHEM, V274, P33991, DOI 10.1074/jbc.274.48.33991; Ketchum CJ, 1998, BIOCHEM J, V330, P707; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; Kobayashi M, 2010, J MOL BIOL, V398, P189, DOI 10.1016/j.jmb.2010.03.013; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; MATSUI T, 1995, BBA-BIOENERGETICS, V1231, P139, DOI 10.1016/0005-2728(95)00070-Y; MATSUMOTO S, 1975, BIOCHEMISTRY-US, V14, P214, DOI 10.1021/bi00673a004; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P26519, DOI 10.1074/jbc.M109.030528; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P11336, DOI 10.1074/jbc.M900374200; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; NOJI H, 2001, FEBS LETT, V276, P61; Pu JZ, 2008, P NATL ACAD SCI USA, V105, P1192, DOI 10.1073/pnas.0708746105; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; Scanlon JAB, 2008, J BIOL CHEM, V283, P26228, DOI 10.1074/jbc.M804858200; SENIOR AE, 1984, ARCH BIOCHEM BIOPHYS, V228, P49, DOI 10.1016/0003-9861(84)90045-6; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; SZABO AG, 1980, J AM CHEM SOC, V102, P554, DOI 10.1021/ja00522a020; Vinogradov AD, 2000, J EXP BIOL, V203, P41; WATANABE T, 1982, BIOCHEMISTRY-US, V21, P3245; Weber J, 2004, METHOD ENZYMOL, V380, P132; WEBER J, 1993, J BIOL CHEM, V268, P20126; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Yagi H, 2004, J AM CHEM SOC, V126, P16632, DOI 10.1021/ja045279o; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; Yagi H, 2009, J BIOL CHEM, V284, P2374, DOI 10.1074/jbc.M808212200; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	48	17	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29788	29796		10.1074/jbc.M111.254730	http://dx.doi.org/10.1074/jbc.M111.254730			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21705326	hybrid, Green Published			2022-12-25	WOS:000294046600038
J	Brailoiu, GC; Oprea, TI; Zhao, PW; Abood, ME; Brailoiu, E				Brailoiu, G. Cristina; Oprea, Tudor I.; Zhao, Pingwei; Abood, Mary E.; Brailoiu, Eugen			Intracellular Cannabinoid Type 1 (CB1) Receptors Are Activated by Anandamide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; MOBILIZES CALCIUM; CA2+ RELEASE; NAADP; CELLS; TRAFFICKING; STORES; ENDOCYTOSIS; MECHANISMS; ORGANELLES	Recent studies have demonstrated that the majority of endogenous cannabinoid type 1 (CB1) receptors do not reach the cell surface but are instead associated with endosomal and lysosomal compartments. Using calcium imaging and intracellular microinjection in CB1 receptor-transfected HEK293 cells and NG108-15 neuroblastoma x glioma cells, we provide evidence that anandamide acting on CB1 receptors increases intracellular calcium concentration when administered intracellularly but not extracellularly. The calcium-mobilizing effect of intracellular anandamide was dose-dependent and abolished by pretreatment with SR141716A, a CB1 receptor antagonist. The anandamide-induced calcium increase was reduced by blocking nicotinic acid-adenine dinucleotide phosphate-or inositol 1,4,5-trisphosphate-dependent calcium release and abolished when both lysosomal and endoplasmic reticulum calcium release pathways were blocked. Taken together, our results indicate that, in CB1 receptor-transfected HEK293 cells, intracellular CB1 receptors are functional; they are located in acid-filled calcium stores (endolysosomes). Activation of intracellular CB1 receptors releases calcium from endoplasmic reticulum and lysosomal calcium stores. In addition, our results support a novel role for nicotinic acid-adenine dinucleotide phosphate in cannabinoid-induced calcium signaling.	[Zhao, Pingwei; Abood, Mary E.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; [Brailoiu, G. Cristina; Brailoiu, Eugen] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Zhao, Pingwei; Abood, Mary E.] Temple Univ, Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA; [Oprea, Tudor I.] Univ New Mexico, Sch Med, Div Biocomp, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of New Mexico	Abood, ME (corresponding author), Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA.	mabood@temple.edu; ebrailou@temple.edu	Oprea, Tudor I/A-5746-2011	Oprea, Tudor I/0000-0002-6195-6976; Abood, Mary/0000-0002-1744-2820	National Institutes of Health [HL90804, DA023204, DA05274]; Sunset Molecular Discovery (Santa Fe, NM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023204, P50DA005274] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sunset Molecular Discovery (Santa Fe, NM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants HL90804 (to E. B.), and DA023204 and DA05274 (to M. E. A.). This work was also supported by a donation from Sunset Molecular Discovery (Santa Fe, NM).	Aoyama M, 2004, J CELL SCI, V117, P2813, DOI 10.1242/jcs.01136; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Boittin FX, 2002, CIRC RES, V91, P1168, DOI 10.1161/01.RES.0000047507.22487.85; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brailoiu E, 1999, BRIT J PHARMACOL, V126, P1133, DOI 10.1038/sj.bjp.0702421; Brailoiu E, 2005, J BIOL CHEM, V280, P5646, DOI 10.1074/jbc.M408746200; Brailoiu E, 2001, MOL PHARMACOL, V60, P718; Brailoiu E, 2006, J BIOL CHEM, V281, P15923, DOI 10.1074/jbc.M602249200; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Brailoiu GC, 2009, BIOCHEM J, V419, P91, DOI 10.1042/BJ20081138; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; CAULFIELD MP, 1992, TEST, V106, P231; Chameau P, 2001, PFLUG ARCH EUR J PHY, V443, P289, DOI 10.1007/s004240100691; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; FELDER CC, 1992, MOL PHARMACOL, V42, P838; FELDER CC, 1993, P NATL ACAD SCI USA, V90, P7656, DOI 10.1073/pnas.90.16.7656; Galione A, 2009, PFLUG ARCH EUR J PHY, V458, P869, DOI 10.1007/s00424-009-0682-y; Grimsey NL, 2010, BIOCHEM PHARMACOL, V80, P1050, DOI 10.1016/j.bcp.2010.06.007; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Ho BY, 1996, NEUROSCI LETT, V212, P123, DOI 10.1016/0304-3940(96)12792-0; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; Lauckner JE, 2005, P NATL ACAD SCI USA, V102, P19144, DOI 10.1073/pnas.0509588102; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Leterrier C, 2006, J NEUROSCI, V26, P3141, DOI 10.1523/JNEUROSCI.5437-05.2006; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; MACKIE K, 1992, P NATL ACAD SCI USA, V89, P3825, DOI 10.1073/pnas.89.9.3825; McDonald NA, 2007, MOL PHARMACOL, V71, P976, DOI 10.1124/mol.106.029348; McIntosh HH, 1998, MOL BRAIN RES, V53, P163, DOI 10.1016/S0169-328X(97)00294-5; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Pickel VM, 2004, NEUROSCIENCE, V127, P101, DOI 10.1016/j.neuroscience.2004.05.015; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Re RN, 2007, NAT CLIN PRACT CARD, V4, P549, DOI 10.1038/ncpcardio0985; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Rozenfeld R, 2008, FASEB J, V22, P2311, DOI 10.1096/fj.07-102731; Rozenfeld R, 2011, TRAFFIC, V12, P12, DOI 10.1111/j.1600-0854.2010.01130.x; Santella L, 2000, J BIOL CHEM, V275, P8301, DOI 10.1074/jbc.275.12.8301; Scavone JL, 2010, BRAIN RES, V1312, P18, DOI 10.1016/j.brainres.2009.11.023; Schachter JB, 1997, NEUROPHARMACOLOGY, V36, P1181, DOI 10.1016/S0028-3908(97)00138-X; STYRT B, 1988, BIOCHEM BIOPH RES CO, V154, P1308, DOI 10.1016/0006-291X(88)90282-3; Tao Q, 1998, J PHARMACOL EXP THER, V285, P651; Zhang F, 2006, AM J PHYSIOL-HEART C, V291, pH274, DOI 10.1152/ajpheart.01064.2005; Zhang F, 2010, AM J PHYSIOL-CELL PH, V298, pC1209, DOI 10.1152/ajpcell.00533.2009	49	71	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29166	29174		10.1074/jbc.M110.217463	http://dx.doi.org/10.1074/jbc.M110.217463			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21719698	Green Published, hybrid			2022-12-25	WOS:000293837000053
J	Li, J; Hoop, CL; Kodali, R; Sivanandam, VN; van der Wel, PCA				Li, Jun; Hoop, Cody L.; Kodali, Ravindra; Sivanandam, V. N.; van der Wel, Patrick C. A.			Amyloid-like Fibrils from a Domain-swapping Protein Feature a Parallel, in-Register Conformation without Native-like Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SHEET STRUCTURE; HUMAN PRION PROTEIN; HUMAN CYSTATIN-C; SOLID-STATE NMR; ANGLE-SPINNING NMR; CHEMICAL-SHIFTS; FORM PRIONS; BETA(2)-MICROGLOBULIN; GB1; DIMERIZATION	The formation of amyloid-like fibrils is characteristic of various diseases, but the underlying mechanism and the factors that determine whether, when, and how proteins form amyloid, remain uncertain. Certain mechanisms have been proposed based on the three-dimensional or runaway domain swapping, inspired by the fact that some proteins show an apparent correlation between the ability to form domain-swapped dimers and a tendency to form fibrillar aggregates. Intramolecular beta-sheet contacts present in the monomeric state could constitute intermolecular beta-sheets in the dimeric and fibrillar states. One example is an amyloid-forming mutant of the immunoglobulin binding domain B1 of streptococcal protein G, which in its native conformation consists of a four-stranded beta-sheet and one alpha-helix. Under native conditions this mutant adopts a domain-swapped dimer, and it also forms amyloid-like fibrils, seemingly in correlation to its domain-swapping ability. We employ magic angle spinning solid-state NMR and other methods to examine key structural features of these fibrils. Our results reveal a highly rigid fibril structure that lacks mobile domains and indicate a parallel in-register beta-sheet structure and a general loss of native conformation within the mature fibrils. This observation contrasts with predictions that native structure, and in particular intermolecular beta-strand interactions seen in the dimeric state, may be preserved in "domain-swapping" fibrils. We discuss these observations in light of recent work on related amyloid-forming proteins that have been argued to follow similar mechanisms and how this may have implications for the role of domain-swapping propensities for amyloid formation.	[Li, Jun; Hoop, Cody L.; Kodali, Ravindra; Sivanandam, V. N.; van der Wel, Patrick C. A.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	van der Wel, PCA (corresponding author), 3501 5th Ave,BST3 2044, Pittsburgh, PA 15260 USA.	pvdwel@pitt.edu	li, jun/A-1197-2011; van der Wel, Patrick C.A./B-1428-2009	van der Wel, Patrick C.A./0000-0002-5390-3321; Hoop, Cody/0000-0003-4441-8321	National Center for Research Resources [UL1 RR024153]; University of Pittsburgh; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Pittsburgh(University of Pittsburgh); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Center for Research Resources (Grant UL1 RR024153) and startup funds from the University of Pittsburgh.	Abedini A, 2009, PROTEIN ENG DES SEL, V22, P453, DOI 10.1093/protein/gzp036; Alexandrescu AT, 2001, PAC S BIOCOMPUT, V6, P67; Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Byeon IJL, 2004, J MOL BIOL, V340, P615, DOI 10.1016/j.jmb.2004.04.069; Byeon IJL, 2003, J MOL BIOL, V333, P141, DOI 10.1016/S0022-2836(03)00928-8; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Debelouchina GT, 2010, J AM CHEM SOC, V132, P17077, DOI 10.1021/ja107987f; Debelouchina GT, 2010, J AM CHEM SOC, V132, P10414, DOI 10.1021/ja102775u; Domanska K, 2011, P NATL ACAD SCI USA, V108, P1314, DOI 10.1073/pnas.1008560108; Eakin CM, 2005, BBA-PROTEINS PROTEOM, V1753, P92, DOI 10.1016/j.bbapap.2005.09.002; Eisenberg D, 2006, ACCOUNTS CHEM RES, V39, P568, DOI 10.1021/ar0500618; Fandrich M, 2009, PRION, V3, P89; Franks WT, 2005, J AM CHEM SOC, V127, P12291, DOI 10.1021/ja044497e; Guo ZF, 2006, P NATL ACAD SCI USA, V103, P8042, DOI 10.1073/pnas.0602607103; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Hoshino M, 2007, BBA-BIOMEMBRANES, V1768, P1886, DOI 10.1016/j.bbamem.2007.03.001; Iwata K, 2006, P NATL ACAD SCI USA, V103, P18119, DOI 10.1073/pnas.0607180103; Janowski R, 2005, PROTEINS, V61, P570, DOI 10.1002/prot.20633; Janowski R, 2004, J MOL BIOL, V341, P151, DOI 10.1016/j.jmb.2004.06.013; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Jee J, 2008, PROTEINS, V71, P1420, DOI 10.1002/prot.21831; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Ladner CL, 2010, J BIOL CHEM, V285, P17137, DOI 10.1074/jbc.M110.117234; Laidman J, 2006, ACCOUNTS CHEM RES, V39, P576, DOI 10.1021/ar050017s; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Liu G, 2010, J AM CHEM SOC, V132, P18223, DOI 10.1021/ja1069882; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; Loquet A, 2009, J MOL BIOL, V394, P108, DOI 10.1016/j.jmb.2009.09.016; Louis JM, 2005, J MOL BIOL, V348, P687, DOI 10.1016/j.jmb.2005.02.071; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; Nilsson M, 2004, J BIOL CHEM, V279, P24236, DOI 10.1074/jbc.M402621200; Olofsson A, 2004, J BIOL CHEM, V279, P5699, DOI 10.1074/jbc.M310605200; Ramirez-Alvarado M, 2003, PROTEIN SCI, V12, P567, DOI 10.1110/ps.0227403; Ramirez-Alvarado M, 2002, J MOL BIOL, V323, P17, DOI 10.1016/S0022-2836(02)00840-9; Ramirez-Alvarado M, 2000, P NATL ACAD SCI USA, V97, P8979, DOI 10.1073/pnas.150091797; Robustelli P, 2008, STRUCTURE, V16, P1764, DOI 10.1016/j.str.2008.10.016; Rodziewicz-Motowidlo S, 2006, J STRUCT BIOL, V154, P68, DOI 10.1016/j.jsb.2005.11.015; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Rousseau F, 2006, J MOL BIOL, V363, P496, DOI 10.1016/j.jmb.2006.07.061; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Sasahara K, 2008, BIOCHEMISTRY-US, V47, P2650, DOI 10.1021/bi701968g; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shewmaker F, 2008, BIOCHEMISTRY-US, V47, P4000, DOI 10.1021/bi7024589; Shewmaker F, 2009, J BIOL CHEM, V284, P25065, DOI 10.1074/jbc.M109.007054; Shewmaker F, 2009, BIOCHEMISTRY-US, V48, P5074, DOI 10.1021/bi900345q; Sicorello A, 2009, BIOPHYS J, V96, P2289, DOI 10.1016/j.bpj.2008.11.042; Sivanandam VN, 2011, J AM CHEM SOC, V133, P4558, DOI 10.1021/ja110715f; SMITH CK, 1994, BIOCHEMISTRY-US, V33, P5510, DOI 10.1021/bi00184a020; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tycko R, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2437194; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Ventura S, 2002, J MOL BIOL, V322, P1147, DOI 10.1016/S0022-2836(02)00783-0; Veshtort M, 2006, J MAGN RESON, V178, P248, DOI 10.1016/j.jmr.2005.07.018; Walsh P, 2009, STRUCTURE, V17, P417, DOI 10.1016/j.str.2008.12.018; Wang JM, 2005, STRUCTURE, V13, P1279, DOI 10.1016/j.str.2005.06.010; Weingarth M, 2009, J AM CHEM SOC, V131, P13937, DOI 10.1021/ja9036143; Weingarth M, 2009, CHEM PHYS LETT, V469, P342, DOI 10.1016/j.cplett.2008.12.084; Wickner RB, 2008, P NATL ACAD SCI USA, V105, P2403, DOI 10.1073/pnas.0712032105; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yang SC, 2005, FASEB J, V19, P1778, DOI 10.1096/fj.05-4067hyp; ZHANG YZ, 1995, PROTEIN SCI, V4, P804	68	26	26	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28988	28995		10.1074/jbc.M111.261750	http://dx.doi.org/10.1074/jbc.M111.261750			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21715337	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000293837000035
J	Morato-Marques, M; Campos, MR; Kane, S; Rangel, AP; Lewis, C; Ballinger, MN; Kim, SH; Peters-Golden, M; Jancar, S; Serezani, CH				Morato-Marques, Mariana; Campos, Marina R.; Kane, Steve; Rangel, Ana P.; Lewis, Casey; Ballinger, Megan N.; Kim, Sang-Hoon; Peters-Golden, Marc; Jancar, Sonia; Serezani, Carlos H.			Leukotrienes Target F-actin/Cofilin-1 to Enhance Alveolar Macrophage Anti-fungal Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE CASCADE; CANDIDA-ALBICANS; NADPH OXIDASE; HOST-DEFENSE; 5-LIPOXYGENASE METABOLISM; DEPENDENT PHAGOCYTOSIS; REGULATES PHAGOCYTOSIS; KLEBSIELLA-PNEUMONIAE; MURINE MACROPHAGES; BLOOD MONOCYTES	Candida albicans is the most common opportunistic fungal pathogen and causes local and systemic disease in immunocompromised patients. Alveolar macrophages (AMs) are pivotal for the clearance of C. albicans from the lung. Activated AMs secrete 5-lipoxygenase-derived leukotrienes (LTs), which in turn enhance phagocytosis and microbicidal activity against a diverse array of pathogens. Our aim was to investigate the role of LTB4 and LTD4 in AM antimicrobial functions against C. albicans and the signaling pathways involved. Pharmacologic and genetic inhibition of LT biosynthesis as well as receptor antagonism reduced phagocytosis of C. albicans when compared with untreated or WT controls. Conversely, exogenous LTs of both classes augmented base-line C. albicans phagocytosis by AMs. Although LTB4 enhanced mainly mannose receptor-dependent fungal ingestion, LTD4 enhanced mainly dectin-1 receptor-mediated phagocytosis. LT enhancement of yeast ingestion was dependent on protein kinase C-delta (PKC delta) and PI3K but not PKC alpha and MAPK activation. Both LTs reduced activation of cofilin-1, whereas they enhanced total cellular F-actin; however, LTB4 accomplished this through the activation of LIM kinases (LIMKs) 1 and 2, whereas LTD4 did so exclusively via LIMK-2. Finally, both exogenous LTB4 and LTD4 enhanced AM fungicidal activity in an NADPH oxidase-dependent manner. Our data identify LTB4 and LTD4 as key mediators of innate immunity against C. albicans, which act by both distinct and conserved signaling mechanisms to enhance multiple antimicrobial functions of AMs.	[Kane, Steve; Lewis, Casey; Ballinger, Megan N.; Peters-Golden, Marc; Serezani, Carlos H.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Sch Med, Ann Arbor, MI 48109 USA; [Morato-Marques, Mariana; Campos, Marina R.; Rangel, Ana P.; Jancar, Sonia] Univ Sao Paulo, Inst Biomed Sci 4, Dept Immunol, BR-05508900 Sao Paulo, Brazil; [Kim, Sang-Hoon] Eulji Univ, Sch Med, Dept Internal Med, Div Allergy & Resp Med, Seoul 139711, South Korea	University of Michigan System; University of Michigan; Universidade de Sao Paulo; Eulji University	Serezani, CH (corresponding author), Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Sch Med, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	cserezan@med.umich.edu	Connor, Toni R/C-6964-2012; Jancar, Sonia/C-5153-2012; serezani, C. Henrique/H-1675-2013	Jancar, Sonia/0000-0001-7983-3459; Ballinger, Megan/0000-0002-2202-3049; serezani, C. Henrique/0000-0002-5363-415X	National Institutes of Health [HL-058897, HL-103777-01]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL103777, R56HL058897, R01HL058897, K99HL103777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-058897 (to M. P.-G.) and HL-103777-01 (C. H. S.). This work was also supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior.	Adachi R, 2002, J BIOL CHEM, V277, P45566, DOI 10.1074/jbc.M207419200; Allen LAH, 1996, CURR OPIN IMMUNOL, V8, P36, DOI 10.1016/S0952-7915(96)80102-6; Allen LAH, 2005, J LEUKOCYTE BIOL, V78, P220, DOI 10.1189/jlb.0205091; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Bailie MB, 1996, J IMMUNOL, V157, P5221; Balestrieri B, 2006, J BIOL CHEM, V281, P6691, DOI 10.1074/jbc.M508314200; Balestrieri B, 2009, J IMMUNOL, V182, P4891, DOI 10.4049/jimmunol.0803776; BALTER MS, 1989, J IMMUNOL, V142, P602; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Bierne H, 2001, J CELL BIOL, V155, P101, DOI 10.1083/jcb.200104037; Campos MRM, 2009, MOL IMMUNOL, V46, P1204, DOI 10.1016/j.molimm.2008.11.024; Canetti C, 2003, BLOOD, V102, P1877, DOI 10.1182/blood-2003-02-0534; Canetti C, 2007, J IMMUNOL, V179, P8350, DOI 10.4049/jimmunol.179.12.8350; Canetti C, 2006, J LEUKOCYTE BIOL, V79, P1234, DOI 10.1189/jlb.0705374; CASTRO M, 1994, INFECT IMMUN, V62, P3138, DOI 10.1128/IAI.62.8.3138-3145.1994; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; Chung J, 2008, J IMMUNOL, V181, P5501, DOI 10.4049/jimmunol.181.8.5501; Coffey MJ, 1998, J CLIN INVEST, V102, P663, DOI 10.1172/JCI2117; Coffey MJ, 1996, J IMMUNOL, V157, P393; Coffey MJ, 2004, PROSTAG LEUKOTR ESS, V71, P185, DOI 10.1016/j.plefa.2004.03.012; Coffey MJ, 1999, BLOOD, V94, P3897, DOI 10.1182/blood.V94.11.3897.423k12_3897_3905; Costa MFD, 2010, J LEUKOCYTE BIOL, V87, P323, DOI 10.1189/jlb.0809563; Dictar MO, 2000, MED MYCOL, V38, P251, DOI 10.1080/mmy.38.s1.251.258; Donini M, 2007, EUR J IMMUNOL, V37, P1194, DOI 10.1002/eji.200636532; Duarte-Escalante E, 2003, ARCH MED RES, V34, P176, DOI 10.1016/S0188-4409(03)00044-4; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Evans Scott E, 2010, Proc Am Thorac Soc, V7, P197, DOI 10.1513/pats.200907-075AL; Flamand L, 2007, J IMMUNOL, V178, P8036, DOI 10.4049/jimmunol.178.12.8036; Gales A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000714; Gaudreault E, 2007, VIRAL IMMUNOL, V20, P407, DOI 10.1089/vim.2006.0099; Gillooly DJ, 2001, J CELL BIOL, V155, P15, DOI 10.1083/jcb.200109001; Giraldo E, 2010, MOL CELL BIOCHEM, V333, P115, DOI 10.1007/s11010-009-0211-5; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; HO NK, 1984, AUST PAEDIATR J, V20, P127; Hoover DM, 2002, J BIOL CHEM, V277, P37647, DOI 10.1074/jbc.M203907200; Hu B, 2002, J LEUKOCYTE BIOL, V71, P881; Ibata-Ombetta S, 2001, J LEUKOCYTE BIOL, V70, P149; JAKAB GJ, 1981, INFECT IMMUN, V34, P610, DOI 10.1128/IAI.34.2.610-622.1981; Kaposzta R, 1999, J CELL SCI, V112, P3237; Kilpatrick LE, 2010, J LEUKOCYTE BIOL, V87, P153, DOI 10.1189/jlb.0408230; KYRIAZIS AP, 1993, DIAGN CYTOPATHOL, V9, P487, DOI 10.1002/dc.2840090503; Lee C, 2005, J LEUKOCYTE BIOL, V78, P1016, DOI 10.1189/jlb.0105056; Lee S, 2004, J BIOL CHEM, V279, P1885, DOI 10.1074/jbc.M306968200; Lee SP, 2009, J IMMUNOL, V182, P530, DOI 10.4049/jimmunol.182.1.530; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Linden JR, 2010, MED MYCOL, V48, P355, DOI [10.1080/13693780903164566, 10.3109/13693780903164566]; Lynch KR, 1999, NATURE, V399, P789; Mancuso P, 1998, INFECT IMMUN, V66, P5140, DOI 10.1128/IAI.66.11.5140-5146.1998; Mancuso P, 2010, INFECT IMMUN, V78, P2264, DOI 10.1128/IAI.01323-09; Massoumi R, 1998, EUR J CELL BIOL, V76, P185, DOI 10.1016/S0171-9335(98)80033-2; Medeiros AI, 2004, INFECT IMMUN, V72, P1637, DOI 10.1128/IAI.72.3.1637-1644.2004; Monget P, 2002, DOMEST ANIM ENDOCRIN, V23, P139, DOI 10.1016/S0739-7240(02)00152-2; Morre DJ, 2002, ANTIOXID REDOX SIGN, V4, P207, DOI 10.1089/152308602753625960; Mugnai S, 1997, BRIT J PHARMACOL, V122, P1345, DOI 10.1038/sj.bjp.0701521; Netea MG, 2010, TRENDS IMMUNOL, V31, P346, DOI 10.1016/j.it.2010.06.007; Okamoto F, 2010, J BIOL CHEM, V285, P41113, DOI 10.1074/jbc.M110.175497; OMANN GM, 1987, J IMMUNOL, V138, P2626; Parti RP, 2010, AM J RESP CELL MOL, V42, P415, DOI 10.1165/rcmb.2009-0110OC; Peres CM, 2007, J IMMUNOL, V179, P5454, DOI 10.4049/jimmunol.179.8.5454; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; SAWYER RT, 1990, MYCOPATHOLOGIA, V109, P99, DOI 10.1007/BF00436790; Schindler B, 2008, MED MYCOL, V46, P251, DOI 10.1080/13693780701837157; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; Serezani CH, 2006, J IMMUNOL, V177, P3201, DOI 10.4049/jimmunol.177.5.3201; Serezani CH, 2009, BLOOD, V114, P3316, DOI 10.1182/blood-2009-01-199919; Serezani CHC, 2005, J LEUKOCYTE BIOL, V78, P976, DOI 10.1189/jlb.1004587; Serezani CHC, 2005, BLOOD, V106, P1067, DOI 10.1182/blood-2004-08-3323; SKERRETT SJ, 1990, J IMMUNOL, V144, P1052; Smacchia C, 1997, HAEMATOLOGICA, V82, P526; Smallwood ND, 2005, AM J PHYSIOL-CELL PH, V288, pC906, DOI 10.1152/ajpcell.00484.2004; STENKE L, 1987, EXP HEMATOL, V15, P203; Suram S, 2010, J BIOL CHEM, V285, P30676, DOI 10.1074/jbc.M110.143800; Takao S, 1996, AM J PHYSIOL-CELL PH, V271, pC1278, DOI 10.1152/ajpcell.1996.271.4.C1278; THORSEN S, 1989, AIDS, V3, P651, DOI 10.1097/00002030-198910000-00006; VazquezTorres A, 1997, MICROBIOL MOL BIOL R, V61, P170; Virgili Annarosa, 2002, Am J Clin Dermatol, V3, P19, DOI 10.2165/00128071-200203010-00003; Waki K, 2006, FREE RADICAL RES, V40, P359, DOI 10.1080/10715760500539121; Yao ZR, 2006, CURR OPIN PULM MED, V12, P222, DOI 10.1097/01.mcp.0000219272.57933.01; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	81	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28902	28913		10.1074/jbc.M111.235309	http://dx.doi.org/10.1074/jbc.M111.235309			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21715328	Green Published, hybrid			2022-12-25	WOS:000293837000027
J	Yeh, YY; Shah, KH; Herman, PK				Yeh, Yuh-Ying; Shah, Khyati H.; Herman, Paul K.			An Atg13 Protein-mediated Self-association of the Atg1 Protein Kinase Is Important for the Induction of Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION-LOOP AUTOPHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; PHOSPHORYLATION; COMPLEX; YEAST; MACHINERY; MECHANISM; DISEASE; SITES; TOR	Autophagy pathways in eukaryotic cells mediate the turnover of a diverse set of cytoplasmic components, including damaged organelles and abnormal protein aggregates. Autophagy-mediated degradation is highly regulated, and defects in these pathways have been linked to a number of human disorders. The Atg1 protein kinase appears to be a key site of this control and is targeted by multiple signaling pathways to ensure the appropriate autophagic response to changing environmental conditions. Despite the importance of this kinase, relatively little is known about the molecular details of Atg1 activation. In this study we show that Atg13, an evolutionarily conserved regulator of Atg1, promotes the formation of a specific Atg1 self-interaction in the budding yeast, Saccharomyces cerevisiae. The appearance of this Atg1-Atg1 complex is correlated with the induction of autophagy, and conditions that disrupt this complex result in diminished levels of both autophagy and Atg1 kinase activity. Moreover, the addition of a heterologous dimerization domain to Atg1 resulted in elevated kinase activity both in vivo and in vitro. The formation of this complex appears to be an important prerequisite for the subsequent autophosphorylation of Thr-226 in the Atg1 activation loop. Previous work indicates that this modification is necessary and perhaps sufficient for Atg1 kinase activity. Interestingly, this Atg1 self-association does not require Atg17, suggesting that this second conserved regulator might activate Atg1 in a manner mechanistically distinct from that of Atg13. In all, this work suggests a model whereby this self-association stimulates the autophosphorylation of Atg1 within its activation loop.	[Yeh, Yuh-Ying; Shah, Khyati H.; Herman, Paul K.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Yeh, Yuh-Ying; Herman, Paul K.] Ohio State Univ, Program Mol Cellular & Dev Biol, Columbus, OH 43210 USA; [Shah, Khyati H.; Herman, Paul K.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Herman, PK (corresponding author), Ohio State Univ, Dept Mol Genet, 484 W 12th Ave,Rm 112, Columbus, OH 43210 USA.	herman.81@osu.edu			National Institutes of Health [GM65227]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM65227 (to P. K. H.).	Abeliovich H, 2003, MOL BIOL CELL, V14, P477, DOI 10.1091/mbc.E02-07-0413; Baba M, 1995, CELL STRUCT FUNCT, V20, P465, DOI 10.1247/csf.20.465; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Cebollero E, 2009, BBA-MOL CELL RES, V1793, P1413, DOI 10.1016/j.bbamcr.2009.01.008; Chan EY, 2009, AUTOPHAGY, V5, P758, DOI 10.4161/auto.8709; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Chang YW, 2001, GENETICS, V157, P17; Cheong H, 2005, MOL BIOL CELL, V16, P3438, DOI 10.1091/mbc.E04-10-0894; Deminoff SJ, 2009, GENETICS, V182, P529, DOI 10.1534/genetics.109.102178; Deretic V, 2010, CURR OPIN CELL BIOL, V22, P252, DOI 10.1016/j.ceb.2009.12.009; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.e04-08-0669; Kaiser C. S., 1994, METHODS YEAST GENETI, P207; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kijanska M, 2010, AUTOPHAGY, V6, P1168, DOI 10.4161/auto.6.8.13849; Kim J, 2002, J BIOL CHEM, V277, P763, DOI 10.1074/jbc.M109134200; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 2008, METHOD ENZYMOL, V451, P33, DOI 10.1016/S0076-6879(08)03203-5; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Rieker JD, 2000, METHOD ENZYMOL, V328, P282, DOI 10.1016/S0076-6879(00)28403-6; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Stephan JS, 2006, AUTOPHAGY, V2, P146, DOI 10.4161/auto.2.2.2485; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; Todde V, 2009, BBA-MOL BASIS DIS, V1792, P3, DOI 10.1016/j.bbadis.2008.10.016; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Winslow AR, 2008, BBA-MOL BASIS DIS, V1782, P723, DOI 10.1016/j.bbadis.2008.06.010; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yeh YY, 2011, AUTOPHAGY, V7, P716, DOI 10.4161/auto.7.7.15155; Yeh YY, 2010, GENETICS, V185, P871, DOI 10.1534/genetics.110.116566	53	40	46	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28931	28939		10.1074/jbc.M111.250324	http://dx.doi.org/10.1074/jbc.M111.250324			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21712380	Green Published, hybrid			2022-12-25	WOS:000293837000030
J	Chen, J; Jia, ZY; Ma, ZL; Wang, YY; Teng, GJ				Chen, Jun; Jia, Zhen-Yu; Ma, Zhan-Long; Wang, Yuan-Yuan; Teng, Gao-Jun			In Vivo Serial MR Imaging of Magnetically Labeled Endothelial Progenitor Cells Homing to the Endothelium Injured Artery in Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; IRON-OXIDE NANOPARTICLES; CAROTID-ARTERY; NEOINTIMAL HYPERPLASIA; ATHEROSCLEROSIS; MOUSE; TRANSPLANTATION; ANGIOGENESIS; TRAFFICKING; MICROSCOPY	Background: Emerging evidence of histopathological analyses suggests that endothelial progenitor cells (EPCs) play an important role in vascular diseases. Neointimal hyperplasia can be reduced by intravenous transfusion of EPCs after vascular injury in mice. Therefore, it would be advantageous to develop an in vivo technique that can explore the temporal and spatial migration of EPCs homing to the damaged endothelium noninvasively. Methodology/Principal Findings: The left carotid common artery (LCCA) was injured by removal of endothelium with a flexible wire in Kunming mice. EPCs were collected by in vitro culture of spleen-derived mouse mononuclear cells (MNCs). EPCs labeling was carried out in vitro using Fe2O3-poly-L-lysine (Fe2O3-PLL). In vivo serial MR imaging was performed to follow-up the injured artery at different time points after intravenous transfusion of EPCs. Vessel wall areas of injured artery were computed on T2WI. Larger MR signal voids of vessel wall on T2WI was revealed in all 6 mice of the labeled EPC transfusion group 15 days after LCCA injury, and it was found only in 1 mouse in the unlabeled EPC transfusion group (p = 0.015). Quantitative analyses of vessel wall areas on T2WI showed that the vessel wall areas of labeled EPC transfusion group were less than those of unlabeled EPC transfusion group and control group fifteen days after artery injury (p < 0.05). Histopathological analyses confirmed accumulation and distribution of transfused EPCs at the injury site of LCCA. Conclusions/Significance: These data indicate that MR imaging might be used as an in vivo method for the tracking of EPCs homing to the endothelium injured artery.	[Chen, Jun; Jia, Zhen-Yu; Ma, Zhan-Long; Wang, Yuan-Yuan; Teng, Gao-Jun] Southeast Univ, Jiangsu Key Lab Mol Imaging & Funct Imaging, Dept Radiol, Zhongda Hosp, Nanjing, Peoples R China	Southeast University - China	Chen, J (corresponding author), Southeast Univ, Jiangsu Key Lab Mol Imaging & Funct Imaging, Dept Radiol, Zhongda Hosp, Nanjing, Peoples R China.	gjteng@vip.sina.com			National Nature Science Foundation of China [90606007, 30910103905]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by National Nature Science Foundation of China (Grant number: 90606007,30910103905). URL: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbab AS, 2006, STEM CELLS, V24, P671, DOI 10.1634/stemcells.2005-0017; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bergeron P, 2005, J VASC SURG, V41, P213, DOI 10.1016/j.jvs.2004.11.037; Chen J, 2011, J NEUROIMAGING, V21, P49, DOI 10.1111/j.1552-6569.2010.00490.x; Choudhury RP, 2003, J MAGN RESON IMAGING, V17, P184, DOI 10.1002/jmri.10246; FERRUCCI JT, 1990, AM J ROENTGENOL, V155, P943, DOI 10.2214/ajr.155.5.2120963; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Griese DP, 2003, CIRCULATION, V108, P2710, DOI 10.1161/01.CIR.0000096490.16596.A6; Groschel K, 2009, STROKE, V40, pE340, DOI 10.1161/STROKEAHA.108.532713; Jia Zhen-Yu, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P166; Ju SH, 2007, RADIOLOGY, V245, P206, DOI 10.1148/radiol.2443061290; Ju SH, 2006, MAGN RESON IMAGING, V24, P611, DOI 10.1016/j.mri.2005.12.017; Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048; Kong D, 2004, CIRCULATION, V109, P1769, DOI 10.1161/01.CIR.0000121732.85572.6F; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; LINDNER V, 1993, CIRC RES, V73, P792, DOI 10.1161/01.RES.73.5.792; Litovsky S, 2003, CIRCULATION, V107, P1545, DOI 10.1161/01.CIR.0000055323.57885.88; Liu W, 2009, EUR J RADIOL, V70, P258, DOI 10.1016/j.ejrad.2008.09.021; Ma ZL, 2008, EUR RADIOL, V18, P2174, DOI 10.1007/s00330-008-0978-x; Ma ZL, 2009, ATHEROSCLEROSIS, V205, P80, DOI 10.1016/j.atherosclerosis.2008.07.048; Mai XL, 2009, CELL TRANSPLANT, V18, P171, DOI 10.3727/096368909788341306; Manka DR, 2000, J MAGN RESON IMAGING, V12, P790, DOI 10.1002/1522-2586(200011)12:5<790::AID-JMRI19>3.0.CO;2-6; POULIQUEN D, 1991, MAGN RESON IMAGING, V9, P275, DOI 10.1016/0730-725X(91)90412-F; Qiu BS, 2007, J MAGN RESON IMAGING, V26, P339, DOI 10.1002/jmri.21016; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Shapiro EM, 2006, MAGN RESON MED, V55, P242, DOI 10.1002/mrm.20718; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Sun JH, 2008, CELL TRANSPLANT, V17, P279, DOI 10.3727/096368908784153878; Werner N, 2006, J CELL MOL MED, V10, P318, DOI 10.1111/j.1582-4934.2006.tb00402.x; Werner N, 2003, CIRC RES, V93, pE17, DOI 10.1161/01.RES.0000083812.30141.74; Werner N, 2007, ANN MED, V39, P82, DOI 10.1080/07853890601073429; Yocum GT, 2005, RADIOLOGY, V235, P547, DOI 10.1148/radiol.2352040383; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081	34	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e20790	10.1371/journal.pone.0020790	http://dx.doi.org/10.1371/journal.pone.0020790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731624	Green Published, Green Submitted, gold			2022-12-25	WOS:000292036900005
J	Stouffer, PC; Johnson, EI; Bierregaard, RO; Lovejoy, TE				Stouffer, Philip C.; Johnson, Erik I.; Bierregaard, Richard O., Jr.; Lovejoy, Thomas E.			Understory Bird Communities in Amazonian Rainforest Fragments: Species Turnover through 25 Years Post-Isolation in Recovering Landscapes	PLOS ONE			English	Article							HABITAT FRAGMENTATION; EXTINCTION; DEFORESTATION; RATES; COLONIZATION; DYNAMICS; ISLAND; AREA; BIOGEOGRAPHY; ASSEMBLAGES	Inferences about species loss following habitat conversion are typically drawn from short-term surveys, which cannot reconstruct long-term temporal dynamics of extinction and colonization. A long-term view can be critical, however, to determine the stability of communities within fragments. Likewise, landscape dynamics must be considered, as second growth structure and overall forest cover contribute to processes in fragments. Here we examine bird communities in 11 Amazonian rainforest fragments of 1-100 ha, beginning before the fragments were isolated in the 1980s, and continuing through 2007. Using a method that accounts for imperfect detection, we estimated extinction and colonization based on standardized mist-net surveys within discreet time intervals (1-2 preisolation samples and 4-5 post-isolation samples). Between preisolation and 2007, all fragments lost species in an area-dependent fashion, with loss of as few as,10% of preisolation species from 100-ha fragments, but up to 70% in 1-ha fragments. Analysis of individual time intervals revealed that the 2007 result was not due to gradual species loss beginning at isolation; both extinction and colonization occurred in every time interval. In the last two samples, 2000 and 2007, extinction and colonization were approximately balanced. Further, 97 of 101 species netted before isolation were detected in at least one fragment in 2007. Although a small subset of species is extremely vulnerable to fragmentation, and predictably goes extinct in fragments, developing second growth in the matrix around fragments encourages recolonization in our landscapes. Species richness in these fragments now reflects local turnover, not long-term attrition of species. We expect that similar processes could be operating in other fragmented systems that show unexpectedly low extinction.	[Stouffer, Philip C.; Johnson, Erik I.] Louisiana State Univ, Ctr Agr, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA; [Bierregaard, Richard O., Jr.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA; [Lovejoy, Thomas E.] Heinz Ctr, Washington, DC USA; [Stouffer, Philip C.; Johnson, Erik I.; Bierregaard, Richard O., Jr.; Lovejoy, Thomas E.] Inst Nacl de Pesquisas da Amazonia, Projeto Dinam Fragmentos Florestais, Manaus, Amazonas, Brazil; [Stouffer, Philip C.; Johnson, Erik I.; Bierregaard, Richard O., Jr.; Lovejoy, Thomas E.] Smithsonian Trop Res Inst, Manaus, Amazonas, Brazil	Louisiana State University System; Louisiana State University; University of North Carolina; University of North Carolina Charlotte; Institute Nacional de Pesquisas da Amazonia; Smithsonian Institution; Smithsonian Tropical Research Institute	Stouffer, PC (corresponding author), Louisiana State Univ, Ctr Agr, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA.	pstouffer@lsu.edu	stouffer, phil/AAF-7281-2020		National Institute for Amazonian Research (INPA); World Wildlife Fund-US; Smithsonian Institution; MacArthur Foundation; U.S. National Science Foundation [DEB 0545491]; United States Agency for International Development; Mellon Foundation	National Institute for Amazonian Research (INPA); World Wildlife Fund-US; Smithsonian Institution(Smithsonian Institution); MacArthur Foundation; U.S. National Science Foundation(National Science Foundation (NSF)); United States Agency for International Development(United States Agency for International Development (USAID)); Mellon Foundation	The National Institute for Amazonian Research (INPA), World Wildlife Fund-US, Smithsonian Institution, MacArthur Foundation, U.S. National Science Foundation (DEB 0545491), United States Agency for International Development, Mellon Foundation, and other organizations generously supported this work and the Biological Dynamics of Forest Fragments Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; BIERREGAARD R O JR, 1989, Acta Amazonica, V19, P215; Blake JG, 2001, AUK, V118, P304, DOI 10.1642/0004-8038(2001)118[0304:BAISGA]2.0.CO;2; Borgella R, 2005, ECOL APPL, V15, P1062, DOI 10.1890/04-0352; Borges SH, 2007, J TROP ECOL, V23, P469, DOI 10.1017/S0266467407004105; Borges SH, 1999, CONDOR, V101, P529, DOI 10.2307/1370182; BORGES SH, 1995, THESIS INPA; Boulinier T, 1998, ECOLOGY, V79, P1018, DOI 10.2307/176597; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; Canaday C, 1996, BIOL CONSERV, V77, P63, DOI 10.1016/0006-3207(95)00115-8; Castellon TD, 2006, CONSERV BIOL, V20, P135, DOI 10.1111/j.1523-1739.2006.00332.x; Castellon TD, 2006, ECOL APPL, V16, P2223, DOI 10.1890/1051-0761(2006)016[2223:LHFAPO]2.0.CO;2; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Cohn-Haft Mario, 1997, Ornithological Monographs, V48, P205; Collinge SK, 1998, OIKOS, V82, P66, DOI 10.2307/3546918; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Feeley K, 2003, OECOLOGIA, V137, P104, DOI 10.1007/s00442-003-1321-5; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Gascon Claude, 2001, P31; Hagan JM, 1996, CONSERV BIOL, V10, P188, DOI 10.1046/j.1523-1739.1996.10010188.x; Haila Y, 2002, ECOL APPL, V12, P321, DOI 10.1890/1051-0761(2002)012[0321:ACGOFR]2.0.CO;2; Hanski I, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P186; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Hines JE, 1999, BIRD STUDY, V46, P209; Jaramillo A, CLASSIFICATION BIRD; Johnson DH, 1999, J WILDLIFE MANAGE, V63, P763, DOI 10.2307/3802789; Johnson EI, 2011, REV BRAS ORNITOL, V19, P1; Jullien M, 1998, J ANIM ECOL, V67, P227, DOI 10.1046/j.1365-2656.1998.00171.x; KATTAN GH, 1994, CONSERV BIOL, V8, P138, DOI 10.1046/j.1523-1739.1994.08010138.x; Kramer AM, 2008, ECOLOGY, V89, P2760, DOI 10.1890/07-1505.1; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Laurance WF, 2008, BIOL CONSERV, V141, P1731, DOI 10.1016/j.biocon.2008.05.011; Laurance WF, 2009, CONSERV BIOL, V23, P1382, DOI 10.1111/j.1523-1739.2009.01339.x; Lees AC, 2008, ANIM CONSERV, V11, P128, DOI 10.1111/j.1469-1795.2008.00162.x; Lees AC, 2006, BIOL CONSERV, V133, P198, DOI 10.1016/j.biocon.2006.06.005; Lovejoy T.E., 1986, P257; MAC ARTHUR ROBERT H., 1967; Nichols JD, 1998, CONSERV BIOL, V12, P1390, DOI 10.1046/j.1523-1739.1998.97331.x; Nichols JD, 1998, ECOL APPL, V8, P1213, DOI 10.2307/2640974; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Patten MA, 2010, BIODIVERS CONSERV, V19, P21, DOI 10.1007/s10531-009-9698-z; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Renjifo LM, 1999, CONSERV BIOL, V13, P1124, DOI 10.1046/j.1523-1739.1999.98311.x; Robinson WD, 1999, CONSERV BIOL, V13, P85, DOI 10.1046/j.1523-1739.1999.97492.x; Ruiz-Gutierrez V, 2010, J APPL ECOL, V47, P621, DOI 10.1111/j.1365-2664.2010.01811.x; SAUER JR, 1989, J WILDLIFE MANAGE, V53, P137, DOI 10.2307/3801320; Schoener TW, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P52; Sekercioglu CH, 2007, CONSERV BIOL, V21, P482, DOI 10.1111/j.1523-1739.2007.00655.x; SIEVING KE, 1992, ECOLOGY, V73, P2310, DOI 10.2307/1941477; Sigel BJ, 2006, CONSERV BIOL, V20, P111, DOI 10.1111/j.1523-1739.2005.00293.x; SILVA JVC, 2010, THESIS INPA; SIMBERLOFF DS, 1969, ECOLOGY, V50, P278, DOI 10.2307/1934856; Sodhi NS, 2006, CONSERV BIOL, V20, P772, DOI 10.1111/j.1523-1739.2006.00363.x; Sodhi NS, 2004, ANNU REV ECOL EVOL S, V35, P323, DOI 10.1146/annurev.ecolsys.35.112202.130209; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; STOUFFER PC, 1993, CONDOR, V95, P896, DOI 10.2307/1369427; STOUFFER PC, 1995, ECOLOGY, V76, P2429, DOI 10.2307/2265818; Stouffer PC, 2007, AUK, V124, P291, DOI 10.1642/0004-8038(2007)124[291:DTSALS]2.0.CO;2; Stouffer PC, 2006, CONSERV BIOL, V20, P1212, DOI 10.1111/j.1523-1739.2006.00427.x; Stouffer PC, 2009, DIVERS DISTRIB, V15, P88, DOI 10.1111/j.1472-4642.2008.00497.x; Stratford JA, 1999, CONSERV BIOL, V13, P1416, DOI 10.1046/j.1523-1739.1999.98494.x; Terborgh J, 1997, ECOLOGY, V78, P1494, DOI 10.1890/0012-9658(1997)078[1494:BCITTL]2.0.CO;2; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Wright SJ, 2006, BIOTROPICA, V38, P443, DOI 10.1111/j.1744-7429.2006.00177.x; Wright SJ, 2006, BIOTROPICA, V38, P287, DOI 10.1111/j.1744-7429.2006.00154.x; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x	71	76	79	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20543	10.1371/journal.pone.0020543	http://dx.doi.org/10.1371/journal.pone.0020543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731616	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700009
J	Huang, NK; Lin, JH; Lin, JT; Lin, CI; Liu, EMW; Lin, CJ; Chen, WP; Shen, YC; Chen, HM; Chen, JB; Lai, HL; Yang, CW; Chiang, MC; Wu, YS; Chang, C; Chen, JF; Fang, JM; Lin, YL; Chern, YJ				Huang, Nai-Kuei; Lin, Jung-Hsin; Lin, Jiun-Tsai; Lin, Chia-I; Liu, Eric Minwei; Lin, Chun-Jung; Chen, Wan-Ping; Shen, Yuh-Chiang; Chen, Hui-Mei; Chen, Jhih-Bin; Lai, Hsing-Lin; Yang, Chieh-Wen; Chiang, Ming-Chang; Wu, Yu-Shuo; Chang, Chen; Chen, Jiang-Fan; Fang, Jim-Min; Lin, Yun-Lian; Chern, Yijuang			A New Drug Design Targeting the Adenosinergic System for Huntington's Disease	PLOS ONE			English	Article							DEPRIVATION-INDUCED APOPTOSIS; RAT PHEOCHROMOCYTOMA CELLS; SITE-DIRECTED MUTAGENESIS; TRANSGENIC MOUSE MODEL; A(2A) RECEPTOR AGONIST; CENTRAL-NERVOUS-SYSTEM; GASTRODIA-ELATA BLUME; UREA CYCLE DEFICIENCY; LIGAND RECOGNITION; SERUM DEPRIVATION	Background: Huntington's disease (HD) is a neurodegenerative disease caused by a CAG trinucleotide expansion in the Huntingtin (Htt) gene. The expanded CAG repeats are translated into polyglutamine (polyQ), causing aberrant functions as well as aggregate formation of mutant Htt. Effective treatments for HD are yet to be developed. Methodology/Principal Findings: Here, we report a novel dual-function compound, N-6-(4-hydroxybenzyl) adenine riboside (designated T1-11) which activates the A(2A)R and a major adenosine transporter (ENT1). T1-11 was originally isolated from a Chinese medicinal herb. Molecular modeling analyses showed that T1-11 binds to the adenosine pockets of the A(2A)R and ENT1. Introduction of T1-11 into the striatum significantly enhanced the level of striatal adenosine as determined by a microdialysis technique, demonstrating that T1-11 inhibited adenosine uptake in vivo. A single intraperitoneal injection of T1-11 in wildtype mice, but not in A(2A)R knockout mice, increased cAMP level in the brain. Thus, T1-11 enters the brain and elevates cAMP via activation of the A(2A)R in vivo. Most importantly, addition of T1-11 (0.05 mg/ml) to the drinking water of a transgenic mouse model of HD (R6/2) ameliorated the progressive deterioration in motor coordination, reduced the formation of striatal Htt aggregates, elevated proteasome activity, and increased the level of an important neurotrophic factor (brain derived neurotrophic factor) in the brain. These results demonstrate the therapeutic potential of T1-11 for treating HD. Conclusions/Significance: The dual functions of T1-11 enable T1-11 to effectively activate the adenosinergic system and subsequently delay the progression of HD. This is a novel therapeutic strategy for HD. Similar dual-function drugs aimed at a particular neurotransmitter system as proposed herein may be applicable to other neurotransmitter systems (e. g., the dopamine receptor/dopamine transporter and the serotonin receptor/serotonin transporter) and may facilitate the development of new drugs for other neurodegenerative diseases.	[Huang, Nai-Kuei; Chen, Wan-Ping; Shen, Yuh-Chiang; Lin, Yun-Lian] Natl Res Inst Chinese Med, Taipei, Taiwan; [Lin, Jung-Hsin] Acad Sinica, Div Mech, Res Ctr Appl Sci, Taipei 115, Taiwan; [Lin, Jung-Hsin; Lin, Jiun-Tsai; Chen, Hui-Mei; Lai, Hsing-Lin; Wu, Yu-Shuo; Chang, Chen; Chern, Yijuang] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Liu, Eric Minwei; Lin, Chun-Jung] Natl Taiwan Univ, Sch Pharm, Taipei 10764, Taiwan; [Lin, Chia-I; Chen, Jhih-Bin; Yang, Chieh-Wen; Fang, Jim-Min] Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan; [Fang, Jim-Min] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chiang, Ming-Chang] Chinese Culture Univ, Grad Inst Biotechnol, Taipei, Taiwan; [Chen, Jiang-Fan] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	National Research Institute of Chinese Medicine; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; Chinese Culture University; Boston University	Huang, NK (corresponding author), Natl Res Inst Chinese Med, Taipei, Taiwan.	jmfang@ntu.edu.tw; yllin@nricm.edu.tw; bmychern@ibms.sinica.edu.tw	Chang, Chen/B-5079-2009; Lin, Jung-Hsin/B-7512-2012; Liu, Eric Minwei/V-1738-2019; Lin, Jung-Hsin/T-7390-2019; chern, yijuang/S-7013-2018	Lin, Jung-Hsin/0000-0002-6712-4994; Liu, Eric Minwei/0000-0002-3594-6678; chern, yijuang/0000-0002-5842-5429; Fang, Jim-Min/0000-0002-6070-3408; Chen, Jiang-Fan/0000-0002-0446-3956; CHUN-JUNG, LIN/0000-0001-9220-3507	National Science Council [NRICM 94-DMC-2, NRICM 95-DMC-2, NSC95-2323-B-077-002, NSC96-2323-B-077-001, NSC96-2628-M-002-003, NSC 97-2323-B-077-001]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council for financial support (NRICM 94-DMC-2, NRICM 95-DMC-2, NSC95-2323-B-077-002, NSC96-2323-B-077-001, NSC96-2628-M-002-003, and NSC 97-2323-B-077-001). The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; An SJ, 2003, J NEUROSCI RES, V71, P534, DOI 10.1002/jnr.10502; Assaife-Lopes N, 2010, J NEUROSCI, V30, P8468, DOI 10.1523/JNEUROSCI.5695-09.2010; Blum D, 2003, J NEUROSCI, V23, P5361; Blum D, 2002, J NEUROSCI, V22, P9122; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Brusa L, 2009, MOVEMENT DISORD, V24, P126, DOI 10.1002/mds.22376; Carter RJ, 1999, J NEUROSCI, V19, P3248; Case D, 2006, AMBER 9; Cepeda C., 2010, PLOS CURR, V2; Chen JF, 2002, J BIOL CHEM, V277, P36040, DOI 10.1074/jbc.M206830200; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chiang MC, 2005, J BIOL CHEM, V280, P14331, DOI 10.1074/jbc.M413279200; Chiang MC, 2007, HUM MOL GENET, V16, P483, DOI 10.1093/hmg/ddl481; Chiang MC, 2009, HUM MOL GENET, V18, P2929, DOI 10.1093/hmg/ddp230; Chou SY, 2005, J NEUROCHEM, V93, P310, DOI 10.1111/j.1471-4159.2005.03029.x; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Domenici MR, 2007, NEUROBIOL DIS, V28, P197, DOI 10.1016/j.nbd.2007.07.009; Dworak M, 2007, NEUROSCIENCE, V150, P789, DOI 10.1016/j.neuroscience.2007.09.062; Fink JS, 2004, J NEUROCHEM, V88, P538, DOI 10.1046/j.1471-4159.2003.02145.x; Flajolet M, 2008, NAT NEUROSCI, V11, P1402, DOI 10.1038/nn.2216; Fontinha BM, 2008, NEUROPHARMACOLOGY, V54, P924, DOI 10.1016/j.neuropharm.2008.01.011; FREDHOLM BB, 1992, FUNDAM CLIN PHARM, V6, P99, DOI 10.1111/j.1472-8206.1992.tb00101.x; Fredholm BB, 2005, INT REV NEUROBIOL, V63, P191, DOI 10.1016/S0074-7742(05)63007-3; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P661, DOI 10.1016/S0006-2952(00)00357-9; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Gidday JM, 1996, BRAIN RES, V734, P261, DOI 10.1016/0006-8993(96)00647-6; Golder FJ, 2008, J NEUROSCI, V28, P2033, DOI 10.1523/JNEUROSCI.3570-07.2008; Gomes CARV, 2006, BRAIN RES, V1113, P129, DOI 10.1016/j.brainres.2006.07.025; Gordi T, 2006, CLIN PHARMACOKINET, V45, P1201, DOI 10.2165/00003088-200645120-00005; Hayashi J, 2002, PHYTOCHEMISTRY, V59, P513, DOI 10.1016/S0031-9422(02)00008-0; He ZX, 2000, CIRCULATION, V102, P438; Huang NK, 2007, J NAT PROD, V70, P571, DOI 10.1021/np0605182; Huang NK, 1997, PHARMACOL BIOCHEM BE, V56, P363, DOI 10.1016/S0091-3057(96)00236-5; Huang NK, 2005, FEMS MICROBIOL LETT, V244, P213, DOI 10.1016/j.femsle.2005.01.048; Huang NK, 2004, LIFE SCI, V75, P1649, DOI 10.1016/j.lfs.2004.05.008; Huang NK, 2001, J BIOL CHEM, V276, P13838, DOI 10.1074/jbc.M008589200; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jacobson KA, 1997, NEUROPHARMACOLOGY, V36, P1157, DOI 10.1016/S0028-3908(97)00104-4; Jennings LL, 2001, NEUROPHARMACOLOGY, V40, P722, DOI 10.1016/S0028-3908(00)00207-0; Jiang QL, 1996, MOL PHARMACOL, V50, P512; Jin KL, 2005, P NATL ACAD SCI USA, V102, P18189, DOI 10.1073/pnas.0506375102; Joshi PR, 2009, J NEUROSCI, V29, P2414, DOI 10.1523/JNEUROSCI.5687-08.2009; Kells AP, 2004, MOL THER, V9, P682, DOI 10.1016/j.ymthe.2004.02.016; Kim HJ, 2003, J ETHNOPHARMACOL, V84, P95, DOI 10.1016/S0378-8741(02)00290-8; Kim JH, 1996, MOL PHARMACOL, V49, P683; KIM JH, 1995, J BIOL CHEM, V270, P13987, DOI 10.1074/jbc.270.23.13987; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Lin JH, 1996, PHYTOCHEMISTRY, V42, P549, DOI 10.1016/0031-9422(95)00955-8; Lin JH, 2002, BIOPHYS J, V83, P1374, DOI 10.1016/S0006-3495(02)73908-8; Liu FC, 1998, FEBS LETT, V436, P92, DOI 10.1016/S0014-5793(98)01098-9; Lu MK, 2006, LIFE SCI, V79, P252, DOI 10.1016/j.lfs.2005.12.042; Luo CX, 2010, NEUROREPORT, V21, P892, DOI 10.1097/WNR.0b013e32833dbd13; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martire A, 2007, NEUROSCI LETT, V417, P78, DOI 10.1016/j.neulet.2007.02.034; Mestre T, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006455.pub2; Mievis S, 2011, NEUROBIOL DIS, V41, P570, DOI 10.1016/j.nbd.2010.09.021; Mingote S, 2008, PHARMACOL BIOCHEM BE, V89, P345, DOI 10.1016/j.pbb.2008.01.006; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; OLAH ME, 1994, MOL PHARMACOL, V45, P978; Orru M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016088; Panov AV, 2005, MOL CELL BIOCHEM, V269, P143, DOI 10.1007/s11010-005-3454-9; Parkinson FE, 2009, J NEUROCHEM, V109, P562, DOI 10.1111/j.1471-4159.2009.05991.x; Popoli P, 2008, CURR PHARM DESIGN, V14, P1500, DOI 10.2174/138161208784480117; Ribeiro FM, 2010, J NEUROSCI, V30, P316, DOI 10.1523/JNEUROSCI.4974-09.2010; Rooseboom M, 2004, PHARMACOL REV, V56, P53, DOI 10.1124/pr.56.1.3; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALVATORE CA, 1993, P NATL ACAD SCI USA, V90, P10365, DOI 10.1073/pnas.90.21.10365; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; TAGUCHI H, 1981, CHEM PHARM BULL, V29, P55; Tarditi A, 2006, NEUROBIOL DIS, V23, P44, DOI 10.1016/j.nbd.2006.01.014; Tebano MT, 2010, THESCIENTIFICWORLDJO, V10, P1768, DOI 10.1100/tsw.2010.164; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Too K, 2007, BIOORGAN MED CHEM, V15, P5551, DOI 10.1016/j.bmc.2007.05.038; Tzschentke TM, 2007, J PHARMACOL EXP THER, V323, P265, DOI 10.1124/jpet.107.126052; Varani K, 1996, BRIT J PHARMACOL, V117, P1693, DOI 10.1111/j.1476-5381.1996.tb15341.x; Varani K, 2003, FASEB J, V17, P2148, DOI 10.1096/fj.03-0079fje; VERMA A, 1985, LIFE SCI, V36, P283, DOI 10.1016/0024-3205(85)90071-2; Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375; Wiese S, 2007, P NATL ACAD SCI USA, V104, P17210, DOI 10.1073/pnas.0705267104; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zhang Y, 2004, P NATL ACAD SCI USA, V101, P7594, DOI 10.1073/pnas.0305695101; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	94	61	65	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e20934	10.1371/journal.pone.0020934	http://dx.doi.org/10.1371/journal.pone.0020934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713039	Green Submitted, gold, Green Published			2022-12-25	WOS:000291985100007
J	Jones, GJ; Pirson, C; Gideon, HP; Wilkinson, KA; Sherman, DR; Wilkinson, RJ; Hewinson, RG; Vordermeier, HM				Jones, Gareth J.; Pirson, Chris; Gideon, Hannah P.; Wilkinson, Katalin A.; Sherman, David R.; Wilkinson, Robert J.; Hewinson, R. Glyn; Vordermeier, H. Martin			Immune Responses to the Enduring Hypoxic Response Antigen Rv0188 Are Preferentially Detected in Mycobacterium bovis Infected Cattle with Low Pathology	PLOS ONE			English	Article							ALPHA-CRYSTALLIN; BCG VACCINATION; TUBERCULOSIS; REGULON; REACTIVATION; RECOGNITION; INSIGHTS; BIOLOGY; PROTEIN; LATENCY	The DosR regulon and the Enduring Hypoxic Response (EHR) define a group of M. tuberculosis genes that are specifically induced in bacilli exposed in vitro to conditions thought to mimic the environment encountered by Mycobacteria during latent infection. Although well described in humans, latent mycobacterial infection in cattle remains poorly understood. Thus, the aim of this study was to identify antigens that may potentially disclose cattle with latent M. bovis infection. To this end, we initially screened 57 pools of overlapping peptides representing 4 DosR regulon and 29 EHR antigens for their ability to stimulate an immune response in whole blood from TB-reactor cattle using IFN-gamma and IL-2 as readouts. All 4 DosR regulon proteins were poorly recognized (maximum responder frequency of 10%). For the EHR antigens, both IFN-gamma and IL-2 revealed similar response hierarchies, with responder frequencies ranging from 54% down to 3% depending on the given EHR antigen. Furthermore, these results demonstrated that responses in the infected cattle were largely IFN-gamma biased. To support the concept for their role in latency, we evaluated if EHR antigen responses were associated with lower pathology. The EHR antigen Rv0188 was recognised predominantly in animals presenting with low pathology scores, whereas responses to ESAT-6/CFP-10 or the other EHR antigens tested were prevalent across the pathology spectrum. However, when we determined the production of additional cytokines induced by the M. bovis antigens PPD-B or ESAT-6/CFP-10, we detected significantly greater PPD-B-induced production of the pro-inflammatory cytokine IL-1 beta in animals recognizing Rv0188 (i.e. those with limited or no pathology). Thus, these results are consistent with the idea that responses to Rv0188 may identify a subset of animals at early stages of infection or in which disease progression may be limited.	[Jones, Gareth J.; Pirson, Chris; Hewinson, R. Glyn; Vordermeier, H. Martin] Anim Hlth & Vet Labs Agcy Weybridge, Dept Bacteriol, Surrey, England; [Gideon, Hannah P.; Wilkinson, Katalin A.; Wilkinson, Robert J.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, Western Cape, South Africa; [Wilkinson, Katalin A.; Wilkinson, Robert J.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Sherman, David R.] Seattle Biomed Res Inst, TB Program, Seattle, WA 98109 USA; [Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England; [Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London, England	Veterinary Laboratories Agency; University of Cape Town; MRC National Institute for Medical Research; Center for Infectious Disease Research; Imperial College London; Imperial College London	Jones, GJ (corresponding author), Anim Hlth & Vet Labs Agcy Weybridge, Dept Bacteriol, Surrey, England.	Gareth.J.Jones@ahvla.gsi.gov.uk	Vordermeier, H Martin/C-6936-2011; Hewinson, Glyn/F-7077-2010; Wilkinson, Katalin/AAF-6805-2020; Hewinson, Glyn/AAA-2364-2019; Pirson, Chris/D-8494-2011; Jones, Gareth/C-6270-2011; Hewinson, Glyn/J-1902-2014; Wilkinson, Katalin/AAQ-7713-2021	Pirson, Chris/0000-0002-5293-0221; Wilkinson, Katalin/0000-0002-9796-2040; Gideon, Hannah/0000-0002-4443-2134; Wilkinson, Robert/0000-0002-2753-1800; Hewinson, Glyn/0000-0002-5517-4281	Department for Environment, Food and Rural Affairs (DEFRA) UK; Bill and Melinda Gates Foundation [37822]; Wellcome Trust [088316]; Medical Research Council [MC_U117588499] Funding Source: researchfish; MRC [MC_U117588499] Funding Source: UKRI	Department for Environment, Food and Rural Affairs (DEFRA) UK(Department for Environment, Food & Rural Affairs (DEFRA)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Department for Environment, Food and Rural Affairs (DEFRA) UK and by the Bill and Melinda Gates Foundation (Ref 37822, Drugs for Latent Tuberculosis). RJW receives personal support from the Wellcome Trust (088316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AH, 2009, VET RES, V40, DOI 10.1051/vetres/2009005; Arend SM, 2002, J INFECT DIS, V186, P876, DOI 10.1086/342604; Arriaga AK, 2002, CLIN EXP IMMUNOL, V128, P229, DOI 10.1046/j.1365-2249.2002.01832.x; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09; Cahn Pedro, 2003, J Int Assoc Physicians AIDS Care (Chic), V2, P106, DOI 10.1177/154510970300200303; Cassidy JP, 2006, VET MICROBIOL, V112, P151, DOI 10.1016/j.vetmic.2005.11.031; Coad M, 2010, VET RES, V41, DOI 10.1051/vetres/2009062; Demissie A, 2006, CLIN VACCINE IMMUNOL, V13, P179, DOI 10.1128/CVI.13.2.179-186.2006; Geluk A, 2007, INFECT IMMUN, V75, P2914, DOI 10.1128/IAI.01990-06; Gideon HP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001237; Goletti D, 2010, EUR RESPIR J, V36, P135, DOI 10.1183/09031936.00140009; Hinks TSC, 2009, INFECT IMMUN, V77, P5486, DOI 10.1128/IAI.01436-08; Larsen MV, 2008, EUR RESPIR J, V32, P229, DOI 10.1183/09031936.00125607; Lauzi S, 2000, VET J, V160, P17, DOI 10.1053/tvjl.1999.0444; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Lin MY, 2007, INFECT IMMUN, V75, P3523, DOI 10.1128/IAI.01999-06; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Pollock JM, 2002, VET J, V163, P115, DOI 10.1053/tvjl.2001.0655; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Vordermeier HM, 1999, CLIN DIAGN LAB IMMUN, V6, P675, DOI 10.1128/CDLI.6.5.675-682.1999; Vordermeier HM, 2001, CLIN DIAGN LAB IMMUN, V8, P571, DOI 10.1128/CDLI.8.3.571-578.2001; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Whipple DL, 1996, J VET DIAGN INVEST, V8, P351, DOI 10.1177/104063879600800312; Wilkinson KA, 2005, J IMMUNOL, V174, P4237, DOI 10.4049/jimmunol.174.7.4237; Wilkinson RJ, 1998, SCAND J IMMUNOL, V48, P403	31	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21371	10.1371/journal.pone.0021371	http://dx.doi.org/10.1371/journal.pone.0021371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712953	Green Published, gold, Green Submitted			2022-12-25	WOS:000291985100036
J	Dyall-Smith, ML; Pfeiffer, F; Klee, K; Palm, P; Gross, K; Schuster, SC; Rampp, M; Oesterhelt, D				Dyall-Smith, Mike L.; Pfeiffer, Friedhelm; Klee, Kathrin; Palm, Peter; Gross, Karin; Schuster, Stephan C.; Rampp, Markus; Oesterhelt, Dieter			Haloquadratum walsbyi: Limited Diversity in a Global Pond	PLOS ONE			English	Article							MULTIPLE REPLICATION ORIGINS; SQUARE HALOARCHAEON; HALOPHILIC ARCHAEA; HALOFERAX-VOLCANII; HALOBACTERIUM-SALINARUM; TRANSPOSABLE ELEMENTS; PATHOGENICITY ISLAND; SEQUENCE-ANALYSIS; DNA-REPLICATION; GENOME SEQUENCE	Background: Haloquadratum walsbyi commonly dominates the microbial flora of hypersaline waters. Its cells are extremely fragile squares requiring > 14%(w/v) salt for growth, properties that should limit its dispersal and promote geographical isolation and divergence. To assess this, the genome sequences of two isolates recovered from sites at near maximum distance on Earth, were compared. Principal Findings: Both chromosomes are 3.1 MB in size, and 84% of each sequence was highly similar to the other (98.6% identity), comprising the core sequence. ORFs of this shared sequence were completely synteneic (conserved in genomic orientation and order), without inversion or rearrangement. Strain-specific insertions/deletions could be precisely mapped, often allowing the genetic events to be inferred. Many inferred deletions were associated with short direct repeats (4-20 bp). Deletion-coupled insertions are frequent, producing different sequences at identical positions. In cases where the inserted and deleted sequences are homologous, this leads to variant genes in a common synteneic background (as already described by others). Cas/CRISPR systems are present in C23(T) but have been lost in HBSQ001 except for a few spacer remnants. Numerous types of mobile genetic elements occur in both strains, most of which appear to be active, and with some specifically targetting others. Strain C23(T) carries two similar to 6 kb plasmids that show similarity to halovirus His1 and to sequences nearby halovirus/plasmid gene clusters commonly found in haloarchaea. Conclusions: Deletion-coupled insertions show that Hqr. walsbyi evolves by uptake and precise integration of foreign DNA, probably originating from close relatives. Change is also driven by mobile genetic elements but these do not by themselves explain the atypically low gene coding density found in this species. The remarkable genome conservation despite the presence of active systems for genome rearrangement implies both an efficient global dispersal system, and a high selective fitness for this species.	[Dyall-Smith, Mike L.; Pfeiffer, Friedhelm; Klee, Kathrin; Palm, Peter; Oesterhelt, Dieter] Max Planck Inst Biochem, Dept Membrane Biochem, D-82152 Martinsried, Germany; [Gross, Karin; Rampp, Markus] Max Planck Inst Plasma Phys, Max Planck Soc, Comp Ctr RZG, D-85748 Garching, Germany; [Schuster, Stephan C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA	Max Planck Society; Max Planck Society; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Dyall-Smith, ML (corresponding author), Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia.	mdyall-smith@csu.edu.au	Pfeiffer, Friedhelm/K-1757-2019	Pfeiffer, Friedhelm/0000-0003-4691-3246; Klee, Kathrin/0000-0003-2408-1282; Rampp, Markus/0000-0001-8177-8698	Max-Planck-Society, Germany	Max-Planck-Society, Germany(Max Planck Society)	This work was funded by the Max-Planck-Society, Germany, to Dieter Oesterhelt, Director of the Department of Membrane Biochemistry, MPI for Biochemistry (http://www.biochem.mpg.de/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Anton J, 1999, ENVIRON MICROBIOL, V1, P517, DOI 10.1046/j.1462-2920.1999.00065.x; Bao TH, 2005, EMBO J, V24, P3325, DOI 10.1038/sj.emboj.7600787; Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; Bath C, 2006, VIROLOGY, V350, P228, DOI 10.1016/j.virol.2006.02.005; Berquist BR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-31; Bolhuis H, 2004, ENVIRON MICROBIOL, V6, P1287, DOI 10.1111/j.1462-2920.2004.00692.x; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Burns DG, 2007, INT J SYST EVOL MICR, V57, P387, DOI 10.1099/ijs.0.64690-0; Burns DG, 2004, FEMS MICROBIOL LETT, V238, P469, DOI 10.1016/j.femsle.2004.08.016; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Chen Y, 2009, GENE, V436, P1, DOI 10.1016/j.gene.2009.01.019; Coker JA, 2009, J BACTERIOL, V191, P5253, DOI 10.1128/JB.00210-09; Cuadros-Orellana S, 2007, ISME J, V1, P235, DOI 10.1038/ismej.2007.35; Delmas S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000552; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Ellen AF, 2010, ARCHAEA, V2010, DOI 10.1155/2010/608243; Falb M, 2005, GENOME RES, V15, P1336, DOI 10.1101/gr.3952905; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Fu H. Y., 2010, J BACTERIOL; Gao F, 2006, NUCLEIC ACIDS RES, V34, pW686, DOI 10.1093/nar/gkl040; Gordon D., 2003, CURR PROTOC BIOINFOR, V11, P1, DOI DOI 10.1002/0471250953.BI1102S02; Greve Bo, 2005, Archaea, V1, P319, DOI 10.1155/2005/159218; Grosjean H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-470; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; GuixaBoixareu N, 1996, AQUAT MICROB ECOL, V11, P215, DOI 10.3354/ame011215; Held NL, 2009, ENVIRON MICROBIOL, V11, P457, DOI 10.1111/j.1462-2920.2008.01784.x; Hickman AB, 2010, CRIT REV BIOCHEM MOL, V45, P50, DOI 10.3109/10409230903505596; HOLMES ML, 1990, J BACTERIOL, V172, P756, DOI 10.1128/jb.172.2.756-761.1990; HOLMES ML, 1995, GENE, V153, P117, DOI 10.1016/0378-1119(94)00761-G; HORVATH P, 2008, INT J FOOD MICROBIOL; Ikeuchi Y, 2010, NAT CHEM BIOL, V6, P277, DOI [10.1038/NCHEMBIO.323, 10.1038/nchembio.323]; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Kers JA, 2005, MOL MICROBIOL, V55, P1025, DOI 10.1111/j.1365-2958.2004.04461.x; Kersulyte D, 2002, J BACTERIOL, V184, P992, DOI 10.1128/jb.184.4.992-1002.2002; KESSEL M, 1982, J BACTERIOL, V150, P851, DOI 10.1128/JB.150.2.851-860.1982; Klein C, 2007, J PROTEOME RES, V6, P1510, DOI 10.1021/pr060634q; Legault BA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-171; Lobry JR, 1996, BIOCHIMIE, V78, P323, DOI 10.1016/0300-9084(96)84764-X; Lopez P, 1999, MOL MICROBIOL, V32, P883, DOI 10.1046/j.1365-2958.1999.01370.x; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Myllykallio H, 2000, SCIENCE, V288, P2212, DOI 10.1126/science.288.5474.2212; Norais C, 2007, PLOS GENET, V3, P729, DOI 10.1371/journal.pgen.0030077; Oesterhelt D, 1974, Methods Enzymol, V31, P667; Oh D, 2010, EXTREMOPHILES, V14, P161, DOI 10.1007/s00792-009-0295-6; Oren A, 2002, FEMS MICROBIOL ECOL, V39, P1, DOI 10.1111/j.1574-6941.2002.tb00900.x; Oren A, 1996, FEMS MICROBIOL LETT, V138, P135, DOI 10.1111/j.1574-6968.1996.tb08146.x; OREN A, 2007, PROKARYOTES; Pagaling E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-410; Pedros-Alio C, 2000, FEMS MICROBIOL ECOL, V32, P143, DOI 10.1016/S0168-6496(00)00025-8; PFEIFER F, 1981, J BACTERIOL, V145, P375, DOI 10.1128/JB.145.1.375-381.1981; Pfeiffer F, 2008, GENOMICS, V91, P335, DOI 10.1016/j.ygeno.2008.01.001; Pfeiffer F, 2008, ARCH MICROBIOL, V190, P281, DOI 10.1007/s00203-008-0389-z; Pietila MK, 2009, MOL MICROBIOL, V72, P307, DOI 10.1111/j.1365-2958.2009.06642.x; Pritham EJ, 2007, GENE, V390, P3, DOI 10.1016/j.gene.2006.08.008; Rampp M, 2006, NUCLEIC ACIDS RES, V34, pW15, DOI 10.1093/nar/gkl254; Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106; Robinson NP, 2007, P NATL ACAD SCI USA, V104, P5806, DOI 10.1073/pnas.0700206104; Roine E, 2010, J VIROL, V84, P3682, DOI 10.1128/JVI.01879-09; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Santos F, 2010, ENV MICROBIOL; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; SOLER N, 2010, NUCL ACIDS RES; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; STOECKENIUS W, 1981, J BACTERIOL, V148, P352, DOI 10.1128/JB.148.1.352-360.1981; SUMPER M, 1990, J BACTERIOL, V172, P7111, DOI 10.1128/jb.172.12.7111-7118.1990; Szabo Z, 2007, J BACTERIOL, V189, P772, DOI 10.1128/JB.01547-06; Tang SL, 2004, J BACTERIOL, V186, P2810, DOI 10.1128/JB.186.9.2810-2817.2004; Tang SL, 2002, MOL MICROBIOL, V44, P283, DOI 10.1046/j.1365-2958.2002.02890.x; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; van Schaik W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-239; Vieira-Silva S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000808; WALSBY AE, 1980, NATURE, V283, P69, DOI 10.1038/283069a0; Yurist-Doutsch S, 2010, MOL MICROBIOL, V75, P1047, DOI 10.1111/j.1365-2958.2009.07045.x	79	81	90	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20968	10.1371/journal.pone.0020968	http://dx.doi.org/10.1371/journal.pone.0020968			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701686	Green Published, gold, Green Submitted			2022-12-25	WOS:000291983800016
J	Bussolati, G; Annaratone, L; Medico, E; D'Armento, G; Sapino, A				Bussolati, Gianni; Annaratone, Laura; Medico, Enzo; D'Armento, Giuseppe; Sapino, Anna			Formalin Fixation at Low Temperature Better Preserves Nucleic Acid Integrity	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUE; GENOME GENE-EXPRESSION; RNA EXTRACTION; BREAST-CANCER; OPTIMIZATION; TIME; RECOMMENDATIONS; RECOVERY; VACUUM; ISSUES	Fixation with formalin, a widely adopted procedure to preserve tissue samples, leads to extensive degradation of nucleic acids and thereby compromises procedures like microarray-based gene expression profiling. We hypothesized that RNA fragmentation is caused by activation of RNAses during the interval between formalin penetration and tissue fixation. To prevent RNAse activation, a series of tissue samples were kept under-vacuum at 4 degrees C until fixation and then fixed at 4 degrees C, for 24 hours, in formalin followed by 4 hours in ethanol 95%. This cold-fixation (CF) procedure preserved DNA and RNA, so that RNA segments up to 660 bp were efficiently amplified. Histological and immunohistochemical features were fully comparable with those of standard fixation. Microarray-based gene expression profiles were comparable with those obtained on matched frozen samples for probes hybridizing within 700 bases from the reverse transcription start site. In conclusion, CF preserves tissues and nucleic acids, enabling reliable gene expression profiling of fixed tissues.	[Bussolati, Gianni; Annaratone, Laura; D'Armento, Giuseppe; Sapino, Anna] Univ Turin, Dept Biomed Sci & Human Oncol, I-10124 Turin, Italy; [Medico, Enzo] Univ Turin, Inst Canc Res & Treatment IRCC, Dept Oncol Sci, Candiolo, Italy	University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin	Bussolati, G (corresponding author), Univ Turin, Dept Biomed Sci & Human Oncol, I-10124 Turin, Italy.	enzo.medico@ircc.it; anna.sapino@unito.it	Sapino, Anna/AGY-9901-2022; Medico, Enzo/AAC-3185-2021; Annaratone, Laura/J-9261-2016; Sapino, Anna/J-4113-2018	Sapino, Anna/0000-0003-3542-9571; Medico, Enzo/0000-0002-3917-2438; Annaratone, Laura/0000-0001-5750-1445; Sapino, Anna/0000-0003-3542-9571	MI.S.E.-ICE-CRUI, Uso del sottovuoto per la conservazione ed il trasferimento di biopsie [108]; AIRC [IG-9127]	MI.S.E.-ICE-CRUI, Uso del sottovuoto per la conservazione ed il trasferimento di biopsie; AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by MI.S.E.-ICE-CRUI Prog. n. 108 (2008) "Uso del sottovuoto per la conservazione ed il trasferimento di biopsie" research fund grants to G.B.; AIRC 2007-2009 "Micropapillary phenomenon: embolization, metastases and drug resistance" and AIRC 2010 "Tumour microenvironment and cell polarity in breast cancer: roles and implications for metastasis" research fund grants to A.S.; and AIRC (IG-9127) research fund grants to E.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz M, 2008, BIOTECHNIQUES, V44, P417, DOI 10.2144/000112703; April C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008162; Blum F, 1983, Z WISS MIKROSK, V10, P314; Bussolati G, 2008, VIRCHOWS ARCH, V452, P229, DOI 10.1007/s00428-007-0529-x; Chen J, 2007, DIAGN MOL PATHOL, V16, P61, DOI 10.1097/PDM.0b013e31802f0804; Chung JY, 2008, J HISTOCHEM CYTOCHEM, V56, P1033, DOI 10.1369/jhc.2008.951863; Dabbs DJ, 2008, AM J CLIN PATHOL, V129, P355, DOI 10.1309/NKF29KCHNMYEMCT3; Di Novi C, 2010, SCI TOTAL ENVIRON, V408, P3092, DOI 10.1016/j.scitotenv.2010.04.022; Dotti I, 2010, DIAGN MOL PATHOL, V19, P112, DOI 10.1097/PDM.0b013e3181b520f8; Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7; Ferrer I, 2007, BRAIN PATHOL, V17, P297, DOI 10.1111/j.1750-3639.2007.00073.x; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Fu LM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-3; Goldstein NS, 2007, APPL IMMUNOHISTO M M, V15, P124, DOI 10.1097/PAI.0b013e31804c7283; Goldstein NS, 2003, AM J CLIN PATHOL, V120, P86, DOI 10.1309/QPHDRB00QXGMUQ9N; HELANDER KG, 1994, BIOTECH HISTOCHEM, V69, P177, DOI 10.3109/10520299409106282; Hewitt SM, 2008, ARCH PATHOL LAB MED, V132, P1929, DOI 10.1043/1543-2165-132.12.1929; Kibriya MG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-622; Lewis F, 2001, J PATHOL, V195, P66, DOI 10.1002/1096-9896(200109)195:1<66::AID-PATH921>3.0.CO;2-F; Marchio C, 2009, J PATHOL, V219, P16, DOI 10.1002/path.2574; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Medeiros F, 2007, ARCH PATHOL LAB MED, V131, P1805; Paska C, 2004, DIAGN MOL PATHOL, V13, P234, DOI 10.1097/01.pdm.0000134778.37729.9f; Pearse A. G., 1980, HISTOCHEMISTRY THEOR; Scicchitano MS, 2006, J HISTOCHEM CYTOCHEM, V54, P1229, DOI 10.1369/jhc.6A6999.2006; STANTA G, 1991, BIOTECHNIQUES, V11, P304; van Maldegem F, 2008, DIAGN MOL PATHOL, V17, P51, DOI 10.1097/PDM.0b013e31814b8866; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775	28	58	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21043	10.1371/journal.pone.0021043	http://dx.doi.org/10.1371/journal.pone.0021043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698245	Green Submitted, Green Published, gold			2022-12-25	WOS:000291730000043
J	Li, Y; Jaramillo-Lambert, AN; Yang, Y; Williams, R; Lee, NH; Zhu, W				Li, Y.; Jaramillo-Lambert, A. N.; Yang, Y.; Williams, R.; Lee, N. H.; Zhu, W.			And-1 is required for the stability of histone acetyltransferase Gcn5	ONCOGENE			English	Article						Ctf4/And-1; Gcn5; DNA replication; histone acetylation	DNA-POLYMERASE-ALPHA; BINDING PROTEIN; REPLICATION; ACETYLATION; COMPLEX; CTF4; YEAST; DOMAIN; H3; ACTIVATION	Histone acetyltransferases (HATs) have a central role in the modification of chromatin as well as in the pathogenesis of a broad set of diseases including cancers. Gcn5 is the first identified transcription-related HAT that has been implicated in the regulation of diverse cellular functions. However, how Gcn5 proteins are regulated remains largely unknown. Here we show that acidic nucleoplasmic DNA-binding protein (And-1, a high mobility group domain-containing protein) has remarkable capability to regulate the stability of Gcn5 proteins and thereby histone H3 acetylation. We find that And-1 forms a complex with both histone H3 and Gcn5. Downregulation of And-1 results in Gcn5 degradation, leading to the reduction of H3K9 and H3K56 acetylation. And-1 overexpression stabilizes Gcn5 through protein-protein interactions in vivo. Furthermore, And-1 expression is increased in cancer cells in a manner correlating with increased Gcn5 and H3K9Ac and H3K56Ac. Thus, our data reveal not only a functional link between Gcn5 and And-1 that is essential for Gcn5 protein stability and histone H3 acetylation, but also a potential role of And-1 in cancer. Oncogene (2012) 31, 643-652; doi:10.1038/onc.2011.261; published online 4 July 2011	[Li, Y.; Jaramillo-Lambert, A. N.; Yang, Y.; Zhu, W.] George Washington Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Williams, R.; Lee, N. H.] George Washington Univ, Sch Med, Dept Pharmacol & Physiol, Washington, DC 20037 USA	George Washington University; George Washington University	Zhu, W (corresponding author), George Washington Univ, Sch Med, Dept Biochem & Mol Biol, 2300 Eye St NW, Washington, DC 20037 USA.	bcmwxz@gwumc.edu		Jaramillo-Lambert, Aimee/0000-0001-7697-8580	National Institutes of Health [4R00CA136555, CA120316]; NATIONAL CANCER INSTITUTE [R01CA120316, R00CA136555] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Anindya Dutta for And-1 plasmids and antibodies, Ezra Burstein for Gcn5 plasmids, Rakesh Kumar and Jeyanthy Eswaran for reading the manuscript. This work was supported by funding from the National Institutes of Health (4R00CA136555 awarded to WZ; CA120316 awarded to NHL).	Armas-Pineda C, 2007, J EXP CLIN CANC RES, V26, P269; Atanassov BS, 2009, MOL CELL, V35, P352, DOI 10.1016/j.molcel.2009.06.015; Bermudez VP, 2010, J BIOL CHEM, V285, P9493, DOI 10.1074/jbc.M109.093609; Brand M, 2001, EMBO J, V20, P3187, DOI 10.1093/emboj/20.12.3187; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Burgess RJ, 2010, CELL CYCLE, V9, P2979, DOI 10.4161/cc.9.15.12498; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Cavusoglu N, 2003, PROTEOMICS, V3, P217, DOI 10.1002/pmic.200390030; Celic I, 2008, GENETICS, V179, P1769, DOI 10.1534/genetics.108.088914; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Espinosa MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008964; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Goren A, 2008, GENE DEV, V22, P1319, DOI 10.1101/gad.468308; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Karnani N, 2007, GENOME RES, V17, P865, DOI 10.1101/gr.5427007; Kikuchi H, 2011, BIOCHEM BIOPH RES CO, V405, P657, DOI 10.1016/j.bbrc.2011.01.088; KOUPRINA N, 1992, MOL CELL BIOL, V12, P5736, DOI 10.1128/MCB.12.12.5736; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Lang SE, 2001, J BIOL CHEM, V276, P32627, DOI 10.1074/jbc.M102067200; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Liu XH, 2003, J BIOL CHEM, V278, P20405, DOI 10.1074/jbc.M211795200; Lucas I, 2007, EMBO REP, V8, P770, DOI 10.1038/sj.embor.7401026; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Orpinell M, 2010, EMBO J, V29, P2381, DOI 10.1038/emboj.2010.125; Paolinelli R, 2009, NAT STRUCT MOL BIOL, V16, P412, DOI 10.1038/nsmb.1583; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Tsutsui Y, 2005, CURR GENET, V48, P34, DOI 10.1007/s00294-005-0584-2; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wang LA, 1997, MOL CELL BIOL, V17, P519, DOI 10.1128/MCB.17.1.519; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Williams DR, 2002, EUKARYOT CELL, V1, P758, DOI 10.1128/EC.1.5.758-773.2002; Yoshizawa-Sugata N, 2009, J BIOL CHEM, V284, P20718, DOI 10.1074/jbc.M806711200; Zhou J, 2005, CELL CYCLE, V4, P889, DOI 10.4161/cc.4.7.1823; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	46	23	23	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	5					643	652		10.1038/onc.2011.261	http://dx.doi.org/10.1038/onc.2011.261			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MS	21725360	Green Accepted			2022-12-25	WOS:000300221800010
J	Wang, P; Zhu, F; Tong, ZQ; Konstantopoulos, K				Wang, Pu; Zhu, Fei; Tong, ZiQiu; Konstantopoulos, Konstantinos			Response of chondrocytes to shear stress: antagonistic effects of the binding partners Toll-like receptor 4 and caveolin-1	FASEB JOURNAL			English	Article						interleukin-6; mPGES-1; L-PGDS	PROTEIN-KINASE-A; OSTEOARTHRITIC CHONDROCYTES; INTERLEUKIN-6 EXPRESSION; PROSTAGLANDIN D-2; NITRIC-OXIDE; CROSS-TALK; PATHWAY; CARTILAGE; MAPK; INFLAMMATION	Osteoarthritis (OA) is often a consequence of excessive mechanical loading of cartilage, which produces hydrostatic stress, tensile strain, and fluid flow. Application of high fluid shear to chondrocytes recapitulates the earmarks of OA, as evidenced by the induction of cyclooxygenase-2, prostaglandins (PGs), and interleukin-6 (IL-6). Here, we delineated the signaling pathway by which high fluid shear mediates the temporal regulation of IL-6 synthesis in human chondrocytes. We determined that Toll-like receptor 4 (TLR4) and caveolin-1 are binding partners in chondrocytes. Their expression is temporally regulated by fluid shear via the sequential up-regulation of microsomal PGE synthase-1 (mPGES-1) and L-PGDS. High shear stress rapidly induces an 8-fold up-regulation of TLR4 expression via an mPGES-1-dependent pathway, whereas prolonged shear exposure concurrently down-regulates TLR4 by >4-fold and up-regulates caveolin-1 expression by > 2.5-fold in an L-PGDS-dependent manner. TLR4 and caveolin-1 exert opposing effects on the activation of ERK1/2, PI3-K and PKA signaling pathways, which, in turn, regulate the NF-kappa B-dependent IL-6 synthesis in a time-dependent fashion. Reconstructing the signaling network regulating shear-induced IL-6 expression in chondrocytes may provide insights for developing therapeutic strategies to combat osteoarthritis.-Wang, P., Zhu, F., Tong, Z., Konstantopoulos, K. Response of chondrocytes to shear stress: antagonistic effects of the binding partners Toll-like receptor 4 and caveolin-1. FASEB J. 25, 3401-3415 (2011). www.fasebj.org	[Wang, Pu; Zhu, Fei; Tong, ZiQiu; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD 21218 USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Konstantopoulos, K (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	konstant@jhu.edu	Tong, Ziqiu/AAR-6182-2020; Konstantopoulos, Konstantinos/A-7045-2011	Tong, Ziqiu/0000-0003-4183-1858; 	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [RO1 AR053358]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053358] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases grant RO1 AR053358.	Abulencia JP, 2003, J BIOL CHEM, V278, P28388, DOI 10.1074/jbc.M301378200; Amin AR, 1997, J CLIN INVEST, V99, P1231, DOI 10.1172/JCI119280; Bobacz K, 2007, ARTHRITIS RHEUM-US, V56, P1880, DOI 10.1002/art.22637; Bokmann S, 2003, EUR J CANCER PREV, V12, P469, DOI [10.1097/01.cej.0000102800.33147.d9, 10.1097/00008469-200312000-00005]; Brenn D, 2007, ARTHRITIS RHEUM, V56, P351, DOI 10.1002/art.22282; Buckwalter JA, 2006, BIORHEOLOGY, V43, P603; Dai SM, 2006, ARTHRITIS RHEUM-US, V54, P818, DOI 10.1002/art.21639; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Fahmi H, 2001, ARTHRITIS RHEUM, V44, P595, DOI 10.1002/1529-0131(200103)44:3<595::AID-ANR108>3.3.CO;2-#; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Goldring MB, 2004, METH MOLEC MED, V100, P37; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; He Q, 2010, AM J PHYSIOL-HEART C, V298, pH136, DOI 10.1152/ajpheart.00251.2009; Healy ZR, 2008, AM J PHYSIOL-CELL PH, V294, pC1146, DOI 10.1152/ajpcell.00542.2007; Healy ZR, 2005, P NATL ACAD SCI USA, V102, P14010, DOI 10.1073/pnas.0506620102; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Li XF, 2005, J RHEUMATOL, V32, P887; Mohtai M, 1996, J ORTHOP RES, V14, P67, DOI 10.1002/jor.1100140112; Muller G, 1999, CELL MOL LIFE SCI, V56, P945, DOI 10.1007/s000180050485; Palmer CD, 2008, BLOOD, V111, P1781, DOI 10.1182/blood-2007-07-102343; Pavlides S, 2010, CELL CYCLE, V9, P2201, DOI 10.4161/cc.9.11.11848; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; Portanova JP, 1996, J EXP MED, V184, P883, DOI 10.1084/jem.184.3.883; Qian YG, 2009, J CANCER RES CLIN, V135, P379, DOI 10.1007/s00432-008-0478-z; Razani B, 2001, AM J PHYSIOL-CELL PH, V281, pC1241, DOI 10.1152/ajpcell.2001.281.4.C1241; Schuligoi R, 2005, BIOCHEM BIOPH RES CO, V335, P684, DOI 10.1016/j.bbrc.2005.07.130; Shan ZZ, 2004, J BIOL CHEM, V279, P37939, DOI 10.1074/jbc.M402424200; Song JM, 2007, PLOS PATHOG, V3, P541, DOI 10.1371/journal.ppat.0030060; Starkman BG, 2005, BIOCHEM J, V389, P723, DOI 10.1042/BJ20041636; Walton KA, 2003, ARTERIOSCL THROM VAS, V23, P1197, DOI 10.1161/01.ATV.0000079340.80744.B8; Wang P, 2010, J BIOL CHEM, V285, P24793, DOI 10.1074/jbc.M110.110320; Wang P, 2010, AM J PHYSIOL-CELL PH, V298, pC1445, DOI 10.1152/ajpcell.00508.2009; Wang XM, 2009, J IMMUNOL, V182, P3809, DOI 10.4049/jimmunol.0712437; Wang XM, 2006, AM J RESP CELL MOL, V34, P434, DOI 10.1165/rcmb.2005-0376OC; Yudoh K, 2009, INT J RHEUM DIS, V12, P90, DOI 10.1111/j.1756-185X.2009.01390.x; Zayed N, 2008, ARTHRITIS RHEUM-US, V58, P3530, DOI 10.1002/art.23958; Zayed N, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2581; Zhu F, 2010, CELL DEATH DIFFER, V17, P1325, DOI 10.1038/cdd.2010.13; Zhu F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015174	39	64	66	0	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3401	3415		10.1096/fj.11-184861	http://dx.doi.org/10.1096/fj.11-184861			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21715681	Green Published			2022-12-25	WOS:000295356400012
J	Fukushima, M; Villar, J; Tsai-Morris, CH; Dufau, ML				Fukushima, Masato; Villar, Joaquin; Tsai-Morris, Chon-Hwa; Dufau, Maria L.			Gonadotropin-regulated Testicular RNA Helicase (GRTH/DDX25), a Negative Regulator of Luteinizing/Chorionic Gonadotropin Hormone-induced Steroidogenesis in Leydig Cells CENTRAL ROLE OF STEROIDOGENIC ACUTE REGULATORY PROTEIN (StAR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED STEROIDOGENESIS; CHOLESTEROL; TRANSLATION; MODULATION	Gonadotropin-regulated testicular RNA helicase (GRTH/DDX25) is a testis-specific gonadotropin-regulated RNA helicase that is present in Leydig cells (LCs) and germ cells and is essential for spermatid development and completion of spermatogenesis. Normal basal levels of testosterone in serum and LCs were observed in GRTH null (GRTH(-/-)) mice. However, testosterone production was enhanced in LCs of GRTH(-/-) mice compared with WT mice by both in vivo and in vitro human chorionic gonadotropin stimulation. LCs of GRTH(-/-) mice had swollen mitochondria with a significantly increased cholesterol content in the inner mitochondrial membrane. Basal protein levels of SREBP2, HMG-CoAreductase, and steroidogenic acute regulatory protein (StAR; a protein that transports cholesterol to the inner mitochondrial membrane) were markedly increased in LCs of GRTH(-/-) mice compared with WT mice. Gonadotropin stimulation caused an increase in StAR mRNA levels and protein expression inGRTH(-/-) mice versus WT mice, with no further increase in SREBP2 and down-regulation of HMG-CoA reductase protein. The half-life of StAR mRNA was significantly increased in GRTH(-/-) mice. Moreover, association of StAR mRNA with GRTH protein was observed in WT mice. Human chorionic gonadotropin increased GRTH gene expression and its associated StAR protein at cytoplasmic sites. Taken together, these findings indicate that, through its negative role in StAR message stability, GRTH regulates cholesterol availability at the mitochondrial level. The finding of an inhibitory action of GRTH associated with gonadotropin-mediated steroidogenesis has provided insights into a novel negative autocrine molecular control mechanism of this helicase in the regulation of steroid production in the male.	[Fukushima, Masato; Villar, Joaquin; Tsai-Morris, Chon-Hwa; Dufau, Maria L.] Eunice Kennedy Shriver NICHD, Sect Mol Endocrinol, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dufau, ML (corresponding author), Eunice Kennedy Shriver NICHD, Sect Mol Endocrinol, Program Dev Endocrinol & Genet, NIH, Bldg 49,Rm 6A-36, Bethesda, MD 20892 USA.	dufaum@mail.nih.gov		Tsai Morris, Chon Hwa/0000-0002-8113-0979	NICHD, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000150] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the NICHD Intramural Research Program, National Institutes of Health.	Allen JA, 2006, ENDOCRINOLOGY, V147, P3924, DOI 10.1210/en.2005-1204; AQUILANO DR, 1984, ENDOCRINOLOGY, V114, P499, DOI 10.1210/endo-114-2-499; Barbar E, 2009, MOL CELL ENDOCRINOL, V300, P89, DOI 10.1016/j.mce.2008.12.007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHARREAU EH, 1981, J BIOL CHEM, V256, P2719; Dufau ML, 2007, TRENDS ENDOCRIN MET, V18, P314, DOI 10.1016/j.tem.2007.09.001; Dyson MT, 2008, BIOL REPROD, V78, P267, DOI 10.1095/biolreprod.107.064238; Eacker SM, 2008, MOL ENDOCRINOL, V22, P623, DOI 10.1210/me.2006-0534; Haelens A, 1999, MOL CELL ENDOCRINOL, V153, P91, DOI 10.1016/S0303-7207(99)00079-9; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Manna PR, 2009, ENDOCRINOLOGY, V150, P3308, DOI 10.1210/en.2008-1668; Mascaro C, 2000, BIOCHEM J, V350, P785, DOI 10.1042/0264-6021:3500785; Midzak A, 2011, MOL CELL ENDOCRINOL, V336, P70, DOI 10.1016/j.mce.2010.12.007; Sato H, 2010, BBA-MOL CELL RES, V1803, P534, DOI 10.1016/j.bbamcr.2010.02.004; Sheng Y, 2003, J BIOL CHEM, V278, P27796, DOI 10.1074/jbc.M302411200; Sheng Y, 2006, J BIOL CHEM, V281, P35048, DOI 10.1074/jbc.M605086200; Tang PZ, 1998, ENDOCRINOLOGY, V139, P4496, DOI 10.1210/en.139.11.4496; Tang PZ, 1999, J BIOL CHEM, V274, P37932, DOI 10.1074/jbc.274.53.37932; Tsai-Morris CH, 2004, GENE, V331, P83, DOI 10.1016/j.gene.2004.02.004; Tsai-Morris CH, 2004, P NATL ACAD SCI USA, V101, P6373, DOI 10.1073/pnas.0401855101; Tsai-Morris CH, 2010, J ANDROL, V31, P45, DOI 10.2164/jandrol.109.008219; TSAIMORRIS CH, 1985, ENDOCRINOLOGY, V116, P31, DOI 10.1210/endo-116-1-31; Villar J, 2010, FASEB J, V24	23	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29932	29940		10.1074/jbc.M111.236083	http://dx.doi.org/10.1074/jbc.M111.236083			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21719703	hybrid, Green Published			2022-12-25	WOS:000294046600052
J	Keber, R; Motaln, H; Wagner, KD; Debeljak, N; Rassoulzadegan, M; Acimovic, J; Rozman, D; Horvat, S				Keber, Rok; Motaln, Helena; Wagner, Kay D.; Debeljak, Natasa; Rassoulzadegan, Minoo; Acimovic, Jure; Rozman, Damjana; Horvat, Simon			Mouse Knockout of the Cholesterogenic Cytochrome P450 Lanosterol 14 alpha-Demethylase (Cyp51) Resembles Antley-Bixler Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR SUPPRESSOR WT1; HMG-COA REDUCTASE; EMBRYONIC LETHALITY; CORONARY VASCULOGENESIS; TARGETED DISRUPTION; P450 OXIDOREDUCTASE; GENE-EXPRESSION; RXR-ALPHA; MICE; RECEPTOR	Antley-Bixler syndrome (ABS) represents a group of heterogeneous disorders characterized by skeletal, cardiac, and urogenital abnormalities that have frequently been associated with mutations in fibroblast growth factor receptor 2 or cytochrome P450 reductase genes. In some ABS patients, reduced activity of the cholesterogenic cytochrome P450 CYP51A1, an ortholog of the mouse CYP51, and accumulation of lanosterol and 24,25-dihydrolanosterol has been reported, but the role of CYP51A1 in the ABS etiology has remained obscure. To test whether Cyp51 could be involved in generating an ABS-like phenotype, a mouse knock-out model was developed that exhibited several prenatal ABS-like features leading to lethality at embryonic day 15. Cyp51(-/-) mice had no functional Cyp51 mRNA and no immunodetectable CYP51 protein. The two CYP51 enzyme substrates (lanosterol and 24,25-dihydrolanosterol) were markedly accumulated. Cholesterol precursors downstream of the CYP51 enzymatic step were not detected, indicating that the targeting in this study blocked de novo cholesterol synthesis. This was reflected in the up-regulation of 10 cholesterol synthesis genes, with the exception of 7-dehydrocholesterol reductase. Lethality was ascribed to heart failure due to hypoplasia, ventricle septum, and epicardial and vasculogenesis defects, suggesting that Cyp51 deficiency was involved in heart development and coronary vessel formation. As the most likely downstream molecular mechanisms, alterations were identified in the sonic hedgehog and retinoic acid signaling pathways. Cyp51 knock-out mice provide evidence that Cyp51 is essential for embryogenesis and present a potential animal model for studying ABS syndrome in humans.	[Keber, Rok; Motaln, Helena; Horvat, Simon] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Ljubljana 1000, Slovenia; [Debeljak, Natasa; Acimovic, Jure; Rozman, Damjana] Univ Ljubljana, Fac Med, Ctr Funct Genom & Biochips, Inst Biochem, Ljubljana 1000, Slovenia; [Motaln, Helena] Natl Inst Biol, Dept Genet Toxicol Canc Biol, Ljubljana 1000, Slovenia; [Horvat, Simon] Natl Inst Chem, Ljubljana 1000, Slovenia; [Wagner, Kay D.] INSERM, U907, Sophia Antipolis, France; [Wagner, Kay D.; Rassoulzadegan, Minoo] Univ Nice, Sophia Antipolis, France; [Rassoulzadegan, Minoo] Fac Med Nice, INSERM, Ctr Biochim, U636, F-06034 Nice, France	University of Ljubljana; University of Ljubljana; National Institute of Biology - Slovenia; National Institute of Chemistry - Slovenia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Horvat, S (corresponding author), Univ Ljubljana, Biotech Fac, Dept Anim Sci, Groblje 3, Domzale 1230, Slovenia.	simon.horvat@bf.uni-lj.si	Motaln, Helena/AAF-3489-2019; Motaln, Helena/AAD-1507-2022; Rassoulzadegan, Minoo/O-7939-2016; Wagner, Kay-Dietrich/E-6119-2016	Motaln, Helena/0000-0002-0646-7934; Wagner, Kay-Dietrich/0000-0001-5483-7760; Rozman, Damjana/0000-0002-6501-2163; Debeljak, Natasa/0000-0003-1294-292X	Association pour la Recherche sur le Cancer; Fondation Coeur et Arteres; Slovenian Research Agency [P4-0220, P4-0104, J1-9438, J2-2197]	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation Coeur et Arteres; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by grants from the Association pour la Recherche sur le Cancer and Fondation Coeur et Arteres (to K. D. W.), and Slovenian Research Agency for core funding program P4-0220 and project 878 and project Syntol (to S. H.), program P4-0104 and projects J1-9438 and J2-2197 (to D. R.), a post-doctoral fellowship (to H. M.), and young researcher Ph.D. scholarship (to R. K.).	Acimovic J, 2009, J CHROMATOGR B, V877, P2081, DOI 10.1016/j.jchromb.2009.05.050; Aleck KA, 1997, AM J MED GENET, V72, P253, DOI 10.1002/(SICI)1096-8628(19971031)72:3&lt;253::AID-AJMG1&gt;3.0.CO;2-S; Antley R, 1975, Birth Defects Orig Artic Ser, V11, P397; Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Beachy PA, 1997, COLD SPRING HARB SYM, V62, P191; BINNS WAYNE, 1959, JOUR AMER VET MED ASSOC, V134, P180; Bischoff SR, 2009, BIOL REPROD, V81, P906, DOI 10.1095/biolreprod.109.078139; Cragun DL, 2004, AM J MED GENET A, V129A, P1, DOI 10.1002/ajmg.a.30170; Cunningham D, 2005, J LIPID RES, V46, P1150, DOI 10.1194/jlr.M400462-JLR200; Debeljak N, 2000, ARCH BIOCHEM BIOPHYS, V379, P37, DOI 10.1006/abbi.2000.1859; Fakheri RJ, 2011, STEROIDS, V76, P211, DOI 10.1016/j.steroids.2010.10.003; Fitzky BU, 2001, J CLIN INVEST, V108, P905, DOI 10.1172/JCI200112103; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Fukami M, 2005, J CLIN ENDOCR METAB, V90, P414, DOI 10.1210/jc.2004-0810; Gibbons GF, 2002, LIPIDS, V37, P1163, DOI 10.1007/s11745-002-1016-x; Hager EJ, 2007, J INHERIT METAB DIS, V30, P888, DOI 10.1007/s10545-007-0776-7; Horvat S, 2011, DRUG METAB REV, V43, P69, DOI 10.3109/03602532.2010.540580; Huq MDM, 2006, EMBO J, V25, P3203, DOI 10.1038/sj.emboj.7601181; Hyett JA, 2002, PRENATAL DIAG, V22, P864, DOI 10.1002/pd.413; Javitt NB, 2008, STEROIDS, V73, P149, DOI 10.1016/j.steroids.2007.10.004; JEGALIAN BG, 1992, CELL, V71, P901, DOI 10.1016/0092-8674(92)90387-R; Jiang XS, 2010, MOL CELL PROTEOMICS, V9, P1461, DOI 10.1074/mcp.M900548-MCP200; Jokela H, 2010, ENDOCRINOLOGY, V151, P1884, DOI 10.1210/en.2009-0928; Kastner P, 1997, DEVELOPMENT, V124, P4749; KEMPEN HJ, 1987, BIOCHEM PHARMACOL, V36, P1245, DOI 10.1016/0006-2952(87)90077-3; Kenworthy A, 2002, TRENDS BIOCHEM SCI, V27, P435, DOI 10.1016/S0968-0004(02)02178-3; Kim JH, 2001, J BIOL CHEM, V276, P18153, DOI 10.1074/jbc.M101661200; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Krakowiak PA, 2003, HUM MOL GENET, V12, P1631, DOI 10.1093/hmg/ddg172; Lamb DC, 1999, YEAST, V15, P755, DOI 10.1002/(SICI)1097-0061(19990630)15:9&lt;755::AID-YEA417&gt;3.0.CO;2-8; Lauth M, 2010, MOL PHARMACOL, V78, P486, DOI 10.1124/mol.110.066431; Lavine KJ, 2008, J CLIN INVEST, V118, P2404, DOI 10.1172/JCI34561; LEE BE, 1992, PEDIATR INFECT DIS J, V11, P1062, DOI 10.1097/00006454-199211120-00017; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; McGlaughlin KL, 2010, J CRANIOFAC SURG, V21, P1560, DOI 10.1097/SCS.0b013e3181ec6afe; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Mirza R, 2006, J INVEST DERMATOL, V126, P638, DOI 10.1038/sj.jid.5700111; Mirza R, 2009, AM J DERMATOPATH, V31, P446, DOI 10.1097/DAD.0b013e318196f10c; Ohashi K, 2003, J BIOL CHEM, V278, P42936, DOI 10.1074/jbc.M307228200; Olivey HE, 2010, CIRC RES, V106, P818, DOI 10.1161/CIRCRESAHA.109.209197; Otto DME, 2003, MOL CELL BIOL, V23, P6103, DOI 10.1128/MCB.23.17.6103-6116.2003; Peoples R, 2000, AM J HUM GENET, V66, P47, DOI 10.1086/302722; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Pursley TJ, 1996, CLIN INFECT DIS, V22, P336, DOI 10.1093/clinids/22.2.336; Rezen T, 2004, J MOL EVOL, V59, P51, DOI 10.1007/s00239-004-2603-1; Rhee DY, 2009, DEVELOPMENT, V136, P3185, DOI 10.1242/dev.032334; Shehu A, 2008, MOL ENDOCRINOL, V22, P2268, DOI 10.1210/me.2008-0165; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; SIMMONS DL, 1985, J BIOL CHEM, V260, P515; Stromstedt M, 1996, ARCH BIOCHEM BIOPHYS, V329, P73, DOI 10.1006/abbi.1996.0193; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Tanaka M, 1999, DEVELOPMENT, V126, P1439; Tozawa R, 1999, J BIOL CHEM, V274, P30843, DOI 10.1074/jbc.274.43.30843; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wagner KD, 2003, FASEB J, V17, P1364, DOI 10.1096/fj.02-1065fje; Wagner KD, 2002, FASEB J, V16, P1117, DOI 10.1096/fj.01-0986fje; Wagner N, 2005, GENE DEV, V19, P2631, DOI 10.1101/gad.346405; Walker DL, 2005, DEV BIOL, V284, P479, DOI 10.1016/j.ydbio.2005.06.004; Wassif CA, 2001, HUM MOL GENET, V10, P555, DOI 10.1093/hmg/10.6.555; Wechsler A, 2003, SCIENCE, V302, P2087, DOI 10.1126/science.1090776	62	67	68	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29086	29097		10.1074/jbc.M111.253245	http://dx.doi.org/10.1074/jbc.M111.253245			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21705796	Green Published, hybrid			2022-12-25	WOS:000293837000045
J	Hannan, S; Wilkins, ME; Dehghani-Tafti, E; Thomas, P; Baddeley, SM; Smart, TG				Hannan, Saad; Wilkins, Megan E.; Dehghani-Tafti, Ebrahim; Thomas, Philip; Baddeley, Stuart M.; Smart, Trevor G.			gamma-Aminobutyric Acid Type B (GABA(B)) Receptor Internalization Is Regulated by the R2 Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE STABILITY; LYSOSOMAL DEGRADATION; ALPHA-BUNGAROTOXIN; GB2 SUBUNITS; BINDING; HETERODIMERIZATION; PATHWAY; PHOSPHORYLATION; TRAFFICKING; ENDOCYTOSIS	gamma-Aminobutyric acid type B (GABA(B)) receptors are important for slow synaptic inhibition in the CNS. The efficacy of inhibition is directly related to the stability of cell surface receptors. For GABA(B) receptors, heterodimerization between R1 and R2 subunits is critical for cell surface expression and signaling, but how this determines the rate and extent of receptor internalization is unknown. Here, we insert a high affinity alpha-bungarotoxin binding site into the N terminus of the R2 subunit and reveal its dominant role in regulating the internalization of GABA(B) receptors in live cells. To simultaneously study R1a and R2 trafficking, a new alpha-bungarotoxin binding site-labeling technique was used, allowing alpha-bungarotoxin conjugated to different fluorophores to selectively label R1a and R2 subunits. This approach demonstrated that R1a and R2 are internalized as dimers. In heterologous expression systems and neurons, the rates and extents of internalization for R1aR2 heteromers and R2 homomers are similar, suggesting a regulatory role for R2 in determining cell surface receptor stability. The fast internalization rate of R1a, which has been engineered to exit the endoplasmic reticulum, was slowed to that of R2 by truncating the R1a C-terminal tail or by removing a dileucine motif in its coiled-coil domain. Slowing the rate of internalization by co-assembly with R2 represents a novel role for GPCR heterodimerization whereby R2 subunits, via their C terminus coiled-coil domain, mask a dileucine motif on R1a subunits to determine the surface stability of the GABA(B) receptor.	[Hannan, Saad; Wilkins, Megan E.; Dehghani-Tafti, Ebrahim; Thomas, Philip; Smart, Trevor G.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Hannan, Saad; Baddeley, Stuart M.] GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England	University of London; University College London; GlaxoSmithKline	Smart, TG (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	t.smart@ucl.ac.uk	Hannan, Saad/AAX-6478-2020	Hannan, Saad/0000-0003-4594-0808; Wilkins, Megan/0000-0003-0150-4457	Medical Research Council; Biotechnology and Biological Sciences Research Council-GlaxoSmithKline; MRC [G0601529] Funding Source: UKRI; Medical Research Council [G0601529] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council-GlaxoSmithKline(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)GlaxoSmithKline); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council and by a Biotechnology and Biological Sciences Research Council-GlaxoSmithKline studentship.	Arancibia-Carcamo IL, 2009, P NATL ACAD SCI USA, V106, P17552, DOI 10.1073/pnas.0905502106; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; BOWERY N, 1989, TRENDS PHARMACOL SCI, V10, P401, DOI 10.1016/0165-6147(89)90188-0; Bowery NG, 2000, J PHARMACOL EXP THER, V292, P2; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Couve A, 1998, J BIOL CHEM, V273, P26361, DOI 10.1074/jbc.273.41.26361; DEHOOP MJ, 1994, NEURON, V13, P11, DOI 10.1016/0896-6273(94)90456-1; Donnelly SR, 1999, HUM MOL GENET, V8, P1723, DOI 10.1093/hmg/8.9.1723; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Enna SJ, 2004, BIOCHEM PHARMACOL, V68, P1541, DOI 10.1016/j.bcp.2004.06.037; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Grampp T, 2008, MOL CELL NEUROSCI, V39, P628, DOI 10.1016/j.mcn.2008.09.004; Harel M, 2001, NEURON, V32, P265, DOI 10.1016/S0896-6273(01)00461-5; Havlickova M, 2002, MOL PHARMACOL, V62, P343, DOI 10.1124/mol.62.2.343; Jackson TR, 2000, TRENDS BIOCHEM SCI, V25, P489, DOI 10.1016/S0968-0004(00)01644-3; Kammerer RA, 1999, BIOCHEMISTRY-US, V38, P13263, DOI 10.1021/bi991018t; Kantamneni S, 2008, J NEUROCHEM, V107, P86, DOI 10.1111/j.1471-4159.2008.05580.x; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; MERESSE S, 1995, J CELL SCI, V108, P3349; Mohrmann K, 1999, MOL MEMBR BIOL, V16, P81, DOI 10.1080/096876899294797; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Pooler AM, 2009, EUR J NEUROSCI, V29, P869, DOI 10.1111/j.1460-9568.2009.06636.x; Restituito S, 2005, MOL CELL NEUROSCI, V28, P747, DOI 10.1016/j.mcn.2004.12.006; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Rondard P, 2008, EMBO J, V27, P1321, DOI 10.1038/emboj.2008.64; Stenmark H, 2001, GENOME BIOL, V2; Terunuma M, 2010, P NATL ACAD SCI USA, V107, P13918, DOI 10.1073/pnas.1000853107; Vargas KJ, 2008, J BIOL CHEM, V283, P24641, DOI 10.1074/jbc.M802419200; Villemure JF, 2005, BIOCHEM J, V388, P47, DOI 10.1042/BJ20041435; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wilkins ME, 2008, J BIOL CHEM, V283, P34745, DOI 10.1074/jbc.M803197200; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	43	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24324	24335		10.1074/jbc.M110.220814	http://dx.doi.org/10.1074/jbc.M110.220814			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21724853	Green Published, Bronze			2022-12-25	WOS:000292294900073
J	Zou, X; Coyle, D; Wong-Lin, K; Maguire, L				Zou, Xin; Coyle, Damien; Wong-Lin, KongFatt; Maguire, Liam			Computational Study of Hippocampal-Septal Theta Rhythm Changes Due to Beta-Amyloid-Altered Ionic Channels	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NEURONAL-ACTIVITY; PYRAMIDAL CELLS; FREQUENCY BANDS; K+ CHANNELS; DEMENTIA; INTERNEURONS; INHIBITION; ACTIVATION; DYNAMICS	Electroencephagraphy (EEG) of many dementia patients has been characterized by an increase in low frequency field potential oscillations. One of the characteristics of early stage Alzheimer's disease (AD) is an increase in theta band power (4-7 Hz). However, the mechanism(s) underlying the changes in theta oscillations are still unclear. To address this issue, we investigate the theta band power changes associated with beta-Amyloid (Ab) peptide (one of the main markers of AD) using a computational model, and by mediating the toxicity of hippocampal pyramidal neurons. We use an established biophysical hippocampal CA1-medial septum network model to evaluate four ionic channels in pyramidal neurons, which were demonstrated to be affected by Ab. They are the L-type Ca2+ channel, delayed rectifying K+ channel, A-type fast-inactivating K+ channel and large-conductance Ca2+-activated K+ channel. Our simulation results demonstrate that only the Ab inhibited A-type fast-inactivating K+ channel can induce an increase in hippocampo-septal theta band power, while the other channels do not affect theta rhythm. We further deduce that this increased theta band power is due to enhanced synchrony of the pyramidal neurons. Our research may elucidate potential biomarkers and therapeutics for AD. Further investigation will be helpful for better understanding of AD-induced theta rhythm abnormalities and associated cognitive deficits.	[Zou, Xin; Coyle, Damien; Wong-Lin, KongFatt; Maguire, Liam] Univ Ulster, Intelligent Syst Res Ctr, Derry, North Ireland	Ulster University	Zou, X (corresponding author), Univ Ulster, Intelligent Syst Res Ctr, Magee Campus, Derry, North Ireland.	x.zou@ulster.ac.uk	Coyle, Damien H/D-1161-2013; Coyle, Damien/S-5332-2019	Coyle, Damien H/0000-0002-4739-1040; Coyle, Damien/0000-0002-4739-1040; Maguire, Liam/0000-0001-6153-3298; Wong-Lin, KongFatt/0000-0001-8724-4398	Northern Ireland Department for Employment and Learning through its "Strengthening the All-Island Research Base" initiative	Northern Ireland Department for Employment and Learning through its "Strengthening the All-Island Research Base" initiative	This study is currently supported under the CNRT award by the Northern Ireland Department for Employment and Learning through its "Strengthening the All-Island Research Base" initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeli H, 2005, J ALZHEIMERS DIS, V7, P187; Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; BHATTACHARYA B, 2011, ADV EXPT MED BIOL, P718; BHATTACHARYA B, 2011, NEURAL NETW IN PRESS; Bonanni L, 2008, BRAIN, V131, P690, DOI 10.1093/brain/awm322; Braak H, 1998, J NEURAL TRANSM-SUPP, P97; Chen C, 2005, BIOCHEM BIOPH RES CO, V338, P1913, DOI 10.1016/j.bbrc.2005.10.169; Chi S, 2006, BRIT J PHARMACOL, V149, P1031, DOI 10.1038/sj.bjp.0706947; Chiaramonti R, 1997, NEUROPSYCHOBIOLOGY, V36, P153, DOI 10.1159/000119375; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Dauwels J, 2010, CURR ALZHEIMER RES, V7, P487, DOI 10.2174/156720510792231720; DAVIDSON RM, 1994, BRAIN RES, V643, P324, DOI 10.1016/0006-8993(94)90041-8; DEADWYLER SA, 1995, J PHARMACOL EXP THER, V273, P734; Furukawa K, 1996, NATURE, V379, P74, DOI 10.1038/379074a0; GERSTEIN GL, 1960, BIOPHYS J, V1, P15, DOI 10.1016/S0006-3495(60)86872-5; Good TA, 1996, BIOPHYS J, V70, P296, DOI 10.1016/S0006-3495(96)79570-X; Hajos M, 2004, NEUROSCIENCE, V126, P599, DOI 10.1016/j.neuroscience.2004.03.043; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Ihl R, 1996, BIOL PSYCHIAT, V39, P319, DOI 10.1016/0006-3223(95)00174-3; Jhamandas JH, 2001, J NEUROPHYSIOL, V86, P1312, DOI 10.1152/jn.2001.86.3.1312; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Li X., 2010, NEURORADIOLOGY; Mazzoni A, 2010, NEUROIMAGE, V52, P956, DOI 10.1016/j.neuroimage.2009.12.040; Morse TM, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00016; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Ponomareva NV, 2008, NEUROBIOL AGING, V29, P819, DOI 10.1016/j.neurobiolaging.2006.12.019; Qi Jin-Shun, 2001, Shengli Xuebao, V53, P198; Qi JS, 2004, SYNAPSE, V51, P165, DOI 10.1002/syn.10299; Robbe D, 2009, J NEUROSCI, V29, P12597, DOI 10.1523/JNEUROSCI.2407-09.2009; Rotstein HG, 2005, J NEUROPHYSIOL, V94, P1509, DOI 10.1152/jn.00957.2004; Roxin A, 2011, PHYSICA D, V240, P323, DOI 10.1016/j.physd.2010.09.009; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; Shirwany Najeeb A, 2007, Neuropsychiatr Dis Treat, V3, P597; Takahashi RH, 2010, NEUROBIOL AGING, V31, P1145, DOI 10.1016/j.neurobiolaging.2008.07.021; Tran MH, 2002, PEPTIDES, V23, P1271, DOI 10.1016/S0196-9781(02)00062-1; Villette V, 2010, J NEUROSCI, V30, P10991, DOI 10.1523/JNEUROSCI.6284-09.2010; Volicer L, 1997, INT J GERIATR PSYCH, V12, P913, DOI 10.1002/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.3.CO;2-4; Wang XJ, 1998, J NEUROPHYSIOL, V79, P1549, DOI 10.1152/jn.1998.79.3.1549; Wang XJ, 2002, J NEUROPHYSIOL, V87, P889, DOI 10.1152/jn.00135.2001; Wang XJ, 1996, J NEUROSCI, V16, P6402; WARMAN EN, 1994, J NEUROPHYSIOL, V71, P2033, DOI 10.1152/jn.1994.71.6.2033; Webster NJ, 2006, NEUROBIOL AGING, V27, P439, DOI 10.1016/j.neurobiolaging.2005.02.002; Ye H, 2010, NEUROBIOL AGING, V31, P591, DOI 10.1016/j.neurobiolaging.2008.05.012; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110; Yu SP, 1998, NEUROBIOL DIS, V5, P81, DOI 10.1006/nbdi.1998.0186	48	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21579	10.1371/journal.pone.0021579	http://dx.doi.org/10.1371/journal.pone.0021579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720560	Green Published, Green Submitted, gold			2022-12-25	WOS:000292036900056
J	Brune, M; Schobel, A; Karau, R; Faustmann, PM; Dermietzel, R; Juckel, G; Petrasch-Parwez, E				Bruene, Martin; Schoebel, Andreas; Karau, Ramona; Faustmann, Pedro M.; Dermietzel, Rolf; Juckel, Georg; Petrasch-Parwez, Elisabeth			Neuroanatomical Correlates of Suicide in Psychosis: The Possible Role of von Economo Neurons	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; FRONTOTEMPORAL DEMENTIA; CEREBRAL-CORTEX; GREAT APES; SCHIZOPHRENIA; HUMANS; EVOLUTION; RISK; REEXAMINATION; PSYCHOLOGY	Suicide is the most important incident in psychiatric disorders. Psychological pain and empathy to pain involves a neural network that involves the anterior cingulate cortex (ACC) and the anterior insula (AI). At the neuronal level, little is known about how complex emotions such as shame, guilt, self-derogation and social isolation, all of which feature suicidal behavior, are represented in the brain. Based on the observation that the ACC and the AI contain a large spindle-shaped cell type, referred to as von Economo neuron (VEN), which has dramatically increased in density during human evolution, and on growing evidence that VENs play a role in the pathophysiology of various neuropsychiatric disorders, including autism, psychosis and dementia, we examined the density of VENs in the ACC of suicide victims. The density of VENs was determined using cresyl violet-stained sections of the ACC of 39 individuals with psychosis (20 cases with schizophrenia, 19 with bipolar disorder). Nine subjects had died from suicide. Twenty specimen were available from the right, 19 from the left ACC. The density of VENs was significantly greater in the ACC of suicide victims with psychotic disorders compared with psychotic individuals who died from other causes. This effect was restricted to the right ACC. VEN density in the ACC seems to be increased in suicide victims with psychosis. This finding may support the assumption that VEN have a special role in emotion processing and self-evaluation, including negative self-appraisal.	[Bruene, Martin] Univ Hosp Bochum, Res Dept Cognit Neuropsychiat & Psychiat Prevent, Bochum, Germany; [Bruene, Martin; Juckel, Georg] Ruhr Univ Bochum, Univ Hosp Bochum, Dept Psychiat, Bochum, Germany; [Schoebel, Andreas; Karau, Ramona; Faustmann, Pedro M.; Dermietzel, Rolf; Petrasch-Parwez, Elisabeth] Ruhr Univ Bochum, Inst Anat, Dept Neuroanat & Mol Brain Res, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Brune, M (corresponding author), Univ Hosp Bochum, Res Dept Cognit Neuropsychiat & Psychiat Prevent, Bochum, Germany.	martin.bruene@rub.de	Brüne, Martin/AAX-3202-2020	Brüne, Martin/0000-0002-2507-0561	Stanley Medical Research Institute [07R - 1750]	Stanley Medical Research Institute	The study was supported by a grant from the Stanley Medical Research Institute (grant number 07R - 1750). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman J, 2002, NEUROSCIENTIST, V8, P335, DOI 10.1177/107385840200800409; Allman JM, 2005, TRENDS COGN SCI, V9, P367, DOI 10.1016/j.tics.2005.06.008; Allman JM, 2001, ANN NY ACAD SCI, V935, P107, DOI 10.1111/j.1749-6632.2001.tb03476.x; Allman JM, 2010, BRAIN STRUCT FUNCT, V214, P495, DOI 10.1007/s00429-010-0254-0; Amador XF, 1996, AM J PSYCHIAT, V153, P1185; Antypa N, 2011, NEUROSCIENCE, V172, P303, DOI 10.1016/j.neuroscience.2010.10.042; Bostwick JM, 2000, AM J PSYCHIAT, V157, P1925, DOI 10.1176/appi.ajp.157.12.1925; Brune M, 2008, NEUROPSYCHOLOGIA, V46, P1992, DOI 10.1016/j.neuropsychologia.2008.01.023; Brune M, 2010, ACTA NEUROPATHOL, V119, P771, DOI 10.1007/s00401-010-0673-2; Butti C, 2009, J COMP NEUROL, V515, P243, DOI 10.1002/cne.22055; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Economo C.v., 1926, Z GES NEUROL PSYCH, V100, P706, DOI [10.1007/BF02970950, DOI 10.1007/BF02970950]; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fajardo C, 2008, NEUROSCI LETT, V435, P215, DOI 10.1016/j.neulet.2008.02.048; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gilbert P, 2010, BRIT J CLIN PSYCHOL, V49, P563, DOI 10.1348/014466509X479771; Hakeem AY, 2009, ANAT REC, V292, P242, DOI 10.1002/ar.20829; Hof PR, 2007, ANAT REC, V290, P1, DOI 10.1002/ar.a.20407; Joiner TE, 2005, ANNU REV PSYCHOL, V56, P287, DOI 10.1146/annurev.psych.56.091103.070320; Kaufman JA, 2008, ACTA NEUROPATHOL, V116, P479, DOI 10.1007/s00401-008-0434-7; Longe O, 2010, NEUROIMAGE, V49, P1849, DOI 10.1016/j.neuroimage.2009.09.019; Lysaker PH, 2007, SCHIZOPHRENIA BULL, V33, P192, DOI 10.1093/schbul/sbl016; Nimchinsky EA, 1999, P NATL ACAD SCI USA, V96, P5268, DOI 10.1073/pnas.96.9.5268; NIMCHINSKY EA, 1995, J COMP NEUROL, V355, P27, DOI 10.1002/cne.903550106; NORTHOFF G, 2010, CONSC C; Palmer BA, 2005, ARCH GEN PSYCHIAT, V62, P247, DOI 10.1001/archpsyc.62.3.247; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; REUTERLORENZ P, 1981, NEUROPSYCHOLOGIA, V19, P609, DOI 10.1016/0028-3932(81)90030-0; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; SANTOS M, 2009, BRAIN RES IN PRESS, DOI DOI 10.1016/J.BRAINRES.2010.08.067); Schwartz RC, 2004, J PSYCHIATR RES, V38, P185, DOI 10.1016/S0022-3956(03)00088-8; Seeley WW, 2007, ALZ DIS ASSOC DIS, V21, pS50, DOI 10.1097/WAD.0b013e31815c0f14; Seeley WW, 2006, ANN NEUROL, V60, P660, DOI 10.1002/ana.21055; Simms ML, 2009, ACTA NEUROPATHOL, V118, P673, DOI 10.1007/s00401-009-0568-2; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Stimpson CD, 2011, AM J HUM BIOL, V23, P22, DOI 10.1002/ajhb.21135; VOGT BA, 1995, J COMP NEUROL, V359, P490, DOI 10.1002/cne.903590310; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Watson KK, 2006, NEUROSCIENCE, V141, P1107, DOI 10.1016/j.neuroscience.2006.04.084; Watson KK, 2008, ANN NY ACAD SCI, V1128, P8, DOI 10.1196/annals.1399.002	41	36	36	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e20936	10.1371/journal.pone.0020936	http://dx.doi.org/10.1371/journal.pone.0020936			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731632	Green Submitted, Green Published, gold			2022-12-25	WOS:000292033700019
J	Shebl, FM; Dollard, SC; Pfeiffer, RM; Biryahwaho, B; Amin, MM; Munuo, SS; Hladik, W; Parsons, R; Graubard, BI; Mbulaiteye, SM				Shebl, Fatma M.; Dollard, Sheila C.; Pfeiffer, Ruth M.; Biryahwaho, Benon; Amin, Minal M.; Munuo, Stella S.; Hladik, Wolfgang; Parsons, Ruth; Graubard, Barry I.; Mbulaiteye, Sam M.			Human Herpesvirus 8 Seropositivity Among Sexually Active Adults in Uganda	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; TO-CHILD TRANSMISSION; KAPOSIS-SARCOMA; RISK-FACTORS; INFECTION; SEROPREVALENCE; AIDS; ADOLESCENTS; PREVALENCE; PATTERNS	Introduction: Sexual transmission of human herpesvirus 8 (HHV8) has been implicated among homosexual men, but the evidence for sexual transmission among heterosexual individuals is controversial. We investigated the role of sexual transmission of HHV8 in a nationally representative sample in Uganda, where HHV8 infection is endemic and transmitted mostly during childhood. Materials and Methods: The study population was a subset of participants (n = 2681) from a population-based HIV/AIDS serobehavioral survey of adults aged 15-59 years conducted in 2004/2005. High risk for sexual transmission was assessed by questionnaire and serological testing for HIV and herpes simplex virus 2. Anti-HHV8 antibodies were measured using two enzyme immunoassays targeting synthetic peptides from the K8.1 and orf65 viral genes. The current study was restricted to 2288 sexually active adults. ORs and 95% CIs for HHV8 seropositivity were estimated by fitting logistic regression models with a random intercept using MPLUS and SAS software. Results: The weighted prevalence of HHV8 seropositivity was 56.2%, based on 1302 seropositive individuals, and it increased significantly with age (P-trend<0.0001). In analyses adjusting for age, sex, geography, education, and HIV status, HHV8 seropositivity was positively associated with reporting two versus one marital union (OR:1.52, 95% CI: 1.17-1.97) and each unit increase in the number of children born (OR: 1.04, 95% CI: 1.00-1.08), and was inversely associated with ever having used a condom (OR: 0.64, 95% CI: 0.45-0.89). HHV8 seropositivity was not associated with HIV (P = 0.660) or with herpes simplex virus 2 (P = 0.732) seropositivity. Other sexual variables, including lifetime number of sexual partners or having had at least one sexually transmitted disease, and socioeconomic variables were unrelated to HHV8 seropositivity. Conclusion: Our findings are compatible with the conclusion that sexual transmission of HHV8 in Uganda, if it occurs, is weak.	[Shebl, Fatma M.; Pfeiffer, Ruth M.; Graubard, Barry I.; Mbulaiteye, Sam M.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Dollard, Sheila C.; Amin, Minal M.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Biryahwaho, Benon] Uganda Virus Res Inst, Entebbe, Uganda; [Munuo, Stella S.; Parsons, Ruth] Informat Management Serv Inc, Rockville, MD USA; [Hladik, Wolfgang] Ctr Dis Control & Prevent, Entebbe, Uganda	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centers for Disease Control & Prevention - USA; Uganda Virus Research Institute; Information Management Services, Inc.	Shebl, FM (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	mbulaits@mail.nih.gov	Pfeiffer, Ruth M/F-4748-2011; Mbulaiteye, Sam/O-3056-2019	Mbulaiteye, Sam/0000-0002-8273-9831	Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI); National Institutes of Health, Department of Health and Human Services [HHSN2612009004060P]; Support Services contract [NO2-CP-31003]; NCI [IAA Y1CP903801]; Centers for Disease Control and Prevention [IAA Y1CP903801]; NATIONAL CANCER INSTITUTE [ZIACP010176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000732] Funding Source: NIH RePORTER	Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Support Services contract; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Department of Health and Human Services (contract HHSN2612009004060P and Support Services contract NO2-CP-31003) and with an Inter-Agency Agreement between NCI and the Centers for Disease Control and Prevention (IAA Y1CP903801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LA, 2008, PEDIATR INFECT DIS J, V27, P661, DOI 10.1097/INF.0b013e3181691740; Baeten JM, 2002, AIDS, V16, P2073, DOI 10.1097/00002030-200210180-00013; BERAL V, 1990, LANCET, V335, P123, DOI 10.1016/0140-6736(90)90001-L; Biryahwaho B, 2010, J INFECT DIS, V202, P1347, DOI 10.1086/656525; Bourboulia D, 1998, JAMA-J AM MED ASSOC, V280, P31, DOI 10.1001/jama.280.1.31-a; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Butler LM, 2011, J INFECT DIS, V203, P625, DOI 10.1093/infdis/jiq092; Butler LM, 2009, J INFECT DIS, V200, P430, DOI 10.1086/600103; Casper C, 2006, SEX TRANSM INFECT, V82, P229, DOI 10.1136/sti.2005.016568; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Dedicoat M, 2003, BRIT J CANCER, V88, P1, DOI 10.1038/sj.bjc.6600745; DOLLARD SC, 2008, INT J CANCER, V127, P2395; Eltom MA, 2002, AIDS, V16, P2473, DOI 10.1097/00002030-200212060-00014; *GOV UG UG BUR STA, 2007, 2002 UG POP HOUS CEN; Hladik W, 2003, JAIDS-J ACQ IMM DEF, V33, P206, DOI 10.1097/00126334-200306010-00015; Hladik W, 2006, NEW ENGL J MED, V355, P1331, DOI 10.1056/NEJMoa055009; HOERAUF A, N ENGL J MED, V363, P1476; Lavreys L, 2003, J INFECT DIS, V187, P359, DOI 10.1086/367703; Malope BI, 2008, AIDS, V22, P519, DOI 10.1097/QAD.0b013e3282f46582; Mbulaiteye S, 2006, J INFECT DIS, V193, P1250, DOI 10.1086/503052; Mbulaiteye SM, 2008, AIDS, V22, P535, DOI 10.1097/QAD.0b013e3282f4352e; Mbulaiteye SM, 2005, JAIDS-J ACQ IMM DEF, V38, P474, DOI 10.1097/01.qai.0000132495.89162.c0; Mbulaiteye SM, 2003, J INFECT DIS, V187, P1780, DOI 10.1086/374973; Mbulaiteye SM, 2003, J NATL CANCER I, V95, P1330, DOI 10.1093/jnci/djg039; Mbulaiteye SM, 2003, HEMATOL ONCOL CLIN N, V17, P673, DOI 10.1016/S0889-8588(03)00048-0; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; Newton R, 2003, INT J CANCER, V103, P226, DOI 10.1002/ijc.10817; Olsen SJ, 1998, AIDS, V12, P1921, DOI 10.1097/00002030-199814000-00024; Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X; Pau CP, 1998, J CLIN MICROBIOL, V36, P1574, DOI 10.1128/JCM.36.6.1574-1577.1998; Pfeffermann D, 1998, J ROY STAT SOC B, V60, P23, DOI 10.1111/1467-9868.00106; PFEIFFER RM, 2010, ANN EPIDEMI IN PRESS; Rabkin CS, 1998, J INFECT DIS, V178, P304, DOI 10.1086/515649; RAO JNK, 1981, J AM STAT ASSOC, V76, P221, DOI 10.2307/2287815; Sitas F, 1999, NEW ENGL J MED, V340, P1863, DOI 10.1056/NEJM199906173402403; Skrondal A., 2010, MULTILEVEL MODELLING; Spira TJ, 2000, J CLIN MICROBIOL, V38, P2174; Wawer MJ, 2001, SEX TRANSM DIS, V28, P77, DOI 10.1097/00007435-200102000-00003	38	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21286	10.1371/journal.pone.0021286	http://dx.doi.org/10.1371/journal.pone.0021286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21712983	Green Submitted, Green Published, gold			2022-12-25	WOS:000291985100025
J	Tsai, PW; Yang, CY; Chang, HT; Lan, CY				Tsai, Pei-Wen; Yang, Cheng-Yao; Chang, Hao-Teng; Lan, Chung-Yu			Characterizing the Role of Cell-Wall beta-1,3-Exoglucanase Xog1p in Candida albicans Adhesion by the Human Antimicrobial Peptide LL-37	PLOS ONE			English	Article							HUMAN CATHELICIDIN; GENE; INHIBITION; PROTEINS; IDENTIFICATION; YEAST; EXO-BETA-(1,3)-GLUCANASE; MANNOPROTEIN; DISRUPTION; DEFENSINS	Candida albicans is the major fungal pathogen of humans. Its adhesion to host-cell surfaces is the first critical step during mucosal infection. Antimicrobial peptides play important roles in the first line of mucosal immunity against C. albicans infection. LL-37 is the only member of the human cathelicidin antimicrobial peptide family and is commonly expressed in various tissues, including epithelium. We previously showed that LL-37 significantly reduced C. albicans adhesion to plastic, oral epidermoid OECM-1 cells, and urinary bladders of female BALB/c mice. The inhibitory effect of LL-37 on cell adhesion occurred via the binding of LL-37 to cell-wall carbohydrates. Here we showed that formation of LL-37-cell-wall protein complexes potentially inhibits C. albicans adhesion to polystyrene. Using phage display and ELISA, we identified 10 peptide sequences that could bind LL-37. A BLAST search revealed that four sequences in the major C. albicans cell-wall beta-1,3-exoglucanase, Xog1p, were highly similar to the consensus sequence derived from the 10 biopanned peptides. One Xog1p-derived peptide, Xog1p(90-115), and recombinant Xog1p associated with LL-37, thereby reversing the inhibitory effect of LL37 on C. albicans adhesion. LL-37 reduced Xog1p activity and thus interrupted cell-wall remodeling. Moreover, deletion of XOG1 or another beta-1,3-exoglucanase-encoding gene EXG2 showed that only when XOG1 was deleted did cellular exoglucanase activity, cell adhesion and LL-37 binding decrease. Antibodies against Xog1p also decreased cell adhesion. These data reveal that Xog1p, originally identified from LL-37 binding, has a role in C. albicans adhesion to polystyrene and, by inference, attach to host cells via direct or indirect manners. Compounds that target Xog1p might find use as drugs that prevent C. albicans infection. Additionally, LL-37 could potentially be used to screen for other cell-wall components involved in fungal cell adhesion.	[Tsai, Pei-Wen; Lan, Chung-Yu] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Yang, Cheng-Yao] Anim Technol Inst Taiwan, Div Anim Med, Miaoli, Taiwan; [Chang, Hao-Teng] China Med Univ, Grad Inst Mol Syst Biomed, Taichung, Taiwan; [Chang, Hao-Teng] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Chang, Hao-Teng] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chang, Hao-Teng] China Med Univ, PhD Program Aging, Taichung, Taiwan; [Lan, Chung-Yu] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan	National Tsing Hua University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; National Tsing Hua University	Tsai, PW (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.	htchang@mail.cmu.edu.tw; cylan@life.nthu.edu.tw	Chang, Hao-Teng/O-2875-2015	Chang, Hao-Teng/0000-0001-8756-5220; Lan, Chung-Yu/0000-0002-1533-3049; Yang, Cheng-Yao/0000-0002-8694-9561	National Science Council (Taiwan) [NSC98-2311-B-007-010-MY3, NSC99-2627-B-007-007]; China Medical University (Taiwan) [CMU98-N2-13]	National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); China Medical University (Taiwan)(China Medical University)	This work was supported by grants NSC98-2311-B-007-010-MY3 and NSC99-2627-B-007-007 (to CYL) from the National Science Council (Taiwan) and in part by CMU98-N2-13 (to HTC) from China Medical University (Taiwan). The funders only supported the funding for the scientific research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; AGERBERTH B, 1995, P NATL ACAD SCI USA, V92, P195, DOI 10.1073/pnas.92.1.195; Alloush HM, 1997, MICROBIOL-SGM, V143, P321, DOI 10.1099/00221287-143-2-321; Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25; Bergsson G, 2009, J IMMUNOL, V183, P543, DOI 10.4049/jimmunol.0803959; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; BROWN JA, 1992, CARBOHYD RES, V227, P195, DOI 10.1016/0008-6215(92)85071-7; Burton MF, 2009, NAT PROD REP, V26, P1572, DOI 10.1039/b912533g; Calderone RA., 2002, CANDIDA CANDIDIASIS; CASANOVA M, 1992, INFECT IMMUN, V60, P4898, DOI 10.1128/IAI.60.11.4898-4906.1992; Castillo L, 2006, FUNGAL GENET BIOL, V43, P124, DOI 10.1016/j.fgb.2005.12.002; Chaffin WL, 2008, MICROBIOL MOL BIOL R, V72, P495, DOI 10.1128/MMBR.00032-07; Chaffin WL, 1998, MICROBIOL MOL BIOL R, V62, P130, DOI 10.1128/MMBR.62.1.130-180.1998; CHAMBERS RS, 1993, FEBS LETT, V327, P366, DOI 10.1016/0014-5793(93)81022-R; Chang HT, 2010, PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON COMPLEX, INTELLIGENT AND SOFTWARE INTENSIVE SYSTEMS (CISIS 2010), P672, DOI 10.1109/CISIS.2010.82; CHAPMAN T, 1992, ANTIMICROB AGENTS CH, V36, P1909, DOI 10.1128/AAC.36.9.1909; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005; Cutfield SM, 1999, J MOL BIOL, V294, P771, DOI 10.1006/jmbi.1999.3287; de Groot PWJ, 2004, EUKARYOT CELL, V3, P955, DOI 10.1128/EC.3.4.955-965.2004; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; den Hertog AL, 2005, BIOCHEM J, V388, P689, DOI 10.1042/BJ20042099; DENOBEL JG, 1990, YEAST, V6, P491, DOI 10.1002/yea.320060606; Dietrich DE, 2008, INFECT IMMUN, V76, P5714, DOI 10.1128/IAI.00997-08; Foschiatti M, 2009, MOL MICROBIOL, V72, P1137, DOI 10.1111/j.1365-2958.2009.06707.x; Frick IM, 2008, MOL MICROBIOL, V70, P695, DOI 10.1111/j.1365-2958.2008.06439.x; Gonzalez MD, 1997, MICROBIOL-UK, V143, P3023, DOI 10.1099/00221287-143-9-3023; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Kai-Larsen Y, 2008, FRONT BIOSCI, V13, P3760, DOI 10.2741/2964; Kai-Larsen Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001010; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; Klis FM, 2009, FEMS YEAST RES, V9, P1013, DOI 10.1111/j.1567-1364.2009.00541.x; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; KOLLAR R, 1995, J BIOL CHEM, V270, P1170, DOI 10.1074/jbc.270.3.1170; La Valle R, 2000, INFECT IMMUN, V68, P6777, DOI 10.1128/IAI.68.12.6777-6784.2000; LARRIBA G, 1995, FEMS MICROBIOL LETT, V125, P121; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Li XWS, 2006, J BIOL CHEM, V281, P22453, DOI 10.1074/jbc.M604064200; Li XWS, 2003, J BIOL CHEM, V278, P28553, DOI 10.1074/jbc.M300680200; LopezRibot JL, 1996, INFECT IMMUN, V64, P3333; LUNAARIAS JP, 1991, YEAST, V7, P833, DOI 10.1002/yea.320070808; McKenzie CGJ, 2010, INFECT IMMUN, V78, P1650, DOI 10.1128/IAI.00001-10; Meletiadis J, 2001, J CLIN MICROBIOL, V39, P3402, DOI 10.1128/JCM.39.9.3402-3408.2001; Mendez-Samperio P, 2010, PEPTIDES, V31, P1791, DOI 10.1016/j.peptides.2010.06.016; Mookherjee N, 2009, J IMMUNOL, V183, P2688, DOI 10.4049/jimmunol.0802586; Moura-Tamames SA, 2009, J MOL GRAPH MODEL, V27, P908, DOI 10.1016/j.jmgm.2009.01.007; Naglik J, 2004, CELL MICROBIOL, V6, P915, DOI 10.1111/j.1462-5822.2004.00439.x; Nather K, 2008, FEMS MICROBIOL LETT, V285, P137, DOI 10.1111/j.1574-6968.2008.01263.x; Nett J, 2007, ANTIMICROB AGENTS CH, V51, P510, DOI 10.1128/AAC.01056-06; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; Nimrichter L, 2005, MICROBES INFECT, V7, P789, DOI 10.1016/j.micinf.2005.03.002; ODDS FC, 1979, CANDIDA CANDIDOSIS, P382; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Pingel LC, 2008, IMMUNOL CELL BIOL, V86, P643, DOI 10.1038/icb.2008.56; Rast DM, 2003, PHYTOCHEMISTRY, V64, P339, DOI 10.1016/S0031-9422(03)00350-9; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Sambrook J, 2001, MOL CLONING LAB MANU; Sandini S, 2007, CELL MICROBIOL, V9, P1223, DOI 10.1111/j.1462-5822.2006.00862.x; SANSEGUNDO P, 1993, J BACTERIOL, V175, P3823, DOI 10.1128/JB.175.12.3823-3837.1993; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Stubbs HJ, 1999, EUR J BIOCHEM, V263, P889, DOI 10.1046/j.1432-1327.1999.00581.x; Torosantucci A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005392; Tronchin G, 2008, MED MYCOL, V46, P749, DOI 10.1080/13693780802206435; Tsai PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017755; Zaiou M, 2002, J MOL MED, V80, P549, DOI 10.1007/s00109-002-0350-6; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179; Zasloff M, 2006, NAT MED, V12, P606, DOI 10.1038/nm0606-607; Zhu WD, 2010, CELL MICROBIOL, V12, P273, DOI 10.1111/j.1462-5822.2009.01412.x	70	29	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21394	10.1371/journal.pone.0021394	http://dx.doi.org/10.1371/journal.pone.0021394			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713010	gold, Green Published, Green Submitted			2022-12-25	WOS:000291985100037
J	Blumenfeld-Katzir, T; Pasternak, O; Dagan, M; Assaf, Y				Blumenfeld-Katzir, Tamar; Pasternak, Ofer; Dagan, Michael; Assaf, Yaniv			Diffusion MRI of Structural Brain Plasticity Induced by a Learning and Memory Task	PLOS ONE			English	Article							WHITE-MATTER PLASTICITY; SYNAPTIC PLASTICITY; HIPPOCAMPAL NEUROGENESIS; FUNCTIONAL PLASTICITY; ADULT BRAIN; ASTROCYTES; EXPERIENCE; POTENTIATION; ANISOTROPY; SPINES	Background: Activity-induced structural remodeling of dendritic spines and glial cells was recently proposed as an important factor in neuroplasticity and suggested to accompany the induction of long-term potentiation (LTP). Although T1 and diffusion MRI have been used to study structural changes resulting from long-term training, the cellular basis of the findings obtained and their relationship to neuroplasticity are poorly understood. Methodology/Principal Finding: Here we used diffusion tensor imaging (DTI) to examine the microstructural manifestations of neuroplasticity in rats that performed a spatial navigation task. We found that DTI can be used to define the selective localization of neuroplasticity induced by different tasks and that this process is age-dependent in cingulate cortex and corpus callosum and age-independent in the dentate gyrus. Conclusion/Significance: We relate the observed DTI changes to the structural plasticity that occurs in astrocytes and discuss the potential of MRI for probing structural neuroplasticity and hence indirectly localizing LTP.	[Blumenfeld-Katzir, Tamar; Dagan, Michael; Assaf, Yaniv] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Pasternak, Ofer] Harvard Univ, Sch Med, Dept Radiol, Brigham & Womens Hosp,Lab Math Imaging, Boston, MA 02115 USA	Tel Aviv University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Blumenfeld-Katzir, T (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	assafyan@post.tau.ac.il		Assaf, Yaniv/0000-0001-6828-7595	Israel Science Foundation (ISF) [994/08]; National Institute for Psychobiology in Israel (NIPI); EU	Israel Science Foundation (ISF)(Israel Science Foundation); National Institute for Psychobiology in Israel (NIPI); EU(European Commission)	The authors wish to thank the Raymond and Beverly Sackler Insitute for Biophysics, the Israel Science Foundation and the Strauss Center for Computation Neuroimaging of Tel Aviv University for the purchase and maintenance of the MRI system. Y.A. wishes to thank the Israel Science Foundation (ISF grant no. 994/08), the National Institute for Psychobiology in Israel (NIPI) and the CONNECT consortium supported by the future and emerging technologies program of PF7 of EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Becker N, 2008, NEURON, V60, P590, DOI 10.1016/j.neuron.2008.09.018; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Bruel-Jungerman E, 2007, NEUROSCIENTIST, V13, P492, DOI 10.1177/1073858407302725; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Butz M, 2009, BRAIN RES REV, V60, P287, DOI 10.1016/j.brainresrev.2008.12.023; Chao TC, 2009, MAGN RESON IMAGING, V27, P681, DOI 10.1016/j.mri.2008.09.004; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Gould E, 2000, BIOL PSYCHIAT, V48, P715, DOI 10.1016/S0006-3223(00)01021-0; Gregg C, 2007, J NEUROSCI, V27, P1812, DOI 10.1523/JNEUROSCI.4441-06.2007; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Hickmott PW, 2006, NEUROSCIENTIST, V12, P16, DOI 10.1177/1073858405282417; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Imfeld A, 2009, NEUROIMAGE, V46, P600, DOI 10.1016/j.neuroimage.2009.02.025; Johansen-Berg H, 2007, CURR BIOL, V17, pR141, DOI 10.1016/j.cub.2006.12.022; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lushnikova I, 2009, HIPPOCAMPUS, V19, P753, DOI 10.1002/hipo.20551; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muller Dominique, 2002, Current Molecular Medicine (Hilversum), V2, P605, DOI 10.2174/1566524023362041; Paxinos G., 2005, RAT BRAIN STEREOTAXI, Vxliii; Pekny M, 2007, INT REV NEUROBIOL, V82, P95, DOI 10.1016/S0074-7742(07)82005-8; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; Schlaug G, 2009, ANN NY ACAD SCI, V1169, P385, DOI 10.1111/j.1749-6632.2009.04587.x; SCHOLTZ J, 2009, P HUMAN BRAIN MAPPIN, V15, P362; SHAO YP, 1994, GLIA, V11, P147, DOI 10.1002/glia.440110209; Slezak M, 2006, J PHYSIOLOGY-PARIS, V99, P84, DOI 10.1016/j.jphysparis.2005.12.082; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; Theodosis DT, 1999, ADV EXP MED BIOL, V468, P175; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Voss HU, 2009, PROG BRAIN RES, V175, P483, DOI 10.1016/S0079-6123(09)17532-5; Yovel Y, 2007, NEUROIMAGE, V35, P58, DOI 10.1016/j.neuroimage.2006.08.055	43	193	194	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e20678	10.1371/journal.pone.0020678	http://dx.doi.org/10.1371/journal.pone.0020678			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701690	Green Published, gold			2022-12-25	WOS:000291983800010
J	Villoutreix, BO; Laconde, G; Lagorce, D; Martineau, P; Miteva, MA; Dariavach, P				Villoutreix, Bruno O.; Laconde, Guillaume; Lagorce, David; Martineau, Pierre; Miteva, Maria A.; Dariavach, Piona			Tyrosine Kinase Syk Non-Enzymatic Inhibitors and Potential Anti-Allergic Drug-Like Compounds Discovered by Virtual and In Vitro Screening	PLOS ONE			English	Article							3D CONFORMATION; SMALL MOLECULES; DOCKING; PERFORMANCE; ANTIBODIES; GENERATOR; DOMAINS; BIOLOGY; SYSTEM; TOOL	In the past decade, the spleen tyrosine kinase (Syk) has shown a high potential for the discovery of new treatments for inflammatory and autoimmune disorders. Pharmacological inhibitors of Syk catalytic site bearing therapeutic potential have been developed, with however limited specificity towards Syk. To address this topic, we opted for the design of drug-like compounds that could impede the interaction of Syk with its cellular partners while maintaining an active kinase protein. To achieve this challenging task, we used the powerful potential of intracellular antibodies for the modulation of cellular functions in vivo, combined to structure-based in silico screening. In our previous studies, we reported the anti-allergic properties of the intracellular antibody G4G11. With the aim of finding functional mimics of G4G11, we developed an Antibody Displacement Assay and we isolated the drug-like compound C-13, with promising in vivo anti-allergic activity. The likely binding cavity of this compound is located at the close vicinity of G4G11 epitope, far away from the catalytic site of Syk. Here we report the virtual screen of a collection of 500,000 molecules against this new cavity, which led to the isolation of 1000 compounds subsequently evaluated for their in vitro inhibitory effects using the Antibody Displacement Assay. Eighty five compounds were selected and evaluated for their ability to inhibit the liberation of allergic mediators from mast cells. Among them, 10 compounds inhibited degranulation with IC(50) values <= 10 mu M. The most bioactive compounds combine biological activity, significant inhibition of antibody binding and strong affinity for Syk. Moreover, these molecules show a good potential for oral bioavailability and are not kinase catalytic site inhibitors. These bioactive compounds could be used as starting points for the development of new classes of non-enzymatic inhibitors of Syk and for drug discovery endeavour in the field of inflammation related disorders.	[Villoutreix, Bruno O.; Laconde, Guillaume; Lagorce, David; Miteva, Maria A.] Univ Paris Diderot, INSERM, U973, MTi Unit, Paris, France; [Martineau, Pierre; Dariavach, Piona] Inst Rech Cancerol Montpellier, IRCM, Montpellier, France; [Martineau, Pierre; Dariavach, Piona] INSERM, U896, Montpellier, France; [Martineau, Pierre; Dariavach, Piona] Univ Montpellier 1, Montpellier, France; [Martineau, Pierre; Dariavach, Piona] Univ Montpellier 2, Montpellier, France; [Martineau, Pierre; Dariavach, Piona] CRLC Val dAurelle Paul Lamarque, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Villoutreix, BO (corresponding author), Univ Paris Diderot, INSERM, U973, MTi Unit, Paris, France.	piona.dariavach@inserm.fr	Miteva, Maria M/N-2419-2018; Martineau, Pierre/N-4386-2017; Villoutreix, Bruno/I-4565-2015	Miteva, Maria M/0000-0001-6895-1214; Martineau, Pierre/0000-0002-7993-7183; Villoutreix, Bruno/0000-0002-6456-7730; Laconde, Guillaume/0000-0001-5577-6111				An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; Arias-Palomo E, 2007, BBA-PROTEINS PROTEOM, V1774, P1493, DOI 10.1016/j.bbapap.2007.10.008; Arkin MR, 2009, CURR OPIN CHEM BIOL, V13, P284, DOI 10.1016/j.cbpa.2009.05.125; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; Dauvillier S, 2002, J IMMUNOL, V169, P2274, DOI 10.4049/jimmunol.169.5.2274; Fahy JV, 1997, AM J RESP CRIT CARE, V155, P1828, DOI 10.1164/ajrccm.155.6.9196082; Futterer K, 1998, J MOL BIOL, V281, P523, DOI 10.1006/jmbi.1998.1964; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Kirchmair J, 2006, J CHEM INF MODEL, V46, P1848, DOI 10.1021/ci060084g; Lagorce David, 2009, BMC Chemical Biology, V9, P6, DOI 10.1186/1472-6769-9-6; Lagorce D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-396; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lobato MN, 2003, TRENDS MOL MED, V9, P390, DOI 10.1016/S1471-4914(03)00163-1; Maiorov V, 2005, J CHEM INF MODEL, V45, P1017, DOI 10.1021/ci050089y; Masuda ES, 2008, PULM PHARMACOL THER, V21, P461, DOI 10.1016/j.pupt.2007.06.002; Mazuc E, 2008, J ALLERGY CLIN IMMUN, V122, P188, DOI 10.1016/j.jaci.2008.04.026; Miteva MA, 2005, J MED CHEM, V48, P6012, DOI 10.1021/jm050262h; Miteva MA, 2010, NUCLEIC ACIDS RES, V38, pW622, DOI 10.1093/nar/gkq325; Moustakas DT, 2006, J COMPUT AID MOL DES, V20, P601, DOI 10.1007/s10822-006-9060-4; Peneff C, 2000, J IMMUNOL METHODS, V236, P105, DOI 10.1016/S0022-1759(99)00228-8; Perot S, 2010, DRUG DISCOV TODAY, V15, P656, DOI 10.1016/j.drudis.2010.05.015; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Riccaboni M, 2010, DRUG DISCOV TODAY, V15, P517, DOI 10.1016/j.drudis.2010.05.001; Sauton N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-184; Scott DL, 2006, NEW ENGL J MED, V355, P704, DOI 10.1056/NEJMct055183; Sperandio O, 2010, DRUG DISCOV TODAY, V15, P220, DOI 10.1016/j.drudis.2009.11.007; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Villoutreix BO, 2008, CURR PHARM BIOTECHNO, V9, P103, DOI 10.2174/138920108783955218; von Grotthuss M, 2003, BIOINFORMATICS, V19, P1041, DOI 10.1093/bioinformatics/btg117; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wong WSF, 2004, BBA-PROTEINS PROTEOM, V1697, P53, DOI 10.1016/j.bbapap.2003.11.013; Yanagi S, 2001, BIOCHEM BIOPH RES CO, V288, P495, DOI 10.1006/bbrc.2001.5788	34	19	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21117	10.1371/journal.pone.0021117	http://dx.doi.org/10.1371/journal.pone.0021117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701581	Green Submitted, Green Published, gold			2022-12-25	WOS:000291983800024
J	Pope, EC; Powell, A; Roberts, EC; Shields, RJ; Wardle, R; Rowley, AF				Pope, Edward C.; Powell, Adam; Roberts, Emily C.; Shields, Robin J.; Wardle, Robin; Rowley, Andrew F.			Enhanced Cellular Immunity in Shrimp (Litopenaeus vannamei) after 'Vaccination'	PLOS ONE			English	Article							PENAEIDIN ANTIMICROBIAL PEPTIDES; LARVAL STAGES; TIGER SHRIMP; EXPRESSION; PROPHENOLOXIDASE; POPULATIONS; BEETLE; GENES	It has long been viewed that invertebrates rely exclusively upon a wide variety of innate mechanisms for protection from disease and parasite invasion and lack any specific acquired immune mechanisms comparable to those of vertebrates. Recent findings, however, suggest certain invertebrates may be able to mount some form of specific immunity, termed 'specific immune priming', although the mechanism of this is not fully understood (see Textbox S1). In our initial experiments, either formalin-inactivated Vibrio harveyi or sterile saline were injected into the main body cavity (haemocoel) of juvenile shrimp (Litopenaeus vannamei). Haemocytes (blood cells) from V. harveyi-injected shrimp were collected 7 days later and incubated with a 1: 1 mix of V. harveyi and an unrelated Gram positive bacterium, Bacillus subtilis. Haemocytes from 'vaccinated' shrimp showed elevated levels of phagocytosis of V. harveyi, but not B. subtilis, compared with those from saline-injected (non-immunised) animals. The increased phagocytic activity was characterised by a significant increase in the percentage of phagocytic cells. When shrimp were injected with B. subtilis rather than vibrio, there was no significant increase in the phagocytic activity of haemocytes from these animals in comparison to the non-immunised (saline injected) controls. Whole haemolymph (blood) from either 'immunised' or non-immunised' shrimp was shown to display innate humoral antibacterial activity against V. harveyi that was absent against B. subtilis. However, there was no difference in the potency of antibacterial activity between V. harveyi-injected shrimp and control (saline injected) animals showing that 'vaccination' has no effect on this component of the shrimp's immune system. These results imply that the cellular immune system of shrimp, particularly phagocytosis, is capable of a degree of specificity and shows the phenomenon of 'immune priming' reported by other workers. However, in agreement with other studies, this phenomenon is not universal to all potential pathogens.	[Pope, Edward C.; Powell, Adam; Roberts, Emily C.; Shields, Robin J.; Rowley, Andrew F.] Swansea Univ, Coll Sci, Dept Biosci, Ctr Sustainable Aquat Res, Swansea, W Glam, Wales; [Wardle, Robin] Aquaculture Ctr, Saffron Walden, Essex, England	Swansea University	Pope, EC (corresponding author), Swansea Univ, Coll Sci, Dept Biosci, Ctr Sustainable Aquat Res, Swansea, W Glam, Wales.	a.f.rowley@swansea.ac.uk	Pope, Edward/G-5665-2011	Pope, Edward/0000-0001-5781-5575	Intervet/Schering-Plough Animal Health	Intervet/Schering-Plough Animal Health	This study was partially supported by a pilot project grant from Intervet/Schering-Plough Animal Health (http://www.intervet.com) to A.F.R. and R.J.S. The funders contributed to the design of the study but had no role in data collection and analysis or preparation of the manuscript.	Bexfield A, 2004, MICROBES INFECT, V6, P1297, DOI 10.1016/j.micinf.2004.08.011; Brites D, 2008, MOL BIOL EVOL, V25, P1429, DOI 10.1093/molbev/msn087; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Chou PH, 2011, FISH SHELLFISH IMMUN, V30, P1109, DOI 10.1016/j.fsi.2011.02.009; Chou PH, 2009, DEV COMP IMMUNOL, V33, P1258, DOI 10.1016/j.dci.2009.07.006; Diamond S, 2008, AQUACULTURE, V285, P14, DOI 10.1016/j.aquaculture.2008.08.029; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; FAO, 2006, FAO FISHERIES TECHNI; FITZGERALD SW, 1982, DEV COMP IMMUNOL, V6, P23, DOI 10.1016/0145-305X(82)90004-0; Garcia SM, 2005, PHILOS T R SOC B, V360, P21, DOI 10.1098/rstb.2004.1580; Ghosh J, 2011, DEV COMP IMMUNOL, V35, P959, DOI 10.1016/j.dci.2010.12.009; Hauton C, 2007, BIOESSAYS, V29, P1138, DOI 10.1002/bies.20650; Jiravanichpaisal P, 2007, FISH SHELLFISH IMMUN, V23, P815, DOI 10.1016/j.fsi.2007.03.003; Lightner DV, 2005, J WORLD AQUACULT SOC, V36, P229, DOI 10.1111/j.1749-7345.2005.tb00328.x; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Manilal A, 2010, J WORLD AQUACULT SOC, V41, P332, DOI 10.1111/j.1749-7345.2010.00375.x; Mone Y, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000813; Moret Y, 2006, P R SOC B, V273, P1399, DOI 10.1098/rspb.2006.3465; Mori K, 2006, DIS AQUAT ORGAN, V69, P197, DOI 10.3354/dao069197; Munoz M, 2003, DEV COMP IMMUNOL, V27, P283, DOI 10.1016/S0145-305X(02)00102-7; Munoz M, 2002, EUR J BIOCHEM, V269, P2678, DOI 10.1046/j.1432-1033.2002.02934.x; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Powell A, 2011, J INVERTEBR PATHOL, V107, P95, DOI 10.1016/j.jip.2011.02.006; Roth O, 2009, P ROY SOC B-BIOL SCI, V276, P145, DOI 10.1098/rspb.2008.1157; Roth O, 2009, DEV COMP IMMUNOL, V33, P1151, DOI 10.1016/j.dci.2009.04.005; Rowley AF, 2007, J IMMUNOL, V179, P7209, DOI 10.4049/jimmunol.179.11.7209; Sadd BM, 2005, BIOL LETTERS, V1, P386, DOI 10.1098/rsbl.2005.0369; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; VARGASALBORES F, 1993, COMP BIOCHEM PHYS A, V106, P299, DOI 10.1016/0300-9629(93)90516-7; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069; Zhang XW, 2009, MOL IMMUNOL, V46, P1626, DOI 10.1016/j.molimm.2009.02.029	34	82	87	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20960	10.1371/journal.pone.0020960	http://dx.doi.org/10.1371/journal.pone.0020960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698190	Green Published, gold, Green Submitted			2022-12-25	WOS:000291734100036
J	Tkacik, G; Garrigan, P; Ratliff, C; Milcinski, G; Klein, JM; Seyfarth, LH; Sterling, P; Brainard, DH; Balasubramanian, V				Tkacik, Gasper; Garrigan, Patrick; Ratliff, Charles; Milcinski, Grega; Klein, Jennifer M.; Seyfarth, Lucia H.; Sterling, Peter; Brainard, David H.; Balasubramanian, Vijay			Natural Images from the Birthplace of the Human Eye	PLOS ONE			English	Article							STATISTICS; COLOR; SCENES; MODELS; SENSITIVITIES; ADAPTATION; RETINA; SCALE	Here we introduce a database of calibrated natural images publicly available through an easy-to-use web interface. Using a Nikon D70 digital SLR camera, we acquired about 5000 six-megapixel images of Okavango Delta of Botswana, a tropical savanna habitat similar to where the human eye is thought to have evolved. Some sequences of images were captured unsystematically while following a baboon troop, while others were designed to vary a single parameter such as aperture, object distance, time of day or position on the horizon. Images are available in the raw RGB format and in grayscale. Images are also available in units relevant to the physiology of human cone photoreceptors, where pixel values represent the expected number of photoisomerizations per second for cones sensitive to long (L), medium (M) and short (S) wavelengths. This database is distributed under a Creative Commons Attribution-Noncommercial Unported license to facilitate research in computer vision, psychophysics of perception, and visual neuroscience.	[Tkacik, Gasper; Balasubramanian, Vijay] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Tkacik, Gasper] IST Austria, Klosterneuburg, Austria; [Garrigan, Patrick] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA; [Ratliff, Charles] Northwestern Univ, Dept Ophthalmol, Chicago, IL 60611 USA; [Milcinski, Grega] Sinergise Doo, Ljubljana, Slovenia; [Seyfarth, Lucia H.; Sterling, Peter] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Klein, Jennifer M.; Brainard, David H.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	University of Pennsylvania; Institute of Science & Technology - Austria; Saint Joseph's University; Northwestern University; University of Pennsylvania; University of Pennsylvania	Tkacik, G (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.	gtkacik@ist.ac.at	Tkacik, Gasper/C-3510-2011	Tkacik, Gasper/0000-0002-6699-1455	NEI [R01 EY10016]; NSF [IBN-0344678, EF-0928048]; NIH [R01 EY08124]; NATIONAL EYE INSTITUTE [R01EY008124, R01EY010016] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NEI R01 EY10016 (http://www.nei.nih.gov/) NSF IBN-0344678 (http://www.nsf.gov/), NSF EF-0928048 (http://www.nsf.gov/), NIH R01 EY08124 (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CREATIVE COMMONS LIC; ATICK JJ, 1992, NEURAL COMPUT, V4, P196, DOI 10.1162/neco.1992.4.2.196; BARLOW HB, 1982, VISION RES, V22, P635, DOI 10.1016/0042-6989(82)90099-2; Battiti Roberto, NEURAL COMPUT, V4, P141, DOI [10.1162/neco.1992.4.2.141, DOI 10.1162/NECO.1992.4.2.141, DOI 10.1162/NECO.1992.4.4.559]; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; BONE RA, 1992, VISION RES, V32, P105, DOI 10.1016/0042-6989(92)90118-3; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BURTON GJ, 1987, APPL OPTICS, V26, P157, DOI 10.1364/AO.26.000157; *CENTR BUR COMM IN, 1701 CENTR BUR COMM; Chandler DM, 2007, J OPT SOC AM A, V24, P922, DOI 10.1364/JOSAA.24.000922; CHITTKA L, 1992, J COMP PHYSIOL A, V171, P171, DOI 10.1007/BF00188925; Doi E, 2007, IEEE T IMAGE PROCESS, V16, P442, DOI 10.1109/TIP.2006.888352; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Finlayson GD, 1996, FOURTH COLOR IMAGING CONFERENCE: COLOR SCIENCE, SYSTEMS AND APPLICATIONS, P202; Forsyth DA, 2002, PRENT HALL PROF TECH; Garrigan P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000677; Geisler WS, 2009, VISUAL NEUROSCI, V26, P1, DOI 10.1017/S0952523808081005; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; HORN BKP, 1984, COMPUT VISION GRAPH, V26, P135, DOI 10.1016/0734-189X(84)90180-4; Karklin Y, 2003, NETWORK-COMP NEURAL, V14, P483, DOI 10.1088/0954-898X/14/3/306; Karklin Y, 2009, NATURE, V457, P83, DOI 10.1038/nature07481; KERSTEN D, 1987, J OPT SOC AM A, V4, P2395, DOI 10.1364/JOSAA.4.002395; Lewis A, 2006, J VISION, V6, P285, DOI 10.1167/6.3.8; LYTHGOE JN, 1989, J EXP BIOL, V146, P1; MALONEY LT, 1986, J OPT SOC AM A, V3, P1673, DOI 10.1364/JOSAA.3.001673; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Olmos A., 2004, MCGILL CALIBRATED CO; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Packer O., 2003, SCI COLOR, P41, DOI 10.1016/B978-044451251-2/50003-9; Parraga C, 2009, PERCEPTION, V38, P180; Pennebaker WB., 1993, JPEG STILL IMAGE DAT; Pokorny J, 1997, DOC OPHTH P, V59, P491; Portilla J, 2000, INT J COMPUT VISION, V40, P49, DOI 10.1023/A:1026553619983; Ratliff CP, 2010, P NATL ACAD SCI USA, V107, P17368, DOI 10.1073/pnas.1005846107; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; RICHARDS WA, 1982, APPL OPTICS, V21, P2569, DOI 10.1364/AO.21.002569; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; Rodieck RW, 1998, 1 STEPS SEEING; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; RUDERMAN DL, 1994, NETWORK-COMP NEURAL, V5, P517, DOI 10.1088/0954-898X/5/4/006; Sharpe LT, 2005, J VISION, V5, P948, DOI 10.1167/5.11.3; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; STEPHENS GJ, 2008, ARXIVQBIO08062694; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Stockman A, 1999, VISION RES, V39, P2901, DOI 10.1016/S0042-6989(98)00225-9; THACIK G, 2010, P NATL ACAD SCI USA, V107, P18149; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; VANHATEREN JH, 1992, NATURE, V360, P68, DOI 10.1038/360068a0; VORHEES H, 1998, NATURE, V333, P364; WANDELL BA, 1987, IEEE T PATTERN ANAL, V9, P2, DOI 10.1109/TPAMI.1987.4767868; Yin L, 2006, J NEUROSCI, V26, P12351, DOI 10.1523/JNEUROSCI.1071-06.2006; Zhang X, 2004, SER INF MANAGE SCI, V3, P308; PUBLIC DOMAIN INTERN; NIKON D70 NEF RAW FO; DARPA IM UND WORKSH; PHOTO RES PR 650 SPE; PUBLIC DOMAIN IMAGE; PUBLIC DOMAIN IMPLEM; NIKON DOCUMENTATION; KODAK CAROUSEL 4400	64	59	60	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20409	10.1371/journal.pone.0020409	http://dx.doi.org/10.1371/journal.pone.0020409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698187	Green Published, Green Submitted, gold			2022-12-25	WOS:000291734100007
J	Bereswill, S; Fischer, A; Plickert, R; Haag, LM; Otto, B; Kuhl, AA; Dashti, JI; Zautner, AE; Munoz, M; Loddenkemper, C; Gross, U; Gobel, UB; Heimesaat, MM				Bereswill, Stefan; Fischer, Andre; Plickert, Rita; Haag, Lea-Maxie; Otto, Bettina; Kuehl, Anja A.; Dashti, Javid I.; Zautner, Andreas E.; Munoz, Melba; Loddenkemper, Christoph; Gross, Uwe; Goebel, Ulf B.; Heimesaat, Markus M.			Novel Murine Infection Models Provide Deep Insights into the "Menage a Trois" of Campylobacter jejuni, Microbiota and Host Innate Immunity	PLOS ONE			English	Article							GERM-FREE-MICE; TOLL-LIKE RECEPTORS; ESCHERICHIA-COLI; COLONIZATION; PATHOGENESIS; BACTERIA; IMMUNOPATHOLOGY; IDENTIFICATION; ACTIVATION; RESPONSES	Background: Although Campylobacter jejuni-infections have a high prevalence worldwide and represent a significant socioeconomic burden, it is still not well understood how C. jejuni causes intestinal inflammation. Detailed investigation of C. jejuni-mediated intestinal immunopathology is hampered by the lack of appropriate vertebrate models. In particular, mice display colonization resistance against this pathogen. Methodology/Principal Findings: To overcome these limitations we developed a novel C. jejuni-infection model using gnotobiotic mice in which the intestinal flora was eradicated by antibiotic treatment. These animals could then be permanently associated with a complete human (hfa) or murine (mfa) microbiota. After peroral infection C. jejuni colonized the gastrointestinal tract of gnotobiotic and hfa mice for six weeks, whereas mfa mice cleared the pathogen within two days. Strikingly, stable C. jejuni colonization was accompanied by a pro-inflammatory immune response indicated by increased numbers of T-and B-lymphocytes, regulatory T-cells, neutrophils and apoptotic cells, as well as increased concentrations of TNF-alpha, IL-6, and MCP-1 in the colon mucosa of hfa mice. Analysis of MyD88(-/-), TRIF-/-, TLR4(-/-), and TLR9(-/-) mice revealed that TLR4- and TLR9-signaling was essential for immunopathology following C. jejuni-infection. Interestingly, C. jejuni-mutant strains deficient in formic acid metabolism and perception induced less intestinal immunopathology compared to the parental strain infection. In summary, the murine gut flora is essential for colonization resistance against C. jejuni and can be overcome by reconstitution of gnotobiotic mice with human flora. Detection of C. jejuni-LPS and -CpG-DNA by host TLR4 and TLR9, respectively, plays a key role in immunopathology. Finally, the host immune response is tightly coupled to bacterial formic acid metabolism and invasion fitness. Conclusion/Significance: We conclude that gnotobiotic and "humanized" mice represent excellent novel C. jejuni-infection and -inflammation models and provide deep insights into the immunological and molecular interplays between C. jejuni, microbiota and innate immunity in human campylobacteriosis.	[Bereswill, Stefan; Fischer, Andre; Plickert, Rita; Haag, Lea-Maxie; Otto, Bettina; Munoz, Melba; Goebel, Ulf B.; Heimesaat, Markus M.] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Kuehl, Anja A.; Loddenkemper, Christoph] Charite, Dept Pathol, RCIS, D-13353 Berlin, Germany; [Dashti, Javid I.; Zautner, Andreas E.; Gross, Uwe] Univ Med Ctr Gottingen, Dept Med Microbiol, Gottingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Gottingen	Bereswill, S (corresponding author), Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany.	markus.heimesaat@charite.de	Zautner, Andreas Erich/ABA-9655-2020; Zautner, Andreas Erich/AAE-7425-2019; Haag, Lea Maxie/AAP-9001-2020	Zautner, Andreas Erich/0000-0003-0984-013X; Zautner, Andreas Erich/0000-0003-0984-013X; Kuhl, Anja/0000-0003-2293-5387; Haag, Lea-Maxie/0000-0002-3754-5317; Heimesaat, Markus/0000-0001-6399-651X	German Research Foundation (DFG) [GR906/13-1, GO363/12-1, SFB633, TP A7, TP Z1, TP B6]; German Federal Ministry of Education and Research (BMBF) [TP1.1]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the German Research Foundation (DFG) to UG (GR906/13-1, CampyGerm), UBG (GO363/12-1, CampyGerm; SFB633, TP A7), AK and CL (SFB633, TP Z1), MM and MMH (SFB633, TP B6), LMH and BO (SFB633, Immuco), and from the German Federal Ministry of Education and Research (BMBF) to SB (TP1.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Bacon DJ, 2000, INFECT IMMUN, V68, P4384, DOI 10.1128/IAI.68.8.4384-4390.2000; Bell JA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-57; Bereswill S, 2003, CURR OPIN INFECT DIS, V16, P487, DOI 10.1097/00001432-200310000-00017; Chang C, 2006, INFECT IMMUN, V74, P5261, DOI 10.1128/IAI.01094-05; Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; de Zoete MR, 2010, INFECT IMMUN, V78, P1229, DOI 10.1128/IAI.00897-09; Dorrell N, 2007, CURR OPIN INFECT DIS, V20, P514, DOI 10.1097/QCO.0b013e3282a56b15; FRIEDMAN CR, 2000, CAMPYLOBACTER, V1, P121; Friis LM, 2009, INFECT IMMUN, V77, P1553, DOI 10.1128/IAI.00707-08; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Heimesaat MM, 2010, GUT, V59, P1079, DOI 10.1136/gut.2009.197434; Hodgson AE, 1998, J MED MICROBIOL, V47, P799, DOI 10.1099/00222615-47-9-799; JESUDASON MV, 1989, INFECT IMMUN, V57, P2279, DOI 10.1128/IAI.57.8.2279-2282.1989; Ketley JM, 1997, MICROBIOL-UK, V143, P5, DOI 10.1099/00221287-143-1-5; Kist M, 2001, Contrib Microbiol, V8, P150; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; Mansfield LS, 2007, INFECT IMMUN, V75, P1099, DOI 10.1128/IAI.00833-06; Mansfield LS, 2008, MICROB PATHOGENESIS, V45, P241, DOI 10.1016/j.micpath.2008.05.010; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; PENNER JL, 1983, EUR J CLIN MICROBIOL, V2, P378, DOI 10.1007/BF02019474; Poly F, 2005, J CLIN MICROBIOL, V43, P2330, DOI 10.1128/JCM.43.5.2330-2338.2005; Poly F, 2004, J BACTERIOL, V186, P4781, DOI 10.1128/JB.186.14.4781-4795.2004; Rathinam VAK, 2009, INFECT IMMUN, V77, P2499, DOI 10.1128/IAI.01562-08; SAVIDGE TC, 1991, AM J PATHOL, V139, P177; SHROFF KE, 1995, ADV EXP MED BIOL, V371, P441; Singh M, 2003, INT J PARASITOL, V33, P469, DOI 10.1016/S0020-7519(03)00053-5; Tareen AM, 2010, MICROBIOL-SGM, V156, P3123, DOI 10.1099/mic.0.039438-0; Tsang RSW, 2002, CURR OPIN INFECT DIS, V15, P221, DOI 10.1097/00001432-200206000-00002; van Mourik A, 2010, J BIOL CHEM, V285, P15828, DOI 10.1074/jbc.M110.102061; VANSPREEUWEL JP, 1985, GUT, V26, P945, DOI 10.1136/gut.26.9.945; WALKER RI, 1986, MICROBIOL REV, V50, P81, DOI 10.1128/MMBR.50.1.81-94.1986; Watson RO, 2005, CELL MICROBIOL, V7, P655, DOI 10.1111/j.1462-5822.2004.00498.x; Watson RO, 2007, INFECT IMMUN, V75, P1994, DOI 10.1128/IAI.01216-06; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; YOUSSEF M, 1987, INFECT IMMUN, V55, P1019, DOI 10.1128/IAI.55.4.1019-1021.1987; YRIOS JW, 1986, INFECT IMMUN, V53, P378, DOI 10.1128/IAI.53.2.378-383.1986; YRIOS JW, 1986, INFECT IMMUN, V53, P384, DOI 10.1128/IAI.53.2.384-392.1986; YRIOS JW, 1986, INFECT IMMUN, V54, P339, DOI 10.1128/IAI.54.2.339-346.1986	41	194	196	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20953	10.1371/journal.pone.0020953	http://dx.doi.org/10.1371/journal.pone.0020953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698299	Green Submitted, gold, Green Published			2022-12-25	WOS:000291730000031
J	Khaidakov, M; Wang, XW; Mehta, JL				Khaidakov, Magomed; Wang, Xianwei; Mehta, Jawahar L.			Potential Involvement of LOX-1 in Functional Consequences of Endothelial Senescence	PLOS ONE			English	Article							NF-KAPPA-B; REDOX-SENSITIVE PATHWAY; CELLULAR SENESCENCE; ADHESION MOLECULES; OXIDATIVE STRESS; NITRIC-OXIDE; LECTIN-LIKE; CELLS; EXPRESSION; ATHEROSCLEROSIS	Numerous studies have described the process of senescence associated with accumulation of oxidative damage, mutations and decline in proliferative potential. Although the changes observed in senescent cells are likely to result in significant phenotypic alterations, the studies on consequences of endothelial senescence, especially in relation to aging-associated diseases, are scarce. We have analyzed effects of senescence on the functions of endothelial cells relevant to the development of atherosclerosis including angiogenesis, adhesion, apoptosis and inflammation. In the course of progressing through the passages, human umbilical vein endothelial cells (HUVECs) displayed significant increase in size (+36% passage 12 vs. passage 4, p < 0.001) and reduction in both basal and VEGF-stimulated tube formation. The analysis of a scavenger receptor LOX-1, a key molecule implicated in atherogenesis, revealed a significant decline of its message (mRNA) and protein content in senescent endothelial cells (-33%) and in aortas of 50 wk (vs. 5 wk) old mice (all p < 0.01). These effects were accompanied by a marked reduction of the basal expression of VCAM-1 and ICAM-1. Compared to early cultures, late passage HUVECs also exhibited nuclear translocation of NF-kappa B (p65) and reciprocal shifts in BAX and BCL2 protein content resulting in almost 2-fold increase in BAX/BCL2 ratio and 3-fold increase in apoptotic response to TNF alpha exposure (p < 0.04). These changes in senescent endothelial cells are suggestive of aberrant responses to physiological stimuli resulting in a less permissive environment for tissue remodeling and progression of diseases requiring angiogenesis and cell adhesion in elderly, possibly, mediated by LOX-1.	[Khaidakov, Magomed] Cent Arkansas Vet Healthcare Syst, Dept Med, Little Rock, AR USA; Univ Arkansas Med Sci, Little Rock, AR 72205 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences	Khaidakov, M (corresponding author), Cent Arkansas Vet Healthcare Syst, Dept Med, Little Rock, AR USA.	mkhaidakov@uams.edu; MehtaJL@UAMS.edu	Mehta, JL/AAG-7572-2020; Wang, Xianwei/AAN-8915-2020; Mehta, jl/AAB-8832-2019	Wang, Xianwei/0000-0002-1490-8736; Mehta, jl/0000-0003-0384-2097	Department of Veterans Affairs, Washington, D.C.; Arkansas Bioventures, Little Rock, Arkansas	Department of Veterans Affairs, Washington, D.C.(US Department of Veterans Affairs); Arkansas Bioventures, Little Rock, Arkansas	Funding was received from the Department of Veterans Affairs, Washington, D.C., and Arkansas Bioventures, Little Rock, Arkansas. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton M, 2010, PFLUG ARCH EUR J PHY, V460, P825, DOI 10.1007/s00424-010-0860-y; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Chen JW, 2010, CHINESE MED J-PEKING, V123, P1553, DOI 10.3760/cma.j.issn.0366-6999.2010.12.014; Chen JW, 2004, CIRC RES, V94, P370, DOI 10.1161/01.RES.0000113782.07824.BE; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Cortes MJ, 2002, FEBS LETT, V522, P99, DOI 10.1016/S0014-5793(02)02902-2; Dandapat A, 2007, ARTERIOSCL THROM VAS, V27, P2435, DOI 10.1161/ATVBAHA.107.152272; Donato AJ, 2008, AGING CELL, V7, P805, DOI 10.1111/j.1474-9726.2008.00438.x; Farhat N, 2008, CAN J PHYSIOL PHARM, V86, P761, DOI 10.1139/Y08-082; Giorgadze S, 2009, GEORGIAN MED NEWS, V174, P88; Hoenig MR, 2008, CURR MOL MED, V8, P754, DOI 10.2174/156652408786733685; Hoffmann J, 2001, CIRC RES, V89, P709, DOI 10.1161/hh2001.097796; Holvoet P, 2008, Verh K Acad Geneeskd Belg, V70, P193; Hu CP, 2007, HYPERTENSION, V50, P952, DOI 10.1161/HYPERTENSIONAHA.107.096446; Jakob S, 2007, Z GERONTOL GERIATR, V40, P334, DOI 10.1007/s00391-007-0482-y; Kang BY, 2010, PHYSIOL GENOMICS, V42, P42, DOI 10.1152/physiolgenomics.00009.2010; Kurz DJ, 2000, J CELL SCI, V113, P3613; Li DY, 2001, CARDIOVASC RES, V52, P130, DOI 10.1016/S0008-6363(01)00371-6; Li YH, 2008, J VASC RES, V45, P205, DOI 10.1159/000112133; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Minamino T, 2010, CIRC J, V74, P2527, DOI 10.1253/circj.CJ-10-0916; Ogura S, 2009, CIRC J, V73, P1993, DOI 10.1253/circj.CJ-09-0587; Okuda K, 2000, ATHEROSCLEROSIS, V152, P391, DOI 10.1016/S0021-9150(99)00482-7; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; SHEN JK, 1995, MICROVASC RES, V50, P360, DOI 10.1006/mvre.1995.1064; Tamilselvan J, 2007, FREE RADICAL BIO MED, V43, P1656, DOI 10.1016/j.freeradbiomed.2007.08.028; Terman A, 1999, EXP GERONTOL, V34, P755, DOI 10.1016/S0531-5565(99)00045-5; Vannini N, 2008, CURR PHARM DESIGN, V14, P221; Vasa M, 2000, CIRC RES, V87, P540, DOI 10.1161/01.RES.87.7.540; Voghel G, 2007, MECH AGEING DEV, V128, P662, DOI 10.1016/j.mad.2007.09.006	32	32	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20964	10.1371/journal.pone.0020964	http://dx.doi.org/10.1371/journal.pone.0020964			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698300	gold, Green Submitted, Green Published			2022-12-25	WOS:000291730000032
J	Krzyzanowski, PM; Price, FD; Muro, EM; Rudnicki, MA; Andrade-Navarro, MA				Krzyzanowski, Paul M.; Price, Feodor D.; Muro, Enrique M.; Rudnicki, Michael A.; Andrade-Navarro, Miguel A.			Integration of Expressed Sequence Tag Data Flanking Predicted RNA Secondary Structures Facilitates Novel Non-Coding RNA Discovery	PLOS ONE			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; MICRORNA PRECURSORS; GENE-EXPRESSION; DYSTROPHIN GENE; HUMAN GENOME; STEM-CELLS; MIR-206; TRANSCRIPTION; IDENTIFICATION; GROWTH	Many computational methods have been used to predict novel non-coding RNAs (ncRNAs), but none, to our knowledge, have explicitly investigated the impact of integrating existing cDNA-based Expressed Sequence Tag (EST) data that flank structural RNA predictions. To determine whether flanking EST data can assist in microRNA (miRNA) prediction, we identified genomic sites encoding putative miRNAs by combining functional RNA predictions with flanking ESTs data in a model consistent with miRNAs undergoing cleavage during maturation. In both human and mouse genomes, we observed that the inclusion of flanking ESTs adjacent to and not overlapping predicted miRNAs significantly improved the performance of various methods of miRNA prediction, including direct high-throughput sequencing of small RNA libraries. We analyzed the expression of hundreds of miRNAs predicted to be expressed during myogenic differentiation using a customized microarray and identified several known and predicted myogenic miRNA hairpins. Our results indicate that integrating ESTs flanking structural RNA predictions improves the quality of cleaved miRNA predictions and suggest that this strategy can be used to predict other non-coding RNAs undergoing cleavage during maturation.	[Krzyzanowski, Paul M.; Price, Feodor D.; Rudnicki, Michael A.] Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON, Canada; [Krzyzanowski, Paul M.] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Muro, Enrique M.; Andrade-Navarro, Miguel A.] Max Delbruck Ctr Mol Med, Berlin, Germany	University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Krzyzanowski, PM (corresponding author), Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON, Canada.	paul.krzyzanowski@utoronto.ca	Andrade, Miguel A/B-6565-2008; Muro, Enrique M./AAX-3698-2021	Andrade, Miguel A/0000-0001-6650-1711; Rudnicki, Michael/0000-0002-3866-5249; Krzyzanowski, Paul/0000-0001-6430-5995	Ontario Government; High Performance Computing Virtual Laboratory; Canadian Institute of Health Research; Canadian Stem Cell Network; Canada Research Chair programme; Helmholtz Germany's National Genome Research Network (Bundesministerium fur Bildung und Forschung); Helmholtz Alliance on Systems Biology (Helmholtz-Gemeinschaft Deutscher Forschungszentren)	Ontario Government; High Performance Computing Virtual Laboratory; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Stem Cell Network; Canada Research Chair programme(Canada Research Chairs); Helmholtz Germany's National Genome Research Network (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance on Systems Biology (Helmholtz-Gemeinschaft Deutscher Forschungszentren)(Helmholtz Association)	The authors acknowledge support from the Ontario Government Scholarships in Science and Technology (PMK), the High Performance Computing Virtual Laboratory (PMK), the Canadian Institute of Health Research (FDP, MAR); the Canadian Stem Cell Network (PMK, EMM, MAR, MAA); the Canada Research Chair programme (MAA); the Helmholtz Germany's National Genome Research Network (Bundesministerium fur Bildung und Forschung) (EMM, MAA); and The Helmholtz Alliance on Systems Biology (Helmholtz-Gemeinschaft Deutscher Forschungszentren) (EMM, MAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexakis C, 2007, AM J PHYSIOL-CELL PH, V293, pC661, DOI 10.1152/ajpcell.00061.2007; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Brennecke J, 2005, GENE DEV, V19, P2261, DOI 10.1101/gad.1363905; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Daubas P, 2009, DEV BIOL, V327, P71, DOI 10.1016/j.ydbio.2008.11.031; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Ge XJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-285; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Ghosh T, 2008, NUCLEIC ACIDS RES, V36, P6318, DOI 10.1093/nar/gkn624; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu J, 2006, MAMM GENOME, V17, P1033, DOI 10.1007/s00335-006-0007-9; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hofacker IL, 2004, BIOINFORMATICS, V20, P186, DOI 10.1093/bioinformatics/btg388; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; KLAMUT HJ, 1989, BRIT MED BULL, V45, P681, DOI 10.1093/oxfordjournals.bmb.a072352; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Laneve P, 2007, P NATL ACAD SCI USA, V104, P7957, DOI 10.1073/pnas.0700071104; Legendre M, 2006, PLOS COMPUT BIOL, V2, P333, DOI 10.1371/journal.pcbi.0020043; Li SC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-164; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Martick M, 2008, NATURE, V454, P899, DOI 10.1038/nature07117; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nakajima N, 2006, BIOCHEM BIOPH RES CO, V350, P1006, DOI 10.1016/j.bbrc.2006.09.153; Nguyen HT, 2006, CURR OPIN GENET DEV, V16, P533, DOI 10.1016/j.gde.2006.08.010; NUDEL U, 1988, NATURE, V331, P635, DOI 10.1038/331635a0; O'Toole AS, 2006, NUCLEIC ACIDS RES, V34, P3338, DOI 10.1093/nar/gkl428; Pawlicki JM, 2009, CELL CYCLE, V8, P345, DOI 10.4161/cc.8.3.7494; Pornprasertsuk S, 2004, J BONE MINER RES, V19, P1349, DOI 10.1359/JBMR.040323; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rogler CE, 2009, HEPATOLOGY, V50, P575, DOI 10.1002/hep.22982; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Salo AM, 2006, MATRIX BIOL, V25, P475, DOI 10.1016/j.matbio.2006.08.260; Sewer A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-267; Sironi M, 2002, FEBS LETT, V517, P163, DOI 10.1016/S0014-5793(02)02613-3; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Sweetman D, 2006, DEV DYNAM, V235, P2185, DOI 10.1002/dvdy.20881; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Washietl S, 2007, GENOME RES, V17, P852, DOI 10.1101/gr.5650707; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Xiong HP, 2009, BIOCHEM BIOPH RES CO, V378, P883, DOI 10.1016/j.bbrc.2008.12.010; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zohn IE, 2001, DEV BIOL, V239, P118, DOI 10.1006/dbio.2001.0420	69	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20561	10.1371/journal.pone.0020561	http://dx.doi.org/10.1371/journal.pone.0020561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698286	Green Published, Green Accepted, gold			2022-12-25	WOS:000291730000015
J	Zheng, YQ; Brady, OA; Meng, PS; Mao, YX; Hu, FH				Zheng, Yanqiu; Brady, Owen A.; Meng, Peter S.; Mao, Yuxin; Hu, Fenghua			C-Terminus of Progranulin Interacts with the Beta-Propeller Region of Sortilin to Regulate Progranulin Trafficking	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; GROWTH-FACTOR PROGRANULIN; MOTOR-NEURONS; DEMENTIA; TUMORIGENESIS; MUTATIONS; MICE	Progranulin haplo-insufficiency is a main cause of frontotemporal lobar degeneration (FTLD) with TDP-43 aggregates. Previous studies have shown that sortilin regulates progranulin trafficking and is a main determinant of progranulin level in the brain. In this study, we mapped the binding site between progranulin and sortilin. Progranulin binds to the beta-propeller region of sortilin through its C-terminal tail. The C-terminal progranulin fragment is fully sufficient for sortilin binding and progranulin C-terminal peptide displaces progranulin binding to sortilin. Deletion of the last 3 residues of progranulin (QLL) abolishes its binding to sortilin and also sortilin dependent regulation of progranulin trafficking. Since progranulin haplo-insufficiency results in FTLD, these results may provide important insights into future studies of progranulin trafficking and signaling and progranulin based therapy for FTLD.	[Zheng, Yanqiu; Brady, Owen A.; Meng, Peter S.; Mao, Yuxin; Hu, Fenghua] Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14850 USA	Cornell University	Zheng, YQ (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	fh87@cornell.edu		Mao, Yuxin/0000-0002-5064-1397	Weill Institute for Cell and Molecular Biology; Rosalinde and Arthur Gilbert Foundation/AFAR; BMCB, NIH [5 T32 GM07273]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007273] Funding Source: NIH RePORTER	Weill Institute for Cell and Molecular Biology; Rosalinde and Arthur Gilbert Foundation/AFAR; BMCB, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding to FH from the Weill Institute for Cell and Molecular Biology and from the Rosalinde and Arthur Gilbert Foundation/AFAR New Investigator Award in Alzheimer's Disease. OAB was supported by BMCB training grant (5 T32 GM07273 - NIH Predoctoral Training in Cellular and Molecular Biology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen OS, 2010, J BIOL CHEM, V285, P12210, DOI 10.1074/jbc.M109.062364; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Carrasquillo MM, 2010, AM J HUM GENET, V87, P890, DOI 10.1016/j.ajhg.2010.11.002; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chen-Plotkin AS, 2010, ACTA NEUROPATHOL, V119, P111, DOI 10.1007/s00401-009-0576-2; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Laird AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013368; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neary D, 2005, LANCET NEUROL, V4, P771, DOI 10.1016/S1474-4422(05)70223-4; Pereson S, 2009, J PATHOL, V219, P173, DOI 10.1002/path.2580; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Ryan CL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-130; Serrero G, 2003, BIOCHEM BIOPH RES CO, V308, P409, DOI 10.1016/S0006-291X(03)01452-9; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Vancha AR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-23; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568	23	71	77	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21023	10.1371/journal.pone.0021023	http://dx.doi.org/10.1371/journal.pone.0021023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698296	gold, Green Published, Green Submitted			2022-12-25	WOS:000291730000040
J	Stoddart, A; Tennant, TR; Fernald, AA; Anastasi, J; Brodsky, FM; Le Beau, MM				Stoddart, A.; Tennant, T. R.; Fernald, A. A.; Anastasi, J.; Brodsky, F. M.; Le Beau, M. M.			The clathrin-binding domain of CALM-AF10 alters the phenotype of myeloid neoplasms in mice	ONCOGENE			English	Article						AML; MPD; endocytosis; DOT1L; H3K79 methylation; oligomerization	ACUTE LYMPHOBLASTIC-LEUKEMIA; MLL FUSION PARTNER; TRANSGENIC MICE; CALM/AF10 FUSION; ASSEMBLY PROTEIN; CELL-LINE; T-ALL; GENE; CALM; AF10	The PICALM(CALM) gene, whose product is involved in clathrin-mediated endocytosis, has been identified in two recurring chromosomal translocations, involving either MLL or MLLT10 (AF10). We developed a mouse model of CALM-AF10(+) leukemia to examine the hypothesis that disruption of endocytosis contributes to leukemogenesis. Exclusion of the C-terminal portion of CALM from the fusion protein, which is required for optimal binding to clathrin, resulted in the development of a myeloproliferative disease, whereas inclusion of this domain led to the development of acute myeloid leukemia and changes in gene expression of several cancer-related genes, notably Pim1 and Crebbp. Nonetheless, the development of leukemia could not be attributed directly to interference with endocytosis or consequential changes in proliferation and signaling. In leukemia cells, full-length CALM-AF10 localized to the nucleus with no consistent effect on growth factor endocyctosis, and suppressed histone H3 lysine 79 methylation regardless of the presence of clathrin. Using fluorescence resonance energy transfer analysis, we show that CALM-AF10 has a propensity to homo-oligomerize, raising the possibility that the function of endocytic proteins involved in chimeric fusions may be to provide dimerization properties, a recognized mechanism for unleashing oncogenic properties of chimeric transcription factors, rather than disrupting the internalization of growth factor receptors. Oncogene (2012) 31, 494-506; doi: 10.1038/onc.2011.251; published online 27 June 2011	[Stoddart, A.; Tennant, T. R.; Fernald, A. A.; Le Beau, M. M.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Anastasi, J.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Brodsky, F. M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of Chicago; University of Chicago; University of California System; University of California San Francisco	Stoddart, A (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, 900 E,57th St,KCBD 7th Floor, Chicago, IL 60637 USA.	astoddar@bsd.uchicago.edu		Brodsky, Frances/0000-0002-1334-9258	Leukemia and Lymphoma Society [7015]; Special Fellow Award; Cancer Research Foundation; Lauri Strauss Leukemia Foundation; NIH [GM038093]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038093] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Special Fellow Award; Cancer Research Foundation; Lauri Strauss Leukemia Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr Vytas Bindokas and the University of Chicago Comprehensive Cancer Center Integrated Microscopy, and Flow Cytometry Facilities for their assistance. We also thank Scott Kogan for advice on classifying myeloid malignancies and Elizabeth Davis for technical assistance and members of the Le Beau laboratory for helpful discussions. This work was supported by a Special Fellow Award and SCOR (7015) from the Leukemia and Lymphoma Society, and grants from the Cancer Research Foundation, Lauri Strauss Leukemia Foundation and NIH (GM038093).	Archangelo LF, 2006, ONCOGENE, V25, P4099, DOI 10.1038/sj.onc.1209438; Asnafi V, 2003, BLOOD, V102, P1000, DOI 10.1182/blood-2002-09-2913; BERNARD OA, 1994, ONCOGENE, V9, P1039; Bhattacharya N, 2002, CHROMOSOMA, V111, P80, DOI 10.1007/s00412-002-0192-6; Bohlander SK, 2000, LEUKEMIA, V14, P93, DOI 10.1038/sj.leu.2401614; Bradley SV, 2007, CANCER RES, V67, P8923, DOI 10.1158/0008-5472.CAN-07-2153; Broudy VC, 1999, BLOOD, V94, P1979; Carlson KM, 2000, LEUKEMIA, V14, P100, DOI 10.1038/sj.leu.2401629; Caudell D, 2007, CANCER RES, V67, P8022, DOI 10.1158/0008-5472.CAN-06-3749; CHAKRABARTI R, 1993, J CELL BIOL, V123, P79, DOI 10.1083/jcb.123.1.79; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Chikatsu N, 2003, MODERN PATHOL, V16, P828, DOI 10.1097/01.MP.0000081729.40230.1F; Cho H, 2007, J CELL BIOL, V178, P245, DOI 10.1083/jcb.200604114; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Debernardi S, 2002, BLOOD, V99, P275, DOI 10.1182/blood.V99.1.275; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Dik WA, 2005, LEUKEMIA, V19, P1948, DOI 10.1038/sj.leu.2403891; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Dreyling MH, 1998, BLOOD, V91, P4662; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Forissier S, 2007, BIOL CELL, V99, P563, DOI 10.1042/BC20060131; Fu JF, 2003, GENE CHROMOSOME CANC, V37, P214, DOI 10.1002/gcc.10204; Harborth J, 2000, J BIOL CHEM, V275, P31979, DOI 10.1074/jbc.M000994200; HOPKINS CR, 1985, CELL, V40, P199, DOI 10.1016/0092-8674(85)90323-X; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Kung AL, 2000, GENE DEV, V14, P272; Lanzetti L, 2008, TRAFFIC, V9, P2011, DOI 10.1111/j.1600-0854.2008.00816.x; Le Beau MM, 2002, BLOOD, V99, P2985, DOI 10.1182/blood.V99.8.2985; LEMMON SK, 1990, GENETICS, V124, P27; Lian Z, 2002, BLOOD, V100, P3209, DOI 10.1182/blood-2002-03-0850; Lin YH, 2009, BLOOD, V114, P651, DOI 10.1182/blood-2009-03-209395; Linder B, 2000, J MOL BIOL, V299, P369, DOI 10.1006/jmbi.2000.3766; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Muntau AC, 2003, EUR J CELL BIOL, V82, P333, DOI 10.1078/0171-9335-00325; Okada Y, 2006, NAT CELL BIOL, V8, P1017, DOI 10.1038/ncb1464; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; SELTEN G, 1985, EMBO J, V4, P1793, DOI 10.1002/j.1460-2075.1985.tb03852.x; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; So CW, 2004, BLOOD, V104, P919, DOI 10.1182/blood-2004-03-0992; So CW, 2003, CANCER CELL, V4, P99, DOI 10.1016/S1535-6108(03)00188-0; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; Vecchi M, 2001, J CELL BIOL, V153, P1511, DOI 10.1083/jcb.153.7.1511; Wechsler DS, 2003, GENE CHROMOSOME CANC, V36, P26, DOI 10.1002/gcc.10136	45	9	9	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2012	31	4					494	506		10.1038/onc.2011.251	http://dx.doi.org/10.1038/onc.2011.251			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891LU	21706055	Green Accepted, Green Submitted			2022-12-25	WOS:000300219300008
J	Ando, T; Ohashi, K; Ochiai, A; Mikami, B; Kawai, S; Murata, K				Ando, Takuya; Ohashi, Kazuto; Ochiai, Akihito; Mikami, Bunzo; Kawai, Shigeyuki; Murata, Kousaku			Structural Determinants of Discrimination of NAD(+) from NADH in Yeast Mitochondrial NADH Kinase Pos5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; IDENTIFICATION; ATP; ARABIDOPSIS; INHIBITION; CLONING	NAD kinase catalyzes the phosphorylation of NAD(+) to synthesize NADP(+), whereas NADH kinase catalyzes conversion of NADH to NADPH. The mitochondrial protein Pos5 of Saccharomyces cerevisiae shows much higher NADH kinase than NAD kinase activity and is therefore referred to as NADH kinase. To clarify the structural determinant underlying the high NADH kinase activity of Pos5 and its selectivity for NADH over NAD(+), we determined the tertiary structure of Pos5 complexed with NADH at a resolution of 2.0 angstrom. Detailed analysis, including a comparison of the tertiary structure of Pos5 with the structures of human and bacterial NAD kinases, revealed that Arg-293 of Pos5, corresponding to His-351 of human NAD kinase, confers a positive charge on the surface of NADH-binding site, whereas the corresponding His residue does not. Accordingly, conversion of the Arg-293 into a His residue reduced the ratio of NADH kinase activity to NAD kinase activity from 8.6 to 2.1. Conversely, simultaneous changes of Ala-330 and His-351 of human NAD kinase into Ser and Arg residues significantly increased the ratio of NADH kinase activity to NAD kinase activity from 0.043 to 1.39; human Ala-330 corresponds to Pos5 Ser-272, which interacts with the side chain of Arg-293. Arg-293 and Ser-272 were highly conserved in Pos5 homologs (putative NADH kinases), but not in putative NAD kinases. Thus, Arg-293 of Pos5 is a major determinant of NADH selectivity. Moreover, Ser-272 appears to assist Arg-293 in achieving the appropriate conformation.	[Ando, Takuya; Ohashi, Kazuto; Ochiai, Akihito; Kawai, Shigeyuki; Murata, Kousaku] Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Lab Appl Struct Biol, Grad Sch Agr, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Murata, K (corresponding author), Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan.	kmurata@kais.kyoto-u.ac.jp	Ohashi, Kazuto/M-8377-2019	Ohashi, Kazuto/0000-0002-6517-1156	Ministry of Education, Culture, Sports, Science and Technology of Japan [21780069]; Program for Promotion of Basic Research Activities for Innovative Biosciences	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Basic Research Activities for Innovative Biosciences	This work was supported in part by Grant-in-Aid for Scientific Research 21780069 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to S. K.) and by the Program for Promotion of Basic Research Activities for Innovative Biosciences.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bieganowski P, 2006, J BIOL CHEM, V281, P22439, DOI 10.1074/jbc.M513919200; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grose JH, 2006, P NATL ACAD SCI USA, V103, P7601, DOI 10.1073/pnas.0602494103; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kawai S, 2000, BIOCHEM BIOPH RES CO, V276, P57, DOI 10.1006/bbrc.2000.3433; Kawai S, 2008, BIOSCI BIOTECH BIOCH, V72, P919, DOI 10.1271/bbb.70738; Lerner F, 2001, BIOCHEM BIOPH RES CO, V288, P69, DOI 10.1006/bbrc.2001.5735; Liu JY, 2005, J MOL BIOL, V354, P289, DOI 10.1016/j.jmb.2005.09.026; Miyagi H, 2009, J BIOL CHEM, V284, P7553, DOI 10.1074/jbc.M804100200; Mori S, 2005, BIOCHEM BIOPH RES CO, V327, P500, DOI 10.1016/j.bbrc.2004.11.163; Mori S, 2005, J BIOL CHEM, V280, P24104, DOI 10.1074/jbc.M502518200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ochiai A, 2004, PROTEIN EXPRES PURIF, V36, P124, DOI 10.1016/j.pep.2004.03.012; Oganesyan V, 2005, ACTA CRYSTALLOGR F, V61, P640, DOI 10.1107/S1744309105019780; OHASHI K, 2011, MOL CELL BI IN PRESS; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrelli R, 2009, BIOORGAN MED CHEM, V17, P5656, DOI 10.1016/j.bmc.2009.06.013; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Poncet-Montange G, 2007, J BIOL CHEM, V282, P33925, DOI 10.1074/jbc.M701394200; Raffaelli N, 2004, BIOCHEMISTRY-US, V43, P7610, DOI 10.1021/bi049650w; Shi F, 2005, FEBS J, V272, P3337, DOI 10.1111/j.1742-4658.2005.04749.x; Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner WL, 2005, BIOCHEM J, V385, P217, DOI 10.1042/BJ20040292; Turner WL, 2004, PLANT PHYSIOL, V135, P1243, DOI 10.1104/pp.104.040428; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	31	13	13	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29984	29992		10.1074/jbc.M111.249011	http://dx.doi.org/10.1074/jbc.M111.249011			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21730068	hybrid, Green Published			2022-12-25	WOS:000294046600057
J	Shi, CW; Lu, J; Wu, W; Ma, FX; Georges, J; Huang, HJ; Balducci, J; Chang, YC; Huang, Y				Shi, Chunwei; Lu, Jia; Wu, Wen; Ma, Fanxin; Georges, Joseph; Huang, Hanju; Balducci, James; Chang, Yongchang; Huang, Yao			Endothelial Cell-Specific Molecule 2 (ECSM2) Localizes to Cell-Cell Junctions and Modulates bFGF-Directed Cell Migration via the ERK-FAK Pathway	PLOS ONE			English	Article							FOCAL ADHESION KINASE; FIBROBLAST-GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; VASCULAR-PERMEABILITY; BIOLOGICAL RESPONSES; INDUCED ANGIOGENESIS; INTEGRATING SIGNALS; ADHERENS JUNCTIONS; FACTOR RECEPTOR; BETA-CATENIN	Background: Despite its first discovery by in silico cloning of novel endothelial cell-specific genes a decade ago, the biological functions of endothelial cell-specific molecule 2 (ECSM2) have only recently begun to be understood. Limited data suggest its involvement in cell migration and apoptosis. However, the underlying signaling mechanisms and novel functions of ECSM2 remain to be explored. Methodology/Principal Findings: A rabbit anti-ECSM2 monoclonal antibody (RabMAb) was generated and used to characterize the endogenous ECSM2 protein. Immunoblotting, immunoprecipitation, deglycosylation, immunostaining and confocal microscopy validated that endogenous ECSM2 is a plasma membrane glycoprotein preferentially expressed in vascular endothelial cells (ECs). Expression patterns of heterologously expressed and endogenous ECSM2 identified that ECSM2 was particularly concentrated at cell-cell contacts. Cell aggregation and transwell assays showed that ECSM2 promoted cell-cell adhesion and attenuated basic fibroblast growth factor (bFGF)-driven EC migration. Gain or loss of function assays by overexpression or knockdown of ECSM2 in ECs demonstrated that ECSM2 modulated bFGF-directed EC motility via the FGF receptor (FGFR)-extracellular regulated kinase (ERK)-focal adhesion kinase (FAK) pathway. The counterbalance between FAK tyrosine phosphorylation (activation) and ERK-dependent serine phosphorylation of FAK was critically involved. A model of how ECSM2 signals to impact bFGF/FGFR-driven EC migration was proposed. Conclusions/Significance: ECSM2 is likely a novel EC junctional protein. It can promote cell-cell adhesion and inhibit bFGF-mediated cell migration. Mechanistically, ECSM2 attenuates EC motility through the FGFR-ERK-FAK pathway. The findings suggest that ECSM2 could be a key player in coordinating receptor tyrosine kinase (RTK)-, integrin-, and EC junctional component-mediated signaling and may have important implications in disorders related to endothelial dysfunction and impaired EC junction signaling.	[Shi, Chunwei; Lu, Jia; Wu, Wen; Ma, Fanxin; Balducci, James; Huang, Yao] St Josephs Hosp, Dept Obstet & Gynecol, Phoenix, AZ 85013 USA; [Shi, Chunwei; Lu, Jia; Wu, Wen; Ma, Fanxin; Georges, Joseph; Balducci, James; Chang, Yongchang; Huang, Yao] Med Ctr, Phoenix, AZ USA; [Georges, Joseph; Chang, Yongchang] St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Shi, Chunwei; Lu, Jia; Wu, Wen; Huang, Hanju] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathogen Biol, Wuhan 430074, Peoples R China; [Ma, Fanxin] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Coll Life Sci, Chengdu 610064, Peoples R China	St. Joseph's Hospital and Medical Center; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Huazhong University of Science & Technology; Sichuan University	Shi, CW (corresponding author), St Josephs Hosp, Dept Obstet & Gynecol, Phoenix, AZ 85013 USA.	yhuang@chw.edu	Wu, Wen/V-7065-2017		St. Joseph's Foundation; Catholic Healthcare West Intellectual Innovation Network (CHWiin); American Heart Association; China Scholarship Council (CSC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085237] Funding Source: NIH RePORTER	St. Joseph's Foundation; Catholic Healthcare West Intellectual Innovation Network (CHWiin); American Heart Association(American Heart Association); China Scholarship Council (CSC)(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a St. Joseph's Foundation Startup Fund and a Catholic Healthcare West Intellectual Innovation Network (CHWiin) SEED Fund, and in part by an American Heart Association Award (to Y. Huang). W. Wu was partially supported by a China Scholarship Council (CSC) studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong LJ, 2008, ARTERIOSCL THROM VAS, V28, P1640, DOI 10.1161/ATVBAHA.108.162511; AYALON O, 1994, J CELL BIOL, V126, P247, DOI 10.1083/jcb.126.1.247; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Brizzi MF, 2001, CIRCULATION, V103, P549, DOI 10.1161/01.CIR.103.4.549; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Brouillet S, 2010, MOL BIOL CELL, V21, P2832, DOI 10.1091/mbc.E10-01-0059; Bryant DM, 2005, MOL BIOL CELL, V16, P14, DOI 10.1091/mbc.E04-09-0845; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; EIDE BL, 1995, MOL CELL BIOL, V15, P2819; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Falk MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-34; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; FRIESEL RE, 1995, FASEB J, V9, P919, DOI 10.1096/fasebj.9.10.7542215; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Henriksen K, 2003, J BIOL CHEM, V278, P48745, DOI 10.1074/jbc.M309193200; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang Y, 2006, ONCOGENE, V25, P7565, DOI 10.1038/sj.onc.1209740; Huang Y, 2004, MOL ENDOCRINOL, V18, P1471, DOI 10.1210/me.2003-0418; Huang Y, 2003, J BIOL CHEM, V278, P18902, DOI 10.1074/jbc.M300939200; Huang ZY, 2003, MOL CELL BIOL, V23, P566, DOI 10.1128/MCB.23.2.566-578.2003; Huminiecki L, 2000, GENOME RES, V10, P1796, DOI 10.1101/gr.150700; Hunger-Glaser I, 2003, J BIOL CHEM, V278, P22631, DOI 10.1074/jbc.M210876200; Hunger-Glaser I, 2004, J CELL PHYSIOL, V200, P213, DOI 10.1002/jcp.20018; Ikeda K, 2009, P NATL ACAD SCI USA, V106, P8227, DOI 10.1073/pnas.0806780106; Javerzat S, 2002, TRENDS MOL MED, V8, P483, DOI 10.1016/S1471-4914(02)02394-8; Jiang XH, 2007, CELL SIGNAL, V19, P1000, DOI 10.1016/j.cellsig.2006.11.004; Joseph-Silverstein J, 1998, CANCER INVEST, V16, P176, DOI 10.3109/07357909809050034; KLINT P, 1999, FRONT BIOSCI, V4, P165; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Ma FX, 2009, GENES CELLS, V14, P281, DOI 10.1111/j.1365-2443.2008.01267.x; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Odintsova E, 2000, CURR BIOL, V10, P1009, DOI 10.1016/S0960-9822(00)00652-7; Orian-Rousseau V, 2008, ADV CANCER RES, V101, P63, DOI 10.1016/S0065-230X(08)00404-1; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Pintucci G, 2002, FASEB J, V16, P598, DOI 10.1096/fj.01-0815fje; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rojas AI, 1999, CRIT REV ORAL BIOL M, V10, P337, DOI 10.1177/10454411990100030601; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Simons M, 2004, MOL CELL BIOCHEM, V264, P99, DOI 10.1023/B:MCBI.0000044379.25823.03; SPIEKERPOLET H, 1995, P NATL ACAD SCI USA, V92, P9348, DOI 10.1073/pnas.92.20.9348; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Verissimo AR, 2009, BIOCHEM SOC T, V37, P1214, DOI 10.1042/BST0371214; Verma A, 2010, BLOOD, V115, P4614, DOI 10.1182/blood-2009-10-248856; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771; Yan W, 2008, MOL BIOL CELL, V19, P2278, DOI 10.1091/mbc.E07-10-1068; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zheng YH, 2009, MOL CELL, V35, P11, DOI 10.1016/j.molcel.2009.06.013	60	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21482	10.1371/journal.pone.0021482	http://dx.doi.org/10.1371/journal.pone.0021482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21720547	Green Published, gold			2022-12-25	WOS:000292036900039
J	Zhang, YW; Li, HL; Luo, YL; Shi, X; Tian, JQ; Sun, XP				Zhang, Yingwei; Li, Hailong; Luo, Yonglan; Shi, Xu; Tian, Jingqi; Sun, Xuping			Poly(m-Phenylenediamine) Nanospheres and Nanorods: Selective Synthesis and Their Application for Multiplex Nucleic Acid Detection	PLOS ONE			English	Article							POLYANILINE NANOFIBERS; HYDROGEN-PEROXIDE; SENSING PLATFORM; CARBON NANOTUBES; DNA; REDUCTION; PROBES; POLY(ORTHO-PHENYLENEDIAMINE); ELECTROPOLYMERIZATION; PHENYLENEDIAMINE	In this paper, we demonstrate for the first time that poly(m-phenylenediamine) (PMPD) nanospheres and nanorods can be selectively synthesized via chemical oxidation polymerization of m-phenylenediamine (MPD) monomers using ammonium persulfate (APS) as an oxidant at room temperature. It suggests that the pH value plays a critical role in controlling the the morphology of the nanostructures and fast polymerization rate favors the anisotropic growth of PMPD under homogeneous nucleation condition. We further demonstrate that such PMPD nanostructures can be used as an effective fluorescent sensing platform for multiplex nucleic acid detection. A detection limit as low as 50 pM and a high selectivity down to single-base mismatch could be achieved. The fluorescence quenching is attributed to photoinduced electron transfer from nitrogen atom in PMPD to excited fluorophore. Most importantly, the successful use of this sensing platform in human blood serum system is also demonstrated.	[Zhang, Yingwei; Li, Hailong; Luo, Yonglan; Tian, Jingqi; Sun, Xuping] Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun, Jilin, Peoples R China; [Li, Hailong; Tian, Jingqi] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Shi, Xu] Jilin Univ, Affiliated Hosp 1, Inst Virol & AIDS Res, Changchun 130023, Jilin, Peoples R China	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Jilin University	Zhang, YW (corresponding author), Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun, Jilin, Peoples R China.	sunxp@ciac.jl.cn	Li, Hailong/H-2527-2018	Li, Hailong/0000-0002-1209-2315; TIAN, Jingqi/0000-0002-3695-7563				Bernard Valeur, 2001, MOL FLUORESCENCE PRI; Brayner R, 2008, NANO TODAY, V3, P48, DOI 10.1016/S1748-0132(08)70015-X; BURR HE, 1982, NUCLEIC ACIDS RES, V10, P719, DOI 10.1093/nar/10.2.719; Cai LT, 1999, SENSOR ACTUAT B-CHEM, V55, P14, DOI 10.1016/S0925-4005(99)00024-6; Cataldo F, 1996, EUR POLYM J, V32, P43, DOI 10.1016/0014-3057(95)00118-2; Dai HP, 1998, J ELECTROANAL CHEM, V456, P47, DOI 10.1016/S0022-0728(98)00211-3; DEMPSEY E, 1993, TALANTA, V40, P445, DOI 10.1016/0039-9140(93)80257-R; DENG Q, 1994, J ELECTROANAL CHEM, V377, P191, DOI 10.1016/0022-0728(94)03465-6; Dubertret B, 2001, NAT BIOTECHNOL, V19, P365, DOI 10.1038/86762; Fan CH, 2003, P NATL ACAD SCI USA, V100, P6297, DOI 10.1073/pnas.1132025100; Forzani ES, 2007, ANAL CHEM, V79, P5217, DOI 10.1021/ac0703202; Gao H, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/28/285203; Gornall DD, 2010, ELECTROANAL, V22, P384, DOI 10.1002/elan.200900392; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Han J, 2009, LANGMUIR, V25, P11054, DOI 10.1021/la901373t; He SJ, 2010, ADV FUNCT MATER, V20, P453, DOI 10.1002/adfm.200901639; Huang MR, 2006, CHEM-EUR J, V12, P4341, DOI 10.1002/chem.200501070; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Li D, 2009, ACCOUNTS CHEM RES, V42, P135, DOI 10.1021/ar800080n; Li D, 2010, ACCOUNTS CHEM RES, V43, P631, DOI 10.1021/ar900245u; Li HL, 2011, SMALL, V7, P1562, DOI 10.1002/smll.201100068; Li HL, 2011, MACROMOL RAPID COMM, V32, P899, DOI 10.1002/marc.201100108; Li HL, 2011, ANAL METHODS-UK, V3, P1051, DOI 10.1039/c0ay00746c; Li HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018958; Li HL, 2011, J MATER CHEM, V21, P824, DOI 10.1039/c0jm02695f; Li HL, 2011, J MATER CHEM, V21, P4663, DOI 10.1039/c0jm04107f; Li HL, 2011, CHEM COMMUN, V47, P2625, DOI 10.1039/c0cc05394e; Li HL, 2011, CHEM COMMUN, V47, P961, DOI 10.1039/c0cc04326e; Li HX, 2004, ANAL CHEM, V76, P5414, DOI 10.1021/ac049173n; Li XG, 2002, CHEM REV, V102, P2925, DOI 10.1021/cr010423z; Li XG, 2009, LANGMUIR, V25, P1675, DOI 10.1021/la802410p; Li YJ, 1998, ELECTROANAL, V10, P671, DOI 10.1002/(SICI)1521-4109(199808)10:10<671::AID-ELAN671>3.3.CO;2-M; Liu S, 2011, NANOSCALE, V3, P967, DOI 10.1039/c0nr00873g; Liu S, 2011, J MATER CHEM, V21, P339, DOI 10.1039/c0jm03337e; Lu CH, 2009, ANGEW CHEM INT EDIT, V48, P4785, DOI 10.1002/anie.200901479; MALITESTA C, 1990, ANAL CHEM, V62, P2735, DOI 10.1021/ac00223a016; Maxwell DJ, 2002, J AM CHEM SOC, V124, P9606, DOI 10.1021/ja025814p; Ogura K, 1998, J ELECTROCHEM SOC, V145, P3351, DOI 10.1149/1.1838811; OHSAKA T, 1991, J CHEM SOC CHEM COMM, P1072, DOI 10.1039/c39910001072; PREMASIRI AH, 1995, MACROMOL CHEM PHYSIC, V196, P3655, DOI 10.1002/macp.1995.021961118; Ray PC, 2007, PLASMONICS, V2, P173, DOI 10.1007/s11468-007-9036-9; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Song SP, 2009, ANGEW CHEM INT EDIT, V48, P8670, DOI 10.1002/anie.200901887; Stoeva SI, 2006, ANGEW CHEM INT EDIT, V45, P3303, DOI 10.1002/anie.200600124; Sulimenko T, 2001, J COLLOID INTERF SCI, V236, P328, DOI 10.1006/jcis.2000.7415; Sun XP, 2004, CHEM COMMUN, P1182, DOI 10.1039/b401777c; Tian JQ, 2011, ANALYST, V136, P2221, DOI 10.1039/c0an00944j; Tian JQ, 2011, LANGMUIR, V27, P874, DOI 10.1021/la103799e; Tran HD, 2008, MACROMOLECULES, V41, P7405, DOI 10.1021/ma800122d; Tran HD, 2008, ACS NANO, V2, P1841, DOI 10.1021/nn800272z; Trueba M, 2004, ELECTROCHIM ACTA, V49, P4341, DOI 10.1016/j.electacta.2004.03.043; Varghese N, 2009, CHEMPHYSCHEM, V10, P206, DOI 10.1002/cphc.200800459; WAN MX, 1995, J APPL POLYM SCI, V55, P399, DOI 10.1002/app.1995.070550304; Wang L, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1294; Yang RH, 2008, ANAL CHEM, V80, P7408, DOI 10.1021/ac801118p; Yang RH, 2008, J AM CHEM SOC, V130, P8351, DOI 10.1021/ja800604z; Zhang YW, 2011, LANGMUIR, V27, P2170, DOI 10.1021/la105092f	57	29	29	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e20569	10.1371/journal.pone.0020569	http://dx.doi.org/10.1371/journal.pone.0020569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731617	gold, Green Published, Green Submitted			2022-12-25	WOS:000292035400004
J	Helliwell, CA; Robertson, M; Finnegan, EJ; Buzas, DM; Dennis, ES				Helliwell, Chris A.; Robertson, Masumi; Finnegan, E. Jean; Buzas, Diana M.; Dennis, Elizabeth S.			Vernalization-Repression of Arabidopsis FLC Requires Promoter Sequences but Not Antisense Transcripts	PLOS ONE			English	Article							FLOWERING-LOCUS-C; HISTONE H3; GENE; PROTEIN; CHROMATIN; TRIMETHYLATION; RNA; THALIANA; COMPLEX	The repression of Arabidopsis FLC expression by vernalization (extended cold) has become a model for understanding polycomb-associated epigenetic regulation in plants. Antisense and sense non-coding RNAs have been respectively implicated in initiation and maintenance of FLC repression by vernalization. We show that the promoter and first exon of the FLC gene are sufficient to initiate repression during vernalization; this initial repression of FLC does not require antisense transcription. Long-term maintenance of FLC repression requires additional regions of the gene body, including those encoding sense non-coding transcripts.	[Helliwell, Chris A.; Robertson, Masumi; Finnegan, E. Jean; Buzas, Diana M.; Dennis, Elizabeth S.] CSIRO Plant Ind, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Helliwell, CA (corresponding author), CSIRO Plant Ind, Canberra, ACT, Australia.	chris.helliwell@csiro.au	Buzas, Diana M/J-3826-2014; Finnegan, Elizabeth J/A-1183-2010; Helliwell, Chris/A-1469-2008; Buzas, Diana Mihaela/AAA-1431-2020; Dennis, Elizabeth S/A-6074-2008	Finnegan, Elizabeth J/0000-0002-2724-9311; Helliwell, Chris/0000-0001-5943-897X; Buzas, Diana Mihaela/0000-0002-8625-7872; Dennis, Elizabeth S/0000-0002-7850-591X				Buzas DM, 2011, PLANT J, V65, P872, DOI 10.1111/j.1365-313X.2010.04471.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; Deng WW, 2011, P NATL ACAD SCI USA, V108, P6680, DOI 10.1073/pnas.1103175108; Finnegan EJ, 2007, CURR BIOL, V17, P1978, DOI 10.1016/j.cub.2007.10.026; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Helliwell CA, 2006, PLANT J, V46, P183, DOI 10.1111/j.1365-313X.2006.02686.x; Helliwell CA, 2002, FUNCT PLANT BIOL, V29, P1217, DOI 10.1071/FP02033; Heo JB, 2011, EPIGENETICS-US, V6, P544, DOI 10.4161/epi.6.5.15235; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Hornyik C, 2010, DEV CELL, V18, P203, DOI 10.1016/j.devcel.2009.12.009; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; LEE I, 1994, PLANT CELL, V6, P75, DOI 10.1105/tpc.6.1.75; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Maenner S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000276; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Sheldon CC, 2002, PLANT CELL, V14, P2527, DOI 10.1105/tpc.004564; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Shirzadi R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001303; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Swiezewski S, 2007, P NATL ACAD SCI USA, V104, P3633, DOI 10.1073/pnas.0611459104; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103	28	92	103	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2011	6	6							e21513	10.1371/journal.pone.0021513	http://dx.doi.org/10.1371/journal.pone.0021513			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782CL	21713009	Green Submitted, gold, Green Published			2022-12-25	WOS:000291985100040
J	Lee, SKW; Teng, YF; Wong, HK; Ng, TK; Huang, L; Lei, P; Choy, KW; Liu, YP; Zhang, MZ; Lam, DSC; Yam, GHF; Pang, CP				Lee, Sharon Ka-Wai; Teng, Yufei; Wong, Hoi-Kin; Tsz-Kin Ng; Huang, Li; Lei, Peng; Choy, Kwong-Wai; Liu, Yingpeng; Zhang, Mingzhi; Lam, Dennis Shun-Chiu; Yam, Gary Hin-Fai; Pang, Chi-Pui			MicroRNA-145 Regulates Human Corneal Epithelial Differentiation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GROWTH-FACTOR-BETA; INTEGRIN EXPRESSION; MICROARRAY ANALYSIS; PROGENITOR CELLS; GENE-EXPRESSION; OCULAR SURFACE; PROLIFERATION; ACTIVATION; MIR-145	Background: Epigenetic factors, such as microRNAs, are important regulators in the self-renewal and differentiation of stem cells and progenies. Here we investigated the microRNAs expressed in human limbal-peripheral corneal (LPC) epithelia containing corneal epithelial progenitor cells (CEPCs) and early transit amplifying cells, and their role in corneal epithelium. Methodology/Principal Findings: Human LPC epithelia was extracted for small RNAs or dissociated for CEPC culture. By Agilent Human microRNA Microarray V2 platform and GeneSpring GX11.0 analysis, we found differential expression of 18 microRNAs against central corneal (CC) epithelia, which were devoid of CEPCs. Among them, miR-184 was up-regulated in CC epithelia, similar to reported finding. Cluster miR-143/145 was expressed strongly in LPC but weakly in CC epithelia (P = 0.0004, Mann-Whitney U-test). This was validated by quantitative polymerase chain reaction (qPCR). Locked nucleic acid-based in situ hybridization on corneal rim cryosections showed miR-143/145 presence localized to the parabasal cells of limbal epithelium but negligible in basal and superficial epithelia. With holoclone forming ability, CEPCs transfected with lentiviral plasmid containing mature miR-145 sequence gave rise to defective epithelium in organotypic culture and had increased cytokeratin-3/12 and connexin-43 expressions and decreased ABCG2 and p63 compared with cells transfected with scrambled sequences. Global gene expression was analyzed using Agilent Whole Human Genome Oligo Microarray and GeneSpring GX11.0. With a 5-fold difference compared to cells with scrambled sequences, miR-145 up-regulated 324 genes (containing genes for immune response) and down-regulated 277 genes (containing genes for epithelial development and stem cell maintenance). As validated by qPCR and luciferase reporter assay, our results showed miR-145 suppressed integrin beta 8 (ITGB8) expression in both human corneal epithelial cells and primary CEPCs. Conclusion/Significance: We found expression of miR-143/145 cluster in human corneal epithelium. Our results also showed that miR-145 regulated the corneal epithelium formation and maintenance of epithelial integrity, via ITGB8 targeting.	[Lee, Sharon Ka-Wai; Teng, Yufei; Tsz-Kin Ng; Huang, Li; Lei, Peng; Lam, Dennis Shun-Chiu; Yam, Gary Hin-Fai; Pang, Chi-Pui] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; [Wong, Hoi-Kin; Choy, Kwong-Wai] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Liu, Yingpeng; Zhang, Mingzhi] Joint Shantou Int Eye Ctr, Shantou, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Lee, SKW (corresponding author), Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China.	gary_yam@cuhk.edu.hk; cppang@cuhk.edu.hk	Yam, Gary Hin-Fai/ABE-1710-2020; Choy, Richard/AAW-8230-2020; Ng, Tsz Kin/I-8061-2014; Pang, Chi P/I-5388-2014; Lam, Dennis/AAL-1211-2020	Choy, Richard/0000-0002-3616-6200; Ng, Tsz Kin/0000-0001-7863-7229; 	The Chinese University of Hong Kong [2006.1.059, 2041576]; University Grants Committee, Hong Kong	The Chinese University of Hong Kong(Chinese University of Hong Kong); University Grants Committee, Hong Kong	This study was financially supported by the Direct Grant from The Chinese University of Hong Kong (Grant Ref: 2006.1.059 and 2041576) and a block grant of the University Grants Committee, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2007, INVEST OPHTH VIS SCI, V48, P3962, DOI 10.1167/iovs.06-1221; Ashkar S, 2004, J OCUL PHARMACOL TH, V20, P65, DOI 10.1089/108076804772745473; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Budak MT, 2005, J CELL SCI, V118, P1715, DOI 10.1242/jcs.02279; Burbach GJ, 2001, CURR EYE RES, V23, P64, DOI 10.1076/ceyr.23.1.64.5425; Cambier S, 2005, AM J PATHOL, V166, P1883, DOI 10.1016/S0002-9440(10)62497-2; Chen JM, 2010, AM J PATHOL, V176, P2520, DOI 10.2353/ajpath.2010.091061; Chen Z, 2006, STEM CELLS, V24, P1265, DOI 10.1634/stemcells.2005-0363; Cheng LC, 2005, NEURON, V46, P363, DOI 10.1016/j.neuron.2005.04.027; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Espana EM, 2003, INVEST OPHTH VIS SCI, V44, P4275, DOI 10.1167/iovs.03-0089; Feng HC, 2008, HISTOPATHOLOGY, V52, P167, DOI 10.1111/j.1365-2559.2007.02925.x; Figueira EC, 2007, INVEST OPHTH VIS SCI, V48, P144, DOI 10.1167/iovs.06-0346; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Hasseine LK, 2009, BIOCHEM BIOPH RES CO, V390, P1278, DOI 10.1016/j.bbrc.2009.10.135; Higa K, 2009, INVEST OPHTH VIS SCI, V50, P4640, DOI 10.1167/iovs.09-3503; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Huang XH, 2009, HEPATOL RES, V39, P786, DOI 10.1111/j.1872-034X.2009.00502.x; Jarad G, 2002, J BIOL CHEM, V277, P47826, DOI 10.1074/jbc.M204901200; Jukic DM, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-27; Kimura K, 2006, INVEST OPHTH VIS SCI, V47, P4323, DOI 10.1167/iovs.05-1508; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Lakhe-Reddy S, 2006, J BIOL CHEM, V281, P19688, DOI 10.1074/jbc.M601110200; Lee HJ, 2004, FASEB J, V18, P1200, DOI 10.1096/fj.03-1466com; Lehrer MS, 1998, J CELL SCI, V111, P2867; Lekhanont K, 2009, MOL VIS, V15, P1294; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Lin Z, 2010, J VIROL, V84, P7892, DOI 10.1128/JVI.00379-10; Liu CM, 2010, CELL STEM CELL, V6, P433, DOI 10.1016/j.stem.2010.02.017; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Lyu J, 2006, CORNEA, V25, pS24, DOI 10.1097/01.ico.0000247209.01262.4e; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Markovics JA, 2010, J BIOL CHEM, V285, P24695, DOI 10.1074/jbc.M110.113977; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Minagawa H, 1997, ANTIVIR RES, V36, P99, DOI 10.1016/S0166-3542(97)00044-2; Minsel I, 2009, ENDOCRINOLOGY, V150, P2254, DOI 10.1210/en.2008-0577; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Niederkorn JY, 1999, TRANSPLANTATION, V67, P1503, DOI 10.1097/00007890-199906270-00001; O'Brien WJ, 2001, INVEST OPHTH VIS SCI, V42, P713; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Ryan D, 2006, MOL VIS, V12, P1175; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Stein-Streilein Joan, 2002, Int Rev Immunol, V21, P123, DOI 10.1080/08830180212066; Stepp MA, 1999, DEV DYNAM, V214, P216, DOI 10.1002/(SICI)1097-0177(199903)214:3<216::AID-AJA5>3.3.CO;2-W; SUNDERKOTTER C, 1990, AM J PATHOL, V137, P511; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Toyo-Oka K, 2005, HUM MOL GENET, V14, P3113, DOI 10.1093/hmg/ddi339; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wollensak G, 2002, CURR EYE RES, V24, P6, DOI 10.1076/ceyr.24.1.6.5431; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yamagami H, 2003, INVEST OPHTH VIS SCI, V44, P514, DOI 10.1167/iovs.02-0498; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yu J, 2010, FASEB J, V24, P3950, DOI 10.1096/fj.10-157404; Zeng L, 2009, P NATL ACAD SCI USA, V106, P17793, DOI 10.1073/pnas.0903693106; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	74	63	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21249	10.1371/journal.pone.0021249	http://dx.doi.org/10.1371/journal.pone.0021249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701675	Green Published, Green Submitted, gold			2022-12-25	WOS:000291983800034
J	Tamerius, JD; Comrie, AC				Tamerius, James D.; Comrie, Andrew C.			Coccidioidomycosis Incidence in Arizona Predicted by Seasonal Precipitation	PLOS ONE			English	Article							CLIMATE; SURVEILLANCE; CALIFORNIA	The environmental mechanisms that determine the inter-annual and seasonal variability in incidence of coccidioidomycosis are unclear. In this study, we use Arizona coccidioidomycosis case data for 1995-2006 to generate a timeseries of monthly estimates of exposure rates in Maricopa County, AZ and Pima County, AZ. We reveal a seasonal autocorrelation structure for exposure rates in both Maricopa County and Pima County which indicates that exposure rates are strongly related from the fall to the spring. An abrupt end to this autocorrelation relationship occurs near the the onset of the summer precipitation season and increasing exposure rates related to the subsequent season. The identification of the autocorrelation structure enabled us to construct a "primary" exposure season that spans August-March and a "secondary" season that spans April-June which are then used in subsequent analyses. We show that October-December precipitation is positively associated with rates of exposure for the primary exposure season in both Maricopa County (R = 0.72, p = 0.012) and Pima County (R = 0.69, p = 0.019). In addition, exposure rates during the primary exposure seasons are negatively associated with concurrent precipitation in Maricopa (R = -0.79, p = 0.004) and Pima (R = -0.64, p = 0.019), possibly due to reduced spore dispersion. These associations enabled the generation of models to estimate exposure rates for the primary exposure season. The models explain 69% (p = 0.009) and 54% (p = 0.045) of the variance in the study period for Maricopa and Pima counties, respectively. We did not find any significant predictors for exposure rates during the secondary season. This study builds on previous studies examining the causes of temporal fluctuations in coccidioidomycosis, and corroborates the "grow and blow" hypothesis.	[Tamerius, James D.; Comrie, Andrew C.] Univ Arizona, Sch Geog & Dev, Tucson, AZ 85721 USA	University of Arizona	Tamerius, JD (corresponding author), Univ Arizona, Sch Geog & Dev, Tucson, AZ 85721 USA.	james.tamerius@gmail.com			United States Environmental Protection Agency [RD-83275401-0]	United States Environmental Protection Agency(United States Environmental Protection Agency)	Although the research described in this article has been funded wholly or in part by the United States Environmental Protection Agency (http://www.epa.gov/) through grant RD-83275401-0 to the University of Arizona, it has not been subjected to the Agency's required peer and policy review and therefore does not necessarily reflect the views of the agency and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ampel NM, 2007, ANN NY ACAD SCI, V1111, P336, DOI 10.1196/annals.1406.033; Brown JH, 2002, BIOSCIENCE, V52, P979, DOI 10.1641/0006-3568(2002)052[0979:RARCDO]2.0.CO;2; CHIN J, 2000, CONTROL COMMUNICABLE; Comrie AC, 2005, ENVIRON HEALTH PERSP, V113, P688, DOI 10.1289/ehp.7786; Comrie AC, 2007, ANN NY ACAD SCI, V1111, P83, DOI 10.1196/annals.1406.024; Fisher FS, 2007, ANN NY ACAD SCI, V1111, P47, DOI 10.1196/annals.1406.031; Fisher MC, 2002, MYCOLOGIA, V94, P73, DOI 10.2307/3761847; Hugenholtz P., 1957, P S COCC, P136; Kolivras KN, 2003, INT J BIOMETEOROL, V47, P87, DOI 10.1007/s00484-002-0155-x; MOSLEY D, 1996, MMWR-MORBID MORTAL W, V45, P1069; Pappagianis D, 1988, Curr Top Med Mycol, V2, P199; Park BJ, 2005, J INFECT DIS, V191, P1981, DOI 10.1086/430092; Sharpton TJ, 2009, GENOME RES, V19, P1722, DOI 10.1101/gr.087551.108; Sunenshine RH, 2007, ANN NY ACAD SCI, V1111, P96, DOI 10.1196/annals.1406.045; Tabor JA, 2010, SCI TOTAL ENVIRON, V408, P2199, DOI 10.1016/j.scitotenv.2010.02.013; Talamantes J, 2007, ANN NY ACAD SCI, V1111, P73, DOI 10.1196/annals.1406.028; Tsang CA, 2010, EMERG INFECT DIS, V16, P1738, DOI 10.3201/eid1611.100475; Valdivia L, 2006, EMERG INFECT DIS, V12, P958; *WESTMAP W CLIM MA, 2010, CLIM AN MOD	19	49	49	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21009	10.1371/journal.pone.0021009	http://dx.doi.org/10.1371/journal.pone.0021009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	21701590	Green Submitted, Green Published, gold			2022-12-25	WOS:000291983800018
J	Campillo, S; Serra, M; Carmona, MJ; Gomez, A				Campillo, Sergi; Serra, Manuel; Jose Carmona, Maria; Gomez, Africa			Widespread Secondary Contact and New Glacial Refugia in the Halophilic Rotifer Brachionus plicatilis in the Iberian Peninsula	PLOS ONE			English	Article							GENETIC-STRUCTURE; MICROSATELLITE ANALYSIS; SEXUAL REPRODUCTION; PHYLOGEOGRAPHY; DISTANCE; PATTERNS; FLOW; COLONIZATION; POPULATIONS; DIVERGENCE	Small aquatic organisms harbour deep phylogeographic patterns and highly structured populations even at local scales. These patterns indicate restricted gene flow, despite these organisms' high dispersal abilities, and have been explained by a combination of (1) strong founder effects due to rapidly growing populations and very large population sizes, and (2) the development of diapausing egg banks and local adaptation, resulting in low effective gene flow, what is known as the Monopolization hypothesis. In this study, we build up on our understanding of the mitochondrial phylogeography of the halophilic rotifer Brachionus plicatilis in the Iberian Peninsula by both increasing the number of sampled ponds in areas where secondary contact is likely and doubling sample sizes. We analyzed partial mitochondrial sequences of 252 individuals. We found two deep mitochondrial DNA lineages differing in both their genetic diversity and the complexity of their phylogeographic structure. Our analyses suggest that several events of secondary contact between clades occurred after their expansion from glacial refugia. We found a pattern of isolation-by-distance, which we interpret as being the result of historical colonization events. We propose the existence of at least one glacial refugium in the SE of the Iberian Peninsula. Our findings challenge predictions of the Monopolization hypothesis, since coexistence (i.e., secondary contact) of divergent lineages in some ponds in the Iberian Peninsula is common. Our results indicate that phylogeographic structures in small organisms can be very complex and that gene flow between diverse lineages after population establishment can indeed occur.	[Campillo, Sergi; Serra, Manuel; Jose Carmona, Maria] Univ Valencia, Inst Cavanilles Biodivers & Biol Evolutiva, Valencia, Spain; [Gomez, Africa] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Valencia; University of Hull	Campillo, S (corresponding author), Univ Valencia, Inst Cavanilles Biodivers & Biol Evolutiva, Valencia, Spain.	sergi.campillo@uv.es	Carmona, María José/AAM-4340-2020; Serra, Manuel/H-7817-2015; Gomez, A/L-6505-2014; Carmona, María José/H-6452-2015	Carmona, María José/0000-0002-4835-6933; Serra, Manuel/0000-0003-1731-1529; Gomez, A/0000-0002-1297-4502; Carmona, María José/0000-0002-4835-6933	Spanish Ministerio de Ciencia y Tecnologia [BOS2000-1451]; Spanish Ministerio de Educacion y Ciencia [BOS2003-0075]; Conselleria d'Empresa, Universitat i Ciencia (Generalitat Valenciana) [GRUPOS2004/20]; NERC (UK) [NE/B501298 /1]; Universitat de Valencia (Spain); Natural Environment Research Council [NE/B501298/1] Funding Source: researchfish	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministerio de Educacion y Ciencia(Spanish Government); Conselleria d'Empresa, Universitat i Ciencia (Generalitat Valenciana)(Center for Forestry Research & Experimentation (CIEF)); NERC (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Universitat de Valencia (Spain); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by grant BOS2000-1451 from the Spanish Ministerio de Ciencia y Tecnologia, grant BOS2003-0075 from the Spanish Ministerio de Educacion y Ciencia and grant GRUPOS2004/20 from the Conselleria d'Empresa, Universitat i Ciencia (Generalitat Valenciana) to MS and an advanced NERC fellowship NE/B501298 /1 (UK) to AG. SC was supported by a 'V Segles' fellowship from the Universitat de Valencia (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan P, 2007, CONSERV GENET, V8, P79, DOI 10.1007/s10592-006-9150-9; Avise J.C, 2000, PHYLOGEOGRAPHY HIST, DOI DOI 10.2307/J.CTV1NZFGJ7; Avise JC, 1998, MOL ECOL, V7, P371, DOI 10.1046/j.1365-294x.1998.00391.x; Berrieman HK, 2005, HYDROBIOLOGIA, V546, P125, DOI 10.1007/s10750-005-4109-2; BOILEAU MG, 1992, J EVOLUTION BIOL, V5, P25, DOI 10.1046/j.1420-9101.1992.5010025.x; Campillo S, 2005, HYDROBIOLOGIA, V546, P181, DOI 10.1007/s10750-005-4120-7; Campillo S, 2009, J EVOLUTION BIOL, V22, P2542, DOI 10.1111/j.1420-9101.2009.01871.x; Carmona MJ, 1995, HYDROBIOLOGIA, V313, P365, DOI 10.1007/BF00025971; CARMONA MJ, 1993, HYDROBIOLOGIA, V255, P145, DOI 10.1007/BF00025832; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COMIN FA, 1988, HYDROBIOLOGIA, V158, P237, DOI 10.1007/BF00026281; De Gelas K, 2005, MOL ECOL, V14, P753, DOI 10.1111/j.1365-294X.2004.02434.x; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Garcia-Roger EM, 2006, J EXP MAR BIOL ECOL, V336, P198, DOI 10.1016/j.jembe.2006.05.009; Gomez A, 2000, MOL ECOL, V9, P203, DOI 10.1046/j.1365-294x.2000.00849.x; Gomez A, 1998, MOL ECOL, V7, P1619; Gomez A, 2002, EVOLUTION, V56, P1431; Gomez A, 2002, J EVOLUTION BIOL, V15, P158, DOI 10.1046/j.1420-9101.2002.00368.x; Gomez A, 2000, P ROY SOC B-BIOL SCI, V267, P2189, DOI 10.1098/rspb.2000.1268; Gomez A, 2007, MOL ECOL, V16, P3228, DOI 10.1111/j.1365-294X.2007.03372.x; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Gonzalez-Samperiz P, 2008, PALAEOGEOGR PALAEOCL, V259, P157, DOI 10.1016/j.palaeo.2007.10.005; Gouws G, 2007, HYDROBIOLOGIA, V589, P249, DOI 10.1007/s10750-007-0742-2; Green AJ, 2005, DIVERS DISTRIB, V11, P149, DOI 10.1111/j.1366-9516.2005.00147.x; Haag CR, 2006, HEREDITY, V96, P150, DOI 10.1038/sj.hdy.6800774; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Mayr E., 1963, ANIMAL SPECIES EVOLU; Mills S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-225; Morellon M, 2009, QUATERNARY SCI REV, V28, P2582, DOI 10.1016/j.quascirev.2009.05.014; Munoz J, 2008, MOL ECOL, V17, P3160, DOI 10.1111/j.1365-294X.2008.03818.x; Ortego J, 2009, BIOL J LINN SOC, V97, P623, DOI 10.1111/j.1095-8312.2009.01206.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Posada D, 2000, MOL ECOL, V9, P487, DOI 10.1046/j.1365-294x.2000.00887.x; POSADA D, 2005, COLLAPSE DESCRIBING; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; ROSSELLO VM, 1993, CUADERNOS GEOGRAFIA, V53, P35; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SLATKIN M, 1991, GENETICS, V129, P555; Snell TW, 2006, MAR BIOL, V149, P763, DOI 10.1007/s00227-006-0251-2; SNELL TW, 1987, INT J INVER REP DEV, V12, P103, DOI 10.1080/01688170.1987.10510306; Stelzer CP, 2003, LIMNOL OCEANOGR, V48, P939, DOI 10.4319/lo.2003.48.2.0939; Suatoni E, 2006, MOL PHYLOGENET EVOL, V41, P86, DOI 10.1016/j.ympev.2006.04.025; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; Templeton AR, 2001, MOL ECOL, V10, P779, DOI 10.1046/j.1365-294x.2001.01199.x; TEMPLETON AR, 2006, POPULATION GENETICS; Tortajada AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008195; WALLACE RL, 2006, ROTIFERA, V1	55	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20986	10.1371/journal.pone.0020986	http://dx.doi.org/10.1371/journal.pone.0020986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698199	gold, Green Published			2022-12-25	WOS:000291734100040
J	Mohanram, V; Johansson, U; Skold, AE; Fink, J; Pathak, SK; Makitalo, B; Walther-Jallow, L; Spetz, AL				Mohanram, Venkatramanan; Johansson, Ulrika; Skold, Annette E.; Fink, Joshua; Pathak, Sushil Kumar; Makitalo, Barbro; Walther-Jallow, Lilian; Spetz, Anna-Lena			Exposure to Apoptotic Activated CD4(+) T Cells Induces Maturation and APOBEC3G-Mediated Inhibition of HIV-1 Infection in Dendritic Cells	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TUMOR-NECROSIS-FACTOR; BLOOD MONONUCLEAR-CELLS; NF-KAPPA-B; FACTOR-ALPHA; INDUCTION; REPLICATION; EXPRESSION; STIMULATION; PROTEINS	Dendritic cells (DCs) are activated by signaling via pathogen-specific receptors or exposure to inflammatory mediators. Here we show that co-culturing DCs with apoptotic HIV-infected activated CD4(+) T cells (ApoInf) or apoptotic uninfected activated CD4(+) T cells (ApoAct) induced expression of co-stimulatory molecules and cytokine release. In addition, we measured a reduced HIV infection rate in DCs after co-culture with ApoAct. A prerequisite for reduced HIV infection in DCs was activation of CD4(+) T cells before apoptosis induction. DCs exposed to ApoAct or ApoInf secreted MIP-1 alpha, MIP-1 beta, MCP-1, and TNF-alpha; this effect was retained in the presence of exogenous HIV. The ApoAct-mediated induction of co-stimulatory CD86 molecules and reduction of HIV infection in DCs were partially abrogated after blocking TNF-alpha using monoclonal antibodies. APOBEC3G expression in DCs was increased in co-cultures of DCs and ApoAct but not by apoptotic resting CD4(+) T cells (ApoRest). Silencing of APOBEC3G in DC abrogated the HIV inhibitory effect mediated by ApoAct. Sequence analyses of an env region revealed significant induction of G-to-A hypermutations in the context of GG or GA dinucleotides in DNA isolated from DCs exposed to HIV and ApoAct. Thus, ApoAct-mediated DC maturation resulted in induction of APOBEC3G that was important for inhibition of HIV-infection in DCs. These findings underscore the complexity of differential DC responses evoked upon interaction with resting as compared with activated dying cells during HIV infection.	[Mohanram, Venkatramanan; Johansson, Ulrika; Skold, Annette E.; Fink, Joshua; Pathak, Sushil Kumar; Makitalo, Barbro; Walther-Jallow, Lilian; Spetz, Anna-Lena] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Mohanram, V (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden.	anna-lena.spetz@ki.se	Spetz, Anna-Lena/C-3543-2016; Sköld, Annette/P-5718-2015	Spetz, Anna-Lena/0000-0003-3964-9512; Sköld, Annette/0000-0002-5309-8860; Walther-Jallow, Lilian/0000-0001-8731-1917	Swedish Research Council; Swedish International Development Cooperation Agency/Department for Research Cooperation; Hedlunds Foundation; European Commission [EC-FP6-018953, EC-FP6-037611, EC-FP7-242135]; Swedish Foundation for Strategic Research;  [SLL 20050348]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency/Department for Research Cooperation; Hedlunds Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); 	This research was supported by the Swedish Research Council, Swedish International Development Cooperation Agency/Department for Research Cooperation, Hedlunds Foundation, SLL 20050348, European Commission; EC-FP6-018953 Auto/AlloCell, EC-FP6-037611 EUROPRISE, EC-FP7-242135 CHAARM and Swedish Foundation for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Alkhatib G, 2009, CURR OPIN HIV AIDS, V4, P96, DOI 10.1097/COH.0b013e328324bbec; Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Bakri Y, 2001, J IMMUNOL, V166, P3780, DOI 10.4049/jimmunol.166.6.3780; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Bruhl P, 1996, AIDS RES HUM RETROV, V12, P31, DOI 10.1089/aid.1996.12.31; Cavrois M, 2006, J VIROL, V80, P1992, DOI 10.1128/JVI.80.4.1992-1999.2006; CLOUSE KA, 1989, J IMMUNOL, V142, P431; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; CONNOR RI, 1993, AIDS RES HUM RETROV, V9, P541, DOI 10.1089/aid.1993.9.541; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; Douek Daniel, 2007, Top HIV Med, V15, P114; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; Ferguson TA, 2005, IMMUNOL RES, V32, P99, DOI 10.1385/IR:32:1-3:099; Flint SJE W, 2009, VIROLOGICAL METHODS; FOLKS T, 1986, SCIENCE, V231, P600, DOI 10.1126/science.3003906; Geonnotti AR, 2010, AIDS RES HUM RETROV, V26, P279, DOI 10.1089/aid.2009.0186; Gougeon ML, 2009, APOPTOSIS, V14, P501, DOI 10.1007/s10495-009-0314-1; Gougeon ML, 2005, CELL DEATH DIFFER, V12, P845, DOI 10.1038/sj.cdd.4401616; Granelli-Piperno A, 1998, J VIROL, V72, P2733, DOI 10.1128/JVI.72.4.2733-2737.1998; GRIFFIN GE, 1989, NATURE, V339, P70, DOI 10.1038/339070a0; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Herbein G, 1996, J VIROL, V70, P7388, DOI 10.1128/JVI.70.11.7388-7397.1996; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hu QX, 2004, J EXP MED, V199, P1065, DOI 10.1084/jem.20022212; Jeffrey PL, 2009, EUR J IMMUNOL, V39, P1956, DOI 10.1002/eji.200939228; Johansson U, 2007, J IMMUNOL, V179, P1711, DOI 10.4049/jimmunol.179.3.1711; Kabelitz D, 1997, FRONT BIOSCI, V2, P61; Knoepfel SA, 2008, J VIROL, V82, P6536, DOI 10.1128/JVI.00554-08; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Larsson M, 2002, AIDS, V16, P1319, DOI 10.1097/00002030-200207050-00003; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Maranon C, 2004, P NATL ACAD SCI USA, V101, P6092, DOI 10.1073/pnas.0304860101; Morelli AE, 2010, APOPTOSIS, V15, P1083, DOI 10.1007/s10495-010-0469-9; Obeid M, 2007, CELL DEATH DIFFER, V14, P1848, DOI 10.1038/sj.cdd.4402201; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Paiardini M, 2009, ANNU REV MED, V60, P485, DOI 10.1146/annurev.med.60.041807.123753; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Peters B, 2004, LANCET, V363, P518, DOI 10.1016/S0140-6736(04)15538-4; Piantadosi A, 2007, PLOS PATHOG, V3, P1745, DOI 10.1371/journal.ppat.0030177; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Pion M, 2006, J EXP MED, V203, P2887, DOI 10.1084/jem.20061519; Sakai K, 2006, P NATL ACAD SCI USA, V103, P3369, DOI 10.1073/pnas.0509417103; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Smed-Sorensen A, 2004, BLOOD, V104, P2810, DOI 10.1182/blood-2003-07-2314; Spetz AL, 1999, J IMMUNOL, V163, P736; Stevceva L, 2005, CURR PHARM DESIGN, V11, P801, DOI 10.2174/1381612053381846; Sui YJ, 2010, P NATL ACAD SCI USA, V107, P9843, DOI 10.1073/pnas.0911932107; Vicenzi E, 1997, J LEUKOCYTE BIOL, V62, P34, DOI 10.1002/jlb.62.1.34; Yun ZB, 2002, J CLIN MICROBIOL, V40, P3883, DOI 10.1128/JCM.40.10.3883-3884.2002; Zhao XQ, 2002, J VIROL, V76, P3007, DOI 10.1128/JVI.76.6.3007-3014.2002	56	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21171	10.1371/journal.pone.0021171	http://dx.doi.org/10.1371/journal.pone.0021171			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698207	Green Submitted, Green Published, gold			2022-12-25	WOS:000291734100063
J	Spanholtz, J; Preijers, F; Tordoir, M; Trilsbeek, C; Paardekooper, J; de Witte, T; Schaap, N; Dolstra, H				Spanholtz, Jan; Preijers, Frank; Tordoir, Marleen; Trilsbeek, Carel; Paardekooper, Jos; de Witte, Theo; Schaap, Nicolaas; Dolstra, Harry			Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; EX-VIVO EXPANSION; HYDROXYETHYL STARCH SEDIMENTATION; STEM-CELL; IMMUNOMAGNETIC METHOD; SEMIAUTOMATED SYSTEM; VOLUME REDUCTION; TRANSPLANTATION; CANCER; PURIFICATION	Natural killer (NK) cell-based adoptive immunotherapy is a promising treatment approach for many cancers. However, development of protocols that provide large numbers of functional NK cells produced under GMP conditions are required to facilitate clinical studies. In this study, we translated our cytokine-based culture protocol for ex vivo expansion of NK cells from umbilical cord blood (UCB) hematopoietic stem cells into a fully closed, large-scale, cell culture bioprocess. We optimized enrichment of CD34(+) cells from cryopreserved UCB units using the CliniMACS system followed by efficient expansion for 14 days in gas-permeable cell culture bags. Thereafter, expanded CD34(+) UCB cells could be reproducibly amplified and differentiated into CD56(+)CD3(-) NK cell products using bioreactors with a mean expansion of more than 2,000 fold and a purity of >90%. Moreover, expansion in the bioreactor yielded a clinically relevant dose of NK cells (mean: 2x10(9) NK cells), which display high expression of activating NK receptors and cytolytic activity against K562. Finally, we established a versatile closed washing procedure resulting in optimal reduction of medium, serum and cytokines used in the cell culture process without changes in phenotype and cytotoxic activity. These results demonstrate that large numbers of UCB stem cell-derived NK cell products for adoptive immunotherapy can be produced in closed, large-scale bioreactors for the use in clinical trials.	[Spanholtz, Jan; Preijers, Frank; Tordoir, Marleen; Trilsbeek, Carel; Paardekooper, Jos; Dolstra, Harry] Radboud Univ Nijmegen, Med Ctr, Hematol Lab, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Schaap, Nicolaas] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6525 ED Nijmegen, Netherlands; [de Witte, Theo] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Spanholtz, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Hematol Lab, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands.	h.dolstra@labgk.umcn.nl	Dolstra, H./L-4276-2015; de Witte, T.J.M./L-4762-2015; Preijers, Frank/L-4586-2015; Schaap, Nicolaas/L-4625-2015	Dolstra, H./0000-0002-3998-687X; Schaap, Nicolaas/0000-0001-7696-4752; Spanholtz, Jan/0000-0001-7152-6956	ZonMw [40-41400-98-9018]; Glycostem Therapeutics; Radboud University Nijmegen Medical Centre	ZonMw(Netherlands Organization for Health Research and Development); Glycostem Therapeutics; Radboud University Nijmegen Medical Centre	This work was financially supported by the ZonMw grant 40-41400-98-9018, Glycostem Therapeutics and Radboud University Nijmegen Medical Centre. Authors Spanholtz and Tordoir, who played a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript are employees of Glycostem. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas M, 2010, CYTOTHERAPY, V12, P338, DOI 10.3109/14653241003695034; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Barkholt L, 2009, IMMUNOTHERAPY, V1, P753, DOI 10.2217/IMT.09.47; Berg M, 2009, CYTOTHERAPY, V11, P341, DOI 10.1080/14653240902807034; Carlens S, 2001, HUM IMMUNOL, V62, P1092, DOI 10.1016/S0198-8859(01)00313-5; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Eichler H, 2002, TRANSFUSION, V42, P1285, DOI 10.1046/j.1537-2995.2002.00223.x; Fujisaki H, 2009, CANCER RES, V69, P4010, DOI 10.1158/0008-5472.CAN-08-3712; Giordano R, 2003, BONE MARROW TRANSPL, V32, P965, DOI 10.1038/sj.bmt.1704263; Iyengar R, 2003, CYTOTHERAPY, V5, P479, DOI 10.1080/14653240310003558; Klingemann HG, 2004, CYTOTHERAPY, V6, P15, DOI 10.1080/14653240310004548; Koehl U, 2005, KLIN PADIATR, V217, P345, DOI 10.1055/s-2005-872520; Lapierre V, 2007, CYTOTHERAPY, V9, P165, DOI 10.1080/14653240701196811; Lecchi L, 2009, TRANSFUSION, V49, P563, DOI 10.1111/j.1537-2995.2008.02013.x; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; McKenna DH, 2007, TRANSFUSION, V47, P520, DOI 10.1111/j.1537-2995.2006.01145.x; McNiece IK, 1998, J HEMATOTHER, V7, P457, DOI 10.1089/scd.1.1998.7.457; Meyer-Monard S, 2009, TRANSFUSION, V49, P362, DOI 10.1111/j.1537-2995.2008.01969.x; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Overes IM, 2008, BRIT J HAEMATOL, V141, P799, DOI 10.1111/j.1365-2141.2008.07125.x; Passweg JR, 2006, BEST PRACT RES CL HA, V19, P811, DOI 10.1016/j.beha.2006.06.004; Querol S, 2000, TRANSFUSION, V40, P625, DOI 10.1046/j.1537-2995.2000.40060625.x; RUBINSTEIN P, 1995, P NATL ACAD SCI USA, V92, P10119, DOI 10.1073/pnas.92.22.10119; Rubnitz JE, 2010, J CLIN ONCOL, V28, P955, DOI 10.1200/JCO.2009.24.4590; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; SIEGLER U, 2010, CYTOTHERAPY; Solves P, 2006, CLIN LAB HAEMATOL, V28, P202, DOI 10.1111/j.1365-2257.2006.00778.x; Solves P, 2005, TRANSFUSION, V45, P867, DOI 10.1111/j.1537-2995.2005.04357.x; Spanholtz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009221; Sutlu T, 2010, CYTOTHERAPY, V12, P1044, DOI 10.3109/14653249.2010.504770; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; 2009, INT SYSTEM HUMAN CYT	32	164	178	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20740	10.1371/journal.pone.0020740	http://dx.doi.org/10.1371/journal.pone.0020740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698239	Green Submitted, Green Published, gold			2022-12-25	WOS:000291734100016
J	Takatsuka, M; Osada-Oka, M; Satoh, EF; Kitadokoro, K; Nishiuchi, Y; Niki, M; Inoue, M; Iwai, K; Arakawa, T; Shimoji, Y; Ogura, H; Kobayashi, K; Rambukkana, A; Matsumoto, S				Takatsuka, Masaki; Osada-Oka, Mayuko; Satoh, Eisuke F.; Kitadokoro, Kengo; Nishiuchi, Yukiko; Niki, Mamiko; Inoue, Masayasu; Iwai, Kazuhiro; Arakawa, Tetsuo; Shimoji, Yoshihiro; Ogura, Hisashi; Kobayashi, Kazuo; Rambukkana, Anura; Matsumoto, Sohkichi			A Histone-Like Protein of Mycobacteria Possesses Ferritin Superfamily Protein-Like Activity and Protects against DNA Damage by Fenton Reaction	PLOS ONE			English	Article							BINDING PROTEIN-1; IRON ACQUISITION; TUBERCULOSIS; BACTERIOFERRITIN; STORAGE; GROWTH; IDENTIFICATION; TRANSCRIPTION; CONTAINS; SEQUENCE	Iron is an essential metal for living organisms but its level must be strictly controlled in cells, because ferrous ion induces toxicity by generating highly active reactive oxygen, hydroxyl radicals, through the Fenton reaction. In addition, ferric ion shows low solubility under physiological conditions. To overcome these obstacles living organisms possess Ferritin superfamily proteins that are distributed in all three domains of life: bacteria, archaea, and eukaryotes. These proteins minimize hydroxyl radical formation by ferroxidase activity that converts Fe2+ into Fe3+ and sequesters iron by storing it as a mineral inside a protein cage. In this study, we discovered that mycobacterial DNA-binding protein 1 (MDP1), a histone-like protein, has similar activity to ferritin superfamily proteins. MDP1 prevented the Fenton reaction and protects DNA by the ferroxidase activity. The K-m values of the ferroxidase activity by MDP1 of Mycobacterium bovis bacillus Calmette-Guerin (BCG-3007c), Mycobacterium tuberculosis (Rv2986c), and Mycobacterium leprae (ML1683; ML-LBP) were 0.292, 0.252, and 0.129 mM, respectively. Furthermore, one MDP1 molecule directly captured 81.4 +/- 19.1 iron atoms, suggesting the role of this protein in iron storage. This study describes for the first time a ferroxidase-iron storage protein outside of the ferritin superfamily proteins and the protective role of this bacterial protein from DNA damage.	[Takatsuka, Masaki; Osada-Oka, Mayuko; Niki, Mamiko; Matsumoto, Sohkichi] Osaka City Univ, Grad Sch Med, Dept Bacteriol, Abeno Ku, Osaka 558, Japan; [Takatsuka, Masaki; Arakawa, Tetsuo] Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Abeno Ku, Osaka 558, Japan; [Satoh, Eisuke F.; Inoue, Masayasu] Osaka City Univ, Grad Sch Med, Dept Mol Pathol, Abeno Ku, Osaka 558, Japan; [Kitadokoro, Kengo] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 606, Japan; [Nishiuchi, Yukiko] Osaka City Univ, Sch Med, Toneyama Inst TB Res, Osaka 545, Japan; [Iwai, Kazuhiro] Osaka Univ, Grad Sch Frontier Biosci, Cell Biol & Metab Grp, Osaka, Japan; [Iwai, Kazuhiro] Osaka Univ, Grad Sch Med, Dept Biophys & Biochem, Osaka, Japan; [Shimoji, Yoshihiro] Natl Inst Anim Hlth, Tsukuba, Ibaraki 305, Japan; [Ogura, Hisashi] Osaka City Univ, Grad Sch Med, Dept Virol, Abeno Ku, Osaka 558, Japan; [Kobayashi, Kazuo] Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan; [Rambukkana, Anura] Univ Edinburgh, Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Rambukkana, Anura] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh, Midlothian, Scotland; [Rambukkana, Anura] Univ Edinburgh, Ctr Infect Dis, Edinburgh, Midlothian, Scotland	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University; Kyoto Institute of Technology; Osaka Metropolitan University; Osaka University; Osaka University; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Osaka Metropolitan University; National Institute of Infectious Diseases (NIID); University of Edinburgh; University of Edinburgh; University of Edinburgh	Takatsuka, M (corresponding author), Osaka City Univ, Grad Sch Med, Dept Bacteriol, Abeno Ku, Osaka 558, Japan.	sohkichi@med.osaka-cu.ac.jp	IWAI, KAZUHIRO/GSN-7385-2022	Nishiuchi, Yukiko/0000-0002-2973-9285; rambukkana, anura/0000-0002-6286-9145; Matsumoto, Sohkichi/0000-0002-6106-7538; Kitadokoro, Kengo/0000-0001-5969-7939; Iwai, Kazuhiro/0000-0001-5620-5951	Ministry of Education Culture Sports Science and Technology; Ministry of Health, Labor and Welfare; The Japan Health Sciences Foundation; The United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy; NIAID; NINDS; Medical Research Council [G0700711B] Funding Source: researchfish; Grants-in-Aid for Scientific Research [23121515] Funding Source: KAKEN	Ministry of Education Culture Sports Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); The Japan Health Sciences Foundation; The United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education Culture Sports Science and Technology, Ministry of Health, Labor and Welfare (Research on Emerging and Re-emerging Infectious Diseases, Health Sciences Research Grants), The Japan Health Sciences Foundation (to S.M. and K.K.), The United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy, and NIAID and NINDS (to A.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Aoki K, 2004, J BIOL CHEM, V279, P39798, DOI 10.1074/jbc.M402677200; BANYARD SH, 1978, NATURE, V271, P282, DOI 10.1038/271282a0; Barry CE, 2005, NAT CHEM BIOL, V1, P127, DOI 10.1038/nchembio0805-127; Boelaert JR, 2007, J INFECT DIS, V195, P1745, DOI 10.1086/518040; Bou-Abdallah F, 2002, J BIOL CHEM, V277, P37064, DOI 10.1074/jbc.M205712200; Bozzi M, 1997, J BIOL CHEM, V272, P3259, DOI 10.1074/jbc.272.6.3259; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS BW, 1991, J CLIN MICROBIOL, V29, P1652, DOI 10.1128/JCM.29.8.1652-1658.1991; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Chiancone E, 2004, BIOMETALS, V17, P197, DOI 10.1023/B:BIOM.0000027692.24395.76; Cirillo SLG, 2009, INFECT IMMUN, V77, P2557, DOI 10.1128/IAI.01481-08; Colangeli R, 2009, P NATL ACAD SCI USA, V106, P4414, DOI 10.1073/pnas.0810126106; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Davis TM, 2000, ANAL BIOCHEM, V284, P348, DOI 10.1006/abio.2000.4726; de Lima CS, 2005, MICROBES INFECT, V7, P1097, DOI 10.1016/j.micinf.2005.02.013; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; EISENTHAL R, 1974, BIOCHEM J, V139, P715, DOI 10.1042/bj1390715; Farhana A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002087; Furugen M, 2001, MICROB PATHOGENESIS, V30, P129, DOI 10.1006/mpat.2000.0416; GOBIN J, 1995, P NATL ACAD SCI USA, V92, P5189, DOI 10.1073/pnas.92.11.5189; Gobin J, 1996, J EXP MED, V183, P1527, DOI 10.1084/jem.183.4.1527; Gold B, 2001, MOL MICROBIOL, V42, P851, DOI 10.1046/j.1365-2958.2001.02684.x; Gupta V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008028; HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X; Ilari A, 2000, NAT STRUCT BIOL, V7, P38; Imada I, 1999, ANAL BIOCHEM, V271, P53, DOI 10.1006/abio.1999.4107; INGLIS NF, 1994, GENE, V150, P205, DOI 10.1016/0378-1119(94)90889-3; Janowski R, 2008, PROTEIN SCI, V17, P1138, DOI 10.1110/ps.034819.108; Katsube T, 2007, J BACTERIOL, V189, P8241, DOI 10.1128/JB.00550-07; Lee BH, 1998, MOL GEN GENET, V260, P475, DOI 10.1007/s004380050919; Lewin A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-91; Matsumoto S, 2005, J IMMUNOL, V175, P441, DOI 10.4049/jimmunol.175.1.441; Matsumoto S, 1999, MICROBIOL IMMUNOL, V43, P1027, DOI 10.1111/j.1348-0421.1999.tb01232.x; Matsumoto S, 2000, FEMS MICROBIOL LETT, V182, P297, DOI 10.1016/S0378-1097(99)00606-0; PESSOLANI MCV, 1994, J EXP MED, V180, P319, DOI 10.1084/jem.180.1.319; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shimoji Y, 1999, P NATL ACAD SCI USA, V96, P9857, DOI 10.1073/pnas.96.17.9857	39	21	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e20985	10.1371/journal.pone.0020985	http://dx.doi.org/10.1371/journal.pone.0020985			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698192	Green Published, Green Submitted, gold			2022-12-25	WOS:000291734100039
J	Tryon, RC; Higdon, CW; Johnson, SL				Tryon, Robert C.; Higdon, Charles W.; Johnson, Stephen L.			Lineage Relationship of Direct-Developing Melanocytes and Melanocyte Stem Cells in the Zebrafish	PLOS ONE			English	Article							NEURAL CREST; IN-VITRO; CLONAL ANALYSIS; MESSENGER-RNAS; REGENERATION; FATE; MELANOBLASTS; PLURIPOTENT; ACTIVATION; ABLATION	Previous research in zebrafish has demonstrated that embryonic and larval regeneration melanocytes are derived from separate lineages. The embryonic melanocytes that establish the larval pigment pattern do not require regulative melanocyte stem cell (MSC) precursors, and are termed direct-developing melanocytes. In contrast, the larval regeneration melanocytes that restore the pigment pattern after ablation develop from MSC precursors. Here, we explore whether embryonic melanocytes and MSCs share bipotent progenitors. Furthermore, we explore when fate segregation of embryonic melanocytes and MSCs occurs in zebrafish development. In order to achieve this, we develop and apply a novel lineage tracing method. We first demonstrate that Tol2-mediated genomic integration of reporter constructs from plasmids injected at the 1-2 cell stage occurs most frequently after the midblastula transition but prior to shield stage, between 3 and 6 hours post-fertilization. This previously uncharacterized timing of Tol2-mediated genomic integration establishes Tol2-mediated transposition as a means for conducting lineage tracing in zebrafish. Combining the Tol2-mediated lineage tracing strategy with a melanocyte regeneration assay previously developed in our lab, we find that embryonic melanocytes and larval regeneration melanocytes are derived from progenitors that contribute to both lineages. We estimate 50-60 such bipotent melanogenic progenitors to be present in the shield-stage embryo. Furthermore, our examination of direct-developing and MSC-restricted lineages suggests that these are segregated from bipotent precursors after the shield stage, but prior to the end of convergence and extension. Following this early fate segregation, we estimate approximately 100 embryonic melanocyte and 90 MSC-restricted lineages are generated to establish or regenerate the zebrafish larval pigment pattern, respectively. Thus, the dual strategies of direct-development and MSC-derived development are established in the early gastrula, via fate segregation of the two lineages.	[Tryon, Robert C.; Higdon, Charles W.; Johnson, Stephen L.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL)	Tryon, RC (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	rtryon@genetics.wustl.edu			NIH [RO1-GM56988, T32AR007284-30]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056988] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH RO1-GM56988 and NIH Training Grant T32AR007284-30. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALADHAMI MA, 1977, DEV GROWTH DIFFER, V19, P171; Bertrand JY, 2007, DEVELOPMENT, V134, P4147, DOI 10.1242/dev.012385; Budi EH, 2008, DEVELOPMENT, V135, P2603, DOI 10.1242/dev.019299; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; DUNCAN JT, 1966, J EXP ZOOL, V163, P331, DOI 10.1002/jez.1401630311; Dupin E, 2006, ADV EXP MED BIOL, V589, P96; Dushane GP, 1935, J EXP ZOOL, V72, P1, DOI 10.1002/jez.1400720102; HENSON PD, 1997, DEVELOPMENT, V124, P4351; Hultman KA, 2010, DEV BIOL, V337, P425, DOI 10.1016/j.ydbio.2009.11.019; Hultman KA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000544; Ikegami R, 1997, ZYGOTE, V5, P153, DOI 10.1017/S0967199400003828; ITO K, 1993, DEV BIOL, V157, P517, DOI 10.1006/dbio.1993.1154; JOHNSON SL, 2011, DEV BIOL        1210; KANE DA, 1993, DEVELOPMENT, V119, P447; Kawakami K, 2004, METHOD CELL BIOL, V77, P201; KIMMEL CB, 1994, DEVELOPMENT, V120, P265; LEDOUARIN NM, 1993, J NEUROBIOL, V24, P146, DOI 10.1002/neu.480240203; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Mak SS, 2006, DEV BIOL, V291, P144, DOI 10.1016/j.ydbio.2005.12.025; MARINX O, 1994, FEBS LETT, V345, P107, DOI 10.1016/0014-5793(94)00413-7; MINTZ B, 1967, P NATL ACAD SCI USA, V58, P344, DOI 10.1073/pnas.58.1.344; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; OELLACHER J, 1872, Z WISS ZOOL, V23, P373; RAIBLE DW, 1994, DEVELOPMENT, V120, P495; RAWLES ME, 1947, PHYSIOL ZOOL, V20, P248, DOI 10.1086/physzool.20.3.30151958; Sheets L, 2007, CURR BIOL, V17, P1721, DOI 10.1016/j.cub.2007.09.028; SHEETS MD, 1994, GENE DEV, V8, P926, DOI 10.1101/gad.8.8.926; Sieber-Blum M, 2004, DEV DYNAM, V231, P258, DOI 10.1002/dvdy.20129; Sieber-Blum M, 1982, Prog Clin Biol Res, V85 Pt B, P485; Sieber-Blum M, 2000, INT REV CYTOL, V197, P1, DOI 10.1016/S0074-7696(00)97001-3; SIEBERBLUM M, 1980, DEV BIOL, V80, P96, DOI 10.1016/0012-1606(80)90501-1; STEMPLE DL, 1993, DEV BIOL, V159, P12, DOI 10.1006/dbio.1993.1218; Tu S, 2011, DEV CELL, V20, P725, DOI 10.1016/j.devcel.2011.04.013; Tu S, 2010, DEVELOPMENT, V137, P3931, DOI 10.1242/dev.057075; Twitty VC, 1936, J EXP ZOOL, V74, P239, DOI 10.1002/jez.1400740206; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Warga RM, 2009, DEV CELL, V16, P744, DOI 10.1016/j.devcel.2009.04.007; Weidinger G, 1999, DEVELOPMENT, V126, P5295; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Wilkie AL, 2002, DEVELOPMENT, V129, P3349; Yang CT, 2006, DEVELOPMENT, V133, P3563, DOI 10.1242/dev.02533; Yang CT, 2004, J INVEST DERMATOL, V123, P924, DOI 10.1111/j.0022-202X.2004.23475.x; Yoon C, 1997, DEVELOPMENT, V124, P3157; ZOO J, 2006, PIGMENT CELL RES, V19, P615	44	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21010	10.1371/journal.pone.0021010	http://dx.doi.org/10.1371/journal.pone.0021010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698209	Green Published, gold, Green Submitted			2022-12-25	WOS:000291734100044
J	Bohnert, JA; Schuster, S; Szymaniak-Vits, M; Kern, WV				Bohnert, Juergen A.; Schuster, Sabine; Szymaniak-Vits, Magdalena; Kern, Winfried V.			Determination of Real-Time Efflux Phenotypes in Escherichia coli AcrB Binding Pocket Phenylalanine Mutants Using a 1,2 '-Dinaphthylamine Efflux Assay	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; PUMP ACRB; MULTIDRUG; MECHANISM; INHIBITORS	To evaluate the importance of phenylalanine residues for substrate transport in the Escherichia coli efflux pump protein AcrB, we subjected Phe-to-Ala binding pocket mutants to a real-time efflux assay with the novel near-infrared lipophilic membrane probe 1,2'-dinaphthylamine (1,2'-DNA). All mutations, with the exception of F617A, led to considerable retardation of efflux. F610A was the point mutation with the most pronounced impact, followed by F628A, F615A, F136A, and F178A. This is the first study to demonstrate the importance of single phenylalanine residues within the AcrB binding pocket for real-time substrate transport.	[Bohnert, Juergen A.; Schuster, Sabine; Szymaniak-Vits, Magdalena; Kern, Winfried V.] Univ Freiburg, Dept Med, Univ Hosp, Ctr Infect Dis & Travel Med, D-7800 Freiburg, Germany	University of Freiburg	Bohnert, JA (corresponding author), Univ Freiburg, Dept Med, Univ Hosp, Ctr Infect Dis & Travel Med, D-7800 Freiburg, Germany.	juergen@bohnert.name		Schuster, Sabine/0000-0002-8817-6224	University of Freiburg	University of Freiburg	The work was funded by the University of Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohnert JA, 2010, ANTIMICROB AGENTS CH, V54, P3770, DOI 10.1128/AAC.00620-10; Bohnert JA, 2007, J ANTIMICROB CHEMOTH, V59, P1216, DOI 10.1093/jac/dkl426; Bohnert JA, 2008, J BACTERIOL, V190, P8225, DOI 10.1128/JB.00912-08; Jellen-Ritter AS, 2001, ANTIMICROB AGENTS CH, V45, P1467, DOI 10.1128/AAC.45.5.1467-1472.2001; Kalchenko V, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2364903; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Mao WM, 2002, MOL MICROBIOL, V46, P889, DOI 10.1046/j.1365-2958.2002.03223.x; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nagano K, 2009, P NATL ACAD SCI USA, V106, P5854, DOI 10.1073/pnas.0901695106; Nikaido H, 1998, CLIN INFECT DIS, V27, pS32, DOI 10.1086/514920; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007	13	31	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21196	10.1371/journal.pone.0021196	http://dx.doi.org/10.1371/journal.pone.0021196			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21698261	Green Published, Green Submitted, gold			2022-12-25	WOS:000291730000060
J	Yang, J; Liang, SY; Zhang, Y				Yang, Jing; Liang, Siyang; Zhang, Yi			Travelling Waves of a Delayed SIR Epidemic Model with Nonlinear Incidence Rate and Spatial Diffusion	PLOS ONE			English	Article							PREDATOR-PREY SYSTEM; GLOBAL STABILITY; STAGE STRUCTURE; TIME-DELAY; DEPENDENCE; FRONTS; TERMS	This paper is concerned with the existence of travlelling waves to a SIR epidemic model with nonlinear incidence rate, spatial diffusion and time delay. By analyzing the corresponding characteristic equations, the local stability of a disease-free steady state and an endemic steady state to this system under homogeneous Neumann boundary conditions is discussed. By using the cross iteration method and the Schauder's fixed point theorem, we reduce the existence of travelling waves to the existence of a pair of upper-lower solutions. By constructing a pair of upper-lower solutions, we derive the existence of a travelling wave connecting the disease-free steady state and the endemic steady state. Numerical simulations are carried out to illustrate the main results.	[Yang, Jing; Zhang, Yi] Hebei Med Univ, Dept Physiol, Shijiazhuang, Peoples R China; [Liang, Siyang] Beijing Inst Technol, Beijing 100081, Peoples R China	Hebei Medical University; Beijing Institute of Technology	Yang, J (corresponding author), Hebei Med Univ, Dept Physiol, Shijiazhuang, Peoples R China.	zhyhenry@sina.cn	Anderson, Alisha/C-1499-2008	Anderson, Alisha/0000-0001-7013-116X	National Natural Science Foundation of China [31071002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (No. 31071002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON C, 1976, MATH PROC CAMBRIDGE, V80, P315, DOI 10.1017/S0305004100052944; BERETTA E, 1995, J MATH BIOL, V33, P250, DOI 10.1007/BF00169563; Cooke K. L., 1979, ROCKY MT J MATH, V9, P31, DOI [10.1216/RMJ-1979-9-1-31, DOI 10.1216/RMJ-1979-9-1-31]; Fuentes MA, 1999, PHYSICA A, V267, P471, DOI 10.1016/S0378-4371(99)00027-8; Ge ZH, 2009, NONLINEAR ANAL-REAL, V10, P1691, DOI 10.1016/j.nonrwa.2008.02.007; Ge ZH, 2009, APPL MATH MODEL, V33, P1356, DOI 10.1016/j.apm.2007.09.037; HUANG J, 2006, ACTA MATH APPL SIN-E, V22, P243; Jianhong Wu, 2001, Journal of Dynamics and Differential Equations, V13, P651, DOI 10.1023/A:1016690424892; Kim KI, 2010, NONLINEAR ANAL-REAL, V11, P313, DOI 10.1016/j.nonrwa.2008.11.015; Kuperman MN, 1999, PHYSICA A, V272, P206, DOI 10.1016/S0378-4371(99)00284-8; Leung A.W., 1989, SYSTEMS NONLINEAR PA; Li WT, 2006, NONLINEARITY, V19, P1253, DOI 10.1088/0951-7715/19/6/003; Ma WB, 2004, APPL MATH LETT, V17, P1141, DOI 10.1016/j.aml.2003.11.005; Maidana NA, 2009, J THEOR BIOL, V258, P403, DOI 10.1016/j.jtbi.2008.12.032; Murray J. D., 1989, MATH BIOL, DOI DOI 10.1007/978-3-662-08539-4; NOBLE JV, 1974, NATURE, V250, P276; Peng R, 2009, NONLINEAR ANAL-THEOR, V71, P239, DOI 10.1016/j.na.2008.10.043; Saccomandi G, 1997, MATH COMPUT MODEL, V25, P83, DOI 10.1016/S0895-7177(97)00096-4; Sazonov I, 2011, MATH MED BIOL, V28, P165, DOI 10.1093/imammb/dqq016; Sazonov I, 2008, MATH MODEL NAT PHENO, V3, P28, DOI 10.1051/mmnp:2008069; Takeuchi Y, 2000, NONLINEAR ANAL-THEOR, V42, P931, DOI 10.1016/S0362-546X(99)00138-8; Taylor ML, 2009, J MATH BIOL, V59, P841, DOI 10.1007/s00285-009-0256-9; Wu J., 1998, CANAD APPL MATH Q, V6, P397; Xu R, 2009, NONLINEAR ANAL-REAL, V10, P3175, DOI 10.1016/j.nonrwa.2008.10.013; Zeidler E., 1986, NONLINEAR FUNCTIONAL	25	144	145	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21128	10.1371/journal.pone.0021128	http://dx.doi.org/10.1371/journal.pone.0021128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21912618	gold, Green Published			2022-12-25	WOS:000292036900011
J	Li, W; Zhu, S; Li, JH; Huang, Y; Zhou, RR; Fan, XG; Yang, HA; Gong, X; Eissa, NT; Jahnen-Dechent, W; Wang, P; Tracey, KJ; Sama, AE; Wang, HC				Li, Wei; Zhu, Shu; Li, Jianhua; Huang, Yan; Zhou, Rongrong; Fan, Xuegong; Yang, Huan; Gong, Xing; Eissa, N. Tony; Jahnen-Dechent, Willi; Wang, Ping; Tracey, Kevin J.; Sama, Andrew E.; Wang, Haichao			A Hepatic Protein, Fetuin-A, Occupies a Protective Role in Lethal Systemic Inflammation	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; HUMAN ALPHA-2-HS GLYCOPROTEIN; ACUTE-PHASE PROTEIN; IFN-GAMMA; EXPERIMENTAL SEPSIS; BOVINE FETUIN; APOPTOTIC CELLS; TYROSINE KINASE; HMGB1 RELEASE; BACTERIAL-DNA	Background: A liver-derived protein, fetuin-A, was first purified from calf fetal serum in 1944, but its potential role in lethal systemic inflammation was previously unknown. This study aims to delineate the molecular mechanisms underlying the regulation of hepatic fetuin-A expression during lethal systemic inflammation (LSI), and investigated whether alterations of fetuin-A levels affect animal survival, and influence systemic accumulation of a late mediator, HMGB1. Methods and Findings: LSI was induced by endotoxemia or cecal ligation and puncture (CLP) in fetuin-A knock-out or wildtype mice, and animal survival rates were compared. Murine peritoneal macrophages were challenged with exogenous (endotoxin) or endogenous (IFN-gamma) stimuli in the absence or presence of fetuin-A, and HMGB1 expression and release was assessed. Circulating fetuin-A levels were decreased in a time-dependent manner, starting between 26 h, reaching a nadir around 24-48 h, and returning towards base-line approximately 72 h post onset of endotoxemia or sepsis. These dynamic changes were mirrored by an early cytokine IFN-gamma-mediated inhibition (up to 50-70%) of hepatic fetuin-A expression. Disruption of fetuin-A expression rendered animals more susceptible to LSI, whereas supplementation of fetuin-A (20100 mg/kg) dose-dependently increased animal survival rates. The protection was associated with a significant reduction in systemic HMGB1 accumulation in vivo, and parallel inhibition of IFN-gamma or LPS-induced HMGB1 release in vitro. Conclusions: These experimental data suggest that fetuin-A is protective against lethal systemic inflammation partly by inhibiting active HMGB1 release.	[Li, Wei; Zhu, Shu; Li, Jianhua; Huang, Yan; Zhou, Rongrong; Yang, Huan; Wang, Ping; Tracey, Kevin J.; Sama, Andrew E.; Wang, Haichao] Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Li, Wei; Zhu, Shu; Sama, Andrew E.; Wang, Haichao] N Shore Univ Hosp, Dept Emergency Med, Manhasset, NY USA; [Huang, Yan; Zhou, Rongrong; Fan, Xuegong] Cent S Univ, Xiangya Hosp, Dept Infect Dis, Changsha, Hunan, Peoples R China; [Gong, Xing; Eissa, N. Tony] Baylor Coll Med, Pulm Crit Care & Sleep Med Sect, Houston, TX 77030 USA; [Jahnen-Dechent, Willi] RWTH Aachen Univ Hosp, Dept Biomed Engn, Biointerface Lab, Aachen, Germany	Northwell Health; Northwell Health; North Shore University Hospital; Central South University; Baylor College of Medicine; RWTH Aachen University; RWTH Aachen University Hospital	Li, W (corresponding author), Feinstein Inst Med Res, Manhasset, NY 11030 USA.	hwang@nshs.edu	Wang, Haichao/AAU-2237-2021; Jahnen-Dechent, Willi/A-7608-2011	Wang, Haichao/0000-0002-0211-9000; Wang, Ping/0000-0002-1557-0394; Jahnen-Dechent, Willi/0000-0003-1315-4407; Li, Wei/0000-0002-7941-7022; Tracey, Kevin J/0000-0003-1884-6314	National Institute of General Medical Sciences [R01GM063075, R01GM070817]; National Center for Complementary & Integrative Health [R01AT005076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062508, R01GM070817, R01GM063075] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (R01GM063075 and R01GM070817 to HW.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Ao LH, 2009, AM J PHYSIOL-HEART C, V297, pH21, DOI 10.1152/ajpheart.00292.2009; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Chen GQ, 2005, J LIPID RES, V46, P623, DOI 10.1194/jlr.C400018-JLR200; Chen GQ, 2004, J LEUKOCYTE BIOL, V76, P994, DOI 10.1189/jlb.0404242; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chmiela M, 1997, GUT, V40, P20, DOI 10.1136/gut.40.1.20; CHRISTIE DL, 1987, FEBS LETT, V214, P45, DOI 10.1016/0014-5793(87)80010-8; DAVEAU M, 1988, FEBS LETT, V241, P191, DOI 10.1016/0014-5793(88)81059-7; Demetriou M, 1996, J BIOL CHEM, V271, P12755, DOI 10.1074/jbc.271.22.12755; Deriy LV, 2002, SHOCK, V17, P312, DOI 10.1097/00024382-200204000-00013; DOHERTY GM, 1992, J IMMUNOL, V149, P1666; Dubreuil JD, 2002, MICROBIOL MOL BIOL R, V66, P617, DOI 10.1128/MMBR.66.4.617-629.2002; DZIEGIELEWSKA KM, 1992, J COMP PHYSIOL B, V162, P168, DOI 10.1007/BF00398343; Dziegielewska KM, 1998, IMMUNOL LETT, V60, P31, DOI 10.1016/S0165-2478(97)00126-0; Dziegielewska KM, 1995, FETUIN, P1; Fan J, 2007, J IMMUNOL, V178, P6573, DOI 10.4049/jimmunol.178.10.6573; HAASEMANN M, 1991, BIOCHEM J, V274, P899, DOI 10.1042/bj2740899; HEINZEL FP, 1990, J IMMUNOL, V145, P2920; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Jersmann HPA, 2003, CLIN SCI, V105, P273, DOI 10.1042/CS20030126; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Li W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001153; Li W, 2007, J IMMUNOL, V178, P3856, DOI 10.4049/jimmunol.178.6.3856; Li YH, 2009, AM J PHYSIOL-REG I, V297, pR1670, DOI 10.1152/ajpregu.00445.2009; Lord JM, 2003, CLIN SCI, V105, P267, DOI 10.1042/CS20030177; Mathews ST, 1997, LIFE SCI, V61, P1583, DOI 10.1016/S0024-3205(97)00737-6; OHNISHI T, 1993, J BONE MINER RES, V8, P367; Ombrellino M, 2001, SHOCK, V15, P181, DOI 10.1097/00024382-200115030-00004; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rendon-Mitchell B, 2003, J IMMUNOL, V170, P3890, DOI 10.4049/jimmunol.170.7.3890; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Su X, 2008, BBA-MOL CELL RES, V1783, P1623, DOI 10.1016/j.bbamcr.2008.04.009; SUZUKI M, 1994, J EXP ZOOL, V270, P501, DOI 10.1002/jez.1402700603; Szweras M, 2002, J BIOL CHEM, V277, P19991, DOI 10.1074/jbc.M112234200; Tang DL, 2009, AM J RESP CELL MOL, V41, P651, DOI 10.1165/rcmb.2008-0119OC; Tuttolomondo A, 2010, ATHEROSCLEROSIS, V208, P290, DOI 10.1016/j.atherosclerosis.2009.07.032; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang HC, 2010, J CEREBR BLOOD F MET, V30, P493, DOI 10.1038/jcbfm.2009.247; Wang HC, 2009, SHOCK, V32, P348, DOI 10.1097/SHK.0b013e3181a551bd; Wang Haichao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000884; Wang HC, 2006, J NUTR, V136, P360, DOI 10.1093/jn/136.2.360; Wang HC, 1997, LANCET, V350, P861, DOI 10.1016/S0140-6736(05)62030-2; Wang HC, 2004, NAT MED, V10, P124, DOI 10.1038/nm0204-124; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Weikert C, 2008, CIRCULATION, V118, P2555, DOI 10.1161/CIRCULATIONAHA.108.814418; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang SL, 2002, ANN SURG, V236, P625, DOI 10.1097/00000658-200211000-00013; Yin KS, 2005, SHOCK, V24, P396, DOI 10.1097/01.shk.0000175556.03300.c6; Zhu S, 2009, MOL MED, V15, P275, DOI 10.2119/molmed.2009.00062	57	262	275	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16945	10.1371/journal.pone.0016945	http://dx.doi.org/10.1371/journal.pone.0016945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347455	gold, Green Submitted, Green Published			2022-12-25	WOS:000287077600035
J	Wang, QY; Chen, GR; Perc, M				Wang, Qingyun; Chen, Guanrong; Perc, Matjaz			Synchronous Bursts on Scale-Free Neuronal Networks with Attractive and Repulsive Coupling	PLOS ONE			English	Article							SYNCHRONIZATION; OSCILLATIONS; REGULARIZATION; CHAOS	This paper investigates the dependence of synchronization transitions of bursting oscillations on the information transmission delay over scale-free neuronal networks with attractive and repulsive coupling. It is shown that for both types of coupling, the delay always plays a subtle role in either promoting or impairing synchronization. In particular, depending on the inherent oscillation period of individual neurons, regions of irregular and regular propagating excitatory fronts appear intermittently as the delay increases. These delay-induced synchronization transitions are manifested as well-expressed minima in the measure for spatiotemporal synchrony. For attractive coupling, the minima appear at every integer multiple of the average oscillation period, while for the repulsive coupling, they appear at every odd multiple of the half of the average oscillation period. The obtained results are robust to the variations of the dynamics of individual neurons, the system size, and the neuronal firing type. Hence, they can be used to characterize attractively or repulsively coupled scale-free neuronal networks with delays.	[Wang, Qingyun] Beihang Univ, Dept Dynam & Control, Beijing, Peoples R China; [Chen, Guanrong] City Univ Hong Kong, Dept Elect Engn, Hong Kong, Hong Kong, Peoples R China; [Perc, Matjaz] Univ Maribor, Fac Nat Sci & Math, Dept Phys, SLO-2000 Maribor, Slovenia	Beihang University; City University of Hong Kong; University of Maribor	Wang, QY (corresponding author), Beihang Univ, Dept Dynam & Control, Beijing, Peoples R China.	drwangqy@gmail.com; matjaz.perc@uni-mb.si	wang, qinyu/GYA-0366-2022; Wang, Qingyun/G-2309-2010; Chen, Guanrong/F-6000-2011; Perc, Matjaz/A-5148-2009	Wang, Qingyun/0000-0003-2931-4663; Chen, Guanrong/0000-0003-1381-7418; Perc, Matjaz/0000-0002-3087-541X; Zhang, Min/0000-0001-5812-9518	National Science Foundation of China [10972001, 10702023, 10832006]; Slovenian Research Agency [Z1-2032]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	QW and GC acknowledge support from the National Science Foundation of China (Funds number 10972001, 10702023 and 10832006). MP acknowledges support from the Slovenian Research Agency (Grant Z1-2032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel H. D. I., 1996, Physics-Uspekhi, V39, P337, DOI 10.1070/PU1996v039n04ABEH000141; Achuthan S, 2009, J NEUROSCI, V29, P5218, DOI 10.1523/JNEUROSCI.0426-09.2009; Arenas A, 2006, PHYSICA D, V224, P27, DOI 10.1016/j.physd.2006.09.029; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batista CAS, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.016218; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; Belykh I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.188101; DAVID G, 2001, PHYS REV LETT, V86, P4179; Drover J, 2004, SIAM J APPL MATH, V65, P69, DOI 10.1137/S0036139903431233; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Gao Z., 2001, PHYS REV E, V65, DOI DOI 10.1103/PHYSREVE.65.016209; Gomez-Gardenes J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012313; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huang L, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016103; Huang L, 2008, CHAOS, V18, DOI 10.1063/1.2826289; Hunt D, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.068701; Kaiser M, 2007, EUR J NEUROSCI, V25, P3185, DOI 10.1111/j.1460-9568.2007.05574.x; Kandel E.R., 1991, PRINC NEUROSCI; Kitajo K, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/40009; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; Kryukov AK, 2008, CHAOS, V18, DOI 10.1063/1.2956985; Kunichika T., 2003, INT J BIFURCAT CHAOS, V13, P653; Lai YC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108102; Leyva I, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056112; Li XM, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083045; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Neiman A, 1999, PHYS REV LETT, V83, P4896, DOI 10.1103/PhysRevLett.83.4896; Nowotny T, 2008, CHAOS, V18, DOI 10.1063/1.2949925; Oh M, 2009, J COMPUT NEUROSCI, V26, P303, DOI 10.1007/s10827-008-0112-8; Osan R, 2002, PHYSICA D, V163, P217, DOI 10.1016/S0167-2789(02)00347-0; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Raichman N, 2008, J NEUROSCI METH, V170, P96, DOI 10.1016/j.jneumeth.2007.12.020; Rossoni E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061904; Roxin A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.238103; Rulkov NF, 2004, J COMPUT NEUROSCI, V17, P203, DOI 10.1023/B:JCNS.0000037683.55688.7e; Rulkov NF, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041922; Rulkov NF, 2001, PHYS REV LETT, V86, P183, DOI 10.1103/PhysRevLett.86.183; Sainz-Trapaga M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031904; Shein M, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036008; Shilnikov AL, 2003, INT J BIFURCAT CHAOS, V13, P3325, DOI 10.1142/S0218127403008521; Stephens GJ, 2010, P NATL ACAD SCI USA, V107, P14425, DOI 10.1073/pnas.1008662107; Suykens JAK, 2008, CHAOS, V18, DOI 10.1063/1.2985139; Martins TV, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041103; Volman V, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043013; Wang QY, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/10/383; Wang QY, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/10004; Wang QY, 2006, PHYS LETT A, V356, P17, DOI 10.1016/j.physleta.2006.03.017; Wang QY, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/50008; Wang QY, 2005, CHINESE PHYS LETT, V22, P543, DOI 10.1088/0256-307X/22/3/007; Yanagita T, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056218	56	311	316	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15851	10.1371/journal.pone.0015851	http://dx.doi.org/10.1371/journal.pone.0015851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21701596	Green Published, gold, Green Submitted			2022-12-25	WOS:000286511900014
